<SEC-DOCUMENT>0001613103-20-000051.txt : 20201203
<SEC-HEADER>0001613103-20-000051.hdr.sgml : 20201203
<ACCEPTANCE-DATETIME>20201203161510
ACCESSION NUMBER:		0001613103-20-000051
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		109
CONFORMED PERIOD OF REPORT:	20201030
FILED AS OF DATE:		20201203
DATE AS OF CHANGE:		20201203

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Medtronic plc
		CENTRAL INDEX KEY:			0001613103
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36820
		FILM NUMBER:		201367077

	BUSINESS ADDRESS:	
		STREET 1:		20 ON HATCH, LOWER HATCH STREET
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2
		BUSINESS PHONE:		01135314381700

	MAIL ADDRESS:	
		STREET 1:		20 ON HATCH, LOWER HATCH STREET
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Medtronic Ltd
		DATE OF NAME CHANGE:	20150112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Medtronic Holdings Ltd
		DATE OF NAME CHANGE:	20140711

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kalani I Ltd
		DATE OF NAME CHANGE:	20140709
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mdt-20201030.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:8939d385-98d2-4684-bfa0-0279309cacd9,g:e5f1341e-11f4-4035-86fa-7f937a6230d9,d:6128593e20e44bbc8b0671c482ec9b79--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:mdt="http://www.medtronic.com/20201030" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mdt-20201030</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M18zLTEtMS0xLTA_9321cd5b-51ea-4d06-9d77-2488f92861a4">Medtronic plc</ix:nonNumeric><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M180LTEtMS0xLTA_e6cf4e76-9a88-4ca4-bf98-6f9064b19220">0001613103</ix:nonNumeric><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M181LTEtMS0xLTA_3a199808-add8-4cd5-b19a-d079073a87c8">--04-30</ix:nonNumeric><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M182LTEtMS0xLTA_95544cc1-08c3-48ff-a2ce-8cd4a6b39aaa">false</ix:nonNumeric><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M183LTEtMS0xLTA_6ade8fc8-f105-4cc7-affb-b46f95c96465">Q2</ix:nonNumeric><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M184LTEtMS0xLTA_3c4fd062-835c-4dca-a606-c7e5b026995a">2021</ix:nonNumeric><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M185LTEtMS0xLTA_98165042-0457-4fbd-8530-01ffde9c080d">D02 XH02</ix:nonNumeric><ix:nonNumeric contextRef="ib96559476e2e42589c348e36cfd88199_D20180428-20190426" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMC0xLTEtMA_dcfb84c1-15e9-41b1-a86c-3cf4872b75bf">us-gaap:AccountingStandardsUpdate201602Member</ix:nonNumeric><ix:nonNumeric contextRef="i1d2d81b4b2be47f6a03325d659a6d72c_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS04NDc2L3RleHRyZWdpb246MzI5ZGJlZDllYWVkNDA2YWI5MDdiMTQ4NzNkNWQxZDZfNzY5NjU4MTM5NDQ3OA_1fc66852-89e8-4b7b-81e1-6369f8dd3419">P7Y</ix:nonNumeric><ix:nonNumeric contextRef="i5d89dd5c6578482489f58901b2ece021_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS03MDUxL3RleHRyZWdpb246Zjg2ZWM0YTg4NDI3NGFhOWI0ZGJmYWViM2QzZThlZjBfNzY5NjU4MTM5NDQ3OA_0f544188-5492-43f0-8466-e9aa66f80bd2">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="i8d3143e089ba4dedb2736c33c618581e_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS03MDU5L3RleHRyZWdpb246M2VjNzUyNTAyZmE1NDIzNWE0OWI2YzNhZTZlZGEyM2JfMTU_434d6196-cd71-423f-b1c6-94ab8fd6f545">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="idb442835a80449de9586e9b37e7d2fa5_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS0wL3RleHRyZWdpb246NjI0ZTZhYTM4MjA3NGI3ZDhkOTYyYWNiZjQ4NDUyNjVfMTU_4e71358d-8a7e-40b6-8487-19339f167751">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="ib19d6634ce714827868d024d9dcd796f_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS02NTEyL3RleHRyZWdpb246ZWM4Njk1YWJlNjBlNGViOTg3ZWU3MjczM2E3NGIzODJfNzY5NjU4MTM5NDQ5NA_f18bfa88-ad2a-419f-b369-44b60f7697ef">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="ib3b2928adcf54c788d62edf96564e9d1_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS0wL3RleHRyZWdpb246ZTc2YTM4MTBiNTI1NDMyYzkwY2FhNTg2ZWNhYmU0ZjJfMTU_7216313b-f8c0-40e6-99ac-4a1d7fa40514">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="i951264b62a9e4692b9bd3d00cdf796f4_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfOS0wLTEtMS0wL3RleHRyZWdpb246NDM3NzdkMzViODVmNDM1NTlmNjI1MGRlNTNjYjIyNTZfMTU_73fcdfe3-1699-4e4e-a1b3-6abc413aba37">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="i500cfbc200ff4165a5a6b3019322c7fa_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjBkZGE4M2Y1MTQ5YTQ2NWNiYTYyNGI3YzQ2Y2FmOTc2XzE1_3cf05ffe-b2a6-4335-96b8-f9d8eb8335a3">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="i067a568cac5e437685072c3a831fcb18_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjMwZDAzODE1ZTQ2YjQ0MGI5YWRkOGIyNjE4NjI1MTY4XzE1_5a8917d8-b557-4f27-97d0-e5d0ca330706">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="i3ea8b5906172403087cb9b21adb1404c_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjY4MTNkM2VlNGE3MjQ2MzQ5ZGY4NjgzMGRjNjA5ZmI2XzE1_dd01a2f7-a10b-4245-962c-1c722b265da7">P7Y</ix:nonNumeric><ix:nonNumeric contextRef="i8fd93231ec0d40e7a081151b1edbb42e_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtNjUzMS90ZXh0cmVnaW9uOjY5NDIwNWJkNjIxNDQzYTE5ZmI3NGVmZDI1MzkyOTgzXzc2OTY1ODEzOTQ0OTU_7e8547d7-3068-4d97-88c7-8a5e777cd5be">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i9b0d659e4c6a464fbf2ba9f69ce97fe0_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjVlMTZkMTQyM2ZlNjQ1ZTRiMzQzYjA0ZWU5YzMwZThhXzE1_aeaca299-dcdb-4b89-b32d-ea5647d9bdae">P8Y</ix:nonNumeric><ix:nonNumeric contextRef="i2670923c73ce43568a500471620aded0_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjUwOWNjZGNhZTZjYzQ4NTBiNjg1YmNjMDYwZTVkYWYwXzE1_6c38aec9-7242-49e4-a3a0-97185e834427">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="i88732c4da6c743a0af188e6a1f418126_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtNjU1MS90ZXh0cmVnaW9uOjZiZjEyYmVlZGI5NTQwYzQ5N2ZiNTc3OGJmMjk5MmM1Xzc2OTY1ODEzOTQ0ODk_3f1d490f-a710-44cb-aa4c-f5db8f0fa208">P8Y</ix:nonNumeric><ix:nonNumeric contextRef="i234bad29861943d29016c98eaae4756d_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOmQ1YTI2NTk1ZGQ3OTRmYjU4YmUzYjRhZDFmMjE1ZDk1XzE1_5b30e37a-feeb-41bf-b826-7121e730e737">P12Y</ix:nonNumeric><ix:nonNumeric contextRef="if0d67cdde98740db854f9c8a7ce28877_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjZmZDA0ZmIzNjYyNDQ3ZDY5ZjAwN2FlYTRlZjRhZGU4XzE1_932ae6cf-26e5-4bad-b22d-29b416b48b23">P13Y</ix:nonNumeric><ix:nonNumeric contextRef="i31c17a3e93a04f5dae5066f13f61ca5b_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtNjU2NC90ZXh0cmVnaW9uOjVjZTJlM2ZhNTQ5ZTQ4NjBhZmQyOGQxMDdmNDVkMTJmXzc2OTY1ODEzOTQ0OTk_c2fcbcbb-9062-4210-8500-cae9fda3b843">P12Y</ix:nonNumeric><ix:nonNumeric contextRef="i1101d7005cf341858d3178156e6689d8_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDA2NzRiOTUwOTQzMjViMjhlYTFkZGQ2YWFjNzY3XzE1_d33f3c62-a9b3-4939-acb6-efa5d1c533e4">P20Y</ix:nonNumeric><ix:nonNumeric contextRef="i3a1a36d6b7bd48309ca75990b50ebbf4_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTI3ZmUyY2I4NjRiODBiYjg3ZDEzZjgzNjI2NDEwXzE1_3ef70171-17bb-4da9-8dc5-bfdf0b5cd24e">P30Y</ix:nonNumeric><ix:nonNumeric contextRef="ib904bd0a37594de291e3a3b7199e4ea6_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjg1NzhjYzgwNmZjMzQ0NzNhNjczOTJiNGVlYjg5N2YwXzE1_3df5c742-c214-41f0-b3d0-5224780e9379">P20Y</ix:nonNumeric><ix:nonNumeric contextRef="i3136a8a092264e9fb60259353a08f685_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOmY0MDRlOGZmYTIyMTQzOWM4YmRlNWYyNWIwNjE1YjQ5XzE1_c2981a7f-89c2-4f44-9205-b4e86754b2c1">P30Y</ix:nonNumeric><ix:nonNumeric contextRef="i0cb1150cbdbc4d9fabc3a8722c52cd68_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtNzA2Ny90ZXh0cmVnaW9uOjEwMDFhY2UzNjJkYjRkNDNiZjc4NWIwMmU2MzVlY2U5XzE1_057deae6-4bb1-452e-b86a-80173d533019">P20Y</ix:nonNumeric><ix:nonNumeric contextRef="ib528782405ef426781d9bf2ee3a1488f_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjQ1ODFmMjY1ZmNmMjRjYzZiMmNlN2Q2MjViM2Q2NjA1XzE1_db79b77e-7b88-4758-a617-823b3f2a7b0c">P30Y</ix:nonNumeric><ix:nonNumeric contextRef="ica522c618bfb4a6e9eefa808b1383660_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtNjU3NC90ZXh0cmVnaW9uOjhlYTQ1NjhhOTU4YzQwNDU5M2NkMGY1YzdkMjQxYjZmXzc2OTY1ODEzOTQ0OTU_ef0d6972-d506-46e3-9082-3bddd7a7d890">P20Y</ix:nonNumeric><ix:nonNumeric contextRef="i5f438443ec234ccdbae9a060908aff2a_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlYTljZmNjYzNiOTQzODM5MzBkNWFhMDBkNmNhNWM4XzE1_df7243fa-33e3-441e-9e5c-0d5e8f72b28c">P30Y</ix:nonNumeric><ix:nonNumeric contextRef="ibe85b9a673d44ee8b743ecbca5126981_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjQtMC0xLTEtMC90ZXh0cmVnaW9uOjNhMmQ4M2U3MzY4YzQxYzBiYjk4NTU2YjA1ODJhYjA2XzE1_8015ac63-f366-4764-bf6a-46db806b09cf">P30Y</ix:nonNumeric><ix:nonNumeric contextRef="i837dd563301e43b3bc43f6ce023f2f56_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjg1ZmFkZGU0NTAyOTQ4OWFiZGI0NDVmMmNkN2Q2OTA5XzE1_194c751d-bc01-4752-9b92-6d1dd7b2c6bd">P30Y</ix:nonNumeric><ix:nonNumeric contextRef="i04b01691f1a24f5e9e29f783c2ea2c56_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOmY2MmI2NWE5YjUyMzRiN2NhYzMwNmRhNTRkZjFjNmE2XzE1_816125dd-3eea-4f07-9610-e050c2e8a8b8">P30Y</ix:nonNumeric><ix:nonNumeric contextRef="i7c4e4384f2a44e0d9f3213e1b69ff161_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmRjYTc3ZGQ5MTBlMTQzMWZiY2FmMGExNjI2ZjA1YzUyXzE1_affa4ede-4085-4b4a-8013-9f2c5a3af318">P30Y</ix:nonNumeric><ix:nonNumeric contextRef="i13912243cb92485aad14f40321031fa9_D20200425-20201030" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzMtMC0xLTEtNjU4Ni90ZXh0cmVnaW9uOjEzNTMyNGVhY2U0MTQ2NmJiN2EyYTcxMmI4MzcyMDI3Xzc2OTY1ODEzOTQ0OTU_ecf3e18f-537f-414b-994f-f458754db39a">P30Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mdt-20201030.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9690ac488cf0498597a1dee299c08d4a_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie597491265f54e5b83c5e498b9e5e35d_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2021FloatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if431af446740495eafa610045eee2dee_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6946ebb61b914bfa814743c0b4901fc9_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20230.375PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7de46d31eff94c88bf5224b071d2649f_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5b334ffdc574053ad9c42fd2a5e06d9_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fda69c384584c999349f0452905a004_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86350dcdf5e0430ab236aa4e72a95677_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib87a49f46e80456aaae50a2676d2b9c4_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd6d2a65b5a74087a9cd3322dafc9078_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20311.625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfc007fd29af4d10aae7f839ce84e9d0_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20311.00PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id98bb264c6ae40ce9fa7d1c6480a5695_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd770a2a644746b3a8f33af164792726_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20392.250PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bd98a03670c4e72ad51a2c7363e7490_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20391.50PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcfa923f30854b80900b6aea7decd075_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic21aaaba5ba242f4a805034963baca6d_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2049Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55564036473c42538449804d30b330bc_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i57886cddd4384344b30a7a72843fef41_I20201201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i56cbe72d4f164d52b063093c431c9843_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3e9504309af4083b6fd5bf477afa1c6_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic572c413537c418298b2634dbfaaf017_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd6a86ad9b714d9081642559e2ff2934_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c85755ec4074136b1ee5356437a2b17_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b5b7d170f3340e696de1c1470de9cdd_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b268c905e614cd0838cbabb6383cd70_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9156b821fc84f4eafacc70d98d9cd2b_D20200425-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6371626247f34091a93b2dc205920ab8_D20200425-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85c770bf95844dd9931cef47b1f7be43_D20200425-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i673be33df7fd4f9bbded121055267d0d_D20200425-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id71e33001d124f7794452cdccb09c623_D20200425-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if639f48dcce540048c90f61ab3fb7bc7_D20200425-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib94296a7b45e4e3dbe2d67900645d435_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib110981db8f14c9cb4cbb63889887dd7_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic409e1c550db48e5bcd4ce67616935c8_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72605901d1f74ce597b028c09d4dd3a7_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25a5dac7b3084d7a84a6335f68c0ceed_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id628b7deeefa46eba3e8cce6bf5edf04_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie418c42f639e4cb68a0a9bac1b9871d8_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie49fd01017d6410babb0baa6095d8df8_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90d56739612b4fba968994692f0deff1_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08ae410a74984dc0a1a2e5d64185b3a1_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69cfa6db80bb43d89a510e85d2efae77_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieedf1ec037a4442aaef3abd0076151d8_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i720289bbdf744d3c8b2dcfad03251c89_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if31334823c424f9c82c6d16a6bd8c729_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28dc26d87a9e4efaa4d5051ff8841788_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia21542305a5946e8b39788bc982841f6_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbe9b124d8ca41e981b8cf95b5ea6242_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i992522324432452d9ca66c8a4b298efd_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fb60693b842404b9c6c710c434a9f46_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if93a3ed7d08a4808a025b1a3549ab044_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i111f8934e3d049098d7b0406e926375e_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52de462b431c4555b295ebb144b8351f_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9126a007a995490e9cb89a8340e8a989_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i552f2062fa83483db3124c50e8e701c8_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idce4f3b26c5a4fefb9a2268a16c018e1_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2f9007fbf9043ab8f457f9c90c97961_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i488d2783b01647579ba73905fa797719_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33145a1d36f644e3a8066f41beb5b5e2_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fb0dd42a0a04276b76c07255e58b0db_D20190427-20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i044332ce225b4db4897be21e46da5d03_D20190427-20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28055ea3470d4effb3ed77de9befc2f5_D20190427-20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8308e83ae1a947b48941212c51887a44_D20190427-20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8759e14cc5034a7993bfef890b7d7418_D20190427-20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia87757d6c9d640d48a2c1a16626f5bc4_D20190427-20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i678e0b51f4cf4d5690b48a63a626a8cc_D20190427-20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib96559476e2e42589c348e36cfd88199_D20180428-20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-28</xbrli:startDate><xbrli:endDate>2019-04-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4484008ce40941a9abb0b87591c12b24_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59aafb40e1c3487fb79f88def0cabe5e_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93af46c007a64220a69e96a35444a4d0_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i275643f747c34984beeb90478e79ad20_I20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12ad7c520edd49219af398dc688a28c2_I20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27b17bf8998541b3b1a8eaadaa465cb5_I20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a33cca3e32b47bfa87a465de4ceb4fa_I20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieae2d147c0744537a2b2ec49b9cb4379_I20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c2221645f1143a588fcb530d45d397a_I20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b67d8b2f5e5423fab22a58594388040_I20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id40604cb0c8742fc840c198c66ddfbfe_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02207236d5774c39981a6d0d117258bb_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27b99796b29e40eabeac0a12c20105e4_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91d0e9197fce4eaea0b4d58bb59f7b58_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c4d81e283664aefab974994912b8be4_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52c82d1243664ffb830c526ef6fcaf0b_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ccab2a935344b5791bfcee3cae77ce7_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26eeffc415cf4e6b8336a920c96e512d_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a319d67f7224e6f8d72495027df5e84_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36754839d63e4461b94b37c7bae9a3fb_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77e3bce30a1c435e86c5538940a335df_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife38249405474a528870b8419d041fea_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20cd473a93b445c7a57a0c7284cf0cc7_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06dc9f6bc4aa419bbfe27b17af09fe0a_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i269fa9ffafa24ecebf48c60b39842dab_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91fb2eb368934993bcd7a0f9575fa788_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacc575534b9240399501f15b894e067a_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i487ad5972a2c47febec797b0e0776ddb_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryandStructuralHeartDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b5caf67e2be4f68ad7f92d16ada67f7_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryandStructuralHeartDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i919fa29680244ba4b8253a93aa18f460_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryandStructuralHeartDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia64dace9b6414c26928f6b70651158e4_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryandStructuralHeartDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id24613977cb54f098d9805b207b29a55_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:AorticPeripheralandVenousDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i220395ee33ee437396566fcc3626b2a2_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:AorticPeripheralandVenousDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic09f65a4d2d84a4c92acaac75a0e15d9_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:AorticPeripheralandVenousDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c9f4935fea44124bf3d4a1a49aa9040_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:AorticPeripheralandVenousDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a312d23d83d4502a1392fed0d7ba764_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3b239a3126a4bb49c5e7d5b60ab13f1_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ca6f74752024dcb8dbf523283f9b0ef_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05fc22c6d55b43f2baae1649a5d9aebe_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id48f0ff947294dd49ff34d19b294e672_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60c6177e6a344d759591f1b0f76cb5ba_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic752b9473c764500acd5730cdefe3be4_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bb60e8143094d27a9a05d4c84ead362_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id131618c7183472b800356aed3d45c7c_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83ca6860129f4055bed2c98b4ce69e3e_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4e72a8a6dab4f788a302f0f0cf79096_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bd062672d454f1e8a9d5bb8d4322a32_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b3758a87a354529882de9d3335644c0_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70d63caefd6b48e69f2a86e37189768c_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieac0a2b04a964cccb353c56583b8d073_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71d43d788d014fd7a1ba8bdea4691710_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide47cbfb7b0b4342bf4ea373f2ce909a_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief0f6318a0b04247be6884fe9e17d5b1_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb0ec325078447fab69eeca2bdca138e_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d27cd3056dc4459a2cc70f6dc711dff_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82f5d914dd8d4e04b7d2a35e01bb9bf3_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i313d0d047bd048469aa9949a611758d3_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fc4e1b636e5420f8ac12b6b27b04d28_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dccdf4f50614d0e9c893b4f40f55384_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9d5d26f5da740a198a88bb8f7973c42_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if53fca09d7ef4b848279a7fe2579e3d8_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4524b53e676148ca86cbcc0f07a84bb3_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93119b416ab149a386216f786e016df5_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec22bedaccaa44e19dc9acca8eff8a10_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4600b695100d4820a01604a104cbadaf_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79d7d6e72a3d4a20b5a5c636e920c38c_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15f5b5dfb4654786b8a1527a73a00fcd_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0be4b9113414c3d997bc3e01adfe216_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cf2e96e50c04872a16be9a18ec034d0_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i374e41da3175425682886e64b4e59ac7_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i852dbc45d1014705a3144b798acc4dfa_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbacdf5a92134ca0b1da1422f776402f_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4524b8f3efaf418c873e6e495a80bbc3_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35f7007d83ec443f927267bb6df4c0fc_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i537a942bf4fb4b6eb80e288f1c249edb_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f8e3cc16c4a404488402b32b4689b44_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaf5d087ffa84fa8abd5a5aa306fda7a_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b6321183ca146979a393ac5b3ac26a5_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7031548bb00d44e4984fe848fdd877ac_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95113ab22bfc47679021038cda3626d5_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide26e733fd264ebeac15b9b238bd8cb1_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1024da8bb25a4ecab9fdd229633f9fef_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82224f56dda849528eedfeb6a2648d87_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc5dc04ed0d044db9fb861aa2555e5b6_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc7c7a1e02fe46c59155bfc029734bd7_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6cce28fd6194e2c961aede987941a6c_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafacc4a2c7db427383b4b9439b78bf84_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6948db30839464bb1b8614f17820d69_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2db71be890924f94a20e986c13b7cfd0_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icba853bd219340caac53ef75115336f3_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d1f7d1f952b46de9a5ec5bf956f8c4a_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3a781a1a3014264be590e09689a0392_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ad14b6e2d99494ca8b0e3e32a58c09a_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i481e2bb36b4f4ad58fcf6c68706875aa_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if569aa4c250e4165a6f2453aded60f03_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e59a2f196984183a973f8905eda8c10_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc31344ce037435086c6584f0cbc5603_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c0b9d71f9af4be0bdef0b12e789d63a_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7976d05e19ea43479f40263835baa0f6_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief279681dad24d0ab1a402ba5b0534d8_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61edff06ccbe49e0923a8285fc14b9d8_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe51a58c91ff4d568cfa875dc418aa53_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id82317500d8042669bd53b4daa560b23_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a2cb34fbe86434d9d2e4abed35fa190_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9bd82a0a27841599fc9f6054adf2db0_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3c0e6b71596419bbee4ef75a287dfb0_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2589b11b8c8b419f90d2110eedd22e72_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0943ccf01b541bd8b688fa0231ab07d_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i857871df90664c4ea9084d7f52e58287_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad390d4335a84981b4dbe016e84fec16_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i221826c350e8440fa29609ad85dbfe00_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87f2d291a1d14c8da1ca068a8184f596_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d18cd69e527443cbb52344bfc5d1d17_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0def346fe6e84c4fa17ebb19cef19a26_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3bfd6d86b3b4f0fb2300c2d7f9d363f_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23af05bd2c5d45359d3998fa371a34ae_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaf607ee11904bcd9cf888c004bb4fb5_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9ae29ca0bdc4f73936473ec74e2520d_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91fc95de785c40258c208144bffa2343_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5940248053940f3ad40aa0896988543_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i359b10ddf4d64149867a3e367a9b382a_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i086f2718cdec44d5b96ebdb32ebdbe23_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i156b9ba3ff10454382c5d0aebee43dcf_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45d51c0af50d408484ec761c3c800e8c_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i706ca6327a9945bea2a852ef2e7fc4fb_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i650829f108154ef79219df52ed0dd76e_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e309488f2d44b4f90cf8c46966b9320_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0c73c0c36c949138a78ac8a9b55a7ea_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c94a76a97fb4905b120a4bc756ade5b_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cb21b8ecb894dc6b9eb7b6003425d7b_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15270ce2423347719255bea4dd215ab4_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ff95eb833ec4ac8a94740b1dc4672ec_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i201f7a25b37d4a639737b126db6b299c_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief6cc83a0158450c8c8c8dfb1b72cb01_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia759ed90b92c4979a7b3cae67b7f74fa_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27dc3723a0be438391652135f2101c29_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3302135c65a2484782311fd82ec693dd_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia659fbb5fcf346a9a90200d57a4a5578_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b0455f24d0b4a3791fb3fd9fc1efc9a_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5259c4355fa34167856c9efd29463eab_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie996b89b72df4251ba0beb6f36061915_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286b913f59ce44a89a6efc03a44edd01_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58932d951c2a4621825726d182be8121_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i894a513621284324b46eb9a6b6583b3b_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f58e96a62054a76beef660302748e4f_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6458efd12f3d493e954c2b482e7b1267_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied47c882b8944b9a824975e730d6084c_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f89188c42c54dea947302b6c32918d2_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieea3c92fd22346e3ba0cbae8446c3146_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36b61101ccc34fe1a098c7a0a1438f56_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a9f49019242491fa2753b5c0b454587_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23fc05bb0ae84039aed38c9e14a8d9ba_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4420ff33a4ea4338b79bc63a916e8eaa_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i206d5cfac8764545b5c73b964083df22_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3e605d554a34a48aafc28f4aec2bc10_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6686b72c8d254c0a8ae89c915b162323_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e362e921abc4ec38c51136161f1dd32_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b72725bfde146b59806f55b4de68183_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mdt:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf29640eead0423b8af20621f7e82a6e_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mdt:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6796994ca7b1457ea2f0996b5fda014e_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mdt:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17f40c5d5c144485bcaae9a942364fe9_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4628c29036454d5fa0fc10c68641fb73_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i478c6a017fc349f59ff0568390ff4f01_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i294a126245e1491797b98713fe0945c9_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mdt:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc28c29bd1fa43b782141ceb32766ec0_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mdt:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4bab39e35944924a3cd9ffc1393059f_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mdt:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie19586da83c548419c65ce54dda4ac85_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:PreTaxExitandDisposalCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i593837cb940d49fa93ab3e7716b6faa5_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:PreTaxExitandDisposalCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i406d848cd3404dd991012a6440565838_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87f3513e1ffc40c7bede0ba00efe2ed4_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc70a688a0d74e63819c4ade21969f2d_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95902727c56e4c2290a1ca75aaa9d4ee_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i882643c31d764908a9b439838cdcac4e_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfe2201ad4e547e4a67d546069665441_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7a56850c3644238ba02de19c9b1c11b_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf9700f41544535a38b9d85f3853147_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b1e1f29dda94d8db00dc1fb059072d7_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2040f3b39be34880bc79b81b3bbcd824_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3654a2c834ae4cf7b134b2e121f5c339_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68f172d54ac643f69996cb767c6659f4_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3cc36b2ab0b40f69449ff35ae8ea230_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedfe76d8c426489e9bea058060893444_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i351e8abc52b741a6b52e469c40e2e761_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1da6f2608bec495282ec262dc76cf183_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5464a7ffeef4485685b5fd1e3a463e37_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63278b6a1dd844309858a5b5ee35779e_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5616aebc236a4e4d97246ff6cb32b98b_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94f2a1c0fa6447faa4ffa5ae06ecf9a6_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib247e010f8064236b932fbe29a46c299_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia24d860e2e7247b88d59a33bffba5d44_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c765c8437494e3bb8ad2b29a7d4886a_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f09f557003848f4b76b538b6807be01_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:PreTaxExitandDisposalCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if533fbb2e7804a49bd733441ec860383_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:PreTaxExitandDisposalCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19b7c0d54b864709b8a1d14cc7a5d52d_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b3a4116ab3044c5a696abbccd7ee5d6_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebed8f31e2bc4cb98986dd61dcc84584_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia114c5bf3f0c4db3be119ae9d303c54c_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f140a7453f54937a77f1945a683e562_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3619e5e7c1d747c897276367eac949cc_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied9a45419b034ba293d451d739803159_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1327a9ff18894e94bd64778ed9244151_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ee1ecb91f93417abbd820fb1b9263dd_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d94b407eb34ffcb5ba920befb20402_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief7515addc7a424bb17ccbb5efd1bcc0_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i443dc4a6e4e7449cb7687aaf2b213890_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i245f5fb276724559bcadde6864aa9761_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia14e107ca6b34c7aa82198c4055050a7_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20efc4b8d5624a738f090883fed2d123_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e3d9441863d40fe83d2a6994feb032d_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4320454dbec403185b511f1c64206cd_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2231b706751d46d79c1f65ba057fbb62_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aa2e63b28634ba9a0d5b4373eb935d8_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22d5b93a4050490ba354a793fe73ddce_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie865d31224d248118707ff2a738a5f53_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic589592a3ea647eb82528ebff28b6c83_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i678b3811da1f402d875ac6b3061da9aa_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35bc96620aae4f20b504721d4972a52c_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if998b6ae16134f37a39d249efcbcc3f7_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83e463dc1191437ca3f924fd6bd29a84_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f069030f0a3460c8d945b8cd90214d7_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46c2eb1479d44550a2ab2d69a99636f3_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i929d7ecd50044541af233ec2313878da_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fb2f890b1ec4198b387f05c2c65bc8c_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8afc49c379f449b49731bf51824ea01f_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50ab07cf2ffc404da2ed9d85ac2200c8_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia06764135b2b4cd0a275054067eb22ca_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i111933045e354d4f8658708753547778_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1db728fe13014c45b129b04929119976_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15721ef42f5a4b64a1a941878d5e80bd_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i126bbe583d1b40e989cd54f8bc8b5fdb_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89cf40cd27a43f2829d8c0220e90d7b_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0af3ac423bf349678613c24c3b8a11a2_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i028f280fa1334ede95f2032c53ba9603_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52d4f679d87a43208fe9aa6ceee5a507_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f41bbdd83db46cb896344dc0006b64d_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5844ce5002374c9ca4435645ef347572_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c4a3739c026430f9cb994dd2f7f80e0_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8a65bbd4df441ffbbe386c670a74731_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15191dfa528f4503a0e2853a1733b631_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a12fc35b75d4ccf8c6c5a6b5f9df288_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f385943a6ed411da591a03f5bc3abb5_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90b3cafb39ad43129046e5127bb34a7b_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32cab75680864139a62ff1b5cebde24d_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf012b1a7edb49289534410a88491a96_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6697a4efd1dc4d249dcfab34c0f70d31_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3978608b42c04cc5af43262c255f20e6_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i463d7b834e2145ad88a0dc521b32cb6e_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30fd371d44e44ab2b7a26ae857aed3d8_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i355296bb1c604ce98363ad84c2d4096b_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa3a8fa30d954c43b8b42c71861c0bae_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0380d38afb13425093e55e205d427bd7_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f7ad3736e1640118162dc647a316234_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7af353247eb47508c8e5a3b145eee36_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac8769618c434a12a6120cf93b18a7cb_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d8fc61f591a4b00a4f09dbee10c57e3_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80fccbbafaac424ba13d8f2e11e26efb_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6433dc1e1b474da0b55da283f18ec450_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79d2f91d85114433aa75b3dde1c711d7_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ba52b8426984dcca753b63310d1ba95_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2870ad45d3744aacaab561141a1ede79_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fa258e7bccc4d1d9172fc22def7a0d3_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i235a5116037045f2960d6c6e2d85ff59_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea98fb3a66024e57afe1c39a4f163883_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia258ad2862e4409e90d97a6a185618ba_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8028e573868a4c60958ff50408279137_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8683c78419049719e43eefc5616a8bc_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92bacf56288041769a792da708300ace_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefff988b78344694a0de74324a70e787_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c177b7debcf4ed489a1c287af63efa8_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2015CommercialPaperProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3958a76b22149358ea04e9d59ab3dab_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2015CommercialPaperProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i949f35c9b7de4f3cbafef0e58607a8f9_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:AmendedandRestatedRevolvingCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3e7e6a0bf3f41a69f7e5b02e57a1cd7_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:AmendedandRestatedRevolvingCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a912ba559184edb828b6c18fff14699_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:AmendedandRestatedRevolvingCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e7ded1a38a347e09432a07dee3c0a9c_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d2d81b4b2be47f6a03325d659a6d72c_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ea679a6b4a74ebeb862f8ec5a9324fc_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i510c4360710e4c0a914d63f14acbfc0f_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d89dd5c6578482489f58901b2ece021_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2f2f4fae83043f3b68e29781af9902c_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28c3585b4c314e93b0ffe730217c8c72_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20230.000PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d3143e089ba4dedb2736c33c618581e_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20230.000PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b52a5b1a53c4ac39014d4b15543f3ec_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20230.000PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69901d8744fd4d879877219042968d11_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20230.375PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb442835a80449de9586e9b37e7d2fa5_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20230.375PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if267642c06af4e0fa5a4118f57c3905d_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20230.375PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i044094c947f94eeba950fa8a0c905013_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib19d6634ce714827868d024d9dcd796f_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb7d89c620764ee4a60c49931ad7a1fe_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2511d50310fe4d6296fc4346e10dd64e_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3b2928adcf54c788d62edf96564e9d1_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id20e750596f440789ec340620cf569f8_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic67fdda296f8439da5d36130db1168cc_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i951264b62a9e4692b9bd3d00cdf796f4_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b917b2cd2a4484bb2a8f5bd83abdc3c_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69633ff6d0b54867b5bf49aa176cfef1_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i500cfbc200ff4165a5a6b3019322c7fa_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47bb4791a9be48879236f93b8dbf5a54_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5c8bd11650841f792d159c232d7e48d_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i067a568cac5e437685072c3a831fcb18_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i282da68e884d461f91dc382fe42a1836_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c789745205747e59bcd97e1084d2e14_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ea8b5906172403087cb9b21adb1404c_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1102d65e5bbb46288b7d98a976952c66_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i750ff2c060f8493d976f1ebc84a53c58_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fd93231ec0d40e7a081151b1edbb42e_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c3778ef9fd049c4aa110c60dca8ae9e_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i054d412daa1342d9a8adc483ef5ee68a_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b0d659e4c6a464fbf2ba9f69ce97fe0_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f65dfc39b1d4cd496b6246f1492221e_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d2033de84454b43a7ecdc388b152f04_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2670923c73ce43568a500471620aded0_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8727095c1e24f2ca3873ea9374eea75_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47ee4b0280454a5c98e0ec794d136853_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88732c4da6c743a0af188e6a1f418126_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7910a7e253b74bb6bf57f31ca1e1cc96_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic82db9dbf25f4810bdca165d071df06e_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311.625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i234bad29861943d29016c98eaae4756d_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311.625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92885844bcb04599b66e758b5d76ae0b_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311.625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i565f1750cbac4f25983798f87bb8d5da_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0d67cdde98740db854f9c8a7ce28877_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54d8e43d6f024394b56e6aed2e55b5b7_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85287c89df5c4ee8bb7372bcad0e3d62_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31c17a3e93a04f5dae5066f13f61ca5b_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib824b6753fdd4d998c09bff251b0120c_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06322b5dd15e4cf88a13870353dc869c_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1101d7005cf341858d3178156e6689d8_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b577715d9c647778ab87a85896e3ff6_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83d24b071bbd4084bc5c15d3c012fa6e_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2007Due2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a1a36d6b7bd48309ca75990b50ebbf4_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2007Due2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i950765e074ae4226bcc6450b9efc0ac4_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2007Due2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabf27779745645c392a68929410ce222_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392.250PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib904bd0a37594de291e3a3b7199e4ea6_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392.250PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69f9f92316aa4bd9a6b5dca506e8a598_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392.250PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f70c23d31a04b9aa0f47612bada4682_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3136a8a092264e9fb60259353a08f685_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6683088e6e054026a6a7bdb9e6391a9a_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec3a4aa6910146c4a58dfc971610fa11_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cb1150cbdbc4d9fabc3a8722c52cd68_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id20d878354164798a7a7a92885288fed_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37040ee9a2694677a6a593b2e2d36c88_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib528782405ef426781d9bf2ee3a1488f_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff148c09a35d4309af70243e1e4a1d6f_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20c62f91aaa741a19f4b61315da66964_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica522c618bfb4a6e9eefa808b1383660_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae5109e80f914300a5a387ebde6c8776_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0af3561ae38a455788310e9883ab62ac_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f438443ec234ccdbae9a060908aff2a_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c9e7d2efbc24021807fa47750a582ac_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7e8238cae344221b36d9ab213d64ec0_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe85b9a673d44ee8b743ecbca5126981_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4c1c10ae78d45fb991c7444838f455a_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49d71ddf48d24bdcadb9fae5bdae5c01_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i837dd563301e43b3bc43f6ce023f2f56_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i535f2391eaba4f61bbb4700d09ee8601_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf19d18ef5f54fb2a1e2e30d815f91b0_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04b01691f1a24f5e9e29f783c2ea2c56_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i361b55cbce594a09970ba9fd123f2b16_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i047b42eae5e7495c83549c009df4d1d4_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c4e4384f2a44e0d9f3213e1b69ff161_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if210b924935c4b4d81d00ae7c8599261_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i819e50da385f459f903ea9d6d5d47c66_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2051Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13912243cb92485aad14f40321031fa9_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2051Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d83db0a3a404462a7f0f25f297ae072_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2051Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9090df86b8294bf988864695140aea55_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id954a5663cfc43e69849fbce86b15b9a_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="tranche"><xbrli:measure>mdt:tranche</xbrli:measure></xbrli:unit><xbrli:context id="i43ca1b9479324066bf20af6381092405_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i03edad1ee21c45e8bae5af91c450f7d7_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i486f35ff70c14b7cbda1a961e72c4759_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i419528b46438459b85358d801fe6c31d_D20190427-20190726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2b8c1f994574df88bd778df94f6e8d6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc8fac86e3e34735bd2213a5c893c73c_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i322602253ac842238d97f6323baf0b2a_D20201001-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicIncAndCIFSASeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89c3b3d9a895475985db2b36880fecca_D20201001-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f534412b2ac4f5d9802c54fd029f5a9_D20201001-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3d8d5311ebb4a75a24f1e7a8af56005_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e1f6fd2fd7b47459d0613747fb74d8f_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="iae6ac6ba362d46f7a069d17790df5dde_I20200512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia15b2fe50423464a9cf5623ac357741d_D20200512-20200512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-12</xbrli:startDate><xbrli:endDate>2020-05-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae724a5cf9f94ef18e23e8e16d639ab6_D20200512-20200512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">mdt:TokyoInterBankOfferedRateTIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-12</xbrli:startDate><xbrli:endDate>2020-05-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfb13d6a6af84816860e81aaba6f97d0_D20201112-20201112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-12</xbrli:startDate><xbrli:endDate>2020-11-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7831176c62f74ba4a4024a989e6285a2_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i383c6b4f4aa24169b24e351562e05365_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ea2a0e5eb0e4f09a8904720d94ebebf_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibef9e0da89e44b89b330d067b8948c58_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife2e4bf093494b09ba98f801beb8b9c5_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2e03acd84264aa29f524bb28094ffe8_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bb7d8650d424a3794638ac05acc85b1_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i062f1ed49909469d842f2bc395542043_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf768e66580b409297df422a6b58cc7b_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48ef881065414c91bb7f52fc1c7a7c86_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cafeb122608423eb2b62ea29bc09a5c_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c49d00a2f3f4bba86faabfc7866ed13_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iada485b3a6b245668a27a3b5fa95eb3c_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a16715731e144e2a482d62407c58c16_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eaf93d2e883447e94be4b40d4ea2307_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28d09151fa8641dca241e92bb8200f44_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib696730068be4184a7cba30530fe6e73_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16ecf308db934c58b716f575ffc1e8e2_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f39166258654e8b962cb7a6c6db3661_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb04dfb4fa234538bad556529f05fd2c_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74eac46b3d2b4217a1efbf920f47ff09_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id17a89cb1d9e431db69c4426862755a5_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3af287ba57845e88cc3662a0cc58115_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida9267d57494477c8173b527d15ad048_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i627fbb34d41b4c299271b22b6ba80293_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84ca06f620184bbfa7d366fe5853ce18_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98e4061404054b75be5b3c8c2b4acd40_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib482970decd34242a76c6fbf96fcb507_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26298cf036964bed9c4492fcb3a09498_D20190427-20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2020-04-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e2b35bd149d4cbfb0cca99cf6451e78_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4037e9fe4924327a9124f0dad580c10_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0504cba5977424e8efe09ff95da6e08_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9156d299a6eb46b38ada2503236b8881_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dd052a01e6746ebaefd3cc094cc9a4e_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b2fe42efd06408a92475c4755fa36e2_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54ccbe94efc24035ad053ab14a80da93_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia739284ae42640b9b1169f2e13f10c3b_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04c7a73cee65490ea0fe051fe67b36b0_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i408b5639feb74594bf9ffbf99932a0c2_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3781ad92456b4930a744c241338e1df9_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcab7a8fe5904101bf276c6cd9d3e02e_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2971cc416b8c4c3baf1b346e6ac07274_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfcb1d2adbee455fa6c5c158e39b057f_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac89da0aac834ad28b17ac773234402d_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf80c1f6bec9491da1665ff45eca0305_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4f0c5b496724100b2925b08781c93be_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79215fa9290949fc8d58b9442e87c752_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i300b4c6841cf48e1b89be1521f13f8c5_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id705573c47564fec859646f338ee424a_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia27d4054116c4424b00fa6fcc5fb1097_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61a28b7b81914f18b60a8f618393f4b0_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i640a2e9158494775bd661da415d6991a_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16cbb6d304b141dfa3c2506664f80306_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf105fb217564fb0b368560e0802c567_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c36d14889444b32a4a8a500df0426de_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f928c10bd3447a8acf72dba427f6d0f_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8649cc913994f28bba97e9a820cd77c_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a71eca48ecb47368f7ad737a8dd9f78_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9261483dc6f74bb484c0adf25775e549_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03fcd15b1ac94eb194a37776a48e4b87_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42f9a191936c4fddb70e6c4259646375_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75a0c623324e4c58a147690be5ec9a8c_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib23daffd559644c684e6f30a2989e54b_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie23caf8aac694eb5b8a3fbdfd8f4ec01_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82b2207772e84810aa69081bf91dec30_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i271d615350834f588b83b7a2b7f99350_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i501c025a1be4439dab95e8898d228126_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibae2e9403d704584a6e2c9aec89b4fbe_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37db224b055b4110b0851847038077cc_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia23e15999c1646ddbb7df2cda73a7aec_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id873cde847774be59ee4570ffd483d68_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c3c106af2b14c32ac0754fe26996414_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54a71bd600c64796b0dda6f39160e883_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6df7d3cc9f44895b99362ae686d8a29_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82923a0349f6443ab5eb2ec2e25dbb27_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40f981d3461b436c8ea0d4236782cc68_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba50466d7292490bb6538e2b946dd0e0_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3e0650de43b4e1f8c3d2b521e13e0ef_D20180728-20181026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-28</xbrli:startDate><xbrli:endDate>2018-10-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4a60149be38443fb2d916de554d6254_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3767fcfe1389419994824ecb077fef38_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3d7fb880809444bae1c970a1373d381_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdt:PurchasedTechnologyAndPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id014282d690d4c5a896ab2b26bacaa6d_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdt:PurchasedTechnologyAndPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03c038d0f8344416b953ecf5e0e5a61d_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1504f2bee7c143859a17a93113ddf64c_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if300d7f5eef94b9bbab7fef186492d3f_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic16cb2a7cf0049afb87f33af952987fb_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb9b67e332e24b35b2d7941bda8317f3_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie963904705b8409cb3f2f8c8ca2bf137_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72dff3c52a304a0bab96f9563e0abd46_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdt:AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie63e2a6be41a4756afe92a2464f79dd6_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdt:AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i038d289ad6de4b8f85679e45d0448c91_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17f2e9ba8db047a49f7e5293b1dc77f7_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37cf6705fcb445ac9da8563c668b75cd_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c5e5989168e41efb2ee254d247c516e_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00b67cb0c676413da10bbe00d1f895a2_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb3c7b067b2a490a80be46ac5e1bf7dd_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87f020c9e8ce45279dc4d7550054f8f3_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaa63515bf8647dd9bf70dfb44e3a57e_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if98bf19b12ea4baca1ee2d733327d267_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41db5984a04f476c9e1643f4d8215c73_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3500b71577b74f76a424e65d43544367_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8755e7c5c19246d985fd44c7bbf450b0_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbfbe22288704f4294f5d6ad2a6bbdb4_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e7073f7fded4be99ae2a0b2a3a31757_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31ca63612edf4a8295126af8750e6ae4_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i609d7c4a83e640db9dccf290d58342ce_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9acd77d49d4840c18802f8875a75d339_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70cc00740a274a9382f8faf2cfd6c19e_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf2c5bd78d0142318be39bad4bfa6c50_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id65399fc03ca4ad7987953d64a511415_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i041edce7b2f84381a0ffac6ba095e1fd_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be4b5dbd3a843788549eca186a30ccc_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib483fb15c6034697bfe54c44860b3101_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea08a324b22a4b3585ccc68dd6591808_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc8350b91b4146b3901beacd17a1c4e2_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i541ed731bef54145b54be9fcb6064899_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i169643d5df3945a980638c7f94c6cf7b_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f3edae1486d484084c48f942aa09416_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0579786642984f61b518ad7ce2988383_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48966b2b67e54988b474069368fd3c54_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i079d0741b4814caf97785cd103555063_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if525bf943aab4cbb91e9eb6d27a46bf6_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d0206d6a5fc41a49d8a7cc2ef0f0f5a_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida6a709f1f574db2a0ee55985446dde8_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ffaa96aa77b425a843a25fa1ef58542_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05e20d1638064e7e909e1fc85204b962_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib42695173b6e44668e0e633108f36472_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a3f0bf4841e4466b909762f6987805d_I20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia259e32147694c1a90acdfc351d3be37_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ea3630e377a437682567a4587f0b46a_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0d4590a839f4f359683bd936959376a_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8db26e60a874f328bde32ae1fffb625_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5b5d4d785ba4390854bcea8e68a032f_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefd7e349f18840e98869efd76dfa5aee_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25a603a65af64e6889139205388d2a5e_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie00c23bcd7924f48a43b264894ae1590_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5386101e521b4ca1b362aaa02cd87dcb_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i449e4d657bf0449ba7b52e557589bbf1_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99b3bd351a494528906e3d120cfc830f_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ea2e72c446043e2a75ada4300c76bf2_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c2ce4c6cbd84b4fb1294afa3a54a8a7_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice02b0738fd5434fb3f67530d843a491_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i707bc78abce44fed88d7746e65fcc6c1_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9eea4603bf34820985c1564d60a7ae8_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie397d3f57a424feab9c1039773fe2c37_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i594c98fce3834e6c911b55d203d09432_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fc63908080e457f944dc31cb02f1ece_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6233127143d474ca30c57ef1e30c869_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i853467b20db64187814759647e0063ff_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c01efddfd944a258a76ab642888a572_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8fcd13d6b3740c6a5a4e7d8f673420a_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6555488fb0954ade9760238ea2f0aee2_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2dc5e7853c24bc8a015eae803815058_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54f47cb7887f45f1b52b527c507264dc_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8a7dc5cbd8f473f99e012510c678690_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="subsidiary"><xbrli:measure>mdt:subsidiary</xbrli:measure></xbrli:unit><xbrli:context id="i9f541ce4dcef4da4a428c97cc7a8f5c3_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="manufacturer"><xbrli:measure>mdt:manufacturer</xbrli:measure></xbrli:unit><xbrli:context id="i9229de7c6045441d80355b6acb70f350_D20150425-20160429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-04-25</xbrli:startDate><xbrli:endDate>2016-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>mdt:claim</xbrli:measure></xbrli:unit><xbrli:context id="i60457532fbeb40878969effee2b3390c_D20170501-20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ef87e2613a04c5888f894f05867fc25_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic14d3bd294c046c9afca0a4d2276f819_D20201104-20201104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-04</xbrli:startDate><xbrli:endDate>2020-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="patent"><xbrli:measure>mdt:patent</xbrli:measure></xbrli:unit><xbrli:context id="i77dc59d697684886bbf5fe519c310541_D20111214-20111214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:EthiconPatentInfringementLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2011-12-14</xbrli:startDate><xbrli:endDate>2011-12-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86701a14cb434b819fd00f6ad2cdbbaa_D20181128-20181128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:SassoLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-28</xbrli:startDate><xbrli:endDate>2018-11-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="landfill"><xbrli:measure>mdt:landfill</xbrli:measure></xbrli:unit><xbrli:context id="ife64dfaf0edf41ea9552b05b5b7e1839_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">mdt:OrringtonMaineChemicalManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63d7c5081980421eb104ef0db2d640cc_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f4ddf14e8a5413696daf99ce008d00b_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i009f0737e76549b7bdd8727292bc324c_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34ef1f0d5805418690793935607c575e_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75f00ee586cf4b098983f7fd448c12ed_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b7f6004ebaa4580aa2cd2c369060e7c_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaf85161beb9449b9986565bb7507a94_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5e5b0ae3f9b4c4a8f83073dab95f175_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a9fdeedad9e48189c04e1acb1feea25_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae65e8a1899f46cf9f81db9fd9dc523e_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i190a27e4543e49f095f067588a9750ad_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3bd9b003d9d458cbf0d73f754eece1c_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c39d3319d5441938058ead345505a10_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81bf88cc900e42b7baca3ed7b2f9944f_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20c9d172c84641f8b5f43c19bf9b11e3_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75e5044db63f4573911d00a91522924b_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8fbed3ebbc54e9e8e04c5281af315e7_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd9ab457b664428faf530e0f31bec7ee_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50e105716e0b4d349b5afd9f55b817bb_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33de1043570543228ee3f7f6b21ee2b8_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i088828113b7e4efdae6630f46542249d_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd378229d53d485bb7a50d60b19bcbf3_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64a435269abb416984f5c417e8039a20_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac6ac704ee814208a2a8abf74b89f68b_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea846304c7ad47a28600ef1e4d71c7b2_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1638723f8ae47fba660e3d982eb8ed6_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3def68be9d64a24ac8a6ae505945a1d_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i785ae642d0794ba291eac2202104f152_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa7a5c2518f94595a35212683b056ac2_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf457dbfafc248478ffb42c3a45acab8_D20200801-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i969f5c5c54b6415c806918f433b06994_D20190727-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69d3fa2bd18b4dc98db60dce376f37f2_D20200425-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-25</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i457910bb69fc4038abf6fe2156ebc07f_D20190427-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-27</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtOC0xLTEtMA_64fed4ed-ae93-4548-bd94-6c4d709d1c30 id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMTItMS0xLTA_59c874bf-43c5-442b-8592-f58c242b75de id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNTgz_64fed4ed-ae93-4548-bd94-6c4d709d1c30 id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMTYtMS0xLTA_970ca307-0bd1-473b-bf1f-c3bdbea9361e" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczOA_d51809bd-4de2-47ba-92ac-2e5076ce670d" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtOC0xLTEtMA_e9f5a671-e985-4efa-a7de-32b8d8ba52dc id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtMTItMS0xLTA_ddd13094-0923-471e-945c-abade1a03459 id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtMTYtMS0xLTA_9f0883c5-6692-4daf-b6ef-72a9af546716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczNw_fa25eaf7-b332-49ab-a18e-8831f6fd4c6f" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i6128593e20e44bbc8b0671c482ec9b79_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM184Mw_204b8c60-10d5-41be-b4c3-bdbfcc0274d0">10-Q</ix:nonNumeric> </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.200%"><tr><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:69.076%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6ZWRjNzliYmE2ZmQ4NDg0MzljZjY3NGEwMDRmZGU2NWEvdGFibGVyYW5nZTplZGM3OWJiYTZmZDg0ODQzOWNmNjc0YTAwNGZkZTY1YV8wLTAtMS0xLTA_038664ce-79f3-4b13-a75f-44772a26ecb6">&#9746;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the quarterly period ended </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6ZWRjNzliYmE2ZmQ4NDg0MzljZjY3NGEwMDRmZGU2NWEvdGFibGVyYW5nZTplZGM3OWJiYTZmZDg0ODQzOWNmNjc0YTAwNGZkZTY1YV8xLTItMS0xLTA_68feb279-19e8-4192-9ebc-666c86e47a9e">October 30, 2020</ix:nonNumeric></span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6ZWRjNzliYmE2ZmQ4NDg0MzljZjY3NGEwMDRmZGU2NWEvdGFibGVyYW5nZTplZGM3OWJiYTZmZDg0ODQzOWNmNjc0YTAwNGZkZTY1YV8zLTAtMS0xLTA_bdf07f74-650b-438f-bbb1-682032940314">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.<br/>For the transition period from __________ to __________</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xMTI_d2278cf6-92ff-40df-abc2-9a8b4de5bedd">001-36820</ix:nonNumeric> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><img src="mdt-20201030_g1.jpg" alt="mdt-20201030_g1.jpg" style="height:101px;margin-bottom:5pt;vertical-align:text-bottom;width:448px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.800%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MEDTRONIC PUBLIC LIMITED COMPANY</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6MzI5NmZkNTA0ZTcwNDUxNmJmYzVjMjc1MzM1ZWQ4ZjIvdGFibGVyYW5nZTozMjk2ZmQ1MDRlNzA0NTE2YmZjNWMyNzUzMzVlZDhmMl8zLTAtMS0xLTA_11595148-898a-4549-8c17-ebea2221a7c5">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6MzI5NmZkNTA0ZTcwNDUxNmJmYzVjMjc1MzM1ZWQ4ZjIvdGFibGVyYW5nZTozMjk2ZmQ1MDRlNzA0NTE2YmZjNWMyNzUzMzVlZDhmMl8zLTEtMS0xLTA_37cd525e-7729-4f45-ac8c-be548b460e41">98-1183488</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xMjE_1933301e-cae5-4fdf-928d-2efb7d5b3a0a">20 On Hatch, Lower Hatch Street</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xMjU_e9682c36-4a6a-4b15-9898-e413798cc68e">Dublin 2</ix:nonNumeric>, <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xMjk_53be8a46-5814-4bda-8bae-880c981e7d62">Ireland</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+<ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:CountryRegion" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xODc_614b6d67-81c8-4587-b304-147310921675">353</ix:nonNumeric> <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xOTA_475aab69-597e-4eb3-b9fe-cb8e57e83b7e">1</ix:nonNumeric> <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xOTM_1b6fc61d-ca07-442d-9046-3a5388be1a30">438-1700</ix:nonNumeric> </span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.933%"><tr><td style="width:1.0%"></td><td style="width:38.196%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.574%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.930%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9690ac488cf0498597a1dee299c08d4a_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xLTAtMS0xLTA_14f997d5-7d48-4e38-b1f4-8533e33d88fc">Ordinary shares, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9690ac488cf0498597a1dee299c08d4a_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xLTEtMS0xLTA_a41b5e96-458a-4683-ba4d-d6bad9868455">MDT</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9690ac488cf0498597a1dee299c08d4a_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xLTItMS0xLTA_2d86cf84-1195-4958-aacd-02344d17373e">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie597491265f54e5b83c5e498b9e5e35d_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8yLTAtMS0xLTA_f57e67a3-bbf2-40ca-857f-1d304d3a68a7">Floating Rate Notes due 2021</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie597491265f54e5b83c5e498b9e5e35d_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8yLTEtMS0xLTA_26ea3a99-5676-4ca9-8839-b95188605c64">MDT/21</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie597491265f54e5b83c5e498b9e5e35d_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8yLTItMS0xLTA_863070b7-39a8-4b19-9871-03100a5c6700">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if431af446740495eafa610045eee2dee_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF80LTAtMS0xLTA_a2010255-1fc8-4491-8d69-5e7aabfdf3bb">0.00% Senior Notes due 2022</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if431af446740495eafa610045eee2dee_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF80LTEtMS0xLTA_501d0265-743f-486e-9c06-4363c9d5d12e">MDT/22B</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if431af446740495eafa610045eee2dee_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF80LTItMS0xLTA_ed99be60-b055-40b0-81e1-f8cc5c0abc1d">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6946ebb61b914bfa814743c0b4901fc9_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF81LTAtMS0xLTA_19bc6dd0-be2d-435c-93b8-99b11e5ed7b9">0.375% Senior Notes due 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6946ebb61b914bfa814743c0b4901fc9_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF81LTEtMS0xLTA_c35a4e02-2bce-4548-bfb8-ae7061da4446">MDT/23B</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6946ebb61b914bfa814743c0b4901fc9_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF81LTItMS0xLTA_bd745a46-f298-4155-95d2-b9bb73f5ec50">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7de46d31eff94c88bf5224b071d2649f_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF82LTAtMS0xLTM2NTA_7768c9c4-dc3c-487f-bec9-3a2e37d88b6d">0.000% Senior Notes due 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7de46d31eff94c88bf5224b071d2649f_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF82LTEtMS0xLTQ2MzQ_39a2df40-f4bb-4e07-9d9d-a7dc52a55e23">MDT/23C</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7de46d31eff94c88bf5224b071d2649f_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF82LTItMS0xLTQ2MzQ_c2fd3fcb-0568-4fcd-8b5e-646474dd6c8f">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic5b334ffdc574053ad9c42fd2a5e06d9_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF82LTAtMS0xLTA_4275740c-46da-4b86-96da-35885e9ad659">0.25% Senior Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic5b334ffdc574053ad9c42fd2a5e06d9_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF82LTEtMS0xLTA_cdf82a1d-85a4-4d49-879c-cbddc9434050">MDT/25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic5b334ffdc574053ad9c42fd2a5e06d9_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF82LTItMS0xLTA_a26175a0-a2c8-4884-8e97-7cd366b6090f">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0fda69c384584c999349f0452905a004_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF84LTAtMS0xLTQ2MzY_d1a414e4-a624-471a-87c8-d8b5d6f3c5fe">0.000% Senior Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0fda69c384584c999349f0452905a004_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF84LTEtMS0xLTQ2MzY_fce6afec-605e-4f43-9695-ee0d98a67fed">MDT/25A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0fda69c384584c999349f0452905a004_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF84LTItMS0xLTQ2MzY_1a53c651-33e3-408f-a576-cc79a59cbb5e">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i86350dcdf5e0430ab236aa4e72a95677_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF83LTAtMS0xLTA_74379398-c0c7-4cf5-8025-fd89229cb8e2">1.125% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i86350dcdf5e0430ab236aa4e72a95677_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF83LTEtMS0xLTA_839303bc-77c4-4a2f-82e7-8e1d2f8380bc">MDT/27</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i86350dcdf5e0430ab236aa4e72a95677_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF83LTItMS0xLTA_6512c01d-6012-48ef-a10a-a19b9473ea15">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib87a49f46e80456aaae50a2676d2b9c4_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMC0wLTEtMS00NjM4_746baa8d-3874-424b-9285-de4b0eb269c9">0.375% Senior Notes due 2028</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib87a49f46e80456aaae50a2676d2b9c4_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMC0xLTEtMS00NjM4_aa26c9c6-3104-42ae-8e0e-d87985993195">MDT/28</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib87a49f46e80456aaae50a2676d2b9c4_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMC0yLTEtMS00NjM4_76259537-dc43-4820-bf1a-a42cb2691b7c">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifd6d2a65b5a74087a9cd3322dafc9078_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF84LTAtMS0xLTA_5dfc65ab-01f7-40ec-ab36-338632102ce6">1.625% Senior Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifd6d2a65b5a74087a9cd3322dafc9078_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF84LTEtMS0xLTA_b2b76d5c-efda-478a-abd0-6735771b6bb9">MDT/31</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifd6d2a65b5a74087a9cd3322dafc9078_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF84LTItMS0xLTA_abc7b51d-6094-4699-a12d-1a2ba2320501">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibfc007fd29af4d10aae7f839ce84e9d0_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF85LTAtMS0xLTA_5e95d1e0-4d6b-44cd-85a4-7cb6471a9a14">1.00% Senior Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibfc007fd29af4d10aae7f839ce84e9d0_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF85LTEtMS0xLTA_385bd5de-eb96-4b40-8e8f-a4b241ab5001">MDT/31A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibfc007fd29af4d10aae7f839ce84e9d0_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF85LTItMS0xLTA_68c3423a-959b-4468-b026-02e3256aa652">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id98bb264c6ae40ce9fa7d1c6480a5695_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMy0wLTEtMS00NjQw_a10e9282-b393-44cb-a42f-76060db1840b">0.750% Senior Notes due 2032</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id98bb264c6ae40ce9fa7d1c6480a5695_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMy0xLTEtMS00NjQw_a126e0c1-55a5-4c81-8779-72c23651568e">MDT/32</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id98bb264c6ae40ce9fa7d1c6480a5695_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMy0yLTEtMS00NjQw_2e68c521-f4df-43fc-b5e7-c4cf9b355406">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icd770a2a644746b3a8f33af164792726_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMC0wLTEtMS0w_7a697c99-f4fa-4177-9148-76623df9f324">2.250% Senior Notes due 2039</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icd770a2a644746b3a8f33af164792726_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMC0xLTEtMS0w_8ac940d4-1152-4c69-8d5b-65ab8876e77d">MDT/39A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icd770a2a644746b3a8f33af164792726_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMC0yLTEtMS0w_ebb3883a-eeac-4b31-8f11-7b97e853d9ea">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2bd98a03670c4e72ad51a2c7363e7490_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMS0wLTEtMS0w_574a137f-9165-437a-8696-5fd253f58c19">1.50% Senior Notes due 2039</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2bd98a03670c4e72ad51a2c7363e7490_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMS0xLTEtMS0w_b6372097-7559-4b27-9878-8cc8acaa6d85">MDT/39B</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2bd98a03670c4e72ad51a2c7363e7490_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMS0yLTEtMS0w_aad237d5-386f-4cb7-9b68-b94f7cd63198">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifcfa923f30854b80900b6aea7decd075_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xNi0wLTEtMS00NjQy_3b0c9544-fb42-42d4-8a18-6a44db71b87e">1.375% Senior Notes due 2040</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifcfa923f30854b80900b6aea7decd075_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xNi0xLTEtMS00NjQy_7b97630c-b7c9-42f6-a717-f5ffda07f712">MDT/40A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifcfa923f30854b80900b6aea7decd075_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xNi0yLTEtMS00NjQy_b06ca999-aaab-4fd2-a277-633b7e51a068">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic21aaaba5ba242f4a805034963baca6d_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMi0wLTEtMS0w_52212e2a-ab32-49c3-ae4d-053eebba5a06">1.75% Senior Notes due 2049</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic21aaaba5ba242f4a805034963baca6d_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMi0xLTEtMS0w_30dce7a3-7349-418c-a6b0-3a1ae595f8f7">MDT/49</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic21aaaba5ba242f4a805034963baca6d_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMi0yLTEtMS0w_df5a3098-bd4b-4613-8e9a-d3f0ee983d42">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i55564036473c42538449804d30b330bc_D20200425-20201030" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xOC0wLTEtMS00NjQ0_2ee2ef38-e095-4bb6-b268-19b2f1c501d0">1.625% Senior Notes due 2050</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i55564036473c42538449804d30b330bc_D20200425-20201030" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xOC0xLTEtMS00NjQ0_42125fa4-1801-4c32-9321-918492bed533">MDT/50</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i55564036473c42538449804d30b330bc_D20200425-20201030" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xOC0yLTEtMS00NjQ0_6fbc6e55-fc8a-465a-8631-559def8ca767">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM182NTg_5dcdad5a-8181-42a0-9393-df84d11fa1e4">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM185ODY_0d8bef72-4497-418e-8316-23482a9411ed">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.200%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.727%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NDRlNWI2MGMwZGI4NDNiYzhmNzVhZjY2Y2YwOGUzNDEvdGFibGVyYW5nZTo0NGU1YjYwYzBkYjg0M2JjOGY3NWFmNjZjZjA4ZTM0MV8wLTAtMS0xLTA_b9afb4cf-519f-4a2e-91e6-f92f7beefe0b">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NDRlNWI2MGMwZGI4NDNiYzhmNzVhZjY2Y2YwOGUzNDEvdGFibGVyYW5nZTo0NGU1YjYwYzBkYjg0M2JjOGY3NWFmNjZjZjA4ZTM0MV8wLTUtMS0xLTA_5bcf355c-0348-411e-9508-29d234d54e49">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NDRlNWI2MGMwZGI4NDNiYzhmNzVhZjY2Y2YwOGUzNDEvdGFibGVyYW5nZTo0NGU1YjYwYzBkYjg0M2JjOGY3NWFmNjZjZjA4ZTM0MV8xLTMtMS0xLTA_b14f6c96-a5c8-4452-9e6d-274cec9ca85e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If&#160;an&#160;emerging&#160;growth&#160;company,&#160;indicate&#160;by&#160;check&#160;mark&#160;if&#160;the&#160;registrant&#160;has&#160;elected&#160;not&#160;to&#160;use&#160;the&#160;extended&#160;transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;1(a)&#160;of&#160;the&#160;Exchange&#160;Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xNzE3_ab152ff6-18e0-4d57-b719-a2476fc0eb7f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:3pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 1, 2020, <ix:nonFraction unitRef="shares" contextRef="i57886cddd4384344b30a7a72843fef41_I20201201" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xNzUw_8981f5eb-ccbb-4579-b9c4-859fc5ae5820">1,346,019,949</ix:nonFraction> ordinary shares, par value $0.0001, and 1,872 A preferred shares, par value $1.00, of the registrant were outstanding. </span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:8pt"><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Item</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_13">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_16">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_103">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_103">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_172">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_172">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_175">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_175">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_178">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_181">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_181">60</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_184">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_184">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_187">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_187">61</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_190">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6128593e20e44bbc8b0671c482ec9b79_190">62</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8212; FINANCIAL INFORMATION</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_16"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Income</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.637%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMi0xLTEtMS0w_9a622a96-f13c-44fe-928d-b4d03aa74b2f">7,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMi0zLTEtMS0w_d64b9906-7f0b-4ba9-904e-a931cc09e4d8">7,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMi01LTEtMS04Mg_800d7dbf-eed3-43a0-b483-e01d4be04ceb">14,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMi03LTEtMS04Mg_3ecb8682-b37e-4015-8376-09419af16f7c">15,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNC0xLTEtMS0w_e31ce11c-27b1-4bce-b08e-93cf3bee8eed">2,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNC0zLTEtMS0w_e345a28a-6fa4-4db7-a16c-55bbf1e2ab3d">2,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNC01LTEtMS04NQ_71ed333b-11a8-4282-9ef5-c47b96aec460">5,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNC03LTEtMS04NQ_87e7c720-3d71-42a7-94ed-6a652f2dfeac">4,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNS0xLTEtMS0w_98c64ce5-93b5-4c1f-8f99-8db3dc7ddd0c">639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNS0zLTEtMS0w_577b29ae-5e20-431a-b489-f1cff5146647">603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNS01LTEtMS04NQ_847afdc5-4ab9-46ab-9bf6-bfc1f0f5d5cb">1,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNS03LTEtMS04NQ_d4a963f6-02bb-4412-b84a-a10283626e10">1,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNi0xLTEtMS0w_0407a084-4efa-4294-9073-814988920c87">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNi0zLTEtMS0w_65d67efb-1745-47ba-9aa2-044318fa82c1">2,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNi01LTEtMS04NQ_31825bd6-f44e-42be-addd-38a8e81267f5">5,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNi03LTEtMS04NQ_88bb9fae-9859-4a14-9f82-c43df742d94a">5,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNy0xLTEtMS0w_71800004-2bf9-4ac7-a529-3c855f1e617c">443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNy0zLTEtMS0w_1e13fc4e-9aa6-4737-89d6-c3bccdf4d1ad">441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNy01LTEtMS04OA_09eb1bac-4237-431d-8da1-0d3c2e803da5">884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNy03LTEtMS04OA_650024d4-2b2c-47d7-b32c-9501b4bb7a2d">881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="mdt:RestructuringChargesNetofRestructuringReversals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOC0xLTEtMS0w_c2b1dfba-53f2-434d-9d1c-ea97237ba6f8">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="mdt:RestructuringChargesNetofRestructuringReversals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOC0zLTEtMS0w_cfbfdff6-c1cd-48d1-b492-47e5a1945c3f">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="mdt:RestructuringChargesNetofRestructuringReversals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOC01LTEtMS04OA_5dd0683e-dcd6-43f5-8ae5-e7aabf0a44e1">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="mdt:RestructuringChargesNetofRestructuringReversals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOC03LTEtMS04OA_063f0c8a-766a-4122-a626-78c5bf057a12">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOS0xLTEtMS0w_7bb32e8d-fb76-43c3-a483-df5319aa3b5d">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOS0zLTEtMS0w_6811a97a-5b79-466d-905d-75351685b787">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOS01LTEtMS04OA_2e2f1fa1-0cd7-46e7-b580-52fbfef6d6d6">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOS03LTEtMS04OA_485769a7-2dd6-412f-a9dd-74aa56f755ee">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTEtMS0xLTEtMA_7306feaa-feac-4539-befc-9a2392de4c68">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTEtMy0xLTEtMA_35f4033d-3ac0-4ab7-bc78-bafac967c181">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTEtNS0xLTEtOTE_7293c62a-22e4-4ca2-a4e3-aa50f068decf"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTEtNS0xLTEtOTE_8dd1fe46-c1a6-4e6d-a33e-96f1c125884d">35</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTEtNy0xLTEtOTE_60a49eca-9214-426e-b575-376f14499bfe"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTEtNy0xLTEtOTE_8cbffb02-bc95-44fa-97f4-22f8a97acd8b">127</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTItMS0xLTEtMA_b29ba3dd-0d11-4c59-b83a-599a57ce932c">930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTItMy0xLTEtMA_e84f2e51-ee7d-4ffa-af23-2ae674063661">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTItNS0xLTEtOTc1_9524de0c-7bf1-4ea6-9647-7073bba29d05">1,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTItNy0xLTEtOTc1_327ab2be-c76b-410d-868d-efa57c777c4e">2,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTMtMS0xLTEtMA_df4ea049-2d31-4fb7-8375-68566d9b2f35">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTMtMy0xLTEtMA_21a484c7-298a-418a-a0ae-8c94d860a0b6">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTMtNS0xLTEtOTQ_5fd75cfb-15e0-4d81-8d86-7c6953b6d741">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTMtNy0xLTEtOTQ_380b3c12-5bab-4153-bbe2-545512234498">209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTQtMS0xLTEtMA_f6e7b378-f5e1-47df-b72c-7b1f2e7b40f9">470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTQtMy0xLTEtMA_1e83e078-3224-410b-a84a-fdd99ad1765e">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTQtNS0xLTEtOTQ_4a2def58-4f11-4c76-868d-a16fb0fd5745">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTQtNy0xLTEtOTQ_4c029160-b73c-45ff-9f40-4ef9a7a16539">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTUtMS0xLTEtMA_c6a29caf-9fce-4345-955d-5df7987d16bd">525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTUtMy0xLTEtMA_9ffc9031-d8ef-495b-8a7d-98adc420096e">1,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTUtNS0xLTEtOTc1_edb68712-ed19-4e00-b1b1-4c7ad552cdfd">1,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTUtNy0xLTEtOTc1_862b16ac-0baa-4810-bfd4-5463c6405f45">2,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax provision (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTYtMS0xLTEtMA_536f9ba3-58c2-4fde-9cbd-4c815c9506ca">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTYtMy0xLTEtMA_ed07b5ca-e1d5-42d1-8e77-6056fa4114c6">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTYtNS0xLTEtOTc1_84ae2653-a80d-4de2-9714-db281c3c81a2">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTYtNy0xLTEtOTc1_4a4fc38e-6cda-4399-aa8d-859c3b7c43f7">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTctMS0xLTEtMA_f0d480d9-4f08-40f8-8159-f7c69c223673">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTctMy0xLTEtMA_5964d9a3-32fb-44df-a982-7a55bac0c79b">1,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTctNS0xLTEtOTc1_669cae51-9438-4fbd-8172-f959b600fc96">985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTctNy0xLTEtOTc1_a999a231-9242-4a69-9fbf-d17638e86a66">2,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTgtMS0xLTEtMA_a5246070-3644-4e73-bdc2-7bbe3c22b242">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTgtMy0xLTEtMA_222560a9-91e1-45dd-896d-e2dc9099b4d1">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTgtNS0xLTEtMTA0_2dfce8e8-8ff9-49ed-8bf1-8c4ec814f868">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTgtNy0xLTEtMTA0_beddc6ee-273d-4e4b-927b-305e98e9f3f5">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Medtronic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTktMS0xLTEtMA_1fece2ae-9e7b-4502-811d-05e70ca1d85c">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTktMy0xLTEtMA_dd41772c-1d33-44f5-8be8-22ec54c182bb">1,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTktNS0xLTEtOTc1_5454ff0b-c98a-467b-8f7f-473cef221170">976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTktNy0xLTEtOTc1_93adfd88-3e4d-4b06-a577-1165ac46f645">2,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings per share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjAtMS0xLTEtMA_1b507879-8937-4e36-b187-ec69d9464ae7">0.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjAtMy0xLTEtMA_b8932550-879c-4d74-8b78-259447093a00">1.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjAtNS0xLTEtMTA3_f7f6e0da-8922-4e53-861b-f7829e610dfe">0.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjAtNy0xLTEtMTA3_c3857a75-717f-441e-9751-e3c757ef214f">1.66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjEtMS0xLTEtMA_bf8088ea-372e-4384-b84a-7923042525d4">0.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjEtMy0xLTEtMA_9260f3ee-fec3-46a4-a3ba-7bdadd3c6227">1.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjEtNS0xLTEtMTA3_1d66f666-96e2-43d9-a2e5-90739ac37768">0.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjEtNy0xLTEtMTA3_88fc9643-02d6-4545-ae07-cace5f1915ba">1.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjItMS0xLTEtMA_4b595cf2-d43c-4950-90db-fd0074c9ba0d">1,344.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjItMy0xLTEtMA_c0ef0c0c-5d78-4856-bb5f-0f53245cb5c4">1,340.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjItNS0xLTEtMTA3_45ff78f3-c94b-409f-beb2-3f7c3d475a62">1,343.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjItNy0xLTEtMTA3_72986b7e-9c66-447c-8f1c-e90d1857ced6">1,340.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjMtMS0xLTEtMA_cd6f5016-ff91-479e-851c-ef4e40fb70ff">1,352.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjMtMy0xLTEtMA_0a174250-347e-45ca-97b0-7161b8c4132c">1,351.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjMtNS0xLTEtMTA3_3532f99f-c52d-4ae5-b737-eeb62af2a571">1,351.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjMtNy0xLTEtMTA3_b041af52-4b2d-4b00-a6ee-2a3f45db024f">1,351.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMi0xLTEtMS0w_0b7510b8-d146-457d-b81d-cc357f23b314">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMi0zLTEtMS0w_cc5d5fe8-873c-4ca4-a04c-331e33584d18">1,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMi01LTEtMS0yODc_9e3ca57f-bee6-4ddc-bef7-baa854ab58d7">985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMi03LTEtMS0yODc_95d00d19-aff2-4cce-9de6-0b46f6da9a8a">2,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (loss) gain on investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNS0xLTEtMS0w_efd453c7-57b5-4a5c-b12a-6d60c306139c">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNS0zLTEtMS0w_a6a5a7b7-421f-4d25-bb78-d28ae3f3ded4">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNS01LTEtMS0yODM_56b72a46-0068-48ab-b6ad-32e1647c687f">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNS03LTEtMS0yODM_d83975b9-1820-4ad6-8b5e-0c62bdf475ad">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNi0xLTEtMS0w_db1868eb-3085-4d56-bd91-9b776003bb13">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNi0zLTEtMS0w_eaa26bc8-6238-45a9-ad03-4b67fd8e5c1d">214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNi01LTEtMS0yODM_5751f77c-96bb-4232-951f-9da7f54c6232">1,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNi03LTEtMS0yODM_fe2d9b98-3de9-4455-96ec-0980b246be0d">148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNy0xLTEtMS0w_161a1dc3-e92c-4398-9a0e-3a4d6be62727">164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNy0zLTEtMS0w_de1dc729-c8d3-402a-9942-d95b29fd85d2">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNy01LTEtMS0yODM_cb40f530-96ba-4b7c-99e8-d1e0119afbeb">1,276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNy03LTEtMS0yODM_10ecb8c7-6e22-4cb7-bcc6-0f1015d316fd">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in retirement obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOC0xLTEtMS0w_29403163-d6e1-4015-b453-7d9394d8de92">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOC0zLTEtMS0w_d169fc85-5e0b-4f0a-9d0f-903449e007d6">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOC01LTEtMS0yODM_c9fae156-899f-4cad-ad7c-33b115c18e74">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOC03LTEtMS0yODM_89bd99da-4da8-4511-962d-63ac851bd3b9">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOS0xLTEtMS0w_6d6ca0d3-830b-47b1-8e54-bcfabb02fcf5">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOS0zLTEtMS0w_8db035f5-f629-43f8-83e0-99ca49406e5c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOS01LTEtMS0yODM_1d01d072-3991-405a-baf2-3721c3bc2b9e">395</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOS03LTEtMS0yODM_f3e1d008-cf5e-48ba-a539-70ebe8bd8d70">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTAtMS0xLTEtMA_929e4385-cc6d-4b3f-b85c-ee355408629e">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTAtMy0xLTEtMA_6fc5b84a-12b6-4360-a94c-f6859756c73d">127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTAtNS0xLTEtOTc3_1ec32e79-7d93-446d-9be8-0e820b8b3109">277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTAtNy0xLTEtOTc3_4f647036-c8bb-4528-92ab-3a974f1eecfe">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income including noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTEtMS0xLTEtMA_f27c8fd9-0a9d-4925-a679-4840119301ff">434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTEtMy0xLTEtMA_fe6e2d1c-3fa4-4917-936a-60f6decb0f6e">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTEtNS0xLTEtOTc3_0e2cdd0d-bc06-4297-9a23-36a7815fa21b">708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTEtNy0xLTEtOTc3_eebca5e6-ab06-4547-98ee-ab56556f0d85">2,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTItMS0xLTEtMA_7353e0df-f108-4ec6-8b22-edb16d88da0e">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTItMy0xLTEtMA_4130fc76-68bd-4373-b025-09d340f43eff">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTItNS0xLTEtMjk5_4e899944-2a97-4e07-bab0-8752372cfb33">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTItNy0xLTEtMjk5_15e0f2b3-af03-491b-ae4d-1a4b01c28d9f">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to Medtronic</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTMtMS0xLTEtMA_2314ad31-11c6-42ca-bede-3894a07b3e7f">428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTMtMy0xLTEtMA_8dedda5a-e142-4af2-8c66-ba82eec0716e">1,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTMtNS0xLTEtOTc3_c6b425ce-d6b9-450d-bb25-d4638dad84df">693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTMtNy0xLTEtOTc3_b5950bf5-2cf2-4785-8ab4-30825a566a20">2,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.635%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMy0xLTEtMS0w_4b9bc5b0-10c1-46af-b325-d2d45084e02f">6,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMy0zLTEtMS0w_3d6b1a59-c250-40ad-b134-8ef23abaa94a">4,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNC0xLTEtMS0w_800bea35-584c-49bf-a026-45949b5ad0dc">7,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNC0zLTEtMS0w_6ab7275c-a0de-4a0a-8031-ee40a946d7f4">6,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, less allowances and credit losses of $<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNS0wLTEtMS0wL3RleHRyZWdpb246MjU5N2IwY2I4Y2QyNGUyY2FmZTJjNGJlMDNhODUxNzNfNjI_4a66dca5-4424-46da-84d0-557577955b44">312</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNS0wLTEtMS0wL3RleHRyZWdpb246MjU5N2IwY2I4Y2QyNGUyY2FmZTJjNGJlMDNhODUxNzNfNjk_8656e1d0-1860-4d44-a9c8-1c08132b374f">208</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNS0xLTEtMS0w_b3dd57bf-f4c7-4581-b505-33ab95592883">5,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNS0zLTEtMS0w_8668169a-1583-4171-ba02-febc8d79ab03">4,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNi0xLTEtMS0w_48440ec6-c083-4fd3-89b6-49b42c02d396">4,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNi0zLTEtMS0w_e52f5d18-2180-4c9c-8bcd-0bcebb2a1df7">4,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNy0xLTEtMS0w_8e9a5a2c-0feb-4fc1-90fa-5f135aa82103">1,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNy0zLTEtMS0w_050a239a-c74c-41e0-af23-b85d08d54620">2,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfOC0xLTEtMS0w_3445b120-36b8-4034-afcd-fcb67c8ea2f0">26,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfOC0zLTEtMS0w_6cc52ac1-1477-4408-837c-b1d135033931">22,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfOS0xLTEtMS0w_bcb8450a-0fcb-441d-9ceb-470fbb01892a">12,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfOS0zLTEtMS0w_6070da65-a98a-42a2-8bc7-9d4150089bde">11,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTAtMS0xLTEtMA_728a9e89-c18f-4a1d-9569-9038e7a2aa87">7,260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTAtMy0xLTEtMA_f4d8f11c-481a-46dc-a3f4-5b6c1c78eeb3">6,816</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTEtMS0xLTEtMA_8a391e13-cd0e-4f39-a5a7-c8364dcf7961">4,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTEtMy0xLTEtMA_58c9713f-5292-494b-a580-1b1e33a02b25">4,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTItMS0xLTEtMA_d6b2cf9c-ef64-40e1-9b90-6d0a3613efe3">41,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTItMy0xLTEtMA_4ea69afa-99ed-4bc6-b663-e76a4df343bd">39,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTMtMS0xLTEtMA_cb2c783a-f1e5-4cfa-9750-359585cd24f0">18,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTMtMy0xLTEtMA_834fdbb4-aaee-401d-b019-a94f21f5d841">19,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTQtMS0xLTEtMA_2f51500d-9f27-433f-aa8c-584e61c8db26">3,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTQtMy0xLTEtMA_c92acd1c-dfac-41d3-a70a-8044e7b31627">2,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTUtMS0xLTEtMA_70d38a01-2719-4838-8964-134f558ba47f">2,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTUtMy0xLTEtMA_a04a463a-5efb-40d1-bfe2-f170d755accc">2,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTYtMS0xLTEtMA_bb9e08aa-5f13-472f-a4e5-d988c1d3f71b">95,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTYtMy0xLTEtMA_83a6b195-6c69-40a9-aac1-d5c5f5172e27">90,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTktMS0xLTEtMA_5e6931da-c73e-4748-9895-09444cd5dcd6">4,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTktMy0xLTEtMA_cae783c4-cd26-4904-ac53-011f8fc0ac59">2,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjAtMS0xLTEtMA_81596a52-c33c-4368-88c4-1f52d80669f1">1,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjAtMy0xLTEtMA_f35ceab0-8da7-4abe-8d8d-2e2e74a9d071">1,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjEtMS0xLTEtMA_497696f7-f962-4ff8-b747-0840bfa3d164">2,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjEtMy0xLTEtMA_4d1610d5-0c24-4ae8-8984-0ff03c5f24c5">2,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjItMS0xLTEtMA_facdf768-da11-42f7-9489-d917d61758d7">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjItMy0xLTEtMA_9e12fd23-7a61-487e-9a48-553b4127cdc2">502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjMtMS0xLTEtMA_b405e0d0-cef9-43ef-b045-3e7ec2e5eed9">3,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjMtMy0xLTEtMA_2d64d9b0-bec3-4b09-b6a5-3f27a8d77bf6">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjQtMS0xLTEtMA_f45ba901-ec17-4a08-b997-4a4772ceddfe">12,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjQtMy0xLTEtMA_9cfbc414-8b1e-4a26-bd47-59927c0d6fff">10,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjUtMS0xLTEtMA_bf37691b-41c8-4049-b9c8-b315f37b9e8c">25,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjUtMy0xLTEtMA_52a15e2f-9016-43be-b00b-b7afd0fd2fe3">22,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued compensation and retirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjYtMS0xLTEtMA_2ac1067b-ee37-4d72-a294-b031ffec36c0">2,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjYtMy0xLTEtMA_be61f83c-9fd1-4c44-b610-07fea3674a52">1,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjctMS0xLTEtMA_491990bd-a07a-4f96-8c7b-285da5360c71">2,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjctMy0xLTEtMA_e0109c55-5d4f-4a94-9789-b476dc9bed8d">2,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjgtMS0xLTEtMA_3b07102f-69a0-46a3-b7a4-8587752861e4">1,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjgtMy0xLTEtMA_890fff01-d3a5-4802-88df-2f6bf69d96f2">1,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjktMS0xLTEtMA_ec0d445b-b2c3-49c8-8182-688b02817191">1,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjktMy0xLTEtMA_e51edc63-66dc-4dcb-9384-e1e60d329139">1,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzAtMS0xLTEtMA_59e84d10-596b-41b3-85b4-ec37c9fbefc8">45,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzAtMy0xLTEtMA_337553c6-329a-4395-addd-42bea7203832">39,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and contingencies (Note 16)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzEtMS0xLTEtMA_8c8e7b79-5e2f-4e00-b849-8a24e25d6b2c"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzEtMy0xLTEtMA_005aebf2-9a44-465f-9310-a18101a9dfe4"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary shares&#8212; par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzMx_ae1bf35a-936c-4c3d-95d0-4c0bd1481f50"><ix:nonFraction unitRef="usdPerShare" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzMx_cd735b61-d55a-4af9-8100-88cba42af018">0.0001</ix:nonFraction></ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzM1_99a04297-8a5e-4789-8996-8a400a1ca7a0"><ix:nonFraction unitRef="shares" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzM1_b0f48a0f-7635-436b-acd5-1be189849cf6">2.6</ix:nonFraction></ix:nonFraction> billion shares authorized, <ix:nonFraction unitRef="shares" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzU3_a18c77ac-0759-4619-aa4f-03499c8b7100"><ix:nonFraction unitRef="shares" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzU3_c9d8a59c-27d7-47d1-973a-b7075e5a4ce3">1,345,547,814</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzY0_6abc397f-3c9c-4650-9d00-e8ddf1fcd425"><ix:nonFraction unitRef="shares" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzY0_90e2986f-7b0a-4afa-83ae-174e0b23b18d">1,341,074,724</ix:nonFraction></ix:nonFraction> shares issued and outstanding, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMS0xLTEtMA_00e913c4-c44a-4c58-b350-249dc9901746">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMy0xLTEtMA_ec6bb0e9-6fd2-4b0d-a399-2e58297027fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzQtMS0xLTEtMA_671fedc9-81bc-47ad-86ac-80e597b443a0">26,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzQtMy0xLTEtMA_a0a41803-1bb1-42cd-82a5-1c5235e907e2">26,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzUtMS0xLTEtMA_d5682a89-5156-415a-ab88-3bb68df22d6c">27,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzUtMy0xLTEtMA_f6b57f98-bbfc-4586-ac28-33f5867da769">28,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzYtMS0xLTEtMA_a4765af5-a728-40d5-8ba9-56c420096d4e">3,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzYtMy0xLTEtMA_2c52e5cd-2251-4eed-a1a5-bf5d670b610b">3,560</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzctMS0xLTEtMA_3e1f5df2-aa7d-4a3c-8830-b1e322181d1a">50,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzctMy0xLTEtMA_d07b4c9f-c13d-4239-9bad-94671d4d4727">50,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzgtMS0xLTEtMA_6a455646-4a5f-4b29-9f46-f799e657753c">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzgtMy0xLTEtMA_e3ff639e-5abe-4b3c-b425-92c57dff1ffc">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzktMS0xLTEtMA_ef85bf54-b3b3-4c1d-b32e-7cbca7a5d501">50,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzktMy0xLTEtMA_1cc00fc1-431b-44b3-9919-81e4a1771c4a">50,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNDAtMS0xLTEtMA_0de52f8f-1bc5-4aab-bcf1-6dfafaa72618">95,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNDAtMy0xLTEtMA_700e688c-4cec-48f8-9abc-ce28ebcd1ead">90,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Equity</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.308%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/> Shareholders&#8217;<br/> Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 24, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if3e9504309af4083b6fd5bf477afa1c6_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi0yLTEtMS0w_d7e69376-3462-477d-b09f-ab6e20bbdff7">1,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e9504309af4083b6fd5bf477afa1c6_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi00LTEtMS0w_f0014691-ccca-4cca-ad9f-d7808fa95d59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic572c413537c418298b2634dbfaaf017_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi02LTEtMS0w_4df75fdd-f337-4204-8d18-12e3ba0b436c">26,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd6a86ad9b714d9081642559e2ff2934_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi04LTEtMS0w_48806650-5983-4aa6-b0db-3e1860479ed6">28,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c85755ec4074136b1ee5356437a2b17_I20200424" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi0xMC0xLTEtMA_2f5c3d62-cf36-4956-852d-072686d7beb4">3,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5b7d170f3340e696de1c1470de9cdd_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi0xMi0xLTEtMA_e2c59992-2dab-4a3c-aaf0-c34eda633bba">50,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b268c905e614cd0838cbabb6383cd70_I20200424" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi0xNC0xLTEtMA_205b42d2-cb5e-4594-aa8a-cec10a5628eb">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi0xNi0xLTEtMA_a0109c96-ff93-4cee-be87-699e483cf575">50,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9156b821fc84f4eafacc70d98d9cd2b_D20200425-20200731" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMy04LTEtMS0w_5f563b66-016c-433c-937c-1ad265b01a9b">487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6371626247f34091a93b2dc205920ab8_D20200425-20200731" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMy0xMi0xLTEtMA_24c07eee-5c57-4dc1-9bdb-17d1e9127b4b">487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85c770bf95844dd9931cef47b1f7be43_D20200425-20200731" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMy0xNC0xLTEtMA_039a86b8-ae8c-427b-a063-d393b3ad1de4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMy0xNi0xLTEtMA_49fc3173-dcf6-486a-9b2d-48a049599168">491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i673be33df7fd4f9bbded121055267d0d_D20200425-20200731" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNC0xMC0xLTEtMA_6cbe1141-20f0-4127-ba92-4bcb12bbf845">222</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6371626247f34091a93b2dc205920ab8_D20200425-20200731" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNC0xMi0xLTEtMA_3d62923f-6639-4e58-89bc-22365743228f">222</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85c770bf95844dd9931cef47b1f7be43_D20200425-20200731" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNC0xNC0xLTEtMA_9b7421cd-edbb-4555-8db1-b3cac8592765">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNC0xNi0xLTEtMA_dd97b32a-6040-435c-8e61-f8067d332bc0">217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends to shareholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNS0wLTEtMS0wL3RleHRyZWdpb246ZWI4ZjA3NzY4ZjBiNDRkNWIzYzhiN2RiNWU1MTM1YWNfMzI_6439617c-7dfe-4193-b21c-af43002a75cb">0.58</ix:nonFraction> per ordinary share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9156b821fc84f4eafacc70d98d9cd2b_D20200425-20200731" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNS04LTEtMS0w_5728fc1a-f280-4c23-8f2e-94590f52f14a">778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6371626247f34091a93b2dc205920ab8_D20200425-20200731" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNS0xMi0xLTEtMA_4b343329-dc41-4b1a-9ccf-8eec6cc243f3">778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNS0xNi0xLTEtMA_130ca680-4c44-49b4-b61c-16f7d6cf9662">778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares under stock purchase and award plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id71e33001d124f7794452cdccb09c623_D20200425-20200731" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNi0yLTEtMS0w_8f9a0cc2-869f-42fa-a36e-876323dbc9c6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if639f48dcce540048c90f61ab3fb7bc7_D20200425-20200731" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNi02LTEtMS0w_6a4ffcfc-e73e-4e72-ac3d-3a1875428f26">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6371626247f34091a93b2dc205920ab8_D20200425-20200731" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNi0xMi0xLTEtMA_217242da-783e-4bf0-8db6-99f4e5fbf857">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNi0xNi0xLTEtMA_d39e0acc-b246-4d44-be84-3c8574f88434">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if639f48dcce540048c90f61ab3fb7bc7_D20200425-20200731" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfOC02LTEtMS0w_497a2195-db50-4c6b-93f2-79b05032e96e">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6371626247f34091a93b2dc205920ab8_D20200425-20200731" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfOC0xMi0xLTEtMA_807fc4f0-6a3c-4e41-a2d7-4303e9cf7f6e">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfOC0xNi0xLTEtMA_26a5c279-40e4-4606-9f58-c5da67e9bce9">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes to noncontrolling ownership interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85c770bf95844dd9931cef47b1f7be43_D20200425-20200731" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfOS0xNC0xLTEtMA_0b869657-06ca-4868-b63b-531a60e55b1a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfOS0xNi0xLTEtMA_5ccadc4c-b251-41a8-807c-df20cdd813ce">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative effect of change in accounting principle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94296a7b45e4e3dbe2d67900645d435_I20200424" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtOC0xLTEtMA_e9f5a671-e985-4efa-a7de-32b8d8ba52dc">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib110981db8f14c9cb4cbb63889887dd7_I20200424" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtMTItMS0xLTA_ddd13094-0923-471e-945c-abade1a03459">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic409e1c550db48e5bcd4ce67616935c8_I20200424" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtMTYtMS0xLTA_9f0883c5-6692-4daf-b6ef-72a9af546716">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i72605901d1f74ce597b028c09d4dd3a7_I20200731" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtMi0xLTEtMA_cae18615-6d82-4feb-aa27-3c6bdf5495cb">1,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72605901d1f74ce597b028c09d4dd3a7_I20200731" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtNC0xLTEtMA_a2ed7179-f446-44a3-a3ac-d3c8fe184baf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a5dac7b3084d7a84a6335f68c0ceed_I20200731" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtNi0xLTEtMA_41a7b3ad-7ec8-476d-bfea-ee2e24084ecf">26,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id628b7deeefa46eba3e8cce6bf5edf04_I20200731" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtOC0xLTEtMA_7b6633d1-c0ae-421d-8b87-ed8078988f74">27,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie418c42f639e4cb68a0a9bac1b9871d8_I20200731" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtMTAtMS0xLTA_d39033c4-23b6-48c2-825f-ecf5e53b2f31">3,782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie49fd01017d6410babb0baa6095d8df8_I20200731" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtMTItMS0xLTA_eb634018-ae8d-45a4-a083-cef02b792c00">50,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d56739612b4fba968994692f0deff1_I20200731" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtMTQtMS0xLTA_a6a4b872-b7ea-4a5d-b04f-ef8b2b027221">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08ae410a74984dc0a1a2e5d64185b3a1_I20200731" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtMTYtMS0xLTA_a353d099-0d2d-4a52-aad0-f877a7b756d8">50,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69cfa6db80bb43d89a510e85d2efae77_D20200801-20201030" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTItOC0xLTEtMA_7b5d6ef7-ad23-4a02-a008-b700ea173728">489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTItMTItMS0xLTA_2aeff4d4-8d48-489e-9d61-c89e55a91e10">489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieedf1ec037a4442aaef3abd0076151d8_D20200801-20201030" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTItMTQtMS0xLTA_262fda62-66b4-474e-a67c-c3f9534c035b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTItMTYtMS0xLTA_ba58cc0d-9637-4ef6-a073-a4e69387640b">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i720289bbdf744d3c8b2dcfad03251c89_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTMtMTAtMS0xLTA_5371965a-ff35-4522-9ed1-c68ef80ba223">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTMtMTItMS0xLTA_561ef073-29f2-463a-83b3-9945c4b88212">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieedf1ec037a4442aaef3abd0076151d8_D20200801-20201030" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTMtMTQtMS0xLTA_6d61e8b1-1448-4840-9f0c-86a9040d6d95">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTMtMTYtMS0xLTA_751eae9e-0901-4996-9683-5826aedcb014">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends to shareholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOmU2MTM0MmIzZjlhYzQ4MDY5NmM4NzIwODI2ZjJlZDdiXzMx_cdcfc864-c20e-4bf1-a27a-976f7805e0a9">0.58</ix:nonFraction> per ordinary share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69cfa6db80bb43d89a510e85d2efae77_D20200801-20201030" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTQtOC0xLTEtMA_6bb561aa-fe94-45b0-a9eb-6b4945c4748a">780</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTQtMTItMS0xLTA_0167480d-41c8-4c17-a5f8-cb605800d270">780</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTQtMTYtMS0xLTA_44e04391-1424-4baf-8396-1dbcb5464668">780</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares under stock purchase and award plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if31334823c424f9c82c6d16a6bd8c729_D20200801-20201030" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTUtMi0xLTEtMA_2193f123-8062-434e-b5a4-6568e4d5f260">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28dc26d87a9e4efaa4d5051ff8841788_D20200801-20201030" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTUtNi0xLTEtMA_695f90bc-f76e-4a9e-89ff-a9874278f1ce">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTUtMTItMS0xLTA_a569cea1-1b68-4cbc-b15b-5b820698bcbc">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTUtMTYtMS0xLTA_12ef080c-8a2c-418c-8499-352cf4acd558">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28dc26d87a9e4efaa4d5051ff8841788_D20200801-20201030" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTctNi0xLTEtMA_69d732ad-5f8d-414b-b06a-e1a0d941de34">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTctMTItMS0xLTA_0ec43889-7c33-4e94-842d-b62227d7259c">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTctMTYtMS0xLTA_78614c7c-e491-4b17-8cfd-139994cc0d84">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes to noncontrolling ownership interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28dc26d87a9e4efaa4d5051ff8841788_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTgtNi0xLTEtMA_7081657f-11ed-4639-850c-426442405241">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTgtMTItMS0xLTA_1e764d0a-d2ec-404b-bf7e-337acf21a3df">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieedf1ec037a4442aaef3abd0076151d8_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTgtMTQtMS0xLTA_f224ba5b-1a4e-44f3-a457-c829c0413a40">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTgtMTYtMS0xLTA_37ffdbd4-cab0-420e-886b-a0eef4b9acde">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia21542305a5946e8b39788bc982841f6_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtMi0xLTEtMA_6c448352-7ddc-4baa-acc9-6728a7a02f54">1,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia21542305a5946e8b39788bc982841f6_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtNC0xLTEtMA_396631eb-3b4a-4af6-9ecd-b5084e990194">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe9b124d8ca41e981b8cf95b5ea6242_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtNi0xLTEtMA_e0ed17fa-770c-4359-b154-3157cab68255">26,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i992522324432452d9ca66c8a4b298efd_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtOC0xLTEtMA_3823b1f4-bf49-4d11-af74-9f6fcea281bb">27,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fb60693b842404b9c6c710c434a9f46_I20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtMTAtMS0xLTA_3b62e83c-e763-4335-9ec9-5619b0783266">3,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if93a3ed7d08a4808a025b1a3549ab044_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtMTItMS0xLTA_82fb7606-f3dc-4c52-a45e-06d2fc2fa176">50,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i111f8934e3d049098d7b0406e926375e_I20201030" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtMTQtMS0xLTA_2a8b0674-a422-45bb-98b0-e1e06cb77871">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtMTYtMS0xLTA_a59cdcd9-dda4-4158-8757-994cb343a543">50,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczNw_fa25eaf7-b332-49ab-a18e-8831f6fd4c6f" footnoteRole="http://www.xbrl.org/2003/role/footnote">See Note 2 to the consolidated financial statements for discussion regarding the adoption of accounting standards during the first quarter of fiscal year 2021.</ix:footnote></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.308%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/> Shareholders&#8217;<br/> Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 26, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52de462b431c4555b295ebb144b8351f_I20190426" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi0yLTEtMS0w_63b382e2-639d-4528-bb21-5880403d4ff8">1,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52de462b431c4555b295ebb144b8351f_I20190426" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi00LTEtMS0w_e0db199e-9230-4a06-9dbe-dd7ecee99dcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9126a007a995490e9cb89a8340e8a989_I20190426" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi02LTEtMS0w_7444708d-fdd8-424d-82db-76418cc1e59f">26,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i552f2062fa83483db3124c50e8e701c8_I20190426" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi04LTEtMS0w_3448e61d-0651-424b-9f25-33cf78318fe0">26,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idce4f3b26c5a4fefb9a2268a16c018e1_I20190426" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi0xMC0xLTEtMA_032f1b9c-38de-4537-b05a-96252cd0f527">2,711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f9007fbf9043ab8f457f9c90c97961_I20190426" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi0xMi0xLTEtMA_4eb4793c-7975-42b3-9708-a6fee3e4a23c">50,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488d2783b01647579ba73905fa797719_I20190426" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi0xNC0xLTEtMA_10847a2c-22b7-406e-b55e-c455853f2c77">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33145a1d36f644e3a8066f41beb5b5e2_I20190426" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi0xNi0xLTEtMA_0e0582f0-aea7-422e-b66e-d53b3063899d">50,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb0dd42a0a04276b76c07255e58b0db_D20190427-20190726" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMy04LTEtMS0w_77c6f134-f6de-4a93-aee1-dadc931fbf56">864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044332ce225b4db4897be21e46da5d03_D20190427-20190726" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMy0xMi0xLTEtMA_b72089cf-0e36-4615-9e43-9f5d2b85dbf5">864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28055ea3470d4effb3ed77de9befc2f5_D20190427-20190726" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMy0xNC0xLTEtMA_668f070d-688b-4f47-b2b7-c96511359ce4">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMy0xNi0xLTEtMA_eed6d1f9-02cf-455a-b541-ac19d501e225">877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8759e14cc5034a7993bfef890b7d7418_D20190427-20190726" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNC0xMC0xLTEtMA_4c9ba673-bab0-4feb-a572-741b55a37c06">227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044332ce225b4db4897be21e46da5d03_D20190427-20190726" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNC0xMi0xLTEtMA_c6ab8bba-7915-4df8-9530-9564d1b996e3">227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNC0xNi0xLTEtMA_75b3b132-11c0-4f8c-9bc9-f0bc4cf2ac5d">227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends to shareholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNS0wLTEtMS0wL3RleHRyZWdpb246OTA1ZWU2MGM2YTNmNDQ3MDgxZWJlYmUxODIxNjhlZjVfMzE_13f7749f-6738-4c09-b093-42a3687b4e32">0.54</ix:nonFraction> per ordinary share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb0dd42a0a04276b76c07255e58b0db_D20190427-20190726" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNS04LTEtMS0w_0ae7c179-3fa2-4752-b735-6d5ca47e62e2">724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044332ce225b4db4897be21e46da5d03_D20190427-20190726" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNS0xMi0xLTEtMA_8d05f4ca-acdb-4374-b482-45a8d09f03d4">724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNS0xNi0xLTEtMA_d2d7f012-fc22-480d-b778-f8a528d12c40">724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares under stock purchase and award plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia87757d6c9d640d48a2c1a16626f5bc4_D20190427-20190726" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNi0yLTEtMS0w_5149a73b-14d1-4ed5-b233-5e553ac53f48">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i678e0b51f4cf4d5690b48a63a626a8cc_D20190427-20190726" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNi02LTEtMS0w_84bb0d01-d617-4f64-99fb-ee92db348459">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044332ce225b4db4897be21e46da5d03_D20190427-20190726" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNi0xMi0xLTEtMA_c345f13b-aa33-4f20-a679-daad375e26ea">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNi0xNi0xLTEtMA_a4d1d722-6c8e-49b0-99a8-14743137dfc3">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia87757d6c9d640d48a2c1a16626f5bc4_D20190427-20190726" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNy0yLTEtMS0w_a7041c26-1b7d-4ede-b10a-400ddabb56e6">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i678e0b51f4cf4d5690b48a63a626a8cc_D20190427-20190726" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNy02LTEtMS0w_e958df71-908f-4bfc-9af2-e0ebaa1329e8">328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044332ce225b4db4897be21e46da5d03_D20190427-20190726" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNy0xMi0xLTEtMA_956b2de6-9a8e-45b8-a392-021a4fb64bf9">328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNy0xNi0xLTEtMA_c2de69d7-8260-4281-998d-5937eb3d6dcc">328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i678e0b51f4cf4d5690b48a63a626a8cc_D20190427-20190726" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfOC02LTEtMS0w_231ad45f-8147-476b-8bba-5038b1a20690">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044332ce225b4db4897be21e46da5d03_D20190427-20190726" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfOC0xMi0xLTEtMA_37cedadf-3845-49e9-8874-8bbe720bd361">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfOC0xNi0xLTEtMA_07c17e75-f79d-4bce-8d50-90bce897226b">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMC0xLTEtMA_dcfb84c1-15e9-41b1-a86c-3cf4872b75bf"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative effect of change in accounting principle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4484008ce40941a9abb0b87591c12b24_I20190426" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtOC0xLTEtMA_64fed4ed-ae93-4548-bd94-6c4d709d1c30">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59aafb40e1c3487fb79f88def0cabe5e_I20190426" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMTItMS0xLTA_59c874bf-43c5-442b-8592-f58c242b75de">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93af46c007a64220a69e96a35444a4d0_I20190426" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMTYtMS0xLTA_970ca307-0bd1-473b-bf1f-c3bdbea9361e">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 26, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i275643f747c34984beeb90478e79ad20_I20190726" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtMi0xLTEtMA_ae2c11fb-5e38-4b00-829f-9c8419d67925">1,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i275643f747c34984beeb90478e79ad20_I20190726" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtNC0xLTEtMA_bdbe0f26-bbf4-4f6b-927a-9d671c26b568">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12ad7c520edd49219af398dc688a28c2_I20190726" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtNi0xLTEtMA_2057464d-e61d-4fc2-8d99-11ca945489be">26,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b17bf8998541b3b1a8eaadaa465cb5_I20190726" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtOC0xLTEtMA_c7657a1e-4f59-46c7-b2b5-eda4e650b6a5">26,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a33cca3e32b47bfa87a465de4ceb4fa_I20190726" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtMTAtMS0xLTA_4efce461-5ac2-47f1-835b-44aaac701781">2,484</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieae2d147c0744537a2b2ec49b9cb4379_I20190726" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtMTItMS0xLTA_506957e0-5acb-49c2-aa27-6405c806538c">50,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c2221645f1143a588fcb530d45d397a_I20190726" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtMTQtMS0xLTA_5755cecf-9ee0-4171-ba3a-6c64fa5c9747">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b67d8b2f5e5423fab22a58594388040_I20190726" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtMTYtMS0xLTA_1b5a7820-7149-4175-afeb-adddaf72b1f3">50,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40604cb0c8742fc840c198c66ddfbfe_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTItOC0xLTEtMA_1782f3c8-61e0-4e45-90b7-f6cbc37b1d60">1,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02207236d5774c39981a6d0d117258bb_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTItMTItMS0xLTA_5ff9eff3-4d30-4358-a9a9-9282e4d08b3d">1,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b99796b29e40eabeac0a12c20105e4_D20190727-20191025" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTItMTQtMS0xLTA_32d688be-7c7a-49d9-9510-544788911db4">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTItMTYtMS0xLTA_a9c06ba4-580a-439d-b1d0-1ee4ee6d06a2">1,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91d0e9197fce4eaea0b4d58bb59f7b58_D20190727-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTMtMTAtMS0xLTA_a18ef862-9435-4a7d-8c43-dbfb93e40f1c">127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02207236d5774c39981a6d0d117258bb_D20190727-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTMtMTItMS0xLTA_a800409b-07c7-43fe-9c60-d4c0f5af9cb7">127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b99796b29e40eabeac0a12c20105e4_D20190727-20191025" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTMtMTQtMS0xLTA_41bae09b-c2a5-4fd4-a94d-7aa1eb9e9fae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTMtMTYtMS0xLTA_478e0cd3-366f-489c-b67a-f5b8381f50e5">127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends to shareholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOmUyYTM5MTkxNDUwNDQ4MjlhZTg3OTA5OGI4NWY2ZWU1XzMx_bf759f07-88ae-4b35-b4bb-e21e66359a63">0.54</ix:nonFraction> per ordinary share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id40604cb0c8742fc840c198c66ddfbfe_D20190727-20191025" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTQtOC0xLTEtMA_68010d73-95e8-499e-b38c-9c425b9828b5">723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02207236d5774c39981a6d0d117258bb_D20190727-20191025" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTQtMTItMS0xLTA_85fa499e-8ed6-41df-a767-c341227d9817">723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTQtMTYtMS0xLTA_9167d3a8-b628-4aee-a7db-ae95eef2bce0">723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares under stock purchase and award plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c4d81e283664aefab974994912b8be4_D20190727-20191025" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTUtMi0xLTEtMA_1addbb87-1f0c-4ced-96a1-6ebd781cfd17">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52c82d1243664ffb830c526ef6fcaf0b_D20190727-20191025" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTUtNi0xLTEtMA_1994f06e-b51b-4ef7-a15f-530e3479da75">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02207236d5774c39981a6d0d117258bb_D20190727-20191025" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTUtMTItMS0xLTA_a0800171-2e2c-454d-a3b4-308589b4d4ea">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTUtMTYtMS0xLTA_0ebe0bff-bb8d-4726-85d1-ddeb124d8444">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9c4d81e283664aefab974994912b8be4_D20190727-20191025" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTYtMi0xLTEtMA_ce142405-64de-48a3-831b-b185e586ee79">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52c82d1243664ffb830c526ef6fcaf0b_D20190727-20191025" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTYtNi0xLTEtMA_c59bb31c-7b0f-472a-97dc-75dd2d9d684d">552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02207236d5774c39981a6d0d117258bb_D20190727-20191025" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTYtMTItMS0xLTA_3f94b7d5-1450-418c-9518-593ab3dab117">552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTYtMTYtMS0xLTA_63b8977f-80e0-438f-8a44-c6b42f299c8b">552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52c82d1243664ffb830c526ef6fcaf0b_D20190727-20191025" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTctNi0xLTEtMA_125ab99a-9593-4c0a-ad47-ccfc0a23ba92">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02207236d5774c39981a6d0d117258bb_D20190727-20191025" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTctMTItMS0xLTA_cf7358cf-e5e1-4cbf-ac69-414cc05e1552">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTctMTYtMS0xLTA_b495cd79-1885-43c7-9f3d-35b175e9900e">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ccab2a935344b5791bfcee3cae77ce7_I20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtMi0xLTEtMA_b6d34fda-2ce1-4525-8b74-aaff05122620">1,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ccab2a935344b5791bfcee3cae77ce7_I20191025" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtNC0xLTEtMA_e47792e2-fff6-428e-932d-2b3f16506d50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26eeffc415cf4e6b8336a920c96e512d_I20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtNi0xLTEtMA_9e37d97e-4a23-4797-9b24-1547d8cade95">26,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a319d67f7224e6f8d72495027df5e84_I20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtOC0xLTEtMA_76212a53-a807-4f67-a313-bef1af21c1c4">27,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36754839d63e4461b94b37c7bae9a3fb_I20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtMTAtMS0xLTA_a11d3bf5-7c0b-4762-8c2f-985444399bec">2,611</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77e3bce30a1c435e86c5538940a335df_I20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtMTItMS0xLTA_9818852f-daec-4e6e-bf04-57f228ef4243">50,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife38249405474a528870b8419d041fea_I20191025" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtMTQtMS0xLTA_733ceb84-85ef-413e-9417-ea0030bbee88">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20cd473a93b445c7a57a0c7284cf0cc7_I20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtMTYtMS0xLTA_6ddcbc50-9f88-4327-9c34-f12caa9926e8">50,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczOA_d51809bd-4de2-47ba-92ac-2e5076ce670d" footnoteRole="http://www.xbrl.org/2003/role/footnote">The cumulative effect of change in accounting principle during the first quarter of fiscal year 2020 resulted from the adoption of accounting guidance that requires lessees to recognize right-of-use assets and lease liabilities on the balance sheet. As a result of the adoption, the Company adjusted the opening balance of retained earnings for $<ix:nonFraction unitRef="usd" contextRef="i4484008ce40941a9abb0b87591c12b24_I20190426" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNTgz_64fed4ed-ae93-4548-bd94-6c4d709d1c30">33</ix:nonFraction> million as of April 27, 2019.</ix:footnote></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.635%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMy0xLTEtMS0w_2632bbf6-91e8-46a4-8fa8-86c6b67aa9f3">985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMy0zLTEtMS0w_2b3f4f8f-d3dc-4eb1-b1eb-906dc5ce1f16">2,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNS0xLTEtMS0w_c5e6f70d-acc5-4a16-9608-9c647696b22b">1,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNS0zLTEtMS0w_a30f0d78-f24d-4335-9be1-96d1c4f28a96">1,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfOC0xLTEtMS0w_797ea586-ed34-4107-a0e7-0bc053324ed5">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfOC0zLTEtMS0w_e77611f7-b0a2-44da-b454-857bdb4ff072">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfOS0xLTEtMS0w_626c3252-e316-4b19-88d3-b0600122cb85">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfOS0zLTEtMS0w_27e81f77-1eb0-4b2f-9eaf-7ae3228e3cf4">245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTAtMS0xLTEtMA_f5796d4f-1e85-4145-8413-228489d0f062">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTAtMy0xLTEtMA_ba567cde-b457-4421-a048-5efca6a1bbe2">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTEtMS0xLTEtMA_cf610f66-2370-4adc-b501-0455848a117b">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTEtMy0xLTEtMA_8e5deecf-e3fd-4f94-8dd0-73dc6e99189a">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTQtMS0xLTEtMA_8d0af8d5-4996-4367-a953-4954497712ae">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTQtMy0xLTEtMA_3fe895e0-91e8-47a1-8be5-5cc1c0cc7ede">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of acquisitions and divestitures:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTYtMS0xLTEtMA_a50fda8a-9236-4dec-949d-151d562a3671">669</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTYtMy0xLTEtMA_b1ffa010-4352-4fe5-ace9-d46c187c8ed2">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTctMS0xLTEtMA_015673a8-9ecd-4091-9f3d-7048e8d01d01">145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTctMy0xLTEtMA_138da5e0-1e2a-4171-9018-624e093b007e">267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTgtMS0xLTEtMA_e0130b78-bb52-44f9-a83f-0ba5a757286c">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTgtMy0xLTEtMA_e193e977-c83e-4b41-aafe-6628eb335b00">294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating assets and liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTktMS0xLTEtMA_47e1a967-0240-4115-9bcb-6c3e4817ad50">127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTktMy0xLTEtMA_659e38cf-9a4e-4c76-974e-507220ee2070">170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjItMS0xLTEtMA_49549270-bec4-4b5c-851a-990e8039de37">2,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjItMy0xLTEtMA_b9344316-03d8-438a-beb0-89ed4fab3cb6">3,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjQtMS0xLTEtMA_149b4d31-3cc2-42e3-88a5-26d3b4290286">370</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjQtMy0xLTEtMA_934b8517-1ddf-42fb-bf14-de493235f351">201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjYtMS0xLTEtMA_e8fac6b5-f66a-4e5e-a5d9-3558d5a5f82a">615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjYtMy0xLTEtMA_8325ad7a-f69e-4f0c-8432-f49b996c876f">584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjctMS0xLTEtMA_e7e8cf7c-2c5a-45a2-8760-4621b4360f67">5,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjctMy0xLTEtMA_627d23f8-1039-4ad5-915b-e637fe781c09">4,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and maturities of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjgtMS0xLTEtMA_969a7188-3c2b-40c3-a563-2c567c49a4ab">4,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjgtMy0xLTEtMA_8cce93b3-410d-4926-9124-152140508232">3,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjktMS0xLTEtMA_9bd27bf2-d45e-4eb9-9a05-7325ad7201eb">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjktMy0xLTEtMA_077c1316-78a0-4034-a65f-917be65c257e">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzAtMS0xLTEtMA_e2d2c07c-04f4-45b2-93fb-8011e93dc78f">2,012</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzAtMy0xLTEtMA_0e308dab-f403-475e-946a-a26cbe37568f">1,767</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in current debt obligations, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzMtMS0xLTEtMA_4f68e498-56ce-43b1-8bf4-a2ce8f9538cd">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzMtMy0xLTEtMA_f9d1f782-a31b-4b0f-81dd-a44f2451802d">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings (maturities greater than 90 days)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzUtMS0xLTEtMA_335eb9c2-194e-444a-931b-2fa2adb7080c">2,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzUtMy0xLTEtMA_fa78e6ba-c3cb-4250-a606-cfcd5368626e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzYtMS0xLTEtMA_929d19ac-f46b-45f4-8c86-8cb43fefc937">7,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzYtMy0xLTEtMA_abbfbc7c-e4a2-448f-8b6a-04a6830a8e09">5,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzctMS0xLTEtMA_68ec4bf9-8561-4f54-bf84-8246c81036cd">6,336</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzctMy0xLTEtMA_17dfecc5-535e-4b80-9751-28016b758752">5,594</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends to shareholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzgtMS0xLTEtMA_11190945-c1ca-43de-a8e0-a8bcb20ff5b2">1,558</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzgtMy0xLTEtMA_fb815995-90b7-4121-866d-68888d7050a7">1,447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzktMS0xLTEtMA_e3f4ef9b-93a5-46fe-8c94-45414d1f9648">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzktMy0xLTEtMA_fff6c05d-d819-4954-b3f7-37776beb32b6">432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDAtMS0xLTEtMA_b05ae6d7-ca53-4f82-9c36-c64e25ef735a">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDAtMy0xLTEtMA_d4cf7491-7ab1-4356-9c3d-6638822eb27c">962</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDEtMS0xLTEtMA_ce45f21a-7a1e-4423-89c9-fe09b17d5183">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDEtMy0xLTEtMA_f6819217-fbfa-414d-81d5-da5d13df0875">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDItMS0xLTEtMA_dca6968d-e9c4-40fc-a08c-a1e4e6ef4f67">1,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDItMy0xLTEtMA_06fa043a-f561-4838-bce1-7a6bd39b3f46">2,015</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDMtMS0xLTEtMA_2bf03672-5dde-4910-a440-32af353f44da">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDMtMy0xLTEtMA_3b2571cb-a0c1-43bb-8ef4-d835ce6588d1">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDQtMS0xLTEtMA_2870ad16-5ca9-414b-bf6b-14a85b733e73">2,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDQtMy0xLTEtMA_d72456fc-7691-472d-b2fa-b9a0a3916191">431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDUtMS0xLTEtMA_efb46eb2-6063-4b5a-aca8-c145a8d79205">4,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33145a1d36f644e3a8066f41beb5b5e2_I20190426" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDUtMy0xLTEtMA_6cca8aed-d423-48d6-b02b-c153d433c675">4,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDYtMS0xLTEtMA_78ff43e6-aba9-479e-8a3e-0e439f011f43">6,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20cd473a93b445c7a57a0c7284cf0cc7_I20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDYtMy0xLTEtMA_5aa34d8b-324a-4f89-9173-7878b8fc7d79">3,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNTAtMS0xLTEtMA_5516603f-9c0b-4697-b8d6-3c5f9ead0c10">384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNTAtMy0xLTEtMA_87085bf0-d95b-47a9-9946-eb036c901030">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNTEtMS0xLTEtMA_9204c26b-862f-4c71-ad88-c4a2e8221248">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNTEtMy0xLTEtMA_55229583-a001-4e17-9fdd-45b3793d071b">322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_34"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_37"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:BasisOfAccounting" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zNy9mcmFnOmE1OWNlN2U2NmY0YzRkYTVhOWRjYWIzYmM4ODMwOTM5L3RleHRyZWdpb246YTU5Y2U3ZTY2ZjRjNGRhNWE5ZGNhYjNiYzg4MzA5MzlfMzE2MQ_d630d79d-7c0d-4ecd-b671-c4e60b1a416f" continuedAt="i5ee7ae72ffe54b9b8cb7f0ddf81f9851" escape="true">Basis of Presentation </ix:nonNumeric></span></div><ix:continuation id="i5ee7ae72ffe54b9b8cb7f0ddf81f9851" continuedAt="id505e5f3887c4113ba7536ee45850cd6"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zNy9mcmFnOmE1OWNlN2U2NmY0YzRkYTVhOWRjYWIzYmM4ODMwOTM5L3RleHRyZWdpb246YTU5Y2U3ZTY2ZjRjNGRhNWE5ZGNhYjNiYzg4MzA5MzlfMzE1OA_89379d6e-f067-4410-a6ab-e771b8bc3de3" continuedAt="i41071be3f8564079964dd43859333b61" escape="true">The accompanying unaudited consolidated financial statements of Medtronic plc and its subsidiaries (Medtronic plc, Medtronic, or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S.) (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the consolidated financial statements include all of the adjustments necessary for a fair statement in conformity with U.S. GAAP. Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year. </ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i41071be3f8564079964dd43859333b61">Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates.</ix:continuation> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Covid-19 pandemic ("COVID-19" or the "pandemic") has had, and may continue to have, an adverse effect on our business, results of operations, financial condition, and cash flows, and its future impacts remain highly uncertain and unpredictable. The Company has considered the disruptions caused by COVID-19, including lower sales and customer demand than the prior year in many businesses and macroeconomic factors, and has assessed the potential impact on certain accounting estimates including, but not limited to, the allowance for doubtful accounts, inventory reserves, return reserves, the valuation of goodwill, intangible assets, other long-lived assets, investments and contingent consideration, as of October 30, 2020 and through the date of this report. While there was not a material impact to the Company&#8217;s consolidated financial statements as of and for the three and six months ended October 30, 2020, changes in the Company&#8217;s assessment about the length and severity of the pandemic, as well as other factors, could result in actual results differing from estimates. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zNy9mcmFnOmE1OWNlN2U2NmY0YzRkYTVhOWRjYWIzYmM4ODMwOTM5L3RleHRyZWdpb246YTU5Y2U3ZTY2ZjRjNGRhNWE5ZGNhYjNiYzg4MzA5MzlfMzEzNg_d92acb95-2532-4ada-a4fd-1a83a42c0231" escape="true">The accompanying unaudited consolidated financial statements include the accounts of Medtronic plc, its wholly-owned subsidiaries, entities for which the Company has a controlling financial interest, and variable interest entities for which the Company is the primary beneficiary. Intercompany transactions and balances have been eliminated in consolidation.</ix:nonNumeric> </span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id505e5f3887c4113ba7536ee45850cd6">The accompanying unaudited consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements of the Company and related notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended April&#160;24, 2020. <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zNy9mcmFnOmE1OWNlN2U2NmY0YzRkYTVhOWRjYWIzYmM4ODMwOTM5L3RleHRyZWdpb246YTU5Y2U3ZTY2ZjRjNGRhNWE5ZGNhYjNiYzg4MzA5MzlfMzE0OA_aef86e2b-8b1f-4ebd-a773-398711131f11" escape="true">The Company&#8217;s fiscal years 2021, 2020, and 2019 will end or ended on April&#160;30, 2021, April&#160;24, 2020, and April&#160;26, 2019, respectively. Fiscal year 2021 is a 53-week year, with the extra week having occurred in the first fiscal month of the first quarter.</ix:nonNumeric></ix:continuation> </span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_40"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80MC9mcmFnOmM1ZjRmYWFhZDc3ZDQ4OTE5NDZiMjdlZjUwYzI3MTNhL3RleHRyZWdpb246YzVmNGZhYWFkNzdkNDg5MTk0NmIyN2VmNTBjMjcxM2FfNzAx_e7a7ddf6-96f1-4925-849e-e5f1353c2c3b" continuedAt="i981e097c952f4150b18b01500bda355c" escape="true">New Accounting Pronouncements</ix:nonNumeric></span></div><ix:continuation id="i981e097c952f4150b18b01500bda355c" continuedAt="id89cbb41f71c49e98130aa057e2adf5b"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80MC9mcmFnOmM1ZjRmYWFhZDc3ZDQ4OTE5NDZiMjdlZjUwYzI3MTNhL3RleHRyZWdpb246YzVmNGZhYWFkNzdkNDg5MTk0NmIyN2VmNTBjMjcxM2FfNjky_ca3c4315-17a0-40e8-8b22-a9a1b185baa3" continuedAt="i880b311337a14a0aa237b2245b02f258" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Current Expected Credit Losses</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="id89cbb41f71c49e98130aa057e2adf5b"><ix:continuation id="i880b311337a14a0aa237b2245b02f258">In June 2016, the Financial Accounting Standards Board (FASB) issued guidance which changes the methodology to be used to measure credit losses for certain financial instruments and financial assets, including trade receivables. The new methodology requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset. The Company adopted this guidance using the modified retrospective method in the first quarter of fiscal year 2021. The adoption of this guidance did not have a material impact to the Company&#8217;s consolidated financial statements.</ix:continuation></ix:continuation> </span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_43"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzkyMg_e1c8145c-517d-4b63-b144-db9b5bec8a2d" continuedAt="i1a286da704364ada910ed60e8b11cd20" escape="true">Revenue </ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1a286da704364ada910ed60e8b11cd20" continuedAt="i807ac4921f6a4626bf5d006f02007455">The Company's revenues are principally derived from device-based medical therapies and services related to cardiac rhythm disorders, cardiovascular disease, renal disease, neurological disorders and diseases, spinal conditions and musculoskeletal trauma, chronic pain, urological and digestive disorders, ear, nose, and throat conditions, and diabetes conditions as well as advanced and general surgical care products, respiratory and monitoring solutions, and neurological surgery technologies. The Company's primary customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations.  </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i807ac4921f6a4626bf5d006f02007455" continuedAt="i3f1a5332adc6418ba26efbc2d28773d4"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzkyNw_8ddb5457-179a-4ee1-8f90-87f7ae5bb6be" continuedAt="i100d0eda754945a3862317997220c384" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by segment and division for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm &amp; Heart Failure</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06dc9f6bc4aa419bbfe27b17af09fe0a_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMi0xLTEtMS0w_e15a2c16-5828-4593-8ff4-cb44e8aec8fb">1,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i269fa9ffafa24ecebf48c60b39842dab_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMi0zLTEtMS0w_849a36ee-1c70-46dc-abbd-cd6f371ded75">1,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91fb2eb368934993bcd7a0f9575fa788_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMi01LTEtMS05Nzk_391653f1-7112-421a-a811-25710b1dfd46">2,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacc575534b9240399501f15b894e067a_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMi03LTEtMS05Nzk_10e15d50-c89a-4b82-ad5c-72042d53c483">2,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coronary &amp; Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i487ad5972a2c47febec797b0e0776ddb_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMy0xLTEtMS0w_54580fb0-41ba-48a0-a659-c782371fe1c7">831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5caf67e2be4f68ad7f92d16ada67f7_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMy0zLTEtMS0w_999a82a9-b640-43bd-b3cc-ec3a99dec2f3">955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i919fa29680244ba4b8253a93aa18f460_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMy01LTEtMS05Nzk_bcebe9fc-c7ad-4eff-a8d9-2e014733661b">1,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia64dace9b6414c26928f6b70651158e4_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMy03LTEtMS05Nzk_62ae519c-1e78-4d29-89a9-00a78ab4af46">1,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aortic, Peripheral, &amp; Venous </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id24613977cb54f098d9805b207b29a55_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNC0xLTEtMS0w_0212b8fa-2b5f-4e77-919c-3644e0a8c12e">468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220395ee33ee437396566fcc3626b2a2_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNC0zLTEtMS0w_cde55e4f-be29-468e-979a-45330c24a7e3">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic09f65a4d2d84a4c92acaac75a0e15d9_D20200425-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNC01LTEtMS05Nzk_9d7fc28c-152c-4020-b420-36e6fc2947a5">873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c9f4935fea44124bf3d4a1a49aa9040_D20190427-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNC03LTEtMS05Nzk_1f8eeacf-8a2e-497d-821c-0db9108387c4">942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac &amp; Vascular Group</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a312d23d83d4502a1392fed0d7ba764_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNS0xLTEtMS0w_cb2f123f-248e-4023-b76d-2f6f2e4956f3">2,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b239a3126a4bb49c5e7d5b60ab13f1_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNS0zLTEtMS0w_a7076fd3-e5bb-47b4-bd16-5b9c22236c3e">2,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ca6f74752024dcb8dbf523283f9b0ef_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNS01LTEtMS05Nzk_6316894d-5392-4306-84fb-898fa8b10346">5,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fc22c6d55b43f2baae1649a5d9aebe_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNS03LTEtMS05Nzk_7c4c7556-520f-4d79-bbd9-2d31765aee2f">5,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Innovations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id48f0ff947294dd49ff34d19b294e672_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNi0xLTEtMS0w_a47e0cda-40d7-42d2-9224-a4a990f9222d">1,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c6177e6a344d759591f1b0f76cb5ba_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNi0zLTEtMS0w_8d102cc1-9014-4f50-9db5-eb2b49577f94">1,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic752b9473c764500acd5730cdefe3be4_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNi01LTEtMS05Nzk_92932ddf-e1b9-4d6c-9e2c-a85961e3a2ef">2,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb60e8143094d27a9a05d4c84ead362_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNi03LTEtMS05Nzk_8ae2f8c3-e79b-41ec-b89c-5cd6a6b30221">2,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Respiratory, Gastrointestinal, &amp; Renal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131618c7183472b800356aed3d45c7c_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNy0xLTEtMS0w_e7b3b995-293e-4508-be24-4091cb7a69fb">893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ca6860129f4055bed2c98b4ce69e3e_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNy0zLTEtMS0w_a15659cf-bc54-47fc-be1d-33322e824750">688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4e72a8a6dab4f788a302f0f0cf79096_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNy01LTEtMS05Nzk_e2d26444-4716-4cb9-8fc2-29ccbc0816a2">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bd062672d454f1e8a9d5bb8d4322a32_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNy03LTEtMS05Nzk_727176f0-f312-4fc3-9adc-2e35b7f6fdbb">1,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b3758a87a354529882de9d3335644c0_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOC0xLTEtMS0w_61ec105e-20d2-4673-8ce3-c3a79dfd97d6">2,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d63caefd6b48e69f2a86e37189768c_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOC0zLTEtMS0w_56d864b2-e2e1-4fc5-9c39-6c4f011d7026">2,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieac0a2b04a964cccb353c56583b8d073_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOC01LTEtMS05Nzk_6eb9e1be-caa5-436f-a1fc-d24195c418a3">4,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71d43d788d014fd7a1ba8bdea4691710_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOC03LTEtMS05Nzk_a8eda7c2-05a2-4bde-89ae-dcd172e22f74">4,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cranial &amp; Spinal Technologies</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide47cbfb7b0b4342bf4ea373f2ce909a_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOS0xLTEtMS0w_c10116d5-e1e7-4baf-8fee-811a96a18357">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief0f6318a0b04247be6884fe9e17d5b1_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOS0zLTEtMS0w_a8669b17-fc74-4a74-9555-70fbd33fff2a">1,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0ec325078447fab69eeca2bdca138e_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOS01LTEtMS05Nzk_fe2502e9-0eaf-4e47-8eef-0b35deee30eb">2,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d27cd3056dc4459a2cc70f6dc711dff_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOS03LTEtMS05Nzk_936d15b5-6b70-4f4a-bf6f-25d3664e6877">2,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f5d914dd8d4e04b7d2a35e01bb9bf3_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTAtMS0xLTEtMA_8dc74ef4-e572-4118-be04-b280944db0e8">581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313d0d047bd048469aa9949a611758d3_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTAtMy0xLTEtMA_0379a826-a514-4f97-9e1d-16bd12161fec">575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fc4e1b636e5420f8ac12b6b27b04d28_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTAtNS0xLTEtOTc5_e768ddf5-f935-4c6e-99e0-e9bce1b7f98e">1,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dccdf4f50614d0e9c893b4f40f55384_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTAtNy0xLTEtOTc5_a84c462e-6eec-4beb-813a-bdb25149ec70">1,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9d5d26f5da740a198a88bb8f7973c42_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTEtMS0xLTEtMA_4cf10c62-cd6e-4ae4-befe-395166379045">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if53fca09d7ef4b848279a7fe2579e3d8_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTEtMy0xLTEtMA_441bd2d8-6f2f-4396-bd35-0006921bd448">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4524b53e676148ca86cbcc0f07a84bb3_D20200425-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTEtNS0xLTEtOTc5_85edf310-4674-491f-8f40-1cd5529b6ab7">725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93119b416ab149a386216f786e016df5_D20190427-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTEtNy0xLTEtOTc5_68fa385e-a44a-4981-a1a7-1879715e6d06">818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec22bedaccaa44e19dc9acca8eff8a10_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTItMS0xLTEtMA_65edabf6-cced-4e70-beb4-67e630b5932e">2,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4600b695100d4820a01604a104cbadaf_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTItMy0xLTEtMA_4b23160e-2ffc-4747-b984-9a72a91126dd">2,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d7d6e72a3d4a20b5a5c636e920c38c_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTItNS0xLTEtOTc5_478cbd2d-1189-486e-936b-41e8e2439066">3,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f5b5dfb4654786b8a1527a73a00fcd_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTItNy0xLTEtOTc5_474121cc-c584-4400-96b7-f3afd3a373bc">4,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0be4b9113414c3d997bc3e01adfe216_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTMtMS0xLTEtMA_5877545b-d54a-4b34-b713-ca55262514ef">574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf2e96e50c04872a16be9a18ec034d0_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTMtMy0xLTEtMA_2c63e6e0-6e13-484e-964d-e78ddb930c96">596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i374e41da3175425682886e64b4e59ac7_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTMtNS0xLTEtOTc5_c42f349e-ebcb-4256-8599-986f4be51091">1,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852dbc45d1014705a3144b798acc4dfa_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTMtNy0xLTEtOTc5_85c8da33-e035-4293-9da2-91b50b0896e9">1,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTQtMS0xLTEtMA_ecc134e9-39b3-4ee4-9793-49327fdef0cc">7,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTQtMy0xLTEtMA_821f536a-32b2-4b48-9a93-a34fd1660b88">7,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTQtNS0xLTEtOTc5_6d472cbb-489d-46ac-8ee9-baf7a7799ab6">14,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTQtNy0xLTEtOTc5_16d059d7-3f1b-4eb6-a9be-bec278802715">15,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)   Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal year 2021, the Company realigned the divisions within the Restorative Therapies Group to the following: Cranial &amp; Spinal Technologies (includes Core Spine and Biologics, Enabling Technologies, and China Orthopedics), Specialty Therapies (includes ENT, Pelvic Health, and Neurovascular), and Neuromodulation (includes Pain Therapies, Brain Modulation, and Interventional). As a result, net sales for fiscal year 2020 have been recast to adjust for this realignment.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i3f1a5332adc6418ba26efbc2d28773d4"><ix:continuation id="i100d0eda754945a3862317997220c384" continuedAt="ic3d5d0b8794f43f0ac32a4b1c4daebb5"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by market geography for each segment for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)(4)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac &amp; Vascular Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbacdf5a92134ca0b1da1422f776402f_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMy0xLTEtMS0w_26b8721f-8db2-47bd-83e9-72e224975a5e">1,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4524b8f3efaf418c873e6e495a80bbc3_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMy0zLTEtMS0w_f72b1ee9-2ca1-415c-92a3-533417014b05">1,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35f7007d83ec443f927267bb6df4c0fc_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMy01LTEtMS0w_5b3facf1-748a-412a-aa8d-f1c1fb44a503">945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i537a942bf4fb4b6eb80e288f1c249edb_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMy03LTEtMS0w_9d90d91c-e721-4538-a440-0df9af1fdf41">890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f8e3cc16c4a404488402b32b4689b44_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMy05LTEtMS0w_7b3dd1b2-0d6f-4908-88cf-728ea0574e41">404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf5d087ffa84fa8abd5a5aa306fda7a_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMy0xMS0xLTEtMA_ddeb2be4-d69e-43eb-8c5c-858ca4b3327b">510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b6321183ca146979a393ac5b3ac26a5_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNC0xLTEtMS0w_3e57f663-7c06-4b45-ba32-278a50babf5e">996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7031548bb00d44e4984fe848fdd877ac_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNC0zLTEtMS0w_8954b547-6ed4-40dd-8ebd-b9c0ce4b8005">922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95113ab22bfc47679021038cda3626d5_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNC01LTEtMS0w_64c07e4c-b70a-42db-91a0-ed11d02f3838">837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide26e733fd264ebeac15b9b238bd8cb1_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNC03LTEtMS0w_ebc05eb3-3e51-4329-b1fc-e624313cd246">782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1024da8bb25a4ecab9fdd229633f9fef_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNC05LTEtMS0w_ffbc1cfb-c7bc-4f13-9f76-21f637aa86c4">452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82224f56dda849528eedfeb6a2648d87_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNC0xMS0xLTEtMA_f3d3f540-56d1-40ff-82ad-c94ea6505851">438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5dc04ed0d044db9fb861aa2555e5b6_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNS0xLTEtMS0w_f4dbb069-0647-43b4-bc52-c69a2e947d72">1,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7c7a1e02fe46c59155bfc029734bd7_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNS0zLTEtMS0w_4977ccce-b47b-411e-b6b2-059cfb64cc20">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cce28fd6194e2c961aede987941a6c_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNS01LTEtMS0w_5da8abb5-5aa7-4fab-b9bd-087422fc0cbc">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafacc4a2c7db427383b4b9439b78bf84_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNS03LTEtMS0w_039e8ed0-f6a9-410a-9ac4-f3966dbc509a">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6948db30839464bb1b8614f17820d69_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNS05LTEtMS0w_1b00f763-bf90-424e-b2ca-c14698c7ae47">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2db71be890924f94a20e986c13b7cfd0_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNS0xMS0xLTEtMA_96fcd02f-e706-4889-8cd8-34a0f342c185">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icba853bd219340caac53ef75115336f3_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNi0xLTEtMS0w_dd6d97e1-73fd-4910-9303-f9ba93608d89">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d1f7d1f952b46de9a5ec5bf956f8c4a_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNi0zLTEtMS0w_cd32f438-077d-4531-9ca3-44cbc788c283">311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3a781a1a3014264be590e09689a0392_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNi01LTEtMS0w_c4703d8f-51c8-400d-bbbd-e93eadd7228e">238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ad14b6e2d99494ca8b0e3e32a58c09a_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNi03LTEtMS0w_21fb723c-1582-46ca-b810-15c87f86b763">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i481e2bb36b4f4ad58fcf6c68706875aa_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNi05LTEtMS0w_611b81e3-6345-4337-bb57-732352dcf8f7">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if569aa4c250e4165a6f2453aded60f03_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNi0xMS0xLTEtMA_5e20aef0-9221-4322-b208-e498850c7324">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e59a2f196984183a973f8905eda8c10_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNy0xLTEtMS0w_bc56d19d-2667-45ab-9334-4870e29dad22">4,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc31344ce037435086c6584f0cbc5603_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNy0zLTEtMS0w_58e05f28-adc7-4fc0-beba-4098accc095a">4,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0b9d71f9af4be0bdef0b12e789d63a_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNy01LTEtMS0w_c312a577-3ec9-480e-9b81-c03345e65a1d">2,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7976d05e19ea43479f40263835baa0f6_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNy03LTEtMS0w_4f7b6724-80e5-496d-996c-53f70ddbf698">2,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief279681dad24d0ab1a402ba5b0534d8_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNy05LTEtMS0w_fe4193a2-8c3a-4b0b-9b73-250d3969ce00">1,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61edff06ccbe49e0923a8285fc14b9d8_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNy0xMS0xLTEtMA_f23fdd88-c28a-48d4-b267-ff987c2586c1">1,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)(4)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac &amp; Vascular Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe51a58c91ff4d568cfa875dc418aa53_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTItMS0xLTEtNzY1Mw_e5cd9f35-b22e-471e-a9ef-5280283d1241">2,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id82317500d8042669bd53b4daa560b23_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTItMy0xLTEtNzY1Mw_a9e4ac20-d3f5-4ba2-9dc0-fe6387ea4165">2,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2cb34fbe86434d9d2e4abed35fa190_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTItNS0xLTEtNzY1Nw_3a7db808-596e-4045-9452-063c4fc4b9fa">1,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9bd82a0a27841599fc9f6054adf2db0_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTItNy0xLTEtNzY1Nw_de7018ce-03fa-43e4-aa01-b22ebd5683e2">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c0e6b71596419bbee4ef75a287dfb0_D20200425-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTItOS0xLTEtNzY2MQ_ad0ec405-b064-4d50-a2ff-482c75008ca8">778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2589b11b8c8b419f90d2110eedd22e72_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTItMTEtMS0xLTc2NjE_7c53b771-95b5-4c32-9edf-a28f7f8e56b3">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0943ccf01b541bd8b688fa0231ab07d_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTMtMS0xLTEtNzY1Mw_798343b5-a15d-4a85-9607-d8bfff0fd145">1,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i857871df90664c4ea9084d7f52e58287_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTMtMy0xLTEtNzY1Mw_21bbbb15-e8dd-4154-a287-ba2e01aefc00">1,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad390d4335a84981b4dbe016e84fec16_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTMtNS0xLTEtNzY1Nw_377dcdfa-a6f8-4d28-bb8d-d760bee34500">1,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i221826c350e8440fa29609ad85dbfe00_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTMtNy0xLTEtNzY1Nw_69e02c83-6ac2-40bf-b8f4-d5f300aebe97">1,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f2d291a1d14c8da1ca068a8184f596_D20200425-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTMtOS0xLTEtNzY2MQ_fe7a26f6-cda6-445d-9ed5-1cd77a63577f">811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d18cd69e527443cbb52344bfc5d1d17_D20190427-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTMtMTEtMS0xLTc2NjE_529c7f55-34e9-458c-b10c-12ad3379bb15">834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0def346fe6e84c4fa17ebb19cef19a26_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTQtMS0xLTEtNzY1Mw_a0c248c8-ce94-4f71-b57a-fd2abad9e7da">2,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3bfd6d86b3b4f0fb2300c2d7f9d363f_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTQtMy0xLTEtNzY1Mw_129b782e-5e09-4c01-b828-4f5e28b57215">2,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23af05bd2c5d45359d3998fa371a34ae_D20200425-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTQtNS0xLTEtNzY1Nw_3be830a6-4f21-4c20-8d95-32c4017e6497">802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaf607ee11904bcd9cf888c004bb4fb5_D20190427-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTQtNy0xLTEtNzY1Nw_47d6a073-492c-4be8-a446-f78e56febf03">842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ae29ca0bdc4f73936473ec74e2520d_D20200425-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTQtOS0xLTEtNzY2MQ_3b3ea53a-4ca5-434d-b6af-0fc248a3fa7b">439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91fc95de785c40258c208144bffa2343_D20190427-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTQtMTEtMS0xLTc2NjE_e65058f2-fc83-4125-8922-7411bd5aa20d">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5940248053940f3ad40aa0896988543_D20200425-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTUtMS0xLTEtNzY1Mw_6d5a3cb4-8ac4-44c9-af9a-31b292d550f2">572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i359b10ddf4d64149867a3e367a9b382a_D20190427-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTUtMy0xLTEtNzY1Mw_20036d18-1462-4634-b007-96825ba078a3">618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i086f2718cdec44d5b96ebdb32ebdbe23_D20200425-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTUtNS0xLTEtNzY1Nw_31d9084a-0b76-4a25-aa4d-496130073141">465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i156b9ba3ff10454382c5d0aebee43dcf_D20190427-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTUtNy0xLTEtNzY1Nw_37aab9fb-75c6-4b14-8ff2-bb8c9b54b994">457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45d51c0af50d408484ec761c3c800e8c_D20200425-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTUtOS0xLTEtNzY2MQ_befd9968-3f7e-4d06-ba3b-2ea5371208e0">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i706ca6327a9945bea2a852ef2e7fc4fb_D20190427-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTUtMTEtMS0xLTc2NjE_526137a8-2bf6-4c2d-be75-63b12ddf356b">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i650829f108154ef79219df52ed0dd76e_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTYtMS0xLTEtNzY1Mw_cf0f07fa-816a-438f-9501-5309804a7103">7,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e309488f2d44b4f90cf8c46966b9320_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTYtMy0xLTEtNzY1Mw_f1156549-9b30-46f6-b418-0fa99f09d1d0">8,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c73c0c36c949138a78ac8a9b55a7ea_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTYtNS0xLTEtNzY1Nw_fef30e3c-ca9d-4ad7-a510-3f58eca7adf8">4,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c94a76a97fb4905b120a4bc756ade5b_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTYtNy0xLTEtNzY1Nw_c0bb569a-06d8-4bf4-9d8d-96541235662d">4,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cb21b8ecb894dc6b9eb7b6003425d7b_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTYtOS0xLTEtNzY2MQ_7c63b9d3-f4ca-4192-8715-aab802090554">2,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15270ce2423347719255bea4dd215ab4_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTYtMTEtMS0xLTc2NjE_97ec1ee2-b798-4661-9787-34c58b886db5">2,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">U.S. includes the United States and U.S. territories.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.</span></div></ix:continuation><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ic3d5d0b8794f43f0ac32a4b1c4daebb5" continuedAt="iaf0b26c305de4e8b8d39c2431618f711">(4)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"><ix:continuation id="iaf0b26c305de4e8b8d39c2431618f711">Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum.</ix:continuation> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of revenue recognized is reduced by sales rebates and returns. Adjustments to rebates and returns reserves are recorded as increases or decreases to revenue. At October&#160;30, 2020, $<ix:nonFraction unitRef="usd" contextRef="i0ff95eb833ec4ac8a94740b1dc4672ec_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMjE2OQ_ec9027a3-4248-4297-bcea-a3562555632e">955</ix:nonFraction> million of rebates were classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i201f7a25b37d4a639737b126db6b299c_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMjIyOQ_cc4b2f1b-2aa1-4ed1-a4f0-1dfe16483658">464</ix:nonFraction> million of rebates were classified as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheet. At April&#160;24, 2020, $<ix:nonFraction unitRef="usd" contextRef="ief6cc83a0158450c8c8c8dfb1b72cb01_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMjMzOQ_7b585870-d1c5-4485-acab-cf001cfd8e14">706</ix:nonFraction> million of rebates were classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="ia759ed90b92c4979a7b3cae67b7f74fa_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMjM5OQ_eb741bbb-108f-484b-bc86-05eabfa812c7">321</ix:nonFraction> million of rebates were classified as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheet. For the three and six months ended October&#160;30, 2020 and October&#160;25, 2019, adjustments to rebate and return reserves recognized in revenue that were included in the rebate and return reserves at the beginning of the period were not material. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Revenue and Remaining Performance Obligations</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a deferred revenue liability if a customer pays consideration, or the Company has the right to invoice, before the Company transfers a good or service to the customer. Deferred revenue at October&#160;30, 2020 and April&#160;24, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMjk2OQ_515ddb56-e76b-4008-ba65-a4d675b1655e">317</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMjk3Ng_31a99ea4-2b5f-4934-99a9-c568ab0220a1">303</ix:nonFraction> million, respectively. At October&#160;30, 2020 and April&#160;24, 2020, $<ix:nonFraction unitRef="usd" contextRef="i0ff95eb833ec4ac8a94740b1dc4672ec_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzAwOA_62e2f411-d628-463d-b1e0-5693f2b366c0">225</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ief6cc83a0158450c8c8c8dfb1b72cb01_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzAxNQ_b9c25c57-2a9f-4486-866c-0e5db7800d89">213</ix:nonFraction> million, respectively, was included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="i27dc3723a0be438391652135f2101c29_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzA3Ng_4dfc74a2-ff11-4053-a956-da284f307bce">92</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3302135c65a2484782311fd82ec693dd_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfNDM5ODA0NjUxNTk2NA_2c179419-5503-4566-a229-170705b401f2">90</ix:nonFraction>&#160;million, respectively, was included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the six months ended October&#160;30, 2020, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfNzY5NjU4MTM5ODg5NQ_63c06629-096b-4990-bca8-ea8ea36fc892">162</ix:nonFraction>&#160;million of revenue that was included in deferred revenue as of April&#160;24, 2020. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations include deferred revenue and amounts the Company expects to receive for goods and services that have not yet been delivered or provided under existing, noncancellable contracts with minimum purchase commitments. At October&#160;30, 2020, the estimated revenue expected to be recognized in future periods related to unsatisfied performance obligations for executed contracts with an original duration of one year or more was approximately $<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzgwMg_01a3df62-c118-4200-a2c1-6453a6a1de9b">1.1</ix:nonFraction> billion. The Company expects to recognize revenue on the majority of these remaining performance obligations over the next <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:RevenuePerformanceObligationDescriptionOfTiming" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzkyMA_bcbffc6c-ef2b-4c8c-ada8-5ca89ef92f92">four years</ix:nonNumeric>.</span></div></ix:continuation><div id="i6128593e20e44bbc8b0671c482ec9b79_46"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfNTAxOA_fe8f8c89-fc14-47f6-9844-bb34e4123bfd" continuedAt="i3ec092781b60499e9be1503a5b4f5257" escape="true">Acquisitions</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3ec092781b60499e9be1503a5b4f5257" continuedAt="ibacd496da6ac4e5dbeae663a90653a45">The Company had acquisitions during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 that were accounted for as business combinations. The assets and liabilities of the businesses acquired were recorded and consolidated on the acquisition date at their respective fair values. Goodwill resulting from business combinations is largely attributable to future yet to be defined technologies, new customer relationships, existing workforce of the acquired businesses, and synergies expected to arise after the Company's acquisition of these businesses. The pro forma impact of these acquisitions was not significant, either individually or in the aggregate, to the consolidated results of the Company for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019. The results of operations of acquired businesses have been included in the Company's consolidated statements of income since the date each business was acquired.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="ibacd496da6ac4e5dbeae663a90653a45" continuedAt="i9aec988823cf49b9af1997eafd018bf4"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year 2021</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair value of net assets acquired during the six months ended October&#160;30, 2020 was $<ix:nonFraction unitRef="usd" contextRef="ia659fbb5fcf346a9a90200d57a4a5578_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTExMw_bbc5f3a9-1121-4b9a-9e20-b6c009486c4f">539</ix:nonFraction>&#160;million, consisting of $<ix:nonFraction unitRef="usd" contextRef="ia659fbb5fcf346a9a90200d57a4a5578_I20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTE0MQ_4fdf843c-6f2d-4b46-9766-b6643600a246">577</ix:nonFraction>&#160;million of assets acquired and $<ix:nonFraction unitRef="usd" contextRef="ia659fbb5fcf346a9a90200d57a4a5578_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTE3Mw_e80bc8e5-0099-4cf1-92f7-344fce904521">38</ix:nonFraction>&#160;million of liabilities assumed. Based upon preliminary valuations, assets acquired were primarily comprised of $<ix:nonFraction unitRef="usd" contextRef="i5b0455f24d0b4a3791fb3fd9fc1efc9a_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTI2OQ_89b87845-317f-4f06-b88e-d7bc29eba4fb">156</ix:nonFraction> million of technology-based intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i5259c4355fa34167856c9efd29463eab_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTMyMA_1669e0b8-e35d-4471-85a1-7e24ebcb7dc6">13</ix:nonFraction> million of customer-related intangible assets with estimated useful lives ranging from <ix:nonNumeric contextRef="ie996b89b72df4251ba0beb6f36061915_D20200425-20201030" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTQzNA_0f6d4e1f-108e-4add-b011-bdabd0dd2be8"><ix:nonNumeric contextRef="i286b913f59ce44a89a6efc03a44edd01_D20200425-20201030" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTQzNA_ec96a79a-1796-4423-aa6d-d057985fbb78">8</ix:nonNumeric></ix:nonNumeric> to <ix:nonNumeric contextRef="i58932d951c2a4621825726d182be8121_D20200425-20201030" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTQ0Mw_20395367-6760-4ce7-bc08-410734f72dc9"><ix:nonNumeric contextRef="i894a513621284324b46eb9a6b6583b3b_D20200425-20201030" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTQ0Mw_a29615ee-8849-4a91-a51c-1301a1b3cee4">15</ix:nonNumeric></ix:nonNumeric> years and $<ix:nonFraction unitRef="usd" contextRef="ia659fbb5fcf346a9a90200d57a4a5578_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTQ4NQ_8f605755-43c5-42d3-83fe-4fb8926a68d2">381</ix:nonFraction>&#160;million of goodwill. The goodwill is not deductible for tax purposes. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i3f58e96a62054a76beef660302748e4f_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:BusinessAcquisitionPurchasePriceContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfNDM5ODA0NjUyMzIwOQ_1e9ee0f5-68fb-414a-ba28-63189d381e06">158</ix:nonFraction>&#160;million of contingent consideration liabilities in connection with business combinations during the six months ended October&#160;30, 2020, which are comprised of revenue and product development milestone-based payments. Additionally, during the six months ended October&#160;30, 2020, the Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjEx_856e44d9-9829-48e6-80ca-dcdd0163967e"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjEx_a9297bfa-24b7-4272-afa0-c9a2f1409177">132</ix:nonFraction></ix:nonFraction> million related to a change in amounts accrued for certain contingent liabilities from a recent acquisition. The benefit was recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income as the purchase accounting was finalized in fiscal year 2020. For the three and six months ended October&#160;30, 2020, purchase price allocation adjustments were not significant.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year 2020</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair value of net assets acquired during the six months ended October&#160;25, 2019 was $<ix:nonFraction unitRef="usd" contextRef="i6458efd12f3d493e954c2b482e7b1267_I20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODM3Nw_e46dda5c-5d42-4118-871c-b5b128eb67a4">272</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="i6458efd12f3d493e954c2b482e7b1267_I20191025" decimals="-6" format="ixt:numdotdecimal" name="mdt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODM4Mw_872830c4-3e73-4dd2-8351-7b72de264ec8">324</ix:nonFraction> million of assets acquired and $<ix:nonFraction unitRef="usd" contextRef="i6458efd12f3d493e954c2b482e7b1267_I20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODM5Mw_e5556857-4ef3-4298-8766-95ecfb89c412">52</ix:nonFraction> million of liabilities assumed. Assets acquired were primarily comprised of $<ix:nonFraction unitRef="usd" contextRef="ied47c882b8944b9a824975e730d6084c_I20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODM5OQ_16c76491-4339-4bd4-a7cd-ec0e8bca8797">139</ix:nonFraction> million of technology-based intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i7f89188c42c54dea947302b6c32918d2_I20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQwNg_8e950918-5b9e-4c56-b739-1524bffb3949">26</ix:nonFraction> million of customer-related intangible assets with estimated useful lives ranging from <ix:nonNumeric contextRef="ieea3c92fd22346e3ba0cbae8446c3146_D20190427-20191025" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQxMw_3e5881af-5fdd-4fe7-bd34-13e254f2fd25"><ix:nonNumeric contextRef="i36b61101ccc34fe1a098c7a0a1438f56_D20190427-20191025" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQxMw_aeeced5b-7f5e-42d7-89db-52ae9f2fdaca">8</ix:nonNumeric></ix:nonNumeric> to <ix:nonNumeric contextRef="i8a9f49019242491fa2753b5c0b454587_D20190427-20191025" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQzNg_0a3858d3-36fe-4556-b9ec-07e58b5c4e1c"><ix:nonNumeric contextRef="i23fc05bb0ae84039aed38c9e14a8d9ba_D20190427-20191025" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQzNg_5a457cc7-dfdb-4473-b6d7-6377925f4da8">16</ix:nonNumeric></ix:nonNumeric> years, $<ix:nonFraction unitRef="usd" contextRef="i6458efd12f3d493e954c2b482e7b1267_I20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQ0Mg_40307eb7-edf5-429a-ae91-e27998e10a1c">40</ix:nonFraction> million of inventory, and $<ix:nonFraction unitRef="usd" contextRef="i6458efd12f3d493e954c2b482e7b1267_I20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQ0OA_b201e0f6-25be-4193-a86a-6eaf9b4059d1">92</ix:nonFraction> million of goodwill. The goodwill is not deductible for tax purposes. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i4420ff33a4ea4338b79bc63a916e8eaa_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="mdt:BusinessAcquisitionPurchasePriceContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQ2NQ_8ac88dfa-d5cc-4484-96c9-450159051012">65</ix:nonFraction>&#160;million of contingent consideration liabilities in connection with business combinations during the six months ended October&#160;25, 2019, which are comprised of revenue milestone-based payments. For the three and six months ended October&#160;25, 2019, purchase price allocation adjustments were not significant.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s business combinations involve potential payment of future consideration that is contingent upon the achievement of certain product development milestones and/or contingent on the acquired business reaching certain performance milestones. A liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is remeasured at each reporting period, and the change in fair value is recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. Contingent consideration payments made soon after the acquisition date are classified as investing activities in the consolidated statements of cash flows. Contingent consideration payments not made soon after the acquisition date that are related to the acquisition date fair value are reported as financing activities in the consolidated statements of cash flows, and amounts paid in excess of the original acquisition date fair value are reported as operating activities in the consolidated statements of cash flows. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of contingent consideration at October&#160;30, 2020 and April&#160;24, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMzc1NA_47844e2f-44ce-40d6-8dac-15413c092d05">461</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMzc2MQ_dd2914d5-a7bc-4c99-9f36-eac7dc68119f">280</ix:nonFraction> million,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively. At October&#160;30, 2020, $<ix:nonFraction unitRef="usd" contextRef="i0ff95eb833ec4ac8a94740b1dc4672ec_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMzc4Ng_a02c3b8a-5a7f-415a-875c-a7fe2a6ce476">342</ix:nonFraction> million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and $<ix:nonFraction unitRef="usd" contextRef="i27dc3723a0be438391652135f2101c29_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMzgzMg_4e7927ee-0cc7-402e-98d2-b659a2b6cd90">119</ix:nonFraction> million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated balance sheets. At April&#160;24, 2020, $<ix:nonFraction unitRef="usd" contextRef="ief6cc83a0158450c8c8c8dfb1b72cb01_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMzkxMg_9bd8c1fa-4602-4562-a6d6-351785a375c0">112</ix:nonFraction> million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and $<ix:nonFraction unitRef="usd" contextRef="i3302135c65a2484782311fd82ec693dd_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMzk1OA_c5108571-f5a5-4f26-b9d0-2626aea3aec2">168</ix:nonFraction> million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated balance sheets. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i9aec988823cf49b9af1997eafd018bf4"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfNTAwMQ_a46fd247-ec1c-44c9-a85c-05ed4703daa0" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of contingent consideration:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08ae410a74984dc0a1a2e5d64185b3a1_I20200731" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMi0xLTEtMS0w_d94c29dc-87e7-4921-be8a-6aab87f907be">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b67d8b2f5e5423fab22a58594388040_I20190726" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMi0zLTEtMS0w_c8ba62a1-80ba-45eb-9521-71d677c10d35">269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMi01LTEtMS05ODE_7bfa48fd-0ff3-41e4-b95d-8a98cb17f05b">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33145a1d36f644e3a8066f41beb5b5e2_I20190426" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMi03LTEtMS05ODE_ac3a192a-e73b-4cdc-a260-2fd55bb98592">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="mdt:BusinessAcquisitionPurchasePriceContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMy0xLTEtMS0w_7e2263ab-bfe7-4bc6-811c-3e5c3562db8f">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="mdt:BusinessAcquisitionPurchasePriceContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMy0zLTEtMS0w_123c1ea9-9d2c-422d-8683-c7f1f6043f91">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="mdt:BusinessAcquisitionPurchasePriceContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMy01LTEtMS05ODE_31cac151-f981-4571-8d4e-0f11a908c5c8">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="mdt:BusinessAcquisitionPurchasePriceContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMy03LTEtMS05ODE_01d62b50-350a-4c55-9a14-473d29f0dc41">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="mdt:BusinessAcquisitionContingentConsiderationMilestonePayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNC0xLTEtMS0w_d8890552-a9a2-4dee-8ee4-707b8a15f808">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="mdt:BusinessAcquisitionContingentConsiderationMilestonePayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNC0zLTEtMS0w_9f1fdce8-96b8-4b08-9230-f4dae361b1e9">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="mdt:BusinessAcquisitionContingentConsiderationMilestonePayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNC01LTEtMS05ODE_a3a9e326-8aed-4a89-8525-293b563e5f3d">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="mdt:BusinessAcquisitionContingentConsiderationMilestonePayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNC03LTEtMS05ODE_09e1cfdd-36b8-4d4c-9388-ef9db99910f3">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNS0xLTEtMS0w_d2a682dd-2dba-4208-907e-1abe6ca7736c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNS0zLTEtMS0w_164a34d1-0d9e-4356-9430-d31cb25585ea">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNS01LTEtMS05ODE_23da7c41-4602-4a4b-a931-0793e5a63ed2">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNS03LTEtMS05ODE_a829bef2-fdcb-4272-bc81-4260ea597b00">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNi0xLTEtMS0w_048e0c02-8b99-4ccf-94d8-08d8bc5c5ce9">461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20cd473a93b445c7a57a0c7284cf0cc7_I20191025" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNi0zLTEtMS0w_162e5f6f-3b6e-4f40-afbd-56d37d32b4c2">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNi01LTEtMS05ODE_546419ec-25df-4261-adde-81d541ba53ba">461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20cd473a93b445c7a57a0c7284cf0cc7_I20191025" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNi03LTEtMS05ODE_03726711-b027-4222-8941-ef185e367a1a">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of contingent consideration is measured using projected payment dates, discount rates, probabilities of payment, and projected revenues (for revenue-based consideration). Projected revenues are based on the Company's most recent internal operational budgets and long-range strategic plans. Changes in projected payment dates, discount rates, probabilities of payment, and projected revenues may result in adjustments to the fair value measurement. <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfNTAwNw_00d797b5-b73e-47f3-b8e2-bc91333ba7e4" continuedAt="i937af51a37d046158049ef5161f0fce3" escape="true">The recurring Level 3 fair value measurements of contingent consideration for which a liability is recorded include the following significant unobservable inputs:</ix:nonNumeric></span></div><ix:continuation id="i937af51a37d046158049ef5161f0fce3"><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:22.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i206d5cfac8764545b5c73b964083df22_I20201030" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMi04LTEtMS0wL3RleHRyZWdpb246YmYwMTkxMTIzZjQ3NGMwNjg1NTM2MjljMTc2ZTVhZjRfNA_7d0eb01f-4338-46ac-9295-6ee104ebc17c">14.0</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ie3e605d554a34a48aafc28f4aec2bc10_I20201030" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMi04LTEtMS0wL3RleHRyZWdpb246YmYwMTkxMTIzZjQ3NGMwNjg1NTM2MjljMTc2ZTVhZjRfOQ_58438a65-d676-4c0d-9378-592638af3fb5">32.4</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6686b72c8d254c0a8ae89c915b162323_I20201030" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMi0xMC0xLTEtMA_62233294-e795-4c6f-8c1b-77f5be95c755">20.7</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Revenue and other performance-based payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i0e362e921abc4ec38c51136161f1dd32_I20201030" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMy0yLTEtMS0w_8f42cf3c-23de-4c88-9fac-441e0c8a0f1d">203</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b72725bfde146b59806f55b4de68183_I20201030" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMy04LTEtMS0wL3RleHRyZWdpb246ZWQ1YmI5NTRlZDc4NGZmY2FjOGUwYTUzOTlmZDAxZGVfMjc0ODc3OTA2OTQ1Mg_66d2dbdb-b9e6-41c5-9eca-1f3d3aa1864a">40</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ibf29640eead0423b8af20621f7e82a6e_I20201030" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMy04LTEtMS0wL3RleHRyZWdpb246ZWQ1YmI5NTRlZDc4NGZmY2FjOGUwYTUzOTlmZDAxZGVfMjc0ODc3OTA2OTQ1Ng_57cea4b0-1c7c-4467-8a97-60e0ae894438">100</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6796994ca7b1457ea2f0996b5fda014e_I20201030" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMy0xMC0xLTEtMA_4447bd10-e065-4a59-ac16-0c212bcaf9e1">99.4</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">2021 - 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17f40c5d5c144485bcaae9a942364fe9_I20201030" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfNS04LTEtMS0w_f9665e72-9a09-447f-9415-2473ed4be7a6">5.5</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4628c29036454d5fa0fc10c68641fb73_I20201030" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfNS0xMC0xLTEtMA_00329409-a3c4-444e-89bb-2cf43761bde4">5.5</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Product development and other milestone-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i478c6a017fc349f59ff0568390ff4f01_I20201030" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfNi0yLTEtMS0w_38967e92-8f96-4e17-a643-b0847f5107ae">258</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i294a126245e1491797b98713fe0945c9_I20201030" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfNi04LTEtMS0wL3RleHRyZWdpb246MTA1OGM5Yjg3YTRlNDFlM2JkOGUyZDA1MzdjMTViNTFfNA_85ad57d1-6b08-40e4-894e-dab4f61c2099">50</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ifc28c29bd1fa43b782141ceb32766ec0_I20201030" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfNi04LTEtMS0wL3RleHRyZWdpb246MTA1OGM5Yjg3YTRlNDFlM2JkOGUyZDA1MzdjMTViNTFfOQ_4e20bb33-cb12-40a6-8a1e-89b5db6f5dc0">100</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id4bab39e35944924a3cd9ffc1393059f_I20201030" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfNi0xMC0xLTEtMA_ca62938b-1d00-438d-afc2-7dbb3663f765">93.2</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">2021 - 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)   Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected fiscal year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:continuation></ix:continuation><div id="i6128593e20e44bbc8b0671c482ec9b79_52"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjU2Nw_d28e6f23-8fc5-4c5c-af81-c08c7e726be6" continuedAt="ia77b611689054a3190fa2d6833292f40" escape="true">Restructuring</ix:nonNumeric></span></div><ix:continuation id="ia77b611689054a3190fa2d6833292f40" continuedAt="i0876dd955b7f462897f9bd4b2b94b16f"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Enterprise Excellence</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of fiscal year 2018, the Company announced its Enterprise Excellence restructuring program, which is expected to leverage the Company's global size and scale, as well as enhance the customer and employee experience, with a focus on three objectives: global operations, functional optimization, and commercial optimization. Primary activities of the restructuring program include integrating and enhancing global manufacturing and supply processes, systems and site presence, enhancing and leveraging global operating models across several enabling functions, and optimizing certain commercial processes, systems, and models.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates that, in connection with its Enterprise Excellence restructuring program, it will recognize pre-tax exit and disposal costs and other costs across all segments of approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="ie19586da83c548419c65ce54dda4ac85_I20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfODc5_0b3924f9-5327-469b-9622-0ca0a8b5bbea">1.6</ix:nonFraction> billion&#160;to&#160;$<ix:nonFraction unitRef="usd" contextRef="i593837cb940d49fa93ab3e7716b6faa5_I20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfODg1_445784b2-22c6-4de2-b270-fbb4b7f989c0">1.8</ix:nonFraction> billion, the majority of which are expected to be incurred by the end of fiscal year 2022. Approximately half of the estimated charges are related to employee termination benefits. The remaining charges are costs associated with the restructuring program, such as salaries for employees supporting the program and consulting expenses. These charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">restructuring charges, net, cost of products sold, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;30, 2020, the Company recognized charges of $<ix:nonFraction unitRef="usd" contextRef="i406d848cd3404dd991012a6440565838_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMTQ2MA_ba8fee60-27c4-4bbf-9226-d05ebd91ef05">90</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i87f3513e1ffc40c7bede0ba00efe2ed4_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDM3Mg_0a70d098-9f3a-4fb1-91c6-3aa2fad7d267">169</ix:nonFraction> million, respectively. Additionally, the Company incurred accrual adjustments of $<ix:nonFraction unitRef="usd" contextRef="i406d848cd3404dd991012a6440565838_D20200801-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMTUwMA_264bc9a1-8112-4b59-bcba-3b52f3b38158">3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i87f3513e1ffc40c7bede0ba00efe2ed4_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDM5MQ_ddfafd9a-1d33-4684-a569-b32691c9b1b0">5</ix:nonFraction> million for the three and six months ended October&#160;30, 2020, respectively, related to certain employees identified for termination finding other positions within Medtronic and contract terminations being settled for less than originally estimated. For the three and six months ended October&#160;30, 2020, charges included $<ix:nonFraction unitRef="usd" contextRef="ifc70a688a0d74e63819c4ade21969f2d_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMTYzNA_f74e0599-98fd-497e-be69-d7163fca10dd">32</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i95902727c56e4c2290a1ca75aaa9d4ee_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDUxMw_44513052-d994-4672-b427-361885fd3b5b">59</ix:nonFraction> million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="i882643c31d764908a9b439838cdcac4e_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMTY4MQ_8516c7ec-035e-43aa-9dac-1659c39186ca">48</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icfe2201ad4e547e4a67d546069665441_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDUzOA_4cd850b0-0e3f-461e-8baa-8103dc4bc4eb">95</ix:nonFraction> million, respectively, recognized within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;25, 2019, the Company recognized charges of $<ix:nonFraction unitRef="usd" contextRef="ic7a56850c3644238ba02de19c9b1c11b_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMTg1Ng_878f332f-3d1c-41c2-9dff-d64877b59c71">95</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8cf9700f41544535a38b9d85f3853147_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDU2NA_f91df618-b244-4912-98ec-e68a2e49b243">231</ix:nonFraction> million, respectively. Additionally, the Company incurred accrual adjustments of $<ix:nonFraction unitRef="usd" contextRef="ic7a56850c3644238ba02de19c9b1c11b_D20190727-20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMTkxOA_53798106-bec1-4d41-9830-4d9cc8290c3b">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8cf9700f41544535a38b9d85f3853147_D20190427-20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDU5Nw_4442356a-628d-45c5-9940-c4955af3b3df">13</ix:nonFraction> million for the three and six months ended October&#160;25, 2019, respectively, related to certain employees identified for termination finding other positions within Medtronic. For the three and six months ended October&#160;25, 2019, charges included $<ix:nonFraction unitRef="usd" contextRef="i6b1e1f29dda94d8db00dc1fb059072d7_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjA5Nw_3f435e06-6c77-45c5-9c23-b6ea26563ee9">32</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i2040f3b39be34880bc79b81b3bbcd824_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDY4MA_313c5a08-e5e9-482b-98b0-d2c3db6ff0f3">67</ix:nonFraction>&#160;million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="i3654a2c834ae4cf7b134b2e121f5c339_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjE0NA_e8356f9e-9906-4fd1-bbdb-5d5723df92a7">35</ix:nonFraction> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i0876dd955b7f462897f9bd4b2b94b16f" continuedAt="ia4f057549d1e4f57a51300732720cbbc"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million and $<ix:nonFraction unitRef="usd" contextRef="i68f172d54ac643f69996cb767c6659f4_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDcwOQ_a1f86159-e140-43ec-a3c7-cd1c5a09349b">77</ix:nonFraction> million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjU2MQ_5ee761d4-6b95-492d-ae4a-1225cc31f702" continuedAt="i823a8e53358e4642935c502d06ceac9d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Enterprise Excellence restructuring program for the six months ended October&#160;30, 2020:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Termination Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Associated Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 24, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3cc36b2ab0b40f69449ff35ae8ea230_I20200424" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMS0xLTEtMS0w_39c56a21-1cd7-4d82-ac79-fda6905ef32a">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedfe76d8c426489e9bea058060893444_I20200424" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMS03LTEtMS0w_ff5be25c-e5b9-474d-a0b3-1da61289a583">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i351e8abc52b741a6b52e469c40e2e761_I20200424" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMS0xMS0xLTEtMA_133379d1-08a5-4d41-be66-1cc39d7e41ce">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da6f2608bec495282ec262dc76cf183_I20200424" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMS0xMy0xLTEtMA_f9dd5d43-93bc-41ef-ac90-7531f173206e">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5464a7ffeef4485685b5fd1e3a463e37_D20200425-20201030" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMi0xLTEtMS0w_01ae3430-2fed-4d75-8578-eb96d0987b1b">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63278b6a1dd844309858a5b5ee35779e_D20200425-20201030" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMi03LTEtMS0w_c040011d-cae4-483a-9c86-81ee766b7d87">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5616aebc236a4e4d97246ff6cb32b98b_D20200425-20201030" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMi0xMS0xLTEtMA_cebcfc7e-bbcd-4cb3-a38e-f2b57f35ce86">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f3513e1ffc40c7bede0ba00efe2ed4_D20200425-20201030" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMi0xMy0xLTEtMA_d9c29ccb-f888-4074-9cb2-8c5bdc0bc10c">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5464a7ffeef4485685b5fd1e3a463e37_D20200425-20201030" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMy0xLTEtMS0w_a0a2533a-b9c8-471c-805f-35352934bf51">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63278b6a1dd844309858a5b5ee35779e_D20200425-20201030" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMy03LTEtMS0w_5b3d2003-806f-45ad-9d25-f3389653d269">146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5616aebc236a4e4d97246ff6cb32b98b_D20200425-20201030" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMy0xMS0xLTEtMA_d60dcd43-db5d-4d51-a08c-e1fe06b323f7">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87f3513e1ffc40c7bede0ba00efe2ed4_D20200425-20201030" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMy0xMy0xLTEtMA_bbb8875f-8258-4514-9a9d-1bc423824301">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5464a7ffeef4485685b5fd1e3a463e37_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNS0xLTEtMS0w_ee9d9bb5-10bc-4942-96c6-27cc925afaa2">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63278b6a1dd844309858a5b5ee35779e_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNS03LTEtMS0w_98043f6b-a4c1-4bad-aadb-9e390d90bae8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5616aebc236a4e4d97246ff6cb32b98b_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNS0xMS0xLTEtMA_8e2715bd-2408-4965-bf0d-3941ad6c25a9">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87f3513e1ffc40c7bede0ba00efe2ed4_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNS0xMy0xLTEtMA_9c85d022-b778-4482-920c-bca318ff5d2e">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94f2a1c0fa6447faa4ffa5ae06ecf9a6_I20201030" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNi0xLTEtMS0w_23649bef-8ca1-4e6c-abf5-7b9139ba3e7e">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247e010f8064236b932fbe29a46c299_I20201030" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNi03LTEtMS0w_e24dab98-3153-4729-918f-8c77d133b012">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia24d860e2e7247b88d59a33bffba5d44_I20201030" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNi0xMS0xLTEtMA_d601beba-789b-4a52-b875-d530db376ee0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c765c8437494e3bb8ad2b29a7d4886a_I20201030" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNi0xMy0xLTEtMA_0022cd79-9458-46ab-9a19-53655ab5b056">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. </span></div></ix:nonNumeric><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplification</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2021, the Company initiated the Simplification restructuring program, designed to make the Company a more nimble and competitive organization focused on accelerating innovation, enhancing the customer experience, driving revenue growth, and winning market share, while also more efficiently and effectively leveraging the Enterprise scale. Under the oversight of the portfolio leaders, this new operating model, which will be fully operational the beginning of the fourth quarter of fiscal year 2021, will simplify the Company's organizational structure and accelerate decision-making and execution. Primary activities of the restructuring program will include reorganizing the Company into a portfolio-level structure, including the creation of highly focused, accountable, and empowered Operating Units (OUs), consolidating Operations at the Enterprise level, establishing Technology Development Centers in areas where the Company has deep core technology competencies to be leveraged by multiple OUs, and forming dedicated sales organizations that leverage the Company's scale but move with the same agility as smaller, local competitors.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company estimates that, in connection with its Simplification restructuring program, it will recognize pre-tax exit and disposal costs and other costs across all segments of approximately $<ix:nonFraction unitRef="usd" contextRef="i7f09f557003848f4b76b538b6807be01_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDMxOA_64624ee1-137a-4d76-8775-91013ea71425">400</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="if533fbb2e7804a49bd733441ec860383_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDM0NQ_b6789c83-4d27-4122-8845-1cc97b41db95">450</ix:nonFraction>&#160;million, the majority of which are expected to be incurred by the end of fiscal year 2022. Approximately three quarters of the estimated charges are related to employee termination benefits. The remaining charges are costs associated with the restructuring program, such as salaries for employees supporting the program and consulting expenses. These charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">restructuring charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the three and six months ended October&#160;30, 2020, the Company recognized charges of $<ix:nonFraction unitRef="usd" contextRef="i19b7c0d54b864709b8a1d14cc7a5d52d_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NjIyMg_9d0297ff-5385-4dbd-8524-36a6883badf7">102</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NjEyNw_2169165d-ae55-481a-8f4d-63b36d79795a">153</ix:nonFraction> million, respectively, which included $<ix:nonFraction unitRef="usd" contextRef="i19b7c0d54b864709b8a1d14cc7a5d52d_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NjEzMw_9d04bd02-a362-4f84-8740-ede05e0aa908"><ix:nonFraction unitRef="usd" contextRef="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NjEzMw_eb35c29b-3311-4a73-97bf-4d65e5074f12">97</ix:nonFraction></ix:nonFraction> million of incremental defined benefit pension and post-retirement related expenses for employees that accepted voluntary early retirement packages. These costs are not included in the table summarizing restructuring charges below, because they are associated with costs that are accounted for under the pension and post-retirement rules. See Note 14 for further discussion on the incremental defined benefit pension and post-retirement expenses. The charges recognized for the three and six months ended October&#160;30, 2020 were partially offset by accrual adjustments of $<ix:nonFraction unitRef="usd" contextRef="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NjM0MQ_1bec6d72-39c0-442e-a249-16f0993fc1b7"><ix:nonFraction unitRef="usd" contextRef="i19b7c0d54b864709b8a1d14cc7a5d52d_D20200801-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NjM0MQ_501e4e39-7ea2-4cdb-b551-f35aa1454550">8</ix:nonFraction></ix:nonFraction> million for both periods related to certain employees identified for termination finding other positions within the Company. The charges recognized for the three and six months ended October&#160;30, 2020 also included $<ix:nonFraction unitRef="usd" contextRef="i6b3a4116ab3044c5a696abbccd7ee5d6_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3Mzg2MA_9be644f0-2d6f-47d3-a59e-82e6639c8ac3">2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iebed8f31e2bc4cb98986dd61dcc84584_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NTk2Mg_51cf91d6-8433-4524-8093-660da2e33135">3</ix:nonFraction> million, respectively, recognized within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income. </span></div><ix:continuation id="i823a8e53358e4642935c502d06ceac9d" continuedAt="i014daca49a9e41d09c13d4a4e0ae8804"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the activity related to the Simplification restructuring program for the six months ended October&#160;30, 2020:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Termination Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Associated Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 24, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia114c5bf3f0c4db3be119ae9d303c54c_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMS0xLTEtMS0xODc2_02adfd15-6954-4bd5-a3d3-a8c5b243f71c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f140a7453f54937a77f1945a683e562_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMS0zLTEtMS0xODc2_9df7c8a7-3fe6-4432-9b94-f57d5ce8b25e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3619e5e7c1d747c897276367eac949cc_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMS05LTEtMS0xODc2_18d297d8-e3f4-48e4-83d6-45828d3e1593">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied9a45419b034ba293d451d739803159_D20200425-20201030" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMi0xLTEtMS0xODc2_a1049af8-4522-45a7-ae1e-c103ffbb4b7c">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1327a9ff18894e94bd64778ed9244151_D20200425-20201030" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMi0zLTEtMS0xODc2_87a92d36-c8a1-4138-8080-3f3d802c70af">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMi05LTEtMS0xODc2_7d5f346b-702a-4b78-921c-29a634fc28b3">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied9a45419b034ba293d451d739803159_D20200425-20201030" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMy0xLTEtMS0xODc2_b05e87dd-9e35-473c-a11b-73470f2b206a">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1327a9ff18894e94bd64778ed9244151_D20200425-20201030" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMy0zLTEtMS0xODc2_6cd534c1-87e0-4fbd-89aa-7e9c107ce63c">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMy05LTEtMS0xODc2_03249afd-8945-49ad-9256-274557558fb5">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied9a45419b034ba293d451d739803159_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfNC0xLTEtMS0yNjQ5_43f32913-1a14-4d3a-9972-f3de125b0510">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1327a9ff18894e94bd64778ed9244151_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfNC0zLTEtMS0yNjUz_156f5a61-0a16-4c57-a292-4327af7a2237">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfNC05LTEtMS0yNjU3_ce213c84-fcce-468a-b12e-3a3b4285ce61">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee1ecb91f93417abbd820fb1b9263dd_I20201030" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfNC0xLTEtMS0xODc2_7e573a24-3f62-45d9-aef3-48023c428ac8">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d94b407eb34ffcb5ba920befb20402_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfNC0zLTEtMS0xODc2_18edf192-3f79-403a-b5f7-ea26b4b63afb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief7515addc7a424bb17ccbb5efd1bcc0_I20201030" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfNC05LTEtMS0xODc2_19226484-0fda-447e-bcb4-12770f88a7be">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ia4f057549d1e4f57a51300732720cbbc"><ix:continuation id="i014daca49a9e41d09c13d4a4e0ae8804">(1)  Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses.</ix:continuation></ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_58"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDcyMA_eb50e719-132d-49c8-82b1-31580ef6bf03" continuedAt="i00cb7d855a714c35993e6ad1703eb966" escape="true">Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="i00cb7d855a714c35993e6ad1703eb966" continuedAt="i0a23c49a524947d892682c2b8d3450ef"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Securities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company holds investments in marketable debt securities that are classified and accounted for as available-for-sale and held-to-maturity. Investments classified as available-for-sale are remeasured on a recurring basis. Investments classified as held-to-maturity are measured at amortized cost. <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDY3NQ_b6b3a20f-f019-4a7a-9bf8-cdde6f040d80" continuedAt="icd4ab7eb78ce4f4ca6b045b1d2eb1b96" escape="true">The following tables summarize the Company's investments in available-for-sale and held-to-maturity debt securities by significant investment category and the related consolidated balance sheet classification at October&#160;30, 2020 and April&#160;24, 2020:&#160;&#160;&#160;&#160;</ix:nonNumeric></span></div><ix:continuation id="icd4ab7eb78ce4f4ca6b045b1d2eb1b96"><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Available-for-sale securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i443dc4a6e4e7449cb7687aaf2b213890_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNC0xLTEtMS0w_40bc4774-9a68-4482-aaf5-bc6dbc3c7782">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i443dc4a6e4e7449cb7687aaf2b213890_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNC0zLTEtMS0w_fa9b2bb3-0d3b-4ce8-acab-88c385fbf5f2">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i443dc4a6e4e7449cb7687aaf2b213890_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNC01LTEtMS0w_c86bebec-7e79-45ed-93d2-1788de6e9212">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i443dc4a6e4e7449cb7687aaf2b213890_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNC03LTEtMS0w_e2ba1084-b9cd-4b27-aef2-c4f21a95f079">536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245f5fb276724559bcadde6864aa9761_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNC05LTEtMS0w_a17796c0-0601-4071-bd8a-c45b297698b1">536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14e107ca6b34c7aa82198c4055050a7_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNC0xMS0xLTEtMA_07bc117b-8906-4bbb-837b-56ca77352d64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20efc4b8d5624a738f090883fed2d123_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNi0xLTEtMS0w_efe8c9be-007a-41d0-8936-593f8bc63cfa">4,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20efc4b8d5624a738f090883fed2d123_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNi0zLTEtMS0w_aef8c59f-9301-491a-8b3e-d8963df0f677">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20efc4b8d5624a738f090883fed2d123_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNi01LTEtMS0w_317014fd-7cf3-4f83-a734-0697efcb8efa">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20efc4b8d5624a738f090883fed2d123_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNi03LTEtMS0w_0f338ca2-5c03-46aa-af0e-c89ded494635">4,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e3d9441863d40fe83d2a6994feb032d_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNi05LTEtMS0w_c7778d37-3821-430f-b36c-7531dc7f58aa">4,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4320454dbec403185b511f1c64206cd_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNi0xMS0xLTEtMA_d26b06a1-7be2-41e7-8e4d-e21fc94f2634">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2231b706751d46d79c1f65ba057fbb62_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNy0xLTEtMS0w_37402037-3e27-483d-beee-85c091ba15b5">888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2231b706751d46d79c1f65ba057fbb62_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNy0zLTEtMS0w_0c3b8908-443e-4cab-b535-cdc25b4ecaa9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2231b706751d46d79c1f65ba057fbb62_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNy01LTEtMS0w_8f1087d8-8532-4ddf-8fb7-04aa4ba694b6">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2231b706751d46d79c1f65ba057fbb62_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNy03LTEtMS0w_bd78263a-05c7-4679-bf4d-d1cc4ca6e343">888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aa2e63b28634ba9a0d5b4373eb935d8_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNy05LTEtMS0w_de4e4f81-bda6-46a0-b1c3-063c544a281c">888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d5b93a4050490ba354a793fe73ddce_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNy0xMS0xLTEtMA_a4cf04f2-7044-4a8f-ad8a-464ff8ed309c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie865d31224d248118707ff2a738a5f53_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOC0xLTEtMS0w_a2b413c8-3c24-49d9-bdf8-8cc469fefe20">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie865d31224d248118707ff2a738a5f53_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOC0zLTEtMS0w_068c6855-880f-4ef2-bec4-01ee98c4b30c">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie865d31224d248118707ff2a738a5f53_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOC01LTEtMS0w_086fdd28-c0d3-4a38-846e-e45757cb67c8">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie865d31224d248118707ff2a738a5f53_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOC03LTEtMS0w_db22c08e-c8a5-48d7-ad08-ecf10385e3e3">669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic589592a3ea647eb82528ebff28b6c83_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOC05LTEtMS0w_04f40b87-f078-4225-aa93-c64d2126fa9c">669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i678b3811da1f402d875ac6b3061da9aa_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOC0xMS0xLTEtMA_5911d38d-42f0-4929-831c-1456c3b79a06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bc96620aae4f20b504721d4972a52c_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOS0xLTEtMS0w_fb67a394-783a-41cc-b38b-9a26b9e260eb">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bc96620aae4f20b504721d4972a52c_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOS0zLTEtMS0w_4b4dfa70-5e56-46fd-91b2-b26157ea95c1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bc96620aae4f20b504721d4972a52c_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOS01LTEtMS0w_a5ba872c-6e6c-4bb6-98bb-0b0f9a937680">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bc96620aae4f20b504721d4972a52c_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOS03LTEtMS0w_ce0018ca-8ecd-4232-bed0-35109c241420">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if998b6ae16134f37a39d249efcbcc3f7_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOS05LTEtMS0w_11b0a46f-2d00-4a18-92b4-7d12c5ac7d34">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83e463dc1191437ca3f924fd6bd29a84_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOS0xMS0xLTEtMA_919f9b6e-8aaa-49e8-a113-8e30f041b22b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f069030f0a3460c8d945b8cd90214d7_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTAtMS0xLTEtMA_e6894106-1dad-4a17-9739-f68a80b44816">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f069030f0a3460c8d945b8cd90214d7_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTAtMy0xLTEtMA_712cc8d6-d7f1-4519-a18f-6282aebb1b64">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f069030f0a3460c8d945b8cd90214d7_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTAtNS0xLTEtMA_5f155516-df60-4053-957b-13783bcd1bb8">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f069030f0a3460c8d945b8cd90214d7_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTAtNy0xLTEtMA_05c20591-fe43-4a81-840f-0431849eb96e">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46c2eb1479d44550a2ab2d69a99636f3_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTAtOS0xLTEtMA_b65b5f1e-b0c9-4742-bd96-f27c8efb3cdf">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i929d7ecd50044541af233ec2313878da_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTAtMTEtMS0xLTA_383a5990-6705-40a4-b7d3-88ed5aa281e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb2f890b1ec4198b387f05c2c65bc8c_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTEtMS0xLTEtMA_481dd8d3-7de2-41f1-817a-5a984f52f9a7">6,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb2f890b1ec4198b387f05c2c65bc8c_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTEtMy0xLTEtMA_36175ccc-98fa-4a8e-87a1-e83359465517">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb2f890b1ec4198b387f05c2c65bc8c_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTEtNS0xLTEtMA_0fc8398a-8439-4eb0-9806-0403e104d529">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb2f890b1ec4198b387f05c2c65bc8c_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTEtNy0xLTEtMA_05f259a4-28d1-4ea4-b8a8-a09c24750810">6,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afc49c379f449b49731bf51824ea01f_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTEtOS0xLTEtMA_3ca11e46-b310-4af8-9a2c-ced13c89024b">6,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50ab07cf2ffc404da2ed9d85ac2200c8_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTEtMTEtMS0xLTA_e397db97-2473-4e4a-a63f-e1c8fd766222">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06764135b2b4cd0a275054067eb22ca_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTQtMS0xLTEtMA_c9144a03-a295-4119-b224-74a0c64009df">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06764135b2b4cd0a275054067eb22ca_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTQtMy0xLTEtMA_4567845b-4dd8-42fe-8c06-14f12460a9b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06764135b2b4cd0a275054067eb22ca_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTQtNS0xLTEtMA_b8fbda94-e0a5-446f-aa23-05cbd03fead7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06764135b2b4cd0a275054067eb22ca_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTQtNy0xLTEtMA_9d1798bc-03cf-4028-9b12-de1bad29f8c9">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i111933045e354d4f8658708753547778_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTQtOS0xLTEtMA_d71fb4d7-a918-452d-b65b-0f3ded3306ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1db728fe13014c45b129b04929119976_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTQtMTEtMS0xLTA_bec21957-d995-4e1f-b7a2-733c21e3d4de">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTctMS0xLTEtNjczNw_1ca05b59-7d70-40f3-9317-d1bc64ea33f2">6,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTctMy0xLTEtNjczNw_5059c944-ac96-488d-83fb-53bcdf14fe3e">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTctNS0xLTEtNjczNw_2b87dcb1-a9ea-4a34-87d4-a1eff7b6525d">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTctNy0xLTEtNjczNw_b8bdd54a-8fa0-451a-99fb-7a7f60fa7d74">7,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15721ef42f5a4b64a1a941878d5e80bd_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTctOS0xLTEtNjczNw_56f43d71-daf7-42aa-b963-0113aba2a839">6,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTctMTEtMS0xLTY3Mzc_b772c6b9-fb8b-422c-8ec2-12d8635b9187">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Held-to-maturity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126bbe583d1b40e989cd54f8bc8b5fdb_I20201030" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMjAtMS0xLTEtNjc0MA_85385e20-23f4-4003-8325-05ca9c7b70fd">886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126bbe583d1b40e989cd54f8bc8b5fdb_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMjAtMy0xLTEtNjc0MA_8629ad85-9bf6-4cf2-b8c1-5b434ec17009">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126bbe583d1b40e989cd54f8bc8b5fdb_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMjAtNS0xLTEtNjc0MA_378e9407-446b-4b9a-9961-fa26bb27eeb9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126bbe583d1b40e989cd54f8bc8b5fdb_I20201030" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMjAtNy0xLTEtNjc0MA_5f502803-0d78-484b-85b9-ce16a2475b0e">886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89cf40cd27a43f2829d8c0220e90d7b_I20201030" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMjAtOS0xLTEtNjc0MA_b14c43af-ea9e-4a07-b9dc-d1b98000fac6">886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0af3ac423bf349678613c24c3b8a11a2_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMjAtMTEtMS0xLTY3NDA_81e0fb1c-59c6-4e50-9c3a-afb7ddd38d9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTYtMS0xLTEtMA_b8f4c0f0-5d2d-43b0-b886-d4e191bf5e86">7,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTYtMy0xLTEtMA_6dbac435-9acb-4e4f-803c-c0ccc3efb905">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTYtNS0xLTEtMA_85242c47-1d51-47b9-8e44-3933615141de">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTYtNy0xLTEtMA_a315e69a-5d5f-4f56-a0a2-716f86d44d0b">7,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15721ef42f5a4b64a1a941878d5e80bd_I20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTYtOS0xLTEtMA_ddd63645-3b17-4e90-a98d-2a7b351af20e">7,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030" decimals="-6" name="mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTYtMTEtMS0xLTA_96b86e2e-bf7c-46be-bd82-0a8f14eef901">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i028f280fa1334ede95f2032c53ba9603_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNC0xLTEtMS0w_44f93fb0-4b5b-4dda-afe8-0a8ceefc9dab">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i028f280fa1334ede95f2032c53ba9603_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNC0zLTEtMS0w_aa607aff-2f0c-49ec-942c-bef757cf14fc">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i028f280fa1334ede95f2032c53ba9603_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNC01LTEtMS0w_89a59bb9-3d24-4c0d-b0e0-d66c87ce464c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i028f280fa1334ede95f2032c53ba9603_I20200424" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNC03LTEtMS0w_52c29987-111c-409d-84b2-1b1e5a9802c6">589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d4f679d87a43208fe9aa6ceee5a507_I20200424" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNC05LTEtMS0w_3dfbfce9-91ba-4b5e-bcad-968551fe4431">589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f41bbdd83db46cb896344dc0006b64d_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNC0xMS0xLTEtMA_569e32e1-0343-4c40-9365-1aaf0f71b99a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5844ce5002374c9ca4435645ef347572_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNi0xLTEtMS0w_6274f145-cbad-49b3-83b5-32e1239eb350">4,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5844ce5002374c9ca4435645ef347572_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNi0zLTEtMS0w_80fa413e-7c66-4f13-be6d-c95cf4c5c98a">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5844ce5002374c9ca4435645ef347572_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNi01LTEtMS0w_d1af4e78-a1b5-43e0-a4ce-bf100396e1c7">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5844ce5002374c9ca4435645ef347572_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNi03LTEtMS0w_1f370342-732b-4567-81c6-969eac507570">4,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c4a3739c026430f9cb994dd2f7f80e0_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNi05LTEtMS0w_f91540d6-7413-4134-beeb-f434884c5c04">4,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a65bbd4df441ffbbe386c670a74731_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNi0xMS0xLTEtMA_867f9d61-6d93-4c3f-b18d-37d1a5a50768">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15191dfa528f4503a0e2853a1733b631_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNy0xLTEtMS0w_bd2e60a2-ad3b-4187-9ef8-a1cad61106ac">746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15191dfa528f4503a0e2853a1733b631_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNy0zLTEtMS0w_13ef23ed-ebe3-4028-8cfa-76265d63dc6b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15191dfa528f4503a0e2853a1733b631_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNy01LTEtMS0w_24952f7f-4e32-4efd-a1ea-cedfc5acd95f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15191dfa528f4503a0e2853a1733b631_I20200424" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNy03LTEtMS0w_59f22162-2785-4faa-88fb-efef58596ce7">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a12fc35b75d4ccf8c6c5a6b5f9df288_I20200424" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNy05LTEtMS0w_6642c455-4fb6-4214-92ba-15e63f9e44be">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f385943a6ed411da591a03f5bc3abb5_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNy0xMS0xLTEtMA_64ecb50b-64e1-4cfc-a342-4451e51d47c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b3cafb39ad43129046e5127bb34a7b_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOC0xLTEtMS0w_0fd72ec5-bd3d-477b-ad84-a41c28fe5f33">705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b3cafb39ad43129046e5127bb34a7b_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOC0zLTEtMS0w_2e5ca593-0b24-4f14-9320-6cf8f04440b0">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90b3cafb39ad43129046e5127bb34a7b_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOC01LTEtMS0w_da2a3680-887b-4848-9327-7c79f263c0c4">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b3cafb39ad43129046e5127bb34a7b_I20200424" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOC03LTEtMS0w_6161a82d-019b-4ec6-87fb-a3853026a352">697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32cab75680864139a62ff1b5cebde24d_I20200424" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOC05LTEtMS0w_6e4d5a61-f113-48b5-9509-3e8525a40277">697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf012b1a7edb49289534410a88491a96_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOC0xMS0xLTEtMA_babe5260-f34a-47f7-a450-01c7ab448625">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6697a4efd1dc4d249dcfab34c0f70d31_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOS0xLTEtMS0w_bffdea07-c559-4135-b42e-bd5351c4c7a2">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6697a4efd1dc4d249dcfab34c0f70d31_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOS0zLTEtMS0w_6918b83b-35bc-4599-990c-2e681484f580">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6697a4efd1dc4d249dcfab34c0f70d31_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOS01LTEtMS0w_fb62c413-df0d-4765-945c-394f67828c2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6697a4efd1dc4d249dcfab34c0f70d31_I20200424" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOS03LTEtMS0w_46a9f1c0-f48d-4f9c-8e71-b01217a11b85">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3978608b42c04cc5af43262c255f20e6_I20200424" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOS05LTEtMS0w_a4697919-5de0-4b7e-94fd-f2608d295bc5">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463d7b834e2145ad88a0dc521b32cb6e_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOS0xMS0xLTEtMA_5a95d004-bcb0-48bf-9689-ee4a90ddae8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30fd371d44e44ab2b7a26ae857aed3d8_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTAtMS0xLTEtMA_b3ee5dd9-9e37-4ab5-b316-238186273856">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30fd371d44e44ab2b7a26ae857aed3d8_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTAtMy0xLTEtMA_95b0438c-d262-4b18-9627-7e1a0190a277">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30fd371d44e44ab2b7a26ae857aed3d8_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTAtNS0xLTEtMA_d321aaff-fe5b-4795-974e-a02779890488">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30fd371d44e44ab2b7a26ae857aed3d8_I20200424" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTAtNy0xLTEtMA_70556340-8cd7-48ba-b137-444829b16c77">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i355296bb1c604ce98363ad84c2d4096b_I20200424" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTAtOS0xLTEtMA_054a26d3-53a9-484f-9467-47e22590a28f">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa3a8fa30d954c43b8b42c71861c0bae_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTAtMTEtMS0xLTA_1d0a3793-7f05-4ce8-a9d5-575963efc10b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0380d38afb13425093e55e205d427bd7_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTEtMS0xLTEtMA_06d53963-29cb-45d8-9907-2858fbced7f4">6,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0380d38afb13425093e55e205d427bd7_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTEtMy0xLTEtMA_c922e626-932e-49bc-9f67-e8c08bba9d39">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0380d38afb13425093e55e205d427bd7_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTEtNS0xLTEtMA_e0ed7074-1bc9-41cd-960c-61206f748b21">138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0380d38afb13425093e55e205d427bd7_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTEtNy0xLTEtMA_8a482ae0-07ea-4142-931d-8d5cf4002aa1">6,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7ad3736e1640118162dc647a316234_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTEtOS0xLTEtMA_7f53de64-cfe4-4183-a3df-c5ec3e754cee">6,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7af353247eb47508c8e5a3b145eee36_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTEtMTEtMS0xLTA_464bb47b-ca26-4ba2-ae43-86adde7da494">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac8769618c434a12a6120cf93b18a7cb_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTMtMS0xLTEtMA_513c9bb3-989d-47d1-83a8-75b69b64a8b4">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac8769618c434a12a6120cf93b18a7cb_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTMtMy0xLTEtMA_550f5bf5-af5e-4d93-905c-4b08941ea88b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac8769618c434a12a6120cf93b18a7cb_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTMtNS0xLTEtMA_13f48554-126c-43d5-88d6-1df9dcdf5a41">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac8769618c434a12a6120cf93b18a7cb_I20200424" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTMtNy0xLTEtMA_37fafca3-1fe4-45bd-a846-63a716be9749">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d8fc61f591a4b00a4f09dbee10c57e3_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTMtOS0xLTEtMA_442420c2-36eb-4305-88dd-52d22b48f28d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80fccbbafaac424ba13d8f2e11e26efb_I20200424" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTMtMTEtMS0xLTA_c5c0b280-aef6-4998-b775-9a86ce5f3fdf">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTQtMS0xLTEtMA_8d87a656-c6c8-47f6-b53b-0befa7481d13">6,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTQtMy0xLTEtMA_9b8ee439-d1a4-451e-82f9-d7f7379413ff">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTQtNS0xLTEtMA_82e62af6-0b55-4515-bde0-e25fa5626fda">141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTQtNy0xLTEtMA_55aad005-1038-479c-89fb-e1101c59ada7">6,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6433dc1e1b474da0b55da283f18ec450_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTQtOS0xLTEtMA_bbd01466-9c36-4ba8-bf6f-33cd261496bc">6,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d2f91d85114433aa75b3dde1c711d7_I20200424" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTQtMTEtMS0xLTA_5364fefd-61cc-4f11-972b-e35ef6be98b6">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i0a23c49a524947d892682c2b8d3450ef" continuedAt="i3ba62757084a4ee292a0b9acfd3baa24"><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost of debt securities excludes accrued interest, which is reported in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheets.</span></div><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDY4MQ_c803c9e4-0f93-43e6-bab6-6bfa89719396" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the gross unrealized losses and fair values of the Company&#8217;s available-for-sale debt securities that have been in a continuous unrealized loss position deemed to be temporary, aggregated by investment category at October&#160;30, 2020 and April&#160;24, 2020:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than 12 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba52b8426984dcca753b63310d1ba95_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfMy0xLTEtMS0w_126dfdea-919e-4e68-86ee-ba069b4c8c47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba52b8426984dcca753b63310d1ba95_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfMy0zLTEtMS0w_5d55d62e-78a2-45a1-8e4c-8d9b349b7f73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba52b8426984dcca753b63310d1ba95_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfMy01LTEtMS0w_a7dd3bcc-9a8f-45df-a1a7-a407d3babf33">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ba52b8426984dcca753b63310d1ba95_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfMy03LTEtMS0w_addd3cb5-6b0a-4c7f-930c-c50fdc1be237">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2870ad45d3744aacaab561141a1ede79_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNC0xLTEtMS0w_e48b0894-9d2a-4e17-b372-2502b7e36904">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2870ad45d3744aacaab561141a1ede79_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNC0zLTEtMS0w_7de13a62-77be-4257-9daa-25b004e73ba0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2870ad45d3744aacaab561141a1ede79_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNC01LTEtMS0w_4a87fa00-f875-41a4-a96b-4b67ef3f554e">858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2870ad45d3744aacaab561141a1ede79_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNC03LTEtMS0w_e47e6f76-3729-4b96-aca9-d7abcc6651f7">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa258e7bccc4d1d9172fc22def7a0d3_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNS0xLTEtMS0w_adad290a-2caf-41aa-a22f-49a668cf96e0">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fa258e7bccc4d1d9172fc22def7a0d3_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNS0zLTEtMS0w_0a9f5dd4-8259-4843-80be-bd7b461cae86">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa258e7bccc4d1d9172fc22def7a0d3_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNS01LTEtMS0w_5f5ac4cd-4aec-4469-a076-47c67caac8e6">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fa258e7bccc4d1d9172fc22def7a0d3_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNS03LTEtMS0w_7e01e87b-dd77-419f-b524-60ef1214ac52">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i235a5116037045f2960d6c6e2d85ff59_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNy0xLTEtMS0w_ae4183dc-b15c-413b-a07a-c4305ba369b8">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i235a5116037045f2960d6c6e2d85ff59_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNy0zLTEtMS0w_c5c30d4f-064f-4ce5-bea8-b085564eb7bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i235a5116037045f2960d6c6e2d85ff59_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNy01LTEtMS0w_f03af113-8129-49e0-ab42-987f08630b2a">347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i235a5116037045f2960d6c6e2d85ff59_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNy03LTEtMS0w_d0f6ec78-1699-4ec2-8011-6490e31ec8b4">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfOS0xLTEtMS0w_e73b3785-673c-4678-a7a0-e89eff34e227">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfOS0zLTEtMS0w_b8630b94-6d23-41a6-8d23-0feb10fb1a6a">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfOS01LTEtMS0w_1c450c25-fcbe-48d8-96bf-4141327a1f33">1,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfOS03LTEtMS0w_f2bf3396-2409-4979-9342-bfe7bd49a8bf">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than 12 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea98fb3a66024e57afe1c39a4f163883_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNC0xLTEtMS0w_2ae270eb-342d-4b8a-abe2-44879d87f547">1,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea98fb3a66024e57afe1c39a4f163883_I20200424" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNC0zLTEtMS0w_333172cf-e709-4fd4-afc2-4843687f0268">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea98fb3a66024e57afe1c39a4f163883_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNC01LTEtMS0w_2895831f-c0ed-481e-a118-41c361d552e2">2,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea98fb3a66024e57afe1c39a4f163883_I20200424" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNC03LTEtMS0w_3ff37b9d-1a1f-4e65-ae9d-dc793d83a595">88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia258ad2862e4409e90d97a6a185618ba_I20200424" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNS0xLTEtMS0w_ad219a98-e638-46b0-a65b-8a11cf5d803f">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia258ad2862e4409e90d97a6a185618ba_I20200424" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNS0zLTEtMS0w_015b287d-ea2f-4048-b216-f3b5bc24ad18">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia258ad2862e4409e90d97a6a185618ba_I20200424" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNS01LTEtMS0w_ed793e15-88f0-4610-add1-25a22b19646a">663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia258ad2862e4409e90d97a6a185618ba_I20200424" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNS03LTEtMS0w_1b58df63-3d6f-4435-819c-41ab76579a49">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8028e573868a4c60958ff50408279137_I20200424" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNy0xLTEtMS0w_c6cd878b-511a-4ab8-a7d2-54c903789b7c">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8028e573868a4c60958ff50408279137_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNy0zLTEtMS0w_1f697fdc-2aa2-458c-bb6a-28df83fb7034">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8028e573868a4c60958ff50408279137_I20200424" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNy01LTEtMS0w_41f964d2-932f-4230-934a-f221aab2642e">463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8028e573868a4c60958ff50408279137_I20200424" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNy03LTEtMS0w_6c7d6872-489a-49af-adae-f8b57c23d2bb">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8683c78419049719e43eefc5616a8bc_I20200424" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOC0xLTEtMS0w_9162d671-1d26-46e7-8293-c28d34242fdb">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8683c78419049719e43eefc5616a8bc_I20200424" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOC0zLTEtMS0w_de86475f-a4ae-47aa-9564-8b3ca3142e52">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8683c78419049719e43eefc5616a8bc_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOC01LTEtMS0w_97b4f8d5-4365-4dd1-aa84-e92e4b802112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8683c78419049719e43eefc5616a8bc_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOC03LTEtMS0w_db11baef-0d81-4b69-96ea-b8d8d7d4373b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOS0xLTEtMS0w_f2c103cb-0bb5-436c-a76f-570dffd47dc7">1,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOS0zLTEtMS0w_4b10cc84-f794-4206-8791-e683d5128003">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOS01LTEtMS0w_a1671f5d-71ae-415a-bf1f-1d0013d0fcd4">4,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOS03LTEtMS0w_2bda56b1-6bac-4094-9f54-2166537848e8">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy. There were no transfers into or out of Level 3 during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019. When a determination is made to classify an asset or liability within Level 3, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no purchases, sales, settlements, or significant gains or losses recognized in earnings or other comprehensive income for debt securities classified as Level 3 during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019. </span></div><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:GainLossOnInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDY2NQ_2c65d3dd-96a5-4d68-a7dd-0c8b27ca16a2" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity related to the Company&#8217;s available-for-sale debt securities portfolio is as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMi0xLTEtMS0w_4954a8ea-bf28-4766-83d8-68e6adf9714f">1,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMi0zLTEtMS0w_c9a0413e-4b5e-4beb-811a-5e21b85f4c65">1,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMi01LTEtMS01NDg_0c53b8db-619e-4b47-97d3-8670ec01534e">4,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMi03LTEtMS01NTI_293b5388-c510-4107-991d-5409a4e2d30d">3,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMy0xLTEtMS0w_37f1d187-ed4c-41b4-b8c2-91cd989b9908">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMy0zLTEtMS0w_378a60a9-519c-499f-b9d0-937645c4bf2f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMy01LTEtMS01NDg_0fd7bc9e-def4-4cc6-adda-f156730ed55d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMy03LTEtMS01NTI_a3eea48b-6a35-4986-84a8-ece9f4cc14c3">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfNC0xLTEtMS0w_d1f343b3-51ce-4772-bb9c-08b4f3d89661">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfNC0zLTEtMS0w_c5da38cb-ff40-47d8-92b8-cc9f45254b5d">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfNC01LTEtMS01NDg_6a8c069f-78cc-4a2a-a978-7a5dce95e615">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfNC03LTEtMS01NTI_7d425f8e-a15b-4098-a036-60a1f251a182">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit losses represent the difference between the present value of cash flows expected to be collected on certain mortgage-backed securities and auction rate securities and the amortized cost of these securities. Based on the Company&#8217;s assessment of the credit quality of the underlying collateral and credit support available to each of the remaining securities in which the Company is invested, the Company believes it has recognized all necessary impairments, as the Company does not have the intent to sell, nor is it more likely than not that the Company will be required to sell, before recovery of the amortized cost. At October&#160;30, 2020 and April&#160;24, 2020, there were <ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMjI2OA_1a976e9b-9710-40a4-956f-24cae6c01824"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMjI2OA_2376bb26-644d-4adc-ba57-4fce0a0d3c53">no</ix:nonFraction></ix:nonFraction> debt securities in a credit loss position. <ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMjMxNA_68564bb7-a6ad-4a15-aa34-fdfcfcccf3ec"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMjMxNA_68624405-6b24-4ca8-9dbc-545b3329e7b9"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMjMxNA_b104b66b-b6b0-4a77-80cd-d8a92f322e9d"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMjMxNA_cf66743c-2cfb-4ff7-b09e-39ad32513316">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> available-for-sale or held-to-maturity securities were sold for significantly less than carrying value during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i3ba62757084a4ee292a0b9acfd3baa24" continuedAt="ica0c612dc82645519bdf59fa39a0f653"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDczMQ_afb263dd-cc2f-4022-b56c-d459360b25e8" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The October&#160;30, 2020 balance of available-for-sale and held-to-maturity debt securities by contractual maturity is shown in the following table. Within the table, maturities of mortgage-backed securities have been allocated based upon timing of estimated cash flows assuming no change in the current interest rate environment. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-For-Sale</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-To-Maturity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfMS0xLTEtMS0w_9276e895-4735-4368-b65d-b4235b2c0002">1,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfMi0zLTEtMS03ODMx_1d488000-415d-4dba-b5a4-e620203fc73e">886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfMi0xLTEtMS0w_63532a5f-7bef-4978-8ec1-d5fa75389db6">3,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfMy0zLTEtMS03ODMx_0af90074-60c8-43a3-b40e-01583e74701f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfMy0xLTEtMS0w_3677258c-7f76-4865-824d-66e63caf8119">1,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfNC0zLTEtMS03ODMx_93ebd1be-d5c9-4a56-90fa-cfb0614f28cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfNC0xLTEtMS0w_91b722a2-cfb2-423c-b743-0283ecf4aede">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfNS0zLTEtMS03ODMx_ff82b979-d7bb-48aa-bd45-1abbe2ad2b37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfNS0xLTEtMS0w_e8a3f2fb-5cb5-4481-982e-c1ff893b9ba4">7,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfNi0zLTEtMS03ODMx_562e37a6-930e-4b81-b2cb-a70e07d484b0">886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Securities, Equity Method Investments, and Other Investments </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities with readily determinable fair values, equity investments without readily determinable fair values, investments accounted for under the equity method, and other investments. Equity securities with readily determinable fair values are included in Level 1 of the fair value hierarchy, as they are measured using quoted market prices. Equity method investments and investments without readily determinable fair values are included within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs to determine fair value. To determine the fair value of these investments, the Company uses all pertinent financial information available related to the investees, including financial statements, market participant valuations from recent and proposed equity offerings, and other third-party data. </span></div><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDY4OQ_0773bbfd-5870-4af8-8309-69f17d800e2f" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's equity and other investments at October&#160;30, 2020 and April&#160;24, 2020, which are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheets:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments with readily determinable fair value (marketable equity securities)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfMS0yLTEtMS0w_ab2d96a7-db56-490a-bf48-631bca790ea0">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d2f91d85114433aa75b3dde1c711d7_I20200424" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfMS00LTEtMS0w_d67ecbf9-5dbf-4730-b07c-d39a8ee0307b">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfMi0yLTEtMS0w_8ce163e4-5dae-43ec-98ff-b121a93ae5d1">478</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d2f91d85114433aa75b3dde1c711d7_I20200424" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfMi00LTEtMS0w_2f047eaf-f644-43d4-a703-75b16758a75b">391</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method and other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfMy0yLTEtMS0w_6c4eae9c-7b16-4a32-b58b-2571535c33a6">74</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d2f91d85114433aa75b3dde1c711d7_I20200424" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfMy00LTEtMS0w_2ffc306f-3a52-49b4-9f8a-dada5d85f965">71</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity and other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030" decimals="-6" name="mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfNC0yLTEtMS0w_0b513c20-61e1-44fc-b75a-7899d266e004">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d2f91d85114433aa75b3dde1c711d7_I20200424" decimals="-6" name="mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfNC00LTEtMS0w_a181f520-8c72-4a50-b5df-81772fb53eb3">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="mdt:ScheduleofInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDcyOA_63193c1b-8f34-48bc-b111-781c1c1a3c54" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes activity related to the Company&#8217;s portfolio of equity and other investments. Gains and losses on equity and other investments are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.100%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92bacf56288041769a792da708300ace_D20200801-20201030" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMi0yLTEtMS0w_10d0ce9e-7727-458d-bd69-458a5660a195">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefff988b78344694a0de74324a70e787_D20190727-20191025" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMi00LTEtMS0w_82c1ced9-0826-4743-99b0-8c80e841fad5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMi02LTEtMS01NzQ_58954920-9a3c-4018-a0f3-e9787f23d4b9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMi04LTEtMS01NzQ_a22cad81-4267-41d0-af67-1bb112b9f9ef">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92bacf56288041769a792da708300ace_D20200801-20201030" decimals="-6" name="mdt:GainonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMy0yLTEtMS0w_0c41fad4-c5e1-4b2b-aa53-f4af279c9ee3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefff988b78344694a0de74324a70e787_D20190727-20191025" decimals="-6" name="mdt:GainonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMy00LTEtMS0w_25052804-1577-447a-b576-6d7e9e07e468">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030" decimals="-6" name="mdt:GainonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMy02LTEtMS01NzQ_ef55f7b5-8ed2-48ed-a89d-81cb67a0f2b2">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025" decimals="-6" name="mdt:GainonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMy04LTEtMS01NzQ_37ff5f2f-f015-4e8a-a1bd-a0449662e239">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92bacf56288041769a792da708300ace_D20200801-20201030" decimals="-6" name="mdt:LossonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNC0yLTEtMS0w_a78d382f-b53c-4f9b-813c-ffa1604c85ce">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefff988b78344694a0de74324a70e787_D20190727-20191025" decimals="-6" format="ixt:zerodash" name="mdt:LossonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNC00LTEtMS0w_5eb748f4-3123-4d60-a4e8-b35ea79c5ef2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030" decimals="-6" name="mdt:LossonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNC02LTEtMS01NzQ_ce2542ac-c11b-4ffd-bd1a-883e603aa6f5">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025" decimals="-6" format="ixt:zerodash" name="mdt:LossonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNC04LTEtMS01NzQ_81cd475d-9f4d-49f2-8d2c-074f67d20d0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment losses recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92bacf56288041769a792da708300ace_D20200801-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:ImpairmentOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNS0yLTEtMS0w_4ac74a95-92ee-46b1-9823-d3203c3c0e2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefff988b78344694a0de74324a70e787_D20190727-20191025" decimals="-6" name="us-gaap:ImpairmentOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNS00LTEtMS0w_455eaa25-76f9-45ce-a3a9-526fb6d1bddd">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030" decimals="-6" name="us-gaap:ImpairmentOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNS02LTEtMS01NzQ_17b2e884-31ea-4859-a790-146582818cfe">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025" decimals="-6" name="us-gaap:ImpairmentOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNS04LTEtMS01NzQ_5f4fa455-b947-4101-8661-9f994bd9d316">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ica0c612dc82645519bdf59fa39a0f653">The net gains recognized for the three months ended October&#160;30, 2020 were <ix:nonFraction unitRef="usd" contextRef="i92bacf56288041769a792da708300ace_D20200801-20201030" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:GainLossOnInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDM5ODA0NjUxNzgxMQ_a21c0764-fd48-441a-88cb-36188e9088c8">no</ix:nonFraction>t significant, and the net gains recognized for the six months ended October&#160;30, 2020 were $<ix:nonFraction unitRef="usd" contextRef="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDMwNQ_cc2119d9-3eec-48f8-8a09-6f0408b1d9cd"><ix:nonFraction unitRef="usd" contextRef="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDMwNQ_fa7b0795-81d5-40ef-b005-2e5e25bec27b">12</ix:nonFraction></ix:nonFraction>&#160;million, comprised of unrealized gains on equity securities and other investments still held at October&#160;30, 2020. The net gains recognized for the three and six months ended October&#160;25, 2019 were $<ix:nonFraction unitRef="usd" contextRef="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMTA5OTUxMTYzMzc1MQ_0c643c62-b766-4196-aac8-cc7f74ace831"><ix:nonFraction unitRef="usd" contextRef="iefff988b78344694a0de74324a70e787_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMTA5OTUxMTYzMzc1MQ_179967b0-99fa-42f4-8fea-f557bd001866"><ix:nonFraction unitRef="usd" contextRef="iefff988b78344694a0de74324a70e787_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMTA5OTUxMTYzMzc1MQ_82bc61df-0a1a-4e08-949e-7fd2936e5de1"><ix:nonFraction unitRef="usd" contextRef="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMTA5OTUxMTYzMzc1MQ_c8bcbea2-ba9c-4315-87fb-39035773b0f0">14</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;million comprised of unrealized gains on equity securities and other investments still held at October&#160;25, 2019. There were <ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDM5ODA0NjUxODA1NA_1416d994-886b-47a4-9e74-145498fbe9cc">no</ix:nonFraction> impairment charges incurred on the Company's equity securities, equity method investments, and other investments during the three months ended October&#160;30, 2020. Impairment charges incurred on the Company's equity securities, equity method investments, and other investments during the six months ended October&#160;30, 2020 and the three and six months ended October&#160;25, 2019 were not significant.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_61"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDI4MA_58f8085b-0d31-4555-a26f-5fa0977fac94" continuedAt="i84df8cb70a2d4292b6b34fc444b23208" escape="true">Financing Arrangements </ix:nonNumeric></span></div><ix:continuation id="i84df8cb70a2d4292b6b34fc444b23208" continuedAt="ib7ef2f510fd74b36ac3cd579204851cd"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains commercial paper programs that allow the Company to issue U.S. dollar or Euro-denominated unsecured commercial paper notes. The aggregate amount outstanding at any time under the commercial paper programs may not exceed the equivalent of $<ix:nonFraction unitRef="usd" contextRef="i6c177b7debcf4ed489a1c287af63efa8_I20201030" decimals="INF" format="ixt:numdotdecimal" name="mdt:CommercialPaperMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMjkx_1e23a262-7c72-453a-983f-03f94811152f">3.5</ix:nonFraction> billion. <ix:nonFraction unitRef="usd" contextRef="id3958a76b22149358ea04e9d59ab3dab_I20200424" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMjk1_31b6fb3e-1bdb-4581-8fa8-af177c66b99b"><ix:nonFraction unitRef="usd" contextRef="i6c177b7debcf4ed489a1c287af63efa8_I20201030" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMjk1_d934a1a7-a9d9-4075-a3ef-949e202f1753">No</ix:nonFraction></ix:nonFraction> commercial paper was outstanding at both October&#160;30, 2020 and April&#160;24, 2020. The issuance of commercial paper reduces the amount of credit available under the Company&#8217;s existing Credit Facility, as defined below.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Line of Credit</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a $<ix:nonFraction unitRef="usd" contextRef="i949f35c9b7de4f3cbafef0e58607a8f9_I20201030" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNTE5_d67f4165-59ec-4bfb-aa2a-612999ac6fa9">3.5</ix:nonFraction> billion <ix:nonNumeric contextRef="ie3e7e6a0bf3f41a69f7e5b02e57a1cd7_D20200425-20201030" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNTM5Mw_c6db45d4-709a-498b-9a12-3460838a55d2">five-year</ix:nonNumeric> unsecured revolving credit facility (Credit Facility), which provides back-up funding for the commercial paper programs described above. The Credit Facility includes a multi-currency borrowing feature for certain specified foreign currencies. At October&#160;30, 2020 and April&#160;24, 2020, <ix:nonFraction unitRef="usd" contextRef="i949f35c9b7de4f3cbafef0e58607a8f9_I20201030" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNzg3_42c1f2a5-b14b-47b5-92c2-d7f79c833e7b"><ix:nonFraction unitRef="usd" contextRef="i9a912ba559184edb828b6c18fff14699_I20200424" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNzg3_fbe37a6b-af1b-46b8-a3bb-0523f4e72d27">no</ix:nonFraction></ix:nonFraction> amounts were outstanding under the Credit Facility. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rates on advances on the Credit Facility are determined by a pricing matrix, based on the Company&#8217;s long-term debt ratings, assigned by Standard &amp; Poor&#8217;s Ratings Services and Moody&#8217;s Investors Service. Facility fees are payable on the Credit Facility and are determined in the same manner as the interest rates. The agreement also contains customary covenants, all of which the Company was in compliance with at October&#160;30, 2020. </span></div></ix:continuation><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="ib7ef2f510fd74b36ac3cd579204851cd" continuedAt="i580cb1e88def46c0a304977360f38fc6"><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Obligations</span></div><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDI4Mg_1f3090fd-c28f-4cad-ba5e-d936afac8e27" escape="true"><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's debt obligations consisted of the following:</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity by <br/>Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current debt obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMS00LTEtMS0w_5e6931da-c73e-4748-9895-09444cd5dcd6">4,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMS02LTEtMS0w_cae783c4-cd26-4904-ac53-011f8fc0ac59">2,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6e7ded1a38a347e09432a07dee3c0a9c_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS04NDc2L3RleHRyZWdpb246MzI5ZGJlZDllYWVkNDA2YWI5MDdiMTQ4NzNkNWQxZDZfNzY5NjU4MTM5NDQ3Mw_84042592-5c2b-490d-a05a-e19b0b2505a9">3.150</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS04NDc2L3RleHRyZWdpb246MzI5ZGJlZDllYWVkNDA2YWI5MDdiMTQ4NzNkNWQxZDZfNzY5NjU4MTM5NDQ3OA_1fc66852-89e8-4b7b-81e1-6369f8dd3419">seven</span>-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7ded1a38a347e09432a07dee3c0a9c_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC00LTEtMS04NDc2_8e235300-8c5f-43e6-b4aa-94b4956ead40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea679a6b4a74ebeb862f8ec5a9324fc_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC02LTEtMS04NDc2_a53e1a00-0062-4bff-a53f-4095d6531e11">1,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i510c4360710e4c0a914d63f14acbfc0f_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS03MDUxL3RleHRyZWdpb246Zjg2ZWM0YTg4NDI3NGFhOWI0ZGJmYWViM2QzZThlZjBfNzY5NjU4MTM5NDQ3Mw_c5b49f65-edec-49f4-a219-b0925e1d0b91">3.200</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS03MDUxL3RleHRyZWdpb246Zjg2ZWM0YTg4NDI3NGFhOWI0ZGJmYWViM2QzZThlZjBfNzY5NjU4MTM5NDQ3OA_0f544188-5492-43f0-8466-e9aa66f80bd2">ten</span>-year 2012 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i510c4360710e4c0a914d63f14acbfc0f_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC00LTEtMS03MDUx_7d63c37e-8c2f-4a8b-bd51-5b40dec3e27e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f2f4fae83043f3b68e29781af9902c_I20200424" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC02LTEtMS03MDUx_3f0077ca-ebd0-499d-959e-bc023444e49f">650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i28c3585b4c314e93b0ffe730217c8c72_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS03MDU5L3RleHRyZWdpb246M2VjNzUyNTAyZmE1NDIzNWE0OWI2YzNhZTZlZGEyM2JfNA_7a95e7ad-804b-4510-8664-5e3c4e211d1c">0.000</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS03MDU5L3RleHRyZWdpb246M2VjNzUyNTAyZmE1NDIzNWE0OWI2YzNhZTZlZGEyM2JfMTU_434d6196-cd71-423f-b1c6-94ab8fd6f545">four</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28c3585b4c314e93b0ffe730217c8c72_I20201030" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi00LTEtMS03MDU5_587e0ae0-f81f-43f6-a8ad-8586ea6a2257">886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b52a5b1a53c4ac39014d4b15543f3ec_I20200424" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi02LTEtMS03MDU5_962f561b-aa7c-4911-8b43-4c1eb48be352">815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69901d8744fd4d879877219042968d11_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS0wL3RleHRyZWdpb246NjI0ZTZhYTM4MjA3NGI3ZDhkOTYyYWNiZjQ4NDUyNjVfNA_57ac5253-eb9e-4bfc-a41a-92045ccc313d">0.375</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS0wL3RleHRyZWdpb246NjI0ZTZhYTM4MjA3NGI3ZDhkOTYyYWNiZjQ4NDUyNjVfMTU_4e71358d-8a7e-40b6-8487-19339f167751">four</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69901d8744fd4d879877219042968d11_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi00LTEtMS0w_8734c700-0eb9-418d-85d8-ca72f0e707d8">1,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if267642c06af4e0fa5a4118f57c3905d_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi02LTEtMS0w_09f9ebf4-bacb-4795-b070-7132bf626014">1,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i044094c947f94eeba950fa8a0c905013_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS02NTEyL3RleHRyZWdpb246ZWM4Njk1YWJlNjBlNGViOTg3ZWU3MjczM2E3NGIzODJfNzY5NjU4MTM5NDQ4Mg_0c22356a-8a90-41ec-ab27-853ae8544622">0.000</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS02NTEyL3RleHRyZWdpb246ZWM4Njk1YWJlNjBlNGViOTg3ZWU3MjczM2E3NGIzODJfNzY5NjU4MTM5NDQ5NA_f18bfa88-ad2a-419f-b369-44b60f7697ef">two</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044094c947f94eeba950fa8a0c905013_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy00LTEtMS02NTI3_509b0cd7-59a9-4f47-8167-f19cde0fe07a">1,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb7d89c620764ee4a60c49931ad7a1fe_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy02LTEtMS02NTI3_5317693c-ece7-4fc4-b32f-7d500e7ce7cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2511d50310fe4d6296fc4346e10dd64e_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS0wL3RleHRyZWdpb246ZTc2YTM4MTBiNTI1NDMyYzkwY2FhNTg2ZWNhYmU0ZjJfNA_d345961c-e6aa-4001-8d54-273c160569c1">2.750</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS0wL3RleHRyZWdpb246ZTc2YTM4MTBiNTI1NDMyYzkwY2FhNTg2ZWNhYmU0ZjJfMTU_7216313b-f8c0-40e6-99ac-4a1d7fa40514">ten</span>-year 2013 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2511d50310fe4d6296fc4346e10dd64e_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy00LTEtMS0w_0a307da9-8bd5-41eb-af78-18608ef2b93b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id20e750596f440789ec340620cf569f8_I20200424" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy02LTEtMS0w_a77b3c01-0c6b-406c-838c-bbf2fb3de7d6">530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic67fdda296f8439da5d36130db1168cc_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfOS0wLTEtMS0wL3RleHRyZWdpb246NDM3NzdkMzViODVmNDM1NTlmNjI1MGRlNTNjYjIyNTZfNA_76e38993-f103-4e54-ae68-a5d310bf20e5">2.950</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfOS0wLTEtMS0wL3RleHRyZWdpb246NDM3NzdkMzViODVmNDM1NTlmNjI1MGRlNTNjYjIyNTZfMTU_73fcdfe3-1699-4e4e-a1b3-6abc413aba37">ten</span>-year 2013 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67fdda296f8439da5d36130db1168cc_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfOS00LTEtMS0w_f32ba5f3-fe85-45c1-8976-1ad9cc3f2f9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b917b2cd2a4484bb2a8f5bd83abdc3c_I20200424" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfOS02LTEtMS0w_23fbd9cf-908a-421e-98b5-1ac6e90a9538">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69633ff6d0b54867b5bf49aa176cfef1_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjBkZGE4M2Y1MTQ5YTQ2NWNiYTYyNGI3YzQ2Y2FmOTc2XzQ_dfb35555-6923-442d-a488-498fb18148a6">3.625</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjBkZGE4M2Y1MTQ5YTQ2NWNiYTYyNGI3YzQ2Y2FmOTc2XzE1_3cf05ffe-b2a6-4335-96b8-f9d8eb8335a3">ten</span>-year 2014 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69633ff6d0b54867b5bf49aa176cfef1_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTAtNC0xLTEtMA_82ea1a37-7da2-419d-bc5f-6e4caa29536d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bb4791a9be48879236f93b8dbf5a54_I20200424" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTAtNi0xLTEtMA_615efe9b-de92-4702-bbc3-239a11da8a9e">432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5c8bd11650841f792d159c232d7e48d_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjMwZDAzODE1ZTQ2YjQ0MGI5YWRkOGIyNjE4NjI1MTY4XzQ_7fd38da2-64a0-4bed-aa1c-eeb0d5029fd5">3.500</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjMwZDAzODE1ZTQ2YjQ0MGI5YWRkOGIyNjE4NjI1MTY4XzE1_5a8917d8-b557-4f27-97d0-e5d0ca330706">ten</span>-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5c8bd11650841f792d159c232d7e48d_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTEtNC0xLTEtMA_9ebf87ff-4f9d-4c9a-90e6-37cc3fab812f">1,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i282da68e884d461f91dc382fe42a1836_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTEtNi0xLTEtMA_df16b23c-6870-4deb-87e5-177d0a52fcfc">2,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c789745205747e59bcd97e1084d2e14_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjY4MTNkM2VlNGE3MjQ2MzQ5ZGY4NjgzMGRjNjA5ZmI2XzQ_9b12f6fd-9f56-4807-a84e-c903a0eb9631">0.250</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjY4MTNkM2VlNGE3MjQ2MzQ5ZGY4NjgzMGRjNjA5ZmI2XzE1_dd01a2f7-a10b-4245-962c-1c722b265da7">seven</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c789745205747e59bcd97e1084d2e14_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTItNC0xLTEtMA_ab30a0da-18c9-449c-996b-557a1bdfee1a">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1102d65e5bbb46288b7d98a976952c66_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTItNi0xLTEtMA_848a8d5d-4979-4306-8ed7-b6bd281b2efc">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i750ff2c060f8493d976f1ebc84a53c58_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtNjUzMS90ZXh0cmVnaW9uOjY5NDIwNWJkNjIxNDQzYTE5ZmI3NGVmZDI1MzkyOTgzXzc2OTY1ODEzOTQ0ODM_930d43f0-bc85-4a0c-8eb6-61757a8918c5">0.000</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtNjUzMS90ZXh0cmVnaW9uOjY5NDIwNWJkNjIxNDQzYTE5ZmI3NGVmZDI1MzkyOTgzXzc2OTY1ODEzOTQ0OTU_7e8547d7-3068-4d97-88c7-8a5e777cd5be">five</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750ff2c060f8493d976f1ebc84a53c58_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtNC0xLTEtNjU0Nw_1f7d2dc2-2818-4acc-bc18-4f3d680b12bf">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3778ef9fd049c4aa110c60dca8ae9e_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtNi0xLTEtNjU0Nw_5eff56a7-3953-4ec0-9b00-f545a317c364">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i054d412daa1342d9a8adc483ef5ee68a_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjVlMTZkMTQyM2ZlNjQ1ZTRiMzQzYjA0ZWU5YzMwZThhXzQ_7c43c884-7755-481f-a075-df22150763bf">1.125</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjVlMTZkMTQyM2ZlNjQ1ZTRiMzQzYjA0ZWU5YzMwZThhXzE1_aeaca299-dcdb-4b89-b32d-ea5647d9bdae">eight</span>-year 2019 senior notes </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054d412daa1342d9a8adc483ef5ee68a_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTMtNC0xLTEtMA_1a5b9d78-f323-45a6-b737-c222db5472f6">1,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f65dfc39b1d4cd496b6246f1492221e_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTMtNi0xLTEtMA_8679dc8f-de0a-4988-8536-fcb3aff290d2">1,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d2033de84454b43a7ecdc388b152f04_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjUwOWNjZGNhZTZjYzQ4NTBiNjg1YmNjMDYwZTVkYWYwXzQ_4a9c5aa9-63df-4116-86fa-aa52d7fb11d5">3.350</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjUwOWNjZGNhZTZjYzQ4NTBiNjg1YmNjMDYwZTVkYWYwXzE1_6c38aec9-7242-49e4-a3a0-97185e834427">ten</span>-year 2017 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2033de84454b43a7ecdc388b152f04_I20201030" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtNC0xLTEtMA_69d145ac-0c24-420d-8002-b366ae9efd79">368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8727095c1e24f2ca3873ea9374eea75_I20200424" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtNi0xLTEtMA_53a6bd55-050c-4e5a-ba8c-40da1b5833b7">368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i47ee4b0280454a5c98e0ec794d136853_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtNjU1MS90ZXh0cmVnaW9uOjZiZjEyYmVlZGI5NTQwYzQ5N2ZiNTc3OGJmMjk5MmM1Xzc2OTY1ODEzOTQ0ODE_af16b91b-3b85-4ab3-9982-34b2c4af9800">0.375</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtNjU1MS90ZXh0cmVnaW9uOjZiZjEyYmVlZGI5NTQwYzQ5N2ZiNTc3OGJmMjk5MmM1Xzc2OTY1ODEzOTQ0ODk_3f1d490f-a710-44cb-aa4c-f5db8f0fa208">eight</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47ee4b0280454a5c98e0ec794d136853_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctNC0xLTEtNjU1Nw_00796b34-a8a1-4e54-b82a-058c17654601">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7910a7e253b74bb6bf57f31ca1e1cc96_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctNi0xLTEtNjU1Nw_0b7e3f59-e826-4495-8042-3b9048c0e8a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic82db9dbf25f4810bdca165d071df06e_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOmQ1YTI2NTk1ZGQ3OTRmYjU4YmUzYjRhZDFmMjE1ZDk1XzQ_7a3b7ac2-b1ce-46b0-8bee-6ca63566ecbb">1.625</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOmQ1YTI2NTk1ZGQ3OTRmYjU4YmUzYjRhZDFmMjE1ZDk1XzE1_5b30e37a-feeb-41bf-b826-7121e730e737">twelve</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic82db9dbf25f4810bdca165d071df06e_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTUtNC0xLTEtMA_9db91ee8-981a-4bb8-b085-a06bd2069ffc">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92885844bcb04599b66e758b5d76ae0b_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTUtNi0xLTEtMA_a5309f05-d9f1-4e30-af0b-2434014585a3">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i565f1750cbac4f25983798f87bb8d5da_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjZmZDA0ZmIzNjYyNDQ3ZDY5ZjAwN2FlYTRlZjRhZGU4XzQ_2cfbb5e1-07e8-4fa9-8a90-f248b40f6cc7">1.000</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjZmZDA0ZmIzNjYyNDQ3ZDY5ZjAwN2FlYTRlZjRhZGU4XzE1_932ae6cf-26e5-4bad-b22d-29b416b48b23">thirteen</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565f1750cbac4f25983798f87bb8d5da_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTYtNC0xLTEtMA_c8a8c2c5-dbd5-40d0-b899-cb4324ab5e54">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d8e43d6f024394b56e6aed2e55b5b7_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTYtNi0xLTEtMA_d3d1746e-5968-44a1-8080-4f71fc587093">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i85287c89df5c4ee8bb7372bcad0e3d62_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtNjU2NC90ZXh0cmVnaW9uOjVjZTJlM2ZhNTQ5ZTQ4NjBhZmQyOGQxMDdmNDVkMTJmXzc2OTY1ODEzOTQ0ODY_27b5ef29-ba17-47e2-9163-53d08e79d7c8">0.750</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtNjU2NC90ZXh0cmVnaW9uOjVjZTJlM2ZhNTQ5ZTQ4NjBhZmQyOGQxMDdmNDVkMTJmXzc2OTY1ODEzOTQ0OTk_c2fcbcbb-9062-4210-8500-cae9fda3b843">twelve</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85287c89df5c4ee8bb7372bcad0e3d62_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtNC0xLTEtNjU2MQ_cdb12acd-58e6-4529-8dd2-25986f3d5908">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib824b6753fdd4d998c09bff251b0120c_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtNi0xLTEtNjU2MQ_493a8d24-a531-4390-a6e0-8b814e6794a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i06322b5dd15e4cf88a13870353dc869c_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDA2NzRiOTUwOTQzMjViMjhlYTFkZGQ2YWFjNzY3XzQ_1032f911-24d3-434f-9f02-83d1c2f5c8fb">4.375</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDA2NzRiOTUwOTQzMjViMjhlYTFkZGQ2YWFjNzY3XzE1_d33f3c62-a9b3-4939-acb6-efa5d1c533e4">twenty</span>-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06322b5dd15e4cf88a13870353dc869c_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctNC0xLTEtMA_c77243cc-e68b-41e6-99f7-e72c3139c712">1,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b577715d9c647778ab87a85896e3ff6_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctNi0xLTEtMA_2bdbcd00-f9fa-471d-9701-b06a0571822e">1,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83d24b071bbd4084bc5c15d3c012fa6e_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTI3ZmUyY2I4NjRiODBiYjg3ZDEzZjgzNjI2NDEwXzQ_106342c2-e34b-4b03-bc99-c182b5acf551">6.550</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTI3ZmUyY2I4NjRiODBiYjg3ZDEzZjgzNjI2NDEwXzE1_3ef70171-17bb-4da9-8dc5-bfdf0b5cd24e">thirty</span>-year 2007 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2038</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83d24b071bbd4084bc5c15d3c012fa6e_I20201030" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTgtNC0xLTEtMA_3ba53d75-838f-4726-ac77-e5eda0c2c139">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950765e074ae4226bcc6450b9efc0ac4_I20200424" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTgtNi0xLTEtMA_d5a4896e-7f1c-4eeb-a0d5-1670adc75961">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iabf27779745645c392a68929410ce222_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjg1NzhjYzgwNmZjMzQ0NzNhNjczOTJiNGVlYjg5N2YwXzQ_396999a9-e794-44a9-803a-d4951b2e5e61">2.250</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjg1NzhjYzgwNmZjMzQ0NzNhNjczOTJiNGVlYjg5N2YwXzE1_3df5c742-c214-41f0-b3d0-5224780e9379">twenty</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabf27779745645c392a68929410ce222_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTktNC0xLTEtMA_18899692-f848-4a98-a8e5-d8d319be803c">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f9f92316aa4bd9a6b5dca506e8a598_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTktNi0xLTEtMA_0d6f5e8c-27e9-4b98-aa2d-23e305318fbd">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f70c23d31a04b9aa0f47612bada4682_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOmY0MDRlOGZmYTIyMTQzOWM4YmRlNWYyNWIwNjE1YjQ5XzQ_df08ccea-262d-4dc7-a7f0-dbf6567e7214">6.500</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOmY0MDRlOGZmYTIyMTQzOWM4YmRlNWYyNWIwNjE1YjQ5XzE1_c2981a7f-89c2-4f44-9205-b4e86754b2c1">thirty</span>-year 2009 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f70c23d31a04b9aa0f47612bada4682_I20201030" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtNC0xLTEtMA_a0590822-7ac5-48c3-b72d-83f94e8b7672">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6683088e6e054026a6a7bdb9e6391a9a_I20200424" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtNi0xLTEtMA_6b6b1f39-94c2-4632-927c-90cb09247261">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iec3a4aa6910146c4a58dfc971610fa11_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtNzA2Ny90ZXh0cmVnaW9uOjEwMDFhY2UzNjJkYjRkNDNiZjc4NWIwMmU2MzVlY2U5XzQ_aeadd553-cf54-4cdb-a1ef-ede9d3fb8f61">1.500</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtNzA2Ny90ZXh0cmVnaW9uOjEwMDFhY2UzNjJkYjRkNDNiZjc4NWIwMmU2MzVlY2U5XzE1_057deae6-4bb1-452e-b86a-80173d533019">twenty</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec3a4aa6910146c4a58dfc971610fa11_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtNC0xLTEtNzA2Nw_1d5e781f-8409-440f-910b-8bc56b1ded37">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id20d878354164798a7a7a92885288fed_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtNi0xLTEtNzA2Nw_95c1f89b-f255-4cf6-af84-c80ddabd60ff">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37040ee9a2694677a6a593b2e2d36c88_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjQ1ODFmMjY1ZmNmMjRjYzZiMmNlN2Q2MjViM2Q2NjA1XzQ_3f9ad542-e49c-46a9-9f6d-06579d5bc194">5.550</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjQ1ODFmMjY1ZmNmMjRjYzZiMmNlN2Q2MjViM2Q2NjA1XzE1_db79b77e-7b88-4758-a617-823b3f2a7b0c">thirty</span>-year 2010 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37040ee9a2694677a6a593b2e2d36c88_I20201030" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjEtNC0xLTEtMA_7db16b3b-6197-4184-b40b-e11f1d8ff013">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff148c09a35d4309af70243e1e4a1d6f_I20200424" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjEtNi0xLTEtMA_0097feda-78cd-4950-807c-19d7cc0dc9a1">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i20c62f91aaa741a19f4b61315da66964_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtNjU3NC90ZXh0cmVnaW9uOjhlYTQ1NjhhOTU4YzQwNDU5M2NkMGY1YzdkMjQxYjZmXzc2OTY1ODEzOTQ0ODQ_4b7e95bd-4a08-463e-b7a0-0b84172c9506">1.375</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtNjU3NC90ZXh0cmVnaW9uOjhlYTQ1NjhhOTU4YzQwNDU5M2NkMGY1YzdkMjQxYjZmXzc2OTY1ODEzOTQ0OTU_ef0d6972-d506-46e3-9082-3bddd7a7d890">twenty</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2041</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c62f91aaa741a19f4b61315da66964_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctNC0xLTEtNjU3MQ_d7b99a4f-5236-4071-9a1e-a7dcabc7e4f5">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae5109e80f914300a5a387ebde6c8776_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctNi0xLTEtNjU3MQ_475d97dc-4b58-4a28-89e4-ee1675539f37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0af3561ae38a455788310e9883ab62ac_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlYTljZmNjYzNiOTQzODM5MzBkNWFhMDBkNmNhNWM4XzQ_890e7a84-bde2-4064-b266-83be2963f784">4.500</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlYTljZmNjYzNiOTQzODM5MzBkNWFhMDBkNmNhNWM4XzE1_df7243fa-33e3-441e-9e5c-0d5e8f72b28c">thirty</span>-year 2012 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2042</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0af3561ae38a455788310e9883ab62ac_I20201030" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjMtNC0xLTEtMA_4a2873ca-8c6b-45ff-a3d1-645c5a07b4d5">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c9e7d2efbc24021807fa47750a582ac_I20200424" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjMtNi0xLTEtMA_3b0d51c6-7d7c-44f9-85ec-d97fa9099347">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7e8238cae344221b36d9ab213d64ec0_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjQtMC0xLTEtMC90ZXh0cmVnaW9uOjNhMmQ4M2U3MzY4YzQxYzBiYjk4NTU2YjA1ODJhYjA2XzQ_a9008fe4-c9ed-4457-8647-4059c2a62f58">4.000</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjQtMC0xLTEtMC90ZXh0cmVnaW9uOjNhMmQ4M2U3MzY4YzQxYzBiYjk4NTU2YjA1ODJhYjA2XzE1_8015ac63-f366-4764-bf6a-46db806b09cf">thirty</span>-year 2013 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2043</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e8238cae344221b36d9ab213d64ec0_I20201030" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjQtNC0xLTEtMA_b5968eea-1e0f-44b0-a2ba-a3677410499e">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4c1c10ae78d45fb991c7444838f455a_I20200424" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjQtNi0xLTEtMA_6081a3d3-3dd8-442b-ba43-a4056e52888a">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49d71ddf48d24bdcadb9fae5bdae5c01_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjg1ZmFkZGU0NTAyOTQ4OWFiZGI0NDVmMmNkN2Q2OTA5XzQ_fc90c9f1-32e3-4211-b8b2-60ea4f1a9121">4.625</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjg1ZmFkZGU0NTAyOTQ4OWFiZGI0NDVmMmNkN2Q2OTA5XzE1_194c751d-bc01-4752-9b92-6d1dd7b2c6bd">thirty</span>-year 2014 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2044</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49d71ddf48d24bdcadb9fae5bdae5c01_I20201030" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtNC0xLTEtMA_696212d6-75b2-4699-880c-31f284d953d9">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i535f2391eaba4f61bbb4700d09ee8601_I20200424" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtNi0xLTEtMA_08813e63-2e98-4e76-b0ca-e8966804a9a1">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icf19d18ef5f54fb2a1e2e30d815f91b0_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOmY2MmI2NWE5YjUyMzRiN2NhYzMwNmRhNTRkZjFjNmE2XzQ_54761768-f052-4830-8e47-b5143e5fe74c">4.625</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOmY2MmI2NWE5YjUyMzRiN2NhYzMwNmRhNTRkZjFjNmE2XzE1_816125dd-3eea-4f07-9610-e050c2e8a8b8">thirty</span>-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf19d18ef5f54fb2a1e2e30d815f91b0_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjYtNC0xLTEtMA_2b1a16eb-0edf-44b3-9cfe-7e7c83eb8b4e">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i361b55cbce594a09970ba9fd123f2b16_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjYtNi0xLTEtMA_32bc3c0b-8fbd-4c7b-90c7-1d6ae0b7584a">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i047b42eae5e7495c83549c009df4d1d4_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmRjYTc3ZGQ5MTBlMTQzMWZiY2FmMGExNjI2ZjA1YzUyXzQ_8e48b08d-1630-4061-8f87-4b4db20a67b4">1.750</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmRjYTc3ZGQ5MTBlMTQzMWZiY2FmMGExNjI2ZjA1YzUyXzE1_affa4ede-4085-4b4a-8013-9f2c5a3af318">thirty</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047b42eae5e7495c83549c009df4d1d4_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctNC0xLTEtMA_d1373aff-8f1d-42a7-9e47-d2e4c2ec99f6">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if210b924935c4b4d81d00ae7c8599261_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctNi0xLTEtMA_e99e9ecb-c07a-4c45-8392-580f2c1a7844">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i819e50da385f459f903ea9d6d5d47c66_I20201030" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzMtMC0xLTEtNjU4Ni90ZXh0cmVnaW9uOjEzNTMyNGVhY2U0MTQ2NmJiN2EyYTcxMmI4MzcyMDI3Xzc2OTY1ODEzOTQ0ODQ_65dc7923-0eb0-44f4-a643-2ef12cce584d">1.625</ix:nonFraction> percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzMtMC0xLTEtNjU4Ni90ZXh0cmVnaW9uOjEzNTMyNGVhY2U0MTQ2NmJiN2EyYTcxMmI4MzcyMDI3Xzc2OTY1ODEzOTQ0OTU_ecf3e18f-537f-414b-994f-f458754db39a">thirty</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i819e50da385f459f903ea9d6d5d47c66_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzMtNC0xLTEtNjU4Mw_1e6996a6-fc13-4254-a5a8-b5f22a6bedb6">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d83db0a3a404462a7f0f25f297ae072_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzMtNi0xLTEtNjU4Mw_da01bbad-ff06-4d2d-8b3f-c61606e6b96e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9090df86b8294bf988864695140aea55_I20201030" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjgtNC0xLTEtMA_d625ba49-e061-4756-8bff-06be340860ba">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id954a5663cfc43e69849fbce86b15b9a_I20200424" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjgtNi0xLTEtMA_ccf67c59-be6d-4b2c-aec1-64722f9284b6">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 - 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzUtNC0xLTEtNzA4Mw_5f379146-ea5f-40b4-922a-61cd5d1612e7">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzUtNi0xLTEtNzA4Mw_cd7874a3-fa11-49c2-b311-c4ec7ac0f494">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 - 2051</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzUtNC0xLTEtNzA3Ng_abf50726-2713-457f-98e0-cb8f4fd3e2ed">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzUtNi0xLTEtNzA3Ng_c4046492-d1bc-490b-aec4-685c81bbc47b">104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 - 2051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjktNC0xLTEtMA_d40806d0-3a56-46d3-a7cc-c24edb9be980">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjktNi0xLTEtMA_c4b7a297-cd60-43ce-9021-f3f967e1e316">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzItNC0xLTEtMA_2bcf7bbb-cc9b-4bab-9f3a-1e74c03dcc32">25,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzItNi0xLTEtMA_48d3a033-afce-4c9e-9f88-513c329fbc8d">22,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i580cb1e88def46c0a304977360f38fc6"><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has outstanding unsecured senior obligations, described as senior notes in the tables above (collectively, the Senior Notes). The Senior Notes rank equally with all other unsecured and unsubordinated indebtedness of the Company. The indentures under which the Senior Notes were issued contain customary covenants, all of which the Company remained in compliance with at October&#160;30, 2020.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, Medtronic Luxco issued <ix:nonFraction unitRef="tranche" contextRef="i43ca1b9479324066bf20af6381092405_I20190630" decimals="INF" format="ixt-sec:numwordsen" name="mdt:DebtInstrumentNumberofTranches" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMTc4NA_66f8ab78-43c7-4a2f-98b4-c0b9e48d149e">six</ix:nonFraction> tranches of Euro-denominated Senior Notes with an aggregate principal of &#8364;<ix:nonFraction unitRef="eur" contextRef="i43ca1b9479324066bf20af6381092405_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMTg2MA_6670c21e-4223-449f-a40d-4418e4dc48cd">5.0</ix:nonFraction> billion, with maturities ranging from fiscal year 2021 to fiscal year 2050, resulting in cash proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i03edad1ee21c45e8bae5af91c450f7d7_D20190601-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMTk3NQ_83eab008-c511-4c0a-919f-374d81a484e6">5.6</ix:nonFraction> billion, net of discounts and issuance costs. The Company used the net proceeds of the offering to fund the cash tender offer and early redemption of $<ix:nonFraction unitRef="usd" contextRef="i486f35ff70c14b7cbda1a961e72c4759_D20190601-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMjM3Nw_6d9f3a91-f994-4cb9-9858-696d35e259cf">5.2</ix:nonFraction> billion of Medtronic Inc., CIFSA, and Medtronic Luxco Senior Notes for $<ix:nonFraction unitRef="usd" contextRef="i486f35ff70c14b7cbda1a961e72c4759_D20190601-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSeniorDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMjQ0Mw_88fccb61-6e11-47ac-873a-f6547a285475">5.6</ix:nonFraction> billion of total consideration. The Company recognized a loss on debt extinguishment of $<ix:nonFraction unitRef="usd" contextRef="i419528b46438459b85358d801fe6c31d_D20190427-20190726" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMjUzOQ_7b64fead-b349-4bd2-a008-fe2510ce0e3d">413</ix:nonFraction> million during the first quarter of fiscal year 2020, which primarily included cash premiums and accelerated amortization of deferred financing costs and debt discounts and premiums. The loss was recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statement of income for the six months ended October&#160;25, 2019. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, Medtronic Luxco issued an additional <ix:nonFraction unitRef="tranche" contextRef="ie2b8c1f994574df88bd778df94f6e8d6_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="mdt:DebtInstrumentNumberofTranches" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzY5Mw_1d17977b-4a2f-4491-8f36-f698900f6742">six</ix:nonFraction> tranches of Euro-denominated Senior Notes with an aggregate principal of &#8364;<ix:nonFraction unitRef="eur" contextRef="ie2b8c1f994574df88bd778df94f6e8d6_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzcwMg_2f15b111-4045-4c47-b986-2a6fd3603fb3">6.3</ix:nonFraction>&#160;billion, with maturities ranging from fiscal year 2023 to fiscal year 2051, resulting in cash proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="ibc8fac86e3e34735bd2213a5c893c73c_D20200901-20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzcxNg_63da51d7-c0dc-401b-bee1-03c83bd13ed6">7.2</ix:nonFraction>&#160;billion, net of discounts and issuance costs. The Company used the net proceeds of the offering to fund the early redemption of $<ix:nonFraction unitRef="usd" contextRef="i322602253ac842238d97f6323baf0b2a_D20201001-20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzczMA_467e3346-3f0e-4655-9280-66bf1d64fe1a">4.3</ix:nonFraction>&#160;billion of Medtronic Inc. and CIFSA Senior Notes and &#8364;<ix:nonFraction unitRef="eur" contextRef="i89c3b3d9a895475985db2b36880fecca_D20201001-20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxODgxMQ_595f7e95-83da-4320-b6b4-d051190f16b7">1.5</ix:nonFraction>&#160;billion of Medtronic Luxco Senior Notes for $<ix:nonFraction unitRef="usd" contextRef="i1f534412b2ac4f5d9802c54fd029f5a9_D20201001-20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSeniorDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzc0NA_c7bf11b7-5cc0-488d-8e62-8e551bbcd871">6.3</ix:nonFraction>&#160;billion of total consideration in October 2020. Additionally, the Company intends to use the proceeds to repay its &#8364;<ix:nonFraction unitRef="eur" contextRef="id3d8d5311ebb4a75a24f1e7a8af56005_D20210301-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxODQzMw_036e08a2-62ea-415a-9319-750475c34265">750</ix:nonFraction>&#160;million floating rate senior notes at maturity in March 2021. The Company recognized a loss on debt extinguishment of $<ix:nonFraction unitRef="usd" contextRef="i6e1f6fd2fd7b47459d0613747fb74d8f_D20200801-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzc1OA_3f88677d-409a-46c2-aeec-4f4183b59f6e">308</ix:nonFraction>&#160;million during the current quarter, which primarily included cash premiums and accelerated amortization of deferred financing costs and debt discounts and premiums. The loss was recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income for the three and six months ended October&#160;30, 2020. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Euro-denominated debt issued in June 2019 and September 2020 is designated as a net investment hedge of certain of the Company's European operations. Refer to Note 8 for additional information regarding the net investment hedge.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Agreements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2020, Medtronic Luxco entered into a term loan agreement (Loan Agreement) by and among Medtronic Luxco, Medtronic plc, Medtronic, Inc., and Mizuho Bank, Ltd. as administrative agent and as lender. The Loan Agreement provides an unsecured term loan in an aggregate principal amount of up to &#165;<ix:nonFraction unitRef="jpy" contextRef="iae6ac6ba362d46f7a069d17790df5dde_I20200512" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzE1Ng_314463b7-6adb-4bbf-ac4f-780cda60eb44">300</ix:nonFraction>&#160;billion, or approximately $<ix:nonFraction unitRef="usd" contextRef="iae6ac6ba362d46f7a069d17790df5dde_I20200512" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzE3Nw_e57798a4-4cd9-4f9f-a9e9-9e324885eaab">2.8</ix:nonFraction>&#160;billion, with a term of <ix:nonNumeric contextRef="ia15b2fe50423464a9cf5623ac357741d_D20200512-20200512" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzE5Ng_43f1f7eb-8243-42e3-8c43-fed4a4e56e08">six months</ix:nonNumeric>, which may be extended for an additional <ix:nonNumeric contextRef="ia15b2fe50423464a9cf5623ac357741d_D20200512-20200512" format="ixt-sec:durwordsen" name="mdt:DebtInstrumentExtensionOptionTermOfExtension" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzI0MA_ce3ec862-d749-4ade-8485-6f7cd482a5a3">six months</ix:nonNumeric> at Medtronic Luxco&#8217;s option. On May 13, 2020, Medtronic Luxco borrowed the entire amount of the term loan under the Loan Agreement. Borrowings under the Loan Agreement will bear interest at the TIBOR Rate (as defined in the Loan Agreement) plus a margin of <ix:nonFraction unitRef="number" contextRef="iae724a5cf9f94ef18e23e8e16d639ab6_D20200512-20200512" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzUwMA_03da22ca-89f5-478e-92e9-efbaa9bcc028">0.50</ix:nonFraction>% per annum. Medtronic plc and Medtronic, Inc. have guaranteed the obligations of Medtronic Luxco under the Loan Agreement. On November 12, 2020, the Company exercised its option to extend the term loan for an additional <ix:nonNumeric contextRef="icfb13d6a6af84816860e81aaba6f97d0_D20201112-20201112" format="ixt-sec:durwordsen" name="mdt:DebtInstrumentExtensionOptionTermOfExtension" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzc3MQ_c0209ef2-6805-42d8-af99-722b2c27289c">six months</ix:nonNumeric>. The Japanese Yen-denominated debt is designated as a net investment hedge of certain of our Japanese operations. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments Not Measured at Fair Value</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At October&#160;30, 2020, the estimated fair value of the Company&#8217;s Senior Notes was $<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzg1NA_cda2c9d8-b58a-4f09-adca-6c934bfaf6ee">29.9</ix:nonFraction> billion compared to a principal value of $<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzg5MA_2106e8b8-f6a6-4740-ba52-00b80bd81c42">27.0</ix:nonFraction> billion. At April&#160;24, 2020, the estimated fair value was $<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzkzMA_b43effa1-fca9-4890-ae86-310ccaa19c33">27.1</ix:nonFraction> billion compared to a principal value of $<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzk2Ng_51195fa1-dae9-4371-bd5d-b5f3fce081b9">24.5</ix:nonFraction> billion. The fair value was estimated using quoted market prices for the publicly registered Senior Notes, which are classified as Level 2 within the fair value hierarchy. The fair values and principal values consider the terms of the related debt and exclude the impacts of debt discounts and hedging activity.</span></div></ix:continuation><div id="i6128593e20e44bbc8b0671c482ec9b79_64"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1Mzk_1e33f642-d0b6-4808-a2f5-613cfcc5d6aa" continuedAt="i3881b27cbb0c425dbe51e24b7ff1b476" escape="true">Derivatives and Currency Exchange Risk Management </ix:nonNumeric></span></div><ix:continuation id="i3881b27cbb0c425dbe51e24b7ff1b476" continuedAt="ia495743e13a74c31b8c277018bea375f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses operational and economic hedges, including currency exchange rate derivative contracts and interest rate derivative instruments, to manage the impact of currency exchange and interest rate changes on earnings and cash flows. In addition, the Company uses cross currency interest rate swaps to manage currency risk related to certain debt. In order to minimize earnings and cash flow volatility resulting from currency exchange rate changes, the Company enters into derivative instruments, principally forward currency exchange rate contracts. These contracts are designed to hedge anticipated foreign currency transactions and changes in the value of specific assets and liabilities. At inception of the contract, the derivative is designated as either a freestanding derivative or a cash flow hedge. Currencies of our derivative instruments include the Euro, Japanese Yen, Chinese Yuan, and others. The Company does not enter into currency exchange rate derivative contracts for speculative purposes. The gross notional amount of all currency exchange rate derivative instruments outstanding was $<ix:nonFraction unitRef="usd" contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTEyNw_099392d3-3aab-4570-8710-db66cfae9fe9">18.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTEzNA_f3e2dbca-a8ab-4620-9459-50f566c41ca1">11.9</ix:nonFraction> billion at October&#160;30, 2020 and April&#160;24, 2020, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also uses derivative and non-derivative instruments to manage the impact of currency exchange rate changes on net investments in foreign currency-denominated operations. The information that follows explains the various types of derivatives and financial instruments used by the Company, reasons the Company uses such instruments, and the impact such instruments have on the Company&#8217;s consolidated balance sheets and statements of income.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="ia495743e13a74c31b8c277018bea375f" continuedAt="i8d273625ea78485d9233b122d999164d"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Freestanding Derivative Contracts</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Freestanding derivative contracts are primarily used to offset the Company&#8217;s exposure to the change in value of specific foreign-currency-denominated assets and liabilities, and to offset variability of cash flows associated with forecasted transactions denominated in foreign currencies. The gross notional amount of the Company's freestanding currency exchange rate contracts outstanding at October&#160;30, 2020 and April&#160;24, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i6ea2a0e5eb0e4f09a8904720d94ebebf_I20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMjA1OA_08e9d96c-d274-455f-81f1-533d605a5353">10.7</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ibef9e0da89e44b89b330d067b8948c58_I20200424" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMjA2NQ_0d7a9587-216a-4b5d-bde9-a4d34ac56b35">4.9</ix:nonFraction> billion, respectively. The Company's freestanding currency exchange rate contracts are not designated as hedges, and therefore, changes in the value of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related change in value of foreign-currency-denominated assets, liabilities, and cash flows. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also uses total return swaps to hedge the liability of a non-qualified, deferred compensation plan. The gross notional amount of the Company's total return swaps outstanding at October&#160;30, 2020 and April&#160;24, 2020 was $<ix:nonFraction unitRef="usd" contextRef="ife2e4bf093494b09ba98f801beb8b9c5_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMjYwNw_da406e03-cce2-4186-a2ec-bfee978d5d14">197</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if2e03acd84264aa29f524bb28094ffe8_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMjYxNA_ccf22e24-9a5e-4ecb-a372-2a21bf9d9e92">181</ix:nonFraction> million, respectively. The Company's total return swaps are not designated as hedges, and therefore, changes in the value of these instruments are recognized in earnings. The cash flows related to the Company's freestanding derivative contracts are reported as operating activities in the consolidated statements of cash flows. </span></div><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="mdt:ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NDk_90dd08ef-08b2-4cb7-808d-6a2dded669eb" escape="true"><div style="margin-bottom:9pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts and classification of the (gains) losses in the consolidated statements of income related to derivative instruments not designated as hedging instruments for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.866%"><tr><td style="width:1.0%"></td><td style="width:26.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bb7d8650d424a3794638ac05acc85b1_D20200801-20201030" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMi00LTEtMS0w_8db53b65-909d-4019-9eab-6f8faf7793ad">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i062f1ed49909469d842f2bc395542043_D20190727-20191025" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMi02LTEtMS0w_00320cd2-7ac0-4df4-b544-a4614f261f6e">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf768e66580b409297df422a6b58cc7b_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMi04LTEtMS01OTI_611a0603-07ad-4723-a3f6-4fb2703fae96">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48ef881065414c91bb7f52fc1c7a7c86_D20190427-20191025" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMi0xMC0xLTEtNTky_c19170a7-ea8c-4f59-973f-5c18d2498fd7">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cafeb122608423eb2b62ea29bc09a5c_D20200801-20201030" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMy00LTEtMS0w_3d03e1ae-f1a4-45ea-b097-42fa86fb3a3b">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c49d00a2f3f4bba86faabfc7866ed13_D20190727-20191025" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMy02LTEtMS0w_cfad2956-69c8-41f9-85ab-356be7cb6c2b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iada485b3a6b245668a27a3b5fa95eb3c_D20200425-20201030" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMy04LTEtMS01OTI_ebaedbfb-bb5f-4567-9711-ecb17d5d80c6">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a16715731e144e2a482d62407c58c16_D20190427-20191025" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMy0xMC0xLTEtNTky_3e69ef99-22ea-452d-91fa-96758e329b38">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfNC00LTEtMS0w_12e17a75-0b5f-4570-833e-ec59242bc498">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfNC02LTEtMS0w_52054d88-f3cc-4869-8f51-2b5fbaeb6c71">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfNC04LTEtMS05ODU_e9dd3719-6e49-4351-a06c-4a37956e2cc2">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfNC0xMC0xLTEtOTg1_eb0711ae-82fa-4580-9cef-9dfc9085cc85">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. The gross notional amount of these contracts, designated as cash flow hedges, outstanding at October&#160;30, 2020 and April&#160;24, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i0eaf93d2e883447e94be4b40d4ea2307_I20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMzQ5NQ_4a7aefe4-abf7-4466-8275-630179e30da0">7.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i28d09151fa8641dca241e92bb8200f44_I20200424" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMzUwMg_fb0d71d4-7894-4991-b3c6-d11801613095">7.0</ix:nonFraction> billion, respectively, and will mature within the subsequent <ix:nonNumeric contextRef="ib696730068be4184a7cba30530fe6e73_D20200425-20201030" format="ixt-sec:durwordsen" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1Nzg_b8db7431-0a79-445e-bba0-767ada9a5b47">three-year</ix:nonNumeric> period. For derivative instruments that are designated and qualify as a cash flow hedge, the gain or loss on the derivative instrument is reported as a component of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The gain or loss on the derivative instrument is reclassified into earnings and is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income in the same period or periods during which the hedged transaction affects earnings. Amounts excluded from the measurement of hedge effectiveness are recognized in earnings in the current period. The cash flows related to all of the Company's derivative instruments designated as cash flow hedges are reported as operating activities in the consolidated statements of cash flows. No components of the hedge contracts were excluded in the measurement of hedge effectiveness, and no forward contracts designated as cash flow hedges were derecognized or discontinued during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019.</span></div><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NjQ_27b19361-f5ca-47fa-a6be-40d91bc0b02c" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the (gains) losses recognized in accumulated other comprehensive loss (AOCI) related to the currency exchange rate contract derivative instruments designated as cash flow hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.100%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16ecf308db934c58b716f575ffc1e8e2_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZlM2EzZmRlMjQ3OTQ5NDk5MTUwNDQ0NzZkNTBjOWU5L3RhYmxlcmFuZ2U6ZmUzYTNmZGUyNDc5NDk0OTkxNTA0NDQ3NmQ1MGM5ZTlfMi0yLTEtMS0w_5061d061-51f2-4447-a063-a8ca8551b69e">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f39166258654e8b962cb7a6c6db3661_D20190727-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZlM2EzZmRlMjQ3OTQ5NDk5MTUwNDQ0NzZkNTBjOWU5L3RhYmxlcmFuZ2U6ZmUzYTNmZGUyNDc5NDk0OTkxNTA0NDQ3NmQ1MGM5ZTlfMi00LTEtMS0w_1a68921b-6b80-4419-aea4-581b44b7c11a">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb04dfb4fa234538bad556529f05fd2c_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZlM2EzZmRlMjQ3OTQ5NDk5MTUwNDQ0NzZkNTBjOWU5L3RhYmxlcmFuZ2U6ZmUzYTNmZGUyNDc5NDk0OTkxNTA0NDQ3NmQ1MGM5ZTlfMi02LTEtMS05ODc_726ebf88-78c1-4921-b6aa-fe3a2851ef0f">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74eac46b3d2b4217a1efbf920f47ff09_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZlM2EzZmRlMjQ3OTQ5NDk5MTUwNDQ0NzZkNTBjOWU5L3RhYmxlcmFuZ2U6ZmUzYTNmZGUyNDc5NDk0OTkxNTA0NDQ3NmQ1MGM5ZTlfMi04LTEtMS05ODc_e7e5b997-5e79-473e-9e83-8a8cdc3a74bb">103</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i8d273625ea78485d9233b122d999164d" continuedAt="i443b93b042ab4417a39a44b7e5c4971f"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NTI_abb826a2-059d-4dd0-a570-e636cb092311" escape="true"><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the (gains) losses recognized in the consolidated statements of income related to derivative instruments designated as cash flow hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other operating expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated statements of income in which the effects of cash flow hedges are recorded</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfMy0yLTEtMS0w_7306feaa-feac-4539-befc-9a2392de4c68">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfMy00LTEtMS0w_35f4033d-3ac0-4ab7-bc78-bafac967c181">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfMy02LTEtMS05ODk_7293c62a-22e4-4ca2-a4e3-aa50f068decf"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfMy02LTEtMS05ODk_8dd1fe46-c1a6-4e6d-a33e-96f1c125884d">35</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfMy04LTEtMS05ODk_60a49eca-9214-426e-b575-376f14499bfe"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfMy04LTEtMS05ODk_8cbffb02-bc95-44fa-97f4-22f8a97acd8b">127</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency exchange rate contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain reclassified from AOCI into income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id17a89cb1d9e431db69c4426862755a5_D20200801-20201030" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfOC0yLTEtMS0w_3a752774-e7e2-4b40-aaee-ab891ddbf0e3">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3af287ba57845e88cc3662a0cc58115_D20190727-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfOC00LTEtMS0w_7fa0c9cc-871e-4c2d-9269-f668280c4ca4">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida9267d57494477c8173b527d15ad048_D20200425-20201030" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfOC02LTEtMS05ODk_dbd950ea-a531-4b3b-9792-ee598157abc6">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i627fbb34d41b4c299271b22b6ba80293_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfOC04LTEtMS05ODk_41860cc8-670a-4843-9f54-bf7abcfd1755">125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forecasted Debt Issuance Interest Rate Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward starting interest rate derivative instruments designated as cash flow hedges are designed to manage the exposure to interest rate volatility with regard to future issuances of fixed-rate debt. The gains or losses on forward starting interest rate derivative instruments that are designated and qualify as cash flow hedges are reported as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Beginning in the period in which the planned debt issuance occurs and the related derivative instruments are terminated, the gains or losses are then reclassified into </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">over the term of the related debt. For the three and six months ended October&#160;30, 2020 and October&#160;25, 2019, the reclassifications of net (gains) losses on forward starting interest rate derivative instruments from accumulated other comprehensive loss to interest expense were not significant. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At October&#160;30, 2020 and April&#160;24, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNTkwOA_64640c66-5bc3-439a-8f33-bed8e17abdb8">129</ix:nonFraction> million in after-tax net unrealized losses and $<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNTk1MA_b965f20c-c68d-4099-a756-406fa18f1ee9">266</ix:nonFraction> million in after-tax net unrealized gains, respectively, associated with cash flow hedging instruments recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company expects that $<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNjEyMw_5df4ea7e-7a11-4092-a4cf-b89c36c8a6db">34</ix:nonFraction> million of after-tax net unrealized losses at October&#160;30, 2020 will be recognized in the consolidated statements of income over the next 12 months.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated Euro-denominated and Japanese Yen-denominated debt as net investment hedges of certain of its European and Japanese operations to manage the exposure to currency and exchange rate movements for foreign currency-denominated net investments in foreign operations. At October&#160;30, 2020, the Company had &#8364;<ix:nonFraction unitRef="eur" contextRef="i84ca06f620184bbfa7d366fe5853ce18_I20201030" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNjU4Ng_909b1973-7d36-45f9-92a1-c64aa65ae095">16.0</ix:nonFraction> billion, or $<ix:nonFraction unitRef="usd" contextRef="i98e4061404054b75be5b3c8c2b4acd40_I20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNjU5Mw_a3ebc7c7-72fb-4a15-ba36-9e4ccfa0c677">18.9</ix:nonFraction> billion, of outstanding Euro-denominated debt designated as a hedge of its net investment in certain of its European operations, and &#165;<ix:nonFraction unitRef="jpy" contextRef="i84ca06f620184bbfa7d366fe5853ce18_I20201030" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNjcyMQ_5cdf7216-7d0a-42a3-a5fc-bbc17be037a3">300</ix:nonFraction> billion, or $<ix:nonFraction unitRef="usd" contextRef="ib482970decd34242a76c6fbf96fcb507_I20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNjcyOA_8dc33526-6218-4525-b6ef-107207db2248">2.9</ix:nonFraction> billion, of outstanding Yen-denominated debt designated as a hedge of its net investment in certain of its Japanese operations. The Euro-denominated debt will mature in fiscal years 2023 through 2051 and the Yen-denominated debt will mature in fiscal year 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, during the first quarter of fiscal year 2020, the Company entered into and settled forward currency exchange rate contracts to manage the exposure to exchange rate movements in anticipation of the issuance of Euro-denominated senior notes. Certain of these forward currency exchange rate contracts were designated as a net investment hedge of certain of the Company's European operations. These contracts matured in conjunction with the issuance of Euro-denominated debt in the first quarter of fiscal year 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instruments that are designated and qualify as net investment hedges, the gains or losses are reported as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The gains or losses are reclassified into earnings upon a liquidation event or deconsolidation of the foreign subsidiary. Amounts excluded from the assessment of effectiveness are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The cash flows related to the Company's derivative instruments designated as net investment hedges are reported as investing activities in the consolidated statements of cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At October&#160;30, 2020 and April&#160;24, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-8" sign="-" format="ixt:numdotdecimal" name="mdt:UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODE4NQ_04b28a45-1956-4053-9419-e297a74c6d62">1.0</ix:nonFraction> billion in after-tax unrealized losses and $<ix:nonFraction unitRef="usd" contextRef="i26298cf036964bed9c4492fcb3a09498_D20190427-20200424" decimals="-6" format="ixt:numdotdecimal" name="mdt:UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODIyMw_0e92f454-cca5-4887-91a5-be8b9ac00e16">236</ix:nonFraction> million in after-tax unrealized gains, respectively, associated with net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company does <ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="INF" format="ixt-sec:numwordsen" name="mdt:NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODM3Ng_4195eb4b-4b44-427c-afd5-76c98d3ac315">no</ix:nonFraction>t expect any of the after-tax unrealized gains at October&#160;30, 2020 to be recognized in the consolidated statements of income over the next 12 months. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did <ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="INF" format="ixt-sec:numwordsen" name="mdt:GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODUzMQ_048311f2-586f-4148-a8e3-678bdce9555e"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="INF" format="ixt-sec:numwordsen" name="mdt:GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODUzMQ_15b55ee7-a4ff-4663-9b8f-7408a42a90a9"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="INF" format="ixt-sec:numwordsen" name="mdt:GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODUzMQ_38e636b4-b427-493d-998d-250b3f1e7f62"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="INF" format="ixt-sec:numwordsen" name="mdt:GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODUzMQ_fea15a9c-0246-4e29-8af6-8ea7ae736ca9">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t recognize any gains or losses during the three and six months ended October&#160;30, 2020 or October&#160;25, 2019 on instruments that no longer qualify as net investment hedges. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i443b93b042ab4417a39a44b7e5c4971f" continuedAt="if747cf37151f46b499105a3d4b1ddf82"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NjI_0d8f5cb4-1df9-4fed-beb2-0b3818e2c5c3" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount and classifications of the (gains) losses recognized in the consolidated statements of income for the portion of the net investment hedges excluded from the measurement of hedge effectiveness were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.833%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2b35bd149d4cbfb0cca99cf6451e78_D20200801-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjE0YmQxYzdhYTFiZTQ1MjM5Nzc0YTA5YTkwY2UxYWFlL3RhYmxlcmFuZ2U6MTRiZDFjN2FhMWJlNDUyMzk3NzRhMDlhOTBjZTFhYWVfMi00LTEtMS0w_37a50073-a633-4421-bc65-d0c799415c8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4037e9fe4924327a9124f0dad580c10_D20190727-20191025" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjE0YmQxYzdhYTFiZTQ1MjM5Nzc0YTA5YTkwY2UxYWFlL3RhYmxlcmFuZ2U6MTRiZDFjN2FhMWJlNDUyMzk3NzRhMDlhOTBjZTFhYWVfMi02LTEtMS0w_5aebbac9-d60c-4627-92d3-f6b94921be6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0504cba5977424e8efe09ff95da6e08_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjE0YmQxYzdhYTFiZTQ1MjM5Nzc0YTA5YTkwY2UxYWFlL3RhYmxlcmFuZ2U6MTRiZDFjN2FhMWJlNDUyMzk3NzRhMDlhOTBjZTFhYWVfMi04LTEtMS05OTE_e5f047f2-14b8-4744-9017-da8718694997">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9156d299a6eb46b38ada2503236b8881_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjE0YmQxYzdhYTFiZTQ1MjM5Nzc0YTA5YTkwY2UxYWFlL3RhYmxlcmFuZ2U6MTRiZDFjN2FhMWJlNDUyMzk3NzRhMDlhOTBjZTFhYWVfMi0xMC0xLTEtOTkx_878339b2-cb57-4999-84e6-d674d97ba76d">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NTg_03819164-cd0f-4884-82e5-2eb62598812a" escape="true"><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the (gains) losses recognized in AOCI related to instruments designated as net investment hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows: </span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.100%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd052a01e6746ebaefd3cc094cc9a4e_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjExZjE3NWRkMTVjMDQ3YTQ4NWFkMWRhZjAwNjdhZjc3L3RhYmxlcmFuZ2U6MTFmMTc1ZGQxNWMwNDdhNDg1YWQxZGFmMDA2N2FmNzdfMi0yLTEtMS0w_c0cd5499-9029-403b-bf5e-83cde38ac3cf">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b2fe42efd06408a92475c4755fa36e2_D20190727-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjExZjE3NWRkMTVjMDQ3YTQ4NWFkMWRhZjAwNjdhZjc3L3RhYmxlcmFuZ2U6MTFmMTc1ZGQxNWMwNDdhNDg1YWQxZGFmMDA2N2FmNzdfMi00LTEtMS0w_e419777e-ff65-4661-a9d1-0bbd8a268c64">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ccbe94efc24035ad053ab14a80da93_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjExZjE3NWRkMTVjMDQ3YTQ4NWFkMWRhZjAwNjdhZjc3L3RhYmxlcmFuZ2U6MTFmMTc1ZGQxNWMwNDdhNDg1YWQxZGFmMDA2N2FmNzdfMi02LTEtMS05OTM_22095b3a-edac-4f2e-aa06-28ea064bb413">1,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia739284ae42640b9b1169f2e13f10c3b_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjExZjE3NWRkMTVjMDQ3YTQ4NWFkMWRhZjAwNjdhZjc3L3RhYmxlcmFuZ2U6MTFmMTc1ZGQxNWMwNDdhNDg1YWQxZGFmMDA2N2FmNzdfMi04LTEtMS05OTM_1ff6c6e9-c1af-444e-806f-daea7c09aad1">152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance Sheet Presentation</span></div><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1ODM_02653b78-9a94-4e5f-aa21-b63d259731ae" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the balance sheet classification and fair value of derivative instruments included in the consolidated balance sheets at October&#160;30, 2020 and April&#160;24, 2020. The fair value amounts are presented on a gross basis and are segregated between derivatives that are designated and qualify as hedging instruments and those that are not designated and do not qualify as hedging instruments and are further segregated by type of contract within those two categories.</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04c7a73cee65490ea0fe051fe67b36b0_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfNC0zLTEtMS0w_e54a9419-7b3d-4ffa-bdec-7a952b1a4a85">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i408b5639feb74594bf9ffbf99932a0c2_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfNC03LTEtMS0w_4ad623bb-61f4-4178-a62e-b98fa0c5817b">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3781ad92456b4930a744c241338e1df9_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfNi0zLTEtMS0w_b99f6de2-2e52-4368-a9eb-7b03769c90e5">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcab7a8fe5904101bf276c6cd9d3e02e_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfNi03LTEtMS0w_e35d6e7d-2903-4af7-9913-3c94c7315598">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2971cc416b8c4c3baf1b346e6ac07274_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfNy0zLTEtMS0w_dfffbdf7-696e-4ae3-8079-cd7dee6ba095">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2971cc416b8c4c3baf1b346e6ac07274_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfNy03LTEtMS0w_a885e928-79f0-4480-a590-892cef234385">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfcb1d2adbee455fa6c5c158e39b057f_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfOS0zLTEtMS0w_a80c691c-41df-4870-b2af-56da8e67d315">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac89da0aac834ad28b17ac773234402d_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfOS03LTEtMS0w_f7e1e7e8-1e73-4f75-9ba8-2e84a231085d">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf80c1f6bec9491da1665ff45eca0305_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTAtMy0xLTEtMA_146d28d8-2ac6-459f-b999-5bb259fa9576">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f0c5b496724100b2925b08781c93be_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTAtNy0xLTEtMA_afdea750-8107-4db3-b917-baa0e5f786cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79215fa9290949fc8d58b9442e87c752_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTEtMy0xLTEtMA_600569e4-5ca6-4768-b77c-0a4a50a1e028">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300b4c6841cf48e1b89be1521f13f8c5_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTEtNy0xLTEtMA_0d06d46a-375a-4275-b342-57d1f08c821e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id705573c47564fec859646f338ee424a_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTQtMy0xLTEtMA_620540d8-5ff8-41d1-a874-22c9afc4000f">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id705573c47564fec859646f338ee424a_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTQtNy0xLTEtMA_850923fb-bb42-479b-8167-49d42c3467cd">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTUtMy0xLTEtMA_81ae6640-1e33-4510-86e2-cf8b331c2278">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTUtNy0xLTEtMA_76329b7f-8c59-4936-98ca-6c10f05ba913">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia27d4054116c4424b00fa6fcc5fb1097_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfNC0zLTEtMS0w_a2ba2828-5cb8-45f6-bae7-85bda164fb53">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a28b7b81914f18b60a8f618393f4b0_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfNC03LTEtMS0w_26e99da0-2c07-4ad1-80f8-807c8e49d0fd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640a2e9158494775bd661da415d6991a_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfNi0zLTEtMS0w_0c6dee6a-4490-4109-bd66-2b1d1534fa77">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16cbb6d304b141dfa3c2506664f80306_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfNi03LTEtMS0w_922b3ca3-4b51-460a-bb0f-c03044c1bd68">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf105fb217564fb0b368560e0802c567_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfNy0zLTEtMS0w_25fc45b2-13df-4d4e-9df2-d9e356496014">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf105fb217564fb0b368560e0802c567_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfNy03LTEtMS0w_c1e682df-b11b-4948-b2ba-d55506ce8251">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c36d14889444b32a4a8a500df0426de_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfOS0zLTEtMS0w_2389a946-1134-44cc-8def-d35b59666d87">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f928c10bd3447a8acf72dba427f6d0f_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfOS03LTEtMS0w_0e027ddc-303f-48c8-bb1d-86cc93e16f85">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8649cc913994f28bba97e9a820cd77c_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTAtMy0xLTEtMA_8f08fe09-1b53-49c0-8697-9b4026b0273b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a71eca48ecb47368f7ad737a8dd9f78_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTAtNy0xLTEtMA_dcbe01f4-00db-46a8-87e1-ee6348a207a4">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9261483dc6f74bb484c0adf25775e549_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTEtMy0xLTEtMA_0d2a7c37-a0c2-42bc-8eec-cb60fe0dedbc">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fcd15b1ac94eb194a37776a48e4b87_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTEtNy0xLTEtMA_6d7bf759-a21d-4ea7-9216-24389546200c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f9a191936c4fddb70e6c4259646375_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTMtMy0xLTEtMA_a25473b2-79aa-48a3-acb1-af8b54740302">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f9a191936c4fddb70e6c4259646375_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTMtNy0xLTEtMA_552f2138-85e5-4b1c-a1b0-8848d1be09e1">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTQtMy0xLTEtMA_02519a5d-2f3c-41ce-81a8-8ae84bfdf0f1">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTQtNy0xLTEtMA_ba433a70-a8a7-49c7-a200-3ef331cd732f">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="if747cf37151f46b499105a3d4b1ddf82"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NTY_b2b6ba61-0e97-42bf-a25a-3624e08d055c" escape="true"><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information by level for the derivative assets and liabilities that are measured at fair value on a recurring basis.</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a0c623324e4c58a147690be5ec9a8c_I20201030" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMi0xLTEtMS0w_d4211907-5958-4cb1-9559-674c7431ab11">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib23daffd559644c684e6f30a2989e54b_I20201030" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMi0zLTEtMS0w_2ef09aa0-4cd0-436d-af53-9a1a415fb86a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie23caf8aac694eb5b8a3fbdfd8f4ec01_I20200424" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMi03LTEtMS0w_da01c9b7-44f4-4dbf-a703-16ca9a41884a">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b2207772e84810aa69081bf91dec30_I20200424" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMi05LTEtMS0w_14a9319e-0e2a-4ab4-81e1-fb29bbc78f9c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a0c623324e4c58a147690be5ec9a8c_I20201030" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMy0xLTEtMS0w_be226875-6f3d-48bd-aa9f-bd69e6d1ae09">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib23daffd559644c684e6f30a2989e54b_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMy0zLTEtMS0w_e4d0dacf-89de-41d5-b160-13b7f0e6d9c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie23caf8aac694eb5b8a3fbdfd8f4ec01_I20200424" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMy03LTEtMS0w_75997d21-ead7-48bd-b482-58fc4e8675d9">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b2207772e84810aa69081bf91dec30_I20200424" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMy05LTEtMS0w_e7d96b6f-29d5-4787-9a77-011f4496e775">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to present the fair value of derivative assets and liabilities within the consolidated balance sheets on a gross basis, even when derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation. The cash flows related to collateral posted and received are reported gross as investing and financing activities, respectively, in the consolidated statements of cash flows. </span></div><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:OffsettingAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NDI_063874e8-3724-446c-baf0-9562d5fa672b" escape="true"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:OffsettingLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NTk_bee22050-44bc-4666-a82f-f828f51f50bc" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.833%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recorded Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral Posted (Received)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNC0yLTEtMS0w_7ecaa6d8-0c8f-49d8-89d9-6923e1785f6b">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030" decimals="-6" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNC00LTEtMS0w_b18ada86-902f-4c89-8a29-e4f648862b0a">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeCollateralObligationToReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNC02LTEtMS0w_43305c72-31b4-4a28-968a-4ce665d4436a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNC0xMC0xLTEtMA_95742d83-1eb1-40cd-835c-6892924200f2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271d615350834f588b83b7a2b7f99350_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNi0yLTEtMS0w_3b1f0342-25cb-4725-81e6-bedbf8514b72">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271d615350834f588b83b7a2b7f99350_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNi00LTEtMS0w_e113900b-5e28-48e7-ad27-0308bf53dfba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271d615350834f588b83b7a2b7f99350_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeCollateralObligationToReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNi02LTEtMS0w_19eaae8b-cfa6-4d5a-b617-d2f6d7e073ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271d615350834f588b83b7a2b7f99350_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNi0xMC0xLTEtMA_8cbcb832-e7da-4660-a568-2650c6a16c4d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501c025a1be4439dab95e8898d228126_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNy0yLTEtMS0w_732e1f42-3055-4aba-9e5e-487f4a763d8e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501c025a1be4439dab95e8898d228126_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNy00LTEtMS0w_836704c2-9c3e-443c-aaaa-991ee0183854">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501c025a1be4439dab95e8898d228126_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeCollateralObligationToReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNy02LTEtMS0w_b379be3b-33e3-45d3-aeb5-ec01afe38b6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501c025a1be4439dab95e8898d228126_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNy0xMC0xLTEtMA_12b5e8fa-5f29-4c9a-9b87-25ba02fd622d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfOC0yLTEtMS0w_bc1d4531-314e-4815-82d9-87eff627b6fa">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfOC00LTEtMS0w_78794663-7bcb-40ec-84e5-97b84489adfc">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeCollateralObligationToReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfOC02LTEtMS0w_12a92c90-8ee9-48c1-ac3f-0b61e4dd2dc3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfOC0xMC0xLTEtMA_380933d8-52a1-42c5-9aa6-d9be087a2528">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTAtMi0xLTEtMA_f23a2d8d-78f1-4605-804f-fb8048e61b80">201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030" decimals="-6" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTAtNC0xLTEtMA_baced22b-ef0a-4ee6-bae5-198922979741">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030" decimals="-6" name="us-gaap:DerivativeCollateralRightToReclaimCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTAtNi0xLTEtMA_22eb87bc-b5a9-40ba-bffd-98353fda714f">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTAtMTAtMS0xLTA_bbf1ecf0-85ee-43ee-aa5c-90d839a82fa5">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" sign="-" name="mdt:DerivativeAssetLiabilityFairValueGrossAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTUtMi0xLTEtMA_3cbd35c7-67cb-4b7f-90ce-33a4ea15c2c6">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:zerodash" name="mdt:DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTUtNC0xLTEtMA_9f6e192e-b77c-4a60-b5a1-77abf0a1fc1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" sign="-" name="mdt:DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTUtNi0xLTEtMA_336e968a-8007-452a-b695-b9608ab50046">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueAmountOffsetAgainstCollateralNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTUtMTAtMS0xLTA_3e82eb9b-3291-4cbd-96db-b0fc1ec13ad0">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.833%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recorded Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral Posted (Received)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNC0yLTEtMS0w_c990c18f-5809-4ff6-be65-b4058407fae4">399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424" decimals="-6" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNC00LTEtMS0w_132a3b79-eb7c-47d0-9ee1-c2c56fa6c85a">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424" decimals="-6" name="us-gaap:DerivativeCollateralObligationToReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNC02LTEtMS0w_9c6b0d0c-2eea-422d-92f1-cb282869f290">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNC0xMC0xLTEtMA_eb577bb3-ddfc-4818-9b19-71cfeada4db4">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae2e9403d704584a6e2c9aec89b4fbe_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNi0yLTEtMS0w_30f04dc7-819f-4010-a851-44ff8b422c34">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae2e9403d704584a6e2c9aec89b4fbe_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNi00LTEtMS0w_fcd0b99a-6a74-4055-b4bc-ea2f046e2fc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae2e9403d704584a6e2c9aec89b4fbe_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeCollateralObligationToReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNi02LTEtMS0w_8041ca28-8119-436b-9133-1ff6ea44c836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae2e9403d704584a6e2c9aec89b4fbe_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNi0xMC0xLTEtMA_71602593-de0b-4d4b-841f-73a9a246029a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfOS0yLTEtMS0w_35841501-b805-434d-8b38-a9938b3a5f99">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfOS00LTEtMS0w_e0bd4747-3ffe-46a5-98d3-f30cfd6bc42c">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DerivativeCollateralObligationToReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfOS02LTEtMS0w_9d1192cb-3267-4d19-973c-689d99a6e67f">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfOS0xMC0xLTEtMA_a0497b69-a541-4218-ac05-869ece57cca3">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTEtMi0xLTEtMA_ea5eea4d-c54f-49c6-91c2-10772a164f5f">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424" decimals="-6" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTEtNC0xLTEtMA_695e074e-5968-4233-8a84-a78323121982">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeCollateralRightToReclaimCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTEtNi0xLTEtMA_5913acfc-6e82-44a0-84b3-ac7acb76f1ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTEtMTAtMS0xLTA_f390a78b-61f4-49d8-8b36-25a190dd0b94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37db224b055b4110b0851847038077cc_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTQtMi0xLTEtMA_7629954d-c1b7-418f-a5b3-3c32ecfa678c">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37db224b055b4110b0851847038077cc_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTQtNC0xLTEtMA_fef8ada6-60a6-4d56-b3b4-91f9c79ad022">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37db224b055b4110b0851847038077cc_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeCollateralRightToReclaimCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTQtNi0xLTEtMA_56c6ecef-d599-46fc-bd0b-380b3eda12aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37db224b055b4110b0851847038077cc_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTQtMTAtMS0xLTA_230f3118-9719-462b-8b69-4e78e83e295f">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTUtMi0xLTEtMA_2f5887ba-8b89-4554-a883-ab2455548bc5">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTUtNC0xLTEtMA_b6dc7b4e-b54b-4bd0-b7f5-b70ec5934acb">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeCollateralRightToReclaimCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTUtNi0xLTEtMA_5282e858-fcda-4215-b81e-981954768567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTUtMTAtMS0xLTA_48ae431c-8576-49d2-a5bd-a0c608e9e3e5">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="mdt:DerivativeAssetLiabilityFairValueGrossAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTYtMi0xLTEtMA_a2923d2b-ce3e-414e-9a9e-1080f2acd810">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:zerodash" name="mdt:DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTYtNC0xLTEtMA_4381c309-9e1b-4c87-8488-9ffd9330146d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="mdt:DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTYtNi0xLTEtMA_8cd77294-94cd-43c9-80e9-868a68b1efc1">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:DerivativeFairValueAmountOffsetAgainstCollateralNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTYtMTAtMS0xLTA_a85d6c9f-a094-42eb-a0d1-883f467051da">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_70"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RleHRyZWdpb246ZDE1NWZhMGZjZmI3NDBhZGFjNThmODFmOGQxMGEzOWJfODE_c7509522-a3bc-44fe-823d-28d4e012c117" continuedAt="i0dce3645d09b49c8bfb48b4488c5a620" escape="true">Inventories </ix:nonNumeric></span></div><ix:continuation id="i0dce3645d09b49c8bfb48b4488c5a620"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RleHRyZWdpb246ZDE1NWZhMGZjZmI3NDBhZGFjNThmODFmOGQxMGEzOWJfNzg_d9dceb1b-54cd-4aa8-8a1a-194a8e6c437d" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory balances, net of reserves, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfMS0xLTEtMS0w_6bfb8d9c-0189-43c1-af7d-7a04cb714c1a">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfMS0zLTEtMS0w_937b5e0e-b3aa-4392-8da6-a134854469a1">2,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfMi0xLTEtMS0w_aee43251-d732-4272-84ea-3b1fef193be5">647</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfMi0zLTEtMS0w_daeab5fa-0ba5-4e3c-86d7-ca937e1c1dd6">608</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfMy0xLTEtMS0w_1d9ddf32-d873-4b76-ae86-b32918883567">893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfMy0zLTEtMS0w_192b031b-d9ab-4530-9f2f-29fc1e8ee90b">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfNC0xLTEtMS0w_6bb16090-9fae-41da-8db1-81176a2a1cbe">4,484</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfNC0zLTEtMS0w_7b17a9ca-4c32-498f-9e17-758f0fa897b7">4,229</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_73"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjk0Nw_f4a7de0e-15be-41de-afba-cc81b5670797" continuedAt="ic6adcd3cb31844c482330b0814c24f82" escape="true">Goodwill and Other Intangible Assets </ix:nonNumeric></span></div><ix:continuation id="ic6adcd3cb31844c482330b0814c24f82" continuedAt="ieae359f0867a4196889f7588b9305e04"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjk1Nw_62ed9d40-aa67-490c-b098-da9bede980a8" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of goodwill by segment: </span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cardiac and Vascular Group</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restorative Therapies Group</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diabetes Group</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 24, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23e15999c1646ddbb7df2cda73a7aec_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMS0xLTEtMS0w_51dfda38-7fb0-4ee3-9bc4-8ef74d442857">6,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id873cde847774be59ee4570ffd483d68_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMS0zLTEtMS0w_acaa7023-fb73-4e0a-afe9-3a2471a6df29">20,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c3c106af2b14c32ac0754fe26996414_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMS01LTEtMS0w_97a59c72-5a71-4f2d-a60c-3f38655b5899">10,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54a71bd600c64796b0dda6f39160e883_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMS03LTEtMS0w_c25e6ec2-d186-4ca6-9641-024ab94aa97b">1,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMS05LTEtMS0w_65a9fc7e-8aae-4b2f-82f8-4981d6c3b116">39,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as a result of acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ca6f74752024dcb8dbf523283f9b0ef_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMi0xLTEtMS0w_d1a9f48c-0f42-45a4-9313-26a65b89b6e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieac0a2b04a964cccb353c56583b8d073_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMi0zLTEtMS0w_3cbd6d57-aa62-4e0e-8a03-bdd25e785db4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d7d6e72a3d4a20b5a5c636e920c38c_D20200425-20201030" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMi01LTEtMS0w_1d86ff7f-8261-4d67-8e30-07cf9c365398">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i374e41da3175425682886e64b4e59ac7_D20200425-20201030" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMi03LTEtMS0w_38496731-c321-4840-bbc2-0517f10ddbb9">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMi05LTEtMS0w_50d2709e-84e6-4ee6-94f7-db8c6a986dac">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ca6f74752024dcb8dbf523283f9b0ef_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMy0xLTEtMS0w_5bdddce2-1467-412d-98b3-3aca250abc7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieac0a2b04a964cccb353c56583b8d073_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMy0zLTEtMS0w_78f5fd61-a22c-4405-b91c-58b6b081d42e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d7d6e72a3d4a20b5a5c636e920c38c_D20200425-20201030" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMy01LTEtMS0w_00125ddb-7341-47ca-863b-569de415a6fe">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i374e41da3175425682886e64b4e59ac7_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMy03LTEtMS0w_1be92f0a-bdb2-4950-9120-c2bb7c5093b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMy05LTEtMS0w_c45ad7b8-b05a-4fed-bcfc-6bdef05849b0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ca6f74752024dcb8dbf523283f9b0ef_D20200425-20201030" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNC0xLTEtMS0w_a0e6581e-b62c-466b-a8d5-b3cc587344de">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieac0a2b04a964cccb353c56583b8d073_D20200425-20201030" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNC0zLTEtMS0w_12e4562b-628c-4317-a343-44970f09c973">772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d7d6e72a3d4a20b5a5c636e920c38c_D20200425-20201030" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNC01LTEtMS0w_ffd72e98-24df-4f7c-a3f6-29940b0c85f7">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i374e41da3175425682886e64b4e59ac7_D20200425-20201030" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNC03LTEtMS0w_0593d18d-4f6d-480f-9a36-3953c5654003">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNC05LTEtMS0w_013bea8d-2eb2-4f2b-844e-b7ad2ad66f5b">987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6df7d3cc9f44895b99362ae686d8a29_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNS0xLTEtMS0w_5d29c53e-5534-4e6a-92db-b47d9a0f1863">6,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82923a0349f6443ab5eb2ec2e25dbb27_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNS0zLTEtMS0w_13f3f9c2-7c0b-420e-acbb-436b50bda66a">20,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40f981d3461b436c8ea0d4236782cc68_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNS01LTEtMS0w_3b38667c-48df-433b-8c36-575a9ff10616">11,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba50466d7292490bb6538e2b946dd0e0_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNS03LTEtMS0w_e0fe25b5-1454-4ae2-adb4-f75251ee291e">2,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNS05LTEtMS0w_48505017-3e04-45ad-8a67-2ab624a0fd61">41,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill for impairment annually as of the first day of the third quarter of the fiscal year and whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Impairment testing for goodwill is performed at the reporting unit level. The test for impairment of goodwill requires the Company to make several estimates about fair value, most of which are based on projected future cash flows. The Company calculates the excess of each reporting unit's fair value over its carrying amount, including goodwill, utilizing a discounted cash flow analysis. The Company did <ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNzQ4_243e09de-86a8-457a-853b-b4d82c5b6bf6"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNzQ4_eacf6915-0759-42ed-a086-44b58078f2a8"><ix:nonFraction unitRef="usd" contextRef="if3e0650de43b4e1f8c3d2b521e13e0ef_D20180728-20181026" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNzQ4_f63fdd52-030d-48f6-9034-af25bbb06da0"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNzQ4_feb5dba1-73be-444d-84d6-55b58844037f">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t recognize any goodwill impairment during the three and six months ended October&#160;30, 2020 or October&#160;25, 2019. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets </span></div><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjk0NQ_37058b3e-ed46-4832-9e79-eb745387c348" escape="true"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjk1MQ_e36554b3-cb77-48b4-8009-b3c2266e0e29" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the gross carrying amount and accumulated amortization of intangible assets: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a60149be38443fb2d916de554d6254_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfMy0xLTEtMS0w_1423f457-8f9a-4909-b158-72fadc2ea49d">17,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a60149be38443fb2d916de554d6254_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfMy0zLTEtMS0w_5f77a289-acb5-4e93-a6aa-f0e46720a38a">5,567</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3767fcfe1389419994824ecb077fef38_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfMy01LTEtMS0w_0707f535-fba9-4583-a423-02bf9ee91892">16,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3767fcfe1389419994824ecb077fef38_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfMy03LTEtMS0w_7ff96f97-d159-4348-98f5-74aaa878b337">5,065</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology and patents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3d7fb880809444bae1c970a1373d381_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNC0xLTEtMS0w_db674059-9993-43e2-bbe7-ba5de9f4188a">11,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3d7fb880809444bae1c970a1373d381_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNC0zLTEtMS0w_9c749bca-c287-4bbe-9e22-225ef85aca0e">4,767</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id014282d690d4c5a896ab2b26bacaa6d_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNC01LTEtMS0w_2a23f009-999d-4e94-83d1-579c47836ae6">10,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id014282d690d4c5a896ab2b26bacaa6d_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNC03LTEtMS0w_00719b35-c237-4c07-a23c-64c7791ab7a8">4,354</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c038d0f8344416b953ecf5e0e5a61d_I20201030" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNS0xLTEtMS0w_10d6adc1-8521-485e-94b0-e918d85a2aba">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03c038d0f8344416b953ecf5e0e5a61d_I20201030" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNS0zLTEtMS0w_d4081632-8004-440d-8256-efa74faa1fee">241</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1504f2bee7c143859a17a93113ddf64c_I20200424" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNS01LTEtMS0w_feb15de9-2747-49d3-906d-5cde4f3c7201">464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1504f2bee7c143859a17a93113ddf64c_I20200424" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNS03LTEtMS0w_8c3b937a-4dd3-479b-baaf-9dc1c4848afa">232</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if300d7f5eef94b9bbab7fef186492d3f_I20201030" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNi0xLTEtMS0w_a105cea2-c2f5-4eed-8359-2ce15dfb64e4">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if300d7f5eef94b9bbab7fef186492d3f_I20201030" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNi0zLTEtMS0w_65647fcc-ac54-4b5e-a297-db30f93b4f8e">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic16cb2a7cf0049afb87f33af952987fb_I20200424" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNi01LTEtMS0w_7710cf8d-a920-4ec5-9def-261a01fd75b5">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic16cb2a7cf0049afb87f33af952987fb_I20200424" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNi03LTEtMS0w_ccf57445-ffad-470d-8e69-cb6d203fd384">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNy0xLTEtMS0w_2d354ddf-0cb0-4524-8ac2-fcb34447a543">28,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNy0zLTEtMS0w_a71e8391-4efd-4e7c-ab73-ec77606ddc74">10,633</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNy01LTEtMS0w_28d45843-f5a6-4a22-8df1-c41c834afe5c">28,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNy03LTEtMS0w_3ad442f4-2077-4f9b-98ca-6f041be94e6e">9,704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9b67e332e24b35b2d7941bda8317f3_I20201030" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfOS0xLTEtMS0w_1e5fbf51-56cb-4a30-b5c1-6337c0c7bf02">440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie963904705b8409cb3f2f8c8ca2bf137_I20200424" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfOS01LTEtMS0w_97ba781c-6e6a-483e-a53c-1d0ddb857f2a">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="ieae359f0867a4196889f7588b9305e04"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company assesses definite-lived intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of an intangible asset (asset group) may not be recoverable. When events or changes in circumstances indicate that the carrying value of an intangible asset may not be recoverable, the Company calculates the excess of an intangible asset's carrying value over its undiscounted future cash flows. If the carrying value is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value. The inputs used in the fair value analysis fall within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs to determine fair value. The Company did <ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMTcyNg_e207c20d-cd08-48fe-9113-350a36dfeef3"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMTcyNg_f954d8db-e475-4f25-9bba-ad540c1d2e3a">no</ix:nonFraction></ix:nonFraction>t recognize any definite-lived intangible asset charges during the three and six months ended October&#160;30, 2020. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNDM5ODA0NjUxNDcwNg_022165f2-1107-4afb-998a-92244f7787eb"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNDM5ODA0NjUxNDcwNg_f71503b0-6c86-4c20-a97c-8196f304c834">33</ix:nonFraction></ix:nonFraction>&#160;million of definite-lived intangible asset charges during the three and six months ended October 25, 2019 in connection with exit of businesses within the Restorative Therapies Group segment. Intangible asset impairment charges are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company assesses indefinite-lived intangibles for impairment annually in the third quarter of the fiscal year and whenever an event occurs or circumstances change that would indicate that the carrying value may be impaired. The Company did <ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjA3MA_0b0d0687-3f54-4941-bd86-0eae2b687cd0"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjA3MA_1439fb04-d640-48d1-8bd9-c62b9f6fc26b"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjA3MA_78643bce-a732-4cc5-a4f0-3033e3b2da63"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjA3MA_8b00b839-f530-42c9-9634-10e5da8355f6">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t recognize any indefinite-lived intangible asset impairments during the three and six months ended October&#160;30, 2020 or October&#160;25, 2019. Due to the nature of IPR&amp;D projects, the Company may experience future delays or failures to obtain regulatory approvals to conduct clinical trials, failures of clinical trials, delays or failures to obtain required market clearances, other failures to achieve a commercially viable product, or the discontinuation of certain projects, and as a result, may recognize impairment losses in the future.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortization Expense</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense for the three months ended October&#160;30, 2020 and October&#160;25, 2019 was $<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNzY5NjU4MTM5NzQyMA_71800004-2bf9-4ac7-a529-3c855f1e617c">443</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNzY5NjU4MTM5NzQzNg_1e13fc4e-9aa6-4737-89d6-c3bccdf4d1ad">441</ix:nonFraction>&#160;million, respectively. For the six months ended October&#160;30, 2020 and October&#160;25, 2019, intangible asset amortization expense was $<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMTA5OTUxMTYyODEzMTU_09eb1bac-4237-431d-8da1-0d3c2e803da5">884</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMTA5OTUxMTYyODEzMjM_650024d4-2b2c-47d7-b32c-9501b4bb7a2d">881</ix:nonFraction>&#160;million, respectively. <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjk0Ng_07771e61-cea6-4eaf-be57-e70921254b74" continuedAt="i07d16fe056684c389a64813c986ca0f8" escape="true">Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at October&#160;30, 2020, excluding any possible future amortization associated with acquired IPR&amp;D which has not yet met technological feasibility, is as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><ix:continuation id="i07d16fe056684c389a64813c986ca0f8"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmY0MTBiZTE4YWVhYTQ3ZjNhNjFiNjg4NmU4YjZhYmIxL3RhYmxlcmFuZ2U6ZjQxMGJlMThhZWFhNDdmM2E2MWI2ODg2ZThiNmFiYjFfMS0xLTEtMS0w_90769fd1-2445-4806-975c-b79d121ce4bb">888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmY0MTBiZTE4YWVhYTQ3ZjNhNjFiNjg4NmU4YjZhYmIxL3RhYmxlcmFuZ2U6ZjQxMGJlMThhZWFhNDdmM2E2MWI2ODg2ZThiNmFiYjFfMi0xLTEtMS0w_329c2bc5-4fd1-4450-99e7-b2bfe1657afb">1,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmY0MTBiZTE4YWVhYTQ3ZjNhNjFiNjg4NmU4YjZhYmIxL3RhYmxlcmFuZ2U6ZjQxMGJlMThhZWFhNDdmM2E2MWI2ODg2ZThiNmFiYjFfMy0xLTEtMS0w_36bf246c-0e53-4895-a825-1d88138b957b">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmY0MTBiZTE4YWVhYTQ3ZjNhNjFiNjg4NmU4YjZhYmIxL3RhYmxlcmFuZ2U6ZjQxMGJlMThhZWFhNDdmM2E2MWI2ODg2ZThiNmFiYjFfNC0xLTEtMS0w_50cd7ada-eaea-4941-8b63-0d2064e13833">1,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmY0MTBiZTE4YWVhYTQ3ZjNhNjFiNjg4NmU4YjZhYmIxL3RhYmxlcmFuZ2U6ZjQxMGJlMThhZWFhNDdmM2E2MWI2ODg2ZThiNmFiYjFfNS0xLTEtMS0w_1462fac7-a016-4d65-92eb-bcd9e32c87d0">1,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmY0MTBiZTE4YWVhYTQ3ZjNhNjFiNjg4NmU4YjZhYmIxL3RhYmxlcmFuZ2U6ZjQxMGJlMThhZWFhNDdmM2E2MWI2ODg2ZThiNmFiYjFfNi0xLTEtMS0w_b5f112f4-a032-4a07-baa1-639e16c95545">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_76"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMjgxNQ_38e8afd7-36f0-45af-a241-798462921f9b" continuedAt="i669986aee2644037a21a2781a76b3691" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="i669986aee2644037a21a2781a76b3691" continuedAt="ia277a74de430456a90be3e9219183bb9"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective tax rate for the three and six months ended October&#160;30, 2020 was <ix:nonFraction unitRef="number" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfODA_ae04d77b-917a-42a0-ac54-7da8d5948c07">5.9</ix:nonFraction> percent and <ix:nonFraction unitRef="number" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ0NDQ5Ng_e948c254-67df-49b4-9368-145e701e8557">11.2</ix:nonFraction> percent, respectively, as compared to (<ix:nonFraction unitRef="number" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfOTk_fea64725-d40a-4f45-94ef-957eac7600c7">6.0</ix:nonFraction>) percent and <ix:nonFraction unitRef="number" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ0NDU0Mg_b155a18f-e098-44bd-a527-a68b72cb0b26">1.0</ix:nonFraction> percent for the three and six months ended October&#160;25, 2019, respectively. The increase in the effective tax rate for the three and six months ended October&#160;30, 2020, as compared to the corresponding periods in the prior fiscal year, was primarily due to the impact of certain tax adjustments and year-over-year changes in operational results by jurisdiction. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Tax Adjustments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended October&#160;30, 2020, the cost from certain tax adjustments of $<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTU5Mw_3c858752-9c91-4ce8-ad0c-2081f286ce0e">16</ix:nonFraction>&#160;million, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">income tax provision (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income, included a cost of $<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTYwNg_b595851c-f26e-4499-aff4-06e05624c9a6">16</ix:nonFraction>&#160;million associated with the amortization of the previously established deferred tax assets from intercompany intellectual property transactions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the six months ended October&#160;30, 2020, the net cost from certain tax adjustments of $<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfNDM5ODA0NjUyNTQxNA_8f158f0b-2090-43fd-91f4-4c1bcd90332d">20</ix:nonFraction>&#160;million, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">income tax provision (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income, included the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">A benefit of $<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mdt:TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTYxOQ_1c63a302-8751-43f8-8bb9-28324fd14b8d">3</ix:nonFraction>&#160;million associated with the finalization of an intercompany sale of intellectual property and the establishment of a deferred tax asset. The cumulative amount of deferred tax benefit previously recognized from intercompany intellectual property transactions and recorded as Certain Tax Adjustments is $<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTYzMQ_7a0ba437-8003-44fc-9587-ca0d22fe0fc1">1.5</ix:nonFraction>&#160;billion. The corresponding deferred tax assets will be amortized over a period of approximately <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" format="ixt-sec:duryear" name="mdt:DeferredTaxAssetsAmortizationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfNDM5ODA0NjUyNTQyNg_48feb3bc-f2db-43bc-8baf-5894a5d8bb8f">20</ix:nonNumeric> years. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">A cost of $<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTY0NQ_a5ff4041-5020-4031-9dd0-40ffa35fa8d9">23</ix:nonFraction>&#160;million associated with the amortization of the previously established deferred tax assets from intercompany intellectual property transactions.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="ia277a74de430456a90be3e9219183bb9"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended October&#160;25, 2019, the benefit from certain tax adjustments of $<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTY1OA_c2e0aa7b-8f83-433a-8446-83873788a5ac">251</ix:nonFraction>&#160;million, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">income tax provision (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income, included a benefit of $<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxContingenciesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTY3Mg_31fbd497-7b7f-4fb9-9c11-125041af87cd">251</ix:nonFraction>&#160;million related to tax legislative changes in Switzerland which abolished certain preferential tax regimes the Company benefited from and replaced them with a new set of internationally accepted measures. The legislation provided for higher effective tax rates but allowed for a transitional period whereby an amortizable asset was created for Swiss federal income tax purposes which will be amortized and deducted over a <ix:nonNumeric contextRef="i72dff3c52a304a0bab96f9563e0abd46_D20190727-20191025" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfNDM5ODA0NjUyNTQ0MA_8115c5aa-4223-4a83-bc41-e5c9c42835c2">10</ix:nonNumeric>-year period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended October&#160;25, 2019, the net benefit from certain tax adjustments of $<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTc3OQ_83510c79-09a3-4b8c-b5c4-b03641c6c846">281</ix:nonFraction>&#160;million, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">income tax provision (benefit) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income, included the following: </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A net benefit of $<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTY4Ng_9e73e411-54f8-4b4f-bae9-80557581a4c3">30</ix:nonFraction>&#160;million related to U.S. Treasury&#8217;s issuance of certain Final Regulations associated with U.S. Tax Reform. The primary impact of these regulations resulted in the re-establishment of our permanently reinvested assertion on certain foreign earnings and reversing the previously accrued tax liability. This benefit was partially offset by additional tax associated with a previously executed internal reorganization of certain foreign subsidiaries. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A benefit of $<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxContingenciesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTc5Mw_4b79a8a7-c9bc-49d9-956a-4477e0d10fc4">251</ix:nonFraction>&#160;million related to tax legislative changes in Switzerland which abolished certain preferential tax regimes the Company benefited from and replaced them with a new set of internationally accepted measures. The legislation provided for higher effective tax rates but allowed for a transitional period whereby an amortizable asset was created for Swiss federal income tax purposes which will be amortized and deducted over a <ix:nonNumeric contextRef="ie63e2a6be41a4756afe92a2464f79dd6_D20190427-20191025" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfNDM5ODA0NjUyNTQ0Nw_25d634dc-fa56-4f31-a418-bed806303858">10</ix:nonNumeric>-year period.   </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At both October&#160;30, 2020 and April&#160;24, 2020, the Company's gross unrecognized tax benefits were $<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTgwNw_fbab1e0c-826a-49f4-b003-7f6e6d56933f"><ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTgwNw_fce3d619-6b3f-42d4-9e44-beb83195f20e">1.9</ix:nonFraction></ix:nonFraction>&#160;billion. In addition, the Company had accrued gross interest and penalties of $<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTgyMQ_39f56454-c7eb-4524-ab1d-1f2089b260d4">251</ix:nonFraction>&#160;million at October&#160;30, 2020. If all the Company&#8217;s unrecognized tax benefits were recognized, approximately $<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTgzNQ_8dbf7125-7d70-4905-864b-0a59f04be969">1.8</ix:nonFraction>&#160;billion would impact the Company&#8217;s effective tax rate. At October&#160;30, 2020 and April&#160;24, 2020, the amount of the Company's gross unrecognized tax benefits recorded as a noncurrent liability within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">accrued income taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">on the consolidated balance sheets was $<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTg0OQ_5eeead53-1c53-4101-b8d0-7ddc2c366381">940</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTg2Mw_e7a8a257-3f17-4abc-8407-6977b7dcee82">911</ix:nonFraction>&#160;million, respectively.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company recognizes interest and penalties related to income tax matters within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">income tax provision (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income and records the liability within either current or noncurrent </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">accrued income taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">on the consolidated balance sheets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 16 to the consolidated financial statements for additional information regarding the status of current tax audits and proceedings.</span></div></ix:continuation><div id="i6128593e20e44bbc8b0671c482ec9b79_79"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RleHRyZWdpb246N2Y1YTgyNDM5OWFmNDQ3Zjk5Mjc5MTQ2YTU3YzRiZTJfMTQ4Mw_a7c82690-ef4c-4ab8-9656-23d3690d33a0" continuedAt="ia3c9f0c8dc3448a6b9d85e62e6c8ef98" escape="true">Earnings Per Share </ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia3c9f0c8dc3448a6b9d85e62e6c8ef98" continuedAt="i7081182adda84f71bc151b66a2b0a31a">Earnings per share is calculated using the two-class method, as the Company's A Preferred Shares are considered participating securities. Accordingly, earnings are allocated to both ordinary shares and participating securities in determining earnings per ordinary share. Due to the limited number of A Preferred Shares outstanding, this allocation had no effect on ordinary earnings per share; therefore, it is not presented below. Basic earnings per share is computed based on the weighted average number of ordinary shares outstanding. Diluted earnings per share is computed based on the weighted average number of ordinary shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive ordinary shares been issued, and reduced by the number of shares the Company could have repurchased with the proceeds from issuance of the potentially dilutive shares. Potentially dilutive ordinary shares include stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i7081182adda84f71bc151b66a2b0a31a" continuedAt="ieba71ab18b63444dac29530a53dfc439"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RleHRyZWdpb246N2Y1YTgyNDM5OWFmNDQ3Zjk5Mjc5MTQ2YTU3YzRiZTJfMTQ3OA_b141af61-4619-445c-9dd9-75ecadc965c7" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth the computation of basic and diluted earnings per share:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to ordinary shareholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMy0xLTEtMS0w_2eec1533-e25c-426f-bbd7-ffabda096479">489</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMy0zLTEtMS0w_9ad25ff8-8cce-400f-ae3f-36eeda31ab5a">1,364</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMy01LTEtMS02OTg_de28ae33-dde4-44e7-9f29-51488692d5b8">976</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMy03LTEtMS02OTg_9541a47f-0716-482a-89bb-ed8170be0622">2,228</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic &#8211; weighted average shares outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNS0xLTEtMS0w_4cb64ffc-78b9-4dc0-99f3-d5f6ed3adc68">1,344.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNS0zLTEtMS0w_6b282c6d-5421-41cf-962e-e956823807b5">1,340.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNS01LTEtMS03MDE_45ff78f3-c94b-409f-beb2-3f7c3d475a62">1,343.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNS03LTEtMS03MDE_a8dc74be-66f9-4d52-91b9-028aa2a271ce">1,340.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNy0xLTEtMS0w_4374dc9b-b4c4-43f2-81bf-cf63b559658c">5.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNy0zLTEtMS0w_7a300099-57de-4c61-bbd5-c47ed31ef4f6">8.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNy01LTEtMS03MDQ_f771402d-ca8e-4f6b-97c6-456270d964f0">5.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNy03LTEtMS03MDQ_6ab1647a-e661-4fbb-bc42-2822704c3f93">7.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOC0xLTEtMS0w_2c74c8db-494f-47c5-a774-127890887ec0">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOC0zLTEtMS0w_3aa2a6be-a081-4e7f-8e2c-f9da004089a0">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOC01LTEtMS03MDQ_3b114157-fddd-471c-9c8b-2a69876fce08">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOC03LTEtMS03MDQ_db6a1961-afad-4761-bcf5-ab127b6893cb">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-5" format="ixt:zerodash" name="mdt:IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOS0xLTEtMS0w_b0f352ad-58ef-4d91-bfb8-4e8f52214b4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-5" format="ixt:zerodash" name="mdt:IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOS0zLTEtMS0w_339afbbc-0fb1-48f6-b6d7-f1269245ce37">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-5" name="mdt:IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOS01LTEtMS03MDQ_cb41a379-1465-4c0c-84de-21b41f254160">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-5" name="mdt:IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOS03LTEtMS03MDQ_4b99cf9a-977a-4d7d-897b-b9d3f8d20bca">0.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTAtMS0xLTEtMA_b5f2bb39-ddcd-431e-97cb-77f843b68263">1,352.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTAtMy0xLTEtMA_1f639a3e-dd0b-455f-be52-b6e07558fe18">1,351.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTAtNS0xLTEtNzEx_3532f99f-c52d-4ae5-b737-eeb62af2a571">1,351.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTAtNy0xLTEtNzEx_e684a5ce-5527-47e3-afeb-a9bb6980651c">1,351.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTItMS0xLTEtMA_1b507879-8937-4e36-b187-ec69d9464ae7">0.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTItMy0xLTEtMA_b8932550-879c-4d74-8b78-259447093a00">1.02</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTItNS0xLTEtNzE4_f7f6e0da-8922-4e53-861b-f7829e610dfe">0.73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTItNy0xLTEtNzE4_c3857a75-717f-441e-9751-e3c757ef214f">1.66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTMtMS0xLTEtMA_bf8088ea-372e-4384-b84a-7923042525d4">0.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTMtMy0xLTEtMA_9260f3ee-fec3-46a4-a3ba-7bdadd3c6227">1.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTMtNS0xLTEtNzE4_1d66f666-96e2-43d9-a2e5-90739ac37768">0.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTMtNy0xLTEtNzE4_88fc9643-02d6-4545-ae07-cace5f1915ba">1.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieba71ab18b63444dac29530a53dfc439">The calculation of weighted average diluted shares outstanding excludes options to purchase approximately <ix:nonFraction unitRef="shares" contextRef="i038d289ad6de4b8f85679e45d0448c91_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RleHRyZWdpb246N2Y1YTgyNDM5OWFmNDQ3Zjk5Mjc5MTQ2YTU3YzRiZTJfOTg5NTYwNDY1MTQ4Nw_1f3fce31-3724-400a-a9b1-e93d1782c20b"><ix:nonFraction unitRef="shares" contextRef="i17f2e9ba8db047a49f7e5293b1dc77f7_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RleHRyZWdpb246N2Y1YTgyNDM5OWFmNDQ3Zjk5Mjc5MTQ2YTU3YzRiZTJfOTg5NTYwNDY1MTQ4Nw_b09870d2-d2d1-44ba-9831-3027c4e75dfe">8</ix:nonFraction></ix:nonFraction> million ordinary shares for both the three and six months ended October&#160;30, 2020, and <ix:nonFraction unitRef="shares" contextRef="i37cf6705fcb445ac9da8563c668b75cd_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RleHRyZWdpb246N2Y1YTgyNDM5OWFmNDQ3Zjk5Mjc5MTQ2YTU3YzRiZTJfMTMxOQ_7ed8264b-b64c-45f3-bd95-c778b69fb7f6"><ix:nonFraction unitRef="shares" contextRef="i2c5e5989168e41efb2ee254d247c516e_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RleHRyZWdpb246N2Y1YTgyNDM5OWFmNDQ3Zjk5Mjc5MTQ2YTU3YzRiZTJfMTMxOQ_9232e763-f3d0-4323-b171-bd7385fce8ff">4</ix:nonFraction></ix:nonFraction> million ordinary shares for both the three and six months ended October&#160;25, 2019, because their effect would have been anti-dilutive on the Company&#8217;s earnings per share.</ix:continuation> </span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_82"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RleHRyZWdpb246NDYzODBjMTZkZTM5NGEwMDhiMTU2YzRhN2NkZTM1YTdfMjUy_2bd654eb-53a5-4cd9-ac9e-a1e87652ca85" continuedAt="i6f76c474c3e449f099f064713f0f0a5b" escape="true">Stock-Based Compensation </ix:nonNumeric></span></div><ix:continuation id="i6f76c474c3e449f099f064713f0f0a5b"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RleHRyZWdpb246NDYzODBjMTZkZTM5NGEwMDhiMTU2YzRhN2NkZTM1YTdfMjU0_5b377e8d-aa0b-4175-9839-9f5f8e10d677" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components and classification of stock-based compensation expense for stock options, restricted stock, and employee stock purchase plan shares recognized for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00b67cb0c676413da10bbe00d1f895a2_D20200801-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMi0xLTEtMS0w_e6d3d331-68c6-4b20-8910-fb579338cb9c">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3c7b067b2a490a80be46ac5e1bf7dd_D20190727-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMi0zLTEtMS0w_23458110-5c1e-48b6-84c5-dea5aad458e2">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f020c9e8ce45279dc4d7550054f8f3_D20200425-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMi01LTEtMS03MzM_df55231e-fdd4-4954-b093-bd9b0c12ae87">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa63515bf8647dd9bf70dfb44e3a57e_D20190427-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMi03LTEtMS03MzM_8382e1a1-d379-4523-a062-33efff1c5726">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if98bf19b12ea4baca1ee2d733327d267_D20200801-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMy0xLTEtMS0w_5fcd0091-87f5-46ef-ba7d-dc1349da5cd9">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41db5984a04f476c9e1643f4d8215c73_D20190727-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMy0zLTEtMS0w_0490e85a-c9ad-4ac3-8638-4f0397bdcbc3">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3500b71577b74f76a424e65d43544367_D20200425-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMy01LTEtMS03MzM_83eb9f74-606b-4112-8121-1d4906e4c514">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8755e7c5c19246d985fd44c7bbf450b0_D20190427-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMy03LTEtMS03MzM_69721124-1309-4334-a0ee-d2728a793f93">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbfbe22288704f4294f5d6ad2a6bbdb4_D20200801-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNC0xLTEtMS0w_97ff624b-6804-4cc5-94f1-eaddc0dba845">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7073f7fded4be99ae2a0b2a3a31757_D20190727-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNC0zLTEtMS0w_78b09da7-7a85-4c06-b37a-ef5a9f400f82">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31ca63612edf4a8295126af8750e6ae4_D20200425-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNC01LTEtMS03MzM_0423c971-0250-4d82-a479-db043edf3e5a">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i609d7c4a83e640db9dccf290d58342ce_D20190427-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNC03LTEtMS03MzM_62343855-fd91-42fa-8e7d-90d95dd772d5">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNS0xLTEtMS0w_d6753af6-e77f-4769-be25-64d85487f8d5">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNS0zLTEtMS0w_9c66189a-7414-49fb-9d45-36ca1b74f0c0">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNS01LTEtMS03MzM_c356994a-8be4-423c-bdbc-8b57a18e56fb">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNS03LTEtMS03MzM_a56864f5-ade5-4caa-af02-9e7571c58a25">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9acd77d49d4840c18802f8875a75d339_D20200801-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNy0xLTEtMS0w_72aefd83-5ead-480f-af5d-cd2a094bda78">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70cc00740a274a9382f8faf2cfd6c19e_D20190727-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNy0zLTEtMS0w_688131d4-3580-4a55-952c-9927d8c1753e">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2c5bd78d0142318be39bad4bfa6c50_D20200425-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNy01LTEtMS03MzM_dcaa0fb2-b280-4e94-a3be-62422d46f865">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id65399fc03ca4ad7987953d64a511415_D20190427-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNy03LTEtMS03MzM_a9c3cbdc-0592-464a-8bc4-ef144c1d177e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i041edce7b2f84381a0ffac6ba095e1fd_D20200801-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOC0xLTEtMS0w_bcc302a2-a84a-46d0-9d75-d663a553aca6">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be4b5dbd3a843788549eca186a30ccc_D20190727-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOC0zLTEtMS0w_b4236082-4afc-4dd8-8626-8543a3f88666">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib483fb15c6034697bfe54c44860b3101_D20200425-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOC01LTEtMS03MzM_067fac62-df94-49e6-94fa-8821e686e392">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea08a324b22a4b3585ccc68dd6591808_D20190427-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOC03LTEtMS03MzM_79a6859b-1f68-49cc-b83e-cf530ac040b0">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc8350b91b4146b3901beacd17a1c4e2_D20200801-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOS0xLTEtMS0w_03561b74-bef2-421f-9b1a-4661c6800fd8">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i541ed731bef54145b54be9fcb6064899_D20190727-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOS0zLTEtMS0w_05bdf078-ce7c-4dd7-8ec1-c2eb6dfaa935">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169643d5df3945a980638c7f94c6cf7b_D20200425-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOS01LTEtMS03MzM_85ba70b6-2480-4393-9720-4ac14a2905b3">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f3edae1486d484084c48f942aa09416_D20190427-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOS03LTEtMS03MzM_086f481b-cd3b-46ef-9b22-320b30551c8b">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTAtMS0xLTEtMA_78efca9c-34ca-4627-8c6e-09b4b11fdb5f">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTAtMy0xLTEtMA_c27b6cb6-42af-4d79-ba67-65007c9e534f">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTAtNS0xLTEtNzMz_6581dc8b-c03c-4f23-9dc7-5829be7ac4af">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTAtNy0xLTEtNzMz_35145126-7796-4507-b5ab-bc06c00b96ff">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefits</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTEtMS0xLTEtMA_e8f810ce-4b92-42d8-91c4-c807f91b1d2e">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTEtMy0xLTEtMA_fb148594-792c-47b2-8b25-b10c6c52faaf">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTEtNS0xLTEtNzMz_961a10fe-946e-47ca-a977-8af46433666e">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTEtNy0xLTEtNzMz_611e27ca-4e05-46e5-83e1-778e1e75e31a">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTItMS0xLTEtMA_d0d778ab-1040-4785-a73b-871975e1b867">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTItMy0xLTEtMA_2c97f92c-7169-4db6-b426-2e93e8058fcf">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTItNS0xLTEtNzMz_4b2dfa52-8a1f-4572-9222-bc9b7bf92d8f">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTItNy0xLTEtNzMz_557e86d4-47f3-4e0e-a908-32757aa3aaae">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_85"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfMTEwMQ_3143ee64-30eb-47ad-b57e-d1ffedc3fa8e" continuedAt="i79900443c1d645c0be3f6a7fa2a4daa4" escape="true">Retirement Benefit Plans </ix:nonNumeric></span></div><ix:continuation id="i79900443c1d645c0be3f6a7fa2a4daa4"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various retirement benefit plans, including defined benefit pension plans, post-retirement medical plans, defined contribution savings plans, and termination indemnity plans, covering substantially all U.S. employees and many employees outside the U.S. <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxMjIzNw_58c23093-df64-4f2b-8064-14aa29ed7f6b" continuedAt="ia71d8cbac14846d4bc77fb3ab133f687" escape="true">The net periodic benefit cost of the defined benefit pension plans included the following components for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</ix:nonNumeric></span></div><ix:continuation id="ia71d8cbac14846d4bc77fb3ab133f687"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy0xLTEtMS04NjQ2_6d0f100f-abc2-49a8-831f-1fb0b399e145">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy0zLTEtMS04NjQ2_c320d42a-75e7-421f-ba86-859884f4fa7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy01LTEtMS04NjQ2_3d8d31ad-d7be-461f-8dc0-5ca7d05cb060">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy03LTEtMS04NjQ2_441e38d0-a36a-4707-a82c-0fa698431fc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy0xLTEtMS0xMDA2_d9978de4-4dcb-497f-9c22-cb251bb0fe2b">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy0zLTEtMS0xMDA2_bb4bf2a5-71ac-4ade-a622-97b941cdbd24">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy01LTEtMS0xMDA2_9253951b-5f25-4c59-9314-37b92f26c348">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy03LTEtMS0xMDA2_db512271-b684-49c7-9155-5902116a5807">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNC0xLTEtMS0xMDA2_ffa464ff-4f8c-42e0-b3a7-6d899e7c474d">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNC0zLTEtMS0xMDA2_ae1e2fe9-7ec4-400a-9465-ac6cba9f1e19">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNC01LTEtMS0xMDA2_3e00e989-006d-4a5b-81db-d9e9a4616348">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNC03LTEtMS0xMDA2_b7552752-ef1d-473b-be66-5621223613a7">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNS0xLTEtMS0xMDA2_a336d33a-5ec4-49c6-a4e3-d24afe835ef1">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNS0zLTEtMS0xMDA2_7299fcc2-115c-4ddb-b757-8cc514f480b0">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNS01LTEtMS0xMDA2_1fefeb7f-322d-45d4-9dca-83fd833f7124">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNS03LTEtMS0xMDA2_d51f4fb5-a9e9-4329-8083-396958f3d705">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNi0xLTEtMS0xMDA2_b98e00fa-450b-408b-a4c5-1ab3c57c4eb1">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNi0zLTEtMS0xMDA2_5e639b0e-c2cf-44ca-8170-1be284d9fa12">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNi01LTEtMS0xMDA2_c5ba8cd5-2298-497d-a3d9-cfcab256c5c2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNi03LTEtMS0xMDA2_b44857a8-4300-4449-98a1-396f013ec798">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfOC0xLTEtMS0xMDA2_1265ffbf-d982-43f1-9711-2f82ea1bb4b8">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfOC0zLTEtMS0xMDA2_db65f710-4b6f-484b-91e3-2fb7c8b3716e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfOC01LTEtMS0xMDA2_b348af6c-e005-46b4-99cf-a6c1b2225d09">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfOC03LTEtMS0xMDA2_59b05298-80ba-4b4d-a224-16d17ec93e5f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy0xLTEtMS04NjU2_91ace47a-49d2-4aa6-9a0e-3950dde324ea">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48966b2b67e54988b474069368fd3c54_D20190427-20191025" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy0zLTEtMS04NjU2_412274f3-b0bd-48c9-99f9-b16403400a3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy01LTEtMS04NjU2_c55ba916-abfa-4a6e-b8f7-10699566f561">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i079d0741b4814caf97785cd103555063_D20190427-20191025" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy03LTEtMS04NjU2_6571a976-0fcf-480c-92cd-078ef372ef2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy0xLTEtMS0xMDIz_8998780c-26f0-46f4-91ac-e27475d2dd4b">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48966b2b67e54988b474069368fd3c54_D20190427-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy0zLTEtMS0xMDIz_d6b54661-19b2-4268-9f51-33461813ca66">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy01LTEtMS0xMDIz_dd14e0a4-c9e4-4470-89ff-dbc6ae5ad3b0">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i079d0741b4814caf97785cd103555063_D20190427-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy03LTEtMS03NTA_53992700-4462-4c2a-9f90-8fdb92fa127b">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNC0xLTEtMS0xMDIz_9fff3f5d-d39b-43fd-a2ec-3908f57e3764">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48966b2b67e54988b474069368fd3c54_D20190427-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNC0zLTEtMS0xMDIz_17538861-b22e-4d8a-a5f8-c99d2c15574e">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNC01LTEtMS0xMDIz_1f262215-7af9-4106-99b5-8417ca7a437c">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i079d0741b4814caf97785cd103555063_D20190427-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNC03LTEtMS0xMDIz_36d911df-8fe8-454c-9fc9-52740db93f7c">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNS0xLTEtMS0xMDIz_9d06dea8-1cdd-47e7-ae65-688fe530dda5">122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48966b2b67e54988b474069368fd3c54_D20190427-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNS0zLTEtMS0xMDIz_8901d8ff-7680-437f-909a-b1c772d71a09">112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNS01LTEtMS0xMDIz_51404ddd-713f-4a68-93b8-0befb2ab415d">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i079d0741b4814caf97785cd103555063_D20190427-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNS03LTEtMS0xMDIz_d001fd8c-67c7-4722-bcbd-4724df21fffe">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNi0xLTEtMS0xMDIz_958ffd5b-9edd-4e04-8105-81654e9df415">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48966b2b67e54988b474069368fd3c54_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNi0zLTEtMS0xMDIz_3d5bc677-16f8-4d6e-b640-70c075b142d6">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNi01LTEtMS0xMDIz_eaf3a4fb-8f2f-4cff-8376-0ae8ba9a2c47">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i079d0741b4814caf97785cd103555063_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNi03LTEtMS0xMDIz_9b1b5ae7-e520-46e9-8fb7-bfca702c7eeb">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfOC0xLTEtMS0xMDIz_f8a3510f-86bb-425e-a833-be17be3bc6a7">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48966b2b67e54988b474069368fd3c54_D20190427-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfOC0zLTEtMS0xMDIz_691d77a6-efff-4f61-a653-332fe76e5674">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfOC01LTEtMS0xMDIz_b23cc8e3-b55f-4f3f-86eb-d3404d86e189">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i079d0741b4814caf97785cd103555063_D20190427-20191025" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfOC03LTEtMS0xMDIz_a59ac930-5a37-49c2-a29e-f1e3e646bba6">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost other than the service component are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2021, as part of the Simplification restructuring program, the Company offered certain eligible U.S. employees voluntary early retirement packages, resulting in incremental expense of $<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfODU4_d2c69314-2e53-4798-9bb9-f8accb07fec9"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfODU4_ea16b3a3-2a19-4d31-8099-ffa1e885b7c9">97</ix:nonFraction></ix:nonFraction>&#160;million recognized during the three and six months ended October&#160;30, 2020. Of this amount, $<ix:nonFraction unitRef="usd" contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM1Mw_28cc3d2a-5e20-4698-a194-a4383f3a0621"><ix:nonFraction unitRef="usd" contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM1Mw_4dc72bab-94bf-4be4-93c5-30e6db15fa41">80</ix:nonFraction></ix:nonFraction>&#160;million related to U.S. pension benefits, $<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM2Ng_398c1bf8-3836-4d42-b786-15355de1c689"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM2Ng_e595ff82-81a2-4ae4-8d98-07266a515c18">11</ix:nonFraction></ix:nonFraction>&#160;million related to defined contribution plans, $<ix:nonFraction unitRef="usd" contextRef="if525bf943aab4cbb91e9eb6d27a46bf6_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM3OQ_e0a74775-a244-4a21-a027-1d38ed9dfbc2"><ix:nonFraction unitRef="usd" contextRef="i1d0206d6a5fc41a49d8a7cc2ef0f0f5a_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM3OQ_ec42e193-9e8b-454e-b8e0-609c0cf0f247">4</ix:nonFraction></ix:nonFraction>&#160;million related to U.S. post-retirement benefits, and $<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM5MQ_0487bb12-430a-4aca-bdbf-7a6a7d2b1bf0"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="mdt:DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM5MQ_74dc4003-8cc0-49e8-9ee7-afcdc63e081f">2</ix:nonFraction></ix:nonFraction>&#160;million related to cash payments and administrative fees. See Note 5 for additional information on the Simplification restructuring program.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_91"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjY1Nw_033a20c5-7ab0-4766-9653-c7ccbc019fb4" continuedAt="i9249d5df19324bbc9391cb37287df8b7" escape="true">Accumulated Other Comprehensive Loss </ix:nonNumeric></span></div><ix:continuation id="i9249d5df19324bbc9391cb37287df8b7"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjY2Mg_cc1ec859-619b-45e0-bb24-59431288d3a7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in AOCI, net of tax, and by component:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investment Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Change in Retirement Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 24, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6a709f1f574db2a0ee55985446dde8_I20200424" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMS0xLTEtMS0w_b3e99425-1bd5-44f8-923e-0c77a64eee05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ffaa96aa77b425a843a25fa1ef58542_I20200424" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMS0zLTEtMS0w_62e7916f-d84d-44a1-87ed-55e61b9612f3">2,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05e20d1638064e7e909e1fc85204b962_I20200424" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMS01LTEtMS0w_14b9163a-1218-48a0-81be-a0396c46f788">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib42695173b6e44668e0e633108f36472_I20200424" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMS03LTEtMS0w_8b704bff-56c6-4e79-a51a-c1d1601be278">1,852</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a3f0bf4841e4466b909762f6987805d_I20200424" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMS05LTEtMS0w_61c3a20d-cfc5-4a24-ac00-0c9d48e25121">266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c85755ec4074136b1ee5356437a2b17_I20200424" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMS0xMS0xLTEtMA_58988cf7-9f0b-4a3c-bff5-714b1ac35890">3,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia259e32147694c1a90acdfc351d3be37_D20200425-20201030" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMi0xLTEtMS0w_eafc94cd-1f59-49f1-ba13-6877017e09e7">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea3630e377a437682567a4587f0b46a_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMi0zLTEtMS0w_53800563-8952-474c-aa59-da8d6ef15d28">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0d4590a839f4f359683bd936959376a_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMi01LTEtMS0w_1ad11276-4e08-420d-b218-1d1954d2aa05">1,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8db26e60a874f328bde32ae1fffb625_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMi03LTEtMS0w_cf74a54c-1475-47bd-a427-32daa32ccf12">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5b5d4d785ba4390854bcea8e68a032f_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMi05LTEtMS0w_4b3d7835-32e0-4c24-aed8-280b9bfd7d5f">359</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefd7e349f18840e98869efd76dfa5aee_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMi0xMS0xLTEtMA_80887c35-ea50-4902-9b43-d7ed0241fd90">280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia259e32147694c1a90acdfc351d3be37_D20200425-20201030" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMy0xLTEtMS0w_3b6427f2-d646-463b-bdca-b51173198b5a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea3630e377a437682567a4587f0b46a_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMy0zLTEtMS0w_b1b78d4b-4452-45f6-b3dc-de2fc09864c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0d4590a839f4f359683bd936959376a_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMy01LTEtMS0w_c90c2128-dd08-4f01-a003-d0a0e8a06387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8db26e60a874f328bde32ae1fffb625_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMy03LTEtMS0w_b8c29865-7ad9-4386-a639-bdefbb5a51bf">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5b5d4d785ba4390854bcea8e68a032f_D20200425-20201030" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMy05LTEtMS0w_e7702a7f-da39-4eec-b9eb-4492cb113265">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefd7e349f18840e98869efd76dfa5aee_D20200425-20201030" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMy0xMS0xLTEtMA_e0de67f7-118b-46db-93ae-ae760f02a593">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia259e32147694c1a90acdfc351d3be37_D20200425-20201030" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNC0xLTEtMS0w_80c874f2-5ba2-4e26-a6a5-c5452992b0e3">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea3630e377a437682567a4587f0b46a_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNC0zLTEtMS0w_7ff765de-ecdc-47fc-ac7e-90de62e1dc2b">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0d4590a839f4f359683bd936959376a_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNC01LTEtMS0w_244cc634-f5de-416b-a834-616e04df3d2e">1,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8db26e60a874f328bde32ae1fffb625_D20200425-20201030" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNC03LTEtMS0w_6f82f9c4-21d3-41e7-8a1e-7a84080e8919">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5b5d4d785ba4390854bcea8e68a032f_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNC05LTEtMS0w_3ad66252-ebe7-477a-9429-71b4d9d9ff27">395</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefd7e349f18840e98869efd76dfa5aee_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNC0xMS0xLTEtMA_12ad672d-dad2-4e26-a3b6-0ee9d542edea">283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a603a65af64e6889139205388d2a5e_I20201030" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNS0xLTEtMS0w_45865f2b-973c-474d-9324-dd29f2485655">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie00c23bcd7924f48a43b264894ae1590_I20201030" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNS0zLTEtMS0w_dded9396-e23d-40de-bef9-092d06f29ef5">955</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5386101e521b4ca1b362aaa02cd87dcb_I20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNS01LTEtMS0w_e507c7b1-b2c8-4f49-b599-e7698e598610">1,040</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i449e4d657bf0449ba7b52e557589bbf1_I20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNS03LTEtMS0w_22746b0b-7bf8-4e63-8911-276fed2f9974">1,832</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99b3bd351a494528906e3d120cfc830f_I20201030" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNS05LTEtMS0w_cfa118a7-a8c4-42ad-b666-52d3e42cd447">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fb60693b842404b9c6c710c434a9f46_I20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNS0xMS0xLTEtMA_04fad310-b5ea-4522-9938-075c72b937ec">3,843</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Investment Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Change in Retirement Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 26, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ea2e72c446043e2a75ada4300c76bf2_I20190426" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfOS0xLTEtMS0w_83354cf1-25c3-4fa2-b792-8390f39164ea">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c2ce4c6cbd84b4fb1294afa3a54a8a7_I20190426" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfOS0zLTEtMS0w_b0d6f943-7e03-48b2-bd2f-96c03aef64f0">1,383</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice02b0738fd5434fb3f67530d843a491_I20190426" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfOS01LTEtMS0w_39e1062c-a77f-4ce4-a398-0e270e05f573">169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i707bc78abce44fed88d7746e65fcc6c1_I20190426" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfOS03LTEtMS0w_4ce98125-5bd8-40e7-a663-0fa52ea5eb73">1,308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9eea4603bf34820985c1564d60a7ae8_I20190426" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfOS05LTEtMS0w_d477995e-5227-49d4-a5ef-066bffdd518e">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idce4f3b26c5a4fefb9a2268a16c018e1_I20190426" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfOS0xMS0xLTEtMA_0d341a3a-e2a4-45f7-b80e-b6c35a89f9b8">2,711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie397d3f57a424feab9c1039773fe2c37_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTAtMS0xLTEtMA_bf206a4b-6046-4646-93be-a8616816c19b">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i594c98fce3834e6c911b55d203d09432_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTAtMy0xLTEtMA_677085a7-bcfe-4098-90fc-29e414a8b3b0">148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fc63908080e457f944dc31cb02f1ece_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTAtNS0xLTEtMA_46d4e697-ea12-40b5-9881-46aa4fa5ea22">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6233127143d474ca30c57ef1e30c869_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTAtNy0xLTEtMA_4b29d02e-53c2-4d8f-8808-e7a0de211984">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i853467b20db64187814759647e0063ff_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTAtOS0xLTEtMA_ed4c5389-c029-431a-bb53-f6f8b3f8ac18">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c01efddfd944a258a76ab642888a572_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTAtMTEtMS0xLTA_afbac7f5-3cc3-4a20-85f4-5de905103faf">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie397d3f57a424feab9c1039773fe2c37_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTEtMS0xLTEtMA_d2339a22-9616-4e29-8c58-1d58864804c8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i594c98fce3834e6c911b55d203d09432_D20190427-20191025" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTEtMy0xLTEtMA_8724e9f4-994b-4178-881c-7e20adaa0bc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fc63908080e457f944dc31cb02f1ece_D20190427-20191025" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTEtNS0xLTEtMA_26422f6b-d1f6-44ba-a7d6-182a8bd32eda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6233127143d474ca30c57ef1e30c869_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTEtNy0xLTEtMA_d13cc358-f676-4cef-875e-cb88e32e0cc1">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i853467b20db64187814759647e0063ff_D20190427-20191025" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTEtOS0xLTEtMA_813767d9-1453-4921-b92f-a13ddff341c6">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c01efddfd944a258a76ab642888a572_D20190427-20191025" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTEtMTEtMS0xLTA_6e6b739c-2f34-4410-9a4e-c8ba5b9d1e3b">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie397d3f57a424feab9c1039773fe2c37_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTItMS0xLTEtMA_8fc6b6b0-3518-4723-8e07-0b3cd93e54bc">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i594c98fce3834e6c911b55d203d09432_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTItMy0xLTEtMA_7c81bd4f-b936-49ca-a48c-a7ad72b27f96">148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fc63908080e457f944dc31cb02f1ece_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTItNS0xLTEtMA_7bd5e090-d2f1-44ad-92e2-1fd534ba3449">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6233127143d474ca30c57ef1e30c869_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTItNy0xLTEtMA_94475d4a-75d9-4da5-bcbb-18cb6fc9b84c">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i853467b20db64187814759647e0063ff_D20190427-20191025" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTItOS0xLTEtMA_36600e10-dac4-4c53-b1b7-04e420d517d1">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c01efddfd944a258a76ab642888a572_D20190427-20191025" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTItMTEtMS0xLTA_b5cfca9b-7a8c-4e61-9e4d-bf788ca6d576">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 25, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8fcd13d6b3740c6a5a4e7d8f673420a_I20191025" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTQtMS0xLTEtMA_ea05e19a-33bb-44dd-abe0-40f878e0e7bb">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6555488fb0954ade9760238ea2f0aee2_I20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTQtMy0xLTEtMA_33e2b3e3-1959-4772-8bce-609cfc8ca3bf">1,531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2dc5e7853c24bc8a015eae803815058_I20191025" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTQtNS0xLTEtMA_670a8eda-1504-486a-adb5-887b03d1876b">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54f47cb7887f45f1b52b527c507264dc_I20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTQtNy0xLTEtMA_11d808ab-75fd-421f-8c37-29dc3b9da156">1,283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a7dc5cbd8f473f99e012510c678690_I20191025" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTQtOS0xLTEtMA_2a58a828-a6f6-4cec-8300-9606022e0922">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36754839d63e4461b94b37c7bae9a3fb_I20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTQtMTEtMS0xLTA_da0e16a5-cd87-48d6-9d49-f8733c80d852">2,611</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;padding-left:9pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax on gains and losses on investment securities in other comprehensive income before reclassifications during the six months ended October&#160;30, 2020 and October&#160;25, 2019 was an expense of $<ix:nonFraction unitRef="usd" contextRef="ia259e32147694c1a90acdfc351d3be37_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjQ5_2b647f98-26e6-4dcd-b72c-430dca4bfe96">31</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie397d3f57a424feab9c1039773fe2c37_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjY5_d569163c-f0e7-4596-8e26-cad37a757231">1</ix:nonFraction>&#160;million, respectively. There was <ix:nonFraction unitRef="usd" contextRef="ia259e32147694c1a90acdfc351d3be37_D20200425-20201030" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjk3_f643fc55-89cc-4281-acf7-054bb906df03">no</ix:nonFraction> income tax on gains and losses on investment securities reclassified from AOCI for the six months ended October&#160;30, 2020. During the six months ended October&#160;25, 2019, realized gains and losses on investment securities reclassified from AOCI were reduced by income taxes of $<ix:nonFraction unitRef="usd" contextRef="ie397d3f57a424feab9c1039773fe2c37_D20190427-20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfNTM1_f5b1a1aa-ada4-494d-b9f3-c2e9d3064213">2</ix:nonFraction>&#160;million. When realized, gains and losses on investment securities reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to Note&#160;6&#160;to the consolidated financial statements for additional information.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax on cumulative translation adjustment for the six months ended October&#160;30, 2020, was an expense of $<ix:nonFraction unitRef="usd" contextRef="i9ea3630e377a437682567a4587f0b46a_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfODQ1_5728635f-b244-44d4-ba3f-89eb3e539731">4</ix:nonFraction> million. For the six months ended October&#160;25, 2019, there was <ix:nonFraction unitRef="usd" contextRef="i594c98fce3834e6c911b55d203d09432_D20190427-20191025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfODkw_5261c13c-ce6f-4e3d-81cf-3710932287d4">no</ix:nonFraction> income tax on cumulative translation adjustment. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended October&#160;30, 2020 and October&#160;25, 2019, there were <ix:nonFraction unitRef="usd" contextRef="if0d4590a839f4f359683bd936959376a_D20200425-20201030" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfOTc5_1de2c0a6-5bb1-46c4-a718-9aa210b30db6"><ix:nonFraction unitRef="usd" contextRef="i0fc63908080e457f944dc31cb02f1ece_D20190427-20191025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfOTc5_2fc191b3-ab27-4623-a27b-2a1da4fd72f4">no</ix:nonFraction></ix:nonFraction> tax impacts on net investment hedges. Refer to Note 8 to the consolidated financial statements for additional information. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in retirement obligations in other comprehensive income includes amortization of net actuarial losses included in net periodic benefit cost. During the six months ended October&#160;30, 2020, the net change in retirement obligations in other comprehensive income before reclassifications resulted in an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="if8db26e60a874f328bde32ae1fffb625_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMTQxNA_69b25115-c45e-4570-8c58-77aa00d90a6a">5</ix:nonFraction> million. During the six months ended October&#160;25, 2019, there was <ix:nonFraction unitRef="usd" contextRef="ia6233127143d474ca30c57ef1e30c869_D20190427-20191025" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMTQ0Ng_675a6458-b295-4c39-9aa0-f0bc4cc6f69c">no</ix:nonFraction> income tax impact on the net change in retirement obligations in other comprehensive income before reclassifications. During the six months ended October&#160;30, 2020 and October&#160;25, 2019, the gains and losses on defined benefit and pension items reclassified from AOCI were reduced by income taxes of&#160;$<ix:nonFraction unitRef="usd" contextRef="if8db26e60a874f328bde32ae1fffb625_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMTcwNQ_ba26bbf8-40be-4e53-a122-356203d02a1f">8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia6233127143d474ca30c57ef1e30c869_D20190427-20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMTcxMg_5e5a4b18-000b-4b0c-be42-44c6d95952b2">6</ix:nonFraction>&#160;million, respectively. When realized, net gains and losses on defined benefit and pension items reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to Note&#160;14 to the consolidated financial statements&#160;for additional information.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax on unrealized gains and losses on cash flow hedges in other comprehensive income before reclassifications during the six months ended October&#160;30, 2020 and October&#160;25, 2019&#160;was&#160;a benefit of&#160;$<ix:nonFraction unitRef="usd" contextRef="id5b5d4d785ba4390854bcea8e68a032f_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjEyOQ_202b3746-cb95-4c48-b113-3bb93d7874b8">93</ix:nonFraction> million and an expense of $<ix:nonFraction unitRef="usd" contextRef="i853467b20db64187814759647e0063ff_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjE1MA_4a7b6e82-b365-4a8d-b2a3-846e7933cd13">21</ix:nonFraction>&#160;million, respectively. During the six months ended October&#160;30, 2020 and October&#160;25, 2019, gains and losses on cash flow hedges reclassified from AOCI were reduced by income taxes of&#160;$<ix:nonFraction unitRef="usd" contextRef="id5b5d4d785ba4390854bcea8e68a032f_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjI4NQ_358b4298-75d5-4b4e-a079-ada450c92e0c">10</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i853467b20db64187814759647e0063ff_D20190427-20191025" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfNzE0NjgyNTU4Mzk2NQ_2e22fe92-ee1d-456e-873b-9b32d05a8735">26</ix:nonFraction>&#160;million, respectively. When realized, gains and losses on currency exchange rate contracts reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating expense, net,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and gains and losses on forward starting interest rate derivatives reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Refer to Note&#160;8&#160;to the consolidated financial statements for additional information.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_94"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:LossContingencyDisclosures" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMTg5MjA_e73bc3e2-976c-484d-b492-266e78bee7f7" continuedAt="i482928c29de844368460969b54fd6afc" escape="true">Commitments and Contingencies </ix:nonNumeric></span></div><ix:continuation id="i482928c29de844368460969b54fd6afc" continuedAt="i3259a2b41f4b4ad2bcb847c838726a00"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company and its affiliates are involved in a number of legal actions involving product liability, intellectual property and commercial disputes, shareholder related matters, environmental proceedings, tax disputes, and governmental proceedings and investigations, including those described below. With respect to governmental proceedings and investigations, like other companies in our industry, the Company is subject to extensive regulation by national, state and local governmental agencies in the United States and in other jurisdictions in which the Company and its affiliates operate. As a result, interaction with governmental agencies is ongoing. The Company&#8217;s standard practice is to cooperate with regulators and investigators in responding to inquiries. The outcomes of legal actions are not within the Company&#8217;s complete control and may not be known for prolonged periods of time. In some actions, the enforcement agencies or private claimants seek damages, as well as other civil or criminal remedies (including injunctions barring the sale of products that are the subject of the proceeding), that could require significant expenditures, result in lost revenues, or limit the Company's ability to conduct business in the applicable jurisdictions.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company records a liability in the consolidated financial statements on an undiscounted basis for loss contingencies related to legal actions when a loss is known or considered probable and the amount may be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is reasonably possible but not known or probable, and may be reasonably estimated, the estimated loss or range of loss is disclosed. When determining the estimated loss or range of loss, significant judgment is required. Estimates of probable losses resulting from litigation and governmental proceedings involving the Company are inherently difficult to predict, particularly when the matters are in early procedural stages with incomplete scientific facts or legal discovery, involve unsubstantiated or indeterminate claims for damages, potentially involve penalties, fines or punitive damages, or could result in a change in business practice. The Company classifies litigation charges and gains related to significant legal matters as certain litigation charges. During the three and six months ended October&#160;30, 2020, the Company recognized charges of $<ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMjU0MA_7bb32e8d-fb76-43c3-a483-df5319aa3b5d">84</ix:nonFraction> million and a net benefit of $<ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMzI5ODUzNDkwMjMxMQ_2e2f1fa1-0cd7-46e7-b580-52fbfef6d6d6">4</ix:nonFraction> million, respectively, primarily due to favorable settlements in the first quarter of fiscal year 2021, partially offset by charges recognized in the second quarter of fiscal year 2021. During the three and six months ended October&#160;25, 2019, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMjY1OA_6811a97a-5b79-466d-905d-75351685b787">121</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMzI5ODUzNDkwMjU5OA_485769a7-2dd6-412f-a9dd-74aa56f755ee">168</ix:nonFraction> million, respectively, of certain litigation charges. At October&#160;30, 2020 and April&#160;24, 2020, accrued litigation was approximately $<ix:nonFraction unitRef="usd" contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMjc0Mw_a521f46a-ac0c-4a2b-85b8-5bdaaf8421ce">0.4</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMjc1MA_757bb423-396b-4827-ac82-b59335074ede">0.5</ix:nonFraction> billion, respectively. The ultimate cost to the Company with respect to accrued litigation could be materially different than the amount of the current estimates and accruals and could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position, and/or cash flows. The Company includes accrued litigation in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> on the consolidated balance sheets. While it is not possible to predict the outcome for most of the legal matters discussed below, the Company believes it is possible that the costs associated with these matters could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position, and/or cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Liability Matters</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pelvic Mesh Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is currently involved in litigation in various state and federal courts against manufacturers of pelvic mesh products alleging personal injuries resulting from the implantation of those products. <ix:nonFraction unitRef="subsidiary" contextRef="i9f541ce4dcef4da4a428c97cc7a8f5c3_D20200425-20201030" decimals="INF" format="ixt-sec:numwordsen" name="mdt:LossContingencyNumberofSubsidiaries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMzcxMw_38ec7a10-b730-4cc9-9688-ec1c7f05624a">Two</ix:nonFraction> subsidiaries of Covidien supplied pelvic mesh products to <ix:nonFraction unitRef="manufacturer" contextRef="i9f541ce4dcef4da4a428c97cc7a8f5c3_D20200425-20201030" decimals="INF" format="ixt-sec:numwordsen" name="mdt:LossContingencyNumberofManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMzc3NA_2523d9bd-e30b-4fe8-8d9a-be3326d80ab4">one</ix:nonFraction> of the manufacturers, C.R. Bard (Bard), named in the litigation. The litigation includes a federal multi-district litigation in the U.S. District Court for the Northern District of West Virginia and cases in various state courts and jurisdictions outside the U.S. Generally, complaints allege design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. In fiscal year 2016, Bard paid the Company $<ix:nonFraction unitRef="usd" contextRef="i9229de7c6045441d80355b6acb70f350_D20150425-20160429" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNDI2Ng_7b500a11-57b1-4ff9-bab1-ca618cafcc90">121</ix:nonFraction> million towards the settlement of <ix:nonFraction unitRef="claim" contextRef="i9229de7c6045441d80355b6acb70f350_D20150425-20160429" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyClaimsSettledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNDI5NQ_f2b99c59-b443-45e4-948c-a9742df838ec">11,000</ix:nonFraction> of these claims. In May 2017, the agreement with Bard was amended to extend the terms to apply to up to an additional <ix:nonFraction unitRef="claim" contextRef="i60457532fbeb40878969effee2b3390c_D20170501-20170531" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyClaimsSettledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNDQxNg_fb72af05-6531-4087-a673-2d46b25fe0e8">5,000</ix:nonFraction> claims. That agreement does not resolve the dispute between the Company and Bard with respect to claims that do not settle, if any. As part of the agreement, the Company and Bard agreed to dismiss without prejudice their pending litigation with respect to Bard&#8217;s obligation to defend and indemnify the Company. The Company estimates law firms representing approximately <ix:nonFraction unitRef="claim" contextRef="i7ef87e2613a04c5888f894f05867fc25_I20201030" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNDc4OQ_d3836901-60c3-4012-9bc8-82029ceac9dc">16,200</ix:nonFraction> claimants have asserted or may assert claims involving products manufactured by Covidien&#8217;s subsidiaries. As of November 4, 2020, the Company had reached agreements to settle approximately <ix:nonFraction unitRef="claim" contextRef="ic14d3bd294c046c9afca0a4d2276f819_D20201104-20201104" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:LossContingencyClaimsSettledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNDk3OA_46ea9c05-a43e-488c-9704-5df4ffe5e29a">15,900</ix:nonFraction> of these claims. The Company's accrued expenses for this matter are included within accrued litigation as discussed above. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hernia Mesh Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2020, plaintiffs filed lawsuits against certain subsidiaries of the Company in U.S. state and federal courts alleging personal injury from hernia mesh products sold by those subsidiaries. The majority of the pending cases are in Massachusetts state court, where they have been consolidated before a single judge. Certain plaintiffs' law firms have advised the Company that they may file additional cases in the future. The pending lawsuits relate to hernia mesh products that have not been subject to recalls, withdrawals or other adverse regulatory action. The Company has not recorded an expense related to damages in connection with these matters because any potential loss is not currently probable or reasonably estimable under U.S. GAAP. Additionally, the Company is unable to reasonably estimate the range of loss, if any, that may result from these matters.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i3259a2b41f4b4ad2bcb847c838726a00" continuedAt="i7c1685e7bf9d434a8baa3547a945b47d"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patent Litigation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ethicon</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 14, 2011, Ethicon filed an action against Covidien in the U.S. District Court for the Southern District of Ohio, alleging patent infringement and seeking monetary damages and injunctive relief. On January 22, 2014, the district court entered summary judgment in Covidien's favor, and the majority of this ruling was affirmed by the Federal Circuit on August 7, 2015.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following appeal, the case was remanded back to the District Court with respect to <ix:nonFraction unitRef="patent" contextRef="i77dc59d697684886bbf5fe519c310541_D20111214-20111214" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNjUwMA_f89f8d20-a345-4da3-8db7-ad9437c7dde7">one</ix:nonFraction> patent. On January 21, 2016, Covidien filed a second action in the U.S. District Court for the Southern District of Ohio, seeking a declaration of non-infringement with respect to a second set of patents held by Ethicon. The court consolidated this second action with the remaining patent issues from the first action. Following consolidation of the cases, Ethicon dismissed <ix:nonFraction unitRef="patent" contextRef="i77dc59d697684886bbf5fe519c310541_D20111214-20111214" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPatentsFoundNotInfringedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNjg3OA_bc5742a1-c806-4fbe-9bc0-1b8d86af62bf">six</ix:nonFraction> of the asserted patents, leaving a single asserted patent. The court has scheduled this matter for a bench trial in the first half of calendar year 2021. The Company has not recognized an expense related to damages in connection with this matter because any potential loss is not currently probable or reasonably estimable under U.S. GAAP. Additionally, the Company is unable to reasonably estimate the range of loss, if any, that may result from this matter. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sasso</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is involved in litigation in Indiana relating to certain patent and royalty disputes with Dr. Sasso under agreements originally entered into in 1999 and 2001. On November 28, 2018, a jury in Indiana state court returned a verdict against the Company for approximately $<ix:nonFraction unitRef="usd" contextRef="i86701a14cb434b819fd00f6ad2cdbbaa_D20181128-20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNzYzNQ_4b2762b1-00bc-4a55-a7f1-a4e00ad8efc4">112</ix:nonFraction>&#160;million. The Company has strong arguments to appeal the verdict and has filed post-trial motions and appeals with the appropriate appellate courts. The Company's accrued expenses for this matter are included within accrued litigation as discussed above.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholder Related Matters</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Covidien Acquisition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 2, 2014, Lewis Merenstein filed a putative shareholder class action in Hennepin County, Minnesota, District Court seeking to enjoin the then-potential acquisition of Covidien. The lawsuit named Medtronic, Inc., Covidien, and each member of the Medtronic, Inc. Board of Directors at the time as defendants, and alleged that the directors breached their fiduciary duties to shareholders with regard to the then-potential acquisition. On August 21, 2014, Kenneth Steiner filed a putative shareholder class action in Hennepin County, Minnesota, District Court, also seeking an injunction to prevent the potential Covidien acquisition. In September 2014, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Merenstein</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Steiner</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> matters were consolidated and in December 2014, the plaintiffs filed a preliminary injunction motion seeking to enjoin the Covidien transaction. On March 20, 2015, the District Court issued an order and opinion granting Medtronic&#8217;s motion to dismiss the case. In May 2015, the plaintiffs filed an appeal, and, in January 2016, the Minnesota State Court of Appeals affirmed in part, and reversed in part. On April 19, 2016 the Minnesota Supreme Court granted the Company&#8217;s petition to review the issue of whether most of the original claims are properly characterized as direct or derivative under Minnesota law. In August 2017, the Minnesota Supreme Court affirmed the decision of the Minnesota State Court of Appeals, sending the matter back to the trial court for further proceedings, which are ongoing. In April 2020, the District Court issued an order and opinion denying the plaintiffs' motion for class certification. In June 2020, the Minnesota State Court of Appeals denied the plaintiffs' request to review the District Court's denial of class certification, and in September 2020, the Minnesota Supreme Court denied the plaintiffs' request to review the Court of Appeals decision. The Company has not recognized an expense related to damages in connection with this matter because any potential loss is not currently probable or reasonably estimable under U.S. GAAP. Additionally, the Company is unable to reasonably estimate the range of loss, if any, that may result from these matters.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental Proceedings</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is involved in various stages of investigation and cleanup related to environmental remediation matters at a number of sites. These projects relate to a variety of activities, including removal of solvents, metals and other hazardous substances from soil and groundwater. The ultimate cost of site cleanup and timing of future cash flows is difficult to predict given uncertainties regarding the extent of the required cleanup, the interpretation of applicable laws and regulations, and alternative cleanup methods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is a successor to a company that owned and operated a chemical manufacturing facility in Orrington, Maine from 1967 until 1982, and is responsible for the costs of completing an environmental site investigation as required by the Maine Department of Environmental Protection (MDEP). MDEP served a compliance order on Mallinckrodt LLC and U.S. Surgical Corporation, subsidiaries of Covidien, in December 2008, which included a directive to remove a significant volume of soils at the site. After a hearing on the compliance order before the Maine Board of Environmental Protection (Maine Board) to challenge the terms of the compliance order, the Maine Board modified the MDEP order and issued a final order requiring removal of <ix:nonFraction unitRef="landfill" contextRef="ife64dfaf0edf41ea9552b05b5b7e1839_D20200425-20201030" decimals="INF" format="ixt-sec:numwordsen" name="mdt:SiteContingencyNumberofLandfillsRequiringRemoval" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMTExNDg_81f3fac7-4a10-4d72-88a3-f18b2eb3bd7e">two</ix:nonFraction> landfills, capping of the remaining <ix:nonFraction unitRef="landfill" contextRef="ife64dfaf0edf41ea9552b05b5b7e1839_D20200425-20201030" decimals="INF" format="ixt-sec:numwordsen" name="mdt:SiteContingencyNumberOfLandfillsRequiringCapping" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMTExODc_b0b8a2af-7782-4ca4-851c-b2efb00e1176">three</ix:nonFraction> landfills, installation of a groundwater extraction system and long-term monitoring of the site and the <ix:nonFraction unitRef="landfill" contextRef="ife64dfaf0edf41ea9552b05b5b7e1839_D20200425-20201030" decimals="INF" format="ixt-sec:numwordsen" name="mdt:SiteContingencyNumberOfLandfillsRequiringCapping" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMTEyOTQ_b61602f0-e5ab-4257-8169-51ba9146fb09">three</ix:nonFraction> remaining landfills.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has proceeded with implementation of the investigation and remediation at the site in accordance with the MDEP order as modified by the Maine Board order. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i7c1685e7bf9d434a8baa3547a945b47d" continuedAt="i5e3b7e24edb74c97bca3ef5b4c77c6e9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Since the early 2000s, the Company or its predecessors have also been involved in a lawsuit filed in the U.S. District Court for the District of Maine by the Natural Resources Defense Council and the Maine People&#8217;s Alliance. Plaintiffs sought an injunction requiring the Company's predecessor to conduct extensive studies of mercury contamination of the Penobscot River and Bay and options for remediating such contamination, and to perform appropriate remedial activities, if necessary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following a trial in March 2002, the Court held that conditions in the Penobscot River and Bay may pose an imminent and substantial endangerment and that the Company&#8217;s predecessor was liable for the cost of performing a study of the River and Bay. Following a second trial in June 2014, the Court ordered that further engineering study and engineering design work was needed to determine the nature and extent of remediation in the Penobscot River and Bay. The Court also appointed an engineering firm to conduct such studies and issue a report on potential remediation alternatives. In connection with these proceedings, reports have been produced including a variety of cost estimates for a variety of potential remedial options. A third trial to determine the course of remediation to be pursued is scheduled to occur in fiscal year 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's accrued expenses for environmental proceedings are included within accrued litigation as discussed above. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2009, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2005 and 2006. Medtronic, Inc. reached agreement with the IRS on some, but not all matters related to these fiscal years. The remaining unresolved issue for fiscal years 2005 and 2006 relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico, which is one of the Company's key manufacturing sites. The U.S. Tax Court reviewed this dispute, and on June 9, 2016, issued its opinion with respect to the allocation of income between the parties for fiscal years 2005 and 2006. The U.S. Tax Court generally rejected the IRS&#8217;s position, but also made certain modifications to the Medtronic, Inc. tax returns as filed. On April 21, 2017, the IRS filed their Notice of Appeal to the U.S. Court of Appeals for the 8th Circuit regarding the Tax Court Opinion.&#160;Oral argument for the Appeal occurred on March 14, 2018. The 8th Circuit Court of Appeals issued their opinion on August 16, 2018 and remanded the case back to the U.S. Tax Court for additional factual findings. The U.S. Tax Court trial is scheduled to occur in June of 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2011, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2007 and 2008. Medtronic, Inc. reached agreement with the IRS on some, but not all matters related to these fiscal years. The remaining unresolved issue for fiscal years 2007 and 2008 relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for the businesses that are the subject of the U.S. Tax Court Case for fiscal years 2005 and 2006. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2014, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2009, 2010, and 2011. Medtronic, Inc. reached agreement with the IRS on some but not all matters related to these fiscal years. The remaining unresolved issue for fiscal years 2009, 2010, and 2011 relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for the businesses that are the subject of the U.S. Tax Court Case for fiscal years 2005 and 2006. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2012, 2013, and 2014. Medtronic, Inc. reached agreement with the IRS on some but not all matters related to these fiscal years. The significant issues that remain unresolved relate to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico, and proposed adjustments associated with the utilization of certain net operating losses. The Company disagrees with the IRS and will attempt to resolve these matters at the IRS Appellate level.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to quarter-end, in November 2020, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2015 and 2016. Medtronic, Inc. reached agreement with the IRS on some but not all matters related to these fiscal years. The significant issue that remains unresolved relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for the businesses that are the subject of the U.S. Tax Court Case for fiscal years 2005 and 2006.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic, Inc.&#8217;s fiscal years 2017, 2018, and 2019 U.S. federal income tax returns are currently being audited by the IRS.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covidien and the IRS have concluded and reached agreement on its audit of Covidien&#8217;s U.S. federal income tax returns for all tax years through 2012. The statute of limitations for Covidien&#8217;s 2013 and 2014 U.S. federal income tax returns lapsed during the first quarter of fiscal years 2018 and 2019, respectively. Covidien's fiscal year 2015 U.S. federal income tax returns are currently being audited by the IRS. The statute of limitations for Covidien's 2016 U.S. federal income tax return lapsed during the third quarter of fiscal year 2020. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is not possible to predict the outcome for most of the income tax matters discussed above, the Company believes it is possible that charges associated with these matters could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position, and/or cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 11 for additional discussion of income taxes.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i5e3b7e24edb74c97bca3ef5b4c77c6e9"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Company&#8217;s sale of the Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses to Cardinal on July 29, 2017, the Company has indemnified Cardinal for certain contingent tax liabilities related to the divested businesses that existed prior to the date of divestiture. The actual amounts that the Company may be required to ultimately accrue or pay could vary depending upon the outcome of the unresolved tax matters.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company and/or its affiliates periodically enter into agreements that require one or more of the Company and/or its affiliates to indemnify customers or suppliers for specific risks, such as claims for injury or property damage arising as a result of the Company or its affiliates&#8217; products, the negligence of the Company's personnel, or claims alleging that the Company's products infringe on third-party patents or other intellectual property. The Company also offers warranties on various products. The Company&#8217;s maximum exposure under these guarantees is unable to be estimated. Historically, the Company has not experienced significant losses on these types of guarantees.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the ultimate resolution of the above guarantees is not expected to have a material effect on the Company&#8217;s consolidated earnings, financial position, and/or cash flows.</span></div></ix:continuation><div id="i6128593e20e44bbc8b0671c482ec9b79_97"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RleHRyZWdpb246NTVjYzgzNDNkNGVjNDFlNzlmZjdlMDA4YTU5ZTg2MWRfMTY3OA_0e047a82-12cd-41b7-9962-ed34c3c511a6" continuedAt="i3c0d38c6728849ad9c3e84e8f1f3f4a0" escape="true">Segment and Geographic Information</ix:nonNumeric></span></div><ix:continuation id="i3c0d38c6728849ad9c3e84e8f1f3f4a0" continuedAt="i1b0280fe50d6428a93ff77753d84c6d0"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment disclosures are on a performance basis consistent with internal management reporting. Net sales of the Company's reportable segments include end-customer revenues from the sale of products the segment develops, manufactures, and distributes. There are certain corporate and centralized expenses that are not allocated to the segments.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management evaluates performance of the segments and allocates resources based on net sales and segment operating profit. Segment operating profit represents income before income taxes, excluding interest expense, amortization of intangible assets, centralized distribution costs, non-operating income or expense items, certain corporate charges, and other items not allocated to the segments. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note 1 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 24, 2020. Certain depreciable assets may be recorded by one segment, while the depreciation expense is allocated to another segment. The allocation of depreciation expense is based on the proportion of the assets used by each segment. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div></div><ix:continuation id="i1b0280fe50d6428a93ff77753d84c6d0"><ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RleHRyZWdpb246NTVjYzgzNDNkNGVjNDFlNzlmZjdlMDA4YTU5ZTg2MWRfMTY3OQ_aadc2fc0-e085-4c1e-8ad8-b55cbe12477b" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Operating Profit</span></div><div style="margin-bottom:6pt;margin-top:16pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac and Vascular Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63d7c5081980421eb104ef0db2d640cc_D20200801-20201030" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMi0xLTEtMS0w_71534b01-cd53-4288-8fd5-7cf8ccb9f8c0">992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f4ddf14e8a5413696daf99ce008d00b_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMi0zLTEtMS0w_fcb92d0a-8dee-4fb0-8caf-7ca18959819a">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009f0737e76549b7bdd8727292bc324c_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMi01LTEtMS03OTA_3185dcde-5b2f-4eca-9b34-66549fcb042c">1,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34ef1f0d5805418690793935607c575e_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMi03LTEtMS03OTA_b8e7cc84-3cf4-419e-9ef7-f45464641eb6">2,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f00ee586cf4b098983f7fd448c12ed_D20200801-20201030" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMy0xLTEtMS0w_cdc5a3dc-2fe7-4a9b-8af7-c890796630ba">775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b7f6004ebaa4580aa2cd2c369060e7c_D20190727-20191025" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMy0zLTEtMS0w_7fcfe9ff-b53f-4493-8b21-a4df063f8712">823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaf85161beb9449b9986565bb7507a94_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMy01LTEtMS03OTA_5bcd705d-30b3-470e-9fcb-9e454d43abc8">1,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e5b0ae3f9b4c4a8f83073dab95f175_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMy03LTEtMS03OTA_37123f7c-ee5c-44e5-bed2-0790f639e880">1,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a9fdeedad9e48189c04e1acb1feea25_D20200801-20201030" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNC0xLTEtMS0w_d9214f41-9a41-4373-af1b-20b6cc2b5048">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae65e8a1899f46cf9f81db9fd9dc523e_D20190727-20191025" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNC0zLTEtMS0w_da808b62-e2cb-40fe-b37c-711ab75e3d87">840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i190a27e4543e49f095f067588a9750ad_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNC01LTEtMS03OTA_27e7342d-ab5d-40b6-a0af-48771e7a3757">1,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3bd9b003d9d458cbf0d73f754eece1c_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNC03LTEtMS03OTA_004b1688-741e-43c9-8851-b7a34198a974">1,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c39d3319d5441938058ead345505a10_D20200801-20201030" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNS0xLTEtMS0w_dc7d65c4-ebb7-4205-ad8a-def2cc99b824">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81bf88cc900e42b7baca3ed7b2f9944f_D20190727-20191025" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNS0zLTEtMS0w_f9c9addb-4e21-468d-8069-bf7279414351">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c9d172c84641f8b5f43c19bf9b11e3_D20200425-20201030" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNS01LTEtMS03OTA_d1d03bbf-6df7-4673-959d-dae27605a7d7">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75e5044db63f4573911d00a91522924b_D20190427-20191025" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNS03LTEtMS03OTA_a5bf3506-17f6-4071-8833-2cceb3e9c00b">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8fbed3ebbc54e9e8e04c5281af315e7_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNi0xLTEtMS0w_5933e754-1c84-4e10-aee0-f8a4dc8ab8de">2,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd9ab457b664428faf530e0f31bec7ee_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNi0zLTEtMS0w_76d0a078-dd13-463e-bfb7-fa1d8e50b848">2,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e105716e0b4d349b5afd9f55b817bb_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNi01LTEtMS03OTQ_d344b449-1e63-4691-904b-e30cd591e27a">4,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33de1043570543228ee3f7f6b21ee2b8_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNi03LTEtMS03OTQ_eda064fa-563d-4d4c-abd4-9a7ea53c366a">5,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNy0xLTEtMS0w_8f46e858-84db-411f-b41d-7deef96a1284">470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNy0zLTEtMS0w_1d4a1b71-9cb5-4f76-921a-56b21e6bf5b2">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNy01LTEtMS03OTQ_82d21105-378b-455a-beaa-51600bf17399">641</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNy03LTEtMS03OTQ_bf750b52-811e-45fe-8b8d-558d45e6e328">774</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOC0xLTEtMS0w_05f0fac2-c1e0-46fe-8fa4-53a182d55b4d">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOC0zLTEtMS0w_99f406f6-8e52-42e3-8217-eb15ebed720f">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOC01LTEtMS03OTQ_49881183-477b-482d-a8c2-9bf5b8243edf">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOC03LTEtMS03OTQ_7e755b9a-ff86-4367-9e91-eaa59aba8aad">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOS0xLTEtMS0w_6e5d8a07-d707-4260-86ed-6b19cdb3aede">443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOS0zLTEtMS0w_d0adf668-9c88-4e48-945d-c7e1406ce398">441</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOS01LTEtMS03OTg_e157aec1-5d7e-423e-89bf-ac8ecca24e58">884</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOS03LTEtMS03OTg_c6c16942-ab51-41b4-b1a8-6580e6ab4925">881</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030" decimals="-6" name="mdt:CorporateOverhead" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTAtMS0xLTEtMA_79844eee-39ca-49cf-aaf7-8760619de918">460</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025" decimals="-6" name="mdt:CorporateOverhead" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTAtMy0xLTEtMA_7ace6d72-6ec0-4e4e-bca6-c26f9672d2c2">350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030" decimals="-6" name="mdt:CorporateOverhead" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTAtNS0xLTEtNzk4_e2e4b990-4401-4a6e-bbf3-58a360ae3f8b">825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025" decimals="-6" name="mdt:CorporateOverhead" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTAtNy0xLTEtNzk4_13867956-a6a1-4b93-a759-5aff96bcbec2">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized distribution costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030" decimals="-6" name="mdt:CentralizedDistributionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTEtMS0xLTEtMA_6e2f5b8f-6270-47c9-82ef-a2a4f6e1b017">542</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025" decimals="-6" name="mdt:CentralizedDistributionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTEtMy0xLTEtMA_1f29d435-77b5-4287-b6c9-fbb0c9aa79c6">424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030" decimals="-6" name="mdt:CentralizedDistributionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTEtNS0xLTEtODAy_831e2465-6a45-4dc7-a35d-cf256496a358">940</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025" decimals="-6" name="mdt:CentralizedDistributionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTEtNy0xLTEtODAy_0b87432e-b659-457f-8946-9cd4c1258a1c">768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030" decimals="-6" name="mdt:RestructuringChargesNetofRestructuringReversals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTItMS0xLTEtMA_0a8c44fc-bbdc-40db-ab21-7203ed5c2ef5">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025" decimals="-6" name="mdt:RestructuringChargesNetofRestructuringReversals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTItMy0xLTEtMA_40c8482f-adeb-4331-aac9-3c7154557993">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030" decimals="-6" name="mdt:RestructuringChargesNetofRestructuringReversals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTItNS0xLTEtODAy_dfc0f2c2-015d-4c43-8cbf-8d386fc7778c">307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025" decimals="-6" name="mdt:RestructuringChargesNetofRestructuringReversals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTItNy0xLTEtODAy_ceada1ad-7bec-4383-a3dc-10865878f474">218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTMtMS0xLTEtMA_bb620258-e05d-4845-b411-17ec98d75284">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTMtMy0xLTEtMA_4d55492d-c173-4909-bbb5-2cd4fcf3d51f">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTMtNS0xLTEtODA2_9aef38c1-af3b-4a07-8239-bb3a605ae613">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTMtNy0xLTEtODA2_0a3f161f-be17-438b-a5c5-f81bb0ec0131">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTQtMS0xLTEtMA_6b56ea2c-6129-46bd-a376-db80221d1f0c">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTQtMy0xLTEtMA_4b7b7e42-36f2-4ec4-9c22-fb93eaec5796">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030" decimals="-6" sign="-" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTQtNS0xLTEtODA2_3a672c9e-ee41-4da5-925d-d45dbe23a653">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTQtNy0xLTEtODA2_e41f9b9d-8f0d-4873-b03c-d1b4d2e94e40">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030" decimals="-6" name="mdt:ImpairmentOfInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTUtMS0xLTEtMA_987a8513-9ee7-493b-b602-4b1e06fac7eb">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025" decimals="-6" format="ixt:zerodash" name="mdt:ImpairmentOfInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTUtMy0xLTEtMA_3908ab15-073d-429e-91ac-ead1d224952b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030" decimals="-6" name="mdt:ImpairmentOfInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTUtNS0xLTEtODEw_481d06fd-1a93-4ee6-8cf8-3dfd18800f44">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025" decimals="-6" format="ixt:zerodash" name="mdt:ImpairmentOfInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTUtNy0xLTEtODEw_b594611a-1088-4de8-83ff-20e393a615a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit of businesses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTYtMS0xLTEtMA_681c5c08-4a64-493c-ba46-6dc92a216515">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTYtMy0xLTEtMA_503ff309-91cd-444a-8005-def0527b8db6">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTYtNS0xLTEtNjA3Nw_c26a139b-c3ef-4a54-9087-6231f2b847ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTYtNy0xLTEtNjA3Nw_59ac87e5-decc-445b-aaed-9e502eddce63">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt tender premium and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030" decimals="-6" format="ixt:zerodash" name="mdt:DebtTenderPremiumandOtherCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTctMS0xLTEtMA_a657e9c6-da3e-4b19-bf5a-52e9aad2a188">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025" decimals="-6" format="ixt:zerodash" name="mdt:DebtTenderPremiumandOtherCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTctMy0xLTEtMA_7dbdfcc8-9d56-4590-b0f9-69d9fe7aaf4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="mdt:DebtTenderPremiumandOtherCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTctNS0xLTEtODE0_06de42e1-b747-440d-b1d1-c48f887731b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025" decimals="-6" name="mdt:DebtTenderPremiumandOtherCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTctNy0xLTEtODE0_179866e6-f1c4-4501-92e5-b971bce595cd">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030" decimals="-6" name="mdt:MedicalDeviceRegulations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTgtMS0xLTEtMA_9a91fa9c-f8e1-47ef-b323-d74e127ddf7c">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025" decimals="-6" name="mdt:MedicalDeviceRegulations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTgtMy0xLTEtMA_9e18ea51-6dfa-4f8e-9749-34bb68e08e96">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030" decimals="-6" name="mdt:MedicalDeviceRegulations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTgtNS0xLTEtODE0_4459f442-bdb6-46f6-838f-e617ad9e21d7">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025" decimals="-6" name="mdt:MedicalDeviceRegulations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTgtNy0xLTEtODE0_f1f89d2d-d586-4c50-bc46-fb0fdab3000c">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution to Medtronic Foundation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030" decimals="-6" format="ixt:zerodash" name="mdt:SpecialChargesGains" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTktMS0xLTEtMA_7a120fda-a5d1-49a1-9a6c-2cfcc5bebde4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025" decimals="-6" name="mdt:SpecialChargesGains" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTktMy0xLTEtMA_0bcf3d66-83d2-433a-aa80-4957cbf6a726">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030" decimals="-6" format="ixt:zerodash" name="mdt:SpecialChargesGains" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTktNS0xLTEtNjA4MQ_2f2da480-d18c-4d82-a82d-53b86f60f044">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025" decimals="-6" name="mdt:SpecialChargesGains" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTktNy0xLTEtNjA4MQ_64c3846e-6043-46d6-8c6b-84bee6a2dd94">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMjEtMS0xLTEtMA_372d3254-e703-4dc0-bdb2-4f7cb2e6af6d">525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMjEtMy0xLTEtMA_e28e0ee5-ec8d-4d64-a5a3-e7007ecbfa97">1,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMjEtNS0xLTEtODE4_0322dd4a-2e7f-4399-96c1-53af66b526bd">1,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMjEtNy0xLTEtODE4_39d17ab3-f98e-4054-ab06-226223f03ada">2,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Geographic Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales are attributed to the country based on the location of the customer taking possession of the products or in which the services are rendered. <ix:nonNumeric contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RleHRyZWdpb246NTVjYzgzNDNkNGVjNDFlNzlmZjdlMDA4YTU5ZTg2MWRfMTY5MA_22031924-963a-4e31-997e-d8164b0b34d2" continuedAt="i56e44dee77b4485b8a179432d44ff05b" escape="true">The following table presents net sales for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 for the Company's country of domicile, countries with significant concentrations, and all other countries:&#160;&#160;&#160;&#160;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><ix:continuation id="i56e44dee77b4485b8a179432d44ff05b"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd378229d53d485bb7a50d60b19bcbf3_D20200801-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfMi0xLTEtMS0w_b550daf3-6a4f-403e-b84f-ad4f9a9af6fe">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64a435269abb416984f5c417e8039a20_D20190727-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfMi0zLTEtMS0w_596bab94-15ee-45ff-96c8-f83830a90414">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac6ac704ee814208a2a8abf74b89f68b_D20200425-20201030" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfMi01LTEtMS04MzU_09e99a8b-6c0a-45e4-a469-977028606c1c">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea846304c7ad47a28600ef1e4d71c7b2_D20190427-20191025" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfMi03LTEtMS04MzU_4d83dfd2-3fe3-489f-a794-c93ca8e35dc9">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e59a2f196984183a973f8905eda8c10_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNC0xLTEtMS0w_b698f740-17c2-4cea-83c4-252fc1bb5d44">4,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc31344ce037435086c6584f0cbc5603_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNC0zLTEtMS0w_13e5ab0d-821e-4b1e-ac61-80f496951e6f">4,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i650829f108154ef79219df52ed0dd76e_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNC01LTEtMS04MzU_5da0bba1-dc58-4074-87a7-8a148852ce41">7,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e309488f2d44b4f90cf8c46966b9320_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNC03LTEtMS04MzU_6e5644ca-be18-44bd-a0d8-bfe505d7374f">8,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1638723f8ae47fba660e3d982eb8ed6_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNS0xLTEtMS0w_7f596402-1fab-40e9-bdec-926704c7c712">3,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3def68be9d64a24ac8a6ae505945a1d_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNS0zLTEtMS0w_9c99ab3c-3f29-4b07-96ea-108233afadd7">3,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785ae642d0794ba291eac2202104f152_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNS01LTEtMS04MzU_630661ea-9de5-40cc-a5f8-1468848b2846">6,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7a5c2518f94595a35212683b056ac2_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNS03LTEtMS04MzU_61c7af1d-ec5a-409b-8e2f-e51912c90623">7,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other countries, excluding Ireland</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf457dbfafc248478ffb42c3a45acab8_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNi0xLTEtMS0w_d7f020a6-381d-46fd-95cd-e70d149f26bf">7,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969f5c5c54b6415c806918f433b06994_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNi0zLTEtMS0w_61b4c896-a620-4f54-beab-8497d78356c5">7,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d3fa2bd18b4dc98db60dce376f37f2_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNi01LTEtMS04Mzk_0dc272b8-4a46-4b07-a0f1-164952f3f152">14,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i457910bb69fc4038abf6fe2156ebc07f_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNi03LTEtMS04Mzk_4e859d93-a636-4e51-882e-b8e9d0e51519">15,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNy0xLTEtMS0w_f2e59475-104f-4ace-879f-577328afa477">7,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNy0zLTEtMS0w_5b23aa44-f157-495a-9628-d70a97baf3bc">7,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNy01LTEtMS04Mzk_7d29f753-9ffe-49d9-988f-e25ec4832841">14,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNy03LTEtMS04Mzk_da8061cf-52c5-4f28-a101-8e1065888ce6">15,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDERSTANDING OUR FINANCIAL INFORMATION</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis provides information management believes to be relevant to understanding the financial condition and results of operations of Medtronic plc and its subsidiaries (Medtronic plc, Medtronic, or the Company, or we, us, or our). For a full understanding of financial condition and results of operations, you should read this discussion along with Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended April&#160;24, 2020. In addition, you should read this discussion along with our consolidated financial statements and related notes thereto at and for the three and six months ended October&#160;30, 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Trends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout this Management&#8217;s Discussion and Analysis, we present certain financial measures that we use to evaluate the operational performance of the Company and as a basis for strategic planning; however, such financial measures are not presented in our financial statements prepared in accordance with accounting principles generally accepted in the United States (U.S.) (U.S. GAAP). These financial measures are considered "non-GAAP financial measures" and are intended to supplement, and should not be considered as superior to, financial measures presented in accordance with U.S. GAAP. We generally use non-GAAP financial measures to facilitate management's review of the operational performance of the Company and as a basis for strategic planning. We believe that non-GAAP financial measures provide information useful to investors in understanding the Company's underlying operational performance and trends and may facilitate comparisons with the performance of other companies in the medical technologies industry. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As presented in the GAAP to Non-GAAP Reconciliations section below, our non-GAAP financial measures exclude the impact of certain charges or benefits that contribute to or reduce earnings and that may affect financial trends and include certain charges or benefits that result from transactions or events that we believe may or may not recur with similar materiality or impact to our operations in future periods (Non-GAAP Adjustments). </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event there is a Non-GAAP Adjustment recognized in our operating results, the tax cost or benefit attributable to that item is separately calculated and reported. Because the effective rate can be significantly impacted by the Non-GAAP Adjustments that take place during the period, we often refer to our tax rate using both the effective rate and the non-GAAP nominal tax rate (Non-GAAP Nominal Tax Rate). The Non-GAAP Nominal Tax Rate is calculated as the income tax provision, adjusted for the impact of Non-GAAP Adjustments, as a percentage of income before income taxes, excluding Non-GAAP Adjustments. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow is a non-GAAP financial measure calculated by subtracting property, plant, and equipment additions from operating cash flows. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the &#8220;GAAP to Non-GAAP Reconciliations," "Income Taxes," and "Free Cash Flow" sections for reconciliations of the non-GAAP financial measures to their most directly comparable financial measures prepared in accordance with U.S. GAAP.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_106"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE LEVEL OVERVIEW</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic is among the world's largest medical technology, services, and solutions companies &#8211; alleviating pain, restoring health, and extending life for millions of people around the world. Our primary products include those for cardiac rhythm disorders, cardiovascular disease, advanced and general surgical care, respiratory and monitoring solutions, renal care, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, and ear, nose, and throat, and diabetes conditions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The global healthcare system is facing an unprecedented challenge as a result of the Covid-19 pandemic ("COVID-19" or the "pandemic"). COVID-19 is having, and may continue to have, an adverse impact on significant aspects of our Company and business, including the demand for our products, our operations, supply chains and distribution systems, and our ability to research and develop and bring to market new products and services. While most of our businesses have been affected by a decline in procedural volumes in the spring and early summer, as compared to the corresponding periods in the prior fiscal year, our results for the second quarter of fiscal year 2021 reflect our recovery to date from the depths of the pandemic that we experienced in April. Procedure volumes continued to recover in multiple markets around the world during the second quarter. While many countries are past their initial peak with COVID-19, many regions, including the U.S. and Europe, are now experiencing a second wave. To the extent individuals and hospital systems de-prioritize, delay or cancel deferrable medical procedures, our business, cash flows, financial condition and results of operations will continue to be negatively affected.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Further, COVID-19 is straining hospital systems around the world, resulting in adverse financial impacts to those systems, which has resulted in and may continue to result in reduced expenditures for capital equipment and other products and services we provide. As COVID-19 continues to impact hospital systems and other customers, we may encounter higher inventory levels which could result in inventory obsolescence due to excess and/or expired inventory. Additionally, the pandemic's impact on our customers may adversely impact the collectability of our current and future accounts receivable balance. COVID-19 has also disrupted and may continue to disrupt our product launches for our recently approved products and may negatively impact the regulatory approval of new products. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, a significant number of our global suppliers, vendors, and distributors have been adversely affected by COVID-19, including employee absenteeism which may impact their operations. Therefore, although we work closely with our suppliers to try to ensure </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">continuity of supply while maintaining high quality and reliability, the supply of certain components, raw materials, and services has been and may continue to be interrupted, in certain instances, as a direct result of COVID-19.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We expect medical procedure recovery rates to continue to vary by therapy and country, and to be impacted by regional COVID-19 case volumes, hospital and clinical occupancy and staffing levels, patient&#8217;s willingness to schedule deferrable procedures, travel restrictions, transportation limitations, quarantine restrictions, and COVID-19 resurgence.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following is a summary of revenue and diluted earnings per share for the three months ended October&#160;30, 2020 and October&#160;25, 2019 and operating cash flow for the six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:6pt;text-align:justify"><img src="mdt-20201030_g2.jpg" alt="mdt-20201030_g2.jpg" style="height:502px;margin-bottom:5pt;vertical-align:text-bottom;width:750px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GAAP to Non-GAAP Reconciliations   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present our GAAP to Non-GAAP reconciliations for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income <br/>Tax Provision<br/>(Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Attributable to Medtronic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective <br/>Tax Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain)/loss on minority investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt tender premium </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain tax adjustments, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.02&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 25, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income <br/>Tax Provision (Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Attributable to Medtronic</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective <br/>Tax Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.01&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain)/loss on minority investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit of businesses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution to the Medtronic Foundation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain tax adjustments, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(251)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,096&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts in this column have been intentionally rounded to the nearest $0.01 and, therefore, may not sum.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges primarily include business combination costs and changes in fair value of contingent consideration.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">We exclude unrealized and realized gains and losses on our minority investments as we do not believe that these components of income or expense have a direct correlation to our ongoing or future business operations. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges relate to certain license payments for unapproved technology.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges represent incremental costs of complying with the new European Union medical device regulations for previously registered products and primarily include charges for contractors supporting the project and other direct third-party expenses.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges relate to the early redemption of approximately $6.0 billion of debt.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Relates to the amortization of previously established deferred tax assets from intercompany intellectual property transactions.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges primarily include costs incurred in connection with legacy-Covidien enterprise resource planning deployment activities, business combination related costs, and changes in the fair value of contingent consideration. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">The net charge relates to the exit of businesses and is primarily comprised of intangible asset impairments.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">The benefit relates to the impact of tax reform in Switzerland.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income <br/>Tax Provision (Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Attributable to Medtronic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective <br/>Tax Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain)/loss on minority investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt tender premium and other charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain tax adjustments, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,583&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,216&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended October 25, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income <br/>Tax Provision (Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Attributable to Medtronic</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective <br/>Tax Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain)/loss on minority investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt tender premium and other charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (9)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit of businesses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution to the Medtronic Foundation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain tax adjustments, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,118&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.57&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts in this column have been intentionally rounded to the nearest $0.01 and, therefore, may not sum.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges primarily include business combination costs, changes in the fair value of contingent consideration, and a change in amounts accrued for certain contingent liabilities for recent acquisitions. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">We exclude unrealized and realized gains and losses on our minority investments as we do not believe that these components of income or expense have a direct correlation to our ongoing or future business operations. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges relate to certain license payments for unapproved technology.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges represent incremental costs of complying with the new European Union medical device regulations for previously registered products and primarily include charges for contractors supporting the project and other direct third-party expenses.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges relate to the early redemption of approximately $6.0 billion of debt.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges primarily include costs incurred in connection with legacy-Covidien enterprise resource planning deployment activities, business combination related costs, and changes in the fair value of contingent consideration.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges, which include $413 million recognized in interest expense and ($7 million) recognized in other operating expense, net, primarily related to the early redemption of approximately $5.2 billion of debt.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">The net charges relate to the exit of businesses and are primarily comprised of intangible asset impairments.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">The net benefit primarily relates to the impact of tax reform in Switzerland and the United States.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NET SALES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment and Division</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charts below illustrate the percent of net sales by division for the three months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><img src="mdt-20201030_g3.jpg" alt="mdt-20201030_g3.jpg" style="height:245px;margin-bottom:5pt;vertical-align:text-bottom;width:750px"/></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by segment and division for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.466%"><tr><td style="width:1.0%"></td><td style="width:35.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm &amp; Heart Failure</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coronary &amp; Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aortic, Peripheral, &amp; Venous </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac &amp; Vascular Group</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,855&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,158&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,645&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Innovations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Respiratory, Gastrointestinal, &amp; Renal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cranial &amp; Spinal Technologies</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,706&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,154&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,199&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)  Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The decrease in net sales for the three months ended October&#160;30, 2020, as compared to the corresponding period in the prior fiscal year, was primarily attributable to the impact of COVID-19, partially offset by growth in the Minimally Invasive Therapies Group as demand increased for COVID-19 related diagnostics and therapies, including strong growth in ventilators. The decrease in net sales for the six months ended October&#160;30, 2020, as compared to the corresponding period in the prior fiscal year, was primarily attributable to the decline in procedure volume, particularly in the spring and early summer, in the Cardiac and Vascular Group, Minimally Invasive Therapies Group, and Restorative Therapies Group resulting from the impact of COVID-19. Further contributing to the decrease were delays in new patient starts on insulin pumps and continued competitive pressure in Diabetes. Net sales for the six months ended October&#160;30, 2020 were also impacted by an additional selling week during the first fiscal month of the first quarter of fiscal year 2021 due to our 52/53 week fiscal year calendar. Although we cannot precisely calculate the impact of the extra selling week, we estimate that it benefited net sales for the six months ended October&#160;30, 2020 by approximately $360 to $390 million. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal year 2021, we realigned our divisions within the Restorative Therapies Group. As a result, fiscal year 2020 results have been recast to adjust for this realignment. Additionally, we are in the process of implementing a new operating model, which will be fully operational the beginning of the fourth quarter of our fiscal year 2021, that will simplify our organization in order to accelerate decision making, improve commercial execution, and more effectively leverage the scale of our company.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment and Market Geography  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charts below illustrate the percent of net sales by market geography for the three months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><img src="mdt-20201030_g4.jpg" alt="mdt-20201030_g4.jpg" style="height:247px;margin-bottom:5pt;vertical-align:text-bottom;width:750px"/></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes net sales by market geography for each of our segments for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)(4)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac and Vascular Group </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,315&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:8pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)(4)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac and Vascular Group </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,621&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,460&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">U.S. includes the United States and U.S. territories.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales decreases in the U.S. and emerging markets for the three months ended October&#160;30, 2020, as compared to the corresponding period in the prior fiscal year, were primarily attributable to the impact of COVID-19 driven by reduced procedure volumes. These decreases were partially offset by strong growth in our non-U.S. developed markets across all groups for the three months ended October&#160;30, 2020. Canada, Korea, and Western Europe experienced the largest increases in net sales in non-U.S. developed markets. Currency had a favorable impact on net sales in non-U.S. developed markets and emerging markets of $59 million for the three months ended October&#160;30, 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales decreases in the U.S., non-U.S. developed markets, and emerging markets for the six months ended October&#160;30, 2020, as compared to the corresponding period in the prior fiscal year, were primarily attributable to the impact of COVID-19 driven by a combination of deferred procedures and reduced demand for certain products as hospital systems continued to prioritize the treatment of COVID-19 patients, particularly in the spring and early summer. Japan, Canada, and Australia experienced the largest decreases in net sales in non-U.S. developed markets, and Latin America and South Asia experienced the largest decreases in net sales in emerging markets. Currency had an unfavorable impact on net sales in non-U.S. developed markets and emerging markets of $46 million for the six months ended October&#160;30, 2020. Net sales for the six months ended October&#160;30, 2020 were also impacted by an additional selling week during the first fiscal month of the first quarter of fiscal year 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Looking ahead, we expect COVID-19 could continue to have a significant impact on our business, noting that it is not possible to accurately predict the length and severity of the pandemic. Additionally, our segments are likely to face competitive product launches and pricing pressure, geographic macro-economic risks, reimbursement challenges, impacts from changes in the mix of our product offerings, the timing of product registration approvals, replacement cycle challenges, and fluctuations in currency exchange rates. Additionally, changes in procedural volumes could affect our Cardiac and Vascular, Minimally Invasive Therapies, and Restorative Therapies Groups and changes in new therapy adoptions could affect our Diabetes Group. </span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_115"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cardiac and Vascular Group</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cardiac and Vascular Group&#8217;s products include pacemakers, insertable monitors, cardiac resynchronization therapy devices (CRT-D), implantable cardioverter defibrillators (ICD), leads and delivery systems, ventricular assist systems, ablation products, electrophysiology catheters, products for the treatment of arrhythmias including atrial fibrillation, information systems for the management of patients with Cardiac Rhythm &amp; Heart Failure devices, products designed to reduce surgical site infections, coronary and peripheral stents and related delivery systems, balloons and related delivery systems, endovascular stent graft systems, heart valve replacement technologies, cardiac tissue ablation systems, and open heart and coronary bypass grafting surgical products. The Cardiac and Vascular Group also includes Care Management Services and Cath Lab Managed Services (CLMS) within the Cardiac Rhythm &amp; Heart Failure division. The Cardiac and Vascular Group&#8217;s net sales for the three and six months ended October&#160;30, 2020 were $2.7 billion and $5.2 billion, respectively, which represents a decline of 5 percent and 9 percent, respectively, compared to corresponding periods in the prior fiscal year. Currency had a $27 million favorable impact on net sales for the three months ended October&#160;30, 2020 and an unfavorable impact of $12 million for the six months ended October&#160;30, 2020. The Cardiac and Vascular Group's net sales declines for both periods were a result of a reduction in global procedural volumes, particularly in the spring and early summer, as the COVID-19 pandemic continues to affect the global healthcare system. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graphs below illustrate the percent of Cardiac and Vascular Group net sales by division for the three months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="mdt-20201030_g5.jpg" alt="mdt-20201030_g5.jpg" style="height:206px;margin-bottom:5pt;vertical-align:text-bottom;width:750px"/></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiac Rhythm &amp; Heart Failure net sales for the three months ended October&#160;30, 2020 were $1.4 billion, which was flat compared to the three months ended October&#160;25, 2019. For the six months ended October&#160;30, 2020, net sales of Cardiac Rhythm &amp; Heart Failure were $2.7 billion, a decline of 5 percent compared corresponding period in the prior fiscal year. Net sales for both periods were impacted by a decline in procedural volumes due to the on-going impact of the pandemic. The net sales decline for the six months ended October&#160;30, 2020 was led </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by ICDs, Implantable Diagnostics, and LVADs. Sales of the TYRX antibacterial envelope, Pacemakers, and CRT-Ds, partially offset these declines for the six months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;30, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and led the recovery of net sales for the three months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;30, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Pacemaker growth is the result of recent product launch momentum for the Micra AV pacemaker. The launch of the Cobalt and Crome ICD and CRT-D devices, which include remote programming and remote management capabilities, drove CRT-D growth for the three and six months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;30, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Coronary &amp; Structural Heart net sales for the three and six months ended October&#160;30, 2020 were $831 million and $1.6 billion, respectively, a decrease of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13 percent and 15 percent, respectively, as compared to the corresponding periods in the prior fiscal year. The declines were a result of a decrease in procedural volumes due to COVID-19. Within Structural Heart, while transcatheter aortic valve replacement (TAVR) nets sales declined for both the three and six months ended October&#160;30, 2020, procedural volumes increased sequentially in the second fiscal quarter of fiscal year 2021 as compared to the first fiscal quarter. Coronary net sales for both periods were negatively impacted by the effect of the Chinese national tender on coronary stent sales in China, which resulted in significant price declines.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aortic, Peripheral, &amp; Venous net sales for the three and six months ended October&#160;30, 2020 were $468 million and $873 million, respectively, which represents a decline of 1 percent and 7 percent, respectively, compared to the corresponding periods in the prior fiscal year. These decreases were driven by declines in procedure rates as a result of COVID-19. Partially offsetting the declines was growth in drug-coated balloons and the VenaSeal vein closure system for both the three and six months ended October&#160;30, 2020. Drug-coated balloon growth was the result of strong adoption of the IN.PACT AV drug-coated balloon driven by its pivotal data published during the current quarter as well as the negative impact that uncertainty surrounding Paclitaxel had on the drug-coated balloon market for the corresponding periods in the prior fiscal year. While experiencing declines during the six months ended October&#160;30, 2020, Aortic experienced growth during the three months ended October&#160;30, 2020 as thoracic endovascular aortic repair procedures experienced a rebound in procedural volumes. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the general impacts of COVID-19 on our Company as described in the Executive Level Overview, looking ahead, we expect our Cardiac and Vascular Group could be affected by the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">While many countries are past their initial peak with COVID-19, many regions, including the U.S. and Europe, are now experiencing a second wave. As a result, it is not possible to accurately predict the timing of recovery of a broad resumption of deferrable medical procedures to pre-COVID-19 levels, as to date, we are seeing the speed of recovery vary by therapy and geography. Therapies that might be considered more deferrable include Cardiac Ablation Solutions, EndoVenous, and Diagnostics while more urgent therapies include Pacing, Aortic, Coronary, and Cardiac Surgery. Moderately deferrable procedures include ICD&#8217;s CRT-D&#8217;s, TAVR/Structural Heart, and Peripheral. Extracorporeal Life Support products, including ECMO machines and disposables within our Cardiac Surgery business, are in higher demand as a result of COVID-19.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued growth of our Micra transcatheter pacing system. Micra AV received U.S. FDA approval and CE Mark approval in January and April 2020, respectively. Micra AV expands the Micra target population from 15 percent to 55 percent of pacemaker patients.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Acceptance and growth of the Cobalt and Crome portfolio of ICDs and CRT-Ds. These devices received CE Mark approval during the fourth quarter of fiscal year 2020 and U.S. FDA approval during the first quarter of fiscal year 2021. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth of the Claria MRI CRT-D system with EffectivCRT Diagnostic and Effective CRT during AF algorithm.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth from the Azure XT and S SureScan pacing systems. Azure pacemakers feature Medtronic-exclusive BlueSync technology, which enables automatic, secure wireless remote monitoring with increased device longevity.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Acceptance and growth of the LINQ 2 cardiac monitor, which received CE Mark in November 2019 and gained U.S. FDA approval during the first quarter of fiscal year 2021. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Changes in the U.S. heart transplant guidelines as well as a competitor's product launch as it relates to our LVAD business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth of the CRT-P quadripolar pacing system.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued growth, adoption, and utilization of the TYRX Envelope for implantable devices driven by the favorable results of the WRAP-IT clinical study. In the fourth quarter of fiscal year 2020, we received 12-month shelf-life extension for our TYRX Envelope product.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance of Care Management Services and post-acute care services becoming even more critical in bundled payment models for different interventions or therapies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth of the self-expanding CoreValve Evolut transcatheter aortic valve replacement platform into intermediate risk indication globally and for the treatment of patients determined to be at low risk with surgery. The Platform received both CE Mark for low risk and bicuspid labeling indication in Europe during the first quarter of fiscal year 2021. In August 2020, the U.S. FDA approved revised commercial labeling for the platform that modified a precaution for the treatment of patients at low risk. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Changes to the U.S. Medicare national coverage determination for transcatheter aortic valve replacement that will allow approximately 30 percent more U.S. centers to offer the therapy to patients. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued expansion and training of field support to increase coverage in the U.S. centers performing transcatheter aortic valve replacement procedures.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth from Evolut PRO, which provides industry-leading hemodynamics, reliable delivery, and advanced sealing with an excellent safety profile, as well as acceptance of our next generation Evolut PRO Plus TAVR valve which launched late in the second quarter of fiscal year 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth from the VenaSeal vein closure system in the U.S. The VenaSeal system is a unique non-thermal solution to address superficial venous disease that provides improved patient comfort, reduces the recovery time, and eliminates the risk of thermal nerve injury.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth from the Valiant family of thoracic stent grafts, including the Valiant Navion.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_118"></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Minimally Invasive Therapies Group  </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Minimally Invasive Therapies Group&#8217;s products span the entire continuum of patient care from diagnosis to recovery, with a focus on diseases of the gastrointestinal tract, lungs, pelvic region, kidneys, obesity, and preventable complications. The products include advanced and general surgical products, surgical stapling devices, vessel sealing instruments, wound closure products, electrosurgery products, hernia mechanical devices, hernia mesh implants, advanced ablation, interventional lung devices, ventilators, capnography, airway products, sensors, renal care products, patient monitoring products, and visualization systems. The Minimally Invasive Therapies Group&#8217;s net sales for the three and six months ended October&#160;30, 2020 were $2.3 billion and $4.1 billion, respectively, an increase of 7 percent and a decrease of 4 percent, respectively, as compared to the corresponding periods in the prior fiscal year. Currency had a favorable impact on net sales for the three months ended October&#160;30, 2020 of $11 million and an unfavorable impact for the six months ended October&#160;30, 2020 of $27 million. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales growth for the three months ended October&#160;30, 2020, as compared to the corresponding period in the prior fiscal year, was primarily driven by increased demand for COVID-19 related diagnostics and therapies, particularly due to strong ventilator sales. Additionally, demand for acute catheters and renal access products in the U.S. and China contributed to growth.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales decline for the six months ended October&#160;30, 2020, as compared to the corresponding period in the prior fiscal year, reflects the continued impact of COVID-19, resulting in a decline in procedure volume as elective procedures were delayed. The decline was partially offset by increased demand for COVID-19 related diagnostics and therapies, particularly within the ventilator portfolio.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graphs below illustrate the percent of Minimally Invasive Therapies Group net sales by division for the three months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-top:8pt;text-align:justify"><img src="mdt-20201030_g6.jpg" alt="mdt-20201030_g6.jpg" style="height:221px;margin-bottom:5pt;vertical-align:text-bottom;width:750px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Innovations net sales for the three and six months ended October&#160;30, 2020 were $1.4 billion and $2.5 billion, respectively, a decrease of 4 percent and 14 percent, respectively, as compared to the corresponding periods in the prior fiscal year. The decreases were driven by reduced surgical volumes, though for the three months ended October&#160;30, 2020 Western Europe and the U.S showed improvement resulting from a backlog of delayed procedures from the fourth quarter of fiscal year 2020 and first quarter of fiscal year 2021. The Surgical Innovations decline in procedure volumes, particularly Bariatric, Colorectal, Gynecological Health, Hernia, and Thoracic procedures, resulted in lower demand for Advanced Stapling products and General Surgery products, partially offset by new product launches driving growth in Advanced Energy for the three months ended October&#160;30, 2020.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Respiratory, Gastrointestinal, &amp; Renal net sales for the three and six months ended October&#160;30, 2020 were $893 million and $1.6 billion, respectively, an increase of 30 percent and 18 percent, respectively, as compared to the corresponding periods in the prior fiscal year. Respiratory, Gastrointestinal, &amp; Renal net sales growth was attributable to increased demand for Respiratory Interventions products due to COVID-19, driven by the Puritan Bennett high acuity ventilator portfolio.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the general impacts of COVID-19 on our Company as described in the Executive Level Overview, looking ahead, we expect our Minimally Invasive Therapies Group could be affected by the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">While many countries are past their initial peak with COVID-19, many regions, including the U.S. and Europe, are now experiencing a second wave. As a result, it is not possible to accurately predict the timing of recovery of a broad resumption of deferrable medical procedures to pre-COVID-19 levels, as to date, we are seeing the speed of recovery vary by therapy and geography. Therapies that might be considered more deferrable include Surgical Innovations bariatric, hysterectomy, hernia, advanced parameter monitoring products, and GI while more urgent therapies include Surgical Innovations appendectomy, bowel obstruction, and trauma, Respiratory and Patient Monitoring, and Renal Care. Moderately deferrable procedures include Surgical Innovations CABG and oncology. Ventilators, pulse oximetry and capnography capital within our Respiratory and Patient Monitoring business are in higher demand as a result of COVID-19. As such, we anticipate ventilator demand will decline back to normal pre-COVID-19 levels in fiscal year 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and future growth of Open-to-MIS techniques and tools supported by our efforts to transition open surgery to MIS (minimally invasive surgery). The Open-to-MIS initiative focuses on furthering our presence in and working to optimize open surgery globally, while capturing the market opportunity that exists in transitioning open procedures to MIS, whether through traditional MIS, or advanced technologies including robotics. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and future growth of powered stapling and energy platform, along with our ability to execute ongoing strategies to develop, gain regulatory approval, and commercialize new products including our surgical soft tissue robotics platform. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Our ability to execute ongoing strategies in order to address the competitive pressure of reprocessing of our vessel sealing disposables and growth of surgical soft tissue robotics procedures in the U.S.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Our ability to create markets and drive products and procedures into emerging markets. We have high quality and cost-effective surgical products designed for customers in emerging markets such as the ValleyLab LS10 single channel vessel sealing generator, which is compatible with our line of LigaSure instruments and designed for simplified use and affordability. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth within the end stage renal disease market. The population of patients treated for end stage renal disease globally is expected to double over the next decade. We plan to grow our therapy innovation with scalable and affordable dialysis delivery while investing in vascular creation and maintenance technologies. In addition, the HD multi-pass system reduces infrastructure by requiring less water, less start-up costs, and offers high quality ultrapure dialysate treatment. We are expecting regulatory filing in calendar year 2021, with launch following regulatory clearance in targeted countries.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued elevation of the standard of care for respiratory compromise, a progressive condition impacting a patient&#8217;s ability to breathe effectively, which leverages our market leading MicroStream capnography technology. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth in patient monitoring, airway, and ventilation management. Key products in this area include the Puritan Bennett 980 ventilator, Microstream Capnography, Nellcor pulse oximetry system with OxiMax technology, Shiley tracheostomy and endotracheal tubes, and McGRATH MAC video laryngoscopes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued and future acceptance of less invasive standards of care in Gastrointestinal and Hepatology products, including the areas of GI Diagnostic and Therapeutic product lines. Recently launched products include the PillCam COLON capsule endoscopy, the Barrx platform through ablation with the Barrx 360 Express catheter, EndoFLIP </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">imaging systems, Bravo Calibration-free reflux testing, and the Emprint ablation system with Thermosphere Technology, which maintains predictable spherical ablation zones throughout procedures reducing procedure time and cost.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued and future acceptance of Interventional Lung Solutions. Products include the superDimension GenCut core biopsy system and the Triple Needle Cytology Brush, a lung tissue biopsy tool for use with the superDimension navigation system. The superDimension system enables a minimally invasive approach to accessing difficult-to-reach areas of the lung, which may aid in the diagnosis of lung cancer.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Expanding the use of less invasive treatments and furthering our commitment to improving options for women with abnormal uterine bleeding. Our expanded and strengthened surgical offerings are expected to complement our global gynecology business.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_121"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restorative Therapies Group</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restorative Therapies Group's products focus on various areas of the spine, bone graft substitutes, biologic products, trauma, implantable neurostimulation therapies and drug delivery systems for the treatment of chronic pain, movement disorders, epilepsy, overactive bladder, urinary retention, fecal incontinence and gastroparesis, as well as products to treat conditions of the ear, nose, and throat (ENT), and systems that incorporate advanced energy surgical instruments. The Restorative Therapies Group also manufactures and sells image-guided surgery and intra-operative imaging systems, robotic guidance systems used in robot assisted spine procedures, and therapies to treat diseases of the vasculature in and around the brain, including coils, neurovascular stents and flow diversion products. During the first quarter of fiscal year 2021, the Company realigned the divisions within the Restorative Therapies Group to the following: Cranial &amp; Spinal Technologies (includes Core Spine and Biologics, Enabling Technologies, and China Orthopedics), Specialty Therapies (includes ENT, Pelvic Health, and Neurovascular), and Neuromodulation (includes Pain Therapies, Brain Modulation, and Interventional). The Restorative Therapies Group&#8217;s net sales for the three and six months ended October&#160;30, 2020 were $2.1 billion and $3.8 billion, respectively, a decrease of 2 percent and 8 percent, respectively, as compared to the corresponding periods in the prior fiscal year. Currency had a favorable impact of $13 million on net sales for the three months ended October&#160;30, 2020, and an unfavorable impact of $4 million on net sales for the six months ended October&#160;30, 2020. The Restorative Therapies Group&#8217;s net sales declines for both the three and six months ended October&#160;30, 2020 reflected the continued impact of COVID-19, including a reduction in capital equipment purchases, and declines in deferrable procedures particularly in the first quarter of fiscal year 2021. Net sales declines for the six months ended October&#160;30, 2020 were experienced across all divisions, while declines for the three months ended October&#160;30, 2020 were partially offset by modest gains in Specialty Therapies.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graphs below illustrate the percent of Restorative Therapies Group net sales by division for the three months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><img src="mdt-20201030_g7.jpg" alt="mdt-20201030_g7.jpg" style="height:219px;margin-bottom:5pt;vertical-align:text-bottom;width:750px"/></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cranial and Spinal Technologies net sales for the three and six months ended October&#160;30, 2020 were $1.1 billion and $2.0 billion, respectively, a decrease of 4 percent and 7 percent, respectively, as compared to the corresponding periods in the prior fiscal year. Net sales declines for the six months ended October&#160;30, 2020 were driven by declines both in Core Spine and Enabling Technologies (previously Neurosurgery). Enabling Technologies net sales declines were impacted by continued delays in capital equipment sales due to COVID-19, particularly with the ENT Navigation and Power Systems and O-Arm Imaging Systems. Despite the challenging environment for capital equipment, net sales declines for both the three and six months ended October&#160;30, 2020 were partially offset by growth in Advanced Energy, particularly in the U.S. For the six months ended October&#160;30, 2020, Core Spine net sales continued to be impacted by a decline in procedural volumes when compared to the corresponding period in the prior fiscal year, as a result of the pandemic. However, for the three months ended October&#160;30, 2020, Core Spine saw modest growth in the U.S. driven by the continued acceptance of the products of Titan Spine, which was acquired in the first quarter of fiscal year 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specialty Therapies net sales for the three and six months ended October&#160;30, 2020 were $581 million and $1.0 billion, respectively, an increase of 1 percent and a decrease of 9 percent as compared to the corresponding periods in the prior fiscal year. For the three months ended October&#160;30, 2020, net sales growth was driven by recovery in Pelvic Health and strength in Neurovascular, partially offset by declines in ENT. For the three months ended October&#160;30, 2020, the Pelvic Health business drove net sales growth due to the successful launch of the InterStim Micro neurostimulator and SureScan MRI lead in the U.S., and continued acceptance of the products in Europe. For the six months ended October&#160;30, 2020, net sales declines were driven by ENT and Pelvic Health, partially offset by growth in Neurovascular. Neurovascular's modest growth in both the three and six months ended October&#160;30, 2020 was driven by strength in coil sales, and aspiration catheters as well as catch-up from previously delayed procedures in the Hemorrhagic stroke business. This growth was partially offset by declines in flow diversion products due to two recent competitive entrants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neuromodulation net sales for the three and six months ended October&#160;30, 2020 were&#160;$411 million and $725 million, a decrease of 2 percent and 11 percent, respectively, as compared to the corresponding periods in the prior fiscal year. The declines were seen across both Pain Therapies and Brain Modulation for the six months ended October&#160;30, 2020 and continued to be primarily driven by a decline in procedural volumes particularly in the spring and early summer, as a result of COVID-19. For the three months ended October&#160;30, 2020, net sales declines in Pain Therapies were partially offset by growth in Brain Modulation propelled by sales of the Percept PC deep brain stimulation (DBS) device with Brainsense technology.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to the general impacts of COVID-19 on our Company as described in the Executive Level Overview, looking ahead we expect our Restorative Therapies Group could be affected by the following: </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">While many countries are past their initial peak with COVID-19, many regions, including the U.S. and Europe, are now experiencing a second wave. As a result, it is not possible to accurately predict the timing of recovery of deferrable medical procedures and capital equipment sales to pre-COVID-19 levels, as to date, we are seeing the speed of recovery varies by therapy and geography. The Restorative Therapies Group therapies tend to be used in procedures that are more deferrable. Therapies that might be considered more deferrable include Spine, Pain Therapies, Pelvic Health, and ENT while more urgent therapies include Spine trauma and Neurovascular stroke businesses. Moderately deferrable procedures include Brain Modulation. In addition, COVID-19 may continue to result in delayed evaluation and purchases for certain capital equipment including the Enabling Technologies business, which has a high mix of capital sales.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued growth from Enabling Technologies StealthStation and O-Arm Imaging Systems, Midas, and ENT Navigation and Power Systems, as well as acceptance of the Stealth Autoguide cranial robotic guidance platform.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued sales of Mazor robotic units and associated market adoption of robot-assisted spine procedures, including the Mazor X Stealth, our integrated robotics and navigation platform.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Strengthening of our position in the spine titanium interbody implant marketplace as a result of the June 2019 acquisition of Titan Spine.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued adoption of our integrated solutions through the Surgical Synergy strategy, which integrates our spinal implants with enabling technologies such as imaging, navigation, power instruments, nerve monitoring, and Mazor robotics.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Market acceptance and continued global adoption of innovative new spine products and procedural solutions within our Cranial and Spinal Technologies business such as our Infinity OCT System and Prestige LP cervical disc system.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Growth in the broader vertebral compression fracture (VCF) and adjacent markets as we continue to pursue the development of other therapies to treat more patients with VCF, including continued success of both the Kyphon V vertebroplasty system and the Osteocool RF Spinal Tumor ablation system.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth of our ENT and Pelvic Health therapies within our Specialty Therapies division, including our InterStim therapy with InterStim II and InterStim Micro neurostimulators, which received CE mark approval in January 2020 and U.S. FDA approval in August 2020, for the treatment of the symptoms of overactive bladder, urinary retention, and bowel incontinence, and capital equipment sales of the Stealth Station ENT surgical navigation system and intraoperative NIM nerve monitoring system.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth of the Solitare FR revascularization device for treatment of acute ischemic stroke and the Pipeline Embolization Devices, endovascular treatments for large or giant wide-necked brain aneurysms.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance of our React Catheter and Riptide aspiration system, along with our next-generation Solitaire revascularization device.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Market acceptance and continued global adoption of our Intellis spinal cord stimulator, DTM (differential target multiplexed) proprietary waveform, Evolve workflow algorithm, and Snapshot reporting to treat chronic pain in major markets around the world.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth of our Percept PC deep brain stimulation (DBS) device with Brainsense technology, which received CE Mark approval in January 2020 and U.S. FDA approval in June 2020. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance of our devices for the treatment of Parkinson's Disease, epilepsy and other movement disorders.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Ongoing obligations under the U.S. FDA consent decree entered in April 2015 relating to the SynchroMed drug infusion system and the Neuromodulation quality system. The U.S. FDA lifted its distribution requirements on our implantable drug pump in October 2017 and its warning letter in November 2017.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_124"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diabetes Group</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Diabetes Group's products include insulin pumps, continuous glucose monitoring (CGM) systems, insulin pump consumables, and smart insulin pen systems. The Diabetes Group&#8217;s net sales for the three and six months ended October&#160;30, 2020 were $574 million and $1.1 billion, a decrease of 4 percent as compared to the corresponding periods in the prior fiscal year. Currency had a favorable impact of $8 million on net sales for the three months ended October&#160;30, 2020 and an unfavorable impact of $3 million on net sales for the six months ended October&#160;30, 2020. The Diabetes Group's net sales declines for the three and six months ended October&#160;30, 2020 were primarily attributable to the insulin pump business from new patient start delays associated with COVID-19 and continued competitive pressures in the U.S. The decrease is also largely attributable to COVID-19 pressures in the international markets. The declines were partially offset by growth for the Guardian Connect system. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the general impacts of COVID-19 on our Company as described in the Executive Level Overview, looking ahead we expect our Diabetes Group could be affected by the following:</span></div><div style="margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">While many countries are past their initial peak with COVID-19, many regions, including the U.S. and Europe, are now experiencing a second wave. As a result, it is not possible to accurately predict the timing of recovery of deferrable new therapy adoptions to pre-COVID-19 levels, as to date, we are seeing the speed of recovery varies by therapy and geography. Therapies that might be considered more deferrable include new insulin pump starts while more urgent therapies include ongoing diabetes supplies and consumables, including continuous glucose sensors and infusion sets. </span></div><div style="margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Strengthening our position in the diabetes market as a result of the September 10, 2020 acquisition of Companion Medical. Companion Medical offers a U.S. FDA cleared InPen smart pen system that combines the freedom of a reusable Bluetooth pen with the intelligence of an intuitive mobile application that helps users administer the appropriate insulin dose. In addition, subsequent to quarter end, we have integrated our CGM data into the Companion Medical InPen Application which allows users to have their CGM readings in real-time alongside insulin dose information, all in one view. </span></div><div style="margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued pump competition in an expanding U.S. market. </span></div><div style="margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Patient demand for the MiniMed 770G BLE enabled system, which received U.S. FDA approval in August 2020. The system is powered by SmartGuard technology, as featured in the MiniMed 670 system, with the added benefits of smartphone connectivity and an expanded age indication to children as young as age two. Subsequent to quarter-end, the MiniMed 770G began limited release in the U.S. </span></div><div style="margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Changes in medical reimbursement policies and programs, along with additional payor coverage on insulin pumps.</span></div><div style="margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued future growth internationally for the advanced hybrid closed loop system. The advanced hybrid closed loop system was approved in the European Union (EU) on June 5, 2020, and launched in twelve countries outside the U.S., primarily in Europe, during October 2020. The global adoption of sensor-augmented insulin pump systems has resulted in strong sensor attachment rates. </span></div><div style="margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Our ability to execute ongoing strategies to develop, gain regulatory approval, commercialize, and gain customer acceptance of new products, including our advanced hybrid closed loop system, as well as our Personalized Closed Loop system that was granted "Breakthrough Device" designation by the U.S. FDA. These technologies feature our next-generation algorithms by further automating insulin delivery. </span></div><div style="margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth of the Guardian Connect CGM system, which displays glucose information directly to a smartphone. During the first quarter of fiscal year 2021, we introduced the Guardian Connect system for Android devices to ensure patients have access to their glucose levels seamlessly and discretely. The Guardian Connect CGM system is available on Apple iOS and Android devices. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING ESTIMATES</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have used various accounting policies to prepare the consolidated financial statements in accordance with U.S. GAAP. Our significant accounting policies are disclosed in Note 1 to the consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended April 24, 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements, in conformity with U.S. GAAP, requires us to use judgment in making estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. These estimates reflect our best judgment about economic and market conditions and the potential effects on the valuation and/or carrying value of assets and liabilities based upon relevant information available. We base our estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our critical accounting estimates include the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   We are involved in a number of legal actions involving product liability, intellectual property and commercial disputes, shareholder related matters, environmental proceedings, tax disputes, and governmental proceedings and investigations. The outcomes of these legal actions are not completely within our control and may not be known for prolonged periods of time. In some actions, the enforcement agencies or private claimants seek damages, as well as other civil or criminal remedies (including injunctions barring the sale of products that are the subject of the proceeding), that could require significant expenditures or result in lost revenues or limit our ability to conduct business in the applicable jurisdictions. Estimating probable losses from our litigation and governmental proceedings is inherently difficult, particularly when the matters are in early procedural stages, with incomplete scientific facts or legal discovery; involve unsubstantiated or indeterminate claims for damages; potentially involve penalties, fines, or punitive damages; or could result in a change in business practice. Our significant legal proceedings are discussed in Note 16 to the current period's consolidated financial statements. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Tax Reserves</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   We establish reserves when, despite our belief that our tax return positions are fully supportable, we believe that certain positions are likely to be challenged and that we may or may not prevail. Under U.S. GAAP, if we determine that a tax position is more likely than not of being sustained upon audit, based solely on the technical merits of the position, we recognize the benefit. We measure the benefit by determining the amount that is greater than 50 percent likely of being realized upon settlement. We presume that all tax positions will be examined by a taxing authority with full knowledge of all relevant information. The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations in a multitude of jurisdictions across our global operations. We regularly monitor our tax positions and tax liabilities. We reevaluate the technical merits of our tax positions and recognize an uncertain tax benefit, or derecognize a previously recorded tax benefit, when there is (i) a completion of a tax audit, (ii) effective settlement of an issue, (iii) a change in applicable tax law including a tax case or legislative guidance, or (iv) the expiration of the applicable statute of limitations. Significant judgment is required in accounting for tax reserves. Although we believe that we have adequately provided for liabilities resulting from tax assessments by taxing authorities, positions taken by these tax authorities could have a material impact on our effective tax rate, consolidated earnings, financial position and/or cash flows.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation of Intangible Assets and Goodwill   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we acquire a business, the assets acquired and liabilities assumed are recorded at their respective fair values at the acquisition date. Goodwill is the excess of the purchase price over the estimated fair value of net assets of acquired businesses. Intangible assets primarily include patents, trademarks, tradenames, customer relationships, purchased technology, and in process research and development (IPR&amp;D). Determining the fair value of intangible assets acquired as part of a business combination requires us to make significant estimates. These estimates include the amount and timing of projected future cash flows of each project or technology, the discount rate used to discount those cash flows to present value, the assessment of the asset&#8217;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The test for goodwill impairment requires us to make several estimates to determine fair value, most of which are based on projected future cash flows. Our estimates associated with the goodwill impairment test are considered critical due to the amount of goodwill recorded on our consolidated balance sheets and the judgment required in determining fair value. We assess the impairment of goodwill at the reporting unit level annually as of the first day of the third quarter and whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test definite-lived intangible assets for impairment when an event occurs or circumstances change that would indicate the carrying amount of the assets or asset group may be impaired. Our tests are based on future cash flows that require significant judgment with respect to future revenue and expense growth rates, appropriate discount rates, asset groupings, and other assumptions and estimates. We use estimates that are consistent with the highest and best use of the assets based on a market participant's view of the assets being evaluated. Actual results may differ from our estimates due to a number of factors including, among others, changes in competitive conditions, timing of regulatory approval, results of clinical trials, changes in worldwide economic conditions, and fluctuations in currency exchange rates. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the impairment of indefinite-lived intangible assets annually in the third quarter and whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Our impairment tests of indefinite-lived intangible assets require us to make several estimates to determine fair value, including projected future cash flows and discount rates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEW ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding new accounting pronouncements is included in Note 2 to the current period's consolidated financial statements.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_133"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding acquisitions is included in Note 4 to the current period's consolidated financial statements.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_136"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COSTS AND EXPENSES</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of cost of products sold, research and development, and selling, general, and administrative expenses as a percent of net sales for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 (dollar amounts in millions):</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><img src="mdt-20201030_g8.jpg" alt="mdt-20201030_g8.jpg" style="height:280px;margin-bottom:5pt;vertical-align:text-bottom;width:750px"/></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Products Sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   We continue to focus on reducing our costs of production through supplier management, manufacturing improvements, and optimizing our manufacturing network. Cost of products sold for the three and six months ended October&#160;30, 2020 was $2.7 billion and $5.2 billion, respectively. The increase in cost of products sold as a percentage of net sales for the three and six months ended October&#160;30, 2020, as compared to the corresponding periods in the prior fiscal year, was largely due to increased expenses as a result of COVID-19, primarily due to period expensing of some of our fixed overhead costs due to idle capacity at certain manufacturing facilities and increases in reserves for excess and obsolete inventory, as well as negative impact from mix, as products in higher demand had lower gross margins. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expense   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remain committed to accelerating the development of meaningful innovations to deliver better patient outcomes at appropriate costs that lead to enhanced quality of life and may be validated by clinical and economic evidence. We are also focused on expanding access to quality healthcare. Research and development expense for the three and six months ended October&#160;30, 2020 was $639 million and $1.3 billion, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal year 2021, we entered into arrangements with third parties to fund the development of certain technologies in our Diabetes Group. As there is a substantive and genuine transfer of risk to the third parties, the development funding provided is recognized as an obligation to perform contractual services, and therefore is recorded as income in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income in the period the corresponding research and development expenses are incurred. If the technologies receive regulatory approval and are successfully commercialized, we will pay royalties to the third parties. For the three and six months ended October&#160;30, 2020, no projects were significant, either individually or in aggregate, to our consolidated results.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General, and Administrative Expense   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goal is to continue to leverage selling, general, and administrative expense initiatives and to continue to realize cost synergies expected from our acquisitions. Selling, general, and administrative expense primarily consists of salaries and wages, other administrative costs, such as professional fees and marketing expenses, and certain acquisition and restructuring expenses.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general, and administrative expense for the three and six months ended October&#160;30, 2020 was $2.6 billion and $5.0 billion, respectively. The increase in selling, general, and administrative expense as a percentage of net sales for the six months ended October&#160;30, 2020, as compared to the corresponding period in the prior fiscal year, was primarily driven by the deleveraging experienced due to the impact of COVID-19 on net sales. The decrease in selling, general, and administrative expense in absolute values was primarily due to savings from our Enterprise Excellence program, as well as reduced travel and discretionary spending due to the pandemic. For the three months ended October&#160;30, 2020, selling, general, and administrative expense as a percentage of net sales was flat, as compared to the corresponding period in the prior fiscal year, with increased annual incentive accruals offset by Enterprise Excellence savings.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_139"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of other costs and expenses:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortization of Intangible Assets   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets includes the amortization expense of our definite-lived intangible assets, consisting of purchased patents, trademarks, tradenames, customer relationships, purchased technology, and other intangible assets. Amortization expense was $443 million and $884 million for the three and six months ended October&#160;30, 2020, respectively, as compared to $441 million and $881 million for the three and six months ended October&#160;25, 2019, respectively. </span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_142"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Charges, Net </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Enterprise Excellence</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of fiscal year 2018, we announced a multi-year global Enterprise Excellence Program designed to drive long-term business growth and sustainable efficiency. The Enterprise Excellence Program is expected to further leverage our global size and scale as well as enhance the customer and employee experience.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Enterprise Excellence Program is focused on three objectives:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Global Operations &#8211; integrating and enhancing global manufacturing and supply processes, systems and site presence to improve quality, delivery cost and cash flow</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Functional Optimization &#8211; enhancing and leveraging global operating models and systems across several enabling functions to improve productivity and employee experience</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Commercial Optimization &#8211; optimizing certain processes, systems and models to improve productivity and the customer experience</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Enterprise Excellence Program is designed to drive operating margin improvement as well as fund investment in strategic growth initiatives, with expected annual gross savings of more than $3.0 billion from cost reductions and leverage of our fixed infrastructure by the end of fiscal year 2022. Approximately $500 million to $700 million of gross annual savings are expected to be achieved through the end of fiscal year 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Enterprise Excellence Program is expected to result in pre-tax restructuring charges of approximately&#160;$1.6 billion&#160;to&#160;$1.8 billion, the vast majority of which are expected to be incurred by the end of fiscal year 2022 and result in cash outlays to be substantially complete by the end of fiscal year 2023. Approximately half of the estimated charges are related to employee termination benefits. The remaining charges are costs associated with the restructuring program, such as salaries for employees supporting the program and consulting expenses. We expect these costs to be recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">restructuring charges, net, cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general, and administrative expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months and six months ended October&#160;30, 2020, we recognized charges of $90 million and $169 million, respectively, partially offset by accrual adjustments of $3 million and $5 million, respectively. Accrual adjustments relate to certain employees identified for termination finding other positions within Medtronic and contract terminations being settled for less than originally estimated. For the three and six months ended October&#160;30, 2020, charges included $10 million and $15 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">restructuring charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income, primarily comprised of employee termination benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;30, 2020, charges also included costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses, including $32 million and $59 million, respectively, recognized within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> cost of products </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $48 million and $95 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general, and administrative expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;25, 2019, we recognized charges of $95 million and $231 million, respectively, partially offset by accrual adjustments of $1 million and $13 million, respectively, related to certain employees identified for termination finding other positions within Medtronic. For the three and six months ended October&#160;25, 2019, charges included $28 million and $81 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">restructuring charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income, primarily comprised of employee termination benefits. For the three and six months ended October&#160;25, 2019, charges also included costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses, including $32 million and $61 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $35 million and $77 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general and administrative expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in consolidated statements of income. For the six months ended October&#160;25, 2019, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> also included $6 million of fixed asset write-downs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplification</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the first quarter of fiscal year 2021, we initiated our Simplification restructuring program, designed to make the Company a more nimble and competitive organization focused on accelerating innovation, enhancing the customer experience, driving revenue growth, and winning market share, while also more efficiently and effectively leveraging our Enterprise scale. Under the oversight of the portfolio leaders, this new operating model, which will be fully operational the beginning of the fourth quarter of fiscal year 2021, will simplify our organizational structure and accelerate decision-making and execution. Primary activities of the restructuring program will include reorganizing our business into a portfolio-level structure, including the creation of highly focused, accountable and empowered Operating Units (OUs), consolidating operations at the enterprise level, establishing Technology Development Centers in areas where we have deep core technology competencies to be leveraged by multiple OUs, and forming dedicated sales organizations that leverage our scale but move with the same agility as our smaller, local competitors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Simplification program designed to streamline our operating model, improve competitiveness, and enhance the customer and employee experience will result in substantial reduction in selling, general, and administrative expenses, the majority of which are expected to be achieved through the end of fiscal year 2022. Annual savings of approximately $450&#160;million to $475&#160;million are expected to be realized by the various components of the Simplification program.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimate that, in connection with the Simplification restructuring program, we will recognize pre-tax exit and disposal costs and other costs across all segments of approximately $400&#160;million to $450&#160;million, the majority of which are expected to be incurred by the end of fiscal year 2022. Approximately three quarters of the estimated charges are related to employee termination benefits. The remaining charges are costs associated with the restructuring program, such as salaries for employees supporting the program and consulting expenses. These charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">restructuring charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;30, 2020, we recognized charges of $102 million and $153 million, respectively, partially offset by accrual adjustments of $8 million for both periods, related to certain employees identified for termination finding other positions within Medtronic. For the three and six months ended October&#160;30, 2020, we recognized charges of $100 million and $150 million, respectively, within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">restructuring charges, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income related to employee termination benefits, including $97 million of incremental defined benefit pension and post-retirement related expenses for employees that accepted voluntary early retirement packages. For the three and six months ended October&#160;30, 2020, charges also included costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses, including $2 million and $3 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information about our restructuring programs, refer to Note 5 to the current period's consolidated financial statements.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_148"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Litigation Charges, Net   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify litigation charges and gains related to significant legal matters as certain litigation charges. During the three and six months ended October&#160;30, 2020, we recognized charges of $84 million and a net benefit of $4 million, respectively. The net benefit for the six months ended October&#160;30, 2020 is primarily related to favorable settlements in the first quarter of fiscal year 2021, partially offset by charges recognized in the second quarter of fiscal year 2021. During the three and six months ended October&#160;25, 2019, we recognized charges of $121 million and $168 million, respectively, related to probable and estimable damages.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Operating Expense, Net   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating expense, net primarily includes royalty income and expense, currency remeasurement and derivative gains and losses, Puerto Rico excise taxes, changes in the fair value of contingent consideration, change in amounts accrued for certain contingent liabilities for a recent acquisition, a commitment to the Medtronic Foundation, charges associated with business exits, and income from funded research and development arrangements. For the three and six months ended October&#160;30, 2020, other operating expense, net was $149 million and $35 million, respectively, as compared to $149 million and $127 million, for the three and six months ended October&#160;25, 2019, respectively. The changes in other operating expense, net are primarily attributable to our remeasurement and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hedging programs, change in amounts accrued for certain contingent liabilities, commitment to the Medtronic Foundation, and charges associated with business exits. Combined, our remeasurement and hedging programs resulted in a $16 million loss and $15 million gain for the three and six months ended October&#160;30, 2020, respectively, as compared to a $47 million gain and $121 million gain for the three and six months ended October&#160;25, 2019, respectively. Additionally, for the six months ended October&#160;30, 2020, other operating expense, net includes a $132 million gain related to amounts accrued for certain contingent liabilities for a recent acquisition. For the three and six months ended October&#160;25, 2019, other operating expense, net includes a $41 million charge associated with the exit of businesses and an $80 million charge associated with our commitment to the Medtronic Foundation.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_151"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Non-Operating Income, Net   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-operating income, net includes the non-service component of net periodic pension and postretirement benefit cost, investment gains and losses, and interest income. For the three and six months ended October&#160;30, 2020, other non-operating income, net was $65 million and $147 million, respectively, as compared to $108 million and $209 million for the three and six months ended October&#160;25, 2019, respectively. The change in other non-operating income, net is primarily attributable to interest income, which was $46 million and $98 million for the three and six months ended October&#160;30, 2020, respectively, as compared to $77 million and $160 million for the three and six months ended October&#160;25, 2019, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes interest incurred on our outstanding borrowings, amortization of debt issuance costs and debt premiums or discounts, amortization of gains or losses on terminated or de-designated interest rate derivative instruments, and charges recognized in connection with the tender and early redemption of senior notes. For the three and six months ended October&#160;30, 2020, interest expense was $470 million and $641 million, respectively, as compared to $165 million and $774 million for the three and six months ended October&#160;25, 2019, respectively. The increase in interest expense during the three months ended October&#160;30, 2020, as compared to the corresponding period in the prior fiscal year, was primarily driven by $308 million of charges recognized in connection with the early redemption of $6.0 billion of debt. The decrease in interest expense during the six months ended October&#160;30, 2020 was primarily due to a decrease in charges related to debt tender and redemption transactions, which were $308 million for the six months ended October&#160;30, 2020, as compared to $413 million for the six months ended October&#160;25, 2019, as well as a decrease in the weighted-average interest rate of outstanding debt obligations driven by our debt issuance and tender transactions in the first quarter of fiscal year 2020 and second quarter of fiscal year 2021.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_154"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INCOME TAXES</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP income tax provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Nominal Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Difference between the effective tax rate and Non-GAAP Nominal Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three and six months ended October&#160;30, 2020 was 5.9 percent and 11.2 percent, respectively, as compared to (6.0) percent and 1.0 percent for the three and six months ended October&#160;25, 2019, respectively. The increase in our effective tax rate for the three and six months ended October&#160;30, 2020, as compared to the corresponding periods in the prior fiscal year, was primarily due to the impact of certain tax adjustments and year-over-year changes in operational results by jurisdiction. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Non-GAAP Nominal Tax Rate for the three and six months ended October&#160;30, 2020 was 13.8 percent and 13.9 percent, respectively, as compared to 14.9 percent and 15.0 percent for the three and six months ended October&#160;25, 2019, respectively. The decrease in our Non-GAAP Nominal Tax Rate was due to the impact of year-over-year changes in operational results by jurisdiction. An increase in our Non-GAAP Nominal Tax Rate of 1 percent would result in an additional income tax provision for the three and six months ended October&#160;30, 2020 of approximately $16 million and $26 million, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Tax Adjustments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended October&#160;30, 2020, the cost from certain tax adjustments of $16 million, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">income tax provision (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income, included a cost of $16 million associated with the amortization of the previously established deferred tax assets from intercompany intellectual property transactions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended October&#160;30, 2020, the net cost from certain tax adjustments of $20 million, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">income tax provision (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income, included the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">A benefit of $3 million associated with the finalization of an intercompany sale of intellectual property and the establishment of a deferred tax asset. The cumulative amount of deferred tax benefit previously recognized from intercompany intellectual property transactions and recorded as Certain Tax Adjustments is $1.5 billion. The corresponding deferred tax assets will be amortized over a period of approximately 20 years. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">A cost of $23 million associated with the amortization of the previously established deferred tax assets from intercompany intellectual property transactions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended October&#160;25, 2019, the benefit from certain tax adjustments of $251 million, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">income tax provision (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income, included a benefit of $251 million related to tax legislative changes in Switzerland which abolished certain preferential tax regimes the Company benefited from and replaced them with a new set of internationally accepted measures. The legislation provided for higher effective tax rates but allowed for a transitional period whereby an amortizable asset was created for Swiss federal income tax purposes which will be amortized and deducted over a 10-year period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended October&#160;25, 2019, the net benefit from certain tax adjustments of $281 million, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">income tax provision (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income, included the following: </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A net benefit of $30 million related to U.S. Treasury&#8217;s issuance of certain Final Regulations associated with U.S. Tax Reform. The primary impact of these regulations resulted in the re-establishment of our permanently reinvested assertion on certain foreign earnings and reversing the previously accrued tax liability. This benefit was partially offset by additional tax associated with a previously executed internal reorganization of certain foreign subsidiaries. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A benefit of $251 million related to tax legislative changes in Switzerland, which abolished certain preferential tax regimes the Company benefited from and replaced them with a new set of internationally accepted measures. The legislation provided for higher effective tax rates but allowed for a transitional period whereby an amortizable asset was created for Swiss federal income tax purposes which will be amortized and deducted over a 10-year period.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-bottom:5pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently in a strong financial position. Despite the impact from COVID-19 on operating cash flow and net income, we believe our balance sheet and liquidity provide us with flexibility, and our cash, cash equivalents, and current investments, as well as our credit facility and related commercial paper programs outlined below, will satisfy our foreseeable operating needs. We believe we have ample liquidity, with $14.3&#160;billion of cash and investments as of October&#160;30, 2020, and an undrawn $3.5 billion credit facility, with $4.0 billion of debt obligation due within twelve months of October&#160;30, 2020. Given our strong financial position, we are continuing to focus on making capital allocation decisions to drive our long-term strategies.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity and capital structure is evaluated regularly within the context of our annual operating and strategic planning process. We consider the liquidity necessary to fund our operations, which includes working capital needs, investments in research and development, property, plant, and equipment, and other operating costs. We also consider capital allocation alternatives that balance returning value to shareholders through dividends and share repurchases, satisfying maturing debt, and acquiring businesses and technology.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Cash Flows</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of cash provided by (used in) operating, investing, and financing activities, the effect of exchange rate changes on cash and cash equivalents, and the net change in cash and cash equivalents:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,012)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The $1.2 billion decrease in net cash provided was primarily driven by a decrease in cash collected from customers, partially offset by a decrease in cash paid for income taxes, and a decrease in cash paid to employees. The decrease in cash collected from customers was primarily related to COVID-19 driving decreased sales in the fourth quarter of fiscal year 2020 and first quarter of fiscal year 2021, when compared to the corresponding periods in the prior fiscal year. Our relative sales performance in the three months ended October 30, 2020 compared to the prior fiscal year did not have a significant impact on our net cash provided. The decrease in cash paid for income taxes was primarily due to the decrease in estimated U.S. federal tax payments, as well as tax payments associated with a European audit settlement in the first quarter of fiscal year 2020. Cash paid to employees decreased due to lower annual incentive plan payouts compared the corresponding period in the prior fiscal year. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   The $245 million increase in net cash used was primarily attributable to an increase in cash paid for acquisitions of $169 million and an increase in net purchases of investments of $57 million during the six months ended October&#160;30, 2020, as compared to the corresponding period in the prior fiscal year.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The $4.0 billion increase in net cash provided was primarily attributable to the Mizuho Bank term loan under which the Company borrowed $2.8&#160;billion in the first quarter of fiscal year 2021, as well as the net proceeds from the debt issuance and early redemption described below. Also contributing to the total increase in cash provided was the decrease in net cash used for share repurchases of $894 million. Cash flow activity related to share repurchases for the six months ended October&#160;30, 2020 is related to cash remitted to taxing authorities for shares withheld for employee taxes on share-based payment deliveries and exercises; the Company did not repurchase any shares during the six months ended October&#160;30, 2020. Partially offsetting these items was a decrease in the issuance of ordinary shares of $313 million, when compared to the corresponding period in the prior fiscal year. For the six months ended October&#160;30, 2020 financing cash flows were impacted by the issuance of $7.2 billion of Euro-denominated senior notes offset by the early redemption of $6.0&#160;billion of senior notes for $6.3&#160;billion of total consideration. For comparison, financing cash flows for the six months ended October&#160;25, 2019 were impacted by the issuance of $5.6 billion of Euro-denominated senior notes, offset by the tender of $5.2 billion of senior notes for $5.6&#160;billion of total consideration. For more information on the aforementioned Mizuho Bank term loan, and issuances and redemptions of senior notes, please see the Debt and Capital section.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Free Cash Flow </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow, a non-GAAP financial measure, is calculated by subtracting additions to property, plant, and equipment from net cash provided by operating activities. Management uses this non-GAAP financial measure, in addition to U.S. GAAP financial measures, to evaluate our operating results. Free cash flow should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with U.S. GAAP. Reconciliations between net cash provided by operating activities (the most comparable U.S. GAAP measure) and free cash flow are as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,139</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,377</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to property, plant, and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Free cash flow</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,524</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,793</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the Summary of Cash Flows section for drivers of the change in cash provided by operating activities.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_160"></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt and Capital </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our capital structure consists of equity and interest-bearing debt. We use a combination of bank borrowings and commercial paper issuances to fund our short-term financing needs and unsecured senior debt obligations to meet our long-term financing needs. From time to time, we may repurchase our outstanding debt obligations in the open market or through privately negotiated transactions. Current debt at October&#160;30, 2020, including the current portion of our long-term debt and finance lease obligations, was $4.0 billion as compared to $2.8 billion at April&#160;24, 2020. Long-term debt at October&#160;30, 2020 was $26.0 billion as compared to $22.0 billion at April&#160;24, 2020. The increase in total debt was primarily driven by the net impact of issuance and redemption of senior notes as well as an unsecured term loan agreement entered into with Mizuho Bank, both of which are described below.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we entered into an unsecured term loan agreement with Mizuho Bank, Ltd. for an aggregate principal amount of up to &#165;300 billion, or approximately $2.8 billion, with a term of six months, which may be extended for an additional six months at the Company&#8217;s option. On May 13, 2020, Medtronic Luxco borrowed the entire amount of the term loan under the Loan Agreement. The proceeds of the loan were used for general corporate purposes. The Japanese Yen denominated debt is designated as a net investment hedge of certain of our Japanese operations. On November 12, 2020, we exercised our option to extend the term of the loan for an additional six months. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we issued six tranches of Euro-denominated senior notes with an aggregate principal of &#8364;6.3 billion, with maturities ranging from fiscal year 2023 to fiscal year 2051, resulting in cash proceeds of approximately $7.2 billion, net of discounts and issuance costs. The Euro-denominated debt is designated as a net investment hedge of certain of our European operations. We used the net proceeds of the offering to fund the early redemption of $6.0 billion of senior notes for $6.3 billion of total consideration in October 2020. Additionally, we intend to use proceeds to repay our &#8364;750 million floating rate senior notes at maturity in March 2021. We recognized a loss on debt extinguishment of $308 million during the quarter, which primarily included cash premiums and accelerated amortization of deferred financing costs and debt discounts and premiums. The loss on debt extinguishment was recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain multicurrency commercial paper programs for short-term financing, which allows us to issue unsecured commercial paper notes on a private placement basis up to a maximum aggregate amount outstanding at any time of $3.5 billion. At both October&#160;30, 2020 and April&#160;24, 2020, we had no commercial paper outstanding. The issuance of commercial paper reduces the amount of credit available under our existing line of credit, as explained below.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have a $3.5 billion five-year syndicated credit facility (Credit Facility), which expires in December 2024. The Credit Facility provides backup funding for the commercial paper programs and may also be used for general corporate purposes. The Credit Facility provides us with the ability to increase our borrowing capacity by an additional $1.0 billion at any time during the term of the agreement. At each anniversary date of the Credit Facility, but not more than twice prior to the maturity date, we could also request a one-year extension of the maturity date. At October&#160;30, 2020 and April&#160;24, 2020, no amounts were outstanding under the Credit Facility.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rates on advances of our Credit Facility are determined by a pricing matrix, based on our long-term debt ratings assigned by Standard &amp; Poor's Ratings Services (S&amp;P) and Moody's Investors Service (Moody&#8217;s). For additional information on our credit ratings status by S&amp;P and Moody's, refer to the "Liquidity" section of this Management's Discussion and Analysis. Facility fees are payable on the Credit Facility and are determined in the same manner as the interest rates. The agreements also contain customary covenants, all of which we were in compliance with at October&#160;30, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We repurchase our ordinary shares from time to time as part of our focus on returning value to our shareholders. In March 2019, our Board of Directors authorized an incremental $6.0 billion in excess of prior authorizations for repurchase of our ordinary shares. There is no specific time period associated with these repurchase authorizations. The Company made no repurchases of ordinary shares during the six months ended October&#160;30, 2020. We had approximately $6.0 billion remaining under the share repurchase program authorized by our Board of Directors at October&#160;30, 2020. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on credit arrangements, refer to Note 7 to the current period's consolidated financial statements and Note 7 to the consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended April 24, 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity sources at October&#160;30, 2020 include $6.4 billion of cash and cash equivalents and $7.9 billion of current investments. Additionally, we maintain a commercial paper program (no commercial paper outstanding at October&#160;30, 2020) and Credit Facility. See discussion above regarding changes in our cash and cash equivalents and commercial paper program and Credit Facility. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments include available-for-sale and held-to-maturity debt securities, including U.S. and non-U.S. government and agency securities, corporate debt securities, mortgage-backed securities, other asset-backed securities, auction rate securities, and term deposits. Some of our investments may experience reduced liquidity due to changes in market conditions and investor demand. For the six months ended October&#160;30, 2020, the total impairment losses on available-for-sale debt securities were not significant. Based on our assessment of the credit quality of the underlying collateral and credit support available to each of the remaining securities in which we are invested, we believe we have recognized all necessary impairments as we do not have the intent to sell, nor is it more likely than not that we will be required to sell, before recovery of the amortized cost. At October&#160;30, 2020, we had $59 million of gross unrealized losses on our aggregate available-for-sale debt securities of $7.0 billion. If market conditions deteriorate, some of these holdings may experience impairments in the future, which could adversely affect our financial results. We are required to use estimates and assumptions in our valuation of investments, which requires a high degree of judgment, and therefore, actual results could differ materially from estimates. Refer to Note 6 to the current period's consolidated financial statements for additional information regarding fair value measurements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes our short-term and long-term debt ratings from S&amp;P and Moody's at both October&#160;30, 2020 and April&#160;24, 2020:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agency Rating</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard &amp; Poor's Ratings Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Short-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-1</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Moody's Investors Service</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Short-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P-2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P-2</span></td></tr></table></div><div style="margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)   Agency ratings are subject to change, and there may be no assurance that an agency will continue to provide ratings and/or maintain its current ratings. A security rating is not a recommendation to buy, sell or hold securities, and may be subject to revision or withdrawal at any time by the rating agency, and each rating should be evaluated independently of any other rating.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S&amp;P and Moody's long-term debt ratings and short-term debt ratings at October&#160;30, 2020 were unchanged as compared to the ratings at April&#160;24, 2020. We do not expect the S&amp;P and Moody's ratings to have a significant impact on our liquidity or future flexibility to access additional liquidity given our balance sheet and Credit Facility and related commercial paper program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have future contractual obligations and other minimum commercial commitments that are entered into in the normal course of business. We believe our off-balance sheet arrangements do not have a material current or anticipated future effect on our consolidated earnings, financial position, and/or cash flows. Refer to the "Off-Balance Sheet Arrangements and Long-Term Contractual Obligations" section of this Management's Discussion and Analysis for more information on these obligations and commitments. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 16 to the current period's consolidated financial statements provides information regarding amounts we have accrued related to legal matters. In accordance with U.S. GAAP, we record a liability in our consolidated financial statements for these matters when a loss is known or considered probable and the amount can be reasonably estimated. Actual settlements may be different than estimated and could have a material effect on our consolidated earnings, financial position, and/or cash flows.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record tax liabilities in our consolidated financial statements for amounts that we expect to repatriate from subsidiaries (to the extent the repatriation would be subject to tax); however, no tax liabilities are recorded for amounts that we consider to be permanently reinvested. We expect to have access to the majority of our cash flows in the future. In addition, we continue to evaluate our legal entity structure </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">supporting our business operations, and to the extent such evaluation results in a change to our overall business structure, we may be required to accrue for additional tax obligations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our balance sheet and liquidity provide us with flexibility, and that our cash, cash equivalents, and current investments, as well as our Credit Facility and related commercial paper program, will satisfy our foreseeable operating needs for at least the next 12 months.&#160;We regularly review our capital needs and consider various investing and financing alternatives to support our requirements.&#160;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements and Long-Term Contractual Obligations </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our off-balance sheet arrangements as reported in our most recent Annual Report filed on Form 10-K for the fiscal year ended April&#160;24, 2020. Refer to the Debt and Capital section above for changes in debt obligations during the second quarter of fiscal year 2021; there were no other material changes to our long-term contractual obligations as reported in our most recent Annual Report filed on Form 10-K for the fiscal year ended April&#160;24, 2020.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_166"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUPPLEMENTAL GUARANTOR FINANCIAL INFORMATION </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic plc and Medtronic Global Holdings S.C.A. (Medtronic Luxco), a wholly-owned subsidiary guarantor, each have provided full and unconditional guarantees of the obligations of Medtronic, Inc., a wholly-owned subsidiary issuer, under the Senior Notes (Medtronic Senior Notes) and full and unconditional guarantees of the obligations of Covidien International Finance S.A. (CIFSA), a wholly-owned subsidiary issuer, under the Senior Notes (CIFSA Senior Notes). The guarantees of the CIFSA Senior Notes are in addition to the guarantees of the CIFSA Senior Notes by Covidien Ltd. and Covidien Group Holdings Ltd., both of which are wholly-owned subsidiary guarantors of the CIFSA Senior Notes. Medtronic plc and Medtronic, Inc. each have provided a full and unconditional guarantee of the obligations of Medtronic Luxco under the Senior Notes (Medtronic Luxco Senior Notes). The following is a summary of these guarantees:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees of Medtronic Senior Notes</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Parent Company Guarantor - Medtronic plc</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Subsidiary Issuer - Medtronic, Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Subsidiary Guarantor - Medtronic Luxco</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees of Medtronic Luxco Senior Notes</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Parent Company Guarantor - Medtronic plc</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Subsidiary Issuer - Medtronic Luxco</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Subsidiary Guarantor - Medtronic, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees of CIFSA Senior Notes</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Parent Company Guarantor - Medtronic plc</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Subsidiary Issuer - CIFSA</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Subsidiary Guarantors - Medtronic Luxco, Covidien Ltd., and Covidien Group Holdings Ltd. (CIFSA Subsidiary Guarantors)</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present summarized results of operations for the six months ended October&#160;30, 2020 and summarized balance sheet information at October&#160;30, 2020 and April&#160;24, 2020 for the obligor groups of Medtronic and Medtronic Luxco Senior Notes, and CIFSA Senior Notes. The obligor group consists of the parent company guarantor, subsidiary issuer, and subsidiary guarantors for the applicable senior notes. The summarized financial information is presented after elimination of (i) intercompany transactions and balances among the guarantors and issuers and (ii) equity in earnings from and investments in any subsidiary that is a non-guarantor or issuer.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized results of operations information for the six months ended October&#160;30, 2020 was as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medtronic &amp; Medtronic Luxco Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CIFSA Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Medtronic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(865)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized balance sheet information at October&#160;30, 2020 was as follows:</span></div><div style="margin-bottom:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medtronic &amp; Medtronic Luxco Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CIFSA Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,895&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total noncurrent assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total noncurrent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Medtronic Senior Notes and Medtronic Luxco Senior Notes obligor group consists of the following entities: Medtronic plc, Medtronic Luxco, and Medtronic, Inc. Please refer to the guarantee summary above for further details.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The CIFSA Senior Notes obligor group consists of the following entities: Medtronic plc, Medtronic Luxco, CIFSA, and CIFSA Subsidiary Guarantors. Please refer to the guarantee summary above for further details.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes receivables due from non-guarantor subsidiaries of $16.6&#160;billion and $6.3&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes loans receivable due from non-guarantor subsidiaries of $6.5&#160;billion and $7.9&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes payables due to non-guarantor subsidiaries of $27.7&#160;billion and $12.4&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes loans payable due to non-guarantor subsidiaries of $27.4&#160;billion and $41.5&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized balance sheet information at April&#160;24, 2020 was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medtronic &amp; Medtronic Luxco Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CIFSA Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total noncurrent assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total noncurrent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Medtronic Senior Notes and Medtronic Luxco Senior Notes obligor group consists of the following entities: Medtronic plc, Medtronic Luxco, and Medtronic, Inc. Please refer to the guarantee summary above for further details.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The CIFSA Senior Notes obligor group consists of the following entities: Medtronic plc, Medtronic Luxco, CIFSA, and CIFSA Subsidiary Guarantors. Please refer to the guarantee summary above for further details.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes receivables due from non-guarantor subsidiaries of $19.1&#160;billion and $34&#160;million for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes loans receivable due from non-guarantor subsidiaries of $13.7&#160;billion and $15.0&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes payables due to non-guarantor subsidiaries of $37.0&#160;billion and $13.6&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes loans payable due to non-guarantor subsidiaries of $21.7&#160;billion and $37.9&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q, and other written reports and oral statements made by or with the approval of one of the Company&#8217;s executive officers from time to time, may include &#8220;forward-looking&#8221; statements. All statements other than statements of historical fact contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations and financial position, business strategy and plans, objectives of management for future operations and current expectations or forecasts of future results, are forward-looking statements. These statements involve known and unknown risks, uncertainties, and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Our forward-looking statements may include statements related to our growth and growth strategies, developments in the markets for our products, therapies and services, financial results, product development launches and effectiveness, research and development strategy, regulatory approvals, competitive strengths, the potential or anticipated direct or indirect impact of COVID-19 on our business, results of operations, and/or financial condition, restructuring and cost-saving initiatives, intellectual property rights, litigation and tax matters, governmental proceedings and investigations, mergers and acquisitions, divestitures, market acceptance of our products, therapies and services, accounting estimates, financing activities, ongoing contractual obligations, working capital adequacy, value of our investments, our effective tax rate, our expected returns to shareholders, and sales efforts. In some cases, such statements may be identified by the use of terminology such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;intend,&#8221; &#8220;looking ahead,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; and similar words or expressions. Forward-looking statements in this Quarterly Report include, but are not limited to, statements regarding our ability to drive long-term shareholder value, development and future launches of products and continued or future acceptance of products, therapies and services in our segments; expected timing for completion of research studies relating to our products; market positioning and performance of our products, including stabilization of certain product markets; divestitures and the potential benefits thereof; the costs and benefits of integrating previous acquisitions; anticipated timing for United States (U.S.) Food and Drug Administration (U.S. FDA) and non-U.S. regulatory approval of new products; increased presence in new markets, including markets outside the U.S.; changes in the market and our market share; acquisitions and investment initiatives, as well as integration of acquired companies into our operations; the resolution of tax matters; the effectiveness of our development activities in reducing patient care costs and hospital stay lengths; our approach towards cost containment; our expectations regarding healthcare costs, including potential changes to reimbursement policies and pricing pressures; our expectations regarding changes to patient standards of care; our ability to identify and maintain successful business partnerships; the elimination of certain positions or costs related to restructuring initiatives; outcomes in our litigation matters and governmental proceedings and investigations; general economic conditions; the adequacy of available working capital and our working capital needs; our payment of dividends and redemption of shares; the continued strength of our balance sheet and liquidity; our accounts receivable exposure; and the potential impact of our compliance with governmental regulations and accounting guidance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, results of operations, and/or cash flows. These forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q and are subject to a number of risks, uncertainties and assumptions described in the &#8220;Risk Factors&#8221; section and elsewhere in our Annual Report on Form 10-K. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. One must carefully consider forward-looking statements and understand that such forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and involve a variety of risks and uncertainties, known and unknown, including, among others, those discussed in the sections entitled &#8220;Government Regulation and Other Considerations&#8221; within &#8220;Item 1. Business&#8221; and &#8220;Item 1A. Risk Factors&#8221; in our Annual Report on Form 10-K, as well as those related to:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">the COVID-19 pandemic and the actions of businesses, communities, and governments in response; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">competition in the medical device industry;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">reduction or interruption in our supply;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">laws and governmental regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">quality problems;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">liquidity shortfalls;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">decreasing prices and pricing pressure;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">fluctuations in currency exchange rates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">changes in applicable tax rates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">positions taken by taxing authorities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">adverse regulatory action;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">delays in regulatory approvals;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">litigation results;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">self-insurance;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">commercial insurance;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">healthcare policy changes;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">international operations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">cybersecurity incidents;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">failure to complete or achieve the intended benefits of acquisitions or divestitures; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">disruption of our current plans and operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consequently, no forward-looking statement may be guaranteed, and actual results may vary materially from those projected in the forward-looking statements. We intend to take advantage of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 regarding our forward-looking statements and are including this sentence for the express purpose of enabling us to use the protections of the safe harbor with respect to all forward-looking statements. While we may elect to update these forward-looking statements at some point in the future, whether as a result of any new information, future events, or otherwise, we have no current intention of doing so except to the extent required by applicable law.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_172"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENCY EXCHANGE RATE RISK</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the global nature of our operations, we are exposed to currency exchange rate changes, which may cause fluctuations in earnings and cash flows. We use operational and economic hedges, including currency exchange rate derivative instruments to manage the impact of currency exchange rate fluctuations. In order to minimize earnings and cash flow volatility resulting from currency exchange rate fluctuations, we enter into derivative instruments, principally forward currency exchange rate contracts. These contracts are designed to hedge anticipated transactions in other currencies and changes in the value of specific assets and liabilities. At inception of the contract, the derivative instrument is designated as either a freestanding derivative or a cash flow hedge. Currencies of our derivative instruments include the Euro, Japanese Yen, Chinese Yuan, and others. Fluctuations in the currency exchange rates of currency exposures that are unhedged, such as in certain emerging markets, may result in future earnings and cash flow volatility. We do not enter into currency exchange rate derivative instruments for speculative purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross notional amount of all currency exchange rate derivative instruments outstanding at October&#160;30, 2020 and April&#160;24, 2020 was $18.5 billion and $11.9 billion, respectively. At October&#160;30, 2020, these contracts were in a net unrealized loss position of $116&#160;million. A sensitivity analysis of changes in the fair value of all currency exchange rate derivative contracts at October&#160;30, 2020 indicates that, if the U.S. dollar uniformly strengthened/weakened by 10 percent against all currencies, it would have the following impact on the fair value of these contracts:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.634%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10% appreciation in the U.S. dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10% depreciation in the U.S. dollar</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(864)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any gains and losses on the fair value of derivative contracts would generally be offset by gains and losses on the underlying transactions. These offsetting gains and losses are not reflected in the above analysis. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of fiscal year 2019, we began accounting for our operations in Argentina as highly inflationary, as the prior three-year cumulative inflation rate exceeded 100 percent. The change did not have a material impact on our results for the three months ended October&#160;30, 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEREST RATE RISK</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to interest rate risk on our short-term investments and our borrowings. We manage interest rate risk in the aggregate, while focusing on our immediate and intermediate liquidity needs. Our debt portfolio at October&#160;30, 2020 was comprised of debt predominately denominated in U.S. dollars, Euros, and Japanese Yen, of which substantially all is fixed rate debt. We are also exposed to interest rate changes affecting our investments in interest rate sensitive instruments, which include our marketable debt securities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A sensitivity analysis of the impact on our interest rate-sensitive financial instruments of a hypothetical 10 basis point change in interest rates, as compared to interest rates at October&#160;30, 2020, would have the following impact on the fair value of these instruments:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.634%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 basis point increase in interest rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 basis point decrease in interest rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of current market conditions and the impact on our financial condition and results of operations, please see the &#8220;Liquidity&#8221; section of the current period's Management's Discussion and Analysis. For additional discussion of market risk, refer to Notes 6 and 8 to the current period's consolidated financial statements.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_175"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) and changes in the Company&#8217;s internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this quarterly report, our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) are effective.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) under the Exchange Act) during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting. While there were no material changes in our internal control over financial reporting, we continue to monitor and assess the impact of the COVID-19 pandemic, which has resulted in many of our employees working remotely.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_178"></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8212; OTHER INFORMATION</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_181"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Securities and Exchange Commission issued an updated ruling regarding the threshold for disclosure of proceedings under environmental laws to which a governmental authority is a party. In accordance with this updated ruling, we have adopted a disclosure threshold of $1 million in such circumstances, as we believe matters under this threshold are not material to the Company. A discussion of the Company&#8217;s policies with respect to legal proceedings is included in the management&#8217;s discussion and analysis, and our legal proceedings and other loss contingencies are described in Note 16 to the current period's consolidated financial statements.</span></div><div id="i6128593e20e44bbc8b0671c482ec9b79_184"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuer Purchases of Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There were no shares repurchased by the Company during the second quarter of fiscal year 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_187"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.933%"><tr><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2021q210qxex311.htm">31</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2021q210qxex311.htm">.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2021q210qxex311.htm">1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2021q210qxex311.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2021q210qxex312.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2021q210qxex312.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2021q210qxex321.htm">32.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2021q210qxex321.htm">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2021q210qxex322.htm">32.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2021q210qxex322.htm">Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101-formofperformanc.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101-formofperformanc.htm">Form of</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101-formofperformanc.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101-formofperformanc.htm">Performance Share Unit Award Agreement</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101-formofperformanc.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101-formofperformanc.htm">under Amended and Restated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101-formofperformanc.htm">2013 Stoc</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101-formofperformanc.htm">k Award and In</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101-formofperformanc.htm">centive Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex102-amendedandrestat.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex102-amendedandrestat.htm">Amended and Restated Covidien Supplemental Savings and Retirement Plan (restated November 6, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">Medtronic Non-Qualified Retirement Plan Supplemental </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">restated N</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">ovember 6,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">, and form</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">er</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">ly known</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm"> as t</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">he </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">S</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">upplemental </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">Exec</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">utive Retirement Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex103-medtronicnonxqua.htm">)</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex104-medtroniccapital.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex104-medtroniccapital.htm">Medtronic Capital Accumulation Plan Deferral Program (restated November 6, 2020) </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i6128593e20e44bbc8b0671c482ec9b79_190"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.066%"><tr><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MEDTRONIC PUBLIC LIMITED COMPANY</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 3, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Geoffrey S. Martha</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geoffrey S. Martha</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 3, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Karen L. Parkhill</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karen L. Parkhill</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101-formofperformanc.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ia874a4e174df488c9023058acd57a4ea_37"></div><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="text-align:center;text-indent:14pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">These materials, which may include descriptions of company stock plans, prospectuses and other information and documents, and the information they contain, are provided by your company, not by Fidelity, and are not an offer or solicitation by Fidelity for the purchase of any securities or financial instruments.  These materials were prepared by your company, which is solely responsible for their contents and for compliance with legal and regulatory requirements.  Fidelity is not connected with any offering or acting as an underwriter in connection with any offering of your company's securities or financial instruments.  Fidelity does not review, approve or endorse the contents of these materials and is not responsible for their content.</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><div id="ia874a4e174df488c9023058acd57a4ea_40"></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">MEDTRONIC plc</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PERFORMANCE SHARE UNIT AWARD AGREEMENT </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDED AND RESTATED 2013 STOCK AWARD AND INCENTIVE PLAN</font></div><div><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58;</font></div><div><font><br></font></div><div><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee ID&#58;</font></div><div style="text-align:right"><font><br></font></div><div><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Client Grant ID&#58;</font></div><div><font><br></font></div><div><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Grant Date&#58;</font></div><div><font><br></font></div><div><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Grant Price&#58;</font></div><div><font><br></font></div><div><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Grant Type&#58;</font></div><div><font><br></font></div><div><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Target PERFORMANCE SHARE  UNITS&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Performance Period&#58;  FY2021 to FY2023 (&#8220;Performance Period&#8221;)</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:-2.15pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:-2.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt">Performance Share Unit Award.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   Medtronic plc, an Irish public limited company (&#8220;Medtronic&#8221; or the &#8220;Company&#8221;), hereby grants to the individual named above (&#8220;you&#8221;) an Award (the &#8220;Award&#8221;) consisting of Performance Share Units (&#8220;Performance Share Units&#8221;) in the target number (&#8220;Target Performance Share Units&#8221;) and on the Grant Date as each is set forth above.  The actual number of Performance Share Units that will be earned if the minimum performance threshold is achieved is illustrated in Section 2 below. Each Performance Share Unit represents the right to receive one ordinary share of the Company, par value $0.0001 per share (&#8220;Share&#8221;), subject to the restrictions, limitations, and conditions contained in this Performance Share Unit Award Agreement (the &#8220;Agreement&#8221;) and in the Medtronic plc Amended and Restated 2013 Stock Award and Incentive Plan (the &#8220;Plan&#8221;). In the event of any inconsistency between the terms of the Agreement and the Plan, the terms of the Plan shall govern.  Capitalized terms used but not defined shall have the meaning ascribed thereto in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:-2.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt">Performance Targets.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  The payout, if any, under this Award will be based on the following pre-established performance targets over the 3-year Performance Period&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:-2.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8.69pt">Company performance will be measured using three criteria&#58;  Revenue Growth  (&#8220;Revenue Growth&#8221;), Relative Total Shareholder Return (&#8220;Relative TSR&#8221;), and a 3-year Return on Invested Capital modifier (&#8220;ROIC Modifier&#8221;) as shown below.  The performance measures will be weighted as follows&#58;  Revenue Growth weighted 50.00%, Relative TSR weighted 50.00%. The ROIC Modifier may be applied to reduce (but not increase) the number of Performance Share Units that are paid out.  This means the number of Performance Share Units paid out may be greater than, equal to, or less than the target number of Performance </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13PVFW1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:-2.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Share Units awarded at grant due to actual performance relative to these performance measures.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.290%"><tr><td style="width:1.0%"></td><td style="width:25.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue Growth </font></div><div><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Performance Range</font></div></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8805;12%</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Payout Range</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">50%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">60%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">70%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">80%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">90%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">100%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">120%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">140%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">160%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">180%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">200%</font></td></tr></table></div><div style="padding-right:-2.15pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.290%"><tr><td style="width:1.0%"></td><td style="width:25.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.45pt"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Relative TSR</font></div><div style="padding-left:4.45pt"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Performance Range</font></div></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">25%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">30%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">35%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">40%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">45%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">50%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">55%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">60%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">65%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">70%</font></td><td colspan="3" style="background-color:#808080;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8805;75%</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Payout Range</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">50%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">60%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">70%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">80%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">90%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">100%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">120%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">140%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">160%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">180%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">200%</font></td></tr></table></div><div style="padding-right:-2.15pt;text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">FY2021 &#8211; FY2023 Return on Invested Capital (&#8220;ROIC&#8221;) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The ROIC Modifier will reduce the PSU Payout Factor by 30% if the 3-Fiscal Year ROIC does not meet a minimum of 10% for the FY2021-FY2023 Performance Period. </font></div><div><font><br></font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;padding-right:-2.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The tables above show the percentage of the Target Performance Share Units to be earned based on the actual Company performance against these three criteria over the FY2021 &#8211; FY2023 Performance Period.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:-9pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8.01pt">To determine payout, the percentage across the top of the grid is earned based on achievement of performance targets within the grid for each of the performance measures, multiplied by the weight.  Next, the ROIC Modifier is applied to determine the final number of earned Performance Share Units. To illustrate&#58;</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;padding-right:-9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i) if Company performance results in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue Growth of 7%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Relative TSR of 55%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ROIC of 10.0%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the % payout of Target Performance Share Units would be calculated as follows&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.358%"><tr><td style="width:1.0%"></td><td style="width:45.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Measure</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">% Award Earned</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Weight</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue Growth</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  x</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.00%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.00%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relative TSR</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120%  x</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.00%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.00%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Payout of Target Performance Share Units (Before ROIC Modifier)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.00%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROIC Modifier</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;30% Reduction if ROIC</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">target not achieved</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Reduction</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Payout of Target Performance Share Units (After ROIC Modifier)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.00%</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:49.5pt;padding-right:-9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ii) if Company performance results in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue Growth of 7%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Relative TSR of 55%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ROIC of 8.0%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the % payout of Target Performance Share Units would be calculated as follows&#58;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13PVFW1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.592%"><tr><td style="width:1.0%"></td><td style="width:44.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Measure</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">% Award Earned</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Weight</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue Growth</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  x</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.00%</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.00%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relative TSR</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120%  x</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.00%</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.00%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Payout of Target Performance Share Units (Before ROIC Modifier)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.00%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROIC Modifier</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30% Reduction if ROIC</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-0.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">target not achieved</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.00)%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Payout of Target Performance Share Units (After ROIC Modifier)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.00%</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:-2.15pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:-2.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt">Calculation of Revenue Growth, Relative TSR and the ROIC Modifier</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue Growth Performance Target</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Revenue Growth&#8221; is defined as Medtronic&#8217;s 3-year simple average annual organic revenue growth measured at constant currency.  Each fiscal year&#8217;s growth is measured independently and then averaged.  Organic Constant Currency growth excludes the 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> year of material acquisitions. </font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Relative TSR Performance Target</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Relative TSR&#8221; is defined as (end average share price x re-investment factor) -1 x 100 divided by the start average share price.  The re-investment factor equals the cumulative number of dividend shares divided by one share.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Return on Invested Capital Performance Modifier </font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Return on Invested Capital (&#8220;ROIC&#8221;) is defined as Non-GAAP Earnings as reported to Investors plus Interest Expense net of Tax, divided by Invested Capital for each year, averaged over the 3-year period.  &#8220;Invested Capital&#8221; is defined as Total Equity plus Net Debt (Short and Long-Term Debt) less Cash and Investments.  The ROIC modifier will reduce the PSU Payout Factor by 30% if the 3 Fiscal-Year ROIC does not meet a minimum of 10% for the FY2021-FY2023 PSU Performance Period.   The ROIC PSU Performance modifier cannot increase the PSU payout factor.   </font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt">Vesting &#38; Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Performance Share Units, to the extent earned based on attainment of the performance measures as determined by the Compensation Committee in accordance with Section 2 above, will fully vest on August 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, 2023, provided that you have not incurred a Termination of Employment during the period beginning on the Grant Date and ending on  August 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, 2023(the &#8220;Vesting Period&#8221;).  The Company will issue to you a number of Shares equal to the number of Performance Share Units that are earned (including any dividend equivalents described in Section 7, below) as soon as practicable following the end of the Vesting Period.  Notwithstanding the preceding sentence, if you incur a Termination of Employment during the Vesting Period as a result of your death, Disability or Retirement, you will remain entitled to receive a number of Shares equal to the number of Performance Share Units that are earned (including any dividend equivalents described in Section 7, below) based on actual performance over the 3fiscal-year Performance Period, as soon as practicable following the end of the Vesting Period.  Upon your Termination of Employment during the Vesting Period for any reason other than death, Disability or Retirement, the Performance Share Units will </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13PVFW1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">automatically be forfeited in full and canceled by the Company as of 11&#58;00 p.m. CT (midnight ET) on the date of such Termination of Employment.  For purposes of this Agreement, the terms &#8220;Disability&#8221; and &#8220;Retirement&#8221; shall have the meanings ascribed to those terms, as of the date of this Agreement, under any retirement plan of the Company which is qualified under Section 401 of the Code (which currently provides for retirement on or after age 55, provided you have been employed by the Company and&#47;or one or more Affiliates for at least ten years, or retirement on or after age 62), or under any disability or retirement plan of the Company or any Affiliate applicable to you due to employment by a non-U.S. Affiliate or employment in a non-U.S. location.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If you have received or are entitled to receive delivery of Shares as a result of this Agreement within the period beginning six months prior to the date of your Termination of Employment and ending twelve months following the date of your Termination of Employment, the Company, in its sole discretion, may require you to return or forfeit the cash and&#47;or Shares received or receivable with respect to this Performance Share Unit Award, in the event that you engage in any of the following activities&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.68pt">performing services for or on behalf of any competitor of, or competing with, the Company or any Affiliate, within six months of the date of your Termination of Employment&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">unauthorized disclosure of material proprietary information of the Company or any Affiliate&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.68pt">a violation of applicable business ethics policies or business policies of the Company or any Affiliate&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">any other occurrence determined by the Committee.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#8217;s right to require forfeiture must be exercised not later than 90 days after the Company acquires actual knowledge of such an activity but in no event later than twelve months after your Termination of Employment. Such right shall be deemed to be exercised upon the Company&#8217;s mailing written notice of such exercise to your most recent home address as shown on the personnel records of the Company. In addition to requiring forfeiture as described herein, the Company may exercise its rights under this Section 5 by terminating the Performance Share Units awarded under this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you fail or refuse to forfeit the cash and&#47;or shares of Common Stock demanded by the Company (the number of such shares of Common Stock as may be adjusted for any events described in Section 3.4 of the Plan), you shall be liable to the Company for damages equal to the number of Shares demanded times the highest closing price per share of the Common Stock during the period between the date of your Termination of Employment and the date of any judgment or award to the Company, together with all costs and attorneys&#8217; fees incurred by the Company to enforce this provision.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13PVFW1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this Section 5, forfeiture of Common Stock shall be effected by the redemption of such Common Stock in accordance with the Articles of Association of the Company and to the extent permissible under applicable law.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, this Section 5 shall have no application following a Change of Control, nor shall the Company&#8217;s Incentive Compensation Forfeiture Policy apply following a Change of Control to the Performance Share Units awarded pursuant to this Agreement or to any proceeds in respect of such Award.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:-2.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt">Change of Control. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything in Section 4 of this Agreement to the contrary, if a Change of Control of the Company occurs during the Vesting Period, then the Performance Share Units will become 100% vested upon such Change of Control, and the Company will issue to you a number of Shares equal to the Target Performance Share Units (including any dividend equivalents described in Section 7, below) within six weeks following the Change of Control (unless such Change of Control is not an event described in Section 409A(a)(2)(A)(v) of the Code and the regulations thereunder (a &#8220;Section 409A Change of Control&#8221;), in which case such settlement shall be delayed until the Delayed Payment Date (as defined below)), provided that no such vesting or issuance shall occur if the Performance Share Units are replaced or continued by a Replacement Award that satisfies the requirements of Section 10.1(b) of the Plan. In the event that the Performance Share Units are replaced by a Replacement Award and you incur a Termination of Employment during the two years following a Change of Control by the Company without Cause or by you for Good Reason, such Replacement Award shall vest in full and be settled on the Delayed Payment Date. For purposes of this Agreement, the Delayed Payment Date means the first to occur of&#58; (i) the date on which you incur a &#8220;separation from service&#8221; (within the meaning of Section 409A of the Code), or, if you are a &#8220;specified employee&#8221; (within the meaning of Section 409A(a)(2)(B)(i) of the Code) at the time of such &#8220;separation from service,&#8221; on the date that is six months following the date of your &#8220;separation from service&#8221;&#59; (ii) the originally scheduled vesting date for the applicable Performance Share Units&#59; (iii) the date of your death&#59; and (iv) the date of a Section 409A Change of Control.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:-2.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt">Dividend Equivalents. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You are entitled to receive dividend equivalents on the Performance Share Units generally in the same manner and at the same time as if each Performance Share Unit were a Share. These dividend equivalents will be credited to you in the form of additional Performance Share Units. The additional Performance Share Units will be subject to the terms of this Agreement.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:-2.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt">Withhold Taxes. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You are responsible to promptly pay any Social Security and Medicare taxes (together, &#8220;FICA&#8221;) due upon vesting of the Performance Share Units, and any Federal, State, and local taxes due upon distribution of the Shares. The Company and its Subsidiaries are authorized to deduct from any payment to you any such taxes required to be withheld. As described in Section 15.4 of the Plan and to the extent permissible under applicable law, you may elect to have the Company withhold a portion of the Shares issued upon settlement of the Performance Share Units to satisfy all or part of the withholding tax requirements. You may also elect, at the time you vest in the Performance Share Units, to pay your FICA liability due with respect to those Performance Share Units out of those units. If you choose to do so, the Company will reduce the number of your vested Performance Share Units accordingly. The amount that is applied to pay FICA will be subject to Federal, State, and local taxes.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13PVFW1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:-2.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt">Limitation of Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as set forth in the Agreement, until the Shares are issued to you in settlement of your Performance Share Units, you do not have any right in, or with respect to, any Shares (including any voting rights) by reason of this Agreement. Further, you may not transfer or assign your rights under the Agreement and you do not have any rights in the Company&#8217;s assets that are superior to a general, unsecured creditor of the Company by reason of this Agreement.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:-2.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:3pt">No Employment Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Nothing contained in the Plan or Agreement creates any right to your continued employment or otherwise affects your status as an employee at will. You hereby acknowledge that the Company and you each have the right to terminate your employment at any time for any reason or for no reason at all.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:-2.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:3pt">Amendment to Agreement Under Section 409A of the Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. You acknowledge that the Agreement and the Plan, or portions thereof, may be subject to Section 409A of the Code, and that changes may need to be made to the Agreement to avoid adverse tax consequences under Section 409A of the Code. You agree that following the issuance of such rules, the Company may amend this Agreement as it deems necessary or desirable to avoid such adverse tax consequences&#59; provided, however, that the Company shall accomplish such amendments in a manner that preserves your intended benefits under the Agreement to the greatest extent possible.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:-2.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:3pt">Governing Law, Venue and Personal Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding anything contrary in the Plan, the validity, enforceability, construction and interpretation of the Plan or Agreement shall be governed by the laws of the State of Minnesota.  You irrevocably waive any right to have the laws of any state or nation or other legal jurisdiction other than the State of Minnesota apply to the Plan or Agreement. Any dispute regarding the Plan or Agreement shall be exclusively decided by a state court in the State of Minnesota, and you irrevocably waive any right to have any such disputes decided in any jurisdiction or venue other than a state court in the State of Minnesota.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You irrevocably consent to the personal jurisdiction of the state courts in the State of Minnesota for the purposes of any action arising out of or related to the Plan or Agreement, and irrevocably waive any right to remove any case commenced by Medtronic from a state court in the State of Minnesota to any federal court.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:-2.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:3pt">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. You agree to be bound by the terms and conditions of this Agreement and the Plan. Your signature is not required in order to make this Agreement effective.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13PVFW1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic Stock Administration</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic plc</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c&#47;o Medtronic, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">800 53rd Ave NE #SLK32</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Minneapolis, MN 55432</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">askhr&#64;medtronic.com</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">888-422-1500</font></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13PVFW1</font></div></div></div><div id="ia874a4e174df488c9023058acd57a4ea_43"></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MEDTRONIC PLC </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDED AND RESTATED 2013 STOCK AWARD AND INCENTIVE PLAN SUMMARY</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><img alt="image_01a.jpg" src="image_01a.jpg" style="height:64px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. Headquarters</font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Medtronic plc</font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c&#47;o Medtronic, Inc. </font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">710 Medtronic Parkway</font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Minneapolis, MN 55432-5604</font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">USA</font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Internet&#58; www.medtronic.com</font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Telephone&#58; (763) 514-4000</font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">FAX&#58; (763) 514-4879</font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#169; Medtronic plc 2015</font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All Rights Reserved</font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Printed in USA</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">December 8, 2017</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This document constitutes part of a prospectus covering ordinary shares of Medtronic plc (&#34;Medtronic&#34; or the &#34;Company&#34;) that have been registered under the Securities Act of 1933, as amended. Medtronic's ordinary shares are listed on the New York Stock Exchange (symbol&#58; MDT).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No person is authorized to give any information or to make any representations, other than those contained in this prospectus, in connection with the offering described in this prospectus, and, if given or made, such information or representations must not be relied upon.  This prospectus does not constitute an offer of any securities other than those to which it relates, or an offer to sell, or a solicitation of an offer to buy, any securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.  Neither the delivery of this prospectus nor any sales made hereunder will, under any circumstances, create any implication that there has been no change in the affairs of the Company or its subsidiaries since the date of this prospectus.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Additional information concerning the Company, including information regarding how you may obtain an electronic version or paper copy of the Company's Annual Report to Shareholders for the most recent fiscal year, appears in &#34;Additional Information About Medtronic&#34; at the end of this prospectus.  </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ABOUT THIS PROSPECTUS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">It's Only a Summary</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This prospectus includes information to enable you to understand basic information about the Amended and Restated 2013 Stock Award and Incentive Plan (the &#34;Plan&#34;) and the types of awards that may be granted under the Plan&#58; non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units, other stock awards (unrestricted stock, dividend equivalents, deferred units and convertible debentures), performance-based restricted stock, performance units, and performance cash awards.  However, it is important to remember that this prospectus is only a Summary and provides only general information.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This prospectus serves as a prospectus, as well as a Plan Summary. A prospectus is required by the U.S. Securities and Exchange Commission, or the SEC, whenever securities are offered for sale to a large group of potential buyers. The securities to which this prospectus relates were registered pursuant to a registration statement filed with the SEC on Form S-8 and consist of a number of ordinary shares as set forth below in the section &#34;Overview of the Plan &#8211; Stock Offered Under the Plan.&#34; This prospectus omits certain information contained in the registration statement, and reference is hereby made to the registration statement and related exhibits for further information about Medtronic. Statements contained in this prospectus concerning the provisions of any document are not necessarily complete and, in each instance, reference is made to the copy of such document filed as an exhibit to the registration statement or otherwise filed with the SEC. Each such statement is qualified in its entirety by such reference. See &#34;Additional Information About Medtronic&#34; at the end of this prospectus for directions on how to obtain or access other information.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Read the Entire Prospectus</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">It is important that you read the entire prospectus.  Reading only portions can be confusing and misleading.  </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Additional Information About the Plan</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You can obtain a copy of the Plan document electronically by accessing the Shareholder Resources intranet website at http&#58;&#47;&#47;legalsite&#47;shareholder&#47;default.aspx.  Once there, click on &#34;Amended and Restated 2013 Stock Award and Incentive Plan&#34; from among the choices offered under the &#34;Stock Awards&#34; section.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Please direct any questions regarding the Plan to your Human Resources Representative or to HROC - Stock Administration, Medtronic plc, c&#47;o Medtronic, Inc., 710 Medtronic Parkway NE, MS LS195, Minneapolis, MN 55432-5604 or telephone 763.514.1500.  You can also obtain a paper copy of the Plan document by calling HROC &#8211; Stock Administration or emailing rs.stockadmin&#64;medtronic.com.</font></div><div><font><br></font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I.&#160;&#160;&#160;&#160;OVERVIEW OF THE PLAN</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">II.&#160;&#160;&#160;&#160;STOCK OPTIONS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">III.&#160;&#160;&#160;&#160;STOCK APPRECIATION RIGHTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IV.&#160;&#160;&#160;&#160;RESTRICTED STOCK AWARDS AND RESTRICTED STOCK UNITS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">V.&#160;&#160;&#160;&#160;OTHER STOCK-BASED AWARDS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">VI.&#160;&#160;&#160;&#160;PERFORMANCE-BASED AWARDS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">VII.&#160;&#160;&#160;&#160;ADDITIONAL INFORMATION ABOUT MEDTRONIC</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><div id="ia874a4e174df488c9023058acd57a4ea_46"></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:28.34pt">OVERVIEW OF THE PLAN</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Purpose.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic believes that stock-based compensation programs are a key element in achieving continued financial and operational success. The purpose of the Plan is to give Medtronic a competitive advantage in attracting, retaining, and motivating officers, employees, directors, and consultants, to provide the ability for Medtronic to provide such individuals with financial rewards that are intended to be deductible to the maximum extent possible as &#34;performance-based compensation&#34; within the meaning of Section&#160;162(m) of the Internal Revenue Code (&#34;Section 162(m)&#34;), and to provide Medtronic with an incentive plan that gives officers, employees, directors, and consultants financial incentives directly linked to shareholder value.  Medtronic does not intend for any awards to be subject to any provisions of the Employee Retirement Income Security Act of 1974, as amended, nor is the Plan a qualified plan within the meaning of Section 401(a) of the Code.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Eligible Plan Participants.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All directors, officers, and employees of Medtronic are eligible to receive awards under the Plan.  Consultants who provide services to Medtronic are also eligible to receive awards under the Plan.  Finally, individuals who have accepted offers of employment or consultancy from Medtronic are eligible to receive awards under the Plan, although no grant to such an individual will be effective prior to the date on which the individual's employment or consultancy commences. When we talk about employment with or providing services to Medtronic in this Summary, we include Medtronic subsidiaries.  In addition, awards under the Plan offer you the opportunity to share in Medtronic's success -- a success that you have a role in creating. You should be aware that neither Medtronic nor anyone else can guarantee the future value of Medtronic's shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Types of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Summary describes in detail the types of awards under the Plan, which includes non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units, other stock awards (unrestricted stock, dividend equivalents, deferred units and convertible debentures), performance-based restricted stock, performance units, and performance cash awards.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Stock Offered Under the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  The stock Medtronic offers under the Plan is Medtronic's ordinary shares, par value $0.0001 per share.  As of the date of this Summary, the maximum number of shares that may be issued pursuant to awards granted under the Plan is the sum of (i) 50,000,000 shares, (ii) any shares which are available for grant as of December 8, 2017 under the Plan and (iii) any shares relating to the Plan or certain predecessor plans which become available for grants under the Plan following December 8, 2017.  The maximum number of shares that may be issued pursuant to options intended to be incentive stock options is 50,000,000.  For the purposes of calculating the number of shares issued under the Plan, Medtronic will count each share subject to a stock option or stock appreciation right as one share, but each share issued pursuant to any other award as three shares.   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Limits on Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  For the purposes of calculating share amounts for any individual recipient, Medtronic will count each share issued pursuant to any award as one share.  No individual participant may be granted (a) options or stock appreciation rights under the Plan relating to more than 2,000,000&#160;shares during any fiscal year and (b) awards other than options or stock appreciation rights relating to more than 2,000,000 shares under the Plan during any fiscal year.  Any shares </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">subject to any terminated, expired or forfeited award do not count towards the share limits.  In addition, the Plan authorizes the granting of awards entitling a participant to payment of cash amounts subject to the attainment of certain performance goals established in accordance with the requirements of Section&#160;162(m).  Medtronic refers to such awards as &#34;performance cash awards.&#34; No individual participant may be paid more than $10,000,000 ($20,000,000 in the case of Medtronic's Chief Executive Officer) in respect of such awards during any fiscal year, including any amounts earned during such fiscal year and deferred.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Plan is administered by a committee selected by Medtronic's Board of Directors and composed of two or more directors (the &#34;Committee&#34;). Each Committee member is a non-employee director as defined under federal securities law and an outside director as defined by regulations promulgated under Section&#160;162(m).  Unless otherwise determined by the Board of Directors, Medtronic's Compensation Committee administers the Plan.  The Compensation Committee consists of members of the Board who satisfy the independence requirements of the New York Stock Exchange, as such requirements are interpreted by the Board in its business judgment.  Board members are elected annually for a one-year term and until their successors are elected and qualified, and Compensation Committee members are appointed by the Board and serve until their successors are appointed and qualified.   </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Committee has broad power to make awards under the Plan, including determining eligibility for participation, establishing performance goals for each participant, determining the types of awards to be granted to participants, and interpreting the terms and provisions of the Plan and any award.  The Committee may delegate its responsibilities and Medtronic's full Board of Directors may exercise any of the Committee's powers and responsibilities.  However, the Committee may not delegate any of its powers or responsibilities, and the full Board of Directors may not exercise any of those powers or responsibilities, to the extent that those actions would cause an award that is intended to be exempt from the limits on deductibility under Section&#160;162(m) to lose that exemption or would cause an award to a director or executive officer to fail to be exempt from short-swing profit recovery under Section&#160;16(b) of the Exchange Act.  Different or additional provisions from those generally described in this prospectus may be applied to certain awards, especially those granted to non-U.S. participants.  You are encouraged to review your award agreement carefully. By accepting an award under the Plan, you acknowledge that all decisions of the Committee will be final and binding on you, your beneficiaries and any other person having a claim or interest in the award.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic pays all costs of administering the Plan.  The Medtronic shares distributed under the Plan will be newly issued shares and no fees, brokerage commissions or other charges are added.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Information About Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employees may get information about the status of their outstanding awards from the third party provider, Fidelity, by calling 800-544-9354 (from the U.S.) or by viewing the following website www.netbenefits.com.  Outside the U.S., you may access a toll-free number, which is listed by country on the following website&#58; Fidelity.com&#47;globalcall.  You may also get information about the status of any other award(s) you may have received under the Plan from Medtronic HROC &#8211; Stock Administration by calling 763.514.1500.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Restrictions on Sale or Transfer of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Except for restricted stock, you may generally sell or transfer Medtronic shares you receive upon exercise of options granted under the Plan any time after you receive them.  However, if you possess material nonpublic information about Medtronic, you may not sell Medtronic shares until after such information is disclosed to the investing public.  In addition, if you are a member of Medtronic's board of directors or an executive officer of Medtronic, you are subject to special rules restricting your transactions imposed by Section 16(b) of the Securities Exchange Act and Rule 144, as amended, and Medtronic's Insider Trading Policy.  Further, if you are on a &#34;blackout&#34; list established by Medtronic, you may be subject to restrictions on your transactions during a &#34;blackout&#34; period.  If you have any questions in this regard, you should contact Sarah Maveus at 1.763.505.2951.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Tax Considerations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Awards made under the Plan generally may result in an immediate taxable event to you if you are a U.S. taxpayer.  We have outlined the federal tax consequences for U.S. employees for various awards on the following pages under &#34;Tax Considerations.&#34;  Please review these carefully.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Because U.S. federal tax laws can be very complex, the tax discussions in this Summary are necessarily very general in nature.  These tax laws may change, and their application may vary depending on individual circumstances. You should also be aware of and refer to any state or local tax laws that apply to you.  We recommend that you consult your own tax advisor about how the tax laws apply to your particular situation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you are a non-U.S. employee, you should </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">always</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> consult with your local tax advisor regarding the tax consequences of every award you receive.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Withholding Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may withhold from certain awards, including grants of restricted stock in which you have made a Section 83(b) election, or upon exercise of a non-qualified stock option or stock appreciation right or settlement of a restricted stock unit award, an amount sufficient to cover any required withholding taxes.  You may pay these taxes by check or, to the extent legally permissible, cover withholding obligations through a reduction in the number of shares to be delivered to you.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you are an executive officer, the use of stock to satisfy your tax withholding obligation is subject to the restrictions and reporting requirements of Section 16 of the Securities Exchange Act of 1934, as amended.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Acceleration of Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An award agreement may provide for accelerated performance periods, vesting of awards and expiration of applicable restrictions under various circumstances, including a change of control of Medtronic, or if your employment with Medtronic ends because of your death, disability or retirement.  Under many award agreements, &#34;disability&#34; means you would be considered disabled under any Medtronic qualified retirement plan.  &#34;Retirement&#34; generally means retirement on or after age 55 if you have been employed by Medtronic and&#47;or one of its subsidiaries for at least ten years, or retirement on or after age 62.  Different rules may apply to non-U.S. participants, and the Committee may establish different definitions from time to time.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Unless otherwise provided in an award agreement, upon a change of control (as defined in the Plan), each award granted under the Plan will immediately vest in full and become </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">exercisable and transferable unless the award is replaced by a qualifying replacement award that satisfies certain conditions set forth in the Plan. (We refer to awards that replace awards under the Plan following a change of control as &#34;replacement awards,&#34; and those being replaced as &#34;replaced awards.&#34;)  In the case of performance awards, awards that are not replaced will be deemed to be earned and payable, adjusted pro rata for the amount of the performance period that has elapsed as of the date of the change of control, based on the greater of the applicable target level or the level of achievement of the applicable performance goals through the date of the change of control. In the event that the awards are replaced and, within two years following the Change of Control, your employment is terminated by the Company without Cause or by you for Good Reason (each as defined in the Plan), your replacement awards will vest, be free of restrictions and be deemed to be earned and payable in full, and all options and stock appreciation rights will remain exercisable for three years following the Change of Control (or for their full term, if shorter) unless your award agreement provides for a longer period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Transferability of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  You may not transfer any award under the Plan, except for two situations.  First, an award may be transferred to your beneficiary or legal representative if you die or become legally incompetent.  Second, certain assignments or transfers may be permitted by an applicable award or the Committee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Duration of and Changes to the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Plan will remain in effect until the tenth anniversary of the effective date of the Plan, which effective date is December 8, 2017.  No awards may be granted after the tenth anniversary of the effective date of the Plan.  The Medtronic Board may amend, alter or discontinue the Plan at any time, but any such action may not adversely affect your rights under an award already outstanding unless you agree to the action, except such an amendment made to comply with applicable law, including, without limitation, Section&#160;409A of the Code or stock exchange rules.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Forfeitures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to applicable law, all awards under this Plan are subject to forfeiture or other penalties pursuant (a)&#160;to the Company's Incentive Compensation Forfeiture Policy, as amended from time to time, and (b)&#160;such other forfeiture and&#47;or penalty conditions and provisions as determined by the Committee and set forth in the applicable award agreement.  We may require you to forfeit any stock or cash received as the result of a Plan award if, within six months prior to or twelve months following the date of termination of employment, you&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">compete with Medtronic, including working for a competitor of Medtronic&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">disclose Medtronic's proprietary information without permission&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">violate Medtronic's business or ethics policies&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">cause any other occurrence determined by the Compensation Committee of the Board of Directors to require forfeiture.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an increase or decrease in the number of shares occurs because of a stock dividend, stock split, reverse stock split or any other increase or decrease in the number of shares, the Committee will adjust the number of shares reserved for issuance under the Plan, the number of shares covered by each award and the price per share to reflect such change, as the Committee deems appropriate.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:23.68pt">STOCK OPTIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">General Description</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  The Plan enables the Committee to grant options to purchase our shares at specified exercise prices to participants. Options may be granted as &#34;incentive stock options,&#34; which are intended to qualify for favorable tax treatment under federal tax law, or &#34;nonqualified stock options,&#34; which are not intended to receive such favorable treatment.  Under the Plan, the Committee determines the number of options to be granted to you. Unless otherwise determined by the Committee, each option grant is evidenced by a stock option agreement that specifies the option exercise price, whether the options are intended to be &#34;incentive stock options&#34; or &#34;nonqualified stock options,&#34; the duration of the options, the number of shares underlying the options, and any additional terms determined by the Committee. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A stock option entitles you to purchase Medtronic shares, after any vesting requirements are met, at the exercise (purchase) price specified in the stock option agreement.  The exercise price in all cases is at least 100% of the fair market value of a Medtronic shares on the date the option is granted.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">When an Option May Be Exercised</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Generally, options are subject to vesting during a period of at least one year following the date of grant. This minimum vesting period will not apply&#58; (a) to awards made in payment of earned performance-based awards and other earned cash-based incentive compensation&#59; (b) upon a termination of employment due to death, disability or retirement&#59; (c) upon a change of control&#59; (d) to a substitute award that does not reduce the vesting period of the award being replaced&#59; or (e) to awards involving an aggregate number of shares not in excess of five percent of the shares available for grant as options or free-standing stock appreciation rights.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You must fulfill the conditions set forth in the Plan and your stock option agreement before exercising your option.  The terms of individual awards may vary.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the United States, a stock option grant will normally expire in 10 years, assuming your employment with Medtronic continues.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Because the terms of option awards may vary, especially those granted to non-U.S. participants, you should review carefully the specific terms of your stock option agreement, which may differ from the terms described in this prospectus.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">How to Exercise Your Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  When you exercise your option, you utilize your right to purchase a specified number of Medtronic shares at the predetermined exercise price.  You must pay the full purchase price (the predetermined option exercise price times the number of option shares) plus any taxes required to be withheld at the time of exercise.  To the extent permitted by law, your stock option purchase price can be paid in one of the following ways&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">You may provide a certified or bank check or provide another payment instrument acceptable to Medtronic for the full purchase price of the stock option and an amount equal to any federal, state, local and&#47;or foreign withholding taxes.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">You may swap unrestricted Medtronic shares you already own that are equal in value to the full purchase price of the option and an amount equal to any federal, state, local and&#47;or foreign withholding taxes (a &#34;swap exercise&#34;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that, in the case of an Incentive Stock Option, this can only be authorized at the time the option is granted. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">To the extent permitted by applicable law, you may deliver a properly executed exercise notice to Medtronic or its designated administrator, together with a copy of irrevocable instructions to a broker to deliver promptly to Medtronic the amount of sale or loan proceeds </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">necessary to pay the purchase price, and an amount equal to any federal, state, local, and&#47;or foreign withholding taxes. To facilitate the foregoing, Medtronic may, to the extent permitted by applicable law, enter into agreements for coordinated procedures with one or more brokerage firms.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">You may instruct the Company's broker to withhold a number of shares having a fair market value (based on the fair market value of Medtronic shares on the date the applicable option is exercised) equal to the product of (i) the exercise price multiplied by (ii) the number of shares in respect of which the option shall have been exercised and an amount equal to any federal, state, local and&#47;or foreign withholding taxes (a &#34;cashless exercise&#34;).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Special procedures must be followed which are outlined in the option exercise form.  Certain non-U.S. awards may have fewer payment options than those outlined above.  You are encouraged to review your award carefully for your payment options. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To exercise your option, please contact the third party stock option service provider, Fidelity, by calling 800-544-9354 (from the U.S.).  Outside the U.S., you may access a toll-free number, which is listed by country on the following website&#58; Fidelity.com&#47;globalcall.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">When Your Employment Ends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Most stock option agreements provide that, if your employment with Medtronic ends because of death, disability or retirement, your outstanding options will become fully vested and exercisable and will remain exercisable for five years after your employment ends.  If your option award expires before the end of this five-year period, the option will remain exercisable only until its expiration date.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Most stock option agreements also provide that, if your employment with Medtronic ends for any other reason, the vested but unexercised portion may be exercised for 90 days after the date your employment ends and will terminate after that 90 day period, and the unvested portion will terminate on the date your employment ends.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Conversion to Stock-Settled Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Most stock option agreements provide that Medtronic has the option of converting your non-qualified stock option into a stock-settled stock appreciation right.  If your option is converted, upon exercise of the stock appreciation right, you would receive shares with a value equal to the excess of (1) the fair market value of the shares on the date of exercise over (2) the option price per share multiplied by the number of shares.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Tax Considerations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Tax consequences vary from country to country.  Under current U.S. federal tax laws, you owe no tax at the time you receive a non-qualified stock option award.  However, when you exercise a non-qualified stock option, ordinary income taxes are due on the difference between the market price of the Medtronic shares subject to the option on the date of exercise and the option exercise price of those shares, and Medtronic will generally be entitled to a corresponding tax deduction at that time.  If you later sell the shares, any additional gain or loss you experience generally will be taxed as a capital gain or loss if the required holding period is met.  Because tax requirements can change, and because this brief discussion doesn't address, among other things, the tax laws of states, localities and other countries, you should consult your tax advisor for information about your individual tax situation.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For incentive stock options, you will not recognize taxable income at the time of a grant.  You will also not recognize taxable income (except for purposes of the alternative minimum tax) upon exercise of an incentive stock option. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the shares acquired by exercise of an incentive stock option are held for the longer of (1)&#160;two years from the date the option was granted and (2)&#160;one year from the date the shares were purchased, any gain or loss arising from disposition of those shares, based on the excess of the amount realized upon the disposition over the original exercise price, will be taxed as a long term capital gain or loss, and Medtronic will not be entitled to any deduction. If, however, your shares are not held for these periods, then in the year of disposition you will recognize compensation taxable as ordinary income equal to the excess of the fair market value of such shares on the exercise date less the exercise price.  Medtronic generally will be entitled to a corresponding deduction at that time.  The excess of any amount realized in the disposition over the fair market value of the stock on the exercise date will be treated as a capital gain. If the amount realized upon disposition of the stock is less than the value at exercise, the amount you will recognize as ordinary income will be equal to the fair market value of the stock at the date of exercise less the exercise price of the stock. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.02pt">STOCK APPRECIATION RIGHTS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">General Description</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Plan enables the Committee to grant awards of stock appreciation rights to you. A stock appreciation right entitles you to receive, upon exercise, an amount equal to the excess, if any, of the fair market value of a Medtronic share over the exercise price of the stock appreciation right. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Plan provides that the Committee may determine the exercise price of any stock appreciation right, but (except in limited circumstances involving awards assumed in certain corporate transactions) the exercise price cannot be less than the fair market value of a Medtronic share on the date the stock appreciation right is granted. Under the Plan, Medtronic is able to grant &#34;tandem SARs,&#34; which are stock appreciation rights granted in conjunction with an option, and &#34;free-standing SARs,&#34; which are stock appreciation rights not granted in conjunction with an option. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A &#34;tandem SAR&#34; may be granted on the same date as the related option, will be exercisable only at the time the related option is exercisable, and will have the same exercise price as the related option. When the related option is exercised or forfeited, the &#34;tandem SAR&#34; will terminate or be forfeited&#59; and when the &#34;tandem SAR&#34; is exercised or forfeited, the related option will similarly terminate or be forfeited. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Vesting and Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Generally, stock appreciation rights will be subject to vesting during a period of at least one year following the date of grant.  This minimum vesting period will not apply&#58; (a) to awards made in payment of earned performance-based awards and other earned cash-based incentive compensation&#59; (b) upon a termination of employment due to death, disability or retirement&#59; (c) upon a change of control&#59; (d) to a substitute award that does not reduce the vesting period of the award being replaced&#59; or (e) to awards involving an aggregate number of shares not in excess of five percent of the shares available for grant as options or free-standing stock appreciation rights. Stock appreciation rights issued under the Plan will not be transferable except by will or the laws of descent, except for &#34;free-standing SARs,&#34; which will be transferable on terms set by the Committee.   </font></div><div style="text-align:justify"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Tax Considerations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  You will not recognize taxable income at the time of a grant of a stock appreciation right, and Medtronic will not be entitled to a tax deduction at that time. Upon exercise, however, you will recognize compensation taxable as ordinary income (and subject to income tax withholding) equal to the fair market value of any shares delivered and the amount of cash paid by Medtronic in settlement of the rights, and Medtronic will generally be entitled to a corresponding deduction at that time. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">RESTRICTED STOCK AWARDS AND RESTRICTED STOCK UNITS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">General Description</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  A restricted stock award entitles you to receive Medtronic shares that you cannot sell or otherwise transfer during the restricted period set forth in your award agreement.  The shares comprising a restricted stock award will be forfeited if you do not remain employed by Medtronic throughout the restricted period.  The Committee may also impose other conditions on any restricted stock award, including performance goals. Medtronic refers to awards of restricted stock subject to conditions on grant, transferability, or vesting based on the satisfaction of performance goals as &#34;performance-based restricted stock.&#34; If conditions are not satisfied during the restricted period, you will forfeit the award.  If you remain employed by Medtronic throughout the restricted period, and if all other conditions imposed on your award are satisfied, including any performance goals and&#47;or time-based requirements, your award will vest and the transfer restrictions will lapse as of the last day of the restricted period.  The restricted period is typically at least three years, although a vesting period of at least one year is permissible for performance-based restricted stock.  An award of restricted stock may, however, vest in part on a pro rata basis before the expiration of any restricted period.  These minimum vesting periods will not apply&#58; (a) to awards made in payment of earned performance-based awards and other earned cash-based incentive compensation&#59; (b) upon a termination of employment due to death, disability or retirement&#59; (c) upon a change of control&#59; (d) to a substitute award that does not reduce the vesting period of the award being replaced&#59; or (e) to awards involving an aggregate number of shares not in excess of five percent of shares available for grant as restricted stock (together with all other shares available for grant as awards other than options and stock appreciation rights).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the restricted period you enjoy important rights as a Medtronic shareholder.  Dividends are paid to you on the shares covered by the award (except with respect to performance-based restricted stock where the applicable goals have not yet been attained and the award has not yet vested), you have voting rights, and shareholder communications are distributed to you.  During the restricted period set by the Committee with respect to restricted stock, however, you may not sell, transfer, pledge, exchange, or otherwise encumber shares of unvested restricted stock.  During the restricted period, Medtronic will maintain custody of the unvested shares.  When your award vests, the shares will be delivered to you.  You may generally dispose of shares acquired pursuant to a restricted stock award at any time after the award vests.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A restricted stock unit award entitles you to a specified number of hypothetical Medtronic shares.  Restricted stock units may be subject to conditions on grant or vesting based on your continued service, conditions based on the satisfaction of performance goals, or both. Medtronic refers to awards of restricted stock units subject to conditions on grant or vesting based on the satisfaction of performance goals as &#34;performance units.&#34; </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Generally, any award of restricted stock units will be subject to vesting during a period of at least three years following the date of grant, although a vesting period of at least one year is permissible </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">for performance units. These minimum vesting periods will not apply&#58; (a) to awards made in payment of earned performance-based awards and other earned cash-based incentive compensation&#59; (b) upon a termination of employment due to death, disability or retirement&#59; (c) upon a change of control&#59; (d) to a substitute award that does not reduce the vesting period of the award being replaced&#59; or (e) to awards involving an aggregate number of shares not in excess of five percent of shares available for grant as restricted stock units (together with all other shares available for grant as awards other than options and stock appreciation rights). Because restricted stock units are not actual, issued Medtronic shares, you do not have the rights of a shareholder, but an award of restricted stock units may call for the payment of dividend equivalents (except with respect to performance-based restricted stock where the applicable goals have not yet been attained and the award has not yet vested). Restricted stock units may not be sold, transferred, pledged, or otherwise encumbered before the units have vested. Restricted stock units that vest will be settled in cash or in Medtronic shares or a combination thereof, as determined by the Committee. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">When Your Employment Ends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  If you leave Medtronic during a restricted period because of death, disability or retirement, you will be entitled to receive that number of shares of restricted stock that has been prorated prior to your termination, and all restrictions for those shares will lapse. If you leave Medtronic for any other reason than death, disability or retirement, any shares of restricted stock whose restrictions have not lapsed will automatically be forfeited in full.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For restricted stock units, if you leave Medtronic during a restricted period as a result of your death, disability or retirement, the Company will issue you a number of shares equal to the number of your vested restricted stock units, including any dividend equivalents. If you leave Medtronic for any other reason than death, disability or retirement, the restricted stock units will automatically be forfeited in full. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Tax Considerations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tax consequences vary from country to country.  Under current U.S. federal tax laws, you owe no tax at the time you receive a restricted stock award unless you elect to recognize income under Section 83(b) of the Internal Revenue Code.  Under Section 83(b), you may elect, within thirty days after the date you receive a restricted stock award, to include in your gross income for the year in which the award is made an amount equal to the fair market value of the shares you received on the date of the award.  The fair market value is determined without regard to the restrictions and risk of forfeiture imposed by the Plan.  If you make a Section 83(b) election and you later forfeit the restricted shares granted to you, you are not allowed to deduct the amount that you previously included in your gross income with respect to such shares.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you do not make a Section 83(b) election, you are required to include in your gross income for the year in which the restricted stock award vests (including any vesting due to a &#34;change of control&#34;) an amount equal to the fair market value of the shares as of the date the award vests.  Regardless of whether you elect under Section 83(b) or wait until the award vests, the amount included in your gross income is treated as compensation and taxed as ordinary income.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic is entitled to an income tax deduction equal to the amount included in your gross income.  The deduction is allowed at the same time that the amount is included in your gross income.  If you make a Section 83(b) election and later forfeit the shares, Medtronic must include in its gross income for the year the forfeiture occurs an amount equal to the amount it previously claimed as a deduction with respect to such shares.   </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you do not make a Section 83(b) election, any dividends paid with respect to the shares before they vest are taxed to you as ordinary income and are deductible by Medtronic as compensation.  If you make a Section 83(b) election, such dividends are treated as dividend income to you and are not deductible by Medtronic.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">When you sell your restricted stock award shares, you will recognize long- or short-term capital gain (or loss) equal to the difference between the amount you obtain from the sale and your income tax basis in the shares. For this purpose, your income tax basis is equal to the amount previously included in your gross income.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For restricted stock units, you will not recognize taxable income at the time of a grant of a restricted stock unit, and Medtronic will not be entitled to a tax deduction at that time. You will recognize compensation taxable as ordinary income (and subject to income tax withholding), however, at the time of the settlement of the award, equal to the fair market value of any shares delivered and the amount of cash paid by Medtronic.  Medtronic will be entitled to a corresponding deduction, except to the extent that the deduction limits of Section 162(m) apply.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Because tax requirements can change, and because this brief discussion does not address, among other things, the tax laws of states, localities and other countries, you should consult your tax advisor for information about your individual tax situation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">OTHER STOCK-BASED AWARDS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">General Description</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Plan also enables the Committee to grant other stock-based awards. Other stock-based awards are awards that are valued by reference to our shares, including unrestricted stock, dividend equivalents, deferred units and convertible debentures. Awards of unrestricted stock may only be granted in lieu of compensation that would otherwise be due and payable to the participant. Generally, another stock-based award that is not an option, stock appreciation right, or grant of unrestricted stock will be subject to vesting during a period of at least three years following the date of grant, although a vesting period of at least one year is permissible if vesting of the award is conditioned on performance goals.  Such an award may, however, vest in part on a pro rata basis before the expiration of any vesting period.  This minimum vesting period will not apply&#58; (a) to awards made in payment of earned performance-based awards and other earned cash-based incentive compensation&#59; (b) upon a termination of employment due to death, disability or retirement&#59; (c) upon a change of control&#59; (d) to a substitute award that does not reduce the vesting period of the award being replaced&#59; or (e) to awards involving an aggregate number of shares not in excess of five percent of shares available for grant as other stock-based awards (together with all other shares available for grant as awards other than options and stock appreciation rights). Non-employee directors may receive deferred units, which represent the right to receive Medtronic shares, which deferred units are vested in full as of the grant date, and settled in shares at a later date.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Tax Considerations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you receive unrestricted stock or restricted stock subject only to restrictions on transferability, you will recognize compensation taxable as ordinary income (and subject to income tax withholding) at the time of the grant, equal to the excess of the fair market value of the shares at such time over the amount, if any, paid for such shares.  Medtronic will generally be entitled to a corresponding deduction at that time, except to the extent that the deduction limits of Section 162(m) apply.  If you are a non-employee director who receives a deferred unit award, you will recognize compensation taxable at ordinary income tax rates when payment is made.  Medtronic </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">is generally entitled to a corresponding tax deduction at that time.  The deferred unit awards are intended to comply with Section 409A of the Internal Revenue Code.     </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">PERFORMANCE-BASED AWARDS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">General Description</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Plan authorizes the Committee to grant performance cash awards, performance-based restricted stock, and performance units. Medtronic refers to these kinds of awards collectively as &#34;performance-based awards.&#34;  The performance aspect refers to the fact that one or more performance goals must be met in order for the award to vest and be payable.  Performance goals relate to sales, net sales, revenue, revenue growth or product revenue growth, operating income (before or after taxes), earnings before interest, taxes, depreciation and amortization, operating cash flow, return on invested capital, and other indicators of Medtronic's financial performance, and may be adjusted based on events such as changes in accounting principles and tax laws, corporate transactions and unusual or nonrecurring events (except that for awards intended to qualify as performance-based compensation within the meaning of Section 162(m), any such adjustments must be made in accordance with Section 162(m)).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each qualified performance-based award (other than an option or stock appreciation right) is vested and payable to you upon the achievement of one or more performance goals, together with the satisfaction of any other conditions, such as continued employment, as the Committee may determine to be appropriate. You must be a &#34;covered employee&#34; (as defined in Section 162(m)(3) of the Code) to be eligible for a performance-based award.  No performance-based award may be amended in any manner that would cause the award to cease to qualify for the Section&#160;162(m) exemption.  A &#34;Performance Cash Award&#34; is an award entitling the recipient to payment of a cash amount subject to the attainment of performance goals.  Performance Cash Awards may be paid in cash, shares, other property or any combination thereof, in the sole discretion of the Committee as set forth in the applicable award agreement. The performance levels to be achieved for each performance period and the amount of the award to be distributed shall be conclusively determined by the Committee. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Tax Considerations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  If you receive a performance-based restricted stock award and&#47;or performance unit award, vesting and taxation will be determined in the same manner as that described for time-based restricted stock awards and restricted stock unit awards in the Restricted Stock Awards and Restricted Stock Units section, except that you must meet the additional performance goals described above for your award to vest.  If you receive a performance-based cash award, your award is compensation taxed as ordinary income when payment is made (and subject to withholding), and Medtronic is entitled to a corresponding deduction at that time, provided that such award qualifies for the Section&#160;162(m) exemption, and the terms of any such award (and of the grant thereof) are consistent with such designation.     </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.02pt">ADDITIONAL INFORMATION ABOUT MEDTRONIC</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You can obtain additional information about Medtronic and its shares from these sources, which are all documents filed with the SEC and are incorporated by reference herein&#58;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">Medtronic's latest Annual Report on Form 10-K (or, prior to Medtronic's filing of such report, the most recently filed Medtronic, Inc. annual report and Medtronic's final prospectus filed with the SEC pursuant to Rule 424(b) of the Securities Act of 1933)&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">All other reports filed by Medtronic under Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, since the end of the fiscal year covered by the Annual Report referred to above&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">The description of Medtronic's ordinary shares contained in a registration statement filed under the Securities Exchange Act of 1934, as amended, including any amendment or report updating that description.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The SEC allows us to incorporate by reference the information in documents we file with them, which means that we can disclose important information to you about Medtronic by referring you to those documents.  The information incorporated by reference is an important part of this Summary, and information that we file later with the SEC will automatically update and supersede this information.  We incorporate by reference the documents listed above and any future filings made with the SEC under Sections 13(a), 13(c), 14, or 15(d) of the Securities Exchange Act of 1934, as amended, until all awards granted under the Plan have fully vested and&#47;or been acquired.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You may request a copy of these filings, as well as a copy of Medtronic's most recent Annual Report to shareholders, at no cost, by writing or telephoning us at the following address&#58;</font></div><div style="margin-top:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Investor Relations Department</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic plc</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c&#47;o Medtronic, Inc.</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">710 Medtronic Parkway, LC-480</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Minneapolis, Minnesota 55432</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">763.505.2692</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic is subject to the available information requirements of the Securities Exchange Act of 1934 and files reports and other information with the SEC. Reports, proxy statements and other information filed by Medtronic with the SEC can be inspected and copied at the SEC's Public Reference Room at 100 F Street, NE., Washington, DC 20549, on official business days during the hours of 10 a.m. to 3 p.m.. Copies of such materials can be obtained from the public reference section of the SEC in Washington, D.C. at prescribed rates. You may call the Securities and Exchange Commission at 1-800-SEC-0330 for further information on the Public Reference Room.  Medtronic's SEC reports and filings are also available at the SEC website at http&#58;&#47;&#47;www.sec.gov.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You can also access most of these filings on our website at http&#58;&#47;&#47;www.medtronic.com&#47;. Under &#34;Menu&#34; on the upper portion of the page, click on &#34;About Medtronic,&#34; then click &#34;Investors.&#34; Then, click on &#34;SEC Filings&#34; on the right hand side of the page within the &#34;Tools&#34; box. Medtronic's most recent Annual Report to Shareholders is also available at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;www.medtronic.com&#47;annualmeeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div><div><font><br></font></div></div></div><div id="ia874a4e174df488c9023058acd57a4ea_49"></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:24pt;font-weight:400;line-height:120%">MEDTRONIC&#160;PLC AMENDED AND&#160;RESTATED 2013 STOCK AWARD AND INCENTIVE PLAN</font></div><div><font><br></font></div><div style="padding-left:80pt;text-align:justify;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 1.</font><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Purpose&#59; Definitions</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.1 Purpose</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The purpose of this Medtronic plc Amended and Restated 2013 Stock Award and Incentive Plan (this &#8220;Plan&#8221;) is to give the Company and its Subsidiaries (each as defined below) a competitive advantage in attracting, retaining, and motivating officers, employees, directors, and consultants, to provide the ability for the Company to provide such individuals with financial rewards that are intended to be deductible to the maximum extent possible as &#8220;performance-based compensation&#8221; within the meaning of Section 162(m) of the Code (as defined below), and to provide the Company and its Subsidiaries with an incentive plan that gives officers, employees, directors, and consultants financial incentives directly linked to shareholder value. This Plan is intended to serve as the Company&#8217;s primary vehicle for equity compensation awards and long-term cash incentive awards for employees, directors, and other service providers, as well as annual bonus awards for the Company&#8217;s executive officers. Following the date that this Plan was approved by the Company&#8217;s shareholders, no further equity compensation awards were granted pursuant to any other Company plan (it being understood that outstanding awards under such plans will continue to be settled pursuant to the terms of such plans). The Plan was originally adopted by the board of directors of Medtronic, Inc. and approved by the shareholders of Medtronic, Inc. on July 12, 2013, and was subsequently amended on January 26, 2015 to be assumed by the Company as an Irish public limited company. The Plan is hereby amended and restated as of December 8, 2017, subject to any required approval of the Company&#8217;s shareholders.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.2 Definitions</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain terms used herein have definitions given to them in the first place in which they are used. In addition, for purposes of this Plan, the following terms are defined as set forth&#160;below&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;&#8220;Act&#8221; means the Securities Exchange Act of 1934, as amended from time to time, any regulations promulgated thereunder, and any successor thereto.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;&#8220;Administrator&#8221; shall have the meaning set forth in Section&#160;2.2.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;&#8220;Applicable Exchange&#8221; means the New York Stock Exchange or such other securities exchange as may at the applicable time be the principal market for the Shares.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;&#8220;Award&#8221; means an Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, Other Stock-Based Award, or Performance Award granted pursuant to the terms of this Plan.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;&#8220;Award Agreement&#8221; means a written document or agreement setting forth the terms and conditions of a specific Award.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;&#8220;Beneficial Owner&#8221; shall have the meaning given in Rule 13d-3, promulgated pursuant to the Act.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;&#8220;Board&#8221; means the Board of Directors of the Company.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;&#8220;Cause&#8221; means, unless otherwise provided in an Award Agreement, (i) &#8220;Cause&#8221; as defined in any Individual Agreement to which the applicable Participant is a party and which is operative at the time in question, or (ii) if there is no such Individual Agreement, or if it does not define &#8220;Cause&#8221;&#58; (A)&#160;commission by the Participant of a felony under federal law, local law or the law of the state in which such action occurred, (B) failure on the part of the Participant to perform such Participant&#8217;s employment duties in any material respect, (C) the Participant&#8217;s prolonged absence from duty without the consent of the Company, (D) intentional engagement by the Participant in any activity that is in conflict with or adverse to the business or other interests of the Company, or (E) willful misconduct or malfeasance of </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">duty which is reasonably determined to be detrimental to the Company. Notwithstanding the general rule of Section 2.3, following a Change of Control, any determination by the Committee as to whether &#8220;Cause&#8221; exists shall be subject to de novo review.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;&#8220;Change of Control&#8221; shall have the meaning set forth in Section 10.2.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;&#8220;Code&#8221; means the Internal Revenue Code of 1986, as amended from time to time, and any successor thereto, regulations promulgated thereunder, and other relevant interpretive guidance issued by the Internal Revenue Service or the Treasury Department. Reference to any specific section of the Code shall be deemed to include such regulations and guidance, as well as any successor provision of the Code.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;&#8220;Committee&#8221; means a committee or subcommittee of the Board, appointed from time to time by the Board, which committee or subcommittee shall consist of two or more non-employee directors, each of whom is intended to be, to the extent required by Rule 16b-3, a &#8220;non-employee director&#8221; as defined in Rule 16b-3 and, to the extent required by Section 162(m) of the Code and any regulations promulgated thereunder, an &#8220;outside director&#8221; as defined under Section 162(m) of the Code. Initially, and unless and until otherwise determined by the Board, &#8220;Committee&#8221; means the Compensation Committee of the Board.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;&#8220;Company&#8221; means Medtronic plc, an Irish public limited company.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;&#8220;Disaffiliation&#8221; means a Subsidiary&#8217;s ceasing to be a Subsidiary for any reason (including, without limitation, as a result of a public offering, or a spinoff or sale by the Company, of the stock of the Subsidiary) or a sale of a division of the Company.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;&#8220;Eligible Individuals&#8221; means directors, officers, employees, and consultants of the Company or any Subsidiary, and prospective employees, officers and consultants, who have accepted offers of employment or consultancy from the Company or any Subsidiary&#59; provided however, that no grant shall be effective prior to the date on which such individual&#8217;s employment or consultancy commences.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;&#8220;Fair Market Value&#8221; means, unless otherwise determined by the Committee, the closing price of a Share on the Applicable Exchange on the date of measurement or, if Shares were not traded on the Applicable Exchange on such measurement date, on the next preceding date on which Shares were traded, all as reported by such source as the Committee may select. If the Shares are not listed on a national securities exchange, Fair Market Value shall be determined by the Committee in its good faith discretion, taking into account, to the extent appropriate, the requirements of Section 409A of the Code.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(p)&#160;&#160;&#160;&#160;&#8220;Free-Standing SAR&#8221; shall have the meaning set forth in Section 5.3.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;&#8220;Full-Value Award&#8221; means any Award other than an Option, Stock Appreciation Right, or Performance Cash Award.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(r)&#160;&#160;&#160;&#160;&#8220;Good Reason&#8221; for termination means, unless otherwise provided in an Award Agreement, a Termination of Employment during the two-year period following a Change of Control by a Participant if (i) such Termination of Employment constitutes a termination for &#8220;good reason&#8221; or qualifies under any similar constructive termination provision, in either case, in any Individual Agreement applicable to such Participant, or (ii) if the Participant is not party to any such Individual Agreement, or if such Individual Agreement does not contain such a provision, any Termination of Employment following the occurrence of&#58; (A) an involuntary relocation that increases the Participant&#8217;s commute by more than 50 miles from the commute in effect immediately prior to the applicable Change of Control, (B) a material reduction in either the Participant&#8217;s base pay or in the Participant&#8217;s overall compensation opportunity from the levels in effect immediately prior to the applicable Change of Control or (C) a material reduction in the Participant&#8217;s authority, duties or responsibilities below the levels in effect immediately prior to the applicable Change of Control. Notwithstanding the foregoing, a Termination of Employment shall be deemed to be for Good Reason under clause (ii) of this Section 1.2(r) only if the Participant provides written notice to the Company of the existence of one or more of the conditions giving rise to Good Reason within 90 days of the initial existence of such condition, the Company fails to cure such condition during the 30-day period (the &#8220;Cure Period&#8221;) following its receipt of such notice, and the Participant terminates employment within 180 days following the conclusion of the Cure Period.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(s)&#160;&#160;&#160;&#160;&#8220;Grant Date&#8221; means (i) the date on which the Committee (or its delegate, if applicable) takes action to select an Eligible Individual to receive a grant of an Award and determines the number of Shares to be subject to such Award, or (ii) such later date as is provided by the Committee (or its delegate, if applicable).</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(t)&#160;&#160;&#160;&#160;&#8220;Incentive Stock Option&#8221; means any Option that is designated in the applicable Award Agreement as an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code or any successor provision thereto, and that in fact qualifies.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(u)&#160;&#160;&#160;&#160;&#8220;Individual Agreement&#8221; means an employment, consulting, severance, change of control, or similar agreement between a Participant and the Company or between the Participant and any of the Company&#8217;s Subsidiaries. For purposes of this Plan, an Individual Agreement shall be considered &#8220;operative&#8221; during its term&#59; provided, that an Individual Agreement under which severance or other substantive protections, compensation and&#47;or benefits are provided only following a change of control or termination of employment in anticipation of a change of control shall not be considered &#8220;operative&#8221; until the occurrence of a Change of Control or Termination of Employment in anticipation of a Change of Control, as the case may be.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;&#8220;ISO Eligible Employee&#8221; means an employee of the Company, any subsidiary corporation (within the meaning of Section&#160;424(f) of the Code) of the Company.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(w)&#160;&#160;&#160;&#160;&#8220;Nonqualified Option&#8221; means any Option that either (i) is not designated as an Incentive Stock Option or (ii) is so designated but fails to qualify as such.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(x)&#160;&#160;&#160;&#160;&#8220;Option&#8221; means an Award granted under Section 5.1.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(y)&#160;&#160;&#160;&#160;&#8220;Other Stock-Based Awards&#8221; means Awards of Shares and other Awards that are valued in whole or in part by reference to, or are otherwise based upon, Shares, including (without limitation) unrestricted stock, dividend equivalents, and convertible debentures.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(z)&#160;&#160;&#160;&#160;&#8220;Other Stock-Based Performance Award&#8221; shall have the meaning given in Section&#160;8.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(aa)&#160;&#160;&#160;&#160;&#8220;Participant&#8221; means an Eligible Individual to whom an Award is or has been granted.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(bb)&#160;&#160;&#160;&#160;&#8220;Performance Award&#8221; means a Performance Cash Award, an Other Stock-Based Performance Award, an Award of Performance-Based Restricted Stock, or Performance Units, as each is defined herein.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(cc)&#160;&#160;&#160;&#160;&#8220;Performance-Based Restricted Stock&#8221; shall have the meaning given in Section&#160;6.1.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(dd)&#160;&#160;&#160;&#160;&#8220;Performance Cash Award&#8221; shall have the meaning set forth in Section&#160;9.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ee)&#160;&#160;&#160;&#160;&#8220;Performance Goals&#8221; means the performance goals established by the Committee in connection with the grant of a Performance Award. In the case of Qualified Performance-Based Awards, (i) such Performance Goals shall be based on the attainment of or changes in specified levels of one or more of the following measures&#58; sales, net sales, revenue, revenue growth or product revenue growth, operating income (before or after taxes), earnings before interest, taxes, depreciation and amortization, operating cash flow, return on invested capital, return on capital employed, pre- or after-tax income (before or after allocation or corporate overhead and bonus), net earnings, earnings per share, diluted earnings per share, consolidated earnings before or after taxes (including earnings before some or all of the following&#58; interest, taxes, depreciation and amortization), net income, gross profit, gross margin, year-end cash, debt reductions, book value per share, return on equity, expense management, return on investment, improvements in capital structure, profitability of an identifiable business unit or product, maintenance or improvements of profit margins, stock price, market share, costs, cash flow, working capital, return on assets or net assets, asset turnover, inventory turnover, economic value added (economic profit) or equivalent metrics, comparison with various stock market indices, appreciation in and&#47;or maintenance of share price, reductions in costs, regulatory achievements, implementation, completion or attainment of measurable objectives with respect to research, development, products or projects and recruiting or maintaining personnel, and total shareholder return&#59; each as measured with respect to the Company or one or more Subsidiaries, divisions, business units, or business segments of the Company, either in absolute terms or relative to the performance of one or more other companies or an index covering multiple companies&#59; (ii) such Performance Goals shall be set by the Committee in the time period prescribed </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">by Section 162(m) of the Code and the regulations promulgated thereunder&#59; (iii) such Performance Goals shall be objective, pre-established performance goals within the meaning of Section 162(m) of the Code and the regulations promulgated thereunder and (iv) the achievement of such Performance Goals shall be certified in accordance with the requirements of Section 162(m) of the Code.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ff)&#160;&#160;&#160;&#160;&#8220;Performance Period&#8221; means that period established by the Committee at the time any Performance Award is granted or at any time thereafter during which any Performance Goal specified by the Committee with respect to such Award is to be&#160;measured.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(gg)&#160;&#160;&#160;&#160;&#8220;Performance Units&#8221; shall have the meaning given in Section 7.1.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(hh)&#160;&#160;&#160;&#160;&#8220;Plan&#8221; means this Medtronic plc Amended and Restated 2013 Stock Award and Incentive Plan, as set forth herein and as hereafter amended from time to time.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;&#8220;Predecessor Plans&#8221; means the Company&#8217;s Amended and Restated 1994 Stock Award Plan, 1998 Outside Director Stock Compensation Plan, Executive Incentive Plan, Kyphon Inc. 2002 Stock Plan, 2003 Long-Term Incentive Plan and 2008 Stock Award and Incentive Plan.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(jj)&#160;&#160;&#160;&#160;&#8220;Qualified Performance-Based Award&#8221; means an Award intended to qualify for the Section 162(m) Exemption, as provided in Section 11.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(kk)&#160;&#160;&#160;&#160;&#8220;Replaced Award&#8221; shall have the meaning given in Section&#160;10.1.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ll)&#160;&#160;&#160;&#160;&#8220;Replacement Award&#8221; shall have the meaning given in Section&#160;10.1.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(mm)&#160;&#160;&#160;&#160;&#8220;Restricted Stock&#8221; shall have the meaning given in Section 6.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(nn)&#160;&#160;&#160;&#160;&#8220;Restricted Stock Units&#8221; shall have the meaning given in Section 7.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(oo)&#160;&#160;&#160;&#160;&#8220;Restriction Period&#8221; means, with respect to Restricted Stock and Restricted Stock Units, the period commencing with the Grant Date and ending upon the expiration of the applicable vesting conditions or the achievement of the applicable Performance Goals (it being understood that the Committee may provide that restrictions shall lapse with respect to portions of the applicable Award during the Restriction Period).</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(pp)&#160;&#160;&#160;&#160;&#8220;Section 162(m) Exemption&#8221; means the exemption from the limitation on deductibility imposed by Section 162(m) of the Code that is set forth in Section 162(m)(4)(C) of the&#160;Code.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(qq)&#160;&#160;&#160;&#160;&#8220;Share&#8221; means an ordinary share, par value $0.0001 per share of the Company.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(rr)&#160;&#160;&#160;&#160;&#8220;Stock Appreciation Right&#8221; or &#8220;SAR&#8221; shall have the meaning set forth in Section&#160;5.3.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ss)&#160;&#160;&#160;&#160;&#8220;Subsidiary&#8221; has the meaning set forth in section 7 of the Companies Act 2014 of the Republic of Ireland&#59; provided that, to the extent required to avoid the imposition of additional taxes under Section 409A of the Code, an entity shall not be treated as a Subsidiary unless it is also an entity in which the Company has a &#8220;controlling interest&#8221; (as defined in Treas. Reg. Section 1.409A-1(b)(5)(ii)(E)(1)), either directly or through a chain of corporations or other entities in which each corporation or other entity has a &#8220;controlling interest&#8221; in another corporation or entity in the chain, as determined by the Committee.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:20pt;text-indent:-20pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(tt)&#160;&#160;&#160;&#160;&#8220;Substitute Award&#8221; means any Award granted in assumption of, or in substitution for, an award of a company or business (that is not, prior to the applicable transaction, a Subsidiary of the Company) acquired by the Company or a Subsidiary or with which the Company or a Subsidiary combines.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:20pt;text-indent:-20pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(uu)&#160;&#160;&#160;&#160;&#8220;Tandem SAR&#8221; shall have the meaning set forth in Section&#160;5.3.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="padding-left:20pt;text-indent:-20pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(vv)&#160;&#160;&#160;&#160;&#8220;Ten Percent Shareholder&#8221; means a person owning stock possessing more than 10% of the total combined voting power of all classes of stock of the Company, any subsidiary corporation (within the meaning of Section 424(f) of the Code).</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:20pt;text-indent:-20pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ww)&#160;&#160;&#160;&#160;&#8220;Term&#8221; means the maximum period during which an Option or Stock Appreciation Right may remain outstanding, subject to earlier termination upon Termination of Employment or otherwise, as specified in the applicable Award Agreement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(xx)&#160;&#160;&#160;&#160;&#8220;Termination of Employment&#8221; means, unless otherwise provided in the Award Agreement, the termination of the applicable Participant&#8217;s employment with, or performance of services for, the Company and any of its Subsidiaries. Unless otherwise determined by the Committee, a Participant employed by, or performing services for, a Subsidiary or a division of the Company shall be deemed to incur a Termination of Employment if, as a result of a Disaffiliation, such Subsidiary, or division ceases to be a Subsidiary or division, as the case may be, and the Participant does not immediately become an employee of, or service provider for, the Company or another Subsidiary. Temporary absences from employment because of illness, vacation, or leave of absence, and transfers among the Company and its Subsidiaries, shall not be considered Terminations of Employment. Notwithstanding the foregoing, with respect to any Award that constitutes &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A of the Code, &#8220;Termination of Employment&#8221; shall mean a &#8220;separation from service&#8221; as defined under Section 409A of the Code.</font></div><div style="padding-left:19.85pt;text-indent:-19.85pt"><font><br></font></div><div style="padding-left:80pt;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 2.</font><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Administration</font></div><div><font><br></font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.1 Committee</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Plan shall be administered by the Committee or a duly designated Administrator, as defined herein. The Committee shall, subject to Section 11, have plenary authority to grant Awards to Eligible Individuals pursuant to the terms of the Plan. Among other things, the Committee shall have the authority, subject to the terms and conditions of the Plan&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;To select the Eligible Individuals to whom Awards may be granted&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;To determine whether and to what extent Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Other Stock-Based Awards, or Performance Awards, or any combination thereof, are to be granted hereunder&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;To determine the number of Shares to be covered by each Award granted under the Plan&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;To determine the terms and conditions of each Award granted hereunder, based on such factors as the Committee shall determine&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Subject to Section 12, to modify, amend, or adjust the terms and conditions of any Award&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;To adopt, alter, or repeal such administrative rules, guidelines, and practices governing the Plan as the Committee shall from time to time deem advisable&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;To interpret the terms and provisions of the Plan and any Award issued under the Plan (and any agreement relating thereto)&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;Subject to Sections 11 and 12, to accelerate the vesting or lapse of restrictions of any outstanding Award, based in each case on such considerations as the Committee in its sole discretion may determine&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;To decide all other matters that must be determined in connection with an Award&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;To determine whether, to what extent, and under what circumstances cash, Shares, and other property and other amounts payable with respect to an Award under this Plan shall be deferred either automatically or at the election of the Participant&#59; and</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;To otherwise administer the Plan.</font></div><div style="padding-left:19.85pt;text-indent:-19.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.2 Committee Procedures&#59; Board Authority</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee shall exercise its authority under the Plan as follows&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Committee may act only with the assent of a majority of its members then in office, except that the Committee may, except to the extent prohibited by applicable law or the listing standards of the Applicable Exchange and subject to Section 11.3, allocate all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any part of its responsibilities and powers to any person or persons selected by it (the &#8220;Administrator&#8221;). Notwithstanding the foregoing, the Committee may not so delegate any responsibility or power to the extent that such delegation would cause a Qualified Performance-Based Award hereunder not to qualify for the Section&#160;162(m) Exemption, or make any Award hereunder subject to (and not exempt from) the short-swing recovery rules of Section 16(b) of the Act. Without limiting the generality of the foregoing, the Committee may not delegate its responsibilities and powers to grant, establish the terms and conditions of, and otherwise administer Qualified Performance-Based Awards, nor its responsibilities and powers to grant and establish the terms and conditions of Awards to Participants who are subject to Section 16(b) (as&#160;defined in Section 11.4 below).</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Subject to Section 11.3, any authority granted to the Committee may also be exercised by the full Board. To the extent that any permitted action taken by the Board conflicts with action taken by the Committee, the Board action shall&#160;control.</font></div><div style="padding-left:19.85pt;text-indent:-19.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.3 Discretion of Committee</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subject to Section 1.2(h), any determination made by the Committee or by the Administrator under the provisions of the Plan with respect to any Award shall be made in the sole discretion of the Committee or the Administrator at the time of the grant of the Award or, unless in contravention of any express term of the Plan, at any time thereafter. All decisions made by the Committee or the Administrator shall be final and binding on all persons, including the Company, Participants, and Eligible Individuals, and by accepting an Award under the Plan, each Participant acknowledges that all decisions of the Committee shall be final and binding on the Participant, his or her beneficiaries and any other person having a claim or an interest in the Award.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.4 Award Agreements</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unless otherwise determined by the Committee, the terms and conditions of each Award, as determined by the Committee, shall be set forth in a written Award Agreement. Award Agreements may be amended only in accordance with Section 12 hereof.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:80pt;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 3.</font><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Shares Subject to Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.1 Plan Maximums</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subject to adjustment as provided in Section 3.4, (a) the maximum number of Shares that may be issued pursuant to Awards under the Plan shall be the sum of (i) Fifty Million (50,000,000) Shares, (ii) any Shares which are available for grant as of the Effective Date under the Plan and (iii) any Shares relating to the Plan or Predecessor Plans which become available for grants under the Plan following the Effective Date pursuant to Section 3.2&#59; and (b)&#160;the maximum number of Shares that may be issued pursuant to Options intended to be Incentive Stock Options following the Effective Date shall be 50,000,000. Shares subject to an Award under the Plan may be authorized and unissued Shares or may be treasury Shares.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.2 Rules for Calculating Shares Issued</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For purposes of the limits set forth in Section 3.1 (but not for purposes of the limits set forth in Section 3.3), each Share that is subject to a Full-Value Award shall be counted as 3.0 Shares. To the extent that any Award under this Plan or the Predecessor Plans is forfeited, or any Option and related Tandem SAR or any Free-Standing SAR granted under this Plan or the Predecessor Plans terminates, expires, or lapses without being exercised, or any Award is settled for cash, the Shares subject to such Awards not delivered as a result thereof shall thereupon become available (in the case of Full-Value Awards, based upon the share-counting ratio set forth in the first sentence of this Section 3.2) for Awards under the Plan. In the event that any Shares are withheld by the Company or previously acquired Shares are tendered (either </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">actually or by attestation) by a Participant to satisfy any tax withholding obligation with respect to an Award other than an Option or SAR, then the Shares so tendered or withheld shall automatically again become available for issuance under the Plan and correspondingly increase the total number of Shares available for issuance under Section 3.1 in accordance with the same ratio specified in this Section 3.2. Notwithstanding anything to the contrary in this Section 3.2, the following Shares will not again become available for issuance under the Plan&#58; (a) any Shares which would have been issued upon any exercise of an Option but for the fact that the exercise price was paid by a &#8220;net exercise&#8221; pursuant to Section 5.8(c) or any previously acquired Shares tendered (either actually or by attestation) by a Participant in payment of the exercise price of an Option&#59; (b)&#160;any Shares withheld by the Company or previously acquired Shares tendered (either actually or by attestation) by a Participant to satisfy any tax withholding obligation with respect to an Option or SAR (but not other Awards)&#59; (c) Shares covered by a SAR that are not issued in connection with the stock settlement of the SAR upon its exercise&#59; (d) Shares that are repurchased by the Company using Option exercise proceeds&#59; and (e) if Shares are withheld pursuant to Section 15.4 at a rate that is higher than the minimum statutory tax rate, only the number of Shares withheld at the minimum statutory tax rate will again become available for issuance under the Plan. In addition, in the case of any Substitute Award, Shares delivered or deliverable in connection with such Substitute Award shall not be deemed granted or issued under the Plan for purposes of Sections 3.1 or&#160;3.3.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.3 Individual Limits</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subject to adjustment as provided in Section 3.4, no Participant may be granted (a)&#160;Options and Stock Appreciation Rights relating to more than 2,000,000 Shares under the Plan during any fiscal year and (b) Awards other than Options or Stock Appreciation Rights relating to more than 2,000,000 Shares under the Plan during any fiscal year. In addition to the foregoing, the maximum dollar value that may be paid to any Participant in Qualified Performance-Based Awards denominated in cash in any fiscal year shall be $20,000,000 for the Company&#8217;s Chief Executive Officer and $10,000,000 for each other Participant, including any amounts earned during such fiscal year and deferred. If an Award is cancelled, the cancelled Award shall continue to be counted towards the limitations set forth in this Section 3.3.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.4 Adjustment Provision</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee shall have authority to make adjustments under the Plan as provided below&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;In the event of a merger, consolidation, acquisition of property or shares, stock rights offering, liquidation, separation, spinoff, Disaffiliation, extraordinary dividend of cash or other property, or similar event affecting the Company or any of its Subsidiaries (a &#8220;Corporate Transaction&#8221;), the Committee, or the Board shall make such substitutions or adjustments as it deems appropriate and equitable to (i) the aggregate number and kind of Shares or other securities reserved for issuance and delivery under the Plan, (ii) the various maximum share limitations set forth in Sections 3.1 and 3.3, (iii) the number and kind of Shares or other securities subject to outstanding Awards, and (iv) the exercise price of outstanding Awards. Any fractional Shares resulting from such adjustment shall be eliminated. Any adjustments determined by the Committee shall be final, binding and conclusive.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In the event of a stock dividend, stock split, reverse stock split, reorganization, share combination, recapitalization, or similar event affecting the capital structure of the Company, the Committee or the Board shall make such substitutions or adjustments as it deems appropriate and equitable to (i) the aggregate number and kind of Shares or other securities reserved for issuance and delivery under the Plan, (ii) the various share maximum limitations set forth in Sections 3.1 and 3.3, (iii) the number and kind of Shares or other securities subject to outstanding Awards, and (iv) the exercise price of outstanding Awards, provided that in no event shall the per Share exercise price of an Option or the subscription price payable per Share of an Award be reduced to an amount that is lower than the nominal value of a Share. Any fractional Shares resulting from such adjustment shall be eliminated. Any adjustments determined by the Committee shall be final, binding and conclusive.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;In the case of Corporate Transactions, such adjustments may include, without limitation, (i) the cancellation of outstanding Awards in exchange for payments of cash, property, or a combination thereof having an aggregate value equal to the value (if any) of such Awards, as determined by the Committee or the Board in its sole discretion (it being understood that, in the case of a Corporate Transaction with respect to which holders of Shares receive consideration other than publicly traded equity securities of the Surviving Corporation (as defined below in Section 10.2), any such determination by the Committee that the value of an Option or Stock Appreciation Right shall for this purpose be deemed to equal the excess, if any, of the value of the consideration being paid for each Share pursuant to such Corporate Transaction over the exercise price of such Option or Stock Appreciation Right shall conclusively be deemed valid), (ii) the substitution of other property (including, without limitation, cash or other securities of the Company and securities of entities other than the Company) for the Shares subject to outstanding Awards, and (iii) in connection with a Disaffiliation, arranging for the assumption of Awards, or replacement of Awards with new awards based on other property or other securities (including, without limitation, other securities of the Company and </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">securities of entities other than the Company), by the affected Subsidiary or division of the Company or by the entity that controls such Subsidiary or division of the Company following such Corporate Transaction (as well as any corresponding adjustments to Awards that remain based upon Company securities). For the avoidance of doubt, if the Committee determines that, as of the date of the Corporate Transaction, the Award has no value, then such Award may be terminated by the Company without payment.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Committee may, in its sole discretion, provide that one or more objectively determinable adjustments shall be made to one or more of the Performance Goals. Such adjustments may include, but are not limited to, one or more of the following&#58; (i) items related to a change in accounting principle&#59; (ii) items relating to financing activities&#59; (iii) expenses for restructuring or productivity initiatives&#59; (iv) other non-operating items&#59; (v) items related to acquisitions&#59; (vi)&#160;items attributable to the business operations of any entity acquired by the Company during the Performance Period&#59; (vii)&#160;items related to the disposal or sale of a business or segment of a business&#59; (viii) items related to discontinued operations that do not qualify as a segment of a business under applicable accounting standards&#59; (ix) items attributable to any stock dividend, stock split, combination or exchange of stock occurring during the Performance Period&#59; (x) any other items of significant income or expense which are determined to be appropriate adjustments&#59; (xi) items relating to unusual or infrequently occurring corporate transactions, events or developments, (xii) items related to amortization of acquired intangible assets&#59; (xiii) items that are outside the scope of the Company&#8217;s core, on-going business activities&#59; (xiv) items related to acquired in-process research and development&#59; (xv) items relating to changes in tax laws&#59; (xvi) items relating to major licensing or partnership arrangements&#59; (xvii) items relating to asset impairment charges&#59; (xviii) items relating to gains or losses for litigation, arbitration and contractual settlements&#59; or (xix) items relating to any other unusual or nonrecurring events or changes in applicable laws, accounting principles or business conditions. For all Awards intended to qualify for the Section 162(m) Exemption, such determinations shall be made within the time prescribed by, and otherwise in compliance with, Section 162(m) of the Code.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Notwithstanding the foregoing&#58; (a) any adjustments made pursuant to Section 3.4 to Awards that are considered &#8220;deferred compensation&#8221; within the meaning of Section 409A of the Code shall be made in compliance with the requirements of Section 409A of the Code and (b) any adjustments made pursuant to Section 3.4 to Awards that are not considered &#8220;deferred compensation&#8221; subject to Section 409A of the Code shall be made in such a manner as to ensure that, after such adjustment, the Awards either (i) continue not to be subject to Section 409A of the Code, or (ii)&#160;comply with the requirements of Section 409A of the&#160;Code.</font></div><div style="padding-left:19.85pt;text-indent:-19.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:80pt;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 4.</font><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Eligibility</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.1 Eligible Individuals&#59; Incentive Stock Options</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Awards may be granted under the Plan to Eligible Individuals&#59; provided, that Incentive Stock Options may be granted only to employees of the Company and its Subsidiaries.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:80pt;text-align:justify;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 5.</font><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Options and Stock Appreciation Rights</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.1 Types of Options</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options may be of two types&#58; Incentive Stock Options and Nonqualified Options. The Award Agreement for an Option shall indicate whether the Option is intended to be an Incentive Stock Option or a Nonqualified Option&#59; provided, that any Option that is designated as an Incentive Stock Option but fails to meet the requirements therefor (as described in Section 5.2 or otherwise), and any Option that is not expressly designated as intended to be an Incentive Stock Option shall be treated as a Nonqualified&#160;Option.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.2 Incentive Stock Option Limitations</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the extent that the aggregate Fair Market Value, determined at the time of grant, of the Shares with respect to which Incentive Stock Options are exercisable for the first time during any calendar year under the Plan or any other stock option plan of the Company, any subsidiary corporation (within the meaning of Section 424(f) of the Code) exceeds $100,000, Options relating to such Shares in excess of the limit shall be deemed Nonqualified Options. If an ISO Eligible Employee does not remain employed by the Company, any subsidiary corporation (within the meaning of Section 424(f) of the Code), at all times from the time an Incentive Stock Option is granted until three months prior to the date of exercise </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">thereof (or such other period as required by applicable law), such Option shall be treated as a Nonqualified Stock Option. Should any provision of the Plan not be necessary in order for any Options to qualify as Incentive Stock Options, or should any additional provisions be required, the Committee may amend the Plan accordingly, without the necessity of obtaining the approval of the shareholders of the&#160;Company.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.3 Types and Nature of Stock Appreciation Rights</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock Appreciation Rights may be &#8220;Tandem SARs&#8221;, which are granted in conjunction with an Option, or &#8220;Free-Standing SARs&#8221;, which are not granted in conjunction with an Option. Upon the exercise of a Stock Appreciation Right, the Participant shall be entitled to receive an amount in cash, Shares, or both, in value equal to the product of (a) the excess of the Fair Market Value of one Share over the exercise price of the applicable Stock Appreciation Right, multiplied by (b) the number of Shares in respect of which the Stock Appreciation Right has been exercised. The applicable Award Agreement shall specify whether such payment is to be made in cash or Shares or both, or shall reserve to the Committee or the Participant the right to make that determination prior to or upon the exercise of the Stock Appreciation Right.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.4 Tandem SARs</font></div><div><font style="color:#00497f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A Tandem SAR may be granted at the Grant Date of the related Option. A Tandem SAR shall be exercisable only at such time or times and to the extent that the related Option is exercisable in accordance with the provisions of this Section 5, and shall have the same exercise price as the related Option. A Tandem SAR shall terminate or be forfeited upon the exercise or forfeiture of the related Option, and the related Option shall terminate or be forfeited upon the exercise or forfeiture of the Tandem SAR.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.5 Exercise Price</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Except in respect of Replacement Awards or Substitute Awards, the exercise price per Share subject to an Option or Free-Standing SAR shall be determined by the Committee and set forth in the applicable Award Agreement, and shall not be less than the Fair Market Value of a Share on the applicable Grant Date&#59; provided, that if an Incentive Stock Option is granted to a Ten Percent Shareholder, the exercise price shall be no less than 110% of the Fair Market Value of the Stock on the applicable Grant Date.</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.6 Term</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Term of each Option and each Free-Standing SAR shall be fixed by the Committee, but shall not exceed 10 years from the Grant Date.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.7 Vesting and Exercisability</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Except as otherwise provided herein, Options and Free-Standing SARs shall be exercisable at such time or times and subject to such terms and conditions as shall be determined by the Committee. Subject to the terms of the Plan and the applicable Award Agreement, in no event shall the vesting schedule of an Option or Free-Standing SAR provide that such Option or Free-Standing SAR vest prior to the first anniversary of the Grant Date. The minimum vesting periods specified in the preceding sentence shall not apply&#58; (A) to Awards made in payment of earned performance-based Awards and other earned cash-based incentive compensation&#59; (B) upon a termination of employment due to death, disability or retirement&#59; (C) upon a Change of Control&#59; (D) to a Substitute Award that does not reduce the vesting period of the award being replaced&#59; or (E) to Awards involving an aggregate number of Shares not in excess of five percent of the Shares available for grant as Options or Free-Standing SARs.</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.8 Method of Exercise</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subject to the provisions of this Section 5, Options and Free-Standing SARs may be exercised, in whole or in part, at any time during the applicable Term by giving written notice of exercise to the Company specifying the number of Shares as to which the Option or Free-Standing SAR is being exercised. In the case of the exercise of an Option, such notice shall be accompanied by payment in full of the purchase price (which shall equal the product of such number of shares multiplied by the applicable exercise price) and an amount equal to any federal, state, local or foreign withholding taxes. To the extent permitted by law and if approved by the Committee (which approval may be set forth in the applicable Award </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Agreement or otherwise), payment, in full or in part, may be made by certified or bank check or such other instrument or such other method as the Company may accept, as&#160;follows&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Payment may be made in the form of Shares (by delivery of such shares or by attestation) of the same class as the Shares subject to the Option already owned by the Participant (based on the Fair Market Value of the Shares on the date the Option is exercised)&#59; provided that, in the case of an Incentive Stock Option, the right to make a payment in the form of already owned Shares of the same class as the Shares subject to the Option may be authorized only at the time the Option is&#160;granted.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;To the extent permitted by applicable law, payment may be made by delivering a properly executed exercise notice to the Company, together with a copy of irrevocable instructions to a broker to deliver promptly to the Company the amount of sale or loan proceeds necessary to pay the purchase price, and the amount of any federal, state, local, or foreign withholding taxes. To facilitate the foregoing, the Company may, to the extent permitted by applicable law, enter into agreements for coordinated procedures with one or more brokerage firms.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Payment may be made by instructing the Company to withhold a number of Shares having a Fair Market Value (based on the Fair Market Value of the Shares on the date the applicable Option is exercised) equal to the product of (i) the exercise price multiplied by (ii) the number of Shares in respect of which the Option shall have been exercised and an amount equal to any federal, state, local and&#47;or foreign withholding taxes.</font></div><div style="padding-left:19.85pt;text-indent:-19.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.9 Delivery&#59; Rights of Shareholders</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No Shares shall be delivered pursuant to the exercise of an Option until the exercise price therefor has been fully paid and applicable taxes have been withheld. The applicable Participant shall have all of the rights of a shareholder of the Company holding the class or series of Shares that is subject to the Option or Stock Appreciation Right (including, if applicable, the right to vote the applicable Shares and the right to receive dividends), when (a) the Company has received a written notice from the Participant of exercise that complies with all procedures established under this Plan for effective exercise, including, without limitation, completion and delivery of all required forms, (b) the Participant has, if requested, given the representation described in Section 15.1, and (c) in the case of an Option, the Participant has paid in full for such Shares.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.10 Nontransferability of Options and Stock Appreciation Rights</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No Option or Free-Standing SAR shall be transferable by a Participant other than, for no value or consideration, (a) by will or by the laws of descent and distribution, or (b) in the case of a Nonqualified Option or Free-Standing SAR, as otherwise expressly permitted by the Committee including, if so permitted, pursuant to a transfer to the Participant&#8217;s family members, whether directly or indirectly or by means of a trust or partnership or otherwise. For purposes of this Plan, unless otherwise determined by the Committee, &#8220;family member&#8221; shall have the meaning given to such term in General Instructions A.1(a)(5) to Form S-8 under the Securities Act of 1933, as amended, and any successor thereto. A Tandem SAR shall be transferable only with the related Option and only to the extent the Option is transferable pursuant to the preceding sentence. Any Option or Stock Appreciation Right shall be exercisable, subject to the terms of this Plan, only by the applicable Participant, the guardian or legal representative of such Participant, or any person to whom such Option or Stock Appreciation Right is permissibly transferred pursuant to this Section 5.10, it being understood that the term &#8220;Participant&#8221; includes such guardian, legal representative and other transferee&#59; provided, that the term &#8220;Termination of Employment&#8221; shall continue to refer to the Termination of Employment of the original&#160;Participant.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.11 No Dividend or Dividend Equivalents</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No dividend or other distribution or award of dividend equivalents may be granted with respect to any Option or SAR granted under this Plan.</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.12 No Repricing</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Notwithstanding any other provision of this Plan other than Section 3.4, the Committee may not, without prior approval of the Company&#8217;s stockholders, seek to effect any repricing of any previously granted, &#8220;underwater&#8221; Option or SAR by&#58; (i) amending or modifying the terms of the Option or SAR to lower the exercise price&#59; (ii)&#160;canceling the underwater Option or SAR and granting either replacement Options or SARs having a lower exercise price&#59; or other Awards or cash in exchange&#59; or (iii) repurchasing the underwater Options or SARs. For purposes of this Section 5.12, an Option or SAR will </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">be deemed to be &#8220;underwater&#8221; at any time when the Fair Market Value of the Shares is less than the per share exercise price of the Option or SAR.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:80pt;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 6.</font><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Restricted Stock (Including Performance-Based Restricted Stock)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.1 Nature of Award&#59; Certificates</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares of Restricted Stock are actual Shares issued to a Participant, and shall be evidenced in such manner as the Committee may deem appropriate, including book-entry registration or issuance of one or more stock certificates or delivery to an account in the Participant&#8217;s name at a broker designated by the Company.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;Performance-Based Restricted Stock&#8221; is an Award of Shares of Restricted Stock, the vesting of which is subject to the attainment of Performance Goals. In the event that the Committee grants Shares of Performance-Based Restricted Stock, the performance levels to be achieved for each Performance Period and the amount of the Award to be distributed shall be conclusively determined by the Committee. Any certificate issued in respect of Shares of Restricted Stock shall be registered in the name of the applicable Participant and, in the case of Restricted Stock, shall bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Award. The Committee may require that the certificates evidencing such shares be held in custody by the Company until the restrictions thereon shall have lapsed and that, as a condition of any Award of Restricted Stock, the applicable Participant shall have delivered a stock power, endorsed in blank, relating to the Shares covered by such Award.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.2 Terms and Conditions</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares of Restricted Stock shall be subject to the following terms and conditions&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Committee shall, prior to or at the time of grant, condition the vesting or transferability of an Award of Restricted Stock upon the continued service of the applicable Participant or the attainment of Performance Goals, or the attainment of Performance Goals and the continued service of the applicable Participant. In the event that the Committee conditions the grant or vesting of an Award of Restricted Stock upon the attainment of Performance Goals (or the attainment of Performance Goals and the continued service of the applicable Participant), the Committee may, prior to or at the time of grant, designate such an Award as a Qualified Performance-Based Award. The conditions for grant, vesting, or transferability and the other provisions of Restricted Stock Awards (including without limitation any Performance Goals applicable to Performance-Based Restricted Stock) need not be the same with respect to each Participant.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Subject to the terms of the Plan and the applicable Award Agreement, any Award of Restricted Stock shall be subject to a vesting period of at least three years following the date of grant, provided that vesting during a period of at least one year following the date of grant is permissible if vesting is conditioned upon the achievement of Performance Goals, and provided, further, that an Award may vest in part on a pro rata basis (as specified in the applicable Award Agreement) prior to the expiration of any vesting period. The minimum vesting periods specified in the preceding sentence shall not apply&#58; (A) to Awards made in payment of earned performance-based Awards and other earned cash-based incentive compensation&#59; (B) upon a termination of employment due to death, disability or retirement&#59; (C) upon a Change of Control&#59; (D)&#160;to a Substitute Award that does not reduce the vesting period of the award being replaced&#59; or (E) to Awards involving an aggregate number of Shares not in excess of five percent of Shares available for grant as Restricted Stock (together with all other Shares available for grant as Full-Value Awards). Subject to the provisions of the Plan and the applicable Award Agreement, during the Restriction Period, the Participant shall not be permitted to sell, assign, transfer, pledge, or otherwise encumber Shares of Restricted Stock.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;If any applicable Performance Goals and&#47;or continued service periods are satisfied and the Restriction Period expires without a prior forfeiture of the Shares of Restricted Stock for which legended certificates have been issued, either (i) unlegended certificates for such Shares shall be delivered to the Participant upon surrender of the legended certificates, or (ii) such Shares shall be evidenced in such manner as the Committee may deem appropriate, including book-entry registration or delivery to an account in the Participant&#8217;s name at a broker designated by the Company.</font></div><div style="padding-left:19.85pt;text-indent:-19.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.3 Rights of Shareholder</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Except as provided in the applicable Award Agreement, the applicable Participant shall have, with respect to Shares of Restricted Stock, all of the rights of a shareholder of the Company holding the class or series of Shares that are the </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">subject of the Restricted Stock, including, if applicable, the right to vote the Shares and the right to receive any dividends and other distributions, provided, however, that, notwithstanding anything to the contrary in an Award Agreement, in no event shall a dividend or other distribution or dividend equivalent be paid on Restricted Stock until the Award has vested.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:80pt;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 7.</font><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Restricted Stock Units (Including Performance Units)</font></div><div><font style="color:#00497f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.1 Nature of Award</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Restricted Stock Units are Awards denominated in Shares that will be settled, subject to the terms and conditions of the applicable Award Agreement, (a) in cash, based upon the Fair Market Value of a specified number of Shares, (b) in Shares, or (c) a combination thereof. &#8220;Performance Units&#8221; are Restricted Stock Units, the vesting of which are subject to the attainment of Performance Goals. In the event that the Committee grants Performance Units, the performance levels to be achieved for each Performance Period and the amount of the Award to be distributed shall be conclusively determined by the Committee.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.2 Terms and Conditions</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Restricted Stock Units shall be subject to the following terms and conditions&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Committee shall, prior to or at the time of grant, condition the grant, vesting, or transferability of Restricted Stock Units upon the continued service of the applicable Participant or the attainment of Performance Goals, or the attainment of Performance Goals and the continued service of the applicable Participant. In the event that the Committee conditions the grant or vesting of Restricted Stock Units upon the attainment of Performance Goals (or the attainment of Performance Goals and the continued service of the applicable Participant), the Committee may, prior to or at the time of grant, designate such an Award as a Qualified Performance-Based Award. The conditions for grant, vesting or transferability and the other provisions of Restricted Stock Units (including without limitation any Performance Goals applicable to Performance Units) need not be the same with respect to each Participant. An Award of Restricted Stock Units shall be settled as and when the Restricted Stock Units vest or at a later time specified by the Committee or in accordance with an election of the Participant, if the Committee so permits.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Subject to the terms of the Plan and the applicable Award Agreement, any Restricted Stock Units shall be subject to a vesting period of at least three years following the date of grant, provided that vesting during a period of at least one year following the date of grant is permissible if vesting is conditioned upon the achievement of Performance Goals, and provided, further, that Restricted Stock Units may vest in part on a pro rata basis (as specified in the applicable Award Agreement) prior to the expiration of any vesting period. The minimum vesting periods specified in the preceding sentence shall not apply&#58; (A) to Awards made in payment of earned performance-based Awards and other earned cash-based incentive compensation&#59; (B)&#160;upon a termination of employment due to death, disability or retirement&#59; (C) upon a Change of Control&#59; (D) to a Substitute Award that does not reduce the vesting period of the award being replaced&#59; or (E) to Awards involving an aggregate number of Shares not in excess of five percent of Shares available for grant as Restricted Stock Units (together with all other Shares available for grant as Full-Value Awards).</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Subject to the provisions of the Plan and the applicable Award Agreement, during the period, if any, set by the Committee, during the Restriction Period the Participant shall not be permitted to sell, assign, transfer, pledge, or otherwise encumber Restricted Stock Units.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Award Agreement for Restricted Stock Units may specify whether, to what extent, and on what terms and conditions the applicable Participant shall be entitled to receive current or deferred payments of cash, Shares, or other property corresponding to the dividends payable on the Company&#8217;s Stock (subject to Section 15.5 below), provided, however, that, notwithstanding anything to the contrary in an Award Agreement, in no event shall a dividend or other distribution or dividend equivalent be paid on a Restricted Stock Unit until the Award has vested.</font></div><div style="padding-left:19.85pt;text-indent:-19.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:80pt;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 8.</font><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Other Stock-Based Awards (Including Other Stock-Based Performance Awards)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other Stock-Based Awards may be granted under the Plan, provided that any Other Stock-Based Awards that are Awards of Shares that are unrestricted shall only be granted in lieu of other compensation due and payable to the Participant. &#8220;Other Stock-Based Performance Awards&#8221; are Other Stock-Based Awards, the vesting of which is subject to the attainment of Performance Goals. In the event that the Committee grants Other Stock-Based Performance Awards, the performance levels to be achieved for each Performance Period and the amount of the Award to be distributed shall be conclusively determined by the Committee. Subject to the terms of the Plan and the applicable Award Agreement, any Other Stock-Based Award that is a Full-Value Award (and is not an Award of unrestricted stock) shall be subject to a vesting period of at least three years following the Grant Date&#59; provided that a vesting period of at least one year is permissible if vesting is conditioned upon the achievement of Performance Goals, and provided, further, that any Other Stock-Based Award may vest in part on a pro rata basis prior to the expiration of any vesting period. The minimum vesting periods specified in the preceding sentence shall not apply&#58; (A)&#160;to Awards made in payment of earned performance-based Awards and other earned cash-based incentive compensation&#59; (B) upon a termination of employment due to death, disability or retirement&#59; (C) upon a Change of Control&#59; (D) to a Substitute Award that does not reduce the vesting period of the award being replaced&#59; or (E)&#160;to Awards involving an aggregate number of Shares not in excess of five percent of Shares available for grant as Other Stock Based-Awards that are Full-Value Awards (together with all other Shares available for grant as Full-Value Awards). Notwithstanding anything to the contrary in an Award Agreement, in no event shall a dividend or other distribution or dividend equivalent be paid on an Other-Stock Based Award until the Award has vested.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:80pt;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 9.</font><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Performance Cash Awards</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Performance Cash Awards may be issued under the Plan, for no cash consideration or for such minimum consideration as may be required by applicable law, either alone or in addition to other Awards. A &#8220;Performance Cash Award&#8221; is an Award entitling the recipient to payment of a cash amount subject to the attainment of Performance Goals. The Committee may, in connection with the grant of a Performance Cash Award, designate the Award as a Qualified Performance-Based Award. The conditions for grant or vesting and the other provisions of a Performance Cash Award (including without limitation any applicable Performance Goals) need not be the same with respect to each Participant. Performance Cash Awards may be paid in cash, Shares, other property or any combination thereof, in the sole discretion of the Committee as set forth in the applicable Award Agreement. The performance levels to be achieved for each Performance Period and the amount of the Award to be distributed shall be conclusively determined by the&#160;Committee.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:80pt;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 10. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Change of Control Provisions</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.1 Impact of Event</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Notwithstanding any other provision of this Plan to the contrary, the provisions of this Section 10 shall apply in the event of a Change of Control, unless otherwise provided in the applicable Award Agreement.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Upon a Change of Control, (i) all then-outstanding Options and SARs shall become fully vested and exercisable, and any Full-Value Award (other than a Performance Award) shall vest in full, be free of restrictions, and be deemed to be earned and immediately payable in an amount equal to the full value of such Award, except in each case to the extent that another Award meeting the requirements of Section 10.1(b) (any award meeting the requirements of Section 10.1(b), a &#8220;Replacement Award&#8221;) is provided to the Participant pursuant to Section 3.4 to replace such Award (any award intended to be replaced by a Replacement Award, a &#8220;Replaced Award&#8221;), and (ii)&#160;any Performance Award that is not replaced by a Replacement Award shall be deemed to be earned and immediately payable in an amount equal to the full value of such Performance Award (with all applicable Performance Goals deemed achieved at the greater of (x) the applicable target level and (y) the level of achievement of the Performance Goals for the Award as determined by the Committee not later than the date of the Change of Control, taking into account performance through the latest date preceding the Change of Control as to which performance can, as a practical matter, be determined (but not later than the end of the Performance Period)) multiplied by a fraction, the numerator of which is the number of days during the applicable Performance Period before the date of the Change of Control, and the denominator of which is the number of days in the applicable Performance Period&#59; provided, however, that such fraction shall be equal to one in the event that the applicable Performance Goals in respect of such Performance Award have been fully achieved as of the date of such Change of Control.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;An Award shall meet the conditions of this Section 10.1(b) (and hence qualify as a Replacement Award) if&#58; (i) it is of the same type as the Replaced Award&#59; (ii) it has a Fair Market Value at least equal to the value of the Replaced </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Award as of the date of the Change of Control&#59; (iii) if the underlying Replaced Award was an equity-based award, it relates, following the Change of Control, to publicly traded equity securities of the Company or the Surviving Corporation or the ultimate parent company which results from the Change of Control&#59; and (iv) its other terms and conditions are not less favorable to the Participant than the terms and conditions of the Replaced Award (including the provisions that would apply in the event of a subsequent Change of Control) as of the date of the Change of Control. Without limiting the generality of the foregoing, a Replacement Award may take the form of a continuation of the applicable Replaced Award if the requirements of the preceding sentence are satisfied. The determination whether the conditions of this Section&#160;10.1(b) are satisfied shall be made by the Committee, as constituted immediately before the Change of Control, in its sole discretion.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Upon a Termination of Employment of a Participant occurring in connection with or during the two years following the date of a Change of Control, by the Company other than for Cause or by the Participant for Good Reason, (i)&#160;all Replacement Awards held by such Participant shall vest in full, be free of restrictions, and be deemed to be earned and immediately payable in an amount equal to the full value of such Replacement Award, and (ii) all Options and SARs held by the Participant immediately before the Termination of Employment that the Participant held as of the date of the Change of Control or that constitute Replacement Awards shall remain exercisable until the earlier of (1) the third anniversary of the Change of Control and (2) the expiration of the stated Term of such Option or SAR&#59; provided, that if the applicable Award Agreement provides for a longer period of exercisability, that provision shall control.</font></div><div style="padding-left:19.85pt;text-indent:-19.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.2 Definition of Change of Control</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For purposes of the Plan, a &#8220;Change of Control&#8221; shall mean any of the following events&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Act) (a &#8220;Person&#8221;) becomes the Beneficial Owner (within the meaning of Rule 13d-3 promulgated under the Act) of 30% or more of either (i) the then-outstanding Shares of the Company (the &#8220;Outstanding Company Shares&#8221;) or (ii) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the &#8220;Outstanding Company Voting Securities&#8221;)&#59; provided that, for purposes of this subsection (a), the following acquisitions shall not constitute a Change of Control&#58; (1) an acquisition directly from the Company&#59; (2)&#160;an acquisition by the Company or a Subsidiary&#59; (3)&#160;an acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Subsidiary&#59; (4) any acquisition by an underwriter temporarily holding securities pursuant to an offering of such securities or (5) an acquisition pursuant to a transaction that complies with Sections 10.2(c)(i), 10.2(c)(ii), and 10.2(c)(iii) below&#59;</font></div><div style="padding-left:19.85pt;text-indent:-19.85pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Individuals who, on the Effective Date, constitute the Board (the &#8220;Incumbent Directors&#8221;) cease for any reason to constitute at least a majority of the Board&#59; provided that any person becoming a director subsequent to the Effective Date whose election, or nomination for election by the Company&#8217;s shareholders, was approved by a vote of at least a majority of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without written objection to such nomination) shall be considered an Incumbent Director&#59; but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of any Person other than the Board&#59; or</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The consummation of a reorganization, merger, statutory share exchange or consolidation (or similar corporate transaction) involving the Company or a Subsidiary, the sale or other disposition of all or substantially all of the Company&#8217;s assets, or the acquisition of assets or stock of another entity (a &#8220;Business Combination&#8221;), unless immediately following such Business Combination&#58; (i)&#160;substantially all of the individuals and entities who were Beneficial Owners, respectively, of the Outstanding Company Shares and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of, respectively, the then-outstanding Shares and the total voting power of (A) the corporation resulting from such Business Combination (the &#8220;Surviving Corporation&#8221;) or (B) if applicable, the ultimate parent corporation that directly or indirectly has beneficial ownership of 80% or more of the voting securities eligible to elect directors of the Surviving Corporation (the &#8221; Parent Corporation&#8221;), in substantially the same proportion as their ownership, immediately prior to the Business Combination, of the Outstanding Company Shares and the Outstanding Company Voting Securities, as the case may be, (ii) no Person (other than any employee benefit plan (or related trust) sponsored or maintained by the Surviving Corporation or the Parent Corporation), is or becomes the Beneficial Owner, directly or indirectly, of 30% or more of the outstanding Shares and the total voting power of the outstanding securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) and (iii) at least a </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">majority of the members of the Board of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) following the consummation of the Business Combination were Incumbent Directors at the time of the Board&#8217;s approval of the initial agreement providing for such Business Combination&#59; or</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Approval by the shareholders of the Company of a complete liquidation or dissolution of the Company.</font></div><div style="padding-left:19.85pt;text-indent:-19.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the avoidance of doubt, any one or more of the above events may be effected pursuant to (A) a compromise or arrangement sanctioned by the court under Chapter 1 of Part 9 of the Companies Act 2014 of the Republic of Ireland or (B)&#160;Chapter 2 of Part 9 of the Companies Act 2014 of the Republic of Ireland.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.3 Section 409A of the Code</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if any Award is subject to Section 409A of the Code, (a) this Section 10 shall be applicable only to the extent specifically provided in the Award Agreement and as permitted pursuant to Section 11.6&#59; and (b) in respect of any Award subject to Section 409A of the Code, to the extent required to avoid an accelerated or additional tax under Section 409A of the Code, in no event shall a Change of Control be treated as having occurred if such event is not a &#8220;change of control event&#8221; for purposes of Section 409A of the Code.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:80pt;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 11. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Qualified Performance-Based Awards&#59; Performance Cash Awards</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.1 Qualified Performance-Based Awards</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The provisions of this Plan are intended to ensure that all Options and Stock Appreciation Rights granted hereunder to any Participant who is or may be a &#8220;covered employee&#8221; (within the meaning of Section 162(m)(3) of the Code) in the tax year in which such Option or Stock Appreciation Right is expected to be deductible to the Company qualify for the Section 162(m) Exemption, and all such Awards shall therefore be considered Qualified Performance-Based Awards and this Plan shall be interpreted and operated consistent with that intention. When granting any Award other than an Option or Stock Appreciation Right, the Committee may designate such Award as a Qualified Performance-Based Award, based upon a determination that (a) the recipient is or may be a &#8220;covered employee&#8221; (within the meaning of Section 162(m)(3) of the Code) with respect to such Award, and (b) the Committee wishes such Award to qualify for the Section 162(m) Exemption, and the terms of any such Award (and of the grant thereof) shall be consistent with such designation. Within 90 days after the commencement of a Performance Period or, if earlier, prior to the expiration of 25% of a Performance Period, the Committee will designate one or more Performance Periods, determine the Participants for the Performance Periods, and establish the Performance Goals for the Performance Periods on terms consistent with Section&#160;1.2(ee)(iii).</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.2 Performance Goals and Other Conditions</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each Qualified Performance-Based Award (other than an Option or Stock Appreciation Right) shall be earned, vested, and&#47;or payable (as applicable) upon the achievement of one or more Performance Goals, together with the satisfaction of any other conditions, such as continued employment, as the Committee may determine to be appropriate. Moreover, no Qualified Performance-Based Award may be amended, nor may the Committee exercise any discretionary authority it may otherwise have under this Plan with respect to a Qualified Performance-Based Award under this Plan, in any manner that would cause the Qualified Performance-Based Award to cease to qualify for the Section 162(m) Exemption&#59; provided , that (i) the Committee may provide, either in connection with the grant of the applicable Award or by amendment thereafter, that achievement of such Performance Goals will be waived upon the death or disability of the Participant (or under any other circumstance with respect to which the existence of such possible waiver will not cause the Award to fail to qualify for the Section&#160;162(m) Exemption), and (ii) the provisions of Section 10 shall apply notwithstanding this Section 11.2.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.3 Limits on Board and Administrator Authority</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Neither the full Board nor the Administrator shall be permitted to exercise authority granted to the Committee to the extent that the grant or exercise of such authority to or by the Board or the Administrator would cause an Award designated as a Qualified Performance-Based Award not to qualify for, or to cease to qualify for, the Section 162(m) Exemption.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.4 Section 16(b)</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The provisions of this Plan are intended to ensure that no transaction under the Plan is subject to (and not exempt from) the short-swing recovery rules of Section 16(b) of the Act (&#8220;Section 16(b)&#8221;). Accordingly, the composition of the Committee shall be subject to such limitations as the Board deems appropriate to permit transactions pursuant to this Plan to be exempt (pursuant to Rule 16b-3 promulgated under the Act) from Section 16(b), and no delegation of authority by the Committee shall be permitted if such delegation would cause any such transaction to be subject to (and not exempt from) Section&#160;16(b).</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.5 Awards Valid Notwithstanding Committee Composition</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Notwithstanding any other provision of the Plan to the contrary, if for any reason the appointed Committee does not meet the requirements of Rule 16b-3 or Section 162(m) of the Code, such noncompliance with the requirements of Rule 16b-3 and Section&#160;162(m) of the Code shall not affect the validity of Awards, grants, interpretations of the Plan, or other actions of the Committee.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.6 Section 409A of the Code</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;It is the intention of the Company that no Award shall be &#8220;deferred compensation&#8221; subject to Section 409A of the Code, unless and to the extent that the Committee specifically determines otherwise as provided in the immediately following sentence, and the Plan and the terms and conditions of all Awards shall be interpreted accordingly. The terms and conditions governing any Awards that the Committee determines will be subject to Section 409A of the Code, including any rules for elective or mandatory deferral of the delivery of cash or Shares pursuant thereto and any rules regarding treatment of such Awards in the event of a Change of Control, shall be set forth in the applicable Award Agreement, and shall comply in all respects with Section 409A of the Code. In no event whatsoever shall the Company be liable for any additional tax, interest or penalty that may be imposed on a Participant by Section 409A of the Code or damages for failing to comply with Section 409A of the Code.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The intent of the parties is that payments and benefits under this Plan comply with Section 409A of the Code, to the extent subject thereto, and accordingly, to the maximum extent permitted, this Plan shall be interpreted and administered to be in compliance therewith. Notwithstanding anything contained herein to the contrary, a Participant shall not be considered to have terminated employment with the Company for purposes of any payments under the Plan which are subject to Section 409A of the Code until the Participant has incurred a &#8220;separation from service&#8221; from the Company within the meaning of Section 409A of the Code. Each amount to be paid or benefit to be provided under this Plan shall be construed as a separate identified payment for purposes of Section 409A of the Code. Without limiting the foregoing and notwithstanding anything contained herein to the contrary, to the extent required in order to avoid an accelerated or additional tax under Section 409A of the Code, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to this Plan during the six-month period immediately following a Participant&#8217;s separation from service shall instead be paid on the first business day after the date that is six months following the Participant&#8217;s separation from service (or, if earlier, the Participant&#8217;s date of death). The Company makes no representation that any or all of the payments described in this Plan will be exempt from or comply with Section 409A of the Code and makes no undertaking to preclude Section 409A of the Code from applying to any such payment.</font></div><div style="padding-left:19.85pt;text-indent:-19.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:80pt;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 12. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Term, Amendment, and Termination</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.1 Effectiveness</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Effective Date of the Plan is December 8, 2017, subject to any required approval of the Company&#8217;s shareholders.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.2 Termination</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Plan will terminate on the tenth anniversary of the Effective Date. Awards outstanding as of such termination date shall not be affected or impaired by the termination of the Plan.</font></div><div><font><br></font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.3 Amendment of Plan</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board or the Committee may amend, alter, or discontinue the Plan, but no amendment, alteration, or discontinuation shall be made which would materially impair the rights of any Participant with respect to a previously granted Award </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">without such Participant&#8217;s consent, except such an amendment made to comply with applicable law, including, without limitation, Section 409A of the Code, Section 162(m) of the Code, Section 422 of the Code, stock exchange rules or accounting rules. In addition, no such amendment shall be made without the approval of the Company&#8217;s shareholders to the extent that such approval is required by applicable law or by the listing standards of the Applicable Exchange.</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.4 Amendment of Awards</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subject to Section 5.12, the Committee may unilaterally amend the terms of any Award theretofore granted&#59; provided, however, that no such amendment shall cause a Qualified Performance-Based Award to cease to qualify for the Section 162(m) Exemption. Subject to the foregoing, the amendment authority of the Committee shall include, without limitation, the authority to modify the number of Shares or other terms and conditions of an Award&#59; extend the term of an Award&#59; accelerate the exercisability or vesting or otherwise terminate any restrictions relating to an Award&#59; accept the surrender of any outstanding Award&#59; and, to the extent not previously exercised or vested, authorize the grant of new Awards in substitution for surrendered Awards&#59; provided, however that (a) the amended or modified terms are permitted by the Plan as then in effect&#59; (b) any Participant adversely affected by such amended or modified terms shall have consented to such amendment or modification unless such amendment is necessary to comply with applicable law, including, without limitation, Section&#160;409A of the Code, Section 162(m) of the Code, Section&#160;422 of the Code, stock exchange rules or accounting rules&#59; and (c) the authority to accelerate the exercisability or vesting or otherwise terminate restrictions relating to an Award may be exercised only in connection with a Participant&#8217;s death, disability or retirement, in connection with a Change of Control, or to the extent such actions involve an aggregate number of Shares not in excess of 5% of the number of shares available for Awards.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:80pt;text-align:justify;text-indent:-80pt"><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 13.</font><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Forfeiture</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13.1 Forfeiture</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subject to applicable law, all Awards under this Plan shall be subject to forfeiture or other penalties pursuant (a) to the Company&#8217;s Incentive Compensation Forfeiture Policy, as amended from time to time, and (b)&#160;such other forfeiture and&#47;or penalty conditions and provisions as determined by the Committee and set forth in the applicable Award Agreement.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13.2 Effect of Change of Control</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Notwithstanding the foregoing provisions, unless otherwise provided by the Committee in the applicable Award Agreement or required by applicable law, this Section 13 shall not be applicable to any Participant following a Change of Control.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:80pt;text-align:justify;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 14. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Unfunded Status of Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unfunded Status&#59; Committee Authority. It is presently intended that the Plan will constitute an &#8220;unfunded&#8221; plan for incentive and deferred compensation. The Committee may authorize the creation of trusts or other arrangements to meet the obligations created under the Plan to deliver Shares or make payments&#59; provided, that unless the Committee otherwise determines, the existence of such trusts or other arrangements is consistent with the &#8220;unfunded&#8221; status of the Plan.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:80pt;text-align:justify;text-indent:-80pt"><font style="color:#054e85;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 15. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">General Provisions</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.1 Conditions for Issuance</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee may require each Participant purchasing or receiving Shares pursuant to an Award to represent to and agree with the Company in writing that such person is acquiring the Shares without a view to the distribution thereof. The certificates for such Shares may include any legend which the Committee deems appropriate to reflect any restrictions on transfer. Notwithstanding any other provision of the Plan or agreements made pursuant thereto, the Company shall not be required to issue or deliver any certificate or certificates for Shares under the Plan prior to fulfillment of all of the following conditions&#58; (a)&#160;listing or approval for listing upon notice of issuance of such Shares on the Applicable Exchange, (b) any registration or other qualification of such Shares of the Company under any state or federal law or regulation, or the maintaining in effect of any such registration or other qualification which the Committee shall, in its absolute discretion upon the advice of counsel, deem necessary or advisable, and (c)&#160;obtaining any other consent, approval, or permit from </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">any state or federal governmental agency which the Committee shall, in its absolute discretion after receiving the advice of counsel, determine to be necessary or advisable.</font></div><div><font><br></font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.2 Additional Compensation Arrangements</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Nothing contained in the Plan shall prevent the Company or any Subsidiary from adopting other or additional compensation arrangements for its employees.</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.3 No Contract of Employment</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Plan shall not constitute a contract of employment, and adoption of the Plan shall not confer upon any employee any right to continued employment, nor shall it interfere in any way with the right of the Company or any Subsidiary to terminate the employment of any employee at any time.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.4 Required Taxes</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No later than the date as of which an amount first becomes includible in the gross income of a Participant for federal, state, local, or foreign income or employment or other tax purposes with respect to any Award under the Plan, such Participant shall pay to the Company, or make arrangements satisfactory to the Company regarding the payment of, any federal, state, local, or foreign taxes of any kind required by law to be withheld with respect to such amount. Unless otherwise determined by the Company, withholding obligations may be settled with Shares, including Shares that are part of the Award that gives rise to the withholding requirement, in an amount not to exceed the maximum statutory tax rates in the applicable jurisdiction and that will not cause the Company adverse accounting consequences, all in accordance with such procedures as the Committee establishes and to the extent permissible under applicable law and applicable withholding rules. The obligations of the Company under the Plan shall be conditioned on such payment or arrangements, and the Company and its Subsidiaries shall, to the extent permitted by law, have the right to deduct any such taxes from any payment otherwise due to such Participant. The Committee may establish such procedures as it deems appropriate, including making irrevocable elections, for the settlement of withholding obligations with Shares.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.5 Limit on Dividend Reinvestment and Dividend Equivalents</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reinvestment of dividends in additional Restricted Stock Units to be settled in Shares, and the payment of Shares with respect to dividends to Participants holding Awards of Restricted Stock Units, shall only be permissible if sufficient Shares are available under Section 3 for such reinvestment or payment (taking into account then outstanding Awards). In the event that sufficient Shares are not available for such reinvestment or payment, such reinvestment or payment shall be made in the form of a grant of Restricted Stock Units equal in number to the Restricted Stock Units or Shares that would have been obtained by such payment or reinvestment, the terms of which Restricted Stock Units shall provide for settlement in cash and for dividend equivalent reinvestment in further Restricted Stock Units on the terms contemplated by this Section&#160;15.5.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.6 Written Materials&#59; Electronic Documents</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Electronic documents may be substituted for any written materials required by the terms of the Plan, including, without limitation, Award Agreements.</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.7 Designation of Death Beneficiary</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee shall establish such procedures as it deems appropriate for a Participant to designate a beneficiary to whom any amounts payable in the event of such Participant&#8217;s death are to be paid or by whom any rights of such Participant after such Participant&#8217;s death may be exercised. If no beneficiary designation is in effect for a Participant at the time or his or her death, any such amounts shall be paid to, and any such rights may be exercised by, the estate of the Participant.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.8 Subsidiary Employees</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the case of a grant of an Award to any employee of a Subsidiary of the Company, the Company may, if the Committee so directs, issue or transfer the Shares, if any, covered by the Award to the Subsidiary, for such lawful consideration as the Committee may specify, upon the condition or understanding that the Subsidiary will transfer the Shares to the employee </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">in accordance with the terms of the Award specified by the Committee pursuant to the provisions of the Plan. All Shares underlying Awards that are forfeited or canceled shall revert to the&#160;Company.</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.9 Governing Law</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Plan and all Awards made and actions taken thereunder shall be governed by and construed in accordance with the laws of the State of Minnesota, without reference to principles of conflict of laws.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.10 Non-Transferability</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Except as otherwise provided in Section 5.10 or by the Committee, Awards under the Plan are not transferable except by will or by laws of descent and distribution.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.11 Foreign Employees and Foreign Law Considerations</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee may grant Awards to Eligible Individuals who are foreign nationals, who are located outside the United States, who are United States citizens or resident aliens on global assignments in foreign nations, who are not compensated from a payroll maintained in the United States, or who are otherwise subject to (or could cause the Company to be subject to) legal or regulatory provisions of countries or jurisdictions outside the United States, on such terms and conditions different from those specified in the Plan as may, in the judgment of the Committee, be necessary or desirable to foster and promote achievement of the purposes of the Plan, and, in furtherance of such purposes, the Committee may make such modifications, amendments, procedures, or subplans as may be necessary or advisable to comply with such legal or regulatory provisions.</font></div><div><font><br></font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.12 No Rights to Awards&#59; Non-Uniform Determinations</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No Participant or Eligible Individual shall have any claim to be granted any Award under the Plan. The Company, its Subsidiaries, or the Committee shall not be obligated to treat Participants or Eligible Individuals uniformly, and determinations made under the Plan may be made by the Committee selectively among Participants and&#47;or Eligible Individuals, whether or not such Participants and Eligible Individuals are similarly situated. Awards under a particular Section of the Plan need not be uniform between and among Participants.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.13 Relationship to Other Benefits</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No payment under the Plan shall be taken into account in determining any benefits under any pension, retirement, savings, profit sharing, group insurance, welfare, or benefit plan of the Company or any Subsidiary unless provided otherwise in such plan.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.14 Expenses</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expenses of administering the Plan shall be borne by the Company and its Subsidiaries.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.15 Titles and Headings</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The titles and headings of the Sections in the Plan are for convenience of reference only, and in the event of any conflict, the text of the Plan, rather than such titles or headings, shall control.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.16 Fractional Shares</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No fractional Shares shall be issued under the Plan.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.17 Government and Other Regulations</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Notwithstanding any other provision of the Plan&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;No Participant who acquires Shares pursuant to the Plan may, during any period of time that such Participant is an affiliate of the Company (within the meaning of regulations promulgated pursuant to the Securities Act of 1933 (the &#8220;1933 Act&#8221;)), offer or sell such Shares, unless such offer and sale are made (i)&#160;pursuant to an effective registration </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">statement under the 1933 Act, which is current and includes the Shares to be sold, or (ii) pursuant to an appropriate exemption from the registration requirements of the 1933 Act, such as that set forth in Rule 144 promulgated under the 1933 Act.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If at any time the Committee shall determine that the registration, listing, or qualification of the Shares covered by an Award upon the Applicable Exchange or under any foreign, federal, state, or local law or practice, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of, or in connection with, the granting of such Award or the purchase or receipt of Shares thereunder, no Shares may be purchased, delivered, or received pursuant to such Award unless and until such registration, listing, qualification, consent, or approval shall have been effected or obtained free of any condition not acceptable to the Committee. Any Participant receiving or purchasing Shares pursuant to an Award shall make such representations and agreements and furnish such information as the Committee may request to assure compliance with the foregoing or any other applicable legal requirements. The Company shall not be required to issue or deliver any certificate or certificates for Shares under the Plan prior to the Committee&#8217;s determination that all related requirements have been fulfilled. The Company shall in no event be obligated to register any Shares or any other securities pursuant to the 1933 Act or applicable state or foreign law or to take any other action in order to cause the issuance and delivery of such certificates to comply with any such law, regulation, or requirement.</font></div><div style="padding-left:19.85pt;text-indent:-19.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.18 Additional Provisions</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each Award Agreement may contain such other terms and conditions as the Committee may determine&#59; provided that such other terms and conditions are not inconsistent with the provisions of the Plan.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.19 No Limitations on Rights of the Company</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The grant of any Award shall not in any way affect the right or power of the Company to make adjustments, reclassifications, or changes in its capital or business structure or to merge, consolidate, dissolve, liquidate, sell, or transfer all or any part of its business or assets. The Plan shall not restrict the authority of the Company, for proper corporate purposes, to draft, grant, or assume Awards, other than under the Plan, with respect to any person.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.20 Severability</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the event any provision of the Plan shall be held illegal or invalid for any reason, such illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.21 Blackout Periods</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Notwithstanding any other provision of this Plan or any Award to the contrary, the Company shall have the authority to establish any &#8220;blackout&#8221; period that the Company deems necessary or advisable with respect to any or all Awards.</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.22 Irish Conditions for Issuance</font></div><div><font style="color:#054e85;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Notwithstanding any other provision of this Plan, (a) the Company shall not be obliged to issue any Shares pursuant to an Award unless at least the par (nominal) value of such newly issued Share has been fully paid in advance in accordance with applicable law (which requirement may mean the holder of an Award is obliged to make such payment), (b) no adjustments may be made to an Award which reduce the price payable for a Share subject to such Award below the par (nominal) value of a Share and (c) the Company shall not be obliged to issue or deliver any Shares in satisfaction of Awards until all legal and regulatory requirements associated with such issue or delivery have been complied with to the satisfaction of the Committee.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex102-amendedandrestat.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i82fa59482c674a2a89c591f529746fb3_37"></div><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:198pt;padding-left:3.57pt;padding-right:3.57pt;text-align:center"><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">COVIDIEN SUPPLEMENTAL SAVINGS</font></div><div style="text-align:center"><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> AND RETIREMENT PLAN</font></div><div style="padding-left:3.57pt;padding-right:3.57pt;text-align:center"><font><br></font></div><div style="padding-left:3.57pt;padding-right:3.57pt;text-align:center"><font><br></font></div><div style="padding-left:3.57pt;padding-right:3.57pt;text-align:center"><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">Amended and Restated</font></div><div style="padding-left:3.57pt;padding-right:3.57pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">Adopted by Tyco Healthcare Group LP </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">(renamed as Covidien LP on September 28, 2012) </font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">Effective as of January 1, 2010</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">(Conformed through the Amendment adopted November 6, 2020)</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i82fa59482c674a2a89c591f529746fb3_40"></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.226%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE I</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Purpose</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Supplemental Savings and Retirement Plan</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Background</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Benefits Under the Tyco SSRP and the Plan.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Deferred Compensation Plan</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Adoption of Plan.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE II Definitions</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Administrative Error Correction.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Affiliated Company</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Annual Enrollment Period</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Base Salary</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Base Salary Deferral</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Beneficiary(ies)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Board</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Bonus Compensation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Bonus Compensation Deferral</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cause</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Change of Control</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Code</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Commission Compensation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Company</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Company Credit</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Compensation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Compensation Deferral</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Core Company Credit</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Covidien</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Disability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Discretionary Credit</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Effective Date and Amendment Effective Date</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Eligible Employee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Enrollment and Payment Agreement</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Exchange Act.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.27</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Fiscal Year</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.226%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Matching Credit</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.29</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Maximum Matching Percentage</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Measurement Funds</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Participant</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.32</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payment Date</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.33</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Plan</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.34</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Plan Administrator</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.35</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Plan Year</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.36</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Prior Eligible Employee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.37</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Responsible Company.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.38</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Retirement</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.39</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;RSIP</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.40</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;RSIP Election</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.41</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Separation Date</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.42</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Separation from Service</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.43</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Separation Payment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.44</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Specified Date Payment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.45</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Spillover Deferrals</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.46</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Subsidiary Change of Control</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.47</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Tyco SSRP</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.48</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Unforeseeable Emergency</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.49</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Year of Service</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE III Administration</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Plan Administrator</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IV Participation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Eligible Employees</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Prior Eligible Employees</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE V Basic Deferral Participation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Election to Participate</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Amount of Deferral Election</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Deferral Limits</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Period of Commitment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Vesting of Compensation Deferrals</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Compensation Deferral Cancellation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VI Spillover Participation&#47;Matching, Company and Discretionary Credits</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Spillover Election</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.226%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Matching Credits.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Company Credits.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Core Company Credits</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Discretionary Credits.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Vesting of Matching, Company, Core and Discretionary Credits</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VII Participant Account</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Establishment of Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Earnings (or Losses) on Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Valuation of Account.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Statement of Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payments From Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Separate Accounting</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VIII Payments to Participants</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Distribution Payments.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Change in Election</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cash-Out Payments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Death or Disability Benefit</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Valuation of Payments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Unforeseeable Emergency.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Withholding Taxes</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Effect of Payment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Delay of Payment for Specified Employees</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IX Claims Procedures</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Filing a Claim</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Appeal of Denied Claims</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">17</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Legal Action</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Discretion of the Plan Administrator</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE X Miscellaneous</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Protective Provisions.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inability to Locate Participant or Beneficiary</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i82fa59482c674a2a89c591f529746fb3_43" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Designation of Beneficiary.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No Contract of Employment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No Limitation on Company Actions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Obligations to Company</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No Liability for Action or Omission.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Non-alienation of Benefits</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">19</font></div></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.226%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Liability for Benefit Payments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Covidien Guarantee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Unfunded Status of Plan</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Forfeiture for Cause</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Governing Law</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Severability of Provisions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Headings and Captions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Gender, Singular and Plural</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Notice</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Amendment and Termination</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Special Rule Regarding Election Changes Prior to December 31, 2008</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-top:3.7pt;padding-left:0.6pt;padding-right:0.6pt;text-align:center"><font><br></font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i82fa59482c674a2a89c591f529746fb3_43"></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">COVIDIEN SUPPLEMENTAL SAVINGS AND RETIREMENT PLAN</font></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE I</font></div><div style="text-align:center"><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Purpose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Supplemental Savings and Retirement Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The name of this Plan is the Covidien Supplemental Savings and Retirement Plan. The Plan was created to provide certain of the key employees of the Company with the ability to defer receipt of compensation that would otherwise be payable to them and to make up for amounts that could not be contributed on their behalf as matching contributions under the Covidien Retirement Savings and Investment Plan due to ce1iain restrictions applicable under the Code. Except for amounts that were deferred and vested as of December 31, 2004, the terms of this Plan are intended to, and shall be interpreted and applied so as to, comply in all respects with the provisions of Code Section 409A and regulations and rulings promulgated thereunder and, if necessary, any provision shall be held null and void to the extent such provision (or part thereof) fails to comply with Code Section 409A or the regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Background</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Effective as of April 1, 1994, TME Management Corporation (&#8220;TME&#8221;) adopted the Tyco Deferred Compensation Plan (&#8220;Tyco DCP&#8221;) to allow a select group of key management or other highly compensated employees of TME and its parents, affiliates and subsidiaries to defer the receipt of compensation that would otherwise be payable to them. All compensation deferrals under the Tyco DCP were deferred and vested before January 1, 2005. Except as provided hereunder, such amounts and the earnings thereon shall therefore continue to be administered in accordance with the terms of the Tyco DCP as in effect prior to the adoption of the Plan and shall constitute &#8220;grandfathered&#8221; amounts that are not subject to Code Section 409A and the regulations and rulings promulgated thereunder. TME amended and restated the Tyco DCP, effective as of January 1, 2005 as the Tyco Supplemental Savings and Retirement Plan (&#8220;Tyco SSRP&#8221;). When Tyco&#8217;s healthcare business separated from Tyco International Ltd. on June 29, 2007, and was renamed Covidien Ltd., the Company adopted this Plan as a spin-off and continuation of the Tyco SSRP solely with respect to employees and Participants aligned with Tyco&#8217;s healthcare business unit and the Accounts of such Participants (including grandfathered amounts) were transferred to the Plan. On June 4, 2009, Covidien Ltd. was reorganized by means of a scheme of arrangement whereby the place of incorporation was effectively changed from Bermuda to Ireland and following certain corporate action, the common shares of Covidien Ltd. were exchanged on a one-for-one basis for ordinary shares of Covidien plc. As a result of this reorganization, Covidien Ltd. became a wholly-owned subsidiary of Covidien plc. On September 28, 2012, Tyco Healthcare Group LP was renamed as Covidien LP. In 2016, Medtronic plc acquired Covidien plc, including Covidien LP as a subsidiary of Covidien plc.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Benefits Under the Tyco SSRP and the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. With respect to each Participant (or Beneficiary, as applicable) who participated in the Tyco SSRP prior to June 29, 2007 and who was aligned with Tyco&#8217;s healthcare business unit, Tyco International Management Company transferred from the Tyco SSRP to such Participant&#8217;s or Beneficiary&#8217;s Account under the Plan an amount equal to the value of the notional accounts credited to the Participant or Beneficiary under the Tyco SSRP immediately prior to such transfer. The transfer of the value of such notional </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">accounts pursuant to this paragraph was in lieu of maintaining such credits and liabilities under the Tyco SSRP and the transfer occurred as of Jm1e 29, 2007.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Other than the &#8220;grandfathered&#8221; amounts described in Section 1.2, benefits for any Participant or Beneficiary that were credited under the Tyco SSRP and transferred to this Plan will be determined in accordance with the provisions of the Tyco SSRP, but paid in accordance with this Plan, unless modifications to such transferred benefits are specifically provided by a subsequent amendment to this Plan. Benefits credited on and after the Effective Date shall be determined in accordance with the provisions of this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Deferred Compensation Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company intends that the Plan shall at all times be maintained on an unfunded basis for federal income tax purposes under the Code, and administered as a non-qualified, &#8220;top hat&#8221; plan exempt from the substantive requirements of the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Adoption of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Plan initially was adopted by Tyco Healthcare Group LP effective as of June 29, 2007, and was amended and restated, effective as of January 1, 2009. Effective as of January 1, 2010, Tyco Healthcare Group LP, by action of the Covidien Benefits Committee, hereby amends and restates the Plan.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE II</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Definitions</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For ease of reference, the following definitions will be used in the Plan&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Account&#8221; means the bookkeeping account maintained on the books of the Company used solely to calculate the amount payable to each Participant who defers Compensation under this Plan or is otherwise entitled to a benefit under Article VI and shall not constitute a separate fund of assets. The term &#8220;Account&#8221; includes the value of amounts transferred from the Tyco SSRP in connection with the Company&#8217;s separation from Tyco International Ltd. on June 29, 2007 (as described in Section 1.2 above).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative Error Correction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Administrative Error Correction&#8221; means the discretion used by the Plan Administrator to permit an Administrative Error to be corrected by allowing the affected Eligible Employee&#8217;s or Participant&#8217;s Enrollment and Payment Agreement to be processed after the end of the Annual Enrollment Period or 30- day enrollment period for newly eligible employees, as applicable. Corrections attributable to an Annual Enrollment Period may be processed after such Annual Enrollment Period ends but may not be processed after January 31 of the Plan Year to which the Enrollment and Payment Agreement relates. Corrections attributable to a 30- day enrollment period may be processed after such period expires but may not be processed after the later of (a) 30 days after such expiration date or (b) 60 days after the date the Eligible Employee is notified of eligibility to participate in the Plan. Corrections under this Section 2.2 shall only be allowed to the extent permitted under Code Section 409A and the regulations and rulings promulgated thereunder. &#8220;Administrative Error&#8221; means (x) an error by an Eligible Employee or Participant to properly complete or file an Enrollment and Payment Agreement, or any other similar action, following a good faith attempt, or (y) the failure of the Plan Administrator </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or its delegate to properly process an Eligible Employee or Participant&#8217;s Enrollment and Payment Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliated Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Affiliated Company&#8221; shall mean (a) a corporation which, together with the Company, is a member of a controlled group of corporations (as defined in Code Section 414(b)), (b) a trade or business (whether or not incorporated) which is under common control (as defined in Code Section 414(c)) with Covidien, (c) a corporation, partnership or other entity which, together with Covidien, is a member of an affiliated service group (as defined in Code Section 414(m)), (d) an organization which is required to be aggregated with Covidien pursuant to regulations promulgated under Code Section 414(o), or (e) any service recipient or employer that is within a controlled group of corporations as defined in Code Sections 1563(a)(1), (2) and (3) where the phrase &#8220;at least 50%&#8221; is substituted in each place &#8220;at least 80%&#8221; appears and any service recipient or employer with trades or businesses under common control as defined in Code Section 414(c) and Treas. Reg. Section 1.414(c)-2 where the phrase &#8220;at least 50%&#8221; is substituted in each place &#8220;at least 80%&#8221; appears, provided, however, that when the relevant determination is to be based upon legitimate business criteria (as described in Treas. Reg. Sections 1.409A-1(b)(5)(iii)(E) and 1.409A-1(h)(3)), the phrase &#8220;at least 20%&#8221; shall be substituted in each place &#8220;at least 80%&#8221; appears as described above with respect to both a controlled group of corporations and trades or businesses under common control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Enrollment Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Annual Enrollment Period&#8221; shall mean, with respect to a Plan Year, the period that begins on a date specified by the Plan Administrator and that ends no later than December 31st of the year immediately preceding the Plan Year for which elections made during such period are effective.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Base Salary&#8221; means the annual rate of base salary paid to each Participant as of any date of reference before any reduction for any amounts deferred by the Participant pursuant to Code Section 401(k) or Code Section 125, or pursuant to this Plan or any other non-qualified plan which permits the voluntary deferral of compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Base Salary Deferral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Base Salary Deferral&#8221; means that portion of Base Salary as to which a Participant has made an election to defer receipt pursuant to Article V. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficiary(ies)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Beneficiary&#8221; or &#8220;Beneficiaries&#8221; means the person or persons designated by the Participant to receive payments under this Plan in the event of the Participant&#8217;s death as provided in Section 10.3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Board&#8221; means the Board of Directors of Covidien.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Bonus Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Bonus Compensation&#8221; means any annual performance-based cash bonus or incentive compensation, payable to a Participant pursuant a written plan that provides for annual payments thereunder, as of any date of reference before any reduction for any amounts deferred by the Participant pursuant to Code Section 401(k) or Code Section 125, or pursuant to this Plan or any other non-qualified plan which permits the voluntary deferral of compensation. Bonus Compensation shall not include (a) any special or one-time bonus payment, (b) any amount paid under any equity incentive plan, (c) any bonus paid after Separation from Service, and (d) Commission Compensation.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Bonus Compensation Deferral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Bonus Compensation Deferral&#8221; means that portion of Bonus Compensation as to which a Participant has made an election to defer receipt pursuant to Article V.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Cause&#8221; means a Participant&#8217;s (a) substantial failure or refusal to perform duties and responsibilities of his or her job as required by the Company, (b) violation of any fiduciary duty owed to the Company, (c) conviction of a felony or misdemeanor, (d) dishonesty, (e) theft, (f) violation of Company rules or policy, or (g) other egregious conduct, that has or could have a serious and detrimental impact on the Company and its employees. The Plan Administrator, in its sole and absolute discretion, shall determine Cause. Examples of Cause may include, but are not limited to, excessive absenteeism, misconduct, insubordination, violation of Company policy, dishonesty, and deliberate unsatisfactory performance (,Participant refuses to improve deficient performance).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Change of Control&#8221; means any of the following events.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">any &#8220;person&#8221; (as defined in Sections 13(d) and 14(d) of the Exchange Act), excluding for this purpose (i) Covidien or any subsidiary company (wherever incorporated) of Covidien as defined by Section 86 of the Companies Act 1981 of Bermuda, as amended (a &#8220;Subsidiary&#8221;) and (ii) any employee benefit plan of Covidien or any Subsidiary (or any person or entity organized, appointed or established by Covidien for or pursuant to the terms of any such plan that acquires beneficial ownership of voting securities of Covidien), is or becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under the Exchange Act) directly or indirectly of securities of Covidien representing more than 30% of the combined voting power of Covidien&#8217;s then-outstanding securities&#59; provided, however, that no Change of Control will be deemed to have occurred as a result of a change in ownership percentage resulting solely from an acquisition of securities by Covidien&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;persons who, as of the Amendment Effective Date, constitute the Board (the &#8220;Incumbent Directors&#8221;) cease for any reason (including without limitation, as a result of a tender offer, proxy contest, merger or similar transaction) to constitute at least a majority thereof, provided that any person becoming a Director of Covidien subsequent to the Amendment Effective Date shall be considered an Incumbent Director if such person&#8217;s election or nomination for election was approved by a vote of at least 50% of the Incumbent Directors&#59; but provided further that any such person whose initial assumption of office is in connection with an actual or threatened proxy contest relating to the election of members of the Board or other actual or threatened solicitation of proxies or consents by or on behalf of a &#8220;person&#8221; (as defined in Sections 13(d) and 14(d) of the Exchange Act) other than the Board, including by reason of agreement intended to avoid or settle any such actual or threatened contest or solicitation, shall not be considered an Incumbent Director&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;consummation of a reorganization, merger or consolidation or sale or other disposition of at least 80% of the assets of Covidien (a &#8220;Business Combination&#8221;), in each case, unless, following such Business Combination, all or </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">substantially all of the individuals and entities who were the beneficial owners of outstanding voting securities of Covidien immediately prior to such Business Combination beneficially own directly or indirectly more than 50% of the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the company resulting from such Business Combination (including, without limitation, a company which, as a result of such transaction, owns Covidien or all or substantially all of Covidien&#8217;s assets either directly or through one or more Subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Business Combination, of the outstanding voting securities of Covidien&#59; or (d) approval by the stockholders of Covidien of a complete liquidation or dissolution of Covidien.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Code&#8221; means the Internal Revenue Code of 1986, as amended (and any regulations thereunder).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Commission Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Commission Compensation&#8221; means any sales commission paid to a Participant during a Plan Year before such commission is reduced for any amounts deferred by the Participant pursuant to Code Section 401(k) or Code Section 125, or any other non-qualified plan which permits the voluntary deferral of compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Company&#8221; means Covidien LP (formerly Tyco Healthcare Group LP). Where the context so requires, &#8220;Company&#8221; used in reference to a Participant means the specific entity that is part of the Company as defined herein that employs the Participant at any relevant time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Company Credit&#8221; means an amount credited by the Company for the benefit of a Participant pursuant to Section 6.3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Compensation&#8221; means an Eligible Employee&#8217;s (a) Base Salary as in effect from time to time during a Plan Year, (b) Commission Compensation paid during a Plan Year and (c) Bonus Compensation earned for an applicable Fiscal Year. For purposes of determining a Participant&#8217;s Company Credits under Section 6.3, Core Company Credits under Section 6.4 and Discretionary Credits under Section 6.5 for any Plan Year, Compensation shall include only Base Salary, Bonus Compensation and Commission Compensation actually paid to the Participant during such Plan Year. Moreover, for purposes of Spillover Deferral elections under Section 6.1, Compensation shall not include Commission Compensation. In no event shall any of the following items be treated as Compensation hereunder&#58; (i) payments from this Plan or any other Company nonqualified deferred compensation plan&#59; (ii) income from the exercise of nonqualified stock options or from the disqualifying disposition of incentive stock options, income realized upon the vesting of restricted stock or the delivery of shares in respect of restricted stock units or performance share units (or other similar items of income related to equity compensation grants, exercises or vesting events)&#59; (iii) reimbursement for moving expenses or other relocation expenses&#59; (iv) mortgage interest differentials&#59; (v) payment for reimbursement of taxes&#59; (vi) international assignment premiums, allowances or other reimbursements&#59; (vii) bonuses, other than bonus payments specifically identified in the definition of Bonus Compensation in Section 2.9&#59; or (vii) any other payments as determined by the Plan Administrator in its sole discretion.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation Deferral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Compensation Deferral&#8221; means that portion of Compensation as to which a Participant has made an annual irrevocable election to defer receipt pursuant to Article V or Section 6.1. A Participant&#8217;s Compensation Deferral may consist of Base Salary Deferrals, Bonus Compensation Deferrals, Spillover Deferrals, or a combination thereof, as applicable to the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.19&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Core Company Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Core Company Credit&#8221; means any amount credited to a Participant&#8217;s Account under Section 6.4.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.20&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Covidien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Covidien&#8221; means Covidien pic, a public company with limited liability incorporated in Ireland.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.21&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Disability&#8221; means that a Participant either (a) has been determined to be eligible for Social Security disability benefits or (b) is eligible to receive benefits under the Company&#8217;s long-term disability program as in effect at the time of disability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.22&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Discretionary Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Discretionary Credit&#8221; means any amount credited to a Participant&#8217;s Account under Section 6.5.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.23&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date and Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Effective Date&#8221; means the original effective date of the Plan, which is June 29, 2007. &#8220;Amendment Effective Date&#8221; means the effective date of this amendment and restatement of the Plan, which is January 1, 2010.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.24&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Eligible Employee&#8221; for all purposes under this Plan other than eligibility for a Company Credit under Section 6.3 includes any individual who (a)&#160;&#160;&#160;&#160;was eligible to participate in the Plan on December 31, 2008, or (b) is (i) a common law employee on the payroll of any United States Subsidiary of Covidien Ltd. (other than Puerto Rico), (ii) a U.S. citizen or a resident alien permanently assigned to work in the United States, and (iii) has a Base Salary for the relevant Plan Year that equals or exceeds $125,000, or such other higher amount as determined by the Plan Administrator in its sole discretion to reflect cost-of-living adjustments. Solely for purposes of determining eligibility for Company Credits under Section 6.3 and Core Company Credits under Section 6.4, &#8220;Eligible Employee&#8221; includes any employee of the Company who meets the requirements set forth in (a), (b)(i) and (b)(ii) above and who, for a relevant Plan Year, is paid Compensation in excess of the limitation on includible compensation under Code Section 401(a)(17). Notwithstanding the foregoing, employees eligible to participate in any &#8220;Non-U.S. Covidien Retirement Plan&#8221; shall not be Eligible Employees for purposes of the Plan. A &#8220;Non-U.S. Covidien Retirement Plan&#8221; is defined as any pension or retirement plan, program or scheme established outside the United States of America that is either sponsored by a non-US Covidien Affiliated Company or is mandated by a governmental body or under the terms of a bargaining agreement and shall include any termination or retirement indemnity program and the national social security arrangements in Italy, Portugal and Spain, but shall exclude national social security arrangements in any other country.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.25&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Enrollment and Payment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Enrollment and Payment Agreement&#8221; means the authorization form that an Eligible Employee files with the Plan Administrator to elect a Compensation Deferral under the Plan for a Plan Year, and&#47;or to elect the timing and form of distribution for Company Credits, Core Company Credits or Discretionary Credits for a Plan Year. </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An Enrollment and Payment Agreement may be filed in any form so designated by the Plan Administrator, including electronically.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.26&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Exchange Act&#8221; means the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.27&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Fiscal Year&#8221; means the Company&#8217;s fiscal year, which is the 52- or 53-week period ending on the last Friday of each September.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.28&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Matching Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Matching Credit&#8221; means an amount credited to a Participant&#8217;s Account under Section 6.2.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.29&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Maximum Matching Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Maximum Matching Percentage&#8221; for any Plan Year means the maximum matching contribution percentage available under the RSIP for such Plan Year for the Participant (disregarding any limit on the amount of matching contributions to the RSIP imposed as a result of the operation of the limitations in Code Sections 401(a)(17), 402(g) or 415(c), or any other limit imposed by the Plan or the Plan Administrator in its sole discretion).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.30&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Measurement Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Measurement Funds&#8221; means the investment alternatives offered under the RSIP unless the Covidien Retirement Investments Committee takes an affirmative action, in its sole discretion, to discontinue, substitute, or modify such investment alternatives solely for purposes of this Plan. These Measurement Funds are used solely to calculate the earnings that are credited to each Participant&#8217;s Account(s) in accordance with Article VII below, and do not represent any beneficial interest on the part of the Participant in any asset or other property of the Company. Unless the Covidien Retirement Investments Committee otherwise determines, in its sole discretion, any addition, removal or replacement of investment funds under the RSIP shall automatically result in a corresponding change to the Measurement Funds hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.31&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">articipant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Participant&#8221; means any Eligible Employee who has an Account set forth in Article IV or a former Eligible Employee who has an Account that is not fully distributed. In the event of the death or incompetency of a Participant, the term means his or her personal representative or guardian. An individual shall remain a Participant until that individual has received full payment of all amounts credited to the Participant&#8217;s Account.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.32&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Payment Date&#8221; means February 15 of each respective Plan Year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.33&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Plan&#8221; means this Plan, titled the Covidien Supplemental Savings and Retirement Plan, as amended from time to time hereafter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.34&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Plan Administrator&#8221; means the Covidien Retirement Administrative Committee appointed in accordance with the Covidien Employee Benefit Plans Governance Structure to manage and administer the Plan (or, where the context so requires, any delegate of the Plan Administrator).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.35&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Plan Year&#8221; means the 12-month period beginning on each January 1 and ending on the following December 31.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.36&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Prior Eligible Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Prior Eligible Employee&#8221; means any Eligible Employee who incurred a Separation from Service from the Company or who elected to cancel his or her Compensation Deferral election pursuant to the reasons set forth in Section 5.6 of the Plan and who participated in the Plan or any other nonqualified deferred compensation plan maintained by the Company during the two years preceding such Eligible Employee&#8217;s re-employment date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.37&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Responsible Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Responsible Company&#8221; has the meaning assigned to that term in Section 10.9.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.38&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Retirement&#8221; means a Participant&#8217;s termination of employment with the Company (other than for Cause) after attaining age 55 and having a combined age plus Years of Service equal or exceeding 60.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.39&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">RSIP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;RSIP&#8221; means the Covidien Retirement Savings and Investment Plan (or its immediate predecessor or any successor plan if the context so indicates) applicable to a Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.40&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">RSIP Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;RSIP Election&#8221; means the percentage of the Participant&#8217;s Compensation that he or she has elected to contribute on a pre-tax basis to the RSIP for a Plan Year, determined at the beginning of such Plan Year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.41&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Separation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Separation Date&#8221; means the last day of a Participant&#8217;s active employment with the Company before incurring a Separation from Service without regard to any compensation continuation arrangement, as determined by the Plan Administrator in its sole discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.42&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Separation from Service&#8221; or &#8220;Separates from Service&#8221; means a Participant&#8217;s separation from service with the Company within the meaning of Code Section 409A and the regulations and rulings promulgated thereunder. A Separation from Service shall be deemed to have occurred with respect to any Participant who experiences a Subsidiary Change of Control, even if such Participant remains employed by the affected subsidiary on the day immediately after the Subsidiary Change of Control occurs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.43&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Separation Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Separation Payment&#8221; is the payment made under the Plan that is on account of a Participant&#8217;s Separation from Service as described in Section 8.1.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.44&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Date Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Specified Date Payment&#8221; has the meaning set forth in Section 8.1.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.45&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Spillover Deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Spillover Deferrals&#8221; means Compensation Deferrals credited to the Account of a Participant as a result of an election made for a Plan Year by such Participant in accordance with the terms of Section 6.1.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.46&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Subsidiary Change of Control&#8221; means a change in the ownership of a corporation within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), whereby any one person, or more than one person acting as a group, acquires ownership of stock of the corporation that, together with stock held by such person or group, constitutes more than fifty (50) percent of the total fair market value or total voting power of the stock of such corporation.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.47&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Tyco SSRP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Tyco SSRP&#8221; means the Tyco Supplemental Savings and Retirement Plan in effect on June 29, 2007.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.48&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Unforeseeable Emergency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Unforeseeable Emergency&#8221; means a severe financial hardship to the Participant or the Participant&#8217;s spouse, Beneficiary or dependents within the meaning of Code Section 409A(a)(2)(B)(ii) and the regulations and rulings promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.49&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Year of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#8220;Year of Service&#8221; means a Year of Service as determined under the RSIP.</font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE III</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Administration</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Plan shall be administered by the Plan Administrator, which shall have full discretionary power and authority to interpret the Plan&#59; to prescribe, amend and rescind any rules, forms and procedures as it deems necessary or appropriate for the proper administration of the Plan&#59; and to make any other determinations, including factual determinations, and take such other actions as it deems necessary or advisable in carrying out its duties under the Plan.</font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE IV</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Participation</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any Eligible Employee, other than a Prior Eligible Employee (defined in Section 2.35), will become a Participant for the first full pay period following the date on which a Compensation Defined election is in place or immediately following the date a Company Credit or Discretionary Credit is made on behalf of the Eligible Employee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Prior Eligible Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Prior Eligible Employee will be eligible to become a Participant as of the first day of the Annual Enrollment Period that occurs immediately after the Prior Eligible Employee&#8217;s re-employment date or, if applicable, Compensation Deferral cancellation date.</font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE V</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Basic Deferral Participation</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Election to Participate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as otherwise provided herein, an Eligible Employee may elect, by filing an Enrollment and Payment Agreement with the Plan Administrator during an Annual Enrollment Period, a Compensation Deferral with respect to (a) Base Salary payable in a Plan Year and (b) Bonus Compensation paid in a Plan Year that is attributable to the Fiscal Year ending within such Plan Year. Such Enrollment and Payment Agreement may be filed by such method as may be established by the Plan Administrator, including electronically. With respect to individuals who first become an Eligible Employee during a Plan Year (due to hire or promotion, but excluding Prior Eligible Employees), on or before September 30, or such other date as determined by the Plan Administrator, may file an Enrollment and Payment Agreement, no later than 30 days after first becoming an Eligible Employee, which shall be applicable to Base Salary payable for the remainder of such Plan Year (but only with respect to Compensation earned after </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the filing of such election). With respect to individuals who first become an Eligible Employee during a Plan Year (due to hire or promotion, but excluding Prior Eligible Employees), after September 30, or such other date as determined by the Plan Administrator, may file an Enrollment and Payment Agreement (generally during the next Annual Enrollment Period) that will be effective for Base Salary or Bonus Compensation, as applicable, payable in the next Plan Year&#59; provided, however that in no circumstances will any such Eligible Employee make an election for the Plan Year in which the Eligible Employee is hired or promoted. Notwithstanding the foregoing, to the extent necessary, the Plan Administrator may permit an Administrative Error Correction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amount of Deferral Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Pursuant to each Enrollment and Payment Agreement for a Plan Year a Participant shall irrevocably elect to defer as a whole percentage (a) up to 50% of his or her Base Salary for the applicable Plan Year (or remainder of the Plan Year, as the case may be)&#59; and&#47;or (b) up to 100% of this or her Bonus Compensation (net of required withholding) for the applicable Fiscal Year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Deferral Limits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Plan Administrator may change the minimum or maximum deferral percentages from time to time. Any such limits shall be communicated by the Plan Administrator prior to the due date for the Enrollment and Payment Agreement. Amounts deferred under this Plan will not constitute compensation for any Company-sponsored qualified retirement plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Period of Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant&#8217;s Compensation Deferral shall be effective only for the immediately succeeding Plan Year (or the remainder of the current Plan Year, as applicable), unless otherwise allowed by the Plan Administrator in its sole discretion&#59; provided, however, that nothing herein gives the Plan Administrator the authority to suspend Compensation Deferrals made pursuant to an Enrollment and Payment Agreement other than for Disability, an Administrative Error Correction, an Unforeseeable Emergency (as determined by the Plan Administrator in accordance with Section 8.6 herein) or as otherwise required by applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of Compensation Deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Compensation Deferrals, and earnings credited thereon, shall be 100% vested at all times (subject to Section 10.12).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation Deferral Cancellation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any other provision of the Plan to the contrary, a Participant may elect to cancel his or her Compensation Deferral election due to a Disability or Unforeseeable Emergency. Following such cancellation, a Participant shall be a Prior Eligible Employee and may elect to recommence participation in the Plan, provided that the Participant satisfies the requirements to be an Eligible Employee on a subsequent Annual Enrollment Date in accordance with Sections 5.1 and 6.1 of the Plan.</font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE VI</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Spillover Participation&#47;Matching, Company and Discretionary Credits</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Spillover Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any Eligible Employee may elect to make Spillover Deferrals for a Plan Year. Such election may be made by filing an Enrollment and Payment Agreement with the Plan Administrator during the Annual Enrollment Period. Such election shall be deemed an irrevocable commitment by such Participant to defer hereunder a percentage of his or her periodic Compensation equal to the Participant&#8217;s RSIP Election for such Plan Year, with such deferrals commencing at the time the Participant&#8217;s pretax RSIP contributions are suspended for the Plan </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Year as the result of the imposition of limitations in Code Sections 401(a)(17), 402(g) or 415(c) (or any other limit imposed by the Plan, RSIP or the Plan Administrator in its sole discretion) and continuing for the remainder of the Plan Year&#59; provided, that a Participant who elects to make Spillover Deferrals will be deemed to have made a commitment to maintain his or her RSIP Election in effect for the entire Plan Year (up to the time of such suspension) without change. Notwithstanding the foregoing, to the extent necessary, the Plan Administrator may permit an Administrative Error Correction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Matching Credits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. An Eligible Employee who has elected to make Compensation Deferrals for a Plan Year shall receive Matching Credits, equal to the Participant&#8217;s Maximum Matching Percentage multiplied by (i) the dollar amount of the Participant&#8217;s Compensation Deferrals under Section 5.1 for such Plan Year on Compensation up to the applicable annual dollar limitation set forth in Code Section 401(a)(17), and (ii) the amount of Compensation for such Plan Year from which Spillover Deferrals (if any) are made under Section 6.1 (disregarding any such Compensation that exceeds the applicable annual dollar limitation set forth in Code Section 401(a)(17)). Matching Credits shall be credited to a Participant&#8217;s Account at such time or times as may be determined by the Plan Administrator in its sole discretion, but in no event less frequently than annually.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company Credits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant who is an Eligible Employee for purposes of this Section 6.3 for any Plan Year shall receive Company Credits for such Plan Year in an amount equal to the Participant&#8217;s Maximum Matching Percentage for such Plan Year multiplied by the Participant&#8217;s Compensation in excess of the annual dollar limitation set forth in Code Section 401(a)(17) for such Plan Year. Company Credits shall be credited to a Participant&#8217;s Account at such time or times as may be determined by the Plan Administrator in its sole discretion, but in no event less frequently than annually, as of the last day of a Plan Year. A Participant who has elected to make Compensation Deferrals for a Plan Year, and who receives a Company Credit for such Plan Year, shall have the portion of his or her Account attributable to such Company Credit, if vested, distributed as specified in his or her Enrollment and Payment Agreement for such Plan Year. A Participant who has not elected to make Compensation Deferrals for a Plan Year, but who receives a Company Credit for such Plan Year (and has not previously received any Company Credit under the Plan), shall file with the Plan Administrator an Enrollment and Payment Agreement as soon as practicable (but no later than 30 days) after becoming eligible for such Company Credit, electing the timing and form of payment of the portion of the Participant&#8217;s Account attributable to such Company Credit, if vested. Such election shall be deemed to apply also to any Company Credit received in any future Plan Year for which the Participant does not have in effect an Enrollment and Payment Agreement. If such Participant does not file an Enrollment and Payment Agreement by the date specified by the Plan Administrator, he or she shall be deemed to have elected to have the portion of his or her Account attributable to such Company Credit, and each Company Credit received in a future Plan Year for which the Participant does not have in effect an Enrollment and Payment Agreement, paid as a Separation Payment in a single lump sum on the Payment Date during the year following the year in which the Participant&#8217;s Separation from Service occurs. This deemed election shall apply both prospectively and retroactively to amounts that were (i) deferred and not vested as of December 31, 2004, and (ii) deferred after December 31, 2004.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Core Company Credits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant who is an Eligible Employee for purposes of this Section 6.4 for any Plan Year shall receive Core Company Credits for such Plan Year in an amount equal to the product of the Participant&#8217;s Compensation in excess of the annual dollar limitation under Code Section 401(a)(17) for such Plan Year multiplied by three percent (3%). Core Company Credits shall be credited to a Participant&#8217;s Account at such time or times as may be determined by the Plan Administrator in its sole discretion, but in no event less frequently than annually, as of the last day of a Plan Year. A Participant who has elected to make Compensation Deferrals for a Plan Year, and who receives a Core Company Credit for such Plan Year, shall have the portion of his or her Account attributable to such Core Company Credit, if vested, distributed as specified in his or her Enrollment and Payment Agreement for such Plan Year. A Participant who has not elected to make Compensation Deferrals for a Plan Year, but who receives a Core Company Credit for such Plan Year (and has not previously received any Core Company Credit under the Plan), shall file with the Plan Administrator an Enrollment and Payment Agreement as soon as practicable (but no later than 30 days) after becoming eligible for such Core Company Credit, electing the timing and form of payment of the portion of the Participant&#8217;s Account attributable to such Core Company Credit, if vested. Such election shall be deemed to apply also to any Core Company Credit received in any future Plan Year for which the Participant does not have in effect an Enrollment and Payment Agreement. If such Participant does not file an Enrollment and Payment Agreement by the date specified by the Plan Administrator, he or she shall be deemed to have elected to have the portion of his or her Account attributable to such Core Company Credit, and each Core Company Credit received in a future Plan Year for which the Participant does not have in effect an Enrollment and Payment Agreement, paid as a Separation Payment in a single lump sum on the Payment Date during the year following the year in which the Participant&#8217;s Separation from Service occurs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Discretionary Credits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant who is an Eligible Employee for any Plan Year may receive a Discretionary Credit for such Plan Year. Such credit shall be in such amount as may be determined by the Company in its sole discretion, and shall be credited to the Participant&#8217;s Account at such time or times as may be determined by the Company in its sole discretion. A Participant who has elected to make Compensation Deferrals for a Plan Year, and who receives a Discretionary Credit for such Plan Year, shall have the portion of his or her Account attributable to such Discretionary Credit (if vested) distributed as specified in his or her Enrollment and Payment Agreement for such Plan Year. A Participant who has not elected to make Compensation Deferrals for a Plan Year, but who receives a Discretionary Credit for such Plan Year (and has not previously received any Discretionary Credit under the Plan), shall file with the Plan Administrator an Enrollment and Payment Agreement as soon as practicable (but no later than 30 days) after becoming eligible for such Discretionary Credit, electing the timing and form of payment of the portion of the Participant&#8217;s Account attributable to such Discretionary Credit (if vested). Such election shall be deemed to apply also to any Discretionary Credit received in any future Plan Year for which the Participant does not have in effect an Enrollment and Payment Agreement. If such Participant does not file an Enrollment and Payment Agreement by the date specified by the Plan Administrator, he or she shall be deemed to have elected to have the portion of his or her Account attributable to such Discretionary Credit, and each Discretionary Credit received in a future Plan Year for which the Participant does not have in effect an Enrollment and Payment Agreement, paid (if vested) as a Separation Payment in a single lump sum on the Payment Date during the year following the year in which the Participant&#8217;s Separation from Service occurs.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of Matching, Company, Core and Discretionary Credits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Participants who are actively employed on or after January 1, 2010 shall have the portion of their Account attributable to Matching Credits, Company Credits and Core Company Credits 100% vested upon the completion of two Years of Service (subject to Section 10.12). If earlier, the portion of a Participant&#8217;s Account attributable to Matching Credits, Company Credits and Core Company Credits shall become 100% vested (a) if he or she Separates from Service due to death, Disability or Retirement, (b) if he or she Separates from Service and becomes 100% vested in Company contributions credited to his or her account in the RSIP, or (c) upon the occurrence of a Change of Control (subject in each case to Section 10.12). The portion of a Participant&#8217;s Account attributable to Discretionary Credits shall become 100% vested upon the date and&#47;or upon the occurrence of the event(s) specified by the Company in its sole discretion (subject to Section 10.12).</font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE VII</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Participant Account</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Establishment of Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Plan Administrator shall establish and maintain an Account with respect to each Participant&#8217;s annual Compensation Deferrals, Matching Credits, Company Credits, Core Company Credits and&#47;or Discretionary Credits hereunder, as applicable, and amounts directly transferred from the Tyco SSRP as of the Effective Date, if any, on behalf of such Participant. Compensation Deferrals pursuant to Section 5.1 and Spillover Deferrals pursuant to Section 6.1 shall be credited by the Plan Administrator to the Participant&#8217;s Account as soon as practicable after the date on which such Compensation would otherwise have been paid, in accordance with the Participant&#8217;s election. The Participant&#8217;s Account shall be reduced by the amount of payments made to the Participant or the Participant&#8217;s Beneficiary pursuant to this Plan and by any forfeitures.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Earnings (or Losses) on Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Participants must designate, on an Enrollment and Payment Agreement or by such other means as may be established by the Plan Administrator, the portion of the credits to their Account that shall be allocated among the various Measurement Funds. In default of such designation, credits to a Participant&#8217;s Account shall be allocated to the Measurement Fund(s) that serves as the default investment option in the RSIP, unless the Plan Administrator makes an affirmative election otherwise in its sole discretion. A Participant&#8217;s Account shall be credited with all deemed earnings (or losses) generated by the Measurement Funds, as elected by the Participant, on each business day for the sole purpose of determining the amount of earnings to be credited or debited to such Account as if the designated balance of the Account had been invested in the applicable Measurement Fund. Notwithstanding that the rates of return credited to a Participant&#8217;s Account are based upon the actual performance of the corresponding Measurement Funds, the Company shall not be obligated to invest any amount credited to a Participant&#8217;s Account under this Plan in such Measurement Funds or in any other investment funds. Upon notice to the Plan Administrator in the manner it prescribes, a Participant may reallocate the Funds to which his or her Account is deemed to be allocated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Valuation of Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The value of a Participant&#8217;s Account as of any date shall equal the amounts theretofore credited to such Account, including any earnings (positive or negative) deemed to be earned on such Account in accordance with Section 7.2, less the amounts theretofore deducted from such Account.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Statement of Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Plan Administrator shall provide or make available to each Participant (including electronically), not less frequently than quarterly, a statement in such form as the Plan Administrator deems desirable setting forth the balance standing to the credit of his or her Account.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payments From Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any payment made to or on behalf of a Participant from his or her Account in an amount which is less than the entire balance of his or her Account shall be made pro rata from each of the Measurement Funds to which such Account is then allocated. If a payment is not made by the designated Payment Date under the Plan, the payment shall be made as soon as administratively practicable, but not later than December 31 of the calendar year in which the designated Payment Date occurs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Separate Accounting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If and to the extent required for the proper administration of the vesting or payments provisions of the Plan, the Plan Administrator may segregate a Participant&#8217;s Account into subaccounts on the books and records of the Plan, all of which subaccounts shall, together, constitute the Participant&#8217;s Account.</font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ATRICLE VIII</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Payments to Participants</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Distribution Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">Timing of Payment. Except as otherwise provided in Section 6.3, 6.4, 8.3, 8.4 or 8.9 any portion of the Participant&#8217;s Account attributable to his or her Compensation Deferrals, vested Matching Credits, vested Company Credits, vested Core Company Credits or vested Discretionary Credits for a Plan Year shall be distributed as a payment to be made or to commence following the Participant&#8217;s Separation from Service Date or as a payment to be made or to commence at a specified date, without reference to the Participant&#8217;s Separation from Service.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Form of Payment. Unless Section 8.3 applies, Separation Payments and Specified Date Payments shall be made by one of the following methods, as elected by the Participant in the Enrollment and Payment Agreement filed with the Plan Administrator for such Plan Year&#58; (i) one lump sum, or (ii) annual installments payable over a maximum of 15 years.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;Separation Payments. A Separation Payment shall be made, or shall commence on the Payment Date following the year in which the Participant&#8217;s Separation from Service Date occurs except as provided in Section 8.9 for specified employees.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.&#160;&#160;&#160;&#160;Specified Date Payments. Except as otherwise provided in Section 8.3, a Specified Date Payment shall be made, or shall commence on the Payment Date during the payment year designated by the Participant in the applicable Enrollment and Payment Agreement. A Specified Date Payment may not begin any earlier than the fifth Plan Year following the Plan Year for which the initial filing of the Enrollment and Payment Agreement was made with respect to that Specified Date Payment.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.&#160;&#160;&#160;&#160;Specified Date Payments Following Separation From Service Date. If a Participant&#8217;s Separation from Service Date occurs before the scheduled Payment Date for one or more Specified Date Payments, and the Participant is not reemployed before the last day of the year in which the Participant&#8217;s Separation from Service Date occurs, such Specified Date Payment shall instead be made, or shall commence, on the Payment Date during the year following the year in which the Participant&#8217;s Separation from Service Date occurs and if such Participant is not eligible for Retirement, then notwithstanding the Participant&#8217;s election on any Enrollment and Payment Agreement with respect to the Specified Date Payments, the Participant&#8217;s Specified Date Payments shall be paid in a single lump sum payment on the Payment Date during the year following the year in which the Participant&#8217;s Separation from Service Date occurs except as provided in Section 8.9 for specified employees.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Change in Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Subject to Section 10.19, a Participant may change the payment year and&#47;or the form of an existing Specified Date Payment election for a Plan Year by filing a new payment election, in the form specified by the Plan Administrator, at least 12 months prior to the originally specified Payment Date (in the case of installment payments, the date of the first scheduled installment payment), provided that (a) such new election delays the payment year by at least five years from the original payment year, and (b) such change in election shall not be effective until12 months from the date it is filed, and (c) any change in the form of payment may only occur if the form of payment is changing from a lump sum payment to installments or from installment payments to installment payments of a longer duration. No change in payment date or form of payment may be made with respect to a Separation Payment once elected. In addition, a Participant&#8217;s reemployment following the commencement of installment payments shall not cause any suspension or interruption in such installment payments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cash-Out Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any election made under Section 8.1 or Section 8.2, (a) if the total value of the Participant&#8217;s Account on the first day of the Plan Year following his or her Separation from Service Date is less than $20,000, or (b) if a Participant has not satisfied the requirements that constitute a Retirement under the Plan, then the Participant&#8217;s Account shall be paid to the Participant in one lump sum on the Payment Date following the year in which the Participant&#8217;s Separation from Service Date occurs except as provided in Section 8.9 for specified employees. Notwithstanding the foregoing sentence or any election made under Section 8.1 or Section 8.2, if at any time the present value of any benefit under the Plan that would be considered a &#8220;single plan&#8221; under Treas. Reg. Section 1.409A-1(c)(2) together with the present value of any benefit required to be aggregated with such benefit under Treas. Reg. Section 1.409A-1(c)(2), is less than the dollar limit set forth in Code Section 402(g), the Company may, in its discretion, distribute such benefit (or benefits) to the Participant in the form of a lump sum, provided that the payment results in the liquidation of the entirety of the Participant&#8217;s interest under the &#8220;single plan,&#8221; including all benefits required to be aggregated as part of the &#8220;single plan&#8221; under Treas. Reg. Section 1.409A-1(c)(2).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Death or Disability Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Upon the death or Disability of a Participant, the Participant or the Participant&#8217;s Beneficiary, as applicable, shall be paid the balance in his or her Account in the form of a lump sum payment, within 90 days of the date of the Participant&#8217;s death or Disability. Such payment shall be in an amount equal to the value of the Participant&#8217;s Account </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of the last day of the calendar quarter following the Participant&#8217;s death or Disability, with the Measurement Funds being deemed to have been liquidated on that date to make the payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Valuation of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any lump sum benefit under Sections 8.1, 8.2 or 8.3 shall be payable in an amount equal to the value of the Participant&#8217;s Account (or relevant portion thereof) on the Participant&#8217;s date of distribution, with the Measurement Funds being deemed to have been liquidated on that date to make the payment. The first annual installment payment in a series of installment payments shall be equal to (a) the value of the Participant&#8217;s Account (or relevant portion thereof) on the date of distribution of the first installment payment, with the Measurement Funds being deemed to have been liquidated on that date to make the payment, divided by (b) the number of installment payments elected by the Participant. The remaining installments shall be paid, respectively, in an amount equal to (x) the value of such Account (or relevant portion thereof) on the distribution date of the installment payment, with the Measurement Funds being deemed to have been liquidated on that date to make the payment, divided by (y) the number of remaining unpaid installment payments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Unforeseeable Emergency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event that the Plan Administrator, upon written request of a Participant, determines that the Participant has suffered an Unforeseeable Emergency, the Participant shall be paid from that portion of his or her Account resulting from Compensation Deferrals, as soon as practicable following such determination, an amount necessary to meet the emergency, after deduction of any and all taxes as may be required pursuant to Section 8.7.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company may make such provisions and take such action as it may deem necessary or appropriate for the withholding of any taxes which the Company is required by any law or regulation of any governmental authority, whether federal, state or local, to withhold in connection with any benefits under the Plan, including, but not limited to, the withholding of appropriate sums from any amount otherwise payable to the Participant (or his or her Beneficiary). Each Participant, however, shall be responsible for the payment of all individual tax liabilities relating to any such benefits.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effect of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The full payment of the applicable benefit under this Article VIII shall completely discharge all obligations on the part of the Company to the Participant (and each Beneficiary) with respect to the operation of this Plan, and the Participant&#8217;s (and Beneficiary&#8217;s) rights under this Plan shall terminate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Delay of Payment for Specified Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision of this Plan to the contrary, in the case of any Participant who is a &#8220;specified employee&#8221; as of the date of such Participant&#8217;s Separation from Service within the meaning of Code Section 409A and the regulations and rulings promulgated thereunder, no distribution under this Plan shall be made, or shall commence, before the date which is six months after the date of such Participant&#8217;s Separation from Service (or, if earlier, the date of the Participant&#8217;s death).</font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE IX</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Claims Procedures</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Filing a Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any controversy or claim arising out of or relating to the Plan shall be filed in writing with the Plan Administrator in accordance with the Plan Administrator&#8217;s procedures. The Plan Administrator shall make all determinations concerning such claim. Any </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">decision by the Plan Administrator denying such claim shall be in writing using language calculated to be understood by the Participant or Beneficiary filing the claim (&#8220;Claimant&#8221;) and shall be delivered to the Claimant.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">In General. Notice of a denial of benefits will be provided within 90 days of the Plan Administrator&#8217;s receipt of the Claimant&#8217;s claim for benefits. If the Plan Administrator determines that it needs additional time to review the claim, the Plan Administrator will provide the Claimant with a notice of the extension before the end of the initial 90-day period. The extension will not be more than 90 days from the end of the initial 90-day period and the notice of extension will explain the special circumstances that require the extension and the date by which the Plan Administrator expects to make a decision.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Contents of Notice. If a claim for benefits is completely or partially denied, notice of such denial shall include a written explanation, using language calculated to be understood by the Claimant.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:29.67pt">The decision shall set forth (A) the specific reason or reasons for such denial, (B) specific reference(s) to the relevant provision(s) of this Plan on which such denial is based, (C) a description, where appropriate, as to how the Claimant can perfect the claim, including a description of any additional material or information necessary to complete the claim and why such material or information is necessary, (D) the appropriate information as to the steps to be taken if the Claimant wishes to submit the claim for review, (E) the time limits for requesting a review under Section 9.2, and (F) a statement of the Claimant&#8217;s right to bring a civil action under Section 502(a) of ERISA following an adverse decision on review.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Appeal of Denied Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Claimant whose claim has been completely or partially denied shall be entitled to appeal the claim denial by filing a written appeal with the Plan Administrator within the deadlines described below.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">In General. A Claimant (or his or her authorized representative) who timely requests a review of the denied claim may review, upon request and free of charge, copies of all documents, records and other information relevant to the denial and may submit written comments, documents, records and other information relevant to the claim to the Plan Administrator. All written comments, documents, records, and other information shall be considered &#8220;relevant&#8221; if the information (i) was relied upon in making a benefits dete1mination, (ii) was submitted, considered or generated in the course of making a benefits decision regardless of whether it was relied upon to make the decision, or (iii) demonstrates compliance with administrative processes and safeguards established for making benefit decisions. The Plan Administrator may, in its sole discretion and if it deems appropriate or necessary, decide to hold a hearing with respect to the claim appeal.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Deadline. Appeal of a denied benefits claim must be filed in writing with the Plan Administrator no later than 60 days after receipt of the written notification of such claim denial. The Plan Administrator shall make its decision </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">regarding the merits of the denied claim within 60 days following receipt of the appeal (or within 120 days after such receipt in a case where there are special circumstances requiring an extension of time for reviewing the appealed claim). If an extension of time for reviewing the appeal is required, notice of the extension shall be furnished to the Claimant prior to the commencement of the extension. The notice will indicate the special circumstances requiring the extension of time and the date by which the Plan Administrator expects to render the determination on review. The review will take into account comments, documents, records and other information submitted by the Claimant relating to the claim without regard to whether such information was submitted or considered in the initial benefit determination.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;Contents of Notice. If a benefits claim is completely or partially denied on review, notice of such denial shall set forth the reasons for denial in language calculated to be understood by the Claimant. The decision on review shall set forth (i) the specific reason or reasons for the denial, (ii) specific reference(s) to the relevant provision(s) of this Plan on which the denial is based, (iii) a statement that the Claimant is entitled to receive, upon request and free of charge, reasonable access to and copies of all documents, records, or other information relevant (as defined above) to the Claimant&#8217;s claim, and (iv) a statement of the Claimant&#8217;s right to bring an action under Section 502(a) of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Claimant may not bring any legal action relating to a claim for benefits under the Plan unless and until the Claimant has followed the claims procedures under the Plan and exhausted his or her administrative remedies under such claims procedures.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Discretion of the Plan Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All interpretations, determinations and decisions of the Plan Administrator with respect to any claim shall be made in its sole discretion, and shall be final and conclusive.</font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE X</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Miscellaneous</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Protective Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Participant and Beneficiary shall cooperate with the Plan Administrator by furnishing any and all information requested by the Plan Administrator in order to facilitate the orderly recording of deferral and payment elections and the payment of benefits hereunder. If a Participant or Beneficiary refuses to cooperate with the Plan Administrator, the Company shall have no further obligation to the Participant or Beneficiary under the Plan, other than payment of the then-current balance of the Participant&#8217;s Account in accordance with prior elections and subject to Section 10.11.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Inability to Locate Participant or Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event that the Plan Administrator is unable to locate a Participant or Beneficiary within two years following the date the Participant was to commence receiving payment, the entire amount allocated to the Participant&#8217;s Account shall be forfeited. If, after such forfeiture, the Participant or Beneficiary later claims such benefit, such benefit shall be reinstated without interest or earnings from the date </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">payment was to commence pursuant to Article VIII to the extent permitted by Code Section 409A and the regulations and rulings promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Designation of Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Participant may designate in writing a Beneficiary or Beneficiaries (which Beneficiary may be an entity other than a natural person if approved by the Plan Administrator in its sole discretion) to receive any payments which may be made under the Plan following the Participant&#8217;s death. No Beneficiary designation shall become effective until it is in writing and it is filed with the Plan Administrator. A Beneficiary designation under the Plan may be separate from all other retirement-type plans sponsored by the Company. Such designation may be changed or canceled by the Participant at any time without the consent of any such Beneficiary. Any such designation, change or cancellation must be made in a form approved by the Plan Administrator and shall not be effective until received by the Plan Administrator or its designee. If no Beneficiary has been named, or the designated Beneficiary or Beneficiaries have predeceased the Participant, the Beneficiary shall be the Participant&#8217;s estate. If a Participant designates more than one Beneficiary, the interests of such Beneficiaries shall be paid in equal shares, unless the Participant has specifically designated otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Contract of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Neither the establishment of the Plan, nor any modification thereof, nor the creation of any fund, trust or account, nor the payment of any benefits shall be construed as giving any Participant, or any person whosoever, the right to be retained in the service of the Company, and all Participants and other employees shall remain subject to discharge to the same extent as if the Plan had never been adopted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Limitation on Company Actions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Nothing contained in the Plan shall be construed to prevent the Company from taking any action which is deemed by it to be appropriate or in its best interest. No Participant, Beneficiary, or other person shall have any claim against the Company as a result of such action.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Obligations to Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If a Participant becomes entitled to payment of benefits under the Plan, and if at such time the Participant has any outstanding debt, obligation, or other liability representing an amount owing to the Company, then the Company may offset such amount owed to it against the amount of benefits otherwise distributed&#59; provided, however, that such deductions cannot exceed $5,000 in the aggregate and shall be made in a manner consistent with Treas. Reg. Section 1.409A- 3G) (4)(xiii).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Liability for Action or Omission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Neither the Company, the Plan Administrator nor any director, officer or employee of the Company shall be responsible or liable in any manner to any Participant, Beneficiary or any person claiming through them for any benefit or action taken or omitted in connection with the granting of benefits, the continuation of benefits, or the interpretation and administration of this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Non-alienation of Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as otherwise specifically provided herein, all amounts payable hereunder shall be paid only to the person or persons designated by the Plan and not to any other person or corporation. No part of a Participant&#8217;s Account shall be liable for the debts, contracts, or engagements of any Participant, or his or her Beneficiary or successors in interest, nor shall such Account of a Participant be subject to execution by levy, attachment, or garnishment or by any other legal or equitable proceeding, nor shall any such person have any right to alienate, anticipate, commute, pledge, encumber, or assign any benefits or payments </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">hereunder in any manner whatsoever. If any Participant, Beneficiary or successor in interest is adjudicated bankrupt or purports to anticipate, alienate, sell, transfer, assign, pledge, encumber or charge any payment from the Plan, voluntarily or involuntarily, the Plan Administrator, in its discretion, may cancel such payment (or any part thereof) to or for the benefit of such Participant, Beneficiary or successor in interest in such manner as the Plan Administrator shall direct. Notwithstanding the foregoing, all or a portion of a Participant&#8217;s Account may be awarded to an &#8220;alternate payee&#8221; (within the meaning of Section 206(d)(3)(K) of ERISA) if and to the extent so provided in a judgment, decree or order that, in the Plan Administrator&#8217;s sole discretion, would meet the applicable requirements for qualification as a &#8220;qualified domestic relations order&#8221; (within the meaning of Section 206(d)(3)(B)(i) of ERISA) if the Plan were subject to the provisions of Section 206(d) of ERISA. Such amounts shall be payable to the alternate payee in the form of a lump sum distribution and shall be paid within ninety (90) days following the Plan Administrator&#8217;s determination that the order satisfies the requirements to be a &#8220;qualified domestic relations order.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Liability for Benefit Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The obligation to pay or provide for payment of a benefit hereunder to any Participant or his or her Beneficiary shall, at all times, be the sole and exclusive liability and responsibility of the company that employed the Participant immediately prior to the event giving rise to a payment obligation (the &#8220;Responsible Company&#8221;). No other company or parent, Affiliated Company, subsidiary or associated company shall be liable or responsible for such payment, and nothing in this Plan shall be construed as creating or imposing any joint or shared liability for any such payment (other than the Covidien guarantee set forth in Section 10.10 below). The fact that a company or a parent, Affiliated Company, subsidiary or associated company other than the Responsible Company actually makes one or more payments to a Participant or his or her Beneficiary shall not be deemed a waiver of this provision&#59; rather, any such payment shall be deemed to have been made on behalf of and for the account of the Responsible Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Covidien Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Covidien guarantees the payment by the Responsible Company (as defined in Section 10.9) of any benefits provided for or contemplated under this Plan which either (a) the Responsible Company concedes are due and owing to a Participant or Beneficiary or (b) are finally determined to be due and owing to a Participant or Beneficiary, but which in either case the Responsible Company fails to pay.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Unfunded Status of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Plan is intended to constitute an &#8220;unfunded&#8221; deferred and supplemental retirement compensation plan for Participants, with all benefits payable hereunder constituting an unfunded contractual payment obligation of the Company. Nothing contained in the Plan, and no action taken pursuant to the Plan, shall create or be construed to create a trust of any kind. The Company shall reflect on its books the Participants&#8217; interests hereunder, but no Participant or any other person shall under any circumstances acquire any property interest in any specific assets of the Company. Nothing contained in tills Plan and no action taken pursuant hereto shall create or be construed to create a fiduciary relationship between the Company and any Participant or other person. A Participant&#8217;s right to receive payments under the Plan shall be no greater than the right of an unsecured general creditor of the Company. Except to the extent that the Company determines that a &#8220;rabbi&#8221; trust may be established in connection with the Plan, all payments shall be made from the general funds of the Company, and no special or separate fund shall be established and no segregation of assets shall be made to assure payment. The Company&#8217;s obligations under this Plan are not assignable or transferable except to (a) any </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">corporation or partnership which acquires all or substantially all of the Company&#8217;s assets or (b) any corporation or partnership into which the Company may be merged or consolidated. The provisions of the Plan shall inure to the benefit of each Participant and the Participant&#8217;s Beneficiaries, heirs, executors, administrators or successors in interest.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Forfeiture for Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any other provision of this Plan, if a Participant&#8217;s Separation from Service is for Cause, or if the Plan Administrator determines that a Participant Separates from Service for any other reason had engaged in conduct prior to his or her separation which would have constituted Cause, then the Plan Administrator may determine in its sole discretion that such Participant&#8217;s Account under the Plan shall be forfeited and shall not be payable hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Plan shall be construed in accordance with and governed by the laws of the Commonwealth of Massachusetts to the extent not superseded by federal law, without reference to the principles of conflict of laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severability of Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If any provision of this Plan shall be held invalid or unenforceable, such invalidity or unenforceability shall not affect any other provisions hereof, and this Plan shall be construed and enforced as if such provisions had not been included.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Headings and Captions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The headings and captions herein are provided for reference and convenience only, shall not be considered part of the Plan, and shall not be employed in the construction of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Gender, Singular and Plural</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All pronouns and any variations thereof shall be deemed to refer to the masculine, feminine, or neuter, as the identity of the person or persons may require. As the context may require, the singular may read as the plural and the plural as the singular.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any notice or filing required or permitted to be given to the Plan Administrator under the Plan shall be sufficient if in writing and hand delivered, or sent by registered or certified mail, to the Plan Administrator, Covidien Supplemental Savings and Retirement Plan, c&#47;o Covidien HR Benefits, 15 Hampshire Street, Mansfield, MA 02048 or to such other person or entity as the Plan Administrator may designate from time to time. Such notice shall be deemed given as of the date of delivery, or, if delivery is made by mail, as of the date shown on the postmark on the receipt for registration or certification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Plan may be amended, suspended, or terminated at any time (in whole or in part) by the Company in its sole discretion&#59; provided, however, that no such amendment, suspension or termination shall result in any reduction in the value of a Participant&#8217;s Account determined as of the effective date of such amendment. In addition, the Plan, may be amended at any time and in any respect by the Company (and&#47;or its operation modified by the Plan Administrator) if and to the extent recommended by Company counsel in order to conform to the requirements of Code Section 409A and regulations thereunder or to any other Code Section or regulation that bears on the tax-deferred character of the benefits provided hereunder or to maintain the tax-qualified status of the RSIP. In the event of any suspension or termination of the Plan (or any portion thereof), payment of Participants&#8217; Accounts shall be made under and in accordance with the terms of the Plan and the applicable elections (except that the </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Plan Administrator may determine, in its sole discretion, to accelerate payments to all Participants if and to the extent that such acceleration is permitted under Code Section 409A and regulations thereunder).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.19&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Special Rule Regarding Election Changes Prior to December 31, 2008</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. To the extent permitted under the provisions of the final regulations under Code Section 409A and subsequent related guidance, the Company may, in its sole discretion, permit a Participant to modify an existing election with respect to the timing and form of payment of the Participant&#8217;s Account hereunder without regard to the limitations set forth in Section 8.2, so long as (a) such modification is made on or before December 31, 2008, (b) such modified election is consistent with the provisions of Sections 8.1 and 8.9 hereof, and (c) such modification does not apply to any amount that would otherwise be distributable in the year in which the election is made.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex103-medtronicnonxqua.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i80eb4eb2cb7f4e9f8135179ab14cf718_37"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:258pt;padding-left:3.17pt;padding-right:3.17pt;text-align:center"><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MEDTRONIC</font></div><div style="padding-left:3.42pt;padding-right:3.42pt;text-align:center"><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">NONQUALIFIED RETIREMENT PLAN SUPPLEMENT</font></div><div style="padding-left:3.57pt;padding-right:3.57pt;text-align:center"><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">(as restated generally effective May 1,2017)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">(Conformed through the Amendment adopted November 6, 2020)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i80eb4eb2cb7f4e9f8135179ab14cf718_40"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS </font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 1</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> DEFERRED COMPENSATION ACCOUNT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Establishment of Account.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Property of Company.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 2 DEFINITIONS, GENDER, AND NUMBER</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Definitions..</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Gender and Number.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">17</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 3 PARTICIPATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">17</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Who May Participate..</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">17</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Time and Conditions of Participation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">17</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Termination and Suspension of Participation.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Missing Persons.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Relationship to Other Plans.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 4 RETIREMENT PLAN SUPPLEMENTAL BENEFIT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Calculation of Retirement Plan Supplemental Benefit.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Establishment of Nonqualified Retirement Plan Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest Credited to Nonqualified Retirement Plan Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payment of Nonqualified Retirement Plan Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 5 ESOP SUPPLEMENTAL BENEFIT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Nonqualified ESOP Account.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Gains Credited to Nonqualified ESOP Account.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payment of Nonqualified ESOP Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 6 PERSONAL INVESTMENT ACCOUNT SUPPLEMENTAL BENEFIT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Calculation of Personal Investment Account Supplemental Benefit.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Establishment of Nonqualified Personal Investment Account.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Crediting Gains and Losses to Nonqualified Personal Investment Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Vested Interest in Nonqualified Personal Investment Account.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payment of Nonqualified Personal Investment Account.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">22</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 7 MEDTRONIC CORE CONTRIBUTION ACCOUNT </font></div><div><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SUPPLEMENTAL BENEFIT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">22</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 7.1    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Calculation of Medtronic Core Contribution Account </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Supplemental Benefit.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">22</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 7.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Establishment of Nonqualified Medtronic Core Contribution Account.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">23</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 7.3    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Crediting Gains and Losses to Nonqualified Medtronic Core</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Contribution Account.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">23</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Vested Interest in Nonqualified Medtronic Core Contribution Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">23</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payment of Nonqualified Medtronic Core Contribution Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">23</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 8 ARTICLES. DEATH BENEFITS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">24</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Form and Time of Payment..</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">24</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Beneficiary</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">24</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 9 CHANGE IN CONTROL PROVISIONS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">24</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Application of Article&#160;9.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">24</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payments to and by the Trust</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">25</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 9.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Legal Fees and Expenses.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">25</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 9.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Late Payment and Additional Payment Provisions.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">25</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 10 FUNDING</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">26</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Source of Benefits.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">26</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No Claim on Specific Assets</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">26</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 11 ADMINISTRATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">26</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Administration.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">26</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Powers of Committee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">26</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Actions of the Committee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">26</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 11.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Delegation.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">26</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reports and Records</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">27</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Claims Procedure..</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">27</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Disability Benefit Claims.</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">28</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 11.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Additional Claims Procedure Requirements.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">30</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 12 AMENDMENTS AND TERMINATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">31</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 12.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Amendments.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">31</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 12.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Termination..</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">31</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 13 MISCELLANEOUS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">32</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No Guarantee of Employment.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">32</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Release..</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">32</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Notices..</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">32</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Nonalienation.  </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">32</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Withholding.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">32</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Captions.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">32</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Applicable Law.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">32</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Invalidity of Certain Provisions.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">32</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No Other Agreements</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">33</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Incapacity.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">33</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Electronic Media</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">33</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Delay of Distributions Upon Certain Events</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">33</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Acceleration of Distributions Upon Certain Events.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">34</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Small Account Balances</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">35</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;When a Plan Payment is Deemed to be Made</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">35</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 13.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Restricted Period.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">35</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SCHEDULE A </font><font style="color:#7e7e7e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CREDITING RATE </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SCHEDULE B </font><font style="color:#8e8e8e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SPECIAL BENEFITS </font></div><div style="margin-top:3.7pt;padding-left:0.6pt;padding-right:0.6pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i80eb4eb2cb7f4e9f8135179ab14cf718_43"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MEDTRONIC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NONQUALIFIED RETIREMENT PLAN SUPPLEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(as restated generally effective May 1, 2017)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic, Inc. (the &#8220;Company&#8221;) previously established the Medtronic, Inc. Executive Nonqualified Supplemental Benefit Plan (the &#8220;Plan&#8221;) for the benefit of the Eligible Employees of the Company and certain of its Affiliates, effective May 1, 1986. The Plan was amended and restated effective May 1, 2005, and again restated effective January 1, 2008, to comply with the requirements of the final regulations issued under Section 409A of the Code (&#8220;Section 409A&#8221;). At the time of that restatement, the name of the Plan was the Medtronic, Inc. Supplemental Executive Retirement Plan. The Plan has been amended in other respects, including changing the name of the Plan to the Medtronic, Inc. Nonqualified Retirement Plan Supplement in June of 2011. The Plan is being restated again effective May 1, 2017, as the Medtronic Nonqualified Retirement Plan Supplement to reflect changes to contributions under the Medtronic Savings and Investment Plan and to make other changes to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This restatement applies to amounts deferred under the Plan on or after May 1, 2017 (the &#8220;Restatement Date&#8221;), and to the payment of all amounts deferred under the Plan (whether such amounts were deferred before, on, or after the Restatement Date) that have not yet been distributed as of the Restatement Date. No amount deferred under the Plan is intended to be &#8220;grandfathered&#8221; under Section 409A. The restatement does not change the time or form of any payment required under the Plan, and does not reduce vested amounts credited to a Participant&#8217;s account prior to the date of execution of the restated Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The purpose of the Plan is to provide Eligible Employees with benefits that supplement those provided under certain of the tax-qualified plans maintained by the Company. More specifically, the Plan is intended to provide certain benefits on a nonqualified basis that are not otherwise provided under the Company&#8217;s tax-qualified plans as a result of the application of certain legal limitations on contributions, benefits and includible compensation and as a result of elections made by Eligible Employees under other plans maintained by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Plan is intended to be (and shall be construed and administered as) an employee benefit pension plan under the provisions of ERISA, which is unfunded and maintained primarily for the purpose of providing deferred compensation for Eligible Employees who constitute a select group of management or highly-compensated employees, as described in Sections 201(2), 301(a)(3) and 401(a)(1) of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Plan is not intended to be qualified under Section 401(a) of the Code. The Plan, as restated herein, is subject to, and intended to comply with, Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The obligation of the Company to make payments under the Plan constitutes an unsecured (but legally enforceable) promise of the Company to make such payments and no person, including any Participant or Beneficiary, shall have any lien, prior claim or other security interest in any property of the Company as a result of the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 1</font></div><div style="text-align:center"><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DEFERRED COMPENSATION ACCOUNT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Establishment of Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;The Company shall establish one or more Accounts for each Participant which shall be utilized solely as a device to measure and determine the amount of deferred compensation to be paid under the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Property of Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any amounts set aside for benefits payable under the Plan are the property of the Company, except, and to the extent, provided in the Trust. </font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DEFINITIONS, GENDER, AND NUMBER </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Whenever used in the Plan, the following words and phrases shall have the meanings set forth below unless the context plainly requires a different meaning, and when a defined meaning is intended, the term is capitalized. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.1&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a bookkeeping account established by the Company on its books and records to record and determine the benefits payable to a Participant or Beneficiary under the Plan. The Company shall establish a separate Account on behalf of each Participant for&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">The benefit the Participant is entitled to receive pursuant to Article&#160;4, if any, referred to as the &#8220;Nonqualified Retirement Plan Account.&#8221; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;The benefit the Participant is entitled to receive pursuant to Article&#160;5, if any, referred to as the &#8220;Nonqualified ESOP Account&#8221;&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160; The benefit the Participant is entitled to receive pursuant to Article&#160;6</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">if any, entitled the </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Supplemental </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Personal Investment Account&#8221;&#59; and </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.&#160;&#160;&#160;&#160;The benefit the Participant is entitled to receive pursuant to Article&#160;7, if any, entitled the </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Supplemental </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic Core Contribution Account.&#8221; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Committee may establish any number of sub-accounts on behalf of a Participant or Beneficiary as the Committee considers necessary or advisable for purposes of maintaining a proper accounting of amounts to be credited under the Plan on behalf of a Participant or Beneficiary </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.2&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Company and any entity with which the Company would be considered a single employer under Section 414(b) of the Code (employees of controlled group of corporations) and Section 414(c) of the Code (employees of partnerships, proprietorships, etc</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">under common control)</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.3&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; or </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficiaries</font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the persons or trusts designated by a Participant in writing pursuant to Section 8</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1 of the Plan as being entitled to receive any benefit payable under the Plan by reason of the death of a Participant, or, in the absence of such designation, the persons specified in Section 8.2.2 of the Plan</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.4&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company as constituted at the relevant time. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.5&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Capital Accumulation Plan</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Medtronic, Inc</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Capital Accumulation Plan Deferral Program, as amended or restated from time to time or any successor thereto</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.6&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as amended from time to time and any successor statute. References to a Code section shall be deemed to be to that section or to any successor to that section, and to all guidance issued under that section. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.7&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Committee or individual appointed by the Compensation Committee of the Board (or any person or entity designated by the Committee) to administer the Plan pursuant to Section 11.4. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.8&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Medtronic, Inc</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and its successors and assigns, by merger, purchase or otherwise. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.9&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Domestic Relations Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 414(p)(l)(B) of the Code. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.10&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an elected or appointed officer of the Company, or any other key employee of the Company or an Affiliate, excluding any individual who is neither a United States citizen nor a United States resident. In order to be an Eligible Employee an employee must be a member of a select group of management or highly compensated employees within the meaning of Sections 201(2), 301(a)(3) and 40l(a)(l) of ERISA and rules established by the Committee. The Company may make such projections or estimates as it deems desirable in applying the eligibility requirements, and its determination shall be conclusive. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.11&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Employee Retirement Income Security Act of 1974</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as amended from time to time and any successor statute. References to an ERISA section shall be deemed to be to that section or to any successor to that section, and to all guidance issued under that section. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.12&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ESOP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Medtronic, Inc. Employee Stock Ownership Plan, as in effect prior to April 30, 2001. (As of April 30, 2001, the ESOP was amended to permit elective deferrals under Section 401(k) of the Code and renamed the Medtronic, Inc</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee Stock Ownership and Supplemental Retirement Plan</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As of May 1, 2005, the Medtronic, Inc. Employee Stock Ownership and Supplemental Retirement Plan was amended and renamed the Medtronic, Inc. Savings and Investment Plan. As of January 26, 2015, the Medtronic, Inc. Savings and Investment Plan was amended and renamed the Medtronic Savings and Investment Plan.) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.13&#160;&#160;&#160;&#160;&#8220;ESOP Supplemental Benefit&#8221; means the benefit under the Predecessor Plan that was commonly referred to as the &#8220;ESOP restoration benefit&#8221; and previously called the &#8220;Defined Contribution Supplemental Benefit.&#8221; Under the Plan, this benefit </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">equals the difference between</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) the allocation due to Company contributions the Participant would have received under the ESOP prior to May</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1, 2005</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">but for the Section 401(a)(17) Limitation and Section 415 Limitation&#59; and (b) the allocation actually received by the Participant under the ESOP</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.14&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an event of change in control of the Company, as defined in the Trust. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.15&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Medtronic Core Contribution Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the same meaning as in the Savings and Investment Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.16&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Medtronic Core Contribution Account Supplemental Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Article&#160;7</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.17&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an Eligible Employee who has commenced participation in the Plan</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.18&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Personal Investment Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the same meaning as in the Savings and Investment Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.19&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Personal Investment Account Supplemental Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Article&#160;6. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.20&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the &#8220;Medtronic Nonqualified Retirement Plan Supplement&#8221; as set forth herein and as amended or restated from time to time</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.21&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the 12-month period commenc</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ng May 1 and ending the following April 30</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.22&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Predecessor Plan</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Plan</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as in effect prior to May 1, 2005</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.23&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restatement Date</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means May 1, 2017, the effective date of this restatement. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.24&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Retirement Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Medtronic Retirement Plan, as amended from time to time, and any successor(s) thereto. Effective May 1, 2019, the Company established the Medtronic Retirement Plan for Certain Participants &#38; Beneficiaries and transferred to such plan the portion of the Medtronic Retirement Plan attributable to certain individuals, who, on December 31, 2018, were actively employed with the Company or its Affiliates and accruing pension benefits under the Medtronic Retirement Plan. Accordingly, effective as of May 1, 2019, &#8220;Retirement Plan&#8221; shall also mean the Medtronic Retirement Plan for Certain Participants &#38; Beneficiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In general, the Retirement Plan includes a final average pay benefit for individuals employed by the Company or an Affiliate prior to May 1, 2005. Effective May 1, 2005, the Retirement Plan provides a personal pension account benefit for individuals who become </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">employed on or after May l, 2005 and before January 1, 2016. Individuals participating in the Retirement Plan prior to May 1, 2005, could elect a personal pension account benefit in lieu of the final average pay benefit for Plan Years commencing May 1, 2005. Alternatively, an individual employed before January 1, 2016, and otherwise eligible to participate in the Retirement Plan could elect not to participate in the Retirement Plan and receive a contribution to a Personal Investment Account under the Savings and Investment Plan. The Retirement Plan is now closed to new entrants and, effective April 30, 2027, will be frozen</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.25&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Retirement Plan Supplemental Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth m Article&#160;4. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.26&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Savings and Investment Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Medtronic Savings and Investment Plan, as amended from time to time, and any successor thereto. The Savings and Investment Plan includes a salary reduction benefit under Section 401(k) of the Code and a matching contribution benefit under Section 401(m) of the Code. Effective May 1, 2005, the Savings and Investment Plan also includes a Personal Investment Account for those individuals who elected this retirement benefit option. Individuals who become participants in the Savings and Investment Plan on or after January 1, 2016, can no longer elect a Personal Investment Account, but instead are covered under the Medtronic Core Contribution Account. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.27&#160;&#160;&#160;&#160;&#8220;Section 401(a)(17) Limitation&#8221; means the limitation on the dollar amount of compensation that may be taken into account under qualified retirement plans under Section 401(a)(l7) of the Code. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.28&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 415 Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the limitation on benefits for qualified defined benefit pension plans and the limitation on allocations for qualified defined contribution plans, which are imposed by Section 415(b) and (c), respectively, of the Code. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.29&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Separate from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#8221; with respect to a Participant, means the Participant&#8217;s separation from service with all Affiliates, within the meaning of Section 409A(a)(2)(A)(i) of the Code. Solely for this purpose, a Participant will be considered to have a Separation from Service when the Participant dies, retires, or otherwise has a termination of employment with all Affiliates. The employment relationship is treated as continuing intact while the Participant is on military leave</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">sick leave</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or other bona fide leave of absence if the period of such leave does not exceed six months, or if longer, so long as the individual retains a right to reemployment with the Affiliate under an applicable statute or by contract. For purposes hereof, a leave of absence constitutes a bona fide leave of absence only if there is a reasonable expectation that the Participant will return to perform services for an Affiliate. If the period of leave exceeds six months and the individual does not retain a right to reemployment under an applicable statute or by contract, the employment relationship is deemed to terminate, and the Separation from Service occur, on the day immediately following the end of such six month period. Notwithstanding the foregoing, where a leave of absence is due to any medically determinable physical or mental impairment that can be expected to last for a continuous period of not less than six months, where such impairment causes the employee to be unable to perform the duties of his or her position of employment or any substantially similar position of employment, the Company may substitute a 29-month period of absence for such six-month period</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Whether a termination of employment has occurred is determined based on whether the facts and circumstances indicate that the Affiliate and the Participant reasonably anticipated that no further services will be performed after a certain date or that the level of bona fide services the Participant will perform after such date (whether </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as an employee or independent contractor) will permanently decrease to no more than 40 percent of the average level of bona fide services performed (whether as an employee or independent contractor) over the immediately preceding 36-month period (or the full period of services if the Participant has been providing services for less than 36 months).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything in Section 2.1.2 to the contrary, in determining whether a Participant has had a Separation from Service with an Affiliate, an entity&#8217;s status as an &#8220;Affiliate&#8221; shall be determined substituting &#8220;50 percent&#8221; for &#8220;80 percent&#8221; each place it appears in Section 1563(a)(l),(2), and (3) and in Treasury Regulation Section 1.414(c)-2. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall have discretion to determine whether a Participant has experienced a Separation from Service in connection with an asset sale transaction entered into by the Company or an Affiliate, provided that such determination conforms to the requirements of Section 409A, in which case the Company&#8217;s determination shall be binding on the Participant. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.30&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means section 409A of the Internal Revenue Code, as amended from time to time, any successor statute, and all guidance issued thereunder. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.31&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an employee of an Affiliate who is subject to the six-month delay rule described in Section 409A(2)(B)(i) of the Code. The Company shall establish a written policy for identifying Specified Employees in a manner consistent with Section 409A, which policy may be amended by the Company from time to time as permitted by Section 409A. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.32&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, prior to January 20, 2015, the Company&#8217;s common stock $0.10 par value per share, and on or after January 26, 2015, ordinary shares of Medtronic pic, par value $0.0001 per share (as such par value may be adjusted from time to time). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.33&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Medtronic, Inc. Compensation Trust Agreement Number One, as amended from time to time. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Gender and Number</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as otherwise indicated by context, masculine terminology used herein also includes the feminine and neuter, and terms used in the singular may also include the plural. </font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PARTICIPATION </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Who May Participate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Participation in the Plan is limited to Eligible Employees. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Time and Conditions of Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. An Eligible Employee shall become a Participant on the date on which he or she first accrues a benefit under the Plan, provided that he or she is then in compliance with such terms and conditions as the Committee may from time to time establish for the implementation of the Plan, including, but not limited to, </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any condition the Committee may deem necessary or appropriate for the Company to meet its obligations under the Plan.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination and Suspension of Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Once an individual has become a Participant, participation shall continue until payment in full of all benefits to which the Participant or Beneficiary is entitled under the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Missing Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Participant and Beneficiary entitled to receive benefits under the Plan shall be obligated to keep the Company informed of his or her current address until all Plan benefits that are due to be paid to the Participant or Beneficiary have been paid to him or her. If, after having made reasonable efforts to do so, the Company is unable to locate the Participant or Beneficiary for purposes of making a distribution, the Participant&#8217;s or Beneficiary&#8217;s Plan benefit will be forfeited. In no event will a Participant&#8217;s or Beneficiary&#8217;s benefit be paid to him or her later than the date otherwise required by the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Relationship to Other Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Participation in the Plan shall not preclude participation of the Participant in any other fringe benefit program or plan sponsored by an Affiliate for which the Participant would otherwise be eligible. Notwithstanding anything in the Plan to the contrary, to the extent permitted by Section 409A, the Committee, or anyone to whom the Committee has delegated this authority pursuant to Section 11.4, may reduce the benefits payable to a Participant under the Plan if, and to the extent that, benefits are payable to the Participant under another similar plan or arrangement maintained by the Company or an Affiliate. The Committee (or its delegate) shall have complete and absolute discretion to determine whether another benefit plan or arrangement maintained by the Company or an Affiliate is similar to the Plan, whether the benefit under the Plan can be reduced in a manner that does not cause a violation of Section 409A, and the amount of the reduction to be applied. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Benefits for Participants who Separated from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The benefits provided under the Plan with respect to any Participant who has incurred a Separation from Service shall, except as otherwise specifically provided in the Plan, be governed in all respects by the terms of the Plan as in effect as of the date of the Participant&#8217;s Separation from Service. A Participant&#8217;s reemployment by, or performance of services for, the Company or an Affiliate after incurring a Separation from Service shall not affect the payment timing or amount of his or her Account(s) under the Plan attributable to his or her service prior to his or her Separation from Service. </font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 4</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RETIREMENT PLAN SUPPLEMENTAL BENEFIT </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Calculation of Retirement Plan Supplemental Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. An Eligible Employee shall earn a Retirement Plan Supplemental Benefit as of any Determination Date, as defined in the following sentence, in an amount equal to the lump sum actuarial equivalent value </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of the difference between his or her Unrestricted Retirement Plan Benefit, as defined below in this Section 4.1, and his or her Actual Retirement Plan Benefit, as defined below in this Section 4.1, with both values determined as of the Determination Date. For purposes hereof, the Determination Date is the first day of the month. The lump sum actuarial equivalent value shall be determined in each case by use of the applicable interest rate of six percent (6%) and the applicable mortality table within the meaning of Section 417(e)(3) of the Code. Provided, however, the Retirement Plan Supplemental Benefit determined in accordance with this Section 4.1 shall not be less than the Retirement Plan Supplemental Benefit determined in accordance with the Plan as in effect on May 1, 2010.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes hereof, an Eligible Employee&#8217;s Unrestricted Retirement Plan Benefit as of any Determination Date equals the vested monthly benefit that such individual would have accrued under the Retirement Plan as of such date under the otherwise applicable provisions of the Retirement Plan, but determined for periods from and after May 1, 1986, without application of the Section 415 Limitation or the Section 40l(a)(17) Limitation and based upon the compensation that would have been paid to the Eligible Employee during the Plan Year but for his or her election to defer his or her compensation under the Capital Accumulation Plan.  For purposes hereof, compensation that is reduced pursuant to such an election shall be taken into account for the Plan Year during which such compensation would have been paid to the Eligible Employee but for such election and only to the extent that such compensation would otherwise be taken into account under the Retirement Plan in calculating benefits thereunder had such compensation otherwise been paid directly to the Eligible Employee (but without regard to application of the Section 401(a)(17) Limitation). The Unrestricted Retirement Plan Benefit is determined without reduction for the Actual Retirement Plan Benefit. For the avoidance of doubt, to the extent required under Section 4.3 of the Retirement Plan, an Eligible Employee&#8217;s Unrestricted Retirement Plan Benefit shall reflect actuarial increases determined in accordance with the actuarial adjustment factors set forth for such purpose under the Retirement Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes hereof, an Eligible Employee&#8217;s Actual Retirement Plan Benefit as of any Determination Date equals the vested monthly benefit that the individual has actually accrued as of such date under the provisions of the Retirement Plan, after taking into account all applicable limitations on contributions, benefits and compensation. For the avoidance of doubt, to the extent required under Section 4.3 of the Retirement Plan, an Eligible Employee&#8217;s Actual Retirement Plan Benefit shall reflect actuarial increases determined in accordance with the actuarial adjustment factors set forth for such purpose under the Retirement Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An Eligible Employee&#8217;s Unrestricted Retirement Plan Benefit and Actual Retirement Plan Benefit shall be determined after giving effect to the exclusion of Eligible Employees hired or rehired on or after January 1, 2016 from the Retirement Plan under Section 3.1 of the Retirement Plan, and to the election a Participant makes under Section 3.2 of the Retirement Plan (i.e., the election to receive a contribution to a Personal Investment Account under the Savings and Investment Plan, the final average pay benefit under the Retirement Plan or the personal pension account benefit under the Retirement Plan) for benefits accruing under the Retirement Plan on or after May 1, 2005</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Establishment of Nonqualified Retirement Plan Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant&#8217;s Retirement Plan Supplemental Benefit shall be determined as of the first day of the month following the month in which the Participant has a Separation from Service, and the lump sum value of such Retirement Plan Supplemental Benefit shall be credited as of such date to a bookkeeping account established for the Participant on the books and records of the Company, referred to as the &#8220;Nonqualified Retirement Plan Account.&#8221; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event a Participant terminates employment as a result of death, the value of the benefits, if any, to be credited to his or her Nonqualified Retirement Account shall be based upon the lump sum actuarial equivalent value of the death benefits that would be paid under the Retirement Plan under the same assumptions as used under Section 4.1 hereof in determining the Participant&#8217;s Unrestricted Retirement Plan Benefit (that is, without regard to the Section 415 Limitation and the Section 401(a)(l7) Limitation and without regard to any election the Participant may have made under the Capital Accumulation Plan to defer his or her compensation) less the lump sum actuarial equivalent value of death benefits actually payable with respect to such Participant under the Retirement Plan, if any, taking into account all applicable limitations on contributions, benefits and compensation. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Credited to Nonqualified Retirement Plan Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All amounts credited to the Nonqualified Retirement Plan Account from time to time shall be credited with interest at a rate that is equal to the pre-retirement interest rate or rates used by the Retirement Plan during the period for which interest is to be so credited for purposes of determining actuarially equivalent benefits under the Retirement Plan. Interest as so determined shall be compounded monthly during the Plan Year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Nonqualified Retirement Plan Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Payment to a Participant of his or her Nonqualified Retirement Plan Account shall commence as soon as administratively feasible on or after the first day of the seventh month following his or her Separation from Service. All distributions of the Nonqualified Retirement Account will be made in cash. If the value of the Participant&#8217;s Nonqualified Retirement Account, determined as of the date on which such Account is established, is greater than $100,000, the Account principal together with interest at an annual rate of six percent (6%) thereon shall be paid to the Participant on a monthly basis over a 15-year period in 180 equal monthly installments. If the value of the Participant&#8217;s Nonqualified Retirement Account, determined as of the date on which such Account is established, is $100,000 or less, the Account together with interest thereon shall be paid to the Participant in a lump sum. </font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 5</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ESOP SUPPLEMENTAL BENEFIT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Nonqualified ESOP Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company previously established an Account on behalf of each Participant entitled to an ESOP Supplemental Benefit (defined as a Defined Contribution Supplemental Benefit in the Predecessor Plan and commonly referred to as the &#8220;ESOP restoration benefit&#8221;) now referred to as the &#8220;Nonqualified ESOP Account.&#8221; All contributions to the Nonqualified ESOP Account ceased effective April 30, 2005. A Participant&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Nonqualified ESOP Account, if any, will continue to vest according to the terms of the Predecessor Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Gains Credited to Nonqualified ESOP Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant&#8217;s ESOP Supplemental Benefit is expressed in the form of the right to receive Stock. Because of this, the Nonqualified ESOP Account is adjusted to reflect Stock splits, Stock dividends and recapitalizations in such manner as may be determined by the Committee. The Committee may also, in its discretion, adjust the Nonqualified ESOP Account to reflect dividends payable with respect to the Stock from time to time in such manner as it deems appropriate. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Nonqualified ESOP Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Payment to a Participant of his or her Nonqualified ESOP Account shall be made at the end of the Plan Year in which the Participant&#8217;s Separation from Service occurs. Payment shall be made in Stock in the form of a lump sum. </font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 6</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PERSONAL INVESTMENT ACCOUNT SUPPLEMENTAL BENEFIT </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Calculation of Personal Investment Account Supplemental Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. An Eligible Employee who, pursuant to Section 3.2 of the Retirement Plan, elects to participate in the Personal Investment Account Benefit under the Savings and Investment Plan, shall be credited with a Personal Investment Account Supplemental Benefit as of the end of each Plan Year commencing May 1, 2005, in an amount equal to his or her Unrestricted Personal Investment Account Allocation, as defined below in this Section 6.1, for such year less his or her Actual Personal Investment Account Allocation, as defined below in this Section 6.1, for such year&#59; provided, however, that for the year in which the Participant has a Separation from Service, the Participant&#8217;s Personal Investment Account Supplemental Benefit for such year shall be determined as of the end of the month in which the Separation from Service occurs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An Eligible Employee&#8217;s Unrestricted Personal Investment Account Allocation for a year equals the dollar amount that would have been allocated by the Company to his or her Personal Investment Account for the year, but without application of the Section 415 Limitation or the Section 40l(a)(l7) Limitation and based upon the compensation that would have been paid to the Eligible Employee during the year but for his or her election to defer his or her compensation under the Capital Accumulation Plan. For purposes hereof, compensation that is reduced pursuant to such an election shall be taken into account for the Plan Year during which such compensation would have been paid to the Eligible Employee but for such election and only to the extent that such compensation would otherwise be taken into account under the Savings and Investment Plan in calculating benefits thereunder had such compensation otherwise been paid directly to the Eligible Employee (but without regard to application of the Section 401(a)(l7) Limitation) </font><font style="color:#545454;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Unrestricted Personal Investment Account Allocation is determined without reduction for the Actual Personal Investment Account Allocation. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An Eligible Employee&#8217;s Actual Personal Investment Account Allocation for a year equals the dollar amount that the Company actually allocates as a contribution to the Eligible Employee&#8217;s Personal Investment Account for such year. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Establishment of Nonqualified Personal Investment Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Personal Investment Account Supplemental Benefit to be credited to a Participant for a Plan Year under Section 6.1 shall be credited as of the last day of such year (except for the Plan Year in which a Participant has a Separation from Service, in which case it shall be credited as of the last day of the month in which the Separation from Service occurs) to an account established on the books and records of the Company, referred to as the &#8220;Nonqualified Personal Investment Account.&#8221; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 6.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Crediting Gains and Losses to Nonqualified Personal Investment Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Committee shall designate the manner in which a Participant&#8217;s Nonqualified Personal Investment Account is to be credited with gains and losses as described on Schedule A hereto, which Schedule may be amended from time to time in the Committee&#8217;s discretion. If the Committee designates specific investment funds to serve as an index for crediting gains and losses to a Participant&#8217;s Nonqualified Personal Investment Account&#58; (a) the Participant shall be entitled to designate which such fund or funds shall be used to measure gains and losses on his or her Nonqualified Personal Investment Account and to change such designation in accordance with rules established by the Committee&#59; (b) the Participant&#8217;s Nonqualified Personal Investment Account will be credited with gains and losses as if invested in such fund or funds in accordance with the Participant&#8217;s designation and the rules established by the Committee&#59; and (c) the Committee may, in its sole discretion, eliminate any investment fund or funds previously designated by it, substitute a new investment fund or funds therefore, or add investment fund or funds, at any time. If the Committee makes any such investment funds available for this purpose, the Company shall have no obligation to actually invest any amounts in any such investment funds. Unless the Committee adopts a different rule, investment designations may be changed, generally, on a business daily basis. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 6.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ested Interest in Nonqualified Personal Investment Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant&#8217;s vested interest in his or her Nonqualified Personal Investment Account shall be determined in the same manner as the Participant&#8217;s vested interest in his or her Personal Investment Account, and the Company may forfeit the non-vested portion of the Participant&#8217;s Nonqualified Personal Investment Account under the same rules and subject to the same limitations as provided for the Personal Investment Account under the Savings and Investment Plan. Notwithstanding the preceding sentence, a Participant shall not earn a fully-vested interest in his or her Nonqualified Personal Investment Account as a result of the termination or partial termination of the Plan in those situations where the Participant is not otherwise fully vested in such Account. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 6.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Nonqualified Personal Investment Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Payment to a Participant of his or her Nonqualified Personal Investment Account shall commence as soon as administratively feasible on or after the first day of the seventh month following his or her Separation from Service. All distributions of the Nonqualified Personal Investment Account will be paid in the form of cash. If the value of the Participant&#8217;s Nonqualified Personal Investment Account, determined as soon as administratively feasible following the date on which the Participant&#8217;s Separation from Service occurs, is greater than $100,000, the Account principal shall be paid to the Participant on a monthly basis over a fifteen-year period in 180 equal </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">monthly installments. During the payout period, interest shall be credited on the declining balance at an annual rate of six percent (6%) rather than pursuant to Section 6.3. If the value of the Participant&#8217;s Nonqualified Personal Investment Account, determined as soon as administratively feasible following the date on which the Participant&#8217;s Separation from Service occurs, is $100,000 or less, the Account shall be paid to the Participant in a lump sum. </font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 7</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MEDTRONIC CORE CONTRIBUTION ACCOUNT</font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUPPLEMENTAL BENEFIT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 7.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Calculation of Medtronic Core Contribution Account Supplemental Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. An Eligible Employee who, pursuant to Section 5.4 of the Savings and Investment Plan, is eligible to receive Medtronic Core Contributions under that plan, shall be credited with a Medtronic Core Contribution Account Supplemental Benefit as of the end of each Plan Year that ends on or after April 30, 2016, in an amount equal to his or her Unrestricted Medtronic Core Contribution Account Allocation, as defined below in this Section 7.1, for such year less his or her Actual Medtronic Core Contribution Account Allocation, as defined below in this Section 7.1, for such year&#59; provided, however, that for the year in which the Participant has a Separation from Service, the Participant&#8217;s Medtronic Core Contribution Account Supplemental Benefit for such year shall be determined as of the end of the month in which the Separation from Service occurs.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An Eligible Employee&#8217;s Unrestricted Medtronic Core Contribution Account Allocation for a year equals the dollar amount that would have been allocated by the Company to his or her Medtronic Core Contribution Account for the year, but without application of the Section 415 Limitation or the Section 40l(a)(17) Limitation and based upon the compensation that would have been paid to the Eligible Employee during the year but for his or her election to defer his or her compensation under the Capital Accumulation Plan. For purposes hereof, compensation that is reduced pursuant to such an election shall be taken into account for the Plan Year during which such compensation would have been paid to the Eligible Employee but for such election and only to the extent that such compensation would otherwise be taken into account under the Savings and Investment Plan in calculating benefits thereunder had such compensation otherwise been paid directly to the Eligible Employee (but without regard to application of the Section 401(a)(17) Limitation). In addition, compensation for the Plan Year commencing May 1, 2015, shall be taken into account only from January 1, 2016, through April 30, 2016. The Unrestricted Medtronic Core Contribution Account Allocation is determined without reduction for the Actual Medtronic Core Contribution Account Allocation. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An Eligible Employee&#8217;s Actual Medtronic Core Contribution Account Allocation for a year equals the dollar amount that the Company actually allocates as a contribution to the Eligible Employee&#8217;s Medtronic Core Contribution Account for such year. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 7.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Establishment of Nonqualified Medtronic Core Contribution Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Medtronic Core Contribution Account Supplemental Benefit to be credited to a Participant for a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Plan Year under Section 7.1 shall be credited as of the last day of such year (except for the Plan Year in which a Participant has a Separation from Service, in which case it shall be credited as of the last day of the month in which the Separation from Service occurs) to an account established on the books and records of the Company, referred to as the &#8220;Nonqualified Medtronic Core Contribution Account.&#8221; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 7.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Crediting Gains and Losses to Nonqualified Medtronic Core Contribution Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Committee shall designate the manner in which a Participant&#8217;s Nonqualified Medtronic Core Contribution Account is to be credited with gains and losses as described on Schedule A hereto, which Schedule may be amended from time to time in the Committee&#8217;s discretion. If the Committee designates specific investment funds to serve as an index for crediting gains and losses to a Participant&#8217;s Nonqualified Medtronic Core Contribution Account&#58; (a) the Participant shall be entitled to designate which such fund or funds shall be used to </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">measure gains and losses on his or her Nonqualified Medtronic Core Contribution Account and to change such designation in accordance with rules established by the Committee&#59; (b) the Participant&#8217;s Nonqualified Medtronic Core Contribution Account will be credited with gains and losses as if invested in such fund or funds in accordance with the Participant&#8217;s designation and the rules established by the Committee&#59; and (c) the Committee may, in its sole discretion, eliminate any investment fund or funds previously designated by it, substitute a new investment fund or funds therefor, or add investment fund or funds, at any time. If the Committee makes any such investment funds available for this purpose, the Company shall have no obligation to actually invest any amounts in any such investment funds. Unless the Committee adopts a different rule, investment designations may be changed, generally, on a business daily basis.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 7.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Vested Interest in Nonqualified Medtronic Core Contribution Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant&#8217;s vested interest in his or her Nonqualified Medtronic Core Contribution Account shall be determined in the same manner as the Participant&#8217;s vested interest in his or her Medtronic Core Contribution Account, and the Company may forfeit the non-vested portion of the Participant&#8217;s Nonqualified Medtronic Core Contribution Account under the same rules and subject to the same limitations as provided for the Medtronic Core Contribution Account under the Savings and Investment Plan. Notwithstanding the preceding sentence, a Participant shall not earn a fully-vested interest in his or her Nonqualified Medtronic Core Contribution Account as a result of the termination or partial termination of the Plan in those situations where the Participant is not otherwise fully vested in such Account. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 7.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Nonqualified Medtronic Core Contribution Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Payment to a Participant of his or her Nonqualified Medtronic Core Contribution Account shall commence as soon as administratively practicable on or after the first day of the seventh month following his or her Separation from Service. All distributions of the Nonqualified Medtronic Core Contribution Account will be paid in the form of cash. If the value of the Participant&#8217;s Nonqualified Medtronic Core Contribution Account, determined as soon as administratively feasible following the date on which the Participant&#8217;s Separation from Service occurs, is greater than $100,000, the Account principal shall be paid to the Participant on a monthly basis over a fifteen-year period in 180 equal monthly installments. During the payout period, interest shall be credited on the declining balance at an annual rate of six percent (6%) rather than pursuant to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 7.3. If the value of the Participant&#8217;s Nonqualified Medtronic Core Contribution Account, determined as soon as administratively feasible following the date on which the Participant&#8217;s Separation from Service occurs, is $100,000 or less, the Account shall be paid to the Participant in a lump sum. </font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 8</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLES. DEATH BENEFITS <br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 8.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Form and Time of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If a Participant dies before all amounts in an Account have been distributed to him or her (whether the Participant&#8217;s death occurs before or after distributions have commenced to the Participant), the Account balance, to the extent then vested, shall be paid to the Participant&#8217;s Beneficiary in a lump sum within 90 days after the Participant&#8217;s death. Provided, however, to the extent permitted under Section 409A, such payment can be made any time up to December 31 of the calendar year following the calendar year of death, the exact payment date to be determined by the Committee. The Committee may confer with the Participant&#8217;s Beneficiary in determining the payment date, but retains the discretion to determine the payment date, except that, after an Event, the Participant&#8217;s Beneficiary may, to the extent permitted under Section 409A, determine a reasonable payment date within the above-stated parameters, and the Committee shall honor such determination. &#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 8.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Designation of Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Participant has the right to designate primary and contingent Beneficiaries </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">for </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">death benefits payable under the Plan. Such Beneficiaries may be individuals or trusts for the benefit of individuals. A Beneficiary designation by a Participant shall be in writing on a form acceptable to the Committee and shall only be effective upon delivery to the Company. A Beneficiary designation may be revoked by a Participant at any time by delivering to the Company either written notice of </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">revocation </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or a new Beneficiary designation form</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Beneficiary designation form last delivered to the Company prior to the death of a Participant shall control. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Failure to Designate Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event there is no Beneficiary designation on file with the Company at the Participant&#8217;s death, or if all Beneficiaries designated by a Participant have predeceased the Participant, any benefits payable pursuant to this Article 8 will be paid to the Participant&#8217;s surviving spouse, if living&#59; or if the Participant does not leave a surviving spouse, to the Participant&#8217;s children, if any, in equal shares, except that if any of the children predecease the Participant but leave issue surviving the Participant, such issue shall take by right of representation, the share their parent would have taken if living&#59; for purposes of this provision, &#8220;children&#8221; shall not include stepchildren unless such stepchildren have been legally adopted by the Participant&#59; or, if there are no such surviving issue, to the Participant&#8217;s estate. </font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 9</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CHANGE IN CONTROL PROVISIONS </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 9.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Application of Article&#160;9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. To the extent applicable, the provisions of this Article&#160;9 relating to an Event of change in control of the Company shall control, notwithstanding any other provisions of the Plan to the contrary, and shall supersede any other provisions of the Plan to the extent inconsistent with the provisions of this Article&#160;9. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 9.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payments to and by the Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Pursuant to the terms of the Trust, the Company is required to make certain payments to the Trust if an Event occurs or if the Company determines that it is probable that an Event may occur. The obligation of the Company to make such payments shall be considered an obligation under the Plan&#59; provided, however, that such obligation shall at all times be and remain subject to the terms of the Trust as in effect from time to time</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 9.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Fees and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company shall reimburse a Participant or his or her Beneficiary for all reasonable legal fees and expenses incurred by such Participant or Beneficiary after the date of an Event in seeking to obtain any right or benefit provided by the Plan&#59; provided however, that&#58; (a) any such reimbursement shall be made during a period not to exceed 20 years following the date of the Event&#59; (b) the amount eligible for reimbursement during a taxable year of the Participant or Beneficiary shall not affect the amount eligible for reimbursement in any other taxable year&#59; (c) the reimbursement is made on or before the last day of the Participant&#8217;s or Beneficiary&#8217;s taxable year following the taxable year in which the legal fees and expenses are incurred&#59; and (d) the right to reimbursement is not subject to liquidation or exchange for another benefit. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 9.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Late Payment and Additional Payment Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If after the date of an Event the Company delays a payment required to be made under the Plan past the final date that the payment was due to be made, the amount of each such delayed payment shall be credited with interest at the rate of five percent per year, compounded quarterly, from the date on which the distribution was required to be made under the terms of the Plan until the actual date of the distribution. In the event that this interest is to be credited for some period less than a full calendar quarter, the interest shall be determined and compounded for the fractional quarter. This interest represents a late payment penalty for the delay in payment and is intended to supplement any other interest or gains credited to a Participant&#8217;s Account under the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any benefit payments made by the Company after the date on which a benefit distribution was required to be made under the terms of the Plan shall be applied first against the first due of such benefit distributions (with application first against any applicable late payment penalty and next against the benefit amount itself) until fully paid, and next against the next due of such payments in the same manner, and so forth</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">for purposes of calculating the late payment penalties hereunder. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event that payment of benefits has commenced to a Participant or Beneficiary prior to the date of an Event, then the date on which distribution was required to be made under the terms of the Plan shall be determined with reference to the payment provision that was in effect prior to the date of the Event. No adjustment may be made to any payment form which was in </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">effect prior to the date of an Event with respect to any Account which would have the effect of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">delaying payments otherwise to be made under the payment form or otherwise increasing the period of time over which payments are to be made.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participants and their Beneficiaries shall be entitled to benefit payment under the Plan plus the late payment penalty referred to hereinabove first from the Trust and secondarily from the Company, as otherwise provided in Section 9.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 10</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FUNDING </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 10.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Source of Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All benefits under the Plan shall be paid when due by the Company out of its assets or from the Trust. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 10.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Claim on Specific Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No Participant shall be deemed to have, by virtue of being a Participant in the Plan, any claim on any specific assets of the Company such that the Participant would be subject to income taxation on his or her benefits under the Plan prior to distribution and the rights of Participants and Beneficiaries to benefits to which they are otherwise entitled under the Plan shall be those of an unsecured general creditor of the Company. </font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 11</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ADMINISTRATION </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 11.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Plan shall be administered by the Committee. The Company shall bear all administrative costs of the Plan other than those specifically charged to a Participant or Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 11.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Powers of Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In addition to the other powers granted under the Plan, the Committee shall have all powers necessary to administer the Plan, including, without limitation, powers to&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">interpret the provisions of the Plan&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;establish and revise the method of accounting for the Plan and to maintain the Accounts&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;establish rules for the administration of the Plan and to prescribe any forms required to administer the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Actions of the Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as modified by the Board, the Committee (including any person or entity to whom the Committee has delegated duties, responsibilities or authority, to the extent of such delegation) has total and complete discretionary authority to determine conclusively for all parties all questions arising in the administration of the Plan, to interpret and construe the terms of the Plan, and to determine all questions of eligibility and status of employees, Participants and Beneficiaries under the Plan and their respective interests. Subject to the claims procedures of Section 11.6, all determinations, interpretations, rules and decisions of the Committee (including those made or established by any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">person or entity to whom the Committee has delegated duties, responsibilities or authority, if </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">made or established pursuant to such delegation) are conclusive and binding upon all persons having or claiming to have any interest or right under the Plan.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 11.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Delegation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Committee, or any officer designated by the Committee, shall have the power to delegate specific duties and responsibilities to officers or other employees of the Company or other individuals or entities. Any delegation may be rescinded by the Committee at any time. Each person or entity to whom a duty or responsibility has been delegated shall be responsible for the exercise of such duty or responsibility and shall not be responsible for any act or failure to act of any other person or entity. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 11.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reports and Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Committee, and those to whom the Committee has delegated duties under the Plan, shall keep records of all their proceedings and actions and shall maintain books of account, records, and other data as shall be necessary for the proper administration of the Plan and for compliance with applicable law. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Claims Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as otherwise provided in Section 11.7 with respect to disability claims for benefits, the Committee shall notify a Participant in writing within a reasonable period of time, not to exceed ninety (90) days, following the Plan&#8217;s receipt of the Participant&#8217;s written claim for benefits, of the Participant&#8217;s eligibility or noneligibility (i) for benefits under the Plan or, (ii) if the claim is for different or greater benefits, for the benefits claimed by the Participant. If the Committee determines that a Participant is not eligible for benefits or for the benefits claimed, the notice shall set forth&#58; (a) the specific reasons for the adverse determination&#59; (b) a reference to the specific provisions of the Plan on which the determination is based&#59; (c) a description of any additional information or material necessary for the claimant to perfect the claim and an explanation of why it is needed&#59; and (d) a description of the Plan&#8217;s claims review procedure and the time limits applicable to such procedures, including a statement of the Participant&#8217;s right to bring a civil action under Section 502(a) of the ERISA, following an adverse benefit determination on review. If the Committee determines that there are special circumstances requiring additional time to make a decision, the Committee shall notify the Participant of the special circumstances and the date by which a decision is expected to be made, and may extend the time for up to an additional ninety (90) day period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Participant shall have the opportunity to have a full and fair review of the claim and the adverse benefit determination by the Committee. The Participant must exercise this opportunity by filing a petition for review with the Committee within sixty (60) days after receipt by the Participant of the notice issued by the Committee. Said petition may state the specific reasons the Participant believes the Participant is entitled to benefits or greater or different benefits and may be accompanied by written comments, document, records and other </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">information </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">relating to the claim </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">for </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">benefits. The Participant or the Participant&#8217;s representative shall be permitted, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to the claim for benefits. Whether information is &#8220;relevant&#8221; shall be determined by the Committee taking into account guidance from the Department of Labor. If a Participant does not appeal within the Plan&#8217;s required time period, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participant will lose the right to appeal and the Participant will have failed to exhaust the Plan&#8217;s internal administrative appeal process. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Within a reasonable period of time</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">not to exceed sixty (60) days, following receipt by the Committee of said petition, the Committee shall review the petition, taking into account all comments, document, records and other information submitted by the Participant relating to the claim</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">without regard to whether such information was submitted or considered in the initial benefit determination</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Committee</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8217;</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">s determination is adverse to the Participant, the Committee shall notify the Participant of its decision in writing, setting forth</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) the specific reasons for the adverse determination&#59; (b) a reference to the specific provisions of the Plan on which the determination is based&#59; (c) a statement that the Participant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to the claim for benefits&#59; and (d) a statement of the Participant&#8217;s right to bring a civil action under Section 502(a) of ERISA. If the sixty (60) day period is not sufficient, the Committee shall not</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">fy the Participant of the special circumstances that cause sixty (60) days to be insufficient and the date by which a decision is expected to be made, and may extend the time for up to an additional sixty (60) day period</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event of the death of a Participant, the same procedure shall be applicable to the Participant&#8217;s Beneficiaries.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 11.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disability Benefit Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. For claims for benefits under the Plan where the disability of the Participant is in dispute, special claim rules apply. In the case of a disability benefit claim, the time periods for filing and appealing a claim set out in this Section 11.7 apply instead of the time periods under the general claims procedure described in Section 11</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6. There are also additional rules that apply, such as information that must be provided in certain cases when a disability benefit claim is denied. Where there is not an additional rule or a substitute rule that applies</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the general claims procedure described in Section 11.6 applies</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">The Committee will notify the Participant of its determination regarding the availability of benefits within a reasonable period of time, but not later than forty-five (45) days after receipt of the claim by the Plan</font><font style="color:#676767;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This period may be extended by the Plan for up to thirty (30) days, provided that the Committee both determines that such an extension is necessary due to matters beyond the control of the Plan and notifies the Participant, prior to the expiration of the initial forty-five (45) day period, of the circumstances requiring the extension of time and the date by which the Plan expects to render a decision. If, prior to the end of the first thirty (30) day extension period, the Committee determines that, due to matters beyond the control of the Plan, a decision cannot be rendered within that extension period, the period for making the determination may be extended for up to an additional thirty (30) days, provided that the Committee notifies the Participant </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">prior to the expiration of the first thirty (30) day extension period, of the circumstances requiring the extension and the date as of which the Plan expects to render a decision. In the case of any such extension, the notice of extension shall specifically explain the standards on which entitlement to a benefit is based, the unresolved issues that prevent a decision on the claim, and the additional information </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">needed to resolve those issues, and the Participant shall be afforded at least forty-five (45) days within which to provide the specified information. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b. If a claim is denied, a Participant has one hundred eighty (180) days following receipt of the denial within which to appeal the determination. The Participant&#8217;s appeal will be reviewed in a manner that does not afford deference to the initial adverse benefit determination and that is conducted by an appropriate arbiter who is neither the individual who made the adverse benefit determination that is the subject of the appeal, nor a subordinate of such individual. In deciding an appeal of any adverse benefit determination that is based in whole or in part on a medical judgment, the arbiter will consult with a health care professional who has appropriate training and experience in the field of medicine involved in the medical judgment. Such professional may not be an individual who was consulted in connection with the adverse benefit determination that is the subject of the appeal nor a subordinate of such individual. If the Participant requests, the Plan will furnish the Participant with the identity of any medical or vocational experts whose advice was obtained on behalf of the Plan in connection with a Participant&#8217;s benefit denial (without regard to whether the advice was relied upon in making the benefit determination). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c. The Committee will notify a Participant of the Plan&#8217;s benefit determination on appeal within a reasonable period of time, but not later than forty-five (45) days after receipt of the Participant&#8217;s request for review by the Plan, unless the Committee determines that special circumstances (such as the need to hold a hearing) require an extension of time for processing the claim. If the Committee determines that an extension of time for processing is required, written notice of the extension shall be furnished to the Participant prior to the termination of the initial forty-five (45) day period. In no event will such extension exceed a period of forty-five (45) days from the end of the initial period. The extension notice will indicate the special circumstances requiring an extension of time and the date by which the Plan expects to render the determination on appeal. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d. The period of time within which an initial benefit determination or benefit determination following an appeal is required to be made will begin at the time the claim or appeal is filed in accordance with the procedures of the Plan, without regard to whether all the information necessary to make a determination accompanies the filing. In the event that a period of time is extended as permitted in Section 11.7(a) or (c) due to a Participant&#8217;s failure to submit information necessary to decide a claim, the period for making the determination will be tolled from the date on which the notification of the extension is sent to the Participant until the date on which the Participant responds to the request for additional information. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e. Effective for disability claims filed on or after January 1, 2018, but only to the extent that applicable claims regulations so require, the Committee can issue an adverse benefit determination on review only if the Committee has provided the Participant, free of charge, with any new or additional evidence considered, relied upon, or generated by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or at the direction of the Plan or such person making the benefit determination in connection with the claim. Such evidence must be provided as soon as possible and sufficiently in advance of the date on which the notice of adverse benefit determination on review is required to be provided to give the Participant a reasonable opportunity to respond before that date. Likewise, effective for disability claims filed on or after January 1, 2018, but only to the extent that applicable claims regulations so require, before the Committee can issue an adverse determination on review based on a new or additional rationale, the Committee must provide the Participant, free of charge, with the rationale. The rationale must be provided as soon as possible and sufficiently in advance of the date on which the notice of adverse benefit determination on review is required to be provided to give the Participant a reasonable opportunity to respond before that date. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">f. In the case of any benefit denial, including denial after appeal, if an internal rule, guideline, protocol, or other similar criterion was relied upon in denying the benefit, the Participant will be furnished with either&#58; (1) the specific rule, guideline, protocol, or other similar criterion&#59; or (2) a statement that such rule, guideline, protocol, or other similar criterion was relied upon in making the denial and that a copy of the rule, guideline, protocol, or other similar criterion will be provided free of charge to the Participant upon request. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">g. These special rules for disability claims described in this Section 11.7 apply only if the Plan or someone acting on behalf of the Plan must make the disability determination. They apply to a Participant&#8217;s Beneficiaries if the Participant dies, and the Plan is nevertheless required to make a disability determination. They do not apply if the Plan pays a benefit based on a disability determination made by someone else for purposes of another benefit plan or program. For example, if the Plan pays a disability benefit only to Participants who are determined to be disabled by Social Security or who are determined to be disabled by an insurer under the employer&#8217;s disability insurance policy, these special rules do not apply. Instead, the rules for other claims, described in Section 11.6, apply. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 11.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Additional Claims Procedure Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The following provisions apply to all claims under the Plan. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">The Plan shall comply with applicable Department of Labor regulations regarding the manner in which claims shall be processed. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b. &#160;&#160;&#160;&#160;To be considered timely under the Plan&#8217;s claims procedures, a claim must be filed under Section 11.6 or 11.7 within one year after the claimant knew or reasonably should have known of the principal facts upon which the claim is based. Knowledge of all facts that the Participant knew or reasonably should have known shall be imputed to every claimant who is or claims to be a Beneficiary of the Participant or otherwise claims to derive an entitlement by reference to the Participant for the purpose of applying the previously specified periods. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;The exhaustion of the claims procedures is mandatory for resolving every claim and dispute arising under this Plan. As to such claims and disputes</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i) no claimant shall be permitted to commence any legal action to recover Plan benefits or to enforce or clarify rights under the Plan under Section 502 or Section 510 of ERISA or under any other provision of law, whether or not statutory, until the claims procedures have been exhausted in their entirety&#59; and </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii) in any such legal action all explicit and all implicit determinations by the Committee and any other person or entity (including, but not limited to, determinations as to whether the claim, or a request for a review of a denied claim, was timely filed) shall be afforded the maximum deference permitted by law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.&#160;&#160;&#160;&#160;No legal action to recover Plan benefits or to enforce or clarify rights under the Plan under Section 502 or Section 510 of ERISA or under any other provision of law, whether or not statutory, may be brought by any claimant on any matter pertaining to this Plan unless the legal action is commenced in the proper forum before the earlier of&#58; (i) 30 months after the claimant knew or reasonably should have known of the principal facts on which the claim is based, or (ii) 12 months after the claimant has exhausted the claims procedure under this Plan. Knowledge of all facts that the Participant knew or reasonably should have known shall be imputed to every claimant who is or claims to be a Beneficiary of the Participant or otherwise claims to derive an entitlement by reference to the Participant for the purpose of applying the previously specified periods</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e. &#160;&#160;&#160;&#160;The exclusive venue for any legal action arising out of or relating to this Plan, including, but not limited to, actions under Section 502 or 510 of ERISA, is a state or federal court in Hennepin County, Minnesota</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">f. &#160;&#160;&#160;&#160;The Committee and all persons determining or reviewing claims have full discretion to determine benefit claims under the Plan. Any interpretation, determination or other action of such persons will be overturned only if it is arbitrary or capricious or otherwise an abuse of discretion. Any review of a final decision or action of the persons reviewing a claim shall be based only on such evidence presented to or considered by such persons at the time they made the decision that is the subject of review. </font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 12</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDMENTS AND TERMINATION </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 12.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company, by action of the Compensation Committee of the Board, or the Chief Executive Officer of the Company or the Senior Vice President of Human Resources, to the extent authorized by the Compensation Committee of the Board, may amend the Plan, in whole or in part, at any time and from time to time. Any such amendment shall be filed with the Plan documents. No amendment, however, may be effective to </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">reduce </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the vested amounts credited to a Participant&#8217;s Account (or that would be so credited with respect to a Participant who is actively employed immediately prior to the date of amendment had the Participant had a Separation from Service and had his or her Account been established  </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">immediately prior to such date), as determined immediately prior to such amendment</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">except that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Company may change the investment funds or funds that it may make available for crediting gains and losses pursuant to Section 6</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3 or Section 7.3 at any time in its discretion.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 12.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company reserves the right to terminate the Plan at any time by action of the Compensation Committee of the Board. Upon termination of the Plan, all accruals and contributions shall immediately cease. Termination of the Plan shall not be effective to reduce the vested amounts credited to a Participant&#8217;s Account (or that would be so credited with respect to a Participant who is actively employed immediately prior to the date of such termination had the Participant had a Separation from Service and had his or her Account been established immediately prior to such date). If the Plan is terminated, payments from the Accounts of all Participants and Beneficiaries shall be made at the time and in the manner otherwise specified in the Plan, except as otherwise determined by the Company at the time of termination, subject to Article&#160;9 and the requirements of Section 409A. </font></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 13</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MISCELLANEOUS </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Guarantee of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Neither the adoption nor the maintenance of the Plan shall be deemed to be a contract of employment between any Affiliate and any Participant. Nothing contained herein shall give any Participant the right to be retained in the employ of an Affiliate or to perform services for an Affiliate, or to interfere with the right of an Affiliate to discharge any Participant at any time&#59; nor shall it give an Affiliate the right to require any Participant to remain in its employ or to perform services for it or to interfere with the Participant&#8217;s right to terminate his or her employment or performance of services at any time. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any payment of benefits to or for the benefit of a Participant or a Participant&#8217;s Beneficiary that is made in good faith by the Company in accordance with the Company&#8217;s interpretation of its obligations under the Plan shall be in full satisfaction of all claims against the Company for benefits under the Plan to the extent of such payment. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any notice permitted or required under the Plan shall be in writing and shall be hand-delivered or sent, postage prepaid, by first class mail, or by certified or registered mail with return receipt requested, to the principal office of the Company, if to the Company, or to the address last shown on the records of the Company, if to a Participant or Beneficiary. Any such notice shall be effective as of the date of hand-delivery or mailing. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Nonalienation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No benefit payable at any time under the Plan shall be subject in any manner to alienation, sale, transfer, assignment, pledge, levy, attachment, or encumbrance of any kind by any Participant or Beneficiary, except with respect to a Domestic Relations Order. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company may withhold from any payment of benefits or other compensation payable to a Participant or Beneficiary, or the Company may direct the trustee of the Trust to withhold from any payment of benefits to a Participant or Beneficiary, such amounts as the Company determines are reasonably necessary to pay any taxes or other amounts required to be withheld under applicable law. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Captions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Article&#160;and section headings and captions are provided for purposes of reference and convenience only and shall not be relied upon in any way to construe, define, modify, limit, or extend the scope of any provision of the Plan</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Plan and all rights hereunder shall be governed by and construed according to the laws of the State of Minnesota, except to the extent such laws are preempted by the laws of the United States of America</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Invalidity of Certain Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If any provision of the Plan is held invalid or unenforceable, such invalidity or unenforceability shall not affect any other provision of the Plan and the Plan shall be construed and enforced as if such provision had not been included. The Plan is intended to comply in form and operation with Section 409A, and shall be construed accordingly. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Other Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The terms and conditions set forth herein constitute the entire understanding of the Company and the Participants with respect to the matters addressed herein. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Incapacity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event that any Participant is unable to care for his or her affairs because of illness or accident, any payment due may be paid to the Participant&#8217;s spouse, parent, adult child, brother, sister or other person deemed by the Committee to have incurred expenses for the care of such Participant, unless a duly qualified guardian or other legal representative has been appointed. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Electronic Media</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding anything in the Plan to the contrary, but subject to any applicable requirements of ERISA, the Code, or other law, any action or communication otherwise required to be taken or made in writing by a Participant or Beneficiary or by the Company or Committee shall be effective if accomplished by another method or methods required or made available by the Company or Committee, or their agent, with respect to that action or communication, including e-mail, telephone response systems, intranet systems, or the Internet. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Delay of Distributions Upon Certain Events </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Delay in Distributions</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">Except as set forth in Section 13.13, if a Participant is a Specified Employee as of the date of his or her Separation from Service, any distributions that under the terms of the Plan are to commence to the Participant on his or her Separation from Service (&#8220;separation distributions&#8221;) shall commence on the Participant&#8217;s &#8220;delayed distribution date&#8221; (as defined below). In this case, the Company shall, in its discretion, determine (i) whether the first separation distribution to the Participant shall include the aggregate amount of any separation distributions that, but for this paragraph (a), would have been paid to the Participant from the date of his or her Separation from Service until the delayed distribution date, or (ii) whether each separation distribution shall be delayed for six months. The Company&#8217;s discretion must be exercised without any direct or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">indirect election by the Participant as to whether payment method (i) or </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii) in the foregoing sentence shall be selected. For purposes of this paragraph (a), a Specified Employee&#8217;s &#8220;delayed distribution date&#8217;&#8217; is the first day of the seventh month following the Participant&#8217;s Separation from Service, or if earlier, the date of the Participant&#8217;s death.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;A payment under the Plan may be delayed by the Company under any of the following circumstances so long as all payments to similarly situated Participants are treated on a reasonably consistent basis&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:29.67pt">The Company reasonably anticipates that if such payment were made as scheduled, the Company&#8217;s deduction with respect to such payment would not be permitted under Section 162(m) of the Code, provided that the payment is made either during the first calendar year in which the Company reasonably anticipates, or should reasonably anticipate, that if the payment is made during such year, the deduction of such payment will not be barred by application of Section 162(m) or during the period beginning with the date of the Participant&#8217;s Separation from Service and ending on the later of the last day of the Company&#8217;s fiscal year in which the Participant has a Separation from Service or the 15th day of the third month following the Separation from Service. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ii. &#160;&#160;&#160;&#160;The Company reasonably anticipates that the making of the payment will violate Federal securities laws or other applicable law, provided that the payment is made at the earliest date at which the Company reasonably anticipates that the making of the payment will not cause such violation. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">iii.&#160;&#160;&#160;&#160;Upon such other events as determined by the Company and according to such terms as are consistent with Section 409A or are prescribed by the Commissioner of Internal Revenue. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Acceleration of Distributions Upon Certain Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company may, in its discretion, distribute all or a portion of a Participant&#8217;s Accounts at an earlier time and in a different form than otherwise specified in the Plan under the circumstances described below&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">As may be necessary to fulfill a Domestic Relations Order. Distributions pursuant to a Domestic Relations Order shall be made according to administrative procedures established by the Company&#59; provided, however, that the ESOP Supplemental Benefit shall not be eligible for assignment pursuant to a Domestic Relations Order. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;To the extent reasonably necessary to avoid the violation of ethics laws or conflict of interest laws to the extent permitted under Section 409A. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;To pay FICA on amounts deferred under the Plan and the income tax resulting from such payment. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.&#160;&#160;&#160;&#160;To pay the amount required to be included in income as a result of the Plan&#8217;s failure to comply with Section 409A. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.&#160;&#160;&#160;&#160;If the Company determines, in its discretion, that it is advisable to liquidate the Plan in connection with a termination of the Plan pursuant to Section 12.2, subject to Article&#160;9 and the requirements of Section 409A. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">f.&#160;&#160;&#160;&#160;As satisfaction of a debt of the Participant to an Affiliate, where such debt is incurred in the ordinary course of the service relationship between the Affiliate and the Participant, the entire amount of the reduction </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any calendar year does not exceed $5,000, and the reduction is made at the same time and in the same amount as the debt otherwise would have been due and collected from the Participant. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">g.&#160;&#160;&#160;&#160;As satisfaction of a debt to the extent reasonably necessary to comply with federal law regarding debt collection, but only to the extent permissible under Section 409A.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">h.&#160;&#160;&#160;&#160;To pay state, local or foreign tax obligations that may arise with respect to amounts deferred under the Plan and the income tax resulting from such payment. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything in this Section 13.13 to the contrary, the Company shall not provide the Participant with discretion or a direct or indirect election regarding whether a payment is accelerated pursuant to this Section 13.13. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Small Account Balances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If at any time the present value of any benefit under the Plan that would be considered a &#8220;single plan&#8221; under Treasury Regulation Section 1.409A-l(c)(2), together with the present value of any benefit required to be aggregated with such benefit under Treasury Regulation Section 1.409A-l(cX2), is less than the dollar limit set forth in Section 402(g) of the Code, the Company may, in its discretion, distribute such benefit (or benefits) to the Participant in the form of a lump sum, provided that the payment results in the liquidation of the entirety of the Participant&#8217;s interest under the &#8220;single plan,&#8221; including all benefits required to be aggregated as part of the &#8220;single plan&#8221; under Treasury Regulation Section 1.409A-1(c)(2). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">When a Plan Payment is Deemed to be Made</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any payment that is due to be distributed as of a particular date pursuant to the provisions of the Plan, will be deemed to be distributed as of that date if it is distributed on such date or a later date within the same calendar year, or, if later, by the 15th day of the third calendar month following the date, and the Participant is not permitted, directly or indirectly, to designate the calendar year of payment. Further, a payment will be treated as made on a date if it is made no earlier than 30 days before the date, and the Participant is not permitted, directly or indirectly, to designate the calendar year of payment. For purposes of the foregoing, if the payment is required to be made during a period of time, the specified date is treated as the first day of the period of time. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During any Restricted Period, no assets shall be set aside, transferred, or otherwise restricted in a way that would result in such assets being treated, for the purposes of Section 83 of the Code, as property transferred in connection with the performance of services by reason of Section 409A(b)(3) of the Code with respect to an Applicable Covered Employee. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this Section, &#8220;Restricted Period&#8221; means&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">any period during which any defined benefit plan to which Section 412(a&#125; of the Code applies (&#8220;Defined Benefit Plan&#8221;) of an Affiliate is in at-risk status, as defined in Section 430(i&#125; of the Code&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;any period the Company is a debtor in a case under title 11, United States Code, or similar federal or state law&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;the 12-month period beginning on the date which is six months before the termination date of a Defined Benefit Plan if, as of the termination date, the Defined Benefit Plan is not sufficient for benefit liabilities, within the meaning of Section 4041 of ERISA. </font></div><div style="text-indent:36pt"><font style="color:#282a28;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this Section, </font><font style="color:#464848;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#282a28;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Applicable Covered Employee&#8221; means any&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.&#160;&#160;&#160;&#160;covered employee of an Affiliate&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e. &#160;&#160;&#160;&#160;former employee who was covered&#160;&#160;&#160;&#160;at the time of termination of employment w</font><font style="color:#464848;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">th an Affiliate. </font></div><div style="text-indent:36pt"><font style="color:#282a28;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this Section, &#8220;Covered Employee&#8221; means an individual who is&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">f.&#160;&#160;&#160;&#160; an individual described in Section 162(a)(3) of the Code&#59; or </font></div><div style="margin-bottom:24pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">g.&#160;&#160;&#160;&#160;subject to the requirements of Section 16(a) of the Securities Exchange Act. </font></div><div style="margin-top:3pt;padding-left:1.82pt;padding-right:1.82pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">26</font></div></div></div><div id="i80eb4eb2cb7f4e9f8135179ab14cf718_46"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SCHEDULE A </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Manner of Crediting Gains and Losses to Personal Investment Account </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and Medtronic Core Contribution Account</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to Sections 6</font><font style="color:#666666;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3 and 7.3, respectively</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Personal Investment Accounts and Medtronic Core Contribution Accounts of Participants shall be credited with gains and losses as if invested in one or more of the investments funds listed below that are selected by the Company and communicated to the Participants from time to time, in the proportions designated by the Participant on an investment election form submitted to the Company by the Participant. The investment election form shall be submitted to the Company in the form and manner specified by the Committee, which may be electronically pursuant to Section 13.11. Until and unless changed by the Committee, Participants shall be permitted to change investment elections, generally, on a business daily basis. </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic Interest Income Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Total Bond Market Index Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Wellington Fund</font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard 500 Index Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Windsor II Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Morgan Growth Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard PRIMECAP Fund</font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Extended Market Index Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Explorer Fund</font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard International Growth Fund</font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic pic Stock Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Target Retirement 2050 Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Target Retirement 2045 Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Target Retirement 2040 Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Target Retirement 2035 Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Target Retirement 2030 Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Target Retirement 2025 Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Target Retirement 2020 Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Target Retirement 2015 Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Target Retirement 2010 Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Target Retirement 2005 Fund </font></div><div style="text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Target Retirement Income Fund</font></div><div style="margin-top:3.45pt;padding-left:200.4pt;padding-right:200.4pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">27</font></div></div></div><div id="i80eb4eb2cb7f4e9f8135179ab14cf718_49"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SCHEDULE B</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Special Benefits </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Schedule B describes special benefits for certain participants. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Special Benefit for Geoffrey S. Martha</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Subject to the terms of this Schedule 8.1, the Company will pay to Geoffrey S. Martha (&#8220;Mr. Martha&#8221;) the following amount as a Plan benefit, in addition to the benefit otherwise payable to him under the Plan&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The lump sum present value of the amount that Mr. Martha would have received under the GE Pension Plan as of the date of his Separation from Service with the Company, less the sum of&#58; (a) the value of Mr. Martha&#8217;s vested Personal Investment Account as of this date&#59; (b) the lump sum present value of the vested benefit that Mr. Martha is entitled to receive under the Plan (other than provided under this Schedule 8.1) as of this date&#59; and (c) the lump sum present value of the benefit that Mr. Martha is actually entitled to receive under the GE Pension Plan as of this date. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The lump sum present value of the GE Pension Plan benefit as of the Date of Separation from Service with the Company will be determined based on the following assumptions&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mr. Martha remained employed with the GE Company (&#8220;GE&#8221;) on a full-time basis and continued to accrue benefits under the GE Pension Plan until his Separation from Service with the Company&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No benefit related to or derived from employee contributions, e.g., &#8220;Personal Pension Account&#8221; or &#8220;Voluntary Pension Account&#8221; under the GE Pension Plan, is included in determining the value&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mr. Martha&#8217;s salary with GE increased at the rate of 3% per year starting with the date of his employment with the Company and ending with the date of his Separation from Service with the Company&#59; and </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The actuarial assumptions applicable to the Retirement Plan (rather than the GE Pension Plan) as of Mr. Martha&#8217;s Separation from Service apply. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes hereof, the &#8220;GE Pension Plan&#8221; means the qualified GE Pension Plan as in effect on the date that Mr. Martha first becomes employed by the Company (and assuming that the terms of such plan do not change thereafter). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mr. Martha&#8217;s Plan benefit under this Schedule B.I will vest in, and be paid to him (or his Beneficiary) at the same time and in the same manner as his Plan benefit (other than the benefit provided under this Schedule B.I). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Special Benefit for Hooman Hakami. Subject to the terms of this Schedule B.II, the Company will pay to Hooman Hakami (&#8220;Mr. Hakami&#8221;) the following amount as a Plan benefit in addition to the benefit otherwise payable to him under the Plan&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The lump sum present value of the amount that Mr. Hakami would have received under the GE Pension Plan as of the date of his Separation from Service, less the sum of&#58; (a) the value of Mr. Hakami&#8217;s vested Personal Investment Account under the Savings and Investment Plan as of the date of Mr. Hakami&#8217;s Separation from Service&#59; (b) the lump sum present value of the vested benefit that Mr. Hakami is entitled to receive under the Plan (other than the benefit provided under this Schedule B.II) as of the date of Mr. Hakami&#8217;s Separation from Service&#59; and (c) the lump sum present value of the benefit that Mr. Hakami is entitled to receive under the GE Pension Plan as of the date of Mr. Hakami&#8217; s Separation from Service. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The lump sum present value of the GE Pension Plan benefit as of the date of Mr. Hakami&#8217;s Separation from Service will be determined based on the following assumptions&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mr. Hakami remained employed with the GE Company (&#8220;GE&#8221;) on a full-time basis and continued to accrue benefits under the GE Pension Plan until the date of Mr. Hakami&#8217;s Separation from Service&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No benefit related to or derived from employee contributions, e.g., &#8220;Personal Pension Account&#8221; or &#8220;Voluntary Pension Account&#8221; under the GE Pension Plan, is included in determining the value&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mr. Hakami&#8217;s salary with GE increased at the rate of three percent (3%) per year starting with the date of his employment with the Company and ending with the date of his Separation from Service&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The actuarial assumptions applicable to the Retirement Plan (rather than the GE Pension Plan) as of Mr. Hakami&#8217;s Separation from Service apply. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes hereof, the &#8220;GE Pension Plan&#8221; means the qualified GE Pension Plan as in effect on the date that Mr. Hakami first becomes employed by the Company (and assuming that the terms of such plan do not change thereafter). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mr. Hakami&#8217;s Plan benefit under this Schedule B.II will vest in, and be paid to him (or his Beneficiary) at the same time and in the same manner as Mr. Hakami&#8217;s Personal Investment Account Supplemental Benefit under the Plan, and the benefit provided under this Schedule B.II shall be added to that Account for purposes of calculation and payment of the combined Schedule B.II benefit and Personal Investment Account Supplemental Benefit. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">29</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ex104-medtroniccapital.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i4d22045fd1ec49f0a43f678952ced014_37"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MEDTRONIC CAPITAL ACCUMULATION PLAN</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DEFERRAL PROGRAM</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(as restated generally effective January 1, 2017)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Conformed through the Amendment adopted November 6, 2020)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i4d22045fd1ec49f0a43f678952ced014_40"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 1&#160;&#160;&#160;&#160;DEFERRED COMPENSATION ACCOUNT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1.1&#160;&#160;&#160;&#160;Establishment of Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1.2&#160;&#160;&#160;&#160;Property of Company</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 2&#160;&#160;&#160;&#160;DEFINITIONS, GENDER, AND NUMBER</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.1&#160;&#160;&#160;&#160;Definitions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.2&#160;&#160;&#160;&#160;Gender and Number</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 3&#160;&#160;&#160;&#160;PARTICIPATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.1&#160;&#160;&#160;&#160;Who May Participate</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.2&#160;&#160;&#160;&#160;Time and Conditions of Participation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.3&#160;&#160;&#160;&#160;Termination and Suspension of Participation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.4&#160;&#160;&#160;&#160;Missing Persons</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.5&#160;&#160;&#160;&#160;Relationship to Other Plans</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 4&#160;&#160;&#160;&#160;ENTRIES TO ACCOUNT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 4.1&#160;&#160;&#160;&#160;Contributions.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 4.2&#160;&#160;&#160;&#160;Crediting Rate</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 4.3&#160;&#160;&#160;&#160;Vesting</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 5&#160;&#160;&#160;&#160;DISTRIBUTION OF ACCOUNTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.1&#160;&#160;&#160;&#160;Distribution of Elective Deferrals Accounts.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.2&#160;&#160;&#160;&#160;Distribution of Company Contribution Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.3&#160;&#160;&#160;&#160;Subsequent Election to Change Payment Terms</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.4&#160;&#160;&#160;&#160;Exception to Payment Terms</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.5&#160;&#160;&#160;&#160;Determination of Amount of Installment Payment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 6&#160;&#160;&#160;&#160;SPECIAL RULES FOR DEFERRED STOCK UNIT ACCOUNTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 7&#160;&#160;&#160;&#160;CHANGE IN CONTROL PROVISIONS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 7.1&#160;&#160;&#160;&#160;Application of Article 7</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 7.2&#160;&#160;&#160;&#160;Payments to and by the Trust</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 7.3&#160;&#160;&#160;&#160;Legal Fees and Expenses</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 7.4&#160;&#160;&#160;&#160;Late Payment and Additional Payment Provisions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 8&#160;&#160;&#160;&#160;FUNDING</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 8.1&#160;&#160;&#160;&#160;Source of Benefits</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 8.2&#160;&#160;&#160;&#160;No Claim on Specific Assets</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 9&#160;&#160;&#160;&#160;ADMINISTRATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.1&#160;&#160;&#160;&#160;Administration</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:93.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.2&#160;&#160;&#160;&#160;Powers of Committee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.3&#160;&#160;&#160;&#160;Actions of the Committee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.4&#160;&#160;&#160;&#160;Delegation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.5&#160;&#160;&#160;&#160;Reports and Records</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.6&#160;&#160;&#160;&#160;Claims Procedure</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 10&#160;&#160;&#160;&#160;AMENDMENTS AND TERMINATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 10.1&#160;&#160;&#160;&#160;Amendments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 10.2&#160;&#160;&#160;&#160;Termination</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 11&#160;&#160;&#160;&#160;MISCELLANEOUS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.1&#160;&#160;&#160;&#160;No Guarantee of Employment or Contract to Perform Services</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.2&#160;&#160;&#160;&#160;Release</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.3&#160;&#160;&#160;&#160;Notices</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.4&#160;&#160;&#160;&#160;Nonalienation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.5&#160;&#160;&#160;&#160;Withholding</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.6&#160;&#160;&#160;&#160;Captions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.7&#160;&#160;&#160;&#160;Applicable Law</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.8&#160;&#160;&#160;&#160;Invalidity of Certain Provisions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.9&#160;&#160;&#160;&#160;No Other Agreements</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.10&#160;&#160;&#160;&#160;Incapacity</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.11&#160;&#160;&#160;&#160;Electronic Media</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.12&#160;&#160;&#160;&#160;USERRA Compliance</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SCHEDULE A</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SCHEDULE B</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><div id="i4d22045fd1ec49f0a43f678952ced014_43"></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MEDTRONIC CAPITAL ACCUMULATION PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">DEFERRAL PROGRAM</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(as restated generally effective January 1, 2017)</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic, Inc., a Minnesota corporation (&#8220;Medtronic&#8221;), previously established the Medtronic, Inc. Capital Accumulation Plan Deferral Program (the &#8220;Plan&#8221;) for the benefit of the Eligible Employees of Medtronic and certain of its Affiliates, effective May 1, 1986. The Plan was amended and restated effective January 1, 2008. On June 15, 2014, Medtronic entered into a Transaction Agreement with Covidien plc and the other parties named therein to acquire Covidien through the formation of a new holding company incorporated in Ireland that was renamed Medtronic plc (the &#8220;Transaction&#8221;). Following the Transaction, Medtronic plc, an Irish public limited company, adopted an amended and restated Plan, effective January 26, 2015, pursuant to which the Plan was renamed the Medtronic plc Capital Accumulation Plan Deferral Program. Medtronic plc decided to update the Plan, effective as of January 1, 2017, and to adopt an amended and restated Plan as of such date (the &#8220;Restatement Date&#8221;). Effective July 1, 2019, Medtronic shall assume sponsorship of the Plan and the Plan shall be renamed the Medtronic Capital Accumulation Plan Deferral Program.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This restatement applies, generally, to amounts deferred under the Plan on or after the Restatement Date, and to the payment of all amounts deferred under the Plan (whether such amounts were deferred before, on, or after the Restatement Date that have not yet been distributed as of the Restatement Date. Except as set forth in Article 6, no amount deferred under the Plan is intended to be &#8220;grandfathered&#8221; under Section 409A.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the case of Participants who are employees, the Plan is intended to be (and shall be construed and administered as) an employee benefit pension plan under the provisions of ERISA, which is unfunded and maintained primarily for the purpose of providing deferred compensation for a select group of management or highly compensated employees, as described in Sections 201(2), 301(a)(3) and 401(a)(1) of ERISA.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Plan is not intended to be qualified under Section 401(a) of the Code. The Plan, as restated herein, is subject to, and intended to comply with, Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The obligation of the Company to make payments under the Plan constitutes an unsecured (but legally enforceable) promise of the Company to make such payments and no person, including any Participant or Beneficiary, shall have any lien, prior claim or other security interest in any property of the Company as a result of the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.36pt;text-decoration:underline">DEFERRED COMPENSATION ACCOUNT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Establishment of Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company shall establish one or more Accounts for each Participant which shall be utilized solely as a device to measure and determine the amount of deferred compensation to be paid under the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Property of Company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any amounts set aside for benefits payable under the Plan are the property of the Company, except, and to the extent, provided in the Trust.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.36pt;text-decoration:underline">DEFINITIONS, GENDER, AND NUMBER</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Whenever used in the Plan, the following words and phrases shall have the meanings set forth below unless the context plainly requires a different meaning, and when a defined meaning is intended, the term is capitalized.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.1&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a bookkeeping account established by the Company on its books and records to record and determine the benefits payable to a Participant or Beneficiary under the Plan. The Company shall establish a separate Account on behalf of a Participant for&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">Each Deferral Election Agreement entered into by the Participant pursuant to Section 4.1.1, termed an &#8220;Elective Deferral Account&#59;&#8221;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Each Company Contribution made on the Participant&#8217;s behalf pursuant to Section 4.1.2, termed a &#8220;Company Contribution Account&#59;&#8221; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">Each deferral of Stock Units made by the Participant under the Plan as in effect prior to January 1, 2005, as described in Section 6.1 herein, termed a &#8220;Grandfathered Deferred Stock Unit Account&#59;&#8221; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27pt">Each deferral of Stock Units made by the Participant under the Plan on or after August 1, 2020, in accordance with Section 6.2 herein, termed a &#8220;Non-Grandfathered Deferred Stock Unit Account.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Committee may establish any number of sub-accounts on behalf of a Participant or Beneficiary as the Committee considers necessary or advisable for purposes of maintaining a proper accounting of amounts to be credited under the Plan on behalf of a Participant or Beneficiary.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.2&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Company and any entity with which the Company would be considered a single employer under Section 414(b) of the Code (employees of controlled group of corporations) and Section 414(c) of the Code (employees of partnerships, proprietorships, etc., under common control).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.3&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#8221; of a Participant for any period, means the Participant&#8217;s  total salary and wages from all Affiliates for such period, including any amount that would be included in the definition of Base Salary but for the individual&#8217;s election to defer some of his or her salary pursuant to the Plan or any other deferred compensation plan established by an Affiliate&#59; but excluding disability pay and any other remuneration paid by Affiliates, such as overtime, incentive compensation, stock options, distributions of compensation previously deferred, restricted stock, allowances for expenses (including moving, travel expenses, and automobile allowances), and fringe benefits whether payable in cash or in a form other than cash. In the case of an individual who is a participant in a plan sponsored by an Affiliate that is described in Section 401(k), 125 or 132(f) of the Code, the term Base Salary shall include any amount that would be included in the definition of Base Salary but for the individual&#8217;s election to reduce his or her salary and have the amount of the reduction contributed to or used to purchase benefits under such plan. In the case of a Director, the term &#8220;Base Salary&#8221; shall mean the Director&#8217;s </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">annual retainer, meeting fees, and any other amounts payable to the Director by the Company and its Affiliates for services performed as a Director, excluding any amounts distributable under the Plan or amounts not paid in cash.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.4&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the persons or trusts designated by a Participant in writing pursuant to Section 5.4.1(b) of the Plan as being entitled to receive any benefit payable under the Plan by reason of the death of a Participant, or, in the absence of such designation, the persons specified in Section 5.4.1(c) of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.5&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company as constituted at the relevant time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.6&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as amended from time to time and any successor statute. References to a Code section shall be deemed to be to that section or to any successor to that section.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.7&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Committee or individual appointed by the Compensation Committee of the Board (or any person or entity designated by the Committee) to administer the Plan pursuant to Section 9.4.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.8&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means Medtronic, Inc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.9&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#8221; with respect to a Participant, for any period means the sum of such Participant&#8217;s Base Salary and Incentive Compensation for such period&#59; provided, however, that no such amount shall be treated as Compensation if it is paid or payable in respect of services to any &#8220;non-qualified entity&#8221; within the meaning of Section 457A of the Code.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.10&#160;&#160;&#160;&#160; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Deferral Election Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the agreement described in Section in which the Participant designates the amount of his or her Compensation, if any, that he or she wishes to contribute to the Plan and acknowledges and agrees to the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.11&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a member of the Board who is not an employee of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.12&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Domestic Relations Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 414(p)(1)(B) of the Code.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.13&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Elective Deferral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a contribution to the Plan made by a Participant pursuant to a Deferral Election Agreement that the Participant enters into with the Company. Elective Deferrals shall be made according to the terms of the Plan set forth in Section 4.1.1.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.14&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any employee who is a citizen or resident of the United States or Puerto Rico and who is&#58; (a) an Officer or a Vice President of the Company or an Affiliate&#59; (b) an employee of a Participating Affiliate whose Compensation for the Participating Affiliate&#8217;s fiscal year ending immediately prior to the date on which he or she first enters into a Deferral Election Agreement equals or exceeds the dollar amount set forth on Schedule A, hereto, which schedule may be revised from time to time by the Company&#8217;s Chief Executive </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Officer in his or her discretion&#59; or (c) any individual designated as eligible to participate in the Plan by the Company&#8217;s Chief Executive Officer. Notwithstanding the preceding sentence, in order for an employee to be an &#8220;Eligible Employee,&#8221; he or she must be considered to be a member of a select group of management or highly compensated employees, within the meaning of Sections 201(2), 301(3), and 401(a)(1) of ERISA and rules established by the Committee. The Company may make such projections or estimates as it deems desirable in applying the eligibility requirements, and its determination shall be conclusive.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.15&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Enrollment Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the period designated by the Company during which a Deferral Election Agreement may be entered into with respect to an Eligible Employee&#8217;s Compensation as described in Section 4.1.1. Generally, the Enrollment Period must end no later than the end of the calendar year before the calendar year (or in the case of a Director, the Company&#8217;s fiscal year) in which the services giving rise to the Compensation to be deferred are performed. As described in Section 4.1.1, an exception may be made to this requirement for individuals who first become eligible to participate in the Plan, and may be made in the case of Elective Deferrals from certain types of Incentive Compensation considered to be Performance- Based Compensation, as determined by the Committee from time to time. In addition, other exceptions may be made by the Company from time to time consistent with the requirements of Section 409A.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.16&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Employee Retirement Income Security Act of 1974, as amended from time to time and any successor statute. References to an ERISA section shall be deemed to be to that section or to any successor to that section.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.17&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an event of change in control of the Company, as defined in the Trust.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.18&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#8221; of a Participant for any period, means the total remuneration of the Participant from all Affiliates for the period under the various incentive compensation programs maintained by Affiliates, including, but not limited to, commissions, annual incentive awards, the cash portion of the Medtronic, plc Amended and Restated 2013 Stock Award and Incentive Plan (or any successor thereto) and any amount that would be included in the definition of Incentive Compensation but for the individual&#8217;s election to defer some or all of his or her Incentive Compensation pursuant to the Plan or any other deferred compensation plan established by an Affiliate, but excluding any other type of remuneration paid by Affiliates, such as Base Salary, overtime, stock options, distributions of compensation previously deferred, restricted stock, allowances for expenses (including moving expenses, travel expenses, and automobile allowances), and fringe benefits whether payable in cash or in a form other than cash. In the case of an individual who is a participant in a plan sponsored by an Affiliate that is described in Section 401(k), 125 or 132(f) of the Code, the term Incentive Compensation shall include any amount that would be included in the definition of Incentive Compensation but for the individual&#8217;s election to reduce his or her Incentive Compensation and have the amount of the reduction contributed to or used to purchase benefits under such plan. The Committee shall designate from time to time those items of a Participant&#8217;s Compensation deemed to be Incentive Compensation.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.19&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Officer or Vice President</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an employee who is either elected by the Board or appointed by the Company&#8217;s Chief Executive Officer to such position.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.20&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Ordinary Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s common stock $.10 par value per share (as such par value may be adjusted from time to time).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.21&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an individual who is eligible to participate in the Plan and who has satisfied the requirements set forth in Section 3.2.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.22&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Participating Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Participating Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Company and such Affiliates as may be designated by the Chief Executive Officer of the Company, or his designee, from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.23&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Performance-Based Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#8221; of a Participant for a period, means the Incentive Compensation of the Participant for such period where the amount of, or entitlement to, the Incentive Compensation is contingent on the satisfaction of pre-established organizational or individual performance criteria relating to a performance period of at least 12 consecutive months. Organizational or individual performance criteria are considered pre- established if established in writing by not later than 90 days after the commencement period of service to which the criteria relate, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the outcome is substantially uncertain at the time the criteria are established. Performance-based compensation may include payment based on performance criteria that are not approved by the Board or the Compensation Committee of the Board or by the stockholders of the Company. Performance-Based Compensation does not include any amount or portion of any amount that will be paid either regardless of performance, or based upon a level of performance that is substantially certain to be met at the time the criteria are established.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.24&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the &#8220;Medtronic Capital Accumulation Plan Deferral Program,&#8221; as set forth herein and as amended or restated from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.25&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the 12-month period commencing each January 1 and ending the following December 31.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.26&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Prior Eligible Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;Prior Eligible Employee&#8221; means (i) any Eligible Employee who incurred a Separation from Service from the Company and who participated in the Plan or any other nonqualified deferred compensation plan maintained by the Company during the two years preceding such Eligible Employee&#8217;s re-employment date, and (ii) any Eligible Employee whose Elective Deferral election was cancelled pursuant to the reasons set forth in Section 4.1.1 of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.27&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restatement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means January 1, 2017, the effective date of this restatement.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.28&#160;&#160;&#160;&#160; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#8221; of a Participant who is an Eligible Employee, means the Participant&#8217;s Separation from Service on or after the date on which he or she attains age 55.  In the case of a Director, &#8220;Retirement&#8221; shall mean the Participant&#8217;s Separation from Service for any reason.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.29&#160;&#160;&#160;&#160;&#91;Reserved&#93;</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.30&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Separate from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#8221; with respect to a Participant, means the Participant&#8217;s separation from service with all Affiliates, within the meaning of Section 409A(a)(2)(A)(i) of the Code and the regulations under such section. Solely for this purpose, a Participant who is an Eligible Employee will be considered to have a Separation from Service when the Participant dies, retires, or otherwise has a termination of employment with all Affiliates. The employment relationship is treated as continuing intact while the Participant is on military leave, sick leave, or other bona fide leave of absence if the period of such leave does not exceed six months, or if longer, so long as the individual retains a right to reemployment with an Affiliate under an applicable statute or by contract. For purposes hereof, a leave of absence constitutes a bona fide leave of absence only if there is a reasonable expectation that the Participant will return to perform services for an Affiliate. If the period of leave exceeds six months and the individual does not retain a right to reemployment under an applicable statute or by contract, the employment relationship is deemed to terminate on the first date immediately following such six-month period. Notwithstanding the foregoing, where a leave of absence is due to any medically determinable physical or mental impairment that can be expected to last for a continuous period of not less than six months, where such impairment causes the employee to be unable to perform the duties of his or her position of employment or any substantially similar position of employment, the Company may substitute a 29-month period of absence for such six month.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Whether a termination of employment has occurred is determined based on whether the facts and circumstances indicate that the Affiliate and the Participant reasonably anticipated that no further services will be performed after a certain date or that the level of bona fide services the Participant will perform after such date (whether as an employee or independent contractor) will permanently decrease to no more than 40 percent of the average level of bona fide services performed (whether as an employee or independent contractor) over the immediately preceding 36-month period (or the full period of services if the Participant has been providing services for less than 36 months).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything in Section 2.1.2 to the contrary, in determining whether a Participant has had a Separation from Service with an Affiliate, an entity&#8217;s status as an &#8220;Affiliate&#8221; shall be determined substituting &#8220;50 percent&#8221; for &#8220;80 percent&#8221; each place it appears in Section 1563(a)(1), (2), and (3) and in Treasury Regulation Section 1.414(c)-2.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall have discretion to determine whether a Participant has experienced a Separation from Service in connection with an asset sale transaction entered into by the Company or an Affiliate, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that such determination conforms to the requirements of Section 409A and the regulations and other guidance issued under such section, in which case the Company&#8217;s determination shall be binding on the Participant.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A Director is considered to have a Separation from Service when he or she ceases to perform services as a Director and the Company does not then anticipate that the Director will continue to perform services for any Affiliate. Notwithstanding the foregoing, if a Participant provides services both as a Director and an employee, the services provided as a Director are not taken into account in determining whether the Participant has a Separation from Service as an employee for purposes of the Plan contributions made with respect to services performed as an </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">employee, and the services provided as an employee are not taken into account for purposes of determining whether the Participant has had a Separation from Service for purposes of Plan contributions made with respect to services performed as a Director.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.31&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means section 409A of the Internal Revenue Code, as amended from time to time and any successor statute.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.32&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an employee of an Affiliate who is subject to the six-month delay rule described in Section 409A(2)(B)(i) of the Code. The Company shall establish a written policy for identifying Specified Employees in a manner consistent with Section 409A, which policy may be amended by the Company from time to time as permitted by Section 409A.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.33&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the stock-settled incentive compensation payable pursuant to the Medtronic, plc Amended and Restated 2013 Stock Award and Incentive Plan (or any successor thereto) and any amount that would be included in the definition of Stock Compensation but for the individual&#8217;s election to defer some or all of his or her Stock Compensation pursuant to the Plan or any other deferred compensation plan established by an Affiliate, including, without limitation, awards of restricted stock units and performance stock units.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.34&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Deferral Election Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the agreement described in Section 6.2.1 in which the Participant designates the amount of his or her Stock Compensation, if any, that he or she wishes to contribute to the Plan and acknowledges and agrees to the terms of the Plan. Except as otherwise provided in Section 6.2, a Stock Deferral Election Agreement shall be treated as a Deferral Election Agreement for all Plan purposes.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.35&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Elective Deferral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a contribution to the Plan made by a Participant pursuant to a Stock Deferral Election Agreement that the Participant enters into with the Company. Stock Elective Deferrals shall be made according to the terms of the Plan set forth in Section 6.2. Except as otherwise provided in Section 6.2, a Stock Elective Deferral shall be treated as an Elective Deferral for all Plan purposes.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.36&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a notational unit representing the right to receive one Ordinary Share.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.37&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Medtronic plc Compensation Trust Agreement Number One, as may be amended from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Gender and Number</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as otherwise indicated by context, masculine terminology used herein also includes the feminine and neuter, and terms used in the singular may also include the plural.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.36pt;text-decoration:underline">PARTICIPATION</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Who May Participate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Participation in the Plan is limited to Eligible Employees and, to the extent permitted by the Committee or the Board, Directors.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Time and Conditions of Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. An Eligible Employee or Director shall become a Participant only upon his or her compliance with the following terms and such other terms and conditions as the Committee may from time to time establish for the implementation of the Plan, including, but not limited to, any condition the Committee may deem necessary or appropriate for the Company to meet its obligations under the Plan.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.2.1&#160;&#160;&#160;&#160;A newly hired Eligible Employee who is not a Prior Eligible Employee will be eligible to become a Participant on the thirtieth day after his or her date of hire.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.2.2&#160;&#160;&#160;&#160;A Prior Eligible Employee will be eligible to become a Participant as of the first day of the calendar year that occurs immediately after the Prior Eligible Employee&#8217;s re- employment date or, if applicable, the Elective Deferral cancellation date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination and Suspension of Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Once an individual has become a Participant, participation shall continue until payment in full of all benefits to which the Participant or Beneficiary is entitled under the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Missing Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Participant and Beneficiary entitled to receive benefits under the Plan shall be obligated to keep the Company informed of his or her current address until all Plan benefits that are due to be paid to the Participant or Beneficiary have been paid to him or her. If, after having made reasonable efforts to do so, the Company is unable to locate the Participant or Beneficiary for purposes of making a distribution, the Participant&#8217;s or Beneficiary&#8217;s Plan benefit will be forfeited. In no event will a Participant&#8217;s or Beneficiary&#8217;s benefit be paid to him or her later than the date otherwise required by the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Relationship to Other Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Participation in the Plan shall not preclude participation of the Participant in any other fringe benefit program or plan sponsored by an Affiliate for which such Participant would otherwise be eligible.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.36pt;text-decoration:underline">ENTRIES TO ACCOUNT</font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant may elect to reduce his or her Compensation for a Plan Year and have the amount of the reduction contributed to the Plan on the Participant&#8217;s behalf as an Elective Deferral. A Participant wishing to make an Elective Deferral under the Plan for a Plan Year shall enter into a Deferral Election Agreement during the Enrollment Period immediately preceding the Plan Year, except as described below. A separate Deferral Election Agreement must be entered into for each Plan Year that a Participant wishes to make Elective Deferrals under the Plan. The Committee may require that a Participant enter into a separate Deferral Election Agreement for Base Compensation and Incentive Compensation that he or she wishes to defer and, if the Participant is eligible to receive more than one type of Incentive Compensation, that he or she enter into a separate Deferral Election Agreement for each type of Incentive Compensation he or she is eligible to receive. In order to be effective, the Deferral Election Agreement must be completed and submitted to the Company at the time and in the manner specified by the Committee, which may be no later than the last day of the Enrollment Period. The Company shall not accept Deferral Election Agreements entered into after the end of </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Enrollment Period. Notwithstanding anything in this paragraph to the contrary, in the case of a Director, the Deferral Election Agreement will apply to the Company&#8217;s fiscal year that begins in the Plan Year immediately following the Enrollment Period.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">When an individual (other than a Prior Eligible Employee) first becomes eligible to participate in the Plan (due to hire, but not promotion), the Committee may, in its discretion, allow the individual to enter into a Deferral Election Agreement within 30 days after he or she first becomes eligible to participate in the Plan. Such Deferral Election Agreement may be filed by such method as may be established by the Committee, including electronically.  In order to be effective, the Deferral Election Agreement must be completed and submitted on or before the 30- day period has elapsed. Deferral Election Agreements entered into after the 30-day period has elapsed will not be accepted.  The Deferral Election Agreement may only apply to Compensation earned after the date on which the Deferral Election is filed, consistent with Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the eligible individual fails to complete a Deferral Election Agreement by such time, he or she may enter into a Deferral Election Agreement during any succeeding Enrollment Period in accordance with the rules described in the preceding paragraph. For Compensation that is earned based upon a specified performance period (for example an annual bonus) where a Deferral Election Agreement is entered into in the first year of eligibility but after the beginning of the performance period, the Deferral Election Agreement must apply to Compensation paid for services performed after the Deferral Election Agreement is entered into. For this purpose, a Deferral Election Agreement will be deemed to apply to Compensation paid for services performed after the Deferral Election Agreement is entered into if the Deferral Election Agreement applies to no more than an amount equal to the total amount of the Compensation for the performance period multiplied by the ratio of the number of days remaining in the performance period after the Deferral Election Agreement is entered into over the total number of days in the performance period. The term &#8220;Plan,&#8221; for purposes of this paragraph, means the Plan and any other plan required to be aggregated with the Plan pursuant to Section 409A and the regulations and other guidance under such section.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as otherwise specified in this Section 4.1.1, a Deferral Election Agreement will be effective to defer Compensation earned after the Deferral Election Agreement is entered into, and not before.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Deferral Election Agreements for Base Salary and Incentive Compensation other than Performance-Based Compensation must be completed and submitted to the Company at the time described above that is ordinarily applicable to Deferral Election Agreements (subject to the exception for individuals who are newly eligible to participate). Deferral Election Agreements for Incentive Compensation that is Performance-Based Compensation must be completed and submitted to the Company no later than six months before the end of the performance period for the Incentive Compensation&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in order for such an election to be valid the Participant must perform services continuously from the beginning of the performance period (or the date the performance criteria are established, if later) through the date the Deferral Election Agreement is entered into, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in no event may a Deferral Election Agreement be effective to defer Incentive Compensation after the Incentive Compensation has </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">become reasonably ascertainable. For purposes hereof, if Incentive Compensation is a specific or calculable amount, the Incentive Compensation is readily ascertainable if and when the amount is first substantially certain to be paid. If the Incentive Compensation is not a specific or calculable amount (for example, the amount may vary based upon the level of performance) the Incentive Compensation, or any portion thereof, is readily ascertainable when the amount is both calculable and substantially certain to be paid. Accordingly, in general, any minimum amount that is both calculable and substantially certain to be paid will be treated as readily ascertainable. The Committee shall determine from time to time whether an item of Incentive Compensation is considered Performance-Based Compensation for these purposes.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each Deferral Election Agreement shall specify the amount of Compensation the Participant wishes to have deducted from his or her Compensation and contributed to the Plan by type and percentage or dollar amount, subject to the following rules&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.68pt">Base Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Participant may elect to make an Elective Deferral under the Plan for each Plan Year in an amount equal to any whole percentage or dollar amount not in excess of 50% of his or her Base Compensation (determined on a pay period basis).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27pt">Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Participant may elect to make an Elective Deferral under the Plan for each Plan Year in an amount equal to any whole percentage or dollar amount not in excess of 80% of his or her Incentive Compensation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.68pt">Minimum Elective Deferral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Committee may from time to time establish a minimum amount that may be deferred by a Participant pursuant to this Section 4.1.1 for any Plan Year.  That minimum may be zero for certain categories of Eligible Employees with respect to certain types of Compensation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall establish an Elective Deferral Account for each Elective Deferral Agreement entered into by a Participant, and if more than one type of Compensation is deferred under a Deferral Election Agreement, for each separate type of Compensation deferred. Elective Deferrals made under the Elective Deferral Agreement shall be credited to the Account as soon as administratively reasonable after the Compensation would have been paid to the Participant had the Participant not elected to defer it under the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In general, a Deferral Election Agreement shall become irrevocable as of the last day of the Enrollment Period applicable to it. However, if a Participant incurs an &#8220;unforeseeable emergency,&#8221; as defined in Section 5.4.5(g) after the Deferral Election Agreement otherwise becomes irrevocable, the Deferral Election Agreement shall be cancelled as of the date on which the Participant is determined to have incurred the unforeseeable emergency and no further Elective Deferrals will be made under it. In addition, if a Participant becomes &#8220;disabled&#8221; (as defined below), the Company may, in its discretion, cancel the Participant&#8217;s Deferral Election Agreement then in effect, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> such cancellation is made no later than end of the Plan Year, or if later, the 15th day of the third month following the date on which the Participant becomes disabled, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, further that the Company does not allow the Participant a direct or indirect election regarding the cancellation. For purposes of the preceding sentence, </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;disability&#8221; means any medically determinable physical or mental impairment resulting in the Participant&#8217;s inability to perform the duties of his or her position or any substantially similar position, where such impairment can be expected to result in death or can be expected to last for a continuous period of not less than six months.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">At the time a Participant enters into a Deferral Election Agreement, the Participant shall, as part of such agreement, elect the time, and if applicable the form, of distribution of the Elective Deferral Account or Accounts corresponding to the Deferral Election Agreement in accordance with Section 5.1.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding any other provision of the Plan, no amount may be deferred under the Plan if such deferral would violate the provisions of Section 457A of the Code by virtue of being paid or payable in respect of services to any &#8220;non-qualified entity&#8221; within the meaning of Section 457A of the Code.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company may make a contribution to an Account under the Plan on behalf of one or more Eligible Employees or Directors in such amount and at such time and based upon such criteria as the Company, in its sole and absolute discretion, deems appropriate or desirable. The Company shall establish a separate Company Contribution Account for each Participant for each contribution made by the Company on the Participant&#8217;s behalf pursuant to this Section 4.1.2. The Company Contribution shall be credited to this Account at the time and in the manner specified by the Committee. At the time a Company Contributions Account is established, the Company shall specify the time and manner in which it will be distributed to the Participant.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Crediting Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Committee shall designate the manner in which a Participant&#8217;s Elective Deferral Accounts and Company Contribution Accounts are to be credited with gains and losses as described on Schedule B hereto, which Schedule may be amended from time to time in the Committee&#8217;s discretion. If the Committee designates specific investment funds to serve as an index for crediting gains and losses to such Accounts&#58; (a) the Participant shall be entitled to designate which such fund or funds shall be used to measure gains and losses on such Accounts and to change such designation in accordance with rules established by the Committee (in which case, such change shall be effective prospectively)&#59; (b) the Accounts will be credited with gains and losses as if invested in such fund or funds in accordance with the Participant&#8217;s designation and the rules established by the Committee&#59; and (c) the Committee may, in its sole discretion, eliminate any investment fund or funds previously designated by it, substitute a new investment fund or funds therefore, or add an investment fund or funds, at any time. If the Committee makes any such investment funds available for this purpose, the Company shall have no obligation to actually invest any amounts in any such investment funds.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Elective Deferral Account will be fully vested immediately. Each Company Contribution Account will vest in the manner specified by the Company at the time the Company Contribution Account is established.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.36pt;text-decoration:underline">DISTRIBUTION OF ACCOUNTS</font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Distribution of Elective Deferrals Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Time of Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant shall be entitled to elect whether distribution of an Elective Deferral Account shall begin at&#58; (a) a specified future date, which must be at least five years after the first day of the Plan Year (or in the case of a Director, the first day of the Company&#8217;s fiscal year, and in the case of a deferral of Performance-Based Compensation, the first day of the last year of a performance cycle) to which the Deferral Election Agreement applies&#59; or (b) the Participant&#8217;s Retirement. If the Participant elects to have distribution commence at a specified future date, the distribution commencement date must be specified in his or her Deferral Election Agreement in which case distribution will commence to the Participant no later than the end of the Plan Year, or if later, the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day of the third calendar month, following the specified date. If the Participant elects to have distributions commence at his or her Retirement, distribution will commence to the Participant within 90 days after his or her Retirement. If the Participant does not specify the distribution commencement date of an Elective Deferral Account, the Participant will be deemed to have elected to have distribution of the Elective Deferral Account commence at his or her Retirement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Form of Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If a Participant elects to have distribution of an Elective Deferral Account commence at a specified date, the Elective Deferral Account will be distributed to the Participant in a lump sum. If the Participant elects to have distribution of an Elective Deferral Account commence at Retirement, the Participant shall elect the form of distribution from those specified below&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">lump sum&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">monthly installments over five, ten or 15 years.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Distribution of Company Contribution Account</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Distribution to a Participant of a Company Contribution Account shall be made at the time and in the manner specified by the Company at the time the Participant first has a legally binding right to the amounts credited to the Account, subject to Sections 5.3 and 5.4.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Subsequent Election to Change Payment Terms</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. On or after January 1, 2017, a Participant may modify a Deferral Election Agreement, and the distribution terms specified by the Company with respect to a Company Contribution Account, to postpone the distribution commencement date of the Account to a later date and, in the case of an Account whose distribution is scheduled to commence at Retirement, change the form of distribution to another form permitted under Section 5.1.2 up to two times per Account source as determined by the Committee. In order to be effective, the requested modification must&#58; (a) be in writing and be submitted to the Company at the time and in the manner specified by the Committee&#59; (b) not take effect for at least 12 months from the date on which it is submitted to the Company&#59; (c) in the case of an Account whose distribution is scheduled to commence at a specified date pursuant to clause (a) of Section 5.1.1, be submitted to the Company at least 12 months prior to the specified date&#59; and (d) specify a new distribution commencement date that is no earlier than five years after the date distribution would otherwise have commenced. For purposes hereof, if the &#8220;specified date&#8221; referred to in clause (a) of Section 5.1.1 is a Plan Year </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">rather than a specified date within a Plan Year, the &#8220;specified date&#8221; shall be deemed to be the first day of the Plan Year.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exception to Payment Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding anything in this Article 5 or a Participant&#8217;s Deferral Election Agreement to the contrary, the following terms, if applicable, shall apply to the payment of a Participant&#8217;s Elective Deferral Accounts and Company Contribution Accounts.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt;text-decoration:underline">Time and Form of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event a Participant dies while there are amounts remaining in an Account, the Account (or the remaining balance of the Account if distributions have commenced) shall be paid to the Participant&#8217;s Beneficiary in a lump sum within 90 days after the Participant&#8217;s death.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Designation by Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Participant has the right to designate primary and contingent Beneficiaries for death benefits payable under the Plan. Such Beneficiaries may be individuals or trusts for the benefit of individuals. A Beneficiary designation by a Participant shall be in writing on a form acceptable to the Committee and shall only be effective upon delivery to the Company. A Beneficiary designation may be revoked by a Participant at any time by delivering to the Company either written notice of revocation or a new Beneficiary designation form. The Beneficiary designation form last delivered to the Company prior to the death of a Participant shall control.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt;text-decoration:underline">Failure to Designate Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event there is no Beneficiary designation on file with the Company at the Participant&#8217;s death, or if all Beneficiaries designated by a Participant have predeceased the Participant, any benefits payable pursuant to this Section 5.4.1 will be paid to the Participant&#8217;s surviving spouse, if living&#59; or if the Participant does not leave a surviving spouse, to the Participant&#8217;s children, if any, in equal shares, except that if any of the children predecease the Participant but leave issue surviving the Participant, such issue shall take by right of representation, the share their parent would have taken if living&#59; for purposes of this provision, &#8220;children&#8221; shall not include stepchildren unless such stepchildren have been legally adopted by the Participant&#59; or, if there are no such surviving issue, to the Participant&#8217;s estate.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If a Participant has a Separation from Service other than due to Retirement or death, the Participant shall receive the balance in each of his or her Accounts in the form of monthly installments over a five-year period, regardless of any payment election the Participant may have made under the Plan. Payments pursuant to this Section 5.4.2 shall commence within 90 days after the Participant&#8217;s Separation from Service.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Small Account Balances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If at any time the present value of any benefit under the Plan that would be considered a &#8220;single plan&#8221; under Treasury Regulation Section 1.409A-1(c)(2) together with the present value of any benefit required to be aggregated with such benefit under Treasury Regulation Section 1.409A-1(c)(2), is less than the dollar limit set forth in Section </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">402(g) of the Code, the Company may, in its discretion, distribute such benefit (or benefits) to the Participant in the form of a lump sum, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the payment results in the liquidation of the entirety of the Participant&#8217;s interest under the &#8220;single plan,&#8221; including all benefits required to be aggregated as part of the &#8220;single plan&#8221; under Treasury Regulation Section 1.409A-1(c)(2).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Delay in Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">Except as set forth in Section 5.4.5, if a Participant is a Specified Employee as of the date of his or her Separation from Service, any distributions that under the terms of the Plan are to commence to the Participant on his or her Separation from Service (&#8220;separation distributions&#8221;) shall commence within 90 days after the Participant&#8217;s &#8220;delayed distribution date&#8221; (as defined below). In this case, the Company shall, in its discretion, determine whether the first separation distribution to the Participant shall include the aggregate amount of any separation distributions that, but for this paragraph (a), would have been paid to the Participant from the date of his or her Separation from Service until the delayed distribution date, or whether each separation distribution shall be delayed for six months. For purposes of this paragraph (a), a Specified Employee&#8217;s &#8220;delayed distribution date&#8221; is the first day of the seventh month following the Participant&#8217;s Separation from Service, or if earlier, the date of the Participant&#8217;s death.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">A payment under the Plan may be delayed by the Company under any of the following circumstances so long as all payments to similarly situated Participants are treated on a reasonably consistent basis&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:29.67pt">The Company reasonably anticipates that if such payment were made as scheduled, the Company&#8217;s deduction with respect to such payment would not be permitted under Section 162(m) of the Code, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the payment is made either during the first Plan Year in which the Company reasonably anticipates, or should reasonably anticipate, that if the payment is made during such year, the deduction of such payment will not be barred by application of Section 162(m) or during the period beginning with the date of the Participant&#8217;s Separation from Service and ending on the later of the last day of the Company&#8217;s fiscal year in which the Participant has a Separation from Service or the 15th day of the third month following the Separation from Service.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:26.34pt">The Company reasonably anticipates that the making of the payment will violate Federal securities laws or other applicable law, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the payment is made at the earliest date at which the Company reasonably anticipates that the making of the payment will not cause such violation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:23.01pt">Upon such other events as determined by the Company and according to such terms as are consistent with Section 409A or are prescribed by the Commissioner of Internal Revenue.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.4.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Acceleration of Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company may, in its discretion, distribute all or a portion of a Participant&#8217;s Accounts at an earlier time and in a different form than specified above in this Article 5 under the circumstances described below&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">As may be necessary to fulfill a Domestic Relations Order. Distributions pursuant to a Domestic Relations Order shall be made according to administrative procedures established by the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">To the extent reasonably necessary to avoid the violation of ethics laws or conflict of interest laws pursuant to Section 1.409A-3(j)(ii) of the Treasury regulations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">To pay FICA on amounts deferred under the Plan and the income tax resulting from such payment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">To pay the amount required to be included in income as a result of the Plan&#8217;s failure to comply with Section 409A.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">If the Company determines, in its discretion, that it is advisable to liquidate the Plan in connection with a termination of the Plan pursuant to Section 10.2, subject to Article 7.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:29.01pt">As satisfaction of a debt of the Participant to an Affiliate, where such debt is incurred in the ordinary course of the service relationship between the Affiliate and the Participant, the entire amount of the reduction in any Plan Year does not exceed $5,000, and the reduction is made at the same time and in the same amount as the debt otherwise would have been due and collected from the Participant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">If the Participant has an unforeseeable emergency. For these purposes an &#8220;unforeseeable emergency&#8221; is a severe financial hardship to the Participant, resulting from an illness or accident of the Participant, the Participant&#8217;s spouse, the Beneficiary, or the Participant&#8217;s dependent (as defined in Section 152, without regard to Section 152(b)(1), (b)(2), and (d)(1)(B) of the Code)&#59; loss of the Participant&#8217;s property due to casualty (including the need to rebuild a home following damage to a home not otherwise covered by insurance, for example, not as a result of a natural disaster)&#59; or other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the Participant. For example, the imminent foreclosure of or eviction from the Participant&#8217;s primary residence may constitute an unforeseeable emergency. In addition, the need to pay for medical expenses, including non-refundable deductibles, as well as for the cost of prescription drug medication, may constitute an unforeseeable emergency. Finally, the need to pay for funeral expenses of a spouse, Beneficiary, or a dependent (as defined in Section 152, without regard to 152(b)(1), (b)(2), and (d)(1)(B) of the Code) may also constitute an unforeseeable emergency. Except as otherwise provided in this paragraph (g), the purchase of a home and the payment of college tuition are not unforeseeable emergencies. Whether a Participant or Beneficiary is faced with an unforeseeable emergency permitting a distribution under this paragraph (g) is to be determined based on the relevant facts and circumstances of each </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">case, but, in any case a distribution on account of an unforeseeable emergency may not be made to the extent that such emergency is or may be relieved through reimbursement or compensation from insurance or otherwise, by liquidation of the Participant&#8217;s assets, to the extent the liquidation of such assets would not cause severe financial hardship, or by cessation of Elective Deferrals. Distributions because of an unforeseeable emergency must be limited to the amount reasonably necessary to satisfy the emergency need (which may include amounts necessary to pay any Federal, state, local, or foreign income taxes or penalties reasonably anticipated to result from the distribution). A determination of the amounts reasonably necessary to satisfy the emergency need must take into account any additional compensation that is available due to cancellation of the Participant&#8217;s Deferral Election Agreement pursuant to Section 4.1.1 as a result of this paragraph (g).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything in this Section 5.4.5 to the contrary, except for a Participant&#8217;s election to request a distribution due to an unforeseeable emergency under paragraph (g), above (which the Participant, in his or her discretion, may elect to make or not make), the Company shall not provide the Participant with discretion or a direct or indirect election regarding whether a payment is accelerated pursuant to this Section 5.4.5.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Determination of Amount of Installment Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. An Account to be distributed in the form of installments will be credited with gains and losses pursuant to Section 4.2 during the payout period. The dollar amount of each installment payment will be determined as follows. For the first Plan Year in which installment payments are to be made, the Account balance will be determined as of the distribution commencement date (taking into account any Elective Deferrals, vested Company contributions and gains and losses credited to the Account pursuant to Section 4.2 as of such date). For this year, the amount of each installment payment will be determined by dividing the Account balance, as so determined, by the total number of months that installment payments are required to be made to exhaust the Account. For each Plan Year thereafter, the dollar amount of each installment payment to be paid during the Plan Year will be determined once during the year, at the beginning of the Plan Year (the &#8220;Valuation Date&#8221;), by dividing the Account balance, determined as of the Valuation Date (taking into account gains and losses credited to the Account pursuant to Section 4.2 and payments that have been made from the Account as of such Valuation Date), by the total number of months remaining, determined as of such Valuation Date, that installment payments are required to be made to exhaust the Account.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.36pt;text-decoration:underline">SPECIAL RULES FOR DEFERRED STOCK UNIT ACCOUNTS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Grandfathered Stock Unit Deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Article 5 of the Plan, as in effect prior to January 1, 2005, permitted certain Participants to defer the gain they otherwise would have realized on the exercise of stock options granted to them by Medtronic and to convert that gain to the right to receive stock (now Ordinary Shares) at a future date, expressed in terms of Stock Units. Each deferral of Stock Units by a Participant was credited to a separate Deferred Stock Unit Account maintained by Medtronic on the Participant&#8217;s behalf under the Plan, which Account is credited with dividend equivalents in the manner determined by the Committee and distributed to the Participant at the time and manner elected by the Participant, subject to the terms of the Plan. Effective December 31, 2004, all deferrals of stock option gains ceased and no </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">new Deferred Stock Unit Accounts were permitted to be established under the Plan. The Company shall continue to maintain and administer the Deferred Stock Unit Accounts established prior to January 1, 2005, according to Article 5 of the Plan as in effect immediately prior to January 1, 2005. The Deferred Stock Unit Accounts shall be treated as grandfathered under, and therefore not subject to, Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 6.2</font></div><div style="margin-bottom:12pt;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Grandfathered Stock Unit Deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant may elect to reduce his or her Stock Compensation for a Plan Year and have the amount of the reduction contributed to the Plan and credited as Stock Units in one or more Non-Grandfathered Deferred Stock Unit Accounts. A Participant wishing to defer his or her Stock Compensation under the Plan for a Plan Year shall enter into a Stock Deferral Election Agreement. A separate Stock Deferral Election Agreement must be entered into for each Plan Year that a Participant wishes to defer his or her Stock Compensation under the Plan. In order to be effective, the Stock Deferral Election Agreement must be completed and submitted to the Company at the time and in the manner specified by the Committee. For the avoidance of doubt, with respect to Stock Deferral Election Agreements and Stock Elective Deferrals, the terms of Section 6.2 shall supersede the provisions of the Plan to the extent such provisions are inconsistent with the terms of Section 6.2.</font></div><div style="margin-bottom:12pt;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Deferral Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Stock Deferral Election Agreement shall specify the amount of Stock Compensation the Participant wishes to have deducted from his or her Stock Compensation and contributed to the Plan by percentage.  Each Participant may elect to make a Stock Elective Deferral under the Plan for each Plan Year in an amount equal to any whole percentage equal to not less than 5% and not in excess of 80% of his or her Stock Compensation. </font></div><div style="margin-bottom:12pt;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Crediting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each deferral of Stock Compensation shall be credited as Stock Units to a Non-Grandfathered Deferred Stock Unit Account.   </font></div><div style="margin-bottom:12pt;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Stock Units credited to each Non-Grandfathered Deferred Stock Unit Account will vest in accordance with the terms and conditions of the Medtronic, plc Amended and Restated 2013 Stock Award and Incentive Plan (or any successor thereto) and the written award agreement pursuant to which the underlying Stock Compensation was issued to the Participant.  </font></div><div style="margin-bottom:12pt;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant shall be entitled to elect whether distribution of a Non-Grandfathered Deferred Stock Unit Account shall be made as follows&#58; (a) in a lump sum upon the Participant&#8217;s Separation from Service (or, if later, the vesting date applicable to the underlying Stock Compensation)&#59; (b) in five (5) substantially equal installments over the five (5) year period following the Participant&#8217;s Separation from Service (or, if later, the vesting date applicable to the underlying Stock Compensation) or (c) in ten (10) substantially equal installments over the ten (10) year period following the Participant&#8217;s Separation from Service (or, if later, the vesting date applicable to the underlying Stock Compensation).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.36pt;text-decoration:underline">CHANGE IN CONTROL PROVISIONS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 7.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Application of Article 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. To the extent applicable, the provisions of this Article 7 relating to an Event of change in control of the Company shall control, notwithstanding </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any other provision of the Plan to the contrary, and shall supersede any other provision of the Plan to the extent inconsistent with the provisions of this Article 7.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 7.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payments to and by the Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Pursuant to the terms of the Trust, the Company is required to make certain payments to the Trust if an Event occurs or if the Company determines that it is probable that an Event may occur. The obligation of the Company to make such payments shall be considered an obligation under the Plan&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that such obligation shall at all times be and remain subject to the terms of the Trust as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 7.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Fees and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company shall reimburse a Participant or his or her Beneficiary for all reasonable legal fees and expenses incurred by such Participant or Beneficiary after the date of an Event in seeking to obtain any right or benefit provided by the Plan&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that&#58; (a) any such reimbursement shall be made during a period not to exceed 20 years following the date of the Event&#59; (b) the amount eligible for reimbursement during a taxable year of the Participant or Beneficiary shall not affect the amount eligible for reimbursement in any other taxable year&#59; (c) the reimbursement is made on or before the last day of the Participant&#8217;s or Beneficiary&#8217;s taxable year following the taxable year in which the legal fees and expenses are incurred&#59; and (d) the right to reimbursement is not subject to liquidation or exchange for another benefit.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 7.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Late Payment and Additional Payment Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If, after the date of an Event, the Company delays a payment required to be made under the Plan past the final date that the payment was due to be made, the amount of each such delayed payment shall be credited with interest at the rate of five percent per year, compounded quarterly, from the date on which the distribution was required to be made under the terms of the Plan until the actual date of the distribution. In the event that this interest is to be credited for some period less than a full calendar quarter, the interest shall be determined and compounded for the fractional quarter. This interest represents a late payment penalty for the delay in payment and is intended to supplement any other interest or gains credited to a Participant&#8217;s Account under the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any benefit payments made by the Company after the date on which a benefit distribution was required to be made under the terms of the Plan shall be applied first against the first due of such benefit distributions (with application first against any applicable late payment penalty and next against the benefit amount itself) until fully paid, and next against the next due of such payments in the same manner, and so forth, for purposes of calculating the late payment penalties hereunder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event that payment of benefits has commenced to a Participant or Beneficiary prior to the date of an Event, then the date on which distribution was required to be made under the terms of the Plan shall be determined with reference to the payment provision that was in effect prior to the date of the Event. No adjustment may be made to any payment form which was in effect prior to the date of an Event with respect to any Account which would have the effect of delaying payments otherwise to be made under the payment form or otherwise increasing the period of time over which payments are to be made, except as elected by the Participant pursuant to the Plan.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participants and their Beneficiaries shall be entitled to benefit payments under the Plan plus the late payment penalty referred to hereinabove first from the Trust and secondarily from the Company, as otherwise provided in Section 7.2.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.36pt;text-decoration:underline">FUNDING</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 8.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Source of Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All benefits under the Plan shall be paid when due by the Company out of its assets or from the Trust.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 8.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Claim on Specific Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No Participant shall be deemed to have, by virtue of being a Participant in the Plan, any claim on any specific assets of the Company such that the Participant would be subject to income taxation on his or her benefits under the Plan prior to distribution and the rights of Participants and Beneficiaries to benefits to which they are otherwise entitled under the Plan shall be those of an unsecured general creditor of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.36pt;text-decoration:underline">ADMINISTRATION</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Plan shall be administered by the Committee. The Company shall bear all administrative costs of the Plan other than those specifically charged to a Participant or Beneficiary.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Powers of Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In addition to the other powers granted under the Plan, the Committee shall have all powers necessary to administer the Plan, including, without limitation, powers to&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">interpret the provisions of the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">establish and revise the method of accounting for the Plan and to maintain the Accounts&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">establish rules for the administration of the Plan and to prescribe any forms required to administer the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Actions of the Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as modified by the Board, the Committee (including any person or entity to whom the Committee has delegated duties, responsibilities or authority, to the extent of such delegation) has total and complete discretionary authority to determine conclusively for all parties all questions arising in the administration of the Plan, to interpret and construe the terms of the Plan, and to determine all questions of eligibility and status of employees, Participants and Beneficiaries under the Plan and their respective interests. Subject to the claims procedures of Section 9.6, all determinations, interpretations, rules and decisions of the Committee (including those made or established by any person or entity to whom the Committee has delegated duties, responsibilities or authority, if made or established pursuant to such delegation) are conclusive and binding upon all persons having or claiming to have any interest or right under the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Delegation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Committee, or any officer designated by the Committee, shall have the power to delegate specific duties and responsibilities to officers or other </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">employees of the Company or other individuals or entities. Any delegation may be rescinded by the Committee at any time. Each person or entity to which a duty or responsibility has been delegated shall be responsible for the exercise of such duty or responsibility and shall not be responsible for any act or failure to act of any other person or entity.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reports and Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Committee, and those to whom the Committee has delegated duties under the Plan, shall keep records of all their proceedings and actions and shall maintain books of account, records, and other data as shall be necessary for the proper administration of the Plan and for compliance with applicable law.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Claims Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Committee shall notify a Participant in writing within 90 days of the Participant&#8217;s written application for benefits of his or her eligibility or non- eligibility for benefits under the Plan. If the Committee determines that a Participant is not eligible for benefits or full benefits, the notice shall set forth&#58; (a) the specific reasons for such denial&#59; (b) a specific reference to the provision of the Plan on which the denial is based&#59; (c) a description of any additional information or material necessary for the claimant to perfect his or her claim, and a description of why it is needed&#59; and (d) an explanation of the Plan&#8217;s claims review procedure and other appropriate information as to the steps to be taken if the Participant wishes to have his or her claim reviewed. If the Committee determines that there are special circumstances requiring additional time to make a decision, the Committee shall notify the Participant of the special circumstances and the date by which a decision is expected to be made, and may extend the time for up to an additional 90-day period. If a Participant is determined by the Committee to be not eligible for benefits, or if the Participant believes that he or she is entitled to greater or different benefits, the Participant shall have the opportunity to have his or her claim reviewed by the Committee by filing a petition for review with the Committee within 60 days after receipt by the Participant of the notice issued by the Committee. If a Participant does not appeal on time, the Participant will lose the right to appeal the denial and the right to file suit under ERISA, and the Participant will have failed to exhaust the Plan&#8217;s internal administrative appeal process, which is generally a prerequisite to bringing suit. Said petition shall state the specific reasons the Participant believes he or she is entitled to benefits or greater or different benefits. Within 60 days after receipt by the Committee of said petition, the Committee shall afford the Participant (and his or her counsel, if any) an opportunity to present the Participant&#8217;s position to the Committee orally or in writing, and the Participant (or his or her counsel) shall have the right to review the pertinent documents, and the Committee shall notify the Participant of its decision in writing within said 60-day period, stating specifically the basis of the decision written in a manner calculated to be understood by the Participant and the specific provisions of the Plan on which the decision is based. If, because of the need for a hearing, the 60-day period is not sufficient, the decision may be deferred for up to another 60-day period at the election of the Committee, but notice of this deferral shall be given to the Participant. In the event an appeal of a denial of a claim for benefits is denied, any lawsuit to challenge the denial of such claim must be brought within one year of the date the Committee has rendered a final decision on the appeal.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:3.36pt;text-decoration:underline">AMENDMENTS AND TERMINATION</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 10.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company, by action of the Compensation Committee of the Board, or the Chief Executive Officer or the Chief Human Resources Officer of the Company, to the extent authorized by the Compensation Committee of the Board, may amend the Plan, in whole or in part, at any time and from time to time. Any such amendment shall be filed with the Plan documents. No amendment, however, may be effective to reduce a Participant&#8217;s vested Account balances immediately before the date of such amendment, except that the Company may change investment funds pursuant to Section 4.2.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 10.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company reserves the right to terminate the Plan at any time by action of the Compensation Committee of the Board. Upon termination of the Plan, all Elective Deferrals and Company contributions will cease and no future Elective Deferrals or Company contributions will be made. Termination of the Plan shall not operate to eliminate or reduce a Participant&#8217;s vested Account balances.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Plan is terminated, payments from the Accounts of all Participants and Beneficiaries shall be made at the time and in the manner specified in Articles 5 and 6, except as otherwise determined by the Company at the time of termination, subject to Article 7 and to the requirements of Section 409A.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:3.36pt;text-decoration:underline">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Guarantee of Employment or Contract to Perform Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Neither the adoption and maintenance of the Plan nor the execution by the Company of a Deferral Election Agreement with any Participant shall be deemed to be a contract of employment or for the performance of services between an Affiliate and any Participant. Nothing contained herein shall give any Participant the right to be retained in the employ of an Affiliate or to perform services for an Affiliate, or to interfere with the right of an Affiliate to discharge any Participant at any time&#59; nor shall it give an Affiliate the right to require any Participant to remain in its employ or to perform services for it or to interfere with the Participant&#8217;s right to terminate his or her employment or performance of services at any time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any payment of benefits to or for the benefit of a Participant or a Participant&#8217;s Beneficiary that is made in good faith by the Company in accordance with the Company&#8217;s interpretation of its obligations under the Plan shall be in full satisfaction of all claims against the Company for benefits under the Plan to the extent of such payment.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.3 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any notice permitted or required under the Plan shall be in writing and shall be hand-delivered or sent, postage prepaid, by first class mail, or by certified or registered mail with return receipt requested, to the principal office of the Company, if to the Company, or to the address last shown on the records of the Company, if to a Participant or Beneficiary. Any such notice shall be effective as of the date of hand-delivery or mailing.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Nonalienation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No benefit payable at any time under the Plan shall be subject in any manner to alienation, sale, transfer, assignment, pledge, levy, attachment, or encumbrance of any kind by any Participant or Beneficiary, except with respect to a Domestic Relations Order.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company may withhold from any payment of benefits or other compensation payable to a Participant or Beneficiary, or the Company may direct the trustee of the Trust to withhold from any payment of benefits to a Participant or Beneficiary, such amounts as the Company determines are reasonably necessary to pay any taxes or other amounts required to be withheld under applicable law.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Captions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Article and section headings and captions are provided for purposes of reference and convenience only and shall not be relied upon in any way to construe, define, modify, limit, or extend the scope of any provision of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Plan and all rights under the Plan shall be governed by and construed according to the laws of the State of Minnesota, except to the extent such laws are preempted by the laws of the United States of America.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Invalidity of Certain Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If any provision of the Plan is held invalid or unenforceable, such invalidity or unenforceability shall not affect any other provision of the Plan and the Plan shall be construed and enforced as if such provision had not been included. The Plan is intended to comply in form and operation with Sections 409A and 457A of the Code, and shall be construed accordingly. If any provision of the Plan does not conform to the requirements of Sections 409A and 457A of the Code, the Plan shall be construed and enforced as if such provision had not been included.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Other Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The terms and conditions set forth herein constitute the entire understanding of the Company and the Participants with respect to the matters addressed herein.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Incapacity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event that any Participant is unable to care for his or her affairs because of illness or accident, any payment due may be paid to the Participant&#8217;s spouse, parent, brother, sister or other person deemed by the Committee to have incurred expenses for the care of such Participant, unless a duly qualified guardian or other legal representative has been appointed.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Electronic Media</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding anything in the Plan to the contrary, but subject to the requirements of ERISA, the Code, or other applicable law, any action or communication otherwise required to be taken or made in writing by a Participant or Beneficiary or by the Company or Committee shall be effective if accomplished by another method or methods required or made available by the Company or Committee, or their agent, with respect to that action or communication, including e-mail, telephone response systems, intranet systems, or the Internet.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">USERRA Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Participant and Company deferral and payment election requirements set forth in the Plan are deemed met to the extent a deferral election or payment election is provided to satisfy the requirements of the Uniformed Services Employment and Reemployment Rights Act of 1994, as amended.</font></div><div><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div id="i4d22045fd1ec49f0a43f678952ced014_46"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SCHEDULE A</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Minimum Compensation Level of Employees Considered to be</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Eligible Employees&#8221; Under the Plan</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The minimum compensation level is the annual limit on compensation that can be taken into account for purposes of qualified retirement plans under Section 401(a)(17) of the Internal Revenue Code (as may be adjusted from time to time for cost of living pursuant to Section 401(a)(17)(B) of the Internal Revenue Code).</font></div><div><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23</font></div></div></div><div id="i4d22045fd1ec49f0a43f678952ced014_49"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SCHEDULE B</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Manner of Crediting Gains and Losses to Elective Deferral Accounts and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company Contribution Accounts Pursuant to Section 4.2</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Accounts of all Participants shall be credited with gains and losses as if invested in one or more of the investments funds listed below that are selected by the Company and communicated to the Participants from time to time, in the proportions designated by a Participant on an investment election form submitted to the Company by the Participant. The investment election form shall be submitted to the Company in the form and manner specified by the Committee, which may be electronically pursuant to Section 11.11. Until and unless changed by the Committee, Participants shall be permitted to change investment elections, generally, on a daily basis.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic Interest Income Fund</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Total Bond Market Index Fund</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Wellington Fund</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard 500 Index Fund</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Windsor II Fund</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard U.S. Growth Fund</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard PRIMECAP Fund</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Extended Market Index Fund</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard Explorer Fund</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vanguard International Growth Fund</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Medtronic plc Stock Fund</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything in this Schedule B to the contrary, the Accounts of Participants who have commenced distributions prior to January 1, 2006, shall continue to be credited with interest in the manner set forth in the Plan, as in effective prior to the Restatement Date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-1</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>mdt-2021q210qxex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="iff8e3a62d1dd429a99d160cc16759c6b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Geoffrey S. Martha, certify that&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Medtronic Public Limited Company&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 3, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Geoffrey S. Martha</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geoffrey S. Martha</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>mdt-2021q210qxex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i6320d3d9523a423aae75ef61a62792f0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen L. Parkhill, certify that&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Medtronic Public Limited Company&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 3, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Karen L. Parkhill</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karen L. Parkhill</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>mdt-2021q210qxex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i7004590c34ae4a0e8bf24ffb6ff7fa58_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this quarterly report on Form 10-Q of Medtronic Public Limited Company for the quarter ended October 30, 2020, the undersigned hereby certifies, in his capacity as Chief Executive Officer of Medtronic Public Limited Company, for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Medtronic Public Limited Company. </font></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 3, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Geoffrey S. Martha </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geoffrey S. Martha </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>mdt-2021q210qxex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i387ee1f368cf48e29c6721402f86b960_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this quarterly report on Form 10-Q of Medtronic Public Limited Company for the quarter ended October 30, 2020, the undersigned hereby certifies, in her capacity as Chief Financial Officer of Medtronic Public Limited Company, for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Medtronic Public Limited Company. </font></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 3, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Karen L. Parkhill</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karen L. Parkhill </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>mdt-20201030.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:8939d385-98d2-4684-bfa0-0279309cacd9,g:e5f1341e-11f4-4035-86fa-7f937a6230d9-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mdt="http://www.medtronic.com/20201030" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.medtronic.com/20201030">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20201030_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20201030_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20201030_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20201030_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.medtronic.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncomeUnaudited" roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited">
        <link:definition>1001002 - Statement - Consolidated Statements of Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeUnaudited" roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited">
        <link:definition>1002003 - Statement - Consolidated Statements of Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsUnaudited" roleURI="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited">
        <link:definition>1003004 - Statement - Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>1004005 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquityUnaudited" roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited">
        <link:definition>1005006 - Statement - Consolidated Statements of Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquityUnauditedParenthetical" roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical">
        <link:definition>1006007 - Statement - Consolidated Statements of Equity (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1007008 - Statement - Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.medtronic.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationPolicies" roleURI="http://www.medtronic.com/role/BasisofPresentationPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.medtronic.com/role/NewAccountingPronouncements">
        <link:definition>2103102 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.medtronic.com/role/Revenue">
        <link:definition>2104103 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.medtronic.com/role/RevenueTables">
        <link:definition>2305301 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregationofNetSalesbySegmentandDivisionDetails" roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails">
        <link:definition>2406401 - Disclosure - Revenue - Disaggregation of Net Sales by Segment and Division (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails" roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails">
        <link:definition>2407402 - Disclosure - Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.medtronic.com/role/RevenueNarrativeDetails">
        <link:definition>2408403 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.medtronic.com/role/Acquisitions">
        <link:definition>2109104 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.medtronic.com/role/AcquisitionsTables">
        <link:definition>2310302 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.medtronic.com/role/AcquisitionsNarrativeDetails">
        <link:definition>2411404 - Disclosure - Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails" roleURI="http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails">
        <link:definition>2412405 - Disclosure - Acquisitions - Reconciliation of Beginning and Ending Balances of Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails" roleURI="http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails">
        <link:definition>2413406 - Disclosure - Acquisitions - Fair Value Measurement, Contingent Consideration, Significant Unobservable Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuring" roleURI="http://www.medtronic.com/role/Restructuring">
        <link:definition>2114105 - Disclosure - Restructuring</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringTables" roleURI="http://www.medtronic.com/role/RestructuringTables">
        <link:definition>2315303 - Disclosure - Restructuring (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringNarrativeDetails" roleURI="http://www.medtronic.com/role/RestructuringNarrativeDetails">
        <link:definition>2416407 - Disclosure - Restructuring - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringActivityRelatedtoRestructuringProgramsDetails" roleURI="http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails">
        <link:definition>2417408 - Disclosure - Restructuring - Activity Related to Restructuring Programs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.medtronic.com/role/FinancialInstruments">
        <link:definition>2118106 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.medtronic.com/role/FinancialInstrumentsTables">
        <link:definition>2319304 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" roleURI="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails">
        <link:definition>2420409 - Disclosure - Financial Instruments - Investments by Category and Related Balance Sheet Classification (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails" roleURI="http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails">
        <link:definition>2421410 - Disclosure - Financial Instruments - Available-For-Sale Securities in Continuous Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails" roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails">
        <link:definition>2422411 - Disclosure - Financial Instruments - Activity Related to the Company's Investment Portfolio and Debt Securities Contractual Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsNarrativeDetails" roleURI="http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails">
        <link:definition>2423412 - Disclosure - Financial Instruments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" roleURI="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails">
        <link:definition>2424413 - Disclosure - Financial Instruments - Summary of Equity and Other Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails" roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails">
        <link:definition>2425414 - Disclosure - Financial Instruments - Activity Related to the Company's Investment Portfolio, Equity and Other Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangements" roleURI="http://www.medtronic.com/role/FinancingArrangements">
        <link:definition>2126107 - Disclosure - Financing Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsTables" roleURI="http://www.medtronic.com/role/FinancingArrangementsTables">
        <link:definition>2327305 - Disclosure - Financing Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsNarrativeDetails" roleURI="http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails">
        <link:definition>2428415 - Disclosure - Financing Arrangements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsLongTermDebtDetails" roleURI="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails">
        <link:definition>2429416 - Disclosure - Financing Arrangements - Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagement" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement">
        <link:definition>2130108 - Disclosure - Derivatives and Currency Exchange Risk Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementTables" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables">
        <link:definition>2331306 - Disclosure - Derivatives and Currency Exchange Risk Management (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementNarrativeDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails">
        <link:definition>2432417 - Disclosure - Derivatives and Currency Exchange Risk Management - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails">
        <link:definition>2433418 - Disclosure - Derivatives and Currency Exchange Risk Management - Derivative (Gains) Losses Not Designated as Hedging Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails">
        <link:definition>2434419 - Disclosure - Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in AOCI, Cash Flow Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails">
        <link:definition>2435420 - Disclosure - Derivatives and Currency Exchange Risk Management - Amount of (Gains) Losses Recognized in Consolidated Statements of Income, Cash Flow Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails">
        <link:definition>2436421 - Disclosure - Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in Income, Net Investment Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails">
        <link:definition>2437422 - Disclosure - Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in AOCI, Net Investment Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails">
        <link:definition>2438423 - Disclosure - Derivatives and Currency Exchange Risk Management - Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>2439424 - Disclosure - Derivatives and Currency Exchange Risk Management - Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails">
        <link:definition>2440425 - Disclosure - Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1">
        <link:definition>2440425 - Disclosure - Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.medtronic.com/role/Inventories">
        <link:definition>2141109 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.medtronic.com/role/InventoriesTables">
        <link:definition>2342307 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.medtronic.com/role/InventoriesDetails">
        <link:definition>2443426 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>2144110 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>2345308 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails">
        <link:definition>2446427 - Disclosure - Goodwill and Other Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsNarrativeDetails" roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails">
        <link:definition>2447428 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails" roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails">
        <link:definition>2448429 - Disclosure - Goodwill and Other Intangible Assets - Carrying Amount and Accumulated Amortization of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails" roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails">
        <link:definition>2449430 - Disclosure - Goodwill and Other Intangible Assets - Estimated Future Aggregate Amortization Expense of Amortizable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.medtronic.com/role/IncomeTaxes">
        <link:definition>2150111 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.medtronic.com/role/IncomeTaxesDetails">
        <link:definition>2451431 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.medtronic.com/role/EarningsPerShare">
        <link:definition>2152112 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.medtronic.com/role/EarningsPerShareTables">
        <link:definition>2353309 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" roleURI="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails">
        <link:definition>2454432 - Disclosure - Earnings Per Share - Schedule of Basic and Diluted Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareNarrativeDetails" roleURI="http://www.medtronic.com/role/EarningsPerShareNarrativeDetails">
        <link:definition>2455433 - Disclosure - Earnings Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.medtronic.com/role/StockBasedCompensation">
        <link:definition>2156113 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.medtronic.com/role/StockBasedCompensationTables">
        <link:definition>2357310 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationDetails" roleURI="http://www.medtronic.com/role/StockBasedCompensationDetails">
        <link:definition>2458434 - Disclosure - Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitPlans" roleURI="http://www.medtronic.com/role/RetirementBenefitPlans">
        <link:definition>2159114 - Disclosure - Retirement Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitPlansTables" roleURI="http://www.medtronic.com/role/RetirementBenefitPlansTables">
        <link:definition>2360311 - Disclosure - Retirement Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitPlansDetails" roleURI="http://www.medtronic.com/role/RetirementBenefitPlansDetails">
        <link:definition>2461435 - Disclosure - Retirement Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitPlansNarrativeDetails" roleURI="http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails">
        <link:definition>2462436 - Disclosure - Retirement Benefit Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>2163115 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>2364312 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossChangesinAOCIDetails" roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails">
        <link:definition>2465437 - Disclosure - Accumulated Other Comprehensive Loss - Changes in AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.medtronic.com/role/CommitmentsandContingencies">
        <link:definition>2166116 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.medtronic.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2467438 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformation" roleURI="http://www.medtronic.com/role/SegmentandGeographicInformation">
        <link:definition>2168117 - Disclosure - Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationTables" roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationTables">
        <link:definition>2369313 - Disclosure - Segment and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationDetails" roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationDetails">
        <link:definition>2470439 - Disclosure - Segment and Geographic Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mdt_SassoLitigationMember" abstract="true" name="SassoLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SurgicalInnovationsDivisionMember" abstract="true" name="SurgicalInnovationsDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2027Member" abstract="true" name="SeniorNotes2019Due2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" abstract="false" name="DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" abstract="false" name="DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits" abstract="false" name="DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_MedicalDeviceRegulations" abstract="false" name="MedicalDeviceRegulations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_DiabetesGroupMember" abstract="true" name="DiabetesGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" abstract="false" name="EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" abstract="false" name="DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_DebtTenderPremiumandOtherCharges" abstract="false" name="DebtTenderPremiumandOtherCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2015Due2045Member" abstract="true" name="SeniorNotes2015Due2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_CorporateOverhead" abstract="false" name="CorporateOverhead" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2019Member" abstract="true" name="SeniorNotes2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2025Member" abstract="true" name="SeniorNotes2020Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" abstract="false" name="DerivativeAssetLiabilityFairValueGrossAssetLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" abstract="true" name="TotalOtherCountriesExcludingUnitedStatesandIrelandMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_OtherAccruedExpensesMember" abstract="true" name="OtherAccruedExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_ImpairmentOfInProcessResearchAndDevelopment" abstract="false" name="ImpairmentOfInProcessResearchAndDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2026Member" abstract="true" name="SeniorNotes2020Due2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_ProductDevelopmentMilestoneMember" abstract="true" name="ProductDevelopmentMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2015Due2035Member" abstract="true" name="SeniorNotes2015Due2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_BusinessAcquisitionPurchasePriceContingentConsideration" abstract="false" name="BusinessAcquisitionPurchasePriceContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock" abstract="false" name="ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mdt_DerivativeAssetLiabilityAbstract" abstract="true" name="DerivativeAssetLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdt_SeniorNotes2015Due2022Member" abstract="true" name="SeniorNotes2015Due2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SpecialtyTherapiesDivisionMember" abstract="true" name="SpecialtyTherapiesDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2040Member" abstract="true" name="SeniorNotes2019Due2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_DebtInstrumentNumberofTranches" abstract="false" name="DebtInstrumentNumberofTranches" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2026Member" abstract="true" name="SeniorNotes2019Due2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_DebtInstrumentExtensionOptionTermOfExtension" abstract="false" name="DebtInstrumentExtensionOptionTermOfExtension" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mdt_MinimallyInvasiveTherapiesGroupMember" abstract="true" name="MinimallyInvasiveTherapiesGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax" abstract="false" name="UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost" abstract="false" name="DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2017Due2027Member" abstract="true" name="SeniorNotes2017Due2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2007Due2038Member" abstract="true" name="SeniorNotes2007Due2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_DeferredTaxAssetsAmortizationPeriod" abstract="false" name="DeferredTaxAssetsAmortizationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mdt_SeniorNotes2010Due2040Member" abstract="true" name="SeniorNotes2010Due2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2050Member" abstract="true" name="SeniorNotes2020Due2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_MedtronicLuxcoMember" abstract="true" name="MedtronicLuxcoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20392.250PercentMember" abstract="true" name="SeniorNotes2019Due20392.250PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_CommercialPaperMaximumBorrowingCapacity" abstract="false" name="CommercialPaperMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember" abstract="true" name="AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_NeuromodulationDivisionMember" abstract="true" name="NeuromodulationDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_OffsettingAssetsandLiabilitiesTable" abstract="true" name="OffsettingAssetsandLiabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mdt_EmployeesStockPurchasePlanMember" abstract="true" name="EmployeesStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SpecialChargesGains" abstract="false" name="SpecialChargesGains" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet" abstract="false" name="GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_CentralizedDistributionCosts" abstract="false" name="CentralizedDistributionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2013Due2023Member" abstract="true" name="SeniorNotes2013Due2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" abstract="true" name="BusinessAcquisitionContingentConsiderationAtFairValueRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" abstract="true" name="MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_RevenueMilestoneMember" abstract="true" name="RevenueMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SiteContingencyNumberOfLandfillsRequiringCapping" abstract="false" name="SiteContingencyNumberOfLandfillsRequiringCapping" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdt_EquityInvestmentsMember" abstract="true" name="EquityInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" abstract="false" name="UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_ScheduleOfDebtTable" abstract="true" name="ScheduleOfDebtTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20391.50PercentMember" abstract="true" name="SeniorNotes2019Due20391.50PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_CardiacAndVascularGroupMember" abstract="true" name="CardiacAndVascularGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_AorticPeripheralandVenousDivisionMember" abstract="true" name="AorticPeripheralandVenousDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2032Member" abstract="true" name="SeniorNotes2020Due2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2015Due2025Member" abstract="true" name="SeniorNotes2015Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" abstract="false" name="DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2050Member" abstract="true" name="SeniorNotes2019Due2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_ScheduleofInvestmentsTableTextBlock" abstract="false" name="ScheduleofInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mdt_SeniorNotes2014Due2044Member" abstract="true" name="SeniorNotes2014Due2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2013Due2043Member" abstract="true" name="SeniorNotes2013Due2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_CoronaryandStructuralHeartDivisionMember" abstract="true" name="CoronaryandStructuralHeartDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2012Due2042Member" abstract="true" name="SeniorNotes2012Due2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2023Member" abstract="true" name="SeniorNotes2020Due2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty" abstract="false" name="TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2049Member" abstract="true" name="SeniorNotes2019Due2049Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2033Member" abstract="true" name="SeniorNotes2020Due2033Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" abstract="false" name="DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" abstract="false" name="EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2032Member" abstract="true" name="SeniorNotes2019Due2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_OffsettingAssetsandLiabilitiesLineItems" abstract="true" name="OffsettingAssetsandLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdt_SimplificationRestructuringProgramMember" abstract="true" name="SimplificationRestructuringProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2040Member" abstract="true" name="SeniorNotes2020Due2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_DebtLineItems" abstract="true" name="DebtLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdt_LossContingencyNumberofSubsidiaries" abstract="false" name="LossContingencyNumberofSubsidiaries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdt_MeasurementInputProbabilityofPaymentMember" abstract="true" name="MeasurementInputProbabilityofPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_RestructuringChargesNetofRestructuringReversals" abstract="false" name="RestructuringChargesNetofRestructuringReversals" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_CranialAndSpinalTechnologiesDivisionMember" abstract="true" name="CranialAndSpinalTechnologiesDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20311.00PercentMember" abstract="true" name="SeniorNotes2019Due20311.00PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares" abstract="false" name="IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mdt_SiteContingencyNumberofLandfillsRequiringRemoval" abstract="false" name="SiteContingencyNumberofLandfillsRequiringRemoval" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdt_RestorativeTherapiesGroupMember" abstract="true" name="RestorativeTherapiesGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_AllBusinessAcquisitionsMember" abstract="true" name="AllBusinessAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_LossContingencyNumberofManufacturers" abstract="false" name="LossContingencyNumberofManufacturers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2022Member" abstract="true" name="SeniorNotes2019Due2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_EnterpriseExcellenceMember" abstract="true" name="EnterpriseExcellenceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_PelvicMeshLitigationMember" abstract="true" name="PelvicMeshLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2041Member" abstract="true" name="SeniorNotes2020Due2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20311.625PercentMember" abstract="true" name="SeniorNotes2019Due20311.625PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax" abstract="false" name="DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2028Member" abstract="true" name="SeniorNotes2020Due2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_TokyoInterBankOfferedRateTIBORMember" abstract="true" name="TokyoInterBankOfferedRateTIBORMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_MedtronicLuxcoSeniorNotesMember" abstract="true" name="MedtronicLuxcoSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_EarningsPerShareReconciliationNumeratorAbstract" abstract="true" name="EarningsPerShareReconciliationNumeratorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdt_EthiconPatentInfringementLitigationMember" abstract="true" name="EthiconPatentInfringementLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Member" abstract="true" name="SeniorNotes2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2014Due2024Member" abstract="true" name="SeniorNotes2014Due2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2021FloatingMember" abstract="true" name="SeniorNotes2019Due2021FloatingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment" abstract="false" name="RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_EarningsPerShareReconciliationDenominatorAbstract" abstract="true" name="EarningsPerShareReconciliationDenominatorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdt_SeniorNotes2013Due2024Member" abstract="true" name="SeniorNotes2013Due2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_LossonInvestments" abstract="false" name="LossonInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_MedtronicIncAndCIFSASeniorNotesMember" abstract="true" name="MedtronicIncAndCIFSASeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2029Member" abstract="true" name="SeniorNotes2020Due2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths" abstract="false" name="NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_CardiacRhythmandHeartFailureDivisionMember" abstract="true" name="CardiacRhythmandHeartFailureDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2012Due2023Member" abstract="true" name="SeniorNotes2012Due2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20230.375PercentMember" abstract="true" name="SeniorNotes2019Due20230.375PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_PurchasedTechnologyAndPatentsMember" abstract="true" name="PurchasedTechnologyAndPatentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2025Member" abstract="true" name="SeniorNotes2019Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_PreTaxExitandDisposalCostsMember" abstract="true" name="PreTaxExitandDisposalCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_GainonInvestments" abstract="false" name="GainonInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_RespiratoryGastrointestinalandRenalDivisionMember" abstract="true" name="RespiratoryGastrointestinalandRenalDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2051Member" abstract="true" name="SeniorNotes2020Due2051Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_A2015CommercialPaperProgramMember" abstract="true" name="A2015CommercialPaperProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_OrringtonMaineChemicalManufacturingFacilityMember" abstract="true" name="OrringtonMaineChemicalManufacturingFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2009Due2039Member" abstract="true" name="SeniorNotes2009Due2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_AssociatedCostsMember" abstract="true" name="AssociatedCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" abstract="true" name="JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20230.000PercentMember" abstract="true" name="SeniorNotes2019Due20230.000PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_TotalOtherCountriesExcludingIrelandMember" abstract="true" name="TotalOtherCountriesExcludingIrelandMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax" abstract="false" name="DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" abstract="false" name="BusinessAcquisitionContingentConsiderationMilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_AmendedandRestatedRevolvingCreditAgreementMember" abstract="true" name="AmendedandRestatedRevolvingCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember" abstract="true" name="MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mdt_IncomeTaxesandInterestPaidAbstract" abstract="true" name="IncomeTaxesandInterestPaidAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>mdt-20201030_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:8939d385-98d2-4684-bfa0-0279309cacd9,g:e5f1341e-11f4-4035-86fa-7f937a6230d9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medtronic.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="mdt-20201030.xsd#DocumentandEntityInformation"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DocumentandEntityInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ca47527c-5177-4241-b502-09c57bbacca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_13e3ac3d-3c40-4e9a-93eb-fc0ed60f6f72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_ca47527c-5177-4241-b502-09c57bbacca0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_13e3ac3d-3c40-4e9a-93eb-fc0ed60f6f72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1bdbd782-b43c-4cb6-b413-4c2e75293941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_ca47527c-5177-4241-b502-09c57bbacca0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1bdbd782-b43c-4cb6-b413-4c2e75293941" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_41645962-a878-422c-86fd-67a0123d90eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7769905a-650f-4ee3-9f56-ddb24f387c36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_41645962-a878-422c-86fd-67a0123d90eb" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7769905a-650f-4ee3-9f56-ddb24f387c36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_10e6d13c-5d8c-401b-884b-1d254805c22d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_41645962-a878-422c-86fd-67a0123d90eb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_10e6d13c-5d8c-401b-884b-1d254805c22d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fbc8e4c2-75c6-4a10-b832-4397d2132e9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_41645962-a878-422c-86fd-67a0123d90eb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fbc8e4c2-75c6-4a10-b832-4397d2132e9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesNetofRestructuringReversals_435b6a9c-44fa-4acb-a020-85d0f06cfd66" xlink:href="mdt-20201030.xsd#mdt_RestructuringChargesNetofRestructuringReversals"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_41645962-a878-422c-86fd-67a0123d90eb" xlink:to="loc_mdt_RestructuringChargesNetofRestructuringReversals_435b6a9c-44fa-4acb-a020-85d0f06cfd66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_5cc2d288-1791-4e46-a33b-7745b616e67a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_41645962-a878-422c-86fd-67a0123d90eb" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_5cc2d288-1791-4e46-a33b-7745b616e67a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_a5d8e263-d12c-43a1-b935-03d1d608d3cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_41645962-a878-422c-86fd-67a0123d90eb" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_a5d8e263-d12c-43a1-b935-03d1d608d3cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b0cec798-771d-4382-bcdb-e0ceec6ffe5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_41645962-a878-422c-86fd-67a0123d90eb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b0cec798-771d-4382-bcdb-e0ceec6ffe5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_3ec287ca-4a34-4ab9-abb8-b49f0f733382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_41645962-a878-422c-86fd-67a0123d90eb" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_3ec287ca-4a34-4ab9-abb8-b49f0f733382" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f2afc22d-9862-4ab3-923a-4e224f9da1af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e102b474-8ad9-4a7f-b496-01d564a810c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f2afc22d-9862-4ab3-923a-4e224f9da1af" xlink:to="loc_us-gaap_OperatingIncomeLoss_e102b474-8ad9-4a7f-b496-01d564a810c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_77a13334-7e5e-4355-9f0a-65a513f2ea83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f2afc22d-9862-4ab3-923a-4e224f9da1af" xlink:to="loc_us-gaap_InterestExpense_77a13334-7e5e-4355-9f0a-65a513f2ea83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ecb14377-5e88-4cb0-bf5b-d5067ac452bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f2afc22d-9862-4ab3-923a-4e224f9da1af" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ecb14377-5e88-4cb0-bf5b-d5067ac452bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2b8281af-a3d8-44f7-aef4-7726c9df34dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_78f2416f-a293-46d9-a3c0-ade13ad6ed54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2b8281af-a3d8-44f7-aef4-7726c9df34dc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_78f2416f-a293-46d9-a3c0-ade13ad6ed54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4a922dd8-631d-4c6d-b7ee-218221669f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2b8281af-a3d8-44f7-aef4-7726c9df34dc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4a922dd8-631d-4c6d-b7ee-218221669f83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4120cbd0-e90b-4e06-b8d6-72a1c53857ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2b8281af-a3d8-44f7-aef4-7726c9df34dc" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4120cbd0-e90b-4e06-b8d6-72a1c53857ff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_74bbdc43-96d1-413e-adf3-e1fe802a664a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d5a6cbd5-adae-4c69-92ec-67a6381fde59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_74bbdc43-96d1-413e-adf3-e1fe802a664a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d5a6cbd5-adae-4c69-92ec-67a6381fde59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_601bf7ea-26ff-40e4-a597-59197ff8aef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_74bbdc43-96d1-413e-adf3-e1fe802a664a" xlink:to="loc_us-gaap_ProfitLoss_601bf7ea-26ff-40e4-a597-59197ff8aef4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_42544970-6664-4f5e-93a2-a16740970f84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ea23d28d-df13-44fe-93cc-19f4cb4386b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_42544970-6664-4f5e-93a2-a16740970f84" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ea23d28d-df13-44fe-93cc-19f4cb4386b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3dda4fe9-d063-4446-8aec-61b4917f911a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_42544970-6664-4f5e-93a2-a16740970f84" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3dda4fe9-d063-4446-8aec-61b4917f911a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6574b667-7eb0-42ab-99c9-c108a8f61eb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_945e71f5-f486-4704-89fb-6238000b72ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6574b667-7eb0-42ab-99c9-c108a8f61eb7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_945e71f5-f486-4704-89fb-6238000b72ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_6f222fa1-f614-47c2-a8d4-96712c37bf9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6574b667-7eb0-42ab-99c9-c108a8f61eb7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_6f222fa1-f614-47c2-a8d4-96712c37bf9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_bee74434-5ba1-49d5-9eab-89724a7b9e63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6574b667-7eb0-42ab-99c9-c108a8f61eb7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_bee74434-5ba1-49d5-9eab-89724a7b9e63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_e0cc63cc-9b1e-4bd5-baae-c8e6ff9baace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6574b667-7eb0-42ab-99c9-c108a8f61eb7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_e0cc63cc-9b1e-4bd5-baae-c8e6ff9baace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_f3375ccd-af71-41a3-bd93-67af2f9106af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6574b667-7eb0-42ab-99c9-c108a8f61eb7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_f3375ccd-af71-41a3-bd93-67af2f9106af" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9f5e3c33-f125-48a8-b703-bce4dc214e76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_45b04172-3468-4718-8c05-b9445bc5dca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_9f5e3c33-f125-48a8-b703-bce4dc214e76" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_45b04172-3468-4718-8c05-b9445bc5dca4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_5830d4e2-73b0-48a3-b706-216d64a1e44f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_9f5e3c33-f125-48a8-b703-bce4dc214e76" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_5830d4e2-73b0-48a3-b706-216d64a1e44f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5b758977-8726-4c86-904c-26c5efc169d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_099cb999-9b01-4635-86d4-944826b0b602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5b758977-8726-4c86-904c-26c5efc169d5" xlink:to="loc_us-gaap_StockholdersEquity_099cb999-9b01-4635-86d4-944826b0b602" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3dd3d682-ac77-4da6-bc25-c98452446bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5b758977-8726-4c86-904c-26c5efc169d5" xlink:to="loc_us-gaap_MinorityInterest_3dd3d682-ac77-4da6-bc25-c98452446bb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a6fb90aa-c308-40af-8c89-02426047b89e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5b758977-8726-4c86-904c-26c5efc169d5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a6fb90aa-c308-40af-8c89-02426047b89e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b5db4e7a-3671-4818-be71-cd70c24bac09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5b758977-8726-4c86-904c-26c5efc169d5" xlink:to="loc_us-gaap_Liabilities_b5db4e7a-3671-4818-be71-cd70c24bac09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b569ad46-837c-4a41-9ff2-56b25bdf6c8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d00f04a3-c354-45e2-8ead-054e8d979868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b569ad46-837c-4a41-9ff2-56b25bdf6c8d" xlink:to="loc_us-gaap_CommonStockValue_d00f04a3-c354-45e2-8ead-054e8d979868" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_47707148-e8f5-41bf-9c2f-9bc4ebfd833d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b569ad46-837c-4a41-9ff2-56b25bdf6c8d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_47707148-e8f5-41bf-9c2f-9bc4ebfd833d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e30bb825-1cb3-4820-adf2-58399c2998f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b569ad46-837c-4a41-9ff2-56b25bdf6c8d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e30bb825-1cb3-4820-adf2-58399c2998f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_8a8b81c3-355e-480f-9437-16770eb635b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b569ad46-837c-4a41-9ff2-56b25bdf6c8d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_8a8b81c3-355e-480f-9437-16770eb635b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5d1221ac-6344-4d7f-b53e-b126e2a680c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_db1fd8f2-c2d4-4b05-b887-2eb4363cae7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5d1221ac-6344-4d7f-b53e-b126e2a680c3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_db1fd8f2-c2d4-4b05-b887-2eb4363cae7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b1f41eb1-ce5b-408f-9589-9517a48ec006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5d1221ac-6344-4d7f-b53e-b126e2a680c3" xlink:to="loc_us-gaap_AssetsCurrent_b1f41eb1-ce5b-408f-9589-9517a48ec006" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_680fb150-5409-4863-a171-10375207905e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5d1221ac-6344-4d7f-b53e-b126e2a680c3" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_680fb150-5409-4863-a171-10375207905e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_534f0fc3-6ce0-4a96-b415-3b25aaa75046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5d1221ac-6344-4d7f-b53e-b126e2a680c3" xlink:to="loc_us-gaap_Goodwill_534f0fc3-6ce0-4a96-b415-3b25aaa75046" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4b08684f-1aa1-4910-b6cd-5355488161a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5d1221ac-6344-4d7f-b53e-b126e2a680c3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4b08684f-1aa1-4910-b6cd-5355488161a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_05638bba-db11-49aa-8fc7-f60461d0bcc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5d1221ac-6344-4d7f-b53e-b126e2a680c3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_05638bba-db11-49aa-8fc7-f60461d0bcc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_dc77062e-2233-4916-b3cd-8ae22dd948f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_9de077fd-c8f2-4e90-b9c8-e63cc7421e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dc77062e-2233-4916-b3cd-8ae22dd948f6" xlink:to="loc_us-gaap_OtherAssetsCurrent_9de077fd-c8f2-4e90-b9c8-e63cc7421e33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_889daf64-954a-4c18-84b6-95ec84bd311a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dc77062e-2233-4916-b3cd-8ae22dd948f6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_889daf64-954a-4c18-84b6-95ec84bd311a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cea1d73a-81f4-4f88-af75-3f3959cc3860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dc77062e-2233-4916-b3cd-8ae22dd948f6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_cea1d73a-81f4-4f88-af75-3f3959cc3860" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_c2b02952-0012-4221-a37b-1b22d88ea8ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dc77062e-2233-4916-b3cd-8ae22dd948f6" xlink:to="loc_us-gaap_ShortTermInvestments_c2b02952-0012-4221-a37b-1b22d88ea8ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_39c186d8-4cba-42f2-8a27-6b17e219df22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dc77062e-2233-4916-b3cd-8ae22dd948f6" xlink:to="loc_us-gaap_InventoryNet_39c186d8-4cba-42f2-8a27-6b17e219df22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fd5dc651-03d8-4aa5-acda-1fddb4d87a65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7dc49c9f-0c23-4dcf-89ff-472051a65bd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fd5dc651-03d8-4aa5-acda-1fddb4d87a65" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7dc49c9f-0c23-4dcf-89ff-472051a65bd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_430b0df7-1a45-4cb6-ba9f-7fc11fa9675b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fd5dc651-03d8-4aa5-acda-1fddb4d87a65" xlink:to="loc_us-gaap_LiabilitiesCurrent_430b0df7-1a45-4cb6-ba9f-7fc11fa9675b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c9fc4557-04d0-4a52-ae6f-a1c8bc933798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fd5dc651-03d8-4aa5-acda-1fddb4d87a65" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c9fc4557-04d0-4a52-ae6f-a1c8bc933798" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_cabd0ec0-b25b-433b-a430-b9b21e143aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fd5dc651-03d8-4aa5-acda-1fddb4d87a65" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_cabd0ec0-b25b-433b-a430-b9b21e143aa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ea467762-6014-421e-8d4d-f7abbe23d1cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fd5dc651-03d8-4aa5-acda-1fddb4d87a65" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ea467762-6014-421e-8d4d-f7abbe23d1cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_3d65e4c3-7a10-48a0-8677-defbf6fddacb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fd5dc651-03d8-4aa5-acda-1fddb4d87a65" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_3d65e4c3-7a10-48a0-8677-defbf6fddacb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dd692991-b258-4dd3-8923-1858a8160c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5e958673-acdd-412b-8a6d-a2a71b17af09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dd692991-b258-4dd3-8923-1858a8160c19" xlink:to="loc_us-gaap_StockholdersEquity_5e958673-acdd-412b-8a6d-a2a71b17af09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_9fdcd617-8f09-4b74-9edd-1361247f9634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dd692991-b258-4dd3-8923-1858a8160c19" xlink:to="loc_us-gaap_MinorityInterest_9fdcd617-8f09-4b74-9edd-1361247f9634" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b06114d1-f8c5-437a-a36c-bf72e9e29c5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_46cfa0d0-2043-419a-95c8-50649a37da83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b06114d1-f8c5-437a-a36c-bf72e9e29c5b" xlink:to="loc_us-gaap_AccountsPayableCurrent_46cfa0d0-2043-419a-95c8-50649a37da83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_6c0a20c7-2caf-423f-aaf0-08ea08d710ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b06114d1-f8c5-437a-a36c-bf72e9e29c5b" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_6c0a20c7-2caf-423f-aaf0-08ea08d710ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent_cc46f1d8-2666-4cae-a4e9-518fb350a8c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b06114d1-f8c5-437a-a36c-bf72e9e29c5b" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrent_cc46f1d8-2666-4cae-a4e9-518fb350a8c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_44881842-d816-4303-99d6-70b3123ac3fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b06114d1-f8c5-437a-a36c-bf72e9e29c5b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_44881842-d816-4303-99d6-70b3123ac3fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_782d9e10-0879-4ebd-8a04-2a93cdc6d2f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b06114d1-f8c5-437a-a36c-bf72e9e29c5b" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_782d9e10-0879-4ebd-8a04-2a93cdc6d2f7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofEquityUnaudited"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofEquityUnauditedParenthetical"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3bc15267-8047-46dc-820d-0d8d53c50f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2a082a64-e4c1-4d5f-86ca-03f89856bf3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3bc15267-8047-46dc-820d-0d8d53c50f93" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2a082a64-e4c1-4d5f-86ca-03f89856bf3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_9aa522e0-c78e-445e-83a2-97a30e268b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3bc15267-8047-46dc-820d-0d8d53c50f93" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_9aa522e0-c78e-445e-83a2-97a30e268b1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_31ae9ff7-a714-4fe8-a707-44928e2fc6df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3bc15267-8047-46dc-820d-0d8d53c50f93" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_31ae9ff7-a714-4fe8-a707-44928e2fc6df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_85954c7e-e3e2-4de8-9300-da28a5e504de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3bc15267-8047-46dc-820d-0d8d53c50f93" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_85954c7e-e3e2-4de8-9300-da28a5e504de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d7b44847-f6d4-4a44-bfbc-b4ea9bfb7757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3bc15267-8047-46dc-820d-0d8d53c50f93" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d7b44847-f6d4-4a44-bfbc-b4ea9bfb7757" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95552579-843d-4688-a6ab-d2ece174cf97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_eed6b4e1-b600-418f-ba8a-edba951a2e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95552579-843d-4688-a6ab-d2ece174cf97" xlink:to="loc_us-gaap_ProfitLoss_eed6b4e1-b600-418f-ba8a-edba951a2e7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_bc804a26-0479-437f-9fc7-6b7106901a49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95552579-843d-4688-a6ab-d2ece174cf97" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_bc804a26-0479-437f-9fc7-6b7106901a49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_060a2b22-5de5-411f-ae2b-8d3d8fad8191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95552579-843d-4688-a6ab-d2ece174cf97" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_060a2b22-5de5-411f-ae2b-8d3d8fad8191" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_496bf183-e08c-4766-b89c-df75de8c4ca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95552579-843d-4688-a6ab-d2ece174cf97" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_496bf183-e08c-4766-b89c-df75de8c4ca5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_16c7188d-efed-4da3-a707-8123861e8c8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95552579-843d-4688-a6ab-d2ece174cf97" xlink:to="loc_us-gaap_ShareBasedCompensation_16c7188d-efed-4da3-a707-8123861e8c8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_055f7bac-8911-44a3-a038-ea74dc8c3ef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95552579-843d-4688-a6ab-d2ece174cf97" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_055f7bac-8911-44a3-a038-ea74dc8c3ef2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_e39c0221-15b5-438e-a55d-aae75fc4e930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95552579-843d-4688-a6ab-d2ece174cf97" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_e39c0221-15b5-438e-a55d-aae75fc4e930" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_af77b172-4d7a-4e16-bba1-4ab368783bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95552579-843d-4688-a6ab-d2ece174cf97" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_af77b172-4d7a-4e16-bba1-4ab368783bd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_30ec6dc8-fa65-40ca-bcd9-2b1fc5f73845" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95552579-843d-4688-a6ab-d2ece174cf97" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_30ec6dc8-fa65-40ca-bcd9-2b1fc5f73845" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f041047e-b28b-48ff-97d5-7b8b855dc890" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95552579-843d-4688-a6ab-d2ece174cf97" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f041047e-b28b-48ff-97d5-7b8b855dc890" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b551a939-0935-49ca-a312-51365b0c42e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95552579-843d-4688-a6ab-d2ece174cf97" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b551a939-0935-49ca-a312-51365b0c42e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0d0757e-016f-41fc-bf25-839bc8eef91a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_f8cc2b44-23ce-4d2d-a4f7-617bc8de3985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0d0757e-016f-41fc-bf25-839bc8eef91a" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_f8cc2b44-23ce-4d2d-a4f7-617bc8de3985" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_7bdf40ce-0c18-437a-8efe-ed746566c202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0d0757e-016f-41fc-bf25-839bc8eef91a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_7bdf40ce-0c18-437a-8efe-ed746566c202" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f66f48bb-6446-4178-8f75-24ad2500f0c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0d0757e-016f-41fc-bf25-839bc8eef91a" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f66f48bb-6446-4178-8f75-24ad2500f0c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_d47de83c-c863-4d34-a3d7-fef9255d42d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0d0757e-016f-41fc-bf25-839bc8eef91a" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_d47de83c-c863-4d34-a3d7-fef9255d42d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d10bd45f-5dea-45f6-ada1-ab20e1cbe72e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0d0757e-016f-41fc-bf25-839bc8eef91a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d10bd45f-5dea-45f6-ada1-ab20e1cbe72e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8d2da024-643b-45fc-967d-b3fa231a94ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0d0757e-016f-41fc-bf25-839bc8eef91a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8d2da024-643b-45fc-967d-b3fa231a94ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_d97765ed-bc02-47e5-90ff-8df8e5c9a858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0d0757e-016f-41fc-bf25-839bc8eef91a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_d97765ed-bc02-47e5-90ff-8df8e5c9a858" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_25854e1d-235e-4b5e-9f63-259726a81f20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0d0757e-016f-41fc-bf25-839bc8eef91a" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_25854e1d-235e-4b5e-9f63-259726a81f20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e93c7304-5d74-43bc-9b31-540212f25e61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ea8193ac-5f45-4d34-953c-7dab8e9cd742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e93c7304-5d74-43bc-9b31-540212f25e61" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ea8193ac-5f45-4d34-953c-7dab8e9cd742" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9a35b0f1-00a4-4010-a6c3-6497a457290b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e93c7304-5d74-43bc-9b31-540212f25e61" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9a35b0f1-00a4-4010-a6c3-6497a457290b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f8da6383-d743-4ec7-898f-d112c6c28856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e93c7304-5d74-43bc-9b31-540212f25e61" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f8da6383-d743-4ec7-898f-d112c6c28856" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c9f228b8-375e-4c87-a975-1236d0c32096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e93c7304-5d74-43bc-9b31-540212f25e61" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c9f228b8-375e-4c87-a975-1236d0c32096" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/BasisofPresentation" xlink:type="simple" xlink:href="mdt-20201030.xsd#BasisofPresentation"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/BasisofPresentation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="mdt-20201030.xsd#BasisofPresentationPolicies"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/BasisofPresentationPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="mdt-20201030.xsd#NewAccountingPronouncements"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/NewAccountingPronouncements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/Revenue" xlink:type="simple" xlink:href="mdt-20201030.xsd#Revenue"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#RevenueTables"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/RevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RevenueNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/RevenueNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/Acquisitions" xlink:type="simple" xlink:href="mdt-20201030.xsd#Acquisitions"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/Acquisitions" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#AcquisitionsTables"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/AcquisitionsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#AcquisitionsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_32003f13-7072-45c6-8608-f2da15e2fe5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_046d03ee-c5e3-4a9b-b6ac-dfbd63a28709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_32003f13-7072-45c6-8608-f2da15e2fe5b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_046d03ee-c5e3-4a9b-b6ac-dfbd63a28709" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_7d1e4365-65a8-4c14-8967-7a2d708a4a4c" xlink:href="mdt-20201030.xsd#mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_32003f13-7072-45c6-8608-f2da15e2fe5b" xlink:to="loc_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_7d1e4365-65a8-4c14-8967-7a2d708a4a4c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/Restructuring" xlink:type="simple" xlink:href="mdt-20201030.xsd#Restructuring"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/Restructuring" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#RestructuringTables"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/RestructuringTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RestructuringNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/RestructuringNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RestructuringActivityRelatedtoRestructuringProgramsDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstruments" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstruments"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancialInstruments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsTables"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost_6183722e-88cf-4c1d-89bf-4014b95f9b07" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_dcc6e9aa-0d05-4865-986b-1e9b99633d1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost_6183722e-88cf-4c1d-89bf-4014b95f9b07" xlink:to="loc_us-gaap_HeldToMaturitySecurities_dcc6e9aa-0d05-4865-986b-1e9b99633d1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_81890e57-a98d-478d-8ee3-d42f3f63a151" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost_6183722e-88cf-4c1d-89bf-4014b95f9b07" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_81890e57-a98d-478d-8ee3-d42f3f63a151" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e0fd4bb9-eb2b-4ec8-8a37-ba794c1c4be3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_03a4805d-d6db-42f1-bb32-19b20f1ac288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e0fd4bb9-eb2b-4ec8-8a37-ba794c1c4be3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_03a4805d-d6db-42f1-bb32-19b20f1ac288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_71a38fe9-4460-4d7b-8277-019e62c3e1a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e0fd4bb9-eb2b-4ec8-8a37-ba794c1c4be3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_71a38fe9-4460-4d7b-8277-019e62c3e1a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_db6a97ce-4800-40b3-a54a-dc6d13f328d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e0fd4bb9-eb2b-4ec8-8a37-ba794c1c4be3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_db6a97ce-4800-40b3-a54a-dc6d13f328d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_ffff9692-f5d9-4f5f-942e-e600593fcbe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_e67c1988-a510-489a-af6d-6e3b5d38568a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_ffff9692-f5d9-4f5f-942e-e600593fcbe1" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_e67c1988-a510-489a-af6d-6e3b5d38568a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_bdfc41cd-bcbb-4783-817a-efcd67af8997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_ffff9692-f5d9-4f5f-942e-e600593fcbe1" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_bdfc41cd-bcbb-4783-817a-efcd67af8997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_f7849a00-5387-4fc2-86be-cf0c7d675ee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_ffff9692-f5d9-4f5f-942e-e600593fcbe1" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_f7849a00-5387-4fc2-86be-cf0c7d675ee2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax_1f8bb8db-ec50-4b44-8046-c52494b4846d" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_9a5b418f-f934-41bf-a666-0d64b1c5a83f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax_1f8bb8db-ec50-4b44-8046-c52494b4846d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_9a5b418f-f934-41bf-a666-0d64b1c5a83f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d6c62a86-5384-4008-b9cf-f47004ad8453" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax_1f8bb8db-ec50-4b44-8046-c52494b4846d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d6c62a86-5384-4008-b9cf-f47004ad8453" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_d034bff1-82ee-40cf-abb5-5f55cc59683e" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_74f95d47-29d6-4efc-b834-1f4af030b631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_d034bff1-82ee-40cf-abb5-5f55cc59683e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_74f95d47-29d6-4efc-b834-1f4af030b631" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_4497114e-35c0-4caf-a5da-3760163415c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_d034bff1-82ee-40cf-abb5-5f55cc59683e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_4497114e-35c0-4caf-a5da-3760163415c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax_bc358bd9-473f-4b69-b94d-02239fe59086" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3f769907-9be6-41b7-b3b2-f6fee7ed600e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax_bc358bd9-473f-4b69-b94d-02239fe59086" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3f769907-9be6-41b7-b3b2-f6fee7ed600e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_0347ad36-72f4-4ff0-ba82-df0367084010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax_bc358bd9-473f-4b69-b94d-02239fe59086" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_0347ad36-72f4-4ff0-ba82-df0367084010" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4608454a-9aca-41a6-a529-e4bbb1c09bd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_cd0a4fe4-6d9a-4a0e-9d98-55e3fbc684d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4608454a-9aca-41a6-a529-e4bbb1c09bd9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_cd0a4fe4-6d9a-4a0e-9d98-55e3fbc684d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_558fbf4b-d347-4506-a0c5-8aea06b6a0f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4608454a-9aca-41a6-a529-e4bbb1c09bd9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_558fbf4b-d347-4506-a0c5-8aea06b6a0f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_070c1602-d9af-4f8b-bac1-146e65533e18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4608454a-9aca-41a6-a529-e4bbb1c09bd9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_070c1602-d9af-4f8b-bac1-146e65533e18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_344b9875-49f6-41ee-ae92-999dedd871f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4608454a-9aca-41a6-a529-e4bbb1c09bd9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_344b9875-49f6-41ee-ae92-999dedd871f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2969a047-1820-4af3-993f-047dca36ad9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_73446f70-e5bf-4b7c-b03c-219ec72abf85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2969a047-1820-4af3-993f-047dca36ad9f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_73446f70-e5bf-4b7c-b03c-219ec72abf85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_e487d6e8-b35f-4d06-b64d-65907a5a645f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2969a047-1820-4af3-993f-047dca36ad9f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_e487d6e8-b35f-4d06-b64d-65907a5a645f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_7f55f825-4e9b-4285-9401-d76f275508fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2969a047-1820-4af3-993f-047dca36ad9f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_7f55f825-4e9b-4285-9401-d76f275508fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_c176d207-f3d8-4365-880f-e91de9294ea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2969a047-1820-4af3-993f-047dca36ad9f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_c176d207-f3d8-4365-880f-e91de9294ea7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_6e3c3b36-7587-4d5d-b509-ca2792089592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_c2815eac-1e4b-426e-9e79-946a0a0ca502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnInvestments_6e3c3b36-7587-4d5d-b509-ca2792089592" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_c2815eac-1e4b-426e-9e79-946a0a0ca502" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_663197f4-4593-4a91-b5ac-886266adfa7c" xlink:href="mdt-20201030.xsd#mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_71672aee-c39f-48fe-86cf-f70b0e0f972b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_663197f4-4593-4a91-b5ac-886266adfa7c" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_71672aee-c39f-48fe-86cf-f70b0e0f972b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_1547edbb-65dc-4ba8-9150-5191b6168654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_663197f4-4593-4a91-b5ac-886266adfa7c" xlink:to="loc_us-gaap_EquityMethodInvestments_1547edbb-65dc-4ba8-9150-5191b6168654" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_319bbf46-0269-4743-b24e-abe50c05dcde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_663197f4-4593-4a91-b5ac-886266adfa7c" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_319bbf46-0269-4743-b24e-abe50c05dcde" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangements" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancingArrangements"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancingArrangements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancingArrangementsTables"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancingArrangementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancingArrangementsLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_197579a7-f4d1-4e8a-908a-2de58ac3cdeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_d543d045-e5a9-465a-8cea-df0325257a00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_197579a7-f4d1-4e8a-908a-2de58ac3cdeb" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_d543d045-e5a9-465a-8cea-df0325257a00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_829345e2-efa0-4b7f-9fd4-d538bba5a916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_197579a7-f4d1-4e8a-908a-2de58ac3cdeb" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_829345e2-efa0-4b7f-9fd4-d538bba5a916" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_0dce574e-571a-400a-b442-d26b58c25dcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_197579a7-f4d1-4e8a-908a-2de58ac3cdeb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_0dce574e-571a-400a-b442-d26b58c25dcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ad8cbe62-95d9-4856-ac3e-a5df52d34f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_197579a7-f4d1-4e8a-908a-2de58ac3cdeb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ad8cbe62-95d9-4856-ac3e-a5df52d34f8a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagement"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementTables"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_67e5b41a-49e1-4f39-9ef2-22468448deba" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_38e54eb9-f471-4d74-95da-14bf64ee89b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_67e5b41a-49e1-4f39-9ef2-22468448deba" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_38e54eb9-f471-4d74-95da-14bf64ee89b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_421b9fcc-53f3-4637-af1b-fe644752f2c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_67e5b41a-49e1-4f39-9ef2-22468448deba" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_421b9fcc-53f3-4637-af1b-fe644752f2c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_5833caf7-56c9-4f88-9f37-e8f69e5a6de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_af4f9f35-c9de-4b5f-ba07-52054b0154b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_5833caf7-56c9-4f88-9f37-e8f69e5a6de1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_af4f9f35-c9de-4b5f-ba07-52054b0154b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_1e3267b7-dfe8-40d3-b7e2-c81f892f1e55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_5833caf7-56c9-4f88-9f37-e8f69e5a6de1" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_1e3267b7-dfe8-40d3-b7e2-c81f892f1e55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_60d8a00b-8e1b-46f1-8579-06c1e4cacad8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_5833caf7-56c9-4f88-9f37-e8f69e5a6de1" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_60d8a00b-8e1b-46f1-8579-06c1e4cacad8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_8e537d4c-40e3-43df-bd68-d58241cd9f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0032269c-5c8c-4909-b629-ad69bb17b9aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_8e537d4c-40e3-43df-bd68-d58241cd9f0d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0032269c-5c8c-4909-b629-ad69bb17b9aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_00d9169a-82a9-46e2-94f6-aa24cfb4102c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_8e537d4c-40e3-43df-bd68-d58241cd9f0d" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_00d9169a-82a9-46e2-94f6-aa24cfb4102c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_bb1d8243-aec6-4aed-996b-9d90d250473b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_8e537d4c-40e3-43df-bd68-d58241cd9f0d" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_bb1d8243-aec6-4aed-996b-9d90d250473b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_360a889e-2433-40c0-9967-d48d36e54172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_94f684ee-03ad-4595-8378-23643794fbb3" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_360a889e-2433-40c0-9967-d48d36e54172" xlink:to="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_94f684ee-03ad-4595-8378-23643794fbb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_216466da-662a-4188-87bb-bc2199bc23fa" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_360a889e-2433-40c0-9967-d48d36e54172" xlink:to="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_216466da-662a-4188-87bb-bc2199bc23fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_5288814b-74e6-44a9-83ae-1132615e4b81" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_360a889e-2433-40c0-9967-d48d36e54172" xlink:to="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_5288814b-74e6-44a9-83ae-1132615e4b81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_b9cfe28e-204d-4828-8c1f-219720d6db9f" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_c1cc62cf-1206-4ac8-9f60-b7e37ddd3e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_b9cfe28e-204d-4828-8c1f-219720d6db9f" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_c1cc62cf-1206-4ac8-9f60-b7e37ddd3e5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_49588840-c07b-492a-9e3e-90427ee7cfac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_b9cfe28e-204d-4828-8c1f-219720d6db9f" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_49588840-c07b-492a-9e3e-90427ee7cfac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_93513fcd-4b89-47c7-adbb-28aa6737a148" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_60731ffe-f808-4632-b764-bc2b542cb047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_93513fcd-4b89-47c7-adbb-28aa6737a148" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_60731ffe-f808-4632-b764-bc2b542cb047" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6e641274-acca-4171-bf0e-94ac359b60b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_93513fcd-4b89-47c7-adbb-28aa6737a148" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6e641274-acca-4171-bf0e-94ac359b60b6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_a0cdc04f-9999-4197-bcb4-66d080da7a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_1f6a6eb3-f875-42a9-8f20-a46fd2e1b2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_a0cdc04f-9999-4197-bcb4-66d080da7a60" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_1f6a6eb3-f875-42a9-8f20-a46fd2e1b2de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_91d5fd78-665e-4fc4-9dca-81ada7e399a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_a0cdc04f-9999-4197-bcb4-66d080da7a60" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_91d5fd78-665e-4fc4-9dca-81ada7e399a1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/Inventories" xlink:type="simple" xlink:href="mdt-20201030.xsd#Inventories"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/Inventories" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/InventoriesTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#InventoriesTables"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/InventoriesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/InventoriesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3954a209-001f-43e6-bb72-0cb92d783939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_2c152c66-abe0-4b2e-8c7f-4d52914d9d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3954a209-001f-43e6-bb72-0cb92d783939" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_2c152c66-abe0-4b2e-8c7f-4d52914d9d1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d652b5cf-6146-41b7-9d9f-55275b1c9628" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3954a209-001f-43e6-bb72-0cb92d783939" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d652b5cf-6146-41b7-9d9f-55275b1c9628" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5ffe0643-6fed-4caa-9ded-a5fe09f6517c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3954a209-001f-43e6-bb72-0cb92d783939" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5ffe0643-6fed-4caa-9ded-a5fe09f6517c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mdt-20201030.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_5d7a898c-143d-4a82-a11d-329d04a246bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty_30824bf9-bdfb-4f2b-a9b6-7b99aa0e389e" xlink:href="mdt-20201030.xsd#mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_5d7a898c-143d-4a82-a11d-329d04a246bd" xlink:to="loc_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty_30824bf9-bdfb-4f2b-a9b6-7b99aa0e389e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_3e568b1c-7388-4d1f-91e7-bb3c77325804" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_5d7a898c-143d-4a82-a11d-329d04a246bd" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_3e568b1c-7388-4d1f-91e7-bb3c77325804" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_06374d42-815d-481a-ba5b-f15ca93323e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_5d7a898c-143d-4a82-a11d-329d04a246bd" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_06374d42-815d-481a-ba5b-f15ca93323e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_29553440-07da-435c-9b75-ff7b71a26b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingenciesForeign"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_5d7a898c-143d-4a82-a11d-329d04a246bd" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_29553440-07da-435c-9b75-ff7b71a26b7e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShare" xlink:type="simple" xlink:href="mdt-20201030.xsd#EarningsPerShare"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/EarningsPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#EarningsPerShareTables"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/EarningsPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fdf84e5e-9f77-4684-b8df-896dc283a718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7ea2738f-a0fb-4446-96df-46202bfd7e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fdf84e5e-9f77-4684-b8df-896dc283a718" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7ea2738f-a0fb-4446-96df-46202bfd7e09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_566d9042-094a-4892-ba4b-f982a9ccb71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fdf84e5e-9f77-4684-b8df-896dc283a718" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_566d9042-094a-4892-ba4b-f982a9ccb71a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_525e12ba-b4ac-4f8c-bc25-0937e340b52f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fdf84e5e-9f77-4684-b8df-896dc283a718" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_525e12ba-b4ac-4f8c-bc25-0937e340b52f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares_ceb5296c-2c42-4921-ba37-4718bb4274ce" xlink:href="mdt-20201030.xsd#mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fdf84e5e-9f77-4684-b8df-896dc283a718" xlink:to="loc_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares_ceb5296c-2c42-4921-ba37-4718bb4274ce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#EarningsPerShareNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/EarningsPerShareNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="mdt-20201030.xsd#StockBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/StockBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#StockBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/StockBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#StockBasedCompensationDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/StockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_284053e4-f2a4-4a71-822a-62c1b6e4b4c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2e5af6f9-7c41-4dba-a041-1c918f507556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_284053e4-f2a4-4a71-822a-62c1b6e4b4c5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2e5af6f9-7c41-4dba-a041-1c918f507556" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e9d05c19-6f8f-4be8-b8b7-6bc16b5e5158" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_284053e4-f2a4-4a71-822a-62c1b6e4b4c5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e9d05c19-6f8f-4be8-b8b7-6bc16b5e5158" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlans" xlink:type="simple" xlink:href="mdt-20201030.xsd#RetirementBenefitPlans"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlansTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#RetirementBenefitPlansTables"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlansDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RetirementBenefitPlansDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_5c92c656-153f-4204-a77d-08066e910e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_80455f22-ad56-4d20-b4c0-542edad09471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_5c92c656-153f-4204-a77d-08066e910e3f" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_80455f22-ad56-4d20-b4c0-542edad09471" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_0697170c-a7fb-46ac-bd2c-740d2edea971" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_5c92c656-153f-4204-a77d-08066e910e3f" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_0697170c-a7fb-46ac-bd2c-740d2edea971" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f559e6bf-97c8-4a78-8ba3-92ced024c8fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_5c92c656-153f-4204-a77d-08066e910e3f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f559e6bf-97c8-4a78-8ba3-92ced024c8fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e8783bf2-e7c5-4b55-92ae-4bd94436f286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_5c92c656-153f-4204-a77d-08066e910e3f" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e8783bf2-e7c5-4b55-92ae-4bd94436f286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_c0326754-568b-4ddb-86b1-18caccd07fda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_5c92c656-153f-4204-a77d-08066e910e3f" xlink:to="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_c0326754-568b-4ddb-86b1-18caccd07fda" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RetirementBenefitPlansNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="mdt-20201030.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#AccumulatedOtherComprehensiveLossChangesinAOCIDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_35745138-8118-4fde-9a69-e9cb1133ad25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_8af9cf57-7c2e-47be-a087-c7965683a05b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_35745138-8118-4fde-9a69-e9cb1133ad25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_8af9cf57-7c2e-47be-a087-c7965683a05b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7df8bd22-1e1f-4588-a08a-030f2858f3d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_35745138-8118-4fde-9a69-e9cb1133ad25" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7df8bd22-1e1f-4588-a08a-030f2858f3d5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mdt-20201030.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#CommitmentsandContingenciesDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/CommitmentsandContingenciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformation" xlink:type="simple" xlink:href="mdt-20201030.xsd#SegmentandGeographicInformation"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#SegmentandGeographicInformationTables"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#SegmentandGeographicInformationDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_822206e6-047e-4f8a-80ea-6759d9a64744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_us-gaap_OperatingIncomeLoss_822206e6-047e-4f8a-80ea-6759d9a64744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7fd25cd5-6a64-4c45-9ff3-98fb6e5d68e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_us-gaap_InterestExpense_7fd25cd5-6a64-4c45-9ff3-98fb6e5d68e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_f300ead3-b8ac-40fa-a25a-cecca3925189" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeOperating"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_us-gaap_InterestIncomeOperating_f300ead3-b8ac-40fa-a25a-cecca3925189" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b871aa47-0358-49a5-af06-77cd9915bc3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b871aa47-0358-49a5-af06-77cd9915bc3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CorporateOverhead_e8311ae2-2eab-407b-9ee0-8e9e818c8038" xlink:href="mdt-20201030.xsd#mdt_CorporateOverhead"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_mdt_CorporateOverhead_e8311ae2-2eab-407b-9ee0-8e9e818c8038" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CentralizedDistributionCosts_a9ddbae6-6190-4181-b115-2cb6c9d18107" xlink:href="mdt-20201030.xsd#mdt_CentralizedDistributionCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_mdt_CentralizedDistributionCosts_a9ddbae6-6190-4181-b115-2cb6c9d18107" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesNetofRestructuringReversals_065e6f37-7771-4926-afa7-d2ec069664df" xlink:href="mdt-20201030.xsd#mdt_RestructuringChargesNetofRestructuringReversals"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_mdt_RestructuringChargesNetofRestructuringReversals_065e6f37-7771-4926-afa7-d2ec069664df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_81eafa88-fdaf-4379-9d19-3651ab9cfecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_81eafa88-fdaf-4379-9d19-3651ab9cfecc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_9339c65c-9d15-4161-aae5-3dee5b23659a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_9339c65c-9d15-4161-aae5-3dee5b23659a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ImpairmentOfInProcessResearchAndDevelopment_08094aa7-8ff9-40e3-a7c7-ecd841b3d0fb" xlink:href="mdt-20201030.xsd#mdt_ImpairmentOfInProcessResearchAndDevelopment"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_mdt_ImpairmentOfInProcessResearchAndDevelopment_08094aa7-8ff9-40e3-a7c7-ecd841b3d0fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtTenderPremiumandOtherCharges_b9ea7cd1-1a80-4284-806c-3ef088934157" xlink:href="mdt-20201030.xsd#mdt_DebtTenderPremiumandOtherCharges"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_mdt_DebtTenderPremiumandOtherCharges_b9ea7cd1-1a80-4284-806c-3ef088934157" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalDeviceRegulations_98991931-05f4-481f-b789-ca3398f00ae7" xlink:href="mdt-20201030.xsd#mdt_MedicalDeviceRegulations"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_mdt_MedicalDeviceRegulations_98991931-05f4-481f-b789-ca3398f00ae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_1590e294-38d2-4578-91f5-7ca96ff867a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_us-gaap_BusinessExitCosts1_1590e294-38d2-4578-91f5-7ca96ff867a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SpecialChargesGains_77662c46-4f3d-44cd-8bb6-44076ae38b1a" xlink:href="mdt-20201030.xsd#mdt_SpecialChargesGains"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93d0338-6ced-4606-b9c6-038bcf312c03" xlink:to="loc_mdt_SpecialChargesGains_77662c46-4f3d-44cd-8bb6-44076ae38b1a" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>mdt-20201030_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:8939d385-98d2-4684-bfa0-0279309cacd9,g:e5f1341e-11f4-4035-86fa-7f937a6230d9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="mdt-20201030.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DocumentandEntityInformation" xlink:type="extended" id="i51ae11549b554568a96dbeb65396cc55_DocumentandEntityInformation">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c571a5e1-041c-417a-83d0-a8ecc1f2b49c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_DocumentType_c571a5e1-041c-417a-83d0-a8ecc1f2b49c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_ba5034a9-5ded-4963-8f40-0b26a50be0cd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_DocumentQuarterlyReport_ba5034a9-5ded-4963-8f40-0b26a50be0cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9a9dc254-9ad8-4fa2-a7ba-b9ca15c261d1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_DocumentPeriodEndDate_9a9dc254-9ad8-4fa2-a7ba-b9ca15c261d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_71fcbb91-3de8-4920-ae18-bf20802b391c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_DocumentTransitionReport_71fcbb91-3de8-4920-ae18-bf20802b391c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2f89d03f-98c8-4546-a0e1-f26a35441729" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityFileNumber_2f89d03f-98c8-4546-a0e1-f26a35441729" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e70a2aa2-283d-42e9-a479-35692e6533df" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityRegistrantName_e70a2aa2-283d-42e9-a479-35692e6533df" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e8245331-653d-41b8-b7a0-4cfbe9ef98c9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e8245331-653d-41b8-b7a0-4cfbe9ef98c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_546a34ec-87df-42d7-9c71-d564f5fd1c45" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityTaxIdentificationNumber_546a34ec-87df-42d7-9c71-d564f5fd1c45" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5622de83-7f64-4482-ad51-ea6bf6a177e1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityAddressAddressLine1_5622de83-7f64-4482-ad51-ea6bf6a177e1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c53fd503-39bf-4530-913e-888ec0886b9b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityAddressCityOrTown_c53fd503-39bf-4530-913e-888ec0886b9b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_898950cd-6564-42dd-8590-993db406e368" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityAddressCountry_898950cd-6564-42dd-8590-993db406e368" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_4647dabd-8b8c-4aea-ae2a-ee16b6d3d014" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_CountryRegion_4647dabd-8b8c-4aea-ae2a-ee16b6d3d014" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_11068694-b8be-43a7-9570-126db7d2fcac" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_CityAreaCode_11068694-b8be-43a7-9570-126db7d2fcac" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b2884de2-3cfb-4656-a78f-8cc65ec7e02c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_LocalPhoneNumber_b2884de2-3cfb-4656-a78f-8cc65ec7e02c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9185eda2-26ed-485e-a10a-a35a822d097e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_Security12bTitle_9185eda2-26ed-485e-a10a-a35a822d097e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_40513cf3-f7a0-4c57-a29a-9632e4c91201" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_TradingSymbol_40513cf3-f7a0-4c57-a29a-9632e4c91201" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_3f33e2e5-a1e4-4308-b92b-a13527b04401" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_SecurityExchangeName_3f33e2e5-a1e4-4308-b92b-a13527b04401" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_6c7b28cd-0ea8-432f-9c1c-fc878cc33e6b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityCurrentReportingStatus_6c7b28cd-0ea8-432f-9c1c-fc878cc33e6b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_33f4fb04-07ac-46c3-babe-879434f4f4e1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityInteractiveDataCurrent_33f4fb04-07ac-46c3-babe-879434f4f4e1" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_05f7cee0-2d77-47fe-86ca-aabf562e4d5a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityFilerCategory_05f7cee0-2d77-47fe-86ca-aabf562e4d5a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_df4dd4ef-e3c3-43b4-82aa-fc09bf68b5ae" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntitySmallBusiness_df4dd4ef-e3c3-43b4-82aa-fc09bf68b5ae" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f72d081f-0eeb-4b3a-b22c-99a733e067c0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityEmergingGrowthCompany_f72d081f-0eeb-4b3a-b22c-99a733e067c0" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_65df8e8c-c1c4-434d-834d-ef0356ad7fbf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityShellCompany_65df8e8c-c1c4-434d-834d-ef0356ad7fbf" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_23488be6-99d3-4745-a630-350428c9ed50" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_23488be6-99d3-4745-a630-350428c9ed50" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cb6f7b52-9652-473c-8a1a-74bbbcc4676a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityCentralIndexKey_cb6f7b52-9652-473c-8a1a-74bbbcc4676a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_273aa419-2f33-450a-8170-af61069fca10" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_AmendmentFlag_273aa419-2f33-450a-8170-af61069fca10" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_cb6982f3-0af5-49f0-aad0-462dde4512ff" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_CurrentFiscalYearEndDate_cb6982f3-0af5-49f0-aad0-462dde4512ff" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_b049c446-b539-4ace-9e0b-1394e0f34e1c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_DocumentFiscalPeriodFocus_b049c446-b539-4ace-9e0b-1394e0f34e1c" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5fb9c0dd-771b-4786-a596-84fc347e7e4b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_DocumentFiscalYearFocus_5fb9c0dd-771b-4786-a596-84fc347e7e4b" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4de43da0-c7fe-49d1-bef9-c2ca7f72016f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityAddressPostalZipCode_4de43da0-c7fe-49d1-bef9-c2ca7f72016f" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_300a1da6-1023-47a6-a5d7-9598f53080f6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntitiesTable_300a1da6-1023-47a6-a5d7-9598f53080f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a8311a93-d328-4b3f-a414-df5013c9ca0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_300a1da6-1023-47a6-a5d7-9598f53080f6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a8311a93-d328-4b3f-a414-df5013c9ca0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a8311a93-d328-4b3f-a414-df5013c9ca0c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a8311a93-d328-4b3f-a414-df5013c9ca0c" xlink:to="loc_us-gaap_ClassOfStockDomain_a8311a93-d328-4b3f-a414-df5013c9ca0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a8311a93-d328-4b3f-a414-df5013c9ca0c" xlink:to="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e203a4b5-be30-4ecd-93a0-7fc5b263e670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_us-gaap_CommonStockMember_e203a4b5-be30-4ecd-93a0-7fc5b263e670" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2021FloatingMember_4bb0b51a-4b31-48f4-bbd8-8e449726cf11" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2021FloatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due2021FloatingMember_4bb0b51a-4b31-48f4-bbd8-8e449726cf11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2022Member_b7761ab1-2a6c-4426-9900-e70a07119afa" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due2022Member_b7761ab1-2a6c-4426-9900-e70a07119afa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230.375PercentMember_bdddca19-f505-47f1-ae98-ab02a15fc203" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20230.375PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due20230.375PercentMember_bdddca19-f505-47f1-ae98-ab02a15fc203" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2023Member_d29c9918-0369-437e-9022-a247124fdae7" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2020Due2023Member_d29c9918-0369-437e-9022-a247124fdae7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2025Member_a932d212-3862-44ba-825e-3da168d28596" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due2025Member_a932d212-3862-44ba-825e-3da168d28596" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2025Member_18d19ffc-ad15-4477-ae07-46dec76bc51a" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2020Due2025Member_18d19ffc-ad15-4477-ae07-46dec76bc51a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2027Member_62f1983b-3df7-4ded-8af9-d6c0ba1df5f2" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due2027Member_62f1983b-3df7-4ded-8af9-d6c0ba1df5f2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2028Member_457673f7-cbe5-482b-b16a-01ce262d5bd5" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2020Due2028Member_457673f7-cbe5-482b-b16a-01ce262d5bd5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.625PercentMember_de4dbe51-5df0-4244-85f6-b89b2549e0e7" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20311.625PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due20311.625PercentMember_de4dbe51-5df0-4244-85f6-b89b2549e0e7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.00PercentMember_ab51a522-1906-4deb-86db-fb9e43d80f6c" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20311.00PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due20311.00PercentMember_ab51a522-1906-4deb-86db-fb9e43d80f6c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2032Member_07180fb0-cb88-4902-811b-ecf970ffd050" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2020Due2032Member_07180fb0-cb88-4902-811b-ecf970ffd050" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20392.250PercentMember_c506bc67-1f97-4030-88f5-ef6c56e874ea" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20392.250PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due20392.250PercentMember_c506bc67-1f97-4030-88f5-ef6c56e874ea" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20391.50PercentMember_bd398d33-cf16-46a3-81e1-73c8db80ba5f" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20391.50PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due20391.50PercentMember_bd398d33-cf16-46a3-81e1-73c8db80ba5f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2040Member_af48ab0e-17eb-44d2-a80a-aa74f3221708" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2020Due2040Member_af48ab0e-17eb-44d2-a80a-aa74f3221708" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2049Member_65f83e2f-a806-4878-ac0f-904b8cbbb5b0" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2049Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due2049Member_65f83e2f-a806-4878-ac0f-904b8cbbb5b0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2050Member_6c4abc96-6bec-43be-9313-d0550095aef0" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2020Due2050Member_6c4abc96-6bec-43be-9313-d0550095aef0" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofIncomeUnaudited"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited" xlink:type="extended" id="i553e132b128d4beba7f2c7f8a2fc0e4f_ConsolidatedStatementsofIncomeUnaudited"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended" id="ib9011f67c81f4fd49c8d85468a0ec2c9_ConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended" id="i8c4b79491fb649a289f9c7b3b75d8585_ConsolidatedBalanceSheetsUnaudited"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended" id="if22d9e676dfb400d9a2b1a24615732e0_ConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited" xlink:type="extended" id="i6b7eabf752fc45e9be9f120c5ebc975a_ConsolidatedStatementsofEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_74e473ac-6e2c-44ea-b87e-94808263f868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_74e473ac-6e2c-44ea-b87e-94808263f868" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a20d119d-ff9d-496f-b011-51c7f86f17c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a20d119d-ff9d-496f-b011-51c7f86f17c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c0aa776a-0953-4de5-90fc-c4b99f3ab5aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c0aa776a-0953-4de5-90fc-c4b99f3ab5aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_75f0f2ce-b824-4459-a8da-7e43c66bd207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_ProfitLoss_75f0f2ce-b824-4459-a8da-7e43c66bd207" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_88fe5587-e0cf-420c-ba10-0ddb37c9a514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_88fe5587-e0cf-420c-ba10-0ddb37c9a514" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_15f78268-b273-44f8-9e0b-c68c2426fe43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_DividendsCommonStockCash_15f78268-b273-44f8-9e0b-c68c2426fe43" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_df6e2344-a11a-4816-b5e4-d78881b7fa9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_df6e2344-a11a-4816-b5e4-d78881b7fa9a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5bb34a44-b6b2-4f11-b7e1-6bd572a353af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5bb34a44-b6b2-4f11-b7e1-6bd572a353af" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_7207a4bc-f917-41a6-b822-23770edab965" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_7207a4bc-f917-41a6-b822-23770edab965" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2217e892-3efe-4474-a6dc-6cd72abe676c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2217e892-3efe-4474-a6dc-6cd72abe676c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_80f68ef2-466e-4534-8e8b-1a0ce42cd3a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_80f68ef2-466e-4534-8e8b-1a0ce42cd3a8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_138e5a80-b2c5-4789-acc5-bf6de06de01d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_138e5a80-b2c5-4789-acc5-bf6de06de01d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_4705c0e5-b57b-4061-8510-dcdc51f663ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_4705c0e5-b57b-4061-8510-dcdc51f663ea" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3347d7b1-e456-4f84-907e-30b33d3188b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dad61bb2-302e-4170-ad6a-d127aff92d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_48e93ced-a249-4e0e-bc19-44bef44993a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_74e473ac-6e2c-44ea-b87e-94808263f868" xlink:to="loc_us-gaap_StatementTable_48e93ced-a249-4e0e-bc19-44bef44993a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_52ba3b46-880c-4720-ad27-ef2ff4c17c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_48e93ced-a249-4e0e-bc19-44bef44993a9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_52ba3b46-880c-4720-ad27-ef2ff4c17c03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_52ba3b46-880c-4720-ad27-ef2ff4c17c03_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_52ba3b46-880c-4720-ad27-ef2ff4c17c03" xlink:to="loc_us-gaap_EquityComponentDomain_52ba3b46-880c-4720-ad27-ef2ff4c17c03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1557a796-045f-4d11-9ee9-85d62f2fa4be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_52ba3b46-880c-4720-ad27-ef2ff4c17c03" xlink:to="loc_us-gaap_EquityComponentDomain_1557a796-045f-4d11-9ee9-85d62f2fa4be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_a4925467-e36b-4386-a039-c17cf50809cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1557a796-045f-4d11-9ee9-85d62f2fa4be" xlink:to="loc_us-gaap_ParentMember_a4925467-e36b-4386-a039-c17cf50809cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cb29e7c3-fb31-4855-acf0-7ace7d518a0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_a4925467-e36b-4386-a039-c17cf50809cd" xlink:to="loc_us-gaap_CommonStockMember_cb29e7c3-fb31-4855-acf0-7ace7d518a0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_10c27531-332a-494e-bd9e-d0b91aa2ac8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_a4925467-e36b-4386-a039-c17cf50809cd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_10c27531-332a-494e-bd9e-d0b91aa2ac8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b3900448-876e-4694-b33a-ed7bc444bbe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_a4925467-e36b-4386-a039-c17cf50809cd" xlink:to="loc_us-gaap_RetainedEarningsMember_b3900448-876e-4694-b33a-ed7bc444bbe8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d4f25e45-4231-4ec6-bcae-a4572612174d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_a4925467-e36b-4386-a039-c17cf50809cd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d4f25e45-4231-4ec6-bcae-a4572612174d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_09827281-006a-4314-8201-95f25ad18a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1557a796-045f-4d11-9ee9-85d62f2fa4be" xlink:to="loc_us-gaap_NoncontrollingInterestMember_09827281-006a-4314-8201-95f25ad18a21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8b9ce03b-052d-4ab1-9fab-6ad520567f2b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_48e93ced-a249-4e0e-bc19-44bef44993a9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8b9ce03b-052d-4ab1-9fab-6ad520567f2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8b9ce03b-052d-4ab1-9fab-6ad520567f2b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8b9ce03b-052d-4ab1-9fab-6ad520567f2b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8b9ce03b-052d-4ab1-9fab-6ad520567f2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0fdf0737-b950-4152-ad9a-4be538d2f273" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8b9ce03b-052d-4ab1-9fab-6ad520567f2b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0fdf0737-b950-4152-ad9a-4be538d2f273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_afa8c07f-f1fb-4824-8832-f6747da5ea89" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0fdf0737-b950-4152-ad9a-4be538d2f273" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_afa8c07f-f1fb-4824-8832-f6747da5ea89" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofEquityUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical" xlink:type="extended" id="i0b190d41822348eda6b625241dd41358_ConsolidatedStatementsofEquityUnauditedParenthetical"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended" id="i0f9e11686bcb40b890afb5410725e98e_ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/BasisofPresentation" xlink:type="simple" xlink:href="mdt-20201030.xsd#BasisofPresentation"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/BasisofPresentation" xlink:type="extended" id="i16d2314fab784590a5394e146d68b29c_BasisofPresentation"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="mdt-20201030.xsd#BasisofPresentationPolicies"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/BasisofPresentationPolicies" xlink:type="extended" id="i8981799a74fc49caad4c8a5ece601e34_BasisofPresentationPolicies"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="mdt-20201030.xsd#NewAccountingPronouncements"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/NewAccountingPronouncements" xlink:type="extended" id="i950cad5007ef4272b793b3d4a65ae9fc_NewAccountingPronouncements"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/Revenue" xlink:type="simple" xlink:href="mdt-20201030.xsd#Revenue"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/Revenue" xlink:type="extended" id="i3bac8c6b096e42ed8316406728c50522_Revenue"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#RevenueTables"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RevenueTables" xlink:type="extended" id="i9e50e349c4104581847d0c95923e02b2_RevenueTables"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails" xlink:type="extended" id="i54cf1b9eedef482da8168d0155c65e68_RevenueDisaggregationofNetSalesbySegmentandDivisionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ac017298-9596-49b9-8368-aa7a3081d302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5aea22cf-87bf-44ee-b5a4-c066341f6d59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ac017298-9596-49b9-8368-aa7a3081d302" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5aea22cf-87bf-44ee-b5a4-c066341f6d59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_85cbe511-4a63-49a9-baca-12f58ba749c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ac017298-9596-49b9-8368-aa7a3081d302" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_85cbe511-4a63-49a9-baca-12f58ba749c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_89ba5670-1a39-410d-ada4-0a1fc2ce4c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_85cbe511-4a63-49a9-baca-12f58ba749c7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_89ba5670-1a39-410d-ada4-0a1fc2ce4c6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_89ba5670-1a39-410d-ada4-0a1fc2ce4c6d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_89ba5670-1a39-410d-ada4-0a1fc2ce4c6d" xlink:to="loc_us-gaap_SegmentDomain_89ba5670-1a39-410d-ada4-0a1fc2ce4c6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7931ff96-313f-48bc-aa0a-2c4f2bc340be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_89ba5670-1a39-410d-ada4-0a1fc2ce4c6d" xlink:to="loc_us-gaap_SegmentDomain_7931ff96-313f-48bc-aa0a-2c4f2bc340be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacAndVascularGroupMember_75521c5e-cbbd-48b5-911d-fd253abcc1ea" xlink:href="mdt-20201030.xsd#mdt_CardiacAndVascularGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7931ff96-313f-48bc-aa0a-2c4f2bc340be" xlink:to="loc_mdt_CardiacAndVascularGroupMember_75521c5e-cbbd-48b5-911d-fd253abcc1ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MinimallyInvasiveTherapiesGroupMember_d8fa7993-da09-4850-8bc8-9a6743fc3b20" xlink:href="mdt-20201030.xsd#mdt_MinimallyInvasiveTherapiesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7931ff96-313f-48bc-aa0a-2c4f2bc340be" xlink:to="loc_mdt_MinimallyInvasiveTherapiesGroupMember_d8fa7993-da09-4850-8bc8-9a6743fc3b20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestorativeTherapiesGroupMember_7ffb2d33-7c79-4988-ba27-474b77d80db9" xlink:href="mdt-20201030.xsd#mdt_RestorativeTherapiesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7931ff96-313f-48bc-aa0a-2c4f2bc340be" xlink:to="loc_mdt_RestorativeTherapiesGroupMember_7ffb2d33-7c79-4988-ba27-474b77d80db9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_ac3cd525-8fe7-4c71-8ef9-0982dc809195" xlink:href="mdt-20201030.xsd#mdt_DiabetesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7931ff96-313f-48bc-aa0a-2c4f2bc340be" xlink:to="loc_mdt_DiabetesGroupMember_ac3cd525-8fe7-4c71-8ef9-0982dc809195" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_60afe5d9-e4cf-4278-b775-445b5d01dc19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_85cbe511-4a63-49a9-baca-12f58ba749c7" xlink:to="loc_us-gaap_SubsegmentsAxis_60afe5d9-e4cf-4278-b775-445b5d01dc19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_60afe5d9-e4cf-4278-b775-445b5d01dc19_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_60afe5d9-e4cf-4278-b775-445b5d01dc19" xlink:to="loc_us-gaap_SubsegmentsDomain_60afe5d9-e4cf-4278-b775-445b5d01dc19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_60afe5d9-e4cf-4278-b775-445b5d01dc19" xlink:to="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacRhythmandHeartFailureDivisionMember_2b84c5a0-f286-43e4-b5ff-1548554a09e8" xlink:href="mdt-20201030.xsd#mdt_CardiacRhythmandHeartFailureDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_CardiacRhythmandHeartFailureDivisionMember_2b84c5a0-f286-43e4-b5ff-1548554a09e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CoronaryandStructuralHeartDivisionMember_2c1b5255-3c88-487c-8da7-13062ee3d464" xlink:href="mdt-20201030.xsd#mdt_CoronaryandStructuralHeartDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_CoronaryandStructuralHeartDivisionMember_2c1b5255-3c88-487c-8da7-13062ee3d464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AorticPeripheralandVenousDivisionMember_d9f60bfc-14a1-48d4-beb8-3d510b18e649" xlink:href="mdt-20201030.xsd#mdt_AorticPeripheralandVenousDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_AorticPeripheralandVenousDivisionMember_d9f60bfc-14a1-48d4-beb8-3d510b18e649" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SurgicalInnovationsDivisionMember_4aba189e-378e-4a1e-a8ef-d28dbf313a1b" xlink:href="mdt-20201030.xsd#mdt_SurgicalInnovationsDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_SurgicalInnovationsDivisionMember_4aba189e-378e-4a1e-a8ef-d28dbf313a1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RespiratoryGastrointestinalandRenalDivisionMember_b6c8b99e-3c9a-4f83-9f4d-9a3a8252103f" xlink:href="mdt-20201030.xsd#mdt_RespiratoryGastrointestinalandRenalDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_RespiratoryGastrointestinalandRenalDivisionMember_b6c8b99e-3c9a-4f83-9f4d-9a3a8252103f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CranialAndSpinalTechnologiesDivisionMember_af120a81-0d5e-44dc-baba-838a5509b155" xlink:href="mdt-20201030.xsd#mdt_CranialAndSpinalTechnologiesDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_CranialAndSpinalTechnologiesDivisionMember_af120a81-0d5e-44dc-baba-838a5509b155" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SpecialtyTherapiesDivisionMember_b128948d-7e82-4142-b156-408bfd5427ae" xlink:href="mdt-20201030.xsd#mdt_SpecialtyTherapiesDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_SpecialtyTherapiesDivisionMember_b128948d-7e82-4142-b156-408bfd5427ae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuromodulationDivisionMember_1ef34635-fe2c-4c87-aab9-5c8267fb6bd7" xlink:href="mdt-20201030.xsd#mdt_NeuromodulationDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_NeuromodulationDivisionMember_1ef34635-fe2c-4c87-aab9-5c8267fb6bd7" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails" xlink:type="extended" id="ia37049e2eee746c2a96d109d8d24ae0a_RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f5b21001-8ae9-407e-adb6-9df9e8d80748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_577c2f0f-ee97-4852-bf1c-b5b422880316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f5b21001-8ae9-407e-adb6-9df9e8d80748" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_577c2f0f-ee97-4852-bf1c-b5b422880316" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_9d864082-6898-4ac9-b265-fc2607614e17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f5b21001-8ae9-407e-adb6-9df9e8d80748" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_9d864082-6898-4ac9-b265-fc2607614e17" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6282c487-399f-4cb6-ab84-a0626661e5d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9d864082-6898-4ac9-b265-fc2607614e17" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6282c487-399f-4cb6-ab84-a0626661e5d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6282c487-399f-4cb6-ab84-a0626661e5d0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6282c487-399f-4cb6-ab84-a0626661e5d0" xlink:to="loc_us-gaap_SegmentDomain_6282c487-399f-4cb6-ab84-a0626661e5d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4a335936-2b90-427f-b98f-842fb9aea63e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6282c487-399f-4cb6-ab84-a0626661e5d0" xlink:to="loc_us-gaap_SegmentDomain_4a335936-2b90-427f-b98f-842fb9aea63e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacAndVascularGroupMember_936c80f2-5915-4227-8086-19fa04301c40" xlink:href="mdt-20201030.xsd#mdt_CardiacAndVascularGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4a335936-2b90-427f-b98f-842fb9aea63e" xlink:to="loc_mdt_CardiacAndVascularGroupMember_936c80f2-5915-4227-8086-19fa04301c40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MinimallyInvasiveTherapiesGroupMember_54a67089-19a2-42b9-be7e-e3b8caefcca9" xlink:href="mdt-20201030.xsd#mdt_MinimallyInvasiveTherapiesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4a335936-2b90-427f-b98f-842fb9aea63e" xlink:to="loc_mdt_MinimallyInvasiveTherapiesGroupMember_54a67089-19a2-42b9-be7e-e3b8caefcca9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestorativeTherapiesGroupMember_0dece6d8-e173-4902-9c0c-c26be5472418" xlink:href="mdt-20201030.xsd#mdt_RestorativeTherapiesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4a335936-2b90-427f-b98f-842fb9aea63e" xlink:to="loc_mdt_RestorativeTherapiesGroupMember_0dece6d8-e173-4902-9c0c-c26be5472418" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_c1b6ffe2-6a69-4cd2-9dd6-7a03d0195727" xlink:href="mdt-20201030.xsd#mdt_DiabetesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4a335936-2b90-427f-b98f-842fb9aea63e" xlink:to="loc_mdt_DiabetesGroupMember_c1b6ffe2-6a69-4cd2-9dd6-7a03d0195727" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_edcda0ab-a738-423d-ae93-dc5f5779f660" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9d864082-6898-4ac9-b265-fc2607614e17" xlink:to="loc_srt_StatementGeographicalAxis_edcda0ab-a738-423d-ae93-dc5f5779f660" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_edcda0ab-a738-423d-ae93-dc5f5779f660_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_edcda0ab-a738-423d-ae93-dc5f5779f660" xlink:to="loc_srt_SegmentGeographicalDomain_edcda0ab-a738-423d-ae93-dc5f5779f660_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9b3b086e-b89d-480d-87fd-8e7d37e3eaf6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_edcda0ab-a738-423d-ae93-dc5f5779f660" xlink:to="loc_srt_SegmentGeographicalDomain_9b3b086e-b89d-480d-87fd-8e7d37e3eaf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c6aab99e-b412-44c8-abf5-55f41b196c04" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9b3b086e-b89d-480d-87fd-8e7d37e3eaf6" xlink:to="loc_country_US_c6aab99e-b412-44c8-abf5-55f41b196c04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_08e0093e-48d6-4268-a431-8872464aabf1" xlink:href="mdt-20201030.xsd#mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9b3b086e-b89d-480d-87fd-8e7d37e3eaf6" xlink:to="loc_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_08e0093e-48d6-4268-a431-8872464aabf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_b6fba8da-9fae-460a-8704-3d2ac9ff4477" xlink:href="mdt-20201030.xsd#mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9b3b086e-b89d-480d-87fd-8e7d37e3eaf6" xlink:to="loc_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_b6fba8da-9fae-460a-8704-3d2ac9ff4477" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RevenueNarrativeDetails" xlink:type="extended" id="id027cf8f5c5741aaa5233e134bdcbfdb_RevenueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_5fc0b8fb-2ec0-4692-a709-f3c322803ed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_5fc0b8fb-2ec0-4692-a709-f3c322803ed2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_fb70915f-e0cd-457b-b215-0a3dbc4d5913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:to="loc_us-gaap_ContractWithCustomerLiability_fb70915f-e0cd-457b-b215-0a3dbc4d5913" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a5028218-5374-4405-8f9c-1ef2532194f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a5028218-5374-4405-8f9c-1ef2532194f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d4f04909-5e9f-4c55-9f20-d12289e69c4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d4f04909-5e9f-4c55-9f20-d12289e69c4f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_bd4fddd8-bf1d-4f39-982d-5e5a1a0d468c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_bd4fddd8-bf1d-4f39-982d-5e5a1a0d468c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_89b83cc0-de75-48d7-9dd1-a455f86944c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_89b83cc0-de75-48d7-9dd1-a455f86944c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6f22cf83-b6c5-47aa-8b8c-cdcb23cef82e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_89b83cc0-de75-48d7-9dd1-a455f86944c8" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6f22cf83-b6c5-47aa-8b8c-cdcb23cef82e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6f22cf83-b6c5-47aa-8b8c-cdcb23cef82e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6f22cf83-b6c5-47aa-8b8c-cdcb23cef82e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6f22cf83-b6c5-47aa-8b8c-cdcb23cef82e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_de6263b0-54b4-431e-9f60-dcf028f1daad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6f22cf83-b6c5-47aa-8b8c-cdcb23cef82e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_de6263b0-54b4-431e-9f60-dcf028f1daad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember_617620bc-9ec7-48af-8818-df52faf50d79" xlink:href="mdt-20201030.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de6263b0-54b4-431e-9f60-dcf028f1daad" xlink:to="loc_mdt_OtherAccruedExpensesMember_617620bc-9ec7-48af-8818-df52faf50d79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_7c08650c-c6e3-4c0b-a6b5-ad6d2e82e589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de6263b0-54b4-431e-9f60-dcf028f1daad" xlink:to="loc_us-gaap_AccountsReceivableMember_7c08650c-c6e3-4c0b-a6b5-ad6d2e82e589" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_526957dd-e7a5-4ab1-8063-de0e163aa8b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de6263b0-54b4-431e-9f60-dcf028f1daad" xlink:to="loc_us-gaap_OtherLiabilitiesMember_526957dd-e7a5-4ab1-8063-de0e163aa8b7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/Acquisitions" xlink:type="simple" xlink:href="mdt-20201030.xsd#Acquisitions"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/Acquisitions" xlink:type="extended" id="i8bb1fc7a07174ba3b17ca31b01f041a6_Acquisitions"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#AcquisitionsTables"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/AcquisitionsTables" xlink:type="extended" id="ia9e9ea5507354e70a85946ac565326ed_AcquisitionsTables"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#AcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" id="i974fdb316d924ec4b2e526ca6d41b04d_AcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ec19961a-de27-4a23-9916-ef1e8a2b5c4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ec19961a-de27-4a23-9916-ef1e8a2b5c4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_60f8224f-6a84-402d-8beb-c43d4533eed6" xlink:href="mdt-20201030.xsd#mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_60f8224f-6a84-402d-8beb-c43d4533eed6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a50a16c4-aced-4a1c-b541-3690b4efae8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a50a16c4-aced-4a1c-b541-3690b4efae8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2aa925a5-5049-45f4-8e0e-5fc55661cb41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2aa925a5-5049-45f4-8e0e-5fc55661cb41" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_aa5cea05-c448-4dac-8aba-f88237372b3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_aa5cea05-c448-4dac-8aba-f88237372b3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_395d17ba-2540-4809-bf3a-afa53c3af085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_395d17ba-2540-4809-bf3a-afa53c3af085" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_35180e96-595c-4bad-b49b-ad40c491840c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_Goodwill_35180e96-595c-4bad-b49b-ad40c491840c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_347a9ac2-636c-4056-84e6-893476083b85" xlink:href="mdt-20201030.xsd#mdt_BusinessAcquisitionPurchasePriceContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_347a9ac2-636c-4056-84e6-893476083b85" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_e686d44d-6019-4822-b659-ce3934f68ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_e686d44d-6019-4822-b659-ce3934f68ba6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7dd040de-78d0-4992-8242-464cab3b71fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7dd040de-78d0-4992-8242-464cab3b71fd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db0fd93-fb49-43ba-9f07-a7ccfbb784fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db0fd93-fb49-43ba-9f07-a7ccfbb784fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5914f410-e452-43e0-82cd-bbc1a2b88ae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db0fd93-fb49-43ba-9f07-a7ccfbb784fd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5914f410-e452-43e0-82cd-bbc1a2b88ae3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5914f410-e452-43e0-82cd-bbc1a2b88ae3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5914f410-e452-43e0-82cd-bbc1a2b88ae3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5914f410-e452-43e0-82cd-bbc1a2b88ae3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c49df840-8975-4882-8311-9143505ae890" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5914f410-e452-43e0-82cd-bbc1a2b88ae3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c49df840-8975-4882-8311-9143505ae890" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AllBusinessAcquisitionsMember_a52ce844-d87b-4189-847c-19ff1cfa41c6" xlink:href="mdt-20201030.xsd#mdt_AllBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c49df840-8975-4882-8311-9143505ae890" xlink:to="loc_mdt_AllBusinessAcquisitionsMember_a52ce844-d87b-4189-847c-19ff1cfa41c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82c80441-d531-4d18-9fbf-e70f4f796c31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db0fd93-fb49-43ba-9f07-a7ccfbb784fd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82c80441-d531-4d18-9fbf-e70f4f796c31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_82c80441-d531-4d18-9fbf-e70f4f796c31_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82c80441-d531-4d18-9fbf-e70f4f796c31" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_82c80441-d531-4d18-9fbf-e70f4f796c31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12684919-9c00-4068-ad1f-9b5acfe1ac3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82c80441-d531-4d18-9fbf-e70f4f796c31" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12684919-9c00-4068-ad1f-9b5acfe1ac3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_fa137eca-cb51-43fe-b7f5-0859b37408d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12684919-9c00-4068-ad1f-9b5acfe1ac3a" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_fa137eca-cb51-43fe-b7f5-0859b37408d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_922c6557-826f-47b0-ac8c-8058da3754d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12684919-9c00-4068-ad1f-9b5acfe1ac3a" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_922c6557-826f-47b0-ac8c-8058da3754d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_48b589b8-043e-4bc9-b9aa-ac24dff3ae83" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db0fd93-fb49-43ba-9f07-a7ccfbb784fd" xlink:to="loc_srt_RangeAxis_48b589b8-043e-4bc9-b9aa-ac24dff3ae83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_48b589b8-043e-4bc9-b9aa-ac24dff3ae83_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_48b589b8-043e-4bc9-b9aa-ac24dff3ae83" xlink:to="loc_srt_RangeMember_48b589b8-043e-4bc9-b9aa-ac24dff3ae83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4b318109-228a-4571-9635-8549cb92d858" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_48b589b8-043e-4bc9-b9aa-ac24dff3ae83" xlink:to="loc_srt_RangeMember_4b318109-228a-4571-9635-8549cb92d858" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_641747f1-0771-442e-bb98-5aac327d38ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4b318109-228a-4571-9635-8549cb92d858" xlink:to="loc_srt_MinimumMember_641747f1-0771-442e-bb98-5aac327d38ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_00ce0736-8110-40a8-9426-0654c76f0710" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4b318109-228a-4571-9635-8549cb92d858" xlink:to="loc_srt_MaximumMember_00ce0736-8110-40a8-9426-0654c76f0710" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1691ba08-9974-47b1-87d3-117914581624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db0fd93-fb49-43ba-9f07-a7ccfbb784fd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1691ba08-9974-47b1-87d3-117914581624" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1691ba08-9974-47b1-87d3-117914581624_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1691ba08-9974-47b1-87d3-117914581624" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1691ba08-9974-47b1-87d3-117914581624_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4281fa0d-eb97-48af-9383-583abfaf884c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1691ba08-9974-47b1-87d3-117914581624" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4281fa0d-eb97-48af-9383-583abfaf884c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember_9623bae4-6716-422b-b8b5-de9b152a82fe" xlink:href="mdt-20201030.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4281fa0d-eb97-48af-9383-583abfaf884c" xlink:to="loc_mdt_OtherAccruedExpensesMember_9623bae4-6716-422b-b8b5-de9b152a82fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_c5c2bfde-f59b-4d30-9cd3-0750d962b7f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4281fa0d-eb97-48af-9383-583abfaf884c" xlink:to="loc_us-gaap_OtherLiabilitiesMember_c5c2bfde-f59b-4d30-9cd3-0750d962b7f0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails" xlink:type="extended" id="i2798e6a8fdda4dc7add096b76909b28f_AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails" xlink:type="extended" id="ida0d39e8d576412f99d3d97460e8bafc_AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ec32ac4d-d315-431e-aac9-9b10c2a541a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_37bbfc40-bf2a-41d3-8c66-7b3b9f97cce6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ec32ac4d-d315-431e-aac9-9b10c2a541a3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_37bbfc40-bf2a-41d3-8c66-7b3b9f97cce6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_d4d583b0-3276-4a7a-9f37-a950345f69ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ec32ac4d-d315-431e-aac9-9b10c2a541a3" xlink:to="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_d4d583b0-3276-4a7a-9f37-a950345f69ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_ba52af66-6213-418e-987a-7dcdab136e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_d4d583b0-3276-4a7a-9f37-a950345f69ba" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_ba52af66-6213-418e-987a-7dcdab136e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ec32ac4d-d315-431e-aac9-9b10c2a541a3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_beda77be-7994-4483-b1cd-7ef2335cf018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_beda77be-7994-4483-b1cd-7ef2335cf018" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_beda77be-7994-4483-b1cd-7ef2335cf018_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_beda77be-7994-4483-b1cd-7ef2335cf018" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_beda77be-7994-4483-b1cd-7ef2335cf018_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_35b338df-79ae-4974-818c-1a064dcd0556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_beda77be-7994-4483-b1cd-7ef2335cf018" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_35b338df-79ae-4974-818c-1a064dcd0556" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RevenueMilestoneMember_87368a7b-2312-45e3-bce0-dbabff9ef026" xlink:href="mdt-20201030.xsd#mdt_RevenueMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_35b338df-79ae-4974-818c-1a064dcd0556" xlink:to="loc_mdt_RevenueMilestoneMember_87368a7b-2312-45e3-bce0-dbabff9ef026" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ProductDevelopmentMilestoneMember_bb48a2fa-8184-4415-be29-588ee7fb6ab3" xlink:href="mdt-20201030.xsd#mdt_ProductDevelopmentMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_35b338df-79ae-4974-818c-1a064dcd0556" xlink:to="loc_mdt_ProductDevelopmentMilestoneMember_bb48a2fa-8184-4415-be29-588ee7fb6ab3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a20d24c3-3cb2-45c5-86a9-cf8a84466932" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:to="loc_srt_RangeAxis_a20d24c3-3cb2-45c5-86a9-cf8a84466932" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a20d24c3-3cb2-45c5-86a9-cf8a84466932_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a20d24c3-3cb2-45c5-86a9-cf8a84466932" xlink:to="loc_srt_RangeMember_a20d24c3-3cb2-45c5-86a9-cf8a84466932_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e2c0579-f90c-4c30-ae62-978ec0fafb17" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a20d24c3-3cb2-45c5-86a9-cf8a84466932" xlink:to="loc_srt_RangeMember_6e2c0579-f90c-4c30-ae62-978ec0fafb17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_67e18300-571f-4b4b-ae26-05830ff1c94d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6e2c0579-f90c-4c30-ae62-978ec0fafb17" xlink:to="loc_srt_MinimumMember_67e18300-571f-4b4b-ae26-05830ff1c94d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cc8dbc2c-951e-4113-8706-45383b79ee4b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6e2c0579-f90c-4c30-ae62-978ec0fafb17" xlink:to="loc_srt_MaximumMember_cc8dbc2c-951e-4113-8706-45383b79ee4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_61ef584f-6a31-4d03-a937-5e5da2546f3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6e2c0579-f90c-4c30-ae62-978ec0fafb17" xlink:to="loc_srt_WeightedAverageMember_61ef584f-6a31-4d03-a937-5e5da2546f3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dfa918ef-04e5-4b4d-9ea9-18214f666c5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dfa918ef-04e5-4b4d-9ea9-18214f666c5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_dfa918ef-04e5-4b4d-9ea9-18214f666c5c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dfa918ef-04e5-4b4d-9ea9-18214f666c5c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_dfa918ef-04e5-4b4d-9ea9-18214f666c5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_88693617-d5ee-4e43-8ad4-9ba54266de27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dfa918ef-04e5-4b4d-9ea9-18214f666c5c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_88693617-d5ee-4e43-8ad4-9ba54266de27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_359bfc3b-ebc2-490b-be93-6854a58a064c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_88693617-d5ee-4e43-8ad4-9ba54266de27" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_359bfc3b-ebc2-490b-be93-6854a58a064c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c494c893-5ced-430b-b136-aa4403b77d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c494c893-5ced-430b-b136-aa4403b77d4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c494c893-5ced-430b-b136-aa4403b77d4e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c494c893-5ced-430b-b136-aa4403b77d4e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c494c893-5ced-430b-b136-aa4403b77d4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a566c904-f126-4d6e-abc8-c7359729d467" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c494c893-5ced-430b-b136-aa4403b77d4e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a566c904-f126-4d6e-abc8-c7359729d467" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_590a842f-002c-4efa-b95d-517f46758164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a566c904-f126-4d6e-abc8-c7359729d467" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_590a842f-002c-4efa-b95d-517f46758164" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_3497220a-9df3-4b4d-8ef6-f5e628b5bd14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_3497220a-9df3-4b4d-8ef6-f5e628b5bd14" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_3497220a-9df3-4b4d-8ef6-f5e628b5bd14_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_3497220a-9df3-4b4d-8ef6-f5e628b5bd14" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_3497220a-9df3-4b4d-8ef6-f5e628b5bd14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_da475cac-8b1a-4995-bde8-1cb2922a24fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_3497220a-9df3-4b4d-8ef6-f5e628b5bd14" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_da475cac-8b1a-4995-bde8-1cb2922a24fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_4b04add9-1d0c-4fd2-82a8-64987a33f809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_da475cac-8b1a-4995-bde8-1cb2922a24fc" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_4b04add9-1d0c-4fd2-82a8-64987a33f809" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MeasurementInputProbabilityofPaymentMember_314f6929-a07f-4f5d-ad05-7160d283169a" xlink:href="mdt-20201030.xsd#mdt_MeasurementInputProbabilityofPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_da475cac-8b1a-4995-bde8-1cb2922a24fc" xlink:to="loc_mdt_MeasurementInputProbabilityofPaymentMember_314f6929-a07f-4f5d-ad05-7160d283169a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/Restructuring" xlink:type="simple" xlink:href="mdt-20201030.xsd#Restructuring"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/Restructuring" xlink:type="extended" id="i32116451951d4f6ba1288ed4a9fed2d7_Restructuring"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#RestructuringTables"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RestructuringTables" xlink:type="extended" id="ibf5dca5664974a06ad5137c453657461_RestructuringTables"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RestructuringNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RestructuringNarrativeDetails" xlink:type="extended" id="i1050e2ab722c48bcb152cc8e7e43d176_RestructuringNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_997d69c4-5546-4176-bb5b-09219803374c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_997d69c4-5546-4176-bb5b-09219803374c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_ffd99bab-3e14-43ec-b3bd-3c5ed1a76b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:to="loc_us-gaap_RestructuringCharges_ffd99bab-3e14-43ec-b3bd-3c5ed1a76b26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_f12c5d6c-c0a1-4d6f-988d-893c52079b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_f12c5d6c-c0a1-4d6f-988d-893c52079b1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment_46ca0548-210f-4210-9e13-70657d33c4d8" xlink:href="mdt-20201030.xsd#mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:to="loc_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment_46ca0548-210f-4210-9e13-70657d33c4d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_3c9b85aa-cd1e-4381-91c9-6f90e3012d4a" xlink:href="mdt-20201030.xsd#mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:to="loc_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_3c9b85aa-cd1e-4381-91c9-6f90e3012d4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_acf306b6-342b-4d5f-bdd3-71ae3941a5b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_acf306b6-342b-4d5f-bdd3-71ae3941a5b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_c1bd4a48-8c13-44aa-9c80-e1dd6b9e6a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_acf306b6-342b-4d5f-bdd3-71ae3941a5b9" xlink:to="loc_us-gaap_RestructuringPlanAxis_c1bd4a48-8c13-44aa-9c80-e1dd6b9e6a24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_c1bd4a48-8c13-44aa-9c80-e1dd6b9e6a24_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_c1bd4a48-8c13-44aa-9c80-e1dd6b9e6a24" xlink:to="loc_us-gaap_RestructuringPlanDomain_c1bd4a48-8c13-44aa-9c80-e1dd6b9e6a24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9738514e-8c94-4a60-b3fe-e633e9882872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_c1bd4a48-8c13-44aa-9c80-e1dd6b9e6a24" xlink:to="loc_us-gaap_RestructuringPlanDomain_9738514e-8c94-4a60-b3fe-e633e9882872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EnterpriseExcellenceMember_cd16bec9-e2fc-4755-b469-e578b880b7ed" xlink:href="mdt-20201030.xsd#mdt_EnterpriseExcellenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_9738514e-8c94-4a60-b3fe-e633e9882872" xlink:to="loc_mdt_EnterpriseExcellenceMember_cd16bec9-e2fc-4755-b469-e578b880b7ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SimplificationRestructuringProgramMember_9c79c2ca-981d-4fe2-a5c7-ff184f7a59d1" xlink:href="mdt-20201030.xsd#mdt_SimplificationRestructuringProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_9738514e-8c94-4a60-b3fe-e633e9882872" xlink:to="loc_mdt_SimplificationRestructuringProgramMember_9c79c2ca-981d-4fe2-a5c7-ff184f7a59d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d8644c58-4aa1-4ed3-b7a5-5da56c49ea81" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_acf306b6-342b-4d5f-bdd3-71ae3941a5b9" xlink:to="loc_srt_RangeAxis_d8644c58-4aa1-4ed3-b7a5-5da56c49ea81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d8644c58-4aa1-4ed3-b7a5-5da56c49ea81_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d8644c58-4aa1-4ed3-b7a5-5da56c49ea81" xlink:to="loc_srt_RangeMember_d8644c58-4aa1-4ed3-b7a5-5da56c49ea81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc5d4c93-4008-404f-9355-98bd4e1a77dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d8644c58-4aa1-4ed3-b7a5-5da56c49ea81" xlink:to="loc_srt_RangeMember_cc5d4c93-4008-404f-9355-98bd4e1a77dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e0bfbc44-ebd0-446e-a853-fea884c89560" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cc5d4c93-4008-404f-9355-98bd4e1a77dc" xlink:to="loc_srt_MinimumMember_e0bfbc44-ebd0-446e-a853-fea884c89560" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4baf925e-b31a-4c54-b377-da0a3ba7be9d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cc5d4c93-4008-404f-9355-98bd4e1a77dc" xlink:to="loc_srt_MaximumMember_4baf925e-b31a-4c54-b377-da0a3ba7be9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_ff432ca2-71cd-460f-9ce4-354ca4805a37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_acf306b6-342b-4d5f-bdd3-71ae3941a5b9" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_ff432ca2-71cd-460f-9ce4-354ca4805a37" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_ff432ca2-71cd-460f-9ce4-354ca4805a37_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_ff432ca2-71cd-460f-9ce4-354ca4805a37" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_ff432ca2-71cd-460f-9ce4-354ca4805a37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_cadec691-f0b0-498d-b142-4f96bd1f9498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_ff432ca2-71cd-460f-9ce4-354ca4805a37" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_cadec691-f0b0-498d-b142-4f96bd1f9498" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PreTaxExitandDisposalCostsMember_3cc28403-174f-4a00-8e0a-e1521e974f82" xlink:href="mdt-20201030.xsd#mdt_PreTaxExitandDisposalCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_cadec691-f0b0-498d-b142-4f96bd1f9498" xlink:to="loc_mdt_PreTaxExitandDisposalCostsMember_3cc28403-174f-4a00-8e0a-e1521e974f82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1bc6e317-7d92-47ba-94fb-00525e0197df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_acf306b6-342b-4d5f-bdd3-71ae3941a5b9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1bc6e317-7d92-47ba-94fb-00525e0197df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1bc6e317-7d92-47ba-94fb-00525e0197df_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1bc6e317-7d92-47ba-94fb-00525e0197df" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1bc6e317-7d92-47ba-94fb-00525e0197df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_79e9a0a4-c641-40d2-ae04-45ad8b64cb27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1bc6e317-7d92-47ba-94fb-00525e0197df" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_79e9a0a4-c641-40d2-ae04-45ad8b64cb27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_a3febeab-18e4-4d37-be5c-7346bc937e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_79e9a0a4-c641-40d2-ae04-45ad8b64cb27" xlink:to="loc_us-gaap_CostOfSalesMember_a3febeab-18e4-4d37-be5c-7346bc937e88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1717d364-1892-4917-931c-291df59078de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_79e9a0a4-c641-40d2-ae04-45ad8b64cb27" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1717d364-1892-4917-931c-291df59078de" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RestructuringActivityRelatedtoRestructuringProgramsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails" xlink:type="extended" id="ia5e9ce2ea3f6448ba64b140bbe075694_RestructuringActivityRelatedtoRestructuringProgramsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_6fed0a12-9722-4d4f-a4b0-2f118ad836f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_aa6fbb53-36f6-4315-bfc9-afae62fd9ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_6fed0a12-9722-4d4f-a4b0-2f118ad836f8" xlink:to="loc_us-gaap_RestructuringReserveRollForward_aa6fbb53-36f6-4315-bfc9-afae62fd9ff8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_19a46648-5c99-46f9-bd2e-1ea74e18377d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_aa6fbb53-36f6-4315-bfc9-afae62fd9ff8" xlink:to="loc_us-gaap_RestructuringReserve_19a46648-5c99-46f9-bd2e-1ea74e18377d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_934dba78-abc6-464e-87aa-e991abf94156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_aa6fbb53-36f6-4315-bfc9-afae62fd9ff8" xlink:to="loc_us-gaap_RestructuringCharges_934dba78-abc6-464e-87aa-e991abf94156" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_09c217c2-fd15-428e-be95-7a775cc342fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_aa6fbb53-36f6-4315-bfc9-afae62fd9ff8" xlink:to="loc_us-gaap_PaymentsForRestructuring_09c217c2-fd15-428e-be95-7a775cc342fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_5d32bcd5-c845-48a0-84e8-902432fc856c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_aa6fbb53-36f6-4315-bfc9-afae62fd9ff8" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_5d32bcd5-c845-48a0-84e8-902432fc856c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_09d0b58b-593e-49f8-a406-0f22387069e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_59b1ba08-8982-4b9d-961d-2032a48d5043" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_6fed0a12-9722-4d4f-a4b0-2f118ad836f8" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_59b1ba08-8982-4b9d-961d-2032a48d5043" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_873b7a32-ee63-46b8-9b2f-4c824d10683d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_59b1ba08-8982-4b9d-961d-2032a48d5043" xlink:to="loc_us-gaap_RestructuringPlanAxis_873b7a32-ee63-46b8-9b2f-4c824d10683d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_873b7a32-ee63-46b8-9b2f-4c824d10683d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_873b7a32-ee63-46b8-9b2f-4c824d10683d" xlink:to="loc_us-gaap_RestructuringPlanDomain_873b7a32-ee63-46b8-9b2f-4c824d10683d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_aa0d3dda-9a26-4796-a34f-5dd08f9fac74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_873b7a32-ee63-46b8-9b2f-4c824d10683d" xlink:to="loc_us-gaap_RestructuringPlanDomain_aa0d3dda-9a26-4796-a34f-5dd08f9fac74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EnterpriseExcellenceMember_f93e6ad4-1582-4fd5-a9c7-352c6bf61b58" xlink:href="mdt-20201030.xsd#mdt_EnterpriseExcellenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_aa0d3dda-9a26-4796-a34f-5dd08f9fac74" xlink:to="loc_mdt_EnterpriseExcellenceMember_f93e6ad4-1582-4fd5-a9c7-352c6bf61b58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SimplificationRestructuringProgramMember_b8940cef-f3d4-4a5f-b29a-70bf06666cf5" xlink:href="mdt-20201030.xsd#mdt_SimplificationRestructuringProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_aa0d3dda-9a26-4796-a34f-5dd08f9fac74" xlink:to="loc_mdt_SimplificationRestructuringProgramMember_b8940cef-f3d4-4a5f-b29a-70bf06666cf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_36194f78-19eb-4a68-baa0-7a61e7c798de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_59b1ba08-8982-4b9d-961d-2032a48d5043" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_36194f78-19eb-4a68-baa0-7a61e7c798de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_36194f78-19eb-4a68-baa0-7a61e7c798de_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_36194f78-19eb-4a68-baa0-7a61e7c798de" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_36194f78-19eb-4a68-baa0-7a61e7c798de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_3ee20c53-4b79-4c7b-bfd5-9f013c8c96d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_36194f78-19eb-4a68-baa0-7a61e7c798de" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_3ee20c53-4b79-4c7b-bfd5-9f013c8c96d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_7f060b46-2dff-465b-a544-0ace8d91b87d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3ee20c53-4b79-4c7b-bfd5-9f013c8c96d3" xlink:to="loc_us-gaap_EmployeeSeveranceMember_7f060b46-2dff-465b-a544-0ace8d91b87d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AssociatedCostsMember_cec57776-e5d8-43ac-af36-429b8c47d276" xlink:href="mdt-20201030.xsd#mdt_AssociatedCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3ee20c53-4b79-4c7b-bfd5-9f013c8c96d3" xlink:to="loc_mdt_AssociatedCostsMember_cec57776-e5d8-43ac-af36-429b8c47d276" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_2dae4be2-7555-46dd-8116-53ba423b8d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3ee20c53-4b79-4c7b-bfd5-9f013c8c96d3" xlink:to="loc_us-gaap_OtherRestructuringMember_2dae4be2-7555-46dd-8116-53ba423b8d4e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstruments" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstruments"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancialInstruments" xlink:type="extended" id="ie205ba8b1db740dba9d3f4e65955210b_FinancialInstruments"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsTables"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsTables" xlink:type="extended" id="ie2c4a46b41e549d387c709927bcf8308_FinancialInstrumentsTables"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" xlink:type="extended" id="iaef7509414144e50b4d309c5f7f82fa0_FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_03f0e901-82f0-4596-a7e7-c9523a190d01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d88fc487-141e-41e8-ad74-dffb2a5a2406" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_03f0e901-82f0-4596-a7e7-c9523a190d01" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d88fc487-141e-41e8-ad74-dffb2a5a2406" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0e4eee78-6a1e-4059-aafd-b500e75285ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d88fc487-141e-41e8-ad74-dffb2a5a2406" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0e4eee78-6a1e-4059-aafd-b500e75285ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d5577c11-5f8e-482e-ade8-cae579093732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d88fc487-141e-41e8-ad74-dffb2a5a2406" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d5577c11-5f8e-482e-ade8-cae579093732" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_76fc35dc-2370-405e-8863-98071df894ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d88fc487-141e-41e8-ad74-dffb2a5a2406" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_76fc35dc-2370-405e-8863-98071df894ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5a6b034e-82d8-4ae0-a642-53301ad663e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d88fc487-141e-41e8-ad74-dffb2a5a2406" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5a6b034e-82d8-4ae0-a642-53301ad663e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_e7e5aa4e-897e-40ed-bf82-1245a305506f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesClassifiedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_03f0e901-82f0-4596-a7e7-c9523a190d01" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_e7e5aa4e-897e-40ed-bf82-1245a305506f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_bb619a96-ab62-4f9d-875b-f2ba0ca7b39b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_e7e5aa4e-897e-40ed-bf82-1245a305506f" xlink:to="loc_us-gaap_HeldToMaturitySecurities_bb619a96-ab62-4f9d-875b-f2ba0ca7b39b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_216f19d7-f165-4605-9b8d-5e52875eac3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_e7e5aa4e-897e-40ed-bf82-1245a305506f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_216f19d7-f165-4605-9b8d-5e52875eac3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_dd01b2f0-5241-425d-9f23-320cd5b82dbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_e7e5aa4e-897e-40ed-bf82-1245a305506f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_dd01b2f0-5241-425d-9f23-320cd5b82dbe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_f6db1143-981f-46af-a733-cb282631942e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_e7e5aa4e-897e-40ed-bf82-1245a305506f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_f6db1143-981f-46af-a733-cb282631942e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_688ace67-4286-42f9-8d20-cf204d11ba01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_03f0e901-82f0-4596-a7e7-c9523a190d01" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_688ace67-4286-42f9-8d20-cf204d11ba01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost_9788a231-1cc1-44c1-9c3f-877544414b4c" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_688ace67-4286-42f9-8d20-cf204d11ba01" xlink:to="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost_9788a231-1cc1-44c1-9c3f-877544414b4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax_7e7de100-697c-4f0d-8d75-360d4de9cf06" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_688ace67-4286-42f9-8d20-cf204d11ba01" xlink:to="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax_7e7de100-697c-4f0d-8d75-360d4de9cf06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax_42e8bcad-4476-4508-a378-2a8e26a79fb1" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_688ace67-4286-42f9-8d20-cf204d11ba01" xlink:to="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax_42e8bcad-4476-4508-a378-2a8e26a79fb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_25c87e1a-e989-4346-955d-73a648b5d31c" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_688ace67-4286-42f9-8d20-cf204d11ba01" xlink:to="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_25c87e1a-e989-4346-955d-73a648b5d31c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_1aa33d3d-9f36-4537-a809-c80fccfc99f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_03f0e901-82f0-4596-a7e7-c9523a190d01" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_1aa33d3d-9f36-4537-a809-c80fccfc99f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e9a411a7-c7cd-4faa-a315-a8f2027b0d66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1aa33d3d-9f36-4537-a809-c80fccfc99f7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e9a411a7-c7cd-4faa-a315-a8f2027b0d66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9a411a7-c7cd-4faa-a315-a8f2027b0d66_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e9a411a7-c7cd-4faa-a315-a8f2027b0d66" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9a411a7-c7cd-4faa-a315-a8f2027b0d66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e9a411a7-c7cd-4faa-a315-a8f2027b0d66" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_70c4f3a5-8378-4498-8b91-a0a9c0b81305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_70c4f3a5-8378-4498-8b91-a0a9c0b81305" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f52e2e27-d0fa-4a3e-8366-aa639119ed5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f52e2e27-d0fa-4a3e-8366-aa639119ed5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_6d397491-781a-4b6e-aa8c-b89759aa5c24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_6d397491-781a-4b6e-aa8c-b89759aa5c24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_849cb4a0-8df9-40c2-9569-9e02fe2b6334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_849cb4a0-8df9-40c2-9569-9e02fe2b6334" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_932f94fd-4149-458a-ace8-2d3c2b0cd673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_932f94fd-4149-458a-ace8-2d3c2b0cd673" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionRateSecuritiesMember_28ea6529-9e8c-4d05-869e-2bb83a3611a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionRateSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_AuctionRateSecuritiesMember_28ea6529-9e8c-4d05-869e-2bb83a3611a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_726050ea-29a1-4e7d-8ad8-fc5ac2ff67c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_BankTimeDepositsMember_726050ea-29a1-4e7d-8ad8-fc5ac2ff67c2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae3b260c-f6fc-4f36-b3ea-29525fb0fa78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1aa33d3d-9f36-4537-a809-c80fccfc99f7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae3b260c-f6fc-4f36-b3ea-29525fb0fa78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ae3b260c-f6fc-4f36-b3ea-29525fb0fa78_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae3b260c-f6fc-4f36-b3ea-29525fb0fa78" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ae3b260c-f6fc-4f36-b3ea-29525fb0fa78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56d16212-f9d1-4435-bbe2-4c2e73e7f17e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae3b260c-f6fc-4f36-b3ea-29525fb0fa78" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56d16212-f9d1-4435-bbe2-4c2e73e7f17e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f61c8271-1461-40c5-8603-0bcdd40a60b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56d16212-f9d1-4435-bbe2-4c2e73e7f17e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f61c8271-1461-40c5-8603-0bcdd40a60b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4139aaa4-1c99-489a-82b6-c2322cfbdc87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56d16212-f9d1-4435-bbe2-4c2e73e7f17e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4139aaa4-1c99-489a-82b6-c2322cfbdc87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4401c347-d4ae-498d-b14f-1d3f61a9a073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56d16212-f9d1-4435-bbe2-4c2e73e7f17e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4401c347-d4ae-498d-b14f-1d3f61a9a073" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3bfa8103-896f-4777-9f9f-e150e445018c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1aa33d3d-9f36-4537-a809-c80fccfc99f7" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3bfa8103-896f-4777-9f9f-e150e445018c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3bfa8103-896f-4777-9f9f-e150e445018c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3bfa8103-896f-4777-9f9f-e150e445018c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3bfa8103-896f-4777-9f9f-e150e445018c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b58b501f-ac16-4791-8fe5-de285e6cc6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3bfa8103-896f-4777-9f9f-e150e445018c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b58b501f-ac16-4791-8fe5-de285e6cc6ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_0f0fff41-c4d4-4603-916c-88abec66be58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b58b501f-ac16-4791-8fe5-de285e6cc6ac" xlink:to="loc_us-gaap_InvestmentsMember_0f0fff41-c4d4-4603-916c-88abec66be58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_3c3a6f07-5e99-4baa-b2d8-19e67b7873df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b58b501f-ac16-4791-8fe5-de285e6cc6ac" xlink:to="loc_us-gaap_OtherAssetsMember_3c3a6f07-5e99-4baa-b2d8-19e67b7873df" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails" xlink:type="extended" id="ifd3463eda0d940a2893e83a94878fb9d_FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_42e71a28-a762-43aa-9ffa-71cb88b9d999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_2b41c169-20f4-4dc1-a4ec-54fe0931d1dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_42e71a28-a762-43aa-9ffa-71cb88b9d999" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_2b41c169-20f4-4dc1-a4ec-54fe0931d1dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ff8572a3-40ac-4bc4-a7d1-0e0c1cd26e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_42e71a28-a762-43aa-9ffa-71cb88b9d999" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ff8572a3-40ac-4bc4-a7d1-0e0c1cd26e20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_3e7cc9e9-3a74-43c4-ad6f-a45ba49feeec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_42e71a28-a762-43aa-9ffa-71cb88b9d999" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_3e7cc9e9-3a74-43c4-ad6f-a45ba49feeec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_2aa3609b-3423-4d3d-b39e-6090f4275ef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_42e71a28-a762-43aa-9ffa-71cb88b9d999" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_2aa3609b-3423-4d3d-b39e-6090f4275ef2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2f2fd521-ffa5-47bb-9517-5d7b4f8a724d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_42e71a28-a762-43aa-9ffa-71cb88b9d999" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2f2fd521-ffa5-47bb-9517-5d7b4f8a724d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_528b0d8e-3764-4486-be47-f73d9fce1b3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2f2fd521-ffa5-47bb-9517-5d7b4f8a724d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_528b0d8e-3764-4486-be47-f73d9fce1b3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b0d8e-3764-4486-be47-f73d9fce1b3b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_528b0d8e-3764-4486-be47-f73d9fce1b3b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b0d8e-3764-4486-be47-f73d9fce1b3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_528b0d8e-3764-4486-be47-f73d9fce1b3b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_644efe35-b1d8-4627-86f2-1d1376c6004a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_644efe35-b1d8-4627-86f2-1d1376c6004a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_02303aa2-1c04-49e3-8b25-f5052b28f8c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_02303aa2-1c04-49e3-8b25-f5052b28f8c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_810dbcea-39bb-4d32-bc1d-875d300affdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_810dbcea-39bb-4d32-bc1d-875d300affdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_ef88a275-76cb-440b-9980-9edbd78d185d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_ef88a275-76cb-440b-9980-9edbd78d185d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionRateSecuritiesMember_6a28a7ef-ba59-4234-9154-bffec9283fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionRateSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:to="loc_us-gaap_AuctionRateSecuritiesMember_6a28a7ef-ba59-4234-9154-bffec9283fb2" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails" xlink:type="extended" id="i2e6a5744285e41f9a8e4a63f3b1adb74_FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended" id="i6d185076f3284ba3a18b864875e1628f_FinancialInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d09599c5-08c8-4abf-8239-c052f5c6f5be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_08649024-5440-4981-9c80-2b0ea8eef4aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d09599c5-08c8-4abf-8239-c052f5c6f5be" xlink:to="loc_us-gaap_GainLossOnInvestments_08649024-5440-4981-9c80-2b0ea8eef4aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_2d8424cd-bd4a-4b84-a06f-8503b2d4a1d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d09599c5-08c8-4abf-8239-c052f5c6f5be" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_2d8424cd-bd4a-4b84-a06f-8503b2d4a1d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments_412177c8-f625-41e4-baf4-ae47dfa6e8e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d09599c5-08c8-4abf-8239-c052f5c6f5be" xlink:to="loc_us-gaap_ImpairmentOfInvestments_412177c8-f625-41e4-baf4-ae47dfa6e8e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_e4a8b5f2-058f-4cc2-919a-742107b90254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d09599c5-08c8-4abf-8239-c052f5c6f5be" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_e4a8b5f2-058f-4cc2-919a-742107b90254" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9b46edbd-0e48-403e-ae73-619579e864d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_e4a8b5f2-058f-4cc2-919a-742107b90254" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9b46edbd-0e48-403e-ae73-619579e864d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b46edbd-0e48-403e-ae73-619579e864d9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9b46edbd-0e48-403e-ae73-619579e864d9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b46edbd-0e48-403e-ae73-619579e864d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccb0cb6e-7fc5-42bd-95a6-e36893f232b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9b46edbd-0e48-403e-ae73-619579e864d9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccb0cb6e-7fc5-42bd-95a6-e36893f232b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquityInvestmentsMember_246008e8-c69c-45a2-82dd-411ffed37143" xlink:href="mdt-20201030.xsd#mdt_EquityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccb0cb6e-7fc5-42bd-95a6-e36893f232b1" xlink:to="loc_mdt_EquityInvestmentsMember_246008e8-c69c-45a2-82dd-411ffed37143" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" xlink:type="extended" id="if825d1c326cc42a8ad8c9387d9265562_FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a6101b28-f1d1-46f8-baf5-a3d2e32e7ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_2aae2fd4-7ed1-42b2-8612-cbe90eeb5be9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a6101b28-f1d1-46f8-baf5-a3d2e32e7ca2" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_2aae2fd4-7ed1-42b2-8612-cbe90eeb5be9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_4a08b1b0-791f-45a0-ada1-86745d5719b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a6101b28-f1d1-46f8-baf5-a3d2e32e7ca2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_4a08b1b0-791f-45a0-ada1-86745d5719b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_7a983ada-a369-4089-835d-8506d98a8b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a6101b28-f1d1-46f8-baf5-a3d2e32e7ca2" xlink:to="loc_us-gaap_EquityMethodInvestments_7a983ada-a369-4089-835d-8506d98a8b5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_5e629bdd-5e9c-4d60-ae22-ea74ce5ac92a" xlink:href="mdt-20201030.xsd#mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a6101b28-f1d1-46f8-baf5-a3d2e32e7ca2" xlink:to="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_5e629bdd-5e9c-4d60-ae22-ea74ce5ac92a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1372e959-26d5-4343-b32a-ca53db343449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a6101b28-f1d1-46f8-baf5-a3d2e32e7ca2" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1372e959-26d5-4343-b32a-ca53db343449" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8e0f260b-9d90-48b9-940d-a978b9fab2a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1372e959-26d5-4343-b32a-ca53db343449" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8e0f260b-9d90-48b9-940d-a978b9fab2a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8e0f260b-9d90-48b9-940d-a978b9fab2a6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8e0f260b-9d90-48b9-940d-a978b9fab2a6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8e0f260b-9d90-48b9-940d-a978b9fab2a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7b9d83c5-092f-4d12-a1b9-776a54be4b21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8e0f260b-9d90-48b9-940d-a978b9fab2a6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7b9d83c5-092f-4d12-a1b9-776a54be4b21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_f523b85a-ba70-47b0-ab9e-24541facfce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7b9d83c5-092f-4d12-a1b9-776a54be4b21" xlink:to="loc_us-gaap_OtherAssetsMember_f523b85a-ba70-47b0-ab9e-24541facfce1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails" xlink:type="extended" id="i9234a6e6184a46ee9d5e452012d1deae_FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_e9ac7190-2589-4a4c-98b0-32f59d9e39e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_c22f8278-4b78-4b0d-8b81-9598fa3b1589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_e9ac7190-2589-4a4c-98b0-32f59d9e39e1" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_c22f8278-4b78-4b0d-8b81-9598fa3b1589" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_GainonInvestments_940436e3-2ca4-475a-84c9-b4aa804e59de" xlink:href="mdt-20201030.xsd#mdt_GainonInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_e9ac7190-2589-4a4c-98b0-32f59d9e39e1" xlink:to="loc_mdt_GainonInvestments_940436e3-2ca4-475a-84c9-b4aa804e59de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossonInvestments_259cb65f-3a66-4d03-a143-55eaeeb4dc28" xlink:href="mdt-20201030.xsd#mdt_LossonInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_e9ac7190-2589-4a4c-98b0-32f59d9e39e1" xlink:to="loc_mdt_LossonInvestments_259cb65f-3a66-4d03-a143-55eaeeb4dc28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments_929c2593-6805-49b9-923d-5236eec3855a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_e9ac7190-2589-4a4c-98b0-32f59d9e39e1" xlink:to="loc_us-gaap_ImpairmentOfInvestments_929c2593-6805-49b9-923d-5236eec3855a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_79dd6f5c-c158-4d29-bd51-4e870090fa32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_e9ac7190-2589-4a4c-98b0-32f59d9e39e1" xlink:to="loc_us-gaap_MarketableSecuritiesTable_79dd6f5c-c158-4d29-bd51-4e870090fa32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_17daab00-dfb7-4c87-b919-db5d82095c16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_79dd6f5c-c158-4d29-bd51-4e870090fa32" xlink:to="loc_us-gaap_FinancialInstrumentAxis_17daab00-dfb7-4c87-b919-db5d82095c16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_17daab00-dfb7-4c87-b919-db5d82095c16_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_17daab00-dfb7-4c87-b919-db5d82095c16" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_17daab00-dfb7-4c87-b919-db5d82095c16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_643ac768-7f4a-4d11-a5b7-ed22c6a7ee20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_17daab00-dfb7-4c87-b919-db5d82095c16" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_643ac768-7f4a-4d11-a5b7-ed22c6a7ee20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquityInvestmentsMember_4ce79515-4dea-431b-8fd8-4e8592445f26" xlink:href="mdt-20201030.xsd#mdt_EquityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_643ac768-7f4a-4d11-a5b7-ed22c6a7ee20" xlink:to="loc_mdt_EquityInvestmentsMember_4ce79515-4dea-431b-8fd8-4e8592445f26" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangements" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancingArrangements"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancingArrangements" xlink:type="extended" id="icf106e2d58ef44648b25c2e1601d666a_FinancingArrangements"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancingArrangementsTables"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsTables" xlink:type="extended" id="iaabae7529b5041efb8eb17046e37b622_FinancingArrangementsTables"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancingArrangementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails" xlink:type="extended" id="i6c59b7adfb0544d3996b1fb0daaac5e1_FinancingArrangementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:href="mdt-20201030.xsd#mdt_DebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract_1ea7e653-b70d-4f4b-bd45-f8be8a6c5912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:to="loc_us-gaap_ShortTermBorrowingsAbstract_1ea7e653-b70d-4f4b-bd45-f8be8a6c5912" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CommercialPaperMaximumBorrowingCapacity_ca65ddf2-4b5c-4dc0-a1ef-6b88a45b49e4" xlink:href="mdt-20201030.xsd#mdt_CommercialPaperMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_1ea7e653-b70d-4f4b-bd45-f8be8a6c5912" xlink:to="loc_mdt_CommercialPaperMaximumBorrowingCapacity_ca65ddf2-4b5c-4dc0-a1ef-6b88a45b49e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_7499da2b-0bbf-49d6-8f46-795881ad516c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_1ea7e653-b70d-4f4b-bd45-f8be8a6c5912" xlink:to="loc_us-gaap_CommercialPaper_7499da2b-0bbf-49d6-8f46-795881ad516c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAbstract_f1bf8282-c24a-4562-b76a-667f3526a66f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:to="loc_us-gaap_LineOfCreditFacilityAbstract_f1bf8282-c24a-4562-b76a-667f3526a66f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1ea68c49-e293-400c-8d22-6c99d2e88b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_f1bf8282-c24a-4562-b76a-667f3526a66f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1ea68c49-e293-400c-8d22-6c99d2e88b47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_98590311-f6bf-456d-8f6a-00ddd5f488da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_f1bf8282-c24a-4562-b76a-667f3526a66f" xlink:to="loc_us-gaap_DebtInstrumentTerm_98590311-f6bf-456d-8f6a-00ddd5f488da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_e37e6ae4-2c7b-4b0c-bc91-b606c0222942" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_f1bf8282-c24a-4562-b76a-667f3526a66f" xlink:to="loc_us-gaap_LineOfCredit_e37e6ae4-2c7b-4b0c-bc91-b606c0222942" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:to="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtInstrumentNumberofTranches_dfaa28b3-2784-42c0-bb9e-1b97dbe943e5" xlink:href="mdt-20201030.xsd#mdt_DebtInstrumentNumberofTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:to="loc_mdt_DebtInstrumentNumberofTranches_dfaa28b3-2784-42c0-bb9e-1b97dbe943e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_df7ce255-620f-4176-88cf-b9bfdc64027f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_df7ce255-620f-4176-88cf-b9bfdc64027f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e979e653-8ad2-4e31-8ee0-e499bbdced7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e979e653-8ad2-4e31-8ee0-e499bbdced7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_2999ebea-c342-4af6-b4f8-6dce157b1a02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_2999ebea-c342-4af6-b4f8-6dce157b1a02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_93b22d89-b4e7-4f64-bcdb-45a7e488c809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_93b22d89-b4e7-4f64-bcdb-45a7e488c809" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e9651e20-3cd7-4776-9293-30a13424f22c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e9651e20-3cd7-4776-9293-30a13424f22c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumtermNotesAbstract_116d4d1b-4015-46db-9124-b7c01350400c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MediumtermNotesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:to="loc_us-gaap_MediumtermNotesAbstract_116d4d1b-4015-46db-9124-b7c01350400c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtInstrumentExtensionOptionTermOfExtension_a1eba12c-4be8-4d5b-9d7b-7f704d5f97a4" xlink:href="mdt-20201030.xsd#mdt_DebtInstrumentExtensionOptionTermOfExtension"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MediumtermNotesAbstract_116d4d1b-4015-46db-9124-b7c01350400c" xlink:to="loc_mdt_DebtInstrumentExtensionOptionTermOfExtension_a1eba12c-4be8-4d5b-9d7b-7f704d5f97a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7e8ceb5e-0bba-4af8-a9b8-983d073c8f96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MediumtermNotesAbstract_116d4d1b-4015-46db-9124-b7c01350400c" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7e8ceb5e-0bba-4af8-a9b8-983d073c8f96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_02edd527-f81f-49c1-8e56-1c96e8f7bc7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:to="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_02edd527-f81f-49c1-8e56-1c96e8f7bc7e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_87cab6ba-f6c1-4788-96c3-cbf3d2a57ac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_02edd527-f81f-49c1-8e56-1c96e8f7bc7e" xlink:to="loc_us-gaap_LongTermDebtFairValue_87cab6ba-f6c1-4788-96c3-cbf3d2a57ac1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:href="mdt-20201030.xsd#mdt_ScheduleOfDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:to="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bf5879fa-c528-4e06-8380-31ff93ddc45d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_us-gaap_DebtInstrumentAxis_bf5879fa-c528-4e06-8380-31ff93ddc45d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bf5879fa-c528-4e06-8380-31ff93ddc45d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_bf5879fa-c528-4e06-8380-31ff93ddc45d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bf5879fa-c528-4e06-8380-31ff93ddc45d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_bf5879fa-c528-4e06-8380-31ff93ddc45d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A2015CommercialPaperProgramMember_84647386-e40c-4a7f-9319-df53e6057379" xlink:href="mdt-20201030.xsd#mdt_A2015CommercialPaperProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:to="loc_mdt_A2015CommercialPaperProgramMember_84647386-e40c-4a7f-9319-df53e6057379" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AmendedandRestatedRevolvingCreditAgreementMember_02667258-1ad9-4d11-913c-b8d0845c01fa" xlink:href="mdt-20201030.xsd#mdt_AmendedandRestatedRevolvingCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:to="loc_mdt_AmendedandRestatedRevolvingCreditAgreementMember_02667258-1ad9-4d11-913c-b8d0845c01fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Member_e6659e5d-a5a0-4504-bfae-e82d204f55b6" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:to="loc_mdt_SeniorNotes2019Member_e6659e5d-a5a0-4504-bfae-e82d204f55b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember_c8f24dfd-24e4-4e61-ab57-4caecba2471c" xlink:href="mdt-20201030.xsd#mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:to="loc_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember_c8f24dfd-24e4-4e61-ab57-4caecba2471c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicIncAndCIFSASeniorNotesMember_492e2679-bc21-4c64-96df-262ebe2a04ea" xlink:href="mdt-20201030.xsd#mdt_MedtronicIncAndCIFSASeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember_c8f24dfd-24e4-4e61-ab57-4caecba2471c" xlink:to="loc_mdt_MedtronicIncAndCIFSASeniorNotesMember_492e2679-bc21-4c64-96df-262ebe2a04ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicLuxcoSeniorNotesMember_7262f4ad-0197-4e53-9792-b7cb94af047f" xlink:href="mdt-20201030.xsd#mdt_MedtronicLuxcoSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember_c8f24dfd-24e4-4e61-ab57-4caecba2471c" xlink:to="loc_mdt_MedtronicLuxcoSeniorNotesMember_7262f4ad-0197-4e53-9792-b7cb94af047f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Member_2cd668e2-6c08-437f-8f9c-b4d03ebc53bb" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:to="loc_mdt_SeniorNotes2020Member_2cd668e2-6c08-437f-8f9c-b4d03ebc53bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_11985910-81eb-49be-a291-675664b2b6e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_11985910-81eb-49be-a291-675664b2b6e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_11985910-81eb-49be-a291-675664b2b6e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_11985910-81eb-49be-a291-675664b2b6e1" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_11985910-81eb-49be-a291-675664b2b6e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_8f272d68-1760-400d-8f3c-d9769c749fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_11985910-81eb-49be-a291-675664b2b6e1" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_8f272d68-1760-400d-8f3c-d9769c749fab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_1fd7a04f-44e9-4adc-a323-8a59991e7c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_8f272d68-1760-400d-8f3c-d9769c749fab" xlink:to="loc_us-gaap_CommercialPaperMember_1fd7a04f-44e9-4adc-a323-8a59991e7c55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7144222e-eee9-4a2f-8a2c-e818b5ddb017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_us-gaap_CreditFacilityAxis_7144222e-eee9-4a2f-8a2c-e818b5ddb017" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7144222e-eee9-4a2f-8a2c-e818b5ddb017_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_7144222e-eee9-4a2f-8a2c-e818b5ddb017" xlink:to="loc_us-gaap_CreditFacilityDomain_7144222e-eee9-4a2f-8a2c-e818b5ddb017_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_05f50f70-58ea-4baf-9f57-4711e7fac5d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_7144222e-eee9-4a2f-8a2c-e818b5ddb017" xlink:to="loc_us-gaap_CreditFacilityDomain_05f50f70-58ea-4baf-9f57-4711e7fac5d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_54d58ed0-a70c-439d-8cfa-a976280b440a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_05f50f70-58ea-4baf-9f57-4711e7fac5d5" xlink:to="loc_us-gaap_LineOfCreditMember_54d58ed0-a70c-439d-8cfa-a976280b440a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9caaa31e-bce0-4207-bc72-901ae18de9af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9caaa31e-bce0-4207-bc72-901ae18de9af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9caaa31e-bce0-4207-bc72-901ae18de9af_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9caaa31e-bce0-4207-bc72-901ae18de9af" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9caaa31e-bce0-4207-bc72-901ae18de9af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cb5b28e8-942b-4ffd-96eb-82ad7a5809c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9caaa31e-bce0-4207-bc72-901ae18de9af" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cb5b28e8-942b-4ffd-96eb-82ad7a5809c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9ba4894c-c8be-468f-b7d4-e8503bac2816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cb5b28e8-942b-4ffd-96eb-82ad7a5809c7" xlink:to="loc_us-gaap_SeniorNotesMember_9ba4894c-c8be-468f-b7d4-e8503bac2816" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_1cc14b8c-e642-4f38-a74b-57b4d258c7d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cb5b28e8-942b-4ffd-96eb-82ad7a5809c7" xlink:to="loc_us-gaap_MediumTermNotesMember_1cc14b8c-e642-4f38-a74b-57b4d258c7d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5ca689df-49b3-446c-bb53-2132dd695731" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_dei_LegalEntityAxis_5ca689df-49b3-446c-bb53-2132dd695731" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5ca689df-49b3-446c-bb53-2132dd695731_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_5ca689df-49b3-446c-bb53-2132dd695731" xlink:to="loc_dei_EntityDomain_5ca689df-49b3-446c-bb53-2132dd695731_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a38343c5-1f19-4739-b959-54029d9fdf37" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_5ca689df-49b3-446c-bb53-2132dd695731" xlink:to="loc_dei_EntityDomain_a38343c5-1f19-4739-b959-54029d9fdf37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicLuxcoMember_09e9fb3b-a1f7-4617-8241-8293e1987649" xlink:href="mdt-20201030.xsd#mdt_MedtronicLuxcoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a38343c5-1f19-4739-b959-54029d9fdf37" xlink:to="loc_mdt_MedtronicLuxcoMember_09e9fb3b-a1f7-4617-8241-8293e1987649" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_002818cc-0435-4408-af6d-1a11154d7c90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_us-gaap_VariableRateAxis_002818cc-0435-4408-af6d-1a11154d7c90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_002818cc-0435-4408-af6d-1a11154d7c90_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_002818cc-0435-4408-af6d-1a11154d7c90" xlink:to="loc_us-gaap_VariableRateDomain_002818cc-0435-4408-af6d-1a11154d7c90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_022fe7e9-d001-4a84-9ea0-4c15862c51b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_002818cc-0435-4408-af6d-1a11154d7c90" xlink:to="loc_us-gaap_VariableRateDomain_022fe7e9-d001-4a84-9ea0-4c15862c51b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TokyoInterBankOfferedRateTIBORMember_06f688f8-1d57-487f-a58f-3982067d9d6c" xlink:href="mdt-20201030.xsd#mdt_TokyoInterBankOfferedRateTIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_022fe7e9-d001-4a84-9ea0-4c15862c51b0" xlink:to="loc_mdt_TokyoInterBankOfferedRateTIBORMember_06f688f8-1d57-487f-a58f-3982067d9d6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_09c35213-d9fa-41c2-a5e1-9999960cb32d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_09c35213-d9fa-41c2-a5e1-9999960cb32d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_09c35213-d9fa-41c2-a5e1-9999960cb32d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_09c35213-d9fa-41c2-a5e1-9999960cb32d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_09c35213-d9fa-41c2-a5e1-9999960cb32d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fdb6ea98-c618-48cb-abad-a72d689400de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_09c35213-d9fa-41c2-a5e1-9999960cb32d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fdb6ea98-c618-48cb-abad-a72d689400de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_3b62692e-1b90-4f59-80c3-36b856db7fda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_fdb6ea98-c618-48cb-abad-a72d689400de" xlink:to="loc_us-gaap_SubsequentEventMember_3b62692e-1b90-4f59-80c3-36b856db7fda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a481bd94-5db0-4c7b-835c-a91b63e516d1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_srt_StatementScenarioAxis_a481bd94-5db0-4c7b-835c-a91b63e516d1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a481bd94-5db0-4c7b-835c-a91b63e516d1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a481bd94-5db0-4c7b-835c-a91b63e516d1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a481bd94-5db0-4c7b-835c-a91b63e516d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e2d5d43f-e961-4340-a296-7bbb0a77edcb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a481bd94-5db0-4c7b-835c-a91b63e516d1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e2d5d43f-e961-4340-a296-7bbb0a77edcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_54d024d1-afac-410e-ba0b-94e6bdf9b437" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_e2d5d43f-e961-4340-a296-7bbb0a77edcb" xlink:to="loc_srt_ScenarioForecastMember_54d024d1-afac-410e-ba0b-94e6bdf9b437" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancingArrangementsLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails" xlink:type="extended" id="ibba118c472f84a41a75e479a34f95ba4_FinancingArrangementsLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_62fb1046-3ce1-406f-b2a9-a3e8cf0e81dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f5afe377-4c60-4149-9ede-7704c5385bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_62fb1046-3ce1-406f-b2a9-a3e8cf0e81dd" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f5afe377-4c60-4149-9ede-7704c5385bca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_62fb1046-3ce1-406f-b2a9-a3e8cf0e81dd" xlink:to="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_60875070-fa34-4841-a054-beed3890f9aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_60875070-fa34-4841-a054-beed3890f9aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_39911a7e-cec7-4978-a2d0-aadce5c2d98d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_DebtInstrumentTerm_39911a7e-cec7-4978-a2d0-aadce5c2d98d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_bdc4112e-26de-43d8-bebe-78bfe3bea342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_bdc4112e-26de-43d8-bebe-78bfe3bea342" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ea98e563-0c46-475a-9fd4-7a0176b8f016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ea98e563-0c46-475a-9fd4-7a0176b8f016" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_c503984a-9dda-4420-84b5-d838f5a55123" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_c503984a-9dda-4420-84b5-d838f5a55123" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_268b2900-2063-42cc-956b-d114de736d77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_268b2900-2063-42cc-956b-d114de736d77" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c8d875bc-6381-4781-bd40-147c503aba30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c8d875bc-6381-4781-bd40-147c503aba30" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0c84d4c3-0d57-4149-bf4e-b91cddea2ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_62fb1046-3ce1-406f-b2a9-a3e8cf0e81dd" xlink:to="loc_us-gaap_DebtInstrumentTable_0c84d4c3-0d57-4149-bf4e-b91cddea2ff3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_076d93cf-2c27-488f-86a4-dc5e96568160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0c84d4c3-0d57-4149-bf4e-b91cddea2ff3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_076d93cf-2c27-488f-86a4-dc5e96568160" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_076d93cf-2c27-488f-86a4-dc5e96568160_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_076d93cf-2c27-488f-86a4-dc5e96568160" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_076d93cf-2c27-488f-86a4-dc5e96568160_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_957d3126-b779-4880-8592-2d44a44c9c5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_076d93cf-2c27-488f-86a4-dc5e96568160" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_957d3126-b779-4880-8592-2d44a44c9c5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_4addfba9-d7cd-47e3-9799-a13cfcc5d3db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_957d3126-b779-4880-8592-2d44a44c9c5e" xlink:to="loc_us-gaap_SeniorNotesMember_4addfba9-d7cd-47e3-9799-a13cfcc5d3db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_ccad95b6-ab25-4f7e-b459-a03e91a895b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_957d3126-b779-4880-8592-2d44a44c9c5e" xlink:to="loc_us-gaap_NotesPayableToBanksMember_ccad95b6-ab25-4f7e-b459-a03e91a895b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_45ecb64f-1fdd-468e-adc6-5a3c1e33be28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0c84d4c3-0d57-4149-bf4e-b91cddea2ff3" xlink:to="loc_us-gaap_DebtInstrumentAxis_45ecb64f-1fdd-468e-adc6-5a3c1e33be28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_45ecb64f-1fdd-468e-adc6-5a3c1e33be28_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_45ecb64f-1fdd-468e-adc6-5a3c1e33be28" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_45ecb64f-1fdd-468e-adc6-5a3c1e33be28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_45ecb64f-1fdd-468e-adc6-5a3c1e33be28" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due2022Member_a30f738d-6f98-4e79-9245-683d4329326f" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2015Due2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2015Due2022Member_a30f738d-6f98-4e79-9245-683d4329326f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2012Due2023Member_e7bc29e3-c6ff-41c3-a232-4f4ee331bceb" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2012Due2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2012Due2023Member_e7bc29e3-c6ff-41c3-a232-4f4ee331bceb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230.000PercentMember_1568cc7b-bd9d-4b50-b3de-c5fdad608e94" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20230.000PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due20230.000PercentMember_1568cc7b-bd9d-4b50-b3de-c5fdad608e94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230.375PercentMember_1ee59fed-0958-4561-b39a-30b627bae648" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20230.375PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due20230.375PercentMember_1ee59fed-0958-4561-b39a-30b627bae648" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2023Member_1bf7557b-4fa6-45a5-80ed-a3c6dcd29dbc" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2020Due2023Member_1bf7557b-4fa6-45a5-80ed-a3c6dcd29dbc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2013Due2023Member_d39aa091-20c3-4045-b414-8f9bcfe7832b" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2013Due2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2013Due2023Member_d39aa091-20c3-4045-b414-8f9bcfe7832b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2013Due2024Member_3e10cb3f-0d56-4121-9454-475a0be7907e" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2013Due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2013Due2024Member_3e10cb3f-0d56-4121-9454-475a0be7907e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2014Due2024Member_33be2b4b-f09e-4e32-b9d9-3085f8b07d2b" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2014Due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2014Due2024Member_33be2b4b-f09e-4e32-b9d9-3085f8b07d2b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due2025Member_ac46dadf-5214-4d15-a82f-369cf063cec2" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2015Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2015Due2025Member_ac46dadf-5214-4d15-a82f-369cf063cec2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2026Member_5d027f45-c02d-468d-979d-aa00671b1765" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due2026Member_5d027f45-c02d-468d-979d-aa00671b1765" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2026Member_d68403ab-5473-4f2e-900a-7aca992a3507" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2020Due2026Member_d68403ab-5473-4f2e-900a-7aca992a3507" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2027Member_36617aab-ee9e-441d-bffd-80cfc19cca82" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due2027Member_36617aab-ee9e-441d-bffd-80cfc19cca82" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2017Due2027Member_6db21952-ea57-433a-9bcc-0216f44bcf2f" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2017Due2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2017Due2027Member_6db21952-ea57-433a-9bcc-0216f44bcf2f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2029Member_241eec2e-90ec-4690-800e-5e1f77ef052c" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2020Due2029Member_241eec2e-90ec-4690-800e-5e1f77ef052c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.625PercentMember_cbfb939f-479a-4785-9239-060fef89073d" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20311.625PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due20311.625PercentMember_cbfb939f-479a-4785-9239-060fef89073d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2032Member_f3a6fa3a-9dd3-4299-b811-9b51ff196f14" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due2032Member_f3a6fa3a-9dd3-4299-b811-9b51ff196f14" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2033Member_d20c6be2-7017-429f-8a6b-1d1d74c6c88e" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2033Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2020Due2033Member_d20c6be2-7017-429f-8a6b-1d1d74c6c88e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due2035Member_709b11f1-010e-4d45-927a-a9d65ac0ee32" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2015Due2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2015Due2035Member_709b11f1-010e-4d45-927a-a9d65ac0ee32" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2007Due2038Member_bbcd4824-50ad-4090-99e6-d2ef1e0d95c3" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2007Due2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2007Due2038Member_bbcd4824-50ad-4090-99e6-d2ef1e0d95c3" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20392.250PercentMember_d1507be3-3a92-4f28-891e-5911364c557f" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20392.250PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due20392.250PercentMember_d1507be3-3a92-4f28-891e-5911364c557f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2009Due2039Member_9035bb23-eb86-4415-b820-4bd9918ed655" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2009Due2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2009Due2039Member_9035bb23-eb86-4415-b820-4bd9918ed655" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2040Member_2305deb9-e28f-4b81-9416-ed106ca0f830" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due2040Member_2305deb9-e28f-4b81-9416-ed106ca0f830" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2010Due2040Member_2b735e63-171a-4b9b-91e0-28ed721434c2" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2010Due2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2010Due2040Member_2b735e63-171a-4b9b-91e0-28ed721434c2" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2041Member_89f02fd7-0752-4201-952e-92c33a7c4901" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2020Due2041Member_89f02fd7-0752-4201-952e-92c33a7c4901" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2012Due2042Member_2130f96b-74c5-4025-b410-bdaac48d885d" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2012Due2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2012Due2042Member_2130f96b-74c5-4025-b410-bdaac48d885d" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2013Due2043Member_492e72b2-85aa-4a3a-bd1c-ca1b208d0c32" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2013Due2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2013Due2043Member_492e72b2-85aa-4a3a-bd1c-ca1b208d0c32" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2014Due2044Member_b210f258-73e5-4d43-b507-05d43291137f" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2014Due2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2014Due2044Member_b210f258-73e5-4d43-b507-05d43291137f" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due2045Member_bbc29882-f873-4d10-b35e-24f84829e84a" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2015Due2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2015Due2045Member_bbc29882-f873-4d10-b35e-24f84829e84a" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2050Member_419f89c2-14e8-47d5-a117-bd6f096ef97d" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due2050Member_419f89c2-14e8-47d5-a117-bd6f096ef97d" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2051Member_17c5073a-5bff-4993-92c1-c46e48c07bff" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2051Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2020Due2051Member_17c5073a-5bff-4993-92c1-c46e48c07bff" xlink:type="arc" order="29"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagement"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement" xlink:type="extended" id="ib887de36112a4429b8a1df033078be2d_DerivativesandCurrencyExchangeRiskManagement"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementTables"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables" xlink:type="extended" id="icb66dd4e7d5d4883b44646af5766bb83_DerivativesandCurrencyExchangeRiskManagementTables"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails" xlink:type="extended" id="ibe7420f6ca024f58828b1196fd3e01eb_DerivativesandCurrencyExchangeRiskManagementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9c9d5819-7f7b-4290-9392-6513846c184d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9c9d5819-7f7b-4290-9392-6513846c184d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_e300bb26-a486-44ba-b8dc-75e1b6f42ecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_e300bb26-a486-44ba-b8dc-75e1b6f42ecc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_32db97a8-aa2e-425b-9e36-23577110aaef" xlink:href="mdt-20201030.xsd#mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_32db97a8-aa2e-425b-9e36-23577110aaef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_6d96a8dc-269a-4a58-b9ee-e87f3f4a3e55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_6d96a8dc-269a-4a58-b9ee-e87f3f4a3e55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax_6d4ab9d0-c3e5-423e-a1f5-57d71443b6d8" xlink:href="mdt-20201030.xsd#mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax_6d4ab9d0-c3e5-423e-a1f5-57d71443b6d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths_79f9ef0b-78c0-4fc1-a467-f8a2ee1f1a18" xlink:href="mdt-20201030.xsd#mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths_79f9ef0b-78c0-4fc1-a467-f8a2ee1f1a18" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet_fadb7989-0cb6-47b9-b0b3-f7cf767d8f03" xlink:href="mdt-20201030.xsd#mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet_fadb7989-0cb6-47b9-b0b3-f7cf767d8f03" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c7c4a23-13d5-4c3e-af78-a41f27448ceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c7c4a23-13d5-4c3e-af78-a41f27448ceb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a227ae3f-1964-4ece-9cdf-5da354b8d9fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c7c4a23-13d5-4c3e-af78-a41f27448ceb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a227ae3f-1964-4ece-9cdf-5da354b8d9fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a227ae3f-1964-4ece-9cdf-5da354b8d9fe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a227ae3f-1964-4ece-9cdf-5da354b8d9fe" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a227ae3f-1964-4ece-9cdf-5da354b8d9fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_17119968-fecd-4068-90b0-6d0e33c4e67f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a227ae3f-1964-4ece-9cdf-5da354b8d9fe" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_17119968-fecd-4068-90b0-6d0e33c4e67f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1052bf69-491e-433c-b2eb-cc853080487d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_17119968-fecd-4068-90b0-6d0e33c4e67f" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1052bf69-491e-433c-b2eb-cc853080487d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_72d4c27d-844a-4d40-addd-b245d864338b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_17119968-fecd-4068-90b0-6d0e33c4e67f" xlink:to="loc_us-gaap_TotalReturnSwapMember_72d4c27d-844a-4d40-addd-b245d864338b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b67d3895-c51e-4076-9fe6-f9d7ecebc699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c7c4a23-13d5-4c3e-af78-a41f27448ceb" xlink:to="loc_us-gaap_HedgingDesignationAxis_b67d3895-c51e-4076-9fe6-f9d7ecebc699" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b67d3895-c51e-4076-9fe6-f9d7ecebc699_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b67d3895-c51e-4076-9fe6-f9d7ecebc699" xlink:to="loc_us-gaap_HedgingDesignationDomain_b67d3895-c51e-4076-9fe6-f9d7ecebc699_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_28725ee0-9b08-4634-9e26-e8770b595ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b67d3895-c51e-4076-9fe6-f9d7ecebc699" xlink:to="loc_us-gaap_HedgingDesignationDomain_28725ee0-9b08-4634-9e26-e8770b595ec8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_394a3954-ac90-473c-8a6f-874e377b11d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_28725ee0-9b08-4634-9e26-e8770b595ec8" xlink:to="loc_us-gaap_NondesignatedMember_394a3954-ac90-473c-8a6f-874e377b11d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d177ff49-a7f4-4534-9b64-1be629937f81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_28725ee0-9b08-4634-9e26-e8770b595ec8" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d177ff49-a7f4-4534-9b64-1be629937f81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93027a92-d3d6-4964-835a-e158669ee42e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c7c4a23-13d5-4c3e-af78-a41f27448ceb" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93027a92-d3d6-4964-835a-e158669ee42e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_93027a92-d3d6-4964-835a-e158669ee42e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93027a92-d3d6-4964-835a-e158669ee42e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_93027a92-d3d6-4964-835a-e158669ee42e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d11d2d35-c2c6-4c1c-bae7-6895bdb9d225" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93027a92-d3d6-4964-835a-e158669ee42e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d11d2d35-c2c6-4c1c-bae7-6895bdb9d225" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_4189ac6a-a020-454e-8e07-409128746773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d11d2d35-c2c6-4c1c-bae7-6895bdb9d225" xlink:to="loc_us-gaap_CashFlowHedgingMember_4189ac6a-a020-454e-8e07-409128746773" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_ce379f73-f849-45e3-8374-a30801093f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d11d2d35-c2c6-4c1c-bae7-6895bdb9d225" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_ce379f73-f849-45e3-8374-a30801093f3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_32a6e8ee-7c05-471a-83cd-3cf8d962a5e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c7c4a23-13d5-4c3e-af78-a41f27448ceb" xlink:to="loc_srt_CurrencyAxis_32a6e8ee-7c05-471a-83cd-3cf8d962a5e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_32a6e8ee-7c05-471a-83cd-3cf8d962a5e1_default" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_32a6e8ee-7c05-471a-83cd-3cf8d962a5e1" xlink:to="loc_currency_AllCurrenciesDomain_32a6e8ee-7c05-471a-83cd-3cf8d962a5e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_5bdbfe28-cedb-4aeb-b50c-f897b79a9925" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_32a6e8ee-7c05-471a-83cd-3cf8d962a5e1" xlink:to="loc_currency_AllCurrenciesDomain_5bdbfe28-cedb-4aeb-b50c-f897b79a9925" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_70231d6c-d96d-4888-af83-0164018ea446" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_5bdbfe28-cedb-4aeb-b50c-f897b79a9925" xlink:to="loc_currency_EUR_70231d6c-d96d-4888-af83-0164018ea446" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_5b73706c-6b3d-4975-841b-7b9aaf3bab02" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_5bdbfe28-cedb-4aeb-b50c-f897b79a9925" xlink:to="loc_currency_JPY_5b73706c-6b3d-4975-841b-7b9aaf3bab02" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="ib89a3d7d35ea42b9a02918af2dfd6203_DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9926afe4-4731-426e-be01-249f297d5faf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_33111265-8a9e-4e99-abeb-be8f1aaf6e85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9926afe4-4731-426e-be01-249f297d5faf" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_33111265-8a9e-4e99-abeb-be8f1aaf6e85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d41a529-57db-434c-86ce-a0184009adb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9926afe4-4731-426e-be01-249f297d5faf" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d41a529-57db-434c-86ce-a0184009adb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_12099c5a-0bb0-4229-a894-7805d98b7775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d41a529-57db-434c-86ce-a0184009adb2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_12099c5a-0bb0-4229-a894-7805d98b7775" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_12099c5a-0bb0-4229-a894-7805d98b7775_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_12099c5a-0bb0-4229-a894-7805d98b7775" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_12099c5a-0bb0-4229-a894-7805d98b7775_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ba618580-870d-42b4-b744-7c82d6293124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_12099c5a-0bb0-4229-a894-7805d98b7775" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ba618580-870d-42b4-b744-7c82d6293124" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_3f91d94b-2f3a-4e42-a135-85dcb4d5dc52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ba618580-870d-42b4-b744-7c82d6293124" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_3f91d94b-2f3a-4e42-a135-85dcb4d5dc52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1c292708-802a-4b62-8cdc-e4b91793064c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d41a529-57db-434c-86ce-a0184009adb2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1c292708-802a-4b62-8cdc-e4b91793064c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1c292708-802a-4b62-8cdc-e4b91793064c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1c292708-802a-4b62-8cdc-e4b91793064c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1c292708-802a-4b62-8cdc-e4b91793064c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7325e1c8-cf41-4ac0-b882-81f378363a14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1c292708-802a-4b62-8cdc-e4b91793064c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7325e1c8-cf41-4ac0-b882-81f378363a14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6625de61-f4b9-4374-af13-19b509b4c704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7325e1c8-cf41-4ac0-b882-81f378363a14" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6625de61-f4b9-4374-af13-19b509b4c704" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_a6e40512-3362-406d-a391-610d50e94c92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7325e1c8-cf41-4ac0-b882-81f378363a14" xlink:to="loc_us-gaap_TotalReturnSwapMember_a6e40512-3362-406d-a391-610d50e94c92" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails" xlink:type="extended" id="ib4c049dc60e4492d8ddc9817af352fbf_DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_309a3ba0-3248-4ced-839d-5dd39e7db0b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f0f84236-eafb-4521-b561-b0bd7caf4e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_309a3ba0-3248-4ced-839d-5dd39e7db0b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f0f84236-eafb-4521-b561-b0bd7caf4e20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_01e83c32-c977-42cd-8237-c9c7b0ffd6ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_309a3ba0-3248-4ced-839d-5dd39e7db0b5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_01e83c32-c977-42cd-8237-c9c7b0ffd6ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae296ef-70df-45b0-8b0b-f073d63c6c12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_01e83c32-c977-42cd-8237-c9c7b0ffd6ff" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae296ef-70df-45b0-8b0b-f073d63c6c12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9ae296ef-70df-45b0-8b0b-f073d63c6c12_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae296ef-70df-45b0-8b0b-f073d63c6c12" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9ae296ef-70df-45b0-8b0b-f073d63c6c12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_55f10e9a-01cb-4e0f-8dee-f3e2aadbae2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae296ef-70df-45b0-8b0b-f073d63c6c12" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_55f10e9a-01cb-4e0f-8dee-f3e2aadbae2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_487a3b07-85b7-48fb-8d29-dff07190e827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_55f10e9a-01cb-4e0f-8dee-f3e2aadbae2c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_487a3b07-85b7-48fb-8d29-dff07190e827" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_98f2348b-ee61-421c-971f-a98fdb9c6891" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_01e83c32-c977-42cd-8237-c9c7b0ffd6ff" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_98f2348b-ee61-421c-971f-a98fdb9c6891" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_98f2348b-ee61-421c-971f-a98fdb9c6891_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_98f2348b-ee61-421c-971f-a98fdb9c6891" xlink:to="loc_us-gaap_HedgingRelationshipDomain_98f2348b-ee61-421c-971f-a98fdb9c6891_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b0ccc4f2-15d4-4b62-a7de-f8f69b6e6328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_98f2348b-ee61-421c-971f-a98fdb9c6891" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b0ccc4f2-15d4-4b62-a7de-f8f69b6e6328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_d41cd8df-1c7a-43ce-b28d-a1cb9069609c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b0ccc4f2-15d4-4b62-a7de-f8f69b6e6328" xlink:to="loc_us-gaap_CashFlowHedgingMember_d41cd8df-1c7a-43ce-b28d-a1cb9069609c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails" xlink:type="extended" id="i4fbd64b02e3b4719a47d3777a8e4d27f_DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_d49f85b8-8711-470b-b74a-509cd52445e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_fed3a008-6342-46c2-bb27-2cde29148764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_d49f85b8-8711-470b-b74a-509cd52445e7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_fed3a008-6342-46c2-bb27-2cde29148764" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c2406627-02bd-41a3-8509-3e3fd57d7f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_d49f85b8-8711-470b-b74a-509cd52445e7" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c2406627-02bd-41a3-8509-3e3fd57d7f3c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_db7ad310-faa3-4703-bd97-5b81ae2c3969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c2406627-02bd-41a3-8509-3e3fd57d7f3c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_db7ad310-faa3-4703-bd97-5b81ae2c3969" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_db7ad310-faa3-4703-bd97-5b81ae2c3969_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_db7ad310-faa3-4703-bd97-5b81ae2c3969" xlink:to="loc_us-gaap_HedgingRelationshipDomain_db7ad310-faa3-4703-bd97-5b81ae2c3969_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_de364d46-6349-4724-92ad-d89b52132eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_db7ad310-faa3-4703-bd97-5b81ae2c3969" xlink:to="loc_us-gaap_HedgingRelationshipDomain_de364d46-6349-4724-92ad-d89b52132eb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_b0496733-8665-4435-bb16-52155d1f9c51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_de364d46-6349-4724-92ad-d89b52132eb9" xlink:to="loc_us-gaap_CashFlowHedgingMember_b0496733-8665-4435-bb16-52155d1f9c51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_499705ae-12e5-4d45-89b5-cc0b0d4fab83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c2406627-02bd-41a3-8509-3e3fd57d7f3c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_499705ae-12e5-4d45-89b5-cc0b0d4fab83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_499705ae-12e5-4d45-89b5-cc0b0d4fab83_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_499705ae-12e5-4d45-89b5-cc0b0d4fab83" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_499705ae-12e5-4d45-89b5-cc0b0d4fab83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3cd66446-f7f0-47c2-9cae-b12fd6067aaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_499705ae-12e5-4d45-89b5-cc0b0d4fab83" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3cd66446-f7f0-47c2-9cae-b12fd6067aaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_915700f4-5140-4d1e-b63f-7d320331d686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3cd66446-f7f0-47c2-9cae-b12fd6067aaa" xlink:to="loc_us-gaap_ForeignExchangeContractMember_915700f4-5140-4d1e-b63f-7d320331d686" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c9107ba8-7274-4cc8-a4f5-05e5bba57a33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c2406627-02bd-41a3-8509-3e3fd57d7f3c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c9107ba8-7274-4cc8-a4f5-05e5bba57a33" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c9107ba8-7274-4cc8-a4f5-05e5bba57a33_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c9107ba8-7274-4cc8-a4f5-05e5bba57a33" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c9107ba8-7274-4cc8-a4f5-05e5bba57a33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8893a66c-cd5e-489b-a190-8387d671dc7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c9107ba8-7274-4cc8-a4f5-05e5bba57a33" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8893a66c-cd5e-489b-a190-8387d671dc7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_1790aaaf-e8ba-4a19-84a3-5df056fe2809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8893a66c-cd5e-489b-a190-8387d671dc7d" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_1790aaaf-e8ba-4a19-84a3-5df056fe2809" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails" xlink:type="extended" id="ibb102ca4bc674f95a3b38c33a57fed33_DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_62728532-5842-465e-8cca-d74564a20e40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_73b6d4e4-0d8b-4d1b-a444-c8f8476575a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_62728532-5842-465e-8cca-d74564a20e40" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_73b6d4e4-0d8b-4d1b-a444-c8f8476575a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6482b385-783e-4851-9460-89f1e4c5dfb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_62728532-5842-465e-8cca-d74564a20e40" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6482b385-783e-4851-9460-89f1e4c5dfb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_dae0929a-7b1c-4b29-b865-762ef3f744b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6482b385-783e-4851-9460-89f1e4c5dfb2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_dae0929a-7b1c-4b29-b865-762ef3f744b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dae0929a-7b1c-4b29-b865-762ef3f744b5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_dae0929a-7b1c-4b29-b865-762ef3f744b5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dae0929a-7b1c-4b29-b865-762ef3f744b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0cb73755-c21d-44da-a099-7fbbd5bb5496" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_dae0929a-7b1c-4b29-b865-762ef3f744b5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0cb73755-c21d-44da-a099-7fbbd5bb5496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_4c00261a-b93a-4102-8943-340f83af95fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0cb73755-c21d-44da-a099-7fbbd5bb5496" xlink:to="loc_us-gaap_ForeignExchangeContractMember_4c00261a-b93a-4102-8943-340f83af95fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f4f8a513-33ac-4052-8310-6f467ed3c867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6482b385-783e-4851-9460-89f1e4c5dfb2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f4f8a513-33ac-4052-8310-6f467ed3c867" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f4f8a513-33ac-4052-8310-6f467ed3c867_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f4f8a513-33ac-4052-8310-6f467ed3c867" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f4f8a513-33ac-4052-8310-6f467ed3c867_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9a23e4b7-68f7-4628-b061-995aaa78c2f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f4f8a513-33ac-4052-8310-6f467ed3c867" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9a23e4b7-68f7-4628-b061-995aaa78c2f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_6d13ec78-447e-4df8-aef4-1bf29c4cc2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9a23e4b7-68f7-4628-b061-995aaa78c2f2" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_6d13ec78-447e-4df8-aef4-1bf29c4cc2bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78f0b528-4d54-4b36-b164-270429995597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6482b385-783e-4851-9460-89f1e4c5dfb2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78f0b528-4d54-4b36-b164-270429995597" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_78f0b528-4d54-4b36-b164-270429995597_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78f0b528-4d54-4b36-b164-270429995597" xlink:to="loc_us-gaap_HedgingRelationshipDomain_78f0b528-4d54-4b36-b164-270429995597_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d41ce403-4ea3-4ec0-a58b-736d515f4979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78f0b528-4d54-4b36-b164-270429995597" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d41ce403-4ea3-4ec0-a58b-736d515f4979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_4a193d15-5d9d-48c3-b4c0-2eaef095a9b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d41ce403-4ea3-4ec0-a58b-736d515f4979" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_4a193d15-5d9d-48c3-b4c0-2eaef095a9b3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails" xlink:type="extended" id="ibd5ee3ae5c4442e6be389d5e63a576e2_DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3dd03999-0929-49c6-a65b-efe10d7a1634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_41416dfb-58a0-4da4-acfc-3849a4a2e923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3dd03999-0929-49c6-a65b-efe10d7a1634" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_41416dfb-58a0-4da4-acfc-3849a4a2e923" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fff6152b-c350-4782-9684-68dc8c2f847b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3dd03999-0929-49c6-a65b-efe10d7a1634" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fff6152b-c350-4782-9684-68dc8c2f847b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_15623d98-39a3-4205-975f-a4a96872c8a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fff6152b-c350-4782-9684-68dc8c2f847b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_15623d98-39a3-4205-975f-a4a96872c8a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_15623d98-39a3-4205-975f-a4a96872c8a1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_15623d98-39a3-4205-975f-a4a96872c8a1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_15623d98-39a3-4205-975f-a4a96872c8a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_178cb79e-0565-4571-bff9-c1635466483c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_15623d98-39a3-4205-975f-a4a96872c8a1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_178cb79e-0565-4571-bff9-c1635466483c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1c4f1e71-9d1e-43bf-92e6-72821e4c17bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_178cb79e-0565-4571-bff9-c1635466483c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1c4f1e71-9d1e-43bf-92e6-72821e4c17bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_354a73ce-4956-4719-8a21-c312ed0696fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fff6152b-c350-4782-9684-68dc8c2f847b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_354a73ce-4956-4719-8a21-c312ed0696fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_354a73ce-4956-4719-8a21-c312ed0696fc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_354a73ce-4956-4719-8a21-c312ed0696fc" xlink:to="loc_us-gaap_HedgingRelationshipDomain_354a73ce-4956-4719-8a21-c312ed0696fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f31dc6c2-ef3c-4916-9f5f-6b72a361561d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_354a73ce-4956-4719-8a21-c312ed0696fc" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f31dc6c2-ef3c-4916-9f5f-6b72a361561d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_89bae440-741b-4982-b9c0-ff812e2703af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f31dc6c2-ef3c-4916-9f5f-6b72a361561d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_89bae440-741b-4982-b9c0-ff812e2703af" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails" xlink:type="extended" id="icf0d8a0e53ea425d977efd4b7f5b24d0_DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_e464d002-ec37-4f17-a33e-cdfd078608d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_85bb71fa-7e47-44ed-8caf-cc3fc996bb88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e464d002-ec37-4f17-a33e-cdfd078608d2" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_85bb71fa-7e47-44ed-8caf-cc3fc996bb88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ff5d3168-124c-48e8-b8dd-66169b5bb482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e464d002-ec37-4f17-a33e-cdfd078608d2" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ff5d3168-124c-48e8-b8dd-66169b5bb482" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_605b9f64-9b7a-45fc-8d27-8cf6d7d99916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e464d002-ec37-4f17-a33e-cdfd078608d2" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_605b9f64-9b7a-45fc-8d27-8cf6d7d99916" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_46db55ff-5c43-42fd-82f8-afa22119540e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_605b9f64-9b7a-45fc-8d27-8cf6d7d99916" xlink:to="loc_us-gaap_HedgingDesignationAxis_46db55ff-5c43-42fd-82f8-afa22119540e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_46db55ff-5c43-42fd-82f8-afa22119540e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_46db55ff-5c43-42fd-82f8-afa22119540e" xlink:to="loc_us-gaap_HedgingDesignationDomain_46db55ff-5c43-42fd-82f8-afa22119540e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ae1f96ab-45a4-426a-aec3-e9ec470df095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_46db55ff-5c43-42fd-82f8-afa22119540e" xlink:to="loc_us-gaap_HedgingDesignationDomain_ae1f96ab-45a4-426a-aec3-e9ec470df095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e6602bc7-520c-4160-9cb2-7c54afd91c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ae1f96ab-45a4-426a-aec3-e9ec470df095" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e6602bc7-520c-4160-9cb2-7c54afd91c29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_79bdb45f-21bc-4a2e-8912-f416b13cb4aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ae1f96ab-45a4-426a-aec3-e9ec470df095" xlink:to="loc_us-gaap_NondesignatedMember_79bdb45f-21bc-4a2e-8912-f416b13cb4aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_21ff42ce-faa1-4c07-adf6-fe5ef1f3b907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_605b9f64-9b7a-45fc-8d27-8cf6d7d99916" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_21ff42ce-faa1-4c07-adf6-fe5ef1f3b907" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_21ff42ce-faa1-4c07-adf6-fe5ef1f3b907_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_21ff42ce-faa1-4c07-adf6-fe5ef1f3b907" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_21ff42ce-faa1-4c07-adf6-fe5ef1f3b907_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_559f7fe2-1b15-4c09-b2cc-a09334ddafb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_21ff42ce-faa1-4c07-adf6-fe5ef1f3b907" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_559f7fe2-1b15-4c09-b2cc-a09334ddafb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_359d1b2e-d4d7-44fb-b3aa-c5c4c710d254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_559f7fe2-1b15-4c09-b2cc-a09334ddafb5" xlink:to="loc_us-gaap_ForeignExchangeContractMember_359d1b2e-d4d7-44fb-b3aa-c5c4c710d254" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_985eb15d-0776-41eb-b9dd-8e412eed45d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_559f7fe2-1b15-4c09-b2cc-a09334ddafb5" xlink:to="loc_us-gaap_TotalReturnSwapMember_985eb15d-0776-41eb-b9dd-8e412eed45d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_e9fd4029-fc22-470a-aa92-556f641f911a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_559f7fe2-1b15-4c09-b2cc-a09334ddafb5" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_e9fd4029-fc22-470a-aa92-556f641f911a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0f9c3021-3819-40dc-a15d-5b706b9662db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_605b9f64-9b7a-45fc-8d27-8cf6d7d99916" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0f9c3021-3819-40dc-a15d-5b706b9662db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0f9c3021-3819-40dc-a15d-5b706b9662db_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0f9c3021-3819-40dc-a15d-5b706b9662db" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0f9c3021-3819-40dc-a15d-5b706b9662db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_dc5fae4e-2896-4d29-a3f3-34bbc973ce9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0f9c3021-3819-40dc-a15d-5b706b9662db" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_dc5fae4e-2896-4d29-a3f3-34bbc973ce9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_e973bd4f-6cc6-4811-a111-79c715eb2026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dc5fae4e-2896-4d29-a3f3-34bbc973ce9c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_e973bd4f-6cc6-4811-a111-79c715eb2026" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_73225480-be1c-4f57-b71f-a1a92ff7734c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dc5fae4e-2896-4d29-a3f3-34bbc973ce9c" xlink:to="loc_us-gaap_OtherAssetsMember_73225480-be1c-4f57-b71f-a1a92ff7734c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember_7cc8c2e1-c930-4016-b222-5c63e8ad34ba" xlink:href="mdt-20201030.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dc5fae4e-2896-4d29-a3f3-34bbc973ce9c" xlink:to="loc_mdt_OtherAccruedExpensesMember_7cc8c2e1-c930-4016-b222-5c63e8ad34ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_559d4f21-b642-488b-8714-ecd14d8b88a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dc5fae4e-2896-4d29-a3f3-34bbc973ce9c" xlink:to="loc_us-gaap_OtherLiabilitiesMember_559d4f21-b642-488b-8714-ecd14d8b88a4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended" id="i619d79adbf69480a8abbee9ec19a0f29_DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6390288b-6124-4590-86a9-8195cf7d5987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_aeb4b509-a00f-4605-9c1f-9b5d44c0d4bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6390288b-6124-4590-86a9-8195cf7d5987" xlink:to="loc_us-gaap_DerivativeAssets_aeb4b509-a00f-4605-9c1f-9b5d44c0d4bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_1fa51291-54f0-4dc2-b9a7-79da1ddcd134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6390288b-6124-4590-86a9-8195cf7d5987" xlink:to="loc_us-gaap_DerivativeLiabilities_1fa51291-54f0-4dc2-b9a7-79da1ddcd134" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2c96c8f2-e191-47ae-b268-7a05f0014122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6390288b-6124-4590-86a9-8195cf7d5987" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2c96c8f2-e191-47ae-b268-7a05f0014122" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e590ff0e-0e11-44c4-afa1-97109021e990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2c96c8f2-e191-47ae-b268-7a05f0014122" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e590ff0e-0e11-44c4-afa1-97109021e990" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e590ff0e-0e11-44c4-afa1-97109021e990_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e590ff0e-0e11-44c4-afa1-97109021e990" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e590ff0e-0e11-44c4-afa1-97109021e990_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7d641c4c-9451-409b-8bd5-5901bb8586cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e590ff0e-0e11-44c4-afa1-97109021e990" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7d641c4c-9451-409b-8bd5-5901bb8586cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_c16fd053-cb7f-41af-9cea-2e0f4f97c352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7d641c4c-9451-409b-8bd5-5901bb8586cc" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_c16fd053-cb7f-41af-9cea-2e0f4f97c352" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b40a6dfe-98c3-4649-a6d5-eed5252537bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2c96c8f2-e191-47ae-b268-7a05f0014122" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b40a6dfe-98c3-4649-a6d5-eed5252537bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b40a6dfe-98c3-4649-a6d5-eed5252537bf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b40a6dfe-98c3-4649-a6d5-eed5252537bf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b40a6dfe-98c3-4649-a6d5-eed5252537bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd6bebf9-9c7a-4cf3-8915-2794cf246b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b40a6dfe-98c3-4649-a6d5-eed5252537bf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd6bebf9-9c7a-4cf3-8915-2794cf246b58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1191ac99-8294-457f-9a7b-38017dbc8c12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd6bebf9-9c7a-4cf3-8915-2794cf246b58" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1191ac99-8294-457f-9a7b-38017dbc8c12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c30f0388-28f5-4606-aa71-81af9dd3bc8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd6bebf9-9c7a-4cf3-8915-2794cf246b58" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c30f0388-28f5-4606-aa71-81af9dd3bc8b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" xlink:type="extended" id="i31967c89509542dfaed7135e7fb14562_DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_35c4d5a0-55b7-4acd-a822-b91c600be3b2" xlink:href="mdt-20201030.xsd#mdt_OffsettingAssetsandLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_7e689b50-2431-4db5-8376-4c77d67a3cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_35c4d5a0-55b7-4acd-a822-b91c600be3b2" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_7e689b50-2431-4db5-8376-4c77d67a3cd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6a8c3c88-183c-449e-bf01-9c79bc07e5db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_7e689b50-2431-4db5-8376-4c77d67a3cd5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6a8c3c88-183c-449e-bf01-9c79bc07e5db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_5c8b7f3e-6b79-4411-95ba-5735816eee8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_7e689b50-2431-4db5-8376-4c77d67a3cd5" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_5c8b7f3e-6b79-4411-95ba-5735816eee8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_c904fdcf-42bd-4644-a3fc-34441e482343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_7e689b50-2431-4db5-8376-4c77d67a3cd5" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_c904fdcf-42bd-4644-a3fc-34441e482343" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_718499ba-9b99-4517-9801-fed669719e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_7e689b50-2431-4db5-8376-4c77d67a3cd5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_718499ba-9b99-4517-9801-fed669719e0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_1a034dca-c7f1-4184-9a20-87040fd42997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_35c4d5a0-55b7-4acd-a822-b91c600be3b2" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_1a034dca-c7f1-4184-9a20-87040fd42997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_eacffac1-a50a-4710-bfb6-b0eb6433b4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_1a034dca-c7f1-4184-9a20-87040fd42997" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_eacffac1-a50a-4710-bfb6-b0eb6433b4a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_4fb0d6ee-5200-452e-a160-b8f46269087d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_1a034dca-c7f1-4184-9a20-87040fd42997" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_4fb0d6ee-5200-452e-a160-b8f46269087d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_a7fbd83d-030b-4803-90b6-4ca75f42f6be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_1a034dca-c7f1-4184-9a20-87040fd42997" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_a7fbd83d-030b-4803-90b6-4ca75f42f6be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_96d2f856-100d-4ea4-a10c-567cb50295fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_1a034dca-c7f1-4184-9a20-87040fd42997" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_96d2f856-100d-4ea4-a10c-567cb50295fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityAbstract_80923f10-33a1-4fed-b449-cb6c05527c2b" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetLiabilityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_35c4d5a0-55b7-4acd-a822-b91c600be3b2" xlink:to="loc_mdt_DerivativeAssetLiabilityAbstract_80923f10-33a1-4fed-b449-cb6c05527c2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_0fb39ec3-25b2-4dea-ac14-f22ca68b4f23" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_80923f10-33a1-4fed-b449-cb6c05527c2b" xlink:to="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_0fb39ec3-25b2-4dea-ac14-f22ca68b4f23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_a23ccdbf-f4c8-4be7-bb7c-493ad445b9bc" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_80923f10-33a1-4fed-b449-cb6c05527c2b" xlink:to="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_a23ccdbf-f4c8-4be7-bb7c-493ad445b9bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_f36fb4f7-dcdd-40a0-ae92-2789b838a6ec" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_80923f10-33a1-4fed-b449-cb6c05527c2b" xlink:to="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_f36fb4f7-dcdd-40a0-ae92-2789b838a6ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_f51fd487-8ead-47c3-adb8-2b6398f7e3ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_80923f10-33a1-4fed-b449-cb6c05527c2b" xlink:to="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_f51fd487-8ead-47c3-adb8-2b6398f7e3ea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OffsettingAssetsandLiabilitiesTable_737d3a50-0179-4e87-96a8-178f46389b67" xlink:href="mdt-20201030.xsd#mdt_OffsettingAssetsandLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_35c4d5a0-55b7-4acd-a822-b91c600be3b2" xlink:to="loc_mdt_OffsettingAssetsandLiabilitiesTable_737d3a50-0179-4e87-96a8-178f46389b67" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b7316b36-066d-4da1-bed7-1f811e761912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesTable_737d3a50-0179-4e87-96a8-178f46389b67" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b7316b36-066d-4da1-bed7-1f811e761912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b7316b36-066d-4da1-bed7-1f811e761912_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b7316b36-066d-4da1-bed7-1f811e761912" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b7316b36-066d-4da1-bed7-1f811e761912_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0d14ffa2-b909-4f56-8560-a73e94dfddda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b7316b36-066d-4da1-bed7-1f811e761912" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0d14ffa2-b909-4f56-8560-a73e94dfddda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6f5606b6-678f-4a0e-b082-38f7df9fada1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0d14ffa2-b909-4f56-8560-a73e94dfddda" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6f5606b6-678f-4a0e-b082-38f7df9fada1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_38724ec8-dba3-42b6-ac84-c178a55df7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0d14ffa2-b909-4f56-8560-a73e94dfddda" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_38724ec8-dba3-42b6-ac84-c178a55df7fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_60dcf20e-d64a-40a8-a008-847267557b60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0d14ffa2-b909-4f56-8560-a73e94dfddda" xlink:to="loc_us-gaap_TotalReturnSwapMember_60dcf20e-d64a-40a8-a008-847267557b60" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/Inventories" xlink:type="simple" xlink:href="mdt-20201030.xsd#Inventories"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/Inventories" xlink:type="extended" id="i17843035fc9a4c2ab597bd506e6e3e8e_Inventories"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/InventoriesTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#InventoriesTables"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/InventoriesTables" xlink:type="extended" id="i3a3e21297cab436a8688427de00d6451_InventoriesTables"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/InventoriesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#InventoriesDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/InventoriesDetails" xlink:type="extended" id="i77fe1e4d850a460d877f2b9146b10d19_InventoriesDetails"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended" id="ibb313de8f9fc4184b22bc08818cd1654_GoodwillandOtherIntangibleAssets"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended" id="i1b6b608073754ad49674e2ae47d49d3e_GoodwillandOtherIntangibleAssetsTables"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended" id="i7009da370f0c41a7a916fb35a79c7780_GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_8221bfe7-7a6a-49ad-8242-e6057db073f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_55fad092-500b-41c7-899e-9458a20771cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8221bfe7-7a6a-49ad-8242-e6057db073f3" xlink:to="loc_us-gaap_GoodwillRollForward_55fad092-500b-41c7-899e-9458a20771cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e48ba811-ac70-4347-a00b-84c0796d5145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_55fad092-500b-41c7-899e-9458a20771cc" xlink:to="loc_us-gaap_Goodwill_e48ba811-ac70-4347-a00b-84c0796d5145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8f8151b0-c0fa-4c93-aac3-96c9603d5f26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_55fad092-500b-41c7-899e-9458a20771cc" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8f8151b0-c0fa-4c93-aac3-96c9603d5f26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_22c5357f-9f50-4f5d-b057-516ef2129e57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_55fad092-500b-41c7-899e-9458a20771cc" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_22c5357f-9f50-4f5d-b057-516ef2129e57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_31b2fd01-3df3-4299-8410-6e8b8c624bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_55fad092-500b-41c7-899e-9458a20771cc" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_31b2fd01-3df3-4299-8410-6e8b8c624bde" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b29132fa-12a3-4cdc-8229-02a80f0f353e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_bdbb85d2-f2de-4800-9019-7929d63f8fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_8221bfe7-7a6a-49ad-8242-e6057db073f3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_bdbb85d2-f2de-4800-9019-7929d63f8fb0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d6944702-d9de-464d-8864-9e52d30573b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_bdbb85d2-f2de-4800-9019-7929d63f8fb0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d6944702-d9de-464d-8864-9e52d30573b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d6944702-d9de-464d-8864-9e52d30573b2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d6944702-d9de-464d-8864-9e52d30573b2" xlink:to="loc_us-gaap_SegmentDomain_d6944702-d9de-464d-8864-9e52d30573b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_36c69fb5-8ecf-4783-9134-5f165933e2be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d6944702-d9de-464d-8864-9e52d30573b2" xlink:to="loc_us-gaap_SegmentDomain_36c69fb5-8ecf-4783-9134-5f165933e2be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacAndVascularGroupMember_11ea73f4-3689-4859-9874-32320f3e4d30" xlink:href="mdt-20201030.xsd#mdt_CardiacAndVascularGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_36c69fb5-8ecf-4783-9134-5f165933e2be" xlink:to="loc_mdt_CardiacAndVascularGroupMember_11ea73f4-3689-4859-9874-32320f3e4d30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MinimallyInvasiveTherapiesGroupMember_5e0127fe-f65f-4ab5-ac98-0a1063e553c0" xlink:href="mdt-20201030.xsd#mdt_MinimallyInvasiveTherapiesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_36c69fb5-8ecf-4783-9134-5f165933e2be" xlink:to="loc_mdt_MinimallyInvasiveTherapiesGroupMember_5e0127fe-f65f-4ab5-ac98-0a1063e553c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestorativeTherapiesGroupMember_4352797d-0223-4d64-8810-a496ba2ed433" xlink:href="mdt-20201030.xsd#mdt_RestorativeTherapiesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_36c69fb5-8ecf-4783-9134-5f165933e2be" xlink:to="loc_mdt_RestorativeTherapiesGroupMember_4352797d-0223-4d64-8810-a496ba2ed433" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_4212eb90-9a2b-40f6-8db3-6ca72ba1ddb0" xlink:href="mdt-20201030.xsd#mdt_DiabetesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_36c69fb5-8ecf-4783-9134-5f165933e2be" xlink:to="loc_mdt_DiabetesGroupMember_4212eb90-9a2b-40f6-8db3-6ca72ba1ddb0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended" id="i8aae5f39e67448e4b7448e0c58ec5ca6_GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails" xlink:type="extended" id="i03cb365e6b2742279a0cc7d29dff84c7_GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4d1930a-860e-4f66-b7be-1747dd54d821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a60b0924-5d9d-4884-aab2-c91716f9cafe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4d1930a-860e-4f66-b7be-1747dd54d821" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a60b0924-5d9d-4884-aab2-c91716f9cafe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_10c21ab0-b6f9-44b7-a874-641c241cd328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4d1930a-860e-4f66-b7be-1747dd54d821" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_10c21ab0-b6f9-44b7-a874-641c241cd328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ae88f3f0-fee5-4a16-b865-439685664958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4d1930a-860e-4f66-b7be-1747dd54d821" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ae88f3f0-fee5-4a16-b865-439685664958" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec6d6c16-4bce-499c-b076-8dd66a638234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ae88f3f0-fee5-4a16-b865-439685664958" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec6d6c16-4bce-499c-b076-8dd66a638234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec6d6c16-4bce-499c-b076-8dd66a638234_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec6d6c16-4bce-499c-b076-8dd66a638234" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec6d6c16-4bce-499c-b076-8dd66a638234_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_818b3dc4-dce3-474e-bc7f-760e4715afc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec6d6c16-4bce-499c-b076-8dd66a638234" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_818b3dc4-dce3-474e-bc7f-760e4715afc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_547d1ef0-79b5-423e-bf79-9ddac3c4f498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_818b3dc4-dce3-474e-bc7f-760e4715afc3" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_547d1ef0-79b5-423e-bf79-9ddac3c4f498" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PurchasedTechnologyAndPatentsMember_4585332c-a3c9-4fdb-8de6-573010aea45a" xlink:href="mdt-20201030.xsd#mdt_PurchasedTechnologyAndPatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_818b3dc4-dce3-474e-bc7f-760e4715afc3" xlink:to="loc_mdt_PurchasedTechnologyAndPatentsMember_4585332c-a3c9-4fdb-8de6-573010aea45a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_0b82d383-7ddd-40fb-91b8-5434d1088d50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_818b3dc4-dce3-474e-bc7f-760e4715afc3" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_0b82d383-7ddd-40fb-91b8-5434d1088d50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_4688fd5e-0a5b-495f-8b15-eb6490cccb2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_818b3dc4-dce3-474e-bc7f-760e4715afc3" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_4688fd5e-0a5b-495f-8b15-eb6490cccb2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a11f3f11-d574-4291-847e-253864faebd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d7080d43-3e2d-48d0-8f96-a5b884c51cff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a11f3f11-d574-4291-847e-253864faebd1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d7080d43-3e2d-48d0-8f96-a5b884c51cff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_feb4b91d-a52e-4816-868a-2780834e3488" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a11f3f11-d574-4291-847e-253864faebd1" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_feb4b91d-a52e-4816-868a-2780834e3488" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2be782ff-dd46-4ef6-a224-d01534c9610f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_feb4b91d-a52e-4816-868a-2780834e3488" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2be782ff-dd46-4ef6-a224-d01534c9610f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2be782ff-dd46-4ef6-a224-d01534c9610f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2be782ff-dd46-4ef6-a224-d01534c9610f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2be782ff-dd46-4ef6-a224-d01534c9610f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5ac95b56-5549-4d51-ac01-57f561a07db2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2be782ff-dd46-4ef6-a224-d01534c9610f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5ac95b56-5549-4d51-ac01-57f561a07db2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_e61fe1f5-e983-4f68-b376-6cacf4ddf7cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5ac95b56-5549-4d51-ac01-57f561a07db2" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_e61fe1f5-e983-4f68-b376-6cacf4ddf7cf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails" xlink:type="extended" id="ifc677bb44b0d4f7a9d3eac97b1df10f9_GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mdt-20201030.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/IncomeTaxes" xlink:type="extended" id="i18ad828eac49419080b7a4e3fda106b1_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/IncomeTaxesDetails" xlink:type="extended" id="ic4765af15f14408296184cd412b2d748_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ee829b2-8b90-4fdb-b3a6-6261cd8385f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7b0e9d18-b66a-4efe-9a61-d6d930decc45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ee829b2-8b90-4fdb-b3a6-6261cd8385f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7b0e9d18-b66a-4efe-9a61-d6d930decc45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_06c634f6-55a6-468d-9bd5-4bf532903f9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ee829b2-8b90-4fdb-b3a6-6261cd8385f2" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_06c634f6-55a6-468d-9bd5-4bf532903f9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3b464f8b-90c3-4fdf-b57c-6a3f785c34fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_06c634f6-55a6-468d-9bd5-4bf532903f9d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3b464f8b-90c3-4fdf-b57c-6a3f785c34fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3b464f8b-90c3-4fdf-b57c-6a3f785c34fb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3b464f8b-90c3-4fdf-b57c-6a3f785c34fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3b464f8b-90c3-4fdf-b57c-6a3f785c34fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8a58d1c6-12c1-4d1f-911c-b7ef30ee57b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3b464f8b-90c3-4fdf-b57c-6a3f785c34fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8a58d1c6-12c1-4d1f-911c-b7ef30ee57b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember_d53004d8-1ef4-4ace-9557-40ee63a9f71f" xlink:href="mdt-20201030.xsd#mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8a58d1c6-12c1-4d1f-911c-b7ef30ee57b0" xlink:to="loc_mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember_d53004d8-1ef4-4ace-9557-40ee63a9f71f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShare" xlink:type="simple" xlink:href="mdt-20201030.xsd#EarningsPerShare"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/EarningsPerShare" xlink:type="extended" id="i81e3d1bd1f9f4781996fe8a2c8b5fd77_EarningsPerShare"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#EarningsPerShareTables"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/EarningsPerShareTables" xlink:type="extended" id="i3e960625ebe64c9d84af7d2969f2cba9_EarningsPerShareTables"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" xlink:type="extended" id="iefda4eb5ffa14c0e98c77b1f152d9dcd_EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#EarningsPerShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/EarningsPerShareNarrativeDetails" xlink:type="extended" id="icaad8bd63ab1489f935868d730b11e0e_EarningsPerShareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_61ce41c7-e751-43e7-bfc6-445dff43b594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1ec1a045-9141-4f9d-8677-7395f88a7003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_61ce41c7-e751-43e7-bfc6-445dff43b594" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1ec1a045-9141-4f9d-8677-7395f88a7003" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c532fc97-d0a4-4324-9076-91aeb88b4d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_61ce41c7-e751-43e7-bfc6-445dff43b594" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c532fc97-d0a4-4324-9076-91aeb88b4d9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_00c3589b-6ed2-4f19-b6ac-c0eddebb047b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c532fc97-d0a4-4324-9076-91aeb88b4d9c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_00c3589b-6ed2-4f19-b6ac-c0eddebb047b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_00c3589b-6ed2-4f19-b6ac-c0eddebb047b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_00c3589b-6ed2-4f19-b6ac-c0eddebb047b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_00c3589b-6ed2-4f19-b6ac-c0eddebb047b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_57fe2620-ab10-4b9f-827f-11b1ffae5743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_00c3589b-6ed2-4f19-b6ac-c0eddebb047b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_57fe2620-ab10-4b9f-827f-11b1ffae5743" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d22a43ec-0de2-41ab-948d-47c984ac6cd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_57fe2620-ab10-4b9f-827f-11b1ffae5743" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d22a43ec-0de2-41ab-948d-47c984ac6cd0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="mdt-20201030.xsd#StockBasedCompensation"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/StockBasedCompensation" xlink:type="extended" id="ib0190ebe7de445059d8f83a37cd0c019_StockBasedCompensation"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#StockBasedCompensationTables"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/StockBasedCompensationTables" xlink:type="extended" id="ic46f2a6cd68a46079407569436ac4e92_StockBasedCompensationTables"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#StockBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/StockBasedCompensationDetails" xlink:type="extended" id="i987449c932004096a7288fa8503c606f_StockBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb397208-4218-4189-8a07-fc8418e569c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_db80ecc5-86ac-40f8-85b9-3c707a54c182" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb397208-4218-4189-8a07-fc8418e569c5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_db80ecc5-86ac-40f8-85b9-3c707a54c182" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_fc8a8e89-2d34-4483-b0ba-630ae8eeb3f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb397208-4218-4189-8a07-fc8418e569c5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_fc8a8e89-2d34-4483-b0ba-630ae8eeb3f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_7f7b615c-5aa7-47fd-ab43-a92e74a38067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb397208-4218-4189-8a07-fc8418e569c5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_7f7b615c-5aa7-47fd-ab43-a92e74a38067" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4ef8ed00-f02c-48fc-a2d2-a01a4f792981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb397208-4218-4189-8a07-fc8418e569c5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4ef8ed00-f02c-48fc-a2d2-a01a4f792981" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_82d9d243-1cf8-427a-b7c4-7344de68a256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4ef8ed00-f02c-48fc-a2d2-a01a4f792981" xlink:to="loc_us-gaap_AwardTypeAxis_82d9d243-1cf8-427a-b7c4-7344de68a256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82d9d243-1cf8-427a-b7c4-7344de68a256_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_82d9d243-1cf8-427a-b7c4-7344de68a256" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82d9d243-1cf8-427a-b7c4-7344de68a256_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_805b87ed-14ed-4cc1-921a-ea89f1efb881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_82d9d243-1cf8-427a-b7c4-7344de68a256" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_805b87ed-14ed-4cc1-921a-ea89f1efb881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_dfdde87f-939c-4130-9df0-7165155533f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_805b87ed-14ed-4cc1-921a-ea89f1efb881" xlink:to="loc_us-gaap_EmployeeStockOptionMember_dfdde87f-939c-4130-9df0-7165155533f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_91abb908-7c69-4da0-952c-4b0a288f9686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_805b87ed-14ed-4cc1-921a-ea89f1efb881" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_91abb908-7c69-4da0-952c-4b0a288f9686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EmployeesStockPurchasePlanMember_ef5ec985-64fd-4211-92e2-f1bc7ded202b" xlink:href="mdt-20201030.xsd#mdt_EmployeesStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_805b87ed-14ed-4cc1-921a-ea89f1efb881" xlink:to="loc_mdt_EmployeesStockPurchasePlanMember_ef5ec985-64fd-4211-92e2-f1bc7ded202b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e30db267-98e5-4c7f-8229-0f70ca471e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4ef8ed00-f02c-48fc-a2d2-a01a4f792981" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e30db267-98e5-4c7f-8229-0f70ca471e4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e30db267-98e5-4c7f-8229-0f70ca471e4c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e30db267-98e5-4c7f-8229-0f70ca471e4c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e30db267-98e5-4c7f-8229-0f70ca471e4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d188c0c7-5e3c-4b3d-82e5-c5125eeae805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e30db267-98e5-4c7f-8229-0f70ca471e4c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d188c0c7-5e3c-4b3d-82e5-c5125eeae805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_1a8fb14b-4120-40e1-9bae-ff5db9b1b216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d188c0c7-5e3c-4b3d-82e5-c5125eeae805" xlink:to="loc_us-gaap_CostOfSalesMember_1a8fb14b-4120-40e1-9bae-ff5db9b1b216" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8bbf26c4-43e2-4833-8865-66cd77a2d6df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d188c0c7-5e3c-4b3d-82e5-c5125eeae805" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8bbf26c4-43e2-4833-8865-66cd77a2d6df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d911e737-a295-4dce-ad28-d199229614a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d188c0c7-5e3c-4b3d-82e5-c5125eeae805" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d911e737-a295-4dce-ad28-d199229614a2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlans" xlink:type="simple" xlink:href="mdt-20201030.xsd#RetirementBenefitPlans"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlans" xlink:type="extended" id="i7f82f99d79dc42dfbc5d3255dafdfd6f_RetirementBenefitPlans"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlansTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#RetirementBenefitPlansTables"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlansTables" xlink:type="extended" id="i4e7a09484b69453b87731458a7d5907d_RetirementBenefitPlansTables"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlansDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RetirementBenefitPlansDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlansDetails" xlink:type="extended" id="icd0686be24e14a1bbe976a1e2da026f2_RetirementBenefitPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9cf119a8-bc0b-4be8-b70c-24452cca703b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9cf119a8-bc0b-4be8-b70c-24452cca703b" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_d2dbad22-3b95-4340-839e-acc2092793a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:to="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_d2dbad22-3b95-4340-839e-acc2092793a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_dda01604-07b4-43af-8423-19b21f2e702e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_dda01604-07b4-43af-8423-19b21f2e702e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_cdc9c78f-d866-45cb-a51c-96851a59264a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_cdc9c78f-d866-45cb-a51c-96851a59264a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_86d1d284-59a5-4768-b394-18c9d3996628" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_86d1d284-59a5-4768-b394-18c9d3996628" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_603b5ebe-0853-4638-b4ae-f74ae4bd560f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_603b5ebe-0853-4638-b4ae-f74ae4bd560f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a7c580ab-1237-4b97-9192-6cc62def5dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a7c580ab-1237-4b97-9192-6cc62def5dd1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d292448d-c2ec-4aad-9418-055560bd0d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9cf119a8-bc0b-4be8-b70c-24452cca703b" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d292448d-c2ec-4aad-9418-055560bd0d4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_65b00661-99a4-4f28-b563-ab4ebd8f7c38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d292448d-c2ec-4aad-9418-055560bd0d4b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_65b00661-99a4-4f28-b563-ab4ebd8f7c38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_65b00661-99a4-4f28-b563-ab4ebd8f7c38_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_65b00661-99a4-4f28-b563-ab4ebd8f7c38" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_65b00661-99a4-4f28-b563-ab4ebd8f7c38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8ec8670b-c0dd-424f-a2c9-8b7fb856a032" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_65b00661-99a4-4f28-b563-ab4ebd8f7c38" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8ec8670b-c0dd-424f-a2c9-8b7fb856a032" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_c90f01e3-332c-42e6-bb46-4203b0e84f26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8ec8670b-c0dd-424f-a2c9-8b7fb856a032" xlink:to="loc_us-gaap_DomesticPlanMember_c90f01e3-332c-42e6-bb46-4203b0e84f26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f7eebe81-7949-4155-94f9-f3fd960fbcdd" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_c90f01e3-332c-42e6-bb46-4203b0e84f26" xlink:to="loc_country_US_f7eebe81-7949-4155-94f9-f3fd960fbcdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_ae3ae7e0-70ff-4a95-961f-0f18f1ea4347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8ec8670b-c0dd-424f-a2c9-8b7fb856a032" xlink:to="loc_us-gaap_ForeignPlanMember_ae3ae7e0-70ff-4a95-961f-0f18f1ea4347" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_19a8eeab-8967-4f5f-8fd1-55c61f438658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d292448d-c2ec-4aad-9418-055560bd0d4b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_19a8eeab-8967-4f5f-8fd1-55c61f438658" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_19a8eeab-8967-4f5f-8fd1-55c61f438658_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_19a8eeab-8967-4f5f-8fd1-55c61f438658" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_19a8eeab-8967-4f5f-8fd1-55c61f438658_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3112bf62-ffaa-4e78-83d0-be507a95414a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_19a8eeab-8967-4f5f-8fd1-55c61f438658" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3112bf62-ffaa-4e78-83d0-be507a95414a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_007ccc5b-79d9-42d2-89e2-62e231592eae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3112bf62-ffaa-4e78-83d0-be507a95414a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_007ccc5b-79d9-42d2-89e2-62e231592eae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RetirementBenefitPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails" xlink:type="extended" id="i4c3be64a12664845bd8eb36ebbb80d2f_RetirementBenefitPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86afc516-cd0a-44ca-a995-c3ee61edc614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_cdeffc9f-0f8c-4bd4-9153-dcf62e08ac5c" xlink:href="mdt-20201030.xsd#mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86afc516-cd0a-44ca-a995-c3ee61edc614" xlink:to="loc_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_cdeffc9f-0f8c-4bd4-9153-dcf62e08ac5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_ad0e2a62-0c84-4478-b5e0-e47953892e02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86afc516-cd0a-44ca-a995-c3ee61edc614" xlink:to="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_ad0e2a62-0c84-4478-b5e0-e47953892e02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_78fb496e-866f-4e3b-a2cd-fef4fca34b66" xlink:href="mdt-20201030.xsd#mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86afc516-cd0a-44ca-a995-c3ee61edc614" xlink:to="loc_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_78fb496e-866f-4e3b-a2cd-fef4fca34b66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits_cf0de84d-cd06-4489-9f07-ee620ee7045e" xlink:href="mdt-20201030.xsd#mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86afc516-cd0a-44ca-a995-c3ee61edc614" xlink:to="loc_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits_cf0de84d-cd06-4489-9f07-ee620ee7045e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_443c81e9-66e1-4f81-b483-211079e73ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86afc516-cd0a-44ca-a995-c3ee61edc614" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_443c81e9-66e1-4f81-b483-211079e73ff0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_3ec500a6-9e62-42cb-bcb8-5d56c6544055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_443c81e9-66e1-4f81-b483-211079e73ff0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_3ec500a6-9e62-42cb-bcb8-5d56c6544055" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_3ec500a6-9e62-42cb-bcb8-5d56c6544055_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3ec500a6-9e62-42cb-bcb8-5d56c6544055" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_3ec500a6-9e62-42cb-bcb8-5d56c6544055_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_5a480cd4-a464-43f8-91c9-5b4f515d6db7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3ec500a6-9e62-42cb-bcb8-5d56c6544055" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_5a480cd4-a464-43f8-91c9-5b4f515d6db7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_144ecc7a-5ab4-48d0-8aec-59db1963b477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5a480cd4-a464-43f8-91c9-5b4f515d6db7" xlink:to="loc_us-gaap_DomesticPlanMember_144ecc7a-5ab4-48d0-8aec-59db1963b477" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8afe67b0-247c-44c4-9586-33eb13c9e56f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_144ecc7a-5ab4-48d0-8aec-59db1963b477" xlink:to="loc_country_US_8afe67b0-247c-44c4-9586-33eb13c9e56f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_cab67ad6-32a2-4d94-94fc-773f93056f50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_443c81e9-66e1-4f81-b483-211079e73ff0" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_cab67ad6-32a2-4d94-94fc-773f93056f50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cab67ad6-32a2-4d94-94fc-773f93056f50_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_cab67ad6-32a2-4d94-94fc-773f93056f50" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cab67ad6-32a2-4d94-94fc-773f93056f50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_24c47046-b43c-4793-8045-f5c8c82254bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_cab67ad6-32a2-4d94-94fc-773f93056f50" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_24c47046-b43c-4793-8045-f5c8c82254bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d39c66d7-e6d9-4d5e-8e86-ad2bdc1c74b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_24c47046-b43c-4793-8045-f5c8c82254bc" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d39c66d7-e6d9-4d5e-8e86-ad2bdc1c74b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_a866f6ad-ab7b-471e-b2ed-f2b9a4597474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_24c47046-b43c-4793-8045-f5c8c82254bc" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_a866f6ad-ab7b-471e-b2ed-f2b9a4597474" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="mdt-20201030.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended" id="i2ff41c114f4e4622acc4c49c5e0d1dba_AccumulatedOtherComprehensiveLoss"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended" id="i326d55bc277b460a8a72ba5e23e39046_AccumulatedOtherComprehensiveLossTables"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#AccumulatedOtherComprehensiveLossChangesinAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails" xlink:type="extended" id="ic21b29fb92334bdfa7b3602bf5de2c43_AccumulatedOtherComprehensiveLossChangesinAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_512a21c3-c058-445c-9920-5881c92c03da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b1ef7b2f-5612-4b35-9183-a49a68eee19d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_512a21c3-c058-445c-9920-5881c92c03da" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b1ef7b2f-5612-4b35-9183-a49a68eee19d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e240f50-0cf8-4fde-aac4-e3e5206ce7d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b1ef7b2f-5612-4b35-9183-a49a68eee19d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e240f50-0cf8-4fde-aac4-e3e5206ce7d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_16df150d-da4e-4919-9da1-d2a6032eb516" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b1ef7b2f-5612-4b35-9183-a49a68eee19d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_16df150d-da4e-4919-9da1-d2a6032eb516" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8a691c16-cb88-4b4a-938f-9d81b9444b66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b1ef7b2f-5612-4b35-9183-a49a68eee19d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8a691c16-cb88-4b4a-938f-9d81b9444b66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4c5ccb59-5f87-4fe2-bc14-6f06e7a50a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b1ef7b2f-5612-4b35-9183-a49a68eee19d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4c5ccb59-5f87-4fe2-bc14-6f06e7a50a0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_224036a7-3154-42ab-a9d9-6404a827ee4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9743d003-32ed-4651-a4b2-f0cff88cd97f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_512a21c3-c058-445c-9920-5881c92c03da" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9743d003-32ed-4651-a4b2-f0cff88cd97f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_3dedeb78-0420-43d4-a916-f9d7ca4bf647" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9743d003-32ed-4651-a4b2-f0cff88cd97f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_3dedeb78-0420-43d4-a916-f9d7ca4bf647" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_2275ec9a-8e6e-43fc-b056-4e9360a7865a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9743d003-32ed-4651-a4b2-f0cff88cd97f" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_2275ec9a-8e6e-43fc-b056-4e9360a7865a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1894211b-cc08-46c5-b5f4-16689f4ac377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_512a21c3-c058-445c-9920-5881c92c03da" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1894211b-cc08-46c5-b5f4-16689f4ac377" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a525cc2b-434c-47fa-8262-df08924f2c61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1894211b-cc08-46c5-b5f4-16689f4ac377" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a525cc2b-434c-47fa-8262-df08924f2c61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a525cc2b-434c-47fa-8262-df08924f2c61_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a525cc2b-434c-47fa-8262-df08924f2c61" xlink:to="loc_us-gaap_EquityComponentDomain_a525cc2b-434c-47fa-8262-df08924f2c61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bbc19ade-2b00-4028-ba93-56b4122ef7b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a525cc2b-434c-47fa-8262-df08924f2c61" xlink:to="loc_us-gaap_EquityComponentDomain_bbc19ade-2b00-4028-ba93-56b4122ef7b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bbc19ade-2b00-4028-ba93-56b4122ef7b2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_e3d1daee-b5e6-4a2f-bc0e-c0b49f541b0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_e3d1daee-b5e6-4a2f-bc0e-c0b49f541b0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5090d33e-b1f5-4a7c-9efe-b7277ceff381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5090d33e-b1f5-4a7c-9efe-b7277ceff381" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_5fa18d95-554b-4f9c-999a-a7a237027626" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:to="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_5fa18d95-554b-4f9c-999a-a7a237027626" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_8ceacbad-9f8e-41b5-8d55-f2962aacf107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_8ceacbad-9f8e-41b5-8d55-f2962aacf107" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_acb80389-3da2-4052-8203-3cc01812f5e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_acb80389-3da2-4052-8203-3cc01812f5e9" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mdt-20201030.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/CommitmentsandContingencies" xlink:type="extended" id="ic48d7d96b316442bb3c73f760862d6c2_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i5dd87d3d3c2348c2b844dfb68a5cee07_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_5ac23a48-b0be-4de5-931d-70eabaf8732b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_5ac23a48-b0be-4de5-931d-70eabaf8732b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_eafb52da-4855-48f5-b788-b741e13eb1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_eafb52da-4855-48f5-b788-b741e13eb1c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossContingencyNumberofSubsidiaries_77ae20ef-7b94-4d34-8969-d64e23660b23" xlink:href="mdt-20201030.xsd#mdt_LossContingencyNumberofSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_mdt_LossContingencyNumberofSubsidiaries_77ae20ef-7b94-4d34-8969-d64e23660b23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossContingencyNumberofManufacturers_8131d758-369a-4dec-bb49-1ed26697b1ee" xlink:href="mdt-20201030.xsd#mdt_LossContingencyNumberofManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_mdt_LossContingencyNumberofManufacturers_8131d758-369a-4dec-bb49-1ed26697b1ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29cc72fa-2df7-453c-8719-feca742a96aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29cc72fa-2df7-453c-8719-feca742a96aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_b8137740-3ceb-4591-bc5a-3392d2f39931" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_b8137740-3ceb-4591-bc5a-3392d2f39931" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_f58fcfc8-24e7-4ecb-82a0-44a1bbc39f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_f58fcfc8-24e7-4ecb-82a0-44a1bbc39f7f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_e9dfd819-ee81-4702-b613-88eed2712099" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_e9dfd819-ee81-4702-b613-88eed2712099" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_61d316e1-4242-423c-92bc-4a9c737d9ee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPatentsFoundNotInfringedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_61d316e1-4242-423c-92bc-4a9c737d9ee2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_10a4716d-ae13-43e0-b86f-c59c4621729d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_10a4716d-ae13-43e0-b86f-c59c4621729d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_a5bad32b-fb4e-42c8-9153-49bdc4e44181" xlink:href="mdt-20201030.xsd#mdt_SiteContingencyNumberofLandfillsRequiringRemoval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_a5bad32b-fb4e-42c8-9153-49bdc4e44181" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_a07753e9-9e12-414d-8b0a-b79b8221e588" xlink:href="mdt-20201030.xsd#mdt_SiteContingencyNumberOfLandfillsRequiringCapping"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_a07753e9-9e12-414d-8b0a-b79b8221e588" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_791aff49-2ba7-4039-80fd-ae09e417353a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LossContingenciesTable_791aff49-2ba7-4039-80fd-ae09e417353a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_c68765d6-088f-486a-bb4e-cb56ee6dde23" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_791aff49-2ba7-4039-80fd-ae09e417353a" xlink:to="loc_srt_LitigationCaseAxis_c68765d6-088f-486a-bb4e-cb56ee6dde23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c68765d6-088f-486a-bb4e-cb56ee6dde23_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_c68765d6-088f-486a-bb4e-cb56ee6dde23" xlink:to="loc_srt_LitigationCaseTypeDomain_c68765d6-088f-486a-bb4e-cb56ee6dde23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_16142f7d-b677-4904-8e94-a1b7946bc591" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_c68765d6-088f-486a-bb4e-cb56ee6dde23" xlink:to="loc_srt_LitigationCaseTypeDomain_16142f7d-b677-4904-8e94-a1b7946bc591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PelvicMeshLitigationMember_4f4720f6-1376-4edf-a332-f1cf8cc3193a" xlink:href="mdt-20201030.xsd#mdt_PelvicMeshLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_16142f7d-b677-4904-8e94-a1b7946bc591" xlink:to="loc_mdt_PelvicMeshLitigationMember_4f4720f6-1376-4edf-a332-f1cf8cc3193a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EthiconPatentInfringementLitigationMember_20d2831a-bb04-4ac5-9864-3b3746411296" xlink:href="mdt-20201030.xsd#mdt_EthiconPatentInfringementLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_16142f7d-b677-4904-8e94-a1b7946bc591" xlink:to="loc_mdt_EthiconPatentInfringementLitigationMember_20d2831a-bb04-4ac5-9864-3b3746411296" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SassoLitigationMember_992064d8-b3e9-4d3a-879f-431320b69c98" xlink:href="mdt-20201030.xsd#mdt_SassoLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_16142f7d-b677-4904-8e94-a1b7946bc591" xlink:to="loc_mdt_SassoLitigationMember_992064d8-b3e9-4d3a-879f-431320b69c98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9f69dcc2-2ba5-4e9e-b16b-fdfa82b1b9fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_791aff49-2ba7-4039-80fd-ae09e417353a" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9f69dcc2-2ba5-4e9e-b16b-fdfa82b1b9fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9f69dcc2-2ba5-4e9e-b16b-fdfa82b1b9fa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9f69dcc2-2ba5-4e9e-b16b-fdfa82b1b9fa" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9f69dcc2-2ba5-4e9e-b16b-fdfa82b1b9fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_dca9e033-3af7-4ef4-88c2-a841a37a5521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9f69dcc2-2ba5-4e9e-b16b-fdfa82b1b9fa" xlink:to="loc_us-gaap_LossContingencyNatureDomain_dca9e033-3af7-4ef4-88c2-a841a37a5521" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DamagesFromProductDefectsMember_350b5e34-55c2-4b42-8b33-6d1448562844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DamagesFromProductDefectsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_dca9e033-3af7-4ef4-88c2-a841a37a5521" xlink:to="loc_us-gaap_DamagesFromProductDefectsMember_350b5e34-55c2-4b42-8b33-6d1448562844" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis_47ffea91-e200-49dd-a7d3-c0dcf0c7d457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_791aff49-2ba7-4039-80fd-ae09e417353a" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteAxis_47ffea91-e200-49dd-a7d3-c0dcf0c7d457" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_47ffea91-e200-49dd-a7d3-c0dcf0c7d457_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_47ffea91-e200-49dd-a7d3-c0dcf0c7d457" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_47ffea91-e200-49dd-a7d3-c0dcf0c7d457_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_6d55c2b5-c384-460e-8ba5-1e3c38ea2bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_47ffea91-e200-49dd-a7d3-c0dcf0c7d457" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_6d55c2b5-c384-460e-8ba5-1e3c38ea2bde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OrringtonMaineChemicalManufacturingFacilityMember_2dc839cf-ed5a-448e-a4ae-bcafe89a2658" xlink:href="mdt-20201030.xsd#mdt_OrringtonMaineChemicalManufacturingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain_6d55c2b5-c384-460e-8ba5-1e3c38ea2bde" xlink:to="loc_mdt_OrringtonMaineChemicalManufacturingFacilityMember_2dc839cf-ed5a-448e-a4ae-bcafe89a2658" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8c401888-c195-40a6-a2aa-95c04928e6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_791aff49-2ba7-4039-80fd-ae09e417353a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8c401888-c195-40a6-a2aa-95c04928e6cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8c401888-c195-40a6-a2aa-95c04928e6cf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8c401888-c195-40a6-a2aa-95c04928e6cf" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8c401888-c195-40a6-a2aa-95c04928e6cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_29c7ad77-5676-49dc-a579-2cd1b7cfa66c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8c401888-c195-40a6-a2aa-95c04928e6cf" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_29c7ad77-5676-49dc-a579-2cd1b7cfa66c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_75cf7168-8c52-44a8-8323-a74c1a568c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_29c7ad77-5676-49dc-a579-2cd1b7cfa66c" xlink:to="loc_us-gaap_SubsequentEventMember_75cf7168-8c52-44a8-8323-a74c1a568c29" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformation" xlink:type="simple" xlink:href="mdt-20201030.xsd#SegmentandGeographicInformation"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformation" xlink:type="extended" id="i74647ac470df4fcf905f9a598696ddd8_SegmentandGeographicInformation"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#SegmentandGeographicInformationTables"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformationTables" xlink:type="extended" id="ia5e8bb9c33864e67a5db39008f0be44d_SegmentandGeographicInformationTables"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#SegmentandGeographicInformationDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformationDetails" xlink:type="extended" id="i7182fb1eb16e4ef496b24aa967c02b0c_SegmentandGeographicInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_662fb617-2984-489d-97b8-132ae7fbc6b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_662fb617-2984-489d-97b8-132ae7fbc6b8" xlink:to="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7b96af5a-a545-4aa2-a7f7-f1d1955390fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_OperatingIncomeLoss_7b96af5a-a545-4aa2-a7f7-f1d1955390fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7bb6224a-66a8-4cd2-bf07-7c958aa2c679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_InterestExpense_7bb6224a-66a8-4cd2-bf07-7c958aa2c679" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_3b6b83d8-be8f-49ab-93b6-01cb66b133bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_InterestIncomeOperating_3b6b83d8-be8f-49ab-93b6-01cb66b133bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_add9f5dd-6040-4118-b575-f3f6f857d0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_add9f5dd-6040-4118-b575-f3f6f857d0b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CorporateOverhead_5647d108-9fba-462e-b01d-19e4ef4c6dfc" xlink:href="mdt-20201030.xsd#mdt_CorporateOverhead"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_CorporateOverhead_5647d108-9fba-462e-b01d-19e4ef4c6dfc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CentralizedDistributionCosts_eafe3bea-d25b-43fd-9afe-98b2e2d1aa1d" xlink:href="mdt-20201030.xsd#mdt_CentralizedDistributionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_CentralizedDistributionCosts_eafe3bea-d25b-43fd-9afe-98b2e2d1aa1d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesNetofRestructuringReversals_86cc2d59-5632-4ca1-8934-5a85939c219b" xlink:href="mdt-20201030.xsd#mdt_RestructuringChargesNetofRestructuringReversals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_RestructuringChargesNetofRestructuringReversals_86cc2d59-5632-4ca1-8934-5a85939c219b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a6b839f0-8f5e-45cd-93d7-17d75d4e8a43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a6b839f0-8f5e-45cd-93d7-17d75d4e8a43" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_98259330-cd72-4cdb-a29d-1802e780bd68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_98259330-cd72-4cdb-a29d-1802e780bd68" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ImpairmentOfInProcessResearchAndDevelopment_f55323b2-579b-4b42-b4f1-72c7c1f536ef" xlink:href="mdt-20201030.xsd#mdt_ImpairmentOfInProcessResearchAndDevelopment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_ImpairmentOfInProcessResearchAndDevelopment_f55323b2-579b-4b42-b4f1-72c7c1f536ef" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_b8e280d0-6fa6-42f4-8071-1ff341e75afa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_BusinessExitCosts1_b8e280d0-6fa6-42f4-8071-1ff341e75afa" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtTenderPremiumandOtherCharges_253b4f66-020f-4be1-8b04-a6100a6c2dc3" xlink:href="mdt-20201030.xsd#mdt_DebtTenderPremiumandOtherCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_DebtTenderPremiumandOtherCharges_253b4f66-020f-4be1-8b04-a6100a6c2dc3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalDeviceRegulations_5cd377cf-0c48-4ef1-aacd-dacd4d23f133" xlink:href="mdt-20201030.xsd#mdt_MedicalDeviceRegulations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_MedicalDeviceRegulations_5cd377cf-0c48-4ef1-aacd-dacd4d23f133" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SpecialChargesGains_4317083c-1c07-4dad-8064-ef8be71a79c5" xlink:href="mdt-20201030.xsd#mdt_SpecialChargesGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_SpecialChargesGains_4317083c-1c07-4dad-8064-ef8be71a79c5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_cc636820-5bdf-4cc1-9d5a-e3075208d645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_cc636820-5bdf-4cc1-9d5a-e3075208d645" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_99fb1ccd-1d28-47d9-b212-7e12aeccfaea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_662fb617-2984-489d-97b8-132ae7fbc6b8" xlink:to="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_99fb1ccd-1d28-47d9-b212-7e12aeccfaea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1a47ed73-9d33-4ec7-bce7-d5e15eae93fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_99fb1ccd-1d28-47d9-b212-7e12aeccfaea" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1a47ed73-9d33-4ec7-bce7-d5e15eae93fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_65bce064-bcee-43d3-b4d9-bbc83f19e766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_662fb617-2984-489d-97b8-132ae7fbc6b8" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_65bce064-bcee-43d3-b4d9-bbc83f19e766" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_457c65fe-9598-4f9c-8619-28845860de79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_65bce064-bcee-43d3-b4d9-bbc83f19e766" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_457c65fe-9598-4f9c-8619-28845860de79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_457c65fe-9598-4f9c-8619-28845860de79_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_457c65fe-9598-4f9c-8619-28845860de79" xlink:to="loc_us-gaap_SegmentDomain_457c65fe-9598-4f9c-8619-28845860de79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8b9f9923-285b-45bc-9972-2e7afd9a600c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_457c65fe-9598-4f9c-8619-28845860de79" xlink:to="loc_us-gaap_SegmentDomain_8b9f9923-285b-45bc-9972-2e7afd9a600c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacAndVascularGroupMember_e3fb32ff-bea2-4c48-b716-b40877562051" xlink:href="mdt-20201030.xsd#mdt_CardiacAndVascularGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8b9f9923-285b-45bc-9972-2e7afd9a600c" xlink:to="loc_mdt_CardiacAndVascularGroupMember_e3fb32ff-bea2-4c48-b716-b40877562051" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MinimallyInvasiveTherapiesGroupMember_c50bc0bb-140c-4d15-bd11-fcfb3031b86c" xlink:href="mdt-20201030.xsd#mdt_MinimallyInvasiveTherapiesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8b9f9923-285b-45bc-9972-2e7afd9a600c" xlink:to="loc_mdt_MinimallyInvasiveTherapiesGroupMember_c50bc0bb-140c-4d15-bd11-fcfb3031b86c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestorativeTherapiesGroupMember_fe527ce0-a59e-463c-91eb-4f81b57682ed" xlink:href="mdt-20201030.xsd#mdt_RestorativeTherapiesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8b9f9923-285b-45bc-9972-2e7afd9a600c" xlink:to="loc_mdt_RestorativeTherapiesGroupMember_fe527ce0-a59e-463c-91eb-4f81b57682ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_8f757788-48a8-408d-9b1e-ea3cb8d9d61e" xlink:href="mdt-20201030.xsd#mdt_DiabetesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8b9f9923-285b-45bc-9972-2e7afd9a600c" xlink:to="loc_mdt_DiabetesGroupMember_8f757788-48a8-408d-9b1e-ea3cb8d9d61e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2b7e3a85-41b8-44b9-9352-cd727bfa6ee2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_65bce064-bcee-43d3-b4d9-bbc83f19e766" xlink:to="loc_srt_ConsolidationItemsAxis_2b7e3a85-41b8-44b9-9352-cd727bfa6ee2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2b7e3a85-41b8-44b9-9352-cd727bfa6ee2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_2b7e3a85-41b8-44b9-9352-cd727bfa6ee2" xlink:to="loc_srt_ConsolidationItemsDomain_2b7e3a85-41b8-44b9-9352-cd727bfa6ee2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f9782e23-a781-44ca-a462-fb3de23cb429" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_2b7e3a85-41b8-44b9-9352-cd727bfa6ee2" xlink:to="loc_srt_ConsolidationItemsDomain_f9782e23-a781-44ca-a462-fb3de23cb429" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_eba3fbf5-809b-4d10-a9c8-02b0ca0debe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_f9782e23-a781-44ca-a462-fb3de23cb429" xlink:to="loc_us-gaap_OperatingSegmentsMember_eba3fbf5-809b-4d10-a9c8-02b0ca0debe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_2d2aa9f7-8dfe-4c9d-9382-768295fe8672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_f9782e23-a781-44ca-a462-fb3de23cb429" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_2d2aa9f7-8dfe-4c9d-9382-768295fe8672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_bee12cb0-bed3-4da4-9446-ff3fc22714e2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_65bce064-bcee-43d3-b4d9-bbc83f19e766" xlink:to="loc_srt_StatementGeographicalAxis_bee12cb0-bed3-4da4-9446-ff3fc22714e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bee12cb0-bed3-4da4-9446-ff3fc22714e2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_bee12cb0-bed3-4da4-9446-ff3fc22714e2" xlink:to="loc_srt_SegmentGeographicalDomain_bee12cb0-bed3-4da4-9446-ff3fc22714e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3a6ee021-4c84-4dad-a044-8d86690999c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_bee12cb0-bed3-4da4-9446-ff3fc22714e2" xlink:to="loc_srt_SegmentGeographicalDomain_3a6ee021-4c84-4dad-a044-8d86690999c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_fe1fa873-469d-409a-b152-a7cade45a1ba" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3a6ee021-4c84-4dad-a044-8d86690999c7" xlink:to="loc_country_IE_fe1fa873-469d-409a-b152-a7cade45a1ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9926233c-6fb2-4671-91db-a5402e2ad8b6" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3a6ee021-4c84-4dad-a044-8d86690999c7" xlink:to="loc_country_US_9926233c-6fb2-4671-91db-a5402e2ad8b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_4f1b14c5-4d81-40c9-a6e5-cbf4f519165a" xlink:href="mdt-20201030.xsd#mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3a6ee021-4c84-4dad-a044-8d86690999c7" xlink:to="loc_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_4f1b14c5-4d81-40c9-a6e5-cbf4f519165a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TotalOtherCountriesExcludingIrelandMember_85c3fd88-e7ff-4632-8701-ea25bba5f39a" xlink:href="mdt-20201030.xsd#mdt_TotalOtherCountriesExcludingIrelandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3a6ee021-4c84-4dad-a044-8d86690999c7" xlink:to="loc_mdt_TotalOtherCountriesExcludingIrelandMember_85c3fd88-e7ff-4632-8701-ea25bba5f39a" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>mdt-20201030_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:8939d385-98d2-4684-bfa0-0279309cacd9,g:e5f1341e-11f4-4035-86fa-7f937a6230d9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_258a4974-d9f3-473d-86bc-6dd4311acb12_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c328ce0a-a31f-4c63-9588-78eca399de94_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-operating income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_PurchasedTechnologyAndPatentsMember_88509b2c-053a-4ede-98b5-f1aa2ba3f719_terseLabel_en-US" xlink:label="lab_mdt_PurchasedTechnologyAndPatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased technology and patents</link:label>
    <link:label id="lab_mdt_PurchasedTechnologyAndPatentsMember_label_en-US" xlink:label="lab_mdt_PurchasedTechnologyAndPatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased Technology and Patents [Member]</link:label>
    <link:label id="lab_mdt_PurchasedTechnologyAndPatentsMember_documentation_en-US" xlink:label="lab_mdt_PurchasedTechnologyAndPatentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased technology and patents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PurchasedTechnologyAndPatentsMember" xlink:href="mdt-20201030.xsd#mdt_PurchasedTechnologyAndPatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_PurchasedTechnologyAndPatentsMember" xlink:to="lab_mdt_PurchasedTechnologyAndPatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20391.50PercentMember_8f7b289b-81a1-46de-b75d-7a53796e5251_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Senior Notes due 2039</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20391.50PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2039, 1.50 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20391.50PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2039, 1.50 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20391.50PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b3d65ee7-189d-4d82-be42-d1de676667a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_46a66428-9c3a-4062-8afd-380f488b97b1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-For-Sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost_4a5e0296-b6e8-4085-82be-5cca6ce426a2_totalLabel_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost_label_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Held To Maturity, Amortized Cost</link:label>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost_documentation_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Held To Maturity, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost" xlink:to="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_7bbdfda3-e8f2-46f4-92df-59b4010aad0f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1c54cdca-0c12-42d2-bb8c-94217c59a8a7_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8ed6064d-9614-465a-add6-e6da6365bf41_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in AOCI by Component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_942398be-aec1-415b-a984-898d88ff522b_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_LossContingencyNumberofManufacturers_bd489f62-e170-47e2-a293-d324f59e8c9b_terseLabel_en-US" xlink:label="lab_mdt_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of manufacturers</link:label>
    <link:label id="lab_mdt_LossContingencyNumberofManufacturers_label_en-US" xlink:label="lab_mdt_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Manufacturers</link:label>
    <link:label id="lab_mdt_LossContingencyNumberofManufacturers_documentation_en-US" xlink:label="lab_mdt_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Manufacturers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossContingencyNumberofManufacturers" xlink:href="mdt-20201030.xsd#mdt_LossContingencyNumberofManufacturers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_LossContingencyNumberofManufacturers" xlink:to="lab_mdt_LossContingencyNumberofManufacturers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_dc829f11-9f73-421a-8b52-8b0166e31b0d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_a8ac34b4-0ffb-4488-9bac-7b1b62728e38_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in AOCI, Net investment hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e0b744a0-75ef-423b-b425-8a72e59d584a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_13425608-776f-472e-94c6-4df26dba6d6b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_1ed101a3-c987-4cde-956b-2cd4b9151648_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase accounting adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_a2c22308-6b2f-48fe-a15b-629f00e95237_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2013Due2024Member_ae198dde-9030-4df4-a7ed-bd9aa1c20296_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2013Due2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.950 percent ten-year 2013 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2013Due2024Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2013Due2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2013 Due 2024 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2013Due2024Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2013Due2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2013 Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2013Due2024Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2013Due2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2013Due2024Member" xlink:to="lab_mdt_SeniorNotes2013Due2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_31a04bc5-444c-4b79-aa0f-f36a3a56e423_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_ad34dd91-0917-405c-8323-8a28daf29805_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eb3be94f-5815-4aa2-b637-b744318058c1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_f5f7a951-8805-4aa6-9d99-e79da2bd658c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_93a5f865-d37a-41c7-a70a-b95c2e60c8e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_77df764c-6228-499a-8e0a-f9504ed1eee1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_800f8b34-4fa1-4190-a698-8f7f4f74f782_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_7a52b170-c72b-4749-8188-96e70a296848_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Currency Exchange Risk Management</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_RevenueMilestoneMember_386b17b9-c5cf-4e9f-ac48-fad478b95635_terseLabel_en-US" xlink:label="lab_mdt_RevenueMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue and other performance-based payments</link:label>
    <link:label id="lab_mdt_RevenueMilestoneMember_label_en-US" xlink:label="lab_mdt_RevenueMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Milestone [Member]</link:label>
    <link:label id="lab_mdt_RevenueMilestoneMember_documentation_en-US" xlink:label="lab_mdt_RevenueMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A milestone in achieving certain revenue target.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RevenueMilestoneMember" xlink:href="mdt-20201030.xsd#mdt_RevenueMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_RevenueMilestoneMember" xlink:to="lab_mdt_RevenueMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_cebdba9f-0681-46a4-a7cf-f96ea6536751_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_8875b41d-5221-4422-b8cc-6d535156da15_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2050Member_23704c7b-d1c0-43fa-bdd9-a68327af6fb2_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.750 percent thirty-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2050Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2050 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2050Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2050 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2050Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2050Member" xlink:to="lab_mdt_SeniorNotes2019Due2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2041Member_7270e72d-5bb1-49c4-abd3-6de657eb921f_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.375 percent twenty-year 2020 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2041Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2041 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2041Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2041Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2041Member" xlink:to="lab_mdt_SeniorNotes2020Due2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MedtronicLuxcoSeniorNotesMember_6696f8e2-9ecb-4581-83a6-d5584170ae61_terseLabel_en-US" xlink:label="lab_mdt_MedtronicLuxcoSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Luxco Senior Notes</link:label>
    <link:label id="lab_mdt_MedtronicLuxcoSeniorNotesMember_label_en-US" xlink:label="lab_mdt_MedtronicLuxcoSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Luxco Senior Notes [Member]</link:label>
    <link:label id="lab_mdt_MedtronicLuxcoSeniorNotesMember_documentation_en-US" xlink:label="lab_mdt_MedtronicLuxcoSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Luxco Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicLuxcoSeniorNotesMember" xlink:href="mdt-20201030.xsd#mdt_MedtronicLuxcoSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MedtronicLuxcoSeniorNotesMember" xlink:to="lab_mdt_MedtronicLuxcoSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_16e30100-7931-407f-a944-289e8d97ca33_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and tradenames</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9451251f-7645-4e6d-9218-c3cf58a31c49_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2c93e255-1dd8-4f6d-b9d7-e1ae0dc4c430_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash proceeds, net of discounts and issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_725061ef-9f27-4856-9b40-54422fab3fd6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_48c3ce46-2b72-4690-9bd3-cff3a6b3a2fa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_d6dccab8-9a98-47e0-b3b2-32b0ad01b14e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCollateralObligationToReturnCash_34f70bed-0c83-4da8-9360-5f2f58c1992f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)</link:label>
    <link:label id="lab_us-gaap_DerivativeCollateralObligationToReturnCash_label_en-US" xlink:label="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Collateral, Obligation to Return Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:to="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember_cccd74d6-18d0-4d47-9f42-d2fda5472624_terseLabel_en-US" xlink:label="lab_mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable Asset Created for Swiss Federal Income Tax Purposes</link:label>
    <link:label id="lab_mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember_label_en-US" xlink:label="lab_mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable Asset Created for Swiss Federal Income Tax Purposes [Member]</link:label>
    <link:label id="lab_mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember_documentation_en-US" xlink:label="lab_mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable Asset Created for Swiss Federal Income Tax Purposes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember" xlink:href="mdt-20201030.xsd#mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember" xlink:to="lab_mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_6ec3101d-ab6e-4244-90d5-952033f898b4_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2015Due2045Member_c2dd3cdb-0bb9-4d93-a3aa-3555019b5f43_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2015Due2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625 percent thirty-year 2015 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2015Due2045Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2015Due2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2015 Due 2045 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2015Due2045Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2015Due2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2015 Due 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due2045Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2015Due2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2015Due2045Member" xlink:to="lab_mdt_SeniorNotes2015Due2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_c820c5f8-52ae-4316-8554-e215457ca2ba_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_f41b22b2-bb49-4ed6-932b-506fb7e64602_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fa803fd8-14f3-4b20-918e-da442a20d7ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_8bed7d59-2557-48c6-861c-7ff9cd48d3ad_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 16)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0bc71cd5-02bb-4864-86e7-91aec70088d8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_13ac33e7-cbfc-4aaa-8114-7151aa6e7849_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_71ee9d9e-4614-432c-b94b-4ca17892bcc3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under stock purchase and award plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_74a65369-eb37-46d9-bd36-80362cdc1d8a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_223c79ee-d827-47bc-8058-b0e080de43e0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation and other</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment_53d6b8bb-0493-4a07-a85c-fe00902cdba7_negatedLabel_en-US" xlink:label="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment_label_en-US" xlink:label="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration, Milestone Payment</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment_documentation_en-US" xlink:label="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent milestone payments in business acquisition transactions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" xlink:href="mdt-20201030.xsd#mdt_BusinessAcquisitionContingentConsiderationMilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" xlink:to="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_6ee3cb37-910a-4c79-ac9f-3bf137621150_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_2e47f6e0-a9ea-48cb-89cf-2d7f2c4b8e09_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_83239880-f0b9-4482-af00-985da5e8f130_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MedicalDeviceRegulations_28b97019-6d0d-46a9-b8cc-c59253db771e_negatedTerseLabel_en-US" xlink:label="lab_mdt_MedicalDeviceRegulations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical device regulations</link:label>
    <link:label id="lab_mdt_MedicalDeviceRegulations_label_en-US" xlink:label="lab_mdt_MedicalDeviceRegulations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Device Regulations</link:label>
    <link:label id="lab_mdt_MedicalDeviceRegulations_documentation_en-US" xlink:label="lab_mdt_MedicalDeviceRegulations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Device Regulations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalDeviceRegulations" xlink:href="mdt-20201030.xsd#mdt_MedicalDeviceRegulations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MedicalDeviceRegulations" xlink:to="lab_mdt_MedicalDeviceRegulations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_6c5d0837-6429-457c-9329-5c188d51e6a3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_3210a8da-d68f-447c-bf84-85d799476347_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract_6c4cce2c-5049-46da-b13c-1d350676eb2a_terseLabel_en-US" xlink:label="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract_label_en-US" xlink:label="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation, Denominator [Abstract]</link:label>
    <link:label id="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract_documentation_en-US" xlink:label="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract" xlink:href="mdt-20201030.xsd#mdt_EarningsPerShareReconciliationDenominatorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract" xlink:to="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_923e9984-9971-4c50-9f03-b89cd37405a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_5a1eebd6-a806-4e90-90c2-5bfc72b940ee_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_056890e1-6e73-4260-b603-d7c1b0542f3c_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_62fe5f83-f3c0-443f-b31c-aefb77a6a4bd_totalLabel_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_label_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Held-To-Maturity, Fair Value</link:label>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_documentation_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Held-To-Maturity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" xlink:to="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_a8af155b-953f-4daa-a1ab-9416a601f796_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost associated with amortization of previously established deferred tax assets from intercompany intellectual property transactions</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_e712271b-f56e-42a8-82da-9e2eae177565_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3693dcd2-c220-461e-a740-62c82ef37121_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_95cb16bc-c472-416a-84a5-7aa74641ba76_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_46544eb8-8a58-4b78-a2e8-9477d1d366dc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_80807ef7-a258-448c-8fad-03095931101f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b8247c50-4f86-4f77-a622-fcbe2f9c081a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_AssociatedCostsMember_045d5718-dbaf-4b0c-afc8-38ed4b8e4e31_terseLabel_en-US" xlink:label="lab_mdt_AssociatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associated Costs</link:label>
    <link:label id="lab_mdt_AssociatedCostsMember_label_en-US" xlink:label="lab_mdt_AssociatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associated Costs [Member]</link:label>
    <link:label id="lab_mdt_AssociatedCostsMember_documentation_en-US" xlink:label="lab_mdt_AssociatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associated Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AssociatedCostsMember" xlink:href="mdt-20201030.xsd#mdt_AssociatedCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_AssociatedCostsMember" xlink:to="lab_mdt_AssociatedCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_16d97b94-a563-49bc-9d24-9d00c0201f3b_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_573d332e-19dc-495b-b700-c98c6f288378_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_4bf8cdf2-83c3-4338-9407-dc310da93e8c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_81fad33f-37f5-410f-9d64-625a25cea620_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b0fca7f7-a242-444a-8bbe-136a703932c9_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c6892af-1d09-4816-be90-e38ac5eeceeb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_47149644-ad38-4e2f-9c23-5b6f3f383857_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_a7dc1797-12af-423b-a093-9c27b51d801b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_be1e1e61-4000-4bb3-8817-73db72d8e8e1_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f4567852-7f48-4b15-af9f-a1dd931c2bb9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_e3365917-0d1a-432c-a5d8-0226356459c2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_e7a33624-2e02-4a33-ae8c-3b717f1ec6aa_verboseLabel_en-US" xlink:label="lab_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental expense related to acceptance of voluntary early retirement packages</link:label>
    <link:label id="lab_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_label_en-US" xlink:label="lab_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit And Contribution Plan, Cost of Providing Special and Contractual Termination Benefits</link:label>
    <link:label id="lab_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_documentation_en-US" xlink:label="lab_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit And Contribution Plan, Cost of Providing Special and Contractual Termination Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" xlink:href="mdt-20201030.xsd#mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" xlink:to="lab_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DebtLineItems_e56521fc-4cbf-445e-8d01-b16beefe1472_terseLabel_en-US" xlink:label="lab_mdt_DebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt [Line Items]</link:label>
    <link:label id="lab_mdt_DebtLineItems_label_en-US" xlink:label="lab_mdt_DebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt [Line Items]</link:label>
    <link:label id="lab_mdt_DebtLineItems_documentation_en-US" xlink:label="lab_mdt_DebtLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtLineItems" xlink:href="mdt-20201030.xsd#mdt_DebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DebtLineItems" xlink:to="lab_mdt_DebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_9e8847ce-ee3a-4f11-96fa-64e72091306d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_c0c51132-28dd-4449-95a3-5846b5628a42_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_d7c9ad7e-8096-402a-89bd-a15730318a93_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_f0811d8a-4a9b-44b9-a950-5116e4ce540b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_509871e1-2918-4e17-955a-14b432334270_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_d46e6bf9-267a-42b9-b960-d6b6ac6ba771_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_688f041c-c68a-4be6-9710-81bf2afe8274_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_c717eff6-679b-480f-a2ca-e681b2d57c95_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_4a6530a1-f9fd-411e-8a6d-6bf92c9f971d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains (losses) on equity and other investments still held</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_05bc9050-7ae9-4953-975d-7ece56ff66cc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_94fa7761-485a-4ec2-bae6-fb02933d7c07_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_e02f2e67-d632-41e1-adfa-93d86b72604c_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related items</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_796b237a-dfc5-4048-86c3-55637f9749ec_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_2600501f-5dcf-49c7-bfe0-fbdffc579064_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_c03e4af3-9105-4ade-8168-3131f41d5e8d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_1615003b-b886-427c-80f4-1782f83b17da_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_e26efc9f-f64a-4396-9a77-660528b1aa0c_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_0dfdff03-0d6e-4288-b1e5-e5c25de8bf46_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_314750d2-ee3e-4523-a5ee-6470bcbde9ba_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_4fcc42f8-9aea-4cb8-99f3-5fa76f748d24_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_b49b7c76-47a2-4617-a190-c9fb8974f15f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ae93c0da-5eef-4cce-9399-0baea7e4747f_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government and agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_e93cb49d-bc72-4e48-a0ce-69f402bd7d39_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activities Related to Debt Securities Portfolio</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Gain (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty_7138479f-5810-444c-ad70-016d29cc15da_negatedLabel_en-US" xlink:label="lab_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit associated with finalization of intercompany sale of intellectual property and establishment of deferred tax asset</link:label>
    <link:label id="lab_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty_label_en-US" xlink:label="lab_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Expense (Benefit) Associated With Sale of Intellectual Property</link:label>
    <link:label id="lab_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty_documentation_en-US" xlink:label="lab_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Expense (Benefit) Associated With Sale of Intellectual Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty" xlink:href="mdt-20201030.xsd#mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty" xlink:to="lab_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_4ca993d1-adfc-4b7a-823c-4342fd7fa5f0_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_3da642f6-4eab-4482-aa3a-e1682a9171dd_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain reclassified from AOCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_5ccfcbfd-450e-4101-9b7b-0c944096980b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_bdcd8944-e0bb-40a1-9763-91c39406f878_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DiabetesGroupMember_137a5129-ad33-4c3c-b226-8bbd815f5179_terseLabel_en-US" xlink:label="lab_mdt_DiabetesGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes Group</link:label>
    <link:label id="lab_mdt_DiabetesGroupMember_label_en-US" xlink:label="lab_mdt_DiabetesGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes Group [Member]</link:label>
    <link:label id="lab_mdt_DiabetesGroupMember_documentation_en-US" xlink:label="lab_mdt_DiabetesGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes Group [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember" xlink:href="mdt-20201030.xsd#mdt_DiabetesGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DiabetesGroupMember" xlink:to="lab_mdt_DiabetesGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7fbbe44b-458f-44f9-a454-7005eb74e6b8_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_75cc3d53-78b3-4650-856c-957df8116a4c_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_eb932d10-2a47-4539-b382-62a520b56f23_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_0c19488e-eec8-4c83-a7bf-9139f7a0880a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1bb06dc-646f-4fc8-9ffb-2e86d3c4d82a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_883ab7ae-5f76-43f1-a8ca-e7d8774193af_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_48f7d50a-3b19-40f2-ba5b-da097e3745a5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3bd06636-a7e0-44e6-a3be-d9510c6f5d1b_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_4ec66d55-b625-409e-80e5-4caaeb21b24f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_8ec723fc-2bf7-4a9b-841b-977ab9b7da63_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_fd306d76-7cb8-46f8-bf23-beacdbe53351_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_fc04b2e7-05ce-45c3-9d03-bfcfee28fc56_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information</link:label>
    <link:label id="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_label_en-US" xlink:label="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Areas, Revenues from External Customers [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:to="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_PelvicMeshLitigationMember_d1b8eaaa-4ab8-43bb-83c7-b49f0d5d8d19_terseLabel_en-US" xlink:label="lab_mdt_PelvicMeshLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pelvic mesh</link:label>
    <link:label id="lab_mdt_PelvicMeshLitigationMember_label_en-US" xlink:label="lab_mdt_PelvicMeshLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pelvic Mesh Litigation [Member]</link:label>
    <link:label id="lab_mdt_PelvicMeshLitigationMember_documentation_en-US" xlink:label="lab_mdt_PelvicMeshLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pelvic Mesh Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PelvicMeshLitigationMember" xlink:href="mdt-20201030.xsd#mdt_PelvicMeshLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_PelvicMeshLitigationMember" xlink:to="lab_mdt_PelvicMeshLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec2223ce-12b1-4dee-aa31-2b7e865ad709_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_303dc807-c698-4631-95ce-8825c3906b22_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued gross interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_b5d90010-0281-4ab0-9e47-48b1ba0d8964_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_b978c78b-ae60-4bbc-9b93-aa19879d9880_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, amount outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_72c7813b-5b7a-4e36-9949-7a8363e1abec_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2021FloatingMember_678e1018-ee9b-4ee6-973b-755d99e6947c_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2021FloatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes due 2021</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2021FloatingMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2021FloatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2021, Floating [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2021FloatingMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2021FloatingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2021, Floating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2021FloatingMember" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2021FloatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2021FloatingMember" xlink:to="lab_mdt_SeniorNotes2019Due2021FloatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_950d640e-a75b-471f-909c-308fc0c75863_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_9b0c8cdb-8970-41b7-8188-f942f43bba90_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2033Member_fa748bbf-1aa7-49b2-8437-019669b3382f_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2033Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.750 percent twelve-year 2020 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2033Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2033Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2033 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2033Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2033Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2033</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2033Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2033Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2033Member" xlink:to="lab_mdt_SeniorNotes2020Due2033Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_001110cc-ae94-4724-98cb-6ee4ba8f0652_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DeferredTaxAssetsAmortizationPeriod_d5ff72ef-c681-4148-8791-ae7b0ea53b69_terseLabel_en-US" xlink:label="lab_mdt_DeferredTaxAssetsAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset amortization period</link:label>
    <link:label id="lab_mdt_DeferredTaxAssetsAmortizationPeriod_label_en-US" xlink:label="lab_mdt_DeferredTaxAssetsAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Amortization Period</link:label>
    <link:label id="lab_mdt_DeferredTaxAssetsAmortizationPeriod_documentation_en-US" xlink:label="lab_mdt_DeferredTaxAssetsAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DeferredTaxAssetsAmortizationPeriod" xlink:href="mdt-20201030.xsd#mdt_DeferredTaxAssetsAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DeferredTaxAssetsAmortizationPeriod" xlink:to="lab_mdt_DeferredTaxAssetsAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_13df15b8-92f0-4b14-a137-ca173560aeb1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_86f255dc-9c99-4577-a1ce-4fef8c23d73e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_e1dafd74-dc45-486b-88c3-d8feb0c84127_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patents allegedly infringed upon</link:label>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:to="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_20d0d97c-b982-4827-beda-29777734a6cf_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_baf599d8-8748-4800-932e-6aeb9466dc01_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c5619b86-f369-45f3-bc32-126da1990e73_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08a3caaf-6295-491c-b121-a01ebd1b551a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8b877a45-5174-43d3-8494-821cd9131e34_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent_d95d6dc5-73ee-4bcb-82b2-cf879a101077_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebate obligations</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Refund Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTableTextBlock_d019362c-7863-4827-969c-131db1454a71_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTableTextBlock" xlink:to="lab_us-gaap_OffsettingAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_164bb52c-99e9-4821-ac7e-05977a337da9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount and Accumulated Amortization of Definite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_ff2a8453-5d19-4a2f-9c2f-b97d6f158b15_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings (maturities greater than 90 days)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_de70dfd1-05b4-4111-93c5-0ad22336b8b2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">More than 12 months, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_5db71898-7a28-4bac-88df-6fd715515c56_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold_b3506eeb-0da3-488e-ad33-ed3c9c7f31cd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for available-for-sale or held-to-maturity securities sold</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Securities Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CardiacAndVascularGroupMember_1360b320-d170-416f-97c6-ebdf1082bbcd_terseLabel_en-US" xlink:label="lab_mdt_CardiacAndVascularGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac &amp; Vascular Group</link:label>
    <link:label id="lab_mdt_CardiacAndVascularGroupMember_label_en-US" xlink:label="lab_mdt_CardiacAndVascularGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac and Vascular Group [Member]</link:label>
    <link:label id="lab_mdt_CardiacAndVascularGroupMember_documentation_en-US" xlink:label="lab_mdt_CardiacAndVascularGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac and Vascular Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacAndVascularGroupMember" xlink:href="mdt-20201030.xsd#mdt_CardiacAndVascularGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CardiacAndVascularGroupMember" xlink:to="lab_mdt_CardiacAndVascularGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_6814dd54-d3eb-4a69-a0de-15918d18d9d7_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_1decfaeb-47e9-4518-90b0-7d6b5f351a95_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities:</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:to="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_f6ee093f-1f8d-49ed-8809-09da019242c0_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications, tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2029Member_33c0cb33-42fb-4202-8d2c-ed3fec68e501_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.375 percent eight-year 2020 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2029Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2029 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2029Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2029Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2029Member" xlink:to="lab_mdt_SeniorNotes2020Due2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_IncomeTaxesandInterestPaidAbstract_10342d57-0d22-4f3b-8f01-e7e26667b964_terseLabel_en-US" xlink:label="lab_mdt_IncomeTaxesandInterestPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for:</link:label>
    <link:label id="lab_mdt_IncomeTaxesandInterestPaidAbstract_label_en-US" xlink:label="lab_mdt_IncomeTaxesandInterestPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes and Interest Paid [Abstract]</link:label>
    <link:label id="lab_mdt_IncomeTaxesandInterestPaidAbstract_documentation_en-US" xlink:label="lab_mdt_IncomeTaxesandInterestPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes and Interest Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_IncomeTaxesandInterestPaidAbstract" xlink:href="mdt-20201030.xsd#mdt_IncomeTaxesandInterestPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_IncomeTaxesandInterestPaidAbstract" xlink:to="lab_mdt_IncomeTaxesandInterestPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_1d319d38-494c-4ff0-8a21-8e4dcc66defc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c0bc98d5-f6f1-4a4a-b027-96e73350ac3b_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_ScheduleOfDebtTable_0b0fe0f9-7f9f-4859-b67f-59dbd634f4f9_terseLabel_en-US" xlink:label="lab_mdt_ScheduleOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table]</link:label>
    <link:label id="lab_mdt_ScheduleOfDebtTable_label_en-US" xlink:label="lab_mdt_ScheduleOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table]</link:label>
    <link:label id="lab_mdt_ScheduleOfDebtTable_documentation_en-US" xlink:label="lab_mdt_ScheduleOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A table or schedule providing information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ScheduleOfDebtTable" xlink:href="mdt-20201030.xsd#mdt_ScheduleOfDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_ScheduleOfDebtTable" xlink:to="lab_mdt_ScheduleOfDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_c9eb46f6-dbbe-452e-8a0e-a558adbc8a57_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems" xlink:to="lab_us-gaap_MarketableSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_014815d4-83bb-40e7-975b-8cbea0108ab9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_2c421079-c371-455b-9824-279e9d5ebb6d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_d429ceac-9fa3-486d-a7dc-09d7566060e0_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAbstract_21e0698e-ef19-4847-8253-8a2d77cf6192_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAbstract_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract" xlink:to="lab_us-gaap_LineOfCreditFacilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax_97c2ee56-33be-4f7d-b6fd-e763ee8012b9_negatedTotalLabel_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Held-To-Maturity, Accumulated Unrealized Loss, Before Tax</link:label>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Held-To-Maturity, Accumulated Unrealized Loss, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax" xlink:to="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_4bbc3fd5-4d66-452d-b21b-3282fca5d92c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_27b20f66-9209-4a48-87b6-52aa3d6af29a_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances for accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_391e0853-a9ff-46a6-91f1-819562f1744d_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_0d1cfe6a-4f55-47bf-993e-f59089c765f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7299b6fe-d8a4-4e09-b425-b4882e9f36c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts of (Gains) Losses Recognized in AOCI for Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_bc3633f7-f106-49d1-a056-d0e0ca26d175_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5c7a831a-0a97-4e3a-91aa-5b7f8defbe8e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_LossContingencyNumberofSubsidiaries_acf6d861-d0c4-4634-b1b5-99d92f103890_terseLabel_en-US" xlink:label="lab_mdt_LossContingencyNumberofSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of subsidiaries</link:label>
    <link:label id="lab_mdt_LossContingencyNumberofSubsidiaries_label_en-US" xlink:label="lab_mdt_LossContingencyNumberofSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Subsidiaries</link:label>
    <link:label id="lab_mdt_LossContingencyNumberofSubsidiaries_documentation_en-US" xlink:label="lab_mdt_LossContingencyNumberofSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossContingencyNumberofSubsidiaries" xlink:href="mdt-20201030.xsd#mdt_LossContingencyNumberofSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_LossContingencyNumberofSubsidiaries" xlink:to="lab_mdt_LossContingencyNumberofSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_5000f056-493a-4d90-81f3-1350713b2d5c_totalLabel_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain tax adjustments, provision (benefit)</link:label>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_label_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Adjustments, Settlements, and Unusual Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:to="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_29a7befe-ae37-487c-bf7b-777086d97b23_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SimplificationRestructuringProgramMember_21be25c5-7d28-4c1e-8a8d-4d349c9729de_terseLabel_en-US" xlink:label="lab_mdt_SimplificationRestructuringProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simplification</link:label>
    <link:label id="lab_mdt_SimplificationRestructuringProgramMember_label_en-US" xlink:label="lab_mdt_SimplificationRestructuringProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simplification Restructuring Program [Member]</link:label>
    <link:label id="lab_mdt_SimplificationRestructuringProgramMember_documentation_en-US" xlink:label="lab_mdt_SimplificationRestructuringProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simplification Restructuring Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SimplificationRestructuringProgramMember" xlink:href="mdt-20201030.xsd#mdt_SimplificationRestructuringProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SimplificationRestructuringProgramMember" xlink:to="lab_mdt_SimplificationRestructuringProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_RestorativeTherapiesGroupMember_20c0e07b-842c-4041-8218-04e19af12672_terseLabel_en-US" xlink:label="lab_mdt_RestorativeTherapiesGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restorative Therapies Group</link:label>
    <link:label id="lab_mdt_RestorativeTherapiesGroupMember_label_en-US" xlink:label="lab_mdt_RestorativeTherapiesGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restorative Therapies Group [Member]</link:label>
    <link:label id="lab_mdt_RestorativeTherapiesGroupMember_documentation_en-US" xlink:label="lab_mdt_RestorativeTherapiesGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restorative Therapies Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestorativeTherapiesGroupMember" xlink:href="mdt-20201030.xsd#mdt_RestorativeTherapiesGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_RestorativeTherapiesGroupMember" xlink:to="lab_mdt_RestorativeTherapiesGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_923c5fab-ff79-45de-af2d-40c1c8b17511_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_9c7a648f-ec68-491e-939a-a6b7947bfee2_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_1204a40e-14aa-46f7-ac79-46c634e35e8e_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_bab167d6-4cf9-4e1e-906f-eec742800db9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_1167f4a6-b945-4b66-84b2-d8305e0879fc_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency exchange rate contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2007Due2038Member_5ac27e60-5be7-4620-babe-4cf4d1daf069_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2007Due2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.550 percent thirty-year 2007 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2007Due2038Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2007Due2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2007 Due 2038 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2007Due2038Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2007Due2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2007 Due 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2007Due2038Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2007Due2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2007Due2038Member" xlink:to="lab_mdt_SeniorNotes2007Due2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsMember_1253a409-0e06-491d-b090-5101961ac17f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsMember_label_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsMember" xlink:to="lab_us-gaap_InvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EthiconPatentInfringementLitigationMember_cadec6da-b378-49bc-b646-72dd463b746f_terseLabel_en-US" xlink:label="lab_mdt_EthiconPatentInfringementLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ethicon</link:label>
    <link:label id="lab_mdt_EthiconPatentInfringementLitigationMember_label_en-US" xlink:label="lab_mdt_EthiconPatentInfringementLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ethicon Patent Infringement Litigation [Member]</link:label>
    <link:label id="lab_mdt_EthiconPatentInfringementLitigationMember_documentation_en-US" xlink:label="lab_mdt_EthiconPatentInfringementLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ethicon Patent Infringement Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EthiconPatentInfringementLitigationMember" xlink:href="mdt-20201030.xsd#mdt_EthiconPatentInfringementLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EthiconPatentInfringementLitigationMember" xlink:to="lab_mdt_EthiconPatentInfringementLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_e0247dc5-160e-41ad-acb4-84cbba7bb5c6_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_0d6d972e-e880-45b9-93d2-201e5079428d_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-related</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_46dd1e57-bf39-42d1-891d-134841d06ad5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_7e7e7dd7-418b-4354-834e-33c74bacd353_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SurgicalInnovationsDivisionMember_aa7a0931-e8c5-48bd-adb8-a7903d70e019_terseLabel_en-US" xlink:label="lab_mdt_SurgicalInnovationsDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Innovations</link:label>
    <link:label id="lab_mdt_SurgicalInnovationsDivisionMember_label_en-US" xlink:label="lab_mdt_SurgicalInnovationsDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Innovations Division [Member]</link:label>
    <link:label id="lab_mdt_SurgicalInnovationsDivisionMember_documentation_en-US" xlink:label="lab_mdt_SurgicalInnovationsDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Innovations Division [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SurgicalInnovationsDivisionMember" xlink:href="mdt-20201030.xsd#mdt_SurgicalInnovationsDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SurgicalInnovationsDivisionMember" xlink:to="lab_mdt_SurgicalInnovationsDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_81e81f96-e747-45f4-bc46-2a2402396086_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_39122e02-d1e2-444e-9f1b-685a06ff1710_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_61fbdd4f-f24d-4baf-97cc-a729dd137eae_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_4a5a72fe-2604-4669-bb8c-0062864024da_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. government and agency securities</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Government, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_72f6583e-bc2f-4a72-94a4-a3eb274ab15d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain litigation charges, net</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_5db21165-0d29-489c-883b-92302130fd20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain litigation charges, net</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_fa457b7e-d3a4-4826-942a-a44c43272873_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_f8eaff23-7bc9-4b54-a51a-b680dde85c6a_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_431dc678-22dd-4ecf-a8a0-4d8cf592e211_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts and Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_bc2ad35d-11b3-4284-9116-13d0f2cf6a3b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit of businesses</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CardiacRhythmandHeartFailureDivisionMember_c4c79232-abd8-4a2c-94d6-751405d4632f_terseLabel_en-US" xlink:label="lab_mdt_CardiacRhythmandHeartFailureDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac Rhythm &amp; Heart Failure</link:label>
    <link:label id="lab_mdt_CardiacRhythmandHeartFailureDivisionMember_label_en-US" xlink:label="lab_mdt_CardiacRhythmandHeartFailureDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac Rhythm and Heart Failure Division [Member]</link:label>
    <link:label id="lab_mdt_CardiacRhythmandHeartFailureDivisionMember_documentation_en-US" xlink:label="lab_mdt_CardiacRhythmandHeartFailureDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac Rhythm and Heart Failure Division [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacRhythmandHeartFailureDivisionMember" xlink:href="mdt-20201030.xsd#mdt_CardiacRhythmandHeartFailureDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CardiacRhythmandHeartFailureDivisionMember" xlink:to="lab_mdt_CardiacRhythmandHeartFailureDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_AllBusinessAcquisitionsMember_aa834fb6-3fa1-4c30-9532-2f394fd66d70_terseLabel_en-US" xlink:label="lab_mdt_AllBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Business Acquisitions</link:label>
    <link:label id="lab_mdt_AllBusinessAcquisitionsMember_label_en-US" xlink:label="lab_mdt_AllBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Business Acquisitions [Member]</link:label>
    <link:label id="lab_mdt_AllBusinessAcquisitionsMember_documentation_en-US" xlink:label="lab_mdt_AllBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Business Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AllBusinessAcquisitionsMember" xlink:href="mdt-20201030.xsd#mdt_AllBusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_AllBusinessAcquisitionsMember" xlink:to="lab_mdt_AllBusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_ce60605f-5ce0-44c7-a45e-4e9a84b89f1c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_58ec4fb0-6f33-4b63-8aa6-14e6ae848421_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_5701e9ad-6ca0-48b2-a04c-b2b70e7ce040_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (loss) gain on investment securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6ec371be-6170-4084-b2b6-0aad3623868f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DerivativeAssetLiabilityAbstract_15cbaa46-7a76-4465-bb9f-22b1057848a8_terseLabel_en-US" xlink:label="lab_mdt_DerivativeAssetLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_mdt_DerivativeAssetLiabilityAbstract_label_en-US" xlink:label="lab_mdt_DerivativeAssetLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset (Liability) [Abstract]</link:label>
    <link:label id="lab_mdt_DerivativeAssetLiabilityAbstract_documentation_en-US" xlink:label="lab_mdt_DerivativeAssetLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset (Liability) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityAbstract" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract" xlink:to="lab_mdt_DerivativeAssetLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2015Due2022Member_98a21f39-6009-484f-923c-44a58075ead1_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2015Due2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.150 percent seven-year 2015 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2015Due2022Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2015Due2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2015 Due 2022 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2015Due2022Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2015Due2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2015 Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due2022Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2015Due2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2015Due2022Member" xlink:to="lab_mdt_SeniorNotes2015Due2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_d29f22e6-d3b7-44ab-a071-d12236c0dd8f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_c513b735-9bf3-4edb-b4d8-234e0aab78e1_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japanese Yen-denominated Debt</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_76f6b8cc-bde3-4d9c-9ecd-b97198f3160f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit related to tax legislative changes in Switzerland</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingenciesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_f56f1997-a623-412c-bac7-02e4b7ed9103_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_e3a569da-8a65-40c5-8228-ce2f5509feb3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SpecialChargesGains_29603368-52a0-42eb-af6e-f7cdc4a18179_negatedTerseLabel_en-US" xlink:label="lab_mdt_SpecialChargesGains" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charges (Gains)</link:label>
    <link:label id="lab_mdt_SpecialChargesGains_label_en-US" xlink:label="lab_mdt_SpecialChargesGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charges (Gains)</link:label>
    <link:label id="lab_mdt_SpecialChargesGains_documentation_en-US" xlink:label="lab_mdt_SpecialChargesGains" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charges (Gains)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SpecialChargesGains" xlink:href="mdt-20201030.xsd#mdt_SpecialChargesGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SpecialChargesGains" xlink:to="lab_mdt_SpecialChargesGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteDomain_d82051c8-6f2a-4a8c-89fe-c4d7d9d2edf3_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Domain]</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteDomain_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain" xlink:to="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_9e5faa51-595b-40ca-ac59-8aa82aeeec79_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits_7d602d07-508c-4215-96b5-c3dce32990c0_terseLabel_en-US" xlink:label="lab_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental expense related to acceptance of voluntary early retirement packages, amount related to cash payments and administrative fees</link:label>
    <link:label id="lab_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits_label_en-US" xlink:label="lab_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit And Contribution Plan, Cash Payments And Administrative Expense Related To Providing Special And Contractual Termination Benefits</link:label>
    <link:label id="lab_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits_documentation_en-US" xlink:label="lab_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit And Contribution Plan, Cash Payments And Administrative Expense Related To Providing Special And Contractual Termination Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits" xlink:href="mdt-20201030.xsd#mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits" xlink:to="lab_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_761358fe-0ef4-4e79-a11b-8afc27403c20_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteAxis_61d1b2a6-859c-4370-8f27-5d935c26f283_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Axis]</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteAxis_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis" xlink:to="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_ad3c99bf-79fc-4d2d-a532-a7683cfe9d57_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_0cd5e7cc-05f0-4d71-b741-048d395cdb55_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits recorded as noncurrent liability</link:label>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_OffsettingAssetsandLiabilitiesLineItems_493b7b09-7477-4186-9e63-871c2c08ee01_terseLabel_en-US" xlink:label="lab_mdt_OffsettingAssetsandLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets and Liabilities [Line Items]</link:label>
    <link:label id="lab_mdt_OffsettingAssetsandLiabilitiesLineItems_label_en-US" xlink:label="lab_mdt_OffsettingAssetsandLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets and Liabilities [Line Items]</link:label>
    <link:label id="lab_mdt_OffsettingAssetsandLiabilitiesLineItems_documentation_en-US" xlink:label="lab_mdt_OffsettingAssetsandLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Offsetting Assets and Liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OffsettingAssetsandLiabilitiesLineItems" xlink:href="mdt-20201030.xsd#mdt_OffsettingAssetsandLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems" xlink:to="lab_mdt_OffsettingAssetsandLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_8d0db036-d0bd-4025-9156-251ec597b747_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency interest rate contracts</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CommercialPaperMaximumBorrowingCapacity_b7b5bc1c-b6f4-4aa5-b886-83baa2cc4d70_terseLabel_en-US" xlink:label="lab_mdt_CommercialPaperMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper, maximum borrowing amount</link:label>
    <link:label id="lab_mdt_CommercialPaperMaximumBorrowingCapacity_label_en-US" xlink:label="lab_mdt_CommercialPaperMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_mdt_CommercialPaperMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_mdt_CommercialPaperMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CommercialPaperMaximumBorrowingCapacity" xlink:href="mdt-20201030.xsd#mdt_CommercialPaperMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CommercialPaperMaximumBorrowingCapacity" xlink:to="lab_mdt_CommercialPaperMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld_4f43c78b-3864-4f35-b014-da55333b3e74_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities in credit loss position</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EmployeesStockPurchasePlanMember_4bc815db-4cdb-4f91-a86c-7bf3e301c075_terseLabel_en-US" xlink:label="lab_mdt_EmployeesStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_mdt_EmployeesStockPurchasePlanMember_label_en-US" xlink:label="lab_mdt_EmployeesStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_mdt_EmployeesStockPurchasePlanMember_documentation_en-US" xlink:label="lab_mdt_EmployeesStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EmployeesStockPurchasePlanMember" xlink:href="mdt-20201030.xsd#mdt_EmployeesStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EmployeesStockPurchasePlanMember" xlink:to="lab_mdt_EmployeesStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_4979e4a0-995a-40ea-bdb3-bc38cc7e293e_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_f0249615-df4d-442e-8584-e6e4116243c0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EnterpriseExcellenceMember_9f2e29ba-30ff-4b75-8de0-825eadcf12b4_terseLabel_en-US" xlink:label="lab_mdt_EnterpriseExcellenceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enterprise Excellence</link:label>
    <link:label id="lab_mdt_EnterpriseExcellenceMember_label_en-US" xlink:label="lab_mdt_EnterpriseExcellenceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enterprise Excellence [Member]</link:label>
    <link:label id="lab_mdt_EnterpriseExcellenceMember_documentation_en-US" xlink:label="lab_mdt_EnterpriseExcellenceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enterprise Excellence [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EnterpriseExcellenceMember" xlink:href="mdt-20201030.xsd#mdt_EnterpriseExcellenceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EnterpriseExcellenceMember" xlink:to="lab_mdt_EnterpriseExcellenceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember_a20238e0-0aec-4fc9-98d2-aca9b374c5e7_terseLabel_en-US" xlink:label="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orrington, Maine chemical manufacturing facility</link:label>
    <link:label id="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember_label_en-US" xlink:label="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orrington, Maine Chemical Manufacturing Facility [Member]</link:label>
    <link:label id="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember_documentation_en-US" xlink:label="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orrington, Maine Chemical Manufacturing Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OrringtonMaineChemicalManufacturingFacilityMember" xlink:href="mdt-20201030.xsd#mdt_OrringtonMaineChemicalManufacturingFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_OrringtonMaineChemicalManufacturingFacilityMember" xlink:to="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e130af23-838d-412f-80f9-9a2bd98f2b7f_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized that was previously included in deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3e98ecfb-ce6a-4154-b6e7-09ddb1130789_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5dd5e22b-5350-4d4e-80a6-a1a5c1ac25e2_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to ordinary shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SassoLitigationMember_1751af0c-d7e0-4286-8604-fd81dc551812_terseLabel_en-US" xlink:label="lab_mdt_SassoLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sasso</link:label>
    <link:label id="lab_mdt_SassoLitigationMember_label_en-US" xlink:label="lab_mdt_SassoLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sasso Litigation [Member]</link:label>
    <link:label id="lab_mdt_SassoLitigationMember_documentation_en-US" xlink:label="lab_mdt_SassoLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sasso Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SassoLitigationMember" xlink:href="mdt-20201030.xsd#mdt_SassoLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SassoLitigationMember" xlink:to="lab_mdt_SassoLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_aba7eaf2-7de0-43a3-abf5-5465756b885e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_3fd0e53b-1b49-45cc-9720-67338d4ed197_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in AOCI, Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_b9686f32-8319-4de2-b1eb-f1735e67c6a2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DebtInstrumentNumberofTranches_3980df26-c0d5-444d-b212-b87bc83b9c16_terseLabel_en-US" xlink:label="lab_mdt_DebtInstrumentNumberofTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of tranches</link:label>
    <link:label id="lab_mdt_DebtInstrumentNumberofTranches_label_en-US" xlink:label="lab_mdt_DebtInstrumentNumberofTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Tranches</link:label>
    <link:label id="lab_mdt_DebtInstrumentNumberofTranches_documentation_en-US" xlink:label="lab_mdt_DebtInstrumentNumberofTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtInstrumentNumberofTranches" xlink:href="mdt-20201030.xsd#mdt_DebtInstrumentNumberofTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DebtInstrumentNumberofTranches" xlink:to="lab_mdt_DebtInstrumentNumberofTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember_1b7bf9df-b459-4b83-b252-f3a55cd071e2_terseLabel_en-US" xlink:label="lab_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Inc, CIFSA, and Medtronic Luxco Senior Notes</link:label>
    <link:label id="lab_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember_label_en-US" xlink:label="lab_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Inc, CIFSA, and Medtronic Luxco Senior Notes [Member]</link:label>
    <link:label id="lab_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember_documentation_en-US" xlink:label="lab_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Inc, CIFSA, and Medtronic Luxco Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember" xlink:href="mdt-20201030.xsd#mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember" xlink:to="lab_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_571983b1-0a34-4194-8ec3-426c8f0f2751_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_605d3be3-0e20-4327-80c3-5fc42c2a7654_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount and Location of (Gains) Losses in Statements of Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_5b80d299-4934-4d9f-b25c-0059c42805c4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 12 months, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_abc469dc-b337-44f7-8e7b-e2162dff9d7f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_beb65e01-4686-4c69-b0ea-f18377e1e538_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_02460c91-10ef-4626-a523-d47147ecf212_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount Not Offset on the Balance Sheet, Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Not Offset, Policy Election Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:to="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_e076beeb-8404-4c2f-ba39-e6f7875f531e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized gains</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_5af22116-ff3b-48d2-a04b-e2ae0d94f237_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_5e148ee5-7d29-404c-b9c9-48c8c0404001_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3811597a-f702-4094-9349-15f898726308_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_e51260b9-ec19-4524-9901-7c807edd7945_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_ef9c3364-a154-42b2-9a90-61e5807fa9d0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition of previously deferred tax benefit from intercompany intellectual property transactions</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_6d667b33-b504-410d-9a1d-b05bb38a48f8_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_3da57808-fce8-4b89-990b-bdefd026431f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_219f25b2-621e-4d03-90cc-7b272cd93420_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5fbc7e2-fca2-4cd2-8380-2c0b188f1d5f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_6fa3f265-75c9-426e-95b0-5fb214c391a7_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_5a33f620-ff09-4906-8057-1a71817e9acc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_21c416bd-78dd-4835-9d24-1bc1814baf1e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method and other investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3071b4b5-e6d0-4a32-90ce-4f9f3c73f8ad_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_24bac740-5ca1-42df-a5b4-83f5586de214_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_2317881d-ebce-4c51-afdc-dea1f2f9ad40_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_8974a7f7-d38b-410f-a47b-439d3f4d28db_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_4d348946-92a8-405e-9995-93db7cfff619_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2015Due2035Member_e9ce73fc-aa42-4783-827d-b6e4555f9948_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2015Due2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375 percent twenty-year 2015 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2015Due2035Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2015Due2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2015 Due 2035 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2015Due2035Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2015Due2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2015 Due 2035 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due2035Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2015Due2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2015Due2035Member" xlink:to="lab_mdt_SeniorNotes2015Due2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_c4e3dcfc-3c1f-4bef-aba5-9e1c721b94ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_9c864676-64fd-4f0d-8261-7ae37bb7f53f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_AorticPeripheralandVenousDivisionMember_9606a768-d73c-4af7-9ae9-20f551c1c4f5_terseLabel_en-US" xlink:label="lab_mdt_AorticPeripheralandVenousDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aortic, Peripheral, &amp; Venous</link:label>
    <link:label id="lab_mdt_AorticPeripheralandVenousDivisionMember_label_en-US" xlink:label="lab_mdt_AorticPeripheralandVenousDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aortic, Peripheral and Venous Division [Member]</link:label>
    <link:label id="lab_mdt_AorticPeripheralandVenousDivisionMember_documentation_en-US" xlink:label="lab_mdt_AorticPeripheralandVenousDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aortic, Peripheral and Venous Division [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AorticPeripheralandVenousDivisionMember" xlink:href="mdt-20201030.xsd#mdt_AorticPeripheralandVenousDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_AorticPeripheralandVenousDivisionMember" xlink:to="lab_mdt_AorticPeripheralandVenousDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_3b21798d-468a-4184-beaa-e2317864e87d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_ff183458-faa8-45dc-971a-458d5cd63992_terseLabel_en-US" xlink:label="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax net unrealized gains (losses) associated with cash flow hedging instruments recorded in AOCI</link:label>
    <link:label id="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_documentation_en-US" xlink:label="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of unrealized gain (loss), net of tax as of the balance sheet date, related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="mdt-20201030.xsd#mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_7348c1d0-2583-4548-90bd-630c66471075_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_12f75079-b25a-4102-b788-183503b5b1b4_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank borrowings</link:label>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable to Banks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableToBanksMember" xlink:to="lab_us-gaap_NotesPayableToBanksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_242e537c-4e2b-4325-b8d4-c783e8b7b9e3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_d90903b2-b0d6-4273-9c8c-3b40a6ec1fca_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8689363d-4c84-4607-8a26-68637be93dcf_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock options (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_d40b05e2-f6d9-4b5d-95d1-258ca25a24cd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract_b2aed5bf-61c4-48af-8e65-26ffad8468d1_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-To-Maturity</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_436b6baf-d399-4a11-8109-4dd2bda6dd4d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_edbb68ea-ff49-427a-8f86-ef38f4cf40c7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9dbb6f93-e625-4cd8-822e-e789bc88129c_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_746e0f92-ae45-4c83-9065-a4bef7e0b99c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount and Location of (Gains) Losses in Statements of Income, Derivative Instruments Designated as Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperating_1ac498f3-9113-444c-a82a-2831a2f40e36_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-operating income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperating" xlink:to="lab_us-gaap_InterestIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_c6bbaaf5-8f37-47a4-837b-fd8d5dfa6318_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_04f2c878-e5ab-471a-8b29-aebc8723d8bd_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2d2ce84c-3689-4205-8b96-cd329b93ec01_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_9fa97177-5664-4332-bcc2-c3aa3a65d336_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities Contractual Maturities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_e0d720b3-295e-438f-8fda-5f3163b17555_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_062e4042-edb6-49c3-83aa-0ac10c4b6a1f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in current debt obligations, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_680fb49c-966d-406f-bea9-61434415fbf9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6f4ed52e-0f05-413d-aeca-bfac7efe6d76_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1b7caebd-02d5-49d3-8589-c47054e0e24b_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in retirement obligations</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d4f57b5b-651f-4b4f-a0c8-47226dd37f71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_d50bbb53-8485-4e47-8a7f-a41eb9976bc0_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_4890b343-9bb0-4c62-9754-a8123b99f13c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TotalReturnSwapMember_25b81321-23df-4dd9-bec4-78a62018359e_verboseLabel_en-US" xlink:label="lab_us-gaap_TotalReturnSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total return swaps</link:label>
    <link:label id="lab_us-gaap_TotalReturnSwapMember_label_en-US" xlink:label="lab_us-gaap_TotalReturnSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Return Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TotalReturnSwapMember" xlink:to="lab_us-gaap_TotalReturnSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths_7837687d-d26d-4c7e-a3dd-0bcd78a301dd_terseLabel_en-US" xlink:label="lab_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedge unrealized gains or losses to be reclassified over the next twelve months, net of tax</link:label>
    <link:label id="lab_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedge Gain (Loss) to be Reclassified Within Twelve Months</link:label>
    <link:label id="lab_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths_documentation_en-US" xlink:label="lab_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedge Gain (Loss) to be Reclassified Within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths" xlink:href="mdt-20201030.xsd#mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths" xlink:to="lab_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_2e153be2-66fe-46e5-b01d-c03620302370_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_65242dfc-c00e-458c-a32c-b4e3e3c9ea66_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Medtronic</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CorporateOverhead_18fd1009-d0b0-457f-a94e-760a5723d611_negatedLabel_en-US" xlink:label="lab_mdt_CorporateOverhead" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_mdt_CorporateOverhead_label_en-US" xlink:label="lab_mdt_CorporateOverhead" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Overhead</link:label>
    <link:label id="lab_mdt_CorporateOverhead_documentation_en-US" xlink:label="lab_mdt_CorporateOverhead" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate overhead expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CorporateOverhead" xlink:href="mdt-20201030.xsd#mdt_CorporateOverhead"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CorporateOverhead" xlink:to="lab_mdt_CorporateOverhead" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_1a7a8f4d-98e8-46cb-99cc-8f4caf84b9a1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_329f48ef-2bb9-4c88-8af9-8d33b197bb4b_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_0081b64e-4c8d-4b45-9af6-2e70ce4eb8ce_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_910c021f-2a5c-4378-bb92-d472f54a1ba8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_eb4fd99f-ceff-405d-98e5-6c15f5474308_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_0eeccfce-08d6-4d1a-98e8-abe02cede36d_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable_84101637-f4b5-44f7-8702-2fecfa601c07_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain (Loss) on Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain (Loss) on Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax_40840f4a-8b39-4e91-850b-1d111c16786d_totalLabel_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Held-To-Maturity, Accumulated Unrealized Gain, Before Tax</link:label>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Held-To-Maturity, Accumulated Unrealized Gain, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax" xlink:to="lab_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_93f0627c-286c-4fcf-8f68-60fba6a97277_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax_66826f90-e86e-4d4f-b6db-d5fe6277f33f_terseLabel_en-US" xlink:label="lab_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax net unrealized gains (losses) associated with net investment hedging instruments recorded in AOCI</link:label>
    <link:label id="lab_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax_label_en-US" xlink:label="lab_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Net Investment Hedges, Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax_documentation_en-US" xlink:label="lab_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Net Investment Hedges, Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax" xlink:href="mdt-20201030.xsd#mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax" xlink:to="lab_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_5b145beb-5af7-4d47-87e9-56b093abb4d0_netLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_f165ea28-6924-4e07-be58-5a83748540f4_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_deebd767-efd9-4f43-a79f-90d649c8d305_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_311ec031-7dcc-4f3d-b8e4-4fc735973ef5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2049Member_9463f89d-b38c-41c9-99c4-0386a3b53f94_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2049Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.75% Senior Notes due 2049</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2049Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2049Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2049 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2049Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2049Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2049 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2049Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2049Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2049Member" xlink:to="lab_mdt_SeniorNotes2019Due2049Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_cd6b843e-c9fd-40ff-ad83-775f545bf24d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_4509d663-4b07-4dc3-bdee-bbe1ca6c4688_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued litigation charges</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_e69cd9f4-50ee-46a8-b0af-219ccfb336e3_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_4e9d0ca2-8472-41f0-9a16-3383eab2bcbf_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_77c0655b-20e4-407a-b576-76f055ec4f2f_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_2b6e676a-3cb9-4bff-b099-a7c570219eb5_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_21aec872-bace-4597-b415-2500bf19254f_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2050Member_11b323d6-7615-4b40-baf4-c2b21f4b5ec4_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Senior Notes due 2050</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2050Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2050 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2050Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2050Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2050Member" xlink:to="lab_mdt_SeniorNotes2020Due2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2014Due2024Member_4dc5c5ad-bdc0-4f37-8c2f-56c91b12b0c7_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2014Due2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625 percent ten-year 2014 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2014Due2024Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2014Due2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2014 Due 2024 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2014Due2024Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2014Due2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2014Due2024Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2014Due2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2014Due2024Member" xlink:to="lab_mdt_SeniorNotes2014Due2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_d0748ca7-6bed-4c1c-9f40-e95a7298f7c5_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e3cc3a8c-1615-4008-90d8-d194c4376e6d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c8146cf5-7570-4e2f-a25c-a33bd9a6ef3c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_32ffe925-af1b-4351-ae1b-0065461ed361_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_e6909743-7a12-4895-b737-ce5d34ea6c0f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_ScheduleofInvestmentsTableTextBlock_58fb3ba1-f023-4a67-8fa4-9d0bb34b61fb_terseLabel_en-US" xlink:label="lab_mdt_ScheduleofInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity Related to the Company's Equity and Other Investments Portfolio</link:label>
    <link:label id="lab_mdt_ScheduleofInvestmentsTableTextBlock_label_en-US" xlink:label="lab_mdt_ScheduleofInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table Text Block]</link:label>
    <link:label id="lab_mdt_ScheduleofInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_mdt_ScheduleofInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ScheduleofInvestmentsTableTextBlock" xlink:href="mdt-20201030.xsd#mdt_ScheduleofInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_ScheduleofInvestmentsTableTextBlock" xlink:to="lab_mdt_ScheduleofInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_465fd471-ffd8-4550-8d15-373257180119_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Balances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_97f94f87-5534-4b18-8f77-f443df66aa89_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_3e6f4159-6134-41cf-aa1c-6153a7d86250_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components and Classification of Stock-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_604c1fbb-cce9-4777-ac54-5791c3cb1882_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_9c74e572-3a4d-4fb2-afa6-a617af4c7ed0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_a545e06e-ff09-4efa-b4a4-dc3c608cc6c5_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments with readily determinable fair value (marketable equity securities)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_453c7aed-4513-451f-8387-754d2ddfba22_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_8ee128c0-5e3c-4311-b23d-5df0dc4a3569_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_e2dfe236-dd77-41c1-951b-e59b59a3168f_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2051Member_3d5f8bfe-694c-4ad6-92d2-2aba0ea5ee15_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2051Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625 percent thirty-year 2020 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2051Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2051Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2051 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2051Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2051Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2051</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2051Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2051Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2051Member" xlink:to="lab_mdt_SeniorNotes2020Due2051Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_6356c796-119c-4451-a053-37ee31805185_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTable" xlink:to="lab_us-gaap_MarketableSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_09dab347-85de-4fa5-8cb3-7d82868fb5cb_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_a3869c31-a0ec-455e-b1ab-622faf1ef251_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill as a result of acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_0ee3f9a1-4308-42c1-ab4c-2c88d049f684_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_cf721688-7cf2-4a78-bf02-6751363be58e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_509d45a6-12ab-44b3-9790-8539a63a8ff5_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_1a1f1b68-8e83-4b02-848c-0d7e4e006ab8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments by Category and Related Balance Sheet Classification, Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_fb48a647-5863-4d33-bea0-caea32d37c75_negatedLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual adjustments</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_aaeeb604-d06b-40bf-925f-200777116c17_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual adjustments</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_b6496a54-cd58-4711-8dbf-4c62d000b5d9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_affacec4-9a18-43d4-9836-c27f7ddb341f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_65399156-43f6-43c8-a526-9483c1aad049_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_OffsettingAssetsandLiabilitiesTable_c436aca8-b558-4057-9329-c9c4cf1a5c70_terseLabel_en-US" xlink:label="lab_mdt_OffsettingAssetsandLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets and Liabilities [Table]</link:label>
    <link:label id="lab_mdt_OffsettingAssetsandLiabilitiesTable_label_en-US" xlink:label="lab_mdt_OffsettingAssetsandLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets and Liabilities [Table]</link:label>
    <link:label id="lab_mdt_OffsettingAssetsandLiabilitiesTable_documentation_en-US" xlink:label="lab_mdt_OffsettingAssetsandLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets and Liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OffsettingAssetsandLiabilitiesTable" xlink:href="mdt-20201030.xsd#mdt_OffsettingAssetsandLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesTable" xlink:to="lab_mdt_OffsettingAssetsandLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_32dd49a3-fdd0-4a25-8fd5-df295cd844b6_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum remaining maturity of foreign currency derivatives</link:label>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_label_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Remaining Maturity of Foreign Currency Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:to="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_18348a07-11f1-4074-b3e9-601e00c7cb15_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_221f0a1f-a56f-4bcd-95dd-992dcf014d5b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain related to change in amounts accrued for certain contingent liabilities for recent acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_622163c5-9aab-4889-83db-f4cd6aa79142_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_1aeec895-ebda-4afd-9d04-2c3fcc4d91cc_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreements</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_c1ae94ee-a4ec-42fb-a1cd-f8f8f5d5a7d8_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9c0d80b9-4804-4a87-9602-0839d6625bae_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b654b883-64ae-48a7-ba31-ea82ccd5e59b_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_88381a44-01b8-4e35-a388-63820a948208_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of ordinary shares</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_4c355977-b526-4d5f-adca-c29cf6ad7a42_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a20e02a9-4137-4b57-a251-fc44469edac9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_58e3550e-cf08-483b-9abe-ae945adc4319_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claimants</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_aee46412-9190-4a11-934c-fe60a60fd436_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2ed01e1f-c18c-42ee-8053-f32d661da14b_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_fcb37671-c941-49d3-9749-dd5ccfce6ce5_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in Income, Net investment hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_089d691c-715b-48e9-b5b9-87ac87c1d266_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_03e9bdfa-afa7-4f44-a8b3-26c87919373f_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_006d4bbd-fe60-4cf6-9f5a-ff9311cafc4e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_50b31bec-43a9-4705-9e87-b6e03b533e5f_negatedLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net benefit related to measurement period adjustment related to U.S. Tax Reform</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Measurement Period Adjustment, Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_TokyoInterBankOfferedRateTIBORMember_3667435c-374b-4942-b43a-a645664c4907_terseLabel_en-US" xlink:label="lab_mdt_TokyoInterBankOfferedRateTIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TIBOR Rate</link:label>
    <link:label id="lab_mdt_TokyoInterBankOfferedRateTIBORMember_label_en-US" xlink:label="lab_mdt_TokyoInterBankOfferedRateTIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tokyo Inter-bank Offered Rate (TIBOR) [Member]</link:label>
    <link:label id="lab_mdt_TokyoInterBankOfferedRateTIBORMember_documentation_en-US" xlink:label="lab_mdt_TokyoInterBankOfferedRateTIBORMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tokyo Inter-bank Offered Rate (TIBOR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TokyoInterBankOfferedRateTIBORMember" xlink:href="mdt-20201030.xsd#mdt_TokyoInterBankOfferedRateTIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_TokyoInterBankOfferedRateTIBORMember" xlink:to="lab_mdt_TokyoInterBankOfferedRateTIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DebtTenderPremiumandOtherCharges_d5a07934-b00c-4a33-82ea-c828b68f6be6_terseLabel_en-US" xlink:label="lab_mdt_DebtTenderPremiumandOtherCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt tender premium and other charges</link:label>
    <link:label id="lab_mdt_DebtTenderPremiumandOtherCharges_label_en-US" xlink:label="lab_mdt_DebtTenderPremiumandOtherCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Tender Premium and Other Charges</link:label>
    <link:label id="lab_mdt_DebtTenderPremiumandOtherCharges_documentation_en-US" xlink:label="lab_mdt_DebtTenderPremiumandOtherCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Tender Premium and Other Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtTenderPremiumandOtherCharges" xlink:href="mdt-20201030.xsd#mdt_DebtTenderPremiumandOtherCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DebtTenderPremiumandOtherCharges" xlink:to="lab_mdt_DebtTenderPremiumandOtherCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_a149fefc-7e44-4133-a3db-b046191c7444_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Beginning and Ending Balances of Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3c3402af-f553-4fa2-9104-430617df6b0c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_PreTaxExitandDisposalCostsMember_c2c1c699-c979-46b2-8399-9104aa6dc60a_terseLabel_en-US" xlink:label="lab_mdt_PreTaxExitandDisposalCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax exit and disposal costs and other</link:label>
    <link:label id="lab_mdt_PreTaxExitandDisposalCostsMember_label_en-US" xlink:label="lab_mdt_PreTaxExitandDisposalCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre Tax Exit and Disposal Costs [Member]</link:label>
    <link:label id="lab_mdt_PreTaxExitandDisposalCostsMember_documentation_en-US" xlink:label="lab_mdt_PreTaxExitandDisposalCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre Tax Exit and Disposal Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PreTaxExitandDisposalCostsMember" xlink:href="mdt-20201030.xsd#mdt_PreTaxExitandDisposalCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_PreTaxExitandDisposalCostsMember" xlink:to="lab_mdt_PreTaxExitandDisposalCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_07a33cfb-18d3-4129-9d8f-63aae8da9393_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of net actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_17cac6ae-3cdd-4da5-bf41-1d7a28712469_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_76ed0bea-b213-42ca-9e32-551bd7b9fa58_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, (Gain) Loss [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MeasurementInputProbabilityofPaymentMember_40833cf5-2c32-4273-b894-191414d7716f_terseLabel_en-US" xlink:label="lab_mdt_MeasurementInputProbabilityofPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probability of payment</link:label>
    <link:label id="lab_mdt_MeasurementInputProbabilityofPaymentMember_label_en-US" xlink:label="lab_mdt_MeasurementInputProbabilityofPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability of Payment [Member]</link:label>
    <link:label id="lab_mdt_MeasurementInputProbabilityofPaymentMember_documentation_en-US" xlink:label="lab_mdt_MeasurementInputProbabilityofPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability of Payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MeasurementInputProbabilityofPaymentMember" xlink:href="mdt-20201030.xsd#mdt_MeasurementInputProbabilityofPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MeasurementInputProbabilityofPaymentMember" xlink:to="lab_mdt_MeasurementInputProbabilityofPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_07f49280-8495-4f7d-9df1-5b82303f774d_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d2675485-6fbe-4aad-9bb7-956cf05f2bbe_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_9146dd4f-9018-45ba-ba40-84fd72abd409_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_727c0482-9d4a-48c7-99bf-9bfb305e21fa_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_3781f24b-7e41-4242-8600-00759dfe829a_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6eab8bf1-d097-4329-b1d3-627c3eeb5bce_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e729be05-947d-45b3-aa3b-a6ce4f14e3cb_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_4e4676a8-5d16-44e4-b04c-325012df4a9e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-For-Sale Debt Securities in Continuous Unrealized Loss Position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_99f6c356-e6fa-4d13-93d8-ddd8690495ea_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_cf250dc1-06d5-40e1-aae0-567d349f371d_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_dfae4cab-d2ce-43d7-80c0-e11f43690c6e_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_38b6a5f7-bd53-4db4-9069-a5d999adc940_terseLabel_en-US" xlink:label="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of world</link:label>
    <link:label id="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_label_en-US" xlink:label="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Countries, Excluding United States and Ireland [Member]</link:label>
    <link:label id="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_documentation_en-US" xlink:label="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Countries, Excluding United States and Ireland [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" xlink:href="mdt-20201030.xsd#mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" xlink:to="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_dcd404d7-db3a-45df-8a62-66cbdeb8d524_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_32abc971-4792-4459-9244-5e9a2dfa5e49_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f1746c1e-f7db-48b9-8c7d-a8e4c30690c4_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect of change in accounting principle</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_fb50184a-fe32-4ca8-85aa-db0d109fcac4_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2022Member_c7fd351c-05a2-4f34-be0e-fed160497903_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.00% Senior Notes due 2022</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2022Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2022 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2022Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2022Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2022Member" xlink:to="lab_mdt_SeniorNotes2019Due2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_dcf713c3-53da-4a36-bb4f-cc6529c8369d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate amount of verdict returned against the Company</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_5eae8070-ec4b-4a9e-9190-19774250d1a0_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_0b17ad47-01ed-4fb9-b18f-99d2c0851c3c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_419bff5c-19d5-460b-8815-7657848ea493_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_240f9475-fc1c-4f97-98cb-e8dc12f9baeb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2015Due2025Member_79d443d6-171e-4c46-813e-8848c0e7a9f6_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2015Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500 percent ten-year 2015 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2015Due2025Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2015Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2015 Due 2025 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2015Due2025Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2015Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2015 Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due2025Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2015Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2015Due2025Member" xlink:to="lab_mdt_SeniorNotes2015Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrent_59cc26f6-8657-4130-a4fb-04c7a244d218_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityCurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_fbc7d82c-d082-4ab9-8226-15fa67ff926a_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2014Due2044Member_26e3ecd2-a159-4bf8-8b5c-3b605eb5d37e_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2014Due2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625 percent thirty-year 2014 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2014Due2044Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2014Due2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2014 Due 2044 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2014Due2044Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2014Due2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2044 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2014Due2044Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2014Due2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2014Due2044Member" xlink:to="lab_mdt_SeniorNotes2014Due2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_24f766cd-3530-4a68-8a4f-666be2719d01_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_91461801-d91c-458a-812c-fea5dcff76d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_759cc3ed-eb7e-47ba-981f-dccaf3cd29c9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MinimallyInvasiveTherapiesGroupMember_1d496860-4d98-4bcc-843b-27531e6d9709_terseLabel_en-US" xlink:label="lab_mdt_MinimallyInvasiveTherapiesGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimally Invasive Therapies Group</link:label>
    <link:label id="lab_mdt_MinimallyInvasiveTherapiesGroupMember_label_en-US" xlink:label="lab_mdt_MinimallyInvasiveTherapiesGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimally Invasive Therapies Group [Member]</link:label>
    <link:label id="lab_mdt_MinimallyInvasiveTherapiesGroupMember_documentation_en-US" xlink:label="lab_mdt_MinimallyInvasiveTherapiesGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimally Invasive Therapies Group [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MinimallyInvasiveTherapiesGroupMember" xlink:href="mdt-20201030.xsd#mdt_MinimallyInvasiveTherapiesGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MinimallyInvasiveTherapiesGroupMember" xlink:to="lab_mdt_MinimallyInvasiveTherapiesGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_764e1e95-675e-4615-aa9f-c1761010efce_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_f94e9dbb-edd0-4d65-878b-5cca496c87ef_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Amount Offset Against Collateral, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet" xlink:to="lab_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_1526f86e-d9ce-4871-8f95-f64d33eea4dd_negatedTotalLabel_en-US" xlink:label="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)</link:label>
    <link:label id="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_label_en-US" xlink:label="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash</link:label>
    <link:label id="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_documentation_en-US" xlink:label="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" xlink:to="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b8f48e71-b4d8-432d-88ac-156f31d6b72b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedge unrealized losses to be reclassified over the next 12 months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_eacc259b-750f-45f0-86a2-3e33f8461893_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_c070794f-2a4c-432b-a5aa-5b946859facd_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to shareholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_6e6c819c-082d-4be0-aecb-2111bb1efb16_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_c40da7bd-514e-45d9-8e8b-b4d85bb3305e_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_64b3231a-e9f3-44a1-93cd-0218e03030b4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_d3f97240-0703-4194-8d5f-5b41cd3e6830_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_149f32ec-6951-403b-87bc-b4c3ebf140f7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_e5d7e2ed-6cb2-4ffe-aa1b-5f89dc611a9e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_65914865-8eb6-423f-9046-aee766295c79_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_a2d1fe91-71b7-4941-9fab-635852952891_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less allowances and credit losses of $312 and $208, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment_c32b53d1-f4e8-47c7-9329-c63aa0b1434a_terseLabel_en-US" xlink:label="lab_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges, including incremental defined benefit pension and post-retirement expenses for employees that accepted voluntary early retirement packages</link:label>
    <link:label id="lab_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment_label_en-US" xlink:label="lab_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Including Net Periodic Benefit Credit, Loss Due to Curtailment</link:label>
    <link:label id="lab_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment_documentation_en-US" xlink:label="lab_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Including Net Periodic Benefit Credit, Loss Due to Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment" xlink:href="mdt-20201030.xsd#mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment" xlink:to="lab_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_c5a1dcef-4a58-4b3d-ba0f-42b6ce1aba40_verboseLabel_en-US" xlink:label="lab_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental expense related to acceptance of voluntary early retirement packages, amount related to defined contribution plans</link:label>
    <link:label id="lab_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_label_en-US" xlink:label="lab_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost of Providing Special and Contractual Termination Benefits</link:label>
    <link:label id="lab_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_documentation_en-US" xlink:label="lab_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost of Providing Special and Contractual Termination Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" xlink:href="mdt-20201030.xsd#mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" xlink:to="lab_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_44eaec11-a575-45a2-987d-515a840d64ad_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S.</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Member_a105cde5-095b-4339-b5ab-e8a544e3035e_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Member" xlink:to="lab_mdt_SeniorNotes2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_e316e252-2156-403f-8464-62267d3d74dc_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_f600cbef-67fd-4649-8564-a8eeedd23b50_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2026Member_339dcac3-0099-4eaa-a6bd-33a941bce745_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.000 percent five-year 2020 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2026Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2026 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2026Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2026Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2026Member" xlink:to="lab_mdt_SeniorNotes2020Due2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0a93b3ad-a85f-4526-b229-0c457dce2270_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_b0fb465d-117c-4cc1-a388-cca3c622fa89_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_9b9db4af-ebce-4691-bad0-4413e6103953_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Operating Profit</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Income (Loss) before Income Taxes [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_139eafcc-c4dd-4769-a04c-9f36c15235a2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CentralizedDistributionCosts_65f83a5a-b75c-4b44-991c-8ba53477f45c_negatedTerseLabel_en-US" xlink:label="lab_mdt_CentralizedDistributionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centralized distribution costs</link:label>
    <link:label id="lab_mdt_CentralizedDistributionCosts_label_en-US" xlink:label="lab_mdt_CentralizedDistributionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centralized Distribution Costs</link:label>
    <link:label id="lab_mdt_CentralizedDistributionCosts_documentation_en-US" xlink:label="lab_mdt_CentralizedDistributionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centralized Distribution Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CentralizedDistributionCosts" xlink:href="mdt-20201030.xsd#mdt_CentralizedDistributionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CentralizedDistributionCosts" xlink:to="lab_mdt_CentralizedDistributionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares_ed1632c0-ae8e-489a-a401-aec57f13f57d_terseLabel_en-US" xlink:label="lab_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (shares)</link:label>
    <link:label id="lab_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares_label_en-US" xlink:label="lab_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Other Shares</link:label>
    <link:label id="lab_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares_documentation_en-US" xlink:label="lab_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Other Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares" xlink:href="mdt-20201030.xsd#mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares" xlink:to="lab_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_1fe06e14-b13f-4626-8349-e967d32d0348_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_17e5a4fe-dd1a-438a-8af5-573ca5412995_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_0123e5cb-9096-4c94-84a3-a146255344ed_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_1f1118dc-55a8-4b7e-9deb-e607e46ef701_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_f894cf56-bfdb-43f0-b706-06dec1bd85d3_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5f1ef611-193c-43cb-971f-fe36c87a5a58_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_68112134-64dc-451b-b7e1-dc19f0c85e5c_terseLabel_en-US" xlink:label="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets</link:label>
    <link:label id="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_label_en-US" xlink:label="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Middle East, Africa, Latin America, Eastern Europe, and Asia, Excluding Japan and Korea [Member]</link:label>
    <link:label id="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_documentation_en-US" xlink:label="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Middle East, Africa, Latin America, Eastern Europe, and Asia, Excluding Japan and Korea [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" xlink:href="mdt-20201030.xsd#mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" xlink:to="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_221742f5-d993-4f37-a01d-1e7cd537dae3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_c576db8b-0c84-4f03-ab4a-22a76457e5f1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Contingent Consideration, Significant Unobservable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_89341135-cb2a-4815-8233-a7c425e66a5d_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20392.250PercentMember_1dcb0d5b-5d1f-4cbe-a1f8-89a5147e52fd_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20392.250PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250% Senior Notes due 2039</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20392.250PercentMember_96fcba6e-2a1b-4c33-b8a8-5b71708258ac_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20392.250PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250 percent twenty-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20392.250PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20392.250PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2039, 2.250 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20392.250PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20392.250PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2039, 2.250 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20392.250PercentMember" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20392.250PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20392.250PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20392.250PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2013Due2023Member_8e7a2c0f-223b-4715-9691-9eb99e2f39c9_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2013Due2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750 percent ten-year 2013 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2013Due2023Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2013Due2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2013 Due 2023 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2013Due2023Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2013Due2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2013Due2023Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2013Due2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2013Due2023Member" xlink:to="lab_mdt_SeniorNotes2013Due2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MedtronicLuxcoMember_27eada4f-5c51-43c3-b3bc-f37af9f1fd3e_terseLabel_en-US" xlink:label="lab_mdt_MedtronicLuxcoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Luxco</link:label>
    <link:label id="lab_mdt_MedtronicLuxcoMember_label_en-US" xlink:label="lab_mdt_MedtronicLuxcoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Luxco [Member]</link:label>
    <link:label id="lab_mdt_MedtronicLuxcoMember_documentation_en-US" xlink:label="lab_mdt_MedtronicLuxcoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Luxco [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicLuxcoMember" xlink:href="mdt-20201030.xsd#mdt_MedtronicLuxcoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MedtronicLuxcoMember" xlink:to="lab_mdt_MedtronicLuxcoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_a6cd9ad1-3d39-4699-b3d8-b2e7ed180527_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">More than 12 months, Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_45ff3d3a-e32e-41c1-a001-35e5a0d441b6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets, Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_9054c547-f23f-4475-be43-66a5f18aebee_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount of Recorded Assets (Liabilities)</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_1b336a16-c99d-4a92-b363-b46bd25e1c81_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_8aee407a-c2ee-45d7-9096-063cda64fbf9_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to shareholders (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_0188d43c-a5f5-48fb-aeff-6a9fa9964ba2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_87d38772-e684-4b58-9c6d-632511986760_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_d5e2230c-81d4-45ee-98ba-1c255d6b83b2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_794e209f-dbf2-4b9c-80cd-3f3bf6fd3c87_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_d82be355-f82a-43a7-bfc3-b2bbc5408789_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_db486923-c789-4b26-808e-f0a31054742c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, significant unobservable inputs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_78a272e3-caea-46bb-aa56-c85f0aef8bd2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in the Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_d29a737f-5b10-4779-8ae2-dd06d6e4f40f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_d5baed53-3e27-4cba-9d48-4f8bd8a09308_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccounting_21960f12-5292-4db9-886c-630565491ac8_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccounting_label_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccounting" xlink:to="lab_us-gaap_BasisOfAccounting" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_42ad6700-1bea-42ca-8ec0-08cf67696097_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims dismissed</link:label>
    <link:label id="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Patents Found Not Infringed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPatentsFoundNotInfringedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:to="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_1fdbef91-5bd0-4277-aa6e-93066fcc3daa_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Amount Offset Against Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0f8a694f-2274-4186-a038-dae1ddd05242_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_d8646079-a6b8-4690-8202-e2ff060027a2_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity Related to the Company's Available-for-Sale Debt Securities Portfolio</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_af93603c-6142-4352-98cc-4b8c03700419_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period over which remaining performance obligations are expected to be recognized as revenue</link:label>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_label_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Description of Timing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:to="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_ProductDevelopmentMilestoneMember_c0522a1f-7e3f-4d65-87ad-64d3f7180dd2_terseLabel_en-US" xlink:label="lab_mdt_ProductDevelopmentMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product development and other milestone-based payments</link:label>
    <link:label id="lab_mdt_ProductDevelopmentMilestoneMember_label_en-US" xlink:label="lab_mdt_ProductDevelopmentMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Development Milestone [Member]</link:label>
    <link:label id="lab_mdt_ProductDevelopmentMilestoneMember_documentation_en-US" xlink:label="lab_mdt_ProductDevelopmentMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A milestone in achieving certain product development target.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ProductDevelopmentMilestoneMember" xlink:href="mdt-20201030.xsd#mdt_ProductDevelopmentMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_ProductDevelopmentMilestoneMember" xlink:to="lab_mdt_ProductDevelopmentMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_719b2d80-19ba-4589-b676-391a2737c822_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_a9d2ce66-2827-4ee9-b250-8bec5aecd437_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_82844f93-6cb4-4c18-89bd-9f497afd8fcd_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_2f822cd4-c373-4cf0-a42e-bdc28dd33f4d_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember_ecdd9e34-4237-4c87-938a-8eb3d7ddfca4_terseLabel_en-US" xlink:label="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember_label_en-US" xlink:label="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Revolving Credit Agreement [Member]</link:label>
    <link:label id="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember_documentation_en-US" xlink:label="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Revolving Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AmendedandRestatedRevolvingCreditAgreementMember" xlink:href="mdt-20201030.xsd#mdt_AmendedandRestatedRevolvingCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_AmendedandRestatedRevolvingCreditAgreementMember" xlink:to="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_25c1a10f-e586-410e-8b87-d3b3776abffc_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_16a9b8fc-e10a-47df-b920-12491220c0d4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_750802bf-c7dd-40c8-a53c-399719907b57_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Future Aggregate Amortization Expense, Definite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_822d1ec8-1ada-42c3-a0e8-73fcccd859f3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5399fc89-5d50-40df-b2ff-6560f87dcf2d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_502fa4f3-56e2-46a7-ada4-16b07127e7fc_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted - weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_b18f7489-d464-405f-b82b-250330325754_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount, net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_2bce0117-9499-4e40-9083-164c4ed99d04_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_66a3609e-63f7-4fe8-ad8b-9b20851a5d1c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_a5a36e56-1ff7-4548-be65-26f68de6d8de_terseLabel_en-US" xlink:label="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of landfills requiring removal</link:label>
    <link:label id="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_label_en-US" xlink:label="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency, Number of Landfills Requiring Removal</link:label>
    <link:label id="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_documentation_en-US" xlink:label="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency, Number of Landfills Requiring Removal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SiteContingencyNumberofLandfillsRequiringRemoval" xlink:href="mdt-20201030.xsd#mdt_SiteContingencyNumberofLandfillsRequiringRemoval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SiteContingencyNumberofLandfillsRequiringRemoval" xlink:to="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b56a8cc7-503f-4988-90ca-3645d7ab8066_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_bcd78f07-c981-4f3f-a677-b88607b1d3b5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_A2015CommercialPaperProgramMember_8cf96c32-1834-4b98-a300-fedf9a947623_terseLabel_en-US" xlink:label="lab_mdt_A2015CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program</link:label>
    <link:label id="lab_mdt_A2015CommercialPaperProgramMember_label_en-US" xlink:label="lab_mdt_A2015CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Commercial Paper Program [Member]</link:label>
    <link:label id="lab_mdt_A2015CommercialPaperProgramMember_documentation_en-US" xlink:label="lab_mdt_A2015CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Commercial Paper Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A2015CommercialPaperProgramMember" xlink:href="mdt-20201030.xsd#mdt_A2015CommercialPaperProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_A2015CommercialPaperProgramMember" xlink:to="lab_mdt_A2015CommercialPaperProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2eac6518-60ea-43bd-b404-c3d0b59f3c21_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_5fe10ba1-6cb7-4b9a-bc0c-404ada83eb31_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2028Member_82da34db-1d44-4678-862b-f3387e2b1cce_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.375% Senior Notes due 2028</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2028Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2028 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2028Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2028Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2028Member" xlink:to="lab_mdt_SeniorNotes2020Due2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_244f986d-2ac6-4be7-93f7-36196b319888_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_5c345059-0fed-4356-af92-116b8dfcb1bb_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and retirement benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock_6d725867-e820-44b9-bdd2-0d5d742bb91a_terseLabel_en-US" xlink:label="lab_mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount and Location of (Gains) Losses in Statements of Income, Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock_label_en-US" xlink:label="lab_mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]</link:label>
    <link:label id="lab_mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock_documentation_en-US" xlink:label="lab_mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the location and amount of gains and losses recognized in the statement of financial performance on foreign currency derivative instruments not designated as hedging instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock" xlink:href="mdt-20201030.xsd#mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock" xlink:to="lab_mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_01afd53f-a9c3-4517-86c4-17c90f8b9f31_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1cd81c41-c462-4ce2-b9ad-2b088da6def4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_8d0862fc-090d-417e-a7e3-1ad59f509cca_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_ee46f59c-ebcd-4362-892f-877595710967_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.00PercentMember_4135541e-7082-42bf-9003-f0f973b677a7_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.00% Senior Notes due 2031</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.00PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2031, 1.00 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.00PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2031, 1.00 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20311.00PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_d2febf4f-ef1a-47f9-bae9-bada078a0869_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special termination benefits</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_7a2ddddf-196a-4e02-8d91-4447360bf4fe_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental expense related to acceptance of voluntary early retirement packages, amount related to defined benefit plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cost of Providing Special and Contractual Termination Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" xlink:to="lab_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_3040bb6e-b428-475c-805d-c03a4e4593ef_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of settlement received</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_96dd4964-2fbd-426c-9467-7408b2f20633_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated revenue expected to be recognized in future periods related to unsatisfied performance obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_d4f61e8c-3d3a-49e6-8040-9473fb4e9566_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_51b41f22-af3e-4b31-94fd-3486f173292f_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_ac368bd5-4cd8-42d7-a30f-11de56955a5e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investment Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_7b695b3c-41b2-4435-b086-2de0bf76edd0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_8610a065-d3fe-4866-be36-2f139458dcc6_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2032Member_302a18a1-0487-4396-aab9-d8b521e44aa8_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.750% Senior Notes due 2032</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2032Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2032 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2032Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2032Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2032Member" xlink:to="lab_mdt_SeniorNotes2020Due2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_c48c6c9f-3a08-4e93-82b5-6b55b2bc17d2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares&#8212; par value $0.0001, 2.6 billion shares authorized, 1,345,547,814 and 1,341,074,724 shares issued and outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0a6924ba-1888-4916-8ddf-bed25346e230_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_0c2ae6a9-75ab-4e92-8643-1ae1478c5c70_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_86cf560c-c5a7-4d90-853c-9181a26552c3_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-lived intangible asset charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e16373f8-553c-4d9e-bbff-a2a259f47e6f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1a798a75-5619-4b4a-93a2-3bbacdfb5eef_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_300f8b92-3e49-4429-92e9-57ab82ae4f82_totalLabel_en-US" xlink:label="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity and other investments</link:label>
    <link:label id="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_label_en-US" xlink:label="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments</link:label>
    <link:label id="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_documentation_en-US" xlink:label="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" xlink:href="mdt-20201030.xsd#mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" xlink:to="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_9fca24e8-8690-444c-96ea-11869374ea43_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:to="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_5c67f374-7afe-4ae2-8b9a-092c897d3d0e_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MedtronicIncAndCIFSASeniorNotesMember_2951c766-7bfe-4e92-bbb0-58f5d609bd19_terseLabel_en-US" xlink:label="lab_mdt_MedtronicIncAndCIFSASeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Inc and CIFSA Senior Notes</link:label>
    <link:label id="lab_mdt_MedtronicIncAndCIFSASeniorNotesMember_label_en-US" xlink:label="lab_mdt_MedtronicIncAndCIFSASeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Inc And CIFSA Senior Notes [Member]</link:label>
    <link:label id="lab_mdt_MedtronicIncAndCIFSASeniorNotesMember_documentation_en-US" xlink:label="lab_mdt_MedtronicIncAndCIFSASeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Inc And CIFSA Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicIncAndCIFSASeniorNotesMember" xlink:href="mdt-20201030.xsd#mdt_MedtronicIncAndCIFSASeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MedtronicIncAndCIFSASeniorNotesMember" xlink:to="lab_mdt_MedtronicIncAndCIFSASeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet_9b8c5665-a3fb-4329-a1fb-1a0fead2e3ac_terseLabel_en-US" xlink:label="lab_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on firm commitments that no longer qualify as net investment hedges</link:label>
    <link:label id="lab_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet_label_en-US" xlink:label="lab_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) from Hedged Firm Commitment Not Qualifying as Net Investment Hedge, Net</link:label>
    <link:label id="lab_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet_documentation_en-US" xlink:label="lab_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) from Hedged Firm Commitment Not Qualifying as Net Investment Hedge, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet" xlink:href="mdt-20201030.xsd#mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet" xlink:to="lab_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d58a9f25-380f-49d0-8fa9-a4334a1debaa_negatedLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_14e7c83f-d8f2-4c37-bd45-88279d3e8bbe_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_e526e39a-6ff7-4f52-bee0-bdf556f30f77_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets:</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsAbstract" xlink:to="lab_us-gaap_DerivativeAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_432e98a7-a767-4edc-ae3a-e318a3e7d70f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract_c4120824-d2ba-4441-a9e0-96a2472b1a01_terseLabel_en-US" xlink:label="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract_label_en-US" xlink:label="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation, Numerator [Abstract]</link:label>
    <link:label id="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract_documentation_en-US" xlink:label="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EarningsPerShareReconciliationNumeratorAbstract" xlink:href="mdt-20201030.xsd#mdt_EarningsPerShareReconciliationNumeratorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EarningsPerShareReconciliationNumeratorAbstract" xlink:to="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_954c82de-2210-4464-9ccc-f947568a8bb1_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_c54309d6-e11f-4ebb-ac5e-12cc6e13f24e_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2040Member_d6000957-a558-4da5-9690-5f234d865fa7_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.375% Senior Notes due 2040</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2040Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2040 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2040Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2040Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2040Member" xlink:to="lab_mdt_SeniorNotes2020Due2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0e27ab6d-c964-4b1e-a2c9-c6687778271b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under stock purchase and award plans (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_63ecb526-b0f0-48c8-98cc-6dd16fa9819c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income including noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_36b04ae9-d483-4819-a05e-a42dc518ea2c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_e1948298-3cd4-4ba2-abac-0a23aa909bb2_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_1b4b5096-2983-4356-98be-08ae000d4938_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f20f99fa-5d4c-4155-9128-ddb2b1fcf49d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_d3f6cf45-2272-41d5-8888-c6660d43e4ff_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_a5400318-19ca-4642-8a8f-77527215fd82_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e5f0270d-e76e-4db8-83e5-a757a446604b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_f63b33ae-1b34-43dd-babc-2091ca9b9144_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateralized Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_974e8fec-8eb1-4fc6-845b-37f49536269a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_82579289-819b-4451-a10c-fb56969bac1c_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_01b45ae4-de51-42d6-9ed3-53601f77e8d3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_52e9e2a6-2b93-4f35-acc8-9f16284d2b3e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_85b95120-6c89-4d16-a82e-9e1d2475266b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_aa32f6af-7ecc-42a1-8a54-fcb04b79c624_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DebtInstrumentExtensionOptionTermOfExtension_68a7518d-e926-459a-812d-f72e5dd11d7a_terseLabel_en-US" xlink:label="lab_mdt_DebtInstrumentExtensionOptionTermOfExtension" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional extension option, term of extension</link:label>
    <link:label id="lab_mdt_DebtInstrumentExtensionOptionTermOfExtension_label_en-US" xlink:label="lab_mdt_DebtInstrumentExtensionOptionTermOfExtension" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Option, Term Of Extension</link:label>
    <link:label id="lab_mdt_DebtInstrumentExtensionOptionTermOfExtension_documentation_en-US" xlink:label="lab_mdt_DebtInstrumentExtensionOptionTermOfExtension" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Option, Term Of Extension</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtInstrumentExtensionOptionTermOfExtension" xlink:href="mdt-20201030.xsd#mdt_DebtInstrumentExtensionOptionTermOfExtension"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DebtInstrumentExtensionOptionTermOfExtension" xlink:to="lab_mdt_DebtInstrumentExtensionOptionTermOfExtension" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2017Due2027Member_528b3f2b-e2e7-4e90-9324-32a342c55718_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2017Due2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.350 percent ten-year 2017 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2017Due2027Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2017Due2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2017 Due 2027 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2017Due2027Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2017Due2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2017 Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2017Due2027Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2017Due2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2017Due2027Member" xlink:to="lab_mdt_SeniorNotes2017Due2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_b0f15857-d72e-41d9-9ef4-0b89a3c053fd_terseLabel_en-US" xlink:label="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of landfills requiring capping</link:label>
    <link:label id="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_label_en-US" xlink:label="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency, Number of Landfills Requiring Capping</link:label>
    <link:label id="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_documentation_en-US" xlink:label="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency, Number of Landfills Requiring Capping</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SiteContingencyNumberOfLandfillsRequiringCapping" xlink:href="mdt-20201030.xsd#mdt_SiteContingencyNumberOfLandfillsRequiringCapping"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SiteContingencyNumberOfLandfillsRequiringCapping" xlink:to="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_5951f6dd-acc8-46ae-bf08-df2d2000bbae_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2009Due2039Member_0f244bf7-0bab-43f3-bb7c-375d6a65a299_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2009Due2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.500 percent thirty-year 2009 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2009Due2039Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2009Due2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2009 Due 2039 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2009Due2039Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2009Due2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2039 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2009Due2039Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2009Due2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2009Due2039Member" xlink:to="lab_mdt_SeniorNotes2009Due2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_cb411fdd-c697-4e55-aa69-c87f622fd288_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_490d178a-2871-4d20-ac2d-64a6dd35e214_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_786287a5-729f-498a-b682-e491b2b4b9db_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_135a2f96-e576-45e2-b547-c97fea0cef15_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CoronaryandStructuralHeartDivisionMember_550b04a5-ff4d-47b9-b941-e4b95f94fefd_terseLabel_en-US" xlink:label="lab_mdt_CoronaryandStructuralHeartDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronary &amp; Structural Heart</link:label>
    <link:label id="lab_mdt_CoronaryandStructuralHeartDivisionMember_label_en-US" xlink:label="lab_mdt_CoronaryandStructuralHeartDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronary and Structural Heart Division [Member]</link:label>
    <link:label id="lab_mdt_CoronaryandStructuralHeartDivisionMember_documentation_en-US" xlink:label="lab_mdt_CoronaryandStructuralHeartDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronary and Structural Heart Division [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CoronaryandStructuralHeartDivisionMember" xlink:href="mdt-20201030.xsd#mdt_CoronaryandStructuralHeartDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CoronaryandStructuralHeartDivisionMember" xlink:to="lab_mdt_CoronaryandStructuralHeartDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract_138e279f-b84f-4a6e-bb76-acbfcf45c4b4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Not Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:to="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AuctionRateSecuritiesMember_9ee2a6f2-8636-4a10-9e68-7a62f3c43a48_terseLabel_en-US" xlink:label="lab_us-gaap_AuctionRateSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auction rate securities</link:label>
    <link:label id="lab_us-gaap_AuctionRateSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AuctionRateSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auction Rate Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionRateSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionRateSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AuctionRateSecuritiesMember" xlink:to="lab_us-gaap_AuctionRateSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_6d3cff7a-3cb7-432f-9631-1e126409c46d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_be7cb2ef-e1f2-438e-80c7-35c4395fbd71_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2010Due2040Member_9aa8258c-b7de-4ae8-abea-3bfcf519f795_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2010Due2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.550 percent thirty-year 2010 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2010Due2040Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2010Due2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2010 Due 2040 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2010Due2040Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2010Due2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2040 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2010Due2040Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2010Due2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2010Due2040Member" xlink:to="lab_mdt_SeniorNotes2010Due2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_d588b313-8dc1-4d25-9265-a5abe70976fb_terseLabel_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time deposit</link:label>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_label_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Time Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankTimeDepositsMember" xlink:to="lab_us-gaap_BankTimeDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_9de84a63-ea1c-461c-a99b-0bfa65ec15e6_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_fc7a3712-34d7-449d-b460-1e2085c52e48_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_6f1c0549-9305-497e-8b77-16772833faee_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6a18c7f4-700b-4b7a-9b5c-b6afeee668f4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_0dc90dfd-43bb-4775-9fc4-59fb6b5df668_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_739aecb3-b373-49a7-87d8-791486a47770_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_7ff5a740-9fef-407d-b1b7-e56497cd2cbb_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d6f79665-d91e-4b12-a7f1-8f36de4a7725_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2012Due2023Member_e5231137-0235-49e6-8d8d-6287848b78e6_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2012Due2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.200 percent ten-year 2012 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2012Due2023Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2012Due2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2012 Due 2023 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2012Due2023Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2012Due2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2012 Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2012Due2023Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2012Due2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2012Due2023Member" xlink:to="lab_mdt_SeniorNotes2012Due2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_a585b3f5-2435-448b-b7ab-5ef44d8b3d10_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_5b792aae-6449-4427-8d9a-e16f8f7bd70d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale, Maturity and Collection of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Member_a340b471-0b0d-4ee3-9547-5120df9743c2_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Member" xlink:to="lab_mdt_SeniorNotes2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_b5562b46-5d92-43a1-bbb1-a0a38a8a2cd5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dbc3eccd-e9ea-442d-a6e2-e24492a355f0_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_dddadf83-7910-473c-8a28-40f5c10288aa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_605b34a9-ee3d-4794-b489-76c5e496292e_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period over which amortization asset will be amortized and deducted</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_e08b5973-ae1e-43ac-99a9-a6446e5a1655_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6394adb9-821b-4d92-ba55-2dc3bae11cfb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts of (Gains) Losses Recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_8a02e58b-f88a-44cd-8825-3d3f7e7622d5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims settled</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Settled, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:to="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock_dc3e8ab6-b180-4db2-b82c-b999e6095cfd_terseLabel_en-US" xlink:label="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Equity and Other Investments</link:label>
    <link:label id="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock_label_en-US" xlink:label="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments [Table Text Block]</link:label>
    <link:label id="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" xlink:href="mdt-20201030.xsd#mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" xlink:to="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_931a5f4a-3b73-47d2-b720-208f6bc61732_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_390b88fa-e860-4228-89fd-ddab53b7b0f8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3aeb87f6-5c92-4d8f-bac8-e79de344a79e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember_ae453630-09be-40f5-9aed-e0b991ff796d_terseLabel_en-US" xlink:label="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Respiratory, Gastrointestinal, &amp; Renal</link:label>
    <link:label id="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember_label_en-US" xlink:label="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Respiratory, Gastrointestinal, and Renal Division [Member]</link:label>
    <link:label id="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember_documentation_en-US" xlink:label="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Respiratory, Gastrointestinal, and Renal Division [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RespiratoryGastrointestinalandRenalDivisionMember" xlink:href="mdt-20201030.xsd#mdt_RespiratoryGastrointestinalandRenalDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_RespiratoryGastrointestinalandRenalDivisionMember" xlink:to="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_77bf164f-8a12-4fb7-a011-4a9c5c650e17_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_2c3f87d3-412c-43d9-9fab-7d81924ea640_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Medtronic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_0ef68932-8584-4437-ace6-683b03200fc9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58594595-f804-4a2a-ae04-ad204a9fdcc7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_40000f66-83a6-4cae-98f1-253042f6a280_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_ddc9f962-0b48-4968-a340-69f321761845_terseLabel_en-US" xlink:label="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_label_en-US" xlink:label="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:to="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_11d808ee-ce4a-4e5e-a3db-0458420f4765_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e94978b4-eff0-421f-820f-53f579c40199_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ab92bfc1-e7b9-4d3a-843d-a38271ac04b2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_9138553c-8874-4a42-98ef-a582428ef6ae_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_15227f35-a512-43a6-a5bb-b560a2f05987_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_bf99b00e-910e-41ac-a379-be14e77c7be3_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_68059dce-828d-417a-bac0-03eaab3033f2_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0d338aa7-ab6b-42a0-bee4-df877372540e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_9a4d4589-756a-4247-b893-42a67e6eef65_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_NeuromodulationDivisionMember_cc533509-db42-426f-8409-473a12d0dce8_terseLabel_en-US" xlink:label="lab_mdt_NeuromodulationDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuromodulation</link:label>
    <link:label id="lab_mdt_NeuromodulationDivisionMember_label_en-US" xlink:label="lab_mdt_NeuromodulationDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuromodulation Division [Member]</link:label>
    <link:label id="lab_mdt_NeuromodulationDivisionMember_documentation_en-US" xlink:label="lab_mdt_NeuromodulationDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuromodulation Division</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuromodulationDivisionMember" xlink:href="mdt-20201030.xsd#mdt_NeuromodulationDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_NeuromodulationDivisionMember" xlink:to="lab_mdt_NeuromodulationDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_eb0f1893-f9de-4fda-9066-9e937be1a556_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_623cedbb-fbcd-43f9-a18c-c25a9d405db5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrentAbstract_2b36faef-275d-4c66-9574-8ec6ec75e3e3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract" xlink:to="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2025Member_09b0ee83-96a5-47af-bb19-013aae93afae_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.25% Senior Notes due 2025</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2025Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2025 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2025Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2025Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2025Member" xlink:to="lab_mdt_SeniorNotes2019Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f712bd80-c311-4f38-ac89-672eabaa0198_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_LossonInvestments_091bc411-c118-45b6-86e4-660382a508c1_negatedTerseLabel_en-US" xlink:label="lab_mdt_LossonInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross losses</link:label>
    <link:label id="lab_mdt_LossonInvestments_label_en-US" xlink:label="lab_mdt_LossonInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Investments</link:label>
    <link:label id="lab_mdt_LossonInvestments_documentation_en-US" xlink:label="lab_mdt_LossonInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossonInvestments" xlink:href="mdt-20201030.xsd#mdt_LossonInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_LossonInvestments" xlink:to="lab_mdt_LossonInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_f4bd4cb8-f981-4780-8427-26db156a8aed_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecurities" xlink:to="lab_us-gaap_HeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_405905ee-6836-45e4-8e64-51aeba2081b4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Change in Retirement Obligations</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_d6f069bc-eccc-472b-baa5-beb7e6ac10ba_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_OtherAccruedExpensesMember_5fa2257e-6806-4c30-8307-0436f1a6a82a_terseLabel_en-US" xlink:label="lab_mdt_OtherAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_mdt_OtherAccruedExpensesMember_label_en-US" xlink:label="lab_mdt_OtherAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Expenses [Member]</link:label>
    <link:label id="lab_mdt_OtherAccruedExpensesMember_documentation_en-US" xlink:label="lab_mdt_OtherAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember" xlink:href="mdt-20201030.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_OtherAccruedExpensesMember" xlink:to="lab_mdt_OtherAccruedExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_481a66c7-b07e-452e-b413-fe859b5c3bac_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_b02ae237-7dcd-416c-b8ec-ec921652e7fd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_5d6de1c0-2683-4adb-a535-966e60485554_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_7ed1cf6a-826e-4592-9f5c-856008c47014_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CranialAndSpinalTechnologiesDivisionMember_f9d0c8b7-0729-4f66-8b4d-3192f0e2a9a2_terseLabel_en-US" xlink:label="lab_mdt_CranialAndSpinalTechnologiesDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cranial &amp; Spinal Technologies</link:label>
    <link:label id="lab_mdt_CranialAndSpinalTechnologiesDivisionMember_label_en-US" xlink:label="lab_mdt_CranialAndSpinalTechnologiesDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cranial And Spinal Technologies Division [Member]</link:label>
    <link:label id="lab_mdt_CranialAndSpinalTechnologiesDivisionMember_documentation_en-US" xlink:label="lab_mdt_CranialAndSpinalTechnologiesDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cranial And Spinal Technologies Division</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CranialAndSpinalTechnologiesDivisionMember" xlink:href="mdt-20201030.xsd#mdt_CranialAndSpinalTechnologiesDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CranialAndSpinalTechnologiesDivisionMember" xlink:to="lab_mdt_CranialAndSpinalTechnologiesDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_837aa6ca-be29-4e05-b710-4751de8f39b8_terseLabel_en-US" xlink:label="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price contingent consideration</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_label_en-US" xlink:label="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Purchase Price Contingent Consideration</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_documentation_en-US" xlink:label="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of contingent consideration arrangement resulting from business combinations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionPurchasePriceContingentConsideration" xlink:href="mdt-20201030.xsd#mdt_BusinessAcquisitionPurchasePriceContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_BusinessAcquisitionPurchasePriceContingentConsideration" xlink:to="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_9fd8b280-ff60-410a-81a0-864ff91f1e8b_totalLabel_en-US" xlink:label="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount of Recorded Assets (Liabilities)</link:label>
    <link:label id="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_label_en-US" xlink:label="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset (Liability), Fair Value, Gross Asset (Liability)</link:label>
    <link:label id="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_documentation_en-US" xlink:label="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset (Liability), Fair Value, Gross Asset (Liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" xlink:to="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_dbd71aed-47e8-4469-828d-4f631c813635_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated Debt</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_27ece556-dc4b-481e-99fc-c6ff6477b985_terseLabel_en-US" xlink:label="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Developed Markets</link:label>
    <link:label id="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_label_en-US" xlink:label="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Australia, New Zealand, Korea, Canada, and Western Europe [Member]</link:label>
    <link:label id="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_documentation_en-US" xlink:label="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Australia, New Zealand, Korea, Canada, and Western Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" xlink:href="mdt-20201030.xsd#mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" xlink:to="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_5a3c13ad-e693-47f0-9a08-8e9b3dc7a85a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes to noncontrolling ownership interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_d1bd85ae-4041-41ce-b5b0-2ac63380881c_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_bb088c0e-4690-40de-af31-faf2a5c201e6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20230.375PercentMember_5c9fc355-dd0b-4dfa-9df5-d9f438756fb4_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20230.375PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.375% Senior Notes due 2023</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20230.375PercentMember_a4cea797-e625-4c40-bb0e-9f7e3e0c4ac8_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20230.375PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.375 percent four-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20230.375PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20230.375PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2023, 0.375 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20230.375PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20230.375PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2023, 0.375 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230.375PercentMember" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20230.375PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20230.375PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20230.375PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d9da9b2b-5fe3-49eb-8e3e-b31a1146a0a1_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_3bd32cab-4e77-4bb5-9c17-28ce37f90c9c_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity securities:</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesClassifiedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_fbd1f8aa-adf9-4ded-936e-2ece24be9f88_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value $0.0001 per share</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_8b12616b-a26b-4457-8c8a-5dd6ffa2d801_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_ebd732ac-9549-4fc0-b9d8-8cd6c8227e7e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_34fe403e-10fa-49e3-a8ef-8bbde5cfa3f9_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_48201b85-bbcb-4116-ab00-01157cf5ae61_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_441c74de-c92a-413a-94cb-10e94f93755a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SpecialtyTherapiesDivisionMember_e8709874-2b6f-421f-b35b-0e9be939950b_terseLabel_en-US" xlink:label="lab_mdt_SpecialtyTherapiesDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Therapies</link:label>
    <link:label id="lab_mdt_SpecialtyTherapiesDivisionMember_label_en-US" xlink:label="lab_mdt_SpecialtyTherapiesDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Therapies Division [Member]</link:label>
    <link:label id="lab_mdt_SpecialtyTherapiesDivisionMember_documentation_en-US" xlink:label="lab_mdt_SpecialtyTherapiesDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Therapies Division [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SpecialtyTherapiesDivisionMember" xlink:href="mdt-20201030.xsd#mdt_SpecialtyTherapiesDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SpecialtyTherapiesDivisionMember" xlink:to="lab_mdt_SpecialtyTherapiesDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6d2437ba-fec1-4fbb-9525-21cd1bae3248_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_8859e978-a2dc-425d-a840-f18971ae3449_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_83ffba64-11bd-4ae5-9d72-00ee255ec42d_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 12 months, Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_TotalOtherCountriesExcludingIrelandMember_4bf89082-756f-4a82-80ba-157f77dc8628_terseLabel_en-US" xlink:label="lab_mdt_TotalOtherCountriesExcludingIrelandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other countries, excluding Ireland</link:label>
    <link:label id="lab_mdt_TotalOtherCountriesExcludingIrelandMember_label_en-US" xlink:label="lab_mdt_TotalOtherCountriesExcludingIrelandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Countries, Excluding Ireland [Member]</link:label>
    <link:label id="lab_mdt_TotalOtherCountriesExcludingIrelandMember_documentation_en-US" xlink:label="lab_mdt_TotalOtherCountriesExcludingIrelandMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Countries, Excluding Ireland [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TotalOtherCountriesExcludingIrelandMember" xlink:href="mdt-20201030.xsd#mdt_TotalOtherCountriesExcludingIrelandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_TotalOtherCountriesExcludingIrelandMember" xlink:to="lab_mdt_TotalOtherCountriesExcludingIrelandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_67843ca6-84a5-46c8-be7d-94b8ed5f0a43_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2040Member_790532c2-1d86-4cb9-8ccd-b2dd6d675ab6_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500 percent twenty-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2040Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2040 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2040Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2040 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2040Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2040Member" xlink:to="lab_mdt_SeniorNotes2019Due2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b90d8a50-bbd7-4047-9ca3-53654291b7ff_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_2651490e-fdfe-4cb5-a9f0-3daeace13ffc_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EquityInvestmentsMember_d7bc0650-96fc-4bf4-bf9e-37e4c17d62cf_verboseLabel_en-US" xlink:label="lab_mdt_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities and Other Investments</link:label>
    <link:label id="lab_mdt_EquityInvestmentsMember_25d37e46-1b37-415c-8da6-fb07874b834b_terseLabel_en-US" xlink:label="lab_mdt_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and Other Investments</link:label>
    <link:label id="lab_mdt_EquityInvestmentsMember_label_en-US" xlink:label="lab_mdt_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments [Member]</link:label>
    <link:label id="lab_mdt_EquityInvestmentsMember_documentation_en-US" xlink:label="lab_mdt_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquityInvestmentsMember" xlink:href="mdt-20201030.xsd#mdt_EquityInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EquityInvestmentsMember" xlink:to="lab_mdt_EquityInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DamagesFromProductDefectsMember_dd0199f9-356d-460e-8732-6d0217dd3bda_terseLabel_en-US" xlink:label="lab_us-gaap_DamagesFromProductDefectsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability litigation</link:label>
    <link:label id="lab_us-gaap_DamagesFromProductDefectsMember_label_en-US" xlink:label="lab_us-gaap_DamagesFromProductDefectsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages from Product Defects [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DamagesFromProductDefectsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DamagesFromProductDefectsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DamagesFromProductDefectsMember" xlink:to="lab_us-gaap_DamagesFromProductDefectsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12ec9c6f-24cf-46ab-a679-ef5de7a0b3f7_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumtermNotesAbstract_20414662-2fb6-4f08-a22e-b4e08eb3002b_terseLabel_en-US" xlink:label="lab_us-gaap_MediumtermNotesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreements</link:label>
    <link:label id="lab_us-gaap_MediumtermNotesAbstract_label_en-US" xlink:label="lab_us-gaap_MediumtermNotesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumtermNotesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MediumtermNotesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumtermNotesAbstract" xlink:to="lab_us-gaap_MediumtermNotesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_fd7c9086-097c-4580-b74c-d7b70229a0d6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_28663db3-bc86-4f20-962f-b6c39c42f9f5_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee restricted stock units (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_415f2edf-e59d-4292-b011-d05e99613a51_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6fc59ee2-300e-43e2-a6a8-7b6e082f9ce7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_d70de158-cbb2-4d37-bb64-01d5b96244aa_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_f9334119-c480-46db-b920-9a4202ee6d23_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsQuantitativeInformationAbstract_0977da90-9b1f-4b91-a314-cc50d71bdaf9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueInputsQuantitativeInformationAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:to="lab_us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_6c87008a-4604-4340-abef-1b0bd8ce20ab_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a1f9b04c-a49c-471e-93a5-10c54fb8a9d8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_43116056-6277-4d5c-88ee-1f49f5ac0efc_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic - weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c7f82a8b-c2ee-461b-a475-df1ae789d05d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Margin added to variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_f8f20744-b6d4-4582-bdc0-1477ef52a724_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_f75a6599-50f3-4723-8274-dbaa0134c3a2_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2025Member_8d6d0aa0-313e-48fe-9de4-500c18105e95_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.000% Senior Notes due 2025</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2025Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2025 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2025Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2025Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2025Member" xlink:to="lab_mdt_SeniorNotes2020Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_b41cd338-2499-4c28-ab91-b770148bd0e9_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_1e3e9725-fb18-4c88-bf04-a5f6aea4d3b0_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges incurred</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_74b702d4-39d4-41dd-b159-2554ecb2f985_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment losses recognized</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment Losses, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfInvestments" xlink:to="lab_us-gaap_ImpairmentOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2012Due2042Member_96c54b4b-b500-4306-a960-90c684b384fb_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2012Due2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.500 percent thirty-year 2012 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2012Due2042Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2012Due2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2012 Due 2042 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2012Due2042Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2012Due2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2042 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2012Due2042Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2012Due2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2012Due2042Member" xlink:to="lab_mdt_SeniorNotes2012Due2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_d2a7e602-4948-4e71-a0a8-f362904941e1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Termination Benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_ccb78784-a85b-4382-9ab9-8a99afb7330d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_779164fa-00fa-4f59-81ce-fe9ee1dd7c78_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_9afd1ad6-4484-409b-9d38-038d764df9ea_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_ea253b3b-f8ec-4973-9efa-0bc60f6d2b11_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount Not Offset on the Balance Sheet, Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Not Offset, Policy Election Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:to="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_4624b202-f1af-4357-b4bb-9ab9049f7c79_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_500753c5-ca60-45e0-a7a2-2b1f0fd93fbe_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments without readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90870f80-a224-4c8d-b427-834bfe518a02_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57b27719-e165-4b1c-81d4-fbdf811be41e_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b96a9e07-ea33-44c3-a511-2d8b52c4cf97_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_9db02fc6-4a32-4a01-abc4-4052f14491fe_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8666fcb9-09d1-4c74-9513-3d28c347dbbf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_674b33a9-7fe1-4205-935a-d2709949dfb4_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_68932dfd-bc7f-4d5e-bb23-10ccb06d4dfa_terseLabel_en-US" xlink:label="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Beginning and Ending Balances of Contingent Milestone Payments [Roll Forward]</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_label_en-US" xlink:label="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration, at Fair Value [Roll Forward]</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_documentation_en-US" xlink:label="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" xlink:href="mdt-20201030.xsd#mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" xlink:to="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_b8454850-68b7-4166-ac49-5a68c54fccb2_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_d642c554-e140-4fbd-bca4-c86f78a8522d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_02d746f2-d774-44ee-87cf-dff6d25c03b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_b977e812-5bbe-4b47-bfd5-bc9dec2bbd63_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f279986c-b29e-451f-b31a-1cb04ecb71e4_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cf684627-9ace-4847-be55-936eb3d1ada7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_12034483-4ff1-497b-8f04-c4db29dca251_negatedTotalLabel_en-US" xlink:label="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount Not Offset on the Balance Sheet, Financial Instruments</link:label>
    <link:label id="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets and Liabilities, Net, Not Offset, Policy Election Deduction</link:label>
    <link:label id="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_documentation_en-US" xlink:label="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets and Liabilities, Net, Not Offset, Policy Election Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" xlink:to="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_38a52979-ce30-4d1e-aa10-edb3ea7151f4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c153b6d2-dcfa-4c39-a73e-15157009b511_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_4e014bf7-f94f-4e97-b761-bc6c14cc8a9c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_1759539e-62de-4eab-a1b0-7e063349b302_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales to External Customers by Geography</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_101f6a7a-e2ed-46cc-a391-3e27a88c18d2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d0521aa0-c6d6-4aab-9e84-aba3c2e3a132_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f5bb2ade-a80b-4e15-a7b4-771e5251b94f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_74a2787c-623c-485f-9296-fee2a0319cd7_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_adce2fda-b51f-453b-8a9b-b6ffa3ab3ee2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.625PercentMember_2b7c78b7-f6d5-4bc8-822e-ce93a2fc4ef2_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.625PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Senior Notes due 2031</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.625PercentMember_1fc7cba6-d612-48ad-abf2-83289707e3de_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.625PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625 percent twelve-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.625PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.625PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2031, 1.625 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.625PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.625PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2031, 1.625 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.625PercentMember" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20311.625PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20311.625PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20311.625PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_574aea55-4913-487a-93e9-63bfd95e83d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_ImpairmentOfInProcessResearchAndDevelopment_6a6ba076-3a1a-4bf2-bd09-02afae3dd6a8_negatedLabel_en-US" xlink:label="lab_mdt_ImpairmentOfInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D charges</link:label>
    <link:label id="lab_mdt_ImpairmentOfInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_mdt_ImpairmentOfInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of In Process Research and Development</link:label>
    <link:label id="lab_mdt_ImpairmentOfInProcessResearchAndDevelopment_documentation_en-US" xlink:label="lab_mdt_ImpairmentOfInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of In Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ImpairmentOfInProcessResearchAndDevelopment" xlink:href="mdt-20201030.xsd#mdt_ImpairmentOfInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_ImpairmentOfInProcessResearchAndDevelopment" xlink:to="lab_mdt_ImpairmentOfInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_8fca75eb-ddc4-4ce1-b5d2-18316c616f8e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_8f4c49ba-1ae1-40fb-becc-07df0cd4a872_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1379f2e1-d21e-4fc9-8140-c4f5898eadbc_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0edc1546-825b-4dbf-a292-893f102539e2_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, Indefinite-lived</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_bc68c2d8-2d69-478e-9071-63a36506d6ac_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense, net of tax</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e1f000f8-1403-438b-9033-c0f664b535a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_6673a0cf-b691-41c0-a90d-678ae11f028b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liabilities, Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_3adca478-fa8a-4fbd-a81f-aa7babefe7aa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount of Recorded Assets (Liabilities)</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1a1e9d5f-f82c-4388-94ce-dda958018590_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, maximum capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_0ef17a2f-ae87-49bb-b846-b758ca1c458e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_2e06848d-18bc-4ea7-a617-1a313cebb6af_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Amount Offset Against Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_3b9678fa-405d-4b40-8401-706fb1e6ec93_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2026Member_a8172a6f-ca99-4e2f-a736-ba7a79565256_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.250 percent seven-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2026Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2026 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2026Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2026Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2026Member" xlink:to="lab_mdt_SeniorNotes2019Due2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_16498a5e-6198-4152-b9f0-af924ad1ac6f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_952fcf1b-3431-4b6d-932d-34c44758feaf_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper, amount outstanding</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_1a046234-7a34-4e0e-b529-d682d59ae1fd_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_70e05cf6-f44f-4739-9ccb-bef469fccb18_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_6845a1a4-3e2b-453f-9bb1-11f20cd466f5_totalLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gains (losses) recognized</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_7c5fd6b9-0a5f-49b8-80b6-4e44ffbd8fdf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to shareholders</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_968cdaf9-c2b1-4655-8892-74d90bb257d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_5c29fcca-060f-455c-ac1c-665c5490eab4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_4d4c605d-e54f-4fb1-ad78-422443724281_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_ab437973-3838-48f3-91b8-b95a5f73c65d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_96b689b3-cc6a-4f32-bc0b-afa8a5463e56_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_03e4758b-6b1a-4d3c-9faf-5984c62bc793_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1bc7185-80a9-4c22-9a04-fc4f1ed921cc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_92947ba7-4a09-4ff8-8431-668261418078_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5fae3759-1bb8-4306-bfc5-1e5dd2b87bd4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20230.000PercentMember_e4bc7adb-f688-44da-86a1-af41415d945d_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20230.000PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.000 percent four-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20230.000PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20230.000PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2023, 0.000 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20230.000PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20230.000PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2023, 0.000 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230.000PercentMember" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20230.000PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20230.000PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20230.000PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9394e200-b350-45ab-80b2-6f1c9d25a319_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_GainonInvestments_9e2eeeea-96f2-4f2f-a507-b2a30c430e09_terseLabel_en-US" xlink:label="lab_mdt_GainonInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross gains</link:label>
    <link:label id="lab_mdt_GainonInvestments_label_en-US" xlink:label="lab_mdt_GainonInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Investments</link:label>
    <link:label id="lab_mdt_GainonInvestments_documentation_en-US" xlink:label="lab_mdt_GainonInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_GainonInvestments" xlink:href="mdt-20201030.xsd#mdt_GainonInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_GainonInvestments" xlink:to="lab_mdt_GainonInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingLiabilitiesTableTextBlock_2d21cd25-d9ae-45d7-aa10-c75e46aee942_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Liabilities</link:label>
    <link:label id="lab_us-gaap_OffsettingLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_RestructuringChargesNetofRestructuringReversals_25b862c2-5852-4a3e-9ce2-8b4c8614cd00_terseLabel_en-US" xlink:label="lab_mdt_RestructuringChargesNetofRestructuringReversals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges, net</link:label>
    <link:label id="lab_mdt_RestructuringChargesNetofRestructuringReversals_e639c0a6-0f68-497e-bb74-75cef775967c_negatedLabel_en-US" xlink:label="lab_mdt_RestructuringChargesNetofRestructuringReversals" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and associated costs</link:label>
    <link:label id="lab_mdt_RestructuringChargesNetofRestructuringReversals_label_en-US" xlink:label="lab_mdt_RestructuringChargesNetofRestructuringReversals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Net of Restructuring Reversals</link:label>
    <link:label id="lab_mdt_RestructuringChargesNetofRestructuringReversals_documentation_en-US" xlink:label="lab_mdt_RestructuringChargesNetofRestructuringReversals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of expenses, net of reversals, associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to discontinued operation or an asset retirement obligation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesNetofRestructuringReversals" xlink:href="mdt-20201030.xsd#mdt_RestructuringChargesNetofRestructuringReversals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_RestructuringChargesNetofRestructuringReversals" xlink:to="lab_mdt_RestructuringChargesNetofRestructuringReversals" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2023Member_4b52971b-0383-43f4-a98d-591cd0e41f74_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.000% Senior Notes due 2023</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2023Member_e3f1395e-a23b-461d-9c47-4ddcbfc425a6_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2023Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.000 percent two-year 2020 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2023Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2023 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2023Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2023Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2023Member" xlink:to="lab_mdt_SeniorNotes2020Due2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_f054477f-223c-4de0-bc4d-46f38498a5c7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-retirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_193842a4-f909-49d6-ac9c-77153e7892e4_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_83a06d42-a4e1-4394-a628-30530b57c442_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d38aabc3-1e60-4a52-b727-8daf7c7280c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:to="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_5ce6e81b-cb3c-44e2-bd92-a2e3d2b5b8c8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a6303be0-f7e7-43b0-a3e4-ac4effbbb371_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2013Due2043Member_d5bcd938-b909-455b-a010-e1934248052d_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2013Due2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.000 percent thirty-year 2013 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2013Due2043Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2013Due2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2013 Due 2043 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2013Due2043Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2013Due2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2043 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2013Due2043Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2013Due2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2013Due2043Member" xlink:to="lab_mdt_SeniorNotes2013Due2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_e33321fc-d560-4fcb-bd56-c007f2836f8e_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plans</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_414b57ad-b77f-454a-a48d-2a67aab42119_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCollateralRightToReclaimCash_54407fc9-12b0-4564-8f48-2816d2e86ac4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)</link:label>
    <link:label id="lab_us-gaap_DerivativeCollateralRightToReclaimCash_label_en-US" xlink:label="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Collateral, Right to Reclaim Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:to="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_42ae5d95-87a1-4596-b6f1-1e4ee6a21fd8_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_2d129c28-5f59-4a03-81a6-f63cba5bec02_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_e9867d15-97b8-4369-880e-fcfa0e15f2c1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_090740f9-33df-4498-93ef-0e694584526f_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_d1da8157-bde9-42ee-b06d-abd0e48d6a41_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_7b1ab334-c3b4-4142-a859-403ff483e29e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2085cb72-35a6-4566-96af-cf59a334acc5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Inputs, Liabilities, Quantitative Information [Line Items] (Deprecated 2018-01-31)</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_5d7bbf85-1044-45ee-8639-658bc03d1a45_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_f7871fcd-5d99-4cf1-ac3d-01974bca93ed_terseLabel_en-US" xlink:label="lab_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_label_en-US" xlink:label="lab_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Including Goodwill</link:label>
    <link:label id="lab_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_documentation_en-US" xlink:label="lab_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Including Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" xlink:href="mdt-20201030.xsd#mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" xlink:to="lab_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2032Member_7caf19c2-e94a-4a7e-9f90-1022407df58f_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000 percent thirteen-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2032Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2032 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2032Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2032 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2032Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2032Member" xlink:to="lab_mdt_SeniorNotes2019Due2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_77f15b87-f960-49c0-a823-efd8b36fec90_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_a373f8f7-4427-4594-9a4f-64d3721b773b_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_90770d72-3ac3-4b5a-82d7-666408cf820c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2027Member_aef26351-9efb-4eff-96d8-2ca3b267cae5_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.125% Senior Notes due 2027</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2027Member_ef20501f-3692-4097-ac64-fbd875a4d8c2_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2027Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.125 percent eight-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2027Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2027 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2027Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2027Member" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2027Member" xlink:to="lab_mdt_SeniorNotes2019Due2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_03dfdacf-7748-459a-8608-9ec6ee09d666_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_541b7115-7915-4ffa-8b1b-d3c0e081b692_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>mdt-20201030_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:8939d385-98d2-4684-bfa0-0279309cacd9,g:e5f1341e-11f4-4035-86fa-7f937a6230d9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medtronic.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="mdt-20201030.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_f479bacf-5224-4acc-90d2-0041670b3818" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_300a1da6-1023-47a6-a5d7-9598f53080f6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f479bacf-5224-4acc-90d2-0041670b3818" xlink:to="loc_dei_EntitiesTable_300a1da6-1023-47a6-a5d7-9598f53080f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a8311a93-d328-4b3f-a414-df5013c9ca0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_300a1da6-1023-47a6-a5d7-9598f53080f6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a8311a93-d328-4b3f-a414-df5013c9ca0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a8311a93-d328-4b3f-a414-df5013c9ca0c" xlink:to="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e203a4b5-be30-4ecd-93a0-7fc5b263e670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_us-gaap_CommonStockMember_e203a4b5-be30-4ecd-93a0-7fc5b263e670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2021FloatingMember_4bb0b51a-4b31-48f4-bbd8-8e449726cf11" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2021FloatingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due2021FloatingMember_4bb0b51a-4b31-48f4-bbd8-8e449726cf11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2022Member_b7761ab1-2a6c-4426-9900-e70a07119afa" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due2022Member_b7761ab1-2a6c-4426-9900-e70a07119afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230.375PercentMember_bdddca19-f505-47f1-ae98-ab02a15fc203" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20230.375PercentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due20230.375PercentMember_bdddca19-f505-47f1-ae98-ab02a15fc203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2023Member_d29c9918-0369-437e-9022-a247124fdae7" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2020Due2023Member_d29c9918-0369-437e-9022-a247124fdae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2025Member_a932d212-3862-44ba-825e-3da168d28596" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due2025Member_a932d212-3862-44ba-825e-3da168d28596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2025Member_18d19ffc-ad15-4477-ae07-46dec76bc51a" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2025Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2020Due2025Member_18d19ffc-ad15-4477-ae07-46dec76bc51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2027Member_62f1983b-3df7-4ded-8af9-d6c0ba1df5f2" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2027Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due2027Member_62f1983b-3df7-4ded-8af9-d6c0ba1df5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2028Member_457673f7-cbe5-482b-b16a-01ce262d5bd5" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2028Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2020Due2028Member_457673f7-cbe5-482b-b16a-01ce262d5bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.625PercentMember_de4dbe51-5df0-4244-85f6-b89b2549e0e7" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20311.625PercentMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due20311.625PercentMember_de4dbe51-5df0-4244-85f6-b89b2549e0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.00PercentMember_ab51a522-1906-4deb-86db-fb9e43d80f6c" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20311.00PercentMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due20311.00PercentMember_ab51a522-1906-4deb-86db-fb9e43d80f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2032Member_07180fb0-cb88-4902-811b-ecf970ffd050" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2032Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2020Due2032Member_07180fb0-cb88-4902-811b-ecf970ffd050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20392.250PercentMember_c506bc67-1f97-4030-88f5-ef6c56e874ea" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20392.250PercentMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due20392.250PercentMember_c506bc67-1f97-4030-88f5-ef6c56e874ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20391.50PercentMember_bd398d33-cf16-46a3-81e1-73c8db80ba5f" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20391.50PercentMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due20391.50PercentMember_bd398d33-cf16-46a3-81e1-73c8db80ba5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2040Member_af48ab0e-17eb-44d2-a80a-aa74f3221708" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2040Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2020Due2040Member_af48ab0e-17eb-44d2-a80a-aa74f3221708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2049Member_65f83e2f-a806-4878-ac0f-904b8cbbb5b0" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2049Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2019Due2049Member_65f83e2f-a806-4878-ac0f-904b8cbbb5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2050Member_6c4abc96-6bec-43be-9313-d0550095aef0" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2050Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59caa39-6c3f-4511-bada-8fe649fdec34" xlink:to="loc_mdt_SeniorNotes2020Due2050Member_6c4abc96-6bec-43be-9313-d0550095aef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_300a1da6-1023-47a6-a5d7-9598f53080f6" xlink:to="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c571a5e1-041c-417a-83d0-a8ecc1f2b49c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_DocumentType_c571a5e1-041c-417a-83d0-a8ecc1f2b49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_ba5034a9-5ded-4963-8f40-0b26a50be0cd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_DocumentQuarterlyReport_ba5034a9-5ded-4963-8f40-0b26a50be0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9a9dc254-9ad8-4fa2-a7ba-b9ca15c261d1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_DocumentPeriodEndDate_9a9dc254-9ad8-4fa2-a7ba-b9ca15c261d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_71fcbb91-3de8-4920-ae18-bf20802b391c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_DocumentTransitionReport_71fcbb91-3de8-4920-ae18-bf20802b391c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2f89d03f-98c8-4546-a0e1-f26a35441729" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityFileNumber_2f89d03f-98c8-4546-a0e1-f26a35441729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e70a2aa2-283d-42e9-a479-35692e6533df" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityRegistrantName_e70a2aa2-283d-42e9-a479-35692e6533df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e8245331-653d-41b8-b7a0-4cfbe9ef98c9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e8245331-653d-41b8-b7a0-4cfbe9ef98c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_546a34ec-87df-42d7-9c71-d564f5fd1c45" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityTaxIdentificationNumber_546a34ec-87df-42d7-9c71-d564f5fd1c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5622de83-7f64-4482-ad51-ea6bf6a177e1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityAddressAddressLine1_5622de83-7f64-4482-ad51-ea6bf6a177e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c53fd503-39bf-4530-913e-888ec0886b9b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityAddressCityOrTown_c53fd503-39bf-4530-913e-888ec0886b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_898950cd-6564-42dd-8590-993db406e368" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityAddressCountry_898950cd-6564-42dd-8590-993db406e368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_4647dabd-8b8c-4aea-ae2a-ee16b6d3d014" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_CountryRegion_4647dabd-8b8c-4aea-ae2a-ee16b6d3d014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_11068694-b8be-43a7-9570-126db7d2fcac" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_CityAreaCode_11068694-b8be-43a7-9570-126db7d2fcac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b2884de2-3cfb-4656-a78f-8cc65ec7e02c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_LocalPhoneNumber_b2884de2-3cfb-4656-a78f-8cc65ec7e02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9185eda2-26ed-485e-a10a-a35a822d097e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_Security12bTitle_9185eda2-26ed-485e-a10a-a35a822d097e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_40513cf3-f7a0-4c57-a29a-9632e4c91201" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_TradingSymbol_40513cf3-f7a0-4c57-a29a-9632e4c91201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_3f33e2e5-a1e4-4308-b92b-a13527b04401" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_SecurityExchangeName_3f33e2e5-a1e4-4308-b92b-a13527b04401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_6c7b28cd-0ea8-432f-9c1c-fc878cc33e6b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityCurrentReportingStatus_6c7b28cd-0ea8-432f-9c1c-fc878cc33e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_33f4fb04-07ac-46c3-babe-879434f4f4e1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityInteractiveDataCurrent_33f4fb04-07ac-46c3-babe-879434f4f4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_05f7cee0-2d77-47fe-86ca-aabf562e4d5a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityFilerCategory_05f7cee0-2d77-47fe-86ca-aabf562e4d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_df4dd4ef-e3c3-43b4-82aa-fc09bf68b5ae" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntitySmallBusiness_df4dd4ef-e3c3-43b4-82aa-fc09bf68b5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f72d081f-0eeb-4b3a-b22c-99a733e067c0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityEmergingGrowthCompany_f72d081f-0eeb-4b3a-b22c-99a733e067c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_65df8e8c-c1c4-434d-834d-ef0356ad7fbf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityShellCompany_65df8e8c-c1c4-434d-834d-ef0356ad7fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_23488be6-99d3-4745-a630-350428c9ed50" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_23488be6-99d3-4745-a630-350428c9ed50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cb6f7b52-9652-473c-8a1a-74bbbcc4676a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityCentralIndexKey_cb6f7b52-9652-473c-8a1a-74bbbcc4676a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_273aa419-2f33-450a-8170-af61069fca10" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_AmendmentFlag_273aa419-2f33-450a-8170-af61069fca10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_cb6982f3-0af5-49f0-aad0-462dde4512ff" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_CurrentFiscalYearEndDate_cb6982f3-0af5-49f0-aad0-462dde4512ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_b049c446-b539-4ace-9e0b-1394e0f34e1c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_DocumentFiscalPeriodFocus_b049c446-b539-4ace-9e0b-1394e0f34e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5fb9c0dd-771b-4786-a596-84fc347e7e4b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_DocumentFiscalYearFocus_5fb9c0dd-771b-4786-a596-84fc347e7e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4de43da0-c7fe-49d1-bef9-c2ca7f72016f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_892928db-fc8d-4579-b9b9-562b684ab3a9" xlink:to="loc_dei_EntityAddressPostalZipCode_4de43da0-c7fe-49d1-bef9-c2ca7f72016f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_52b4be15-7129-4709-9179-1c8a4b3da27d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_52b4be15-7129-4709-9179-1c8a4b3da27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_2dee012c-89cf-408f-85b9-9b9628410919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_2dee012c-89cf-408f-85b9-9b9628410919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9aa0fd4d-1742-4149-9410-90d99c4db7eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2dee012c-89cf-408f-85b9-9b9628410919" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9aa0fd4d-1742-4149-9410-90d99c4db7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_65c172b1-b043-43a9-8804-9b6969cfd4f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2dee012c-89cf-408f-85b9-9b9628410919" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_65c172b1-b043-43a9-8804-9b6969cfd4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a2ffb9e7-96ce-4a21-a658-c47ea698c4f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2dee012c-89cf-408f-85b9-9b9628410919" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a2ffb9e7-96ce-4a21-a658-c47ea698c4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_14275c6b-79f5-4edb-a680-7918806a9825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2dee012c-89cf-408f-85b9-9b9628410919" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_14275c6b-79f5-4edb-a680-7918806a9825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesNetofRestructuringReversals_16cd3596-8926-4bb4-a653-801a2977cbc3" xlink:href="mdt-20201030.xsd#mdt_RestructuringChargesNetofRestructuringReversals"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2dee012c-89cf-408f-85b9-9b9628410919" xlink:to="loc_mdt_RestructuringChargesNetofRestructuringReversals_16cd3596-8926-4bb4-a653-801a2977cbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_bb07295a-7acf-4ef1-a1d6-ea366ef0dc59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2dee012c-89cf-408f-85b9-9b9628410919" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_bb07295a-7acf-4ef1-a1d6-ea366ef0dc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_0a482a6d-fe30-4cb4-916e-9710fe4ec06e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2dee012c-89cf-408f-85b9-9b9628410919" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_0a482a6d-fe30-4cb4-916e-9710fe4ec06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_67cbc5f6-bc2d-4f7c-8382-98cd0dd9dcd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_OperatingIncomeLoss_67cbc5f6-bc2d-4f7c-8382-98cd0dd9dcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1ba68d3c-3ce6-442a-8748-d21dbb359557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1ba68d3c-3ce6-442a-8748-d21dbb359557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_83680e8b-a380-4079-878b-2b28bd38ab94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_InterestExpense_83680e8b-a380-4079-878b-2b28bd38ab94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2f0a88d7-280f-4527-aaed-c5499ff5dadd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2f0a88d7-280f-4527-aaed-c5499ff5dadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_60f94790-2555-4f2d-a272-4c9fae25127a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_60f94790-2555-4f2d-a272-4c9fae25127a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7da43450-0ba6-468e-92bd-8c3070ffaaf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_ProfitLoss_7da43450-0ba6-468e-92bd-8c3070ffaaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e01f57a7-92a6-4b90-baa1-b6ea72b12004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e01f57a7-92a6-4b90-baa1-b6ea72b12004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b54b06cd-2606-43eb-ae85-de054dcda6a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_NetIncomeLoss_b54b06cd-2606-43eb-ae85-de054dcda6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_bf0cb542-a3f7-42e3-b17e-f2d67e23eea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_EarningsPerShareBasic_bf0cb542-a3f7-42e3-b17e-f2d67e23eea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_05082410-f3e7-41d4-a140-e1379834acc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_05082410-f3e7-41d4-a140-e1379834acc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5ca365b2-dc72-4cb6-8a02-3474f9f538bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5ca365b2-dc72-4cb6-8a02-3474f9f538bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b50e2913-1a0a-42e3-b51f-6e830564ff77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae1333b2-916d-413c-a28c-8a80aa0b383d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b50e2913-1a0a-42e3-b51f-6e830564ff77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b814ee91-d670-4a0b-b923-82da6eec298d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_cb902594-c064-4623-a72c-da31f9bd957a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b814ee91-d670-4a0b-b923-82da6eec298d" xlink:to="loc_us-gaap_ProfitLoss_cb902594-c064-4623-a72c-da31f9bd957a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5030cea5-a962-44fe-b936-3712166198e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b814ee91-d670-4a0b-b923-82da6eec298d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5030cea5-a962-44fe-b936-3712166198e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_804860bf-8c86-421a-8f37-6b4f40dd0797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5030cea5-a962-44fe-b936-3712166198e2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_804860bf-8c86-421a-8f37-6b4f40dd0797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_dba12024-dbc0-46f6-af70-1337eff30f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5030cea5-a962-44fe-b936-3712166198e2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_dba12024-dbc0-46f6-af70-1337eff30f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_c8031b47-801d-462b-904c-a5746c5d44cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5030cea5-a962-44fe-b936-3712166198e2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_c8031b47-801d-462b-904c-a5746c5d44cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8065812b-5827-41ef-9a3f-5fa2ca7d0394" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5030cea5-a962-44fe-b936-3712166198e2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8065812b-5827-41ef-9a3f-5fa2ca7d0394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2cf3e43d-ca58-41b3-98ff-c9438702a40c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5030cea5-a962-44fe-b936-3712166198e2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2cf3e43d-ca58-41b3-98ff-c9438702a40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_269ba88d-6265-4995-ac18-45ad6b0c08e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5030cea5-a962-44fe-b936-3712166198e2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_269ba88d-6265-4995-ac18-45ad6b0c08e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2dfd7e96-0af6-4b6c-921a-370d826cfd25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b814ee91-d670-4a0b-b923-82da6eec298d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2dfd7e96-0af6-4b6c-921a-370d826cfd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_eb2e858d-bdcb-45aa-a857-171a56e5f017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b814ee91-d670-4a0b-b923-82da6eec298d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_eb2e858d-bdcb-45aa-a857-171a56e5f017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_33cd81ee-c853-43ea-a37a-f3c25f8ea9c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b814ee91-d670-4a0b-b923-82da6eec298d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_33cd81ee-c853-43ea-a37a-f3c25f8ea9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4ab94cec-9b65-4ba8-a682-db99cc296721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0603da0d-b6ca-440b-889c-6251f56a6cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4ab94cec-9b65-4ba8-a682-db99cc296721" xlink:to="loc_us-gaap_AssetsAbstract_0603da0d-b6ca-440b-889c-6251f56a6cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_e7deb49b-d150-4964-b1e9-793074592624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0603da0d-b6ca-440b-889c-6251f56a6cee" xlink:to="loc_us-gaap_AssetsCurrentAbstract_e7deb49b-d150-4964-b1e9-793074592624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a6cc129a-42f1-4301-ae7d-53100b066f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e7deb49b-d150-4964-b1e9-793074592624" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a6cc129a-42f1-4301-ae7d-53100b066f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_9a7d1b49-752c-4d25-a48e-b0faf19da2c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e7deb49b-d150-4964-b1e9-793074592624" xlink:to="loc_us-gaap_ShortTermInvestments_9a7d1b49-752c-4d25-a48e-b0faf19da2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_8c3ca78d-7e29-4342-bb7e-c7f0b54a51e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e7deb49b-d150-4964-b1e9-793074592624" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_8c3ca78d-7e29-4342-bb7e-c7f0b54a51e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7b5887a9-3e40-43f5-82f8-15efcef4a21c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e7deb49b-d150-4964-b1e9-793074592624" xlink:to="loc_us-gaap_InventoryNet_7b5887a9-3e40-43f5-82f8-15efcef4a21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_b5e252b5-15d8-46d0-9feb-42234570a1d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e7deb49b-d150-4964-b1e9-793074592624" xlink:to="loc_us-gaap_OtherAssetsCurrent_b5e252b5-15d8-46d0-9feb-42234570a1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a6427f4a-d6c5-461e-9401-03574d494e57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e7deb49b-d150-4964-b1e9-793074592624" xlink:to="loc_us-gaap_AssetsCurrent_a6427f4a-d6c5-461e-9401-03574d494e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4aa1435a-83d9-4746-8d8d-506b72f67520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0603da0d-b6ca-440b-889c-6251f56a6cee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_4aa1435a-83d9-4746-8d8d-506b72f67520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5817bad6-34e8-4aa9-8cc7-7311a94d7cbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0603da0d-b6ca-440b-889c-6251f56a6cee" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5817bad6-34e8-4aa9-8cc7-7311a94d7cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_be241c1d-7ef4-4113-b43b-f09d9be43288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0603da0d-b6ca-440b-889c-6251f56a6cee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_be241c1d-7ef4-4113-b43b-f09d9be43288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c19edaf7-9b3a-4c73-a498-a6fe7808511f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0603da0d-b6ca-440b-889c-6251f56a6cee" xlink:to="loc_us-gaap_Goodwill_c19edaf7-9b3a-4c73-a498-a6fe7808511f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1b8f61d7-f90e-48c5-8399-f4ce43b9fc86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0603da0d-b6ca-440b-889c-6251f56a6cee" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1b8f61d7-f90e-48c5-8399-f4ce43b9fc86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_0734b109-c518-4828-b7ce-1c6f8dee9d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0603da0d-b6ca-440b-889c-6251f56a6cee" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_0734b109-c518-4828-b7ce-1c6f8dee9d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c6f172ac-9511-4359-9fce-f1ddf39780de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0603da0d-b6ca-440b-889c-6251f56a6cee" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c6f172ac-9511-4359-9fce-f1ddf39780de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e3435f48-ac32-401a-b597-dd500131a38a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0603da0d-b6ca-440b-889c-6251f56a6cee" xlink:to="loc_us-gaap_Assets_e3435f48-ac32-401a-b597-dd500131a38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9c395a4b-82ef-4d39-91ce-e87281dcf408" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4ab94cec-9b65-4ba8-a682-db99cc296721" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9c395a4b-82ef-4d39-91ce-e87281dcf408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3de922c5-e761-47f1-8f61-020fceaa8dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9c395a4b-82ef-4d39-91ce-e87281dcf408" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3de922c5-e761-47f1-8f61-020fceaa8dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_51afa839-21c4-420f-8f5f-93d08244f4c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3de922c5-e761-47f1-8f61-020fceaa8dfd" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_51afa839-21c4-420f-8f5f-93d08244f4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_92469226-b6d3-4ccf-987c-37abce4c4af7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3de922c5-e761-47f1-8f61-020fceaa8dfd" xlink:to="loc_us-gaap_AccountsPayableCurrent_92469226-b6d3-4ccf-987c-37abce4c4af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent_bdbcf235-f3fb-4982-bf77-ee91b5cf0646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3de922c5-e761-47f1-8f61-020fceaa8dfd" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrent_bdbcf235-f3fb-4982-bf77-ee91b5cf0646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_7d413915-357d-4cf2-8c9d-a9dacec712f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3de922c5-e761-47f1-8f61-020fceaa8dfd" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_7d413915-357d-4cf2-8c9d-a9dacec712f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e48f12d7-ca9c-41d5-87f9-32485ef869fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3de922c5-e761-47f1-8f61-020fceaa8dfd" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e48f12d7-ca9c-41d5-87f9-32485ef869fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_802e66aa-82e1-44a8-8cc4-1e7a20536cd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3de922c5-e761-47f1-8f61-020fceaa8dfd" xlink:to="loc_us-gaap_LiabilitiesCurrent_802e66aa-82e1-44a8-8cc4-1e7a20536cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ca26f79f-3861-4162-9d02-aa2197efe07a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9c395a4b-82ef-4d39-91ce-e87281dcf408" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ca26f79f-3861-4162-9d02-aa2197efe07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_efd4e972-8d9a-47e1-8a79-eb6f0d735e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9c395a4b-82ef-4d39-91ce-e87281dcf408" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_efd4e972-8d9a-47e1-8a79-eb6f0d735e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_cef353b2-f97e-4e4c-8822-db31b6afc53a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9c395a4b-82ef-4d39-91ce-e87281dcf408" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_cef353b2-f97e-4e4c-8822-db31b6afc53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_819462da-52d0-470a-9621-13d0af8275b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9c395a4b-82ef-4d39-91ce-e87281dcf408" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_819462da-52d0-470a-9621-13d0af8275b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9bc54596-a6fd-46d7-9203-c69bd446a098" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9c395a4b-82ef-4d39-91ce-e87281dcf408" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9bc54596-a6fd-46d7-9203-c69bd446a098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b3b4035f-8af5-4d54-928a-7dc1f8f46b48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9c395a4b-82ef-4d39-91ce-e87281dcf408" xlink:to="loc_us-gaap_Liabilities_b3b4035f-8af5-4d54-928a-7dc1f8f46b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1a5b5cdf-a89c-42dd-9a0b-eadb7b916923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9c395a4b-82ef-4d39-91ce-e87281dcf408" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1a5b5cdf-a89c-42dd-9a0b-eadb7b916923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_98b0e210-7a2f-43f7-8b43-a21f631604b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9c395a4b-82ef-4d39-91ce-e87281dcf408" xlink:to="loc_us-gaap_StockholdersEquityAbstract_98b0e210-7a2f-43f7-8b43-a21f631604b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b39d9133-c330-44eb-baab-c1dff6223b15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98b0e210-7a2f-43f7-8b43-a21f631604b5" xlink:to="loc_us-gaap_CommonStockValue_b39d9133-c330-44eb-baab-c1dff6223b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_96381df6-5e89-495a-951b-d9ae52b1a96c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98b0e210-7a2f-43f7-8b43-a21f631604b5" xlink:to="loc_us-gaap_AdditionalPaidInCapital_96381df6-5e89-495a-951b-d9ae52b1a96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ffe7d529-a6a0-451f-9cb5-41e6ba356cc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98b0e210-7a2f-43f7-8b43-a21f631604b5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ffe7d529-a6a0-451f-9cb5-41e6ba356cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dba49017-3184-4b1a-b4f7-ea06653d206f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98b0e210-7a2f-43f7-8b43-a21f631604b5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dba49017-3184-4b1a-b4f7-ea06653d206f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a95af0e7-7036-4410-b990-97632d61ea39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98b0e210-7a2f-43f7-8b43-a21f631604b5" xlink:to="loc_us-gaap_StockholdersEquity_a95af0e7-7036-4410-b990-97632d61ea39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_030b58b1-70a1-4a2b-8680-0054b7cacb40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98b0e210-7a2f-43f7-8b43-a21f631604b5" xlink:to="loc_us-gaap_MinorityInterest_030b58b1-70a1-4a2b-8680-0054b7cacb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a3a927ef-ed6c-4490-9096-c8ce822f5294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98b0e210-7a2f-43f7-8b43-a21f631604b5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a3a927ef-ed6c-4490-9096-c8ce822f5294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c8a5cdf0-7ed1-4122-95b7-29dbae3cecbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9c395a4b-82ef-4d39-91ce-e87281dcf408" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_c8a5cdf0-7ed1-4122-95b7-29dbae3cecbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_726c62ac-d0b4-4d08-925a-441348eb6220" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_096e9ca8-0ae0-41e4-8a86-7afee3436c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_726c62ac-d0b4-4d08-925a-441348eb6220" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_096e9ca8-0ae0-41e4-8a86-7afee3436c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_00721106-7207-4108-abaf-e6d29a4e9d57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_726c62ac-d0b4-4d08-925a-441348eb6220" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_00721106-7207-4108-abaf-e6d29a4e9d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8eae09f6-ea81-444d-9eb6-6d0198df8742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_726c62ac-d0b4-4d08-925a-441348eb6220" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8eae09f6-ea81-444d-9eb6-6d0198df8742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_87fa3a29-198b-4495-9cd7-18e78f661017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_726c62ac-d0b4-4d08-925a-441348eb6220" xlink:to="loc_us-gaap_CommonStockSharesIssued_87fa3a29-198b-4495-9cd7-18e78f661017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0c294057-44ee-45c4-8235-c6e2ff74eb4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_726c62ac-d0b4-4d08-925a-441348eb6220" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0c294057-44ee-45c4-8235-c6e2ff74eb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_2e7f6dfa-16ea-45a9-a461-06dea5c1eb35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_48e93ced-a249-4e0e-bc19-44bef44993a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2e7f6dfa-16ea-45a9-a461-06dea5c1eb35" xlink:to="loc_us-gaap_StatementTable_48e93ced-a249-4e0e-bc19-44bef44993a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_52ba3b46-880c-4720-ad27-ef2ff4c17c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_48e93ced-a249-4e0e-bc19-44bef44993a9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_52ba3b46-880c-4720-ad27-ef2ff4c17c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1557a796-045f-4d11-9ee9-85d62f2fa4be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_52ba3b46-880c-4720-ad27-ef2ff4c17c03" xlink:to="loc_us-gaap_EquityComponentDomain_1557a796-045f-4d11-9ee9-85d62f2fa4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_a4925467-e36b-4386-a039-c17cf50809cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1557a796-045f-4d11-9ee9-85d62f2fa4be" xlink:to="loc_us-gaap_ParentMember_a4925467-e36b-4386-a039-c17cf50809cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cb29e7c3-fb31-4855-acf0-7ace7d518a0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_a4925467-e36b-4386-a039-c17cf50809cd" xlink:to="loc_us-gaap_CommonStockMember_cb29e7c3-fb31-4855-acf0-7ace7d518a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_10c27531-332a-494e-bd9e-d0b91aa2ac8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_a4925467-e36b-4386-a039-c17cf50809cd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_10c27531-332a-494e-bd9e-d0b91aa2ac8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b3900448-876e-4694-b33a-ed7bc444bbe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_a4925467-e36b-4386-a039-c17cf50809cd" xlink:to="loc_us-gaap_RetainedEarningsMember_b3900448-876e-4694-b33a-ed7bc444bbe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d4f25e45-4231-4ec6-bcae-a4572612174d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_a4925467-e36b-4386-a039-c17cf50809cd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d4f25e45-4231-4ec6-bcae-a4572612174d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_09827281-006a-4314-8201-95f25ad18a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1557a796-045f-4d11-9ee9-85d62f2fa4be" xlink:to="loc_us-gaap_NoncontrollingInterestMember_09827281-006a-4314-8201-95f25ad18a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8b9ce03b-052d-4ab1-9fab-6ad520567f2b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_48e93ced-a249-4e0e-bc19-44bef44993a9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8b9ce03b-052d-4ab1-9fab-6ad520567f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0fdf0737-b950-4152-ad9a-4be538d2f273" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8b9ce03b-052d-4ab1-9fab-6ad520567f2b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0fdf0737-b950-4152-ad9a-4be538d2f273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_afa8c07f-f1fb-4824-8832-f6747da5ea89" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0fdf0737-b950-4152-ad9a-4be538d2f273" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_afa8c07f-f1fb-4824-8832-f6747da5ea89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_74e473ac-6e2c-44ea-b87e-94808263f868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_48e93ced-a249-4e0e-bc19-44bef44993a9" xlink:to="loc_us-gaap_StatementLineItems_74e473ac-6e2c-44ea-b87e-94808263f868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_74e473ac-6e2c-44ea-b87e-94808263f868" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a20d119d-ff9d-496f-b011-51c7f86f17c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a20d119d-ff9d-496f-b011-51c7f86f17c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c0aa776a-0953-4de5-90fc-c4b99f3ab5aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c0aa776a-0953-4de5-90fc-c4b99f3ab5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_75f0f2ce-b824-4459-a8da-7e43c66bd207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_ProfitLoss_75f0f2ce-b824-4459-a8da-7e43c66bd207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_88fe5587-e0cf-420c-ba10-0ddb37c9a514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_88fe5587-e0cf-420c-ba10-0ddb37c9a514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_15f78268-b273-44f8-9e0b-c68c2426fe43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_DividendsCommonStockCash_15f78268-b273-44f8-9e0b-c68c2426fe43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_df6e2344-a11a-4816-b5e4-d78881b7fa9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_df6e2344-a11a-4816-b5e4-d78881b7fa9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5bb34a44-b6b2-4f11-b7e1-6bd572a353af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5bb34a44-b6b2-4f11-b7e1-6bd572a353af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_7207a4bc-f917-41a6-b822-23770edab965" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_7207a4bc-f917-41a6-b822-23770edab965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2217e892-3efe-4474-a6dc-6cd72abe676c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2217e892-3efe-4474-a6dc-6cd72abe676c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_80f68ef2-466e-4534-8e8b-1a0ce42cd3a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_80f68ef2-466e-4534-8e8b-1a0ce42cd3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_138e5a80-b2c5-4789-acc5-bf6de06de01d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_138e5a80-b2c5-4789-acc5-bf6de06de01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_4705c0e5-b57b-4061-8510-dcdc51f663ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_4705c0e5-b57b-4061-8510-dcdc51f663ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3347d7b1-e456-4f84-907e-30b33d3188b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3347d7b1-e456-4f84-907e-30b33d3188b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dad61bb2-302e-4170-ad6a-d127aff92d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_65043fdc-043d-4419-9230-acfeed5828f0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dad61bb2-302e-4170-ad6a-d127aff92d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofEquityUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a2b6a307-f91f-4da0-94ca-f798cfed8fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_df8c2fc7-710e-4813-bbed-efcbdb8e2c02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a2b6a307-f91f-4da0-94ca-f798cfed8fb7" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_df8c2fc7-710e-4813-bbed-efcbdb8e2c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="mdt-20201030.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_2b74fcfc-3851-4d98-b504-d4e0d82b4e5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_79fa4185-47ac-4386-95d7-03be0b5daa36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2b74fcfc-3851-4d98-b504-d4e0d82b4e5e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_79fa4185-47ac-4386-95d7-03be0b5daa36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_266d022b-6c85-4d83-be58-2829ffeb76f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_79fa4185-47ac-4386-95d7-03be0b5daa36" xlink:to="loc_us-gaap_ProfitLoss_266d022b-6c85-4d83-be58-2829ffeb76f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8607e90e-f795-46f1-b3b1-c430415353ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_79fa4185-47ac-4386-95d7-03be0b5daa36" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8607e90e-f795-46f1-b3b1-c430415353ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2c2e3610-3590-4ec3-a2e8-ab8cefd5e5fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8607e90e-f795-46f1-b3b1-c430415353ac" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2c2e3610-3590-4ec3-a2e8-ab8cefd5e5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_b9979757-432b-4a78-b877-4420e7022569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8607e90e-f795-46f1-b3b1-c430415353ac" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_b9979757-432b-4a78-b877-4420e7022569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_26768c7c-afa3-4c33-8e1b-f0f5e1666904" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8607e90e-f795-46f1-b3b1-c430415353ac" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_26768c7c-afa3-4c33-8e1b-f0f5e1666904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_26756491-b3c0-49c6-b6c0-56c88d4b7b95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8607e90e-f795-46f1-b3b1-c430415353ac" xlink:to="loc_us-gaap_ShareBasedCompensation_26756491-b3c0-49c6-b6c0-56c88d4b7b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e7a5a98e-dad8-4766-b44f-425bc5c0b5a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8607e90e-f795-46f1-b3b1-c430415353ac" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e7a5a98e-dad8-4766-b44f-425bc5c0b5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_7307f279-e861-410a-be35-338864036b3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8607e90e-f795-46f1-b3b1-c430415353ac" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_7307f279-e861-410a-be35-338864036b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c5a0a695-04b1-49f1-87a6-8755f8607f0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8607e90e-f795-46f1-b3b1-c430415353ac" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c5a0a695-04b1-49f1-87a6-8755f8607f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_15455647-ed0c-4e85-b1d7-c911fed87e54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c5a0a695-04b1-49f1-87a6-8755f8607f0e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_15455647-ed0c-4e85-b1d7-c911fed87e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_114b4fb4-2b6d-4762-9ae6-14125beb339e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c5a0a695-04b1-49f1-87a6-8755f8607f0e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_114b4fb4-2b6d-4762-9ae6-14125beb339e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_fc348b60-129b-471c-8ff2-4dd1d8c9f6ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c5a0a695-04b1-49f1-87a6-8755f8607f0e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_fc348b60-129b-471c-8ff2-4dd1d8c9f6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_375e24d8-c9dc-49e6-acf8-351c0c5f3429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c5a0a695-04b1-49f1-87a6-8755f8607f0e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_375e24d8-c9dc-49e6-acf8-351c0c5f3429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_630a9c01-e923-48c6-8b54-1a0f2f7b220c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_79fa4185-47ac-4386-95d7-03be0b5daa36" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_630a9c01-e923-48c6-8b54-1a0f2f7b220c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ad65afa8-d8f0-44cf-85f0-f4c7f68d5266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2b74fcfc-3851-4d98-b504-d4e0d82b4e5e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ad65afa8-d8f0-44cf-85f0-f4c7f68d5266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e4058e24-ec55-4d3f-ac55-421ce3e38984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ad65afa8-d8f0-44cf-85f0-f4c7f68d5266" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e4058e24-ec55-4d3f-ac55-421ce3e38984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_716346ba-e014-4a62-bca2-cc2f75e11244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ad65afa8-d8f0-44cf-85f0-f4c7f68d5266" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_716346ba-e014-4a62-bca2-cc2f75e11244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_4b31ca4e-25cb-47a0-ba1f-25123b181bba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ad65afa8-d8f0-44cf-85f0-f4c7f68d5266" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_4b31ca4e-25cb-47a0-ba1f-25123b181bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_bfa6b2c0-5f28-448a-a904-fc231cf9592b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ad65afa8-d8f0-44cf-85f0-f4c7f68d5266" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_bfa6b2c0-5f28-448a-a904-fc231cf9592b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_fb12cb58-6db5-4c52-b403-2773f38caf59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ad65afa8-d8f0-44cf-85f0-f4c7f68d5266" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_fb12cb58-6db5-4c52-b403-2773f38caf59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ea81c987-175a-4030-8733-db4f1b5b7767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ad65afa8-d8f0-44cf-85f0-f4c7f68d5266" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ea81c987-175a-4030-8733-db4f1b5b7767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38f1d2af-7d44-4262-8e32-e09fecfbf0ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2b74fcfc-3851-4d98-b504-d4e0d82b4e5e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38f1d2af-7d44-4262-8e32-e09fecfbf0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_58f1a52c-0061-4c17-a3cd-1a7d18cc47be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38f1d2af-7d44-4262-8e32-e09fecfbf0ba" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_58f1a52c-0061-4c17-a3cd-1a7d18cc47be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_bd502b8c-af58-4bc0-b836-4f29050d1483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38f1d2af-7d44-4262-8e32-e09fecfbf0ba" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_bd502b8c-af58-4bc0-b836-4f29050d1483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_5739e4a2-e10b-4f46-af6a-51a336177234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38f1d2af-7d44-4262-8e32-e09fecfbf0ba" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_5739e4a2-e10b-4f46-af6a-51a336177234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_494607b3-d743-4587-9e6a-aa9e8bf6794f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38f1d2af-7d44-4262-8e32-e09fecfbf0ba" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_494607b3-d743-4587-9e6a-aa9e8bf6794f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_7d1bc394-f17f-4cbf-8bb5-98eda9cec7c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38f1d2af-7d44-4262-8e32-e09fecfbf0ba" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_7d1bc394-f17f-4cbf-8bb5-98eda9cec7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_06427ab3-4b8c-4a7f-8e48-172edfee4ad2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38f1d2af-7d44-4262-8e32-e09fecfbf0ba" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_06427ab3-4b8c-4a7f-8e48-172edfee4ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0bc1ebf4-3033-40d6-bbc0-e654c9c16e27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38f1d2af-7d44-4262-8e32-e09fecfbf0ba" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0bc1ebf4-3033-40d6-bbc0-e654c9c16e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_51db902a-0c19-4e03-a331-356dbbd306f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38f1d2af-7d44-4262-8e32-e09fecfbf0ba" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_51db902a-0c19-4e03-a331-356dbbd306f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c84ee35-4491-4fc8-9d33-1bd058ff8958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38f1d2af-7d44-4262-8e32-e09fecfbf0ba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c84ee35-4491-4fc8-9d33-1bd058ff8958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ac831539-eab2-43ad-9ac8-04cc58e5891e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2b74fcfc-3851-4d98-b504-d4e0d82b4e5e" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ac831539-eab2-43ad-9ac8-04cc58e5891e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e203bbc1-b3b4-48c2-b446-346023915de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2b74fcfc-3851-4d98-b504-d4e0d82b4e5e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e203bbc1-b3b4-48c2-b446-346023915de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_068b7d9c-f139-42e0-b172-670399bf7126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2b74fcfc-3851-4d98-b504-d4e0d82b4e5e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_068b7d9c-f139-42e0-b172-670399bf7126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82c71f79-96e5-427e-9ec6-a80bf6a05e36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2b74fcfc-3851-4d98-b504-d4e0d82b4e5e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82c71f79-96e5-427e-9ec6-a80bf6a05e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_5c970d0e-2728-40e5-8344-67138439eac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2b74fcfc-3851-4d98-b504-d4e0d82b4e5e" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_5c970d0e-2728-40e5-8344-67138439eac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_IncomeTaxesandInterestPaidAbstract_0481822f-4714-4df8-af19-2cb503156732" xlink:href="mdt-20201030.xsd#mdt_IncomeTaxesandInterestPaidAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5c970d0e-2728-40e5-8344-67138439eac0" xlink:to="loc_mdt_IncomeTaxesandInterestPaidAbstract_0481822f-4714-4df8-af19-2cb503156732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_50e32b2c-17ff-4571-a098-64d13e090366" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_IncomeTaxesandInterestPaidAbstract_0481822f-4714-4df8-af19-2cb503156732" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_50e32b2c-17ff-4571-a098-64d13e090366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_f05190aa-e9d3-4697-83d8-106ddbed6d20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_IncomeTaxesandInterestPaidAbstract_0481822f-4714-4df8-af19-2cb503156732" xlink:to="loc_us-gaap_InterestPaidNet_f05190aa-e9d3-4697-83d8-106ddbed6d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/BasisofPresentation" xlink:type="simple" xlink:href="mdt-20201030.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9fa0a239-5725-4d89-8bab-94ca464ea83f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting_abb81402-b451-40c4-b944-ff308780055e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9fa0a239-5725-4d89-8bab-94ca464ea83f" xlink:to="loc_us-gaap_BasisOfAccounting_abb81402-b451-40c4-b944-ff308780055e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="mdt-20201030.xsd#BasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/BasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a47faf73-85fd-4759-98e4-1275f1c2c89e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_39f94345-6bc5-430b-8708-5b5f5af0f2b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a47faf73-85fd-4759-98e4-1275f1c2c89e" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_39f94345-6bc5-430b-8708-5b5f5af0f2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_148600eb-06c6-4f8d-8ade-2cbf9078c53b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a47faf73-85fd-4759-98e4-1275f1c2c89e" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_148600eb-06c6-4f8d-8ade-2cbf9078c53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_f6e178ac-5cce-4b5e-98d7-85c1edba4355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a47faf73-85fd-4759-98e4-1275f1c2c89e" xlink:to="loc_us-gaap_FiscalPeriod_f6e178ac-5cce-4b5e-98d7-85c1edba4355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_649ac1e4-be16-4dfa-a933-957317d49a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a47faf73-85fd-4759-98e4-1275f1c2c89e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_649ac1e4-be16-4dfa-a933-957317d49a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="mdt-20201030.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_ee9a56c4-46a7-4c6d-a864-1788d765ec98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_4e4d02f2-c567-4ecb-9b5b-1091b26b34be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_ee9a56c4-46a7-4c6d-a864-1788d765ec98" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_4e4d02f2-c567-4ecb-9b5b-1091b26b34be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/Revenue" xlink:type="simple" xlink:href="mdt-20201030.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8ec38330-39bf-4e15-bef8-aaeacf7d9854" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_693b12ad-d190-4e72-8b97-eef6ebc3dc95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8ec38330-39bf-4e15-bef8-aaeacf7d9854" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_693b12ad-d190-4e72-8b97-eef6ebc3dc95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_462f5a13-9fc9-4b40-a622-c8f698232b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e426a4d0-269c-42ce-8b0c-69cd57bb78ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_462f5a13-9fc9-4b40-a622-c8f698232b91" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e426a4d0-269c-42ce-8b0c-69cd57bb78ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f3fc52f0-17cf-4d31-817f-b88586acdfcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_85cbe511-4a63-49a9-baca-12f58ba749c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f3fc52f0-17cf-4d31-817f-b88586acdfcf" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_85cbe511-4a63-49a9-baca-12f58ba749c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_89ba5670-1a39-410d-ada4-0a1fc2ce4c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_85cbe511-4a63-49a9-baca-12f58ba749c7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_89ba5670-1a39-410d-ada4-0a1fc2ce4c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7931ff96-313f-48bc-aa0a-2c4f2bc340be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_89ba5670-1a39-410d-ada4-0a1fc2ce4c6d" xlink:to="loc_us-gaap_SegmentDomain_7931ff96-313f-48bc-aa0a-2c4f2bc340be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacAndVascularGroupMember_75521c5e-cbbd-48b5-911d-fd253abcc1ea" xlink:href="mdt-20201030.xsd#mdt_CardiacAndVascularGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7931ff96-313f-48bc-aa0a-2c4f2bc340be" xlink:to="loc_mdt_CardiacAndVascularGroupMember_75521c5e-cbbd-48b5-911d-fd253abcc1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MinimallyInvasiveTherapiesGroupMember_d8fa7993-da09-4850-8bc8-9a6743fc3b20" xlink:href="mdt-20201030.xsd#mdt_MinimallyInvasiveTherapiesGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7931ff96-313f-48bc-aa0a-2c4f2bc340be" xlink:to="loc_mdt_MinimallyInvasiveTherapiesGroupMember_d8fa7993-da09-4850-8bc8-9a6743fc3b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestorativeTherapiesGroupMember_7ffb2d33-7c79-4988-ba27-474b77d80db9" xlink:href="mdt-20201030.xsd#mdt_RestorativeTherapiesGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7931ff96-313f-48bc-aa0a-2c4f2bc340be" xlink:to="loc_mdt_RestorativeTherapiesGroupMember_7ffb2d33-7c79-4988-ba27-474b77d80db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_ac3cd525-8fe7-4c71-8ef9-0982dc809195" xlink:href="mdt-20201030.xsd#mdt_DiabetesGroupMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7931ff96-313f-48bc-aa0a-2c4f2bc340be" xlink:to="loc_mdt_DiabetesGroupMember_ac3cd525-8fe7-4c71-8ef9-0982dc809195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_60afe5d9-e4cf-4278-b775-445b5d01dc19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_85cbe511-4a63-49a9-baca-12f58ba749c7" xlink:to="loc_us-gaap_SubsegmentsAxis_60afe5d9-e4cf-4278-b775-445b5d01dc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_60afe5d9-e4cf-4278-b775-445b5d01dc19" xlink:to="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacRhythmandHeartFailureDivisionMember_2b84c5a0-f286-43e4-b5ff-1548554a09e8" xlink:href="mdt-20201030.xsd#mdt_CardiacRhythmandHeartFailureDivisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_CardiacRhythmandHeartFailureDivisionMember_2b84c5a0-f286-43e4-b5ff-1548554a09e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CoronaryandStructuralHeartDivisionMember_2c1b5255-3c88-487c-8da7-13062ee3d464" xlink:href="mdt-20201030.xsd#mdt_CoronaryandStructuralHeartDivisionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_CoronaryandStructuralHeartDivisionMember_2c1b5255-3c88-487c-8da7-13062ee3d464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AorticPeripheralandVenousDivisionMember_d9f60bfc-14a1-48d4-beb8-3d510b18e649" xlink:href="mdt-20201030.xsd#mdt_AorticPeripheralandVenousDivisionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_AorticPeripheralandVenousDivisionMember_d9f60bfc-14a1-48d4-beb8-3d510b18e649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SurgicalInnovationsDivisionMember_4aba189e-378e-4a1e-a8ef-d28dbf313a1b" xlink:href="mdt-20201030.xsd#mdt_SurgicalInnovationsDivisionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_SurgicalInnovationsDivisionMember_4aba189e-378e-4a1e-a8ef-d28dbf313a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RespiratoryGastrointestinalandRenalDivisionMember_b6c8b99e-3c9a-4f83-9f4d-9a3a8252103f" xlink:href="mdt-20201030.xsd#mdt_RespiratoryGastrointestinalandRenalDivisionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_RespiratoryGastrointestinalandRenalDivisionMember_b6c8b99e-3c9a-4f83-9f4d-9a3a8252103f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CranialAndSpinalTechnologiesDivisionMember_af120a81-0d5e-44dc-baba-838a5509b155" xlink:href="mdt-20201030.xsd#mdt_CranialAndSpinalTechnologiesDivisionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_CranialAndSpinalTechnologiesDivisionMember_af120a81-0d5e-44dc-baba-838a5509b155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SpecialtyTherapiesDivisionMember_b128948d-7e82-4142-b156-408bfd5427ae" xlink:href="mdt-20201030.xsd#mdt_SpecialtyTherapiesDivisionMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_SpecialtyTherapiesDivisionMember_b128948d-7e82-4142-b156-408bfd5427ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuromodulationDivisionMember_1ef34635-fe2c-4c87-aab9-5c8267fb6bd7" xlink:href="mdt-20201030.xsd#mdt_NeuromodulationDivisionMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_8096a80f-6b6e-4238-8509-ea02576c58c8" xlink:to="loc_mdt_NeuromodulationDivisionMember_1ef34635-fe2c-4c87-aab9-5c8267fb6bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ac017298-9596-49b9-8368-aa7a3081d302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_85cbe511-4a63-49a9-baca-12f58ba749c7" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_ac017298-9596-49b9-8368-aa7a3081d302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5aea22cf-87bf-44ee-b5a4-c066341f6d59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ac017298-9596-49b9-8368-aa7a3081d302" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5aea22cf-87bf-44ee-b5a4-c066341f6d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dc9e21b0-e949-442d-be40-c63639f743be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_9d864082-6898-4ac9-b265-fc2607614e17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dc9e21b0-e949-442d-be40-c63639f743be" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_9d864082-6898-4ac9-b265-fc2607614e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6282c487-399f-4cb6-ab84-a0626661e5d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9d864082-6898-4ac9-b265-fc2607614e17" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6282c487-399f-4cb6-ab84-a0626661e5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4a335936-2b90-427f-b98f-842fb9aea63e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6282c487-399f-4cb6-ab84-a0626661e5d0" xlink:to="loc_us-gaap_SegmentDomain_4a335936-2b90-427f-b98f-842fb9aea63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacAndVascularGroupMember_936c80f2-5915-4227-8086-19fa04301c40" xlink:href="mdt-20201030.xsd#mdt_CardiacAndVascularGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4a335936-2b90-427f-b98f-842fb9aea63e" xlink:to="loc_mdt_CardiacAndVascularGroupMember_936c80f2-5915-4227-8086-19fa04301c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MinimallyInvasiveTherapiesGroupMember_54a67089-19a2-42b9-be7e-e3b8caefcca9" xlink:href="mdt-20201030.xsd#mdt_MinimallyInvasiveTherapiesGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4a335936-2b90-427f-b98f-842fb9aea63e" xlink:to="loc_mdt_MinimallyInvasiveTherapiesGroupMember_54a67089-19a2-42b9-be7e-e3b8caefcca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestorativeTherapiesGroupMember_0dece6d8-e173-4902-9c0c-c26be5472418" xlink:href="mdt-20201030.xsd#mdt_RestorativeTherapiesGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4a335936-2b90-427f-b98f-842fb9aea63e" xlink:to="loc_mdt_RestorativeTherapiesGroupMember_0dece6d8-e173-4902-9c0c-c26be5472418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_c1b6ffe2-6a69-4cd2-9dd6-7a03d0195727" xlink:href="mdt-20201030.xsd#mdt_DiabetesGroupMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4a335936-2b90-427f-b98f-842fb9aea63e" xlink:to="loc_mdt_DiabetesGroupMember_c1b6ffe2-6a69-4cd2-9dd6-7a03d0195727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_edcda0ab-a738-423d-ae93-dc5f5779f660" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9d864082-6898-4ac9-b265-fc2607614e17" xlink:to="loc_srt_StatementGeographicalAxis_edcda0ab-a738-423d-ae93-dc5f5779f660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9b3b086e-b89d-480d-87fd-8e7d37e3eaf6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_edcda0ab-a738-423d-ae93-dc5f5779f660" xlink:to="loc_srt_SegmentGeographicalDomain_9b3b086e-b89d-480d-87fd-8e7d37e3eaf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c6aab99e-b412-44c8-abf5-55f41b196c04" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9b3b086e-b89d-480d-87fd-8e7d37e3eaf6" xlink:to="loc_country_US_c6aab99e-b412-44c8-abf5-55f41b196c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_08e0093e-48d6-4268-a431-8872464aabf1" xlink:href="mdt-20201030.xsd#mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9b3b086e-b89d-480d-87fd-8e7d37e3eaf6" xlink:to="loc_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_08e0093e-48d6-4268-a431-8872464aabf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_b6fba8da-9fae-460a-8704-3d2ac9ff4477" xlink:href="mdt-20201030.xsd#mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9b3b086e-b89d-480d-87fd-8e7d37e3eaf6" xlink:to="loc_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_b6fba8da-9fae-460a-8704-3d2ac9ff4477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f5b21001-8ae9-407e-adb6-9df9e8d80748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9d864082-6898-4ac9-b265-fc2607614e17" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_f5b21001-8ae9-407e-adb6-9df9e8d80748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_577c2f0f-ee97-4852-bf1c-b5b422880316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f5b21001-8ae9-407e-adb6-9df9e8d80748" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_577c2f0f-ee97-4852-bf1c-b5b422880316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c1988778-0ccb-4b08-b416-5e8561f40089" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_89b83cc0-de75-48d7-9dd1-a455f86944c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c1988778-0ccb-4b08-b416-5e8561f40089" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_89b83cc0-de75-48d7-9dd1-a455f86944c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6f22cf83-b6c5-47aa-8b8c-cdcb23cef82e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_89b83cc0-de75-48d7-9dd1-a455f86944c8" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6f22cf83-b6c5-47aa-8b8c-cdcb23cef82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_de6263b0-54b4-431e-9f60-dcf028f1daad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6f22cf83-b6c5-47aa-8b8c-cdcb23cef82e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_de6263b0-54b4-431e-9f60-dcf028f1daad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember_617620bc-9ec7-48af-8818-df52faf50d79" xlink:href="mdt-20201030.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de6263b0-54b4-431e-9f60-dcf028f1daad" xlink:to="loc_mdt_OtherAccruedExpensesMember_617620bc-9ec7-48af-8818-df52faf50d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_7c08650c-c6e3-4c0b-a6b5-ad6d2e82e589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de6263b0-54b4-431e-9f60-dcf028f1daad" xlink:to="loc_us-gaap_AccountsReceivableMember_7c08650c-c6e3-4c0b-a6b5-ad6d2e82e589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_526957dd-e7a5-4ab1-8063-de0e163aa8b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de6263b0-54b4-431e-9f60-dcf028f1daad" xlink:to="loc_us-gaap_OtherLiabilitiesMember_526957dd-e7a5-4ab1-8063-de0e163aa8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_89b83cc0-de75-48d7-9dd1-a455f86944c8" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_5fc0b8fb-2ec0-4692-a709-f3c322803ed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_5fc0b8fb-2ec0-4692-a709-f3c322803ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_fb70915f-e0cd-457b-b215-0a3dbc4d5913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:to="loc_us-gaap_ContractWithCustomerLiability_fb70915f-e0cd-457b-b215-0a3dbc4d5913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a5028218-5374-4405-8f9c-1ef2532194f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a5028218-5374-4405-8f9c-1ef2532194f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d4f04909-5e9f-4c55-9f20-d12289e69c4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d4f04909-5e9f-4c55-9f20-d12289e69c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_bd4fddd8-bf1d-4f39-982d-5e5a1a0d468c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_04555aa7-2e98-4a21-83f9-cd207d119180" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_bd4fddd8-bf1d-4f39-982d-5e5a1a0d468c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/Acquisitions" xlink:type="simple" xlink:href="mdt-20201030.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_a82923a8-91fe-4517-bb8a-82197a84d103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_2d6ee8fc-9e51-4867-bc47-4d9645949e0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_a82923a8-91fe-4517-bb8a-82197a84d103" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_2d6ee8fc-9e51-4867-bc47-4d9645949e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#AcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_768001d8-d5af-4808-a99b-fae8f186e6ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_30a9c501-b538-4e32-bf46-fbf65a30ddaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_768001d8-d5af-4808-a99b-fae8f186e6ca" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_30a9c501-b538-4e32-bf46-fbf65a30ddaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_542e34cc-fc43-4831-a351-518d38d004ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_768001d8-d5af-4808-a99b-fae8f186e6ca" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_542e34cc-fc43-4831-a351-518d38d004ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#AcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_54c237f6-c328-47ba-b208-761aa495a4a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db0fd93-fb49-43ba-9f07-a7ccfbb784fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_54c237f6-c328-47ba-b208-761aa495a4a4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db0fd93-fb49-43ba-9f07-a7ccfbb784fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5914f410-e452-43e0-82cd-bbc1a2b88ae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db0fd93-fb49-43ba-9f07-a7ccfbb784fd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5914f410-e452-43e0-82cd-bbc1a2b88ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c49df840-8975-4882-8311-9143505ae890" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5914f410-e452-43e0-82cd-bbc1a2b88ae3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c49df840-8975-4882-8311-9143505ae890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AllBusinessAcquisitionsMember_a52ce844-d87b-4189-847c-19ff1cfa41c6" xlink:href="mdt-20201030.xsd#mdt_AllBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c49df840-8975-4882-8311-9143505ae890" xlink:to="loc_mdt_AllBusinessAcquisitionsMember_a52ce844-d87b-4189-847c-19ff1cfa41c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82c80441-d531-4d18-9fbf-e70f4f796c31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db0fd93-fb49-43ba-9f07-a7ccfbb784fd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82c80441-d531-4d18-9fbf-e70f4f796c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12684919-9c00-4068-ad1f-9b5acfe1ac3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82c80441-d531-4d18-9fbf-e70f4f796c31" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12684919-9c00-4068-ad1f-9b5acfe1ac3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_fa137eca-cb51-43fe-b7f5-0859b37408d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12684919-9c00-4068-ad1f-9b5acfe1ac3a" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_fa137eca-cb51-43fe-b7f5-0859b37408d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_922c6557-826f-47b0-ac8c-8058da3754d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_12684919-9c00-4068-ad1f-9b5acfe1ac3a" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_922c6557-826f-47b0-ac8c-8058da3754d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_48b589b8-043e-4bc9-b9aa-ac24dff3ae83" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db0fd93-fb49-43ba-9f07-a7ccfbb784fd" xlink:to="loc_srt_RangeAxis_48b589b8-043e-4bc9-b9aa-ac24dff3ae83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4b318109-228a-4571-9635-8549cb92d858" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_48b589b8-043e-4bc9-b9aa-ac24dff3ae83" xlink:to="loc_srt_RangeMember_4b318109-228a-4571-9635-8549cb92d858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_641747f1-0771-442e-bb98-5aac327d38ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4b318109-228a-4571-9635-8549cb92d858" xlink:to="loc_srt_MinimumMember_641747f1-0771-442e-bb98-5aac327d38ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_00ce0736-8110-40a8-9426-0654c76f0710" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4b318109-228a-4571-9635-8549cb92d858" xlink:to="loc_srt_MaximumMember_00ce0736-8110-40a8-9426-0654c76f0710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1691ba08-9974-47b1-87d3-117914581624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db0fd93-fb49-43ba-9f07-a7ccfbb784fd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1691ba08-9974-47b1-87d3-117914581624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4281fa0d-eb97-48af-9383-583abfaf884c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1691ba08-9974-47b1-87d3-117914581624" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4281fa0d-eb97-48af-9383-583abfaf884c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember_9623bae4-6716-422b-b8b5-de9b152a82fe" xlink:href="mdt-20201030.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4281fa0d-eb97-48af-9383-583abfaf884c" xlink:to="loc_mdt_OtherAccruedExpensesMember_9623bae4-6716-422b-b8b5-de9b152a82fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_c5c2bfde-f59b-4d30-9cd3-0750d962b7f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4281fa0d-eb97-48af-9383-583abfaf884c" xlink:to="loc_us-gaap_OtherLiabilitiesMember_c5c2bfde-f59b-4d30-9cd3-0750d962b7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db0fd93-fb49-43ba-9f07-a7ccfbb784fd" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ec19961a-de27-4a23-9916-ef1e8a2b5c4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ec19961a-de27-4a23-9916-ef1e8a2b5c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_60f8224f-6a84-402d-8beb-c43d4533eed6" xlink:href="mdt-20201030.xsd#mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_60f8224f-6a84-402d-8beb-c43d4533eed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a50a16c4-aced-4a1c-b541-3690b4efae8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a50a16c4-aced-4a1c-b541-3690b4efae8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2aa925a5-5049-45f4-8e0e-5fc55661cb41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2aa925a5-5049-45f4-8e0e-5fc55661cb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_aa5cea05-c448-4dac-8aba-f88237372b3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_aa5cea05-c448-4dac-8aba-f88237372b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_395d17ba-2540-4809-bf3a-afa53c3af085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_395d17ba-2540-4809-bf3a-afa53c3af085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_35180e96-595c-4bad-b49b-ad40c491840c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_Goodwill_35180e96-595c-4bad-b49b-ad40c491840c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_347a9ac2-636c-4056-84e6-893476083b85" xlink:href="mdt-20201030.xsd#mdt_BusinessAcquisitionPurchasePriceContingentConsideration"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_347a9ac2-636c-4056-84e6-893476083b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_e686d44d-6019-4822-b659-ce3934f68ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_e686d44d-6019-4822-b659-ce3934f68ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7dd040de-78d0-4992-8242-464cab3b71fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5e6c92c1-db21-44a0-ae8d-b747c4bd2106" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7dd040de-78d0-4992-8242-464cab3b71fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_d666d433-85a5-4740-8507-7fdce29ed511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_36a17efb-03d0-4ea7-bc6b-26889e834f33" xlink:href="mdt-20201030.xsd#mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d666d433-85a5-4740-8507-7fdce29ed511" xlink:to="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_36a17efb-03d0-4ea7-bc6b-26889e834f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ede01fef-f332-446c-bcca-56bf49a2fecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_36a17efb-03d0-4ea7-bc6b-26889e834f33" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ede01fef-f332-446c-bcca-56bf49a2fecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_4d7038df-0107-4b0a-9ef9-1cdb3675d057" xlink:href="mdt-20201030.xsd#mdt_BusinessAcquisitionPurchasePriceContingentConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_36a17efb-03d0-4ea7-bc6b-26889e834f33" xlink:to="loc_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_4d7038df-0107-4b0a-9ef9-1cdb3675d057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment_0387b86c-bb2b-4b22-8af0-c964fae5085d" xlink:href="mdt-20201030.xsd#mdt_BusinessAcquisitionContingentConsiderationMilestonePayment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_36a17efb-03d0-4ea7-bc6b-26889e834f33" xlink:to="loc_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment_0387b86c-bb2b-4b22-8af0-c964fae5085d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5ed6347f-794b-4edd-bcb0-9ec8b563b4ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_36a17efb-03d0-4ea7-bc6b-26889e834f33" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5ed6347f-794b-4edd-bcb0-9ec8b563b4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29615781-b93a-4e66-b73e-8aee734d31c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_36a17efb-03d0-4ea7-bc6b-26889e834f33" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29615781-b93a-4e66-b73e-8aee734d31c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_c9a2937a-0e4d-4815-9447-ea397d90c0d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_c9a2937a-0e4d-4815-9447-ea397d90c0d9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_beda77be-7994-4483-b1cd-7ef2335cf018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_beda77be-7994-4483-b1cd-7ef2335cf018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_35b338df-79ae-4974-818c-1a064dcd0556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_beda77be-7994-4483-b1cd-7ef2335cf018" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_35b338df-79ae-4974-818c-1a064dcd0556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RevenueMilestoneMember_87368a7b-2312-45e3-bce0-dbabff9ef026" xlink:href="mdt-20201030.xsd#mdt_RevenueMilestoneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_35b338df-79ae-4974-818c-1a064dcd0556" xlink:to="loc_mdt_RevenueMilestoneMember_87368a7b-2312-45e3-bce0-dbabff9ef026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ProductDevelopmentMilestoneMember_bb48a2fa-8184-4415-be29-588ee7fb6ab3" xlink:href="mdt-20201030.xsd#mdt_ProductDevelopmentMilestoneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_35b338df-79ae-4974-818c-1a064dcd0556" xlink:to="loc_mdt_ProductDevelopmentMilestoneMember_bb48a2fa-8184-4415-be29-588ee7fb6ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a20d24c3-3cb2-45c5-86a9-cf8a84466932" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:to="loc_srt_RangeAxis_a20d24c3-3cb2-45c5-86a9-cf8a84466932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e2c0579-f90c-4c30-ae62-978ec0fafb17" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a20d24c3-3cb2-45c5-86a9-cf8a84466932" xlink:to="loc_srt_RangeMember_6e2c0579-f90c-4c30-ae62-978ec0fafb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_67e18300-571f-4b4b-ae26-05830ff1c94d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e2c0579-f90c-4c30-ae62-978ec0fafb17" xlink:to="loc_srt_MinimumMember_67e18300-571f-4b4b-ae26-05830ff1c94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cc8dbc2c-951e-4113-8706-45383b79ee4b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e2c0579-f90c-4c30-ae62-978ec0fafb17" xlink:to="loc_srt_MaximumMember_cc8dbc2c-951e-4113-8706-45383b79ee4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_61ef584f-6a31-4d03-a937-5e5da2546f3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e2c0579-f90c-4c30-ae62-978ec0fafb17" xlink:to="loc_srt_WeightedAverageMember_61ef584f-6a31-4d03-a937-5e5da2546f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dfa918ef-04e5-4b4d-9ea9-18214f666c5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dfa918ef-04e5-4b4d-9ea9-18214f666c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_88693617-d5ee-4e43-8ad4-9ba54266de27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dfa918ef-04e5-4b4d-9ea9-18214f666c5c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_88693617-d5ee-4e43-8ad4-9ba54266de27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_359bfc3b-ebc2-490b-be93-6854a58a064c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_88693617-d5ee-4e43-8ad4-9ba54266de27" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_359bfc3b-ebc2-490b-be93-6854a58a064c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c494c893-5ced-430b-b136-aa4403b77d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c494c893-5ced-430b-b136-aa4403b77d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a566c904-f126-4d6e-abc8-c7359729d467" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c494c893-5ced-430b-b136-aa4403b77d4e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a566c904-f126-4d6e-abc8-c7359729d467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_590a842f-002c-4efa-b95d-517f46758164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a566c904-f126-4d6e-abc8-c7359729d467" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_590a842f-002c-4efa-b95d-517f46758164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_3497220a-9df3-4b4d-8ef6-f5e628b5bd14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_3497220a-9df3-4b4d-8ef6-f5e628b5bd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_da475cac-8b1a-4995-bde8-1cb2922a24fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_3497220a-9df3-4b4d-8ef6-f5e628b5bd14" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_da475cac-8b1a-4995-bde8-1cb2922a24fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_4b04add9-1d0c-4fd2-82a8-64987a33f809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_da475cac-8b1a-4995-bde8-1cb2922a24fc" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_4b04add9-1d0c-4fd2-82a8-64987a33f809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MeasurementInputProbabilityofPaymentMember_314f6929-a07f-4f5d-ad05-7160d283169a" xlink:href="mdt-20201030.xsd#mdt_MeasurementInputProbabilityofPaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_da475cac-8b1a-4995-bde8-1cb2922a24fc" xlink:to="loc_mdt_MeasurementInputProbabilityofPaymentMember_314f6929-a07f-4f5d-ad05-7160d283169a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ec32ac4d-d315-431e-aac9-9b10c2a541a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d93a50aa-6e64-444c-adf0-37b52de269f5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ec32ac4d-d315-431e-aac9-9b10c2a541a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_37bbfc40-bf2a-41d3-8c66-7b3b9f97cce6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ec32ac4d-d315-431e-aac9-9b10c2a541a3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_37bbfc40-bf2a-41d3-8c66-7b3b9f97cce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_d4d583b0-3276-4a7a-9f37-a950345f69ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_ec32ac4d-d315-431e-aac9-9b10c2a541a3" xlink:to="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_d4d583b0-3276-4a7a-9f37-a950345f69ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_ba52af66-6213-418e-987a-7dcdab136e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_d4d583b0-3276-4a7a-9f37-a950345f69ba" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_ba52af66-6213-418e-987a-7dcdab136e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/Restructuring" xlink:type="simple" xlink:href="mdt-20201030.xsd#Restructuring"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/Restructuring" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_56d1d783-1d56-49ee-84a1-477035e4b72a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_e9923892-eb66-4628-9b04-d3155cc33419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_56d1d783-1d56-49ee-84a1-477035e4b72a" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_e9923892-eb66-4628-9b04-d3155cc33419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#RestructuringTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RestructuringTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_662d538a-d1b8-47e1-813f-b62d2c6e4f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_d78e4446-f963-496b-b577-c7072e240117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_662d538a-d1b8-47e1-813f-b62d2c6e4f4d" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_d78e4446-f963-496b-b577-c7072e240117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RestructuringNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RestructuringNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6c37dfce-bf3c-489e-a9d9-eae8412bc214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_acf306b6-342b-4d5f-bdd3-71ae3941a5b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6c37dfce-bf3c-489e-a9d9-eae8412bc214" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_acf306b6-342b-4d5f-bdd3-71ae3941a5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_c1bd4a48-8c13-44aa-9c80-e1dd6b9e6a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_acf306b6-342b-4d5f-bdd3-71ae3941a5b9" xlink:to="loc_us-gaap_RestructuringPlanAxis_c1bd4a48-8c13-44aa-9c80-e1dd6b9e6a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9738514e-8c94-4a60-b3fe-e633e9882872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_c1bd4a48-8c13-44aa-9c80-e1dd6b9e6a24" xlink:to="loc_us-gaap_RestructuringPlanDomain_9738514e-8c94-4a60-b3fe-e633e9882872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EnterpriseExcellenceMember_cd16bec9-e2fc-4755-b469-e578b880b7ed" xlink:href="mdt-20201030.xsd#mdt_EnterpriseExcellenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_9738514e-8c94-4a60-b3fe-e633e9882872" xlink:to="loc_mdt_EnterpriseExcellenceMember_cd16bec9-e2fc-4755-b469-e578b880b7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SimplificationRestructuringProgramMember_9c79c2ca-981d-4fe2-a5c7-ff184f7a59d1" xlink:href="mdt-20201030.xsd#mdt_SimplificationRestructuringProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_9738514e-8c94-4a60-b3fe-e633e9882872" xlink:to="loc_mdt_SimplificationRestructuringProgramMember_9c79c2ca-981d-4fe2-a5c7-ff184f7a59d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d8644c58-4aa1-4ed3-b7a5-5da56c49ea81" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_acf306b6-342b-4d5f-bdd3-71ae3941a5b9" xlink:to="loc_srt_RangeAxis_d8644c58-4aa1-4ed3-b7a5-5da56c49ea81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc5d4c93-4008-404f-9355-98bd4e1a77dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d8644c58-4aa1-4ed3-b7a5-5da56c49ea81" xlink:to="loc_srt_RangeMember_cc5d4c93-4008-404f-9355-98bd4e1a77dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e0bfbc44-ebd0-446e-a853-fea884c89560" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cc5d4c93-4008-404f-9355-98bd4e1a77dc" xlink:to="loc_srt_MinimumMember_e0bfbc44-ebd0-446e-a853-fea884c89560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4baf925e-b31a-4c54-b377-da0a3ba7be9d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cc5d4c93-4008-404f-9355-98bd4e1a77dc" xlink:to="loc_srt_MaximumMember_4baf925e-b31a-4c54-b377-da0a3ba7be9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_ff432ca2-71cd-460f-9ce4-354ca4805a37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_acf306b6-342b-4d5f-bdd3-71ae3941a5b9" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_ff432ca2-71cd-460f-9ce4-354ca4805a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_cadec691-f0b0-498d-b142-4f96bd1f9498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_ff432ca2-71cd-460f-9ce4-354ca4805a37" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_cadec691-f0b0-498d-b142-4f96bd1f9498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PreTaxExitandDisposalCostsMember_3cc28403-174f-4a00-8e0a-e1521e974f82" xlink:href="mdt-20201030.xsd#mdt_PreTaxExitandDisposalCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_cadec691-f0b0-498d-b142-4f96bd1f9498" xlink:to="loc_mdt_PreTaxExitandDisposalCostsMember_3cc28403-174f-4a00-8e0a-e1521e974f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1bc6e317-7d92-47ba-94fb-00525e0197df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_acf306b6-342b-4d5f-bdd3-71ae3941a5b9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1bc6e317-7d92-47ba-94fb-00525e0197df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_79e9a0a4-c641-40d2-ae04-45ad8b64cb27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1bc6e317-7d92-47ba-94fb-00525e0197df" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_79e9a0a4-c641-40d2-ae04-45ad8b64cb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_a3febeab-18e4-4d37-be5c-7346bc937e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_79e9a0a4-c641-40d2-ae04-45ad8b64cb27" xlink:to="loc_us-gaap_CostOfSalesMember_a3febeab-18e4-4d37-be5c-7346bc937e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1717d364-1892-4917-931c-291df59078de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_79e9a0a4-c641-40d2-ae04-45ad8b64cb27" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1717d364-1892-4917-931c-291df59078de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_acf306b6-342b-4d5f-bdd3-71ae3941a5b9" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_997d69c4-5546-4176-bb5b-09219803374c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_997d69c4-5546-4176-bb5b-09219803374c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_ffd99bab-3e14-43ec-b3bd-3c5ed1a76b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:to="loc_us-gaap_RestructuringCharges_ffd99bab-3e14-43ec-b3bd-3c5ed1a76b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_f12c5d6c-c0a1-4d6f-988d-893c52079b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_f12c5d6c-c0a1-4d6f-988d-893c52079b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment_46ca0548-210f-4210-9e13-70657d33c4d8" xlink:href="mdt-20201030.xsd#mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:to="loc_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment_46ca0548-210f-4210-9e13-70657d33c4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_3c9b85aa-cd1e-4381-91c9-6f90e3012d4a" xlink:href="mdt-20201030.xsd#mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4d3339da-ca22-4b22-87a1-2c4dc2e65a40" xlink:to="loc_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_3c9b85aa-cd1e-4381-91c9-6f90e3012d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RestructuringActivityRelatedtoRestructuringProgramsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_54608ad1-c90f-4fdd-b38a-b8cf3135ea28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_59b1ba08-8982-4b9d-961d-2032a48d5043" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_54608ad1-c90f-4fdd-b38a-b8cf3135ea28" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_59b1ba08-8982-4b9d-961d-2032a48d5043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_873b7a32-ee63-46b8-9b2f-4c824d10683d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_59b1ba08-8982-4b9d-961d-2032a48d5043" xlink:to="loc_us-gaap_RestructuringPlanAxis_873b7a32-ee63-46b8-9b2f-4c824d10683d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_aa0d3dda-9a26-4796-a34f-5dd08f9fac74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_873b7a32-ee63-46b8-9b2f-4c824d10683d" xlink:to="loc_us-gaap_RestructuringPlanDomain_aa0d3dda-9a26-4796-a34f-5dd08f9fac74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EnterpriseExcellenceMember_f93e6ad4-1582-4fd5-a9c7-352c6bf61b58" xlink:href="mdt-20201030.xsd#mdt_EnterpriseExcellenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_aa0d3dda-9a26-4796-a34f-5dd08f9fac74" xlink:to="loc_mdt_EnterpriseExcellenceMember_f93e6ad4-1582-4fd5-a9c7-352c6bf61b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SimplificationRestructuringProgramMember_b8940cef-f3d4-4a5f-b29a-70bf06666cf5" xlink:href="mdt-20201030.xsd#mdt_SimplificationRestructuringProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_aa0d3dda-9a26-4796-a34f-5dd08f9fac74" xlink:to="loc_mdt_SimplificationRestructuringProgramMember_b8940cef-f3d4-4a5f-b29a-70bf06666cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_36194f78-19eb-4a68-baa0-7a61e7c798de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_59b1ba08-8982-4b9d-961d-2032a48d5043" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_36194f78-19eb-4a68-baa0-7a61e7c798de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_3ee20c53-4b79-4c7b-bfd5-9f013c8c96d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_36194f78-19eb-4a68-baa0-7a61e7c798de" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_3ee20c53-4b79-4c7b-bfd5-9f013c8c96d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_7f060b46-2dff-465b-a544-0ace8d91b87d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3ee20c53-4b79-4c7b-bfd5-9f013c8c96d3" xlink:to="loc_us-gaap_EmployeeSeveranceMember_7f060b46-2dff-465b-a544-0ace8d91b87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AssociatedCostsMember_cec57776-e5d8-43ac-af36-429b8c47d276" xlink:href="mdt-20201030.xsd#mdt_AssociatedCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3ee20c53-4b79-4c7b-bfd5-9f013c8c96d3" xlink:to="loc_mdt_AssociatedCostsMember_cec57776-e5d8-43ac-af36-429b8c47d276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_2dae4be2-7555-46dd-8116-53ba423b8d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3ee20c53-4b79-4c7b-bfd5-9f013c8c96d3" xlink:to="loc_us-gaap_OtherRestructuringMember_2dae4be2-7555-46dd-8116-53ba423b8d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_6fed0a12-9722-4d4f-a4b0-2f118ad836f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_59b1ba08-8982-4b9d-961d-2032a48d5043" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_6fed0a12-9722-4d4f-a4b0-2f118ad836f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_aa6fbb53-36f6-4315-bfc9-afae62fd9ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_6fed0a12-9722-4d4f-a4b0-2f118ad836f8" xlink:to="loc_us-gaap_RestructuringReserveRollForward_aa6fbb53-36f6-4315-bfc9-afae62fd9ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_19a46648-5c99-46f9-bd2e-1ea74e18377d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_aa6fbb53-36f6-4315-bfc9-afae62fd9ff8" xlink:to="loc_us-gaap_RestructuringReserve_19a46648-5c99-46f9-bd2e-1ea74e18377d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_934dba78-abc6-464e-87aa-e991abf94156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_aa6fbb53-36f6-4315-bfc9-afae62fd9ff8" xlink:to="loc_us-gaap_RestructuringCharges_934dba78-abc6-464e-87aa-e991abf94156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_09c217c2-fd15-428e-be95-7a775cc342fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_aa6fbb53-36f6-4315-bfc9-afae62fd9ff8" xlink:to="loc_us-gaap_PaymentsForRestructuring_09c217c2-fd15-428e-be95-7a775cc342fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_5d32bcd5-c845-48a0-84e8-902432fc856c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_aa6fbb53-36f6-4315-bfc9-afae62fd9ff8" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_5d32bcd5-c845-48a0-84e8-902432fc856c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_09d0b58b-593e-49f8-a406-0f22387069e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_aa6fbb53-36f6-4315-bfc9-afae62fd9ff8" xlink:to="loc_us-gaap_RestructuringReserve_09d0b58b-593e-49f8-a406-0f22387069e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstruments" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_dad16059-68f0-4932-8c18-5839f31fdac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_c9c10d33-e22f-47a5-b4a4-a866db4586cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_dad16059-68f0-4932-8c18-5839f31fdac4" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_c9c10d33-e22f-47a5-b4a4-a866db4586cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_3469e9f7-255e-4747-b970-0722a36fdb2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_f5ba8d5c-1bab-46b7-9e57-26554d3c0117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3469e9f7-255e-4747-b970-0722a36fdb2b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_f5ba8d5c-1bab-46b7-9e57-26554d3c0117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_aff2c8a7-9fe1-4d1b-b1be-21eb20c23490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3469e9f7-255e-4747-b970-0722a36fdb2b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_aff2c8a7-9fe1-4d1b-b1be-21eb20c23490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock_d161019a-5956-48f5-88fc-c2a8f4f5dba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3469e9f7-255e-4747-b970-0722a36fdb2b" xlink:to="loc_us-gaap_GainLossOnInvestmentsTextBlock_d161019a-5956-48f5-88fc-c2a8f4f5dba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_268a5a98-228c-487e-b3bf-2da58c664970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3469e9f7-255e-4747-b970-0722a36fdb2b" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_268a5a98-228c-487e-b3bf-2da58c664970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock_11f6c923-50e5-40b1-abf4-ca3ce1d052a6" xlink:href="mdt-20201030.xsd#mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3469e9f7-255e-4747-b970-0722a36fdb2b" xlink:to="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock_11f6c923-50e5-40b1-abf4-ca3ce1d052a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ScheduleofInvestmentsTableTextBlock_920a3a20-63c0-42c1-83d2-104fa2cb53d0" xlink:href="mdt-20201030.xsd#mdt_ScheduleofInvestmentsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3469e9f7-255e-4747-b970-0722a36fdb2b" xlink:to="loc_mdt_ScheduleofInvestmentsTableTextBlock_920a3a20-63c0-42c1-83d2-104fa2cb53d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_18cf5c6e-f226-4ddb-8a16-1450542ec3d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_1aa33d3d-9f36-4537-a809-c80fccfc99f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_18cf5c6e-f226-4ddb-8a16-1450542ec3d1" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_1aa33d3d-9f36-4537-a809-c80fccfc99f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e9a411a7-c7cd-4faa-a315-a8f2027b0d66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1aa33d3d-9f36-4537-a809-c80fccfc99f7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e9a411a7-c7cd-4faa-a315-a8f2027b0d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e9a411a7-c7cd-4faa-a315-a8f2027b0d66" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_70c4f3a5-8378-4498-8b91-a0a9c0b81305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_70c4f3a5-8378-4498-8b91-a0a9c0b81305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f52e2e27-d0fa-4a3e-8366-aa639119ed5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f52e2e27-d0fa-4a3e-8366-aa639119ed5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_6d397491-781a-4b6e-aa8c-b89759aa5c24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_6d397491-781a-4b6e-aa8c-b89759aa5c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_849cb4a0-8df9-40c2-9569-9e02fe2b6334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_849cb4a0-8df9-40c2-9569-9e02fe2b6334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_932f94fd-4149-458a-ace8-2d3c2b0cd673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_932f94fd-4149-458a-ace8-2d3c2b0cd673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionRateSecuritiesMember_28ea6529-9e8c-4d05-869e-2bb83a3611a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionRateSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_AuctionRateSecuritiesMember_28ea6529-9e8c-4d05-869e-2bb83a3611a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_726050ea-29a1-4e7d-8ad8-fc5ac2ff67c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb392404-8476-4878-b6ff-60ac36384c8b" xlink:to="loc_us-gaap_BankTimeDepositsMember_726050ea-29a1-4e7d-8ad8-fc5ac2ff67c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae3b260c-f6fc-4f36-b3ea-29525fb0fa78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1aa33d3d-9f36-4537-a809-c80fccfc99f7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae3b260c-f6fc-4f36-b3ea-29525fb0fa78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56d16212-f9d1-4435-bbe2-4c2e73e7f17e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ae3b260c-f6fc-4f36-b3ea-29525fb0fa78" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56d16212-f9d1-4435-bbe2-4c2e73e7f17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f61c8271-1461-40c5-8603-0bcdd40a60b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56d16212-f9d1-4435-bbe2-4c2e73e7f17e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f61c8271-1461-40c5-8603-0bcdd40a60b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4139aaa4-1c99-489a-82b6-c2322cfbdc87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56d16212-f9d1-4435-bbe2-4c2e73e7f17e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4139aaa4-1c99-489a-82b6-c2322cfbdc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4401c347-d4ae-498d-b14f-1d3f61a9a073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56d16212-f9d1-4435-bbe2-4c2e73e7f17e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4401c347-d4ae-498d-b14f-1d3f61a9a073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3bfa8103-896f-4777-9f9f-e150e445018c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1aa33d3d-9f36-4537-a809-c80fccfc99f7" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3bfa8103-896f-4777-9f9f-e150e445018c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b58b501f-ac16-4791-8fe5-de285e6cc6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3bfa8103-896f-4777-9f9f-e150e445018c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b58b501f-ac16-4791-8fe5-de285e6cc6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_0f0fff41-c4d4-4603-916c-88abec66be58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b58b501f-ac16-4791-8fe5-de285e6cc6ac" xlink:to="loc_us-gaap_InvestmentsMember_0f0fff41-c4d4-4603-916c-88abec66be58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_3c3a6f07-5e99-4baa-b2d8-19e67b7873df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b58b501f-ac16-4791-8fe5-de285e6cc6ac" xlink:to="loc_us-gaap_OtherAssetsMember_3c3a6f07-5e99-4baa-b2d8-19e67b7873df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_03f0e901-82f0-4596-a7e7-c9523a190d01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1aa33d3d-9f36-4537-a809-c80fccfc99f7" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_03f0e901-82f0-4596-a7e7-c9523a190d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d88fc487-141e-41e8-ad74-dffb2a5a2406" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_03f0e901-82f0-4596-a7e7-c9523a190d01" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d88fc487-141e-41e8-ad74-dffb2a5a2406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0e4eee78-6a1e-4059-aafd-b500e75285ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d88fc487-141e-41e8-ad74-dffb2a5a2406" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0e4eee78-6a1e-4059-aafd-b500e75285ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d5577c11-5f8e-482e-ade8-cae579093732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d88fc487-141e-41e8-ad74-dffb2a5a2406" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d5577c11-5f8e-482e-ade8-cae579093732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_76fc35dc-2370-405e-8863-98071df894ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d88fc487-141e-41e8-ad74-dffb2a5a2406" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_76fc35dc-2370-405e-8863-98071df894ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5a6b034e-82d8-4ae0-a642-53301ad663e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d88fc487-141e-41e8-ad74-dffb2a5a2406" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5a6b034e-82d8-4ae0-a642-53301ad663e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_e7e5aa4e-897e-40ed-bf82-1245a305506f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesClassifiedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_03f0e901-82f0-4596-a7e7-c9523a190d01" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_e7e5aa4e-897e-40ed-bf82-1245a305506f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_bb619a96-ab62-4f9d-875b-f2ba0ca7b39b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_e7e5aa4e-897e-40ed-bf82-1245a305506f" xlink:to="loc_us-gaap_HeldToMaturitySecurities_bb619a96-ab62-4f9d-875b-f2ba0ca7b39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_216f19d7-f165-4605-9b8d-5e52875eac3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_e7e5aa4e-897e-40ed-bf82-1245a305506f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_216f19d7-f165-4605-9b8d-5e52875eac3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_dd01b2f0-5241-425d-9f23-320cd5b82dbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_e7e5aa4e-897e-40ed-bf82-1245a305506f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_dd01b2f0-5241-425d-9f23-320cd5b82dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_f6db1143-981f-46af-a733-cb282631942e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_e7e5aa4e-897e-40ed-bf82-1245a305506f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_f6db1143-981f-46af-a733-cb282631942e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_688ace67-4286-42f9-8d20-cf204d11ba01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_03f0e901-82f0-4596-a7e7-c9523a190d01" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_688ace67-4286-42f9-8d20-cf204d11ba01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost_9788a231-1cc1-44c1-9c3f-877544414b4c" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_688ace67-4286-42f9-8d20-cf204d11ba01" xlink:to="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost_9788a231-1cc1-44c1-9c3f-877544414b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax_7e7de100-697c-4f0d-8d75-360d4de9cf06" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_688ace67-4286-42f9-8d20-cf204d11ba01" xlink:to="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax_7e7de100-697c-4f0d-8d75-360d4de9cf06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax_42e8bcad-4476-4508-a378-2a8e26a79fb1" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_688ace67-4286-42f9-8d20-cf204d11ba01" xlink:to="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax_42e8bcad-4476-4508-a378-2a8e26a79fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_25c87e1a-e989-4346-955d-73a648b5d31c" xlink:href="mdt-20201030.xsd#mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_688ace67-4286-42f9-8d20-cf204d11ba01" xlink:to="loc_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_25c87e1a-e989-4346-955d-73a648b5d31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_9603e2fe-2837-4618-a466-a879a53a7b43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2f2fd521-ffa5-47bb-9517-5d7b4f8a724d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9603e2fe-2837-4618-a466-a879a53a7b43" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2f2fd521-ffa5-47bb-9517-5d7b4f8a724d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_528b0d8e-3764-4486-be47-f73d9fce1b3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2f2fd521-ffa5-47bb-9517-5d7b4f8a724d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_528b0d8e-3764-4486-be47-f73d9fce1b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_528b0d8e-3764-4486-be47-f73d9fce1b3b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_644efe35-b1d8-4627-86f2-1d1376c6004a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_644efe35-b1d8-4627-86f2-1d1376c6004a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_02303aa2-1c04-49e3-8b25-f5052b28f8c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_02303aa2-1c04-49e3-8b25-f5052b28f8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_810dbcea-39bb-4d32-bc1d-875d300affdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_810dbcea-39bb-4d32-bc1d-875d300affdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_ef88a275-76cb-440b-9980-9edbd78d185d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_ef88a275-76cb-440b-9980-9edbd78d185d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionRateSecuritiesMember_6a28a7ef-ba59-4234-9154-bffec9283fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionRateSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_761650a8-4d94-44ef-aee5-d4f97cb0a385" xlink:to="loc_us-gaap_AuctionRateSecuritiesMember_6a28a7ef-ba59-4234-9154-bffec9283fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_42e71a28-a762-43aa-9ffa-71cb88b9d999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2f2fd521-ffa5-47bb-9517-5d7b4f8a724d" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_42e71a28-a762-43aa-9ffa-71cb88b9d999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_2b41c169-20f4-4dc1-a4ec-54fe0931d1dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_42e71a28-a762-43aa-9ffa-71cb88b9d999" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_2b41c169-20f4-4dc1-a4ec-54fe0931d1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ff8572a3-40ac-4bc4-a7d1-0e0c1cd26e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_42e71a28-a762-43aa-9ffa-71cb88b9d999" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ff8572a3-40ac-4bc4-a7d1-0e0c1cd26e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_3e7cc9e9-3a74-43c4-ad6f-a45ba49feeec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_42e71a28-a762-43aa-9ffa-71cb88b9d999" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_3e7cc9e9-3a74-43c4-ad6f-a45ba49feeec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_2aa3609b-3423-4d3d-b39e-6090f4275ef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_42e71a28-a762-43aa-9ffa-71cb88b9d999" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_2aa3609b-3423-4d3d-b39e-6090f4275ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_e95b3441-3ddf-4a97-9875-8781a4e02b95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_b5228174-bcc2-4054-b918-8a622fa406f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e95b3441-3ddf-4a97-9875-8781a4e02b95" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_b5228174-bcc2-4054-b918-8a622fa406f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_8b4688a4-f1a0-4b2f-99a1-db7f19e5182f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_b5228174-bcc2-4054-b918-8a622fa406f3" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_8b4688a4-f1a0-4b2f-99a1-db7f19e5182f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_bd934814-5f35-4e73-b984-107dc0df9394" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_b5228174-bcc2-4054-b918-8a622fa406f3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_bd934814-5f35-4e73-b984-107dc0df9394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_cc0f4651-4b86-4909-ad21-6469bd2cf1be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_b5228174-bcc2-4054-b918-8a622fa406f3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_cc0f4651-4b86-4909-ad21-6469bd2cf1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_66f30f64-788f-4472-943a-fddd6767adc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e95b3441-3ddf-4a97-9875-8781a4e02b95" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_66f30f64-788f-4472-943a-fddd6767adc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4fd5f642-915e-47a6-9727-62dbed02072f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_66f30f64-788f-4472-943a-fddd6767adc9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4fd5f642-915e-47a6-9727-62dbed02072f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_f0eb70fc-0c0f-4900-bd36-b92de52a4353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_66f30f64-788f-4472-943a-fddd6767adc9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_f0eb70fc-0c0f-4900-bd36-b92de52a4353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_fd0d8f49-ed26-4a28-9372-22a904b67116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_66f30f64-788f-4472-943a-fddd6767adc9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_fd0d8f49-ed26-4a28-9372-22a904b67116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_d3710ec5-93b1-467b-891b-2bedea34357b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_66f30f64-788f-4472-943a-fddd6767adc9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_d3710ec5-93b1-467b-891b-2bedea34357b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b848f0f3-1f2e-4d86-b8c7-91971cfc46cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_66f30f64-788f-4472-943a-fddd6767adc9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b848f0f3-1f2e-4d86-b8c7-91971cfc46cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract_fc21cacf-215f-4a8e-ae72-92692ad79d61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e95b3441-3ddf-4a97-9875-8781a4e02b95" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract_fc21cacf-215f-4a8e-ae72-92692ad79d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_d0ad1b4e-4fe1-43a6-8086-82c65e173c46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract_fc21cacf-215f-4a8e-ae72-92692ad79d61" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_d0ad1b4e-4fe1-43a6-8086-82c65e173c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_7e9c7590-c989-4777-8499-dffddb15217e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract_fc21cacf-215f-4a8e-ae72-92692ad79d61" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_7e9c7590-c989-4777-8499-dffddb15217e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_a66a33ba-deb3-43c3-90e6-e343c513494c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract_fc21cacf-215f-4a8e-ae72-92692ad79d61" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_a66a33ba-deb3-43c3-90e6-e343c513494c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_1a01a2ac-c116-406b-834c-a193533d39c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract_fc21cacf-215f-4a8e-ae72-92692ad79d61" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_1a01a2ac-c116-406b-834c-a193533d39c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_f62bab09-36c4-4f6f-9858-96cdba435676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract_fc21cacf-215f-4a8e-ae72-92692ad79d61" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_f62bab09-36c4-4f6f-9858-96cdba435676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_89a7507d-7ebd-4881-93e9-6cc5cd28bb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld_0ba148d7-98f0-4ccb-aeb3-91a87a239905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_89a7507d-7ebd-4881-93e9-6cc5cd28bb67" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld_0ba148d7-98f0-4ccb-aeb3-91a87a239905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold_69ee8380-720d-4efe-8e83-1227b072e35a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_89a7507d-7ebd-4881-93e9-6cc5cd28bb67" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold_69ee8380-720d-4efe-8e83-1227b072e35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_e4a8b5f2-058f-4cc2-919a-742107b90254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_89a7507d-7ebd-4881-93e9-6cc5cd28bb67" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_e4a8b5f2-058f-4cc2-919a-742107b90254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9b46edbd-0e48-403e-ae73-619579e864d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_e4a8b5f2-058f-4cc2-919a-742107b90254" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9b46edbd-0e48-403e-ae73-619579e864d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccb0cb6e-7fc5-42bd-95a6-e36893f232b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9b46edbd-0e48-403e-ae73-619579e864d9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccb0cb6e-7fc5-42bd-95a6-e36893f232b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquityInvestmentsMember_246008e8-c69c-45a2-82dd-411ffed37143" xlink:href="mdt-20201030.xsd#mdt_EquityInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccb0cb6e-7fc5-42bd-95a6-e36893f232b1" xlink:to="loc_mdt_EquityInvestmentsMember_246008e8-c69c-45a2-82dd-411ffed37143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d09599c5-08c8-4abf-8239-c052f5c6f5be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_e4a8b5f2-058f-4cc2-919a-742107b90254" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d09599c5-08c8-4abf-8239-c052f5c6f5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_08649024-5440-4981-9c80-2b0ea8eef4aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d09599c5-08c8-4abf-8239-c052f5c6f5be" xlink:to="loc_us-gaap_GainLossOnInvestments_08649024-5440-4981-9c80-2b0ea8eef4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_2d8424cd-bd4a-4b84-a06f-8503b2d4a1d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d09599c5-08c8-4abf-8239-c052f5c6f5be" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_2d8424cd-bd4a-4b84-a06f-8503b2d4a1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments_412177c8-f625-41e4-baf4-ae47dfa6e8e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d09599c5-08c8-4abf-8239-c052f5c6f5be" xlink:to="loc_us-gaap_ImpairmentOfInvestments_412177c8-f625-41e4-baf4-ae47dfa6e8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_539cecc7-f0b2-488e-98f3-5974655cc033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1372e959-26d5-4343-b32a-ca53db343449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_539cecc7-f0b2-488e-98f3-5974655cc033" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1372e959-26d5-4343-b32a-ca53db343449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8e0f260b-9d90-48b9-940d-a978b9fab2a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1372e959-26d5-4343-b32a-ca53db343449" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8e0f260b-9d90-48b9-940d-a978b9fab2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7b9d83c5-092f-4d12-a1b9-776a54be4b21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8e0f260b-9d90-48b9-940d-a978b9fab2a6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7b9d83c5-092f-4d12-a1b9-776a54be4b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_f523b85a-ba70-47b0-ab9e-24541facfce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7b9d83c5-092f-4d12-a1b9-776a54be4b21" xlink:to="loc_us-gaap_OtherAssetsMember_f523b85a-ba70-47b0-ab9e-24541facfce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a6101b28-f1d1-46f8-baf5-a3d2e32e7ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1372e959-26d5-4343-b32a-ca53db343449" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a6101b28-f1d1-46f8-baf5-a3d2e32e7ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_2aae2fd4-7ed1-42b2-8612-cbe90eeb5be9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a6101b28-f1d1-46f8-baf5-a3d2e32e7ca2" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_2aae2fd4-7ed1-42b2-8612-cbe90eeb5be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_4a08b1b0-791f-45a0-ada1-86745d5719b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a6101b28-f1d1-46f8-baf5-a3d2e32e7ca2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_4a08b1b0-791f-45a0-ada1-86745d5719b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_7a983ada-a369-4089-835d-8506d98a8b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a6101b28-f1d1-46f8-baf5-a3d2e32e7ca2" xlink:to="loc_us-gaap_EquityMethodInvestments_7a983ada-a369-4089-835d-8506d98a8b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_5e629bdd-5e9c-4d60-ae22-ea74ce5ac92a" xlink:href="mdt-20201030.xsd#mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a6101b28-f1d1-46f8-baf5-a3d2e32e7ca2" xlink:to="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_5e629bdd-5e9c-4d60-ae22-ea74ce5ac92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_7bcf1098-659b-4527-8f6a-972b4004a11e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_79dd6f5c-c158-4d29-bd51-4e870090fa32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_7bcf1098-659b-4527-8f6a-972b4004a11e" xlink:to="loc_us-gaap_MarketableSecuritiesTable_79dd6f5c-c158-4d29-bd51-4e870090fa32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_17daab00-dfb7-4c87-b919-db5d82095c16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_79dd6f5c-c158-4d29-bd51-4e870090fa32" xlink:to="loc_us-gaap_FinancialInstrumentAxis_17daab00-dfb7-4c87-b919-db5d82095c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_643ac768-7f4a-4d11-a5b7-ed22c6a7ee20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_17daab00-dfb7-4c87-b919-db5d82095c16" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_643ac768-7f4a-4d11-a5b7-ed22c6a7ee20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquityInvestmentsMember_4ce79515-4dea-431b-8fd8-4e8592445f26" xlink:href="mdt-20201030.xsd#mdt_EquityInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_643ac768-7f4a-4d11-a5b7-ed22c6a7ee20" xlink:to="loc_mdt_EquityInvestmentsMember_4ce79515-4dea-431b-8fd8-4e8592445f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_e9ac7190-2589-4a4c-98b0-32f59d9e39e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_79dd6f5c-c158-4d29-bd51-4e870090fa32" xlink:to="loc_us-gaap_MarketableSecuritiesLineItems_e9ac7190-2589-4a4c-98b0-32f59d9e39e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_c22f8278-4b78-4b0d-8b81-9598fa3b1589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_e9ac7190-2589-4a4c-98b0-32f59d9e39e1" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_c22f8278-4b78-4b0d-8b81-9598fa3b1589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_GainonInvestments_940436e3-2ca4-475a-84c9-b4aa804e59de" xlink:href="mdt-20201030.xsd#mdt_GainonInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_e9ac7190-2589-4a4c-98b0-32f59d9e39e1" xlink:to="loc_mdt_GainonInvestments_940436e3-2ca4-475a-84c9-b4aa804e59de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossonInvestments_259cb65f-3a66-4d03-a143-55eaeeb4dc28" xlink:href="mdt-20201030.xsd#mdt_LossonInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_e9ac7190-2589-4a4c-98b0-32f59d9e39e1" xlink:to="loc_mdt_LossonInvestments_259cb65f-3a66-4d03-a143-55eaeeb4dc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments_929c2593-6805-49b9-923d-5236eec3855a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_e9ac7190-2589-4a4c-98b0-32f59d9e39e1" xlink:to="loc_us-gaap_ImpairmentOfInvestments_929c2593-6805-49b9-923d-5236eec3855a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangements" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancingArrangements"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_78e90b6b-68a7-4584-8278-8648d063a6d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_8a7be899-382e-4b2e-970e-5306b7be0d5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_78e90b6b-68a7-4584-8278-8648d063a6d4" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_8a7be899-382e-4b2e-970e-5306b7be0d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancingArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b696d942-492b-4efe-adb6-4d183efa9c3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_d949798a-d9ad-4897-bf31-90df2d2d51e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b696d942-492b-4efe-adb6-4d183efa9c3f" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_d949798a-d9ad-4897-bf31-90df2d2d51e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancingArrangementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2c9b4a06-3c2c-4423-9680-894dc8edc9f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:href="mdt-20201030.xsd#mdt_ScheduleOfDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2c9b4a06-3c2c-4423-9680-894dc8edc9f1" xlink:to="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bf5879fa-c528-4e06-8380-31ff93ddc45d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_us-gaap_DebtInstrumentAxis_bf5879fa-c528-4e06-8380-31ff93ddc45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_bf5879fa-c528-4e06-8380-31ff93ddc45d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A2015CommercialPaperProgramMember_84647386-e40c-4a7f-9319-df53e6057379" xlink:href="mdt-20201030.xsd#mdt_A2015CommercialPaperProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:to="loc_mdt_A2015CommercialPaperProgramMember_84647386-e40c-4a7f-9319-df53e6057379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AmendedandRestatedRevolvingCreditAgreementMember_02667258-1ad9-4d11-913c-b8d0845c01fa" xlink:href="mdt-20201030.xsd#mdt_AmendedandRestatedRevolvingCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:to="loc_mdt_AmendedandRestatedRevolvingCreditAgreementMember_02667258-1ad9-4d11-913c-b8d0845c01fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Member_e6659e5d-a5a0-4504-bfae-e82d204f55b6" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:to="loc_mdt_SeniorNotes2019Member_e6659e5d-a5a0-4504-bfae-e82d204f55b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember_c8f24dfd-24e4-4e61-ab57-4caecba2471c" xlink:href="mdt-20201030.xsd#mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:to="loc_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember_c8f24dfd-24e4-4e61-ab57-4caecba2471c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicIncAndCIFSASeniorNotesMember_492e2679-bc21-4c64-96df-262ebe2a04ea" xlink:href="mdt-20201030.xsd#mdt_MedtronicIncAndCIFSASeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember_c8f24dfd-24e4-4e61-ab57-4caecba2471c" xlink:to="loc_mdt_MedtronicIncAndCIFSASeniorNotesMember_492e2679-bc21-4c64-96df-262ebe2a04ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicLuxcoSeniorNotesMember_7262f4ad-0197-4e53-9792-b7cb94af047f" xlink:href="mdt-20201030.xsd#mdt_MedtronicLuxcoSeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember_c8f24dfd-24e4-4e61-ab57-4caecba2471c" xlink:to="loc_mdt_MedtronicLuxcoSeniorNotesMember_7262f4ad-0197-4e53-9792-b7cb94af047f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Member_2cd668e2-6c08-437f-8f9c-b4d03ebc53bb" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d776b23-327c-41b7-a7b5-75c9a0db8b34" xlink:to="loc_mdt_SeniorNotes2020Member_2cd668e2-6c08-437f-8f9c-b4d03ebc53bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_11985910-81eb-49be-a291-675664b2b6e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_11985910-81eb-49be-a291-675664b2b6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_8f272d68-1760-400d-8f3c-d9769c749fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_11985910-81eb-49be-a291-675664b2b6e1" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_8f272d68-1760-400d-8f3c-d9769c749fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_1fd7a04f-44e9-4adc-a323-8a59991e7c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_8f272d68-1760-400d-8f3c-d9769c749fab" xlink:to="loc_us-gaap_CommercialPaperMember_1fd7a04f-44e9-4adc-a323-8a59991e7c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7144222e-eee9-4a2f-8a2c-e818b5ddb017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_us-gaap_CreditFacilityAxis_7144222e-eee9-4a2f-8a2c-e818b5ddb017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_05f50f70-58ea-4baf-9f57-4711e7fac5d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_7144222e-eee9-4a2f-8a2c-e818b5ddb017" xlink:to="loc_us-gaap_CreditFacilityDomain_05f50f70-58ea-4baf-9f57-4711e7fac5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_54d58ed0-a70c-439d-8cfa-a976280b440a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_05f50f70-58ea-4baf-9f57-4711e7fac5d5" xlink:to="loc_us-gaap_LineOfCreditMember_54d58ed0-a70c-439d-8cfa-a976280b440a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9caaa31e-bce0-4207-bc72-901ae18de9af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9caaa31e-bce0-4207-bc72-901ae18de9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cb5b28e8-942b-4ffd-96eb-82ad7a5809c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9caaa31e-bce0-4207-bc72-901ae18de9af" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cb5b28e8-942b-4ffd-96eb-82ad7a5809c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9ba4894c-c8be-468f-b7d4-e8503bac2816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cb5b28e8-942b-4ffd-96eb-82ad7a5809c7" xlink:to="loc_us-gaap_SeniorNotesMember_9ba4894c-c8be-468f-b7d4-e8503bac2816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_1cc14b8c-e642-4f38-a74b-57b4d258c7d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cb5b28e8-942b-4ffd-96eb-82ad7a5809c7" xlink:to="loc_us-gaap_MediumTermNotesMember_1cc14b8c-e642-4f38-a74b-57b4d258c7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5ca689df-49b3-446c-bb53-2132dd695731" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_dei_LegalEntityAxis_5ca689df-49b3-446c-bb53-2132dd695731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a38343c5-1f19-4739-b959-54029d9fdf37" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_5ca689df-49b3-446c-bb53-2132dd695731" xlink:to="loc_dei_EntityDomain_a38343c5-1f19-4739-b959-54029d9fdf37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicLuxcoMember_09e9fb3b-a1f7-4617-8241-8293e1987649" xlink:href="mdt-20201030.xsd#mdt_MedtronicLuxcoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a38343c5-1f19-4739-b959-54029d9fdf37" xlink:to="loc_mdt_MedtronicLuxcoMember_09e9fb3b-a1f7-4617-8241-8293e1987649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_002818cc-0435-4408-af6d-1a11154d7c90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_us-gaap_VariableRateAxis_002818cc-0435-4408-af6d-1a11154d7c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_022fe7e9-d001-4a84-9ea0-4c15862c51b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_002818cc-0435-4408-af6d-1a11154d7c90" xlink:to="loc_us-gaap_VariableRateDomain_022fe7e9-d001-4a84-9ea0-4c15862c51b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TokyoInterBankOfferedRateTIBORMember_06f688f8-1d57-487f-a58f-3982067d9d6c" xlink:href="mdt-20201030.xsd#mdt_TokyoInterBankOfferedRateTIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_022fe7e9-d001-4a84-9ea0-4c15862c51b0" xlink:to="loc_mdt_TokyoInterBankOfferedRateTIBORMember_06f688f8-1d57-487f-a58f-3982067d9d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_09c35213-d9fa-41c2-a5e1-9999960cb32d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_09c35213-d9fa-41c2-a5e1-9999960cb32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fdb6ea98-c618-48cb-abad-a72d689400de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_09c35213-d9fa-41c2-a5e1-9999960cb32d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fdb6ea98-c618-48cb-abad-a72d689400de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_3b62692e-1b90-4f59-80c3-36b856db7fda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_fdb6ea98-c618-48cb-abad-a72d689400de" xlink:to="loc_us-gaap_SubsequentEventMember_3b62692e-1b90-4f59-80c3-36b856db7fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a481bd94-5db0-4c7b-835c-a91b63e516d1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_srt_StatementScenarioAxis_a481bd94-5db0-4c7b-835c-a91b63e516d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e2d5d43f-e961-4340-a296-7bbb0a77edcb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a481bd94-5db0-4c7b-835c-a91b63e516d1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e2d5d43f-e961-4340-a296-7bbb0a77edcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_54d024d1-afac-410e-ba0b-94e6bdf9b437" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_e2d5d43f-e961-4340-a296-7bbb0a77edcb" xlink:to="loc_srt_ScenarioForecastMember_54d024d1-afac-410e-ba0b-94e6bdf9b437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:href="mdt-20201030.xsd#mdt_DebtLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_ffd49002-53a1-4c66-8e91-79b4dc07eb49" xlink:to="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract_1ea7e653-b70d-4f4b-bd45-f8be8a6c5912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:to="loc_us-gaap_ShortTermBorrowingsAbstract_1ea7e653-b70d-4f4b-bd45-f8be8a6c5912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CommercialPaperMaximumBorrowingCapacity_ca65ddf2-4b5c-4dc0-a1ef-6b88a45b49e4" xlink:href="mdt-20201030.xsd#mdt_CommercialPaperMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_1ea7e653-b70d-4f4b-bd45-f8be8a6c5912" xlink:to="loc_mdt_CommercialPaperMaximumBorrowingCapacity_ca65ddf2-4b5c-4dc0-a1ef-6b88a45b49e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_7499da2b-0bbf-49d6-8f46-795881ad516c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_1ea7e653-b70d-4f4b-bd45-f8be8a6c5912" xlink:to="loc_us-gaap_CommercialPaper_7499da2b-0bbf-49d6-8f46-795881ad516c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAbstract_f1bf8282-c24a-4562-b76a-667f3526a66f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:to="loc_us-gaap_LineOfCreditFacilityAbstract_f1bf8282-c24a-4562-b76a-667f3526a66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1ea68c49-e293-400c-8d22-6c99d2e88b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_f1bf8282-c24a-4562-b76a-667f3526a66f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1ea68c49-e293-400c-8d22-6c99d2e88b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_98590311-f6bf-456d-8f6a-00ddd5f488da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_f1bf8282-c24a-4562-b76a-667f3526a66f" xlink:to="loc_us-gaap_DebtInstrumentTerm_98590311-f6bf-456d-8f6a-00ddd5f488da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_e37e6ae4-2c7b-4b0c-bc91-b606c0222942" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_f1bf8282-c24a-4562-b76a-667f3526a66f" xlink:to="loc_us-gaap_LineOfCredit_e37e6ae4-2c7b-4b0c-bc91-b606c0222942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:to="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtInstrumentNumberofTranches_dfaa28b3-2784-42c0-bb9e-1b97dbe943e5" xlink:href="mdt-20201030.xsd#mdt_DebtInstrumentNumberofTranches"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:to="loc_mdt_DebtInstrumentNumberofTranches_dfaa28b3-2784-42c0-bb9e-1b97dbe943e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_df7ce255-620f-4176-88cf-b9bfdc64027f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_df7ce255-620f-4176-88cf-b9bfdc64027f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e979e653-8ad2-4e31-8ee0-e499bbdced7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e979e653-8ad2-4e31-8ee0-e499bbdced7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_2999ebea-c342-4af6-b4f8-6dce157b1a02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_2999ebea-c342-4af6-b4f8-6dce157b1a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_93b22d89-b4e7-4f64-bcdb-45a7e488c809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_93b22d89-b4e7-4f64-bcdb-45a7e488c809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e9651e20-3cd7-4776-9293-30a13424f22c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b1289539-88ba-4a10-b3e6-19de7d2b95ff" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e9651e20-3cd7-4776-9293-30a13424f22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumtermNotesAbstract_116d4d1b-4015-46db-9124-b7c01350400c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MediumtermNotesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:to="loc_us-gaap_MediumtermNotesAbstract_116d4d1b-4015-46db-9124-b7c01350400c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtInstrumentExtensionOptionTermOfExtension_a1eba12c-4be8-4d5b-9d7b-7f704d5f97a4" xlink:href="mdt-20201030.xsd#mdt_DebtInstrumentExtensionOptionTermOfExtension"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MediumtermNotesAbstract_116d4d1b-4015-46db-9124-b7c01350400c" xlink:to="loc_mdt_DebtInstrumentExtensionOptionTermOfExtension_a1eba12c-4be8-4d5b-9d7b-7f704d5f97a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7e8ceb5e-0bba-4af8-a9b8-983d073c8f96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MediumtermNotesAbstract_116d4d1b-4015-46db-9124-b7c01350400c" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7e8ceb5e-0bba-4af8-a9b8-983d073c8f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_02edd527-f81f-49c1-8e56-1c96e8f7bc7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DebtLineItems_4c60eb69-c984-4425-aa19-44c65f1de2f1" xlink:to="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_02edd527-f81f-49c1-8e56-1c96e8f7bc7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_87cab6ba-f6c1-4788-96c3-cbf3d2a57ac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_02edd527-f81f-49c1-8e56-1c96e8f7bc7e" xlink:to="loc_us-gaap_LongTermDebtFairValue_87cab6ba-f6c1-4788-96c3-cbf3d2a57ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#FinancingArrangementsLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_672c0098-0329-491e-bb51-a85e8c1562f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0c84d4c3-0d57-4149-bf4e-b91cddea2ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_672c0098-0329-491e-bb51-a85e8c1562f6" xlink:to="loc_us-gaap_DebtInstrumentTable_0c84d4c3-0d57-4149-bf4e-b91cddea2ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_076d93cf-2c27-488f-86a4-dc5e96568160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0c84d4c3-0d57-4149-bf4e-b91cddea2ff3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_076d93cf-2c27-488f-86a4-dc5e96568160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_957d3126-b779-4880-8592-2d44a44c9c5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_076d93cf-2c27-488f-86a4-dc5e96568160" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_957d3126-b779-4880-8592-2d44a44c9c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_4addfba9-d7cd-47e3-9799-a13cfcc5d3db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_957d3126-b779-4880-8592-2d44a44c9c5e" xlink:to="loc_us-gaap_SeniorNotesMember_4addfba9-d7cd-47e3-9799-a13cfcc5d3db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_ccad95b6-ab25-4f7e-b459-a03e91a895b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_957d3126-b779-4880-8592-2d44a44c9c5e" xlink:to="loc_us-gaap_NotesPayableToBanksMember_ccad95b6-ab25-4f7e-b459-a03e91a895b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_45ecb64f-1fdd-468e-adc6-5a3c1e33be28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0c84d4c3-0d57-4149-bf4e-b91cddea2ff3" xlink:to="loc_us-gaap_DebtInstrumentAxis_45ecb64f-1fdd-468e-adc6-5a3c1e33be28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_45ecb64f-1fdd-468e-adc6-5a3c1e33be28" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due2022Member_a30f738d-6f98-4e79-9245-683d4329326f" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2015Due2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2015Due2022Member_a30f738d-6f98-4e79-9245-683d4329326f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2012Due2023Member_e7bc29e3-c6ff-41c3-a232-4f4ee331bceb" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2012Due2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2012Due2023Member_e7bc29e3-c6ff-41c3-a232-4f4ee331bceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230.000PercentMember_1568cc7b-bd9d-4b50-b3de-c5fdad608e94" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20230.000PercentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due20230.000PercentMember_1568cc7b-bd9d-4b50-b3de-c5fdad608e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230.375PercentMember_1ee59fed-0958-4561-b39a-30b627bae648" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20230.375PercentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due20230.375PercentMember_1ee59fed-0958-4561-b39a-30b627bae648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2023Member_1bf7557b-4fa6-45a5-80ed-a3c6dcd29dbc" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2020Due2023Member_1bf7557b-4fa6-45a5-80ed-a3c6dcd29dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2013Due2023Member_d39aa091-20c3-4045-b414-8f9bcfe7832b" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2013Due2023Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2013Due2023Member_d39aa091-20c3-4045-b414-8f9bcfe7832b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2013Due2024Member_3e10cb3f-0d56-4121-9454-475a0be7907e" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2013Due2024Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2013Due2024Member_3e10cb3f-0d56-4121-9454-475a0be7907e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2014Due2024Member_33be2b4b-f09e-4e32-b9d9-3085f8b07d2b" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2014Due2024Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2014Due2024Member_33be2b4b-f09e-4e32-b9d9-3085f8b07d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due2025Member_ac46dadf-5214-4d15-a82f-369cf063cec2" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2015Due2025Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2015Due2025Member_ac46dadf-5214-4d15-a82f-369cf063cec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2026Member_5d027f45-c02d-468d-979d-aa00671b1765" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2026Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due2026Member_5d027f45-c02d-468d-979d-aa00671b1765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2026Member_d68403ab-5473-4f2e-900a-7aca992a3507" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2026Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2020Due2026Member_d68403ab-5473-4f2e-900a-7aca992a3507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2027Member_36617aab-ee9e-441d-bffd-80cfc19cca82" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2027Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due2027Member_36617aab-ee9e-441d-bffd-80cfc19cca82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2017Due2027Member_6db21952-ea57-433a-9bcc-0216f44bcf2f" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2017Due2027Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2017Due2027Member_6db21952-ea57-433a-9bcc-0216f44bcf2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2029Member_241eec2e-90ec-4690-800e-5e1f77ef052c" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2029Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2020Due2029Member_241eec2e-90ec-4690-800e-5e1f77ef052c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.625PercentMember_cbfb939f-479a-4785-9239-060fef89073d" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20311.625PercentMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due20311.625PercentMember_cbfb939f-479a-4785-9239-060fef89073d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2032Member_f3a6fa3a-9dd3-4299-b811-9b51ff196f14" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2032Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due2032Member_f3a6fa3a-9dd3-4299-b811-9b51ff196f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2033Member_d20c6be2-7017-429f-8a6b-1d1d74c6c88e" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2033Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2020Due2033Member_d20c6be2-7017-429f-8a6b-1d1d74c6c88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due2035Member_709b11f1-010e-4d45-927a-a9d65ac0ee32" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2015Due2035Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2015Due2035Member_709b11f1-010e-4d45-927a-a9d65ac0ee32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2007Due2038Member_bbcd4824-50ad-4090-99e6-d2ef1e0d95c3" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2007Due2038Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2007Due2038Member_bbcd4824-50ad-4090-99e6-d2ef1e0d95c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20392.250PercentMember_d1507be3-3a92-4f28-891e-5911364c557f" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due20392.250PercentMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due20392.250PercentMember_d1507be3-3a92-4f28-891e-5911364c557f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2009Due2039Member_9035bb23-eb86-4415-b820-4bd9918ed655" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2009Due2039Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2009Due2039Member_9035bb23-eb86-4415-b820-4bd9918ed655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2040Member_2305deb9-e28f-4b81-9416-ed106ca0f830" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2040Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due2040Member_2305deb9-e28f-4b81-9416-ed106ca0f830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2010Due2040Member_2b735e63-171a-4b9b-91e0-28ed721434c2" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2010Due2040Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2010Due2040Member_2b735e63-171a-4b9b-91e0-28ed721434c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2041Member_89f02fd7-0752-4201-952e-92c33a7c4901" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2041Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2020Due2041Member_89f02fd7-0752-4201-952e-92c33a7c4901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2012Due2042Member_2130f96b-74c5-4025-b410-bdaac48d885d" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2012Due2042Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2012Due2042Member_2130f96b-74c5-4025-b410-bdaac48d885d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2013Due2043Member_492e72b2-85aa-4a3a-bd1c-ca1b208d0c32" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2013Due2043Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2013Due2043Member_492e72b2-85aa-4a3a-bd1c-ca1b208d0c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2014Due2044Member_b210f258-73e5-4d43-b507-05d43291137f" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2014Due2044Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2014Due2044Member_b210f258-73e5-4d43-b507-05d43291137f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due2045Member_bbc29882-f873-4d10-b35e-24f84829e84a" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2015Due2045Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2015Due2045Member_bbc29882-f873-4d10-b35e-24f84829e84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2050Member_419f89c2-14e8-47d5-a117-bd6f096ef97d" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2019Due2050Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2019Due2050Member_419f89c2-14e8-47d5-a117-bd6f096ef97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2051Member_17c5073a-5bff-4993-92c1-c46e48c07bff" xlink:href="mdt-20201030.xsd#mdt_SeniorNotes2020Due2051Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c03a2bf-f2f0-43e7-8bdd-0df6d067bb1c" xlink:to="loc_mdt_SeniorNotes2020Due2051Member_17c5073a-5bff-4993-92c1-c46e48c07bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_62fb1046-3ce1-406f-b2a9-a3e8cf0e81dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0c84d4c3-0d57-4149-bf4e-b91cddea2ff3" xlink:to="loc_us-gaap_DebtInstrumentLineItems_62fb1046-3ce1-406f-b2a9-a3e8cf0e81dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f5afe377-4c60-4149-9ede-7704c5385bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_62fb1046-3ce1-406f-b2a9-a3e8cf0e81dd" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f5afe377-4c60-4149-9ede-7704c5385bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_62fb1046-3ce1-406f-b2a9-a3e8cf0e81dd" xlink:to="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_60875070-fa34-4841-a054-beed3890f9aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_60875070-fa34-4841-a054-beed3890f9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_39911a7e-cec7-4978-a2d0-aadce5c2d98d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_DebtInstrumentTerm_39911a7e-cec7-4978-a2d0-aadce5c2d98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_bdc4112e-26de-43d8-bebe-78bfe3bea342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_bdc4112e-26de-43d8-bebe-78bfe3bea342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ea98e563-0c46-475a-9fd4-7a0176b8f016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ea98e563-0c46-475a-9fd4-7a0176b8f016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_c503984a-9dda-4420-84b5-d838f5a55123" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_c503984a-9dda-4420-84b5-d838f5a55123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_268b2900-2063-42cc-956b-d114de736d77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_268b2900-2063-42cc-956b-d114de736d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c8d875bc-6381-4781-bd40-147c503aba30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_226f37fc-6761-4af4-90cc-38512c06d26e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c8d875bc-6381-4781-bd40-147c503aba30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagement"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4330fadd-0ee6-4d92-a70b-0dfe87c6c4b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_e23729ae-5481-4c06-bf32-b6f05f62dc93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4330fadd-0ee6-4d92-a70b-0dfe87c6c4b4" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_e23729ae-5481-4c06-bf32-b6f05f62dc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_73ecf780-ae5a-47e0-8bde-112cd899dc5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock_73a0039e-a677-49fe-9415-855e4a5a66ee" xlink:href="mdt-20201030.xsd#mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_73ecf780-ae5a-47e0-8bde-112cd899dc5d" xlink:to="loc_mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock_73a0039e-a677-49fe-9415-855e4a5a66ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d290d9f5-8adb-4def-88e7-635a95d2dd00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_73ecf780-ae5a-47e0-8bde-112cd899dc5d" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d290d9f5-8adb-4def-88e7-635a95d2dd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_cf1ca0a3-73c0-4632-9a13-5e0127389cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_73ecf780-ae5a-47e0-8bde-112cd899dc5d" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_cf1ca0a3-73c0-4632-9a13-5e0127389cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_a679167e-2237-4a4b-882d-2468b01c5351" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_73ecf780-ae5a-47e0-8bde-112cd899dc5d" xlink:to="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_a679167e-2237-4a4b-882d-2468b01c5351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8ad0141d-60f7-40d4-8780-3cdc03501a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_73ecf780-ae5a-47e0-8bde-112cd899dc5d" xlink:to="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8ad0141d-60f7-40d4-8780-3cdc03501a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_316187bd-2663-4fd5-9911-b2c3f35456a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_73ecf780-ae5a-47e0-8bde-112cd899dc5d" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_316187bd-2663-4fd5-9911-b2c3f35456a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_16d1d6f9-0d82-4ea0-b7a4-68ca28d8fdad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_73ecf780-ae5a-47e0-8bde-112cd899dc5d" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_16d1d6f9-0d82-4ea0-b7a4-68ca28d8fdad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTableTextBlock_7aa015a3-6f43-442c-8e9b-60bf94d1b52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAssetsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_73ecf780-ae5a-47e0-8bde-112cd899dc5d" xlink:to="loc_us-gaap_OffsettingAssetsTableTextBlock_7aa015a3-6f43-442c-8e9b-60bf94d1b52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesTableTextBlock_5f26994b-5088-4c3c-9433-05e539c6957d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingLiabilitiesTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_73ecf780-ae5a-47e0-8bde-112cd899dc5d" xlink:to="loc_us-gaap_OffsettingLiabilitiesTableTextBlock_5f26994b-5088-4c3c-9433-05e539c6957d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0da260b3-1bad-4823-bae8-30280b6263d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c7c4a23-13d5-4c3e-af78-a41f27448ceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0da260b3-1bad-4823-bae8-30280b6263d1" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c7c4a23-13d5-4c3e-af78-a41f27448ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a227ae3f-1964-4ece-9cdf-5da354b8d9fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c7c4a23-13d5-4c3e-af78-a41f27448ceb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a227ae3f-1964-4ece-9cdf-5da354b8d9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_17119968-fecd-4068-90b0-6d0e33c4e67f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a227ae3f-1964-4ece-9cdf-5da354b8d9fe" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_17119968-fecd-4068-90b0-6d0e33c4e67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1052bf69-491e-433c-b2eb-cc853080487d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_17119968-fecd-4068-90b0-6d0e33c4e67f" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1052bf69-491e-433c-b2eb-cc853080487d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_72d4c27d-844a-4d40-addd-b245d864338b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_17119968-fecd-4068-90b0-6d0e33c4e67f" xlink:to="loc_us-gaap_TotalReturnSwapMember_72d4c27d-844a-4d40-addd-b245d864338b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b67d3895-c51e-4076-9fe6-f9d7ecebc699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c7c4a23-13d5-4c3e-af78-a41f27448ceb" xlink:to="loc_us-gaap_HedgingDesignationAxis_b67d3895-c51e-4076-9fe6-f9d7ecebc699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_28725ee0-9b08-4634-9e26-e8770b595ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b67d3895-c51e-4076-9fe6-f9d7ecebc699" xlink:to="loc_us-gaap_HedgingDesignationDomain_28725ee0-9b08-4634-9e26-e8770b595ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_394a3954-ac90-473c-8a6f-874e377b11d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_28725ee0-9b08-4634-9e26-e8770b595ec8" xlink:to="loc_us-gaap_NondesignatedMember_394a3954-ac90-473c-8a6f-874e377b11d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d177ff49-a7f4-4534-9b64-1be629937f81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_28725ee0-9b08-4634-9e26-e8770b595ec8" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d177ff49-a7f4-4534-9b64-1be629937f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93027a92-d3d6-4964-835a-e158669ee42e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c7c4a23-13d5-4c3e-af78-a41f27448ceb" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93027a92-d3d6-4964-835a-e158669ee42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d11d2d35-c2c6-4c1c-bae7-6895bdb9d225" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_93027a92-d3d6-4964-835a-e158669ee42e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d11d2d35-c2c6-4c1c-bae7-6895bdb9d225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_4189ac6a-a020-454e-8e07-409128746773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d11d2d35-c2c6-4c1c-bae7-6895bdb9d225" xlink:to="loc_us-gaap_CashFlowHedgingMember_4189ac6a-a020-454e-8e07-409128746773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_ce379f73-f849-45e3-8374-a30801093f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d11d2d35-c2c6-4c1c-bae7-6895bdb9d225" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_ce379f73-f849-45e3-8374-a30801093f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_32a6e8ee-7c05-471a-83cd-3cf8d962a5e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c7c4a23-13d5-4c3e-af78-a41f27448ceb" xlink:to="loc_srt_CurrencyAxis_32a6e8ee-7c05-471a-83cd-3cf8d962a5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_5bdbfe28-cedb-4aeb-b50c-f897b79a9925" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_32a6e8ee-7c05-471a-83cd-3cf8d962a5e1" xlink:to="loc_currency_AllCurrenciesDomain_5bdbfe28-cedb-4aeb-b50c-f897b79a9925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_70231d6c-d96d-4888-af83-0164018ea446" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_5bdbfe28-cedb-4aeb-b50c-f897b79a9925" xlink:to="loc_currency_EUR_70231d6c-d96d-4888-af83-0164018ea446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_5b73706c-6b3d-4975-841b-7b9aaf3bab02" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_JPY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_5bdbfe28-cedb-4aeb-b50c-f897b79a9925" xlink:to="loc_currency_JPY_5b73706c-6b3d-4975-841b-7b9aaf3bab02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c7c4a23-13d5-4c3e-af78-a41f27448ceb" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9c9d5819-7f7b-4290-9392-6513846c184d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9c9d5819-7f7b-4290-9392-6513846c184d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_e300bb26-a486-44ba-b8dc-75e1b6f42ecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_e300bb26-a486-44ba-b8dc-75e1b6f42ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_32db97a8-aa2e-425b-9e36-23577110aaef" xlink:href="mdt-20201030.xsd#mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_32db97a8-aa2e-425b-9e36-23577110aaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_6d96a8dc-269a-4a58-b9ee-e87f3f4a3e55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_6d96a8dc-269a-4a58-b9ee-e87f3f4a3e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax_6d4ab9d0-c3e5-423e-a1f5-57d71443b6d8" xlink:href="mdt-20201030.xsd#mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax_6d4ab9d0-c3e5-423e-a1f5-57d71443b6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths_79f9ef0b-78c0-4fc1-a467-f8a2ee1f1a18" xlink:href="mdt-20201030.xsd#mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths_79f9ef0b-78c0-4fc1-a467-f8a2ee1f1a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet_fadb7989-0cb6-47b9-b0b3-f7cf767d8f03" xlink:href="mdt-20201030.xsd#mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c5662de3-67e7-4431-898d-cc14f1785081" xlink:to="loc_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet_fadb7989-0cb6-47b9-b0b3-f7cf767d8f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_842398f5-bb71-4166-a9ac-5dc84264cc7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d41a529-57db-434c-86ce-a0184009adb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_842398f5-bb71-4166-a9ac-5dc84264cc7e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d41a529-57db-434c-86ce-a0184009adb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_12099c5a-0bb0-4229-a894-7805d98b7775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d41a529-57db-434c-86ce-a0184009adb2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_12099c5a-0bb0-4229-a894-7805d98b7775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ba618580-870d-42b4-b744-7c82d6293124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_12099c5a-0bb0-4229-a894-7805d98b7775" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ba618580-870d-42b4-b744-7c82d6293124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_3f91d94b-2f3a-4e42-a135-85dcb4d5dc52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ba618580-870d-42b4-b744-7c82d6293124" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_3f91d94b-2f3a-4e42-a135-85dcb4d5dc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1c292708-802a-4b62-8cdc-e4b91793064c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d41a529-57db-434c-86ce-a0184009adb2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1c292708-802a-4b62-8cdc-e4b91793064c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7325e1c8-cf41-4ac0-b882-81f378363a14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1c292708-802a-4b62-8cdc-e4b91793064c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7325e1c8-cf41-4ac0-b882-81f378363a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6625de61-f4b9-4374-af13-19b509b4c704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7325e1c8-cf41-4ac0-b882-81f378363a14" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6625de61-f4b9-4374-af13-19b509b4c704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_a6e40512-3362-406d-a391-610d50e94c92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7325e1c8-cf41-4ac0-b882-81f378363a14" xlink:to="loc_us-gaap_TotalReturnSwapMember_a6e40512-3362-406d-a391-610d50e94c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9926afe4-4731-426e-be01-249f297d5faf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1d41a529-57db-434c-86ce-a0184009adb2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9926afe4-4731-426e-be01-249f297d5faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_33111265-8a9e-4e99-abeb-be8f1aaf6e85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_9926afe4-4731-426e-be01-249f297d5faf" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_33111265-8a9e-4e99-abeb-be8f1aaf6e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7c601353-2d33-41bb-92aa-33fe4e210599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_01e83c32-c977-42cd-8237-c9c7b0ffd6ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7c601353-2d33-41bb-92aa-33fe4e210599" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_01e83c32-c977-42cd-8237-c9c7b0ffd6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae296ef-70df-45b0-8b0b-f073d63c6c12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_01e83c32-c977-42cd-8237-c9c7b0ffd6ff" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae296ef-70df-45b0-8b0b-f073d63c6c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_55f10e9a-01cb-4e0f-8dee-f3e2aadbae2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae296ef-70df-45b0-8b0b-f073d63c6c12" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_55f10e9a-01cb-4e0f-8dee-f3e2aadbae2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_487a3b07-85b7-48fb-8d29-dff07190e827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_55f10e9a-01cb-4e0f-8dee-f3e2aadbae2c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_487a3b07-85b7-48fb-8d29-dff07190e827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_98f2348b-ee61-421c-971f-a98fdb9c6891" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_01e83c32-c977-42cd-8237-c9c7b0ffd6ff" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_98f2348b-ee61-421c-971f-a98fdb9c6891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b0ccc4f2-15d4-4b62-a7de-f8f69b6e6328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_98f2348b-ee61-421c-971f-a98fdb9c6891" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b0ccc4f2-15d4-4b62-a7de-f8f69b6e6328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_d41cd8df-1c7a-43ce-b28d-a1cb9069609c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b0ccc4f2-15d4-4b62-a7de-f8f69b6e6328" xlink:to="loc_us-gaap_CashFlowHedgingMember_d41cd8df-1c7a-43ce-b28d-a1cb9069609c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_309a3ba0-3248-4ced-839d-5dd39e7db0b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_01e83c32-c977-42cd-8237-c9c7b0ffd6ff" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_309a3ba0-3248-4ced-839d-5dd39e7db0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f0f84236-eafb-4521-b561-b0bd7caf4e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_309a3ba0-3248-4ced-839d-5dd39e7db0b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f0f84236-eafb-4521-b561-b0bd7caf4e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_90e3f819-77b2-4e97-ba6b-d957ce6c34e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_b7a26c56-17bf-4a9b-ad54-0d303f16a127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_90e3f819-77b2-4e97-ba6b-d957ce6c34e3" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_b7a26c56-17bf-4a9b-ad54-0d303f16a127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c2406627-02bd-41a3-8509-3e3fd57d7f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_90e3f819-77b2-4e97-ba6b-d957ce6c34e3" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c2406627-02bd-41a3-8509-3e3fd57d7f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_db7ad310-faa3-4703-bd97-5b81ae2c3969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c2406627-02bd-41a3-8509-3e3fd57d7f3c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_db7ad310-faa3-4703-bd97-5b81ae2c3969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_de364d46-6349-4724-92ad-d89b52132eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_db7ad310-faa3-4703-bd97-5b81ae2c3969" xlink:to="loc_us-gaap_HedgingRelationshipDomain_de364d46-6349-4724-92ad-d89b52132eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_b0496733-8665-4435-bb16-52155d1f9c51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_de364d46-6349-4724-92ad-d89b52132eb9" xlink:to="loc_us-gaap_CashFlowHedgingMember_b0496733-8665-4435-bb16-52155d1f9c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_499705ae-12e5-4d45-89b5-cc0b0d4fab83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c2406627-02bd-41a3-8509-3e3fd57d7f3c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_499705ae-12e5-4d45-89b5-cc0b0d4fab83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3cd66446-f7f0-47c2-9cae-b12fd6067aaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_499705ae-12e5-4d45-89b5-cc0b0d4fab83" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3cd66446-f7f0-47c2-9cae-b12fd6067aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_915700f4-5140-4d1e-b63f-7d320331d686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3cd66446-f7f0-47c2-9cae-b12fd6067aaa" xlink:to="loc_us-gaap_ForeignExchangeContractMember_915700f4-5140-4d1e-b63f-7d320331d686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c9107ba8-7274-4cc8-a4f5-05e5bba57a33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c2406627-02bd-41a3-8509-3e3fd57d7f3c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c9107ba8-7274-4cc8-a4f5-05e5bba57a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8893a66c-cd5e-489b-a190-8387d671dc7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c9107ba8-7274-4cc8-a4f5-05e5bba57a33" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8893a66c-cd5e-489b-a190-8387d671dc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_1790aaaf-e8ba-4a19-84a3-5df056fe2809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8893a66c-cd5e-489b-a190-8387d671dc7d" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_1790aaaf-e8ba-4a19-84a3-5df056fe2809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_d49f85b8-8711-470b-b74a-509cd52445e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c2406627-02bd-41a3-8509-3e3fd57d7f3c" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_d49f85b8-8711-470b-b74a-509cd52445e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_fed3a008-6342-46c2-bb27-2cde29148764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_d49f85b8-8711-470b-b74a-509cd52445e7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_fed3a008-6342-46c2-bb27-2cde29148764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f288ec3d-3ba5-48f9-bdcc-4276b21819b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6482b385-783e-4851-9460-89f1e4c5dfb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f288ec3d-3ba5-48f9-bdcc-4276b21819b0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6482b385-783e-4851-9460-89f1e4c5dfb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_dae0929a-7b1c-4b29-b865-762ef3f744b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6482b385-783e-4851-9460-89f1e4c5dfb2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_dae0929a-7b1c-4b29-b865-762ef3f744b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0cb73755-c21d-44da-a099-7fbbd5bb5496" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_dae0929a-7b1c-4b29-b865-762ef3f744b5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0cb73755-c21d-44da-a099-7fbbd5bb5496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_4c00261a-b93a-4102-8943-340f83af95fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0cb73755-c21d-44da-a099-7fbbd5bb5496" xlink:to="loc_us-gaap_ForeignExchangeContractMember_4c00261a-b93a-4102-8943-340f83af95fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f4f8a513-33ac-4052-8310-6f467ed3c867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6482b385-783e-4851-9460-89f1e4c5dfb2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f4f8a513-33ac-4052-8310-6f467ed3c867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9a23e4b7-68f7-4628-b061-995aaa78c2f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f4f8a513-33ac-4052-8310-6f467ed3c867" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9a23e4b7-68f7-4628-b061-995aaa78c2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_6d13ec78-447e-4df8-aef4-1bf29c4cc2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9a23e4b7-68f7-4628-b061-995aaa78c2f2" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_6d13ec78-447e-4df8-aef4-1bf29c4cc2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78f0b528-4d54-4b36-b164-270429995597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6482b385-783e-4851-9460-89f1e4c5dfb2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78f0b528-4d54-4b36-b164-270429995597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d41ce403-4ea3-4ec0-a58b-736d515f4979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78f0b528-4d54-4b36-b164-270429995597" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d41ce403-4ea3-4ec0-a58b-736d515f4979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_4a193d15-5d9d-48c3-b4c0-2eaef095a9b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d41ce403-4ea3-4ec0-a58b-736d515f4979" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_4a193d15-5d9d-48c3-b4c0-2eaef095a9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_62728532-5842-465e-8cca-d74564a20e40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6482b385-783e-4851-9460-89f1e4c5dfb2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_62728532-5842-465e-8cca-d74564a20e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_73b6d4e4-0d8b-4d1b-a444-c8f8476575a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_62728532-5842-465e-8cca-d74564a20e40" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_73b6d4e4-0d8b-4d1b-a444-c8f8476575a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6247bad6-0405-4b6b-9312-0a27eac07623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fff6152b-c350-4782-9684-68dc8c2f847b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6247bad6-0405-4b6b-9312-0a27eac07623" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fff6152b-c350-4782-9684-68dc8c2f847b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_15623d98-39a3-4205-975f-a4a96872c8a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fff6152b-c350-4782-9684-68dc8c2f847b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_15623d98-39a3-4205-975f-a4a96872c8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_178cb79e-0565-4571-bff9-c1635466483c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_15623d98-39a3-4205-975f-a4a96872c8a1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_178cb79e-0565-4571-bff9-c1635466483c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1c4f1e71-9d1e-43bf-92e6-72821e4c17bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_178cb79e-0565-4571-bff9-c1635466483c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1c4f1e71-9d1e-43bf-92e6-72821e4c17bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_354a73ce-4956-4719-8a21-c312ed0696fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fff6152b-c350-4782-9684-68dc8c2f847b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_354a73ce-4956-4719-8a21-c312ed0696fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f31dc6c2-ef3c-4916-9f5f-6b72a361561d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_354a73ce-4956-4719-8a21-c312ed0696fc" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f31dc6c2-ef3c-4916-9f5f-6b72a361561d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_89bae440-741b-4982-b9c0-ff812e2703af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f31dc6c2-ef3c-4916-9f5f-6b72a361561d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_89bae440-741b-4982-b9c0-ff812e2703af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3dd03999-0929-49c6-a65b-efe10d7a1634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_fff6152b-c350-4782-9684-68dc8c2f847b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3dd03999-0929-49c6-a65b-efe10d7a1634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_41416dfb-58a0-4da4-acfc-3849a4a2e923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3dd03999-0929-49c6-a65b-efe10d7a1634" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_41416dfb-58a0-4da4-acfc-3849a4a2e923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_36b7a895-de80-46ac-9a48-8e64eac7b023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_605b9f64-9b7a-45fc-8d27-8cf6d7d99916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_36b7a895-de80-46ac-9a48-8e64eac7b023" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_605b9f64-9b7a-45fc-8d27-8cf6d7d99916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_46db55ff-5c43-42fd-82f8-afa22119540e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_605b9f64-9b7a-45fc-8d27-8cf6d7d99916" xlink:to="loc_us-gaap_HedgingDesignationAxis_46db55ff-5c43-42fd-82f8-afa22119540e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ae1f96ab-45a4-426a-aec3-e9ec470df095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_46db55ff-5c43-42fd-82f8-afa22119540e" xlink:to="loc_us-gaap_HedgingDesignationDomain_ae1f96ab-45a4-426a-aec3-e9ec470df095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e6602bc7-520c-4160-9cb2-7c54afd91c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ae1f96ab-45a4-426a-aec3-e9ec470df095" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e6602bc7-520c-4160-9cb2-7c54afd91c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_79bdb45f-21bc-4a2e-8912-f416b13cb4aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ae1f96ab-45a4-426a-aec3-e9ec470df095" xlink:to="loc_us-gaap_NondesignatedMember_79bdb45f-21bc-4a2e-8912-f416b13cb4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_21ff42ce-faa1-4c07-adf6-fe5ef1f3b907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_605b9f64-9b7a-45fc-8d27-8cf6d7d99916" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_21ff42ce-faa1-4c07-adf6-fe5ef1f3b907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_559f7fe2-1b15-4c09-b2cc-a09334ddafb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_21ff42ce-faa1-4c07-adf6-fe5ef1f3b907" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_559f7fe2-1b15-4c09-b2cc-a09334ddafb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_359d1b2e-d4d7-44fb-b3aa-c5c4c710d254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_559f7fe2-1b15-4c09-b2cc-a09334ddafb5" xlink:to="loc_us-gaap_ForeignExchangeContractMember_359d1b2e-d4d7-44fb-b3aa-c5c4c710d254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_985eb15d-0776-41eb-b9dd-8e412eed45d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_559f7fe2-1b15-4c09-b2cc-a09334ddafb5" xlink:to="loc_us-gaap_TotalReturnSwapMember_985eb15d-0776-41eb-b9dd-8e412eed45d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_e9fd4029-fc22-470a-aa92-556f641f911a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_559f7fe2-1b15-4c09-b2cc-a09334ddafb5" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_e9fd4029-fc22-470a-aa92-556f641f911a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0f9c3021-3819-40dc-a15d-5b706b9662db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_605b9f64-9b7a-45fc-8d27-8cf6d7d99916" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0f9c3021-3819-40dc-a15d-5b706b9662db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_dc5fae4e-2896-4d29-a3f3-34bbc973ce9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0f9c3021-3819-40dc-a15d-5b706b9662db" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_dc5fae4e-2896-4d29-a3f3-34bbc973ce9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_e973bd4f-6cc6-4811-a111-79c715eb2026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dc5fae4e-2896-4d29-a3f3-34bbc973ce9c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_e973bd4f-6cc6-4811-a111-79c715eb2026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_73225480-be1c-4f57-b71f-a1a92ff7734c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dc5fae4e-2896-4d29-a3f3-34bbc973ce9c" xlink:to="loc_us-gaap_OtherAssetsMember_73225480-be1c-4f57-b71f-a1a92ff7734c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember_7cc8c2e1-c930-4016-b222-5c63e8ad34ba" xlink:href="mdt-20201030.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dc5fae4e-2896-4d29-a3f3-34bbc973ce9c" xlink:to="loc_mdt_OtherAccruedExpensesMember_7cc8c2e1-c930-4016-b222-5c63e8ad34ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_559d4f21-b642-488b-8714-ecd14d8b88a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dc5fae4e-2896-4d29-a3f3-34bbc973ce9c" xlink:to="loc_us-gaap_OtherLiabilitiesMember_559d4f21-b642-488b-8714-ecd14d8b88a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_e464d002-ec37-4f17-a33e-cdfd078608d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_605b9f64-9b7a-45fc-8d27-8cf6d7d99916" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_e464d002-ec37-4f17-a33e-cdfd078608d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_85bb71fa-7e47-44ed-8caf-cc3fc996bb88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e464d002-ec37-4f17-a33e-cdfd078608d2" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_85bb71fa-7e47-44ed-8caf-cc3fc996bb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ff5d3168-124c-48e8-b8dd-66169b5bb482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e464d002-ec37-4f17-a33e-cdfd078608d2" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ff5d3168-124c-48e8-b8dd-66169b5bb482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e851ca82-e460-45df-ac45-2a68377f2b82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2c96c8f2-e191-47ae-b268-7a05f0014122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e851ca82-e460-45df-ac45-2a68377f2b82" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2c96c8f2-e191-47ae-b268-7a05f0014122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e590ff0e-0e11-44c4-afa1-97109021e990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2c96c8f2-e191-47ae-b268-7a05f0014122" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e590ff0e-0e11-44c4-afa1-97109021e990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7d641c4c-9451-409b-8bd5-5901bb8586cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e590ff0e-0e11-44c4-afa1-97109021e990" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7d641c4c-9451-409b-8bd5-5901bb8586cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_c16fd053-cb7f-41af-9cea-2e0f4f97c352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7d641c4c-9451-409b-8bd5-5901bb8586cc" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_c16fd053-cb7f-41af-9cea-2e0f4f97c352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b40a6dfe-98c3-4649-a6d5-eed5252537bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2c96c8f2-e191-47ae-b268-7a05f0014122" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b40a6dfe-98c3-4649-a6d5-eed5252537bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd6bebf9-9c7a-4cf3-8915-2794cf246b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b40a6dfe-98c3-4649-a6d5-eed5252537bf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd6bebf9-9c7a-4cf3-8915-2794cf246b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1191ac99-8294-457f-9a7b-38017dbc8c12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd6bebf9-9c7a-4cf3-8915-2794cf246b58" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1191ac99-8294-457f-9a7b-38017dbc8c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c30f0388-28f5-4606-aa71-81af9dd3bc8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd6bebf9-9c7a-4cf3-8915-2794cf246b58" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c30f0388-28f5-4606-aa71-81af9dd3bc8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6390288b-6124-4590-86a9-8195cf7d5987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2c96c8f2-e191-47ae-b268-7a05f0014122" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6390288b-6124-4590-86a9-8195cf7d5987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_aeb4b509-a00f-4605-9c1f-9b5d44c0d4bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6390288b-6124-4590-86a9-8195cf7d5987" xlink:to="loc_us-gaap_DerivativeAssets_aeb4b509-a00f-4605-9c1f-9b5d44c0d4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_1fa51291-54f0-4dc2-b9a7-79da1ddcd134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6390288b-6124-4590-86a9-8195cf7d5987" xlink:to="loc_us-gaap_DerivativeLiabilities_1fa51291-54f0-4dc2-b9a7-79da1ddcd134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_868c7a9c-29fb-4c51-a2a8-00a9f4d34724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OffsettingAssetsandLiabilitiesTable_737d3a50-0179-4e87-96a8-178f46389b67" xlink:href="mdt-20201030.xsd#mdt_OffsettingAssetsandLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_868c7a9c-29fb-4c51-a2a8-00a9f4d34724" xlink:to="loc_mdt_OffsettingAssetsandLiabilitiesTable_737d3a50-0179-4e87-96a8-178f46389b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b7316b36-066d-4da1-bed7-1f811e761912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesTable_737d3a50-0179-4e87-96a8-178f46389b67" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b7316b36-066d-4da1-bed7-1f811e761912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0d14ffa2-b909-4f56-8560-a73e94dfddda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b7316b36-066d-4da1-bed7-1f811e761912" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0d14ffa2-b909-4f56-8560-a73e94dfddda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6f5606b6-678f-4a0e-b082-38f7df9fada1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0d14ffa2-b909-4f56-8560-a73e94dfddda" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6f5606b6-678f-4a0e-b082-38f7df9fada1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_38724ec8-dba3-42b6-ac84-c178a55df7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0d14ffa2-b909-4f56-8560-a73e94dfddda" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_38724ec8-dba3-42b6-ac84-c178a55df7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_60dcf20e-d64a-40a8-a008-847267557b60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0d14ffa2-b909-4f56-8560-a73e94dfddda" xlink:to="loc_us-gaap_TotalReturnSwapMember_60dcf20e-d64a-40a8-a008-847267557b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_35c4d5a0-55b7-4acd-a822-b91c600be3b2" xlink:href="mdt-20201030.xsd#mdt_OffsettingAssetsandLiabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesTable_737d3a50-0179-4e87-96a8-178f46389b67" xlink:to="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_35c4d5a0-55b7-4acd-a822-b91c600be3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_7e689b50-2431-4db5-8376-4c77d67a3cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_35c4d5a0-55b7-4acd-a822-b91c600be3b2" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_7e689b50-2431-4db5-8376-4c77d67a3cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6a8c3c88-183c-449e-bf01-9c79bc07e5db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_7e689b50-2431-4db5-8376-4c77d67a3cd5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6a8c3c88-183c-449e-bf01-9c79bc07e5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_5c8b7f3e-6b79-4411-95ba-5735816eee8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_7e689b50-2431-4db5-8376-4c77d67a3cd5" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_5c8b7f3e-6b79-4411-95ba-5735816eee8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_c904fdcf-42bd-4644-a3fc-34441e482343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_7e689b50-2431-4db5-8376-4c77d67a3cd5" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_c904fdcf-42bd-4644-a3fc-34441e482343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_718499ba-9b99-4517-9801-fed669719e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_7e689b50-2431-4db5-8376-4c77d67a3cd5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_718499ba-9b99-4517-9801-fed669719e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_1a034dca-c7f1-4184-9a20-87040fd42997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_35c4d5a0-55b7-4acd-a822-b91c600be3b2" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_1a034dca-c7f1-4184-9a20-87040fd42997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_eacffac1-a50a-4710-bfb6-b0eb6433b4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_1a034dca-c7f1-4184-9a20-87040fd42997" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_eacffac1-a50a-4710-bfb6-b0eb6433b4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_4fb0d6ee-5200-452e-a160-b8f46269087d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_1a034dca-c7f1-4184-9a20-87040fd42997" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_4fb0d6ee-5200-452e-a160-b8f46269087d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_a7fbd83d-030b-4803-90b6-4ca75f42f6be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_1a034dca-c7f1-4184-9a20-87040fd42997" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_a7fbd83d-030b-4803-90b6-4ca75f42f6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_96d2f856-100d-4ea4-a10c-567cb50295fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_1a034dca-c7f1-4184-9a20-87040fd42997" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_96d2f856-100d-4ea4-a10c-567cb50295fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityAbstract_80923f10-33a1-4fed-b449-cb6c05527c2b" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetLiabilityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_35c4d5a0-55b7-4acd-a822-b91c600be3b2" xlink:to="loc_mdt_DerivativeAssetLiabilityAbstract_80923f10-33a1-4fed-b449-cb6c05527c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_0fb39ec3-25b2-4dea-ac14-f22ca68b4f23" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_80923f10-33a1-4fed-b449-cb6c05527c2b" xlink:to="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_0fb39ec3-25b2-4dea-ac14-f22ca68b4f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_a23ccdbf-f4c8-4be7-bb7c-493ad445b9bc" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_80923f10-33a1-4fed-b449-cb6c05527c2b" xlink:to="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_a23ccdbf-f4c8-4be7-bb7c-493ad445b9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_f36fb4f7-dcdd-40a0-ae92-2789b838a6ec" xlink:href="mdt-20201030.xsd#mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_80923f10-33a1-4fed-b449-cb6c05527c2b" xlink:to="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_f36fb4f7-dcdd-40a0-ae92-2789b838a6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_f51fd487-8ead-47c3-adb8-2b6398f7e3ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_80923f10-33a1-4fed-b449-cb6c05527c2b" xlink:to="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_f51fd487-8ead-47c3-adb8-2b6398f7e3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1" xlink:type="simple" xlink:href="mdt-20201030.xsd#DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/Inventories" xlink:type="simple" xlink:href="mdt-20201030.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_cd576f6e-f724-407a-bfbe-3145fc935071" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_3d592394-db20-4ed3-9b45-6cfd2f5d0932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_cd576f6e-f724-407a-bfbe-3145fc935071" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_3d592394-db20-4ed3-9b45-6cfd2f5d0932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/InventoriesTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_e44a707b-86fa-42e7-84bd-5c010f8855be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_59e815f4-24c0-44d5-92d0-b50b574ac83f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e44a707b-86fa-42e7-84bd-5c010f8855be" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_59e815f4-24c0-44d5-92d0-b50b574ac83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/InventoriesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_e04ba69d-8246-4788-b9b2-ce709405f672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2198813b-ea74-4a95-94a4-2205ade0ccd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e04ba69d-8246-4788-b9b2-ce709405f672" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2198813b-ea74-4a95-94a4-2205ade0ccd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_208b2d84-796e-4b58-8327-bcb04c855e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e04ba69d-8246-4788-b9b2-ce709405f672" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_208b2d84-796e-4b58-8327-bcb04c855e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_95519bac-7bc2-4b23-9b79-d58fa411505a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e04ba69d-8246-4788-b9b2-ce709405f672" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_95519bac-7bc2-4b23-9b79-d58fa411505a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3b72ba4d-1309-4abd-a89d-4d5d16888e8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e04ba69d-8246-4788-b9b2-ce709405f672" xlink:to="loc_us-gaap_InventoryNet_3b72ba4d-1309-4abd-a89d-4d5d16888e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_004ae6eb-7ffd-4ef8-aa1d-056f3b3df1f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_7e50ed3a-040e-49d0-8695-4a7d96fc886d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_004ae6eb-7ffd-4ef8-aa1d-056f3b3df1f7" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_7e50ed3a-040e-49d0-8695-4a7d96fc886d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_96db0efe-76f8-4cf5-9547-faa7013e3972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_e73491cb-4e62-4986-bef3-0a7a2b5631d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_96db0efe-76f8-4cf5-9547-faa7013e3972" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_e73491cb-4e62-4986-bef3-0a7a2b5631d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_48f3061e-bf0c-4d99-bce6-5bd635781613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_96db0efe-76f8-4cf5-9547-faa7013e3972" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_48f3061e-bf0c-4d99-bce6-5bd635781613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_ba840f0a-161e-42d0-8b3a-8f3230c411ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_96db0efe-76f8-4cf5-9547-faa7013e3972" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_ba840f0a-161e-42d0-8b3a-8f3230c411ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_db295e93-f877-499d-914d-27e9d30f2888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_96db0efe-76f8-4cf5-9547-faa7013e3972" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_db295e93-f877-499d-914d-27e9d30f2888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e40e6c2-b12c-4132-ae41-fbeb12141a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_bdbb85d2-f2de-4800-9019-7929d63f8fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e40e6c2-b12c-4132-ae41-fbeb12141a45" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_bdbb85d2-f2de-4800-9019-7929d63f8fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d6944702-d9de-464d-8864-9e52d30573b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_bdbb85d2-f2de-4800-9019-7929d63f8fb0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d6944702-d9de-464d-8864-9e52d30573b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_36c69fb5-8ecf-4783-9134-5f165933e2be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d6944702-d9de-464d-8864-9e52d30573b2" xlink:to="loc_us-gaap_SegmentDomain_36c69fb5-8ecf-4783-9134-5f165933e2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacAndVascularGroupMember_11ea73f4-3689-4859-9874-32320f3e4d30" xlink:href="mdt-20201030.xsd#mdt_CardiacAndVascularGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_36c69fb5-8ecf-4783-9134-5f165933e2be" xlink:to="loc_mdt_CardiacAndVascularGroupMember_11ea73f4-3689-4859-9874-32320f3e4d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MinimallyInvasiveTherapiesGroupMember_5e0127fe-f65f-4ab5-ac98-0a1063e553c0" xlink:href="mdt-20201030.xsd#mdt_MinimallyInvasiveTherapiesGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_36c69fb5-8ecf-4783-9134-5f165933e2be" xlink:to="loc_mdt_MinimallyInvasiveTherapiesGroupMember_5e0127fe-f65f-4ab5-ac98-0a1063e553c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestorativeTherapiesGroupMember_4352797d-0223-4d64-8810-a496ba2ed433" xlink:href="mdt-20201030.xsd#mdt_RestorativeTherapiesGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_36c69fb5-8ecf-4783-9134-5f165933e2be" xlink:to="loc_mdt_RestorativeTherapiesGroupMember_4352797d-0223-4d64-8810-a496ba2ed433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_4212eb90-9a2b-40f6-8db3-6ca72ba1ddb0" xlink:href="mdt-20201030.xsd#mdt_DiabetesGroupMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_36c69fb5-8ecf-4783-9134-5f165933e2be" xlink:to="loc_mdt_DiabetesGroupMember_4212eb90-9a2b-40f6-8db3-6ca72ba1ddb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_8221bfe7-7a6a-49ad-8242-e6057db073f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_bdbb85d2-f2de-4800-9019-7929d63f8fb0" xlink:to="loc_us-gaap_GoodwillLineItems_8221bfe7-7a6a-49ad-8242-e6057db073f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_55fad092-500b-41c7-899e-9458a20771cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8221bfe7-7a6a-49ad-8242-e6057db073f3" xlink:to="loc_us-gaap_GoodwillRollForward_55fad092-500b-41c7-899e-9458a20771cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e48ba811-ac70-4347-a00b-84c0796d5145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_55fad092-500b-41c7-899e-9458a20771cc" xlink:to="loc_us-gaap_Goodwill_e48ba811-ac70-4347-a00b-84c0796d5145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8f8151b0-c0fa-4c93-aac3-96c9603d5f26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_55fad092-500b-41c7-899e-9458a20771cc" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8f8151b0-c0fa-4c93-aac3-96c9603d5f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_22c5357f-9f50-4f5d-b057-516ef2129e57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_55fad092-500b-41c7-899e-9458a20771cc" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_22c5357f-9f50-4f5d-b057-516ef2129e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_31b2fd01-3df3-4299-8410-6e8b8c624bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_55fad092-500b-41c7-899e-9458a20771cc" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_31b2fd01-3df3-4299-8410-6e8b8c624bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b29132fa-12a3-4cdc-8229-02a80f0f353e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_55fad092-500b-41c7-899e-9458a20771cc" xlink:to="loc_us-gaap_Goodwill_b29132fa-12a3-4cdc-8229-02a80f0f353e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b6f035f3-c622-423c-95cf-1976d70a5ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ce28877e-cf28-4b4a-9cf6-19a71ddb19e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b6f035f3-c622-423c-95cf-1976d70a5ad3" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ce28877e-cf28-4b4a-9cf6-19a71ddb19e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_678e815d-0884-4dcd-a913-06a8e6171a06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b6f035f3-c622-423c-95cf-1976d70a5ad3" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_678e815d-0884-4dcd-a913-06a8e6171a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_669830b0-7715-492a-85be-47bc94c02cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b6f035f3-c622-423c-95cf-1976d70a5ad3" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_669830b0-7715-492a-85be-47bc94c02cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_da683b7b-de5c-47eb-bad5-b760d5d089a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b6f035f3-c622-423c-95cf-1976d70a5ad3" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_da683b7b-de5c-47eb-bad5-b760d5d089a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5b30935e-a63f-477e-a08a-9d110e79211d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ae88f3f0-fee5-4a16-b865-439685664958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5b30935e-a63f-477e-a08a-9d110e79211d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ae88f3f0-fee5-4a16-b865-439685664958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec6d6c16-4bce-499c-b076-8dd66a638234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ae88f3f0-fee5-4a16-b865-439685664958" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec6d6c16-4bce-499c-b076-8dd66a638234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_818b3dc4-dce3-474e-bc7f-760e4715afc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec6d6c16-4bce-499c-b076-8dd66a638234" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_818b3dc4-dce3-474e-bc7f-760e4715afc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_547d1ef0-79b5-423e-bf79-9ddac3c4f498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_818b3dc4-dce3-474e-bc7f-760e4715afc3" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_547d1ef0-79b5-423e-bf79-9ddac3c4f498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PurchasedTechnologyAndPatentsMember_4585332c-a3c9-4fdb-8de6-573010aea45a" xlink:href="mdt-20201030.xsd#mdt_PurchasedTechnologyAndPatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_818b3dc4-dce3-474e-bc7f-760e4715afc3" xlink:to="loc_mdt_PurchasedTechnologyAndPatentsMember_4585332c-a3c9-4fdb-8de6-573010aea45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_0b82d383-7ddd-40fb-91b8-5434d1088d50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_818b3dc4-dce3-474e-bc7f-760e4715afc3" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_0b82d383-7ddd-40fb-91b8-5434d1088d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_4688fd5e-0a5b-495f-8b15-eb6490cccb2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_818b3dc4-dce3-474e-bc7f-760e4715afc3" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_4688fd5e-0a5b-495f-8b15-eb6490cccb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4d1930a-860e-4f66-b7be-1747dd54d821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ae88f3f0-fee5-4a16-b865-439685664958" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4d1930a-860e-4f66-b7be-1747dd54d821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a60b0924-5d9d-4884-aab2-c91716f9cafe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4d1930a-860e-4f66-b7be-1747dd54d821" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a60b0924-5d9d-4884-aab2-c91716f9cafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_10c21ab0-b6f9-44b7-a874-641c241cd328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4d1930a-860e-4f66-b7be-1747dd54d821" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_10c21ab0-b6f9-44b7-a874-641c241cd328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_feb4b91d-a52e-4816-868a-2780834e3488" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5b30935e-a63f-477e-a08a-9d110e79211d" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_feb4b91d-a52e-4816-868a-2780834e3488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2be782ff-dd46-4ef6-a224-d01534c9610f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_feb4b91d-a52e-4816-868a-2780834e3488" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2be782ff-dd46-4ef6-a224-d01534c9610f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5ac95b56-5549-4d51-ac01-57f561a07db2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2be782ff-dd46-4ef6-a224-d01534c9610f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5ac95b56-5549-4d51-ac01-57f561a07db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_e61fe1f5-e983-4f68-b376-6cacf4ddf7cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5ac95b56-5549-4d51-ac01-57f561a07db2" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_e61fe1f5-e983-4f68-b376-6cacf4ddf7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a11f3f11-d574-4291-847e-253864faebd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_feb4b91d-a52e-4816-868a-2780834e3488" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a11f3f11-d574-4291-847e-253864faebd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d7080d43-3e2d-48d0-8f96-a5b884c51cff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a11f3f11-d574-4291-847e-253864faebd1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d7080d43-3e2d-48d0-8f96-a5b884c51cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_95a0ad80-b583-48e6-96b6-c1fdbcbc85bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_7165fc24-8eb9-4028-be6b-ce8603633ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_95a0ad80-b583-48e6-96b6-c1fdbcbc85bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_7165fc24-8eb9-4028-be6b-ce8603633ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d5f8d3d6-ef77-4271-811f-33c2077ce5aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_95a0ad80-b583-48e6-96b6-c1fdbcbc85bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d5f8d3d6-ef77-4271-811f-33c2077ce5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0e39fcba-92c4-47dc-ba61-87440fccd198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_95a0ad80-b583-48e6-96b6-c1fdbcbc85bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0e39fcba-92c4-47dc-ba61-87440fccd198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_9beef88c-d17f-4dcb-88a3-df227bb23cef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_95a0ad80-b583-48e6-96b6-c1fdbcbc85bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_9beef88c-d17f-4dcb-88a3-df227bb23cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_91af5484-39dd-4cdd-b65b-f397179d6d19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_95a0ad80-b583-48e6-96b6-c1fdbcbc85bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_91af5484-39dd-4cdd-b65b-f397179d6d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a911b001-c485-4948-8781-11946cc04295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_95a0ad80-b583-48e6-96b6-c1fdbcbc85bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a911b001-c485-4948-8781-11946cc04295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mdt-20201030.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c80028d4-8cf3-471b-b3f8-a67b6553d8ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_7597d2b4-8a51-4fee-8429-abcc172e07ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c80028d4-8cf3-471b-b3f8-a67b6553d8ed" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_7597d2b4-8a51-4fee-8429-abcc172e07ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c5bd06c0-5115-45f7-a692-342ef4a41ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c5bd06c0-5115-45f7-a692-342ef4a41ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_7eae8283-7b22-4fb8-aa39-248372ffe37b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_7eae8283-7b22-4fb8-aa39-248372ffe37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty_5eccd0ee-7597-46e8-b51f-c0227ee4c1d2" xlink:href="mdt-20201030.xsd#mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:to="loc_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty_5eccd0ee-7597-46e8-b51f-c0227ee4c1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_06ac6e67-51af-4dbe-bd1a-ac7776149d59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_06ac6e67-51af-4dbe-bd1a-ac7776149d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DeferredTaxAssetsAmortizationPeriod_5c20fcda-1ff7-490a-b73a-ac41bd6cf3c3" xlink:href="mdt-20201030.xsd#mdt_DeferredTaxAssetsAmortizationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:to="loc_mdt_DeferredTaxAssetsAmortizationPeriod_5c20fcda-1ff7-490a-b73a-ac41bd6cf3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_48beca2d-d6dc-4adc-a277-1d0d3e44bfd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_48beca2d-d6dc-4adc-a277-1d0d3e44bfd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_4e9fd4d5-5a86-41d8-8c56-165aecf6b76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingenciesForeign"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_4e9fd4d5-5a86-41d8-8c56-165aecf6b76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_06c634f6-55a6-468d-9bd5-4bf532903f9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_06c634f6-55a6-468d-9bd5-4bf532903f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3b464f8b-90c3-4fdf-b57c-6a3f785c34fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_06c634f6-55a6-468d-9bd5-4bf532903f9d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3b464f8b-90c3-4fdf-b57c-6a3f785c34fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8a58d1c6-12c1-4d1f-911c-b7ef30ee57b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3b464f8b-90c3-4fdf-b57c-6a3f785c34fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8a58d1c6-12c1-4d1f-911c-b7ef30ee57b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember_d53004d8-1ef4-4ace-9557-40ee63a9f71f" xlink:href="mdt-20201030.xsd#mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8a58d1c6-12c1-4d1f-911c-b7ef30ee57b0" xlink:to="loc_mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember_d53004d8-1ef4-4ace-9557-40ee63a9f71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ee829b2-8b90-4fdb-b3a6-6261cd8385f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_06c634f6-55a6-468d-9bd5-4bf532903f9d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ee829b2-8b90-4fdb-b3a6-6261cd8385f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7b0e9d18-b66a-4efe-9a61-d6d930decc45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5ee829b2-8b90-4fdb-b3a6-6261cd8385f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7b0e9d18-b66a-4efe-9a61-d6d930decc45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_868cb600-9489-4758-b5d4-8f02b51f8e35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_868cb600-9489-4758-b5d4-8f02b51f8e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_d0610345-54ba-41fd-b4a3-8ceb36df63e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_d0610345-54ba-41fd-b4a3-8ceb36df63e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_bf5ee8bc-c23b-410b-a7de-be18cf1a97a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_bf5ee8bc-c23b-410b-a7de-be18cf1a97a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_eafc374c-29d5-400e-8029-8b7298ea25da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_eafc374c-29d5-400e-8029-8b7298ea25da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_07556214-3517-4a65-8d4c-bd49b0888ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01d23bfe-fb1c-47ac-aa23-5337e9f5c69b" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_07556214-3517-4a65-8d4c-bd49b0888ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShare" xlink:type="simple" xlink:href="mdt-20201030.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ea4e52e5-56ab-4a6c-ab0c-febfb29268a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_c4809732-6d05-4fef-a0d5-ebe884301404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ea4e52e5-56ab-4a6c-ab0c-febfb29268a4" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_c4809732-6d05-4fef-a0d5-ebe884301404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9bcaab57-d118-4d20-bf70-91f5f27f1be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_17091bae-cb9a-4b72-b23f-37548247d48e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9bcaab57-d118-4d20-bf70-91f5f27f1be8" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_17091bae-cb9a-4b72-b23f-37548247d48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e43dc6c5-2fdd-4bfc-995e-8386d4875e16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b0b9db44-4a68-4c0b-960f-40a95b22656f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e43dc6c5-2fdd-4bfc-995e-8386d4875e16" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b0b9db44-4a68-4c0b-960f-40a95b22656f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EarningsPerShareReconciliationNumeratorAbstract_345e07b8-eb51-41fa-8ad1-8ae9b59b42b5" xlink:href="mdt-20201030.xsd#mdt_EarningsPerShareReconciliationNumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b0b9db44-4a68-4c0b-960f-40a95b22656f" xlink:to="loc_mdt_EarningsPerShareReconciliationNumeratorAbstract_345e07b8-eb51-41fa-8ad1-8ae9b59b42b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_988fb528-82c7-4e77-bb6e-6f0d70e75db6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_EarningsPerShareReconciliationNumeratorAbstract_345e07b8-eb51-41fa-8ad1-8ae9b59b42b5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_988fb528-82c7-4e77-bb6e-6f0d70e75db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_d40a8b6c-2ce9-4f8e-8cf7-b4d6f5c1f53b" xlink:href="mdt-20201030.xsd#mdt_EarningsPerShareReconciliationDenominatorAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b0b9db44-4a68-4c0b-960f-40a95b22656f" xlink:to="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_d40a8b6c-2ce9-4f8e-8cf7-b4d6f5c1f53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f2fcb708-9078-4878-88ac-f8dd4036a5a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_d40a8b6c-2ce9-4f8e-8cf7-b4d6f5c1f53b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f2fcb708-9078-4878-88ac-f8dd4036a5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_454f5bbc-2d1f-4463-948d-ab65e4b58a37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_d40a8b6c-2ce9-4f8e-8cf7-b4d6f5c1f53b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_454f5bbc-2d1f-4463-948d-ab65e4b58a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_fe6af513-b740-4555-a8da-a5a7f16ed9c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_454f5bbc-2d1f-4463-948d-ab65e4b58a37" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_fe6af513-b740-4555-a8da-a5a7f16ed9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_c81fc0c1-1674-4ca4-919a-9d5cf37403ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_454f5bbc-2d1f-4463-948d-ab65e4b58a37" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_c81fc0c1-1674-4ca4-919a-9d5cf37403ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares_1d1ecd4b-dbda-4e18-85f0-96d62d95b831" xlink:href="mdt-20201030.xsd#mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_454f5bbc-2d1f-4463-948d-ab65e4b58a37" xlink:to="loc_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares_1d1ecd4b-dbda-4e18-85f0-96d62d95b831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_033b7e8a-eb65-4e23-aeb8-31217a2c6ece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_d40a8b6c-2ce9-4f8e-8cf7-b4d6f5c1f53b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_033b7e8a-eb65-4e23-aeb8-31217a2c6ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b13231da-ca78-49a3-852e-d5cff0a71af0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e43dc6c5-2fdd-4bfc-995e-8386d4875e16" xlink:to="loc_us-gaap_EarningsPerShareBasic_b13231da-ca78-49a3-852e-d5cff0a71af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c3f41920-c028-4c15-b7c2-81d572f0119c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e43dc6c5-2fdd-4bfc-995e-8386d4875e16" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c3f41920-c028-4c15-b7c2-81d572f0119c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#EarningsPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/EarningsPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_be6062a5-cc73-4770-b57a-e0dcdb0d6b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c532fc97-d0a4-4324-9076-91aeb88b4d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_be6062a5-cc73-4770-b57a-e0dcdb0d6b3c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c532fc97-d0a4-4324-9076-91aeb88b4d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_00c3589b-6ed2-4f19-b6ac-c0eddebb047b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c532fc97-d0a4-4324-9076-91aeb88b4d9c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_00c3589b-6ed2-4f19-b6ac-c0eddebb047b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_57fe2620-ab10-4b9f-827f-11b1ffae5743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_00c3589b-6ed2-4f19-b6ac-c0eddebb047b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_57fe2620-ab10-4b9f-827f-11b1ffae5743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d22a43ec-0de2-41ab-948d-47c984ac6cd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_57fe2620-ab10-4b9f-827f-11b1ffae5743" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d22a43ec-0de2-41ab-948d-47c984ac6cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_61ce41c7-e751-43e7-bfc6-445dff43b594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c532fc97-d0a4-4324-9076-91aeb88b4d9c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_61ce41c7-e751-43e7-bfc6-445dff43b594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1ec1a045-9141-4f9d-8677-7395f88a7003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_61ce41c7-e751-43e7-bfc6-445dff43b594" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1ec1a045-9141-4f9d-8677-7395f88a7003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="mdt-20201030.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f384389f-590b-40ae-8525-48415de4aa45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6b34f3f7-ae02-49ee-a36d-99454f62c918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f384389f-590b-40ae-8525-48415de4aa45" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6b34f3f7-ae02-49ee-a36d-99454f62c918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c4fc229e-2777-4a5d-b1fd-bbf10f706b6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_9dca3845-174a-4227-a662-03dd3d0df6d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c4fc229e-2777-4a5d-b1fd-bbf10f706b6e" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_9dca3845-174a-4227-a662-03dd3d0df6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#StockBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/StockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0bcaedeb-46b8-49e3-b50b-bbb09996a181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4ef8ed00-f02c-48fc-a2d2-a01a4f792981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0bcaedeb-46b8-49e3-b50b-bbb09996a181" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4ef8ed00-f02c-48fc-a2d2-a01a4f792981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_82d9d243-1cf8-427a-b7c4-7344de68a256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4ef8ed00-f02c-48fc-a2d2-a01a4f792981" xlink:to="loc_us-gaap_AwardTypeAxis_82d9d243-1cf8-427a-b7c4-7344de68a256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_805b87ed-14ed-4cc1-921a-ea89f1efb881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_82d9d243-1cf8-427a-b7c4-7344de68a256" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_805b87ed-14ed-4cc1-921a-ea89f1efb881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_dfdde87f-939c-4130-9df0-7165155533f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_805b87ed-14ed-4cc1-921a-ea89f1efb881" xlink:to="loc_us-gaap_EmployeeStockOptionMember_dfdde87f-939c-4130-9df0-7165155533f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_91abb908-7c69-4da0-952c-4b0a288f9686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_805b87ed-14ed-4cc1-921a-ea89f1efb881" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_91abb908-7c69-4da0-952c-4b0a288f9686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EmployeesStockPurchasePlanMember_ef5ec985-64fd-4211-92e2-f1bc7ded202b" xlink:href="mdt-20201030.xsd#mdt_EmployeesStockPurchasePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_805b87ed-14ed-4cc1-921a-ea89f1efb881" xlink:to="loc_mdt_EmployeesStockPurchasePlanMember_ef5ec985-64fd-4211-92e2-f1bc7ded202b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e30db267-98e5-4c7f-8229-0f70ca471e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4ef8ed00-f02c-48fc-a2d2-a01a4f792981" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e30db267-98e5-4c7f-8229-0f70ca471e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d188c0c7-5e3c-4b3d-82e5-c5125eeae805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e30db267-98e5-4c7f-8229-0f70ca471e4c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d188c0c7-5e3c-4b3d-82e5-c5125eeae805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_1a8fb14b-4120-40e1-9bae-ff5db9b1b216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d188c0c7-5e3c-4b3d-82e5-c5125eeae805" xlink:to="loc_us-gaap_CostOfSalesMember_1a8fb14b-4120-40e1-9bae-ff5db9b1b216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8bbf26c4-43e2-4833-8865-66cd77a2d6df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d188c0c7-5e3c-4b3d-82e5-c5125eeae805" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8bbf26c4-43e2-4833-8865-66cd77a2d6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d911e737-a295-4dce-ad28-d199229614a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d188c0c7-5e3c-4b3d-82e5-c5125eeae805" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d911e737-a295-4dce-ad28-d199229614a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb397208-4218-4189-8a07-fc8418e569c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4ef8ed00-f02c-48fc-a2d2-a01a4f792981" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb397208-4218-4189-8a07-fc8418e569c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_db80ecc5-86ac-40f8-85b9-3c707a54c182" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb397208-4218-4189-8a07-fc8418e569c5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_db80ecc5-86ac-40f8-85b9-3c707a54c182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_fc8a8e89-2d34-4483-b0ba-630ae8eeb3f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb397208-4218-4189-8a07-fc8418e569c5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_fc8a8e89-2d34-4483-b0ba-630ae8eeb3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_7f7b615c-5aa7-47fd-ab43-a92e74a38067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb397208-4218-4189-8a07-fc8418e569c5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_7f7b615c-5aa7-47fd-ab43-a92e74a38067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlans" xlink:type="simple" xlink:href="mdt-20201030.xsd#RetirementBenefitPlans"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e712e866-c8ad-4394-b268-5760f1103699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_4b878c22-77d9-467f-a3e3-9d1fb77e2bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e712e866-c8ad-4394-b268-5760f1103699" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_4b878c22-77d9-467f-a3e3-9d1fb77e2bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlansTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#RetirementBenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c3a65f0f-f44b-4c96-bb70-a7a390b9c5e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_7cd6a4fe-9f8c-4fa8-8df3-2b0eaa095ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c3a65f0f-f44b-4c96-bb70-a7a390b9c5e8" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_7cd6a4fe-9f8c-4fa8-8df3-2b0eaa095ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlansDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RetirementBenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_27272171-e686-4aff-a8a0-1287f20c90ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d292448d-c2ec-4aad-9418-055560bd0d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_27272171-e686-4aff-a8a0-1287f20c90ea" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d292448d-c2ec-4aad-9418-055560bd0d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_65b00661-99a4-4f28-b563-ab4ebd8f7c38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d292448d-c2ec-4aad-9418-055560bd0d4b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_65b00661-99a4-4f28-b563-ab4ebd8f7c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8ec8670b-c0dd-424f-a2c9-8b7fb856a032" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_65b00661-99a4-4f28-b563-ab4ebd8f7c38" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8ec8670b-c0dd-424f-a2c9-8b7fb856a032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_c90f01e3-332c-42e6-bb46-4203b0e84f26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8ec8670b-c0dd-424f-a2c9-8b7fb856a032" xlink:to="loc_us-gaap_DomesticPlanMember_c90f01e3-332c-42e6-bb46-4203b0e84f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f7eebe81-7949-4155-94f9-f3fd960fbcdd" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_c90f01e3-332c-42e6-bb46-4203b0e84f26" xlink:to="loc_country_US_f7eebe81-7949-4155-94f9-f3fd960fbcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_ae3ae7e0-70ff-4a95-961f-0f18f1ea4347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8ec8670b-c0dd-424f-a2c9-8b7fb856a032" xlink:to="loc_us-gaap_ForeignPlanMember_ae3ae7e0-70ff-4a95-961f-0f18f1ea4347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_19a8eeab-8967-4f5f-8fd1-55c61f438658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d292448d-c2ec-4aad-9418-055560bd0d4b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_19a8eeab-8967-4f5f-8fd1-55c61f438658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3112bf62-ffaa-4e78-83d0-be507a95414a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_19a8eeab-8967-4f5f-8fd1-55c61f438658" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3112bf62-ffaa-4e78-83d0-be507a95414a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_007ccc5b-79d9-42d2-89e2-62e231592eae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3112bf62-ffaa-4e78-83d0-be507a95414a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_007ccc5b-79d9-42d2-89e2-62e231592eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9cf119a8-bc0b-4be8-b70c-24452cca703b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d292448d-c2ec-4aad-9418-055560bd0d4b" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9cf119a8-bc0b-4be8-b70c-24452cca703b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9cf119a8-bc0b-4be8-b70c-24452cca703b" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_d2dbad22-3b95-4340-839e-acc2092793a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:to="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_d2dbad22-3b95-4340-839e-acc2092793a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_dda01604-07b4-43af-8423-19b21f2e702e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_dda01604-07b4-43af-8423-19b21f2e702e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_cdc9c78f-d866-45cb-a51c-96851a59264a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_cdc9c78f-d866-45cb-a51c-96851a59264a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_86d1d284-59a5-4768-b394-18c9d3996628" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_86d1d284-59a5-4768-b394-18c9d3996628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_603b5ebe-0853-4638-b4ae-f74ae4bd560f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_603b5ebe-0853-4638-b4ae-f74ae4bd560f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a7c580ab-1237-4b97-9192-6cc62def5dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_61e14c76-ec89-4295-998e-63724bcd5441" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a7c580ab-1237-4b97-9192-6cc62def5dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#RetirementBenefitPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_51c7c19c-4130-4dde-87ba-de2f006cba15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_443c81e9-66e1-4f81-b483-211079e73ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_51c7c19c-4130-4dde-87ba-de2f006cba15" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_443c81e9-66e1-4f81-b483-211079e73ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_3ec500a6-9e62-42cb-bcb8-5d56c6544055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_443c81e9-66e1-4f81-b483-211079e73ff0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_3ec500a6-9e62-42cb-bcb8-5d56c6544055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_5a480cd4-a464-43f8-91c9-5b4f515d6db7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3ec500a6-9e62-42cb-bcb8-5d56c6544055" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_5a480cd4-a464-43f8-91c9-5b4f515d6db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_144ecc7a-5ab4-48d0-8aec-59db1963b477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5a480cd4-a464-43f8-91c9-5b4f515d6db7" xlink:to="loc_us-gaap_DomesticPlanMember_144ecc7a-5ab4-48d0-8aec-59db1963b477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8afe67b0-247c-44c4-9586-33eb13c9e56f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_144ecc7a-5ab4-48d0-8aec-59db1963b477" xlink:to="loc_country_US_8afe67b0-247c-44c4-9586-33eb13c9e56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_cab67ad6-32a2-4d94-94fc-773f93056f50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_443c81e9-66e1-4f81-b483-211079e73ff0" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_cab67ad6-32a2-4d94-94fc-773f93056f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_24c47046-b43c-4793-8045-f5c8c82254bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_cab67ad6-32a2-4d94-94fc-773f93056f50" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_24c47046-b43c-4793-8045-f5c8c82254bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d39c66d7-e6d9-4d5e-8e86-ad2bdc1c74b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_24c47046-b43c-4793-8045-f5c8c82254bc" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d39c66d7-e6d9-4d5e-8e86-ad2bdc1c74b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_a866f6ad-ab7b-471e-b2ed-f2b9a4597474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_24c47046-b43c-4793-8045-f5c8c82254bc" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_a866f6ad-ab7b-471e-b2ed-f2b9a4597474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86afc516-cd0a-44ca-a995-c3ee61edc614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_443c81e9-66e1-4f81-b483-211079e73ff0" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86afc516-cd0a-44ca-a995-c3ee61edc614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_cdeffc9f-0f8c-4bd4-9153-dcf62e08ac5c" xlink:href="mdt-20201030.xsd#mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86afc516-cd0a-44ca-a995-c3ee61edc614" xlink:to="loc_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_cdeffc9f-0f8c-4bd4-9153-dcf62e08ac5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_ad0e2a62-0c84-4478-b5e0-e47953892e02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86afc516-cd0a-44ca-a995-c3ee61edc614" xlink:to="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_ad0e2a62-0c84-4478-b5e0-e47953892e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_78fb496e-866f-4e3b-a2cd-fef4fca34b66" xlink:href="mdt-20201030.xsd#mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86afc516-cd0a-44ca-a995-c3ee61edc614" xlink:to="loc_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits_78fb496e-866f-4e3b-a2cd-fef4fca34b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits_cf0de84d-cd06-4489-9f07-ee620ee7045e" xlink:href="mdt-20201030.xsd#mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86afc516-cd0a-44ca-a995-c3ee61edc614" xlink:to="loc_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits_cf0de84d-cd06-4489-9f07-ee620ee7045e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="mdt-20201030.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6186ab05-3c6d-4893-a561-e21af62caa1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_aaece07b-2d15-415a-b884-aa1c1ed1d8b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6186ab05-3c6d-4893-a561-e21af62caa1d" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_aaece07b-2d15-415a-b884-aa1c1ed1d8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9cbd58b1-10b6-44fe-80f0-119720b1c0ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_900f4dd5-9580-4964-bc04-911771b7695b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9cbd58b1-10b6-44fe-80f0-119720b1c0ea" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_900f4dd5-9580-4964-bc04-911771b7695b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#AccumulatedOtherComprehensiveLossChangesinAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7d931ced-6f08-42cd-b885-2e0e4329e3ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1894211b-cc08-46c5-b5f4-16689f4ac377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7d931ced-6f08-42cd-b885-2e0e4329e3ab" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1894211b-cc08-46c5-b5f4-16689f4ac377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a525cc2b-434c-47fa-8262-df08924f2c61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1894211b-cc08-46c5-b5f4-16689f4ac377" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a525cc2b-434c-47fa-8262-df08924f2c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bbc19ade-2b00-4028-ba93-56b4122ef7b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a525cc2b-434c-47fa-8262-df08924f2c61" xlink:to="loc_us-gaap_EquityComponentDomain_bbc19ade-2b00-4028-ba93-56b4122ef7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bbc19ade-2b00-4028-ba93-56b4122ef7b2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_e3d1daee-b5e6-4a2f-bc0e-c0b49f541b0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_e3d1daee-b5e6-4a2f-bc0e-c0b49f541b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5090d33e-b1f5-4a7c-9efe-b7277ceff381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5090d33e-b1f5-4a7c-9efe-b7277ceff381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_5fa18d95-554b-4f9c-999a-a7a237027626" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:to="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_5fa18d95-554b-4f9c-999a-a7a237027626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_8ceacbad-9f8e-41b5-8d55-f2962aacf107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_8ceacbad-9f8e-41b5-8d55-f2962aacf107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_acb80389-3da2-4052-8203-3cc01812f5e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f02c5b86-9f56-4440-abaa-71fc6a990d8d" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_acb80389-3da2-4052-8203-3cc01812f5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_512a21c3-c058-445c-9920-5881c92c03da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1894211b-cc08-46c5-b5f4-16689f4ac377" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_512a21c3-c058-445c-9920-5881c92c03da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b1ef7b2f-5612-4b35-9183-a49a68eee19d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_512a21c3-c058-445c-9920-5881c92c03da" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b1ef7b2f-5612-4b35-9183-a49a68eee19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e240f50-0cf8-4fde-aac4-e3e5206ce7d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b1ef7b2f-5612-4b35-9183-a49a68eee19d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e240f50-0cf8-4fde-aac4-e3e5206ce7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_16df150d-da4e-4919-9da1-d2a6032eb516" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b1ef7b2f-5612-4b35-9183-a49a68eee19d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_16df150d-da4e-4919-9da1-d2a6032eb516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8a691c16-cb88-4b4a-938f-9d81b9444b66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b1ef7b2f-5612-4b35-9183-a49a68eee19d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8a691c16-cb88-4b4a-938f-9d81b9444b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4c5ccb59-5f87-4fe2-bc14-6f06e7a50a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b1ef7b2f-5612-4b35-9183-a49a68eee19d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4c5ccb59-5f87-4fe2-bc14-6f06e7a50a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_224036a7-3154-42ab-a9d9-6404a827ee4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b1ef7b2f-5612-4b35-9183-a49a68eee19d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_224036a7-3154-42ab-a9d9-6404a827ee4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9743d003-32ed-4651-a4b2-f0cff88cd97f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_512a21c3-c058-445c-9920-5881c92c03da" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9743d003-32ed-4651-a4b2-f0cff88cd97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_3dedeb78-0420-43d4-a916-f9d7ca4bf647" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9743d003-32ed-4651-a4b2-f0cff88cd97f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_3dedeb78-0420-43d4-a916-f9d7ca4bf647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_2275ec9a-8e6e-43fc-b056-4e9360a7865a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9743d003-32ed-4651-a4b2-f0cff88cd97f" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_2275ec9a-8e6e-43fc-b056-4e9360a7865a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mdt-20201030.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ce4af1b6-186b-4cd9-ad80-cf2059dfbc2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_ff202c94-b960-4d3b-bc71-4ccba7237a68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ce4af1b6-186b-4cd9-ad80-cf2059dfbc2f" xlink:to="loc_us-gaap_LossContingencyDisclosures_ff202c94-b960-4d3b-bc71-4ccba7237a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5305725b-0691-44c7-b997-cede00105fc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_791aff49-2ba7-4039-80fd-ae09e417353a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5305725b-0691-44c7-b997-cede00105fc3" xlink:to="loc_us-gaap_LossContingenciesTable_791aff49-2ba7-4039-80fd-ae09e417353a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_c68765d6-088f-486a-bb4e-cb56ee6dde23" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_791aff49-2ba7-4039-80fd-ae09e417353a" xlink:to="loc_srt_LitigationCaseAxis_c68765d6-088f-486a-bb4e-cb56ee6dde23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_16142f7d-b677-4904-8e94-a1b7946bc591" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_c68765d6-088f-486a-bb4e-cb56ee6dde23" xlink:to="loc_srt_LitigationCaseTypeDomain_16142f7d-b677-4904-8e94-a1b7946bc591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PelvicMeshLitigationMember_4f4720f6-1376-4edf-a332-f1cf8cc3193a" xlink:href="mdt-20201030.xsd#mdt_PelvicMeshLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_16142f7d-b677-4904-8e94-a1b7946bc591" xlink:to="loc_mdt_PelvicMeshLitigationMember_4f4720f6-1376-4edf-a332-f1cf8cc3193a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EthiconPatentInfringementLitigationMember_20d2831a-bb04-4ac5-9864-3b3746411296" xlink:href="mdt-20201030.xsd#mdt_EthiconPatentInfringementLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_16142f7d-b677-4904-8e94-a1b7946bc591" xlink:to="loc_mdt_EthiconPatentInfringementLitigationMember_20d2831a-bb04-4ac5-9864-3b3746411296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SassoLitigationMember_992064d8-b3e9-4d3a-879f-431320b69c98" xlink:href="mdt-20201030.xsd#mdt_SassoLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_16142f7d-b677-4904-8e94-a1b7946bc591" xlink:to="loc_mdt_SassoLitigationMember_992064d8-b3e9-4d3a-879f-431320b69c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9f69dcc2-2ba5-4e9e-b16b-fdfa82b1b9fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_791aff49-2ba7-4039-80fd-ae09e417353a" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9f69dcc2-2ba5-4e9e-b16b-fdfa82b1b9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_dca9e033-3af7-4ef4-88c2-a841a37a5521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9f69dcc2-2ba5-4e9e-b16b-fdfa82b1b9fa" xlink:to="loc_us-gaap_LossContingencyNatureDomain_dca9e033-3af7-4ef4-88c2-a841a37a5521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DamagesFromProductDefectsMember_350b5e34-55c2-4b42-8b33-6d1448562844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DamagesFromProductDefectsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_dca9e033-3af7-4ef4-88c2-a841a37a5521" xlink:to="loc_us-gaap_DamagesFromProductDefectsMember_350b5e34-55c2-4b42-8b33-6d1448562844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis_47ffea91-e200-49dd-a7d3-c0dcf0c7d457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_791aff49-2ba7-4039-80fd-ae09e417353a" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteAxis_47ffea91-e200-49dd-a7d3-c0dcf0c7d457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_6d55c2b5-c384-460e-8ba5-1e3c38ea2bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_47ffea91-e200-49dd-a7d3-c0dcf0c7d457" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_6d55c2b5-c384-460e-8ba5-1e3c38ea2bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OrringtonMaineChemicalManufacturingFacilityMember_2dc839cf-ed5a-448e-a4ae-bcafe89a2658" xlink:href="mdt-20201030.xsd#mdt_OrringtonMaineChemicalManufacturingFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain_6d55c2b5-c384-460e-8ba5-1e3c38ea2bde" xlink:to="loc_mdt_OrringtonMaineChemicalManufacturingFacilityMember_2dc839cf-ed5a-448e-a4ae-bcafe89a2658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8c401888-c195-40a6-a2aa-95c04928e6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_791aff49-2ba7-4039-80fd-ae09e417353a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8c401888-c195-40a6-a2aa-95c04928e6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_29c7ad77-5676-49dc-a579-2cd1b7cfa66c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8c401888-c195-40a6-a2aa-95c04928e6cf" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_29c7ad77-5676-49dc-a579-2cd1b7cfa66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_75cf7168-8c52-44a8-8323-a74c1a568c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_29c7ad77-5676-49dc-a579-2cd1b7cfa66c" xlink:to="loc_us-gaap_SubsequentEventMember_75cf7168-8c52-44a8-8323-a74c1a568c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_791aff49-2ba7-4039-80fd-ae09e417353a" xlink:to="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_5ac23a48-b0be-4de5-931d-70eabaf8732b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_5ac23a48-b0be-4de5-931d-70eabaf8732b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_eafb52da-4855-48f5-b788-b741e13eb1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_eafb52da-4855-48f5-b788-b741e13eb1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossContingencyNumberofSubsidiaries_77ae20ef-7b94-4d34-8969-d64e23660b23" xlink:href="mdt-20201030.xsd#mdt_LossContingencyNumberofSubsidiaries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_mdt_LossContingencyNumberofSubsidiaries_77ae20ef-7b94-4d34-8969-d64e23660b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossContingencyNumberofManufacturers_8131d758-369a-4dec-bb49-1ed26697b1ee" xlink:href="mdt-20201030.xsd#mdt_LossContingencyNumberofManufacturers"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_mdt_LossContingencyNumberofManufacturers_8131d758-369a-4dec-bb49-1ed26697b1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29cc72fa-2df7-453c-8719-feca742a96aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29cc72fa-2df7-453c-8719-feca742a96aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_b8137740-3ceb-4591-bc5a-3392d2f39931" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_b8137740-3ceb-4591-bc5a-3392d2f39931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_f58fcfc8-24e7-4ecb-82a0-44a1bbc39f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_f58fcfc8-24e7-4ecb-82a0-44a1bbc39f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_e9dfd819-ee81-4702-b613-88eed2712099" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_e9dfd819-ee81-4702-b613-88eed2712099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_61d316e1-4242-423c-92bc-4a9c737d9ee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPatentsFoundNotInfringedNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_61d316e1-4242-423c-92bc-4a9c737d9ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_10a4716d-ae13-43e0-b86f-c59c4621729d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_10a4716d-ae13-43e0-b86f-c59c4621729d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_a5bad32b-fb4e-42c8-9153-49bdc4e44181" xlink:href="mdt-20201030.xsd#mdt_SiteContingencyNumberofLandfillsRequiringRemoval"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_a5bad32b-fb4e-42c8-9153-49bdc4e44181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_a07753e9-9e12-414d-8b0a-b79b8221e588" xlink:href="mdt-20201030.xsd#mdt_SiteContingencyNumberOfLandfillsRequiringCapping"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f02a2dac-0a88-4c15-b8c1-4e0cc0ae19a2" xlink:to="loc_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_a07753e9-9e12-414d-8b0a-b79b8221e588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformation" xlink:type="simple" xlink:href="mdt-20201030.xsd#SegmentandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_40317bfe-435d-4f47-95ce-767ec0244c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_1fe764b3-7dfb-45b9-bf79-6e85cce4b3c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_40317bfe-435d-4f47-95ce-767ec0244c58" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_1fe764b3-7dfb-45b9-bf79-6e85cce4b3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationTables" xlink:type="simple" xlink:href="mdt-20201030.xsd#SegmentandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ddab31bb-13b7-42d3-b32f-16be9930225a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_68a58e18-67e6-4af9-9362-499893f0b98d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ddab31bb-13b7-42d3-b32f-16be9930225a" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_68a58e18-67e6-4af9-9362-499893f0b98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_87e9bff9-ef4d-432b-93c0-45b4ced38e8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ddab31bb-13b7-42d3-b32f-16be9930225a" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_87e9bff9-ef4d-432b-93c0-45b4ced38e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationDetails" xlink:type="simple" xlink:href="mdt-20201030.xsd#SegmentandGeographicInformationDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a84700e9-4cc0-4e32-80c2-6f17eb3e3d81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_65bce064-bcee-43d3-b4d9-bbc83f19e766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a84700e9-4cc0-4e32-80c2-6f17eb3e3d81" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_65bce064-bcee-43d3-b4d9-bbc83f19e766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_457c65fe-9598-4f9c-8619-28845860de79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_65bce064-bcee-43d3-b4d9-bbc83f19e766" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_457c65fe-9598-4f9c-8619-28845860de79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8b9f9923-285b-45bc-9972-2e7afd9a600c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_457c65fe-9598-4f9c-8619-28845860de79" xlink:to="loc_us-gaap_SegmentDomain_8b9f9923-285b-45bc-9972-2e7afd9a600c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacAndVascularGroupMember_e3fb32ff-bea2-4c48-b716-b40877562051" xlink:href="mdt-20201030.xsd#mdt_CardiacAndVascularGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8b9f9923-285b-45bc-9972-2e7afd9a600c" xlink:to="loc_mdt_CardiacAndVascularGroupMember_e3fb32ff-bea2-4c48-b716-b40877562051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MinimallyInvasiveTherapiesGroupMember_c50bc0bb-140c-4d15-bd11-fcfb3031b86c" xlink:href="mdt-20201030.xsd#mdt_MinimallyInvasiveTherapiesGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8b9f9923-285b-45bc-9972-2e7afd9a600c" xlink:to="loc_mdt_MinimallyInvasiveTherapiesGroupMember_c50bc0bb-140c-4d15-bd11-fcfb3031b86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestorativeTherapiesGroupMember_fe527ce0-a59e-463c-91eb-4f81b57682ed" xlink:href="mdt-20201030.xsd#mdt_RestorativeTherapiesGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8b9f9923-285b-45bc-9972-2e7afd9a600c" xlink:to="loc_mdt_RestorativeTherapiesGroupMember_fe527ce0-a59e-463c-91eb-4f81b57682ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_8f757788-48a8-408d-9b1e-ea3cb8d9d61e" xlink:href="mdt-20201030.xsd#mdt_DiabetesGroupMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8b9f9923-285b-45bc-9972-2e7afd9a600c" xlink:to="loc_mdt_DiabetesGroupMember_8f757788-48a8-408d-9b1e-ea3cb8d9d61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2b7e3a85-41b8-44b9-9352-cd727bfa6ee2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_65bce064-bcee-43d3-b4d9-bbc83f19e766" xlink:to="loc_srt_ConsolidationItemsAxis_2b7e3a85-41b8-44b9-9352-cd727bfa6ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f9782e23-a781-44ca-a462-fb3de23cb429" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_2b7e3a85-41b8-44b9-9352-cd727bfa6ee2" xlink:to="loc_srt_ConsolidationItemsDomain_f9782e23-a781-44ca-a462-fb3de23cb429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_eba3fbf5-809b-4d10-a9c8-02b0ca0debe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_f9782e23-a781-44ca-a462-fb3de23cb429" xlink:to="loc_us-gaap_OperatingSegmentsMember_eba3fbf5-809b-4d10-a9c8-02b0ca0debe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_2d2aa9f7-8dfe-4c9d-9382-768295fe8672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_f9782e23-a781-44ca-a462-fb3de23cb429" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_2d2aa9f7-8dfe-4c9d-9382-768295fe8672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_bee12cb0-bed3-4da4-9446-ff3fc22714e2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_65bce064-bcee-43d3-b4d9-bbc83f19e766" xlink:to="loc_srt_StatementGeographicalAxis_bee12cb0-bed3-4da4-9446-ff3fc22714e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3a6ee021-4c84-4dad-a044-8d86690999c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_bee12cb0-bed3-4da4-9446-ff3fc22714e2" xlink:to="loc_srt_SegmentGeographicalDomain_3a6ee021-4c84-4dad-a044-8d86690999c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_fe1fa873-469d-409a-b152-a7cade45a1ba" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3a6ee021-4c84-4dad-a044-8d86690999c7" xlink:to="loc_country_IE_fe1fa873-469d-409a-b152-a7cade45a1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9926233c-6fb2-4671-91db-a5402e2ad8b6" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3a6ee021-4c84-4dad-a044-8d86690999c7" xlink:to="loc_country_US_9926233c-6fb2-4671-91db-a5402e2ad8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_4f1b14c5-4d81-40c9-a6e5-cbf4f519165a" xlink:href="mdt-20201030.xsd#mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3a6ee021-4c84-4dad-a044-8d86690999c7" xlink:to="loc_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_4f1b14c5-4d81-40c9-a6e5-cbf4f519165a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TotalOtherCountriesExcludingIrelandMember_85c3fd88-e7ff-4632-8701-ea25bba5f39a" xlink:href="mdt-20201030.xsd#mdt_TotalOtherCountriesExcludingIrelandMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3a6ee021-4c84-4dad-a044-8d86690999c7" xlink:to="loc_mdt_TotalOtherCountriesExcludingIrelandMember_85c3fd88-e7ff-4632-8701-ea25bba5f39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_662fb617-2984-489d-97b8-132ae7fbc6b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_65bce064-bcee-43d3-b4d9-bbc83f19e766" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_662fb617-2984-489d-97b8-132ae7fbc6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_662fb617-2984-489d-97b8-132ae7fbc6b8" xlink:to="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7b96af5a-a545-4aa2-a7f7-f1d1955390fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_OperatingIncomeLoss_7b96af5a-a545-4aa2-a7f7-f1d1955390fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7bb6224a-66a8-4cd2-bf07-7c958aa2c679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_InterestExpense_7bb6224a-66a8-4cd2-bf07-7c958aa2c679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_3b6b83d8-be8f-49ab-93b6-01cb66b133bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeOperating"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_InterestIncomeOperating_3b6b83d8-be8f-49ab-93b6-01cb66b133bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_add9f5dd-6040-4118-b575-f3f6f857d0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_add9f5dd-6040-4118-b575-f3f6f857d0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CorporateOverhead_5647d108-9fba-462e-b01d-19e4ef4c6dfc" xlink:href="mdt-20201030.xsd#mdt_CorporateOverhead"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_CorporateOverhead_5647d108-9fba-462e-b01d-19e4ef4c6dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CentralizedDistributionCosts_eafe3bea-d25b-43fd-9afe-98b2e2d1aa1d" xlink:href="mdt-20201030.xsd#mdt_CentralizedDistributionCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_CentralizedDistributionCosts_eafe3bea-d25b-43fd-9afe-98b2e2d1aa1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesNetofRestructuringReversals_86cc2d59-5632-4ca1-8934-5a85939c219b" xlink:href="mdt-20201030.xsd#mdt_RestructuringChargesNetofRestructuringReversals"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_RestructuringChargesNetofRestructuringReversals_86cc2d59-5632-4ca1-8934-5a85939c219b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a6b839f0-8f5e-45cd-93d7-17d75d4e8a43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a6b839f0-8f5e-45cd-93d7-17d75d4e8a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_98259330-cd72-4cdb-a29d-1802e780bd68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_98259330-cd72-4cdb-a29d-1802e780bd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ImpairmentOfInProcessResearchAndDevelopment_f55323b2-579b-4b42-b4f1-72c7c1f536ef" xlink:href="mdt-20201030.xsd#mdt_ImpairmentOfInProcessResearchAndDevelopment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_ImpairmentOfInProcessResearchAndDevelopment_f55323b2-579b-4b42-b4f1-72c7c1f536ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_b8e280d0-6fa6-42f4-8071-1ff341e75afa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_BusinessExitCosts1_b8e280d0-6fa6-42f4-8071-1ff341e75afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtTenderPremiumandOtherCharges_253b4f66-020f-4be1-8b04-a6100a6c2dc3" xlink:href="mdt-20201030.xsd#mdt_DebtTenderPremiumandOtherCharges"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_DebtTenderPremiumandOtherCharges_253b4f66-020f-4be1-8b04-a6100a6c2dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalDeviceRegulations_5cd377cf-0c48-4ef1-aacd-dacd4d23f133" xlink:href="mdt-20201030.xsd#mdt_MedicalDeviceRegulations"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_MedicalDeviceRegulations_5cd377cf-0c48-4ef1-aacd-dacd4d23f133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SpecialChargesGains_4317083c-1c07-4dad-8064-ef8be71a79c5" xlink:href="mdt-20201030.xsd#mdt_SpecialChargesGains"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_mdt_SpecialChargesGains_4317083c-1c07-4dad-8064-ef8be71a79c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_cc636820-5bdf-4cc1-9d5a-e3075208d645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract_5dd08972-2662-4e52-8a1a-7e02eea892b6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_cc636820-5bdf-4cc1-9d5a-e3075208d645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_99fb1ccd-1d28-47d9-b212-7e12aeccfaea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_662fb617-2984-489d-97b8-132ae7fbc6b8" xlink:to="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_99fb1ccd-1d28-47d9-b212-7e12aeccfaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1a47ed73-9d33-4ec7-bce7-d5e15eae93fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_99fb1ccd-1d28-47d9-b212-7e12aeccfaea" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1a47ed73-9d33-4ec7-bce7-d5e15eae93fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_01a.jpg
<DESCRIPTION>IMAGE 1
<TEXT>
begin 644 image_01a.jpg
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M]0YUB[F<Y;FK55J$;!<:^Y'Y@JV6]SNG!=OKG7?>B9?KS53_6D1D5D$+0!/
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MI.->U1S@RZ*G4#Z.0)F\]Y19V8L(^&$O2IL%TDPH+LZ"N,C-#).&L%=2LHA
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MO1)*_7[M25PD0XL,./9N@KF2<Y_]AWV(_<BLK?)07*P!.$HL6&Y]V)Q)-6;
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MDB:=%!=1^_D]V1SY_3BH.0A;0Y%A:L LN^RRJ;IB\ZX8,3C'. 3).<*FC%'
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M%!<["\7%<J&X&!<$13IZXI@@/L4^'UL%CC31\@@Q1<EBJ ;[P+!APX*#QYG
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MLYT5%XO-DL[VO'N1-$YIQ44*=2(4X2 RD3!R6>2UZA]A,%%7 04; P$A">.
M^CIY:@]U$V41%^N!Z,@--((+@FQE#A F76T.("8CMG$X<HA0>V?999==XCQC
M,T/4N^222Q+"ZNO]C5:@N)@?OA'?BF_&M^,R >,*(ZO(AF :Q47%Q1AP/K#'
M$N%#@Z?8Z[E5^T)/3T]RZ:67!J.5"Z78XYX5S@.>F?.!<R++N_/>V$F\-V<#
M#B..%1']9147TW">;[/--L&I)"TN3\IX98Y4QHJ+*03VPP\_O%1[+&(($1_4
M(&N5K5P6<1%1!+N(.=^N1G5E%!?3?.I3GPKK"=N9NF=9UE-ZCZ7,$_O4O_[K
MOR8;;[QQ]'?*B^)BL<7%- 2H$(ARSCGGA""3]'LI+I8+SG;\VZ.//CJ\+^_-
M_L)YULH4:?8S_@;[&8)FFAC:0#LIK;C(HN?@H;@RA_ 66VP1')LUUURSJL%+
M>A!U%>CT1O,3(A_OO??><("UJG9*I] IXB*=KNFL3;H>CB$"=:7^%(7NT^_-
MX4@4 YW)B5QC_A#]P0T7M7BJ"8R(V+OLLDO8R(A>I'/U P\\$+J0MTNT4US,
M#T8P-^9T#T>$XO:2HO^[[[Y[J>:^XJ+B8@PZ55QD3V0/9R]G3Y\^?7K8+XG2
M)"LB]KAGI5%Q$>,7D8QT(LY"S@>$#[) J#G)95OL=VH&S1 7<3IQPA$0$(CH
MT$UTZ_#APT/CO=COF!6<T.VVVR[8/-C*1.QA*S_YY)--LY45%VO3K>(BX\ME
M[H,//AAJG\^8,2/\^Z%#AX:F&['?*2^*BXJ+1:!;Q47V(BXG""XC((UW)H*1
M$FC48$3D:\4^3N8" 4:,-=D>V!6]88]CKV//:]?9TDY**RYBZ" .41N!"8/!
M3,T$C+AJ:=(<TDPP#FS25D\]]=3@('"05TN1E8_I%'&1>F X1!@K')K4GT(\
M(L4=!RK]WMPN8 2S,2#2T,@'8QC#&X&QFF-%>#T"Y&Z[[18*!)-63?3"G7?>
MV;*:F&D4%_/#@8 CA? V>?+D$'5"DR N+T@OC#V'LZ*XJ+@8@TX5%TF#I 0)
M>SE[.GL[>SRE$KC0C#WN66E47,21(C46)Q'GF#,"1QEGD8NT(G?*;H1FB(L(
M;UQ64@,;QY1T:)Q4'#?J0<=^QZQ@*_?MVS?LC]C*V-<56QE'J!GK27&Q-MTJ
M+F*3X(A3AH8T=,1M+G4I<80P$ON=\J*XJ+A8!+I97&0-5FHP$I!&!BM-<%F/
MK=K7"5Q#HR*0B3J>V!:]88]CK^-;5.L!479**RXB B PLOCY@&S<HT>/#A.H
MFL-(7046%\X/AQ4%SMD<V.1)D8W]/D6F4\1%1&<$(M*C$8N(**!N)W61F$OI
M]R:D&:<2)YD-X+KKK@N-?!@'G$K2I--_@VZI'$Z(W-2=H<;5^/'CDZNOOCIS
M&MK2HKB8'PP_G$N$9VIM]N_?/XSAYS__^4)WA4VCN*BX&(-.%1>);F</1VAA
M3V=O9X]GKV?/CSWN66E47.0L8+U0KPBA"2>12UJ,=80/#/?8[]0,FB$N<GF(
MC8#3@(VPY99;AI1Y:C^5:9])V\I<QF(K<Q%+!&LSUI/B8FVZ55Q$N,;^Y&PF
MR@C!XQ__\1^#,%^F/3:-XJ+B8A'H5G$1\ M8AUR:X>L>>."!R90I4T(62JLR
M5\ERP<XB4Y+ -_;#WK#'L=>QYS7KTJY(E%9<K$"N.A!]=N:99P;1</755Z\Y
MR3CT@#1I%AK1271:COT>1:93Q,7T'"#R@O2NRJ%?;XXA-N(\$,%(BC1&>+V_
M@>&\[[[[AO2B9AGF]5!<S ^W341#5\:N\AUCS]E&45Q47(Q!IXJ+7$#V%D/*
MNB\T*B[B@!")AX&, U+6]ZY',\1%'(3>#2C*/E:5YZ\XI5RLXI0V8STI+M:F
M6\7%BI_!^;'!!AN4?OU44%Q47"P"W2PN5JCL*5R:X?O@ Q% U*I]G Q9]G'\
MDLK?KL >QU['GL?>UXZSI9V47ERL@+A(NE(]<;'W0J/3(^)BLPRF3B6&N$A4
M("G&&)ZD&7,X]6; @ 'A%H(ZBBS</'\C?>C7&P<*KU)_B#I*]<3%"J1/TVVP
ME>(BASBI_:2O44N"" ,./NJ!(:"FGPE'ZF_^YF_"_P\G"&&1J%^Z0_+O\SA6
MG4)%7.1FBUOSV(=A7NJ)B]S6<6O'[1WOVHSU%(/*/L$ZPU#GAA A!/&$F\-J
MWUAQL740I<6XXI!3,VO!@@5A;T5X*<JE!1=%K[[Z:M+3T_-1Y@,UF)=$I;XS
M\POG(_8XYX4]OW<D6KWW)G6H$JV9]:*JC' F<A82K<XE-0)CO;%)0XH37;1)
MER]R!_%&P59 *$)HH/YTH^,"=]QQ1Q#HJ7%5*3>CN%B=3A$764]<WI,%DF4]
MD7I/K7+JHG..Q'Z'O%0RI! /N+BEK YID5===57(D%)<+#:4SQHX<&!(R\=^
M3L]3A$7."/PZRFR5I31(6ERDSP![#2G"7#CB!W9B5D(UR%XD<_&44TX)EZ=Y
MSK1ZT!"-(!6$VVJ1UV@I:"J*BP5'<;%UQ! 724'%F<&90_S@@.H- @(.#Z((
M@DB>C;!3Q$5N7IC#&"]GGWUVJ/6$0</M3+5Z8-2*I$ V#@/&'^.)L(@!R#.V
MJL!M&>@6<1'#CSF/>(!Q@7!"/1+6$^NB+(;%2BNM%-)3!P\>G.R___[!B*=3
M.X(1W[+:-U9<;!V<O5P&<;92KY3S%=&%FK/5ZMK& '&QIZ<GN?'&&\-:IVP%
M\V9)T @.T0AGD&9>L<<Y+YP'%8>7<Z+>>Q/)QQF)XU%FA[\>E4P&(E'(-*")
M5[VQ24,$"!$OE%PA,R;V.S4+'"-L,40?.O<V.BZ C<590P'[-]YX0W%Q"72*
MN,AZPL;$_LVRGC@OJ+'(^9'%ARLJZ=KN9YQQQB=JNRLN%AM\3R[:67]$H:?G
M*7.9,X*S@F9N9147B<"DJ0G?B+(G"/NDZE;J*9<E(C,/E%J@; GOR_Z>YTRK
M!S[D#COL$"X9EE]^^<6>07&Q)"@NMHX8XB+?D,V;PPW#E-2*WG#;@%.((,)!
MT,WB(O7 ,-PK73PY'!@3Z@0BOJ2?B6@O##B>BUME#A<Z@1)9@/%#^G?L.1>+
M;A$7$9")(L&X(+J,] @BE%A/W%Z615PDJH;YCM.+2$KS)1IOT*6-NKS5OK'B
M8NL@:@/#C5ISE0+:[-/LU]7JVL: ?9Q2*(C0"$*()H,&#5HBB.X(+$0M]NG3
M)_HXYX7S@'.!\X%U4^^]B># 4<;9*%-$<Z.PW[&7<.G&V4C3MGICDP8AA;T3
M$;9,]7GK@;V O8R31*W11L<%.$^Y^,1^HC:EXF)M.D%<A,IZ0D#+LI[88SDW
M.#^J->4L"P0[<*9PMM#,@4LL&CU1AH)H,<7%8H,0Q.40T6U$G:7G*;X?9P1S
MFXO&LMC*:7'QSW_^<_#W\$O)6,.'Q"[&A^3;5VM8VBE@]^/_\Y[;;KMMKC.M
M'ESBXH>1655M+!472X+B8NN((2[BQ!&VS$:(6, M2V\0#A!$N&W!B<US>]0I
MXB*_E]]?J56#,[#<<LN%FZ=J!Q_.,9L?-W"$^),&C=C$8<,[QIYO,>D6<;$R
MG_GF?/M*_176$X9@F6YCV<?9^SD#V!MX'P3R6G-9<;%UL-^P[V!,L0^Q_Y%J
M2F3TPH4+HZ]O8&ZPCW.[3&0\0A .Q9+@77BG6GMJ6:A\'\X'WJG>>T/E+"G+
MGI 7WJ\R-EG&I=H<6=*Y6U9X%\:FLJ;SC TB"F(*-2DID:"X6)M.$1<;74^=
MLL<B2N$K,;^YL*<, '86YPY1\XJ+Q2;+?E?&,S$M+J9] (1O:NZ3K8#@5JUA
M::>0QPYJ%'XW<ZC6'%%<+ F*BZVC'>(B0AT*/[=!U&K!L&*3XQ"NMO XL(FX
M(IR;>A'<J)..U!MN01$0N5VJ=G/0*>(BT6=3ITX-3CQA^O6>"7&1<&V<:VI#
M8/#$GF-%H:SB(C?][&DX:D0:L;?Q?8D8([*UWGLCRI$6SYHC8K@L1A,WS*1X
M8C!E;<REN-@^F)/L-41Q4%.+/3LV?']JC9)&3^D(C,!&WPN#%#N#B#ZB (ED
MX&RDUE:U:'&1;H8U0G0Y>\"SSSZKN+@$B'(CXHV& T3\,7;L,^PW>?8J:2^4
M:3G@@ /"-ZP6K:^X*#&H)B[V!I&1S!_J!I.QT,GB8A%07"P)BHNMHQWB(BD4
M&%%$DG P(XP@\N (TJPD_4QLA(AJW+10.)7Z44<>>>0G(+R;&QB>N5J:A>*B
MXF*:LHJ+"/.(BKOLLDLR:M2HT*6,*!'V1=+0ZKVWXJ*T B)O<%*HI86S3$1.
M;%@;%-HF>IL(WSRUA1 0B5#A'*#^$K69J,F(6(G &'O<18J$XF)V$*2P,QD?
M&B]A/R(RDI52K3& % O%Q44H+A8+Q<5BH;A8$A076T<[Q$72H''VQHP9\U%S
M$9H ]/3TA,ZVZ6="Z*-F'!V2Y\V;E\R>/7LQSCKKK!"=TK]__ZKUHA07%1?3
ME%5<)+(!L0R1G;6*D8#8QOMDZ=*KN"BM@+V&&EJ("\PK(M*+ +64.,LHOI]G
MKA,-3SD.1$KFWF6771:<*.R/=I4.$2D+BHO9>>655\+X4 >;.FCL+^PSU"3D
M$C[VF,B245Q<A.)BL5!<+!:*BR5!<;%UM$-<1(0CTI HQ'OOO3=T%.1P(OVY
M5NTT-D-$$<03:L:EH9 R32IVW777X$2F_Z;BHN)BFK**BS2;P*"EQB+SK+)^
MJ*62I8ZFXJ*T N81J7SLE43[,=Y%@$AVZN+D+5K.O,-^H"$6-=)P(A%.<,8V
MVVRSZ.,N4B04%[-#;3[L7NQ:+M8YK^@X3/0W?DOL,9$EH[BX",7%8J&X6"P4
M%TO"@P\^&#;SPPX[+'3M(V6)KHC<]%6K4X( B4!$+:@9,V8D]]UW7_C ;/P4
M-HW]/D6B'>(BZ6G\?L219BTT(A^)7L0H(VTT_3=)7T-@0%"9.7-FJ'5#EUDB
M(JL9DD41%WDVNGSQK \\\$!RY957)L<==UQ(B25*J-XS*2[6IJSB(EU*1X\>
M'?8R"N8W^M[=)"YR><$^@^&\Y99;AG0SU@TIO)W<(4^:!Y'V>^RQ1W+..><$
MVX%HHZNNNBJD?E/O-_;SB10)Q<7\<%[1:9L&AY9<*#Z*BQ_[*8J+Q:&>N,BE
M!M'2]#' _^&2%+\<6X<+V3SE8Z0VBHLE 5'@NNNN"Q%<8\>.34:.'!GJ[>$X
M5BNP3H=(-D^B#Q 8B9C#.;CCCCMR.>>=3*>*BZ2V42,+)Q$#DG1L.N:R\2(P
MIG]?4<1%A$4,SJNOOCK,=P[O/??<,^G7KU^FJ%W%Q=HH+G:^N(@H3Y=TC"C2
MR+_[W>^&"RGVH&JU6472*"Z*9$=Q,3^*B^5"<7$1BHO%HIZXB'^+CTHI!O8;
M K6PK;F )R/.2,;FHKA8$C#N61BD$&#D(RJQP5,7J9K@0DH4T2ILH A%I,>>
M<LHI(8*-.GZQWZ=(=*JXB)"P]MIKAP,>L0U#E_03.NP^\<03B_V^HHB+B",(
MBZ3D[;???LG@P8-#MU+2O+,4_%9<K(WB8N>+BS2XH93 S3??G,R:-2NL>?8>
MZO 1O1C[G:3X*"Z*9$=Q,3^*B^5"<7$1BHO%HIZXB!](4,W"A0N#7WC%%5<$
M301M!/_2B_?FHKA8$J@7P&9&K3V<1QQ'.D,2F8@CD/ZP.,\(C$0UDCJ-,D\$
M"S48"0V._3Y%HE/%1<*\$0B)8B6*D51Z.G\2T81!E_Y]11$72=\F8I'Q0@#C
MV7D'GB=+Z+KB8FT4%SM?7*0.)?6L_OC'/X8H8"+>QX\?'VJSKKGFFM'?28J/
MXJ)(=A07\Z.X6"X4%Q>AN%@LZHF+U6QCHA@IN86_:'WRYJ*X6%*HP7C>>><E
M(T:,2-9::ZVZ'YJ(+S9 0H&G39L6&GQP,+# J,'8S0),IXJ+:?AO^&_Y-_S;
M].\KBKC(P< !P4&1I< W@B/B(_\M784Q&NBBS?J@$5(WS^TTBHN=+RZFX=_Q
M[_D]_+[8[R3%)RTN<JE),70:!?%_YZ**J'@:B7GC+]V.XF)^B++')L$WX7FP
M*1$95UEE%5,5"P!^ !?\U/C'CZ&..X(,ETW5;#'%18E!%G$Q#<WJL&F&#!D2
M]IO8[]!)*"Z6E$;%10Z(KW[UJ\ENN^T6ZG#107CV[-FA!N,SSSR3J>-JIZ*X
MN(BRBHL\)Z(B:9_,[X,//CB9-&E2J"_),RDN?HSBHN)B['>2XI,6%[GM)\+H
M\LLO3R9,F!#*5>!DXCSRWW[J4Y^*_LPBL5!<S _^!]'UU 3'-Z&^-C6"J2=O
M-%%\N$!B?@\:-"C9>^^]D^.//SY$+2Y8L"!Y^>67%_N>BHL2 \7%8J&X6%(:
M%1?I*(T3L,DFFX1#@CH#I(WB+)"&2MIU['>*A>+B(LHJ+I+Z3\T,FAPQIQ&@
MB+*ATS2&3NSY5204%Q478[^3%)^TN/C>>^\%$>"NN^X*#A7GY=%''QTN<TB3
M*\MZ$FD%BHOY>?755S^J$4P=M(D3)P;[A&?+8O]):Z&DUHX[[I@<>NBAP>>D
M9ONMM]Z:4!N=2Z?T]U1<E!@H+A8+Q<62TJBX2&0!8A$+")&)YA@XFS3-N.FF
MFT(M@MCO% O%Q46455RDIBA-7\:-&Q<,'YQ@TOU??_WU("K%GE]%0G%1<3'V
M.TGQ28N+G WOO/-.J%6$\\@9=MEEER5CQHP)$>-9:N&*="J*B_G!]WCCC3="
M%!QG._X(?@DU&/%38H]1M\/<)E*=R%*BUQ'BJ,&+L/C^^^\O]CT5%R4&BHO%
M0G&QI#SZZ*.A=B*W2;121V!$/*+V'%&*]3[\LLLN&YQL:F?,F3,G1";$?J=8
M*"XN @>25 <VY[WVVBM$I-!QG&[DU-6J)LA0=XNF0J>>>FHR=^[<4,<3XX(:
M75GG%$XKM]?//?=<PFTH B'S\MO?_G9(R:CW7CS?T*%#DS///--F177H5G&1
MN4AD!'.$QE:(X@@HU!*J-;=CP+[,'LY:94_OUZ]?2/-G?Z).;IYO7E9QD<L-
M+@ZHOT7T!'M1T;Y7IY(6%]-S"K$>NX$+'>R(;A(7J0-'NB;-D3C_>MM>K-_8
MSR?M1W&Q>?3T] 3!AQ1I]A;6&&N--6<-QM;#N;OJJJL&6X%R0S2"(^#@FFNN
MJ9H&G:9;Q$7\EAMOO#$(X9R57_K2ESZR*6DJ::F0]I)'7.2_H\$I-?K)ZJ2N
M*#XG/2JZR:9I!8J+)04#ACHE+ P*(2/P#!@P((A8611XQ<6/45Q<!+4)$3"N
MO/+*T(F<#9>Z6IMMMEEPH*H9=AA]S#O>#8$1\8?H1WX/MYM9WN.%%UX(J?G,
M0X2O$TXX(:0X;[[YYIEJ[B@N9J=;Q47*/I F3]H5->/HFHYXC?&+:%4440"!
M F>T?__^(>44 WW*E"DAZI)OE^>;EU%<Q##G63'XZ.3'94>]O4B:A^)B;1"\
M:6A#73BBJUBG7/"R;EF_L9]/VH_B8O- G$*TF3IU:A 8.;<J-1A9>[''K-/!
MIF<^D[V$'4Z-10)9J,]/-E"6[]<-XB(^,WX+[SI^_/B0P85-^?6O?[U0-F6W
MD$=<9)^^^NJK@T\\:M2H(*1OL<46051'(([]3F5&<;&D$.GUT$,/)3?<<$/R
MBU_\(H3V(@9A+&1Q(!47/T9Q<1&(BT0/(D9@;%Y\\<4AC10GDP.S6E?0BAB"
M<\7O)I(6,80Y]?333V=ZC\H&3ZV=/!N\XF)VNE5<)'T'IX^:<;_YS6_".J1F
M')<R&-+++[]\]'>LK%'6$DXI(BC.*I=("Q<NS!0U4(VRBHLXD^P%1QQQ1&A
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M3CHI7)I:3[DQ%!<[!#8S'.\Q8\:$IAK4^J/1!NEB65.4. APX&GXP&3 8.:
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MA:7W?=AFFVW"^<%YU\U./Z('$5?4_2-S)3U.7 21^HG ]N"##RHN-AGV 4I
M41JKXJ/Q+?@FUHEN+JT0%[$U\5?Q9]G?T^NGF\_V>B@N=@@(9ACW<^;,"88P
MH;P8-A@/61LW<!!S&+!@Z)9$#48VWKONNJMI=0*+ &(?P@+CA,A5V?0Q1II5
MNZL=XB*'.)LH]3UP9.BF1RH;(ERUC8[##$.7.4$#%2(KN%5#1*ZU^(L@+N+L
M(8I6:BPBO" J(#3@R,6>3T5&<;$VBHO%!9&'NK6(@Z2D\.W9ATB%IB8.(@\7
M(NPQ"&#4-R)JKC<T&F$L$8FL?;=DN(7G,I)S@51SQI-Q97QK73RE85TBP'%I
MQ84=-1@1YS@+B[*^ZD$T"8X" BO.! (K>PY[!:5GLI0T(=N#E"K$<%+%V6,H
M5\-YQ\5?['=L)YPY"(J5FM[8'#3%P;$GJCCV\S4+Q<7V0285]BH"/N.=WO>!
M#"ZR=*@M79:+C5: /X-/Q]F/$)L>)^QT+H2P\ZFAVXSOH[CXR;' ?R8(A"PS
M+JJ&#Q\>+O&L$]U<6B$N$B6-Z$X-1C+ETNNGF\_V>B@N=@@8O0@M1!F0QH3(
M2'0:-U-9:C "T6[4KL+!Q9EG$V3Q8'A01R+V.S8+)CH'"F(<3@0&"%$;A#@W
MRQ!IA[B(,4C-*YP>A#8.=!Q#(G:J16 BY'&@(38S)X@FX!E)+:RU&1=!7&33
M1F#@AI5#NE(7ACG921&UK4!QL3:*B\6&;\+SXIRSGW[O>]\+#36(T*^4<V /
M8"]@3\"([PT&(8(&%RX(1K'?I\@02<$>3_HO=6P1<"M[;%;1@8@BG#2$%?9^
MFI@A,"(N$<$6^QVS0'HXS<(HNX$S2(040B&"$8U;**E2;QR(JJ7#+1D?7/@R
M7YFWS%\N,&._8SMAWV8_PQ&KB$$_^M&/0A15)W7Z55QL'ZQ!UB)B&&LSO>\#
M8T\V$J4U.JG^:Z/@S^'CX.M4 D5Z@VW 7,5'X5*D&=]'<?%CN 1-^VC'''-,
MJ!.-&!9[##J)5HB+7&1PN8JN@LB87C_T4^C6L[T>BHL="AL\41X8]XA(.&I$
MKE&#! ,ZR^1@L7#CC&)/H7*<!\0<C.<RUV#$$:4K&E$:1,>T8F&U0UQ,@ZA,
M!".U(Q%+ZSTCM8^(V#S^^..#(TX-2@Y#-M2*$T4]2C9K''0<4/Y-I899M5HV
M:7&1- L*<O,[*]%&I EP@X=AFT5<9)/B=HA-BD,Z]OPI$PA4K%_6,>N9:)$R
M0N0J]?<PSIJUGB@,CW!.>@,B5NQW!)Q4HL:)JL;H;\9[(A15ZO[@Z,9^Q[S0
MX 5'F$AM;I3KO3?SA/G"O&'^5/N=E;I<6<_$(L(^S#[*Q1CODV=L.:_HP$JD
M7;/V6/9_(A@QO!'-TW^S<I90X[!=]:?JC147:)24.>644X(H6*L6<2,@-#)G
M<?"9P[7F(<]4ZUR- =^$;\,WXEOEF5<(RV0;$ 6+?8&#S5[$95>UO2C&G,@"
M^P/[!#9TM?<DZI=NN]2'9=]17(Q+Y6PG2C;+V5[4>;>D>8A/5^^]"")@#A*)
MGK5V[M*BN%@;+IL(YL"?V7###>M^OSQ^>[?2"G&Q'MBA]<[V,ISU>:BW%Y'^
MSX7;M&G3$BZJ8Y\)S:9KQ44F/9$YW+ZS@1*=PXT\]:>RU@8@T@E#FYMFG%W2
M?+CIHLY=EMI#145Q<1$84X3G(SI0$X2HP/GSYX=H-R)6$)"Y&29M@C1[!$:,
M48K]DV98K6926EQ$6.3@YMF8CY6:7(P]40U9#DS%Q?QPNX_C0'H?MTBLYS+"
M6L(IO?'&&X.SWJSU@F%)%"U&2>QW!.8Y-Z&(_43 -.,]63,(^A,F3 A"3^QW
MS N=B(GH7+!@0:8H"^8)\X5YP_Q)_SXBO!$=B6HDBJJLAAY&*A$J."M<).89
MVTH=6TID-.N\XK::*$BB@SF3TG\3X0D#E,CT=D4.8]1S1G'10KI\^IF(WL11
MH(@[MDZ62,5Z(*HQ9YF[S.%JX\]WX_OQ'8OB1.($81]ARY!ED&=>(>PCLA$!
MBLU8;R^JS GL%QR4V&, [ OL#^P3B(A$':6?F_T%FY+]A@PBQ<6X5,YV+LZS
MG.W,.\2F=NY%><!WPX?#ER,BL=Y[$36,;4]M^9Z>GK:,O>)B;?"=N6@YXXPS
M0CFN>M\/O[U2-]J:?DLFAKB('5KO;$^#W4&V))<>B'.QQRTO]?8BLC_(6"!3
ML5T:2#OI6G&1*$.$(=*CB5RB_A2&#NIZ%N$)J'6'H4<-1A1H4LP0RZBKE+4.
M4Q%17%P$M[3KK+-.,#"I9XB(C"..H4G$&\(@*:@X!G2_G#QY<MA 25'F8*9!
M3/IWIL5%(EUY+FYW^+]QNT^Z/<X4AER66V+%Q?S@Z/ =&'\N&C TRPB.&L('
M-[_L;<T8&X17# .,2P2]V.\(?",< 2)\FB6BDI9SYYUWAEIXYYQS3O1WS,LE
MEUR27'?==2&*/DLY!.8)\X5YP_Q)_SY$+T0U4C0QDHH<L;(D$,P0IA ].*?S
MC"WG!O..*-<L4:%9P,DD\IT,"O;^]-]$Q*-L"X(-HEH[Q@K!BNC@H4.'AKIL
MZ6?"Z2.UE8NPGK\XX\W(T&"N,F>9N\SA:N,_:M2HX$@2:504AX-4=BX?.<^I
ME9AG7A$)2P0H8ALE49@32]J+$+JPRQ#]BY(VR+Y Y&VE=B11K>GG[GT^X7 J
M+L:E<K8329KE;(^Q%^4!FYEF-0A3E FJ]U[X.8CYB"WM*FVEN%@;_&8NK0CD
MX-O4^WYY_/9N)8:XF.5L3\.Z0%,A2(>(Z=CCEA?V(N9EK;V(<EP(Z>@MS;(I
MBT37BHND\R L$(Z*HXIZ3)H Z2@8UUDF#S?7+%AN;#DD2#$@ZHR-L5G%?V.@
MN+@((B2HP4BZ,Y$<=+W"R:G4FL(9P%!&8$2H1E0FHH-4>]*I$9_3OS,M+O+O
MJ;7$_XY R"T<G3@9=\3)+-%"BHOYX?##V,/9H48(Z4)EA+G$7H9QUHQ412"B
MB.A '$+F>^QW!(PBOA6"8+/JB1(QQ![$A0&.?>QWS O"%[5O$%VY^*CWWLP3
MY@OSAOF3_GV5?8F(7LZWHD2,-0KG-)<U[-WL_T69=XB[E7F'R)C^FXB.U'CD
MLJI=]6")0!LX<&"XY"(;(_U,"!*<H]1+I*Y;,[JG,E>9LST]/6$.5QM_SER^
M'V=P4;J(DIU ="_B$PYXGGF%K<6:Q;D@"K3>7D2D*XX*C8"X^(P]!H"XR/[
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M=1IK!ZT0%U=9995PXXE!C$"'&$94#&/4K/3&>A AP$*GGA&WFP,&# BW"XB
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MA&(B%NE>SO>=.7-FB)147!01$1$1$1&1O"@NMA$B[7IZ>D(-1J((SSOOO,5
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M>,@AARP5HT>/#K4IJ25);<)6B(M$AY*F3 U$_B81I8BL.^VT4XCN;$;#G69
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9LX2?_P.(V@%-N5"$O     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>mdt-20201030_g1.jpg
<DESCRIPTION>IMAGE 2
<TEXT>
begin 644 mdt-20201030_g1.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>IZV5YY@\PYOJDK\MKZ-;W[^A-1117DGKA1110 4444 %%%% !1110 4444
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!L@R/QK\>?^#L$
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M+N#<QQN'CBJ/+RRVO*SWMV/E<PXQR_!XB6&K<W-'>RNMD^_F?T 45_/_ /\
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MW?%KQ"D_V>Y70)M.M9 <,D]WBTC88YR'G4\>E?R[=2>.Y)_'_P#4?PK]V_\
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MH?\ ;W_I$CY/C7_D35_^W?\ TN)^/5%%%?T$?@9[Q_P2[_Y2*_!7_L<-._\
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MJ&$I.OB)<L4?3/QH^/'@_P#9Z\$3>(_&_B?1_"VB6WW[O4+E848XSM7)R[$
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M7#F:5EJUIOT:/9RWB#'8"#IX2?*F[O1/7;JF?L'_ ,18G_5!1_X7'_WOH/\
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MR;SQE>V7A^W.?O>9,)IA^-O!,/QK\IRS"?6<72P_\TDOQU/U3-,5]7P=6O\
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M0]1]:6D/4?6OT%GY^C^JO_@G=_RC_P#@9_V3[0/_ $VV]>Q5X[_P3N_Y1_\
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M3SC_ .M_("OUSPWP"C1JXR6[?*O16_5GY'XCXYRK4\''9+F?J_\ @("<FE&
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MZII/\&?F?B/@H.C2Q:6J?*_1JZ_(^2J-N\A?[Q HI5.T],_@37[ ?D9^U/\
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M^_V6;;]G_P#8$T77;FT2/Q#\2W/B"^D9/G\ALI:QYZ[!" X'0&9R/O'/W*%
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MR>,O^_Z?_$4?\/@/VF?^BR>,O^_Z?_$5\UX'H*,#T%1_9."_Y\Q_\!7^1?\
M:V-_Y_2_\"?^9]*?\/@/VF?^BR>,O^_Z?_$4?\/@/VF?^BR>,O\ O^G_ ,17
MS7@>@HP/04?V3@O^?,?_  %?Y!_:V-_Y_2_\"?\ F?1]]_P5U_:4U"REMY_C
M'XO>"X1HI$:= '5@01]S/?MS7SAGY\'&>>1QWYXP,48&",#!I?7WYKHH82C1
MO[&"C?LDOR.>OBZU:WMIN5N[;_,*,9(]<C\>:*"=JEO[O/3-=)SG]2__  32
MU>76?^">?P0GE_U@\%:3"3G[WEVD:9_$+FOR<_X.DO$+W7[9W@+2CGR[+P5%
M=@9X!FOKQ3_Z(%?K+_P3;T9M _X)\_!*WD+,_P#PA.CRX(QM\RTB?&/;<1^%
M?D?_ ,'1EA+%^W;X,NBF()_ 5I$K9ZLFH:B6'_CZ_G7XCP?&/^L4K=YV/VGB
MV4O]7XI]H7/S6HHHK]N/Q8^BO^"2/@^+QQ_P4I^#-E*@D6'Q)!?@$@ -;!KD
M'GWB%?T_Q<X.,<?6OYE/^",6M1:#_P %/O@_/-]Q]7>V'./FEMIHE_\ 'G%?
MTUQ#';%?C'B5?Z]23_D_5G['X<)?4:K6_/\ HA]%%%?G1^BA1110 UR  3V/
MI7YL_P#!T#X0BU7]A'PMJX5!<Z-XSM\.1SY4MI=AE'U98_\ OD5^DTG0=.OK
MBOSI_P"#G/4(+3_@G;I$,K$/>>-+&&+_ &G%K>OC\E/->]PNVLVH.._,>#Q0
MD\JKI_RGX%LVYSQC'2BAR3*21MSSUSGFBOZ./YU6Q[Q_P2[_ .4BOP5_['#3
MO_1Z5_4C']XU_+=_P2[_ .4BOP5_['#3O_1Z5_4C']XU^->)?^^T?\'_ +<?
ML'AO_NE7_&O_ $D?2/T'U%+2/T'U%?G!^CL_&#_@ZR_Y*!\%_P#L'ZM_Z,M:
M_).OUL_X.LO^2@?!?_L'ZM_Z,M:_).OZ$X+_ .1-0]'_ .E,_G[C'_D<5O5?
M^DH*^D?^"/\ _P I,_@U_P!C G_HN2OFZOI'_@C_ /\ *3/X-?\ 8P)_Z+DK
MU\X_W"M_@E^3/)RG_?J/^./YH_IZ7[Q_SZTM(OWC_GUI:_F-'],!1113 ^5/
M^"W?_*+/XN?]>%I_Z7VU?S._\M#_ )[U_3%_P6[_ .46?Q<_Z\+3_P!+[:OY
MG?\ EH?\]Z_:/#?_ )%]3_'_ .VQ/QGQ'_W^G_@_5BTJD[@!P3Q]*2CO^E?H
M;/ST_JN_X)_^'4\)_L,_!S3TVG[+X)T=7('WG^Q1%S^+9/XUZ]7F?[%O_)GW
MPI_[$[2/_2&&O3*_EW&N^(J-_P S_,_I[ JV&II?RK\@ILOW>I!]OI3J1S@?
M_7KF.IGYA?\ !TMXG-G^R!\/]&$A U#Q>MV4_OB&SN5Y/IF8<5^&)Y.>]?MW
M_P '3FDR2_LV?#*]&TPV_B::!^>0TEK(P]ND9K\1*_>. 4O['@UWE^9^$<=M
M_P!KS3Z*/Y!3[:VDO+J.*)#)+*P5$ )+,> /Q.*95SP]JK:%X@L+Y4\PV5Q'
M/MW!=VU@V,]NE?93=HMGR$=T?US?#OPC;> / VBZ%9@+::+806$ "[<)%&J+
MQ]%%;55]-F2YMHI8V5TD0.K*00P/((JQ7\K2;;;EN?U'3244D%%%%(L****
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M97YMU^DO_!KE_P G_P#C#_LGU[_Z<M,K'BO_ )%%?_"='"O_ "-J'^(_>8*
M<@#-+117\YG]$A1110 C ,,$9K^>3_@XZ 7_ (*9ZI@8SX>TW/\ WPU?T.'I
M7\\?_!QW_P I,]4_[%[3?_0&K[KP\_Y&K_P2_.)\)XA?\BQ?XE^3/@^@C-%%
M?N1^)'Z2_P#!KD3_ ,-_>,.?^:?7G_IQTROWGK\&/^#7+_D__P 8?]D^O?\
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M@)QUP,X'>OVUL_%C[V\/_M5&V_X-Z/$7@-YD^U/\1X- BCW_ #K:2!=5#X[
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MN?>;/>OR;PWQ2IX^="7VXZ>JU_*Y^J>(F%<\#"M'[$M?1Z?G8^ Z#GL&)[
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M_P#$2,P_Y]P_\F_S/H?^(<X#_GY/_P E_P C^9W_ (<B_M4?]$AUC_P/L?\
MY(H_X<B_M4?]$AUC_P #['_Y(K^F+ ]!1@>@H_XB1F'_ #[A_P"3?YA_Q#G
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M +)]>_\ IRTRL>*_^117_P )T<*_\C:A_B/WGHHHK^<S^B0HHHH #TK^>/\
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M(55!)( R/Z6?^"7?_!/G1_\ @GI^SC:^&8_LVH>*]5VWOB75(X\"^NB/N(2
M?)B!9$!QU9L N:^1XQX@CE^$=.F_WL]%Y+J_ET/J^$,@EF&+52:_=PU?GV1]
M'VQ&XX&,C./3\.W6ICTI%14)P ,]<#K2GI7X(?O/0_G,_P"#A/\ Y2D^-O\
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M'_!+K]HL'GX*_$=?<:'/_P#$U^H_VGA/^?T/_ D?F']G8O\ Y]2_\!9^QO\
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M_$FDV&M:%K,)M[VQNXA)#<1D=&!]."",$$ @@BO$X>SZKE6*]M!7B])+NO\
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MF_#.!Q,,TH2G3DDI=8L_9RBBBOY_/WX****  ]*_GC_X.._^4F>J?]B]IO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
944 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>mdt-20201030_g2.jpg
<DESCRIPTION>IMAGE 3
<TEXT>
begin 644 mdt-20201030_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $9R:65D<FEC
M:"P@365G86X    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,Q
M-   DI(  @    ,Q-   ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M]D=I17SG_P -!^*O^@?H_P#WYE_^.4?\-!^*O^@?H_\ WYE_^.5V?V?7./\
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M 'ZD_P#BZ/\ A<_B'_GSTS_OU)_\71_96)[+[P_MO"=W]Q[=17B/_"Y_$/\
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M^?/3/^_4G_Q=']E8GLOO#^V\)W?W'MU%>(_\+G\0_P#/GIG_ 'ZD_P#BZ/\
MA<_B'_GSTS_OU)_\71_96)[+[P_MO"=W]Q[=17B/_"Y_$/\ SYZ9_P!^I/\
MXNC_ (7/XA_Y\],_[]2?_%T?V5B>R^\/[;PG=_<>W45XC_PN?Q#_ ,^>F?\
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M_;]U_P \X?\ OD_XT?V_=?\ /.'_ +Y/^-'LI![:!T-%<]_;]U_SSA_[Y/\
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MI![:!T-%<]_;]U_SSA_[Y/\ C1_;]U_SSA_[Y/\ C1[*0>V@=#17/?V_=?\
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MZBMQ'I=K'"O_ "ZAY2C?4E]WY,.E<U#%1KN2BGIZ?YG9B<%/#*+G)>]M:_\
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M;[,H44451(4444 %%%% !1110 4444 %=!H'_'@__74_R%<_70:!_P >#_\
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M^@&O%=7\/RZ+X>TRXOH6BN[]Y) K'!2)0NW(]223],5[5H/_ "2JV_[!A_\
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M %S7-7TZV2":<PPK=H\C%B1DJI..">#SGM6_\&/^1-N_^O\ ?_T7'7D.O?\
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M*QW;6*D;8U 4^K#[W\_TK*L%\L27;+E81\N>A8\"FPWHAG65;:(,#G(+Y_\
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M/['_ +"D?_HJ6NG"_P >/J<V*_@2/G.BBBOJ#Y@**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KI_A_SXDF$(;[8VG7@LRIP1-]G?;CWZX]\5S%2
MVMS-97D-U:R-%/!(LD<B]493D$?0BIG'FBT5"7+),]*\#Z NH>$]'N6\-1WQ
M_P"$DA269K5W\RW*$,6(_@4_1<@;@><P^.-&D_X1.ZOY/#\>G-::[-;1/;V7
MD 6VP!=Q ^8%APS$\D@$#BO/;VZ^VWLESY$-N9#N:.!-B XY(7H,GG P!G
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MHKZ@^8"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKR+P1_R.5C_VT_\ 1;5Z[7@9E_&7I^K/I\H_@/U_1!1117FGL!1110 4444
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M-NFMM1M9[2=1EHIXRC#\#S5>GN+8**** "BBB@ HHHH **** "BBB@ HHHH
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MG5_^?3_R*G^->@45P?6I]D>A]4I]V>?_ /",ZO\ \^G_ )%3_&C_ (1G5_\
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MHIWL*=-PM<****L@DA@EN'*P1/*P&2$4DX_"IO[-OO\ GRN/^_3?X5I>$_\
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MO3*\SK*<.4[\'BI8CFNK6L%%%%9G>7+"P^W>9^\V;,?PYSG/^%7/[!_Z>?\
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5T'@W_ )#,O_7
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M^/%\2R:*DDEO8?8[2)K@EHCT$C.5^=L%AT&0?SY'1]1T^VU&>XU_2VUE)8V
M1KIX2)"01(67)..>#US67141I0BK)%RJSD[LZ_2?&6F^'K.[;0M"E@U&[L39
M/<S7WFHH;[SB/8/F. >20,=*Y"BBKC!1;:ZDRFY))] HHHJB#<\)_P#(6E_Z
MX'_T):["N/\ "?\ R%I?^N!_]"6NPKJI?"?-9C_'^2"BBBM3S@HHHH ****
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M&-636MXJ_P"1QUG_ *_Y_P#T8U9->_#X4>)+XF%%%%42%%%% !1110 4444
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MH **** "BBB@ HHHH *\SKTRO,ZPK=#V\J^W\OU"BBBN<]LV-!_Y>/\ @/\
M6MBL?0?^7C_@/]:V*[*?P(\7%?QG_70****T.<**** "BBB@ HHHH **** (
M;O\ X\I_^N;?RKE:ZJ[_ ./*?_KFW\JY6N:MNCT\%\+"BBBL#O"BBB@ HHHH
M Z32O^09%^/\S5RJ>E?\@R+\?YFKE=T/A1X-7^)+U844451F%%%% !1110 4
M444 %%%% !1110 5Z7I7_(&LO^N"?^@BO-*]+TK_ ) UE_UP3_T$5QXOX4=N
M#^)ENBBBO//2"BBB@ HHHH Y_P 9?\@>+_KN/_06KB:[;QE_R!XO^NX_]!:N
M)KT\-_#/)Q7\0****Z3F.;U;_D)R_A_(53JYJW_(3E_#^0JG7#+XF>]2_AQ]
M$%%%%2:!1110 5V7PQ_Y&:X_Z\V_]#2N-KLOAC_R,UQ_UYM_Z&E3/X6)['JE
M%%%<I(4444 %%%% !7G_ (G_ .1BN?\ @'_H(KT"O/\ Q/\ \C%<_P# /_01
M75A?C?H<>+_AKU,FBBBO2/,"BBB@ HHHH W_  1_R.5C_P!M/_1;5Z[7D7@C
M_D<K'_MI_P"BVKUVO S+^,O3]6?3Y1_ ?K^B"BBBO-/8"BBB@ HHHH ****
M"BBB@ HHHH M+I\C0ARZ*S*&5">2.?P[4'3IOLK3Y0A1ED#?,H]Q5RWD1M/,
M=V\<L 4%3NPR'!XQUZC\O:H5A\G3GVW4 :09=1("V!T4"LN9FO*BI;6YNIA$
MCJK'INSS^0IDB&.1D;JI(.*NV40M]2A+S0E0-Q82# ]N>]5;L8NY<%2"Y(*L
M"""?:KOJ0U:-R*BBBJ)"BBB@ HHHH **** "BBB@#YI\5?\ (XZS_P!?\_\
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MY_\ T8U9->_#X4>)+XF%%%%42%%%% !1110 4444 %%%% 'H'P;_ .1QNO\
MKP?_ -&1U[97B?P;_P"1QNO^O!__ $9'7ME>1B_XIZF&_AA1117*=(4444 %
M%%% !70:!_QX/_UU/\A7/UT&@?\ '@__ %U/\A657X3:C\9J4445R':%%%%
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MK4\X**** "BBB@ HHHH **** "O,Z],KS.L*W0]O*OM_+]0HHHKG/;-C0?\
MEX_X#_6MBL?0?^7C_@/]:V*[*?P(\7%?QG_70****T.<**** "BBB@ HHHH
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M (IZF&_AA1117*=(4444 %%%% !70:!_QX/_ -=3_(5S]=!H'_'@_P#UU/\
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MS_P#_P!!%>@5Y_XG_P"1BN?^ ?\ H(KJPOQOT./%_P ->IDT445Z1Y@4444
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MF%%%% !5/5?^09+^'\Q5RJ>J_P#(,E_#^8J9?"S2E_$CZHYNBBBN$]X****
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MT_\ 1;5Z[7@9E_&7I^K/I\H_@/U_1!1117FGL!1110 4444 %>4_&W_F"?\
M;Q_[3KU:O*?C;_S!/^WC_P!IUT8;^*OZZ'/B/X3/*:***]D\H**** "BBB@
MHHHH **** "BBB@#ZLHHHKYX]T**** "BBB@#YI\5?\ (XZS_P!?\_\ Z,:L
MFM;Q5_R..L_]?\__ *,:LFO?A\*/$E\3"BBBJ)"BBB@ HHHH **** "BBB@#
MT#X-_P#(XW7_ %X/_P"C(Z]LKQ/X-_\ (XW7_7@__HR.O;*\C%_Q3U,-_#"B
MBBN4Z0HHHH **** "N@T#_CP?_KJ?Y"N?KH- _X\'_ZZG^0K*K\)M1^,U***
M*Y#M"BBB@ KRO]H/_DG]C_V%(_\ T5+7JE>5_M!_\D_L?^PI'_Z*EKIPO\>/
MJ<V*_@2/G.BBBOJ#Y@**** "N]^&L]C;VVLM;SV-MXE$<9TB;4"HC5MWS[2W
MRB3&,9[^V:X*M_PMK>EZ9<&WU_1K74M.N'7[0S1DSHH_YY,'7:?QYK*M'F@T
M:T9<LTSI+;PC>7OBF_U#QMID6C:9I4*SWT=M$L*2#&$2/;P2Y'53Z\C@5C?$
MO1K#P_\ $34],TB#[/9P>5Y<6]GV[HD8\L2>I)ZTS5/B)XFU+4?M<6ISZ:/*
M2%8-.F>"-43.T8#9.,GJ3UJ2^^(&H:IXKN=>U73],OYI[?[.MM=0-+!"N!S&
MK,2IR">O5F/>LH1JJ2D]K;?=_P $UE*DXN*WOO\ ?_P#=M?#VB:EX1M_^$8M
M=)U35K;3FNM32ZGNDG4Y_P"6:JRQG:#@]>W'//F]=/:^.;G3M/N+?2=)TO3Y
MKFT^QRWEO'()FC[\ERH)[L!DUS%:4HRBWS&=646ERA1116QB;GA/_D+2_P#7
M _\ H2UV%<?X3_Y"TO\ UP/_ *$M=A752^$^:S'^/\D%%%%:GG!1110 4444
M %%%% !1110 5YG7IE>9UA6Z'MY5]OY?J%%%%<Y[9L:#_P O'_ ?ZUL5CZ#_
M ,O'_ ?ZUL5V4_@1XN*_C/\ KH%%%%:'.%%%% !1110 4444 %%%% $-W_QY
M3_\ 7-OY5RM=5=_\>4__ %S;^5<K7-6W1Z>"^%A1116!WA1110 4444 =)I7
M_(,B_'^9JY5/2O\ D&1?C_,U<KNA\*/!J_Q)>K"BBBJ,PHHHH *IZK_R#)?P
M_F*N53U7_D&2_A_,5,OA9I2_B1]4<W1117">\%%%% !1110 5[KX>_Y%G2_^
MO.+_ - %>%5[KX>_Y%G2_P#KSB_] %95=B6:-%%%8""BBB@ HHHH Y_QE_R!
MXO\ KN/_ $%JXFNV\9?\@>+_ *[C_P!!:N)KT\-_#/)Q7\0****Z3F.;U;_D
M)R_A_(53JYJW_(3E_#^0JG7#+XF>]2_AQ]$%%%%2:!1110 5V7PQ_P"1FN/^
MO-O_ $-*XVNR^&/_ ",UQ_UYM_Z&E3/X6)['JE%%%<I(4444 %%%% !7G_B?
M_D8KG_@'_H(KT"O/_$__ ",5S_P#_P!!%=6%^-^AQXO^&O4R:***](\P****
M "BBB@#?\$?\CE8_]M/_ $6U>NUY%X(_Y'*Q_P"VG_HMJ]=KP,R_C+T_5GT^
M4?P'Z_H@HHHKS3V HHHH **** "O*?C;_P P3_MX_P#:=>K5Y3\;?^8)_P!O
M'_M.NC#?Q5_70Y\1_"9Y31117LGE!1110 4444 %%%% !1110 4444 ?5E%%
M%?/'NA1110 4444 ?-/BK_D<=9_Z_P"?_P!&-636MXJ_Y''6?^O^?_T8U9->
M_#X4>)+XF%%%%42%%%% !1110 4444 %%%% 'H'P;_Y'&Z_Z\'_]&1U[97B?
MP;_Y'&Z_Z\'_ /1D=>V5Y&+_ (IZF&_AA1117*=(4444 %%%% !70:!_QX/_
M -=3_(5S]=!H'_'@_P#UU/\ (5E5^$VH_&:E%%%<AVA1110 5Y7^T'_R3^Q_
M["D?_HJ6O5*\K_:#_P"2?V/_ &%(_P#T5+73A?X\?4YL5_ D?.=%%%?4'S 4
M444 %%%=!X8\*/X@CO+VZO8=,TG3U5KR^F4L(PQPH51RS$] /ZC,RDHJ[*C%
MR=D<_16I+H-PWB"/1],GM]6N)658FL6+(Y89 !8#IGG/3G/0U#K.C7_A_5YM
M,U>#[/>0;?,BWJ^W<H8<J2.A!ZT*46[7!QDE>Q1HKH(/ WB.ZTE=1@TQFMWA
M:X0>:@D>)3@NL9;>5]P,<BN?H4HRV8.,H[H****HDW/"?_(6E_ZX'_T):["N
M/\)_\A:7_K@?_0EKL*ZJ7PGS68_Q_D@HHHK4\X**** "BBB@ HHHH **** "
MO,Z],KS.L*W0]O*OM_+]0HHHKG/;-C0?^7C_ (#_ %K8K'T'_EX_X#_6MBNR
MG\"/%Q7\9_UT"BBBM#G"BBB@ HHHH **** "BBB@"&[_ ./*?_KFW\JY6NJN
M_P#CRG_ZYM_*N5KFK;H]/!?"PHHHK [PHHHH **** .DTK_D&1?C_,U<JGI7
M_(,B_'^9JY7=#X4>#5_B2]6%%%%49A1110 53U7_ )!DOX?S%7*IZK_R#)?P
M_F*F7PLTI?Q(^J.;HHHKA/>"BBB@ HHHH *]U\/?\BSI?_7G%_Z *\*KW7P]
M_P BSI?_ %YQ?^@"LJNQ+-&BBBL!!1110 4444 <_P",O^0/%_UW'_H+5Q-=
MMXR_Y \7_7<?^@M7$UZ>&_AGDXK^(%%%%=)S'-ZM_P A.7\/Y"J=7-6_Y"<O
MX?R%4ZX9?$SWJ7\./H@HHHJ30**** "NR^&/_(S7'_7FW_H:5QM=E\,?^1FN
M/^O-O_0TJ9_"Q/8]4HHHKE)"BBB@ HHHH *\_P#$_P#R,5S_ , _]!%>@5Y_
MXG_Y&*Y_X!_Z"*ZL+\;]#CQ?\->IDT445Z1Y@4444 %%%% &_P""/^1RL?\
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M#_\ HR.O;*\C%_Q3U,-_#"BBBN4Z0HHHH **** "N@T#_CP?_KJ?Y"N?KH-
M_P"/!_\ KJ?Y"LJOPFU'XS4HHHKD.T**** "O*_V@_\ DG]C_P!A2/\ ]%2U
MZI7E?[0?_)/['_L*1_\ HJ6NG"_QX^IS8K^!(^<Z***^H/F HHHH *[?X>MJ
MSPZC9Z7_ &1>PWPCBFTC49U1KS!)'EY(^9>><C&>^..(J6VNKBRNH[FSGDMY
MXSN26)RK(?4$<BHJ1YXV+IRY97/49M3\#>#-:U/^P9[K[9=621P75F$O([%V
M!\T(S2)N.,8;)QD^XJA\0+/3_%?Q8U9]*U[3(X3;QS-<W5PJ0,RQHNR-U+!S
MC'ISN';)\XHK*-#EES)ZVM^7^1K*OS1Y6M+W_/\ S/<].\2:&?%>C>+FU2QA
MT^ST#[+-:-.!.DJ[AY8B)W$'=P0".#[9\,HHJJ5%4V[/^OZ9-2LZB5_Z_JP4
M445L8D]I>W%C,9;63RW*[2=H/'X_2KG_  D6J?\ /U_Y#7_"BV\-ZY>Z?]NL
M]&U"XM,$_:(K5VCP.IW 8XP<_2LRA3Z)F<Z$).\XKYHT_P#A(M4_Y^O_ "&O
M^%'_  D6J?\ /U_Y#7_"L\12&%I0C&-6"LX' )R0"?4X/Y&I+.RNM1NTM=/M
MIKJXDSLA@C+NV!DX4<G@$T^=]R?JU'^1?<BY_P )%JG_ #]?^0U_PH_X2+5/
M^?K_ ,AK_A5">"6VN)(+F)X9HG*21R*59&!P00>00>U1T^:7<7U>C_(ON1I_
M\)%JG_/U_P"0U_PH_P"$BU3_ )^O_(:_X5F5<;2-232UU-M/NEL';:MV8&\I
MCDC ?&,Y!'7M2YVMV/ZM1?V%]R)_^$BU3_GZ_P#(:_X4?\)%JG_/U_Y#7_"J
M[Z5J,>EIJ3V%TMA(VQ+HPL(F;)& ^,$\'OV-5*.=O9A]6HK>"^Y&G_PD6J?\
M_7_D-?\ "C_A(M4_Y^O_ "&O^%07VD:EID<$FI:?=6:7 +0M<0-&)0,9*DCG
MJ.GJ*2ZTK4;&UM[F]L+JVM[I=T$LT+(DHP#E21AA@@\>M'M'W']5I?R+[BQ_
MPD6J?\_7_D-?\*S*N7VD:EID<$FI:?=6:7 +0M<0-&)0,9*DCGJ.GJ*34-*U
M'2)DBU6PNK&1UWJES"T99>F0& R*7/S=2XT8T[\L;?(J4444%$UO=S6N[R'V
M[L9X!S^=3?VM>_\ /;_QQ?\ "IQX;UUM-_M%=%U V.SS/M(M7\K9_>W8QCWK
M,IJ;Z,F5*-[RC^!<_M:]_P">W_CB_P"%']K7O_/;_P <7_"JWDR&$S"-O*#!
M"^T[0Q&0,^O!J>PTV^U6Y^SZ797%[/M+>5;Q-(V!U.%!.*.=KJ3[&#^RON'?
MVM>_\]O_ !Q?\*/[6O?^>W_CB_X55DC>*1HY49'0E65A@J1U!%-I\\NX>RI_
MRK[BY_:U[_SV_P#'%_PH_M:]_P">W_CB_P"%4ZN76CZG8V4%Y>Z==V]K< &&
M>6!D24$9&UB,'CGBESM=0]C!_97W!_:U[_SV_P#'%_PH_M:]_P">W_CB_P"%
M3/X=UN/3!J4FCWZ6)0.+IK5Q%M/0[\8P<CG-9M"J-[,;HP6\5]Q<_M:]_P">
MW_CB_P"%']K7O_/;_P <7_"C4='U/2'C35M.N[%I!N07,#1EQZC<!FGW6AZM
M8S6\-[I=[;RW6! DUNZ--T'R@CYNHZ>M'M'W#V$/Y?P(WU.[D1D>7*L,$;1T
M_*JE7KO1-5T^\AM+_3+RUN9\>5#-;NCR9.!M4C)R>.*CO]-OM*N?L^J65Q93
M[0WE7$31M@]#A@#BES\W4I4U#96*M%%% PHHHH **** .DTK_D&1?C_,U<JG
MI7_(,B_'^9JY7=#X4>#5_B2]6%%%%49A1110 4CHLBE74,IZ@C(-+10!#]CM
MO^?>+_O@4?8[;_GWB_[X%:NF:+J&L>>;"#>ENF^:5Y%CCC'^T[$*._4]CZ4F
MIZ+?Z.T/]H6_EK.F^&175TD7U5U)4]1T/>L^:'-RW5S7EJ\O/9V[]#+^QVW_
M #[Q?]\"C[';?\^\7_? JU;V\MW=16ULADFF<1QH.K,3@#\Z8ZE'9&&&4X(]
MZNRO8GFG:]R#[';?\^\7_? H^QVW_/O%_P!\"M6\T6_L=-L]0N856UO03!(L
MJ.'QUX!)!'3!Q5"DN62NAR=2+M*Z(?L=M_S[Q?\ ? J_'J-[#$L<5Y<)&@"J
MBRL H'0 9JM6EHOA[5?$5Q)#HUFUR\:[GPRJ%'N6('X?6E+DBKRT01]I.7+&
M[9!_:NH?\_\ <_\ ?YO\:/[5U#_G_N?^_P W^-6+7PYJMY>W-I#:[9;1ML_F
MR+&L;%MH!9B!DG@#//:J-S;36=U);W4;131,4=&&"I'44DZ;=E8&JD5=WL3?
MVKJ'_/\ W/\ W^;_ !H_M74/^?\ N?\ O\W^-7-(\*ZWKMG/=Z3I\ES! <.Z
MLHYQG !(+''89/(]146F>'M4UB%I=/M?-17\L%I%3>^"=B[B-S8!.U<FDY4E
M>[6FY:IUG:R>NV^OH0?VKJ'_ #_W/_?YO\:/[5U#_G_N?^_S?XU=TKPGKFMV
MEQ<Z7ITEQ#;DK(P*C# 9( )!8X[#)Y'K45MX=U6\TTW]O:%K<*[ EU#.J8WE
M5)W,!D9(! I<]*]KK\ ]G6:3L]?4IS7MU<H$N+F:50<A7D+#/KS4%%%;));&
M#;>X4444 1O;02,6DAC9CU+(":;]CMO^?>+_ +X%35N)X.UUU3%B!+)$9DMF
MFC6=T&>1$6WGH?X><5$I0C\32-81JST@F_0YW[';?\^\7_? H^QVW_/O%_WP
M*G961RKJ593@@C!!J46DYL6O!$WV=9!$9.V\@G'N< _Y(I^Z3S3?4I_8[;_G
MWB_[X%'V.V_Y]XO^^!6EI>EW>LZA'9:=&LMQ)G8AD5-V!G@L0*KW%O+:74MO
M<+LEA<HZY!PP.",CWHO&_+U'^\Y>;6Q5^QVW_/O%_P!\"IK7_093)9?Z/(1M
M+Q?(2/3(^E%%.R)YY=RW_:NH?\_]S_W^;_&C^U=0_P"?^Y_[_-_C5[4/"6NZ
M5I,6I:AITD-I+C;(2IQGID Y7\0*?)X.UV+01K4MB$T\QB03--&/E/0XW9YR
M.,=ZR]I1M>Z[=-S;V5>[7*]%?9[=_0SO[5U#_G_N?^_S?XT?VKJ'_/\ W/\
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MTL**[J-C<!E8,#^(J*J4WT9+BNJ,G_A%?#W_ $ M,_\  ./_  H_X17P]_T
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M>:G=-=:E=SW=PP :6>0R.<# R3S5B_U_6-4MDMM3U:^O((R&2*XN7D52!@$
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M )?_ (FCVD.Z#V<^QAT5N?\ "$>*_P#H6=8_\ )?_B:/^$(\5_\ 0LZQ_P"
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M_H ZG_X!R?X4?\(IXA_Z .I_^ <G^%'M:?\ ,OO#V-7^5_<9-%:W_"*>(?\
MH ZG_P" <G^%'_"*>(?^@#J?_@')_A1[6G_,OO#V-7^5_<9-%:W_  BGB'_H
M ZG_ . <G^%'_"*>(?\ H ZG_P" <G^%'M:?\R^\/8U?Y7]QDT5K?\(IXA_Z
M .I_^ <G^%'_  BGB'_H ZG_ . <G^%'M:?\R^\/8U?Y7]QDT5K?\(IXA_Z
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M (!R?X4?\(IXA_Z .I_^ <G^%'M:?\R^\/8U?Y7]QDT5K?\ "*>(?^@#J?\
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MY60T5-]BNO\ GVF_[]FC[%=?\^TW_?LT70<K(:*F^Q77_/M-_P!^S1]BNO\
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M%'L*W\C^YA[>C_,OO1W%%</_ ,+D\!_]!W_R3G_^(H_X7)X#_P"@[_Y)S_\
MQ%'L*W\C^YA[>C_,OO1W%%</_P +D\!_]!W_ ,DY_P#XBC_A<G@/_H._^2<_
M_P 11["M_(_N8>WH_P R^]'<45P__"Y/ ?\ T'?_ "3G_P#B*/\ A<G@/_H.
M_P#DG/\ _$4>PK?R/[F'MZ/\R^]'<45P_P#PN3P'_P!!W_R3G_\ B*/^%R>
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M_0=_\DY__B*/^%R> _\ H._^2<__ ,11["M_(_N8>WH_S+[T=Q17#_\ "Y/
M?_0=_P#).?\ ^(H_X7)X#_Z#O_DG/_\ $4>PK?R/[F'MZ/\ ,OO1W%%</_PN
M3P'_ -!W_P DY_\ XBC_ (7)X#_Z#O\ Y)S_ /Q%'L*W\C^YA[>C_,OO1W%%
M</\ \+D\!_\ 0=_\DY__ (BC_A<G@/\ Z#O_ ))S_P#Q%'L*W\C^YA[>C_,O
MO1W%%<A%\5/!D\0DBUG<C=#]EF'_ +)3_P#A9_A#_H+_ /DM-_\ $57U6O\
MR/[F9O&89.SJ1^]'645R?_"S_"'_ $%__):;_P"(H_X6?X0_Z"__ )+3?_$4
M?5<1_(_N8?7,-_S\C]Z.LHKD_P#A9_A#_H+_ /DM-_\ $4?\+/\ "'_07_\
M):;_ .(H^JXC^1_<P^N8;_GY'[T=917)_P#"S_"'_07_ /):;_XBC_A9_A#_
M *"__DM-_P#$4?5<1_(_N8?7,-_S\C]Z.LHKD_\ A9_A#_H+_P#DM-_\11_P
ML_PA_P!!?_R6F_\ B*/JN(_D?W,/KF&_Y^1^]'645R?_  L_PA_T%_\ R6F_
M^(H_X6?X0_Z"_P#Y+3?_ !%'U7$?R/[F'US#?\_(_>CK**Y/_A9_A#_H+_\
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M1_(_N8?7,-_S\C]Z.LHKD_\ A9_A#_H+_P#DM-_\11_PL_PA_P!!?_R6F_\
MB*/JN(_D?W,/KF&_Y^1^]'645R?_  L_PA_T%_\ R6F_^(H_X6?X0_Z"_P#Y
M+3?_ !%'U7$?R/[F'US#?\_(_>CK**Y/_A9_A#_H+_\ DM-_\11_PL_PA_T%
M_P#R6F_^(H^JXC^1_<P^N8;_ )^1^]'645R?_"S_  A_T%__ "6F_P#B*/\
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M11]5Q'\C^YA]<PW_ #\C]Z.LHKF['X@^&-2O$M++4_,GDSM7[/*,X!)Y*XZ
MUK_VQ8_\]_\ QQO\*SE2J0=I1:^1K"M2J*\))^C+M%4O[8L?^>__ (XW^%']
ML6/_ #W_ /'&_P *GEEV+YX]R[15+^V+'_GO_P".-_A1_;%C_P ]_P#QQO\
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M-_A1_;%C_P ]_P#QQO\ "CEEV#GCW+M%4O[8L?\ GO\ ^.-_A1_;%C_SW_\
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M@YX]R[15+^V+'_GO_P".-_A1_;%C_P ]_P#QQO\ "CEEV#GCW+M%4O[8L?\
MGO\ ^.-_A1_;%C_SW_\ '&_PHY9=@YX]R[15+^V+'_GO_P".-_A5BWN8KJ,O
M VY0<$X(Y_&DXM;H%*+V9+1112*"BBB@ KRO]H/_ ))_8_\ 84C_ /14M>J5
M@>,?!VG^-]'BTW59KF&&*<3JULRJQ8*RX^92,88]JVH34*L92V1C7@YTG%;L
M^/J*^C/^&?/"G_00UC_O]%_\;H_X9\\*?]!#6/\ O]%_\;KW/[0H>9XG]GUS
MYSHKZ,_X9\\*?]!#6/\ O]%_\;H_X9\\*?\ 00UC_O\ 1?\ QNC^T*'F']GU
MSYSHKZ,_X9\\*?\ 00UC_O\ 1?\ QNC_ (9\\*?]!#6/^_T7_P ;H_M"AYA_
M9]<^<Z*^C/\ AGSPI_T$-8_[_1?_ !NC_AGSPI_T$-8_[_1?_&Z/[0H>8?V?
M7/G.BOHS_AGSPI_T$-8_[_1?_&Z/^&?/"G_00UC_ +_1?_&Z/[0H>8?V?7/G
M.BOHS_AGSPI_T$-8_P"_T7_QNC_AGSPI_P!!#6/^_P!%_P#&Z/[0H>8?V?7/
MG.BOHS_AGSPI_P!!#6/^_P!%_P#&Z/\ AGSPI_T$-8_[_1?_ !NC^T*'F']G
MUSYSHKZ,_P"&?/"G_00UC_O]%_\ &Z/^&?/"G_00UC_O]%_\;H_M"AYA_9]<
M^<Z*^C/^&?/"G_00UC_O]%_\;H_X9\\*?]!#6/\ O]%_\;H_M"AYA_9]<^<Z
M*^C/^&?/"G_00UC_ +_1?_&Z/^&?/"G_ $$-8_[_ $7_ ,;H_M"AYA_9]<^<
MZ*^C/^&?/"G_ $$-8_[_ $7_ ,;H_P"&?/"G_00UC_O]%_\ &Z/[0H>8?V?7
M/G.BOHS_ (9\\*?]!#6/^_T7_P ;H_X9\\*?]!#6/^_T7_QNC^T*'F']GUSY
MSHKZ,_X9\\*?]!#6/^_T7_QNC_AGSPI_T$-8_P"_T7_QNC^T*'F']GUSYSHK
MZ,_X9\\*?]!#6/\ O]%_\;H_X9\\*?\ 00UC_O\ 1?\ QNC^T*'F']GUSYSH
MKZ,_X9\\*?\ 00UC_O\ 1?\ QNC_ (9\\*?]!#6/^_T7_P ;H_M"AYA_9]<^
M<Z*^C/\ AGSPI_T$-8_[_1?_ !NC_AGSPI_T$-8_[_1?_&Z/[0H>8?V?7/G.
MBOHS_AGSPI_T$-8_[_1?_&Z/^&?/"G_00UC_ +_1?_&Z/[0H>8?V?7/G.BOH
MS_AGSPI_T$-8_P"_T7_QNC_AGSPI_P!!#6/^_P!%_P#&Z/[0H>8?V?7/G.BO
MHS_AGSPI_P!!#6/^_P!%_P#&Z/\ AGSPI_T$-8_[_1?_ !NC^T*'F']GUSYS
MHKZ,_P"&?/"G_00UC_O]%_\ &Z/^&?/"G_00UC_O]%_\;H_M"AYA_9]<^<Z*
M^C/^&?/"G_00UC_O]%_\;H_X9\\*?]!#6/\ O]%_\;H_M"AYA_9]<^<Z*^C/
M^&?/"G_00UC_ +_1?_&Z/^&?/"G_ $$-8_[_ $7_ ,;H_M"AYA_9]<^<Z*^C
M/^&?/"G_ $$-8_[_ $7_ ,;H_P"&?/"G_00UC_O]%_\ &Z/[0H>8?V?7/G.B
MOHS_ (9\\*?]!#6/^_T7_P ;H_X9\\*?]!#6/^_T7_QNC^T*'F']GUSQ?2?^
M07%^/_H1JY7M5O\ !'PW;0+%'>ZJ57."98\]<_\ /.I/^%,>'O\ G\U/_O['
M_P#$5TQS3#))7?W'E5,FQ<IMI+[SQ&BO;O\ A3'A[_G\U/\ [^Q__$4?\*8\
M/?\ /YJ?_?V/_P"(JO[5PW=_<1_8F+[+[SQ&BO;O^%,>'O\ G\U/_O['_P#$
M4?\ "F/#W_/YJ?\ W]C_ /B*/[5PW=_<']B8OLOO/$:*]N_X4QX>_P"?S4_^
M_L?_ ,11_P *8\/?\_FI_P#?V/\ ^(H_M7#=W]P?V)B^R^\\1HKV[_A3'A[_
M )_-3_[^Q_\ Q%'_  ICP]_S^:G_ -_8_P#XBC^U<-W?W!_8F+[+[SQ&BO;O
M^%,>'O\ G\U/_O['_P#$4?\ "F/#W_/YJ?\ W]C_ /B*/[5PW=_<']B8OLOO
M/$:*]N_X4QX>_P"?S4_^_L?_ ,11_P *8\/?\_FI_P#?V/\ ^(H_M7#=W]P?
MV)B^R^\\1HKV[_A3'A[_ )_-3_[^Q_\ Q%'_  ICP]_S^:G_ -_8_P#XBC^U
M<-W?W!_8F+[+[SQ&BO;O^%,>'O\ G\U/_O['_P#$4?\ "F/#W_/YJ?\ W]C_
M /B*/[5PW=_<']B8OLOO/$:*]N_X4QX>_P"?S4_^_L?_ ,11_P *8\/?\_FI
M_P#?V/\ ^(H_M7#=W]P?V)B^R^\\1HKV[_A3'A[_ )_-3_[^Q_\ Q%'_  IC
MP]_S^:G_ -_8_P#XBC^U<-W?W!_8F+[+[SQ&BO;O^%,>'O\ G\U/_O['_P#$
M4?\ "F/#W_/YJ?\ W]C_ /B*/[5PW=_<']B8OLOO/$:*]N_X4QX>_P"?S4_^
M_L?_ ,11_P *8\/?\_FI_P#?V/\ ^(H_M7#=W]P?V)B^R^\\1HKV[_A3'A[_
M )_-3_[^Q_\ Q%'_  ICP]_S^:G_ -_8_P#XBC^U<-W?W!_8F+[+[SQ&BO;O
M^%,>'O\ G\U/_O['_P#$4?\ "F/#W_/YJ?\ W]C_ /B*/[5PW=_<']B8OLOO
M/$:*]N_X4QX>_P"?S4_^_L?_ ,11_P *8\/?\_FI_P#?V/\ ^(H_M7#=W]P?
MV)B^R^\\1HKV[_A3'A[_ )_-3_[^Q_\ Q%'_  ICP]_S^:G_ -_8_P#XBC^U
M<-W?W!_8F+[+[SQ&BO;O^%,>'O\ G\U/_O['_P#$4?\ "F/#W_/YJ?\ W]C_
M /B*/[5PW=_<']B8OLOO/$:*]N_X4QX>_P"?S4_^_L?_ ,11_P *8\/?\_FI
M_P#?V/\ ^(H_M7#=W]P?V)B^R^\\1HKV[_A3'A[_ )_-3_[^Q_\ Q%'_  IC
MP]_S^:G_ -_8_P#XBC^U<-W?W!_8F+[+[SQ&BO;O^%,>'O\ G\U/_O['_P#$
M4?\ "F/#W_/YJ?\ W]C_ /B*/[5PW=_<']B8OLOO/$:*]N_X4QX>_P"?S4_^
M_L?_ ,11_P *8\/?\_FI_P#?V/\ ^(H_M7#=W]P?V)B^R^\\1HKV[_A3'A[_
M )_-3_[^Q_\ Q%'_  ICP]_S^:G_ -_8_P#XBC^U<-W?W!_8F+[+[SQ&BO;O
M^%,>'O\ G\U/_O['_P#$4?\ "F/#W_/YJ?\ W]C_ /B*/[5PW=_<']B8OLOO
M/,/!'_(Y6/\ VT_]%M7KM-TKX5:'I&IQ7UM=:@TL6=HDD0J<@CL@]:Z+^P+7
M_GI-_P!]#_"O*QF+I5JBE#L>WE^!K8>DXSWO_D<_170?V!:_\])O^^A_A1_8
M%K_STF_[Z'^%<7M8GH^QF<_170?V!:_\])O^^A_A1_8%K_STF_[Z'^%'M8A[
M&9S]%=!_8%K_ ,])O^^A_A1_8%K_ ,])O^^A_A1[6(>QF<_170?V!:_\])O^
M^A_A1_8%K_STF_[Z'^%'M8A[&9S]%=!_8%K_ ,])O^^A_A1_8%K_ ,])O^^A
M_A1[6(>QF<_170?V!:_\])O^^A_A1_8%K_STF_[Z'^%'M8A[&9S]%=!_8%K_
M ,])O^^A_A1_8%K_ ,])O^^A_A1[6(>QF<_170?V!:_\])O^^A_A1_8%K_ST
MF_[Z'^%'M8A[&9S]%=!_8%K_ ,])O^^A_A1_8%K_ ,])O^^A_A1[6(>QF<_1
M70?V!:_\])O^^A_A1_8%K_STF_[Z'^%'M8A[&9S]%=!_8%K_ ,])O^^A_A1_
M8%K_ ,])O^^A_A1[6(>QF<_170?V!:_\])O^^A_A1_8%K_STF_[Z'^%'M8A[
M&9S]%=!_8%K_ ,])O^^A_A1_8%K_ ,])O^^A_A1[6(>QF<_170?V!:_\])O^
M^A_A1_8%K_STF_[Z'^%'M8A[&9S]%=!_8%K_ ,])O^^A_A1_8%K_ ,])O^^A
M_A1[6(>QF<_170?V!:_\])O^^A_A1_8%K_STF_[Z'^%'M8A[&9S]%=!_8%K_
M ,])O^^A_A1_8%K_ ,])O^^A_A1[6(>QF<_170?V!:_\])O^^A_A1_8%K_ST
MF_[Z'^%'M8A[&9S]%=!_8%K_ ,])O^^A_A1_8%K_ ,])O^^A_A1[6(>QF<_1
M70?V!:_\])O^^A_A1_8%K_STF_[Z'^%'M8A[&9S]%=!_8%K_ ,])O^^A_A1_
M8%K_ ,])O^^A_A1[6(>QF<_170?V!:_\])O^^A_A1_8%K_STF_[Z'^%'M8A[
M&9S]%=!_8%K_ ,])O^^A_A1_8%K_ ,])O^^A_A1[6(>QF<_70:!_QX/_ -=3
M_(4?V!:_\])O^^A_A5VSLX[*$QQ%B"V[YC_GTJ*E2,HV1I3IRC*[)Z***YSI
M"BBB@ HHHH ***Y'XC_$&R^'GAP7]S$;FZG?R[6V#;?,;&22>RCN?H.].*<G
M9";25V==17@WB"_^)6H:+X5UF\\20:*NM:Q:0VUEI\'^J$H8H\C$Y<  9C.5
M.>>F*TSXV^(O@KQUH^@^,8-/U;3]7O([:#48(S&3O<*>G (W9*E>>Q[UK[%]
M&B/:+L>S45Y3\=_'VK>"=#TI/#MX+.^O+AB9/*20^6B\C#@CJZ\X[5XC_P +
MU^(W_0Q?^2-O_P#&ZJ&'G./,B95HQ=F?8E%?+?@3XI?$CQ9XZTK1?^$A)CN9
MQYV+*WXB7YG/^K_N@U]25%2FZ;LRX34U=!117+^./B%H7@'35N-:F9IY0?(M
M(0#+*1Z#L/<\?RK-)R=D4VDKLZBBO*/#VO\ Q+^(*IJ-C%8^$]#D^:&6:$W%
MQ*OJJM@$'U(7VS7>'1-6;0X;0^*=06]C)9[]+>V#2=>"AB*A1[ 'CK52ARNS
M8E*^J1MT5\E^(/C#\1M#\3:GI/\ PD_G?8+R6V\S[!;C?L<KG'E\9Q7JU_I'
MQ>C\-Q:MHGCB'4Y6MUN/L;Z5!$S97<54[2"?RS[5I*@XVNUJ0JJ>R/7J*^>/
MA]^T+J4^NV^E^-HH'@N'$2WL,?EM$Y.!O'0KGK@#'7FOH>HG3E3=I%1FIJZ"
MBBBLRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **\EU;XGZSXA^(4G@KX=QVB3VY87>
MIW@+)'LX?:HZX/&3G)[8YK#T9/BI)JWBK^Q/%D6IW.EWHC>UO;=0DYV@_N\Y
M$?IM! [YK94G;5V,_:+H>[45P'PG\>:KXXTO4?[?T^*QO]-N!;S+$&4%L<Y5
MLE2",8R:Y_QW\6=13QU;>!_ JVYU.:=()[VX7<D+M_"%Z$@<DG..1C-2J<G+
ME'SJUSU^BO$?%'CCQO\ "36M,_X2C4[?Q3I.H!MSK9I;2QE=NX+LXR-P(SG/
M/3K7L>DZI::WI%KJ>FRB:UNXEEB<#&5(].Q]J4H.*3Z#C)-V+=%%<]XBUS5(
M)O[+\*V$5_J[()&^T2%(+5#D!Y&'/)! 4<G!Z 9J4KC;L=#17SIX]\5_&7P'
M<0WFKZG8M8SOM1[*VC>'=C.P[D#@X]>N.#7I/PA^)3?$70KIKVV2WU+3W1+@
M19V.&!VN,\C.UN.<8Z\UK*C*,>;=$*HG+E/0J*1W6.-GD8(B@EF8X 'J37D>
MK?&N?5O$'_"/?##2/[=OR2&NY25MTQP6XP2H_O$J/3.:B,)2V*E)1W/7:*Y+
MPYH_C1+B&\\5^*(92,E].L+*-8>G0R,"Y Z\;:ZVI:LQIW"BBBD,**** "BB
MB@ HHHH **** "BO./B=\5#X+O++1-%LTU#7M0QY,4C8CB#-M4MZDG@#(Z$D
MCORU_;?$X?$;2-.E\:P0:A=:?-<"*"U'V6/:1E"I^_\ [Y&1VK6-)M7>AFYI
M.R/<**\G\$>/?&9^(S^"O'6G6:W(@:9+NW!7S% X8=F!]L8[C/%=IXK\=Z3X
M1A?[:MU=7*Q>=]ELK=I9-G/S''"C(/+$#BI=.2=BE--7.DHKYU@_: USQ/X_
MT/3-'M(=*TVYU*WAE# 2S2HTJJP+$84$'L,CUKZ*ISIRA;F%&:EL%%%4M8U>
MST'1;O5=3E\JTM(C+*^,X ]!W)Z >M9[EEVBO$_"OC'QW\6=0U.X\-ZM;>%M
M*L658\V:74DK$' 8OQVR2,8R.#5WX>?%V_O?&-SX+\;Q01ZM!/)!#=P#:DSH
M2"I'8G!((P#TQG&=G1DK^1FJB9Z_17/^-O%]GX)\,RZK>HT[[A%;6T?WIY6^
MZ@_4GV!Z]*^>/$?QB^*UG=)>7=O-H-I,V889-,"HPZ@!I5);CT-%.C*>P3J*
M.Y]3T5Y/\'OC#)X[EFTC7(8H-6AC\U'A!"7"# /!Z,,CCOGMBO6*SG!P=F5&
M2DKH****DH**** "BBB@ HHHH **** "L7Q#XQ\/>%+5[CQ!JUM9JN/D9MTA
MR0!B-<LW7L#QST%<K\;/&EYX,\ F;29#%?WTXM8I0.8@5+,P]\+@>YSVKR*+
M1_#5Y^S9K'B",1W_ (D\R/[;=7#>9/"YN4  )Y4%.XZY//4#>G2YDI/:]C*5
M2SLCZ3T[6]*UA2VDZG9WR@9)M;A9 !_P$FKU>%_%[X2:?I6AS>+/!$3:3>Z>
M/-GAM&**R=W4#[C+UXP, \9KT7XA2^(;G3;;0O"&8-0U1F1[XY"6<*XWON[,
M=RJ!UY)'3(EPB[.+W*YGK=&U?>*O#VF7GV34M>TRSN<X\FXO(XW_ .^2<UIQ
MR)-&LD3K(C#*LIR"/4&OEWQO^S]J_ASP[<ZY::RFL&W4S7<9@,;A>K,#N;=C
MJ<XXR:L?LY^+]0M?%Q\,RRO+IU[$\D<3'(AD4;MR^@(!!'KCTK1T8N'-!WL9
MJH^;EDCZ<HHHKF-PJO'J%E+?R6,5W ]W$H>2W653(BGH2N<@>]>/_&>?X@Z9
MX3GU:+7;/3]/CE6.2UTY764JQV@^:>2<GD +U[URO[,3M)XJUYY&+NUHA9F.
M23OZFMU1_=N=S)U/?4;'T3J&I6.DV;7>JWMO96RD!IKF58T!)P,LQ ZUC_\
M"P/!O_0VZ%_X,H?_ (JNA(R,'D5\:_&RU@LOC'KL-I#'!$&A8)&H4 M!&Q.!
MZDD_C11IJH[,*DW!7/JG_A8'@W_H;="_\&4/_P 56O8:I8:I$9=,OK:\C4X+
MV\RR ?B":\R\!?#GPCXD^$FB-JN@63SSVF9+F.(1S$DGYMZX)/U-?/=^^I?#
M+XDWT.A7\D<^F731QS#_ ):(#P''0@C&1TJXT8S;C%ZHF51Q2;6A]MT5G^']
M4_MOPUIFJ^7Y7VZTBN=G]W>@;'ZUH5R[&X4444 %%%% !1110 4444 %%%%
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M]E__ )&;7?\ KS3_ -#KTC]H#_DCVH_]=X/_ $8M>;_LO_\ (S:[_P!>:?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?:2TAN4,<]TEQ%%Y$?38@9@<D=QT'3D\>@44>T=T^P^16?F?'?\ PHKXC?\
M0N_^3UO_ /'*ZSX8?!KQ?I'Q'TG4O$>CBUL+.1IGD^TPO\P4[.%<G[VWM7TQ
M16LL3-JQFJ$4[GB?[17A/Q%XAM=&NM"L[C4+:T,JS6]LI=U9MNUM@Y/ (R.G
MXUT/P(\.:YX:^'K6_B&.2W>>Z::"UE^]"A51R/X22"=O;ZDUZ7163JMT^0OD
M7/S'EGQ:MO%?C#PG/X?T'PA>-YLZE[JXO+5%VHV05 E).<#KCCM7'_"'P=X[
M^'?B"\NM3\(3W5K>0")OL]]:[T(;((!E /?N*^@Z*:JM0Y+: Z:<N:Y1N;^Y
MATE;N+2;NXG958V,;PB52>H):0)D=\,1QQFOFSX@?#+XA>,_'>I:]!X4:VBN
MV39$]_;%@$C5!G$G4[<_C7U#12IU'3=TAS@IJS/'?#NH_%?PYX)LM#@^']O-
M<64(ABNWU: *5'W<QAN2./XN:XZV^ _C/Q?XFGU?QQ?VUD;J7S+@HXEE;V4+
M\H   '/ QP:^DZ*I5FKN*2N2Z:>[,_0M$L?#>@VFD:5%Y5I:1^7&IY)[DD]R
M222?4FM"BBL-S4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO,
MO&GB/4]3^*>B^ =)OIM-M[J!KK4;NV.V8Q@.1&C_ ,.=G+#GD8/!!J,7)DR=
MD>FT5S#>%+JSU33KC1-;U&*TBN-]Y9W=[+<K<)M8##2%G4@D' 8*<<C.#7+_
M !G\3Z[H6EVTWAHL/[-FAO\ 461RI\GS-B1G'57;=D>B&G&',TD#E979Z?15
M33=4M-5T:VU2SE#6ES L\<AX^1AG)]..M>8^!_&VJW'Q=U?2/$$CI;:Q;1ZA
MHT3L2%A"\* ?NED^9A_>1OQ%!M/R!R2MYGK-%>)>)+ZTTWXZS:;K7B;4]+T.
M72FNG4ZW<0HLS,W*?O.#Z(..,!>U=7\%-3\0ZM\/EN/$[7$K"X9;*XNE(DGM
M]JE';/+9);YCR?U-2IVCS"4[NQZ%1116184444 %%%% !1110 4444 %%%%
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M?_P/B_\ BJ/^$V\*?]#-H_\ X'Q?_%4>SGV8>TAW-RBL/_A-O"G_ $,VC_\
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M(/\ XNCZQ1_F7WH/85OY7]S.'HKN/^%-^//^@%_Y.0?_ !='_"F_'G_0"_\
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M1_PIOQY_T O_ "<@_P#BZ/K%'^9?>@]A6_E?W,X>BNX_X4WX\_Z 7_DY!_\
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M^3D'_P 71_PIOQY_T O_ "<@_P#BZ/K%'^9?>@]A6_E?W,X>BNX_X4WX\_Z
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MN9R=%=9_PK#Q?_T"/_)F'_XNC_A6'B__ *!'_DS#_P#%T?6J'\Z^]!]3Q/\
MS[E]S.3HKK/^%8>+_P#H$?\ DS#_ /%T?\*P\7_] C_R9A_^+H^M4/YU]Z#Z
MGB?^?<ON9R=%=9_PK#Q?_P! C_R9A_\ BZ/^%8>+_P#H$?\ DS#_ /%T?6J'
M\Z^]!]3Q/_/N7W,Y.BNL_P"%8>+_ /H$?^3,/_Q='_"L/%__ $"/_)F'_P"+
MH^M4/YU]Z#ZGB?\ GW+[F<G176?\*P\7_P#0(_\ )F'_ .+H_P"%8>+_ /H$
M?^3,/_Q='UJA_.OO0?4\3_S[E]S.3HKK/^%8>+_^@1_Y,P__ !='_"L/%_\
MT"/_ "9A_P#BZ/K5#^=?>@^IXG_GW+[F<G176?\ "L/%_P#T"/\ R9A_^+H_
MX5AXO_Z!'_DS#_\ %T?6J'\Z^]!]3Q/_ #[E]S.3HKK/^%8>+_\ H$?^3,/_
M ,71_P *P\7_ /0(_P#)F'_XNCZU0_G7WH/J>)_Y]R^YG)T5UG_"L/%__0(_
M\F8?_BZ/^%8>+_\ H$?^3,/_ ,71]:H?SK[T'U/$_P#/N7W,Y.BNL_X5AXO_
M .@1_P"3,/\ \71_PK#Q?_T"/_)F'_XNCZU0_G7WH/J>)_Y]R^YG)T5UG_"L
M/%__ $"/_)F'_P"+H_X5AXO_ .@1_P"3,/\ \71]:H?SK[T'U/$_\^Y?<SDZ
M*ZS_ (5AXO\ ^@1_Y,P__%T?\*P\7_\ 0(_\F8?_ (NCZU0_G7WH/J>)_P"?
M<ON9R=%=9_PK#Q?_ - C_P F8?\ XNC_ (5AXO\ ^@1_Y,P__%T?6J'\Z^]!
M]3Q/_/N7W,Y.BNL_X5AXO_Z!'_DS#_\ %T?\*P\7_P#0(_\ )F'_ .+H^M4/
MYU]Z#ZGB?^?<ON9R=%=9_P *P\7_ /0(_P#)F'_XNC_A6'B__H$?^3,/_P 7
M1]:H?SK[T'U/$_\ /N7W,Y.BNL_X5AXO_P"@1_Y,P_\ Q='_  K#Q?\ ] C_
M ,F8?_BZ/K5#^=?>@^IXG_GW+[F<G176?\*P\7_] C_R9A_^+H_X5AXO_P"@
M1_Y,P_\ Q='UJA_.OO0?4\3_ ,^Y?<REX(_Y'*Q_[:?^BVKUVN&\*_#[Q/IO
MB:UN[W3/+@CW[F^T1'&48#@-GJ17HW]CWW_/#_Q]?\:\3,*M.=5.,D]._J?1
M971JTZ+4XM:]5Y(I45=_L>^_YX?^/K_C1_8]]_SP_P#'U_QKS^:/<]7DEV*5
M%7?['OO^>'_CZ_XT?V/??\\/_'U_QHYH]PY)=BE15W^Q[[_GA_X^O^-']CWW
M_/#_ ,?7_&CFCW#DEV*5%7?['OO^>'_CZ_XT?V/??\\/_'U_QHYH]PY)=BE1
M5W^Q[[_GA_X^O^-']CWW_/#_ ,?7_&CFCW#DEV*5%7?['OO^>'_CZ_XT?V/?
M?\\/_'U_QHYH]PY)=BE15W^Q[[_GA_X^O^-']CWW_/#_ ,?7_&CFCW#DEV*5
M%7?['OO^>'_CZ_XT?V/??\\/_'U_QHYH]PY)=BE15W^Q[[_GA_X^O^-']CWW
M_/#_ ,?7_&CFCW#DEV*5%7?['OO^>'_CZ_XT?V/??\\/_'U_QHYH]PY)=BE1
M5W^Q[[_GA_X^O^-']CWW_/#_ ,?7_&CFCW#DEV*5%7?['OO^>'_CZ_XT?V/?
M?\\/_'U_QHYH]PY)=BE15W^Q[[_GA_X^O^-']CWW_/#_ ,?7_&CFCW#DEV*5
M%7?['OO^>'_CZ_XT?V/??\\/_'U_QHYH]PY)=BE15W^Q[[_GA_X^O^-']CWW
M_/#_ ,?7_&CFCW#DEV*5%7?['OO^>'_CZ_XT?V/??\\/_'U_QHYH]PY)=BE1
M5W^Q[[_GA_X^O^-']CWW_/#_ ,?7_&CFCW#DEV*5%7?['OO^>'_CZ_XT?V/?
M?\\/_'U_QHYH]PY)=BE15W^Q[[_GA_X^O^-']CWW_/#_ ,?7_&CFCW#DEV*5
M%7?['OO^>'_CZ_XT?V/??\\/_'U_QHYH]PY)=BE15W^Q[[_GA_X^O^-']CWW
M_/#_ ,?7_&CFCW#DEV*5%7?['OO^>'_CZ_XT?V/??\\/_'U_QHYH]PY)=BE1
M5W^Q[[_GA_X^O^-']CWW_/#_ ,?7_&CFCW#DEV*5=!H'_'@__74_R%9G]CWW
M_/#_ ,?7_&MC2+:6UM&2=-K&0D#(/&!Z5G4DG'1FM&,E+5%^BBBN4[ HHHH
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M2-8Q137 7]W'-*8T8^A8*Q ]\'Z5-4-W<I9VDEQ,LK)&NYA#"TKD>R("S'V
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M/JMISR2:9;/-!);2-$I:&7;NC./NG:2,CV)%6:Q- HHHH **** .1L/&\O\
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M=SW,+H51U9DAV,S,6(X9U3 !)Y^6M8\ME?YD2N=3/XBT2VODLKG6-/ANY)A
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M+\7:]XGU>XG/V%K*.7R;G3Q$T<^GMNE&'<L=S@QJ"NU<[\C 'S;7P[L[_3?
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MN.Y)ZU/9Z'I.G7UQ>Z?I=G:W=T2UQ/!;HDDQ)R2S 9;DYY[UROP_U&_O]?\
M%RZA-J!$.HQB*"_92]L#"C&,!/D !)QMR#UR<Y-Y?B#IIO-71[+48K317=-0
MOYH5CA@VQ[\X9A(^1P-J,2<'H5);C*]A)JUS?_LK3_[+;3?L%K]@92C6ODKY
M14]1LQC!R>,50_X0SPOY$,/_  C>D>5;NTD,?V&+;&S8RRC;P3M7)']T>E8N
MF_%3P]J<-\8S*L]F(\VZ2PW#S&1MD:QF&1T9F;"[=P()&<#FL73_ !G=:3XF
M\7WVLVVMR6EN]@HLIFA+60D#C( <(5SMY0L3D9R0<-1GJ'-$[_3-"TG13,='
MTNRT\SD&8VMND7F$9P6V@9ZGKZFE71-*76&U9=,LQJ3+M:]%NOG$8Q@OC=C
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M-HY%R1N4C!&1ST-2T4AG+Z7X&M[+6I-2U#4[[5Y 6%NMZ4*PAHTC;[JC>Q5
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MWYMOEX_AS_%3][N+W2>S^&]O8QZ2D7B#6&32;N2[ME?[-]^3.\-B'D'>_O\
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M@;P)X=:WG@^PR*DUW]MREU*K13;F;?&P;,7+N<(5'S-QR:SIO$MQ>>-O"?\
M8^HQ2Z%K%G<S;$A^:4HBLK%SR!\P^4 $$'.>@U(/&WA^>29%OF3RH&N0\MO)
M&DL*]9(G90LJ<@[D+#!![BG[Z%[HD_@C0KB*U66WN3):L[17*WTZW&7&&S,'
M\Q@1@$,Q& !V%7-%\.Z3X=T?^R]#LDL;/+'RX2026ZG=G.??.>!Z"GZ3KEAK
M<<SZ=+(Y@D\N9)87B>)\!MK(X#*<$'!'<5R7C?QL;">PL]!U$1W(U>UM+O\
MT-I$8/(H:(2D>6K[6R5R6QS@=:$I2?*-\JU-,?#;PT(#"(M1\LW/VO;_ &Q>
M<39+>9_K>&W$G/4GGK5_5/!^B:QJ)OKZTD-P\7D2O#<RP^?'G[D@1@)%_P!E
MP1R1WJ(>.= \@3&YN%3[>-.8M8SKLN#M 1@4^7.]<,< YZU8?Q7H\>L)ICW3
MK/)+Y".;>3R6EP3Y8FV^7OX/R[L\8QFE[_F'NE2\\ ^'KZXOYKBWNMVH0"VN
MECU&XC22(=(]JR!0O48  PS#HQS/8>#M'TS5XM3M$O/M<5N+9'EU"XE B X0
MJ[E2._(Z\]>:9K_BZT\/ZUI&FW-K>32:I*\:O;VLDHC"QLV?D4Y.5 P.0"6.
M #4@\8Z&=972_MC"X><VR.;>00O,!DQ+,5\MG&""H;(((QD$4>_8/=N/U7PM
MI.LZA'?7D,Z7<<1@%Q:W<UL[1DYV,T3*67/(#9 )..IJIJO@'PWK4L[ZAI[L
M+F%()XHKJ6&*5$SL#1HP5MN>"1D<8Q@5'XS\07>EMI.E:.8X]3UJ[^RP3RIO
M2W4 M))MR-Q"C@9 R1GC@LNEUOPU+_:%SK4^JZ-;V\\]X+J&!9DVH67:T:("
MO!XVYR1SC@-<UMQ.W8OIX/T.+4HKV&S:)H61XX([B1;=61 B-Y ;R\JJJ =N
M1M7'057/@'PW]C-J+!UC^T_:HV6ZF$D,FXMF-P^Z,99CA"!\S<<G.)9S^*]5
M\#KXL@UO[->7%H+^VTH6\3680J'6)R5\TDKU8.,,<@8&TUY_$NHWEUX.\26N
MKW5EX?UIXXKJR\J B*1T)C!=D+;6<;&Y[C!%.TNXKQ['3/X'T&3["3;W(:PF
M:X@9+^=6\UNLC$/F1SD@L^202.A-5A\./#8@6(0ZAL6Z^V#_ (F]WGS\Y\S/
MFYW9YSZ\U)>6VJ7FO:E):>(KVTLK>V5/L\$%N0DY!8D,\;'A=AP<CY_PKB[+
M5?$MWH?@2Y?Q7J*2^() MV4MK3@&%Y/DS!QRH'.>/SH2D^H/E70[Q_!NBMJ%
MQ>K#<PR7,AFF2"^GBB>3 'F&)7";^ =V,Y ;.0#26W@K1+30X](MH;J.SBF,
M\0%_/OB<@@E9-^]>IX! R2>I-8T.J:WX;^(6G:!JVHMK&FZVDS6=S-"D<]O+
M$@9HW,:JC*0"0=H/..<<])XDEOH/#.H3:3<16UY%;L\4TL/FJI R?EW#)P#C
MG ."0>A3YE97'IV)+71=/L]'?2X+<?8Y XDCD9G,F\DN79B2Q8L222223FL>
MW^'?AJVW[+2Z??:-8L)M1N)0UNRE3$0TA^0 G"]%))&#S62?$^HOX)\$-)?-
M;7?B'[+%<ZB(D)C9X#(2H(V!V90HRI W'CC%;/A/5;VYOM<TC4[G[9-H]XL*
MW>U5::-XDD7<% 7> ^TX !QG HM))NX7B^@K^ O#TBP VMP#;P-;HZ7\ZL48
M[B&8/E_FY!8D@@$8(%+)X#\/RZ%8Z.T%V+'3Y%EM8UU&X4Q,IRI#"3=\O\.3
M\O;%=%14\TNY7*NQBMX0T-M9.J&R/VAIEN&43R"%Y5&%E:'=Y9<8&'*[@0#G
M(%5=0^'WAG5;NXGU#36G^U3K<S0-<R^1)*H4!S#N\O=A "=N2,@Y!.>DHHYI
M=PLCG;GP'X=NIKF66QD$ES<+<LT=W-&4E7&'CVN/+;Y5R4VYP,YQ21^ ?#L5
MC-:):7'ES7*W98WTYD6<?\M4<ON1SDY92"V3DG)KHZ*.:7<.5=CG[GP/H%WI
M]K92VLXAM;C[5'Y=[/&YFSGS6=7#.^>=S$G/.:F3PEH\6L2:E%!-'-+/]HDC
MCNYE@DEP!YC0AO++?*#DKG(!ZC-;5%',^X604445(PHHHH **** "BBB@ KD
M]=\'7E_K&H7VCZPFG_VK8"QOXY;3SPZKNVR)\Z[' D<<[E.1\O'/644TVMA-
M)G&:7X)U7P\EFVA>(8_.CT^*QNS?V'G).(L^6ZJDD90J&9>IR-N<D;C)=^"[
MW4/$EY>W^KP3V%[IG]ESVQLB)7A^8D^:)-H<LY.0F,< #K77U#;-<LLGVR&*
M(B1A&(I3)N3/RL<JN"1U7D#U/6JYY;BY4<EJ'A#Q%JOA*[T"_P#$UI)%/:&T
M$W]E$.5. 7?]]AGP."NT9))!X N/X9U6;Q/H6KS:M9D:5:R0/"E@X\XR;-[!
MO..W_5K@8;'.2<C'3U5U/4(-)TF[U&\)%O9P//*5&2$12QQ^ HYI;!RHP]/\
M,:EID]Q:VFL0_P!B3W4EP;22S+31B1M[QK-Y@ 0N6/*$@,0#T(R=/^'>HV5Y
MX=#>)=UAX<FD-E$EBJS/$R,@CDD+,K84A=RHI(ST)#+NZ'J^OZG< ZAH-M8V
M31K*EPNH^:7##*@)Y8.1T;) '&TOSC?IN4D+E3.&\<?;Y/&?A+^RA<1RPW$S
M-=#39KJ"$/$R+YFS  )./O+C.20!FGVW@*^M-7TG4(M9@:6TO9[Z[,EB2;J6
M8%9-N)0(UV'"C#8P"2W.>VK"UGQ*^D>)="TK^SY)DU>:2+[5YJJL)6-GQCDL
M3M] /?M0I.UD#BMV9%WX FN!JVGIJZKH.L71NKNRDM=\H9F#2".7> JL1R"C
M$9.",C%_3_#6I:1JMTVEZS%'I=Y>M>RVLMEOE5W;=(J2[P K-D\HQ&3@CC'2
MT5//(?*CE=.\):A86<FCG68Y=!;S52U-GBX6-\_N_.WX*C<<?(#@ 9[U1T[P
M%JEKJWAZYO/$OGV_A^*2"VBBL%C>6-E50LCEF!.% )55S['FNXHI\\@Y4>?Z
M;\.=7TPZ&(/$\030(I8K)1IH^=77 \TF0[N@SMV9'3!YJY8>!+S3_".AZ7#K
M48U#0I1)97RV9"$!2A22(R'<&1F!PR]01C%=I10ZDF'*CCO$?@J_\4Z,EGK.
MH:3=N?,$@N-(+1+N"@-$!,)(V4 _-YASO;_9"Z6M^&'U?P.WAX:E,K&&*(W<
MX\YI-A4GS!D;P^W##(R&;UK?HI<S#E1YS/\ #7693=^7X@TV%;J]M+UD31F"
MQM;A B(!<#"8C48Y.,\U;N/A]J5WJ>I:A+KUNES<:A!J-JT.GL!;RQ1B)0P,
MIWJ8Q@CY3DD@C@#NZ*KVD@Y$<UX8\+7FAZQK.IZAK'VZ;5I4FDBBM1#%&RH$
M^499NB]VZ>IY-6+P//+_ ,)1%JNJ1SV_B!_,(MK4PR6S!%12&,C D!%/0?,"
M>AQ77T5/,]PY4<E?^%-;UO0VLM;\0PO<PO#-9W5GI_D^5/$X=975I'W\J. 5
M&"W?!7/N?AUJ&HMXAGU/Q$KW&MPVZ%;>P$<,+PME'VL[.>@XWCJWJNWO:*:G
M);!RHX2?X=W]_?ZIJ.I>(R;^\^RRP&UL5CAMI[=BT4@1F=F'8J7P0S^J[-2]
M\-ZSJ4%K<7>N6ZZK8W2W%G/;V!2!!M*,C1&1F8,KN#\X_A(P1ST]%'/(.5'*
MWGA;6+J_TW6!KELFLV)F3S/[/)MGAD4 Q^5YNX<HC;O,)R#V(46?!_A9_"WA
M^73+G4I-2\RXFG+O$L07S'+%0%YQDGJ3R3C P!T-%+F;5A\JO<X&T^&]_;2:
M! ?$>=.\/W#R6<2V*B9HV5E$<DC,5;"L%R$7C/<AAH6/A37--T+^Q+3Q#;'3
M88'M[19M.+RI&0519'$H#A5( PJ$[5R>N>NHIN<F+E2.%T[P+K>FW&@S1:_I
M[MHFEOIT(;2GQ("% =OW_4>7'P.OS=,C;1@^%NH0Z;IUJ=?LY38V,]@CRZ67
M")*>9(P9OW<N-R[N000-O'/I%%/VDA<D3@(/A_KD/F9\1:>V[14T9<:2XQ&N
M</\ \?'+?,?;I^(OPZU2"PF@LO$4$+7NE1Z9?L=.++*D:LD<D8,O[MPCD')8
M'K@5W]%+VDA\B.=;PK(_PZ/A8ZM<;_L'V,7X15<?+M#;5P,#ICKC@G/-8EM\
M/-1@DU$G4]',-_;6]N]H-"'V=1 S%0(S,1L(=@R]<\AEQ7>T4*<D'*C!\*>%
MX_#/APZ29EGC:21RB(R11ASG9&C,Q5!Z;CR3ZX&?IO@N\M/#[^&KS6$NO#_V
M:6TC@%ILN/)9654>;>5(56QE44G:I)ZYZZBES,?*CBE\#ZI+!:+J.O6]W+IM
MK+;Z?*=/*E/,387E E_>,$&!MV#DD@\8BT[P+K>FW&@S1:_I[MHFEOIT(;2G
MQ("% =OW_4>7'P.OS=,C;W5%/GD+E1Y1'H&L^'?$7@[1[&]:>33;2\B_M#^P
MYWME$IBV+)M?&3L?D2+C R #@[$WPR=4L39:M%YL-O=1SO>V7GAY;AP\D\0#
MKY4F=X!^8;6Q@XY[^BG[20N1'&>&?!.J:'K%K=WNLV5[#;Z5%I0ACTYHBT49
M)5BQF8;LGGC!]!4MCX,OK?0'\-WFM)<^'_LLMG' +39<^2RLBHTV\J0JM@$(
MI.U<GKGKJ*7/)CY4<7I?@C5K;Q'H^JZGXD6Z_LFS>SCC@L%A,R-MYD8N_/RC
M.T+GC&.<Z.L^%'U;Q-;ZHM\(818S:?=6YAW&:&1T8A7W#8?DQG#<$XP<$='1
M2YW>X<JV.0TCP3=V<NCQZMK"ZE::#N_LY!:>5*/D,:F5]Y$A5"1PJ9/)S77T
M44G)O<:26P53U>.XET.^CL8H9KI[>188[@9C=RIVAQW4G&?:KE%(9XXOA+Q+
M<V^LJ^B:@DNH>&3IPDN[JUP)UWD*$C?9''\P50B@<$L 26.WJ&E:W<ZC]KF\
M+RW<%UX?.GRVS7%N?+<2,P#AGVG(P>,C/!/>O2**U]H^Q'(CR^3P[JJ^"O 5
MM'X7F:_T2YMGN45[8-"L2XD(8R8.\_,,'G'S8/%22^$-3G.K:.VCK&+_ %]=
M4765DBV1QB1)!@9\SS0%9 -N.?O8KTRH;:ZCNUD,2RJ(Y&B;S87CR5."1N R
M/1AD'J":/:,.1'F=[H7B=))[&QT$S_\ %4KJZ7<EY%' \/F*V."9 P[C9T!(
M). 9;C1O$]O#J%O:Z+(\;>(GO_M$4ELTS0/D[H!*2JR X!+[2 3MR>1Z;6?<
MZ]IEGKEEH]S>1IJ-^':WMN2SA068\=!@'DXSC YH]H^PN5=SS73/"FMV=CIL
MDOARXD72O$5SJ(LY;N&666*7S-A5VD(9T+J2793E<@DU:G\,ZW;1:=/;:)-(
MT_BC^VY[6">$?8XMFW82SJ"YSN(3<,E^3P3ZA6?J6O:9H]W86NI7D<%QJ,WD
M6D1R6E?T '8=ST&1D\BCVDF]@Y$D<3H'A*2QUN%-5T'4KJXM-1GN;?5#J[&T
MQ([OYODF;*N0Y4J(\%L\X.:WO$=AJ3^,/#>IZ=8->16;7$<^V5$\OS$558[B
M,J,'.T$^@-=114N;;N5RI*QYGI/AC7?[/\.:+?Z68)]!U(7+ZR)8C'<1@N6*
M -Y@>3< P90.6)8\ ]#XST'4+S4=$\0Z'%'<ZEH4TLD=I))Y8N8Y(RDB!CPK
M8Q@GC(YQG-;>CZ]IFOQ7,NC7D=Y':W#6TKQYVB10"0#T/WAR,CWK0IN;O=B4
M58YJZCU#Q;I=_I5_I$^CV%U:RV\S7CQ/,Y=2HV"*1U &<Y8YR  .<C$CA\6I
MX%7PG_8>;U;/^SQJWVB+[)LV;/.V[O-SMYV>7][C..:] HI*5N@^4X[7O!LG
M_"M;71=!;.H:-'!+IDLA /GP8*$GH-V"I[88U<>UU&W\ W:/8276JWD,CS6M
MO)'D2S$DJ'=E4JF[&2?NIQS@5TM4-1US3=)O+"UU"[CAN-1F\BUB.2TKXR<
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MB>S3?;QNC8R)NHV/@'O)[MCU^L_7->TSPWI;ZCKEY'9VB$*9'R<D]  ,DGV
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M;*,1NPZ,5VX)'K4\\;:H?*SG7O-7L?%FA:5<^*'NHKRPODNIH[>","6$Q[9
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+RW6Y>S>_MX4:%)E!+(?GW@ C:7V[ W!8<X9X)\3W?BK2;B\O-*ET[R[N:%
M[QL'"2,F!M=CD;<-D 9Z9'-,TGPQJFB7TZV&M0+IES>->2VS6.9%=VWR*DGF
M85&;)P48@,0#T(M>%?#L_ANVO+5]06[MI;N:X@00>68A)(\A#'<=YR^,_*,
M<#G,OEMH4N:^I5;QWIZ7D0>SOAITUY]ACU;8AMFFR5V_?W@;P4WE-N[OR":U
MG\2M,OKJ)(=,U9()-1.F&ZFM1$B3Y( (9@^"1V4XZ-M/%10_#^6.(Z4^K++X
M=&H?;X[%[8^=&WF"7R_.WX,?F9;!3=@XW=ZJK\/]<%JD1\1:>676CK.[^R7P
M9"Q;9C[1]W)/?./SJK4Q>^=5KVOP:!#:F6WN+NXO+A;:VM;8+YDTA!; W,J@
M!58DL0./7 //I\3[%K**>30M;C>;46TR* V\;.TZD@J2LA5>1C+$9ZC(!(D^
M(]O->:;ID,:W"1"^$LMQ!8SW1BVQOM^6W=9E.XKAD(QC!.#@Y&F>&=4U71]/
M@LKRUL;73-2%]%)/HMS$]RXR3N2:?S/O,Q+L<L3T &645'ENP;E>R-^]\=V]
M@EP\VC:JZ6*(^I-$D3_V>& ;]X!)EB%(8B/?A>>XJU%XOL[G6VT^RM+R[56C
M1[NW17B1I$$BAL-O *'=O*[.V[=\M9^I>";R?4M9DTO65L[/78PFH6\MIYS9
MV>67B?>NQB@ ^8.,@'':HKCX>1R^)M,U*&YM;>'3'B:W,=F5NT2.,)Y/VA7&
MZ-AG*NC<,PR.,'N#]XV="\46_B"4_8[&]2W(=HKN1%,,RJ^S*LK'!)S\K8<;
M3N4<9S=9^(FGZ-JNI:>=+U>\FTNU6\N3;VH"+$=Q+!G90V IZ=>BY(8!/#_@
M8Z+XJGUR2[M3--;M#(MC9?91<DON\R8!RCN#NPP53\QSGC$.L^"=5U35]>O(
M=;LX(]8TU=-\M].9S#&"WS;O.&YL2/V ^[QP<GN7\@]ZQ>M/'5E>75S FG:H
MACL?[0@W6V6NX,XW1H"7SG'RLJMR.*SS\4]'BL-8N+O3]3@ET9H5N[411S2(
M9<[?]4[J/NG(8@C&#U&:]U\/=7OF<3^([>)7T5M()MM/>-PIY#AC,<'<!D8Y
M&1QG(JW/PQU::VU2"+7=+M8M3MK:VEBM]%9$B6!F*>6HGPN=YR#GVQTII4^K
M%>9T%YXX6R:.%_#^L/>O!)=&RC6 RI A ,A_>[<$L %W;O\ 9JK:^.=)U.[T
M"9[+6;>74;.:^M%V,5,03)WK$[+(Q7!"#>PR,A21G(\=Z?=7VM:<E\]PBPV#
MJUU::1>SI*[L!(H-I,LB#"@[78J0P^\02+]OX;UK4IO#VKP7UAIK:3;3PV]L
MVD2*K+(-JL8S.&C&Q8R(S\PY!(/"EHVN%Y7+N@_$33O$%SI<=OIVIVT6JQR/
M:7%U"J)(8QEEQN+9 YSC:>Q-=;7":-X U;26\-*=>LYH= \Q57^S'5IED&&!
M/GG!VG@X//.#TKM+)+N.SC749H9[D#]Y)!"8D8Y[(68CC_:-1/EO[I4;]2>B
MBBH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*3AVC'*X)RVVO9RL+G1Z56+I_AI-/\4:EKBZE>S2ZBB)+;RB+RE"9V;=J!N
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M',+?:T)(^5ML0)^ZG((/R#U.>JHHYY!RH****DH**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *I:S9S:CH-_96D_V>>YMI(HIN?W;,I ;CT)S5VH;R\MM/
MLIKR^GCM[:!"\LLC;511U)--;@<%I6D:R]]X:NKKP])ILGARSEAF\J:!A>CR
MO+6*':_W20&_>; "%]R-GX<VFI:;X2CT_6-+N-/G@GF;$TD3AQ),\@(,;MT#
M '..?7K70Z;J-KJ^EVVHZ=+YUI=1+-#)M*[D89!P0"./6J)\4Z.E_IUC-=F"
M\U(2&UMIX7CD<(&9B4905 "GE@ >V<BK<FU:Q"26MSS_ $_PUKTGBG1[C6/#
ML\D%O<7L5VB2VHLUAGWA?*A5QE#NW.77S#NYW=!5\">'Y-=\*^#83H*6ECIK
M37,]Z_E&.Z1T>-HE56+'?O&_>H'R$?-QGT>U\0:%XCT4S6<@U33KJ9K)C';/
M-'(<E&# *04Z@L?DQWQ5NUT+2;+2Y=,L]+LK>PF#"2TBMT6)PPPP* 8.1P>.
M:IU':S0E!7/*O!6B7&K>#_"(B\.>5:Z5Y]W+< P8O5:.1##&N\$F3>-WF!5^
M3&2,$ZFE>&=>L/AYX;@@T3R;O0]2^U3Z8\L*_:ER_*,KE,CS PW$?,G;@UZ+
MIVE:?H]I]ETBPMK"WW%O)M85B3)ZG"@#-6Z3J-L%!)'FMUX8U'48];\W0)X(
M/$5_ WD^;#OTW8BJUT=LF/,+#<-C,>%)R<K69?>'_$4W@1/#\GA*6YN-+U2&
M6SO1+: W,:3;VG;,N5E90P8]6+Y/WF"^K7MY;Z=937=[,L-O"A>21SPH%5=&
MU[3]?@GETR61_L\IAF2:"2&2)P =K(ZA@<$'D=Z%4E:]@Y$>7:IX2U*XLO&$
M=MX(E#:SJ=M/!\UF-\2&-GW?O>[(YQW,@/=L:6H:5XCEU3Q%/IWAF6&*\DT]
MH?--F[;(6 ?RU9V02 '*%QM&WUP#W]KK^EWNN7FCVEY'-?V*(]S"@)\H-G;D
M],\=,YZ>HI=6UW3-"2V;5KR.V%U<);0!LDR2.<*H Y/)_ <GBG[26UOZT_R#
ME7<\ULO#?B"UL[O;X?U%MOB>#6(TGO8))9H?+16&XRX\P%"2"0.1M)K2MO"=
MPOB*X.LZ!J%^TFJC4;>\@UEEM(B6# M$95.Z/[HQ$=P5?4X](HJ?:,?(CS.'
M0-1?PIXI;4K.71KE=6FUG3KFXDB8(PPZ,?+=L8V$,#_"QZ\UW'AZWN(M(2?4
M(EBO[QC<W2*<[7;'R9[[5"H#Z(*LWVDZ=J<EO)J6GVMV]K)YD#7$*R&%_P"\
MI(^4\#D>E6Z4I70U&QYIK6CZ_K7CRQG&BO8WUE+'LUJ&91"+=9F9E^]O8M&=
MAC9<;F)Z -2GP=J*V<WAY-+PC:\-5AUM9(PJ)YXGR1N\SS0-T8PN,8.X<@=U
MJFO:9HLME%JEY';R7]PMM:H<EI9&.  !SW&3T'<BM"JYVD+E1R_B*ROM3?3]
M1L],G%UHFI^='!))&#=Q;&C<QD.5&5D)7>5.4P=H.:G\+:7=6]UK.KZE UK<
MZQ>"?[,SJQAC2-(D5BI*[L)DX) SC)QD]#14<SM8JVMPHHHJ1A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>mdt-20201030_g3.jpg
<DESCRIPTION>IMAGE 4
<TEXT>
begin 644 mdt-20201030_g3.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $9R:65D<FEC
M:"P@365G86X    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,W
M,@  DI(  @    ,W,@  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M1O%>@>(69="UFQU!EY9;>=7(_ &M>O /VD=/7PT- \9^'\:?JT-YY#3P#:9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKXT\=:^6L]-O+F1[>248WPK(S;P.N"2 /6O=6177#J&'H1F@HK)M905]".*
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M\3:MHNJ7VH[3;:<BJGEVL.> N6SN8\L<>PKZ;90ZE7 8'J",U']F@_YX1_\
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MU7Q5XF@CM]9UIRPM4 Q:Q%MVSCC)XX'0 5ZOL7=NVC=ZXYI: "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !12,P498@#W-0/J%I']^XC'_  *G9O85TBQ15!M;L%_Y
M;;OHIJ,^(+(=#(?^ U7)+L+FCW-.BO//$7QK\*^&-8;3=3%[YZHKDQP[A@].
M]4X?VA/ 4I^:[O(O]^U;^F:?LI]A>TAW/3Z*X:T^,W@"\(">([>,GM,CQX_%
M@!72:?XIT#5<?V;K5A<[N@BN%8G\,U+A);H:DGLS5HHSGI14E!1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;'93JJ>G4[2BBBN<V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS;;A //M)#^\B/N.X]Q74UY[33LSK335T%%%%(84444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU+29?"FHRYN+)?,LRQY>+NO_  $_H?:O<*\>I!PERL]&,E)7"BBBH*"BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+A)Q9Z49<RN%%%%04%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 5[^Z%G837#?\LU)'N>U
M>:.[22,[G+,<DUV'C&Z\NQBME/,K;C]!_P#7KCJ]7"0M#F[GBXZIS5.7L%%%
M%=AP!1110 4444 %%%% !1110 4444 %%%% &A9R;X=IZKQ^%6*S+:3RY@3T
M/!K3KDJ1M(]/#SYH6[!7@_QW_P"1JT__ *]/_9C7O%>#_'?_ )&K3_\ KT_]
MF-33^(VEL>6T445TF04444 %%%% !1110 5T7A?5M"T>3S]5T'^W+AG 6":4
MI$B^N%Y9C[\#WKG:WM#;Q!X>\GQ1I5G,D$,A1+Q[;?%N[C)!&:F6J*6YW7QL
M\/>%]&70KKP]9C3+V^M_.N=.!_U2D J2/X3DD>^*A'@O1? ?@6S\1^-+5M0U
M34QFPTHN415QG?(1R>"#@>H%=;X\UW3?&?PN\)>)M;M8;;4IM12%B!C>BL1)
M_P !XS[5T_Q!U!8_C)X,TRZM;:\TJ^B,+0SVZ2*=[;002#C'R]*Y%.22B_/\
M#=Q5V_0\C^%F@Z9\0OB8(M8M+6VLXH&F-G:J8TDVX 7KGOD\YXK1\8^%-&F^
M$47BJTLH=/OX=3EM&2W&U)8Q*ZK\OJ !S61\1[=?AW\8+L^#[AK$P;)8A$?]
M274$I].>A[&ETG6+_P 1V;:OXPG$GA[1)#,MG'&L27-RY)$850 2Q)+'L,^M
M::NTT]"-%>+W,>[TRR\->"X_[1MTFUO6%$D*2#FSM\\/C^\_;T7ZUR5>P:7X
M=L?$'@._^('BB(ZE>W>IQVT=OYK1QQ(753]T@\ X S@8%<M\6?!MGX'\=/IF
MF2.]I+ EQ$LARR!B1M)[X*FKA--\O4F47:YQ%=5\-?$I\*?$+2]3+E8!,(KC
MWC?Y6_+.?PKE:6M&DU9D)V=S]! 0R@J<@C(-+7'_  J\0?\ "2_#/2+YVW3)
M#Y$Q/7>GRG\\ _C785XLERNS/33NKA1112&%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKAR\LKGEB:M7VO7=]HMAI++%#9V.YDCB4C>['EWYY;H,^@K+HJK(5V=+X?\
M'>K^'=(N-*@%O=:?/*DS6MTA9!(I!##!!!R!WYQ6=XB\1:EXJUN;5=:N//NI
ML G& H'10.P%9=%+E2=QW=K!1115$GT;^S%K32Z9K6BR/D02)<QJ?1AM;]5'
MYU[S7R7^SWJIT_XJ06VXA+^WD@(]2!O'_H-?6E>5B8VJ'?1=X!1117.;!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME='SI\9_^2C3?]>\7\JX"N_^,_\ R4:;_KWB_E7 5TQ^%&;W"BBBJ)"BBB@
MHHHH **** .X^'EOX"O(=2MO'US<6<SHOV.ZCW%8SSGA0<GIU&*U;[Q)H/@[
MP)JWA?PAJTVM2ZQ*#<7C0&&.*(?PJ#R6/<]*\RHK-PN[MEJ5E8[#X:ZMIGA[
MQ)/K>JSK')86<LEE&5),MP5VHHP..I.3QQ7)32O//)-*Q9Y&+,3W).33**JV
MMR;Z6.I\+ZK8>&]+O-9299==/^CV$.T_Z/D?-.3C&0.%'J<UT'PK\:Z;H%KX
MCTO7)3 NM6C1I=E2P23:P^;&3@[NM>;44I04DTRE)K8](^)GC#2M9\,^%O#^
MD2_:O[%M D]TJE4=RJ@A<@$@;>I KS>BBG&*BK(4FV[A7U'^S9K9OO =WI<C
M[GT^Z.P'LCC(_7=7RY7M/[,^JFV\;:CIK-A+RSWA?5D88_1FK'$1O39I1=IH
M^G:***\H[PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "J^H2^3IMQ)_=C8_I5BLWQ"_EZ#='U4#
M\R!5P5Y)$5':#?D>>T445[Q\R6K?4[VTB\NVN'C3.<+3;K4+N]55NIWE"G(#
M'I5>BIY8WO8KGE:U]"03RBW, <^46W%>Q/K4=%%43=L?)-)*J+(Y81C:H/84
M^"\N+4$02L@8@D#H:AHI65K#YG>XZ21Y9"\C%F8Y))R33:**8@HHHH ****
M"BBB@ H!P01U%%% &K$_F1JP[BO"OCO_ ,C5I_\ UZ?^S&O:[&3!,9[\BO%/
MCO\ \C5I_P#UZ?\ LQKE4>6=CU83YZ=SRVBBBMA!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 =+\.]0_LOXD:!=[MH2^C#'_9+;3^A-?<-? 6GS
M_9=3M;@<&*9'S]"#7WU"_F01O_>4']*\_%K5,[,.]&A]%%%<1TA1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=&Q^20=&_P#K^U4*\F47%V9]-&<9QYHNZ"BBBD4%%%% !1110 4444 %%%%
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M^W?$KP_;XR&OXB?H&!/Z"ID[)L:U9]P@8  [4445XAZ@4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH IZM%Y^CW4?4F,X^HYKS>O4V4.I4]",&O,;J$V]W+"W5'*_D:]'!2T:/
M)S".L9$5%%%>@>8%%%% !1110 4444 %%%% !1110 53U'5+72X/,NGP3]U!
M]YOH*S=;\30Z<&AM=LUST/\ =3Z_X5P]U=SWMPTUS(TCMW-=='#.>LM$<.(Q
M<:?NPU9>UC7KG5I,,?+@!^6)3_/U-9=%%>G&*BK(\:4Y3?-)A1115$A1110
M5A:_X>74 ;FT 2Y Y'02?_7K=HJ*E.-2/+(VHUIT)\\&>5NC12,DBE64X((Z
M4VN]UW08]3C,L "72C@]G]C_ (UPLL3P2M',A1U.&4CD5XE:C*E*S/K<+BH8
MB%X[]4,HHHK$Z@HHHH **** "BBB@ HHHH **** "O2/@+IQO_BYI[XRMI'+
M.?;"D#]6KS>O>OV8-)WZIK>KLO$4*6R-CNQW'_T$5C6=J;9I35YH^C****\@
M]$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH XOQ?;>5J:3CI,G/U''^%<_7<^*K3[1HYE4
M9:!MWX=#7#5[&&ES4UY'@XN'+5?F%%%%=)R!1110 4444 %%,EEC@B:29U1%
M&2S' %<IJ_C#[T.E#V,S#^0K2G3E4=HF-6M"DKR9T&HZO::7'NNI/F(^6->6
M;\*XG5O$EWJ9:-3Y-O\ \\U/)^I[UE2RR3R&29V=VZLQR33*].EAXPU>K/(K
M8N=31:(****Z3C"BBB@ HHHH **** "BBB@ HHHH *P-<\-QWV;BR"QW'5EZ
M!_\  UOT5G4IQJ1M(VHUYT)\T&>62Q202M',C(ZG!5A@BF5Z)J^B6^JQY;]W
M.H^60#]#ZBN$O;&XT^X,-TFUNH/9AZ@UXU:A*D]=CZO"XR&)CIH^Q6HHHK [
M HHHH **** "BBB@ HHJ2"&2YN(X(5+R2N$11W). *0SZ?\ V;="-AX$NM6D
M7#ZC<G;D=43@?J6KV.L?PCH:>&_"&F:1& /LMNJ-CNV,L?SS6Q7C5)<TVSTH
M+EBD%%%%04%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %<'XHMO(UMV ^650X_D?Y5WE<YXPM/,L8KE1S$V&^A_P#KUTX67+47F<>,
MAS4GY''4445[!X04444 %%%% !1110 4451U/5[72H-]RV6/W8U^\U-)R=D3
M*2BKLMRS1P1-+,ZHBC)9C@"N,UOQ7)<[K?328XNC2]&;Z>@K*U;6[K5I<RG9
M$#\L2G@?XFLZO3HX91]Z>YY&(QCG[L-$'7K11178>>%%%% !1110 4444 %%
M%% !65K>AQ:K%N7$=RH^5_7V-:M%1.$9QY9&E*K.E-3@]3RZXMY;6=X;A"DB
M'!4U%7H>LZ+#JT/.$G4?))_0^U<%=6LUE<-#<(4=>Q[^]>+6H2I/R/K<)BX8
MF.FCZHAHHHK [ HHHH **** "BBB@ HHHH *^N?@%H7]C_"VVGD3;+J,KW+<
M?P_=7]%S^-?*>D:;-K.M6>FVJEIKN9(4 '=CBON_2]/BTK2+33[90L5K"D*
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M^ ?ES^-85Y\D#6E'FD>G4445Y)Z 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %07MLMY92V[])%(^E3T4T[.Z$TFK,\MEC:&
M9XW&&1BI'O3:W_%FG_9[\72#Y)^OLU8%>[3FIQ4D?-U8.G-Q844459F%%%%
M!14<\\5M"TMPZQQKU9C7%:WXJEO-T%ANB@Z%^C/_ ("M:=*51Z&%:O"DKR-?
M6_%,5CN@L=LUQT+=53_$UQ5Q<2W4S37$C22-U9C45%>M2HQIK0\2M7G5>NP4
M445J8!1110 4444 %%%% !1110 4444 %%%% !5#5M(@U:VV2?+*O^KD Y4_
MX5?HJ914U:1=.I*G)2@[,\QO+*>PN6@N4VNOY$>HJO7I.IZ7!JEMY4XPP^XX
MZJ:X'4-/GTVZ,%PO/56'1AZBO%KT'2?D?5X/&1Q$;/278J4445SG>%%%% !1
M110 444H!)  R3T H ]@_9T\+'5O&\NM3IFWTJ/*$C@RMP/R&3^5?4M</\(O
M"/\ PA_P]LK:9-MY=#[3<Y'(9APOX# KN*\BM/GFV>C2CRQ"BBBL30**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *KWUHE]8RV\G1UP#Z'L:L44TVG=":35F>7SP/;7#PR
MC#HQ!%1$A5)8@ <DGM71^/H4T^P;65B=Q'A950<^QKQ;5?$%YJC%7;RH.T2'
MC\?6OH\+!XB/,CY3&U(X2;@]7T.BU?Q=#;[H=. FEZ&0_=7_ !KCKJ[GO9S-
M=2M(Y[D]*AHKV*=&%-:'@5:\ZK]X****U, HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *",@@\@]1110!RNN>%_O76F+[O"/YK_A
M7*$$$@C!'4&O5:P]<\.QZB&GML1W..?1_K[^]>;B,)]JG]Q[N"S*UJ=9_/\
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M<NE3K1YG\2/C<VC5H3Y5\+Z_H14445[!X 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[&E.,YS4:>_0XS0OA7JGB?Q1%8:5_P >3'=-<L.+=/?U/IZU]9^&/#6G>$M
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M] YGE&=I_P!D=OYUU2J%4*H  X  Z4M?/XG,*U?39=CZC"950PWO?%+N_P!
MHHHKSCU@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\=<#O4U !14'VZU-[]C%S$;G;N\G>-V/7'6IZ "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *Y?XD>)+SPC\/]2UO3$A>ZM1&4692R'=(JG(!'8G
MO745QWQ8T;4/$'PQU;3-'MFNKR<1^7$K %L2J3R2!T!JH6YE<F5^5V/"?^&E
M/&?_ #YZ1_X#R?\ Q=>]Z'XKN+SX4VWBB_CC^T/8&ZD2($+NP3@ DG%?+_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
40 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>mdt-20201030_g4.jpg
<DESCRIPTION>IMAGE 5
<TEXT>
begin 644 mdt-20201030_g4.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $9R:65D<FEC
M:"P@365G86X    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,X
M,P  DI(  @    ,X,P  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M-,U.RUG3(-0TNYCNK2X0/%+&<AA5JOE_X(^/YO!WP=\57]VC7%OIDZ-:1,<
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MF->,CD94X(KZF7.T;NN.: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX[-1G!9C]YN3TXS^%>F444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"T444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU.ZHJK9:G8ZE%YFGWEO=)C.Z&4./TJU6984444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4$@#). .YJ"\
MO8+"W,URX11T]3["N)U?Q#<:DQCC)AM_[@/+?6MZ5&55Z;'/6Q$**UW-S5?%
M4-MNBL,32="_\*_XUR5U>7%[,9+F5I&]SP/I4-%>I3HPIK0\6K7G5?O;!111
M6Q@%%%% !1110 4444 %>=?&C_D4K/\ Z_5_] >O1:\Z^-'_ "*5G_U^K_Z
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M\NM1=-^1W4ZBFO,U:***P-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]&F[P04445D:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD&O)JNZ=JUWI<FZUD(4_>1N5;\*XJN%4M8:'HT<;*.E35'I]>=?&C_D4K/\
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MI44W));GG_B&];4/$=_=/C=),Q..A.<?TK-I6.YB3U)S25\X]S[I*RL%%%%
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M>_P%,1_!-&WZUX)7U>4_[O\ -GQ.>+_:ODOU"BBBO6/#"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *Q_'.KW$_A^UL+B4R()_,3=R5PI'7_@5;
M%<7XQN/,U2*$?\LH^?J>?Y8KDQC2I:GI99%RQ"MT.=HHHKQCZL**** "BBB@
M HHHH **** "BBB@ HKO/A+X53Q)XJDFO-+EU6QTV SSVD6-TQ/RJ@R0.ISU
M'W374_$C4O!6F:)=:79?#V\T369@!#->0A0@SRRD.<\>E9.I:7*D:*'N\QXU
M17<_"SP/'XQ\56JZH_DZ6LP21B<&=\%A$ON0"3Z 5MGP1I&J_M&7'A@1K::6
MMT1Y,9QE53=L!]Z;J13:["4&U<\KHKVWQ7X)T"Y\!^+=3L]/AT^Y\/ZLUO;M
M!D"2+*#:P)Y/S$YZUY_9:99:'X+EUK6;=)[S4U:'2[:3^%1P]P1Z#HOOD]J4
M:BDK@X-,Y*BBBM2#WG]EW/\ :_B+T\B#_P!">OHVOGK]EV'][XBF]5@3_P!#
M-?0M>3B/XC/0H_ @HHHK U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDX\M"PY[XXKS DDDGDGK7FXZ6T3W\GI_%/Y"4445YI[P4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=+YGV;;S&G\+$^_IZ5<:D))-/?8B5&I!M26VYFT445H9!1110 4444 %%%%
M!1110!C>*KCR="=0>9G5/Z_TK@JZGQI<9FM;<?PJ9#QZ\?TKEJ\3%2YJK\CZ
MW+:?)AEYZA1117,>@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFETJQ/GSJ3CS7Z*O'5FQC/IFM?1[:WU_0_$7B;4X4GN;5=MO"W^KB&../0#
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MA(RV.W)_^M7,UX>*ES56?79?#DPT?/4****YSO"BBB@ HHHH **** "BBB@
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M?.RES2;/NJ<>2"CV04445)84444 %%%% !1110 4444 %%%% !1110 4444
M%%%=5\.O!=SXZ\86VEQ!EME/F7<H_P"6<0//XGH/K4MI*[&DV[(]D_9R\"FU
MLIO%NHQ8DN 8;(,.0G\3_B>!]#7O%06-E;Z;8065E$L5O;QB.-%'"J!@"IZ\
M>I-SES'I0CRQL%%%%04%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %>!_$WPQ_8/B-KFV3;97Q,B8'"M_$O]?QKWRL7Q9X=A\3>'Y[
M"7 DQOA<_P #CH?Z5W8'$_5ZR;V>YYN983ZU0<5\2U7]>9\TT5-=VLUC>2VM
MTACFA<HZGL14-?9IIJZ/S]IIV84444 %%%% !1110 4444 %%%% !1110 5P
MOBVY\[6C&#E84"_CU/\ /]*[KZG ]37F6H7!NM1N)S_'(2,]AGC]*X,=*T5$
M]K**=ZDI]E^96HHHKRCZ,**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ K?\ !7A:Y\9>+;+1K0$><^99 /\ 5QC[S?E^M8-?5_P)^'Q\*>%SJVI1
M;=4U-0Q##F*+JJ_4]3^'I6-:I[.-S2G#GE8],TS3K;2=+MM/L8Q';VT2Q1J.
MP Q5JBBO(/1"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K:A86^J:?-97L8
MD@F0JZGTKYR\5>'+CPQKLMC/EH\[H9<<2)V-?2U<]XR\*6_BO16MWPEU'EK>
M4C[K>A]C7I9?C/J]2TOA?]7/(S3 _6J=X_$MO/R/G"BK%]8W&FWTMG>Q-%/"
MVUT8=#5>OKDTU='PK33LPHHHIB"BBB@ HHHH **** "BBB@ JIJT_P!FT>ZE
MS@K$<'W/ _4U;K#\73>5HFP?\M9%7K]3_2LJTN6FV=&%ASUXQ\SA:***\ ^U
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI: );6UGOKR*UM(FFGF<
M)'&@R68\ "OL?X4_#Z'P%X42&55;4[H"2\E'KV0>P_GFN&^!'PK.EP1^*_$$
M&+R9<V4#CF)#_&1_>/;T'UKW*O.Q%7F?*CMHT[>\PHHHKC.@**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S'XK>#3=P
MG7]-CS-$N+I%'WE'\?U'?V^E>.U]7LH=2K@,K#!!'45X1\1O!+>'=0-_8(3I
MMPW '_+%O[I]O2OH\KQEU["?R_R/D\YR^S^L4UIU_P _\SAZ***]X^9"BBB@
M HHHH **** "BBB@ HHHH J:K<?9=)NIAU6,X^IX'ZFO-*[?QA<>5I"1#K-(
M!^ Y/]*XBO'QDKU+=CZC*J?+0YN["BBBN,]4**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBNJ^'W@6_\>^)H]/M T=LA#W5QCB)/\3T J6TE=C2;=D=
MC\#/AJWBK75US58?^)382 JK#BXE'(7W ZG\!7U6!@8' JAHFBV/A[1;;2]+
MA$-K;($11W]SZD]2:OUY-6HZDKGH4X*"L%%%%9&@4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$2J@XZ<9/ZDUQXR5J5NYZF50YL1?LC&HHHKQSZD**** "BBB@ HHHH ****
M"BBB@ HHHH **** "O</@E\(3K$T/B?Q-!BPC;=:6TB_Z]AT<C^Z/UJ/X/\
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MP'YUSE:&NW'VG7+I\Y ?8.>PX_I6?7S]67-4;/ML-3]G1C'R"BBBLS<****
M"BBB@ HHHH **** "BBB@ HHHH ***W?"7A'5O&FN1Z9HL!=V.9)2/DB7^\Q
M["DVDKL:5]$,\*>%=3\8^((-)T>$O+(<NY'RQ+W9CV K[)\#^"M-\"^'(M+T
MU0S_ 'I[@CYIG[D_T':H/ '@#2_ &@K9:>HEN9 #<W3#YI6_H!V%=57F5JWM
M'9;'=2I\BN]PHHHKF-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP.;RX4$J?]A>B_S]Z[^BBN*4G)W9U))*R"BBBI&%%%% !1110 4444 %%%%
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MP4445)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>QEOG^*E]IDFIW;V4%FERD)<8W%@,$XR1[5K>)([C[=I/V>_N;99KM895A<
M.NUCW'MUK'\Q=+^,4LU\PABO]-6."1CA6=6!*Y]>*V=6N8+[7='L[65)9HKD
MW$BH=VQ%1ADXZ9) H W@-J 9)P,9)Y-</H&J2^*?MX;6Y['4X9Y(Q9Q[0(0I
M(7Y2/FR!DG^5=>-2LVU)].6XC-XD?FM#GY@O3-<5>:/X?\:::=:MKE-,U.+=
MNNH)-K1NI_C]>E '8Z+]L&BVPU1M]X$Q,V,9;/)Q5UUWQLN67<,94X(KE?"?
MB&0>"+"^\37*0RR/Y2S2?+YOS$*?Q%=70!PGAM;_ %3Q!XAM+K6M0\JPNA%
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MN);>VNPTT2;VB9&5MOJ 0"1[BN1\0ZW;:I\/+34='5ELX+F%KJ"'AHD5OF7
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M6>)) #D!U!Q^=%% $/\ 9UE_SYV__?I?\*LT44 4)M"TFXN#//IEG),3DR/
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M=VL+8M<8$S&)<R8_O<<_C3[33[.PW?8K2&WW?>\J,+G\J** +%%%% !1110
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MFW4A/IQQ110!+<:1IMV\3W5A;3/#Q&TD*L4^F1Q4MU96M]!Y-[;0W$0((25
MPR.AP:** (9-%TR:?SI=.M7EX^=H5)XZ<XJ[110 4444 %%%% !1110 4444
' %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>mdt-20201030_g5.jpg
<DESCRIPTION>IMAGE 6
<TEXT>
begin 644 mdt-20201030_g5.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $9R:65D<FEC
M:"P@365G86X    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,S
M-   DI(  @    ,S-   ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M %%%% !1110 4444 %%%% !1110 5S/Q&\/S>*?ASK6CVG_'Q<VS"$9ZN/F
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF"\BFEB7!VE<F,@D<%3Z5]'6UC:66[[':PV^\Y;RHPNX^^*+FQM+T*+RUAN
MARHEC#;3ZC- 'A?Q3L/#>E?L\:D/"5G]BTZ[O8I(=[O_ *0=ZY=0Y)P<?CC-
M>B_!MH6^#OAOR&1@MDH;80<-WS[YKKKK3[.^C6.]M(+A$.56:(.%^@(IUK9V
MMC%Y5E;0V\><[(8P@SZX% $.K:K9Z)I-SJ>ISK;VEK&9)9&/  KYXTGXZ>#G
M\8WOBC6+34[S5Y ;;3H$@3R[6')PH);.YCRQQWQ7T=<6T%W T-W#'/$WWHY4
M#*?P-4U\.Z*K!ET>P!!R"+5./TH P-6^)>@^'_$6FZ%XB>2PN]1@659)$_<*
M3QL,GKGVQ7*0>$M/TGX^R^)]"B6#3HM'DEU)K<93S6/  '<J-Q ],]Z]4NK"
MSOE"WUK!<JIR!-&' _.GQPQP0B*WB2- ,*BJ H_ 4 <MX%^)6@?$2&\?P^]Q
MNLG"RQW$6QAG.&')X.#^5)\2?']A\//"<NIWC*US)F.T@[RR?3T'4U?\.^%X
MM%OM0U*3R3?:B4\[[/$(XT5 0J*/09)R>22:UKO3;'4-OV^RM[G9G;YT2OMS
MZ9'% 'B?PF^)WA6;5+?0= M=2OM=UBX:?4+^ZA2,2-@L[DAB< # 6H/">BGP
M1\9_'R:H1;6NH6$MW9S2?*LJ%MQP>Y&<$>U>WVVC:99S":STVTMY0,!XH%5A
M^(%3W-E:W@47=M#.$.5\V,-M/J,T >0_LV^&;OPY\/+K4-5C:V;4[GSXUE&T
MB(* I.?7DUR_PIOK1OVF_&TBW,)2=[CRFWC$G[X=/6OHB:WAN(&AGB26)AAH
MW4%2/H:IIX?T:-U>/2+%74Y#+;("#Z]* .:^(6L>$]-L5?Q#8VNK:C%S96 A
M$UP\G8(N"1SCFN:^!_P\U#PS%J?B3Q)"L&KZU)O^SC_EWC)+;3[DGIVP*]46
MTMDN6N$MXEG?[TH0!F^IZU-0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !12%E7[S ?4U"]]:Q_?N85^L@IV;V$VEN3T53.K:>.MY#_P!]BLF;X@>$
M;>X>"?Q%IT<L;%'1KA05(Z@T^2787/%]3HJ*Q(/&GABY($'B+2W)Z 7D>?RS
M6I#?VERH:WNH)5/0QR!L_E2LT.Z)Z***0PHHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !111TZT %%9.H>([&QRH?SI1_#'SCZFN;O
M?%-_=96$BW3T3K^==%/#U)]#EJ8JE3TO=G:7%Y;6B[KF9(Q_M&L:Y\76,61;
MI).?4#:/UKBWD>1BTC,S'J6.:2NR.#@OB=S@GCYOX58Z"X\87LF1!''"/IN-
M9LVMZE/_ *R[DQZ*=H_2J-%=,:5..R.65>K+>0YYI)#^\D9O]YLTVBBM#$*^
M9O%__(Z:Q_U^R_\ H1KZ9KYF\7_\CIK'_7[+_P"A&ID=.'W9C5)%/+ ^^"5X
MV_O(Q!J.BH.PZ'3O'OBO2B/[/\0ZC"!_#]H8C\CQ78Z1^T)XXT[ NY[74D'4
M7$ !/XKBO+:*ATX2W12G);,^D=#_ &G--G*IXAT2>U/>6U<2+]<'!_G7IGA[
MXD^$O$^U=)UNV:9ND$K>7)_WRV"?PKXBI02#D<&L986#VT-8UY+<_04'/2BO
MBWPQ\6?&'A1D2QU62XME_P"7:[_>I^&>1^!%>V>$?VC=#U4QVWB>V;2;AN/.
M3+PD_P U_7ZURSP\X[:F\:T9;GLU%5[&_M-3M$NM.N8;J!QE9(7#*?Q%6*YC
M8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPCFSN<))GV[-^%<<Z,X;G3&I&1V5%%%8F@4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&#R?_K5P5[?3ZA<M-</N8]!V4>@KJH8=U-7L<>(Q2I+ECN6-5UBXU2;,AV1
M_+&#P/\ &L^BBO6C%15D>)*3F[R"BBBF2%%%% !1110 4444 %%%% !7S-XO
M_P"1TUC_ *_9?_0C7TS7S-XO_P"1TUC_ *_9?_0C4R.G#[LQJ***DZPHHHH
M**** "BBB@ HHHH *TM"U_4_#6K1:EHMW):W,9X9#PP]".X]C6;12>NXSZ\^
M%_QAT[QU;I8ZAY=CK:+\T&<+/_M)G_T'K]:]*K\_K>XFM+F.XM97AFB8,DB-
MAE(Z$&OI[X/_ !GC\4)%H/B:18M75=L-P3A;K'\G_G7GUL/R^]'8[*=:^DCV
M.BBBN,Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M03Y!XT^=ST_Z9$_R_+TKZ$KR:D'3E9GH0DI*Z"BBBLRPHHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO>Q"2UE65?53TK@J4IT_B1ZE.M3JKW63T445D;!1110 4444 %%%% !1110
M4444 > _%;_D?[G_ *Y1_P#H-<77:?%;_D?[G_KE'_Z#7%UF>E#X4%%%%!04
M444 %%%% !1110 4444 %%%% !1110 4444 %?27[-7BLW>C7WAJYDS)9M]H
MM@3_ ,LV/S ?1N?^!5\VUU_PN\2'PM\1]*OW?9 TH@GYX\M_E.?ID'\*QK0Y
MX-&E.7+),^UZ* <]**\@]$**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\(^+.J_;_ !DU
MJK9CLHQ&!_M'D_S'Y5[I-*L,+RN<*BEB?85\NZI>MJ.KW=XYRT\S2'\3FO;R
M>GS593?1?F?.Y]6Y:,::ZO\ (J4445],?'A1110 4444 %:FF>(+W3"%1_-A
M_P">3G(_#TK+HJ914E9E1G*#O%V/1M+\166IX56\F8_\LW/7Z'O6M7D?3I6[
MI?BJ\L=L=Q_I,(XPQ^8?0UP5,)U@>G1QRVJ?>=_15'3M8L]3CS;2C?CF-N&'
MX5>KA:<79GI1DI*Z"BBBD4%%%% !1110 5\S>+_^1TUC_K]E_P#0C7TS7S-X
MO_Y'36/^OV7_ -"-3(Z</NS&HHHJ3K"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH T-!U670_$-AJEN<26=PDP]\'.*^[[*[BO[""[MSNBGC61#Z
M@C(_G7P!7V-\$=;.M_"G3#(VZ6S#6KG_ '#\O_CI%<6+CHI'5AY:M'H%%%%>
M>=84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%!. 2>@H \2^,6
MJ?:O$T%@C92SA^8?[3<G],5YY6IXEU ZKXGU"])R)9V*_0' _0"LNON<-3]E
M1C#LC\WQE;VV(G4[L****Z#E"BBB@ J:VNI[2426TK1..ZFH:*-]P3:=T=;I
MOC,C;'J<>?\ IK&/YC_"NHM;RWO81):RK*OJIZ5Y54UM=SV<PEM96B<=U-<=
M3"QEK'0[Z6-G'2>J/5J*Y'3?&?W8]3CQ_P!-8Q_,?X5U%M=07<0DMI5E0]U.
M:X)TIT_B1ZE.M"JO=9-11161L%%%% !1110 4444 > _%;_D?[G_ *Y1_P#H
M-<77:?%;_D?[G_KE'_Z#7%UF>E#X4%%%%!04444 %%%% !1110 4444 %%%%
M !1110 4444 %*"001P1TI** /M_X<:]_P )+\.]'U-FW2R6X24GKO3Y6_45
MT]>)_LS:U]J\):GI#MEK*Y$J#_9D'^*G\Z]LKQJL>6;1Z4'>*84445F6%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF\7_ /(Z:Q_U^R_^A&OIFOF;Q?\ \CIK'_7[+_Z$:F1TX?=F-1114G6%%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "LWQ'>_V=X9U&[S@Q6[D'WQ
MQ^M:5<A\4;HVW@"\ .#,R1C\6!/Z UM0ASU8Q[M'/B9^SH3GV3/G[K1117W9
M^:A1110 4444 %%%% !1110 5-:WEQ92B2UE:)O53UJ&BAI/1@FT[HZ_3?&8
M.(]3CP?^>L8_F/\ "NGM[J"[B$EM*LJ'NIS7E-3VMY<64OF6LS1-ZJ>M<=3"
MQEK'0]"ECIQTGJ>JT5R6F^,P<1ZG'M_Z:QC^8KI[>Z@NXA);2K*A[J<UY\Z4
MZ?Q(].G6A57NLFHHHK,V"BBB@#P'XK?\C_<_]<H__0:XNNT^*W_(_P!S_P!<
MH_\ T&N+K,]*'PH****"@HHHH **** /0/ /PWB\0Z'J'B;Q#=266@::K-(\
M0'F3LHR57/ [#/O6/:2>%-5UZ&TFL;K2;&:54%REQYKQ@G&7!&"/IC'O7KG@
MJYB\0?LQZSHNEXDU"SCE\V!?O'YMX..^1Q^%> 6]K/=W4=M:PO+/(VU(T7+,
M?3%80;DY7Z&LDHI6/8?A;\/?"_C&Z\0VFJ6D^[2I2(IHKDKYBEG R.G\(Z51
M^'_@3P]\2='UF"WMY])U6P0/%(DYDBDSG *MR.1Z]ZZ7]FA3&WBE9!AECB#
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MTPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^UMK>"W@MY2D:0Q*@ ]\#G\:TC7YJOLK=+F4\-RT?;7TO8YZBBBNDY HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'&_H@_,Y_"OK6O.Q4KR43LP\=+A1117&=(4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT?CU_*O$_A#X"?QSXQB6YC;^R[(B:[?'##LGU)_3-?8R(L4:QQJ%10 J@8
M[5PXJIIR(ZJ$/M,=1117 =84444 %%%% !1110 4444 %%%% !1110 4444
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M"@8<QP_PC\>OY5Z]2(BQQJD:A5484 < 4M>/.3G+F9Z,8J*L@HHHJ"@HHHH
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M<<R^CN/3T'>LYS4%=EQBY.R+'P.^$)=H/%?B>W^08>PM9!U/:1A_(?C7T-2
M!5 4  #  [4M>54J.I*[.^$%!604445F6%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 4=8T>SUW2Y;#4(Q)#(/
MQ4]B/<5\\^*O"U[X5U5K:Z!>%LF&<#B1?\?45]*5G:[H5CXATN2QU*+?&W*L
M/O(WJ#ZUZ."QLL-*SUBSRLQR^.+A=:26W^3/F"BM_P 5^$;_ ,*:@8;I?,MW
M)\FX4?*X_H?:L"OK83C4BI1=TSX6I3G2FX35F@HHHJR HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG]6]N@KW0<=***\R<Y3=V=T8J*L@HHHJ"@HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)P,CJ*\LED\V9Y#U=BWYUYN.?PH][)XZSEZ#****\T]\**** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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A%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>mdt-20201030_g6.jpg
<DESCRIPTION>IMAGE 7
<TEXT>
begin 644 mdt-20201030_g6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $9R:65D<FEC
M:"P@365G86X    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,Y
M,0  DI(  @    ,Y,0  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHNY81O0$J &R.H!#+D=SCK6AXXBFUS]J/P2NB2>>;.R6ZN)(3N6.'?(221P
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJJ:7K3?*L);]U<'_ *9L>A_V3SZ$UY]7#RAJM4=<*REH]SU"BBBN8W"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHK/UK7=/\/V#7>JW"PQCA1U9SZ*.YJHQ<G:*U)E*,(N4G9(T"0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%5[^_M=,L9;R_F6"WB7<[N>!_\ 7]J:3;LA-I*[))[B*UMWGN9%BBC4L[N<
M!1ZDUXSXX^)T^JF33O#[O;V71[@95YOI_=7]3^E9'CCQY=>*;HV]N7@TR-OW
M<.<&3_:;_#M7(5]+@<M5.U2MOV['Q^99M*K>E0=H]^__   HHHKVSYX****
M"BBB@ HHHH **** "BBB@"2#_CXC_P!\?SKR6O6H/^/B/_?'\Z\EKS,=O$^@
MR?:?R_4****\X]T**** "BBB@ HHHH **** "E#%6#*2"#D$=J2B@#W?X5_'
MJ6P,&A^.9FFM>$@U-B6>+T$O]Y?]KJ.^>H^C(9HKB".:WD26*10Z2(P974C(
M((Z@CO7Y^5ZI\)?C'=>";F/2=;>2ZT"1L8^\]H2>67U7U7\1SD'BK8>_O0.F
MG6MI(^LJ*@L;ZVU*QAO;">.XMIT#Q2QME74]"#4]>>=@4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117&^._'T'A:W
M-I9[9]4D7*H>5A']YOZ#O6M*E.M-0@M3&M6IT(.I4=DBYXP\;V'A.UVOB>_D
M7,5LIY_WF/8?S[5X/KFO:AXAU%KS5)S*YSM7HL8]%'854O+VYU"\DNKV9YYY
M3EY'.234%?6X3!0PT;[R[GPV.S&IBY6VCT7^84445WGF!1110 4444 %%%%
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M_$ZJ-3[+/H2BBBN ZPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#1B5YW7CXS^+\CZC*O]W^?^04445QGJA1110 4444 %%%% !1110 4444
M%%%% !3E=D=71BK*<A@<$'UIM% 'U[\&/B3_ ,)UX;-KJ4B_VUIX"W';ST_A
ME _0^_/&0*])KX4\(>*;[P;XHM-:TUCO@?\ >1YP)HS]Y#[$?D<'M7VWH.MV
M?B/0+/5],D\RUO(A(A[CU4^X.01Z@UY>(I<DKK9G?1J<RL]S0HHHKF-@HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ H)P,G@45Q/Q1\2'0_#)M;9]MW?DQK@\JG\3?T_&M
M:-*5:HJ<>IC7K1H4I5);(\P^(7B@^)?$CF%R;*T)BMQGAN>7_$C\@*Y2BBON
M*5.-*"A'9'YQ6JRK5'4GNPHHHK0R"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@"2#_CXC_P!\?SKR6O6H/^/B/_?'\Z\EKS,=O$^@R?:?R_4****\X]T*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "O4O@3X\/A3QDNF7TNW2]698
M7W'Y8I>B/^?RGV.3TKRVESCI42BIQY65&3B[H_06BN"^#GC3_A,_A_;2W,F_
M4;'%K=Y/+,H^5_\ @2X.?7=Z5WM>/*+B[,])--704445(PHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB**X*BVM+7;YDF>02S9 XR>G3WXK;^*UA?):Z?=6-QYWA\HH@AB"B.!MN!C
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MG@2$_NV_[Z^7Z.:^NJ_/M':*19(V*NI#*P."".]?</@#Q*OB[P'I6L[@TT\
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M* "BBB@ HHHH **** "BBB@ HHHH \=^,^K^=JMEI,;?+;QF:0>K-P/R _\
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M@ HHHH **** "FR2+%&TDC!40%F8]@*=7,?$34SI?@74)$;;),@MT^KG!_\
M'<UI3@ZDU!=695JBI4Y5'T5SP;7M4?6M?O=1DSFXF9U![+_"/P&!6?117WD8
MJ*45T/S24G.3D]V%%%%,D**** "BBNZTGPEX<U?P]J<T.I7R76G1EI+N6-5M
M7;)P%ZL1QCD@G(..U95:L:2O(VHT)UFXPW.%HKKO">A>'-5NK.QUB^O1>WV?
M*6TV!(<;L!V.3N.. !QD9Z\2:3X%6X\9ZGH]]=,8-,B>622# :0#& ,YVDY'
MKC!%9RQ-.+DGTU-8X.K-1E'6[MOUWU^1QM%=5K7@XP:GH\6C-)+#K%LD\"SD
M;XL@%@Y  P!SG XSZ5A:M%80:@\&E2RSP1 (9Y"/WK#[SJ .%)Z Y..I[#2%
M6-2W*95*$Z=^;H4J***U,0HHHH **** "BBB@#-\1?\ (LW_ /N)_P"C$KSN
MO1/$7_(LW_\ N)_Z,2O.Z\?&?Q?D?495_N_S_P @HHHKC/5"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *^K_V=_$1UCX;?V=,^Z?29VAP6R3&W
MSH3^)91[+7RA7L/[-NM_8/B%=:6[XCU*T8*OK)&=P_\ '?,KGQ$>:F_(VHRM
M,^I:***\H[PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *R_$]^=+\*ZE>*=KQ6SE#_M8POZD5J5P_P 7
M+W[+X%>$'FZN(XNO89?_ -EK?#P]I6C'NT<V+J>RH3GV3/!Z***^Z/S8****
M "BBB@#UCX9ZE/J,%]8>?IQM5MF2+1C$%,K8 WLY7)SC!.6^\> ,"J?AVTN+
M7P!K?]A1/'XDM[P+-';\S1HKK\JXR2O!XYS@]:Q(]<\+:9K%EK.@6FH6US:I
MEK.3:T3OMQ_K"Y8#DY^4Y_V:S].U314OI=7UN"[U'4&G,PM5"Q0,Q;)+/DL1
MSG&T=,'(->0Z$FY2BFD[.UNJZ/6WS_$]R.)C&,82:;7,KWZ-;K2Z:Z*WR/0K
M[3-$LOC'I4UTD,+7=MYS1%0%^T9(5L= 21Q_M#/4UE^+=*&IQZ$NJR>1>V\$
MLNJSN1OB@##:6[ECDA1W)K@-<UN\\0ZO+J.HN&FDQ\JY"H!T51V J:ZU2!-!
MM]+TU9$1OWM[(ZA6GE[#@GY$' YY))(':X82I%PES:I6_/\ S^^Q%3&TIJI%
M1]UN_KMT^7R39T'B;PWK%Q:->[8(K2PMXWCTU';S+2W<MM+ C!)VDL02<\G%
M<37H.I?$6UO-)OS':SKJ.HV,5G*C!?*C"E]SJV<G(?@$#'J:\^KIPOM>5JHK
M6_K\SDQOL>=.D[WW_3\.G0****ZSA"BBB@ HHHH **** )(/^/B/_?'\Z\EK
MUJ#_ (^(_P#?'\Z\EKS,=O$^@R?:?R_4****\X]T**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ J2":2VN(YX6VR1.'1AV(.0:CHI#/OC1-336O#
M^GZI%C9>VT=PN.P=0W]:O5Y_\#]3.I_"#1B[;I+826[>VQV"C_OG;7H%>+)<
MLFCTHNZ3"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRWXUZ@5L],TY6XD=YW'
M^Z %_P#0FKU*O"OB]>&X\<>1GBUMD3'H3EO_ &85Z>5PY\2GVU/(SFIR8-KO
M9'"4445]<?"!1110 4444 201>?<1Q;TC\QPN^1L*N3C)/85ZCX<CUOP3>W.
ME^*0LOAW[,[22-EX.1T0D=6.1LZG)..]>545SUZ/MERMZ>GXKL=6&Q"P\N=+
M7U_!KJF>A>!O"VJQ02>)K33&N)4##3K9W"AG(QYC%B,HH/U)],9K";4]<\'^
M+[J>Z>*749$(NTD^=7\P!BK8QZC[IZCK7-44E0;G)S::>FW_  2GB$J<8TTT
MUKOU[VM^NQWNJZ[):BSM]6"0W-U%%!<6\*E5L+($?N5'+!G'+9.<8'>NB\=?
M9O\ A#]8\[R_LWVFW_L;&-FSRXL^5_LXW=.*\@HK+ZFN:,D]O\U_E;T-ECY<
MLXM7O_DU\][]-0HHHKN/-"BBB@ HHHH **** ,WQ%_R+-_\ [B?^C$KSNO1/
M$7_(LW_^XG_HQ*\[KQ\9_%^1]1E7^[_/_(****XSU0HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "N@\":R?#_C_ $34]VU(+R,R$?\ /,G:_P#X
MZ37/TN<=*35U8:=G<_06BLOPQJ7]L^$M)U,DL;RRAG8GKED!/ZFM2O$>CL>I
MN%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *\/^,KEO&EN/[MB@_\ 'W->
MX5X;\8Q_Q6T7_7DG_H3UZN4_[S\F>+G?^Z?-' T445]8?#A1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% $D'_'Q'_OC^=>2UZ3JNK)H]G]H
M;#2DXAC)^\W^ ZG\!WKS:O*QLDY)+H?1Y1"482DUHPHHHK@/:"BBB@ HHHH
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M_NZJY_.*+_"O9*\8_9D'_% :H?74V'_D*.O9Z\BM_$9Z-+X$%%%%8F@4444
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M@ HHHH **** "BBB@ KS?XTVOF>'+"Z R8;K8?8,I/\ [**](KEOB38F_P#
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MLVFZE'[I2,X'=B/3^9^AKS]W:21GD8N[$EF8Y)/J:EO;R:_O)+FY;=(YR<=
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M'8#H*=117BGIA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHHHH *]#^!NB_P!L_%K2]R[HK$/>/[;!\I_[[*UYY7T5^S%X?,=CK'B&5?\
M7.MG ?9?F?\ 4I^1K&M+EIMFE-7FCWRBBBO(/1"BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3/"5YN+Q'_+N/S/?RW!?\OJB]/\ /_(****\T]X**** "BBB@ HHHH ****
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M*O!3^./'=I921DV%N1<7K=O+4_=^K'"_B3VJ9245=C2;=D?0'P"\'?\ "-^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "O./B-\._[6636-#BQ? 9GMU'^O']X?[7\_KU]'HK>A7G0GSP.?$X:G
MB:;IU%H?*#*58JP((."".E)7N'CWX;QZZ)-3T55BU+J\?1;C_!O?OW]:^?O$
MVI2>'E>VDC:/4"2HBD7!B[%B#Z'H/7Z$5]91QU*K3YUTW1\16RVO2K*E:]]G
MT,SQ1KGV>-M.M&_>N/WS@_<']T>Y[^W'<XXVG.[2.SNQ9F.2Q.23ZTVO-J5)
M5)<S/H\/0C0IJ$0HHHK,W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *D@@FNKB.WMHGFFE8)''&I9G8G   ZFIM-TV]UC4
MH-/TNVDNKNX;9%%&,EC7U9\*/@[:>!H5U/5_+O-=D7[X&4M01RJ>I[%OP'&<
MXU:L::U-(4W-E3X-_"!/!]NFN>((UDUN9/W<9Y%HIZ@?[9'4]N@[Y];HHKRY
MS<W=G?&*BK(****@H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7H4L1&6DM&<<Z+CJCQRBG.C1R,DBE'4X96&"#Z&FUUG.%%%% !1110 4444
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MPHKBJ5ISWV.F%*,0HHHK$U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY /T KLD1(HU2-51%&%51@ >F*=16#DY;LT22V"BBBD,**** "BBB@ HHHH
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M/NS&/?(/^!MEOUKHZ**Q;;W-$DM@HHHI#"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
1HHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>mdt-20201030_g7.jpg
<DESCRIPTION>IMAGE 8
<TEXT>
begin 644 mdt-20201030_g7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $9R:65D<FEC
M:"P@365G86X    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,V
M-0  DI(  @    ,V-0  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYD6.&%"\CL<!5 R2?PIT4BS0I*G*NH93[&B6*.:%XID62-U*NCC(8'J".XH
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M*O\ 3[3PW&9]4:_M7A ?]SB%-ZCS"3$067*X.<U[=10 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBER2NMF=U&?,K/<T:***YC<**** "BBB@ HHHH **** "BBB@ HHHH ****
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MK<6%>>/;/&/^6<J\./ID''L170UX[33LST4[JZ"BBBD,**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *P_%&I_8M/\ (B.);C(X[+W/]*W"0H))P!R37G.L
M7YU+4Y9\_)G;&/11T_Q_&NK#4^>=WLCCQE7V=.RW91HHHKUSP@HHHH ****
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M&X(JD_4@<U7HHJDDE9$-MN["BBBF(\]^-'_(EVO_ &$$_P#1<E>'U[A\:/\
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MV(X/L:^[--U"WU;2[74+)]]O=PI-$WJK $?H:\W%0M+F[G;0E>-BS1117(=
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M )$NU_[""?\ HN2O#Z]P^-'_ ")=K_V$$_\ 1<E>'U#W.ZC\ 4444C8****
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M7_\ QYW,<IY^4'#?7:>:MUS--.S.Q-25T%%%%(84444 %%%% !1110 4444
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M#Z]P^-'_ ")=K_V$$_\ 1<E>'U#W.ZC\ 4444C8**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K[#^!WB#^W_A3IPDDWW&G%K*7VV?<'_?!2OCRO
M>OV8-:\O5=;T-V.)H4NXQG@%#M;\]Z_E7-B8WIW[&]&5IGT91117EG<%%%%
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M>3#K' [?DI-?+-?0Y-'XY>GZGRW$$OX<?7] HHHKZ ^6"BBB@ HHHH ****
M"BBB@ K2LO$&I6.!%=,R# V2?,,#L,]!],5FT4I14E9HJ,I1=XNQV%GXW4C&
MH6A!P<O <Y/8;3T_.M^SUC3[\A;6ZC=R<!"=K$XSP#@FO,**Y9X2$MM#LACJ
MD?BU/7**\TL]>U*Q 6"Z<H  $D^90!V&>GX8K>L_&XX&H6A'7+P'\OE/^-<L
M\+4CMJ=L,;2EOH=;15&SUG3[\A;6ZC9R<!&.UB<=@>3^%7JY6FG9G9&2DKIA
M1112*///C1_R)EI_V$$_]%R5XA7M_P :/^1,M/\ L()_Z+DKQ"HEN=U#X HH
MHI&P4444 %%%% '41?$;Q2FCQ:5/J,=[8P_ZN#4+2&[5/3'FHW3MZ5EZCXCU
M?5M0@OKZ_F>XM\>0R'RQ!@Y'EA<!,'GY0.:RZ*GEBMD5=G;7OQA\?7^FM8W/
MB2X\AEVMY<<<;D?[ZJ&_6J,WQ)\7W'A?_A'IM=N'TLIY9A(7<4_NE\;RO;&<
M8XZ5F>'?#6K^+-673/#]DUY=LC2>6'5,*.I+,0 /J>X%:NK_  T\7:%J5AI^
MIZ.R7FHL4M8(IXI7E(QGA&. ,]3@?E46IIVT'>;5R*+XA>)H].BT]]02XL88
MDACM+NUAGA55^[B.1"N?]K&3W-9NN>(M6\27BW6MWLEU*B"./< JQJ.BJH 5
M1[ "M#Q1X \4>#(H)?$NDR6<5PQ6.3S$D4L.<$HQ /L>N#Z4A\!>)E\-?V^=
M*D_L[R1/O\Q-XB)P)/+SOV<?>VXQSG%-<FZL#YMF7M,^*GB_1]#71],U&WM]
M.">6;==.MBK@C!W9C^8D=2V2>^:Y2XG>YN99Y!&KRN781QK&H).>%4 */8
M=JLV6C7^HV%]>VD :UT]%>YE:146,,<*,L1EB>BC).#@<&J-4E%/03;>X444
M51(4444 %%%% 'VA\';W[?\ "'P_*3DK;F'_ +X=D_\ 9:[:O+_V>KCSOA';
M)_SPNID_\>W?^S5ZA7C5%:;/2AK%!1116984444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %>#_%RS^S>.WE _X^K>.7IZ I_P"R5[Q7
ME7QLT\F'2]14<*SP.?KAE_DU>GE<^7$I=[H\?.:?/A&^S3_3]3R2BBBOKCX4
M**** "NAE\87-W86MEJ.GZ??6]G$L4"S1L#&% '#(RMS@9YQ[5SU%1*$9VYE
ML:0J3A?E>YVWAC5M2\2?$'13+&/*LV C@MX]L=O&!S@=ATY/M[5L^./$FJ>&
M?'.HRV6GV\,ES"L4-^\#;RFQ,[3G:<-WP3QCMBO,*T='TR'49Y&O;Z/3[.$
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M 4444 %%%% !1110 4444 %%%% !7IGP"T7^U_BO9SLI:+3H9+IN.,@;5_\
M'G!_"O,Z^E?V9?#QM?#FJ:],F&O9A;PDC^",9)'U9L?\!K&O+EILUI*\T>XT
M445Y!Z 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7*_$K3?[3\!WP1=TEL!<)[
M;3\Q_P"^=U=53)HDG@>&5=T<BE64]P1@UI2J.G44UT9E6IJK2E3?56/E*BKN
ML:;)I&M7FGRYW6TS1Y(^\ >#^(P?QJE7WD6I*Z/S.47%N+W04444Q!1110 5
MH:)HUYK^K0Z?I\>^60\GLB]V/L/_ *W6L^K=CJFH:8SG3;ZYLS)@.;>9H]V.
MF<'FIGS<KY=RZ?)S+GV.I\=R7\EO8VJ:=>6NC:6JVMM+=PM$T[%>7PP!YV>G
M'?&<52C;^R?AS(P.V?6[K8.O,$/)^GSL![XK%O=8U/4XU34=1N[M$.56>=G"
MGU&35>6ZN)X8HIIY)(X05B1W)$8)R0H[<^E<\*+4(P?1W_7\]3IJ8B,JDIJ^
MJLO+I^6AW'A/QG?>3INCV^G1W-]:M(ME<//L2(.IR77!W!1D]1P*MZ/-IM_:
MZY';B*YCT;3Y)K831JRW,Y!\RZ9&SN.0H .0H(XS7GD-S/;>9]GFDB\U#')Y
M;E=Z'JIQU!QTI;6[N+&Y6XLIY;>=,[98G*,N1@X(Y'!(J)X2+;<=+_Y_U][-
M*>.DE%3UM^5K+]'KV1U'Q*TRQTOQ6L>G0QP++;)+)#&,*CG.0!VX ./>N1J2
M>XFNKAY[J62::0Y>21BS,?4D]:CKII0<*:BW=HY:]2-2K*<59-[!1116AB%%
M%% !6!XPG$>C)$'(>68?+_>4 D_KMK?KDO&T^9[.W*_=1I0?7<<?^R?K7-BI
M6I,]#+H<V)CY:G+4445XA]:%%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#L.WUR3T]%%>6VV[L[DDE9!1112&%%%% !1110 4444 %%%% !1110 4444
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MGD>']-AM21AYL;I9/]YSR?ITK>HHKE;;=V;I);!1112&%%%% !1110 4444
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M4-3D[@R"*,_@HW?^/5[!16<J]1]2U2@NAA:)X)\,^&]IT30[*T=>DJQ R?\
M?9RWZUNT45BVWN:));!1112&%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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? "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>mdt-20201030_g8.jpg
<DESCRIPTION>IMAGE 9
<TEXT>
begin 644 mdt-20201030_g8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $9R:65D<FEC
M:"P@365G86X    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,V
M-   DI(  @    ,V-   ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MDDDAL$G)/&:YOPE%'XV^#/Q#\6>(U-WK9:7R[QF.^%5B#"-#_"GS$%1P1P:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(4@CCN""#[BH(]-L_#O[9&DV&AVT=C:S6#"2*%<!_P#1I22?4DJI)/)(R>:
M/=Y_$6BVNH/876L6$-Y'$9GMI+I%D6,#)<J3D+CG/2M&OG'QBNL_#GQ#KNKW
MMI:^*_ >OZDTM^@8&2UFW[2NX<JR,-J\X&T#Y6KZ+BE6:%)4^ZZAAGT- %&_
M\1:+I=[#9ZGK%A9W5Q_J8+BZ2-Y.<?*I()Y]*CU/Q5X>T6]CL]9UW3-/NI%#
MI!=7D<3NI) (5B"02",^H-?._@J#4O'/C/XE^'M4UBPL+[4I6BF^WV37$QB1
MY%VQ?O4""/Y>S?PGM3_CKIWV/P3\.K!]3?5/)=H!?[#&TZ@1@.,DGD8P<G/7
M)S0!]&VFM:7?WUS96&I6=S=VAQ<00SJ\D)_VU!ROXUF^*-:T^TLY-.?Q)!HN
MIW$>ZU(F@$[$'/R)*&#9QC[IX)Q@\CQ?1=-L_#O[8C:=H=M'8V;:?M:&%<*1
M]G#'/N64$GJ3R:E^&J'7/BC\5_\ A(X4N)_GMRDXW;8=\B[!G^':J?D* .J_
M9\\:^(/''@_4K[Q1?_;KB"_,,;^3''M3RU.,(H'4FO1[3Q%HM_J4VG6.L6%S
M?0?ZVUAND>6/_>0'(_&OFOX47VH:=^S1X[NM'=X[R*=RKQG#(IBC#,#V(7<<
M]L5N_#;PZ_BGP!X)U:'Q/INFIX>O\K!:Z:QN/-:7#122>=SY@()P@R&Z$4 >
MX:]JVFVT:Z;=>([?1+Z\ 6V<SPK,3G^!900WI]TUYS^SUXY\1>.?#NKW/BG4
M/MTUM=+'$WD1Q[5*9(PB@'GUK$^'*G6_V@OB.GB.%+AU5[9$G&[%MYFT* ?X
M2@3\ZB_9./\ Q2>O_P#7\G_H% 'OU%%% !1110 4444 %%%% !1110 4444
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M[@@@CL010 ^BBN:3XA^&7\;+X1^WRIKKE@MI)9S)NVJ6)#L@4C:I((.#CC-
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MH **** "BBB@ HHHH **** "BBB@ HJ*>ZM[;;]IGBAW?=\QPN?SJ+^U=/\
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MHRDCV)QT]*Y_3?BAHNH7.EB2UU"QM-9<IIE_=Q(D-XP[+ABRD]MZKN[9KLZ
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M]ITWD7MC=*%FMW[!@I((/9E)![&MBXN(;2VEN;J:.""%#))+(P544#)8D\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/$&E?V[X9U/2/.\C[?:2VWF[=WE[T*[L9&<9SC(IQT:$]CX.KZ _9<Z^*?\
MMS_]K4?\,N'_ *'#_P I?_VZO0/A;\+?^%:_VK_Q./[3_M#R?^77R?+\O?\
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M#%\"^$K[P9\$_'?B/[-)87>M6=Q<VUJ1M:V@2.0Q$CLV'9L=ABN:_P";)/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JD^D6$NM1ZM+;+)?0Q
M&&*9R3Y:DDG:#PI.>2!DC )P!5VB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@"KJ6FVFL:=+8:C%YUK, )(]Q4.
M0<'!&0<<CH1D'()%3Q11P0I#!&L<4:A41%PJ@<  #H*?10 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5$EK;QW,EQ'!&
ML\H DE5 &<#H">IQ4M% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% $5Q:V]VJ+=01S*CAU$B!@K#HPST(]:EHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH J_P!JZ?\ \_UM_P!_E_QH_M73
M_P#G^MO^_P O^->:T5Z?U*/<\C^T)?RGI7]JZ?\ \_UM_P!_E_QH_M73_P#G
M^MO^_P O^-><P6\MU,L5O&TDC=%458O-(O["(275NR(3C=D$?H:EX2"=G(I8
MVHU=1T.^_M73_P#G^MO^_P O^-']JZ?_ ,_UM_W^7_&O.K>VFNY1';1-*_HH
MS2W5G-92".X55?&=H<-CZX/%/ZI"]N87UZI:_+H>B?VKI_\ S_6W_?Y?\:/[
M5T__ )_K;_O\O^->>6EC<WS,MK$7VC+'( 4>Y/ I;FPN;2-'GCPDGW'5@RM^
M(R*7U2%[<P_KM2U^70]"_M73_P#G^MO^_P O^-']JZ?_ ,_UM_W^7_&N!_LB
M^-K]H^SGR]F_[PSM]<9SC\*KP02W4ZPP)OD<X5?6CZI![2!XVHM'$]&_M73_
M /G^MO\ O\O^-']JZ?\ \_UM_P!_E_QKS5AM8@XR#C@YHJOJ<>Y/]H3_ )3T
MK^U=/_Y_K;_O\O\ C4D-[:W+E+>YAE8#)5) QQZ\5YC6_P"#O^0Q+_UP/_H2
MUG4PL80<KFE+&RG-1:W.UHHHK@/3"BBB@ HHHH **** "BBB@ HHHH ****
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M#^T(_P IZ517FO\ :NH?\_US_P!_F_QH_M74/^?ZY_[_ #?XT?4I=P_M"/\
M*>E45YK_ &KJ'_/]<_\ ?YO\:/[5U#_G^N?^_P W^-'U*7</[0C_ "GI5%>:
M_P!JZA_S_7/_ '^;_&M/P]?WD^O6\<UW/(AW95Y"0?E/:IEA)1BW<J&.C*2C
M;<[>BBBN(] **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]_E_QKS6GP^5YR_:"XC_ (M@Y_#-=/U./<Y/K\NQZ/\ VKI__/\ 6W_?Y?\
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MRR^BC^IZ51N'CDN':"/RHR?E3).!]36BPL&]&9/&SBM8H]&_M73_ /G^MO\
MO\O^-']JZ?\ \_UM_P!_E_QKS6BK^I1[D?VA+^4].AO;6Y<I;W,,K 9*I(&.
M/7BIJXKP=_R&)?\ K@?_ $):[6N*M35.?*CT,/5=6',PHHHK$W"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /*Z***^A/EB6UF-O.)%2-V'W?,&0#Z
M^GYUUFI"Z?PF3?1I<S=1)%C"#/7C^E<[I&E_VK</")UA94W+N&=Q]*U8EFT+
M1[^WU!U_?+LAB5PQ)((+8[#D?E7+6LY*VZL=M#F4'?9IEKPY"T6FYLKFT^TR
MG=(CC>0/X1PPQW/XUC>(9K^34%34D1'C7"B/.TCU&?\ /%,31;[[#'?6NV53
MR!"V73\/\*NW_FZY=V-G')&;F.']Z[-QN[CCJ>.U))1J<][[_(<FY4E"S6UO
M,Q;6W:ZFV A5 +.YZ(HZDUT.OQ0P^&M/%JI6)B&&>IRN<GWK-AN(-+%S8WUD
MMTWF?,R3E1QVX'([_P#ZJV?$$L)\,616WP'5/*&\_NOES^/''-%23=2/:XJ<
M8JE/76WZEVVBB62QMX@#9O:.67'RO]WD^_/ZUS=I!':M)?!?, D*6<9&3(V>
M#CN!_.H-.%S=,;;[3+%:*I:;#G:J]^.E:>CZC!/XCC+@10)&8[9&_@]/Q//Y
MU/*Z:EU+YXU''2W;\/R_,P[J*YCF+7D<B22$L?,4@M[\U#72:T1%X>@@NO\
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MKO\ X,IO_BJ/^$]\8_\ 0V:[_P"#*;_XJJ_L^?=!]9CV/N&BO*OV>M7U+6O
M%]<:SJ-WJ$ZZI(BRW<[2L%\J([06).,DG'N:]5K@J0<).+Z'1&7,KA1114%!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% 'E=%%%?0GRP4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*I3;U .1R<]:J_VK+_:Z7^T91AMC[*HXVC\*T+[7X)+2\CM$E#WCAG,@ "#
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MP("@1LJY!P .N<CC_B+X&M/"EOH6IZ/<3S:7KMF+JW6ZP98CM5BK%0 >'7D
M=^.,FGX(\<R^#UU:UDLA?Z;K%J;6\MO-\IF4A@"KX.T@,W8]:3QOXXF\8OIL
M"6:6&FZ3;+:V5HLGF&-  "6<@;B=J]AT''4FHPJ1J>7]?J)RBX^9RM%%%=1B
M?4'[-'_)-]0_["TG_HF&O8:\>_9H_P"2;ZA_V%I/_1,->PU\YB/XTO4]2E\"
M"BBBL#0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 >5T445]"?+!1110 4444 %%
M%% !1110 4444 %;_@[_ )#$O_7 _P#H2U@5RWQ \5ZUX/T""_\ #E[]CNI+
MI8'D\I),H4=B,.".JCGVK.I%S@XKJ;4)*-5-GOM%?'W_  O/XC?]#'_Y(V__
M ,;H_P"%Y_$;_H8__)&W_P#C=</U"KY'M?68'V#17RQX<^)7Q3\2S2_9_%5G
M96L&//O=0BM8((=WW0S&/J<< 9-:_C?Q'\9/ =K:W>K>);2YL[IMD=S9VT#I
MNQD#F('D9/3'%0\)-2Y;JY7MXVO9GTA17S1I7BOXUZMX;O=?CU1K;2[.V>X:
MXN;*WC$JJN["#RLMD="!CWKE?^%Y_$;_ *&/_P D;?\ ^-TU@JCT30GB(K=,
M^P:*^:?"GB_XM>+$CDA\7Z;IL,\GE6\FI1VT/VEQU6-?*+/Z<#&>.M0>+/&_
MQB\'>(8=&U76UDN;@*UNUM96[K/D[1M_= YSQ@@'\Q2^J3YN6ZN/VRM>S/IV
MBOG?6-7^,VC:7J%W+XJT^YETN..34+.V@@>:T5QE2X\D#H"?E)X!-<YH7Q0^
M*&O+?2P^*(;6UT^W-Q<W5S9P+%&O0 D1$EF/"J!DFA82;5TT#K).S3/JNBOC
M[_A>?Q&_Z&/_ ,D;?_XW1_PO/XC?]#'_ .2-O_\ &ZOZA5\B?K,#[!HKX^_X
M7G\1O^AC_P#)&W_^-U[Q\#?%FM>,/!-Y?^([W[9=1:B\*2>4D>$$<; 80 =6
M//O657"SI1YI%PK1F[(])HHHKE-@HHHH *\KKU2O*Z]#!?:^1Y68?9^?Z!11
M17HGEA1110 4444 %%%% !1110 4444 >??&7_D3;3_K_3_T7)7B=>V?&7_D
M3;3_ *_T_P#1<E>)UK3V.RE\(4445H:A1110 4444 %%%% !1110 4444 ?4
M'[-'_).-1_["TG_HF&O8:\>_9H_Y)QJ/_86D_P#1,->PU\YB/XTO4]2E\""B
MBBL#0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#RNBBBOH3Y8**** "BBB@ HHHH **** "BBB@ KD_B=_R3G4_^V/_
M *.2NLKD_B=_R3G4_P#MC_Z.2@J'Q(^?J***Z3O-[PC<Q6^L*$\/1Z_J$I6.
MSM9]S1;R>2T:X+^PR!U)SQCU3XR:+H]A\.-"OKCPO;Z%XAN9%\U-/MPD*?*=
MZLRC:3T(&=W7G ->=>#_ (=>(?&>FZAJ/AP0.VFLN8FFV22,<D!.,9&.Y'M7
MHFMZSK5I^SC>:7X_\^+5;B^6'38[T$3R1H\;EB#S@8<;CV(]1GCJM>UBXOKJ
M;P^!W(_A-X8\%:WX/UZ]:PN;[5]/LBTS7ZJ88V='(\I03G!0\MSTQBO$J]S_
M &?;>=_"7CITAD99;6..,A20[".;*CU/S+Q[CUKR?PWX/U[Q?=SVWAW3I+V6
MW3?* ZH$&<<EB!GVZGFJIRY:D^9Z*WY"DKQC9'2?"'1?"OB'QE:Z9XGAOKF>
MX<BWAB*K =J,Q\QLAOX> OXU7^(FCV,/QDU'2+*.#3[(W<4*B- J0JRH"<#C
MN35KX+VEQ%\:M'AD@D62WDG$R%3F/$3@[O3!XJM\9HWC^+VO;T9=TR,,C&1Y
M:\T7?UBU^GZA_P N[^9[)J?@+PO-J7B/PU_9-A:66GZ'!<6]TL"B:*3,N9#+
MC<WW5R"<?+[G/B_AVPL_#OA:7Q;KEK;W<EQOMM&L;E Z3R='F9#P4CSP#P6P
M.,5I^&O$7BGQ@EQIVM:]-#X?M;13JUX(4$@M8R<1F4+O<DDJJDG)8\'FNQ^&
M.M6GBKQ1XFU46\<%UIND^5H5H ";2!0P^0?WA\F3ZN?6L;3I1?,[[?U\^OD7
M[LVK'@Y.23Z^@HKUOXRQVTOA/P-J-W_R'KS3%:]=E DE78F&D[YR6P3UY]*\
MDKMISYX\QA*/*[!7U!^S1_R3?4?^PM)_Z)AKY?KZ@_9H_P"2;ZC_ -A:3_T3
M#7)COX/S-L/\9[#1117AGH!1110 5Y77JE>5UZ&"^U\CRLP^S\_T"BBBO1/+
M"BBB@ HHHH **** "BBB@ HHHH Y/XG?\DYU/_MC_P"CDKY^KZ!^)W_).=3_
M .V/_HY*^?JUIG71^$****T-@HHHH **** "BBB@ HHHH **** /J#]FC_DF
M^H?]A:3_ -$PU[#7CW[-'_)-]0_["TG_ *)AKV&OG,1_&EZGJ4O@04445@:!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% 'E=%%%?0GRP4444 %%%% !1110 4444 %%%%
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MY4"LH!(&>3U!KA/#/B.S\,:5J-U:13-XAG7[/9W!4>79QL,22*<Y\PCY1P,
MDYYQ6GX!\=VOAO0_$.@ZO%</IVN6K0F6V56D@?:RA@K%0PPW(W#H*ETI03Y/
M+^ODA\ZD_>*/CWP'=>!M0LT>Z2^LM0@%Q:72IL\Q>,@KD[2,CN>HY].4KM_B
M9X^A\;7NFPZ=;2V^FZ3;"WMA.1YK\#<S $@?= P">G7GCB*Z:7-R+GW,IVYO
M=V"OJ#]FC_DF^H_]A:3_ -$PU\OU]0?LT?\ )-]1_P"PM)_Z)AKEQW\'YFV'
M^,]AHHHKPST HHHH *\KKU2O*Z]#!?:^1Y68?9^?Z!1117HGEA1110 4444
M%%%% !1110 4444 >??&7_D3;3_K_3_T7)7B=>V?&7_D3;3_ *_T_P#1<E>)
MUK3V.RE\(4445H:A1110 4444 %%%% !1110 4444 ?4'[-'_).-1_["TG_H
MF&O8:\>_9H_Y)QJ/_86D_P#1,->PU\YB/XTO4]2E\""BBBL#0**** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_K_3_P!%R5XG7MGQE_Y$VT_Z_P!/_1<E>)UK3V.RE\(4445H:A1110 4444
M%%%% !1110 4444 ?4'[-'_).-1_["TG_HF&O8:\>_9H_P"2<:C_ -A:3_T3
M#7L-?.8C^-+U/4I? @HHHK T"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]2E\""BBBL#0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3_K_ $_]%R5XG7MGQE_Y$VT_Z_T_]%R5XG6M/8[*7PA1116AJ%%%% !1110
M4444 %%%% !1110!]0?LT?\ ).-1_P"PM)_Z)AKV&O'OV:/^2<:C_P!A:3_T
M3#7L-?.8C^-+U/4I? @HHHK T"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH \KHHHKZ$^6"BBB@ HHHH **** "BBB@
MHHHH *Y/XG?\DYU/_MC_ .CDKK*Y/XG?\DYU/_MC_P"CDH*A\2/GZBBBND[P
MHHHH **** "BBB@ HHHH **** "OJ#]FC_DF^H_]A:3_ -$PU\OU]0?LT?\
M)-]1_P"PM)_Z)AKAQW\'YG1A_C/8:***\,] **** "O*Z]4KRNO0P7VOD>5F
M'V?G^@4445Z)Y84444 %%%% !1110 4444 %%%% ')_$[_DG.I_]L?\ T<E?
M/U?0/Q._Y)SJ?_;'_P!')7S]6M,ZZ/PA1116AL%%%% !1110 4444 %%%% !
M1110!]0?LT?\DWU#_L+2?^B8:]AKQ[]FC_DF^H?]A:3_ -$PU[#7SF(_C2]3
MU*7P(****P- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 >5T445]"?+!1110 4444 %%%% !1
M110 4444 %<G\3O^2<ZG_P!L?_1R5UE<G\3O^2<ZG_VQ_P#1R4%0^)'S]111
M72=X4444 %%%% !1110 4444 %%%% !7U!^S1_R3?4?^PM)_Z)AKY?KZ@_9H
M_P"2;ZC_ -A:3_T3#7#COX/S.C#_ !GL-%%%>&>@%%%% !7E=>J5Y77H8+[7
MR/*S#[/S_0****]$\L**** "BBB@ HHHH **** "BBB@#D_B=_R3G4_^V/\
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MTG_HF&OE^OJ#]FC_ ))OJ/\ V%I/_1,-<.._@_,Z,/\ &>PT445X9Z 4444
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RNBBBOH3Y8****
M"BBB@ HHHH **** "BBB@ KD_B=_R3G4_P#MC_Z.2NLKD_B=_P DYU/_ +8_
M^CDH*A\2/GZBBBND[PHHHH **** "BBB@ HHHH **** "OJ#]FC_ ))OJ/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\>_9H_Y)OJ'_ &%I/_1,->PU\YB/XTO4]2E\""BBBL#0**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH \KHHHKZ$^6"BBB@ HHHH **** "BBB@ HHHH *\^^,O_ ")MI_U_
MI_Z+DKT&O/OC+_R)MI_U_I_Z+DIK<NG\2/$Z***Z#N"BBB@ HHHH **** "B
MBB@ HHHH *^H/V:/^2;ZC_V%I/\ T3#7R_7U!^S1_P DWU'_ +"TG_HF&N''
M?P?F=&'^,]AHHHKPST HHHH *\KKU2O*Z]#!?:^1Y68?9^?Z!114]A)%#J$$
MERNZ)9 7'MFO0>B/,2N[#O[-O?LXG%K-Y9. VP_G]/>H88)KA]EO$\K8SM12
MQQ^%=G?Q7$:)J.E2-<+YOG,H;[RX *CU'%9/AR:RMX93+?\ V6YD8 $*.%'N
MP(Y)_05S1K-P<K'7+#QC-1;_ *\C%FLKJV0-<6TT2DX!>,J"?QJ$ D@ 9)Z"
MM_Q-#J$7E&ZNOM5L2?+8(%P?0X]N]-\)6RS:PTCKD0QEA[-D ?UJU5_=\[,W
M1_>^S7XF/-:W%N ;B"6(-T+H5S^=,CC>60)$C.[=%49)KI+%!=Z)K*S_ #['
M:1<]F )S^E/\'3[I)H?)B&U,^8%^9N>YI.LU%NVQ4:"E.*OHSF(HI)I!'"C2
M.W14&2?PJP=+U #)L;G_ +\M_A26%\^G7!GA53)M*H6_A)[_ )9_.MJ'6;^3
M0KVXO+C>&Q!$-JK\QZG@=A53E-/1:$4XTY+WF[G.4445L8'GWQE_Y$VT_P"O
M]/\ T7)7B=>V?&7_ )$VT_Z_T_\ 1<E>)UK3V.RE\(4445H:A1110!/:7MU8
M3&6QN9K:1E*%X9"A*GJ,CL?2H*** "BBB@ HHHH **** /J#]FC_ ))QJ/\
MV%I/_1,->PUX]^S1_P DXU'_ +"TG_HF&O8:^<Q'\:7J>I2^!!1116!H%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P!A:3_T3#7L-?.8C^-+U/4I? @HHHK T"BBB@ HHHH **** "BBB@ HHHH
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M3?4?^PM)_P"B8:^7Z^H/V:/^2;ZC_P!A:3_T3#7#COX/S.C#_&>PT445X9Z
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M_$[_ ))SJ?\ VQ_]')6QE#XD?/U%%%=)WA1110 4444 %%%% !1110 4444
M%?4'[-'_ "3?4?\ L+2?^B8:^7Z^H/V:/^2;ZC_V%I/_ $3#7#COX/S.C#_&
M>PT445X9Z 4444 %>5UZI7E=>A@OM?(\K,/L_/\ 0****]$\L**** "BBB@
MHHHH **** "BBB@#D_B=_P DYU/_ +8_^CDKY^KZ!^)W_).=3_[8_P#HY*^?
MJUIG71^$****T-@HHHH **** "BBB@ HHHH **** /J#]FC_ ))OJ'_86D_]
M$PU[#7CW[-'_ "3?4/\ L+2?^B8:]AKYS$?QI>IZE+X$%%%%8&@4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!Y71117T)\L%%%% !1110 4444 %%%% !1110 5Y]\9?\
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MT^#WQ$UE;#Q3K?C'5KF\TJSA64M</G]\Q.$CSTSC&T<<CCFLI59JGSPL_O\
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M%%% !1110 4444 %%%% !7GWQE_Y$VT_Z_T_]%R5Z#7GWQE_Y$VT_P"O]/\
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M4445@:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M117AGH!1110 5Y77JE>5UZ&"^U\CRLP^S\_T"BBBO1/+"BBB@ HHHH ****
M"BBB@ HHHH Y/XG?\DYU/_MC_P"CDKY^KZ!^)W_).=3_ .V/_HY*^?JUIG71
M^$****T-@HHHH **** "BBB@ HHHH **** /J#]FC_DF^H?]A:3_ -$PU[#7
MCW[-'_)-]0_["TG_ *)AKV&OG,1_&EZGJ4O@04445@:!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% 'E=%%%?0GRP4444 %%%% !1110 4444 %%%% !7GWQE_Y$VT_Z_T_
M]%R5Z#7GWQE_Y$VT_P"O]/\ T7)36Y=/XD>)T445T'<%%%% !1110 4444 %
M%%% !1110 5]0?LT?\DWU'_L+2?^B8:^7Z^H/V:/^2;ZC_V%I/\ T3#7#COX
M/S.C#_&>PT445X9Z 4444 %>5UZI7E=>A@OM?(\K,/L_/] HHHKT3RPHHHH
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MR5\_5K3.NC\(4445H;!1110 4444 %%%% !1110 4444 ?4'[-'_ "3?4/\
ML+2?^B8:]AKQ[]FC_DF^H?\ 86D_]$PU[#7SF(_C2]3U*7P(****P- HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#RNBBBOH3Y8**** "BBB@ HHHH **** "BBB@ KS[X
MR_\ (FVG_7^G_HN2O0:\^^,O_(FVG_7^G_HN2FMRZ?Q(\3HHHKH.X**** "B
MBB@ HHHH **** "BBB@ KZ@_9H_Y)OJ/_86D_P#1,-?+]?4'[-'_ "3?4?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#RNBBBOH3Y8**** "BBB@ HHHH **** "BBB@ KD_B=_R3G4_^
MV/\ Z.2NLKD_B=_R3G4_^V/_ *.2@J'Q(^?J***Z3O"BBB@ J:WO+FT$PM;B
M6 3QF*41N5\Q"02K8ZC('!XX%0T4 %%%% !1110 4444 %?4'[-'_)-]1_["
MTG_HF&OE^OJ#]FC_ ))OJ/\ V%I/_1,-<.._@_,Z,/\ &>PT445X9Z 4444
M%>5UZI7E=>A@OM?(\K,/L_/] HHHKT3RPHHHH **** "BBB@ HHHH **** .
M3^)W_).=3_[8_P#HY*^?J^@?B=_R3G4_^V/_ *.2OGZM:9UT?A"BBBM#8***
M* "BBB@ HHHH **** "BBB@#Z@_9H_Y)OJ'_ &%I/_1,->PUX]^S1_R3?4/^
MPM)_Z)AKV&OG,1_&EZGJ4O@04445@:!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'E=%%%
M?0GRP4444 %%%% !1110 4444 %%%% !7GWQE_Y$VT_Z_P!/_1<E>@UY]\9?
M^1-M/^O]/_1<E-;ET_B1XG11170=P4444 %%%% !1110 4444 %%%% !7U!^
MS1_R3?4?^PM)_P"B8:^7Z^H/V:/^2;ZC_P!A:3_T3#7#COX/S.C#_&>PT445
MX9Z 4444 %>5UZI7E=>A@OM?(\K,/L_/] HHHKT3RPHHHH **** "BBB@ HH
MHH **** //OC+_R)MI_U_I_Z+DKQ.O;/C+_R)MI_U_I_Z+DKQ.M:>QV4OA"B
MBBM#4**** "BBB@ HHHH **** "BBB@#Z@_9H_Y)QJ/_ &%I/_1,->PUX]^S
M1_R3C4?^PM)_Z)AKV&OG,1_&EZGJ4O@04445@:!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 >5T445]"?+!1110 444
M4 %%%% !1110 4444 %<G\3O^2<ZG_VQ_P#1R5UE<G\3O^2<ZG_VQ_\ 1R4%
M0^)'S]11172=X4444 %%%% !1110 4444 %%%% !7U!^S1_R3?4?^PM)_P"B
M8:^7Z^H/V:/^2;ZC_P!A:3_T3#7#COX/S.C#_&>PT445X9Z 4444 %>5UZI7
ME=>A@OM?(\K,/L_/] HHHKT3RPHHHH **** "BBB@ HHHH **** .3^)W_).
M=3_[8_\ HY*^?J^@?B=_R3G4_P#MC_Z.2OGZM:9UT?A"BBBM#8**** "BBB@
M HHHH **** "BBB@#Z@_9H_Y)OJ'_86D_P#1,->PUX]^S1_R3?4/^PM)_P"B
M8:]AKYS$?QI>IZE+X$%%%%8&@4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y71117T)\L%
M%%% !1110 4444 %%%% !1110 5Y]\9?^1-M/^O]/_1<E>@UY]\9?^1-M/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[P[?U_7<YRBKNK:>=,U%[?=O4 ,K>H-4JZ8M25T<DHN+<6%;_@[_ )#$O_7
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M\((XV P@ ZL>?>LJN%G2CS2+A6C-V1Z31117*;!1110 4444 %%%% !1110
M4444 %%%% !1110!Y71117T)\L%%%% !1110 4444 %%%% !1110 5R?Q._Y
M)SJ?_;'_ -')765R?Q._Y)SJ?_;'_P!')05#XD?/U%%%=)WA1110 4444 %%
M%% !1110 4444 %?4'[-'_)-]1_["TG_ *)AKY?KZ@_9H_Y)OJ/_ &%I/_1,
M-<.._@_,Z,/\9[#1117AGH!1110 5Y77JE>5UZ&"^U\CRLP^S\_T"BBBO1/+
M"BBB@ HHHH **** "BBB@ HHHH Y/XG?\DYU/_MC_P"CDKY^KZ!^)W_).=3_
M .V/_HY*^?JUIG71^$****T-@HHHH **** "BBB@ HHHH **** /J#]FC_DF
M^H?]A:3_ -$PU[#7CW[-'_)-]0_["TG_ *)AKV&OG,1_&EZGJ4O@04445@:!
M1110!Y71117T)\L%:OAR"XGUE/LLHB* NS$9RO0C'?K654]E>SZ?=+/;-M<<
M<C((]#433<6D73DHS3>QUTEQ;Z_I%Z;4F"5/OD?Q@9VY]C7&P1B:XCC9UC5W
M"EVZ*">IJ[)K4[6\\,,,-NMP<RF)2"_MR3Q]*9/JL]QID-BZ1"*(Y4JGS'\:
MRIPE"Z6WY&]6I&I9O=?B=;H< ANI_+N;:6%45(HX)=Y49/)XZGK7+V=\^B7L
M\8,5U&Z[)!&_RL/4-^-1Z7J\^DO(ULD;&0 'S 3T^A%4:4*+4I<VSL.==.,>
M71JYO_;A+:0WD\.RVLU\NUB+;C))CJ3QD#&:M1:7:3-IXO(VGGU%'D>8N05.
MT-P!QWKG;J\DNA$K*J)$FU$08 '^)]:MV^O7=O!%&JQ.T(*Q2.N6C!ZXYQ^=
M*5*5O='&M"_OZ_U_EHBE=0_9KN:#.[RY&3/K@XJ*E9F=BSDLS'))[FDKJ6VI
MR.U] KS[XR_\B;:?]?Z?^BY*]!KS[XR_\B;:?]?Z?^BY*:W*I_$CQ.BBBN@[
M@KN=%^+/BCP[X:L="\,31Z?' 7,CK DKSNSL<_.I X*C '\/7G X:NJ^&T&F
MR?$#39]=NX+6PLG-W,\\JH&\L;E49ZDL%&!R<FLZBBXWDKV*BW?1G3?'#Q!?
MWVMZ1H6IW7VJ[T>P07DH0+NN9%5I.  ,8V=!ZU>_9VUK2--\9WEEJ8$=YJ,
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MFC_DF^H?]A:3_P!$PUPX[^#\SHP_QGL-%%%>&>@%%%% !1110 4444 %%%%
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MU'_L+2?^B8:]AKYS$?QI>IZE+X$%%%%8&@4444 >5T445]"?+!1110 4444
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M:&H4444 %%%% !1110 4444 %%%% 'U!^S1_R3C4?^PM)_Z)AKV&O'OV:/\
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M^H/V:/\ DF^H?]A:3_T3#7#COX/S.C#_ !GL-%%%>&>@%%%% !1110 4444
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M)BKY?KZ@_9H_Y)QJ/_86D_\ 1,5<V._@_,UP_P 9[#1117AGH!1110 4444
M%%%% !1110 4444 %%%% !1110!Y71117T)\L%%%% !1110 4444 %%%% !1
M110 5R?Q._Y)SJ?_ &Q_]')765R?Q._Y)SJ?_;'_ -')05#XD?/U%%%=)WA1
M110 4444 %%%% !1110 4444 %?4'[-'_)-]1_["TG_HF&OE^OJ#]FC_ ))O
MJ/\ V%I/_1,-<.._@_,Z,/\ &>PT445X9Z 4444 %>5UZI7E=>A@OM?(\K,/
ML_/] HHHKT3RPHHHH **** "BBB@ HHHH **** .3^)W_).=3_[8_P#HY*^?
MJ^@?B=_R3G4_^V/_ *.2OGZM:9UT?A"BBBM#8**** "BBB@ HHHH **** "B
MBB@#Z@_9H_Y)OJ'_ &%I/_1,->PUX]^S1_R3?4/^PM)_Z)AKV&OG,1_&EZGJ
M4O@04445@:!1110!Y71117T)\L%%%% !1110 4444 %%%% !1110 5Y]\9?^
M1-M/^O\ 3_T7)7H->??&7_D3;3_K_3_T7)36Y=/XD>)T445T'<%%%% $L]U<
M7*Q"YGDF$,8BB$CEO+0$D*N>@R2<#U-1444 %%%% !1110 4444 %?4'[-'_
M "3?4/\ L+2?^B8:^7Z^H/V:/^2;ZA_V%I/_ $3#7#COX/S.C#_&>PT445X9
MZ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'E=%%%?0GRP4444 %%%% !1110 4444 %%%% !7GWQE_Y$VT_P"O]/\ T7)7
MH->??&7_ )$VT_Z_T_\ 1<E-;ET_B1XG11170=P4444 %%%% !1110 4444
M%%%% !7U!^S1_P DWU'_ +"TG_HF&OE^OJ#]FC_DF^H_]A:3_P!$PUPX[^#\
MSHP_QGL-%%%>&>@%%%% !7E=>J5Y77H8+[7R/*S#[/S_ $"BBBO1/+"BBB@
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M , T_P */^%<>"_^A5TC_P  T_PH_M"/\H?5GW/B.BOMS_A7'@O_ *%72/\
MP#3_  H_X5QX+_Z%72/_  #3_"C^T(_RA]6?<X/]FC_DG&H_]A:3_P!$PU[#
M6=IGA[2=%MFM]&L(=/@9][16@\I2V -Q"X&< #/L*N?9D_O2_P#?UO\ &O+J
MSYYN7<ZX1Y8I$M%1?9D_O2_]_6_QJ."%7C)9I2=[#_6MT#$>M9E%FBHOLR?W
MI?\ OZW^-'V9/[TO_?UO\: /,**]$_L+3/\ GRC_ "H_L+3/^?*/\J]/Z['L
M>1_9\OYCSNBO1/["TS_GRC_*C^PM,_Y\H_RH^NQ[!_9\OYCSNBO1/["TS_GR
MC_*C^PM,_P"?*/\ *CZ['L']GR_F/.Z*]$_L+3/^?*/\J/["TS_GRC_*CZ['
ML']GR_F/.Z*]$_L+3/\ GRC_ "H_L+3/^?*/\J/KL>P?V?+^8\[HKT3^PM,_
MY\H_RH_L+3/^?*/\J/KL>P?V?+^8\[KS[XR_\B;:?]?Z?^BY*^A?["TS_GRC
M_*J][X2\/ZE"(=1T>SNXE;<$GB#J#TS@]^3^='UV-]BHX&47>Y\+45]N?\*X
M\%_]"KI'_@&G^%'_  KCP7_T*ND?^ :?X5K_ &A'^4Z/JS[GQ'17VY_PKCP7
M_P!"KI'_ (!I_A1_PKCP7_T*ND?^ :?X4?VA'^4/JS[GQ'17VY_PKCP7_P!"
MKI'_ (!I_A1_PKCP7_T*ND?^ :?X4?VA'^4/JS[GQ'17VY_PKCP7_P!"KI'_
M (!I_A1_PKCP7_T*ND?^ :?X4?VA'^4/JS[GQ'17VY_PKCP7_P!"KI'_ (!I
M_A1_PKCP7_T*ND?^ :?X4?VA'^4/JS[GQ'17VY_PKCP7_P!"KI'_ (!I_A1_
MPKCP7_T*ND?^ :?X4?VA'^4/JS[GQ'7U!^S1_P DXU'_ +"TG_HF*N\_X5QX
M+_Z%72/_  #3_"M33/#VDZ+;-;Z-80Z? S[VBM!Y2EL ;B%P,X &?85SXC%Q
MK0Y4C2G1<)7N:-%1?9D_O2_]_6_QH^S)_>E_[^M_C7GG22T5%;$^3R2<.P!)
MSP&(J6@ HHHH **** "BBB@ HHHH *15"C"C R3^=+10 4444 %%9VJ^(M%T
M$(=<UBPTT/\ =-Y=)#N^FXC-2V>L:9J$<,EAJ-I=).2(FAG5Q)@9.T@\X'I0
M!<HHHH **** "BBB@ HK,U#Q-H.DWT5EJFMZ=974V/+@N;N.-WSTPK$$UIT
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M&2?SI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *15"C"C
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MG2_B)X7U?7CHEKJ9BU7_ )\KRVEM9CQGA)54GCGBNFH **** "BBB@ HHHH
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M%% !1110 444R&>*XC\RWE25-S+N1@PR"01D=P00?<4 .50HPHP,D_G2T44
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M?_(AZ_\ ]@VY_P#134 >;:?\=M0OOAU/XU_X0[;I-G=BVNPNIAI5!*C>B^4
MP!< Y*]>XR1I_$'XT1^#/#.A^(--T>/6=,UE-T3F\,#KE=PROEMV]\@\8KR;
MP3)>ZC^R_JWAW2-(U&_U'4M1,5N+>U9XS\T18M(!M0  _?([8[D:OQ?\%:[;
M?"/P3X8T[2M0U74-.3=<BPLY9D0[,'YE4C[Q('.3C- 'KEC\1;AKS6IM<\,W
M^BZ'IMF+V+5;D@K<Q]>% X;'.W);L0IXK$B^-D4.CZ+X@UG0S8>'=;NFMK6\
M^V!YHR"0&EBV@*IVDY5VP!74>--(;Q[\+]4TW3_-@DU&T/D"YA>%@X(90ZN
MRY( .1WKQ+4O!OB'Q3\*/!W@*+0]2L]3TZ^8ZA+<VCI!;QYD&\2D;'X<$!&)
MXH ]B\1_$4:9X[TWP;HFFKJFN7T;3LDMQ]GAMXP&.YWV,<G:< *?PR*\K^$5
MQ=R_'_XA3Q6*Q7IBG9;2>78HD\Y?E+J&P,_Q 'CG!Z5T.M^%]3\-_M&Z1XP2
MPOK_ $2>T^RS36D#3O;.(C&"R("VT_*<X[GTJK\,]#\0Z?\ 'OQ7K=_X<U&V
MTS57F2*YE5%5/W@<%@6R00N,J&Y([9( +^E_'JYU7P/XD\0Q^%HXSX?FBCFM
MFU,_O5<E25;R>H('!'()Y&,'K+/XHZ;_ ,*B@\>ZS;-86LD)D-LDGFMNWE%1
M3A<DD#L.O/3->#6OASQ?X<\'?$'PJ?!NM7ESJ=Q&T-U;VQ: QI(26#=7)!&%
M4$\G.,5VK>!M9\5_LJZ?X?MK&[M=9T]_-^Q7D#V[NZR.2N' SE7R#TS@9ZT
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M9YKX9:'J%Q\3OB&-2TC6-/LO$9NEL[JYTR>)&1Y9&!W,@"G:P.&QZ=: .O\
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M6QF(4#S4:2-U+-_L^6V/]\^E<!\.-"\9?"[3)_#EYHS>(])2=I;*\TVXA25
MW)5XYG0=>>&."3UKT/3FU>_FGDU>UALK-X]D5F'\R4YZM(P^4<<!5SW.XYP
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MCUWPG'!'-IMQ<1 W C$8.UU8IUBR,D<-S@C% &+J_P#:J_M?>&$UQK22X2U
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M+--!U!)387L,VZ8^7&&9G&[A<D+]T<D<F@#6^(_C:/X?^![O7Y+4W;Q%8XH
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M-&"A#LQ1F4=2%^8G&,]* ,8?M#,=&/B3?HRZ:-1%L-%,O_$R-OT,_P!_ /\
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M*_*,[@ H)^[G/.  =Y1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR2WFJ,85>,>O)S@>CT4 16BW*6<2WTL4UR% EDAB,:,W<A2S%1[%C]:EHHH
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M,DMFND$B+_>*YR!R.?>N.\3?&#P_H'CS2O"_V^S\^>9AJ$\TP2*RC",0&8D
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M]% $5I"]O9Q0S7,MW)&H5IY@H>0_WB$55R?8 >U2T44 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ",RHI9R%51DDG  KY)
M\5W>B3?!OQ#;^%KNXOM)BU])%O-4E#3SSN,MY2@ JFW)W-EFR>!S7ULRAE*L
M 01@@CK7$P_!OX?V^FWUC#X9M5@OR#<#?(6.&# *^[<@R <*0* /*?BK=W=Q
M8_"&SN6:33+MK>2Y#G*3.! /G]>&;KZFK/B:UM[7]LOPXUO%'$9K59)2@QO?
MRYER??  _"O8KSP#X6O_  K;^&[O1K=](ML&"V&Y?*(S\RL"&#<GD'/)YYJ
M_#/P?)JT.J7.A07=]"J*ES=N\[_*<J27)W$?WCD].>* /(/'NFV>J_M=>'++
M4;=+BUGL5$L3_=D&V;AAW!Q@@\$<'BN>\'>'])NO%OQ=T^XT^"2RT];U[2U9
M?W4#(\JHRIT#*.%.,J"<8S7O]Y\-/"M_XNC\475C</K,3AX[O^T+@%,= %$F
MT+U^4#')XY-5+/X1>#+";49;/3KN*75(WCO9!JMWNN%8Y;>?-R<G.3UY/J:
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M,:+=L=\D_,RDT[Q#\/O"OBK5K/4_$&BP7UY9#$,KEA@9R P! 89R<-D<GUH
M\:^*5C;:M^U1X,M+D>9;7%A")%4X$B^;/E3Z@C@^H)%=/\5/#7@+P9\+[FWG
M6[T2QNM22Z6'2'Q)<7(!PH#94+A<XX5=H(YP#VNL_#+PIX@\3+XAU6QN9-6C
M"B*ZCU&YB:(+T";) $[GY0.23U)-:7BCPAH7C32UT[Q-IZ7]JDHE1&=D*N,@
M$,I!'!(Z]Z /$M%NYY_VMM/FG^SPSW.D S16LF\#,!(5VXWL %).!T'' J;P
MO-'!^V-XI>:18T^Q$;G8 9*P ?K7J\/PQ\&6^LZ?JMOX>M(KS34$=H\8*B(
MD@[0=I())W$$Y[U/=?#[PK>^,(O%-UHL$FM0[2EV2V<K]UBN=I8<88C(P.>*
M /(_AZBM^UMXY5E!5K&8$$<'][;U2T*.]^&'QR\0^#])B9+7Q1")=**Q[A"Y
M)*MC^['F4'V05[%IOPT\+:1XJE\2Z?8W$6KS%C+='4+AC+NZA@TA5AP."".!
MZ"MFXT'3+KQ!9ZW<6B/J5E%)#;W!)S&CXW#&<'..XXYQU- 'AWQ\=O"[_#_2
M+ 1V?AZVNP9(Y(R\!,31;?,4$;@%+'&1G+<YY'H?@WPK/I/Q UO7I_$UIJ,F
MNVT4TME8630P+M 5903+)U /4\Y8CIQU7B/POHOBW2CIOB/3H;^T+;@DF05;
MIN5A@J>3R"#S47ACPAH/@S36L/#.FQ6%NS;W"%F9V]69B6;\30!M4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
$% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>mdt-20201030_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mdt="http://www.medtronic.com/20201030"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mdt-20201030.xsd" xlink:type="simple"/>
    <context id="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i9690ac488cf0498597a1dee299c08d4a_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ie597491265f54e5b83c5e498b9e5e35d_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2021FloatingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="if431af446740495eafa610045eee2dee_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i6946ebb61b914bfa814743c0b4901fc9_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20230.375PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i7de46d31eff94c88bf5224b071d2649f_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ic5b334ffdc574053ad9c42fd2a5e06d9_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i0fda69c384584c999349f0452905a004_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i86350dcdf5e0430ab236aa4e72a95677_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ib87a49f46e80456aaae50a2676d2b9c4_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ifd6d2a65b5a74087a9cd3322dafc9078_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20311.625PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ibfc007fd29af4d10aae7f839ce84e9d0_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20311.00PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="id98bb264c6ae40ce9fa7d1c6480a5695_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="icd770a2a644746b3a8f33af164792726_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20392.250PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i2bd98a03670c4e72ad51a2c7363e7490_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20391.50PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ifcfa923f30854b80900b6aea7decd075_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ic21aaaba5ba242f4a805034963baca6d_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2049Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i55564036473c42538449804d30b330bc_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i57886cddd4384344b30a7a72843fef41_I20201201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2020-12-01</instant>
        </period>
    </context>
    <context id="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="id878a47f7fe0468895f6089921c8baca_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i56cbe72d4f164d52b063093c431c9843_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ib91d3cafbd584b8ca35b1b380bde9703_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="if3e9504309af4083b6fd5bf477afa1c6_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ic572c413537c418298b2634dbfaaf017_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="idd6a86ad9b714d9081642559e2ff2934_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i5c85755ec4074136b1ee5356437a2b17_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i7b5b7d170f3340e696de1c1470de9cdd_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i1b268c905e614cd0838cbabb6383cd70_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="id9156b821fc84f4eafacc70d98d9cd2b_D20200425-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i6371626247f34091a93b2dc205920ab8_D20200425-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i85c770bf95844dd9931cef47b1f7be43_D20200425-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i673be33df7fd4f9bbded121055267d0d_D20200425-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="id71e33001d124f7794452cdccb09c623_D20200425-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="if639f48dcce540048c90f61ab3fb7bc7_D20200425-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="ib94296a7b45e4e3dbe2d67900645d435_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ib110981db8f14c9cb4cbb63889887dd7_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ic409e1c550db48e5bcd4ce67616935c8_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i72605901d1f74ce597b028c09d4dd3a7_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i25a5dac7b3084d7a84a6335f68c0ceed_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="id628b7deeefa46eba3e8cce6bf5edf04_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="ie418c42f639e4cb68a0a9bac1b9871d8_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="ie49fd01017d6410babb0baa6095d8df8_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i90d56739612b4fba968994692f0deff1_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i08ae410a74984dc0a1a2e5d64185b3a1_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i69cfa6db80bb43d89a510e85d2efae77_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ieedf1ec037a4442aaef3abd0076151d8_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i720289bbdf744d3c8b2dcfad03251c89_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="if31334823c424f9c82c6d16a6bd8c729_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i28dc26d87a9e4efaa4d5051ff8841788_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ia21542305a5946e8b39788bc982841f6_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ibbe9b124d8ca41e981b8cf95b5ea6242_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i992522324432452d9ca66c8a4b298efd_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i1fb60693b842404b9c6c710c434a9f46_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="if93a3ed7d08a4808a025b1a3549ab044_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i111f8934e3d049098d7b0406e926375e_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i52de462b431c4555b295ebb144b8351f_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="i9126a007a995490e9cb89a8340e8a989_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="i552f2062fa83483db3124c50e8e701c8_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="idce4f3b26c5a4fefb9a2268a16c018e1_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="if2f9007fbf9043ab8f457f9c90c97961_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="i488d2783b01647579ba73905fa797719_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="i33145a1d36f644e3a8066f41beb5b5e2_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="i7fb0dd42a0a04276b76c07255e58b0db_D20190427-20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-07-26</endDate>
        </period>
    </context>
    <context id="i044332ce225b4db4897be21e46da5d03_D20190427-20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-07-26</endDate>
        </period>
    </context>
    <context id="i28055ea3470d4effb3ed77de9befc2f5_D20190427-20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-07-26</endDate>
        </period>
    </context>
    <context id="i8308e83ae1a947b48941212c51887a44_D20190427-20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-07-26</endDate>
        </period>
    </context>
    <context id="i8759e14cc5034a7993bfef890b7d7418_D20190427-20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-07-26</endDate>
        </period>
    </context>
    <context id="ia87757d6c9d640d48a2c1a16626f5bc4_D20190427-20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-07-26</endDate>
        </period>
    </context>
    <context id="i678e0b51f4cf4d5690b48a63a626a8cc_D20190427-20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-07-26</endDate>
        </period>
    </context>
    <context id="ib96559476e2e42589c348e36cfd88199_D20180428-20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2018-04-28</startDate>
            <endDate>2019-04-26</endDate>
        </period>
    </context>
    <context id="i4484008ce40941a9abb0b87591c12b24_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="i59aafb40e1c3487fb79f88def0cabe5e_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="i93af46c007a64220a69e96a35444a4d0_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="i275643f747c34984beeb90478e79ad20_I20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-26</instant>
        </period>
    </context>
    <context id="i12ad7c520edd49219af398dc688a28c2_I20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-26</instant>
        </period>
    </context>
    <context id="i27b17bf8998541b3b1a8eaadaa465cb5_I20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-26</instant>
        </period>
    </context>
    <context id="i6a33cca3e32b47bfa87a465de4ceb4fa_I20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-26</instant>
        </period>
    </context>
    <context id="ieae2d147c0744537a2b2ec49b9cb4379_I20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-26</instant>
        </period>
    </context>
    <context id="i8c2221645f1143a588fcb530d45d397a_I20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-26</instant>
        </period>
    </context>
    <context id="i4b67d8b2f5e5423fab22a58594388040_I20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2019-07-26</instant>
        </period>
    </context>
    <context id="id40604cb0c8742fc840c198c66ddfbfe_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i02207236d5774c39981a6d0d117258bb_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i27b99796b29e40eabeac0a12c20105e4_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i91d0e9197fce4eaea0b4d58bb59f7b58_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i9c4d81e283664aefab974994912b8be4_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i52c82d1243664ffb830c526ef6fcaf0b_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i0ccab2a935344b5791bfcee3cae77ce7_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i26eeffc415cf4e6b8336a920c96e512d_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i9a319d67f7224e6f8d72495027df5e84_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i36754839d63e4461b94b37c7bae9a3fb_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i77e3bce30a1c435e86c5538940a335df_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="ife38249405474a528870b8419d041fea_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i20cd473a93b445c7a57a0c7284cf0cc7_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i06dc9f6bc4aa419bbfe27b17af09fe0a_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i269fa9ffafa24ecebf48c60b39842dab_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i91fb2eb368934993bcd7a0f9575fa788_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iacc575534b9240399501f15b894e067a_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i487ad5972a2c47febec797b0e0776ddb_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryandStructuralHeartDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i0b5caf67e2be4f68ad7f92d16ada67f7_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryandStructuralHeartDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i919fa29680244ba4b8253a93aa18f460_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryandStructuralHeartDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ia64dace9b6414c26928f6b70651158e4_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryandStructuralHeartDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="id24613977cb54f098d9805b207b29a55_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:AorticPeripheralandVenousDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i220395ee33ee437396566fcc3626b2a2_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:AorticPeripheralandVenousDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ic09f65a4d2d84a4c92acaac75a0e15d9_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:AorticPeripheralandVenousDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i3c9f4935fea44124bf3d4a1a49aa9040_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:AorticPeripheralandVenousDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i1a312d23d83d4502a1392fed0d7ba764_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ic3b239a3126a4bb49c5e7d5b60ab13f1_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i9ca6f74752024dcb8dbf523283f9b0ef_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i05fc22c6d55b43f2baae1649a5d9aebe_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="id48f0ff947294dd49ff34d19b294e672_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i60c6177e6a344d759591f1b0f76cb5ba_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ic752b9473c764500acd5730cdefe3be4_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i5bb60e8143094d27a9a05d4c84ead362_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="id131618c7183472b800356aed3d45c7c_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i83ca6860129f4055bed2c98b4ce69e3e_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ia4e72a8a6dab4f788a302f0f0cf79096_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i2bd062672d454f1e8a9d5bb8d4322a32_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i5b3758a87a354529882de9d3335644c0_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i70d63caefd6b48e69f2a86e37189768c_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ieac0a2b04a964cccb353c56583b8d073_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i71d43d788d014fd7a1ba8bdea4691710_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ide47cbfb7b0b4342bf4ea373f2ce909a_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ief0f6318a0b04247be6884fe9e17d5b1_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ibb0ec325078447fab69eeca2bdca138e_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i4d27cd3056dc4459a2cc70f6dc711dff_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i82f5d914dd8d4e04b7d2a35e01bb9bf3_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i313d0d047bd048469aa9949a611758d3_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i2fc4e1b636e5420f8ac12b6b27b04d28_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i6dccdf4f50614d0e9c893b4f40f55384_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ib9d5d26f5da740a198a88bb8f7973c42_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="if53fca09d7ef4b848279a7fe2579e3d8_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i4524b53e676148ca86cbcc0f07a84bb3_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i93119b416ab149a386216f786e016df5_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="iec22bedaccaa44e19dc9acca8eff8a10_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i4600b695100d4820a01604a104cbadaf_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i79d7d6e72a3d4a20b5a5c636e920c38c_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i15f5b5dfb4654786b8a1527a73a00fcd_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ic0be4b9113414c3d997bc3e01adfe216_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i2cf2e96e50c04872a16be9a18ec034d0_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i374e41da3175425682886e64b4e59ac7_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i852dbc45d1014705a3144b798acc4dfa_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ibbacdf5a92134ca0b1da1422f776402f_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i4524b8f3efaf418c873e6e495a80bbc3_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i35f7007d83ec443f927267bb6df4c0fc_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i537a942bf4fb4b6eb80e288f1c249edb_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i0f8e3cc16c4a404488402b32b4689b44_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iaaf5d087ffa84fa8abd5a5aa306fda7a_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i1b6321183ca146979a393ac5b3ac26a5_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i7031548bb00d44e4984fe848fdd877ac_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i95113ab22bfc47679021038cda3626d5_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ide26e733fd264ebeac15b9b238bd8cb1_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i1024da8bb25a4ecab9fdd229633f9fef_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i82224f56dda849528eedfeb6a2648d87_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="icc5dc04ed0d044db9fb861aa2555e5b6_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="icc7c7a1e02fe46c59155bfc029734bd7_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ia6cce28fd6194e2c961aede987941a6c_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iafacc4a2c7db427383b4b9439b78bf84_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ia6948db30839464bb1b8614f17820d69_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i2db71be890924f94a20e986c13b7cfd0_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="icba853bd219340caac53ef75115336f3_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i8d1f7d1f952b46de9a5ec5bf956f8c4a_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ie3a781a1a3014264be590e09689a0392_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i4ad14b6e2d99494ca8b0e3e32a58c09a_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i481e2bb36b4f4ad58fcf6c68706875aa_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="if569aa4c250e4165a6f2453aded60f03_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i2e59a2f196984183a973f8905eda8c10_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="idc31344ce037435086c6584f0cbc5603_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i8c0b9d71f9af4be0bdef0b12e789d63a_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i7976d05e19ea43479f40263835baa0f6_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ief279681dad24d0ab1a402ba5b0534d8_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i61edff06ccbe49e0923a8285fc14b9d8_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ibe51a58c91ff4d568cfa875dc418aa53_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="id82317500d8042669bd53b4daa560b23_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i1a2cb34fbe86434d9d2e4abed35fa190_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ia9bd82a0a27841599fc9f6054adf2db0_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="if3c0e6b71596419bbee4ef75a287dfb0_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i2589b11b8c8b419f90d2110eedd22e72_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ia0943ccf01b541bd8b688fa0231ab07d_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i857871df90664c4ea9084d7f52e58287_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="iad390d4335a84981b4dbe016e84fec16_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i221826c350e8440fa29609ad85dbfe00_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i87f2d291a1d14c8da1ca068a8184f596_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i5d18cd69e527443cbb52344bfc5d1d17_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i0def346fe6e84c4fa17ebb19cef19a26_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ie3bfd6d86b3b4f0fb2300c2d7f9d363f_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i23af05bd2c5d45359d3998fa371a34ae_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="idaf607ee11904bcd9cf888c004bb4fb5_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="if9ae29ca0bdc4f73936473ec74e2520d_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i91fc95de785c40258c208144bffa2343_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="id5940248053940f3ad40aa0896988543_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i359b10ddf4d64149867a3e367a9b382a_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i086f2718cdec44d5b96ebdb32ebdbe23_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i156b9ba3ff10454382c5d0aebee43dcf_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i45d51c0af50d408484ec761c3c800e8c_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i706ca6327a9945bea2a852ef2e7fc4fb_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i650829f108154ef79219df52ed0dd76e_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i9e309488f2d44b4f90cf8c46966b9320_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ia0c73c0c36c949138a78ac8a9b55a7ea_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i1c94a76a97fb4905b120a4bc756ade5b_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i3cb21b8ecb894dc6b9eb7b6003425d7b_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i15270ce2423347719255bea4dd215ab4_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i0ff95eb833ec4ac8a94740b1dc4672ec_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i201f7a25b37d4a639737b126db6b299c_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ief6cc83a0158450c8c8c8dfb1b72cb01_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ia759ed90b92c4979a7b3cae67b7f74fa_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i27dc3723a0be438391652135f2101c29_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i3302135c65a2484782311fd82ec693dd_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ia659fbb5fcf346a9a90200d57a4a5578_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i5b0455f24d0b4a3791fb3fd9fc1efc9a_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i5259c4355fa34167856c9efd29463eab_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ie996b89b72df4251ba0beb6f36061915_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i286b913f59ce44a89a6efc03a44edd01_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i58932d951c2a4621825726d182be8121_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i894a513621284324b46eb9a6b6583b3b_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i3f58e96a62054a76beef660302748e4f_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i6458efd12f3d493e954c2b482e7b1267_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="ied47c882b8944b9a824975e730d6084c_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i7f89188c42c54dea947302b6c32918d2_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="ieea3c92fd22346e3ba0cbae8446c3146_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i36b61101ccc34fe1a098c7a0a1438f56_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i8a9f49019242491fa2753b5c0b454587_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i23fc05bb0ae84039aed38c9e14a8d9ba_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i4420ff33a4ea4338b79bc63a916e8eaa_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i206d5cfac8764545b5c73b964083df22_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ie3e605d554a34a48aafc28f4aec2bc10_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i6686b72c8d254c0a8ae89c915b162323_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i0e362e921abc4ec38c51136161f1dd32_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i6b72725bfde146b59806f55b4de68183_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mdt:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ibf29640eead0423b8af20621f7e82a6e_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mdt:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i6796994ca7b1457ea2f0996b5fda014e_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mdt:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i17f40c5d5c144485bcaae9a942364fe9_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i4628c29036454d5fa0fc10c68641fb73_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i478c6a017fc349f59ff0568390ff4f01_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i294a126245e1491797b98713fe0945c9_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mdt:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ifc28c29bd1fa43b782141ceb32766ec0_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mdt:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="id4bab39e35944924a3cd9ffc1393059f_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mdt:MeasurementInputProbabilityofPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ie19586da83c548419c65ce54dda4ac85_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:PreTaxExitandDisposalCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i593837cb940d49fa93ab3e7716b6faa5_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:PreTaxExitandDisposalCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i406d848cd3404dd991012a6440565838_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i87f3513e1ffc40c7bede0ba00efe2ed4_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ifc70a688a0d74e63819c4ade21969f2d_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i95902727c56e4c2290a1ca75aaa9d4ee_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i882643c31d764908a9b439838cdcac4e_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="icfe2201ad4e547e4a67d546069665441_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ic7a56850c3644238ba02de19c9b1c11b_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i8cf9700f41544535a38b9d85f3853147_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i6b1e1f29dda94d8db00dc1fb059072d7_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i2040f3b39be34880bc79b81b3bbcd824_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i3654a2c834ae4cf7b134b2e121f5c339_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i68f172d54ac643f69996cb767c6659f4_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="if3cc36b2ab0b40f69449ff35ae8ea230_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="iedfe76d8c426489e9bea058060893444_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i351e8abc52b741a6b52e469c40e2e761_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i1da6f2608bec495282ec262dc76cf183_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i5464a7ffeef4485685b5fd1e3a463e37_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i63278b6a1dd844309858a5b5ee35779e_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i5616aebc236a4e4d97246ff6cb32b98b_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i94f2a1c0fa6447faa4ffa5ae06ecf9a6_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ib247e010f8064236b932fbe29a46c299_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ia24d860e2e7247b88d59a33bffba5d44_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i4c765c8437494e3bb8ad2b29a7d4886a_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i7f09f557003848f4b76b538b6807be01_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:PreTaxExitandDisposalCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="if533fbb2e7804a49bd733441ec860383_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:PreTaxExitandDisposalCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i19b7c0d54b864709b8a1d14cc7a5d52d_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i6b3a4116ab3044c5a696abbccd7ee5d6_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iebed8f31e2bc4cb98986dd61dcc84584_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ia114c5bf3f0c4db3be119ae9d303c54c_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i0f140a7453f54937a77f1945a683e562_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i3619e5e7c1d747c897276367eac949cc_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ied9a45419b034ba293d451d739803159_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i1327a9ff18894e94bd64778ed9244151_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i4ee1ecb91f93417abbd820fb1b9263dd_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i59d94b407eb34ffcb5ba920befb20402_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ief7515addc7a424bb17ccbb5efd1bcc0_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i443dc4a6e4e7449cb7687aaf2b213890_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i245f5fb276724559bcadde6864aa9761_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ia14e107ca6b34c7aa82198c4055050a7_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i20efc4b8d5624a738f090883fed2d123_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i1e3d9441863d40fe83d2a6994feb032d_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ia4320454dbec403185b511f1c64206cd_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i2231b706751d46d79c1f65ba057fbb62_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i2aa2e63b28634ba9a0d5b4373eb935d8_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i22d5b93a4050490ba354a793fe73ddce_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ie865d31224d248118707ff2a738a5f53_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ic589592a3ea647eb82528ebff28b6c83_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i678b3811da1f402d875ac6b3061da9aa_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i35bc96620aae4f20b504721d4972a52c_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="if998b6ae16134f37a39d249efcbcc3f7_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i83e463dc1191437ca3f924fd6bd29a84_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i1f069030f0a3460c8d945b8cd90214d7_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i46c2eb1479d44550a2ab2d69a99636f3_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i929d7ecd50044541af233ec2313878da_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i7fb2f890b1ec4198b387f05c2c65bc8c_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i8afc49c379f449b49731bf51824ea01f_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i50ab07cf2ffc404da2ed9d85ac2200c8_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ia06764135b2b4cd0a275054067eb22ca_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i111933045e354d4f8658708753547778_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i1db728fe13014c45b129b04929119976_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i15721ef42f5a4b64a1a941878d5e80bd_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i126bbe583d1b40e989cd54f8bc8b5fdb_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ia89cf40cd27a43f2829d8c0220e90d7b_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i0af3ac423bf349678613c24c3b8a11a2_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i028f280fa1334ede95f2032c53ba9603_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i52d4f679d87a43208fe9aa6ceee5a507_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i5f41bbdd83db46cb896344dc0006b64d_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i5844ce5002374c9ca4435645ef347572_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i8c4a3739c026430f9cb994dd2f7f80e0_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ib8a65bbd4df441ffbbe386c670a74731_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i15191dfa528f4503a0e2853a1733b631_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i8a12fc35b75d4ccf8c6c5a6b5f9df288_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i2f385943a6ed411da591a03f5bc3abb5_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i90b3cafb39ad43129046e5127bb34a7b_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i32cab75680864139a62ff1b5cebde24d_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="iaf012b1a7edb49289534410a88491a96_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i6697a4efd1dc4d249dcfab34c0f70d31_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i3978608b42c04cc5af43262c255f20e6_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i463d7b834e2145ad88a0dc521b32cb6e_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i30fd371d44e44ab2b7a26ae857aed3d8_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i355296bb1c604ce98363ad84c2d4096b_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="iaa3a8fa30d954c43b8b42c71861c0bae_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i0380d38afb13425093e55e205d427bd7_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i9f7ad3736e1640118162dc647a316234_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ib7af353247eb47508c8e5a3b145eee36_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="iac8769618c434a12a6120cf93b18a7cb_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i7d8fc61f591a4b00a4f09dbee10c57e3_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i80fccbbafaac424ba13d8f2e11e26efb_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i6433dc1e1b474da0b55da283f18ec450_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i79d2f91d85114433aa75b3dde1c711d7_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i1ba52b8426984dcca753b63310d1ba95_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i2870ad45d3744aacaab561141a1ede79_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i1fa258e7bccc4d1d9172fc22def7a0d3_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i235a5116037045f2960d6c6e2d85ff59_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="iea98fb3a66024e57afe1c39a4f163883_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ia258ad2862e4409e90d97a6a185618ba_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i8028e573868a4c60958ff50408279137_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ia8683c78419049719e43eefc5616a8bc_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i92bacf56288041769a792da708300ace_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iefff988b78344694a0de74324a70e787_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i6c177b7debcf4ed489a1c287af63efa8_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2015CommercialPaperProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="id3958a76b22149358ea04e9d59ab3dab_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2015CommercialPaperProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i949f35c9b7de4f3cbafef0e58607a8f9_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:AmendedandRestatedRevolvingCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ie3e7e6a0bf3f41a69f7e5b02e57a1cd7_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:AmendedandRestatedRevolvingCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i9a912ba559184edb828b6c18fff14699_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:AmendedandRestatedRevolvingCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i6e7ded1a38a347e09432a07dee3c0a9c_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i1d2d81b4b2be47f6a03325d659a6d72c_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i5ea679a6b4a74ebeb862f8ec5a9324fc_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i510c4360710e4c0a914d63f14acbfc0f_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i5d89dd5c6578482489f58901b2ece021_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="if2f2f4fae83043f3b68e29781af9902c_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i28c3585b4c314e93b0ffe730217c8c72_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20230.000PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i8d3143e089ba4dedb2736c33c618581e_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20230.000PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i5b52a5b1a53c4ac39014d4b15543f3ec_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20230.000PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i69901d8744fd4d879877219042968d11_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20230.375PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="idb442835a80449de9586e9b37e7d2fa5_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20230.375PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="if267642c06af4e0fa5a4118f57c3905d_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20230.375PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i044094c947f94eeba950fa8a0c905013_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ib19d6634ce714827868d024d9dcd796f_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ibb7d89c620764ee4a60c49931ad7a1fe_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i2511d50310fe4d6296fc4346e10dd64e_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ib3b2928adcf54c788d62edf96564e9d1_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="id20e750596f440789ec340620cf569f8_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ic67fdda296f8439da5d36130db1168cc_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i951264b62a9e4692b9bd3d00cdf796f4_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i9b917b2cd2a4484bb2a8f5bd83abdc3c_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i69633ff6d0b54867b5bf49aa176cfef1_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i500cfbc200ff4165a5a6b3019322c7fa_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i47bb4791a9be48879236f93b8dbf5a54_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="id5c8bd11650841f792d159c232d7e48d_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i067a568cac5e437685072c3a831fcb18_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i282da68e884d461f91dc382fe42a1836_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i2c789745205747e59bcd97e1084d2e14_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i3ea8b5906172403087cb9b21adb1404c_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i1102d65e5bbb46288b7d98a976952c66_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i750ff2c060f8493d976f1ebc84a53c58_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i8fd93231ec0d40e7a081151b1edbb42e_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i2c3778ef9fd049c4aa110c60dca8ae9e_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i054d412daa1342d9a8adc483ef5ee68a_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i9b0d659e4c6a464fbf2ba9f69ce97fe0_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i6f65dfc39b1d4cd496b6246f1492221e_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i0d2033de84454b43a7ecdc388b152f04_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i2670923c73ce43568a500471620aded0_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="if8727095c1e24f2ca3873ea9374eea75_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i47ee4b0280454a5c98e0ec794d136853_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i88732c4da6c743a0af188e6a1f418126_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i7910a7e253b74bb6bf57f31ca1e1cc96_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ic82db9dbf25f4810bdca165d071df06e_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311.625PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i234bad29861943d29016c98eaae4756d_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311.625PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i92885844bcb04599b66e758b5d76ae0b_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311.625PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i565f1750cbac4f25983798f87bb8d5da_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="if0d67cdde98740db854f9c8a7ce28877_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i54d8e43d6f024394b56e6aed2e55b5b7_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i85287c89df5c4ee8bb7372bcad0e3d62_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i31c17a3e93a04f5dae5066f13f61ca5b_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ib824b6753fdd4d998c09bff251b0120c_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i06322b5dd15e4cf88a13870353dc869c_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i1101d7005cf341858d3178156e6689d8_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i9b577715d9c647778ab87a85896e3ff6_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i83d24b071bbd4084bc5c15d3c012fa6e_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2007Due2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i3a1a36d6b7bd48309ca75990b50ebbf4_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2007Due2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i950765e074ae4226bcc6450b9efc0ac4_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2007Due2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="iabf27779745645c392a68929410ce222_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392.250PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ib904bd0a37594de291e3a3b7199e4ea6_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392.250PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i69f9f92316aa4bd9a6b5dca506e8a598_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392.250PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i6f70c23d31a04b9aa0f47612bada4682_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i3136a8a092264e9fb60259353a08f685_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i6683088e6e054026a6a7bdb9e6391a9a_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="iec3a4aa6910146c4a58dfc971610fa11_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i0cb1150cbdbc4d9fabc3a8722c52cd68_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="id20d878354164798a7a7a92885288fed_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i37040ee9a2694677a6a593b2e2d36c88_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ib528782405ef426781d9bf2ee3a1488f_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iff148c09a35d4309af70243e1e4a1d6f_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i20c62f91aaa741a19f4b61315da66964_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ica522c618bfb4a6e9eefa808b1383660_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iae5109e80f914300a5a387ebde6c8776_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i0af3561ae38a455788310e9883ab62ac_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i5f438443ec234ccdbae9a060908aff2a_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i0c9e7d2efbc24021807fa47750a582ac_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="id7e8238cae344221b36d9ab213d64ec0_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ibe85b9a673d44ee8b743ecbca5126981_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ie4c1c10ae78d45fb991c7444838f455a_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i49d71ddf48d24bdcadb9fae5bdae5c01_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i837dd563301e43b3bc43f6ce023f2f56_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i535f2391eaba4f61bbb4700d09ee8601_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="icf19d18ef5f54fb2a1e2e30d815f91b0_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i04b01691f1a24f5e9e29f783c2ea2c56_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i361b55cbce594a09970ba9fd123f2b16_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i047b42eae5e7495c83549c009df4d1d4_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i7c4e4384f2a44e0d9f3213e1b69ff161_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="if210b924935c4b4d81d00ae7c8599261_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i819e50da385f459f903ea9d6d5d47c66_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2051Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i13912243cb92485aad14f40321031fa9_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2051Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i8d83db0a3a404462a7f0f25f297ae072_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due2051Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i9090df86b8294bf988864695140aea55_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="id954a5663cfc43e69849fbce86b15b9a_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i43ca1b9479324066bf20af6381092405_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i03edad1ee21c45e8bae5af91c450f7d7_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i486f35ff70c14b7cbda1a961e72c4759_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i419528b46438459b85358d801fe6c31d_D20190427-20190726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-07-26</endDate>
        </period>
    </context>
    <context id="ie2b8c1f994574df88bd778df94f6e8d6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibc8fac86e3e34735bd2213a5c893c73c_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i322602253ac842238d97f6323baf0b2a_D20201001-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicIncAndCIFSASeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i89c3b3d9a895475985db2b36880fecca_D20201001-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i1f534412b2ac4f5d9802c54fd029f5a9_D20201001-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="id3d8d5311ebb4a75a24f1e7a8af56005_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6e1f6fd2fd7b47459d0613747fb74d8f_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iae6ac6ba362d46f7a069d17790df5dde_I20200512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-12</instant>
        </period>
    </context>
    <context id="ia15b2fe50423464a9cf5623ac357741d_D20200512-20200512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-12</startDate>
            <endDate>2020-05-12</endDate>
        </period>
    </context>
    <context id="iae724a5cf9f94ef18e23e8e16d639ab6_D20200512-20200512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">mdt:TokyoInterBankOfferedRateTIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-12</startDate>
            <endDate>2020-05-12</endDate>
        </period>
    </context>
    <context id="icfb13d6a6af84816860e81aaba6f97d0_D20201112-20201112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-12</startDate>
            <endDate>2020-11-12</endDate>
        </period>
    </context>
    <context id="i7831176c62f74ba4a4024a989e6285a2_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i383c6b4f4aa24169b24e351562e05365_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i6ea2a0e5eb0e4f09a8904720d94ebebf_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ibef9e0da89e44b89b330d067b8948c58_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ife2e4bf093494b09ba98f801beb8b9c5_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="if2e03acd84264aa29f524bb28094ffe8_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i3bb7d8650d424a3794638ac05acc85b1_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i062f1ed49909469d842f2bc395542043_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="iaf768e66580b409297df422a6b58cc7b_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i48ef881065414c91bb7f52fc1c7a7c86_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i0cafeb122608423eb2b62ea29bc09a5c_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i7c49d00a2f3f4bba86faabfc7866ed13_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="iada485b3a6b245668a27a3b5fa95eb3c_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i7a16715731e144e2a482d62407c58c16_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i0eaf93d2e883447e94be4b40d4ea2307_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i28d09151fa8641dca241e92bb8200f44_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ib696730068be4184a7cba30530fe6e73_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i16ecf308db934c58b716f575ffc1e8e2_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i5f39166258654e8b962cb7a6c6db3661_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ibb04dfb4fa234538bad556529f05fd2c_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i74eac46b3d2b4217a1efbf920f47ff09_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="id17a89cb1d9e431db69c4426862755a5_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ic3af287ba57845e88cc3662a0cc58115_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ida9267d57494477c8173b527d15ad048_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i627fbb34d41b4c299271b22b6ba80293_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i84ca06f620184bbfa7d366fe5853ce18_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i98e4061404054b75be5b3c8c2b4acd40_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ib482970decd34242a76c6fbf96fcb507_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i26298cf036964bed9c4492fcb3a09498_D20190427-20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2020-04-24</endDate>
        </period>
    </context>
    <context id="i0e2b35bd149d4cbfb0cca99cf6451e78_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ia4037e9fe4924327a9124f0dad580c10_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="id0504cba5977424e8efe09ff95da6e08_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i9156d299a6eb46b38ada2503236b8881_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i9dd052a01e6746ebaefd3cc094cc9a4e_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i7b2fe42efd06408a92475c4755fa36e2_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i54ccbe94efc24035ad053ab14a80da93_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ia739284ae42640b9b1169f2e13f10c3b_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i04c7a73cee65490ea0fe051fe67b36b0_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i408b5639feb74594bf9ffbf99932a0c2_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i3781ad92456b4930a744c241338e1df9_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ibcab7a8fe5904101bf276c6cd9d3e02e_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i2971cc416b8c4c3baf1b346e6ac07274_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="idfcb1d2adbee455fa6c5c158e39b057f_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="iac89da0aac834ad28b17ac773234402d_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="iaf80c1f6bec9491da1665ff45eca0305_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ia4f0c5b496724100b2925b08781c93be_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i79215fa9290949fc8d58b9442e87c752_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i300b4c6841cf48e1b89be1521f13f8c5_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="id705573c47564fec859646f338ee424a_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ia27d4054116c4424b00fa6fcc5fb1097_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i61a28b7b81914f18b60a8f618393f4b0_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i640a2e9158494775bd661da415d6991a_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i16cbb6d304b141dfa3c2506664f80306_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="iaf105fb217564fb0b368560e0802c567_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i6c36d14889444b32a4a8a500df0426de_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i5f928c10bd3447a8acf72dba427f6d0f_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="if8649cc913994f28bba97e9a820cd77c_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i2a71eca48ecb47368f7ad737a8dd9f78_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i9261483dc6f74bb484c0adf25775e549_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i03fcd15b1ac94eb194a37776a48e4b87_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i42f9a191936c4fddb70e6c4259646375_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i75a0c623324e4c58a147690be5ec9a8c_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ib23daffd559644c684e6f30a2989e54b_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ie23caf8aac694eb5b8a3fbdfd8f4ec01_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i82b2207772e84810aa69081bf91dec30_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i271d615350834f588b83b7a2b7f99350_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i501c025a1be4439dab95e8898d228126_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ibae2e9403d704584a6e2c9aec89b4fbe_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i37db224b055b4110b0851847038077cc_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ia23e15999c1646ddbb7df2cda73a7aec_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="id873cde847774be59ee4570ffd483d68_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i7c3c106af2b14c32ac0754fe26996414_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i54a71bd600c64796b0dda6f39160e883_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ic6df7d3cc9f44895b99362ae686d8a29_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i82923a0349f6443ab5eb2ec2e25dbb27_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i40f981d3461b436c8ea0d4236782cc68_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="iba50466d7292490bb6538e2b946dd0e0_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="if3e0650de43b4e1f8c3d2b521e13e0ef_D20180728-20181026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2018-07-28</startDate>
            <endDate>2018-10-26</endDate>
        </period>
    </context>
    <context id="ib4a60149be38443fb2d916de554d6254_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i3767fcfe1389419994824ecb077fef38_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ic3d7fb880809444bae1c970a1373d381_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdt:PurchasedTechnologyAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="id014282d690d4c5a896ab2b26bacaa6d_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdt:PurchasedTechnologyAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i03c038d0f8344416b953ecf5e0e5a61d_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i1504f2bee7c143859a17a93113ddf64c_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="if300d7f5eef94b9bbab7fef186492d3f_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ic16cb2a7cf0049afb87f33af952987fb_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ieb9b67e332e24b35b2d7941bda8317f3_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ie963904705b8409cb3f2f8c8ca2bf137_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i72dff3c52a304a0bab96f9563e0abd46_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdt:AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ie63e2a6be41a4756afe92a2464f79dd6_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdt:AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i038d289ad6de4b8f85679e45d0448c91_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i17f2e9ba8db047a49f7e5293b1dc77f7_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i37cf6705fcb445ac9da8563c668b75cd_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i2c5e5989168e41efb2ee254d247c516e_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i00b67cb0c676413da10bbe00d1f895a2_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="icb3c7b067b2a490a80be46ac5e1bf7dd_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i87f020c9e8ce45279dc4d7550054f8f3_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="idaa63515bf8647dd9bf70dfb44e3a57e_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="if98bf19b12ea4baca1ee2d733327d267_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i41db5984a04f476c9e1643f4d8215c73_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i3500b71577b74f76a424e65d43544367_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i8755e7c5c19246d985fd44c7bbf450b0_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="idbfbe22288704f4294f5d6ad2a6bbdb4_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i6e7073f7fded4be99ae2a0b2a3a31757_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i31ca63612edf4a8295126af8750e6ae4_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i609d7c4a83e640db9dccf290d58342ce_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i9acd77d49d4840c18802f8875a75d339_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i70cc00740a274a9382f8faf2cfd6c19e_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="iaf2c5bd78d0142318be39bad4bfa6c50_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="id65399fc03ca4ad7987953d64a511415_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i041edce7b2f84381a0ffac6ba095e1fd_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i2be4b5dbd3a843788549eca186a30ccc_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ib483fb15c6034697bfe54c44860b3101_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iea08a324b22a4b3585ccc68dd6591808_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ifc8350b91b4146b3901beacd17a1c4e2_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i541ed731bef54145b54be9fcb6064899_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i169643d5df3945a980638c7f94c6cf7b_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i8f3edae1486d484084c48f942aa09416_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i0579786642984f61b518ad7ce2988383_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i48966b2b67e54988b474069368fd3c54_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i079d0741b4814caf97785cd103555063_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="if525bf943aab4cbb91e9eb6d27a46bf6_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i1d0206d6a5fc41a49d8a7cc2ef0f0f5a_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ida6a709f1f574db2a0ee55985446dde8_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i0ffaa96aa77b425a843a25fa1ef58542_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i05e20d1638064e7e909e1fc85204b962_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ib42695173b6e44668e0e633108f36472_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="i6a3f0bf4841e4466b909762f6987805d_I20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-24</instant>
        </period>
    </context>
    <context id="ia259e32147694c1a90acdfc351d3be37_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i9ea3630e377a437682567a4587f0b46a_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="if0d4590a839f4f359683bd936959376a_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="if8db26e60a874f328bde32ae1fffb625_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="id5b5d4d785ba4390854bcea8e68a032f_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iefd7e349f18840e98869efd76dfa5aee_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i25a603a65af64e6889139205388d2a5e_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ie00c23bcd7924f48a43b264894ae1590_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i5386101e521b4ca1b362aaa02cd87dcb_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i449e4d657bf0449ba7b52e557589bbf1_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i99b3bd351a494528906e3d120cfc830f_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i9ea2e72c446043e2a75ada4300c76bf2_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="i3c2ce4c6cbd84b4fb1294afa3a54a8a7_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="ice02b0738fd5434fb3f67530d843a491_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="i707bc78abce44fed88d7746e65fcc6c1_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="ie9eea4603bf34820985c1564d60a7ae8_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="ie397d3f57a424feab9c1039773fe2c37_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i594c98fce3834e6c911b55d203d09432_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i0fc63908080e457f944dc31cb02f1ece_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ia6233127143d474ca30c57ef1e30c869_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i853467b20db64187814759647e0063ff_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i3c01efddfd944a258a76ab642888a572_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="if8fcd13d6b3740c6a5a4e7d8f673420a_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i6555488fb0954ade9760238ea2f0aee2_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="if2dc5e7853c24bc8a015eae803815058_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i54f47cb7887f45f1b52b527c507264dc_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="ic8a7dc5cbd8f473f99e012510c678690_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i9f541ce4dcef4da4a428c97cc7a8f5c3_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i9229de7c6045441d80355b6acb70f350_D20150425-20160429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-04-25</startDate>
            <endDate>2016-04-29</endDate>
        </period>
    </context>
    <context id="i60457532fbeb40878969effee2b3390c_D20170501-20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="i7ef87e2613a04c5888f894f05867fc25_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="ic14d3bd294c046c9afca0a4d2276f819_D20201104-20201104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-04</startDate>
            <endDate>2020-11-04</endDate>
        </period>
    </context>
    <context id="i77dc59d697684886bbf5fe519c310541_D20111214-20111214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:EthiconPatentInfringementLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2011-12-14</startDate>
            <endDate>2011-12-14</endDate>
        </period>
    </context>
    <context id="i86701a14cb434b819fd00f6ad2cdbbaa_D20181128-20181128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:SassoLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-28</startDate>
            <endDate>2018-11-28</endDate>
        </period>
    </context>
    <context id="ife64dfaf0edf41ea9552b05b5b7e1839_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">mdt:OrringtonMaineChemicalManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i63d7c5081980421eb104ef0db2d640cc_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i9f4ddf14e8a5413696daf99ce008d00b_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i009f0737e76549b7bdd8727292bc324c_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i34ef1f0d5805418690793935607c575e_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiacAndVascularGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i75f00ee586cf4b098983f7fd448c12ed_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i6b7f6004ebaa4580aa2cd2c369060e7c_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="icaf85161beb9449b9986565bb7507a94_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ie5e5b0ae3f9b4c4a8f83073dab95f175_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MinimallyInvasiveTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i8a9fdeedad9e48189c04e1acb1feea25_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iae65e8a1899f46cf9f81db9fd9dc523e_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i190a27e4543e49f095f067588a9750ad_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ib3bd9b003d9d458cbf0d73f754eece1c_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:RestorativeTherapiesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i9c39d3319d5441938058ead345505a10_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i81bf88cc900e42b7baca3ed7b2f9944f_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i20c9d172c84641f8b5f43c19bf9b11e3_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i75e5044db63f4573911d00a91522924b_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="if8fbed3ebbc54e9e8e04c5281af315e7_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ibd9ab457b664428faf530e0f31bec7ee_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i50e105716e0b4d349b5afd9f55b817bb_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i33de1043570543228ee3f7f6b21ee2b8_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i088828113b7e4efdae6630f46542249d_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ifd378229d53d485bb7a50d60b19bcbf3_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i64a435269abb416984f5c417e8039a20_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="iac6ac704ee814208a2a8abf74b89f68b_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iea846304c7ad47a28600ef1e4d71c7b2_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ib1638723f8ae47fba660e3d982eb8ed6_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="ib3def68be9d64a24ac8a6ae505945a1d_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i785ae642d0794ba291eac2202104f152_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="iaa7a5c2518f94595a35212683b056ac2_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="idf457dbfafc248478ffb42c3a45acab8_D20200801-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i969f5c5c54b6415c806918f433b06994_D20190727-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="i69d3fa2bd18b4dc98db60dce376f37f2_D20200425-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-25</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i457910bb69fc4038abf6fe2156ebc07f_D20190427-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-27</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="tranche">
        <measure>mdt:tranche</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="subsidiary">
        <measure>mdt:subsidiary</measure>
    </unit>
    <unit id="manufacturer">
        <measure>mdt:manufacturer</measure>
    </unit>
    <unit id="claim">
        <measure>mdt:claim</measure>
    </unit>
    <unit id="patent">
        <measure>mdt:patent</measure>
    </unit>
    <unit id="landfill">
        <measure>mdt:landfill</measure>
    </unit>
    <dei:EntityRegistrantName
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M18zLTEtMS0xLTA_9321cd5b-51ea-4d06-9d77-2488f92861a4">Medtronic plc</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M180LTEtMS0xLTA_e6cf4e76-9a88-4ca4-bf98-6f9064b19220">0001613103</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M181LTEtMS0xLTA_3a199808-add8-4cd5-b19a-d079073a87c8">--04-30</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M182LTEtMS0xLTA_95544cc1-08c3-48ff-a2ce-8cd4a6b39aaa">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M183LTEtMS0xLTA_6ade8fc8-f105-4cc7-affb-b46f95c96465">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M184LTEtMS0xLTA_3c4fd062-835c-4dca-a606-c7e5b026995a">2021</dei:DocumentFiscalYearFocus>
    <dei:EntityAddressPostalZipCode
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80L2ZyYWc6MjcxY2EwMGNmNmI4NGVjYWFmNmUzYmE3ODZlMDEzYTIvdGFibGU6ZjcyNjU0ZTdlNDA2NGM5NjgyYzQ0ZGUwNDI2YmExODMvdGFibGVyYW5nZTpmNzI2NTRlN2U0MDY0Yzk2ODJjNDRkZTA0MjZiYTE4M185LTEtMS0xLTA_98165042-0457-4fbd-8530-01ffde9c080d">D02 XH02</dei:EntityAddressPostalZipCode>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="ib96559476e2e42589c348e36cfd88199_D20180428-20190426"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMC0xLTEtMA_dcfb84c1-15e9-41b1-a86c-3cf4872b75bf">us-gaap:AccountingStandardsUpdate201602Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:DebtInstrumentTerm
      contextRef="i1d2d81b4b2be47f6a03325d659a6d72c_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS04NDc2L3RleHRyZWdpb246MzI5ZGJlZDllYWVkNDA2YWI5MDdiMTQ4NzNkNWQxZDZfNzY5NjU4MTM5NDQ3OA_1fc66852-89e8-4b7b-81e1-6369f8dd3419">P7Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i5d89dd5c6578482489f58901b2ece021_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS03MDUxL3RleHRyZWdpb246Zjg2ZWM0YTg4NDI3NGFhOWI0ZGJmYWViM2QzZThlZjBfNzY5NjU4MTM5NDQ3OA_0f544188-5492-43f0-8466-e9aa66f80bd2">P10Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i8d3143e089ba4dedb2736c33c618581e_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS03MDU5L3RleHRyZWdpb246M2VjNzUyNTAyZmE1NDIzNWE0OWI2YzNhZTZlZGEyM2JfMTU_434d6196-cd71-423f-b1c6-94ab8fd6f545">P4Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="idb442835a80449de9586e9b37e7d2fa5_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS0wL3RleHRyZWdpb246NjI0ZTZhYTM4MjA3NGI3ZDhkOTYyYWNiZjQ4NDUyNjVfMTU_4e71358d-8a7e-40b6-8487-19339f167751">P4Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="ib19d6634ce714827868d024d9dcd796f_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS02NTEyL3RleHRyZWdpb246ZWM4Njk1YWJlNjBlNGViOTg3ZWU3MjczM2E3NGIzODJfNzY5NjU4MTM5NDQ5NA_f18bfa88-ad2a-419f-b369-44b60f7697ef">P2Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="ib3b2928adcf54c788d62edf96564e9d1_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS0wL3RleHRyZWdpb246ZTc2YTM4MTBiNTI1NDMyYzkwY2FhNTg2ZWNhYmU0ZjJfMTU_7216313b-f8c0-40e6-99ac-4a1d7fa40514">P10Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i951264b62a9e4692b9bd3d00cdf796f4_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfOS0wLTEtMS0wL3RleHRyZWdpb246NDM3NzdkMzViODVmNDM1NTlmNjI1MGRlNTNjYjIyNTZfMTU_73fcdfe3-1699-4e4e-a1b3-6abc413aba37">P10Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i500cfbc200ff4165a5a6b3019322c7fa_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjBkZGE4M2Y1MTQ5YTQ2NWNiYTYyNGI3YzQ2Y2FmOTc2XzE1_3cf05ffe-b2a6-4335-96b8-f9d8eb8335a3">P10Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i067a568cac5e437685072c3a831fcb18_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjMwZDAzODE1ZTQ2YjQ0MGI5YWRkOGIyNjE4NjI1MTY4XzE1_5a8917d8-b557-4f27-97d0-e5d0ca330706">P10Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i3ea8b5906172403087cb9b21adb1404c_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjY4MTNkM2VlNGE3MjQ2MzQ5ZGY4NjgzMGRjNjA5ZmI2XzE1_dd01a2f7-a10b-4245-962c-1c722b265da7">P7Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i8fd93231ec0d40e7a081151b1edbb42e_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtNjUzMS90ZXh0cmVnaW9uOjY5NDIwNWJkNjIxNDQzYTE5ZmI3NGVmZDI1MzkyOTgzXzc2OTY1ODEzOTQ0OTU_7e8547d7-3068-4d97-88c7-8a5e777cd5be">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i9b0d659e4c6a464fbf2ba9f69ce97fe0_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjVlMTZkMTQyM2ZlNjQ1ZTRiMzQzYjA0ZWU5YzMwZThhXzE1_aeaca299-dcdb-4b89-b32d-ea5647d9bdae">P8Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i2670923c73ce43568a500471620aded0_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjUwOWNjZGNhZTZjYzQ4NTBiNjg1YmNjMDYwZTVkYWYwXzE1_6c38aec9-7242-49e4-a3a0-97185e834427">P10Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i88732c4da6c743a0af188e6a1f418126_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtNjU1MS90ZXh0cmVnaW9uOjZiZjEyYmVlZGI5NTQwYzQ5N2ZiNTc3OGJmMjk5MmM1Xzc2OTY1ODEzOTQ0ODk_3f1d490f-a710-44cb-aa4c-f5db8f0fa208">P8Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i234bad29861943d29016c98eaae4756d_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOmQ1YTI2NTk1ZGQ3OTRmYjU4YmUzYjRhZDFmMjE1ZDk1XzE1_5b30e37a-feeb-41bf-b826-7121e730e737">P12Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="if0d67cdde98740db854f9c8a7ce28877_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjZmZDA0ZmIzNjYyNDQ3ZDY5ZjAwN2FlYTRlZjRhZGU4XzE1_932ae6cf-26e5-4bad-b22d-29b416b48b23">P13Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i31c17a3e93a04f5dae5066f13f61ca5b_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtNjU2NC90ZXh0cmVnaW9uOjVjZTJlM2ZhNTQ5ZTQ4NjBhZmQyOGQxMDdmNDVkMTJmXzc2OTY1ODEzOTQ0OTk_c2fcbcbb-9062-4210-8500-cae9fda3b843">P12Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i1101d7005cf341858d3178156e6689d8_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDA2NzRiOTUwOTQzMjViMjhlYTFkZGQ2YWFjNzY3XzE1_d33f3c62-a9b3-4939-acb6-efa5d1c533e4">P20Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i3a1a36d6b7bd48309ca75990b50ebbf4_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTI3ZmUyY2I4NjRiODBiYjg3ZDEzZjgzNjI2NDEwXzE1_3ef70171-17bb-4da9-8dc5-bfdf0b5cd24e">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="ib904bd0a37594de291e3a3b7199e4ea6_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjg1NzhjYzgwNmZjMzQ0NzNhNjczOTJiNGVlYjg5N2YwXzE1_3df5c742-c214-41f0-b3d0-5224780e9379">P20Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i3136a8a092264e9fb60259353a08f685_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOmY0MDRlOGZmYTIyMTQzOWM4YmRlNWYyNWIwNjE1YjQ5XzE1_c2981a7f-89c2-4f44-9205-b4e86754b2c1">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i0cb1150cbdbc4d9fabc3a8722c52cd68_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtNzA2Ny90ZXh0cmVnaW9uOjEwMDFhY2UzNjJkYjRkNDNiZjc4NWIwMmU2MzVlY2U5XzE1_057deae6-4bb1-452e-b86a-80173d533019">P20Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="ib528782405ef426781d9bf2ee3a1488f_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjQ1ODFmMjY1ZmNmMjRjYzZiMmNlN2Q2MjViM2Q2NjA1XzE1_db79b77e-7b88-4758-a617-823b3f2a7b0c">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="ica522c618bfb4a6e9eefa808b1383660_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtNjU3NC90ZXh0cmVnaW9uOjhlYTQ1NjhhOTU4YzQwNDU5M2NkMGY1YzdkMjQxYjZmXzc2OTY1ODEzOTQ0OTU_ef0d6972-d506-46e3-9082-3bddd7a7d890">P20Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i5f438443ec234ccdbae9a060908aff2a_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlYTljZmNjYzNiOTQzODM5MzBkNWFhMDBkNmNhNWM4XzE1_df7243fa-33e3-441e-9e5c-0d5e8f72b28c">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="ibe85b9a673d44ee8b743ecbca5126981_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjQtMC0xLTEtMC90ZXh0cmVnaW9uOjNhMmQ4M2U3MzY4YzQxYzBiYjk4NTU2YjA1ODJhYjA2XzE1_8015ac63-f366-4764-bf6a-46db806b09cf">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i837dd563301e43b3bc43f6ce023f2f56_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjg1ZmFkZGU0NTAyOTQ4OWFiZGI0NDVmMmNkN2Q2OTA5XzE1_194c751d-bc01-4752-9b92-6d1dd7b2c6bd">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i04b01691f1a24f5e9e29f783c2ea2c56_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOmY2MmI2NWE5YjUyMzRiN2NhYzMwNmRhNTRkZjFjNmE2XzE1_816125dd-3eea-4f07-9610-e050c2e8a8b8">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i7c4e4384f2a44e0d9f3213e1b69ff161_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmRjYTc3ZGQ5MTBlMTQzMWZiY2FmMGExNjI2ZjA1YzUyXzE1_affa4ede-4085-4b4a-8013-9f2c5a3af318">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i13912243cb92485aad14f40321031fa9_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzMtMC0xLTEtNjU4Ni90ZXh0cmVnaW9uOjEzNTMyNGVhY2U0MTQ2NmJiN2EyYTcxMmI4MzcyMDI3Xzc2OTY1ODEzOTQ0OTU_ecf3e18f-537f-414b-994f-f458754db39a">P30Y</us-gaap:DebtInstrumentTerm>
    <dei:DocumentType
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM184Mw_204b8c60-10d5-41be-b4c3-bdbfcc0274d0">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6ZWRjNzliYmE2ZmQ4NDg0MzljZjY3NGEwMDRmZGU2NWEvdGFibGVyYW5nZTplZGM3OWJiYTZmZDg0ODQzOWNmNjc0YTAwNGZkZTY1YV8wLTAtMS0xLTA_038664ce-79f3-4b13-a75f-44772a26ecb6">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6ZWRjNzliYmE2ZmQ4NDg0MzljZjY3NGEwMDRmZGU2NWEvdGFibGVyYW5nZTplZGM3OWJiYTZmZDg0ODQzOWNmNjc0YTAwNGZkZTY1YV8xLTItMS0xLTA_68feb279-19e8-4192-9ebc-666c86e47a9e">2020-10-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6ZWRjNzliYmE2ZmQ4NDg0MzljZjY3NGEwMDRmZGU2NWEvdGFibGVyYW5nZTplZGM3OWJiYTZmZDg0ODQzOWNmNjc0YTAwNGZkZTY1YV8zLTAtMS0xLTA_bdf07f74-650b-438f-bbb1-682032940314">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xMTI_d2278cf6-92ff-40df-abc2-9a8b4de5bedd">001-36820</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6MzI5NmZkNTA0ZTcwNDUxNmJmYzVjMjc1MzM1ZWQ4ZjIvdGFibGVyYW5nZTozMjk2ZmQ1MDRlNzA0NTE2YmZjNWMyNzUzMzVlZDhmMl8zLTAtMS0xLTA_11595148-898a-4549-8c17-ebea2221a7c5">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6MzI5NmZkNTA0ZTcwNDUxNmJmYzVjMjc1MzM1ZWQ4ZjIvdGFibGVyYW5nZTozMjk2ZmQ1MDRlNzA0NTE2YmZjNWMyNzUzMzVlZDhmMl8zLTEtMS0xLTA_37cd525e-7729-4f45-ac8c-be548b460e41">98-1183488</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xMjE_1933301e-cae5-4fdf-928d-2efb7d5b3a0a">20 On Hatch, Lower Hatch Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xMjU_e9682c36-4a6a-4b15-9898-e413798cc68e">Dublin 2</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xMjk_53be8a46-5814-4bda-8bae-880c981e7d62">IE</dei:EntityAddressCountry>
    <dei:CountryRegion
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xODc_614b6d67-81c8-4587-b304-147310921675">353</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xOTA_475aab69-597e-4eb3-b9fe-cb8e57e83b7e">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xOTM_1b6fc61d-ca07-442d-9046-3a5388be1a30">438-1700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i9690ac488cf0498597a1dee299c08d4a_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xLTAtMS0xLTA_14f997d5-7d48-4e38-b1f4-8533e33d88fc">Ordinary shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9690ac488cf0498597a1dee299c08d4a_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xLTEtMS0xLTA_a41b5e96-458a-4683-ba4d-d6bad9868455">MDT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9690ac488cf0498597a1dee299c08d4a_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xLTItMS0xLTA_2d86cf84-1195-4958-aacd-02344d17373e">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ie597491265f54e5b83c5e498b9e5e35d_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8yLTAtMS0xLTA_f57e67a3-bbf2-40ca-857f-1d304d3a68a7">Floating Rate Notes due 2021</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie597491265f54e5b83c5e498b9e5e35d_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8yLTEtMS0xLTA_26ea3a99-5676-4ca9-8839-b95188605c64">MDT/21</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie597491265f54e5b83c5e498b9e5e35d_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8yLTItMS0xLTA_863070b7-39a8-4b19-9871-03100a5c6700">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="if431af446740495eafa610045eee2dee_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF80LTAtMS0xLTA_a2010255-1fc8-4491-8d69-5e7aabfdf3bb">0.00% Senior Notes due 2022</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if431af446740495eafa610045eee2dee_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF80LTEtMS0xLTA_501d0265-743f-486e-9c06-4363c9d5d12e">MDT/22B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if431af446740495eafa610045eee2dee_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF80LTItMS0xLTA_ed99be60-b055-40b0-81e1-f8cc5c0abc1d">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i6946ebb61b914bfa814743c0b4901fc9_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF81LTAtMS0xLTA_19bc6dd0-be2d-435c-93b8-99b11e5ed7b9">0.375% Senior Notes due 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6946ebb61b914bfa814743c0b4901fc9_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF81LTEtMS0xLTA_c35a4e02-2bce-4548-bfb8-ae7061da4446">MDT/23B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6946ebb61b914bfa814743c0b4901fc9_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF81LTItMS0xLTA_bd745a46-f298-4155-95d2-b9bb73f5ec50">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i7de46d31eff94c88bf5224b071d2649f_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF82LTAtMS0xLTM2NTA_7768c9c4-dc3c-487f-bec9-3a2e37d88b6d">0.000% Senior Notes due 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7de46d31eff94c88bf5224b071d2649f_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF82LTEtMS0xLTQ2MzQ_39a2df40-f4bb-4e07-9d9d-a7dc52a55e23">MDT/23C</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7de46d31eff94c88bf5224b071d2649f_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF82LTItMS0xLTQ2MzQ_c2fd3fcb-0568-4fcd-8b5e-646474dd6c8f">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ic5b334ffdc574053ad9c42fd2a5e06d9_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF82LTAtMS0xLTA_4275740c-46da-4b86-96da-35885e9ad659">0.25% Senior Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic5b334ffdc574053ad9c42fd2a5e06d9_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF82LTEtMS0xLTA_cdf82a1d-85a4-4d49-879c-cbddc9434050">MDT/25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic5b334ffdc574053ad9c42fd2a5e06d9_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF82LTItMS0xLTA_a26175a0-a2c8-4884-8e97-7cd366b6090f">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i0fda69c384584c999349f0452905a004_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF84LTAtMS0xLTQ2MzY_d1a414e4-a624-471a-87c8-d8b5d6f3c5fe">0.000% Senior Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0fda69c384584c999349f0452905a004_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF84LTEtMS0xLTQ2MzY_fce6afec-605e-4f43-9695-ee0d98a67fed">MDT/25A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0fda69c384584c999349f0452905a004_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF84LTItMS0xLTQ2MzY_1a53c651-33e3-408f-a576-cc79a59cbb5e">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i86350dcdf5e0430ab236aa4e72a95677_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF83LTAtMS0xLTA_74379398-c0c7-4cf5-8025-fd89229cb8e2">1.125% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i86350dcdf5e0430ab236aa4e72a95677_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF83LTEtMS0xLTA_839303bc-77c4-4a2f-82e7-8e1d2f8380bc">MDT/27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i86350dcdf5e0430ab236aa4e72a95677_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF83LTItMS0xLTA_6512c01d-6012-48ef-a10a-a19b9473ea15">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ib87a49f46e80456aaae50a2676d2b9c4_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMC0wLTEtMS00NjM4_746baa8d-3874-424b-9285-de4b0eb269c9">0.375% Senior Notes due 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib87a49f46e80456aaae50a2676d2b9c4_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMC0xLTEtMS00NjM4_aa26c9c6-3104-42ae-8e0e-d87985993195">MDT/28</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib87a49f46e80456aaae50a2676d2b9c4_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMC0yLTEtMS00NjM4_76259537-dc43-4820-bf1a-a42cb2691b7c">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ifd6d2a65b5a74087a9cd3322dafc9078_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF84LTAtMS0xLTA_5dfc65ab-01f7-40ec-ab36-338632102ce6">1.625% Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ifd6d2a65b5a74087a9cd3322dafc9078_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF84LTEtMS0xLTA_b2b76d5c-efda-478a-abd0-6735771b6bb9">MDT/31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ifd6d2a65b5a74087a9cd3322dafc9078_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF84LTItMS0xLTA_abc7b51d-6094-4699-a12d-1a2ba2320501">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ibfc007fd29af4d10aae7f839ce84e9d0_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF85LTAtMS0xLTA_5e95d1e0-4d6b-44cd-85a4-7cb6471a9a14">1.00% Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ibfc007fd29af4d10aae7f839ce84e9d0_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF85LTEtMS0xLTA_385bd5de-eb96-4b40-8e8f-a4b241ab5001">MDT/31A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ibfc007fd29af4d10aae7f839ce84e9d0_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF85LTItMS0xLTA_68c3423a-959b-4468-b026-02e3256aa652">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="id98bb264c6ae40ce9fa7d1c6480a5695_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMy0wLTEtMS00NjQw_a10e9282-b393-44cb-a42f-76060db1840b">0.750% Senior Notes due 2032</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id98bb264c6ae40ce9fa7d1c6480a5695_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMy0xLTEtMS00NjQw_a126e0c1-55a5-4c81-8779-72c23651568e">MDT/32</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id98bb264c6ae40ce9fa7d1c6480a5695_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMy0yLTEtMS00NjQw_2e68c521-f4df-43fc-b5e7-c4cf9b355406">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="icd770a2a644746b3a8f33af164792726_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMC0wLTEtMS0w_7a697c99-f4fa-4177-9148-76623df9f324">2.250% Senior Notes due 2039</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="icd770a2a644746b3a8f33af164792726_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMC0xLTEtMS0w_8ac940d4-1152-4c69-8d5b-65ab8876e77d">MDT/39A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="icd770a2a644746b3a8f33af164792726_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMC0yLTEtMS0w_ebb3883a-eeac-4b31-8f11-7b97e853d9ea">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i2bd98a03670c4e72ad51a2c7363e7490_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMS0wLTEtMS0w_574a137f-9165-437a-8696-5fd253f58c19">1.50% Senior Notes due 2039</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i2bd98a03670c4e72ad51a2c7363e7490_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMS0xLTEtMS0w_b6372097-7559-4b27-9878-8cc8acaa6d85">MDT/39B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i2bd98a03670c4e72ad51a2c7363e7490_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMS0yLTEtMS0w_aad237d5-386f-4cb7-9b68-b94f7cd63198">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ifcfa923f30854b80900b6aea7decd075_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xNi0wLTEtMS00NjQy_3b0c9544-fb42-42d4-8a18-6a44db71b87e">1.375% Senior Notes due 2040</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ifcfa923f30854b80900b6aea7decd075_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xNi0xLTEtMS00NjQy_7b97630c-b7c9-42f6-a717-f5ffda07f712">MDT/40A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ifcfa923f30854b80900b6aea7decd075_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xNi0yLTEtMS00NjQy_b06ca999-aaab-4fd2-a277-633b7e51a068">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ic21aaaba5ba242f4a805034963baca6d_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMi0wLTEtMS0w_52212e2a-ab32-49c3-ae4d-053eebba5a06">1.75% Senior Notes due 2049</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic21aaaba5ba242f4a805034963baca6d_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMi0xLTEtMS0w_30dce7a3-7349-418c-a6b0-3a1ae595f8f7">MDT/49</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic21aaaba5ba242f4a805034963baca6d_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xMi0yLTEtMS0w_df5a3098-bd4b-4613-8e9a-d3f0ee983d42">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i55564036473c42538449804d30b330bc_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xOC0wLTEtMS00NjQ0_2ee2ef38-e095-4bb6-b268-19b2f1c501d0">1.625% Senior Notes due 2050</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i55564036473c42538449804d30b330bc_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xOC0xLTEtMS00NjQ0_42125fa4-1801-4c32-9321-918492bed533">MDT/50</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i55564036473c42538449804d30b330bc_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NjM5YzcyZmZhZTRhNGZkMDhjY2UzYWZmYmM3NjU5YjQvdGFibGVyYW5nZTo2MzljNzJmZmFlNGE0ZmQwOGNjZTNhZmZiYzc2NTliNF8xOC0yLTEtMS00NjQ0_6fbc6e55-fc8a-465a-8631-559def8ca767">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM182NTg_5dcdad5a-8181-42a0-9393-df84d11fa1e4">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM185ODY_0d8bef72-4497-418e-8316-23482a9411ed">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NDRlNWI2MGMwZGI4NDNiYzhmNzVhZjY2Y2YwOGUzNDEvdGFibGVyYW5nZTo0NGU1YjYwYzBkYjg0M2JjOGY3NWFmNjZjZjA4ZTM0MV8wLTAtMS0xLTA_b9afb4cf-519f-4a2e-91e6-f92f7beefe0b">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NDRlNWI2MGMwZGI4NDNiYzhmNzVhZjY2Y2YwOGUzNDEvdGFibGVyYW5nZTo0NGU1YjYwYzBkYjg0M2JjOGY3NWFmNjZjZjA4ZTM0MV8wLTUtMS0xLTA_5bcf355c-0348-411e-9508-29d234d54e49">false</dei:EntityEmergingGrowthCompany>
    <dei:EntitySmallBusiness
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGFibGU6NDRlNWI2MGMwZGI4NDNiYzhmNzVhZjY2Y2YwOGUzNDEvdGFibGVyYW5nZTo0NGU1YjYwYzBkYjg0M2JjOGY3NWFmNjZjZjA4ZTM0MV8xLTMtMS0xLTA_b14f6c96-a5c8-4452-9e6d-274cec9ca85e">false</dei:EntitySmallBusiness>
    <dei:EntityShellCompany
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xNzE3_ab152ff6-18e0-4d57-b719-a2476fc0eb7f">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i57886cddd4384344b30a7a72843fef41_I20201201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xL2ZyYWc6MmVhMzc3ZjUzZDE1NDAzYTllNjRjNWUyYWIyOTRjZjMvdGV4dHJlZ2lvbjoyZWEzNzdmNTNkMTU0MDNhOWU2NGM1ZTJhYjI5NGNmM18xNzUw_8981f5eb-ccbb-4579-b9c4-859fc5ae5820"
      unitRef="shares">1346019949</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMi0xLTEtMS0w_9a622a96-f13c-44fe-928d-b4d03aa74b2f"
      unitRef="usd">7647000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMi0zLTEtMS0w_d64b9906-7f0b-4ba9-904e-a931cc09e4d8"
      unitRef="usd">7706000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMi01LTEtMS04Mg_800d7dbf-eed3-43a0-b483-e01d4be04ceb"
      unitRef="usd">14154000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMi03LTEtMS04Mg_3ecb8682-b37e-4015-8376-09419af16f7c"
      unitRef="usd">15199000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNC0xLTEtMS0w_e31ce11c-27b1-4bce-b08e-93cf3bee8eed"
      unitRef="usd">2705000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNC0zLTEtMS0w_e345a28a-6fa4-4db7-a16c-55bbf1e2ab3d"
      unitRef="usd">2394000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNC01LTEtMS04NQ_71ed333b-11a8-4282-9ef5-c47b96aec460"
      unitRef="usd">5209000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNC03LTEtMS04NQ_87e7c720-3d71-42a7-94ed-6a652f2dfeac"
      unitRef="usd">4760000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNS0xLTEtMS0w_98c64ce5-93b5-4c1f-8f99-8db3dc7ddd0c"
      unitRef="usd">639000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNS0zLTEtMS0w_577b29ae-5e20-431a-b489-f1cff5146647"
      unitRef="usd">603000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNS01LTEtMS04NQ_847afdc5-4ab9-46ab-9bf6-bfc1f0f5d5cb"
      unitRef="usd">1260000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNS03LTEtMS04NQ_d4a963f6-02bb-4412-b84a-a10283626e10"
      unitRef="usd">1190000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNi0xLTEtMS0w_0407a084-4efa-4294-9073-814988920c87"
      unitRef="usd">2600000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNi0zLTEtMS0w_65d67efb-1745-47ba-9aa2-044318fa82c1"
      unitRef="usd">2620000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNi01LTEtMS04NQ_31825bd6-f44e-42be-addd-38a8e81267f5"
      unitRef="usd">5017000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNi03LTEtMS04NQ_88bb9fae-9859-4a14-9f82-c43df742d94a"
      unitRef="usd">5163000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNy0xLTEtMS0w_71800004-2bf9-4ac7-a529-3c855f1e617c"
      unitRef="usd">443000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNy0zLTEtMS0w_1e13fc4e-9aa6-4737-89d6-c3bccdf4d1ad"
      unitRef="usd">441000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNy01LTEtMS04OA_09eb1bac-4237-431d-8da1-0d3c2e803da5"
      unitRef="usd">884000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfNy03LTEtMS04OA_650024d4-2b2c-47d7-b32c-9501b4bb7a2d"
      unitRef="usd">881000000</us-gaap:AmortizationOfIntangibleAssets>
    <mdt:RestructuringChargesNetofRestructuringReversals
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOC0xLTEtMS0w_c2b1dfba-53f2-434d-9d1c-ea97237ba6f8"
      unitRef="usd">97000000</mdt:RestructuringChargesNetofRestructuringReversals>
    <mdt:RestructuringChargesNetofRestructuringReversals
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOC0zLTEtMS0w_cfbfdff6-c1cd-48d1-b492-47e5a1945c3f"
      unitRef="usd">27000000</mdt:RestructuringChargesNetofRestructuringReversals>
    <mdt:RestructuringChargesNetofRestructuringReversals
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOC01LTEtMS04OA_5dd0683e-dcd6-43f5-8ae5-e7aabf0a44e1"
      unitRef="usd">150000000</mdt:RestructuringChargesNetofRestructuringReversals>
    <mdt:RestructuringChargesNetofRestructuringReversals
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOC03LTEtMS04OA_063f0c8a-766a-4122-a626-78c5bf057a12"
      unitRef="usd">74000000</mdt:RestructuringChargesNetofRestructuringReversals>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOS0xLTEtMS0w_7bb32e8d-fb76-43c3-a483-df5319aa3b5d"
      unitRef="usd">84000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOS0zLTEtMS0w_6811a97a-5b79-466d-905d-75351685b787"
      unitRef="usd">121000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOS01LTEtMS04OA_2e2f1fa1-0cd7-46e7-b580-52fbfef6d6d6"
      unitRef="usd">-4000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfOS03LTEtMS04OA_485769a7-2dd6-412f-a9dd-74aa56f755ee"
      unitRef="usd">168000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTEtMS0xLTEtMA_7306feaa-feac-4539-befc-9a2392de4c68"
      unitRef="usd">-149000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTEtMy0xLTEtMA_35f4033d-3ac0-4ab7-bc78-bafac967c181"
      unitRef="usd">-149000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTEtNS0xLTEtOTE_7293c62a-22e4-4ca2-a4e3-aa50f068decf"
      unitRef="usd">-35000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTEtNS0xLTEtOTE_8dd1fe46-c1a6-4e6d-a33e-96f1c125884d"
      unitRef="usd">-35000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTEtNy0xLTEtOTE_60a49eca-9214-426e-b575-376f14499bfe"
      unitRef="usd">-127000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTEtNy0xLTEtOTE_8cbffb02-bc95-44fa-97f4-22f8a97acd8b"
      unitRef="usd">-127000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OperatingIncomeLoss
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTItMS0xLTEtMA_b29ba3dd-0d11-4c59-b83a-599a57ce932c"
      unitRef="usd">930000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTItMy0xLTEtMA_e84f2e51-ee7d-4ffa-af23-2ae674063661"
      unitRef="usd">1351000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTItNS0xLTEtOTc1_9524de0c-7bf1-4ea6-9647-7073bba29d05"
      unitRef="usd">1603000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTItNy0xLTEtOTc1_327ab2be-c76b-410d-868d-efa57c777c4e"
      unitRef="usd">2836000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTMtMS0xLTEtMA_df4ea049-2d31-4fb7-8375-68566d9b2f35"
      unitRef="usd">65000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTMtMy0xLTEtMA_21a484c7-298a-418a-a0ae-8c94d860a0b6"
      unitRef="usd">108000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTMtNS0xLTEtOTQ_5fd75cfb-15e0-4d81-8d86-7c6953b6d741"
      unitRef="usd">147000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTMtNy0xLTEtOTQ_380b3c12-5bab-4153-bbe2-545512234498"
      unitRef="usd">209000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTQtMS0xLTEtMA_f6e7b378-f5e1-47df-b72c-7b1f2e7b40f9"
      unitRef="usd">470000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTQtMy0xLTEtMA_1e83e078-3224-410b-a84a-fdd99ad1765e"
      unitRef="usd">165000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTQtNS0xLTEtOTQ_4a2def58-4f11-4c76-868d-a16fb0fd5745"
      unitRef="usd">641000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTQtNy0xLTEtOTQ_4c029160-b73c-45ff-9f40-4ef9a7a16539"
      unitRef="usd">774000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTUtMS0xLTEtMA_c6a29caf-9fce-4345-955d-5df7987d16bd"
      unitRef="usd">525000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTUtMy0xLTEtMA_9ffc9031-d8ef-495b-8a7d-98adc420096e"
      unitRef="usd">1294000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTUtNS0xLTEtOTc1_edb68712-ed19-4e00-b1b1-4c7ad552cdfd"
      unitRef="usd">1109000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTUtNy0xLTEtOTc1_862b16ac-0baa-4810-bfd4-5463c6405f45"
      unitRef="usd">2271000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTYtMS0xLTEtMA_536f9ba3-58c2-4fde-9cbd-4c815c9506ca"
      unitRef="usd">31000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTYtMy0xLTEtMA_ed07b5ca-e1d5-42d1-8e77-6056fa4114c6"
      unitRef="usd">-77000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTYtNS0xLTEtOTc1_84ae2653-a80d-4de2-9714-db281c3c81a2"
      unitRef="usd">124000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTYtNy0xLTEtOTc1_4a4fc38e-6cda-4399-aa8d-859c3b7c43f7"
      unitRef="usd">23000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTctMS0xLTEtMA_f0d480d9-4f08-40f8-8159-f7c69c223673"
      unitRef="usd">494000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTctMy0xLTEtMA_5964d9a3-32fb-44df-a982-7a55bac0c79b"
      unitRef="usd">1371000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTctNS0xLTEtOTc1_669cae51-9438-4fbd-8172-f959b600fc96"
      unitRef="usd">985000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTctNy0xLTEtOTc1_a999a231-9242-4a69-9fbf-d17638e86a66"
      unitRef="usd">2248000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTgtMS0xLTEtMA_a5246070-3644-4e73-bdc2-7bbe3c22b242"
      unitRef="usd">5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTgtMy0xLTEtMA_222560a9-91e1-45dd-896d-e2dc9099b4d1"
      unitRef="usd">7000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTgtNS0xLTEtMTA0_2dfce8e8-8ff9-49ed-8bf1-8c4ec814f868"
      unitRef="usd">9000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTgtNy0xLTEtMTA0_beddc6ee-273d-4e4b-927b-305e98e9f3f5"
      unitRef="usd">20000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTktMS0xLTEtMA_1fece2ae-9e7b-4502-811d-05e70ca1d85c"
      unitRef="usd">489000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTktMy0xLTEtMA_dd41772c-1d33-44f5-8be8-22ec54c182bb"
      unitRef="usd">1364000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTktNS0xLTEtOTc1_5454ff0b-c98a-467b-8f7f-473cef221170"
      unitRef="usd">976000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMTktNy0xLTEtOTc1_93adfd88-3e4d-4b06-a577-1165ac46f645"
      unitRef="usd">2228000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjAtMS0xLTEtMA_1b507879-8937-4e36-b187-ec69d9464ae7"
      unitRef="usdPerShare">0.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjAtMy0xLTEtMA_b8932550-879c-4d74-8b78-259447093a00"
      unitRef="usdPerShare">1.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjAtNS0xLTEtMTA3_f7f6e0da-8922-4e53-861b-f7829e610dfe"
      unitRef="usdPerShare">0.73</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjAtNy0xLTEtMTA3_c3857a75-717f-441e-9751-e3c757ef214f"
      unitRef="usdPerShare">1.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjEtMS0xLTEtMA_bf8088ea-372e-4384-b84a-7923042525d4"
      unitRef="usdPerShare">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjEtMy0xLTEtMA_9260f3ee-fec3-46a4-a3ba-7bdadd3c6227"
      unitRef="usdPerShare">1.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjEtNS0xLTEtMTA3_1d66f666-96e2-43d9-a2e5-90739ac37768"
      unitRef="usdPerShare">0.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjEtNy0xLTEtMTA3_88fc9643-02d6-4545-ae07-cace5f1915ba"
      unitRef="usdPerShare">1.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjItMS0xLTEtMA_4b595cf2-d43c-4950-90db-fd0074c9ba0d"
      unitRef="shares">1344400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjItMy0xLTEtMA_c0ef0c0c-5d78-4856-bb5f-0f53245cb5c4"
      unitRef="shares">1340800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjItNS0xLTEtMTA3_45ff78f3-c94b-409f-beb2-3f7c3d475a62"
      unitRef="shares">1343100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjItNy0xLTEtMTA3_72986b7e-9c66-447c-8f1c-e90d1857ced6"
      unitRef="shares">1340800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjMtMS0xLTEtMA_cd6f5016-ff91-479e-851c-ef4e40fb70ff"
      unitRef="shares">1352100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjMtMy0xLTEtMA_0a174250-347e-45ca-97b0-7161b8c4132c"
      unitRef="shares">1351400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjMtNS0xLTEtMTA3_3532f99f-c52d-4ae5-b737-eeb62af2a571"
      unitRef="shares">1351100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8xOS9mcmFnOmNlMWQwYTQ5NTkwYjQ0NWU4NDgwMmM2ODE3NTgyNTA2L3RhYmxlOjc0ZTI0OGQ2OWY0YzQ4MjA5NDZhMzVmNTkzNDNhZWIwL3RhYmxlcmFuZ2U6NzRlMjQ4ZDY5ZjRjNDgyMDk0NmEzNWY1OTM0M2FlYjBfMjMtNy0xLTEtMTA3_b041af52-4b2d-4b00-a6ee-2a3f45db024f"
      unitRef="shares">1351600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMi0xLTEtMS0w_0b7510b8-d146-457d-b81d-cc357f23b314"
      unitRef="usd">494000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMi0zLTEtMS0w_cc5d5fe8-873c-4ca4-a04c-331e33584d18"
      unitRef="usd">1371000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMi01LTEtMS0yODc_9e3ca57f-bee6-4ddc-bef7-baa854ab58d7"
      unitRef="usd">985000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMi03LTEtMS0yODc_95d00d19-aff2-4cce-9de6-0b46f6da9a8a"
      unitRef="usd">2248000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNS0xLTEtMS0w_efd453c7-57b5-4a5c-b12a-6d60c306139c"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNS0zLTEtMS0w_a6a5a7b7-421f-4d25-bb78-d28ae3f3ded4"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNS01LTEtMS0yODM_56b72a46-0068-48ab-b6ad-32e1647c687f"
      unitRef="usd">113000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNS03LTEtMS0yODM_d83975b9-1820-4ad6-8b5e-0c62bdf475ad"
      unitRef="usd">73000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNi0xLTEtMS0w_db1868eb-3085-4d56-bd91-9b776003bb13"
      unitRef="usd">144000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNi0zLTEtMS0w_eaa26bc8-6238-45a9-ad03-4b67fd8e5c1d"
      unitRef="usd">-214000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNi01LTEtMS0yODM_5751f77c-96bb-4232-951f-9da7f54c6232"
      unitRef="usd">1261000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNi03LTEtMS0yODM_fe2d9b98-3de9-4455-96ec-0980b246be0d"
      unitRef="usd">-148000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNy0xLTEtMS0w_161a1dc3-e92c-4398-9a0e-3a4d6be62727"
      unitRef="usd">-164000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNy0zLTEtMS0w_de1dc729-c8d3-402a-9942-d95b29fd85d2"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNy01LTEtMS0yODM_cb40f530-96ba-4b7c-99e8-d1e0119afbeb"
      unitRef="usd">-1276000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfNy03LTEtMS0yODM_10ecb8c7-6e22-4cb7-bcc6-0f1015d316fd"
      unitRef="usd">152000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOC0xLTEtMS0w_29403163-d6e1-4015-b453-7d9394d8de92"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOC0zLTEtMS0w_d169fc85-5e0b-4f0a-9d0f-903449e007d6"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOC01LTEtMS0yODM_c9fae156-899f-4cad-ad7c-33b115c18e74"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOC03LTEtMS0yODM_89bd99da-4da8-4511-962d-63ac851bd3b9"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOS0xLTEtMS0w_6d6ca0d3-830b-47b1-8e54-bcfabb02fcf5"
      unitRef="usd">-45000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOS0zLTEtMS0w_8db035f5-f629-43f8-83e0-99ca49406e5c"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOS01LTEtMS0yODM_1d01d072-3991-405a-baf2-3721c3bc2b9e"
      unitRef="usd">-395000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfOS03LTEtMS0yODM_f3e1d008-cf5e-48ba-a539-70ebe8bd8d70"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTAtMS0xLTEtMA_929e4385-cc6d-4b3f-b85c-ee355408629e"
      unitRef="usd">-60000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTAtMy0xLTEtMA_6fc5b84a-12b6-4360-a94c-f6859756c73d"
      unitRef="usd">-127000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTAtNS0xLTEtOTc3_1ec32e79-7d93-446d-9be8-0e820b8b3109"
      unitRef="usd">-277000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTAtNy0xLTEtOTc3_4f647036-c8bb-4528-92ab-3a974f1eecfe"
      unitRef="usd">100000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTEtMS0xLTEtMA_f27c8fd9-0a9d-4925-a679-4840119301ff"
      unitRef="usd">434000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTEtMy0xLTEtMA_fe6e2d1c-3fa4-4917-936a-60f6decb0f6e"
      unitRef="usd">1244000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTEtNS0xLTEtOTc3_0e2cdd0d-bc06-4297-9a23-36a7815fa21b"
      unitRef="usd">708000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTEtNy0xLTEtOTc3_eebca5e6-ab06-4547-98ee-ab56556f0d85"
      unitRef="usd">2348000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTItMS0xLTEtMA_7353e0df-f108-4ec6-8b22-edb16d88da0e"
      unitRef="usd">6000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTItMy0xLTEtMA_4130fc76-68bd-4373-b025-09d340f43eff"
      unitRef="usd">7000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTItNS0xLTEtMjk5_4e899944-2a97-4e07-bab0-8752372cfb33"
      unitRef="usd">15000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTItNy0xLTEtMjk5_15e0f2b3-af03-491b-ae4d-1a4b01c28d9f"
      unitRef="usd">20000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTMtMS0xLTEtMA_2314ad31-11c6-42ca-bede-3894a07b3e7f"
      unitRef="usd">428000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTMtMy0xLTEtMA_8dedda5a-e142-4af2-8c66-ba82eec0716e"
      unitRef="usd">1237000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTMtNS0xLTEtOTc3_c6b425ce-d6b9-450d-bb25-d4638dad84df"
      unitRef="usd">693000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yMi9mcmFnOmQxODI5MTU3NTIzMTQzZWViMzE4OTA2NzQ1MDMxOTc0L3RhYmxlOjQwNDNlZDc3ZmRkNDRkMTc5MWFlOGM5MTQzYzg5N2U0L3RhYmxlcmFuZ2U6NDA0M2VkNzdmZGQ0NGQxNzkxYWU4YzkxNDNjODk3ZTRfMTMtNy0xLTEtOTc3_b5950bf5-2cf2-4785-8ab4-30825a566a20"
      unitRef="usd">2328000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMy0xLTEtMS0w_4b9bc5b0-10c1-46af-b325-d2d45084e02f"
      unitRef="usd">6420000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMy0zLTEtMS0w_3d6b1a59-c250-40ad-b134-8ef23abaa94a"
      unitRef="usd">4140000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNC0xLTEtMS0w_800bea35-584c-49bf-a026-45949b5ad0dc"
      unitRef="usd">7857000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNC0zLTEtMS0w_6ab7275c-a0de-4a0a-8031-ee40a946d7f4"
      unitRef="usd">6808000000</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNS0wLTEtMS0wL3RleHRyZWdpb246MjU5N2IwY2I4Y2QyNGUyY2FmZTJjNGJlMDNhODUxNzNfNjI_4a66dca5-4424-46da-84d0-557577955b44"
      unitRef="usd">312000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNS0wLTEtMS0wL3RleHRyZWdpb246MjU5N2IwY2I4Y2QyNGUyY2FmZTJjNGJlMDNhODUxNzNfNjk_8656e1d0-1860-4d44-a9c8-1c08132b374f"
      unitRef="usd">208000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNS0xLTEtMS0w_b3dd57bf-f4c7-4581-b505-33ab95592883"
      unitRef="usd">5348000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNS0zLTEtMS0w_8668169a-1583-4171-ba02-febc8d79ab03"
      unitRef="usd">4645000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNi0xLTEtMS0w_48440ec6-c083-4fd3-89b6-49b42c02d396"
      unitRef="usd">4484000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNi0zLTEtMS0w_e52f5d18-2180-4c9c-8bcd-0bcebb2a1df7"
      unitRef="usd">4229000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNy0xLTEtMS0w_8e9a5a2c-0feb-4fc1-90fa-5f135aa82103"
      unitRef="usd">1927000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNy0zLTEtMS0w_050a239a-c74c-41e0-af23-b85d08d54620"
      unitRef="usd">2209000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfOC0xLTEtMS0w_3445b120-36b8-4034-afcd-fcb67c8ea2f0"
      unitRef="usd">26036000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfOC0zLTEtMS0w_6cc52ac1-1477-4408-837c-b1d135033931"
      unitRef="usd">22031000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfOS0xLTEtMS0w_bcb8450a-0fcb-441d-9ceb-470fbb01892a"
      unitRef="usd">12198000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfOS0zLTEtMS0w_6070da65-a98a-42a2-8bc7-9d4150089bde"
      unitRef="usd">11644000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTAtMS0xLTEtMA_728a9e89-c18f-4a1d-9569-9038e7a2aa87"
      unitRef="usd">7260000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTAtMy0xLTEtMA_f4d8f11c-481a-46dc-a3f4-5b6c1c78eeb3"
      unitRef="usd">6816000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTEtMS0xLTEtMA_8a391e13-cd0e-4f39-a5a7-c8364dcf7961"
      unitRef="usd">4938000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTEtMy0xLTEtMA_58c9713f-5292-494b-a580-1b1e33a02b25"
      unitRef="usd">4828000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTItMS0xLTEtMA_d6b2cf9c-ef64-40e1-9b90-6d0a3613efe3"
      unitRef="usd">41212000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTItMy0xLTEtMA_4ea69afa-99ed-4bc6-b663-e76a4df343bd"
      unitRef="usd">39841000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTMtMS0xLTEtMA_cb2c783a-f1e5-4cfa-9750-359585cd24f0"
      unitRef="usd">18412000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTMtMy0xLTEtMA_834fdbb4-aaee-401d-b019-a94f21f5d841"
      unitRef="usd">19063000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTQtMS0xLTEtMA_2f51500d-9f27-433f-aa8c-584e61c8db26"
      unitRef="usd">3176000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTQtMy0xLTEtMA_c92acd1c-dfac-41d3-a70a-8044e7b31627"
      unitRef="usd">2832000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTUtMS0xLTEtMA_70d38a01-2719-4838-8964-134f558ba47f"
      unitRef="usd">2112000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTUtMy0xLTEtMA_a04a463a-5efb-40d1-bfe2-f170d755accc"
      unitRef="usd">2094000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTYtMS0xLTEtMA_bb9e08aa-5f13-472f-a4e5-d988c1d3f71b"
      unitRef="usd">95886000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTYtMy0xLTEtMA_83a6b195-6c69-40a9-aac1-d5c5f5172e27"
      unitRef="usd">90689000000</us-gaap:Assets>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTktMS0xLTEtMA_5e6931da-c73e-4748-9895-09444cd5dcd6"
      unitRef="usd">4041000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMTktMy0xLTEtMA_cae783c4-cd26-4904-ac53-011f8fc0ac59"
      unitRef="usd">2776000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjAtMS0xLTEtMA_81596a52-c33c-4368-88c4-1f52d80669f1"
      unitRef="usd">1902000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjAtMy0xLTEtMA_f35ceab0-8da7-4abe-8d8d-2e2e74a9d071"
      unitRef="usd">1996000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjEtMS0xLTEtMA_497696f7-f962-4ff8-b747-0840bfa3d164"
      unitRef="usd">2133000000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjEtMy0xLTEtMA_4d1610d5-0c24-4ae8-8984-0ff03c5f24c5"
      unitRef="usd">2099000000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjItMS0xLTEtMA_facdf768-da11-42f7-9489-d917d61758d7"
      unitRef="usd">406000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjItMy0xLTEtMA_9e12fd23-7a61-487e-9a48-553b4127cdc2"
      unitRef="usd">502000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjMtMS0xLTEtMA_b405e0d0-cef9-43ef-b045-3e7ec2e5eed9"
      unitRef="usd">3589000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjMtMy0xLTEtMA_2d64d9b0-bec3-4b09-b6a5-3f27a8d77bf6"
      unitRef="usd">2993000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjQtMS0xLTEtMA_f45ba901-ec17-4a08-b997-4a4772ceddfe"
      unitRef="usd">12071000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjQtMy0xLTEtMA_9cfbc414-8b1e-4a26-bd47-59927c0d6fff"
      unitRef="usd">10366000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjUtMS0xLTEtMA_bf37691b-41c8-4049-b9c8-b315f37b9e8c"
      unitRef="usd">25967000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjUtMy0xLTEtMA_52a15e2f-9016-43be-b00b-b7afd0fd2fe3"
      unitRef="usd">22021000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjYtMS0xLTEtMA_2ac1067b-ee37-4d72-a294-b031ffec36c0"
      unitRef="usd">2024000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjYtMy0xLTEtMA_be61f83c-9fd1-4c44-b610-07fea3674a52"
      unitRef="usd">1910000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjctMS0xLTEtMA_491990bd-a07a-4f96-8c7b-285da5360c71"
      unitRef="usd">2569000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjctMy0xLTEtMA_e0109c55-5d4f-4a94-9789-b476dc9bed8d"
      unitRef="usd">2682000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjgtMS0xLTEtMA_3b07102f-69a0-46a3-b7a4-8587752861e4"
      unitRef="usd">1251000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjgtMy0xLTEtMA_890fff01-d3a5-4802-88df-2f6bf69d96f2"
      unitRef="usd">1174000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjktMS0xLTEtMA_ec0d445b-b2c3-49c8-8182-688b02817191"
      unitRef="usd">1688000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMjktMy0xLTEtMA_e51edc63-66dc-4dcb-9384-e1e60d329139"
      unitRef="usd">1664000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzAtMS0xLTEtMA_59e84d10-596b-41b3-85b4-ec37c9fbefc8"
      unitRef="usd">45570000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzAtMy0xLTEtMA_337553c6-329a-4395-addd-42bea7203832"
      unitRef="usd">39817000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzEtMS0xLTEtMA_8c8e7b79-5e2f-4e00-b849-8a24e25d6b2c"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzEtMy0xLTEtMA_005aebf2-9a44-465f-9310-a18101a9dfe4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzMx_ae1bf35a-936c-4c3d-95d0-4c0bd1481f50"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzMx_cd735b61-d55a-4af9-8100-88cba42af018"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzM1_99a04297-8a5e-4789-8996-8a400a1ca7a0"
      unitRef="shares">2600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzM1_b0f48a0f-7635-436b-acd5-1be189849cf6"
      unitRef="shares">2600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzU3_a18c77ac-0759-4619-aa4f-03499c8b7100"
      unitRef="shares">1345547814</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzU3_c9d8a59c-27d7-47d1-973a-b7075e5a4ce3"
      unitRef="shares">1345547814</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzY0_6abc397f-3c9c-4650-9d00-e8ddf1fcd425"
      unitRef="shares">1341074724</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY0ZWRkYmVjYmJkNTQ0OTY5NzA5MTJlMmI2ODBlOTJhXzY0_90e2986f-7b0a-4afa-83ae-174e0b23b18d"
      unitRef="shares">1341074724</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMS0xLTEtMA_00e913c4-c44a-4c58-b350-249dc9901746"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzMtMy0xLTEtMA_ec6bb0e9-6fd2-4b0d-a399-2e58297027fa"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzQtMS0xLTEtMA_671fedc9-81bc-47ad-86ac-80e597b443a0"
      unitRef="usd">26481000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzQtMy0xLTEtMA_a0a41803-1bb1-42cd-82a5-1c5235e907e2"
      unitRef="usd">26165000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzUtMS0xLTEtMA_d5682a89-5156-415a-ab88-3bb68df22d6c"
      unitRef="usd">27526000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzUtMy0xLTEtMA_f6b57f98-bbfc-4586-ac28-33f5867da769"
      unitRef="usd">28132000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzYtMS0xLTEtMA_a4765af5-a728-40d5-8ba9-56c420096d4e"
      unitRef="usd">-3843000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzYtMy0xLTEtMA_2c52e5cd-2251-4eed-a1a5-bf5d670b610b"
      unitRef="usd">-3560000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzctMS0xLTEtMA_3e1f5df2-aa7d-4a3c-8830-b1e322181d1a"
      unitRef="usd">50164000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzctMy0xLTEtMA_d07b4c9f-c13d-4239-9bad-94671d4d4727"
      unitRef="usd">50737000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzgtMS0xLTEtMA_6a455646-4a5f-4b29-9f46-f799e657753c"
      unitRef="usd">152000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzgtMy0xLTEtMA_e3ff639e-5abe-4b3c-b425-92c57dff1ffc"
      unitRef="usd">135000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzktMS0xLTEtMA_ef85bf54-b3b3-4c1d-b32e-7cbca7a5d501"
      unitRef="usd">50316000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfMzktMy0xLTEtMA_1cc00fc1-431b-44b3-9919-81e4a1771c4a"
      unitRef="usd">50872000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNDAtMS0xLTEtMA_0de52f8f-1bc5-4aab-bcf1-6dfafaa72618"
      unitRef="usd">95886000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yNS9mcmFnOjc0M2IzNDlmNDQyMTQ3OGJiYmFiYzNlMDZjMzI1NWU4L3RhYmxlOjhkMmU3Y2YwNjQxYzQ3YWJiNGM4M2JjYjVlMmU3N2IwL3RhYmxlcmFuZ2U6OGQyZTdjZjA2NDFjNDdhYmI0YzgzYmNiNWUyZTc3YjBfNDAtMy0xLTEtMA_700e688c-4cec-48f8-9abc-ce28ebcd1ead"
      unitRef="usd">90689000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if3e9504309af4083b6fd5bf477afa1c6_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi0yLTEtMS0w_d7e69376-3462-477d-b09f-ab6e20bbdff7"
      unitRef="shares">1341000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if3e9504309af4083b6fd5bf477afa1c6_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi00LTEtMS0w_f0014691-ccca-4cca-ad9f-d7808fa95d59"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic572c413537c418298b2634dbfaaf017_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi02LTEtMS0w_4df75fdd-f337-4204-8d18-12e3ba0b436c"
      unitRef="usd">26165000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd6a86ad9b714d9081642559e2ff2934_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi04LTEtMS0w_48806650-5983-4aa6-b0db-3e1860479ed6"
      unitRef="usd">28132000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5c85755ec4074136b1ee5356437a2b17_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi0xMC0xLTEtMA_2f5c3d62-cf36-4956-852d-072686d7beb4"
      unitRef="usd">-3560000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b5b7d170f3340e696de1c1470de9cdd_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi0xMi0xLTEtMA_e2c59992-2dab-4a3c-aaf0-c34eda633bba"
      unitRef="usd">50737000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b268c905e614cd0838cbabb6383cd70_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi0xNC0xLTEtMA_205b42d2-cb5e-4594-aa8a-cec10a5628eb"
      unitRef="usd">135000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMi0xNi0xLTEtMA_a0109c96-ff93-4cee-be87-699e483cf575"
      unitRef="usd">50872000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="id9156b821fc84f4eafacc70d98d9cd2b_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMy04LTEtMS0w_5f563b66-016c-433c-937c-1ad265b01a9b"
      unitRef="usd">487000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6371626247f34091a93b2dc205920ab8_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMy0xMi0xLTEtMA_24c07eee-5c57-4dc1-9bdb-17d1e9127b4b"
      unitRef="usd">487000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i85c770bf95844dd9931cef47b1f7be43_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMy0xNC0xLTEtMA_039a86b8-ae8c-427b-a063-d393b3ad1de4"
      unitRef="usd">4000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMy0xNi0xLTEtMA_49fc3173-dcf6-486a-9b2d-48a049599168"
      unitRef="usd">491000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i673be33df7fd4f9bbded121055267d0d_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNC0xMC0xLTEtMA_6cbe1141-20f0-4127-ba92-4bcb12bbf845"
      unitRef="usd">-222000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6371626247f34091a93b2dc205920ab8_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNC0xMi0xLTEtMA_3d62923f-6639-4e58-89bc-22365743228f"
      unitRef="usd">-222000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i85c770bf95844dd9931cef47b1f7be43_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNC0xNC0xLTEtMA_9b7421cd-edbb-4555-8db1-b3cac8592765"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNC0xNi0xLTEtMA_dd97b32a-6040-435c-8e61-f8067d332bc0"
      unitRef="usd">-217000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNS0wLTEtMS0wL3RleHRyZWdpb246ZWI4ZjA3NzY4ZjBiNDRkNWIzYzhiN2RiNWU1MTM1YWNfMzI_6439617c-7dfe-4193-b21c-af43002a75cb"
      unitRef="usdPerShare">0.58</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="id9156b821fc84f4eafacc70d98d9cd2b_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNS04LTEtMS0w_5728fc1a-f280-4c23-8f2e-94590f52f14a"
      unitRef="usd">778000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i6371626247f34091a93b2dc205920ab8_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNS0xMi0xLTEtMA_4b343329-dc41-4b1a-9ccf-8eec6cc243f3"
      unitRef="usd">778000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNS0xNi0xLTEtMA_130ca680-4c44-49b4-b61c-16f7d6cf9662"
      unitRef="usd">778000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="id71e33001d124f7794452cdccb09c623_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNi0yLTEtMS0w_8f9a0cc2-869f-42fa-a36e-876323dbc9c6"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if639f48dcce540048c90f61ab3fb7bc7_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNi02LTEtMS0w_6a4ffcfc-e73e-4e72-ac3d-3a1875428f26"
      unitRef="usd">26000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6371626247f34091a93b2dc205920ab8_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNi0xMi0xLTEtMA_217242da-783e-4bf0-8db6-99f4e5fbf857"
      unitRef="usd">26000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfNi0xNi0xLTEtMA_d39e0acc-b246-4d44-be84-3c8574f88434"
      unitRef="usd">26000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if639f48dcce540048c90f61ab3fb7bc7_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfOC02LTEtMS0w_497a2195-db50-4c6b-93f2-79b05032e96e"
      unitRef="usd">70000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6371626247f34091a93b2dc205920ab8_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfOC0xMi0xLTEtMA_807fc4f0-6a3c-4e41-a2d7-4303e9cf7f6e"
      unitRef="usd">70000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfOC0xNi0xLTEtMA_26a5c279-40e4-4606-9f58-c5da67e9bce9"
      unitRef="usd">70000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i85c770bf95844dd9931cef47b1f7be43_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfOS0xNC0xLTEtMA_0b869657-06ca-4868-b63b-531a60e55b1a"
      unitRef="usd">3000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ie0808b5e74f94252af9804f63d275b31_D20200425-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfOS0xNi0xLTEtMA_5ccadc4c-b251-41a8-807c-df20cdd813ce"
      unitRef="usd">3000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib94296a7b45e4e3dbe2d67900645d435_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtOC0xLTEtMA_e9f5a671-e985-4efa-a7de-32b8d8ba52dc"
      unitRef="usd">-24000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib110981db8f14c9cb4cbb63889887dd7_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtMTItMS0xLTA_ddd13094-0923-471e-945c-abade1a03459"
      unitRef="usd">-24000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic409e1c550db48e5bcd4ce67616935c8_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtMTYtMS0xLTA_9f0883c5-6692-4daf-b6ef-72a9af546716"
      unitRef="usd">-24000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i72605901d1f74ce597b028c09d4dd3a7_I20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtMi0xLTEtMA_cae18615-6d82-4feb-aa27-3c6bdf5495cb"
      unitRef="shares">1343000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i72605901d1f74ce597b028c09d4dd3a7_I20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtNC0xLTEtMA_a2ed7179-f446-44a3-a3ac-d3c8fe184baf"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i25a5dac7b3084d7a84a6335f68c0ceed_I20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtNi0xLTEtMA_41a7b3ad-7ec8-476d-bfea-ee2e24084ecf"
      unitRef="usd">26261000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id628b7deeefa46eba3e8cce6bf5edf04_I20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtOC0xLTEtMA_7b6633d1-c0ae-421d-8b87-ed8078988f74"
      unitRef="usd">27817000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie418c42f639e4cb68a0a9bac1b9871d8_I20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtMTAtMS0xLTA_d39033c4-23b6-48c2-825f-ecf5e53b2f31"
      unitRef="usd">-3782000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie49fd01017d6410babb0baa6095d8df8_I20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtMTItMS0xLTA_eb634018-ae8d-45a4-a083-cef02b792c00"
      unitRef="usd">50296000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90d56739612b4fba968994692f0deff1_I20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtMTQtMS0xLTA_a6a4b872-b7ea-4a5d-b04f-ef8b2b027221"
      unitRef="usd">147000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i08ae410a74984dc0a1a2e5d64185b3a1_I20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTEtMTYtMS0xLTA_a353d099-0d2d-4a52-aad0-f877a7b756d8"
      unitRef="usd">50443000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i69cfa6db80bb43d89a510e85d2efae77_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTItOC0xLTEtMA_7b5d6ef7-ad23-4a02-a008-b700ea173728"
      unitRef="usd">489000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTItMTItMS0xLTA_2aeff4d4-8d48-489e-9d61-c89e55a91e10"
      unitRef="usd">489000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ieedf1ec037a4442aaef3abd0076151d8_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTItMTQtMS0xLTA_262fda62-66b4-474e-a67c-c3f9534c035b"
      unitRef="usd">5000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTItMTYtMS0xLTA_ba58cc0d-9637-4ef6-a073-a4e69387640b"
      unitRef="usd">494000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i720289bbdf744d3c8b2dcfad03251c89_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTMtMTAtMS0xLTA_5371965a-ff35-4522-9ed1-c68ef80ba223"
      unitRef="usd">-61000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTMtMTItMS0xLTA_561ef073-29f2-463a-83b3-9945c4b88212"
      unitRef="usd">-61000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ieedf1ec037a4442aaef3abd0076151d8_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTMtMTQtMS0xLTA_6d61e8b1-1448-4840-9f0c-86a9040d6d95"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTMtMTYtMS0xLTA_751eae9e-0901-4996-9683-5826aedcb014"
      unitRef="usd">-60000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOmU2MTM0MmIzZjlhYzQ4MDY5NmM4NzIwODI2ZjJlZDdiXzMx_cdcfc864-c20e-4bf1-a27a-976f7805e0a9"
      unitRef="usdPerShare">0.58</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i69cfa6db80bb43d89a510e85d2efae77_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTQtOC0xLTEtMA_6bb561aa-fe94-45b0-a9eb-6b4945c4748a"
      unitRef="usd">780000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTQtMTItMS0xLTA_0167480d-41c8-4c17-a5f8-cb605800d270"
      unitRef="usd">780000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTQtMTYtMS0xLTA_44e04391-1424-4baf-8396-1dbcb5464668"
      unitRef="usd">780000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="if31334823c424f9c82c6d16a6bd8c729_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTUtMi0xLTEtMA_2193f123-8062-434e-b5a4-6568e4d5f260"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i28dc26d87a9e4efaa4d5051ff8841788_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTUtNi0xLTEtMA_695f90bc-f76e-4a9e-89ff-a9874278f1ce"
      unitRef="usd">93000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTUtMTItMS0xLTA_a569cea1-1b68-4cbc-b15b-5b820698bcbc"
      unitRef="usd">93000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTUtMTYtMS0xLTA_12ef080c-8a2c-418c-8499-352cf4acd558"
      unitRef="usd">93000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i28dc26d87a9e4efaa4d5051ff8841788_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTctNi0xLTEtMA_69d732ad-5f8d-414b-b06a-e1a0d941de34"
      unitRef="usd">140000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTctMTItMS0xLTA_0ec43889-7c33-4e94-842d-b62227d7259c"
      unitRef="usd">140000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTctMTYtMS0xLTA_78614c7c-e491-4b17-8cfd-139994cc0d84"
      unitRef="usd">140000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i28dc26d87a9e4efaa4d5051ff8841788_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTgtNi0xLTEtMA_7081657f-11ed-4639-850c-426442405241"
      unitRef="usd">-13000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="if4e25c7433b94cefaafce2de634cd91d_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTgtMTItMS0xLTA_1e764d0a-d2ec-404b-bf7e-337acf21a3df"
      unitRef="usd">-13000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ieedf1ec037a4442aaef3abd0076151d8_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTgtMTQtMS0xLTA_f224ba5b-1a4e-44f3-a457-c829c0413a40"
      unitRef="usd">-1000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTgtMTYtMS0xLTA_37ffdbd4-cab0-420e-886b-a0eef4b9acde"
      unitRef="usd">-14000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia21542305a5946e8b39788bc982841f6_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtMi0xLTEtMA_6c448352-7ddc-4baa-acc9-6728a7a02f54"
      unitRef="shares">1345000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia21542305a5946e8b39788bc982841f6_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtNC0xLTEtMA_396631eb-3b4a-4af6-9ecd-b5084e990194"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibbe9b124d8ca41e981b8cf95b5ea6242_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtNi0xLTEtMA_e0ed17fa-770c-4359-b154-3157cab68255"
      unitRef="usd">26481000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i992522324432452d9ca66c8a4b298efd_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtOC0xLTEtMA_3823b1f4-bf49-4d11-af74-9f6fcea281bb"
      unitRef="usd">27526000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1fb60693b842404b9c6c710c434a9f46_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtMTAtMS0xLTA_3b62e83c-e763-4335-9ec9-5619b0783266"
      unitRef="usd">-3843000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if93a3ed7d08a4808a025b1a3549ab044_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtMTItMS0xLTA_82fb7606-f3dc-4c52-a45e-06d2fc2fa176"
      unitRef="usd">50164000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i111f8934e3d049098d7b0406e926375e_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtMTQtMS0xLTA_2a8b0674-a422-45bb-98b0-e1e06cb77871"
      unitRef="usd">152000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMjAtMTYtMS0xLTA_a59cdcd9-dda4-4158-8757-994cb343a543"
      unitRef="usd">50316000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i52de462b431c4555b295ebb144b8351f_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi0yLTEtMS0w_63b382e2-639d-4528-bb21-5880403d4ff8"
      unitRef="shares">1341000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52de462b431c4555b295ebb144b8351f_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi00LTEtMS0w_e0db199e-9230-4a06-9dbe-dd7ecee99dcf"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9126a007a995490e9cb89a8340e8a989_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi02LTEtMS0w_7444708d-fdd8-424d-82db-76418cc1e59f"
      unitRef="usd">26532000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i552f2062fa83483db3124c50e8e701c8_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi04LTEtMS0w_3448e61d-0651-424b-9f25-33cf78318fe0"
      unitRef="usd">26270000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idce4f3b26c5a4fefb9a2268a16c018e1_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi0xMC0xLTEtMA_032f1b9c-38de-4537-b05a-96252cd0f527"
      unitRef="usd">-2711000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if2f9007fbf9043ab8f457f9c90c97961_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi0xMi0xLTEtMA_4eb4793c-7975-42b3-9708-a6fee3e4a23c"
      unitRef="usd">50091000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i488d2783b01647579ba73905fa797719_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi0xNC0xLTEtMA_10847a2c-22b7-406e-b55e-c455853f2c77"
      unitRef="usd">121000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i33145a1d36f644e3a8066f41beb5b5e2_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMi0xNi0xLTEtMA_0e0582f0-aea7-422e-b66e-d53b3063899d"
      unitRef="usd">50212000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i7fb0dd42a0a04276b76c07255e58b0db_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMy04LTEtMS0w_77c6f134-f6de-4a93-aee1-dadc931fbf56"
      unitRef="usd">864000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i044332ce225b4db4897be21e46da5d03_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMy0xMi0xLTEtMA_b72089cf-0e36-4615-9e43-9f5d2b85dbf5"
      unitRef="usd">864000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i28055ea3470d4effb3ed77de9befc2f5_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMy0xNC0xLTEtMA_668f070d-688b-4f47-b2b7-c96511359ce4"
      unitRef="usd">13000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMy0xNi0xLTEtMA_eed6d1f9-02cf-455a-b541-ac19d501e225"
      unitRef="usd">877000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8759e14cc5034a7993bfef890b7d7418_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNC0xMC0xLTEtMA_4c9ba673-bab0-4feb-a572-741b55a37c06"
      unitRef="usd">227000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i044332ce225b4db4897be21e46da5d03_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNC0xMi0xLTEtMA_c6ab8bba-7915-4df8-9530-9564d1b996e3"
      unitRef="usd">227000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNC0xNi0xLTEtMA_75b3b132-11c0-4f8c-9bc9-f0bc4cf2ac5d"
      unitRef="usd">227000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNS0wLTEtMS0wL3RleHRyZWdpb246OTA1ZWU2MGM2YTNmNDQ3MDgxZWJlYmUxODIxNjhlZjVfMzE_13f7749f-6738-4c09-b093-42a3687b4e32"
      unitRef="usdPerShare">0.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i7fb0dd42a0a04276b76c07255e58b0db_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNS04LTEtMS0w_0ae7c179-3fa2-4752-b735-6d5ca47e62e2"
      unitRef="usd">724000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i044332ce225b4db4897be21e46da5d03_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNS0xMi0xLTEtMA_8d05f4ca-acdb-4374-b482-45a8d09f03d4"
      unitRef="usd">724000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNS0xNi0xLTEtMA_d2d7f012-fc22-480d-b778-f8a528d12c40"
      unitRef="usd">724000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia87757d6c9d640d48a2c1a16626f5bc4_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNi0yLTEtMS0w_5149a73b-14d1-4ed5-b233-5e553ac53f48"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i678e0b51f4cf4d5690b48a63a626a8cc_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNi02LTEtMS0w_84bb0d01-d617-4f64-99fb-ee92db348459"
      unitRef="usd">205000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i044332ce225b4db4897be21e46da5d03_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNi0xMi0xLTEtMA_c345f13b-aa33-4f20-a679-daad375e26ea"
      unitRef="usd">205000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNi0xNi0xLTEtMA_a4d1d722-6c8e-49b0-99a8-14743137dfc3"
      unitRef="usd">205000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ia87757d6c9d640d48a2c1a16626f5bc4_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNy0yLTEtMS0w_a7041c26-1b7d-4ede-b10a-400ddabb56e6"
      unitRef="shares">3000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i678e0b51f4cf4d5690b48a63a626a8cc_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNy02LTEtMS0w_e958df71-908f-4bfc-9af2-e0ebaa1329e8"
      unitRef="usd">328000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i044332ce225b4db4897be21e46da5d03_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNy0xMi0xLTEtMA_956b2de6-9a8e-45b8-a392-021a4fb64bf9"
      unitRef="usd">328000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfNy0xNi0xLTEtMA_c2de69d7-8260-4281-998d-5937eb3d6dcc"
      unitRef="usd">328000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i678e0b51f4cf4d5690b48a63a626a8cc_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfOC02LTEtMS0w_231ad45f-8147-476b-8bba-5038b1a20690"
      unitRef="usd">61000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i044332ce225b4db4897be21e46da5d03_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfOC0xMi0xLTEtMA_37cedadf-3845-49e9-8874-8bbe720bd361"
      unitRef="usd">61000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8308e83ae1a947b48941212c51887a44_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfOC0xNi0xLTEtMA_07c17e75-f79d-4bce-8d50-90bce897226b"
      unitRef="usd">61000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4484008ce40941a9abb0b87591c12b24_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtOC0xLTEtMA_64fed4ed-ae93-4548-bd94-6c4d709d1c30"
      unitRef="usd">-33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i59aafb40e1c3487fb79f88def0cabe5e_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMTItMS0xLTA_59c874bf-43c5-442b-8592-f58c242b75de"
      unitRef="usd">-33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i93af46c007a64220a69e96a35444a4d0_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMTYtMS0xLTA_970ca307-0bd1-473b-bf1f-c3bdbea9361e"
      unitRef="usd">-33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i275643f747c34984beeb90478e79ad20_I20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtMi0xLTEtMA_ae2c11fb-5e38-4b00-829f-9c8419d67925"
      unitRef="shares">1341000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i275643f747c34984beeb90478e79ad20_I20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtNC0xLTEtMA_bdbe0f26-bbf4-4f6b-927a-9d671c26b568"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i12ad7c520edd49219af398dc688a28c2_I20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtNi0xLTEtMA_2057464d-e61d-4fc2-8d99-11ca945489be"
      unitRef="usd">26470000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27b17bf8998541b3b1a8eaadaa465cb5_I20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtOC0xLTEtMA_c7657a1e-4f59-46c7-b2b5-eda4e650b6a5"
      unitRef="usd">26377000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6a33cca3e32b47bfa87a465de4ceb4fa_I20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtMTAtMS0xLTA_4efce461-5ac2-47f1-835b-44aaac701781"
      unitRef="usd">-2484000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieae2d147c0744537a2b2ec49b9cb4379_I20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtMTItMS0xLTA_506957e0-5acb-49c2-aa27-6405c806538c"
      unitRef="usd">50363000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8c2221645f1143a588fcb530d45d397a_I20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtMTQtMS0xLTA_5755cecf-9ee0-4171-ba3a-6c64fa5c9747"
      unitRef="usd">134000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b67d8b2f5e5423fab22a58594388040_I20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTEtMTYtMS0xLTA_1b5a7820-7149-4175-afeb-adddaf72b1f3"
      unitRef="usd">50497000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="id40604cb0c8742fc840c198c66ddfbfe_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTItOC0xLTEtMA_1782f3c8-61e0-4e45-90b7-f6cbc37b1d60"
      unitRef="usd">1364000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i02207236d5774c39981a6d0d117258bb_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTItMTItMS0xLTA_5ff9eff3-4d30-4358-a9a9-9282e4d08b3d"
      unitRef="usd">1364000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i27b99796b29e40eabeac0a12c20105e4_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTItMTQtMS0xLTA_32d688be-7c7a-49d9-9510-544788911db4"
      unitRef="usd">7000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTItMTYtMS0xLTA_a9c06ba4-580a-439d-b1d0-1ee4ee6d06a2"
      unitRef="usd">1371000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i91d0e9197fce4eaea0b4d58bb59f7b58_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTMtMTAtMS0xLTA_a18ef862-9435-4a7d-8c43-dbfb93e40f1c"
      unitRef="usd">-127000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i02207236d5774c39981a6d0d117258bb_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTMtMTItMS0xLTA_a800409b-07c7-43fe-9c60-d4c0f5af9cb7"
      unitRef="usd">-127000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i27b99796b29e40eabeac0a12c20105e4_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTMtMTQtMS0xLTA_41bae09b-c2a5-4fd4-a94d-7aa1eb9e9fae"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTMtMTYtMS0xLTA_478e0cd3-366f-489c-b67a-f5b8381f50e5"
      unitRef="usd">-127000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOmUyYTM5MTkxNDUwNDQ4MjlhZTg3OTA5OGI4NWY2ZWU1XzMx_bf759f07-88ae-4b35-b4bb-e21e66359a63"
      unitRef="usdPerShare">0.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="id40604cb0c8742fc840c198c66ddfbfe_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTQtOC0xLTEtMA_68010d73-95e8-499e-b38c-9c425b9828b5"
      unitRef="usd">723000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i02207236d5774c39981a6d0d117258bb_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTQtMTItMS0xLTA_85fa499e-8ed6-41df-a767-c341227d9817"
      unitRef="usd">723000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTQtMTYtMS0xLTA_9167d3a8-b628-4aee-a7db-ae95eef2bce0"
      unitRef="usd">723000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i9c4d81e283664aefab974994912b8be4_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTUtMi0xLTEtMA_1addbb87-1f0c-4ced-96a1-6ebd781cfd17"
      unitRef="shares">4000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i52c82d1243664ffb830c526ef6fcaf0b_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTUtNi0xLTEtMA_1994f06e-b51b-4ef7-a15f-530e3479da75"
      unitRef="usd">145000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i02207236d5774c39981a6d0d117258bb_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTUtMTItMS0xLTA_a0800171-2e2c-454d-a3b4-308589b4d4ea"
      unitRef="usd">145000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTUtMTYtMS0xLTA_0ebe0bff-bb8d-4726-85d1-ddeb124d8444"
      unitRef="usd">145000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i9c4d81e283664aefab974994912b8be4_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTYtMi0xLTEtMA_ce142405-64de-48a3-831b-b185e586ee79"
      unitRef="shares">5000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i52c82d1243664ffb830c526ef6fcaf0b_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTYtNi0xLTEtMA_c59bb31c-7b0f-472a-97dc-75dd2d9d684d"
      unitRef="usd">552000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i02207236d5774c39981a6d0d117258bb_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTYtMTItMS0xLTA_3f94b7d5-1450-418c-9518-593ab3dab117"
      unitRef="usd">552000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTYtMTYtMS0xLTA_63b8977f-80e0-438f-8a44-c6b42f299c8b"
      unitRef="usd">552000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i52c82d1243664ffb830c526ef6fcaf0b_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTctNi0xLTEtMA_125ab99a-9593-4c0a-ad47-ccfc0a23ba92"
      unitRef="usd">108000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i02207236d5774c39981a6d0d117258bb_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTctMTItMS0xLTA_cf7358cf-e5e1-4cbf-ac69-414cc05e1552"
      unitRef="usd">108000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTctMTYtMS0xLTA_b495cd79-1885-43c7-9f3d-35b175e9900e"
      unitRef="usd">108000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0ccab2a935344b5791bfcee3cae77ce7_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtMi0xLTEtMA_b6d34fda-2ce1-4525-8b74-aaff05122620"
      unitRef="shares">1340000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ccab2a935344b5791bfcee3cae77ce7_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtNC0xLTEtMA_e47792e2-fff6-428e-932d-2b3f16506d50"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i26eeffc415cf4e6b8336a920c96e512d_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtNi0xLTEtMA_9e37d97e-4a23-4797-9b24-1547d8cade95"
      unitRef="usd">26171000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a319d67f7224e6f8d72495027df5e84_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtOC0xLTEtMA_76212a53-a807-4f67-a313-bef1af21c1c4"
      unitRef="usd">27018000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36754839d63e4461b94b37c7bae9a3fb_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtMTAtMS0xLTA_a11d3bf5-7c0b-4762-8c2f-985444399bec"
      unitRef="usd">-2611000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i77e3bce30a1c435e86c5538940a335df_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtMTItMS0xLTA_9818852f-daec-4e6e-bf04-57f228ef4243"
      unitRef="usd">50578000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife38249405474a528870b8419d041fea_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtMTQtMS0xLTA_733ceb84-85ef-413e-9417-ea0030bbee88"
      unitRef="usd">141000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i20cd473a93b445c7a57a0c7284cf0cc7_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMjAtMTYtMS0xLTA_6ddcbc50-9f88-4327-9c34-f12caa9926e8"
      unitRef="usd">50719000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4484008ce40941a9abb0b87591c12b24_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNTgz_64fed4ed-ae93-4548-bd94-6c4d709d1c30"
      unitRef="usd">-33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMy0xLTEtMS0w_2632bbf6-91e8-46a4-8fa8-86c6b67aa9f3"
      unitRef="usd">985000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMy0zLTEtMS0w_2b3f4f8f-d3dc-4eb1-b1eb-906dc5ce1f16"
      unitRef="usd">2248000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNS0xLTEtMS0w_c5e6f70d-acc5-4a16-9608-9c647696b22b"
      unitRef="usd">1340000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNS0zLTEtMS0w_a30f0d78-f24d-4335-9be1-96d1c4f28a96"
      unitRef="usd">1328000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfOC0xLTEtMS0w_797ea586-ed34-4107-a0e7-0bc053324ed5"
      unitRef="usd">86000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfOC0zLTEtMS0w_e77611f7-b0a2-44da-b454-857bdb4ff072"
      unitRef="usd">44000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfOS0xLTEtMS0w_626c3252-e316-4b19-88d3-b0600122cb85"
      unitRef="usd">-69000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfOS0zLTEtMS0w_27e81f77-1eb0-4b2f-9eaf-7ae3228e3cf4"
      unitRef="usd">-245000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ShareBasedCompensation
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTAtMS0xLTEtMA_f5796d4f-1e85-4145-8413-228489d0f062"
      unitRef="usd">210000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTAtMy0xLTEtMA_ba567cde-b457-4421-a048-5efca6a1bbe2"
      unitRef="usd">169000000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTEtMS0xLTEtMA_cf610f66-2370-4adc-b501-0455848a117b"
      unitRef="usd">-308000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTEtMy0xLTEtMA_8e5deecf-e3fd-4f94-8dd0-73dc6e99189a"
      unitRef="usd">-406000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTQtMS0xLTEtMA_8d0af8d5-4996-4367-a953-4954497712ae"
      unitRef="usd">-112000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTQtMy0xLTEtMA_3fe895e0-91e8-47a1-8be5-5cc1c0cc7ede"
      unitRef="usd">-119000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTYtMS0xLTEtMA_a50fda8a-9236-4dec-949d-151d562a3671"
      unitRef="usd">669000000</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTYtMy0xLTEtMA_b1ffa010-4352-4fe5-ace9-d46c187c8ed2"
      unitRef="usd">-39000000</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTctMS0xLTEtMA_015673a8-9ecd-4091-9f3d-7048e8d01d01"
      unitRef="usd">145000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTctMy0xLTEtMA_138da5e0-1e2a-4171-9018-624e093b007e"
      unitRef="usd">267000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTgtMS0xLTEtMA_e0130b78-bb52-44f9-a83f-0ba5a757286c"
      unitRef="usd">108000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTgtMy0xLTEtMA_e193e977-c83e-4b41-aafe-6628eb335b00"
      unitRef="usd">-294000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTktMS0xLTEtMA_47e1a967-0240-4115-9bcb-6c3e4817ad50"
      unitRef="usd">127000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMTktMy0xLTEtMA_659e38cf-9a4e-4c76-974e-507220ee2070"
      unitRef="usd">170000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjItMS0xLTEtMA_49549270-bec4-4b5c-851a-990e8039de37"
      unitRef="usd">2139000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjItMy0xLTEtMA_b9344316-03d8-438a-beb0-89ed4fab3cb6"
      unitRef="usd">3377000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjQtMS0xLTEtMA_149b4d31-3cc2-42e3-88a5-26d3b4290286"
      unitRef="usd">370000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjQtMy0xLTEtMA_934b8517-1ddf-42fb-bf14-de493235f351"
      unitRef="usd">201000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjYtMS0xLTEtMA_e8fac6b5-f66a-4e5e-a5d9-3558d5a5f82a"
      unitRef="usd">615000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjYtMy0xLTEtMA_8325ad7a-f69e-4f0c-8432-f49b996c876f"
      unitRef="usd">584000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjctMS0xLTEtMA_e7e8cf7c-2c5a-45a2-8760-4621b4360f67"
      unitRef="usd">5360000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjctMy0xLTEtMA_627d23f8-1039-4ad5-915b-e637fe781c09"
      unitRef="usd">4226000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjgtMS0xLTEtMA_969a7188-3c2b-40c3-a563-2c567c49a4ab"
      unitRef="usd">4337000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjgtMy0xLTEtMA_8cce93b3-410d-4926-9124-152140508232"
      unitRef="usd">3260000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjktMS0xLTEtMA_9bd27bf2-d45e-4eb9-9a05-7325ad7201eb"
      unitRef="usd">4000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMjktMy0xLTEtMA_077c1316-78a0-4034-a65f-917be65c257e"
      unitRef="usd">16000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzAtMS0xLTEtMA_e2d2c07c-04f4-45b2-93fb-8011e93dc78f"
      unitRef="usd">-2012000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzAtMy0xLTEtMA_0e308dab-f403-475e-946a-a26cbe37568f"
      unitRef="usd">-1767000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzMtMS0xLTEtMA_4f68e498-56ce-43b1-8bf4-a2ce8f9538cd"
      unitRef="usd">-57000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzMtMy0xLTEtMA_f9d1f782-a31b-4b0f-81dd-a44f2451802d"
      unitRef="usd">42000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzUtMS0xLTEtMA_335eb9c2-194e-444a-931b-2fa2adb7080c"
      unitRef="usd">2789000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzUtMy0xLTEtMA_fa78e6ba-c3cb-4250-a606-cfcd5368626e"
      unitRef="usd">0</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzYtMS0xLTEtMA_929d19ac-f46b-45f4-8c86-8cb43fefc937"
      unitRef="usd">7172000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzYtMy0xLTEtMA_abbfbc7c-e4a2-448f-8b6a-04a6830a8e09"
      unitRef="usd">5568000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzctMS0xLTEtMA_68ec4bf9-8561-4f54-bf84-8246c81036cd"
      unitRef="usd">6336000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzctMy0xLTEtMA_17dfecc5-535e-4b80-9751-28016b758752"
      unitRef="usd">5594000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzgtMS0xLTEtMA_11190945-c1ca-43de-a8e0-a8bcb20ff5b2"
      unitRef="usd">1558000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzgtMy0xLTEtMA_fb815995-90b7-4121-866d-68888d7050a7"
      unitRef="usd">1447000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzktMS0xLTEtMA_e3f4ef9b-93a5-46fe-8c94-45414d1f9648"
      unitRef="usd">119000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfMzktMy0xLTEtMA_fff6c05d-d819-4954-b3f7-37776beb32b6"
      unitRef="usd">432000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDAtMS0xLTEtMA_b05ae6d7-ca53-4f82-9c36-c64e25ef735a"
      unitRef="usd">68000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDAtMy0xLTEtMA_d4cf7491-7ab1-4356-9c3d-6638822eb27c"
      unitRef="usd">962000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDEtMS0xLTEtMA_ce45f21a-7a1e-4423-89c9-fe09b17d5183"
      unitRef="usd">-70000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDEtMy0xLTEtMA_f6819217-fbfa-414d-81d5-da5d13df0875"
      unitRef="usd">-54000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDItMS0xLTEtMA_dca6968d-e9c4-40fc-a08c-a1e4e6ef4f67"
      unitRef="usd">1991000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDItMy0xLTEtMA_06fa043a-f561-4838-bce1-7a6bd39b3f46"
      unitRef="usd">-2015000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDMtMS0xLTEtMA_2bf03672-5dde-4910-a440-32af353f44da"
      unitRef="usd">162000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDMtMy0xLTEtMA_3b2571cb-a0c1-43bb-8ef4-d835ce6588d1"
      unitRef="usd">-26000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDQtMS0xLTEtMA_2870ad16-5ca9-414b-bf6b-14a85b733e73"
      unitRef="usd">2280000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDQtMy0xLTEtMA_d72456fc-7691-472d-b2fa-b9a0a3916191"
      unitRef="usd">-431000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDUtMS0xLTEtMA_efb46eb2-6063-4b5a-aca8-c145a8d79205"
      unitRef="usd">4140000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i33145a1d36f644e3a8066f41beb5b5e2_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDUtMy0xLTEtMA_6cca8aed-d423-48d6-b02b-c153d433c675"
      unitRef="usd">4393000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDYtMS0xLTEtMA_78ff43e6-aba9-479e-8a3e-0e439f011f43"
      unitRef="usd">6420000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i20cd473a93b445c7a57a0c7284cf0cc7_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNDYtMy0xLTEtMA_5aa34d8b-324a-4f89-9173-7878b8fc7d79"
      unitRef="usd">3962000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNTAtMS0xLTEtMA_5516603f-9c0b-4697-b8d6-3c5f9ead0c10"
      unitRef="usd">384000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNTAtMy0xLTEtMA_87085bf0-d95b-47a9-9946-eb036c901030"
      unitRef="usd">494000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNTEtMS0xLTEtMA_9204c26b-862f-4c71-ad88-c4a2e8221248"
      unitRef="usd">321000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zMS9mcmFnOjU1ZjcxYzhkNDkyZjQ3YWJhMzQ3NTc0Yjc2NzAxZjI5L3RhYmxlOjBhZjQ1ZmZjNmM3OTQ1MTNiZjlmMzhjYmYyZGU2MTdlL3RhYmxlcmFuZ2U6MGFmNDVmZmM2Yzc5NDUxM2JmOWYzOGNiZjJkZTYxN2VfNTEtMy0xLTEtMA_55229583-a001-4e17-9fdd-45b3793d071b"
      unitRef="usd">322000000</us-gaap:InterestPaidNet>
    <us-gaap:BasisOfAccounting
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zNy9mcmFnOmE1OWNlN2U2NmY0YzRkYTVhOWRjYWIzYmM4ODMwOTM5L3RleHRyZWdpb246YTU5Y2U3ZTY2ZjRjNGRhNWE5ZGNhYjNiYzg4MzA5MzlfMzE2MQ_d630d79d-7c0d-4ecd-b671-c4e60b1a416f">Basis of Presentation &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements of Medtronic plc and its subsidiaries (Medtronic plc, Medtronic, or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S.) (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the consolidated financial statements include all of the adjustments necessary for a fair statement in conformity with U.S. GAAP. Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Covid-19 pandemic ("COVID-19" or the "pandemic") has had, and may continue to have, an adverse effect on our business, results of operations, financial condition, and cash flows, and its future impacts remain highly uncertain and unpredictable. The Company has considered the disruptions caused by COVID-19, including lower sales and customer demand than the prior year in many businesses and macroeconomic factors, and has assessed the potential impact on certain accounting estimates including, but not limited to, the allowance for doubtful accounts, inventory reserves, return reserves, the valuation of goodwill, intangible assets, other long-lived assets, investments and contingent consideration, as of October 30, 2020 and through the date of this report. While there was not a material impact to the Company&#x2019;s consolidated financial statements as of and for the three and six months ended October 30, 2020, changes in the Company&#x2019;s assessment about the length and severity of the pandemic, as well as other factors, could result in actual results differing from estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements include the accounts of Medtronic plc, its wholly-owned subsidiaries, entities for which the Company has a controlling financial interest, and variable interest entities for which the Company is the primary beneficiary. Intercompany transactions and balances have been eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;The accompanying unaudited consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements of the Company and related notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended April&#160;24, 2020. The Company&#x2019;s fiscal years 2021, 2020, and 2019 will end or ended on April&#160;30, 2021, April&#160;24, 2020, and April&#160;26, 2019, respectively. Fiscal year 2021 is a 53-week year, with the extra week having occurred in the first fiscal month of the first quarter.</us-gaap:BasisOfAccounting>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zNy9mcmFnOmE1OWNlN2U2NmY0YzRkYTVhOWRjYWIzYmM4ODMwOTM5L3RleHRyZWdpb246YTU5Y2U3ZTY2ZjRjNGRhNWE5ZGNhYjNiYzg4MzA5MzlfMzE1OA_89379d6e-f067-4410-a6ab-e771b8bc3de3">The accompanying unaudited consolidated financial statements of Medtronic plc and its subsidiaries (Medtronic plc, Medtronic, or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S.) (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the consolidated financial statements include all of the adjustments necessary for a fair statement in conformity with U.S. GAAP. Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zNy9mcmFnOmE1OWNlN2U2NmY0YzRkYTVhOWRjYWIzYmM4ODMwOTM5L3RleHRyZWdpb246YTU5Y2U3ZTY2ZjRjNGRhNWE5ZGNhYjNiYzg4MzA5MzlfMzEzNg_d92acb95-2532-4ada-a4fd-1a83a42c0231">The accompanying unaudited consolidated financial statements include the accounts of Medtronic plc, its wholly-owned subsidiaries, entities for which the Company has a controlling financial interest, and variable interest entities for which the Company is the primary beneficiary. Intercompany transactions and balances have been eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:FiscalPeriod
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8zNy9mcmFnOmE1OWNlN2U2NmY0YzRkYTVhOWRjYWIzYmM4ODMwOTM5L3RleHRyZWdpb246YTU5Y2U3ZTY2ZjRjNGRhNWE5ZGNhYjNiYzg4MzA5MzlfMzE0OA_aef86e2b-8b1f-4ebd-a773-398711131f11">The Company&#x2019;s fiscal years 2021, 2020, and 2019 will end or ended on April&#160;30, 2021, April&#160;24, 2020, and April&#160;26, 2019, respectively. Fiscal year 2021 is a 53-week year, with the extra week having occurred in the first fiscal month of the first quarter.</us-gaap:FiscalPeriod>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80MC9mcmFnOmM1ZjRmYWFhZDc3ZDQ4OTE5NDZiMjdlZjUwYzI3MTNhL3RleHRyZWdpb246YzVmNGZhYWFkNzdkNDg5MTk0NmIyN2VmNTBjMjcxM2FfNzAx_e7a7ddf6-96f1-4925-849e-e5f1353c2c3b">New Accounting Pronouncements&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Current Expected Credit Losses&lt;/span&gt;&lt;/div&gt;In June 2016, the Financial Accounting Standards Board (FASB) issued guidance which changes the methodology to be used to measure credit losses for certain financial instruments and financial assets, including trade receivables. The new methodology requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset. The Company adopted this guidance using the modified retrospective method in the first quarter of fiscal year 2021. The adoption of this guidance did not have a material impact to the Company&#x2019;s consolidated financial statements.</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80MC9mcmFnOmM1ZjRmYWFhZDc3ZDQ4OTE5NDZiMjdlZjUwYzI3MTNhL3RleHRyZWdpb246YzVmNGZhYWFkNzdkNDg5MTk0NmIyN2VmNTBjMjcxM2FfNjky_ca3c4315-17a0-40e8-8b22-a9a1b185baa3">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Current Expected Credit Losses&lt;/span&gt;&lt;/div&gt;In June 2016, the Financial Accounting Standards Board (FASB) issued guidance which changes the methodology to be used to measure credit losses for certain financial instruments and financial assets, including trade receivables. The new methodology requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset. The Company adopted this guidance using the modified retrospective method in the first quarter of fiscal year 2021. The adoption of this guidance did not have a material impact to the Company&#x2019;s consolidated financial statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzkyMg_e1c8145c-517d-4b63-b144-db9b5bec8a2d">Revenue The Company's revenues are principally derived from device-based medical therapies and services related to cardiac rhythm disorders, cardiovascular disease, renal disease, neurological disorders and diseases, spinal conditions and musculoskeletal trauma, chronic pain, urological and digestive disorders, ear, nose, and throat conditions, and diabetes conditions as well as advanced and general surgical care products, respiratory and monitoring solutions, and neurological surgery technologies. The Company's primary customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations.  &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below illustrates net sales by segment and division for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm &amp;amp; Heart Failure&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Coronary &amp;amp; Structural Heart&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aortic, Peripheral, &amp;amp; Venous &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac &amp;amp; Vascular Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgical Innovations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Respiratory, Gastrointestinal, &amp;amp; Renal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Minimally Invasive Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cranial &amp;amp; Spinal Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restorative Therapies Group &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)   Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of fiscal year 2021, the Company realigned the divisions within the Restorative Therapies Group to the following: Cranial &amp;amp; Spinal Technologies (includes Core Spine and Biologics, Enabling Technologies, and China Orthopedics), Specialty Therapies (includes ENT, Pelvic Health, and Neurovascular), and Neuromodulation (includes Pain Therapies, Brain Modulation, and Interventional). As a result, net sales for fiscal year 2020 have been recast to adjust for this realignment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below illustrates net sales by market geography for each segment for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S. Developed Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac &amp;amp; Vascular Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Minimally Invasive Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restorative Therapies Group &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S. Developed Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac &amp;amp; Vascular Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Minimally Invasive Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restorative Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;U.S. includes the United States and U.S. territories.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of revenue recognized is reduced by sales rebates and returns. Adjustments to rebates and returns reserves are recorded as increases or decreases to revenue. At October&#160;30, 2020, $955 million of rebates were classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$464 million of rebates were classified as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;accounts receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated balance sheet. At April&#160;24, 2020, $706 million of rebates were classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other accrued expenses, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $321 million of rebates were classified as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;accounts receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated balance sheet. For the three and six months ended October&#160;30, 2020 and October&#160;25, 2019, adjustments to rebate and return reserves recognized in revenue that were included in the rebate and return reserves at the beginning of the period were not material. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deferred Revenue and Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records a deferred revenue liability if a customer pays consideration, or the Company has the right to invoice, before the Company transfers a good or service to the customer. Deferred revenue at October&#160;30, 2020 and April&#160;24, 2020 was $317 million and $303 million, respectively. At October&#160;30, 2020 and April&#160;24, 2020, $225 million and $213 million, respectively, was included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $92 million and $90&#160;million, respectively, was included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. During the six months ended October&#160;30, 2020, the Company recognized $162&#160;million of revenue that was included in deferred revenue as of April&#160;24, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remaining performance obligations include deferred revenue and amounts the Company expects to receive for goods and services that have not yet been delivered or provided under existing, noncancellable contracts with minimum purchase commitments. At October&#160;30, 2020, the estimated revenue expected to be recognized in future periods related to unsatisfied performance obligations for executed contracts with an original duration of one year or more was approximately $1.1 billion. The Company expects to recognize revenue on the majority of these remaining performance obligations over the next four years.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzkyNw_8ddb5457-179a-4ee1-8f90-87f7ae5bb6be">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below illustrates net sales by segment and division for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm &amp;amp; Heart Failure&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Coronary &amp;amp; Structural Heart&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aortic, Peripheral, &amp;amp; Venous &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac &amp;amp; Vascular Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgical Innovations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Respiratory, Gastrointestinal, &amp;amp; Renal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Minimally Invasive Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cranial &amp;amp; Spinal Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restorative Therapies Group &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)   Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of fiscal year 2021, the Company realigned the divisions within the Restorative Therapies Group to the following: Cranial &amp;amp; Spinal Technologies (includes Core Spine and Biologics, Enabling Technologies, and China Orthopedics), Specialty Therapies (includes ENT, Pelvic Health, and Neurovascular), and Neuromodulation (includes Pain Therapies, Brain Modulation, and Interventional). As a result, net sales for fiscal year 2020 have been recast to adjust for this realignment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below illustrates net sales by market geography for each segment for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S. Developed Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac &amp;amp; Vascular Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Minimally Invasive Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restorative Therapies Group &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S. Developed Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac &amp;amp; Vascular Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Minimally Invasive Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restorative Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;U.S. includes the United States and U.S. territories.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.&lt;/span&gt;&lt;/div&gt;(4)Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum.</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06dc9f6bc4aa419bbfe27b17af09fe0a_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMi0xLTEtMS0w_e15a2c16-5828-4593-8ff4-cb44e8aec8fb"
      unitRef="usd">1426000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i269fa9ffafa24ecebf48c60b39842dab_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMi0zLTEtMS0w_849a36ee-1c70-46dc-abbd-cd6f371ded75"
      unitRef="usd">1426000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91fb2eb368934993bcd7a0f9575fa788_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMi01LTEtMS05Nzk_391653f1-7112-421a-a811-25710b1dfd46"
      unitRef="usd">2673000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacc575534b9240399501f15b894e067a_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMi03LTEtMS05Nzk_10e15d50-c89a-4b82-ad5c-72042d53c483"
      unitRef="usd">2807000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i487ad5972a2c47febec797b0e0776ddb_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMy0xLTEtMS0w_54580fb0-41ba-48a0-a659-c782371fe1c7"
      unitRef="usd">831000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b5caf67e2be4f68ad7f92d16ada67f7_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMy0zLTEtMS0w_999a82a9-b640-43bd-b3cc-ec3a99dec2f3"
      unitRef="usd">955000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i919fa29680244ba4b8253a93aa18f460_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMy01LTEtMS05Nzk_bcebe9fc-c7ad-4eff-a8d9-2e014733661b"
      unitRef="usd">1611000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia64dace9b6414c26928f6b70651158e4_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMy03LTEtMS05Nzk_62ae519c-1e78-4d29-89a9-00a78ab4af46"
      unitRef="usd">1896000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id24613977cb54f098d9805b207b29a55_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNC0xLTEtMS0w_0212b8fa-2b5f-4e77-919c-3644e0a8c12e"
      unitRef="usd">468000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i220395ee33ee437396566fcc3626b2a2_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNC0zLTEtMS0w_cde55e4f-be29-468e-979a-45330c24a7e3"
      unitRef="usd">474000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic09f65a4d2d84a4c92acaac75a0e15d9_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNC01LTEtMS05Nzk_9d7fc28c-152c-4020-b420-36e6fc2947a5"
      unitRef="usd">873000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c9f4935fea44124bf3d4a1a49aa9040_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNC03LTEtMS05Nzk_1f8eeacf-8a2e-497d-821c-0db9108387c4"
      unitRef="usd">942000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a312d23d83d4502a1392fed0d7ba764_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNS0xLTEtMS0w_cb2f123f-248e-4023-b76d-2f6f2e4956f3"
      unitRef="usd">2725000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3b239a3126a4bb49c5e7d5b60ab13f1_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNS0zLTEtMS0w_a7076fd3-e5bb-47b4-bd16-5b9c22236c3e"
      unitRef="usd">2855000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ca6f74752024dcb8dbf523283f9b0ef_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNS01LTEtMS05Nzk_6316894d-5392-4306-84fb-898fa8b10346"
      unitRef="usd">5158000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i05fc22c6d55b43f2baae1649a5d9aebe_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNS03LTEtMS05Nzk_7c4c7556-520f-4d79-bbd9-2d31765aee2f"
      unitRef="usd">5645000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id48f0ff947294dd49ff34d19b294e672_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNi0xLTEtMS0w_a47e0cda-40d7-42d2-9224-a4a990f9222d"
      unitRef="usd">1393000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60c6177e6a344d759591f1b0f76cb5ba_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNi0zLTEtMS0w_8d102cc1-9014-4f50-9db5-eb2b49577f94"
      unitRef="usd">1454000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic752b9473c764500acd5730cdefe3be4_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNi01LTEtMS05Nzk_92932ddf-e1b9-4d6c-9e2c-a85961e3a2ef"
      unitRef="usd">2473000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bb60e8143094d27a9a05d4c84ead362_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNi03LTEtMS05Nzk_8ae2f8c3-e79b-41ec-b89c-5cd6a6b30221"
      unitRef="usd">2871000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id131618c7183472b800356aed3d45c7c_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNy0xLTEtMS0w_e7b3b995-293e-4508-be24-4091cb7a69fb"
      unitRef="usd">893000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83ca6860129f4055bed2c98b4ce69e3e_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNy0zLTEtMS0w_a15659cf-bc54-47fc-be1d-33322e824750"
      unitRef="usd">688000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4e72a8a6dab4f788a302f0f0cf79096_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNy01LTEtMS05Nzk_e2d26444-4716-4cb9-8fc2-29ccbc0816a2"
      unitRef="usd">1613000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bd062672d454f1e8a9d5bb8d4322a32_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfNy03LTEtMS05Nzk_727176f0-f312-4fc3-9adc-2e35b7f6fdbb"
      unitRef="usd">1371000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b3758a87a354529882de9d3335644c0_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOC0xLTEtMS0w_61ec105e-20d2-4673-8ce3-c3a79dfd97d6"
      unitRef="usd">2285000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70d63caefd6b48e69f2a86e37189768c_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOC0zLTEtMS0w_56d864b2-e2e1-4fc5-9c39-6c4f011d7026"
      unitRef="usd">2142000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieac0a2b04a964cccb353c56583b8d073_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOC01LTEtMS05Nzk_6eb9e1be-caa5-436f-a1fc-d24195c418a3"
      unitRef="usd">4086000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71d43d788d014fd7a1ba8bdea4691710_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOC03LTEtMS05Nzk_a8eda7c2-05a2-4bde-89ae-dcd172e22f74"
      unitRef="usd">4242000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide47cbfb7b0b4342bf4ea373f2ce909a_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOS0xLTEtMS0w_c10116d5-e1e7-4baf-8fee-811a96a18357"
      unitRef="usd">1071000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief0f6318a0b04247be6884fe9e17d5b1_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOS0zLTEtMS0w_a8669b17-fc74-4a74-9555-70fbd33fff2a"
      unitRef="usd">1117000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb0ec325078447fab69eeca2bdca138e_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOS01LTEtMS05Nzk_fe2502e9-0eaf-4e47-8eef-0b35deee30eb"
      unitRef="usd">2015000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d27cd3056dc4459a2cc70f6dc711dff_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfOS03LTEtMS05Nzk_936d15b5-6b70-4f4a-bf6f-25d3664e6877"
      unitRef="usd">2167000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82f5d914dd8d4e04b7d2a35e01bb9bf3_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTAtMS0xLTEtMA_8dc74ef4-e572-4118-be04-b280944db0e8"
      unitRef="usd">581000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i313d0d047bd048469aa9949a611758d3_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTAtMy0xLTEtMA_0379a826-a514-4f97-9e1d-16bd12161fec"
      unitRef="usd">575000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fc4e1b636e5420f8ac12b6b27b04d28_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTAtNS0xLTEtOTc5_e768ddf5-f935-4c6e-99e0-e9bce1b7f98e"
      unitRef="usd">1035000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6dccdf4f50614d0e9c893b4f40f55384_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTAtNy0xLTEtOTc5_a84c462e-6eec-4beb-813a-bdb25149ec70"
      unitRef="usd">1138000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9d5d26f5da740a198a88bb8f7973c42_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTEtMS0xLTEtMA_4cf10c62-cd6e-4ae4-befe-395166379045"
      unitRef="usd">411000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if53fca09d7ef4b848279a7fe2579e3d8_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTEtMy0xLTEtMA_441bd2d8-6f2f-4396-bd35-0006921bd448"
      unitRef="usd">420000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4524b53e676148ca86cbcc0f07a84bb3_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTEtNS0xLTEtOTc5_85edf310-4674-491f-8f40-1cd5529b6ab7"
      unitRef="usd">725000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93119b416ab149a386216f786e016df5_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTEtNy0xLTEtOTc5_68fa385e-a44a-4981-a1a7-1879715e6d06"
      unitRef="usd">818000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec22bedaccaa44e19dc9acca8eff8a10_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTItMS0xLTEtMA_65edabf6-cced-4e70-beb4-67e630b5932e"
      unitRef="usd">2063000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4600b695100d4820a01604a104cbadaf_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTItMy0xLTEtMA_4b23160e-2ffc-4747-b984-9a72a91126dd"
      unitRef="usd">2112000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79d7d6e72a3d4a20b5a5c636e920c38c_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTItNS0xLTEtOTc5_478cbd2d-1189-486e-936b-41e8e2439066"
      unitRef="usd">3774000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15f5b5dfb4654786b8a1527a73a00fcd_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTItNy0xLTEtOTc5_474121cc-c584-4400-96b7-f3afd3a373bc"
      unitRef="usd">4124000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0be4b9113414c3d997bc3e01adfe216_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTMtMS0xLTEtMA_5877545b-d54a-4b34-b713-ca55262514ef"
      unitRef="usd">574000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cf2e96e50c04872a16be9a18ec034d0_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTMtMy0xLTEtMA_2c63e6e0-6e13-484e-964d-e78ddb930c96"
      unitRef="usd">596000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i374e41da3175425682886e64b4e59ac7_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTMtNS0xLTEtOTc5_c42f349e-ebcb-4256-8599-986f4be51091"
      unitRef="usd">1136000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i852dbc45d1014705a3144b798acc4dfa_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTMtNy0xLTEtOTc5_85c8da33-e035-4293-9da2-91b50b0896e9"
      unitRef="usd">1188000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTQtMS0xLTEtMA_ecc134e9-39b3-4ee4-9793-49327fdef0cc"
      unitRef="usd">7647000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTQtMy0xLTEtMA_821f536a-32b2-4b48-9a93-a34fd1660b88"
      unitRef="usd">7706000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTQtNS0xLTEtOTc5_6d472cbb-489d-46ac-8ee9-baf7a7799ab6"
      unitRef="usd">14154000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjM1Y2JkZTk1ODY3ZjQyZWFiYTY5ZTI0YTRhZmRlYmM1L3RhYmxlcmFuZ2U6MzVjYmRlOTU4NjdmNDJlYWJhNjllMjRhNGFmZGViYzVfMTQtNy0xLTEtOTc5_16d059d7-3f1b-4eb6-a9be-bec278802715"
      unitRef="usd">15199000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbacdf5a92134ca0b1da1422f776402f_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMy0xLTEtMS0w_26b8721f-8db2-47bd-83e9-72e224975a5e"
      unitRef="usd">1377000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4524b8f3efaf418c873e6e495a80bbc3_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMy0zLTEtMS0w_f72b1ee9-2ca1-415c-92a3-533417014b05"
      unitRef="usd">1455000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35f7007d83ec443f927267bb6df4c0fc_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMy01LTEtMS0w_5b3facf1-748a-412a-aa8d-f1c1fb44a503"
      unitRef="usd">945000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i537a942bf4fb4b6eb80e288f1c249edb_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMy03LTEtMS0w_9d90d91c-e721-4538-a440-0df9af1fdf41"
      unitRef="usd">890000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f8e3cc16c4a404488402b32b4689b44_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMy05LTEtMS0w_7b3dd1b2-0d6f-4908-88cf-728ea0574e41"
      unitRef="usd">404000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaaf5d087ffa84fa8abd5a5aa306fda7a_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMy0xMS0xLTEtMA_ddeb2be4-d69e-43eb-8c5c-858ca4b3327b"
      unitRef="usd">510000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b6321183ca146979a393ac5b3ac26a5_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNC0xLTEtMS0w_3e57f663-7c06-4b45-ba32-278a50babf5e"
      unitRef="usd">996000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7031548bb00d44e4984fe848fdd877ac_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNC0zLTEtMS0w_8954b547-6ed4-40dd-8ebd-b9c0ce4b8005"
      unitRef="usd">922000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i95113ab22bfc47679021038cda3626d5_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNC01LTEtMS0w_64c07e4c-b70a-42db-91a0-ed11d02f3838"
      unitRef="usd">837000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide26e733fd264ebeac15b9b238bd8cb1_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNC03LTEtMS0w_ebc05eb3-3e51-4329-b1fc-e624313cd246"
      unitRef="usd">782000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1024da8bb25a4ecab9fdd229633f9fef_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNC05LTEtMS0w_ffbc1cfb-c7bc-4f13-9f76-21f637aa86c4"
      unitRef="usd">452000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82224f56dda849528eedfeb6a2648d87_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNC0xMS0xLTEtMA_f3d3f540-56d1-40ff-82ad-c94ea6505851"
      unitRef="usd">438000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc5dc04ed0d044db9fb861aa2555e5b6_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNS0xLTEtMS0w_f4dbb069-0647-43b4-bc52-c69a2e947d72"
      unitRef="usd">1397000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc7c7a1e02fe46c59155bfc029734bd7_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNS0zLTEtMS0w_4977ccce-b47b-411e-b6b2-059cfb64cc20"
      unitRef="usd">1440000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia6cce28fd6194e2c961aede987941a6c_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNS01LTEtMS0w_5da8abb5-5aa7-4fab-b9bd-087422fc0cbc"
      unitRef="usd">426000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iafacc4a2c7db427383b4b9439b78bf84_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNS03LTEtMS0w_039e8ed0-f6a9-410a-9ac4-f3966dbc509a"
      unitRef="usd">416000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia6948db30839464bb1b8614f17820d69_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNS05LTEtMS0w_1b00f763-bf90-424e-b2ca-c14698c7ae47"
      unitRef="usd">240000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2db71be890924f94a20e986c13b7cfd0_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNS0xMS0xLTEtMA_96fcd02f-e706-4889-8cd8-34a0f342c185"
      unitRef="usd">256000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icba853bd219340caac53ef75115336f3_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNi0xLTEtMS0w_dd6d97e1-73fd-4910-9303-f9ba93608d89"
      unitRef="usd">284000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d1f7d1f952b46de9a5ec5bf956f8c4a_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNi0zLTEtMS0w_cd32f438-077d-4531-9ca3-44cbc788c283"
      unitRef="usd">311000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3a781a1a3014264be590e09689a0392_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNi01LTEtMS0w_c4703d8f-51c8-400d-bbbd-e93eadd7228e"
      unitRef="usd">238000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ad14b6e2d99494ca8b0e3e32a58c09a_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNi03LTEtMS0w_21fb723c-1582-46ca-b810-15c87f86b763"
      unitRef="usd">226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i481e2bb36b4f4ad58fcf6c68706875aa_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNi05LTEtMS0w_611b81e3-6345-4337-bb57-732352dcf8f7"
      unitRef="usd">51000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if569aa4c250e4165a6f2453aded60f03_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNi0xMS0xLTEtMA_5e20aef0-9221-4322-b208-e498850c7324"
      unitRef="usd">59000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e59a2f196984183a973f8905eda8c10_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNy0xLTEtMS0w_bc56d19d-2667-45ab-9334-4870e29dad22"
      unitRef="usd">4054000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc31344ce037435086c6584f0cbc5603_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNy0zLTEtMS0w_58e05f28-adc7-4fc0-beba-4098accc095a"
      unitRef="usd">4129000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c0b9d71f9af4be0bdef0b12e789d63a_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNy01LTEtMS0w_c312a577-3ec9-480e-9b81-c03345e65a1d"
      unitRef="usd">2446000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7976d05e19ea43479f40263835baa0f6_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNy03LTEtMS0w_4f7b6724-80e5-496d-996c-53f70ddbf698"
      unitRef="usd">2315000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief279681dad24d0ab1a402ba5b0534d8_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNy05LTEtMS0w_fe4193a2-8c3a-4b0b-9b73-250d3969ce00"
      unitRef="usd">1147000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61edff06ccbe49e0923a8285fc14b9d8_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfNy0xMS0xLTEtMA_f23fdd88-c28a-48d4-b267-ff987c2586c1"
      unitRef="usd">1262000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe51a58c91ff4d568cfa875dc418aa53_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTItMS0xLTEtNzY1Mw_e5cd9f35-b22e-471e-a9ef-5280283d1241"
      unitRef="usd">2582000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id82317500d8042669bd53b4daa560b23_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTItMy0xLTEtNzY1Mw_a9e4ac20-d3f5-4ba2-9dc0-fe6387ea4165"
      unitRef="usd">2816000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a2cb34fbe86434d9d2e4abed35fa190_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTItNS0xLTEtNzY1Nw_3a7db808-596e-4045-9452-063c4fc4b9fa"
      unitRef="usd">1798000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9bd82a0a27841599fc9f6054adf2db0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTItNy0xLTEtNzY1Nw_de7018ce-03fa-43e4-aa01-b22ebd5683e2"
      unitRef="usd">1820000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if3c0e6b71596419bbee4ef75a287dfb0_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTItOS0xLTEtNzY2MQ_ad0ec405-b064-4d50-a2ff-482c75008ca8"
      unitRef="usd">778000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2589b11b8c8b419f90d2110eedd22e72_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTItMTEtMS0xLTc2NjE_7c53b771-95b5-4c32-9edf-a28f7f8e56b3"
      unitRef="usd">1009000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0943ccf01b541bd8b688fa0231ab07d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTMtMS0xLTEtNzY1Mw_798343b5-a15d-4a85-9607-d8bfff0fd145"
      unitRef="usd">1718000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i857871df90664c4ea9084d7f52e58287_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTMtMy0xLTEtNzY1Mw_21bbbb15-e8dd-4154-a287-ba2e01aefc00"
      unitRef="usd">1835000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad390d4335a84981b4dbe016e84fec16_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTMtNS0xLTEtNzY1Nw_377dcdfa-a6f8-4d28-bb8d-d760bee34500"
      unitRef="usd">1556000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i221826c350e8440fa29609ad85dbfe00_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTMtNy0xLTEtNzY1Nw_69e02c83-6ac2-40bf-b8f4-d5f300aebe97"
      unitRef="usd">1573000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87f2d291a1d14c8da1ca068a8184f596_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTMtOS0xLTEtNzY2MQ_fe7a26f6-cda6-445d-9ed5-1cd77a63577f"
      unitRef="usd">811000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d18cd69e527443cbb52344bfc5d1d17_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTMtMTEtMS0xLTc2NjE_529c7f55-34e9-458c-b10c-12ad3379bb15"
      unitRef="usd">834000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0def346fe6e84c4fa17ebb19cef19a26_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTQtMS0xLTEtNzY1Mw_a0c248c8-ce94-4f71-b57a-fd2abad9e7da"
      unitRef="usd">2533000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3bfd6d86b3b4f0fb2300c2d7f9d363f_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTQtMy0xLTEtNzY1Mw_129b782e-5e09-4c01-b828-4f5e28b57215"
      unitRef="usd">2778000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23af05bd2c5d45359d3998fa371a34ae_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTQtNS0xLTEtNzY1Nw_3be830a6-4f21-4c20-8d95-32c4017e6497"
      unitRef="usd">802000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idaf607ee11904bcd9cf888c004bb4fb5_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTQtNy0xLTEtNzY1Nw_47d6a073-492c-4be8-a446-f78e56febf03"
      unitRef="usd">842000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9ae29ca0bdc4f73936473ec74e2520d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTQtOS0xLTEtNzY2MQ_3b3ea53a-4ca5-434d-b6af-0fc248a3fa7b"
      unitRef="usd">439000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91fc95de785c40258c208144bffa2343_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTQtMTEtMS0xLTc2NjE_e65058f2-fc83-4125-8922-7411bd5aa20d"
      unitRef="usd">504000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id5940248053940f3ad40aa0896988543_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTUtMS0xLTEtNzY1Mw_6d5a3cb4-8ac4-44c9-af9a-31b292d550f2"
      unitRef="usd">572000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i359b10ddf4d64149867a3e367a9b382a_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTUtMy0xLTEtNzY1Mw_20036d18-1462-4634-b007-96825ba078a3"
      unitRef="usd">618000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i086f2718cdec44d5b96ebdb32ebdbe23_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTUtNS0xLTEtNzY1Nw_31d9084a-0b76-4a25-aa4d-496130073141"
      unitRef="usd">465000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i156b9ba3ff10454382c5d0aebee43dcf_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTUtNy0xLTEtNzY1Nw_37aab9fb-75c6-4b14-8ff2-bb8c9b54b994"
      unitRef="usd">457000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45d51c0af50d408484ec761c3c800e8c_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTUtOS0xLTEtNzY2MQ_befd9968-3f7e-4d06-ba3b-2ea5371208e0"
      unitRef="usd">100000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i706ca6327a9945bea2a852ef2e7fc4fb_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTUtMTEtMS0xLTc2NjE_526137a8-2bf6-4c2d-be75-63b12ddf356b"
      unitRef="usd">113000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i650829f108154ef79219df52ed0dd76e_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTYtMS0xLTEtNzY1Mw_cf0f07fa-816a-438f-9501-5309804a7103"
      unitRef="usd">7405000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e309488f2d44b4f90cf8c46966b9320_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTYtMy0xLTEtNzY1Mw_f1156549-9b30-46f6-b418-0fa99f09d1d0"
      unitRef="usd">8046000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0c73c0c36c949138a78ac8a9b55a7ea_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTYtNS0xLTEtNzY1Nw_fef30e3c-ca9d-4ad7-a510-3f58eca7adf8"
      unitRef="usd">4621000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c94a76a97fb4905b120a4bc756ade5b_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTYtNy0xLTEtNzY1Nw_c0bb569a-06d8-4bf4-9d8d-96541235662d"
      unitRef="usd">4692000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3cb21b8ecb894dc6b9eb7b6003425d7b_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTYtOS0xLTEtNzY2MQ_7c63b9d3-f4ca-4192-8715-aab802090554"
      unitRef="usd">2128000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15270ce2423347719255bea4dd215ab4_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RhYmxlOjlkNTM5NGQzMzhjODRjMTI5ZTgxZjQ3MTI3MDI1Y2FkL3RhYmxlcmFuZ2U6OWQ1Mzk0ZDMzOGM4NGMxMjllODFmNDcxMjcwMjVjYWRfMTYtMTEtMS0xLTc2NjE_97ec1ee2-b798-4661-9787-34c58b886db5"
      unitRef="usd">2460000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="i0ff95eb833ec4ac8a94740b1dc4672ec_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMjE2OQ_ec9027a3-4248-4297-bcea-a3562555632e"
      unitRef="usd">955000000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="i201f7a25b37d4a639737b126db6b299c_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMjIyOQ_cc4b2f1b-2aa1-4ed1-a4f0-1dfe16483658"
      unitRef="usd">464000000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="ief6cc83a0158450c8c8c8dfb1b72cb01_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMjMzOQ_7b585870-d1c5-4485-acab-cf001cfd8e14"
      unitRef="usd">706000000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="ia759ed90b92c4979a7b3cae67b7f74fa_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMjM5OQ_eb741bbb-108f-484b-bc86-05eabfa812c7"
      unitRef="usd">321000000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMjk2OQ_515ddb56-e76b-4008-ba65-a4d675b1655e"
      unitRef="usd">317000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMjk3Ng_31a99ea4-2b5f-4934-99a9-c568ab0220a1"
      unitRef="usd">303000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i0ff95eb833ec4ac8a94740b1dc4672ec_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzAwOA_62e2f411-d628-463d-b1e0-5693f2b366c0"
      unitRef="usd">225000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ief6cc83a0158450c8c8c8dfb1b72cb01_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzAxNQ_b9c25c57-2a9f-4486-866c-0e5db7800d89"
      unitRef="usd">213000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i27dc3723a0be438391652135f2101c29_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzA3Ng_4dfc74a2-ff11-4053-a956-da284f307bce"
      unitRef="usd">92000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i3302135c65a2484782311fd82ec693dd_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfNDM5ODA0NjUxNTk2NA_2c179419-5503-4566-a229-170705b401f2"
      unitRef="usd">90000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfNzY5NjU4MTM5ODg5NQ_63c06629-096b-4990-bca8-ea8ea36fc892"
      unitRef="usd">162000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzgwMg_01a3df62-c118-4200-a2c1-6453a6a1de9b"
      unitRef="usd">1100000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenuePerformanceObligationDescriptionOfTiming
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80My9mcmFnOmIxNmI2NTdiMGY4MjRlOGI4YmZlMTE4NGYxYmQ1OTk0L3RleHRyZWdpb246YjE2YjY1N2IwZjgyNGU4YjhiZmUxMTg0ZjFiZDU5OTRfMzkyMA_bcbffc6c-ef2b-4c8c-ada8-5ca89ef92f92">four years</us-gaap:RevenuePerformanceObligationDescriptionOfTiming>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfNTAxOA_fe8f8c89-fc14-47f6-9844-bb34e4123bfd">AcquisitionsThe Company had acquisitions during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 that were accounted for as business combinations. The assets and liabilities of the businesses acquired were recorded and consolidated on the acquisition date at their respective fair values. Goodwill resulting from business combinations is largely attributable to future yet to be defined technologies, new customer relationships, existing workforce of the acquired businesses, and synergies expected to arise after the Company's acquisition of these businesses. The pro forma impact of these acquisitions was not significant, either individually or in the aggregate, to the consolidated results of the Company for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019. The results of operations of acquired businesses have been included in the Company's consolidated statements of income since the date each business was acquired.&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fiscal Year 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair value of net assets acquired during the six months ended October&#160;30, 2020 was $539&#160;million, consisting of $577&#160;million of assets acquired and $38&#160;million of liabilities assumed. Based upon preliminary valuations, assets acquired were primarily comprised of $156 million of technology-based intangible assets and $13 million of customer-related intangible assets with estimated useful lives ranging from 8 to 15 years and $381&#160;million of goodwill. The goodwill is not deductible for tax purposes. The Company recognized $158&#160;million of contingent consideration liabilities in connection with business combinations during the six months ended October&#160;30, 2020, which are comprised of revenue and product development milestone-based payments. Additionally, during the six months ended October&#160;30, 2020, the Company recognized a gain of $132 million related to a change in amounts accrued for certain contingent liabilities from a recent acquisition. The benefit was recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other operating expense, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated statements of income as the purchase accounting was finalized in fiscal year 2020. For the three and six months ended October&#160;30, 2020, purchase price allocation adjustments were not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fiscal Year 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair value of net assets acquired during the six months ended October&#160;25, 2019 was $272 million, consisting of $324 million of assets acquired and $52 million of liabilities assumed. Assets acquired were primarily comprised of $139 million of technology-based intangible assets and $26 million of customer-related intangible assets with estimated useful lives ranging from 8 to 16 years, $40 million of inventory, and $92 million of goodwill. The goodwill is not deductible for tax purposes. The Company recognized $65&#160;million of contingent consideration liabilities in connection with business combinations during the six months ended October&#160;25, 2019, which are comprised of revenue milestone-based payments. For the three and six months ended October&#160;25, 2019, purchase price allocation adjustments were not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s business combinations involve potential payment of future consideration that is contingent upon the achievement of certain product development milestones and/or contingent on the acquired business reaching certain performance milestones. A liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is remeasured at each reporting period, and the change in fair value is recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other operating expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income. Contingent consideration payments made soon after the acquisition date are classified as investing activities in the consolidated statements of cash flows. Contingent consideration payments not made soon after the acquisition date that are related to the acquisition date fair value are reported as financing activities in the consolidated statements of cash flows, and amounts paid in excess of the original acquisition date fair value are reported as operating activities in the consolidated statements of cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of contingent consideration at October&#160;30, 2020 and April&#160;24, 2020 was $461 million and $280 million,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;respectively. At October&#160;30, 2020, $342 million was recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and $119 million was recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated balance sheets. At April&#160;24, 2020, $112 million was recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and $168 million was recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balances of contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of contingent consideration is measured using projected payment dates, discount rates, probabilities of payment, and projected revenues (for revenue-based consideration). Projected revenues are based on the Company's most recent internal operational budgets and long-range strategic plans. Changes in projected payment dates, discount rates, probabilities of payment, and projected revenues may result in adjustments to the fair value measurement. The recurring Level 3 fair value measurements of contingent consideration for which a liability is recorded include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;14.0% - 32.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;20.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Revenue and other performance-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;$203&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;40% - 100%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;99.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Projected fiscal year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;2021 - 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;5.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;5.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Product development and other milestone-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;$258&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;50% - 100%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;93.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Projected fiscal year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;2021 - 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)   Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected fiscal year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ia659fbb5fcf346a9a90200d57a4a5578_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTExMw_bbc5f3a9-1121-4b9a-9e20-b6c009486c4f"
      unitRef="usd">539000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <mdt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill
      contextRef="ia659fbb5fcf346a9a90200d57a4a5578_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTE0MQ_4fdf843c-6f2d-4b46-9766-b6643600a246"
      unitRef="usd">577000000</mdt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ia659fbb5fcf346a9a90200d57a4a5578_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTE3Mw_e80bc8e5-0099-4cf1-92f7-344fce904521"
      unitRef="usd">38000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i5b0455f24d0b4a3791fb3fd9fc1efc9a_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTI2OQ_89b87845-317f-4f06-b88e-d7bc29eba4fb"
      unitRef="usd">156000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i5259c4355fa34167856c9efd29463eab_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTMyMA_1669e0b8-e35d-4471-85a1-7e24ebcb7dc6"
      unitRef="usd">13000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie996b89b72df4251ba0beb6f36061915_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTQzNA_0f6d4e1f-108e-4add-b011-bdabd0dd2be8">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i286b913f59ce44a89a6efc03a44edd01_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTQzNA_ec96a79a-1796-4423-aa6d-d057985fbb78">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i58932d951c2a4621825726d182be8121_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTQ0Mw_20395367-6760-4ce7-bc08-410734f72dc9">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i894a513621284324b46eb9a6b6583b3b_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTQ0Mw_a29615ee-8849-4a91-a51c-1301a1b3cee4">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:Goodwill
      contextRef="ia659fbb5fcf346a9a90200d57a4a5578_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3OTQ4NQ_8f605755-43c5-42d3-83fe-4fb8926a68d2"
      unitRef="usd">381000000</us-gaap:Goodwill>
    <mdt:BusinessAcquisitionPurchasePriceContingentConsideration
      contextRef="i3f58e96a62054a76beef660302748e4f_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfNDM5ODA0NjUyMzIwOQ_1e9ee0f5-68fb-414a-ba28-63189d381e06"
      unitRef="usd">158000000</mdt:BusinessAcquisitionPurchasePriceContingentConsideration>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjEx_856e44d9-9829-48e6-80ca-dcdd0163967e"
      unitRef="usd">132000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjEx_a9297bfa-24b7-4272-afa0-c9a2f1409177"
      unitRef="usd">132000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i6458efd12f3d493e954c2b482e7b1267_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODM3Nw_e46dda5c-5d42-4118-871c-b5b128eb67a4"
      unitRef="usd">272000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <mdt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill
      contextRef="i6458efd12f3d493e954c2b482e7b1267_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODM4Mw_872830c4-3e73-4dd2-8351-7b72de264ec8"
      unitRef="usd">324000000</mdt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i6458efd12f3d493e954c2b482e7b1267_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODM5Mw_e5556857-4ef3-4298-8766-95ecfb89c412"
      unitRef="usd">52000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ied47c882b8944b9a824975e730d6084c_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODM5OQ_16c76491-4339-4bd4-a7cd-ec0e8bca8797"
      unitRef="usd">139000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7f89188c42c54dea947302b6c32918d2_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQwNg_8e950918-5b9e-4c56-b739-1524bffb3949"
      unitRef="usd">26000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ieea3c92fd22346e3ba0cbae8446c3146_D20190427-20191025"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQxMw_3e5881af-5fdd-4fe7-bd34-13e254f2fd25">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i36b61101ccc34fe1a098c7a0a1438f56_D20190427-20191025"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQxMw_aeeced5b-7f5e-42d7-89db-52ae9f2fdaca">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8a9f49019242491fa2753b5c0b454587_D20190427-20191025"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQzNg_0a3858d3-36fe-4556-b9ec-07e58b5c4e1c">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i23fc05bb0ae84039aed38c9e14a8d9ba_D20190427-20191025"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQzNg_5a457cc7-dfdb-4473-b6d7-6377925f4da8">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i6458efd12f3d493e954c2b482e7b1267_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQ0Mg_40307eb7-edf5-429a-ae91-e27998e10a1c"
      unitRef="usd">40000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:Goodwill
      contextRef="i6458efd12f3d493e954c2b482e7b1267_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQ0OA_b201e0f6-25be-4193-a86a-6eaf9b4059d1"
      unitRef="usd">92000000</us-gaap:Goodwill>
    <mdt:BusinessAcquisitionPurchasePriceContingentConsideration
      contextRef="i4420ff33a4ea4338b79bc63a916e8eaa_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMjc0ODc3OTA3ODQ2NQ_8ac88dfa-d5cc-4484-96c9-450159051012"
      unitRef="usd">65000000</mdt:BusinessAcquisitionPurchasePriceContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMzc1NA_47844e2f-44ce-40d6-8dac-15413c092d05"
      unitRef="usd">461000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMzc2MQ_dd2914d5-a7bc-4c99-9f36-eac7dc68119f"
      unitRef="usd">280000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0ff95eb833ec4ac8a94740b1dc4672ec_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMzc4Ng_a02c3b8a-5a7f-415a-875c-a7fe2a6ce476"
      unitRef="usd">342000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i27dc3723a0be438391652135f2101c29_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMzgzMg_4e7927ee-0cc7-402e-98d2-b659a2b6cd90"
      unitRef="usd">119000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ief6cc83a0158450c8c8c8dfb1b72cb01_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMzkxMg_9bd8c1fa-4602-4562-a6d6-351785a375c0"
      unitRef="usd">112000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3302135c65a2484782311fd82ec693dd_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfMzk1OA_c5108571-f5a5-4f26-b9d0-2626aea3aec2"
      unitRef="usd">168000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfNTAwMQ_a46fd247-ec1c-44c9-a85c-05ed4703daa0">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balances of contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i08ae410a74984dc0a1a2e5d64185b3a1_I20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMi0xLTEtMS0w_d94c29dc-87e7-4921-be8a-6aab87f907be"
      unitRef="usd">297000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4b67d8b2f5e5423fab22a58594388040_I20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMi0zLTEtMS0w_c8ba62a1-80ba-45eb-9521-71d677c10d35"
      unitRef="usd">269000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMi01LTEtMS05ODE_7bfa48fd-0ff3-41e4-b95d-8a98cb17f05b"
      unitRef="usd">280000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i33145a1d36f644e3a8066f41beb5b5e2_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMi03LTEtMS05ODE_ac3a192a-e73b-4cdc-a260-2fd55bb98592"
      unitRef="usd">222000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <mdt:BusinessAcquisitionPurchasePriceContingentConsideration
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMy0xLTEtMS0w_7e2263ab-bfe7-4bc6-811c-3e5c3562db8f"
      unitRef="usd">158000000</mdt:BusinessAcquisitionPurchasePriceContingentConsideration>
    <mdt:BusinessAcquisitionPurchasePriceContingentConsideration
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMy0zLTEtMS0w_123c1ea9-9d2c-422d-8683-c7f1f6043f91"
      unitRef="usd">7000000</mdt:BusinessAcquisitionPurchasePriceContingentConsideration>
    <mdt:BusinessAcquisitionPurchasePriceContingentConsideration
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMy01LTEtMS05ODE_31cac151-f981-4571-8d4e-0f11a908c5c8"
      unitRef="usd">158000000</mdt:BusinessAcquisitionPurchasePriceContingentConsideration>
    <mdt:BusinessAcquisitionPurchasePriceContingentConsideration
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfMy03LTEtMS05ODE_01d62b50-350a-4c55-9a14-473d29f0dc41"
      unitRef="usd">65000000</mdt:BusinessAcquisitionPurchasePriceContingentConsideration>
    <mdt:BusinessAcquisitionContingentConsiderationMilestonePayment
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNC0xLTEtMS0w_d8890552-a9a2-4dee-8ee4-707b8a15f808"
      unitRef="usd">1000000</mdt:BusinessAcquisitionContingentConsiderationMilestonePayment>
    <mdt:BusinessAcquisitionContingentConsiderationMilestonePayment
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNC0zLTEtMS0w_9f1fdce8-96b8-4b08-9230-f4dae361b1e9"
      unitRef="usd">15000000</mdt:BusinessAcquisitionContingentConsiderationMilestonePayment>
    <mdt:BusinessAcquisitionContingentConsiderationMilestonePayment
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNC01LTEtMS05ODE_a3a9e326-8aed-4a89-8525-293b563e5f3d"
      unitRef="usd">2000000</mdt:BusinessAcquisitionContingentConsiderationMilestonePayment>
    <mdt:BusinessAcquisitionContingentConsiderationMilestonePayment
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNC03LTEtMS05ODE_09e1cfdd-36b8-4d4c-9388-ef9db99910f3"
      unitRef="usd">29000000</mdt:BusinessAcquisitionContingentConsiderationMilestonePayment>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNS0xLTEtMS0w_d2a682dd-2dba-4208-907e-1abe6ca7736c"
      unitRef="usd">-7000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNS0zLTEtMS0w_164a34d1-0d9e-4356-9430-d31cb25585ea"
      unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNS01LTEtMS05ODE_23da7c41-4602-4a4b-a931-0793e5a63ed2"
      unitRef="usd">-25000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNS03LTEtMS05ODE_a829bef2-fdcb-4272-bc81-4260ea597b00"
      unitRef="usd">-2000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNi0xLTEtMS0w_048e0c02-8b99-4ccf-94d8-08d8bc5c5ce9"
      unitRef="usd">461000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i20cd473a93b445c7a57a0c7284cf0cc7_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNi0zLTEtMS0w_162e5f6f-3b6e-4f40-afbd-56d37d32b4c2"
      unitRef="usd">260000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNi01LTEtMS05ODE_546419ec-25df-4261-adde-81d541ba53ba"
      unitRef="usd">461000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i20cd473a93b445c7a57a0c7284cf0cc7_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOmVjMWMzNWZiZGY1ZjRlYmFiMDMxNzlhMTEyMGQ5ZmNjL3RhYmxlcmFuZ2U6ZWMxYzM1ZmJkZjVmNGViYWIwMzE3OWExMTIwZDlmY2NfNi03LTEtMS05ODE_03726711-b027-4222-8941-ef185e367a1a"
      unitRef="usd">260000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RleHRyZWdpb246NDlmNDZiOWJhZGMwNDJjOGI5ZjY0NDYwMTIxMTcwOTBfNTAwNw_00d797b5-b73e-47f3-b8e2-bc91333ba7e4">The recurring Level 3 fair value measurements of contingent consideration for which a liability is recorded include the following significant unobservable inputs:&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;14.0% - 32.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;20.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Revenue and other performance-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;$203&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;40% - 100%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;99.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Projected fiscal year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;2021 - 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;5.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;5.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Product development and other milestone-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;$258&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;50% - 100%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;93.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;Projected fiscal year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;2021 - 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)   Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected fiscal year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i206d5cfac8764545b5c73b964083df22_I20201030"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMi04LTEtMS0wL3RleHRyZWdpb246YmYwMTkxMTIzZjQ3NGMwNjg1NTM2MjljMTc2ZTVhZjRfNA_7d0eb01f-4338-46ac-9295-6ee104ebc17c"
      unitRef="number">0.140</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ie3e605d554a34a48aafc28f4aec2bc10_I20201030"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMi04LTEtMS0wL3RleHRyZWdpb246YmYwMTkxMTIzZjQ3NGMwNjg1NTM2MjljMTc2ZTVhZjRfOQ_58438a65-d676-4c0d-9378-592638af3fb5"
      unitRef="number">0.324</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i6686b72c8d254c0a8ae89c915b162323_I20201030"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMi0xMC0xLTEtMA_62233294-e795-4c6f-8c1b-77f5be95c755"
      unitRef="number">0.207</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0e362e921abc4ec38c51136161f1dd32_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMy0yLTEtMS0w_8f42cf3c-23de-4c88-9fac-441e0c8a0f1d"
      unitRef="usd">203000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i6b72725bfde146b59806f55b4de68183_I20201030"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMy04LTEtMS0wL3RleHRyZWdpb246ZWQ1YmI5NTRlZDc4NGZmY2FjOGUwYTUzOTlmZDAxZGVfMjc0ODc3OTA2OTQ1Mg_66d2dbdb-b9e6-41c5-9eca-1f3d3aa1864a"
      unitRef="number">0.40</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ibf29640eead0423b8af20621f7e82a6e_I20201030"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMy04LTEtMS0wL3RleHRyZWdpb246ZWQ1YmI5NTRlZDc4NGZmY2FjOGUwYTUzOTlmZDAxZGVfMjc0ODc3OTA2OTQ1Ng_57cea4b0-1c7c-4467-8a97-60e0ae894438"
      unitRef="number">1</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i6796994ca7b1457ea2f0996b5fda014e_I20201030"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfMy0xMC0xLTEtMA_4447bd10-e065-4a59-ac16-0c212bcaf9e1"
      unitRef="number">0.994</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i17f40c5d5c144485bcaae9a942364fe9_I20201030"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfNS04LTEtMS0w_f9665e72-9a09-447f-9415-2473ed4be7a6"
      unitRef="number">0.055</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i4628c29036454d5fa0fc10c68641fb73_I20201030"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfNS0xMC0xLTEtMA_00329409-a3c4-444e-89bb-2cf43761bde4"
      unitRef="number">0.055</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i478c6a017fc349f59ff0568390ff4f01_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfNi0yLTEtMS0w_38967e92-8f96-4e17-a643-b0847f5107ae"
      unitRef="usd">258000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i294a126245e1491797b98713fe0945c9_I20201030"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfNi04LTEtMS0wL3RleHRyZWdpb246MTA1OGM5Yjg3YTRlNDFlM2JkOGUyZDA1MzdjMTViNTFfNA_85ad57d1-6b08-40e4-894e-dab4f61c2099"
      unitRef="number">0.50</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ifc28c29bd1fa43b782141ceb32766ec0_I20201030"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfNi04LTEtMS0wL3RleHRyZWdpb246MTA1OGM5Yjg3YTRlNDFlM2JkOGUyZDA1MzdjMTViNTFfOQ_4e20bb33-cb12-40a6-8a1e-89b5db6f5dc0"
      unitRef="number">1</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="id4bab39e35944924a3cd9ffc1393059f_I20201030"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV80Ni9mcmFnOjQ5ZjQ2YjliYWRjMDQyYzhiOWY2NDQ2MDEyMTE3MDkwL3RhYmxlOjQ1M2YzNWQyZTk2NjRiMzBiNDVkMTE3YWViOTY4NGE1L3RhYmxlcmFuZ2U6NDUzZjM1ZDJlOTY2NGIzMGI0NWQxMTdhZWI5Njg0YTVfNi0xMC0xLTEtMA_ca62938b-1d00-438d-afc2-7dbb3663f765"
      unitRef="number">0.932</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjU2Nw_d28e6f23-8fc5-4c5c-af81-c08c7e726be6">Restructuring&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Enterprise Excellence&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the third quarter of fiscal year 2018, the Company announced its Enterprise Excellence restructuring program, which is expected to leverage the Company's global size and scale, as well as enhance the customer and employee experience, with a focus on three objectives: global operations, functional optimization, and commercial optimization. Primary activities of the restructuring program include integrating and enhancing global manufacturing and supply processes, systems and site presence, enhancing and leveraging global operating models across several enabling functions, and optimizing certain commercial processes, systems, and models.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates that, in connection with its Enterprise Excellence restructuring program, it will recognize pre-tax exit and disposal costs and other costs across all segments of approximately&#160;$1.6 billion&#160;to&#160;$1.8 billion, the majority of which are expected to be incurred by the end of fiscal year 2022. Approximately half of the estimated charges are related to employee termination benefits. The remaining charges are costs associated with the restructuring program, such as salaries for employees supporting the program and consulting expenses. These charges are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;restructuring charges, net, cost of products sold, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;selling, general, and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and six months ended October&#160;30, 2020, the Company recognized charges of $90 million and $169 million, respectively. Additionally, the Company incurred accrual adjustments of $3 million and $5 million for the three and six months ended October&#160;30, 2020, respectively, related to certain employees identified for termination finding other positions within Medtronic and contract terminations being settled for less than originally estimated. For the three and six months ended October&#160;30, 2020, charges included $32 million and $59 million, respectively, recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $48 million and $95 million, respectively, recognized within&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; selling, general, and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and six months ended October&#160;25, 2019, the Company recognized charges of $95 million and $231 million, respectively. Additionally, the Company incurred accrual adjustments of $1 million and $13 million for the three and six months ended October&#160;25, 2019, respectively, related to certain employees identified for termination finding other positions within Medtronic. For the three and six months ended October&#160;25, 2019, charges included $32&#160;million and $67&#160;million, respectively, recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $35 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;million and $77 million, respectively, recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;selling, general, and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Enterprise Excellence restructuring program for the six months ended October&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Termination Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Associated Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrual adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of fiscal year 2021, the Company initiated the Simplification restructuring program, designed to make the Company a more nimble and competitive organization focused on accelerating innovation, enhancing the customer experience, driving revenue growth, and winning market share, while also more efficiently and effectively leveraging the Enterprise scale. Under the oversight of the portfolio leaders, this new operating model, which will be fully operational the beginning of the fourth quarter of fiscal year 2021, will simplify the Company's organizational structure and accelerate decision-making and execution. Primary activities of the restructuring program will include reorganizing the Company into a portfolio-level structure, including the creation of highly focused, accountable, and empowered Operating Units (OUs), consolidating Operations at the Enterprise level, establishing Technology Development Centers in areas where the Company has deep core technology competencies to be leveraged by multiple OUs, and forming dedicated sales organizations that leverage the Company's scale but move with the same agility as smaller, local competitors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company estimates that, in connection with its Simplification restructuring program, it will recognize pre-tax exit and disposal costs and other costs across all segments of approximately $400&#160;million to $450&#160;million, the majority of which are expected to be incurred by the end of fiscal year 2022. Approximately three quarters of the estimated charges are related to employee termination benefits. The remaining charges are costs associated with the restructuring program, such as salaries for employees supporting the program and consulting expenses. These charges are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;restructuring charges, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;selling, general, and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the three and six months ended October&#160;30, 2020, the Company recognized charges of $102 million and $153 million, respectively, which included $97 million of incremental defined benefit pension and post-retirement related expenses for employees that accepted voluntary early retirement packages. These costs are not included in the table summarizing restructuring charges below, because they are associated with costs that are accounted for under the pension and post-retirement rules. See Note 14 for further discussion on the incremental defined benefit pension and post-retirement expenses. The charges recognized for the three and six months ended October&#160;30, 2020 were partially offset by accrual adjustments of $8 million for both periods related to certain employees identified for termination finding other positions within the Company. The charges recognized for the three and six months ended October&#160;30, 2020 also included $2 million and $3 million, respectively, recognized within&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; selling, general, and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the consolidated statements of income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the activity related to the Simplification restructuring program for the six months ended October&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Termination Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Associated Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrual adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)  Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="ie19586da83c548419c65ce54dda4ac85_I20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfODc5_0b3924f9-5327-469b-9622-0ca0a8b5bbea"
      unitRef="usd">1600000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i593837cb940d49fa93ab3e7716b6faa5_I20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfODg1_445784b2-22c6-4de2-b270-fbb4b7f989c0"
      unitRef="usd">1800000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringCharges
      contextRef="i406d848cd3404dd991012a6440565838_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMTQ2MA_ba8fee60-27c4-4bbf-9226-d05ebd91ef05"
      unitRef="usd">90000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i87f3513e1ffc40c7bede0ba00efe2ed4_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDM3Mg_0a70d098-9f3a-4fb1-91c6-3aa2fad7d267"
      unitRef="usd">169000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i406d848cd3404dd991012a6440565838_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMTUwMA_264bc9a1-8112-4b59-bcba-3b52f3b38158"
      unitRef="usd">-3000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i87f3513e1ffc40c7bede0ba00efe2ed4_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDM5MQ_ddfafd9a-1d33-4684-a569-b32691c9b1b0"
      unitRef="usd">-5000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringCharges
      contextRef="ifc70a688a0d74e63819c4ade21969f2d_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMTYzNA_f74e0599-98fd-497e-be69-d7163fca10dd"
      unitRef="usd">32000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i95902727c56e4c2290a1ca75aaa9d4ee_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDUxMw_44513052-d994-4672-b427-361885fd3b5b"
      unitRef="usd">59000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i882643c31d764908a9b439838cdcac4e_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMTY4MQ_8516c7ec-035e-43aa-9dac-1659c39186ca"
      unitRef="usd">48000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icfe2201ad4e547e4a67d546069665441_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDUzOA_4cd850b0-0e3f-461e-8baa-8103dc4bc4eb"
      unitRef="usd">95000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic7a56850c3644238ba02de19c9b1c11b_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMTg1Ng_878f332f-3d1c-41c2-9dff-d64877b59c71"
      unitRef="usd">95000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8cf9700f41544535a38b9d85f3853147_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDU2NA_f91df618-b244-4912-98ec-e68a2e49b243"
      unitRef="usd">231000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="ic7a56850c3644238ba02de19c9b1c11b_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMTkxOA_53798106-bec1-4d41-9830-4d9cc8290c3b"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i8cf9700f41544535a38b9d85f3853147_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDU5Nw_4442356a-628d-45c5-9940-c4955af3b3df"
      unitRef="usd">-13000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringCharges
      contextRef="i6b1e1f29dda94d8db00dc1fb059072d7_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjA5Nw_3f435e06-6c77-45c5-9c23-b6ea26563ee9"
      unitRef="usd">32000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2040f3b39be34880bc79b81b3bbcd824_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDY4MA_313c5a08-e5e9-482b-98b0-d2c3db6ff0f3"
      unitRef="usd">67000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3654a2c834ae4cf7b134b2e121f5c339_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjE0NA_e8356f9e-9906-4fd1-bbdb-5d5723df92a7"
      unitRef="usd">35000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i68f172d54ac643f69996cb767c6659f4_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDcwOQ_a1f86159-e140-43ec-a3c7-cd1c5a09349b"
      unitRef="usd">77000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjU2MQ_5ee761d4-6b95-492d-ae4a-1225cc31f702">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Enterprise Excellence restructuring program for the six months ended October&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Termination Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Associated Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrual adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the activity related to the Simplification restructuring program for the six months ended October&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Termination Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Associated Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrual adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)  Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses.</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="if3cc36b2ab0b40f69449ff35ae8ea230_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMS0xLTEtMS0w_39c56a21-1cd7-4d82-ac79-fda6905ef32a"
      unitRef="usd">89000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iedfe76d8c426489e9bea058060893444_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMS03LTEtMS0w_ff5be25c-e5b9-474d-a0b3-1da61289a583"
      unitRef="usd">19000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i351e8abc52b741a6b52e469c40e2e761_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMS0xMS0xLTEtMA_133379d1-08a5-4d41-be66-1cc39d7e41ce"
      unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i1da6f2608bec495282ec262dc76cf183_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMS0xMy0xLTEtMA_f9dd5d43-93bc-41ef-ac90-7531f173206e"
      unitRef="usd">112000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i5464a7ffeef4485685b5fd1e3a463e37_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMi0xLTEtMS0w_01ae3430-2fed-4d75-8578-eb96d0987b1b"
      unitRef="usd">17000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i63278b6a1dd844309858a5b5ee35779e_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMi03LTEtMS0w_c040011d-cae4-483a-9c86-81ee766b7d87"
      unitRef="usd">150000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5616aebc236a4e4d97246ff6cb32b98b_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMi0xMS0xLTEtMA_cebcfc7e-bbcd-4cb3-a38e-f2b57f35ce86"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i87f3513e1ffc40c7bede0ba00efe2ed4_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMi0xMy0xLTEtMA_d9c29ccb-f888-4074-9cb2-8c5bdc0bc10c"
      unitRef="usd">169000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5464a7ffeef4485685b5fd1e3a463e37_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMy0xLTEtMS0w_a0a2533a-b9c8-471c-805f-35352934bf51"
      unitRef="usd">42000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i63278b6a1dd844309858a5b5ee35779e_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMy03LTEtMS0w_5b3d2003-806f-45ad-9d25-f3389653d269"
      unitRef="usd">146000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5616aebc236a4e4d97246ff6cb32b98b_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMy0xMS0xLTEtMA_d60dcd43-db5d-4d51-a08c-e1fe06b323f7"
      unitRef="usd">3000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i87f3513e1ffc40c7bede0ba00efe2ed4_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfMy0xMy0xLTEtMA_bbb8875f-8258-4514-9a9d-1bc423824301"
      unitRef="usd">191000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i5464a7ffeef4485685b5fd1e3a463e37_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNS0xLTEtMS0w_ee9d9bb5-10bc-4942-96c6-27cc925afaa2"
      unitRef="usd">-3000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i63278b6a1dd844309858a5b5ee35779e_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNS03LTEtMS0w_98043f6b-a4c1-4bad-aadb-9e390d90bae8"
      unitRef="usd">0</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i5616aebc236a4e4d97246ff6cb32b98b_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNS0xMS0xLTEtMA_8e2715bd-2408-4965-bf0d-3941ad6c25a9"
      unitRef="usd">-2000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i87f3513e1ffc40c7bede0ba00efe2ed4_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNS0xMy0xLTEtMA_9c85d022-b778-4482-920c-bca318ff5d2e"
      unitRef="usd">-5000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserve
      contextRef="i94f2a1c0fa6447faa4ffa5ae06ecf9a6_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNi0xLTEtMS0w_23649bef-8ca1-4e6c-abf5-7b9139ba3e7e"
      unitRef="usd">61000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib247e010f8064236b932fbe29a46c299_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNi03LTEtMS0w_e24dab98-3153-4729-918f-8c77d133b012"
      unitRef="usd">23000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia24d860e2e7247b88d59a33bffba5d44_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNi0xMS0xLTEtMA_d601beba-789b-4a52-b875-d530db376ee0"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i4c765c8437494e3bb8ad2b29a7d4886a_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjExYzU0M2U1YWZlODRjYjE5YmZkMTIyNTVhMDUyMmRkL3RhYmxlcmFuZ2U6MTFjNTQzZTVhZmU4NGNiMTliZmQxMjI1NWEwNTIyZGRfNi0xMy0xLTEtMA_0022cd79-9458-46ab-9a19-53655ab5b056"
      unitRef="usd">85000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i7f09f557003848f4b76b538b6807be01_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDMxOA_64624ee1-137a-4d76-8775-91013ea71425"
      unitRef="usd">400000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="if533fbb2e7804a49bd733441ec860383_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NDM0NQ_b6789c83-4d27-4122-8845-1cc97b41db95"
      unitRef="usd">450000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <mdt:RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment
      contextRef="i19b7c0d54b864709b8a1d14cc7a5d52d_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NjIyMg_9d0297ff-5385-4dbd-8524-36a6883badf7"
      unitRef="usd">102000000</mdt:RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment>
    <mdt:RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment
      contextRef="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NjEyNw_2169165d-ae55-481a-8f4d-63b36d79795a"
      unitRef="usd">153000000</mdt:RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment>
    <mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits
      contextRef="i19b7c0d54b864709b8a1d14cc7a5d52d_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NjEzMw_9d04bd02-a362-4f84-8740-ede05e0aa908"
      unitRef="usd">97000000</mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits>
    <mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits
      contextRef="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NjEzMw_eb35c29b-3311-4a73-97bf-4d65e5074f12"
      unitRef="usd">97000000</mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NjM0MQ_1bec6d72-39c0-442e-a249-16f0993fc1b7"
      unitRef="usd">-8000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i19b7c0d54b864709b8a1d14cc7a5d52d_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NjM0MQ_501e4e39-7ea2-4cdb-b551-f35aa1454550"
      unitRef="usd">-8000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringCharges
      contextRef="i6b3a4116ab3044c5a696abbccd7ee5d6_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3Mzg2MA_9be644f0-2d6f-47d3-a59e-82e6639c8ac3"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iebed8f31e2bc4cb98986dd61dcc84584_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RleHRyZWdpb246OTE2MWU5YTQ5MjdjNGI1NWExNzk5MDI2ZTc3MTUyMzVfMjc0ODc3OTA3NTk2Mg_51cf91d6-8433-4524-8093-660da2e33135"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserve
      contextRef="ia114c5bf3f0c4db3be119ae9d303c54c_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMS0xLTEtMS0xODc2_02adfd15-6954-4bd5-a3d3-a8c5b243f71c"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0f140a7453f54937a77f1945a683e562_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMS0zLTEtMS0xODc2_9df7c8a7-3fe6-4432-9b94-f57d5ce8b25e"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3619e5e7c1d747c897276367eac949cc_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMS05LTEtMS0xODc2_18d297d8-e3f4-48e4-83d6-45828d3e1593"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="ied9a45419b034ba293d451d739803159_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMi0xLTEtMS0xODc2_a1049af8-4522-45a7-ae1e-c103ffbb4b7c"
      unitRef="usd">53000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i1327a9ff18894e94bd64778ed9244151_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMi0zLTEtMS0xODc2_87a92d36-c8a1-4138-8080-3f3d802c70af"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMi05LTEtMS0xODc2_7d5f346b-702a-4b78-921c-29a634fc28b3"
      unitRef="usd">56000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="ied9a45419b034ba293d451d739803159_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMy0xLTEtMS0xODc2_b05e87dd-9e35-473c-a11b-73470f2b206a"
      unitRef="usd">9000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i1327a9ff18894e94bd64778ed9244151_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMy0zLTEtMS0xODc2_6cd534c1-87e0-4fbd-89aa-7e9c107ce63c"
      unitRef="usd">3000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfMy05LTEtMS0xODc2_03249afd-8945-49ad-9256-274557558fb5"
      unitRef="usd">12000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="ied9a45419b034ba293d451d739803159_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfNC0xLTEtMS0yNjQ5_43f32913-1a14-4d3a-9972-f3de125b0510"
      unitRef="usd">-8000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i1327a9ff18894e94bd64778ed9244151_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfNC0zLTEtMS0yNjUz_156f5a61-0a16-4c57-a292-4327af7a2237"
      unitRef="usd">0</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="iba8d08ba046e443eb88f49ff029588cd_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfNC05LTEtMS0yNjU3_ce213c84-fcce-468a-b12e-3a3b4285ce61"
      unitRef="usd">-8000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserve
      contextRef="i4ee1ecb91f93417abbd820fb1b9263dd_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfNC0xLTEtMS0xODc2_7e573a24-3f62-45d9-aef3-48023c428ac8"
      unitRef="usd">36000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i59d94b407eb34ffcb5ba920befb20402_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfNC0zLTEtMS0xODc2_18edf192-3f79-403a-b5f7-ea26b4b63afb"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ief7515addc7a424bb17ccbb5efd1bcc0_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81Mi9mcmFnOjkxNjFlOWE0OTI3YzRiNTVhMTc5OTAyNmU3NzE1MjM1L3RhYmxlOjQ1Zjc2OTYzYjU1YzQyZTE4MGRiODIzN2E1MDJiNzY1L3RhYmxlcmFuZ2U6NDVmNzY5NjNiNTVjNDJlMTgwZGI4MjM3YTUwMmI3NjVfNC05LTEtMS0xODc2_19226484-0fda-447e-bcb4-12770f88a7be"
      unitRef="usd">36000000</us-gaap:RestructuringReserve>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDcyMA_eb50e719-132d-49c8-82b1-31580ef6bf03">Financial Instruments&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company holds investments in marketable debt securities that are classified and accounted for as available-for-sale and held-to-maturity. Investments classified as available-for-sale are remeasured on a recurring basis. Investments classified as held-to-maturity are measured at amortized cost. The following tables summarize the Company's investments in available-for-sale and held-to-maturity debt securities by significant investment category and the related consolidated balance sheet classification at October&#160;30, 2020 and April&#160;24, 2020:&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Available-for-sale securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Held-to-maturity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:16pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost of debt securities excludes accrued interest, which is reported in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the gross unrealized losses and fair values of the Company&#x2019;s available-for-sale debt securities that have been in a continuous unrealized loss position deemed to be temporary, aggregated by investment category at October&#160;30, 2020 and April&#160;24, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;More than 12 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;More than 12 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy. There were no transfers into or out of Level 3 during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019. When a determination is made to classify an asset or liability within Level 3, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no purchases, sales, settlements, or significant gains or losses recognized in earnings or other comprehensive income for debt securities classified as Level 3 during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity related to the Company&#x2019;s available-for-sale debt securities portfolio is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit losses represent the difference between the present value of cash flows expected to be collected on certain mortgage-backed securities and auction rate securities and the amortized cost of these securities. Based on the Company&#x2019;s assessment of the credit quality of the underlying collateral and credit support available to each of the remaining securities in which the Company is invested, the Company believes it has recognized all necessary impairments, as the Company does not have the intent to sell, nor is it more likely than not that the Company will be required to sell, before recovery of the amortized cost. At October&#160;30, 2020 and April&#160;24, 2020, there were no debt securities in a credit loss position. No available-for-sale or held-to-maturity securities were sold for significantly less than carrying value during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The October&#160;30, 2020 balance of available-for-sale and held-to-maturity debt securities by contractual maturity is shown in the following table. Within the table, maturities of mortgage-backed securities have been allocated based upon timing of estimated cash flows assuming no change in the current interest rate environment. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available-For-Sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-To-Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Equity Securities, Equity Method Investments, and Other Investments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds investments in equity securities with readily determinable fair values, equity investments without readily determinable fair values, investments accounted for under the equity method, and other investments. Equity securities with readily determinable fair values are included in Level 1 of the fair value hierarchy, as they are measured using quoted market prices. Equity method investments and investments without readily determinable fair values are included within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs to determine fair value. To determine the fair value of these investments, the Company uses all pertinent financial information available related to the investees, including financial statements, market participant valuations from recent and proposed equity offerings, and other third-party data. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's equity and other investments at October&#160;30, 2020 and April&#160;24, 2020, which are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments with readily determinable fair value (marketable equity securities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below includes activity related to the Company&#x2019;s portfolio of equity and other investments. Gains and losses on equity and other investments are recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other non-operating income, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment losses recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The net gains recognized for the three months ended October&#160;30, 2020 were not significant, and the net gains recognized for the six months ended October&#160;30, 2020 were $12&#160;million, comprised of unrealized gains on equity securities and other investments still held at October&#160;30, 2020. The net gains recognized for the three and six months ended October&#160;25, 2019 were $14&#160;million comprised of unrealized gains on equity securities and other investments still held at October&#160;25, 2019. There were no impairment charges incurred on the Company's equity securities, equity method investments, and other investments during the three months ended October&#160;30, 2020. Impairment charges incurred on the Company's equity securities, equity method investments, and other investments during the six months ended October&#160;30, 2020 and the three and six months ended October&#160;25, 2019 were not significant.</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDY3NQ_b6b3a20f-f019-4a7a-9bf8-cdde6f040d80">The following tables summarize the Company's investments in available-for-sale and held-to-maturity debt securities by significant investment category and the related consolidated balance sheet classification at October&#160;30, 2020 and April&#160;24, 2020:&#160;&#160;&#160;&#160;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Available-for-sale securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Held-to-maturity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:16pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i443dc4a6e4e7449cb7687aaf2b213890_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNC0xLTEtMS0w_40bc4774-9a68-4482-aaf5-bc6dbc3c7782"
      unitRef="usd">497000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i443dc4a6e4e7449cb7687aaf2b213890_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNC0zLTEtMS0w_fa9b2bb3-0d3b-4ce8-acab-88c385fbf5f2"
      unitRef="usd">39000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i443dc4a6e4e7449cb7687aaf2b213890_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNC01LTEtMS0w_c86bebec-7e79-45ed-93d2-1788de6e9212"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i443dc4a6e4e7449cb7687aaf2b213890_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNC03LTEtMS0w_e2ba1084-b9cd-4b27-aef2-c4f21a95f079"
      unitRef="usd">536000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i245f5fb276724559bcadde6864aa9761_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNC05LTEtMS0w_a17796c0-0601-4071-bd8a-c45b297698b1"
      unitRef="usd">536000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia14e107ca6b34c7aa82198c4055050a7_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNC0xMS0xLTEtMA_07bc117b-8906-4bbb-837b-56ca77352d64"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i20efc4b8d5624a738f090883fed2d123_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNi0xLTEtMS0w_efe8c9be-007a-41d0-8936-593f8bc63cfa"
      unitRef="usd">4234000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i20efc4b8d5624a738f090883fed2d123_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNi0zLTEtMS0w_aef8c59f-9301-491a-8b3e-d8963df0f677"
      unitRef="usd">124000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i20efc4b8d5624a738f090883fed2d123_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNi01LTEtMS0w_317014fd-7cf3-4f83-a734-0697efcb8efa"
      unitRef="usd">32000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i20efc4b8d5624a738f090883fed2d123_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNi03LTEtMS0w_0f338ca2-5c03-46aa-af0e-c89ded494635"
      unitRef="usd">4326000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1e3d9441863d40fe83d2a6994feb032d_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNi05LTEtMS0w_c7778d37-3821-430f-b36c-7531dc7f58aa"
      unitRef="usd">4326000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia4320454dbec403185b511f1c64206cd_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNi0xMS0xLTEtMA_d26b06a1-7be2-41e7-8e4d-e21fc94f2634"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2231b706751d46d79c1f65ba057fbb62_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNy0xLTEtMS0w_37402037-3e27-483d-beee-85c091ba15b5"
      unitRef="usd">888000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2231b706751d46d79c1f65ba057fbb62_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNy0zLTEtMS0w_0c3b8908-443e-4cab-b535-cdc25b4ecaa9"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2231b706751d46d79c1f65ba057fbb62_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNy01LTEtMS0w_8f1087d8-8532-4ddf-8fb7-04aa4ba694b6"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2231b706751d46d79c1f65ba057fbb62_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNy03LTEtMS0w_bd78263a-05c7-4679-bf4d-d1cc4ca6e343"
      unitRef="usd">888000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2aa2e63b28634ba9a0d5b4373eb935d8_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNy05LTEtMS0w_de4e4f81-bda6-46a0-b1c3-063c544a281c"
      unitRef="usd">888000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i22d5b93a4050490ba354a793fe73ddce_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfNy0xMS0xLTEtMA_a4cf04f2-7044-4a8f-ad8a-464ff8ed309c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie865d31224d248118707ff2a738a5f53_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOC0xLTEtMS0w_a2b413c8-3c24-49d9-bdf8-8cc469fefe20"
      unitRef="usd">661000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie865d31224d248118707ff2a738a5f53_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOC0zLTEtMS0w_068c6855-880f-4ef2-bec4-01ee98c4b30c"
      unitRef="usd">27000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie865d31224d248118707ff2a738a5f53_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOC01LTEtMS0w_086fdd28-c0d3-4a38-846e-e45757cb67c8"
      unitRef="usd">19000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie865d31224d248118707ff2a738a5f53_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOC03LTEtMS0w_db22c08e-c8a5-48d7-ad08-ecf10385e3e3"
      unitRef="usd">669000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic589592a3ea647eb82528ebff28b6c83_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOC05LTEtMS0w_04f40b87-f078-4225-aa93-c64d2126fa9c"
      unitRef="usd">669000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i678b3811da1f402d875ac6b3061da9aa_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOC0xMS0xLTEtMA_5911d38d-42f0-4929-831c-1456c3b79a06"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i35bc96620aae4f20b504721d4972a52c_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOS0xLTEtMS0w_fb67a394-783a-41cc-b38b-9a26b9e260eb"
      unitRef="usd">36000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i35bc96620aae4f20b504721d4972a52c_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOS0zLTEtMS0w_4b4dfa70-5e56-46fd-91b2-b26157ea95c1"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i35bc96620aae4f20b504721d4972a52c_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOS01LTEtMS0w_a5ba872c-6e6c-4bb6-98bb-0b0f9a937680"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i35bc96620aae4f20b504721d4972a52c_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOS03LTEtMS0w_ce0018ca-8ecd-4232-bed0-35109c241420"
      unitRef="usd">37000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if998b6ae16134f37a39d249efcbcc3f7_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOS05LTEtMS0w_11b0a46f-2d00-4a18-92b4-7d12c5ac7d34"
      unitRef="usd">37000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i83e463dc1191437ca3f924fd6bd29a84_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfOS0xMS0xLTEtMA_919f9b6e-8aaa-49e8-a113-8e30f041b22b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1f069030f0a3460c8d945b8cd90214d7_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTAtMS0xLTEtMA_e6894106-1dad-4a17-9739-f68a80b44816"
      unitRef="usd">518000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1f069030f0a3460c8d945b8cd90214d7_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTAtMy0xLTEtMA_712cc8d6-d7f1-4519-a18f-6282aebb1b64"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1f069030f0a3460c8d945b8cd90214d7_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTAtNS0xLTEtMA_5f155516-df60-4053-957b-13783bcd1bb8"
      unitRef="usd">7000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1f069030f0a3460c8d945b8cd90214d7_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTAtNy0xLTEtMA_05c20591-fe43-4a81-840f-0431849eb96e"
      unitRef="usd">515000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i46c2eb1479d44550a2ab2d69a99636f3_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTAtOS0xLTEtMA_b65b5f1e-b0c9-4742-bd96-f27c8efb3cdf"
      unitRef="usd">515000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i929d7ecd50044541af233ec2313878da_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTAtMTEtMS0xLTA_383a5990-6705-40a4-b7d3-88ed5aa281e6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7fb2f890b1ec4198b387f05c2c65bc8c_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTEtMS0xLTEtMA_481dd8d3-7de2-41f1-817a-5a984f52f9a7"
      unitRef="usd">6337000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7fb2f890b1ec4198b387f05c2c65bc8c_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTEtMy0xLTEtMA_36175ccc-98fa-4a8e-87a1-e83359465517"
      unitRef="usd">157000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7fb2f890b1ec4198b387f05c2c65bc8c_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTEtNS0xLTEtMA_0fc8398a-8439-4eb0-9806-0403e104d529"
      unitRef="usd">59000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7fb2f890b1ec4198b387f05c2c65bc8c_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTEtNy0xLTEtMA_05f259a4-28d1-4ea4-b8a8-a09c24750810"
      unitRef="usd">6435000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8afc49c379f449b49731bf51824ea01f_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTEtOS0xLTEtMA_3ca11e46-b310-4af8-9a2c-ced13c89024b"
      unitRef="usd">6435000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i50ab07cf2ffc404da2ed9d85ac2200c8_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTEtMTEtMS0xLTA_e397db97-2473-4e4a-a63f-e1c8fd766222"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia06764135b2b4cd0a275054067eb22ca_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTQtMS0xLTEtMA_c9144a03-a295-4119-b224-74a0c64009df"
      unitRef="usd">36000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia06764135b2b4cd0a275054067eb22ca_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTQtMy0xLTEtMA_4567845b-4dd8-42fe-8c06-14f12460a9b8"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia06764135b2b4cd0a275054067eb22ca_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTQtNS0xLTEtMA_b8fbda94-e0a5-446f-aa23-05cbd03fead7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia06764135b2b4cd0a275054067eb22ca_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTQtNy0xLTEtMA_9d1798bc-03cf-4028-9b12-de1bad29f8c9"
      unitRef="usd">36000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i111933045e354d4f8658708753547778_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTQtOS0xLTEtMA_d71fb4d7-a918-452d-b65b-0f3ded3306ee"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1db728fe13014c45b129b04929119976_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTQtMTEtMS0xLTA_bec21957-d995-4e1f-b7a2-733c21e3d4de"
      unitRef="usd">36000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTctMS0xLTEtNjczNw_1ca05b59-7d70-40f3-9317-d1bc64ea33f2"
      unitRef="usd">6870000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTctMy0xLTEtNjczNw_5059c944-ac96-488d-83fb-53bcdf14fe3e"
      unitRef="usd">196000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTctNS0xLTEtNjczNw_2b87dcb1-a9ea-4a34-87d4-a1eff7b6525d"
      unitRef="usd">59000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTctNy0xLTEtNjczNw_b8bdd54a-8fa0-451a-99fb-7a7f60fa7d74"
      unitRef="usd">7007000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i15721ef42f5a4b64a1a941878d5e80bd_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTctOS0xLTEtNjczNw_56f43d71-daf7-42aa-b963-0113aba2a839"
      unitRef="usd">6971000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTctMTEtMS0xLTY3Mzc_b772c6b9-fb8b-422c-8ec2-12d8635b9187"
      unitRef="usd">36000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i126bbe583d1b40e989cd54f8bc8b5fdb_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMjAtMS0xLTEtNjc0MA_85385e20-23f4-4003-8325-05ca9c7b70fd"
      unitRef="usd">886000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i126bbe583d1b40e989cd54f8bc8b5fdb_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMjAtMy0xLTEtNjc0MA_8629ad85-9bf6-4cf2-b8c1-5b434ec17009"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i126bbe583d1b40e989cd54f8bc8b5fdb_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMjAtNS0xLTEtNjc0MA_378e9407-446b-4b9a-9961-fa26bb27eeb9"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i126bbe583d1b40e989cd54f8bc8b5fdb_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMjAtNy0xLTEtNjc0MA_5f502803-0d78-484b-85b9-ce16a2475b0e"
      unitRef="usd">886000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ia89cf40cd27a43f2829d8c0220e90d7b_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMjAtOS0xLTEtNjc0MA_b14c43af-ea9e-4a07-b9dc-d1b98000fac6"
      unitRef="usd">886000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i0af3ac423bf349678613c24c3b8a11a2_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMjAtMTEtMS0xLTY3NDA_81e0fb1c-59c6-4e50-9c3a-afb7ddd38d9b"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTYtMS0xLTEtMA_b8f4c0f0-5d2d-43b0-b886-d4e191bf5e86"
      unitRef="usd">7756000000</mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost>
    <mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTYtMy0xLTEtMA_6dbac435-9acb-4e4f-803c-c0ccc3efb905"
      unitRef="usd">196000000</mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax>
    <mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTYtNS0xLTEtMA_85242c47-1d51-47b9-8e44-3933615141de"
      unitRef="usd">59000000</mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax>
    <mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTYtNy0xLTEtMA_a315e69a-5d5f-4f56-a0a2-716f86d44d0b"
      unitRef="usd">7893000000</mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue>
    <mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue
      contextRef="i15721ef42f5a4b64a1a941878d5e80bd_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTYtOS0xLTEtMA_ddd63645-3b17-4e90-a98d-2a7b351af20e"
      unitRef="usd">7857000000</mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue>
    <mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue
      contextRef="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkNGIyMjNkYmRhOTQyYzk4MzUxYzVkYThmZTM1NmY2L3RhYmxlcmFuZ2U6N2Q0YjIyM2RiZGE5NDJjOTgzNTFjNWRhOGZlMzU2ZjZfMTYtMTEtMS0xLTA_96b86e2e-bf7c-46be-bd82-0a8f14eef901"
      unitRef="usd">36000000</mdt:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i028f280fa1334ede95f2032c53ba9603_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNC0xLTEtMS0w_44f93fb0-4b5b-4dda-afe8-0a8ceefc9dab"
      unitRef="usd">542000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i028f280fa1334ede95f2032c53ba9603_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNC0zLTEtMS0w_aa607aff-2f0c-49ec-942c-bef757cf14fc"
      unitRef="usd">47000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i028f280fa1334ede95f2032c53ba9603_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNC01LTEtMS0w_89a59bb9-3d24-4c0d-b0e0-d66c87ce464c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i028f280fa1334ede95f2032c53ba9603_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNC03LTEtMS0w_52c29987-111c-409d-84b2-1b1e5a9802c6"
      unitRef="usd">589000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i52d4f679d87a43208fe9aa6ceee5a507_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNC05LTEtMS0w_3dfbfce9-91ba-4b5e-bcad-968551fe4431"
      unitRef="usd">589000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5f41bbdd83db46cb896344dc0006b64d_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNC0xMS0xLTEtMA_569e32e1-0343-4c40-9365-1aaf0f71b99a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5844ce5002374c9ca4435645ef347572_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNi0xLTEtMS0w_6274f145-cbad-49b3-83b5-32e1239eb350"
      unitRef="usd">4285000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5844ce5002374c9ca4435645ef347572_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNi0zLTEtMS0w_80fa413e-7c66-4f13-be6d-c95cf4c5c98a"
      unitRef="usd">66000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5844ce5002374c9ca4435645ef347572_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNi01LTEtMS0w_d1af4e78-a1b5-43e0-a4ce-bf100396e1c7"
      unitRef="usd">90000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5844ce5002374c9ca4435645ef347572_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNi03LTEtMS0w_1f370342-732b-4567-81c6-969eac507570"
      unitRef="usd">4261000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8c4a3739c026430f9cb994dd2f7f80e0_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNi05LTEtMS0w_f91540d6-7413-4134-beeb-f434884c5c04"
      unitRef="usd">4261000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib8a65bbd4df441ffbbe386c670a74731_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNi0xMS0xLTEtMA_867f9d61-6d93-4c3f-b18d-37d1a5a50768"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i15191dfa528f4503a0e2853a1733b631_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNy0xLTEtMS0w_bd2e60a2-ad3b-4187-9ef8-a1cad61106ac"
      unitRef="usd">746000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i15191dfa528f4503a0e2853a1733b631_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNy0zLTEtMS0w_13ef23ed-ebe3-4028-8cfa-76265d63dc6b"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i15191dfa528f4503a0e2853a1733b631_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNy01LTEtMS0w_24952f7f-4e32-4efd-a1ea-cedfc5acd95f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i15191dfa528f4503a0e2853a1733b631_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNy03LTEtMS0w_59f22162-2785-4faa-88fb-efef58596ce7"
      unitRef="usd">747000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8a12fc35b75d4ccf8c6c5a6b5f9df288_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNy05LTEtMS0w_6642c455-4fb6-4214-92ba-15e63f9e44be"
      unitRef="usd">747000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2f385943a6ed411da591a03f5bc3abb5_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfNy0xMS0xLTEtMA_64ecb50b-64e1-4cfc-a342-4451e51d47c6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i90b3cafb39ad43129046e5127bb34a7b_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOC0xLTEtMS0w_0fd72ec5-bd3d-477b-ad84-a41c28fe5f33"
      unitRef="usd">705000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i90b3cafb39ad43129046e5127bb34a7b_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOC0zLTEtMS0w_2e5ca593-0b24-4f14-9320-6cf8f04440b0"
      unitRef="usd">20000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i90b3cafb39ad43129046e5127bb34a7b_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOC01LTEtMS0w_da2a3680-887b-4848-9327-7c79f263c0c4"
      unitRef="usd">28000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i90b3cafb39ad43129046e5127bb34a7b_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOC03LTEtMS0w_6161a82d-019b-4ec6-87fb-a3853026a352"
      unitRef="usd">697000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i32cab75680864139a62ff1b5cebde24d_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOC05LTEtMS0w_6e4d5a61-f113-48b5-9509-3e8525a40277"
      unitRef="usd">697000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf012b1a7edb49289534410a88491a96_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOC0xMS0xLTEtMA_babe5260-f34a-47f7-a450-01c7ab448625"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6697a4efd1dc4d249dcfab34c0f70d31_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOS0xLTEtMS0w_bffdea07-c559-4135-b42e-bd5351c4c7a2"
      unitRef="usd">34000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6697a4efd1dc4d249dcfab34c0f70d31_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOS0zLTEtMS0w_6918b83b-35bc-4599-990c-2e681484f580"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6697a4efd1dc4d249dcfab34c0f70d31_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOS01LTEtMS0w_fb62c413-df0d-4765-945c-394f67828c2f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6697a4efd1dc4d249dcfab34c0f70d31_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOS03LTEtMS0w_46a9f1c0-f48d-4f9c-8e71-b01217a11b85"
      unitRef="usd">34000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3978608b42c04cc5af43262c255f20e6_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOS05LTEtMS0w_a4697919-5de0-4b7e-94fd-f2608d295bc5"
      unitRef="usd">34000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i463d7b834e2145ad88a0dc521b32cb6e_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfOS0xMS0xLTEtMA_5a95d004-bcb0-48bf-9689-ee4a90ddae8f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i30fd371d44e44ab2b7a26ae857aed3d8_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTAtMS0xLTEtMA_b3ee5dd9-9e37-4ab5-b316-238186273856"
      unitRef="usd">499000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i30fd371d44e44ab2b7a26ae857aed3d8_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTAtMy0xLTEtMA_95b0438c-d262-4b18-9627-7e1a0190a277"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i30fd371d44e44ab2b7a26ae857aed3d8_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTAtNS0xLTEtMA_d321aaff-fe5b-4795-974e-a02779890488"
      unitRef="usd">20000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i30fd371d44e44ab2b7a26ae857aed3d8_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTAtNy0xLTEtMA_70556340-8cd7-48ba-b137-444829b16c77"
      unitRef="usd">480000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i355296bb1c604ce98363ad84c2d4096b_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTAtOS0xLTEtMA_054a26d3-53a9-484f-9467-47e22590a28f"
      unitRef="usd">480000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaa3a8fa30d954c43b8b42c71861c0bae_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTAtMTEtMS0xLTA_1d0a3793-7f05-4ce8-a9d5-575963efc10b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0380d38afb13425093e55e205d427bd7_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTEtMS0xLTEtMA_06d53963-29cb-45d8-9907-2858fbced7f4"
      unitRef="usd">6269000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0380d38afb13425093e55e205d427bd7_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTEtMy0xLTEtMA_c922e626-932e-49bc-9f67-e8c08bba9d39"
      unitRef="usd">88000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0380d38afb13425093e55e205d427bd7_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTEtNS0xLTEtMA_e0ed7074-1bc9-41cd-960c-61206f748b21"
      unitRef="usd">138000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0380d38afb13425093e55e205d427bd7_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTEtNy0xLTEtMA_8a482ae0-07ea-4142-931d-8d5cf4002aa1"
      unitRef="usd">6219000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9f7ad3736e1640118162dc647a316234_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTEtOS0xLTEtMA_7f53de64-cfe4-4183-a3df-c5ec3e754cee"
      unitRef="usd">6219000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib7af353247eb47508c8e5a3b145eee36_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTEtMTEtMS0xLTA_464bb47b-ca26-4ba2-ae43-86adde7da494"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iac8769618c434a12a6120cf93b18a7cb_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTMtMS0xLTEtMA_513c9bb3-989d-47d1-83a8-75b69b64a8b4"
      unitRef="usd">36000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iac8769618c434a12a6120cf93b18a7cb_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTMtMy0xLTEtMA_550f5bf5-af5e-4d93-905c-4b08941ea88b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iac8769618c434a12a6120cf93b18a7cb_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTMtNS0xLTEtMA_13f48554-126c-43d5-88d6-1df9dcdf5a41"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iac8769618c434a12a6120cf93b18a7cb_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTMtNy0xLTEtMA_37fafca3-1fe4-45bd-a846-63a716be9749"
      unitRef="usd">33000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7d8fc61f591a4b00a4f09dbee10c57e3_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTMtOS0xLTEtMA_442420c2-36eb-4305-88dd-52d22b48f28d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i80fccbbafaac424ba13d8f2e11e26efb_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTMtMTEtMS0xLTA_c5c0b280-aef6-4998-b775-9a86ce5f3fdf"
      unitRef="usd">33000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTQtMS0xLTEtMA_8d87a656-c6c8-47f6-b53b-0befa7481d13"
      unitRef="usd">6847000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTQtMy0xLTEtMA_9b8ee439-d1a4-451e-82f9-d7f7379413ff"
      unitRef="usd">135000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTQtNS0xLTEtMA_82e62af6-0b55-4515-bde0-e25fa5626fda"
      unitRef="usd">141000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTQtNy0xLTEtMA_55aad005-1038-479c-89fb-e1101c59ada7"
      unitRef="usd">6841000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6433dc1e1b474da0b55da283f18ec450_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTQtOS0xLTEtMA_bbd01466-9c36-4ba8-bf6f-33cd261496bc"
      unitRef="usd">6808000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i79d2f91d85114433aa75b3dde1c711d7_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjY3OGZlZjY0YzdmYzQ1Y2VhODgxMDljYmY0ZDA3ZDc1L3RhYmxlcmFuZ2U6Njc4ZmVmNjRjN2ZjNDVjZWE4ODEwOWNiZjRkMDdkNzVfMTQtMTEtMS0xLTA_5364fefd-61cc-4f11-972b-e35ef6be98b6"
      unitRef="usd">33000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDY4MQ_c803c9e4-0f93-43e6-bab6-6bfa89719396">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the gross unrealized losses and fair values of the Company&#x2019;s available-for-sale debt securities that have been in a continuous unrealized loss position deemed to be temporary, aggregated by investment category at October&#160;30, 2020 and April&#160;24, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;More than 12 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;More than 12 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i1ba52b8426984dcca753b63310d1ba95_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfMy0xLTEtMS0w_126dfdea-919e-4e68-86ee-ba069b4c8c47"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i1ba52b8426984dcca753b63310d1ba95_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfMy0zLTEtMS0w_5d55d62e-78a2-45a1-8e4c-8d9b349b7f73"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i1ba52b8426984dcca753b63310d1ba95_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfMy01LTEtMS0w_a7dd3bcc-9a8f-45df-a1a7-a407d3babf33"
      unitRef="usd">196000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i1ba52b8426984dcca753b63310d1ba95_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfMy03LTEtMS0w_addd3cb5-6b0a-4c7f-930c-c50fdc1be237"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2870ad45d3744aacaab561141a1ede79_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNC0xLTEtMS0w_e48b0894-9d2a-4e17-b372-2502b7e36904"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2870ad45d3744aacaab561141a1ede79_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNC0zLTEtMS0w_7de13a62-77be-4257-9daa-25b004e73ba0"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i2870ad45d3744aacaab561141a1ede79_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNC01LTEtMS0w_4a87fa00-f875-41a4-a96b-4b67ef3f554e"
      unitRef="usd">858000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i2870ad45d3744aacaab561141a1ede79_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNC03LTEtMS0w_e47e6f76-3729-4b96-aca9-d7abcc6651f7"
      unitRef="usd">32000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i1fa258e7bccc4d1d9172fc22def7a0d3_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNS0xLTEtMS0w_adad290a-2caf-41aa-a22f-49a668cf96e0"
      unitRef="usd">25000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i1fa258e7bccc4d1d9172fc22def7a0d3_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNS0zLTEtMS0w_0a9f5dd4-8259-4843-80be-bd7b461cae86"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i1fa258e7bccc4d1d9172fc22def7a0d3_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNS01LTEtMS0w_5f5ac4cd-4aec-4469-a076-47c67caac8e6"
      unitRef="usd">119000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i1fa258e7bccc4d1d9172fc22def7a0d3_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNS03LTEtMS0w_7e01e87b-dd77-419f-b524-60ef1214ac52"
      unitRef="usd">16000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i235a5116037045f2960d6c6e2d85ff59_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNy0xLTEtMS0w_ae4183dc-b15c-413b-a07a-c4305ba369b8"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i235a5116037045f2960d6c6e2d85ff59_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNy0zLTEtMS0w_c5c30d4f-064f-4ce5-bea8-b085564eb7bb"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i235a5116037045f2960d6c6e2d85ff59_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNy01LTEtMS0w_f03af113-8129-49e0-ab42-987f08630b2a"
      unitRef="usd">347000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i235a5116037045f2960d6c6e2d85ff59_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfNy03LTEtMS0w_d0f6ec78-1699-4ec2-8011-6490e31ec8b4"
      unitRef="usd">7000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfOS0xLTEtMS0w_e73b3785-673c-4678-a7a0-e89eff34e227"
      unitRef="usd">38000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfOS0zLTEtMS0w_b8630b94-6d23-41a6-8d23-0feb10fb1a6a"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfOS01LTEtMS0w_1c450c25-fcbe-48d8-96bf-4141327a1f33"
      unitRef="usd">1520000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBkNTAwY2I1YWEyNTRkZjE4YmY3ZWQxM2FhZWMwYzMwL3RhYmxlcmFuZ2U6MGQ1MDBjYjVhYTI1NGRmMThiZjdlZDEzYWFlYzBjMzBfOS03LTEtMS0w_f2bf3396-2409-4979-9342-bfe7bd49a8bf"
      unitRef="usd">56000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iea98fb3a66024e57afe1c39a4f163883_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNC0xLTEtMS0w_2ae270eb-342d-4b8a-abe2-44879d87f547"
      unitRef="usd">1368000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iea98fb3a66024e57afe1c39a4f163883_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNC0zLTEtMS0w_333172cf-e709-4fd4-afc2-4843687f0268"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iea98fb3a66024e57afe1c39a4f163883_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNC01LTEtMS0w_2895831f-c0ed-481e-a118-41c361d552e2"
      unitRef="usd">2893000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iea98fb3a66024e57afe1c39a4f163883_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNC03LTEtMS0w_3ff37b9d-1a1f-4e65-ae9d-dc793d83a595"
      unitRef="usd">88000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ia258ad2862e4409e90d97a6a185618ba_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNS0xLTEtMS0w_ad219a98-e638-46b0-a65b-8a11cf5d803f"
      unitRef="usd">35000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ia258ad2862e4409e90d97a6a185618ba_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNS0zLTEtMS0w_015b287d-ea2f-4048-b216-f3b5bc24ad18"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ia258ad2862e4409e90d97a6a185618ba_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNS01LTEtMS0w_ed793e15-88f0-4610-add1-25a22b19646a"
      unitRef="usd">663000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ia258ad2862e4409e90d97a6a185618ba_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNS03LTEtMS0w_1b58df63-3d6f-4435-819c-41ab76579a49"
      unitRef="usd">27000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i8028e573868a4c60958ff50408279137_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNy0xLTEtMS0w_c6cd878b-511a-4ab8-a7d2-54c903789b7c"
      unitRef="usd">17000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i8028e573868a4c60958ff50408279137_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNy0zLTEtMS0w_1f697fdc-2aa2-458c-bb6a-28df83fb7034"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i8028e573868a4c60958ff50408279137_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNy01LTEtMS0w_41f964d2-932f-4230-934a-f221aab2642e"
      unitRef="usd">463000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i8028e573868a4c60958ff50408279137_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfNy03LTEtMS0w_6c7d6872-489a-49af-adae-f8b57c23d2bb"
      unitRef="usd">20000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ia8683c78419049719e43eefc5616a8bc_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOC0xLTEtMS0w_9162d671-1d26-46e7-8293-c28d34242fdb"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ia8683c78419049719e43eefc5616a8bc_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOC0zLTEtMS0w_de86475f-a4ae-47aa-9564-8b3ca3142e52"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ia8683c78419049719e43eefc5616a8bc_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOC01LTEtMS0w_97b4f8d5-4365-4dd1-aa84-e92e4b802112"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ia8683c78419049719e43eefc5616a8bc_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOC03LTEtMS0w_db11baef-0d81-4b69-96ea-b8d8d7d4373b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOS0xLTEtMS0w_f2c103cb-0bb5-436c-a76f-570dffd47dc7"
      unitRef="usd">1453000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOS0zLTEtMS0w_4b10cc84-f794-4206-8791-e683d5128003"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOS01LTEtMS0w_a1671f5d-71ae-415a-bf1f-1d0013d0fcd4"
      unitRef="usd">4019000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmVjZGEzM2U0MDRiOTQ0ZDE5NWI4NTk2MTZkNmZiYmY2L3RhYmxlcmFuZ2U6ZWNkYTMzZTQwNGI5NDRkMTk1Yjg1OTYxNmQ2ZmJiZjZfOS03LTEtMS0w_2bda56b1-6bac-4094-9f54-2166537848e8"
      unitRef="usd">135000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:GainLossOnInvestmentsTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDY2NQ_2c65d3dd-96a5-4d68-a7dd-0c8b27ca16a2">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity related to the Company&#x2019;s available-for-sale debt securities portfolio is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMi0xLTEtMS0w_4954a8ea-bf28-4766-83d8-68e6adf9714f"
      unitRef="usd">1932000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMi0zLTEtMS0w_c9a0413e-4b5e-4beb-811a-5e21b85f4c65"
      unitRef="usd">1691000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMi01LTEtMS01NDg_0c53b8db-619e-4b47-97d3-8670ec01534e"
      unitRef="usd">4335000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMi03LTEtMS01NTI_293b5388-c510-4107-991d-5409a4e2d30d"
      unitRef="usd">3258000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMy0xLTEtMS0w_37f1d187-ed4c-41b4-b8c2-91cd989b9908"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMy0zLTEtMS0w_378a60a9-519c-499f-b9d0-937645c4bf2f"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMy01LTEtMS01NDg_0fd7bc9e-def4-4cc6-adda-f156730ed55d"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfMy03LTEtMS01NTI_a3eea48b-6a35-4986-84a8-ece9f4cc14c3"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfNC0xLTEtMS0w_d1f343b3-51ce-4772-bb9c-08b4f3d89661"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfNC0zLTEtMS0w_c5da38cb-ff40-47d8-92b8-cc9f45254b5d"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfNC01LTEtMS01NDg_6a8c069f-78cc-4a2a-a978-7a5dce95e615"
      unitRef="usd">7000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjQ1ZTE1NTg2YjM0ZDRmN2I4YjMxNmNmMmU3OTI0NjJiL3RhYmxlcmFuZ2U6NDVlMTU1ODZiMzRkNGY3YjhiMzE2Y2YyZTc5MjQ2MmJfNC03LTEtMS01NTI_7d425f8e-a15b-4098-a036-60a1f251a182"
      unitRef="usd">12000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMjI2OA_1a976e9b-9710-40a4-956f-24cae6c01824"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld>
    <us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMjI2OA_2376bb26-644d-4adc-ba57-4fce0a0d3c53"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld>
    <us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMjMxNA_68564bb7-a6ad-4a15-aa34-fdfcfcccf3ec"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold>
    <us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMjMxNA_68624405-6b24-4ca8-9dbc-545b3329e7b9"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold>
    <us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMjMxNA_b104b66b-b6b0-4a77-80cd-d8a92f322e9d"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold>
    <us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMjMxNA_cf66743c-2cfb-4ff7-b09e-39ad32513316"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDczMQ_afb263dd-cc2f-4022-b56c-d459360b25e8">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The October&#160;30, 2020 balance of available-for-sale and held-to-maturity debt securities by contractual maturity is shown in the following table. Within the table, maturities of mortgage-backed securities have been allocated based upon timing of estimated cash flows assuming no change in the current interest rate environment. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available-For-Sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-To-Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfMS0xLTEtMS0w_9276e895-4735-4368-b65d-b4235b2c0002"
      unitRef="usd">1930000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfMi0zLTEtMS03ODMx_1d488000-415d-4dba-b5a4-e620203fc73e"
      unitRef="usd">886000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfMi0xLTEtMS0w_63532a5f-7bef-4978-8ec1-d5fa75389db6"
      unitRef="usd">3315000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfMy0zLTEtMS03ODMx_0af90074-60c8-43a3-b40e-01583e74701f"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfMy0xLTEtMS0w_3677258c-7f76-4865-824d-66e63caf8119"
      unitRef="usd">1695000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfNC0zLTEtMS03ODMx_93ebd1be-d5c9-4a56-90fa-cfb0614f28cd"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfNC0xLTEtMS0w_91b722a2-cfb2-423c-b743-0283ecf4aede"
      unitRef="usd">67000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfNS0zLTEtMS03ODMx_ff82b979-d7bb-48aa-bd45-1abbe2ad2b37"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfNS0xLTEtMS0w_e8a3f2fb-5cb5-4481-982e-c1ff893b9ba4"
      unitRef="usd">7007000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjBjOTAxMjliYWE1YjRhMTg4YmUxOGM0YWFmNjJiZThmL3RhYmxlcmFuZ2U6MGM5MDEyOWJhYTViNGExODhiZTE4YzRhYWY2MmJlOGZfNi0zLTEtMS03ODMx_562e37a6-930e-4b81-b2cb-a70e07d484b0"
      unitRef="usd">886000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDY4OQ_0773bbfd-5870-4af8-8309-69f17d800e2f">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's equity and other investments at October&#160;30, 2020 and April&#160;24, 2020, which are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments with readily determinable fair value (marketable equity securities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfMS0yLTEtMS0w_ab2d96a7-db56-490a-bf48-631bca790ea0"
      unitRef="usd">25000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i79d2f91d85114433aa75b3dde1c711d7_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfMS00LTEtMS0w_d67ecbf9-5dbf-4730-b07c-d39a8ee0307b"
      unitRef="usd">18000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfMi0yLTEtMS0w_8ce163e4-5dae-43ec-98ff-b121a93ae5d1"
      unitRef="usd">478000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i79d2f91d85114433aa75b3dde1c711d7_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfMi00LTEtMS0w_2f047eaf-f644-43d4-a703-75b16758a75b"
      unitRef="usd">391000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfMy0yLTEtMS0w_6c4eae9c-7b16-4a32-b58b-2571535c33a6"
      unitRef="usd">74000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i79d2f91d85114433aa75b3dde1c711d7_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfMy00LTEtMS0w_2ffc306f-3a52-49b4-9f8a-dada5d85f965"
      unitRef="usd">71000000</us-gaap:EquityMethodInvestments>
    <mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments
      contextRef="i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfNC0yLTEtMS0w_0b513c20-61e1-44fc-b75a-7899d266e004"
      unitRef="usd">577000000</mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments>
    <mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments
      contextRef="i79d2f91d85114433aa75b3dde1c711d7_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOjdkYWZiZjdkY2JhOTQyNWNhZTM1ZDUyYTBmNzRkZmY0L3RhYmxlcmFuZ2U6N2RhZmJmN2RjYmE5NDI1Y2FlMzVkNTJhMGY3NGRmZjRfNC00LTEtMS0w_a181f520-8c72-4a50-b5df-81772fb53eb3"
      unitRef="usd">480000000</mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments>
    <mdt:ScheduleofInvestmentsTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDcyOA_63193c1b-8f34-48bc-b111-781c1c1a3c54">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below includes activity related to the Company&#x2019;s portfolio of equity and other investments. Gains and losses on equity and other investments are recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other non-operating income, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment losses recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mdt:ScheduleofInvestmentsTableTextBlock>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i92bacf56288041769a792da708300ace_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMi0yLTEtMS0w_10d0ce9e-7727-458d-bd69-458a5660a195"
      unitRef="usd">2000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="iefff988b78344694a0de74324a70e787_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMi00LTEtMS0w_82c1ced9-0826-4743-99b0-8c80e841fad5"
      unitRef="usd">0</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMi02LTEtMS01NzQ_58954920-9a3c-4018-a0f3-e9787f23d4b9"
      unitRef="usd">2000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMi04LTEtMS01NzQ_a22cad81-4267-41d0-af67-1bb112b9f9ef"
      unitRef="usd">2000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <mdt:GainonInvestments
      contextRef="i92bacf56288041769a792da708300ace_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMy0yLTEtMS0w_0c41fad4-c5e1-4b2b-aa53-f4af279c9ee3"
      unitRef="usd">2000000</mdt:GainonInvestments>
    <mdt:GainonInvestments
      contextRef="iefff988b78344694a0de74324a70e787_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMy00LTEtMS0w_25052804-1577-447a-b576-6d7e9e07e468"
      unitRef="usd">14000000</mdt:GainonInvestments>
    <mdt:GainonInvestments
      contextRef="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMy02LTEtMS01NzQ_ef55f7b5-8ed2-48ed-a89d-81cb67a0f2b2"
      unitRef="usd">14000000</mdt:GainonInvestments>
    <mdt:GainonInvestments
      contextRef="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfMy04LTEtMS01NzQ_37ff5f2f-f015-4e8a-a1bd-a0449662e239"
      unitRef="usd">14000000</mdt:GainonInvestments>
    <mdt:LossonInvestments
      contextRef="i92bacf56288041769a792da708300ace_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNC0yLTEtMS0w_a78d382f-b53c-4f9b-813c-ffa1604c85ce"
      unitRef="usd">2000000</mdt:LossonInvestments>
    <mdt:LossonInvestments
      contextRef="iefff988b78344694a0de74324a70e787_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNC00LTEtMS0w_5eb748f4-3123-4d60-a4e8-b35ea79c5ef2"
      unitRef="usd">0</mdt:LossonInvestments>
    <mdt:LossonInvestments
      contextRef="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNC02LTEtMS01NzQ_ce2542ac-c11b-4ffd-bd1a-883e603aa6f5"
      unitRef="usd">2000000</mdt:LossonInvestments>
    <mdt:LossonInvestments
      contextRef="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNC04LTEtMS01NzQ_81cd475d-9f4d-49f2-8d2c-074f67d20d0b"
      unitRef="usd">0</mdt:LossonInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i92bacf56288041769a792da708300ace_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNS0yLTEtMS0w_4ac74a95-92ee-46b1-9823-d3203c3c0e2d"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="iefff988b78344694a0de74324a70e787_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNS00LTEtMS0w_455eaa25-76f9-45ce-a3a9-526fb6d1bddd"
      unitRef="usd">2000000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNS02LTEtMS01NzQ_17b2e884-31ea-4859-a790-146582818cfe"
      unitRef="usd">2000000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RhYmxlOmM4NjMzYTQxOWRkMjRkZmVhZTA5YTc2YWRlZTkxMjgxL3RhYmxlcmFuZ2U6Yzg2MzNhNDE5ZGQyNGRmZWFlMDlhNzZhZGVlOTEyODFfNS04LTEtMS01NzQ_5f4fa455-b947-4101-8661-9f994bd9d316"
      unitRef="usd">3000000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i92bacf56288041769a792da708300ace_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDM5ODA0NjUxNzgxMQ_a21c0764-fd48-441a-88cb-36188e9088c8"
      unitRef="usd">0</us-gaap:GainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDMwNQ_cc2119d9-3eec-48f8-8a09-6f0408b1d9cd"
      unitRef="usd">12000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i2a4224596ccd40c480694d2eb209b470_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDMwNQ_fa7b0795-81d5-40ef-b005-2e5e25bec27b"
      unitRef="usd">12000000</us-gaap:GainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMTA5OTUxMTYzMzc1MQ_0c643c62-b766-4196-aac8-cc7f74ace831"
      unitRef="usd">14000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="iefff988b78344694a0de74324a70e787_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMTA5OTUxMTYzMzc1MQ_179967b0-99fa-42f4-8fea-f557bd001866"
      unitRef="usd">14000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="iefff988b78344694a0de74324a70e787_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMTA5OTUxMTYzMzc1MQ_82bc61df-0a1a-4e08-949e-7fd2936e5de1"
      unitRef="usd">14000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i08e3ef148de8417f9e6fe22f5737ff76_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfMTA5OTUxMTYzMzc1MQ_c8bcbea2-ba9c-4315-87fb-39035773b0f0"
      unitRef="usd">14000000</us-gaap:GainLossOnInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV81OC9mcmFnOjgxNzZlOTZiZTU0NDRiOTViMDZjYmNhZjJmMjhkOWU3L3RleHRyZWdpb246ODE3NmU5NmJlNTQ0NGI5NWIwNmNiY2FmMmYyOGQ5ZTdfNDM5ODA0NjUxODA1NA_1416d994-886b-47a4-9e74-145498fbe9cc"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDI4MA_58f8085b-0d31-4555-a26f-5fa0977fac94">Financing Arrangements &lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains commercial paper programs that allow the Company to issue U.S. dollar or Euro-denominated unsecured commercial paper notes. The aggregate amount outstanding at any time under the commercial paper programs may not exceed the equivalent of $3.5 billion. No commercial paper was outstanding at both October&#160;30, 2020 and April&#160;24, 2020. The issuance of commercial paper reduces the amount of credit available under the Company&#x2019;s existing Credit Facility, as defined below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Line of Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a $3.5 billion five-year unsecured revolving credit facility (Credit Facility), which provides back-up funding for the commercial paper programs described above. The Credit Facility includes a multi-currency borrowing feature for certain specified foreign currencies. At October&#160;30, 2020 and April&#160;24, 2020, no amounts were outstanding under the Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rates on advances on the Credit Facility are determined by a pricing matrix, based on the Company&#x2019;s long-term debt ratings, assigned by Standard &amp;amp; Poor&#x2019;s Ratings Services and Moody&#x2019;s Investors Service. Facility fees are payable on the Credit Facility and are determined in the same manner as the interest rates. The agreement also contains customary covenants, all of which the Company was in compliance with at October&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Debt Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's debt obligations consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity by &lt;br/&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.150 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS04NDc2L3RleHRyZWdpb246MzI5ZGJlZDllYWVkNDA2YWI5MDdiMTQ4NzNkNWQxZDZfNzY5NjU4MTM5NDQ3OA_1fc66852-89e8-4b7b-81e1-6369f8dd3419"&gt;seven&lt;/span&gt;-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.200 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS03MDUxL3RleHRyZWdpb246Zjg2ZWM0YTg4NDI3NGFhOWI0ZGJmYWViM2QzZThlZjBfNzY5NjU4MTM5NDQ3OA_0f544188-5492-43f0-8466-e9aa66f80bd2"&gt;ten&lt;/span&gt;-year 2012 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS03MDU5L3RleHRyZWdpb246M2VjNzUyNTAyZmE1NDIzNWE0OWI2YzNhZTZlZGEyM2JfMTU_434d6196-cd71-423f-b1c6-94ab8fd6f545"&gt;four&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.375 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS0wL3RleHRyZWdpb246NjI0ZTZhYTM4MjA3NGI3ZDhkOTYyYWNiZjQ4NDUyNjVfMTU_4e71358d-8a7e-40b6-8487-19339f167751"&gt;four&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS02NTEyL3RleHRyZWdpb246ZWM4Njk1YWJlNjBlNGViOTg3ZWU3MjczM2E3NGIzODJfNzY5NjU4MTM5NDQ5NA_f18bfa88-ad2a-419f-b369-44b60f7697ef"&gt;two&lt;/span&gt;-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.750 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS0wL3RleHRyZWdpb246ZTc2YTM4MTBiNTI1NDMyYzkwY2FhNTg2ZWNhYmU0ZjJfMTU_7216313b-f8c0-40e6-99ac-4a1d7fa40514"&gt;ten&lt;/span&gt;-year 2013 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.950 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfOS0wLTEtMS0wL3RleHRyZWdpb246NDM3NzdkMzViODVmNDM1NTlmNjI1MGRlNTNjYjIyNTZfMTU_73fcdfe3-1699-4e4e-a1b3-6abc413aba37"&gt;ten&lt;/span&gt;-year 2013 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.625 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjBkZGE4M2Y1MTQ5YTQ2NWNiYTYyNGI3YzQ2Y2FmOTc2XzE1_3cf05ffe-b2a6-4335-96b8-f9d8eb8335a3"&gt;ten&lt;/span&gt;-year 2014 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.500 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjMwZDAzODE1ZTQ2YjQ0MGI5YWRkOGIyNjE4NjI1MTY4XzE1_5a8917d8-b557-4f27-97d0-e5d0ca330706"&gt;ten&lt;/span&gt;-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.250 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjY4MTNkM2VlNGE3MjQ2MzQ5ZGY4NjgzMGRjNjA5ZmI2XzE1_dd01a2f7-a10b-4245-962c-1c722b265da7"&gt;seven&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtNjUzMS90ZXh0cmVnaW9uOjY5NDIwNWJkNjIxNDQzYTE5ZmI3NGVmZDI1MzkyOTgzXzc2OTY1ODEzOTQ0OTU_7e8547d7-3068-4d97-88c7-8a5e777cd5be"&gt;five&lt;/span&gt;-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.125 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjVlMTZkMTQyM2ZlNjQ1ZTRiMzQzYjA0ZWU5YzMwZThhXzE1_aeaca299-dcdb-4b89-b32d-ea5647d9bdae"&gt;eight&lt;/span&gt;-year 2019 senior notes &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.350 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjUwOWNjZGNhZTZjYzQ4NTBiNjg1YmNjMDYwZTVkYWYwXzE1_6c38aec9-7242-49e4-a3a0-97185e834427"&gt;ten&lt;/span&gt;-year 2017 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.375 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtNjU1MS90ZXh0cmVnaW9uOjZiZjEyYmVlZGI5NTQwYzQ5N2ZiNTc3OGJmMjk5MmM1Xzc2OTY1ODEzOTQ0ODk_3f1d490f-a710-44cb-aa4c-f5db8f0fa208"&gt;eight&lt;/span&gt;-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.625 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOmQ1YTI2NTk1ZGQ3OTRmYjU4YmUzYjRhZDFmMjE1ZDk1XzE1_5b30e37a-feeb-41bf-b826-7121e730e737"&gt;twelve&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.000 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjZmZDA0ZmIzNjYyNDQ3ZDY5ZjAwN2FlYTRlZjRhZGU4XzE1_932ae6cf-26e5-4bad-b22d-29b416b48b23"&gt;thirteen&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtNjU2NC90ZXh0cmVnaW9uOjVjZTJlM2ZhNTQ5ZTQ4NjBhZmQyOGQxMDdmNDVkMTJmXzc2OTY1ODEzOTQ0OTk_c2fcbcbb-9062-4210-8500-cae9fda3b843"&gt;twelve&lt;/span&gt;-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDA2NzRiOTUwOTQzMjViMjhlYTFkZGQ2YWFjNzY3XzE1_d33f3c62-a9b3-4939-acb6-efa5d1c533e4"&gt;twenty&lt;/span&gt;-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.550 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTI3ZmUyY2I4NjRiODBiYjg3ZDEzZjgzNjI2NDEwXzE1_3ef70171-17bb-4da9-8dc5-bfdf0b5cd24e"&gt;thirty&lt;/span&gt;-year 2007 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.250 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjg1NzhjYzgwNmZjMzQ0NzNhNjczOTJiNGVlYjg5N2YwXzE1_3df5c742-c214-41f0-b3d0-5224780e9379"&gt;twenty&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.500 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOmY0MDRlOGZmYTIyMTQzOWM4YmRlNWYyNWIwNjE1YjQ5XzE1_c2981a7f-89c2-4f44-9205-b4e86754b2c1"&gt;thirty&lt;/span&gt;-year 2009 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.500 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtNzA2Ny90ZXh0cmVnaW9uOjEwMDFhY2UzNjJkYjRkNDNiZjc4NWIwMmU2MzVlY2U5XzE1_057deae6-4bb1-452e-b86a-80173d533019"&gt;twenty&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.550 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjQ1ODFmMjY1ZmNmMjRjYzZiMmNlN2Q2MjViM2Q2NjA1XzE1_db79b77e-7b88-4758-a617-823b3f2a7b0c"&gt;thirty&lt;/span&gt;-year 2010 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.375 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtNjU3NC90ZXh0cmVnaW9uOjhlYTQ1NjhhOTU4YzQwNDU5M2NkMGY1YzdkMjQxYjZmXzc2OTY1ODEzOTQ0OTU_ef0d6972-d506-46e3-9082-3bddd7a7d890"&gt;twenty&lt;/span&gt;-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2041&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.500 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlYTljZmNjYzNiOTQzODM5MzBkNWFhMDBkNmNhNWM4XzE1_df7243fa-33e3-441e-9e5c-0d5e8f72b28c"&gt;thirty&lt;/span&gt;-year 2012 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2042&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjQtMC0xLTEtMC90ZXh0cmVnaW9uOjNhMmQ4M2U3MzY4YzQxYzBiYjk4NTU2YjA1ODJhYjA2XzE1_8015ac63-f366-4764-bf6a-46db806b09cf"&gt;thirty&lt;/span&gt;-year 2013 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjg1ZmFkZGU0NTAyOTQ4OWFiZGI0NDVmMmNkN2Q2OTA5XzE1_194c751d-bc01-4752-9b92-6d1dd7b2c6bd"&gt;thirty&lt;/span&gt;-year 2014 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOmY2MmI2NWE5YjUyMzRiN2NhYzMwNmRhNTRkZjFjNmE2XzE1_816125dd-3eea-4f07-9610-e050c2e8a8b8"&gt;thirty&lt;/span&gt;-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.750 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmRjYTc3ZGQ5MTBlMTQzMWZiY2FmMGExNjI2ZjA1YzUyXzE1_affa4ede-4085-4b4a-8013-9f2c5a3af318"&gt;thirty&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.625 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzMtMC0xLTEtNjU4Ni90ZXh0cmVnaW9uOjEzNTMyNGVhY2U0MTQ2NmJiN2EyYTcxMmI4MzcyMDI3Xzc2OTY1ODEzOTQ0OTU_ecf3e18f-537f-414b-994f-f458754db39a"&gt;thirty&lt;/span&gt;-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2051&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 - 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 - 2051&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 - 2051&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has outstanding unsecured senior obligations, described as senior notes in the tables above (collectively, the Senior Notes). The Senior Notes rank equally with all other unsecured and unsubordinated indebtedness of the Company. The indentures under which the Senior Notes were issued contain customary covenants, all of which the Company remained in compliance with at October&#160;30, 2020.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2019, Medtronic Luxco issued six tranches of Euro-denominated Senior Notes with an aggregate principal of &#x20ac;5.0 billion, with maturities ranging from fiscal year 2021 to fiscal year 2050, resulting in cash proceeds of approximately $5.6 billion, net of discounts and issuance costs. The Company used the net proceeds of the offering to fund the cash tender offer and early redemption of $5.2 billion of Medtronic Inc., CIFSA, and Medtronic Luxco Senior Notes for $5.6 billion of total consideration. The Company recognized a loss on debt extinguishment of $413 million during the first quarter of fiscal year 2020, which primarily included cash premiums and accelerated amortization of deferred financing costs and debt discounts and premiums. The loss was recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statement of income for the six months ended October&#160;25, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, Medtronic Luxco issued an additional six tranches of Euro-denominated Senior Notes with an aggregate principal of &#x20ac;6.3&#160;billion, with maturities ranging from fiscal year 2023 to fiscal year 2051, resulting in cash proceeds of approximately $7.2&#160;billion, net of discounts and issuance costs. The Company used the net proceeds of the offering to fund the early redemption of $4.3&#160;billion of Medtronic Inc. and CIFSA Senior Notes and &#x20ac;1.5&#160;billion of Medtronic Luxco Senior Notes for $6.3&#160;billion of total consideration in October 2020. Additionally, the Company intends to use the proceeds to repay its &#x20ac;750&#160;million floating rate senior notes at maturity in March 2021. The Company recognized a loss on debt extinguishment of $308&#160;million during the current quarter, which primarily included cash premiums and accelerated amortization of deferred financing costs and debt discounts and premiums. The loss was recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income for the three and six months ended October&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Euro-denominated debt issued in June 2019 and September 2020 is designated as a net investment hedge of certain of the Company's European operations. Refer to Note 8 for additional information regarding the net investment hedge.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Term Loan Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 12, 2020, Medtronic Luxco entered into a term loan agreement (Loan Agreement) by and among Medtronic Luxco, Medtronic plc, Medtronic, Inc., and Mizuho Bank, Ltd. as administrative agent and as lender. The Loan Agreement provides an unsecured term loan in an aggregate principal amount of up to &#xa5;300&#160;billion, or approximately $2.8&#160;billion, with a term of six months, which may be extended for an additional six months at Medtronic Luxco&#x2019;s option. On May 13, 2020, Medtronic Luxco borrowed the entire amount of the term loan under the Loan Agreement. Borrowings under the Loan Agreement will bear interest at the TIBOR Rate (as defined in the Loan Agreement) plus a margin of 0.50% per annum. Medtronic plc and Medtronic, Inc. have guaranteed the obligations of Medtronic Luxco under the Loan Agreement. On November 12, 2020, the Company exercised its option to extend the term loan for an additional six months. The Japanese Yen-denominated debt is designated as a net investment hedge of certain of our Japanese operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Instruments Not Measured at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At October&#160;30, 2020, the estimated fair value of the Company&#x2019;s Senior Notes was $29.9 billion compared to a principal value of $27.0 billion. At April&#160;24, 2020, the estimated fair value was $27.1 billion compared to a principal value of $24.5 billion. The fair value was estimated using quoted market prices for the publicly registered Senior Notes, which are classified as Level 2 within the fair value hierarchy. The fair values and principal values consider the terms of the related debt and exclude the impacts of debt discounts and hedging activity.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <mdt:CommercialPaperMaximumBorrowingCapacity
      contextRef="i6c177b7debcf4ed489a1c287af63efa8_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMjkx_1e23a262-7c72-453a-983f-03f94811152f"
      unitRef="usd">3500000000</mdt:CommercialPaperMaximumBorrowingCapacity>
    <us-gaap:CommercialPaper
      contextRef="id3958a76b22149358ea04e9d59ab3dab_I20200424"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMjk1_31b6fb3e-1bdb-4581-8fa8-af177c66b99b"
      unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="i6c177b7debcf4ed489a1c287af63efa8_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMjk1_d934a1a7-a9d9-4075-a3ef-949e202f1753"
      unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i949f35c9b7de4f3cbafef0e58607a8f9_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNTE5_d67f4165-59ec-4bfb-aa2a-612999ac6fa9"
      unitRef="usd">3500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ie3e7e6a0bf3f41a69f7e5b02e57a1cd7_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNTM5Mw_c6db45d4-709a-498b-9a12-3460838a55d2">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCredit
      contextRef="i949f35c9b7de4f3cbafef0e58607a8f9_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNzg3_42c1f2a5-b14b-47b5-92c2-d7f79c833e7b"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i9a912ba559184edb828b6c18fff14699_I20200424"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNzg3_fbe37a6b-af1b-46b8-a3bb-0523f4e72d27"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDI4Mg_1f3090fd-c28f-4cad-ba5e-d936afac8e27">&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's debt obligations consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity by &lt;br/&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.150 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS04NDc2L3RleHRyZWdpb246MzI5ZGJlZDllYWVkNDA2YWI5MDdiMTQ4NzNkNWQxZDZfNzY5NjU4MTM5NDQ3OA_1fc66852-89e8-4b7b-81e1-6369f8dd3419"&gt;seven&lt;/span&gt;-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.200 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS03MDUxL3RleHRyZWdpb246Zjg2ZWM0YTg4NDI3NGFhOWI0ZGJmYWViM2QzZThlZjBfNzY5NjU4MTM5NDQ3OA_0f544188-5492-43f0-8466-e9aa66f80bd2"&gt;ten&lt;/span&gt;-year 2012 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS03MDU5L3RleHRyZWdpb246M2VjNzUyNTAyZmE1NDIzNWE0OWI2YzNhZTZlZGEyM2JfMTU_434d6196-cd71-423f-b1c6-94ab8fd6f545"&gt;four&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.375 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS0wL3RleHRyZWdpb246NjI0ZTZhYTM4MjA3NGI3ZDhkOTYyYWNiZjQ4NDUyNjVfMTU_4e71358d-8a7e-40b6-8487-19339f167751"&gt;four&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS02NTEyL3RleHRyZWdpb246ZWM4Njk1YWJlNjBlNGViOTg3ZWU3MjczM2E3NGIzODJfNzY5NjU4MTM5NDQ5NA_f18bfa88-ad2a-419f-b369-44b60f7697ef"&gt;two&lt;/span&gt;-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.750 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS0wL3RleHRyZWdpb246ZTc2YTM4MTBiNTI1NDMyYzkwY2FhNTg2ZWNhYmU0ZjJfMTU_7216313b-f8c0-40e6-99ac-4a1d7fa40514"&gt;ten&lt;/span&gt;-year 2013 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.950 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfOS0wLTEtMS0wL3RleHRyZWdpb246NDM3NzdkMzViODVmNDM1NTlmNjI1MGRlNTNjYjIyNTZfMTU_73fcdfe3-1699-4e4e-a1b3-6abc413aba37"&gt;ten&lt;/span&gt;-year 2013 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.625 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjBkZGE4M2Y1MTQ5YTQ2NWNiYTYyNGI3YzQ2Y2FmOTc2XzE1_3cf05ffe-b2a6-4335-96b8-f9d8eb8335a3"&gt;ten&lt;/span&gt;-year 2014 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.500 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjMwZDAzODE1ZTQ2YjQ0MGI5YWRkOGIyNjE4NjI1MTY4XzE1_5a8917d8-b557-4f27-97d0-e5d0ca330706"&gt;ten&lt;/span&gt;-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.250 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjY4MTNkM2VlNGE3MjQ2MzQ5ZGY4NjgzMGRjNjA5ZmI2XzE1_dd01a2f7-a10b-4245-962c-1c722b265da7"&gt;seven&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtNjUzMS90ZXh0cmVnaW9uOjY5NDIwNWJkNjIxNDQzYTE5ZmI3NGVmZDI1MzkyOTgzXzc2OTY1ODEzOTQ0OTU_7e8547d7-3068-4d97-88c7-8a5e777cd5be"&gt;five&lt;/span&gt;-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.125 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjVlMTZkMTQyM2ZlNjQ1ZTRiMzQzYjA0ZWU5YzMwZThhXzE1_aeaca299-dcdb-4b89-b32d-ea5647d9bdae"&gt;eight&lt;/span&gt;-year 2019 senior notes &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.350 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjUwOWNjZGNhZTZjYzQ4NTBiNjg1YmNjMDYwZTVkYWYwXzE1_6c38aec9-7242-49e4-a3a0-97185e834427"&gt;ten&lt;/span&gt;-year 2017 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.375 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtNjU1MS90ZXh0cmVnaW9uOjZiZjEyYmVlZGI5NTQwYzQ5N2ZiNTc3OGJmMjk5MmM1Xzc2OTY1ODEzOTQ0ODk_3f1d490f-a710-44cb-aa4c-f5db8f0fa208"&gt;eight&lt;/span&gt;-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.625 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOmQ1YTI2NTk1ZGQ3OTRmYjU4YmUzYjRhZDFmMjE1ZDk1XzE1_5b30e37a-feeb-41bf-b826-7121e730e737"&gt;twelve&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.000 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjZmZDA0ZmIzNjYyNDQ3ZDY5ZjAwN2FlYTRlZjRhZGU4XzE1_932ae6cf-26e5-4bad-b22d-29b416b48b23"&gt;thirteen&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtNjU2NC90ZXh0cmVnaW9uOjVjZTJlM2ZhNTQ5ZTQ4NjBhZmQyOGQxMDdmNDVkMTJmXzc2OTY1ODEzOTQ0OTk_c2fcbcbb-9062-4210-8500-cae9fda3b843"&gt;twelve&lt;/span&gt;-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDA2NzRiOTUwOTQzMjViMjhlYTFkZGQ2YWFjNzY3XzE1_d33f3c62-a9b3-4939-acb6-efa5d1c533e4"&gt;twenty&lt;/span&gt;-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.550 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTI3ZmUyY2I4NjRiODBiYjg3ZDEzZjgzNjI2NDEwXzE1_3ef70171-17bb-4da9-8dc5-bfdf0b5cd24e"&gt;thirty&lt;/span&gt;-year 2007 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.250 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjg1NzhjYzgwNmZjMzQ0NzNhNjczOTJiNGVlYjg5N2YwXzE1_3df5c742-c214-41f0-b3d0-5224780e9379"&gt;twenty&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.500 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOmY0MDRlOGZmYTIyMTQzOWM4YmRlNWYyNWIwNjE1YjQ5XzE1_c2981a7f-89c2-4f44-9205-b4e86754b2c1"&gt;thirty&lt;/span&gt;-year 2009 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.500 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtNzA2Ny90ZXh0cmVnaW9uOjEwMDFhY2UzNjJkYjRkNDNiZjc4NWIwMmU2MzVlY2U5XzE1_057deae6-4bb1-452e-b86a-80173d533019"&gt;twenty&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.550 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjQ1ODFmMjY1ZmNmMjRjYzZiMmNlN2Q2MjViM2Q2NjA1XzE1_db79b77e-7b88-4758-a617-823b3f2a7b0c"&gt;thirty&lt;/span&gt;-year 2010 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.375 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtNjU3NC90ZXh0cmVnaW9uOjhlYTQ1NjhhOTU4YzQwNDU5M2NkMGY1YzdkMjQxYjZmXzc2OTY1ODEzOTQ0OTU_ef0d6972-d506-46e3-9082-3bddd7a7d890"&gt;twenty&lt;/span&gt;-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2041&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.500 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlYTljZmNjYzNiOTQzODM5MzBkNWFhMDBkNmNhNWM4XzE1_df7243fa-33e3-441e-9e5c-0d5e8f72b28c"&gt;thirty&lt;/span&gt;-year 2012 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2042&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjQtMC0xLTEtMC90ZXh0cmVnaW9uOjNhMmQ4M2U3MzY4YzQxYzBiYjk4NTU2YjA1ODJhYjA2XzE1_8015ac63-f366-4764-bf6a-46db806b09cf"&gt;thirty&lt;/span&gt;-year 2013 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjg1ZmFkZGU0NTAyOTQ4OWFiZGI0NDVmMmNkN2Q2OTA5XzE1_194c751d-bc01-4752-9b92-6d1dd7b2c6bd"&gt;thirty&lt;/span&gt;-year 2014 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOmY2MmI2NWE5YjUyMzRiN2NhYzMwNmRhNTRkZjFjNmE2XzE1_816125dd-3eea-4f07-9610-e050c2e8a8b8"&gt;thirty&lt;/span&gt;-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.750 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmRjYTc3ZGQ5MTBlMTQzMWZiY2FmMGExNjI2ZjA1YzUyXzE1_affa4ede-4085-4b4a-8013-9f2c5a3af318"&gt;thirty&lt;/span&gt;-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.625 percent &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzMtMC0xLTEtNjU4Ni90ZXh0cmVnaW9uOjEzNTMyNGVhY2U0MTQ2NmJiN2EyYTcxMmI4MzcyMDI3Xzc2OTY1ODEzOTQ0OTU_ecf3e18f-537f-414b-994f-f458754db39a"&gt;thirty&lt;/span&gt;-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2051&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 - 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 - 2051&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 - 2051&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMS00LTEtMS0w_5e6931da-c73e-4748-9895-09444cd5dcd6"
      unitRef="usd">4041000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMS02LTEtMS0w_cae783c4-cd26-4904-ac53-011f8fc0ac59"
      unitRef="usd">2776000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6e7ded1a38a347e09432a07dee3c0a9c_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS04NDc2L3RleHRyZWdpb246MzI5ZGJlZDllYWVkNDA2YWI5MDdiMTQ4NzNkNWQxZDZfNzY5NjU4MTM5NDQ3Mw_84042592-5c2b-490d-a05a-e19b0b2505a9"
      unitRef="number">0.03150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6e7ded1a38a347e09432a07dee3c0a9c_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC00LTEtMS04NDc2_8e235300-8c5f-43e6-b4aa-94b4956ead40"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5ea679a6b4a74ebeb862f8ec5a9324fc_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC02LTEtMS04NDc2_a53e1a00-0062-4bff-a53f-4095d6531e11"
      unitRef="usd">1534000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i510c4360710e4c0a914d63f14acbfc0f_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS03MDUxL3RleHRyZWdpb246Zjg2ZWM0YTg4NDI3NGFhOWI0ZGJmYWViM2QzZThlZjBfNzY5NjU4MTM5NDQ3Mw_c5b49f65-edec-49f4-a219-b0925e1d0b91"
      unitRef="number">0.03200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i510c4360710e4c0a914d63f14acbfc0f_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC00LTEtMS03MDUx_7d63c37e-8c2f-4a8b-bd51-5b40dec3e27e"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if2f2f4fae83043f3b68e29781af9902c_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC02LTEtMS03MDUx_3f0077ca-ebd0-499d-959e-bc023444e49f"
      unitRef="usd">650000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i28c3585b4c314e93b0ffe730217c8c72_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS03MDU5L3RleHRyZWdpb246M2VjNzUyNTAyZmE1NDIzNWE0OWI2YzNhZTZlZGEyM2JfNA_7a95e7ad-804b-4510-8664-5e3c4e211d1c"
      unitRef="number">0.00000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i28c3585b4c314e93b0ffe730217c8c72_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi00LTEtMS03MDU5_587e0ae0-f81f-43f6-a8ad-8586ea6a2257"
      unitRef="usd">886000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5b52a5b1a53c4ac39014d4b15543f3ec_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi02LTEtMS03MDU5_962f561b-aa7c-4911-8b43-4c1eb48be352"
      unitRef="usd">815000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i69901d8744fd4d879877219042968d11_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS0wL3RleHRyZWdpb246NjI0ZTZhYTM4MjA3NGI3ZDhkOTYyYWNiZjQ4NDUyNjVfNA_57ac5253-eb9e-4bfc-a41a-92045ccc313d"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i69901d8744fd4d879877219042968d11_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi00LTEtMS0w_8734c700-0eb9-418d-85d8-ca72f0e707d8"
      unitRef="usd">1772000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if267642c06af4e0fa5a4118f57c3905d_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi02LTEtMS0w_09f9ebf4-bacb-4795-b070-7132bf626014"
      unitRef="usd">1631000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i044094c947f94eeba950fa8a0c905013_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS02NTEyL3RleHRyZWdpb246ZWM4Njk1YWJlNjBlNGViOTg3ZWU3MjczM2E3NGIzODJfNzY5NjU4MTM5NDQ4Mg_0c22356a-8a90-41ec-ab27-853ae8544622"
      unitRef="number">0.00000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i044094c947f94eeba950fa8a0c905013_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy00LTEtMS02NTI3_509b0cd7-59a9-4f47-8167-f19cde0fe07a"
      unitRef="usd">1477000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibb7d89c620764ee4a60c49931ad7a1fe_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy02LTEtMS02NTI3_5317693c-ece7-4fc4-b32f-7d500e7ce7cb"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2511d50310fe4d6296fc4346e10dd64e_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS0wL3RleHRyZWdpb246ZTc2YTM4MTBiNTI1NDMyYzkwY2FhNTg2ZWNhYmU0ZjJfNA_d345961c-e6aa-4001-8d54-273c160569c1"
      unitRef="number">0.02750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2511d50310fe4d6296fc4346e10dd64e_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy00LTEtMS0w_0a307da9-8bd5-41eb-af78-18608ef2b93b"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id20e750596f440789ec340620cf569f8_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy02LTEtMS0w_a77b3c01-0c6b-406c-838c-bbf2fb3de7d6"
      unitRef="usd">530000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic67fdda296f8439da5d36130db1168cc_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfOS0wLTEtMS0wL3RleHRyZWdpb246NDM3NzdkMzViODVmNDM1NTlmNjI1MGRlNTNjYjIyNTZfNA_76e38993-f103-4e54-ae68-a5d310bf20e5"
      unitRef="number">0.02950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic67fdda296f8439da5d36130db1168cc_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfOS00LTEtMS0w_f32ba5f3-fe85-45c1-8976-1ad9cc3f2f9a"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9b917b2cd2a4484bb2a8f5bd83abdc3c_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfOS02LTEtMS0w_23fbd9cf-908a-421e-98b5-1ac6e90a9538"
      unitRef="usd">310000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i69633ff6d0b54867b5bf49aa176cfef1_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjBkZGE4M2Y1MTQ5YTQ2NWNiYTYyNGI3YzQ2Y2FmOTc2XzQ_dfb35555-6923-442d-a488-498fb18148a6"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i69633ff6d0b54867b5bf49aa176cfef1_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTAtNC0xLTEtMA_82ea1a37-7da2-419d-bc5f-6e4caa29536d"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i47bb4791a9be48879236f93b8dbf5a54_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTAtNi0xLTEtMA_615efe9b-de92-4702-bbc3-239a11da8a9e"
      unitRef="usd">432000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id5c8bd11650841f792d159c232d7e48d_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjMwZDAzODE1ZTQ2YjQ0MGI5YWRkOGIyNjE4NjI1MTY4XzQ_7fd38da2-64a0-4bed-aa1c-eeb0d5029fd5"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id5c8bd11650841f792d159c232d7e48d_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTEtNC0xLTEtMA_9ebf87ff-4f9d-4c9a-90e6-37cc3fab812f"
      unitRef="usd">1890000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i282da68e884d461f91dc382fe42a1836_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTEtNi0xLTEtMA_df16b23c-6870-4deb-87e5-177d0a52fcfc"
      unitRef="usd">2700000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2c789745205747e59bcd97e1084d2e14_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjY4MTNkM2VlNGE3MjQ2MzQ5ZGY4NjgzMGRjNjA5ZmI2XzQ_9b12f6fd-9f56-4807-a84e-c903a0eb9631"
      unitRef="number">0.00250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2c789745205747e59bcd97e1084d2e14_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTItNC0xLTEtMA_ab30a0da-18c9-449c-996b-557a1bdfee1a"
      unitRef="usd">1181000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1102d65e5bbb46288b7d98a976952c66_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTItNi0xLTEtMA_848a8d5d-4979-4306-8ed7-b6bd281b2efc"
      unitRef="usd">1087000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i750ff2c060f8493d976f1ebc84a53c58_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtNjUzMS90ZXh0cmVnaW9uOjY5NDIwNWJkNjIxNDQzYTE5ZmI3NGVmZDI1MzkyOTgzXzc2OTY1ODEzOTQ0ODM_930d43f0-bc85-4a0c-8eb6-61757a8918c5"
      unitRef="number">0.00000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i750ff2c060f8493d976f1ebc84a53c58_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtNC0xLTEtNjU0Nw_1f7d2dc2-2818-4acc-bc18-4f3d680b12bf"
      unitRef="usd">1181000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2c3778ef9fd049c4aa110c60dca8ae9e_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtNi0xLTEtNjU0Nw_5eff56a7-3953-4ec0-9b00-f545a317c364"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i054d412daa1342d9a8adc483ef5ee68a_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjVlMTZkMTQyM2ZlNjQ1ZTRiMzQzYjA0ZWU5YzMwZThhXzQ_7c43c884-7755-481f-a075-df22150763bf"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i054d412daa1342d9a8adc483ef5ee68a_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTMtNC0xLTEtMA_1a5b9d78-f323-45a6-b737-c222db5472f6"
      unitRef="usd">1772000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6f65dfc39b1d4cd496b6246f1492221e_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTMtNi0xLTEtMA_8679dc8f-de0a-4988-8536-fcb3aff290d2"
      unitRef="usd">1631000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0d2033de84454b43a7ecdc388b152f04_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjUwOWNjZGNhZTZjYzQ4NTBiNjg1YmNjMDYwZTVkYWYwXzQ_4a9c5aa9-63df-4116-86fa-aa52d7fb11d5"
      unitRef="number">0.03350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0d2033de84454b43a7ecdc388b152f04_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtNC0xLTEtMA_69d145ac-0c24-420d-8002-b366ae9efd79"
      unitRef="usd">368000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if8727095c1e24f2ca3873ea9374eea75_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtNi0xLTEtMA_53a6bd55-050c-4e5a-ba8c-40da1b5833b7"
      unitRef="usd">368000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i47ee4b0280454a5c98e0ec794d136853_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtNjU1MS90ZXh0cmVnaW9uOjZiZjEyYmVlZGI5NTQwYzQ5N2ZiNTc3OGJmMjk5MmM1Xzc2OTY1ODEzOTQ0ODE_af16b91b-3b85-4ab3-9982-34b2c4af9800"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i47ee4b0280454a5c98e0ec794d136853_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctNC0xLTEtNjU1Nw_00796b34-a8a1-4e54-b82a-058c17654601"
      unitRef="usd">1181000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7910a7e253b74bb6bf57f31ca1e1cc96_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctNi0xLTEtNjU1Nw_0b7e3f59-e826-4495-8042-3b9048c0e8a4"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic82db9dbf25f4810bdca165d071df06e_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOmQ1YTI2NTk1ZGQ3OTRmYjU4YmUzYjRhZDFmMjE1ZDk1XzQ_7a3b7ac2-b1ce-46b0-8bee-6ca63566ecbb"
      unitRef="number">0.01625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic82db9dbf25f4810bdca165d071df06e_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTUtNC0xLTEtMA_9db91ee8-981a-4bb8-b085-a06bd2069ffc"
      unitRef="usd">1181000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i92885844bcb04599b66e758b5d76ae0b_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTUtNi0xLTEtMA_a5309f05-d9f1-4e30-af0b-2434014585a3"
      unitRef="usd">1087000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i565f1750cbac4f25983798f87bb8d5da_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjZmZDA0ZmIzNjYyNDQ3ZDY5ZjAwN2FlYTRlZjRhZGU4XzQ_2cfbb5e1-07e8-4fa9-8a90-f248b40f6cc7"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i565f1750cbac4f25983798f87bb8d5da_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTYtNC0xLTEtMA_c8a8c2c5-dbd5-40d0-b899-cb4324ab5e54"
      unitRef="usd">1181000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i54d8e43d6f024394b56e6aed2e55b5b7_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTYtNi0xLTEtMA_d3d1746e-5968-44a1-8080-4f71fc587093"
      unitRef="usd">1087000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i85287c89df5c4ee8bb7372bcad0e3d62_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtNjU2NC90ZXh0cmVnaW9uOjVjZTJlM2ZhNTQ5ZTQ4NjBhZmQyOGQxMDdmNDVkMTJmXzc2OTY1ODEzOTQ0ODY_27b5ef29-ba17-47e2-9163-53d08e79d7c8"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i85287c89df5c4ee8bb7372bcad0e3d62_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtNC0xLTEtNjU2MQ_cdb12acd-58e6-4529-8dd2-25986f3d5908"
      unitRef="usd">1181000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib824b6753fdd4d998c09bff251b0120c_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtNi0xLTEtNjU2MQ_493a8d24-a531-4390-a6e0-8b814e6794a9"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i06322b5dd15e4cf88a13870353dc869c_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDA2NzRiOTUwOTQzMjViMjhlYTFkZGQ2YWFjNzY3XzQ_1032f911-24d3-434f-9f02-83d1c2f5c8fb"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i06322b5dd15e4cf88a13870353dc869c_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctNC0xLTEtMA_c77243cc-e68b-41e6-99f7-e72c3139c712"
      unitRef="usd">1932000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9b577715d9c647778ab87a85896e3ff6_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctNi0xLTEtMA_2bdbcd00-f9fa-471d-9701-b06a0571822e"
      unitRef="usd">1932000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i83d24b071bbd4084bc5c15d3c012fa6e_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTI3ZmUyY2I4NjRiODBiYjg3ZDEzZjgzNjI2NDEwXzQ_106342c2-e34b-4b03-bc99-c182b5acf551"
      unitRef="number">0.06550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i83d24b071bbd4084bc5c15d3c012fa6e_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTgtNC0xLTEtMA_3ba53d75-838f-4726-ac77-e5eda0c2c139"
      unitRef="usd">253000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i950765e074ae4226bcc6450b9efc0ac4_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTgtNi0xLTEtMA_d5a4896e-7f1c-4eeb-a0d5-1670adc75961"
      unitRef="usd">253000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iabf27779745645c392a68929410ce222_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjg1NzhjYzgwNmZjMzQ0NzNhNjczOTJiNGVlYjg5N2YwXzQ_396999a9-e794-44a9-803a-d4951b2e5e61"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iabf27779745645c392a68929410ce222_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTktNC0xLTEtMA_18899692-f848-4a98-a8e5-d8d319be803c"
      unitRef="usd">1181000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i69f9f92316aa4bd9a6b5dca506e8a598_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTktNi0xLTEtMA_0d6f5e8c-27e9-4b98-aa2d-23e305318fbd"
      unitRef="usd">1087000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6f70c23d31a04b9aa0f47612bada4682_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOmY0MDRlOGZmYTIyMTQzOWM4YmRlNWYyNWIwNjE1YjQ5XzQ_df08ccea-262d-4dc7-a7f0-dbf6567e7214"
      unitRef="number">0.06500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6f70c23d31a04b9aa0f47612bada4682_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtNC0xLTEtMA_a0590822-7ac5-48c3-b72d-83f94e8b7672"
      unitRef="usd">158000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6683088e6e054026a6a7bdb9e6391a9a_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtNi0xLTEtMA_6b6b1f39-94c2-4632-927c-90cb09247261"
      unitRef="usd">158000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iec3a4aa6910146c4a58dfc971610fa11_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtNzA2Ny90ZXh0cmVnaW9uOjEwMDFhY2UzNjJkYjRkNDNiZjc4NWIwMmU2MzVlY2U5XzQ_aeadd553-cf54-4cdb-a1ef-ede9d3fb8f61"
      unitRef="number">0.01500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iec3a4aa6910146c4a58dfc971610fa11_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtNC0xLTEtNzA2Nw_1d5e781f-8409-440f-910b-8bc56b1ded37"
      unitRef="usd">1181000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id20d878354164798a7a7a92885288fed_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtNi0xLTEtNzA2Nw_95c1f89b-f255-4cf6-af84-c80ddabd60ff"
      unitRef="usd">1087000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i37040ee9a2694677a6a593b2e2d36c88_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjQ1ODFmMjY1ZmNmMjRjYzZiMmNlN2Q2MjViM2Q2NjA1XzQ_3f9ad542-e49c-46a9-9f6d-06579d5bc194"
      unitRef="number">0.05550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i37040ee9a2694677a6a593b2e2d36c88_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjEtNC0xLTEtMA_7db16b3b-6197-4184-b40b-e11f1d8ff013"
      unitRef="usd">224000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iff148c09a35d4309af70243e1e4a1d6f_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjEtNi0xLTEtMA_0097feda-78cd-4950-807c-19d7cc0dc9a1"
      unitRef="usd">224000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i20c62f91aaa741a19f4b61315da66964_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtNjU3NC90ZXh0cmVnaW9uOjhlYTQ1NjhhOTU4YzQwNDU5M2NkMGY1YzdkMjQxYjZmXzc2OTY1ODEzOTQ0ODQ_4b7e95bd-4a08-463e-b7a0-0b84172c9506"
      unitRef="number">0.01375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i20c62f91aaa741a19f4b61315da66964_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctNC0xLTEtNjU3MQ_d7b99a4f-5236-4071-9a1e-a7dcabc7e4f5"
      unitRef="usd">1181000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iae5109e80f914300a5a387ebde6c8776_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctNi0xLTEtNjU3MQ_475d97dc-4b58-4a28-89e4-ee1675539f37"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0af3561ae38a455788310e9883ab62ac_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlYTljZmNjYzNiOTQzODM5MzBkNWFhMDBkNmNhNWM4XzQ_890e7a84-bde2-4064-b266-83be2963f784"
      unitRef="number">0.04500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0af3561ae38a455788310e9883ab62ac_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjMtNC0xLTEtMA_4a2873ca-8c6b-45ff-a3d1-645c5a07b4d5"
      unitRef="usd">105000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0c9e7d2efbc24021807fa47750a582ac_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjMtNi0xLTEtMA_3b0d51c6-7d7c-44f9-85ec-d97fa9099347"
      unitRef="usd">105000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id7e8238cae344221b36d9ab213d64ec0_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjQtMC0xLTEtMC90ZXh0cmVnaW9uOjNhMmQ4M2U3MzY4YzQxYzBiYjk4NTU2YjA1ODJhYjA2XzQ_a9008fe4-c9ed-4457-8647-4059c2a62f58"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id7e8238cae344221b36d9ab213d64ec0_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjQtNC0xLTEtMA_b5968eea-1e0f-44b0-a2ba-a3677410499e"
      unitRef="usd">305000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie4c1c10ae78d45fb991c7444838f455a_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjQtNi0xLTEtMA_6081a3d3-3dd8-442b-ba43-a4056e52888a"
      unitRef="usd">305000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i49d71ddf48d24bdcadb9fae5bdae5c01_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjg1ZmFkZGU0NTAyOTQ4OWFiZGI0NDVmMmNkN2Q2OTA5XzQ_fc90c9f1-32e3-4211-b8b2-60ea4f1a9121"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i49d71ddf48d24bdcadb9fae5bdae5c01_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtNC0xLTEtMA_696212d6-75b2-4699-880c-31f284d953d9"
      unitRef="usd">127000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i535f2391eaba4f61bbb4700d09ee8601_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtNi0xLTEtMA_08813e63-2e98-4e76-b0ca-e8966804a9a1"
      unitRef="usd">127000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icf19d18ef5f54fb2a1e2e30d815f91b0_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOmY2MmI2NWE5YjUyMzRiN2NhYzMwNmRhNTRkZjFjNmE2XzQ_54761768-f052-4830-8e47-b5143e5fe74c"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="icf19d18ef5f54fb2a1e2e30d815f91b0_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjYtNC0xLTEtMA_2b1a16eb-0edf-44b3-9cfe-7e7c83eb8b4e"
      unitRef="usd">1813000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i361b55cbce594a09970ba9fd123f2b16_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjYtNi0xLTEtMA_32bc3c0b-8fbd-4c7b-90c7-1d6ae0b7584a"
      unitRef="usd">1813000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i047b42eae5e7495c83549c009df4d1d4_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmRjYTc3ZGQ5MTBlMTQzMWZiY2FmMGExNjI2ZjA1YzUyXzQ_8e48b08d-1630-4061-8f87-4b4db20a67b4"
      unitRef="number">0.01750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i047b42eae5e7495c83549c009df4d1d4_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctNC0xLTEtMA_d1373aff-8f1d-42a7-9e47-d2e4c2ec99f6"
      unitRef="usd">1181000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if210b924935c4b4d81d00ae7c8599261_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctNi0xLTEtMA_e99e9ecb-c07a-4c45-8392-580f2c1a7844"
      unitRef="usd">1087000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i819e50da385f459f903ea9d6d5d47c66_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzMtMC0xLTEtNjU4Ni90ZXh0cmVnaW9uOjEzNTMyNGVhY2U0MTQ2NmJiN2EyYTcxMmI4MzcyMDI3Xzc2OTY1ODEzOTQ0ODQ_65dc7923-0eb0-44f4-a643-2ef12cce584d"
      unitRef="number">0.01625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i819e50da385f459f903ea9d6d5d47c66_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzMtNC0xLTEtNjU4Mw_1e6996a6-fc13-4254-a5a8-b5f22a6bedb6"
      unitRef="usd">1181000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8d83db0a3a404462a7f0f25f297ae072_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzMtNi0xLTEtNjU4Mw_da01bbad-ff06-4d2d-8b3f-c61606e6b96e"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9090df86b8294bf988864695140aea55_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjgtNC0xLTEtMA_d625ba49-e061-4756-8bff-06be340860ba"
      unitRef="usd">43000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id954a5663cfc43e69849fbce86b15b9a_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjgtNi0xLTEtMA_ccf67c59-be6d-4b2c-aec1-64722f9284b6"
      unitRef="usd">55000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzUtNC0xLTEtNzA4Mw_5f379146-ea5f-40b4-922a-61cd5d1612e7"
      unitRef="usd">56000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzUtNi0xLTEtNzA4Mw_cd7874a3-fa11-49c2-b311-c4ec7ac0f494"
      unitRef="usd">45000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzUtNC0xLTEtNzA3Ng_abf50726-2713-457f-98e0-cb8f4fd3e2ed"
      unitRef="usd">133000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzUtNi0xLTEtNzA3Ng_c4046492-d1bc-490b-aec4-685c81bbc47b"
      unitRef="usd">104000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjktNC0xLTEtMA_d40806d0-3a56-46d3-a7cc-c24edb9be980"
      unitRef="usd">72000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjktNi0xLTEtMA_c4b7a297-cd60-43ce-9021-f3f967e1e316"
      unitRef="usd">15000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzItNC0xLTEtMA_2bcf7bbb-cc9b-4bab-9f3a-1e74c03dcc32"
      unitRef="usd">25967000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzItNi0xLTEtMA_48d3a033-afce-4c9e-9f88-513c329fbc8d"
      unitRef="usd">22021000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <mdt:DebtInstrumentNumberofTranches
      contextRef="i43ca1b9479324066bf20af6381092405_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMTc4NA_66f8ab78-43c7-4a2f-98b4-c0b9e48d149e"
      unitRef="tranche">6</mdt:DebtInstrumentNumberofTranches>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i43ca1b9479324066bf20af6381092405_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMTg2MA_6670c21e-4223-449f-a40d-4418e4dc48cd"
      unitRef="eur">5000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i03edad1ee21c45e8bae5af91c450f7d7_D20190601-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMTk3NQ_83eab008-c511-4c0a-919f-374d81a484e6"
      unitRef="usd">5600000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i486f35ff70c14b7cbda1a961e72c4759_D20190601-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMjM3Nw_6d9f3a91-f994-4cb9-9858-696d35e259cf"
      unitRef="usd">5200000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i486f35ff70c14b7cbda1a961e72c4759_D20190601-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMjQ0Mw_88fccb61-6e11-47ac-873a-f6547a285475"
      unitRef="usd">5600000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i419528b46438459b85358d801fe6c31d_D20190427-20190726"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMjUzOQ_7b64fead-b349-4bd2-a008-fe2510ce0e3d"
      unitRef="usd">-413000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <mdt:DebtInstrumentNumberofTranches
      contextRef="ie2b8c1f994574df88bd778df94f6e8d6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzY5Mw_1d17977b-4a2f-4491-8f36-f698900f6742"
      unitRef="tranche">6</mdt:DebtInstrumentNumberofTranches>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie2b8c1f994574df88bd778df94f6e8d6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzcwMg_2f15b111-4045-4c47-b986-2a6fd3603fb3"
      unitRef="eur">6300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ibc8fac86e3e34735bd2213a5c893c73c_D20200901-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzcxNg_63da51d7-c0dc-401b-bee1-03c83bd13ed6"
      unitRef="usd">7200000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i322602253ac842238d97f6323baf0b2a_D20201001-20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzczMA_467e3346-3f0e-4655-9280-66bf1d64fe1a"
      unitRef="usd">4300000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i89c3b3d9a895475985db2b36880fecca_D20201001-20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxODgxMQ_595f7e95-83da-4320-b6b4-d051190f16b7"
      unitRef="eur">1500000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i1f534412b2ac4f5d9802c54fd029f5a9_D20201001-20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzc0NA_c7bf11b7-5cc0-488d-8e62-8e551bbcd871"
      unitRef="usd">6300000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="id3d8d5311ebb4a75a24f1e7a8af56005_D20210301-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxODQzMw_036e08a2-62ea-415a-9319-750475c34265"
      unitRef="eur">750000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6e1f6fd2fd7b47459d0613747fb74d8f_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzc1OA_3f88677d-409a-46c2-aeec-4f4183b59f6e"
      unitRef="usd">-308000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iae6ac6ba362d46f7a069d17790df5dde_I20200512"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzE1Ng_314463b7-6adb-4bbf-ac4f-780cda60eb44"
      unitRef="jpy">300000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iae6ac6ba362d46f7a069d17790df5dde_I20200512"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzE3Nw_e57798a4-4cd9-4f9f-a9e9-9e324885eaab"
      unitRef="usd">2800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentTerm
      contextRef="ia15b2fe50423464a9cf5623ac357741d_D20200512-20200512"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzE5Ng_43f1f7eb-8243-42e3-8c43-fed4a4e56e08">P6M</us-gaap:DebtInstrumentTerm>
    <mdt:DebtInstrumentExtensionOptionTermOfExtension
      contextRef="ia15b2fe50423464a9cf5623ac357741d_D20200512-20200512"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzI0MA_ce3ec862-d749-4ade-8485-6f7cd482a5a3">P6M</mdt:DebtInstrumentExtensionOptionTermOfExtension>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iae724a5cf9f94ef18e23e8e16d639ab6_D20200512-20200512"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzUwMA_03da22ca-89f5-478e-92e9-efbaa9bcc028"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <mdt:DebtInstrumentExtensionOptionTermOfExtension
      contextRef="icfb13d6a6af84816860e81aaba6f97d0_D20201112-20201112"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfNDM5ODA0NjUxNzc3MQ_c0209ef2-6805-42d8-af99-722b2c27289c">P6M</mdt:DebtInstrumentExtensionOptionTermOfExtension>
    <us-gaap:LongTermDebtFairValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzg1NA_cda2c9d8-b58a-4f09-adca-6c934bfaf6ee"
      unitRef="usd">29900000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzg5MA_2106e8b8-f6a6-4740-ba52-00b80bd81c42"
      unitRef="usd">27000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtFairValue
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzkzMA_b43effa1-fca9-4890-ae86-310ccaa19c33"
      unitRef="usd">27100000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RleHRyZWdpb246YzhjNWQ3ZjFiNjAyNDc4MTg2MGRjNDFlOTZjYjNjYjdfMzk2Ng_51195fa1-dae9-4371-bd5d-b5f3fce081b9"
      unitRef="usd">24500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1Mzk_1e33f642-d0b6-4808-a2f5-613cfcc5d6aa">Derivatives and Currency Exchange Risk Management &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses operational and economic hedges, including currency exchange rate derivative contracts and interest rate derivative instruments, to manage the impact of currency exchange and interest rate changes on earnings and cash flows. In addition, the Company uses cross currency interest rate swaps to manage currency risk related to certain debt. In order to minimize earnings and cash flow volatility resulting from currency exchange rate changes, the Company enters into derivative instruments, principally forward currency exchange rate contracts. These contracts are designed to hedge anticipated foreign currency transactions and changes in the value of specific assets and liabilities. At inception of the contract, the derivative is designated as either a freestanding derivative or a cash flow hedge. Currencies of our derivative instruments include the Euro, Japanese Yen, Chinese Yuan, and others. The Company does not enter into currency exchange rate derivative contracts for speculative purposes. The gross notional amount of all currency exchange rate derivative instruments outstanding was $18.5 billion and $11.9 billion at October&#160;30, 2020 and April&#160;24, 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also uses derivative and non-derivative instruments to manage the impact of currency exchange rate changes on net investments in foreign currency-denominated operations. The information that follows explains the various types of derivatives and financial instruments used by the Company, reasons the Company uses such instruments, and the impact such instruments have on the Company&#x2019;s consolidated balance sheets and statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Freestanding Derivative Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Freestanding derivative contracts are primarily used to offset the Company&#x2019;s exposure to the change in value of specific foreign-currency-denominated assets and liabilities, and to offset variability of cash flows associated with forecasted transactions denominated in foreign currencies. The gross notional amount of the Company's freestanding currency exchange rate contracts outstanding at October&#160;30, 2020 and April&#160;24, 2020 was $10.7 billion and $4.9 billion, respectively. The Company's freestanding currency exchange rate contracts are not designated as hedges, and therefore, changes in the value of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related change in value of foreign-currency-denominated assets, liabilities, and cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also uses total return swaps to hedge the liability of a non-qualified, deferred compensation plan. The gross notional amount of the Company's total return swaps outstanding at October&#160;30, 2020 and April&#160;24, 2020 was $197 million and $181 million, respectively. The Company's total return swaps are not designated as hedges, and therefore, changes in the value of these instruments are recognized in earnings. The cash flows related to the Company's freestanding derivative contracts are reported as operating activities in the consolidated statements of cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts and classification of the (gains) losses in the consolidated statements of income related to derivative instruments not designated as hedging instruments for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.866%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forward contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. The gross notional amount of these contracts, designated as cash flow hedges, outstanding at October&#160;30, 2020 and April&#160;24, 2020 was $7.8 billion and $7.0 billion, respectively, and will mature within the subsequent three-year period. For derivative instruments that are designated and qualify as a cash flow hedge, the gain or loss on the derivative instrument is reported as a component of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; accumulated other comprehensive loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The gain or loss on the derivative instrument is reclassified into earnings and is included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other operating expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income in the same period or periods during which the hedged transaction affects earnings. Amounts excluded from the measurement of hedge effectiveness are recognized in earnings in the current period. The cash flows related to all of the Company's derivative instruments designated as cash flow hedges are reported as operating activities in the consolidated statements of cash flows. No components of the hedge contracts were excluded in the measurement of hedge effectiveness, and no forward contracts designated as cash flow hedges were derecognized or discontinued during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of the (gains) losses recognized in accumulated other comprehensive loss (AOCI) related to the currency exchange rate contract derivative instruments designated as cash flow hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of the (gains) losses recognized in the consolidated statements of income related to derivative instruments designated as cash flow hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented in the consolidated statements of income in which the effects of cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency exchange rate contracts designated as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Forecasted Debt Issuance Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forward starting interest rate derivative instruments designated as cash flow hedges are designed to manage the exposure to interest rate volatility with regard to future issuances of fixed-rate debt. The gains or losses on forward starting interest rate derivative instruments that are designated and qualify as cash flow hedges are reported as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;accumulated other comprehensive loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Beginning in the period in which the planned debt issuance occurs and the related derivative instruments are terminated, the gains or losses are then reclassified into &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;interest expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;over the term of the related debt. For the three and six months ended October&#160;30, 2020 and October&#160;25, 2019, the reclassifications of net (gains) losses on forward starting interest rate derivative instruments from accumulated other comprehensive loss to interest expense were not significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At October&#160;30, 2020 and April&#160;24, 2020, the Company had $129 million in after-tax net unrealized losses and $266 million in after-tax net unrealized gains, respectively, associated with cash flow hedging instruments recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;accumulated other comprehensive loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company expects that $34 million of after-tax net unrealized losses at October&#160;30, 2020 will be recognized in the consolidated statements of income over the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has designated Euro-denominated and Japanese Yen-denominated debt as net investment hedges of certain of its European and Japanese operations to manage the exposure to currency and exchange rate movements for foreign currency-denominated net investments in foreign operations. At October&#160;30, 2020, the Company had &#x20ac;16.0 billion, or $18.9 billion, of outstanding Euro-denominated debt designated as a hedge of its net investment in certain of its European operations, and &#xa5;300 billion, or $2.9 billion, of outstanding Yen-denominated debt designated as a hedge of its net investment in certain of its Japanese operations. The Euro-denominated debt will mature in fiscal years 2023 through 2051 and the Yen-denominated debt will mature in fiscal year 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, during the first quarter of fiscal year 2020, the Company entered into and settled forward currency exchange rate contracts to manage the exposure to exchange rate movements in anticipation of the issuance of Euro-denominated senior notes. Certain of these forward currency exchange rate contracts were designated as a net investment hedge of certain of the Company's European operations. These contracts matured in conjunction with the issuance of Euro-denominated debt in the first quarter of fiscal year 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For instruments that are designated and qualify as net investment hedges, the gains or losses are reported as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;accumulated other comprehensive loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The gains or losses are reclassified into earnings upon a liquidation event or deconsolidation of the foreign subsidiary. Amounts excluded from the assessment of effectiveness are recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other operating expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The cash flows related to the Company's derivative instruments designated as net investment hedges are reported as investing activities in the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At October&#160;30, 2020 and April&#160;24, 2020, the Company had $1.0 billion in after-tax unrealized losses and $236 million in after-tax unrealized gains, respectively, associated with net investment hedges recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;accumulated other comprehensive loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company does not expect any of the after-tax unrealized gains at October&#160;30, 2020 to be recognized in the consolidated statements of income over the next 12 months. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not recognize any gains or losses during the three and six months ended October&#160;30, 2020 or October&#160;25, 2019 on instruments that no longer qualify as net investment hedges. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount and classifications of the (gains) losses recognized in the consolidated statements of income for the portion of the net investment hedges excluded from the measurement of hedge effectiveness were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of the (gains) losses recognized in AOCI related to instruments designated as net investment hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance Sheet Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the balance sheet classification and fair value of derivative instruments included in the consolidated balance sheets at October&#160;30, 2020 and April&#160;24, 2020. The fair value amounts are presented on a gross basis and are segregated between derivatives that are designated and qualify as hedging instruments and those that are not designated and do not qualify as hedging instruments and are further segregated by type of contract within those two categories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information by level for the derivative assets and liabilities that are measured at fair value on a recurring basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to present the fair value of derivative assets and liabilities within the consolidated balance sheets on a gross basis, even when derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation. The cash flows related to collateral posted and received are reported gross as investing and financing activities, respectively, in the consolidated statements of cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount Not Offset on the Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount of Recorded Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Collateral Posted (Received)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount Not Offset on the Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount of Recorded Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Collateral Posted (Received)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTEyNw_099392d3-3aab-4570-8710-db66cfae9fe9"
      unitRef="usd">18500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTEzNA_f3e2dbca-a8ab-4620-9459-50f566c41ca1"
      unitRef="usd">11900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6ea2a0e5eb0e4f09a8904720d94ebebf_I20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMjA1OA_08e9d96c-d274-455f-81f1-533d605a5353"
      unitRef="usd">10700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibef9e0da89e44b89b330d067b8948c58_I20200424"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMjA2NQ_0d7a9587-216a-4b5d-bde9-a4d34ac56b35"
      unitRef="usd">4900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ife2e4bf093494b09ba98f801beb8b9c5_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMjYwNw_da406e03-cce2-4186-a2ec-bfee978d5d14"
      unitRef="usd">197000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if2e03acd84264aa29f524bb28094ffe8_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMjYxNA_ccf22e24-9a5e-4ecb-a372-2a21bf9d9e92"
      unitRef="usd">181000000</us-gaap:DerivativeNotionalAmount>
    <mdt:ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NDk_90dd08ef-08b2-4cb7-808d-6a2dded669eb">&lt;div style="margin-bottom:9pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts and classification of the (gains) losses in the consolidated statements of income related to derivative instruments not designated as hedging instruments for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.866%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mdt:ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i3bb7d8650d424a3794638ac05acc85b1_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMi00LTEtMS0w_8db53b65-909d-4019-9eab-6f8faf7793ad"
      unitRef="usd">2000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i062f1ed49909469d842f2bc395542043_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMi02LTEtMS0w_00320cd2-7ac0-4df4-b544-a4614f261f6e"
      unitRef="usd">12000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="iaf768e66580b409297df422a6b58cc7b_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMi04LTEtMS01OTI_611a0603-07ad-4723-a3f6-4fb2703fae96"
      unitRef="usd">-125000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i48ef881065414c91bb7f52fc1c7a7c86_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMi0xMC0xLTEtNTky_c19170a7-ea8c-4f59-973f-5c18d2498fd7"
      unitRef="usd">6000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i0cafeb122608423eb2b62ea29bc09a5c_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMy00LTEtMS0w_3d03e1ae-f1a4-45ea-b097-42fa86fb3a3b"
      unitRef="usd">1000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i7c49d00a2f3f4bba86faabfc7866ed13_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMy02LTEtMS0w_cfad2956-69c8-41f9-85ab-356be7cb6c2b"
      unitRef="usd">-1000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="iada485b3a6b245668a27a3b5fa95eb3c_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMy04LTEtMS01OTI_ebaedbfb-bb5f-4567-9711-ecb17d5d80c6"
      unitRef="usd">28000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i7a16715731e144e2a482d62407c58c16_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfMy0xMC0xLTEtNTky_3e69ef99-22ea-452d-91fa-96758e329b38"
      unitRef="usd">4000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfNC00LTEtMS0w_12e17a75-0b5f-4570-833e-ec59242bc498"
      unitRef="usd">3000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfNC02LTEtMS0w_52054d88-f3cc-4869-8f51-2b5fbaeb6c71"
      unitRef="usd">11000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfNC04LTEtMS05ODU_e9dd3719-6e49-4351-a06c-4a37956e2cc2"
      unitRef="usd">-97000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjc2MDliMjI0MTM4YTRkYTI4Y2RmM2VkMjU5NmRhN2UyL3RhYmxlcmFuZ2U6NzYwOWIyMjQxMzhhNGRhMjhjZGYzZWQyNTk2ZGE3ZTJfNC0xMC0xLTEtOTg1_eb0711ae-82fa-4580-9cef-9dfc9085cc85"
      unitRef="usd">10000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0eaf93d2e883447e94be4b40d4ea2307_I20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMzQ5NQ_4a7aefe4-abf7-4466-8275-630179e30da0"
      unitRef="usd">7800000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i28d09151fa8641dca241e92bb8200f44_I20200424"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMzUwMg_fb0d71d4-7894-4991-b3c6-d11801613095"
      unitRef="usd">7000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1
      contextRef="ib696730068be4184a7cba30530fe6e73_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1Nzg_b8db7431-0a79-445e-bba0-767ada9a5b47">P3Y</us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NjQ_27b19361-f5ca-47fa-a6be-40d91bc0b02c">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of the (gains) losses recognized in accumulated other comprehensive loss (AOCI) related to the currency exchange rate contract derivative instruments designated as cash flow hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i16ecf308db934c58b716f575ffc1e8e2_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZlM2EzZmRlMjQ3OTQ5NDk5MTUwNDQ0NzZkNTBjOWU5L3RhYmxlcmFuZ2U6ZmUzYTNmZGUyNDc5NDk0OTkxNTA0NDQ3NmQ1MGM5ZTlfMi0yLTEtMS0w_5061d061-51f2-4447-a063-a8ca8551b69e"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5f39166258654e8b962cb7a6c6db3661_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZlM2EzZmRlMjQ3OTQ5NDk5MTUwNDQ0NzZkNTBjOWU5L3RhYmxlcmFuZ2U6ZmUzYTNmZGUyNDc5NDk0OTkxNTA0NDQ3NmQ1MGM5ZTlfMi00LTEtMS0w_1a68921b-6b80-4419-aea4-581b44b7c11a"
      unitRef="usd">76000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ibb04dfb4fa234538bad556529f05fd2c_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZlM2EzZmRlMjQ3OTQ5NDk5MTUwNDQ0NzZkNTBjOWU5L3RhYmxlcmFuZ2U6ZmUzYTNmZGUyNDc5NDk0OTkxNTA0NDQ3NmQ1MGM5ZTlfMi02LTEtMS05ODc_726ebf88-78c1-4921-b6aa-fe3a2851ef0f"
      unitRef="usd">-451000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i74eac46b3d2b4217a1efbf920f47ff09_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZlM2EzZmRlMjQ3OTQ5NDk5MTUwNDQ0NzZkNTBjOWU5L3RhYmxlcmFuZ2U6ZmUzYTNmZGUyNDc5NDk0OTkxNTA0NDQ3NmQ1MGM5ZTlfMi04LTEtMS05ODc_e7e5b997-5e79-473e-9e83-8a8cdc3a74bb"
      unitRef="usd">103000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NTI_abb826a2-059d-4dd0-a570-e636cb092311">&lt;div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of the (gains) losses recognized in the consolidated statements of income related to derivative instruments designated as cash flow hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented in the consolidated statements of income in which the effects of cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency exchange rate contracts designated as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfMy0yLTEtMS0w_7306feaa-feac-4539-befc-9a2392de4c68"
      unitRef="usd">-149000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfMy00LTEtMS0w_35f4033d-3ac0-4ab7-bc78-bafac967c181"
      unitRef="usd">-149000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfMy02LTEtMS05ODk_7293c62a-22e4-4ca2-a4e3-aa50f068decf"
      unitRef="usd">-35000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfMy02LTEtMS05ODk_8dd1fe46-c1a6-4e6d-a33e-96f1c125884d"
      unitRef="usd">-35000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfMy04LTEtMS05ODk_60a49eca-9214-426e-b575-376f14499bfe"
      unitRef="usd">-127000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfMy04LTEtMS05ODk_8cbffb02-bc95-44fa-97f4-22f8a97acd8b"
      unitRef="usd">-127000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="id17a89cb1d9e431db69c4426862755a5_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfOC0yLTEtMS0w_3a752774-e7e2-4b40-aaee-ab891ddbf0e3"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ic3af287ba57845e88cc3662a0cc58115_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfOC00LTEtMS0w_7fa0c9cc-871e-4c2d-9269-f668280c4ca4"
      unitRef="usd">68000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ida9267d57494477c8173b527d15ad048_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfOC02LTEtMS05ODk_dbd950ea-a531-4b3b-9792-ee598157abc6"
      unitRef="usd">55000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i627fbb34d41b4c299271b22b6ba80293_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMTFkYzA5YmZiMTQ1NTRiNDExMThiNjYzMmFiNGY3L3RhYmxlcmFuZ2U6N2YxMWRjMDliZmIxNDU1NGI0MTExOGI2NjMyYWI0ZjdfOC04LTEtMS05ODk_41860cc8-670a-4843-9f54-bf7abcfd1755"
      unitRef="usd">125000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNTkwOA_64640c66-5bc3-439a-8f33-bed8e17abdb8"
      unitRef="usd">-129000000</mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNTk1MA_b965f20c-c68d-4099-a756-406fa18f1ee9"
      unitRef="usd">266000000</mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNjEyMw_5df4ea7e-7a11-4092-a4cf-b89c36c8a6db"
      unitRef="usd">-34000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i84ca06f620184bbfa7d366fe5853ce18_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNjU4Ng_909b1973-7d36-45f9-92a1-c64aa65ae095"
      unitRef="eur">16000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i98e4061404054b75be5b3c8c2b4acd40_I20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNjU5Mw_a3ebc7c7-72fb-4a15-ba36-9e4ccfa0c677"
      unitRef="usd">18900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i84ca06f620184bbfa7d366fe5853ce18_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNjcyMQ_5cdf7216-7d0a-42a3-a5fc-bbc17be037a3"
      unitRef="jpy">300000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib482970decd34242a76c6fbf96fcb507_I20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfNjcyOA_8dc33526-6218-4525-b6ef-107207db2248"
      unitRef="usd">2900000000</us-gaap:DerivativeNotionalAmount>
    <mdt:UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODE4NQ_04b28a45-1956-4053-9419-e297a74c6d62"
      unitRef="usd">-1000000000.0</mdt:UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax>
    <mdt:UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax
      contextRef="i26298cf036964bed9c4492fcb3a09498_D20190427-20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODIyMw_0e92f454-cca5-4887-91a5-be8b9ac00e16"
      unitRef="usd">236000000</mdt:UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax>
    <mdt:NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODM3Ng_4195eb4b-4b44-427c-afd5-76c98d3ac315"
      unitRef="usd">0</mdt:NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths>
    <mdt:GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODUzMQ_048311f2-586f-4148-a8e3-678bdce9555e"
      unitRef="usd">0</mdt:GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet>
    <mdt:GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODUzMQ_15b55ee7-a4ff-4663-9b8f-7408a42a90a9"
      unitRef="usd">0</mdt:GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet>
    <mdt:GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODUzMQ_38e636b4-b427-493d-998d-250b3f1e7f62"
      unitRef="usd">0</mdt:GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet>
    <mdt:GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfODUzMQ_fea15a9c-0246-4e29-8af6-8ea7ae736ca9"
      unitRef="usd">0</mdt:GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet>
    <us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NjI_0d8f5cb4-1df9-4fed-beb2-0b3818e2c5c3">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount and classifications of the (gains) losses recognized in the consolidated statements of income for the portion of the net investment hedges excluded from the measurement of hedge effectiveness were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i0e2b35bd149d4cbfb0cca99cf6451e78_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjE0YmQxYzdhYTFiZTQ1MjM5Nzc0YTA5YTkwY2UxYWFlL3RhYmxlcmFuZ2U6MTRiZDFjN2FhMWJlNDUyMzk3NzRhMDlhOTBjZTFhYWVfMi00LTEtMS0w_37a50073-a633-4421-bc65-d0c799415c8f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ia4037e9fe4924327a9124f0dad580c10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjE0YmQxYzdhYTFiZTQ1MjM5Nzc0YTA5YTkwY2UxYWFlL3RhYmxlcmFuZ2U6MTRiZDFjN2FhMWJlNDUyMzk3NzRhMDlhOTBjZTFhYWVfMi02LTEtMS0w_5aebbac9-d60c-4627-92d3-f6b94921be6e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="id0504cba5977424e8efe09ff95da6e08_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjE0YmQxYzdhYTFiZTQ1MjM5Nzc0YTA5YTkwY2UxYWFlL3RhYmxlcmFuZ2U6MTRiZDFjN2FhMWJlNDUyMzk3NzRhMDlhOTBjZTFhYWVfMi04LTEtMS05OTE_e5f047f2-14b8-4744-9017-da8718694997"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i9156d299a6eb46b38ada2503236b8881_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjE0YmQxYzdhYTFiZTQ1MjM5Nzc0YTA5YTkwY2UxYWFlL3RhYmxlcmFuZ2U6MTRiZDFjN2FhMWJlNDUyMzk3NzRhMDlhOTBjZTFhYWVfMi0xMC0xLTEtOTkx_878339b2-cb57-4999-84e6-d674d97ba76d"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NTg_03819164-cd0f-4884-82e5-2eb62598812a">&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of the (gains) losses recognized in AOCI related to instruments designated as net investment hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
      contextRef="i9dd052a01e6746ebaefd3cc094cc9a4e_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjExZjE3NWRkMTVjMDQ3YTQ4NWFkMWRhZjAwNjdhZjc3L3RhYmxlcmFuZ2U6MTFmMTc1ZGQxNWMwNDdhNDg1YWQxZGFmMDA2N2FmNzdfMi0yLTEtMS0w_c0cd5499-9029-403b-bf5e-83cde38ac3cf"
      unitRef="usd">-164000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
      contextRef="i7b2fe42efd06408a92475c4755fa36e2_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjExZjE3NWRkMTVjMDQ3YTQ4NWFkMWRhZjAwNjdhZjc3L3RhYmxlcmFuZ2U6MTFmMTc1ZGQxNWMwNDdhNDg1YWQxZGFmMDA2N2FmNzdfMi00LTEtMS0w_e419777e-ff65-4661-a9d1-0bbd8a268c64"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
      contextRef="i54ccbe94efc24035ad053ab14a80da93_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjExZjE3NWRkMTVjMDQ3YTQ4NWFkMWRhZjAwNjdhZjc3L3RhYmxlcmFuZ2U6MTFmMTc1ZGQxNWMwNDdhNDg1YWQxZGFmMDA2N2FmNzdfMi02LTEtMS05OTM_22095b3a-edac-4f2e-aa06-28ea064bb413"
      unitRef="usd">-1276000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
      contextRef="ia739284ae42640b9b1169f2e13f10c3b_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjExZjE3NWRkMTVjMDQ3YTQ4NWFkMWRhZjAwNjdhZjc3L3RhYmxlcmFuZ2U6MTFmMTc1ZGQxNWMwNDdhNDg1YWQxZGFmMDA2N2FmNzdfMi04LTEtMS05OTM_1ff6c6e9-c1af-444e-806f-daea7c09aad1"
      unitRef="usd">152000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1ODM_02653b78-9a94-4e5f-aa21-b63d259731ae">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the balance sheet classification and fair value of derivative instruments included in the consolidated balance sheets at October&#160;30, 2020 and April&#160;24, 2020. The fair value amounts are presented on a gross basis and are segregated between derivatives that are designated and qualify as hedging instruments and those that are not designated and do not qualify as hedging instruments and are further segregated by type of contract within those two categories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i04c7a73cee65490ea0fe051fe67b36b0_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfNC0zLTEtMS0w_e54a9419-7b3d-4ffa-bdec-7a952b1a4a85"
      unitRef="usd">44000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i408b5639feb74594bf9ffbf99932a0c2_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfNC03LTEtMS0w_4ad623bb-61f4-4178-a62e-b98fa0c5817b"
      unitRef="usd">88000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3781ad92456b4930a744c241338e1df9_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfNi0zLTEtMS0w_b99f6de2-2e52-4368-a9eb-7b03769c90e5"
      unitRef="usd">6000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ibcab7a8fe5904101bf276c6cd9d3e02e_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfNi03LTEtMS0w_e35d6e7d-2903-4af7-9913-3c94c7315598"
      unitRef="usd">70000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i2971cc416b8c4c3baf1b346e6ac07274_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfNy0zLTEtMS0w_dfffbdf7-696e-4ae3-8079-cd7dee6ba095"
      unitRef="usd">50000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i2971cc416b8c4c3baf1b346e6ac07274_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfNy03LTEtMS0w_a885e928-79f0-4480-a590-892cef234385"
      unitRef="usd">158000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="idfcb1d2adbee455fa6c5c158e39b057f_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfOS0zLTEtMS0w_a80c691c-41df-4870-b2af-56da8e67d315"
      unitRef="usd">33000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iac89da0aac834ad28b17ac773234402d_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfOS03LTEtMS0w_f7e1e7e8-1e73-4f75-9ba8-2e84a231085d"
      unitRef="usd">43000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iaf80c1f6bec9491da1665ff45eca0305_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTAtMy0xLTEtMA_146d28d8-2ac6-459f-b999-5bb259fa9576"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia4f0c5b496724100b2925b08781c93be_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTAtNy0xLTEtMA_afdea750-8107-4db3-b917-baa0e5f786cc"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i79215fa9290949fc8d58b9442e87c752_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTEtMy0xLTEtMA_600569e4-5ca6-4768-b77c-0a4a50a1e028"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i300b4c6841cf48e1b89be1521f13f8c5_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTEtNy0xLTEtMA_0d06d46a-375a-4275-b342-57d1f08c821e"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id705573c47564fec859646f338ee424a_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTQtMy0xLTEtMA_620540d8-5ff8-41d1-a874-22c9afc4000f"
      unitRef="usd">37000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id705573c47564fec859646f338ee424a_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTQtNy0xLTEtMA_850923fb-bb42-479b-8167-49d42c3467cd"
      unitRef="usd">43000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTUtMy0xLTEtMA_81ae6640-1e33-4510-86e2-cf8b331c2278"
      unitRef="usd">87000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNiNzFiODkxNTEyOTRmMjViZTJhODMzMWU5NzcxNGUwL3RhYmxlcmFuZ2U6M2I3MWI4OTE1MTI5NGYyNWJlMmE4MzMxZTk3NzE0ZTBfMTUtNy0xLTEtMA_76329b7f-8c59-4936-98ca-6c10f05ba913"
      unitRef="usd">201000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia27d4054116c4424b00fa6fcc5fb1097_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfNC0zLTEtMS0w_a2ba2828-5cb8-45f6-bae7-85bda164fb53"
      unitRef="usd">271000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i61a28b7b81914f18b60a8f618393f4b0_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfNC03LTEtMS0w_26e99da0-2c07-4ad1-80f8-807c8e49d0fd"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i640a2e9158494775bd661da415d6991a_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfNi0zLTEtMS0w_0c6dee6a-4490-4109-bd66-2b1d1534fa77"
      unitRef="usd">103000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i16cbb6d304b141dfa3c2506664f80306_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfNi03LTEtMS0w_922b3ca3-4b51-460a-bb0f-c03044c1bd68"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iaf105fb217564fb0b368560e0802c567_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfNy0zLTEtMS0w_25fc45b2-13df-4d4e-9df2-d9e356496014"
      unitRef="usd">374000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iaf105fb217564fb0b368560e0802c567_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfNy03LTEtMS0w_c1e682df-b11b-4948-b2ba-d55506ce8251"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6c36d14889444b32a4a8a500df0426de_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfOS0zLTEtMS0w_2389a946-1134-44cc-8def-d35b59666d87"
      unitRef="usd">25000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i5f928c10bd3447a8acf72dba427f6d0f_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfOS03LTEtMS0w_0e027ddc-303f-48c8-bb1d-86cc93e16f85"
      unitRef="usd">13000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if8649cc913994f28bba97e9a820cd77c_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTAtMy0xLTEtMA_8f08fe09-1b53-49c0-8697-9b4026b0273b"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i2a71eca48ecb47368f7ad737a8dd9f78_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTAtNy0xLTEtMA_dcbe01f4-00db-46a8-87e1-ee6348a207a4"
      unitRef="usd">25000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9261483dc6f74bb484c0adf25775e549_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTEtMy0xLTEtMA_0d2a7c37-a0c2-42bc-8eec-cb60fe0dedbc"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i03fcd15b1ac94eb194a37776a48e4b87_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTEtNy0xLTEtMA_6d7bf759-a21d-4ea7-9216-24389546200c"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i42f9a191936c4fddb70e6c4259646375_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTMtMy0xLTEtMA_a25473b2-79aa-48a3-acb1-af8b54740302"
      unitRef="usd">28000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i42f9a191936c4fddb70e6c4259646375_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTMtNy0xLTEtMA_552f2138-85e5-4b1c-a1b0-8848d1be09e1"
      unitRef="usd">38000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTQtMy0xLTEtMA_02519a5d-2f3c-41ce-81a8-8ae84bfdf0f1"
      unitRef="usd">402000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjdmMGExOWI0YTAyZjQzNjI4YjE4MGIzMWNmOGJkN2M2L3RhYmxlcmFuZ2U6N2YwYTE5YjRhMDJmNDM2MjhiMTgwYjMxY2Y4YmQ3YzZfMTQtNy0xLTEtMA_ba433a70-a8a7-49c7-a200-3ef331cd732f"
      unitRef="usd">42000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NTY_b2b6ba61-0e97-42bf-a25a-3624e08d055c">&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information by level for the derivative assets and liabilities that are measured at fair value on a recurring basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:DerivativeAssets
      contextRef="i75a0c623324e4c58a147690be5ec9a8c_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMi0xLTEtMS0w_d4211907-5958-4cb1-9559-674c7431ab11"
      unitRef="usd">83000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib23daffd559644c684e6f30a2989e54b_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMi0zLTEtMS0w_2ef09aa0-4cd0-436d-af53-9a1a415fb86a"
      unitRef="usd">4000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie23caf8aac694eb5b8a3fbdfd8f4ec01_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMi03LTEtMS0w_da01c9b7-44f4-4dbf-a703-16ca9a41884a"
      unitRef="usd">399000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i82b2207772e84810aa69081bf91dec30_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMi05LTEtMS0w_14a9319e-0e2a-4ab4-81e1-fb29bbc78f9c"
      unitRef="usd">3000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i75a0c623324e4c58a147690be5ec9a8c_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMy0xLTEtMS0w_be226875-6f3d-48bd-aa9f-bd69e6d1ae09"
      unitRef="usd">201000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ib23daffd559644c684e6f30a2989e54b_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMy0zLTEtMS0w_e4d0dacf-89de-41d5-b160-13b7f0e6d9c2"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ie23caf8aac694eb5b8a3fbdfd8f4ec01_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMy03LTEtMS0w_75997d21-ead7-48bd-b482-58fc4e8675d9"
      unitRef="usd">17000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i82b2207772e84810aa69081bf91dec30_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOjNmYThiNDcyMTFjZTRlNTE4OThhNmYyZjIzZjVlMGQ2L3RhYmxlcmFuZ2U6M2ZhOGI0NzIxMWNlNGU1MTg5OGE2ZjJmMjNmNWUwZDZfMy05LTEtMS0w_e7d96b6f-29d5-4787-9a77-011f4496e775"
      unitRef="usd">25000000</us-gaap:DerivativeLiabilities>
    <us-gaap:OffsettingAssetsTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NDI_063874e8-3724-446c-baf0-9562d5fa672b">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount Not Offset on the Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount of Recorded Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Collateral Posted (Received)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount Not Offset on the Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount of Recorded Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Collateral Posted (Received)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OffsettingAssetsTableTextBlock>
    <us-gaap:OffsettingLiabilitiesTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RleHRyZWdpb246NzI1MTAwNjFjMDM2NDE0OTg4YTQ0ODI5MGU4MzIwYmZfMTA1NTk_bee22050-44bc-4666-a82f-f828f51f50bc">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount Not Offset on the Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount of Recorded Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Collateral Posted (Received)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount Not Offset on the Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount of Recorded Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Collateral Posted (Received)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OffsettingLiabilitiesTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNC0yLTEtMS0w_7ecaa6d8-0c8f-49d8-89d9-6923e1785f6b"
      unitRef="usd">83000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction
      contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNC00LTEtMS0w_b18ada86-902f-4c89-8a29-e4f648862b0a"
      unitRef="usd">80000000</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash
      contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNC02LTEtMS0w_43305c72-31b4-4a28-968a-4ce665d4436a"
      unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
      contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNC0xMC0xLTEtMA_95742d83-1eb1-40cd-835c-6892924200f2"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i271d615350834f588b83b7a2b7f99350_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNi0yLTEtMS0w_3b1f0342-25cb-4725-81e6-bedbf8514b72"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction
      contextRef="i271d615350834f588b83b7a2b7f99350_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNi00LTEtMS0w_e113900b-5e28-48e7-ad27-0308bf53dfba"
      unitRef="usd">0</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash
      contextRef="i271d615350834f588b83b7a2b7f99350_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNi02LTEtMS0w_19eaae8b-cfa6-4d5a-b617-d2f6d7e073ae"
      unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
      contextRef="i271d615350834f588b83b7a2b7f99350_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNi0xMC0xLTEtMA_8cbcb832-e7da-4660-a568-2650c6a16c4d"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i501c025a1be4439dab95e8898d228126_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNy0yLTEtMS0w_732e1f42-3055-4aba-9e5e-487f4a763d8e"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction
      contextRef="i501c025a1be4439dab95e8898d228126_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNy00LTEtMS0w_836704c2-9c3e-443c-aaaa-991ee0183854"
      unitRef="usd">0</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash
      contextRef="i501c025a1be4439dab95e8898d228126_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNy02LTEtMS0w_b379be3b-33e3-45d3-aeb5-ec01afe38b6e"
      unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
      contextRef="i501c025a1be4439dab95e8898d228126_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfNy0xMC0xLTEtMA_12b5e8fa-5f29-4c9a-9b87-25ba02fd622d"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfOC0yLTEtMS0w_bc1d4531-314e-4815-82d9-87eff627b6fa"
      unitRef="usd">87000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfOC00LTEtMS0w_78794663-7bcb-40ec-84e5-97b84489adfc"
      unitRef="usd">80000000</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfOC02LTEtMS0w_12a92c90-8ee9-48c1-ac3f-0b61e4dd2dc3"
      unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfOC0xMC0xLTEtMA_380933d8-52a1-42c5-9aa6-d9be087a2528"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTAtMi0xLTEtMA_f23a2d8d-78f1-4605-804f-fb8048e61b80"
      unitRef="usd">201000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTAtNC0xLTEtMA_baced22b-ef0a-4ee6-bae5-198922979741"
      unitRef="usd">80000000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash
      contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTAtNi0xLTEtMA_22eb87bc-b5a9-40ba-bffd-98353fda714f"
      unitRef="usd">17000000</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
      contextRef="i7831176c62f74ba4a4024a989e6285a2_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTAtMTAtMS0xLTA_bbf1ecf0-85ee-43ee-aa5c-90d839a82fa5"
      unitRef="usd">104000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <mdt:DerivativeAssetLiabilityFairValueGrossAssetLiability
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTUtMi0xLTEtMA_3cbd35c7-67cb-4b7f-90ce-33a4ea15c2c6"
      unitRef="usd">-114000000</mdt:DerivativeAssetLiabilityFairValueGrossAssetLiability>
    <mdt:DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTUtNC0xLTEtMA_9f6e192e-b77c-4a60-b5a1-77abf0a1fc1b"
      unitRef="usd">0</mdt:DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction>
    <mdt:DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTUtNi0xLTEtMA_336e968a-8007-452a-b695-b9608ab50046"
      unitRef="usd">-17000000</mdt:DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash>
    <us-gaap:DerivativeFairValueAmountOffsetAgainstCollateralNet
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmZkMmYyN2JlYjM0MTQ4MDdhZGU5MzM5YmU4NTM4ZTQwL3RhYmxlcmFuZ2U6ZmQyZjI3YmViMzQxNDgwN2FkZTkzMzliZTg1MzhlNDBfMTUtMTAtMS0xLTA_3e82eb9b-3291-4cbd-96db-b0fc1ec13ad0"
      unitRef="usd">-97000000</us-gaap:DerivativeFairValueAmountOffsetAgainstCollateralNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNC0yLTEtMS0w_c990c18f-5809-4ff6-be65-b4058407fae4"
      unitRef="usd">399000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction
      contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNC00LTEtMS0w_132a3b79-eb7c-47d0-9ee1-c2c56fa6c85a"
      unitRef="usd">17000000</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash
      contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNC02LTEtMS0w_9c6b0d0c-2eea-422d-92f1-cb282869f290"
      unitRef="usd">48000000</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
      contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNC0xMC0xLTEtMA_eb577bb3-ddfc-4818-9b19-71cfeada4db4"
      unitRef="usd">334000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibae2e9403d704584a6e2c9aec89b4fbe_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNi0yLTEtMS0w_30f04dc7-819f-4010-a851-44ff8b422c34"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction
      contextRef="ibae2e9403d704584a6e2c9aec89b4fbe_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNi00LTEtMS0w_fcd0b99a-6a74-4055-b4bc-ea2f046e2fc2"
      unitRef="usd">0</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash
      contextRef="ibae2e9403d704584a6e2c9aec89b4fbe_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNi02LTEtMS0w_8041ca28-8119-436b-9133-1ff6ea44c836"
      unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
      contextRef="ibae2e9403d704584a6e2c9aec89b4fbe_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfNi0xMC0xLTEtMA_71602593-de0b-4d4b-841f-73a9a246029a"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfOS0yLTEtMS0w_35841501-b805-434d-8b38-a9938b3a5f99"
      unitRef="usd">402000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfOS00LTEtMS0w_e0bd4747-3ffe-46a5-98d3-f30cfd6bc42c"
      unitRef="usd">17000000</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfOS02LTEtMS0w_9d1192cb-3267-4d19-973c-689d99a6e67f"
      unitRef="usd">48000000</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfOS0xMC0xLTEtMA_a0497b69-a541-4218-ac05-869ece57cca3"
      unitRef="usd">337000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTEtMi0xLTEtMA_ea5eea4d-c54f-49c6-91c2-10772a164f5f"
      unitRef="usd">17000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTEtNC0xLTEtMA_695e074e-5968-4233-8a84-a78323121982"
      unitRef="usd">17000000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash
      contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTEtNi0xLTEtMA_5913acfc-6e82-44a0-84b3-ac7acb76f1ac"
      unitRef="usd">0</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
      contextRef="i383c6b4f4aa24169b24e351562e05365_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTEtMTAtMS0xLTA_f390a78b-61f4-49d8-8b36-25a190dd0b94"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i37db224b055b4110b0851847038077cc_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTQtMi0xLTEtMA_7629954d-c1b7-418f-a5b3-3c32ecfa678c"
      unitRef="usd">25000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="i37db224b055b4110b0851847038077cc_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTQtNC0xLTEtMA_fef8ada6-60a6-4d56-b3b4-91f9c79ad022"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash
      contextRef="i37db224b055b4110b0851847038077cc_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTQtNi0xLTEtMA_56c6ecef-d599-46fc-bd0b-380b3eda12aa"
      unitRef="usd">0</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
      contextRef="i37db224b055b4110b0851847038077cc_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTQtMTAtMS0xLTA_230f3118-9719-462b-8b69-4e78e83e295f"
      unitRef="usd">25000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTUtMi0xLTEtMA_2f5887ba-8b89-4554-a883-ab2455548bc5"
      unitRef="usd">42000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTUtNC0xLTEtMA_b6dc7b4e-b54b-4bd0-b7f5-b70ec5934acb"
      unitRef="usd">17000000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTUtNi0xLTEtMA_5282e858-fcda-4215-b81e-981954768567"
      unitRef="usd">0</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTUtMTAtMS0xLTA_48ae431c-8576-49d2-a5bd-a0c608e9e3e5"
      unitRef="usd">25000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <mdt:DerivativeAssetLiabilityFairValueGrossAssetLiability
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTYtMi0xLTEtMA_a2923d2b-ce3e-414e-9a9e-1080f2acd810"
      unitRef="usd">360000000</mdt:DerivativeAssetLiabilityFairValueGrossAssetLiability>
    <mdt:DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTYtNC0xLTEtMA_4381c309-9e1b-4c87-8488-9ffd9330146d"
      unitRef="usd">0</mdt:DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction>
    <mdt:DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTYtNi0xLTEtMA_8cd77294-94cd-43c9-80e9-868a68b1efc1"
      unitRef="usd">48000000</mdt:DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash>
    <us-gaap:DerivativeFairValueAmountOffsetAgainstCollateralNet
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82NC9mcmFnOjcyNTEwMDYxYzAzNjQxNDk4OGE0NDgyOTBlODMyMGJmL3RhYmxlOmYxNTJjZGI3MjhlNzQ3OTQ5MTkyNzMxNmRlYzQ1NDlkL3RhYmxlcmFuZ2U6ZjE1MmNkYjcyOGU3NDc5NDkxOTI3MzE2ZGVjNDU0OWRfMTYtMTAtMS0xLTA_a85d6c9f-a094-42eb-a0d1-883f467051da"
      unitRef="usd">312000000</us-gaap:DerivativeFairValueAmountOffsetAgainstCollateralNet>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RleHRyZWdpb246ZDE1NWZhMGZjZmI3NDBhZGFjNThmODFmOGQxMGEzOWJfODE_c7509522-a3bc-44fe-823d-28d4e012c117">Inventories &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory balances, net of reserves, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RleHRyZWdpb246ZDE1NWZhMGZjZmI3NDBhZGFjNThmODFmOGQxMGEzOWJfNzg_d9dceb1b-54cd-4aa8-8a1a-194a8e6c437d">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory balances, net of reserves, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfMS0xLTEtMS0w_6bfb8d9c-0189-43c1-af7d-7a04cb714c1a"
      unitRef="usd">2944000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfMS0zLTEtMS0w_937b5e0e-b3aa-4392-8da6-a134854469a1"
      unitRef="usd">2874000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfMi0xLTEtMS0w_aee43251-d732-4272-84ea-3b1fef193be5"
      unitRef="usd">647000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfMi0zLTEtMS0w_daeab5fa-0ba5-4e3c-86d7-ca937e1c1dd6"
      unitRef="usd">608000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfMy0xLTEtMS0w_1d9ddf32-d873-4b76-ae86-b32918883567"
      unitRef="usd">893000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfMy0zLTEtMS0w_192b031b-d9ab-4530-9f2f-29fc1e8ee90b"
      unitRef="usd">747000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfNC0xLTEtMS0w_6bb16090-9fae-41da-8db1-81176a2a1cbe"
      unitRef="usd">4484000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83MC9mcmFnOmQxNTVmYTBmY2ZiNzQwYWRhYzU4ZjgxZjhkMTBhMzliL3RhYmxlOjhhNGE3N2M0ZmYwMTQ2NjlhZTlmN2I2MTAyNTMwNDJhL3RhYmxlcmFuZ2U6OGE0YTc3YzRmZjAxNDY2OWFlOWY3YjYxMDI1MzA0MmFfNC0zLTEtMS0w_7b17a9ca-4c32-498f-9e17-758f0fa897b7"
      unitRef="usd">4229000000</us-gaap:InventoryNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjk0Nw_f4a7de0e-15be-41de-afba-cc81b5670797">Goodwill and Other Intangible Assets &lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the carrying amount of goodwill by segment: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cardiac and Vascular Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Minimally Invasive Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restorative Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diabetes Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as a result of acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses goodwill for impairment annually as of the first day of the third quarter of the fiscal year and whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Impairment testing for goodwill is performed at the reporting unit level. The test for impairment of goodwill requires the Company to make several estimates about fair value, most of which are based on projected future cash flows. The Company calculates the excess of each reporting unit's fair value over its carrying amount, including goodwill, utilizing a discounted cash flow analysis. The Company did not recognize any goodwill impairment during the three and six months ended October&#160;30, 2020 or October&#160;25, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the gross carrying amount and accumulated amortization of intangible assets: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Definite-lived:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company assesses definite-lived intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of an intangible asset (asset group) may not be recoverable. When events or changes in circumstances indicate that the carrying value of an intangible asset may not be recoverable, the Company calculates the excess of an intangible asset's carrying value over its undiscounted future cash flows. If the carrying value is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value. The inputs used in the fair value analysis fall within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs to determine fair value. The Company did not recognize any definite-lived intangible asset charges during the three and six months ended October&#160;30, 2020. The Company recognized $33&#160;million of definite-lived intangible asset charges during the three and six months ended October 25, 2019 in connection with exit of businesses within the Restorative Therapies Group segment. Intangible asset impairment charges are recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;other operating expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company assesses indefinite-lived intangibles for impairment annually in the third quarter of the fiscal year and whenever an event occurs or circumstances change that would indicate that the carrying value may be impaired. The Company did not recognize any indefinite-lived intangible asset impairments during the three and six months ended October&#160;30, 2020 or October&#160;25, 2019. Due to the nature of IPR&amp;amp;D projects, the Company may experience future delays or failures to obtain regulatory approvals to conduct clinical trials, failures of clinical trials, delays or failures to obtain required market clearances, other failures to achieve a commercially viable product, or the discontinuation of certain projects, and as a result, may recognize impairment losses in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amortization Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible asset amortization expense for the three months ended October&#160;30, 2020 and October&#160;25, 2019 was $443&#160;million and $441&#160;million, respectively. For the six months ended October&#160;30, 2020 and October&#160;25, 2019, intangible asset amortization expense was $884&#160;million and $881&#160;million, respectively. Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at October&#160;30, 2020, excluding any possible future amortization associated with acquired IPR&amp;amp;D which has not yet met technological feasibility, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjk1Nw_62ed9d40-aa67-490c-b098-da9bede980a8">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the carrying amount of goodwill by segment: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cardiac and Vascular Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Minimally Invasive Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restorative Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diabetes Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as a result of acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ia23e15999c1646ddbb7df2cda73a7aec_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMS0xLTEtMS0w_51dfda38-7fb0-4ee3-9bc4-8ef74d442857"
      unitRef="usd">6831000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id873cde847774be59ee4570ffd483d68_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMS0zLTEtMS0w_acaa7023-fb73-4e0a-afe9-3a2471a6df29"
      unitRef="usd">20176000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7c3c106af2b14c32ac0754fe26996414_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMS01LTEtMS0w_97a59c72-5a71-4f2d-a60c-3f38655b5899"
      unitRef="usd">10920000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i54a71bd600c64796b0dda6f39160e883_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMS03LTEtMS0w_c25e6ec2-d186-4ca6-9641-024ab94aa97b"
      unitRef="usd">1914000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMS05LTEtMS0w_65a9fc7e-8aae-4b2f-82f8-4981d6c3b116"
      unitRef="usd">39841000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9ca6f74752024dcb8dbf523283f9b0ef_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMi0xLTEtMS0w_d1a9f48c-0f42-45a4-9313-26a65b89b6e0"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ieac0a2b04a964cccb353c56583b8d073_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMi0zLTEtMS0w_3cbd6d57-aa62-4e0e-8a03-bdd25e785db4"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i79d7d6e72a3d4a20b5a5c636e920c38c_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMi01LTEtMS0w_1d86ff7f-8261-4d67-8e30-07cf9c365398"
      unitRef="usd">35000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i374e41da3175425682886e64b4e59ac7_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMi03LTEtMS0w_38496731-c321-4840-bbc2-0517f10ddbb9"
      unitRef="usd">346000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMi05LTEtMS0w_50d2709e-84e6-4ee6-94f7-db8c6a986dac"
      unitRef="usd">381000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i9ca6f74752024dcb8dbf523283f9b0ef_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMy0xLTEtMS0w_5bdddce2-1467-412d-98b3-3aca250abc7e"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ieac0a2b04a964cccb353c56583b8d073_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMy0zLTEtMS0w_78f5fd61-a22c-4405-b91c-58b6b081d42e"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i79d7d6e72a3d4a20b5a5c636e920c38c_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMy01LTEtMS0w_00125ddb-7341-47ca-863b-569de415a6fe"
      unitRef="usd">3000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i374e41da3175425682886e64b4e59ac7_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMy03LTEtMS0w_1be92f0a-bdb2-4950-9120-c2bb7c5093b9"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfMy05LTEtMS0w_c45ad7b8-b05a-4fed-bcfc-6bdef05849b0"
      unitRef="usd">3000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i9ca6f74752024dcb8dbf523283f9b0ef_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNC0xLTEtMS0w_a0e6581e-b62c-466b-a8d5-b3cc587344de"
      unitRef="usd">95000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ieac0a2b04a964cccb353c56583b8d073_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNC0zLTEtMS0w_12e4562b-628c-4317-a343-44970f09c973"
      unitRef="usd">772000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i79d7d6e72a3d4a20b5a5c636e920c38c_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNC01LTEtMS0w_ffd72e98-24df-4f7c-a3f6-29940b0c85f7"
      unitRef="usd">119000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i374e41da3175425682886e64b4e59ac7_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNC03LTEtMS0w_0593d18d-4f6d-480f-9a36-3953c5654003"
      unitRef="usd">1000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNC05LTEtMS0w_013bea8d-2eb2-4f2b-844e-b7ad2ad66f5b"
      unitRef="usd">987000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ic6df7d3cc9f44895b99362ae686d8a29_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNS0xLTEtMS0w_5d29c53e-5534-4e6a-92db-b47d9a0f1863"
      unitRef="usd">6926000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i82923a0349f6443ab5eb2ec2e25dbb27_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNS0zLTEtMS0w_13f3f9c2-7c0b-420e-acbb-436b50bda66a"
      unitRef="usd">20948000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i40f981d3461b436c8ea0d4236782cc68_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNS01LTEtMS0w_3b38667c-48df-433b-8c36-575a9ff10616"
      unitRef="usd">11077000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iba50466d7292490bb6538e2b946dd0e0_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNS03LTEtMS0w_e0fe25b5-1454-4ae2-adb4-f75251ee291e"
      unitRef="usd">2261000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOjk1MDU4ZDI0YjZjMjRmYTdiZjNlNDY1NmI0NzM3YjVmL3RhYmxlcmFuZ2U6OTUwNThkMjRiNmMyNGZhN2JmM2U0NjU2YjQ3MzdiNWZfNS05LTEtMS0w_48505017-3e04-45ad-8a67-2ab624a0fd61"
      unitRef="usd">41212000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNzQ4_243e09de-86a8-457a-853b-b4d82c5b6bf6"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNzQ4_eacf6915-0759-42ed-a086-44b58078f2a8"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if3e0650de43b4e1f8c3d2b521e13e0ef_D20180728-20181026"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNzQ4_f63fdd52-030d-48f6-9034-af25bbb06da0"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNzQ4_feb5dba1-73be-444d-84d6-55b58844037f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjk0NQ_37058b3e-ed46-4832-9e79-eb745387c348">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the gross carrying amount and accumulated amortization of intangible assets: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Definite-lived:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjk1MQ_e36554b3-cb77-48b4-8009-b3c2266e0e29">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the gross carrying amount and accumulated amortization of intangible assets: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Definite-lived:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib4a60149be38443fb2d916de554d6254_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfMy0xLTEtMS0w_1423f457-8f9a-4909-b158-72fadc2ea49d"
      unitRef="usd">17017000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib4a60149be38443fb2d916de554d6254_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfMy0zLTEtMS0w_5f77a289-acb5-4e93-a6aa-f0e46720a38a"
      unitRef="usd">5567000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3767fcfe1389419994824ecb077fef38_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfMy01LTEtMS0w_0707f535-fba9-4583-a423-02bf9ee91892"
      unitRef="usd">16963000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3767fcfe1389419994824ecb077fef38_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfMy03LTEtMS0w_7ff96f97-d159-4348-98f5-74aaa878b337"
      unitRef="usd">5065000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic3d7fb880809444bae1c970a1373d381_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNC0xLTEtMS0w_db674059-9993-43e2-bbe7-ba5de9f4188a"
      unitRef="usd">11041000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic3d7fb880809444bae1c970a1373d381_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNC0zLTEtMS0w_9c749bca-c287-4bbe-9e22-225ef85aca0e"
      unitRef="usd">4767000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id014282d690d4c5a896ab2b26bacaa6d_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNC01LTEtMS0w_2a23f009-999d-4e94-83d1-579c47836ae6"
      unitRef="usd">10742000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id014282d690d4c5a896ab2b26bacaa6d_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNC03LTEtMS0w_00719b35-c237-4c07-a23c-64c7791ab7a8"
      unitRef="usd">4354000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i03c038d0f8344416b953ecf5e0e5a61d_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNS0xLTEtMS0w_10d6adc1-8521-485e-94b0-e918d85a2aba"
      unitRef="usd">469000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i03c038d0f8344416b953ecf5e0e5a61d_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNS0zLTEtMS0w_d4081632-8004-440d-8256-efa74faa1fee"
      unitRef="usd">241000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1504f2bee7c143859a17a93113ddf64c_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNS01LTEtMS0w_feb15de9-2747-49d3-906d-5cde4f3c7201"
      unitRef="usd">464000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1504f2bee7c143859a17a93113ddf64c_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNS03LTEtMS0w_8c3b937a-4dd3-479b-baaf-9dc1c4848afa"
      unitRef="usd">232000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if300d7f5eef94b9bbab7fef186492d3f_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNi0xLTEtMS0w_a105cea2-c2f5-4eed-8359-2ce15dfb64e4"
      unitRef="usd">78000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if300d7f5eef94b9bbab7fef186492d3f_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNi0zLTEtMS0w_65647fcc-ac54-4b5e-a297-db30f93b4f8e"
      unitRef="usd">58000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic16cb2a7cf0049afb87f33af952987fb_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNi01LTEtMS0w_7710cf8d-a920-4ec5-9def-261a01fd75b5"
      unitRef="usd">75000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic16cb2a7cf0049afb87f33af952987fb_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNi03LTEtMS0w_ccf57445-ffad-470d-8e69-cb6d203fd384"
      unitRef="usd">53000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNy0xLTEtMS0w_2d354ddf-0cb0-4524-8ac2-fcb34447a543"
      unitRef="usd">28605000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNy0zLTEtMS0w_a71e8391-4efd-4e7c-ab73-ec77606ddc74"
      unitRef="usd">10633000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNy01LTEtMS0w_28d45843-f5a6-4a22-8df1-c41c834afe5c"
      unitRef="usd">28244000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfNy03LTEtMS0w_3ad442f4-2077-4f9b-98ca-6f041be94e6e"
      unitRef="usd">9704000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ieb9b67e332e24b35b2d7941bda8317f3_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfOS0xLTEtMS0w_1e5fbf51-56cb-4a30-b5c1-6337c0c7bf02"
      unitRef="usd">440000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie963904705b8409cb3f2f8c8ca2bf137_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmFhMDA5NzEyMDRhYjRjMmNiMWVhNjU5ZTZhZWQ2YzgxL3RhYmxlcmFuZ2U6YWEwMDk3MTIwNGFiNGMyY2IxZWE2NTllNmFlZDZjODFfOS01LTEtMS0w_97ba781c-6e6a-483e-a53c-1d0ddb857f2a"
      unitRef="usd">523000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMTcyNg_e207c20d-cd08-48fe-9113-350a36dfeef3"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMTcyNg_f954d8db-e475-4f25-9bba-ad540c1d2e3a"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNDM5ODA0NjUxNDcwNg_022165f2-1107-4afb-998a-92244f7787eb"
      unitRef="usd">33000000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNDM5ODA0NjUxNDcwNg_f71503b0-6c86-4c20-a97c-8196f304c834"
      unitRef="usd">33000000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjA3MA_0b0d0687-3f54-4941-bd86-0eae2b687cd0"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjA3MA_1439fb04-d640-48d1-8bd9-c62b9f6fc26b"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjA3MA_78643bce-a732-4cc5-a4f0-3033e3b2da63"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjA3MA_8b00b839-f530-42c9-9634-10e5da8355f6"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNzY5NjU4MTM5NzQyMA_71800004-2bf9-4ac7-a529-3c855f1e617c"
      unitRef="usd">443000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfNzY5NjU4MTM5NzQzNg_1e13fc4e-9aa6-4737-89d6-c3bccdf4d1ad"
      unitRef="usd">441000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMTA5OTUxMTYyODEzMTU_09eb1bac-4237-431d-8da1-0d3c2e803da5"
      unitRef="usd">884000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMTA5OTUxMTYyODEzMjM_650024d4-2b2c-47d7-b32c-9501b4bb7a2d"
      unitRef="usd">881000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RleHRyZWdpb246YmRkMTJmMmVjNjIyNGY1ZmE4ODQ4MzY3ZjM1NDE1NWVfMjk0Ng_07771e61-cea6-4eaf-be57-e70921254b74">Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at October&#160;30, 2020, excluding any possible future amortization associated with acquired IPR&amp;amp;D which has not yet met technological feasibility, is as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmY0MTBiZTE4YWVhYTQ3ZjNhNjFiNjg4NmU4YjZhYmIxL3RhYmxlcmFuZ2U6ZjQxMGJlMThhZWFhNDdmM2E2MWI2ODg2ZThiNmFiYjFfMS0xLTEtMS0w_90769fd1-2445-4806-975c-b79d121ce4bb"
      unitRef="usd">888000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmY0MTBiZTE4YWVhYTQ3ZjNhNjFiNjg4NmU4YjZhYmIxL3RhYmxlcmFuZ2U6ZjQxMGJlMThhZWFhNDdmM2E2MWI2ODg2ZThiNmFiYjFfMi0xLTEtMS0w_329c2bc5-4fd1-4450-99e7-b2bfe1657afb"
      unitRef="usd">1738000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmY0MTBiZTE4YWVhYTQ3ZjNhNjFiNjg4NmU4YjZhYmIxL3RhYmxlcmFuZ2U6ZjQxMGJlMThhZWFhNDdmM2E2MWI2ODg2ZThiNmFiYjFfMy0xLTEtMS0w_36bf246c-0e53-4895-a825-1d88138b957b"
      unitRef="usd">1674000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmY0MTBiZTE4YWVhYTQ3ZjNhNjFiNjg4NmU4YjZhYmIxL3RhYmxlcmFuZ2U6ZjQxMGJlMThhZWFhNDdmM2E2MWI2ODg2ZThiNmFiYjFfNC0xLTEtMS0w_50cd7ada-eaea-4941-8b63-0d2064e13833"
      unitRef="usd">1643000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmY0MTBiZTE4YWVhYTQ3ZjNhNjFiNjg4NmU4YjZhYmIxL3RhYmxlcmFuZ2U6ZjQxMGJlMThhZWFhNDdmM2E2MWI2ODg2ZThiNmFiYjFfNS0xLTEtMS0w_1462fac7-a016-4d65-92eb-bcd9e32c87d0"
      unitRef="usd">1617000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83My9mcmFnOmJkZDEyZjJlYzYyMjRmNWZhODg0ODM2N2YzNTQxNTVlL3RhYmxlOmY0MTBiZTE4YWVhYTQ3ZjNhNjFiNjg4NmU4YjZhYmIxL3RhYmxlcmFuZ2U6ZjQxMGJlMThhZWFhNDdmM2E2MWI2ODg2ZThiNmFiYjFfNi0xLTEtMS0w_b5f112f4-a032-4a07-baa1-639e16c95545"
      unitRef="usd">1604000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMjgxNQ_38e8afd7-36f0-45af-a241-798462921f9b">Income Taxes &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's effective tax rate for the three and six months ended October&#160;30, 2020 was 5.9 percent and 11.2 percent, respectively, as compared to (6.0) percent and 1.0 percent for the three and six months ended October&#160;25, 2019, respectively. The increase in the effective tax rate for the three and six months ended October&#160;30, 2020, as compared to the corresponding periods in the prior fiscal year, was primarily due to the impact of certain tax adjustments and year-over-year changes in operational results by jurisdiction. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Certain Tax Adjustments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the three months ended October&#160;30, 2020, the cost from certain tax adjustments of $16&#160;million, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;income tax provision (benefit)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the consolidated statements of income, included a cost of $16&#160;million associated with the amortization of the previously established deferred tax assets from intercompany intellectual property transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the six months ended October&#160;30, 2020, the net cost from certain tax adjustments of $20&#160;million, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;income tax provision (benefit)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the consolidated statements of income, included the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;A benefit of $3&#160;million associated with the finalization of an intercompany sale of intellectual property and the establishment of a deferred tax asset. The cumulative amount of deferred tax benefit previously recognized from intercompany intellectual property transactions and recorded as Certain Tax Adjustments is $1.5&#160;billion. The corresponding deferred tax assets will be amortized over a period of approximately 20 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;A cost of $23&#160;million associated with the amortization of the previously established deferred tax assets from intercompany intellectual property transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the three months ended October&#160;25, 2019, the benefit from certain tax adjustments of $251&#160;million, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;income tax provision (benefit)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the consolidated statements of income, included a benefit of $251&#160;million related to tax legislative changes in Switzerland which abolished certain preferential tax regimes the Company benefited from and replaced them with a new set of internationally accepted measures. The legislation provided for higher effective tax rates but allowed for a transitional period whereby an amortizable asset was created for Swiss federal income tax purposes which will be amortized and deducted over a 10-year period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended October&#160;25, 2019, the net benefit from certain tax adjustments of $281&#160;million, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;income tax provision (benefit) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated statements of income, included the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A net benefit of $30&#160;million related to U.S. Treasury&#x2019;s issuance of certain Final Regulations associated with U.S. Tax Reform. The primary impact of these regulations resulted in the re-establishment of our permanently reinvested assertion on certain foreign earnings and reversing the previously accrued tax liability. This benefit was partially offset by additional tax associated with a previously executed internal reorganization of certain foreign subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A benefit of $251&#160;million related to tax legislative changes in Switzerland which abolished certain preferential tax regimes the Company benefited from and replaced them with a new set of internationally accepted measures. The legislation provided for higher effective tax rates but allowed for a transitional period whereby an amortizable asset was created for Swiss federal income tax purposes which will be amortized and deducted over a 10-year period.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;At both October&#160;30, 2020 and April&#160;24, 2020, the Company's gross unrecognized tax benefits were $1.9&#160;billion. In addition, the Company had accrued gross interest and penalties of $251&#160;million at October&#160;30, 2020. If all the Company&#x2019;s unrecognized tax benefits were recognized, approximately $1.8&#160;billion would impact the Company&#x2019;s effective tax rate. At October&#160;30, 2020 and April&#160;24, 2020, the amount of the Company's gross unrecognized tax benefits recorded as a noncurrent liability within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;accrued income taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;on the consolidated balance sheets was $940&#160;million and $911&#160;million, respectively.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company recognizes interest and penalties related to income tax matters within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;income tax provision (benefit)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the consolidated statements of income and records the liability within either current or noncurrent &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;accrued income taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 16 to the consolidated financial statements for additional information regarding the status of current tax audits and proceedings.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfODA_ae04d77b-917a-42a0-ac54-7da8d5948c07"
      unitRef="number">0.059</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ0NDQ5Ng_e948c254-67df-49b4-9368-145e701e8557"
      unitRef="number">0.112</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfOTk_fea64725-d40a-4f45-94ef-957eac7600c7"
      unitRef="number">-0.060</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ0NDU0Mg_b155a18f-e098-44bd-a527-a68b72cb0b26"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTU5Mw_3c858752-9c91-4ce8-ad0c-2081f286ce0e"
      unitRef="usd">16000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTYwNg_b595851c-f26e-4499-aff4-06e05624c9a6"
      unitRef="usd">16000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfNDM5ODA0NjUyNTQxNA_8f158f0b-2090-43fd-91f4-4c1bcd90332d"
      unitRef="usd">20000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <mdt:TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTYxOQ_1c63a302-8751-43f8-8bb9-28324fd14b8d"
      unitRef="usd">-3000000</mdt:TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTYzMQ_7a0ba437-8003-44fc-9587-ca0d22fe0fc1"
      unitRef="usd">1500000000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <mdt:DeferredTaxAssetsAmortizationPeriod
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfNDM5ODA0NjUyNTQyNg_48feb3bc-f2db-43bc-8baf-5894a5d8bb8f">P20Y</mdt:DeferredTaxAssetsAmortizationPeriod>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTY0NQ_a5ff4041-5020-4031-9dd0-40ffa35fa8d9"
      unitRef="usd">23000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTY1OA_c2e0aa7b-8f83-433a-8446-83873788a5ac"
      unitRef="usd">-251000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:IncomeTaxReconciliationTaxContingenciesForeign
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTY3Mg_31fbd497-7b7f-4fb9-9c11-125041af87cd"
      unitRef="usd">-251000000</us-gaap:IncomeTaxReconciliationTaxContingenciesForeign>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i72dff3c52a304a0bab96f9563e0abd46_D20190727-20191025"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfNDM5ODA0NjUyNTQ0MA_8115c5aa-4223-4a83-bc41-e5c9c42835c2">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTc3OQ_83510c79-09a3-4b8c-b5c4-b03641c6c846"
      unitRef="usd">-281000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTY4Ng_9e73e411-54f8-4b4f-bae9-80557581a4c3"
      unitRef="usd">-30000000</us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxReconciliationTaxContingenciesForeign
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTc5Mw_4b79a8a7-c9bc-49d9-956a-4477e0d10fc4"
      unitRef="usd">-251000000</us-gaap:IncomeTaxReconciliationTaxContingenciesForeign>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie63e2a6be41a4756afe92a2464f79dd6_D20190427-20191025"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfNDM5ODA0NjUyNTQ0Nw_25d634dc-fa56-4f31-a418-bed806303858">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTgwNw_fbab1e0c-826a-49f4-b003-7f6e6d56933f"
      unitRef="usd">1900000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTgwNw_fce3d619-6b3f-42d4-9e44-beb83195f20e"
      unitRef="usd">1900000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTgyMQ_39f56454-c7eb-4524-ab1d-1f2089b260d4"
      unitRef="usd">251000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTgzNQ_8dbf7125-7d70-4905-864b-0a59f04be969"
      unitRef="usd">1800000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTg0OQ_5eeead53-1c53-4101-b8d0-7ddc2c366381"
      unitRef="usd">940000000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83Ni9mcmFnOjhjMmMwNjA2MzU1MjRhZDU5MzAwYTg3NGU3MGZiZTE2L3RleHRyZWdpb246OGMyYzA2MDYzNTUyNGFkNTkzMDBhODc0ZTcwZmJlMTZfMTY0OTI2NzQ1NTg2Mw_e7a8a257-3f17-4abc-8407-6977b7dcee82"
      unitRef="usd">911000000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RleHRyZWdpb246N2Y1YTgyNDM5OWFmNDQ3Zjk5Mjc5MTQ2YTU3YzRiZTJfMTQ4Mw_a7c82690-ef4c-4ab8-9656-23d3690d33a0">Earnings Per Share Earnings per share is calculated using the two-class method, as the Company's A Preferred Shares are considered participating securities. Accordingly, earnings are allocated to both ordinary shares and participating securities in determining earnings per ordinary share. Due to the limited number of A Preferred Shares outstanding, this allocation had no effect on ordinary earnings per share; therefore, it is not presented below. Basic earnings per share is computed based on the weighted average number of ordinary shares outstanding. Diluted earnings per share is computed based on the weighted average number of ordinary shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive ordinary shares been issued, and reduced by the number of shares the Company could have repurchased with the proceeds from issuance of the potentially dilutive shares. Potentially dilutive ordinary shares include stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan.&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below sets forth the computation of basic and diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to ordinary shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic &#x2013; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,340.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,340.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted &#x2013; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,352.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The calculation of weighted average diluted shares outstanding excludes options to purchase approximately 8 million ordinary shares for both the three and six months ended October&#160;30, 2020, and 4 million ordinary shares for both the three and six months ended October&#160;25, 2019, because their effect would have been anti-dilutive on the Company&#x2019;s earnings per share.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RleHRyZWdpb246N2Y1YTgyNDM5OWFmNDQ3Zjk5Mjc5MTQ2YTU3YzRiZTJfMTQ3OA_b141af61-4619-445c-9dd9-75ecadc965c7">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below sets forth the computation of basic and diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to ordinary shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic &#x2013; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,340.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,340.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted &#x2013; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,352.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMy0xLTEtMS0w_2eec1533-e25c-426f-bbd7-ffabda096479"
      unitRef="usd">489000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMy0zLTEtMS0w_9ad25ff8-8cce-400f-ae3f-36eeda31ab5a"
      unitRef="usd">1364000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMy01LTEtMS02OTg_de28ae33-dde4-44e7-9f29-51488692d5b8"
      unitRef="usd">976000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMy03LTEtMS02OTg_9541a47f-0716-482a-89bb-ed8170be0622"
      unitRef="usd">2228000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNS0xLTEtMS0w_4cb64ffc-78b9-4dc0-99f3-d5f6ed3adc68"
      unitRef="shares">1344400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNS0zLTEtMS0w_6b282c6d-5421-41cf-962e-e956823807b5"
      unitRef="shares">1340800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNS01LTEtMS03MDE_45ff78f3-c94b-409f-beb2-3f7c3d475a62"
      unitRef="shares">1343100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNS03LTEtMS03MDE_a8dc74be-66f9-4d52-91b9-028aa2a271ce"
      unitRef="shares">1340800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNy0xLTEtMS0w_4374dc9b-b4c4-43f2-81bf-cf63b559658c"
      unitRef="shares">5900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNy0zLTEtMS0w_7a300099-57de-4c61-bbd5-c47ed31ef4f6"
      unitRef="shares">8000000.0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNy01LTEtMS03MDQ_f771402d-ca8e-4f6b-97c6-456270d964f0"
      unitRef="shares">5300000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfNy03LTEtMS03MDQ_6ab1647a-e661-4fbb-bc42-2822704c3f93"
      unitRef="shares">7400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOC0xLTEtMS0w_2c74c8db-494f-47c5-a774-127890887ec0"
      unitRef="shares">1800000</us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends>
    <us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOC0zLTEtMS0w_3aa2a6be-a081-4e7f-8e2c-f9da004089a0"
      unitRef="shares">2600000</us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends>
    <us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOC01LTEtMS03MDQ_3b114157-fddd-471c-9c8b-2a69876fce08"
      unitRef="shares">2300000</us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends>
    <us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOC03LTEtMS03MDQ_db6a1961-afad-4761-bcf5-ab127b6893cb"
      unitRef="shares">3100000</us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends>
    <mdt:IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOS0xLTEtMS0w_b0f352ad-58ef-4d91-bfb8-4e8f52214b4d"
      unitRef="shares">0</mdt:IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares>
    <mdt:IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOS0zLTEtMS0w_339afbbc-0fb1-48f6-b6d7-f1269245ce37"
      unitRef="shares">0</mdt:IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares>
    <mdt:IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOS01LTEtMS03MDQ_cb41a379-1465-4c0c-84de-21b41f254160"
      unitRef="shares">400000</mdt:IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares>
    <mdt:IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfOS03LTEtMS03MDQ_4b99cf9a-977a-4d7d-897b-b9d3f8d20bca"
      unitRef="shares">300000</mdt:IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTAtMS0xLTEtMA_b5f2bb39-ddcd-431e-97cb-77f843b68263"
      unitRef="shares">1352100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTAtMy0xLTEtMA_1f639a3e-dd0b-455f-be52-b6e07558fe18"
      unitRef="shares">1351400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTAtNS0xLTEtNzEx_3532f99f-c52d-4ae5-b737-eeb62af2a571"
      unitRef="shares">1351100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTAtNy0xLTEtNzEx_e684a5ce-5527-47e3-afeb-a9bb6980651c"
      unitRef="shares">1351600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTItMS0xLTEtMA_1b507879-8937-4e36-b187-ec69d9464ae7"
      unitRef="usdPerShare">0.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTItMy0xLTEtMA_b8932550-879c-4d74-8b78-259447093a00"
      unitRef="usdPerShare">1.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTItNS0xLTEtNzE4_f7f6e0da-8922-4e53-861b-f7829e610dfe"
      unitRef="usdPerShare">0.73</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTItNy0xLTEtNzE4_c3857a75-717f-441e-9751-e3c757ef214f"
      unitRef="usdPerShare">1.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTMtMS0xLTEtMA_bf8088ea-372e-4384-b84a-7923042525d4"
      unitRef="usdPerShare">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTMtMy0xLTEtMA_9260f3ee-fec3-46a4-a3ba-7bdadd3c6227"
      unitRef="usdPerShare">1.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTMtNS0xLTEtNzE4_1d66f666-96e2-43d9-a2e5-90739ac37768"
      unitRef="usdPerShare">0.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RhYmxlOjQ5MjI4YTNkYzU5YzQyM2M4YTFiZTNhZDYwYzVjZjZiL3RhYmxlcmFuZ2U6NDkyMjhhM2RjNTljNDIzYzhhMWJlM2FkNjBjNWNmNmJfMTMtNy0xLTEtNzE4_88fc9643-02d6-4545-ae07-cace5f1915ba"
      unitRef="usdPerShare">1.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i038d289ad6de4b8f85679e45d0448c91_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RleHRyZWdpb246N2Y1YTgyNDM5OWFmNDQ3Zjk5Mjc5MTQ2YTU3YzRiZTJfOTg5NTYwNDY1MTQ4Nw_1f3fce31-3724-400a-a9b1-e93d1782c20b"
      unitRef="shares">8000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i17f2e9ba8db047a49f7e5293b1dc77f7_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RleHRyZWdpb246N2Y1YTgyNDM5OWFmNDQ3Zjk5Mjc5MTQ2YTU3YzRiZTJfOTg5NTYwNDY1MTQ4Nw_b09870d2-d2d1-44ba-9831-3027c4e75dfe"
      unitRef="shares">8000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i37cf6705fcb445ac9da8563c668b75cd_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RleHRyZWdpb246N2Y1YTgyNDM5OWFmNDQ3Zjk5Mjc5MTQ2YTU3YzRiZTJfMTMxOQ_7ed8264b-b64c-45f3-bd95-c778b69fb7f6"
      unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2c5e5989168e41efb2ee254d247c516e_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV83OS9mcmFnOjdmNWE4MjQzOTlhZjQ0N2Y5OTI3OTE0NmE1N2M0YmUyL3RleHRyZWdpb246N2Y1YTgyNDM5OWFmNDQ3Zjk5Mjc5MTQ2YTU3YzRiZTJfMTMxOQ_9232e763-f3d0-4323-b171-bd7385fce8ff"
      unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RleHRyZWdpb246NDYzODBjMTZkZTM5NGEwMDhiMTU2YzRhN2NkZTM1YTdfMjUy_2bd654eb-53a5-4cd9-ac9e-a1e87652ca85">Stock-Based Compensation &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components and classification of stock-based compensation expense for stock options, restricted stock, and employee stock purchase plan shares recognized for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RleHRyZWdpb246NDYzODBjMTZkZTM5NGEwMDhiMTU2YzRhN2NkZTM1YTdfMjU0_5b377e8d-aa0b-4175-9839-9f5f8e10d677">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components and classification of stock-based compensation expense for stock options, restricted stock, and employee stock purchase plan shares recognized for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i00b67cb0c676413da10bbe00d1f895a2_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMi0xLTEtMS0w_e6d3d331-68c6-4b20-8910-fb579338cb9c"
      unitRef="usd">43000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icb3c7b067b2a490a80be46ac5e1bf7dd_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMi0zLTEtMS0w_23458110-5c1e-48b6-84c5-dea5aad458e2"
      unitRef="usd">31000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i87f020c9e8ce45279dc4d7550054f8f3_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMi01LTEtMS03MzM_df55231e-fdd4-4954-b093-bd9b0c12ae87"
      unitRef="usd">51000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idaa63515bf8647dd9bf70dfb44e3a57e_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMi03LTEtMS03MzM_8382e1a1-d379-4523-a062-33efff1c5726"
      unitRef="usd">40000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if98bf19b12ea4baca1ee2d733327d267_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMy0xLTEtMS0w_5fcd0091-87f5-46ef-ba7d-dc1349da5cd9"
      unitRef="usd">88000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i41db5984a04f476c9e1643f4d8215c73_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMy0zLTEtMS0w_0490e85a-c9ad-4ac3-8638-4f0397bdcbc3"
      unitRef="usd">71000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3500b71577b74f76a424e65d43544367_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMy01LTEtMS03MzM_83eb9f74-606b-4112-8121-1d4906e4c514"
      unitRef="usd">138000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8755e7c5c19246d985fd44c7bbf450b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMy03LTEtMS03MzM_69721124-1309-4334-a0ee-d2728a793f93"
      unitRef="usd">113000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idbfbe22288704f4294f5d6ad2a6bbdb4_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNC0xLTEtMS0w_97ff624b-6804-4cc5-94f1-eaddc0dba845"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6e7073f7fded4be99ae2a0b2a3a31757_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNC0zLTEtMS0w_78b09da7-7a85-4c06-b37a-ef5a9f400f82"
      unitRef="usd">6000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i31ca63612edf4a8295126af8750e6ae4_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNC01LTEtMS03MzM_0423c971-0250-4d82-a479-db043edf3e5a"
      unitRef="usd">21000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i609d7c4a83e640db9dccf290d58342ce_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNC03LTEtMS03MzM_62343855-fd91-42fa-8e7d-90d95dd772d5"
      unitRef="usd">16000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNS0xLTEtMS0w_d6753af6-e77f-4769-be25-64d85487f8d5"
      unitRef="usd">140000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNS0zLTEtMS0w_9c66189a-7414-49fb-9d45-36ca1b74f0c0"
      unitRef="usd">108000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNS01LTEtMS03MzM_c356994a-8be4-423c-bdbc-8b57a18e56fb"
      unitRef="usd">210000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNS03LTEtMS03MzM_a56864f5-ade5-4caa-af02-9e7571c58a25"
      unitRef="usd">169000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9acd77d49d4840c18802f8875a75d339_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNy0xLTEtMS0w_72aefd83-5ead-480f-af5d-cd2a094bda78"
      unitRef="usd">14000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i70cc00740a274a9382f8faf2cfd6c19e_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNy0zLTEtMS0w_688131d4-3580-4a55-952c-9927d8c1753e"
      unitRef="usd">10000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaf2c5bd78d0142318be39bad4bfa6c50_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNy01LTEtMS03MzM_dcaa0fb2-b280-4e94-a3be-62422d46f865"
      unitRef="usd">21000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id65399fc03ca4ad7987953d64a511415_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfNy03LTEtMS03MzM_a9c3cbdc-0592-464a-8bc4-ef144c1d177e"
      unitRef="usd">16000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i041edce7b2f84381a0ffac6ba095e1fd_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOC0xLTEtMS0w_bcc302a2-a84a-46d0-9d75-d663a553aca6"
      unitRef="usd">15000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2be4b5dbd3a843788549eca186a30ccc_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOC0zLTEtMS0w_b4236082-4afc-4dd8-8626-8543a3f88666"
      unitRef="usd">13000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib483fb15c6034697bfe54c44860b3101_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOC01LTEtMS03MzM_067fac62-df94-49e6-94fa-8821e686e392"
      unitRef="usd">23000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iea08a324b22a4b3585ccc68dd6591808_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOC03LTEtMS03MzM_79a6859b-1f68-49cc-b83e-cf530ac040b0"
      unitRef="usd">20000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifc8350b91b4146b3901beacd17a1c4e2_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOS0xLTEtMS0w_03561b74-bef2-421f-9b1a-4661c6800fd8"
      unitRef="usd">111000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i541ed731bef54145b54be9fcb6064899_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOS0zLTEtMS0w_05bdf078-ce7c-4dd7-8ec1-c2eb6dfaa935"
      unitRef="usd">85000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i169643d5df3945a980638c7f94c6cf7b_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOS01LTEtMS03MzM_85ba70b6-2480-4393-9720-4ac14a2905b3"
      unitRef="usd">166000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8f3edae1486d484084c48f942aa09416_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfOS03LTEtMS03MzM_086f481b-cd3b-46ef-9b22-320b30551c8b"
      unitRef="usd">133000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTAtMS0xLTEtMA_78efca9c-34ca-4627-8c6e-09b4b11fdb5f"
      unitRef="usd">140000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTAtMy0xLTEtMA_c27b6cb6-42af-4d79-ba67-65007c9e534f"
      unitRef="usd">108000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTAtNS0xLTEtNzMz_6581dc8b-c03c-4f23-9dc7-5829be7ac4af"
      unitRef="usd">210000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTAtNy0xLTEtNzMz_35145126-7796-4507-b5ab-bc06c00b96ff"
      unitRef="usd">169000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTEtMS0xLTEtMA_e8f810ce-4b92-42d8-91c4-c807f91b1d2e"
      unitRef="usd">24000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTEtMy0xLTEtMA_fb148594-792c-47b2-8b25-b10c6c52faaf"
      unitRef="usd">19000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTEtNS0xLTEtNzMz_961a10fe-946e-47ca-a977-8af46433666e"
      unitRef="usd">36000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTEtNy0xLTEtNzMz_611e27ca-4e05-46e5-83e1-778e1e75e31a"
      unitRef="usd">29000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTItMS0xLTEtMA_d0d778ab-1040-4785-a73b-871975e1b867"
      unitRef="usd">116000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTItMy0xLTEtMA_2c97f92c-7169-4db6-b426-2e93e8058fcf"
      unitRef="usd">89000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTItNS0xLTEtNzMz_4b2dfa52-8a1f-4572-9222-bc9b7bf92d8f"
      unitRef="usd">174000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84Mi9mcmFnOjQ2MzgwYzE2ZGUzOTRhMDA4YjE1NmM0YTdjZGUzNWE3L3RhYmxlOmEwMGVmMmIzZGI3YjRjMTFiZmI1YmE4OTdlOTY4NWVjL3RhYmxlcmFuZ2U6YTAwZWYyYjNkYjdiNGMxMWJmYjViYTg5N2U5Njg1ZWNfMTItNy0xLTEtNzMz_557e86d4-47f3-4e0e-a908-32757aa3aaae"
      unitRef="usd">140000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfMTEwMQ_3143ee64-30eb-47ad-b57e-d1ffedc3fa8e">Retirement Benefit Plans &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors various retirement benefit plans, including defined benefit pension plans, post-retirement medical plans, defined contribution savings plans, and termination indemnity plans, covering substantially all U.S. employees and many employees outside the U.S. The net periodic benefit cost of the defined benefit pension plans included the following components for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Special termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Special termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of net periodic benefit cost other than the service component are recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other non-operating income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal year 2021, as part of the Simplification restructuring program, the Company offered certain eligible U.S. employees voluntary early retirement packages, resulting in incremental expense of $97&#160;million recognized during the three and six months ended October&#160;30, 2020. Of this amount, $80&#160;million related to U.S. pension benefits, $11&#160;million related to defined contribution plans, $4&#160;million related to U.S. post-retirement benefits, and $2&#160;million related to cash payments and administrative fees. See Note 5 for additional information on the Simplification restructuring program.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxMjIzNw_58c23093-df64-4f2b-8064-14aa29ed7f6b">The net periodic benefit cost of the defined benefit pension plans included the following components for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Special termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Special termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod
      contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy0xLTEtMS04NjQ2_6d0f100f-abc2-49a8-831f-1fb0b399e145"
      unitRef="usd">80000000</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod
      contextRef="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy0zLTEtMS04NjQ2_c320d42a-75e7-421f-ba86-859884f4fa7c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod
      contextRef="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy01LTEtMS04NjQ2_3d8d31ad-d7be-461f-8dc0-5ca7d05cb060"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod
      contextRef="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy03LTEtMS04NjQ2_441e38d0-a36a-4707-a82c-0fa698431fc1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy0xLTEtMS0xMDA2_d9978de4-4dcb-497f-9c22-cb251bb0fe2b"
      unitRef="usd">27000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy0zLTEtMS0xMDA2_bb4bf2a5-71ac-4ade-a622-97b941cdbd24"
      unitRef="usd">26000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy01LTEtMS0xMDA2_9253951b-5f25-4c59-9314-37b92f26c348"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfMy03LTEtMS0xMDA2_db512271-b684-49c7-9155-5902116a5807"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNC0xLTEtMS0xMDA2_ffa464ff-4f8c-42e0-b3a7-6d899e7c474d"
      unitRef="usd">27000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNC0zLTEtMS0xMDA2_ae1e2fe9-7ec4-400a-9465-ac6cba9f1e19"
      unitRef="usd">32000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNC01LTEtMS0xMDA2_3e00e989-006d-4a5b-81db-d9e9a4616348"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNC03LTEtMS0xMDA2_b7552752-ef1d-473b-be66-5621223613a7"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNS0xLTEtMS0xMDA2_a336d33a-5ec4-49c6-a4e3-d24afe835ef1"
      unitRef="usd">61000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNS0zLTEtMS0xMDA2_7299fcc2-115c-4ddb-b757-8cc514f480b0"
      unitRef="usd">56000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNS01LTEtMS0xMDA2_1fefeb7f-322d-45d4-9dca-83fd833f7124"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNS03LTEtMS0xMDA2_d51f4fb5-a9e9-4329-8083-396958f3d705"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNi0xLTEtMS0xMDA2_b98e00fa-450b-408b-a4c5-1ab3c57c4eb1"
      unitRef="usd">-17000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNi0zLTEtMS0xMDA2_5e639b0e-c2cf-44ca-8170-1be284d9fa12"
      unitRef="usd">-14000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNi01LTEtMS0xMDA2_c5ba8cd5-2298-497d-a3d9-cfcab256c5c2"
      unitRef="usd">-6000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfNi03LTEtMS0xMDA2_b44857a8-4300-4449-98a1-396f013ec798"
      unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfOC0xLTEtMS0xMDA2_1265ffbf-d982-43f1-9711-2f82ea1bb4b8"
      unitRef="usd">90000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i4d4c65c7af364f09804e56e11dd0024e_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfOC0zLTEtMS0xMDA2_db65f710-4b6f-484b-91e3-2fb7c8b3716e"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i897d6cde314f4a6f8a2292c98071e4c2_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfOC01LTEtMS0xMDA2_b348af6c-e005-46b4-99cf-a6c1b2225d09"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="id2e1f2547f7242aa8b65af9337b421eb_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOmRiYjFlY2Q1MzFmZTQwNzI5MzAxMWU1MmIzYzMyNzAzL3RhYmxlcmFuZ2U6ZGJiMWVjZDUzMWZlNDA3MjkzMDExZTUyYjNjMzI3MDNfOC03LTEtMS0xMDA2_59b05298-80ba-4b4d-a224-16d17ec93e5f"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod
      contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy0xLTEtMS04NjU2_91ace47a-49d2-4aa6-9a0e-3950dde324ea"
      unitRef="usd">80000000</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod
      contextRef="i48966b2b67e54988b474069368fd3c54_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy0zLTEtMS04NjU2_412274f3-b0bd-48c9-99f9-b16403400a3c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod
      contextRef="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy01LTEtMS04NjU2_c55ba916-abfa-4a6e-b8f7-10699566f561"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod
      contextRef="i079d0741b4814caf97785cd103555063_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy03LTEtMS04NjU2_6571a976-0fcf-480c-92cd-078ef372ef2c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy0xLTEtMS0xMDIz_8998780c-26f0-46f4-91ac-e27475d2dd4b"
      unitRef="usd">54000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i48966b2b67e54988b474069368fd3c54_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy0zLTEtMS0xMDIz_d6b54661-19b2-4268-9f51-33461813ca66"
      unitRef="usd">52000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy01LTEtMS0xMDIz_dd14e0a4-c9e4-4470-89ff-dbc6ae5ad3b0"
      unitRef="usd">34000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i079d0741b4814caf97785cd103555063_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfMy03LTEtMS03NTA_53992700-4462-4c2a-9f90-8fdb92fa127b"
      unitRef="usd">30000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNC0xLTEtMS0xMDIz_9fff3f5d-d39b-43fd-a2ec-3908f57e3764"
      unitRef="usd">54000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i48966b2b67e54988b474069368fd3c54_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNC0zLTEtMS0xMDIz_17538861-b22e-4d8a-a5f8-c99d2c15574e"
      unitRef="usd">64000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNC01LTEtMS0xMDIz_1f262215-7af9-4106-99b5-8417ca7a437c"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i079d0741b4814caf97785cd103555063_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNC03LTEtMS0xMDIz_36d911df-8fe8-454c-9fc9-52740db93f7c"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNS0xLTEtMS0xMDIz_9d06dea8-1cdd-47e7-ae65-688fe530dda5"
      unitRef="usd">122000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i48966b2b67e54988b474069368fd3c54_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNS0zLTEtMS0xMDIz_8901d8ff-7680-437f-909a-b1c772d71a09"
      unitRef="usd">112000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNS01LTEtMS0xMDIz_51404ddd-713f-4a68-93b8-0befb2ab415d"
      unitRef="usd">28000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i079d0741b4814caf97785cd103555063_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNS03LTEtMS0xMDIz_d001fd8c-67c7-4722-bcbd-4724df21fffe"
      unitRef="usd">30000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNi0xLTEtMS0xMDIz_958ffd5b-9edd-4e04-8105-81654e9df415"
      unitRef="usd">-35000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i48966b2b67e54988b474069368fd3c54_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNi0zLTEtMS0xMDIz_3d5bc677-16f8-4d6e-b640-70c075b142d6"
      unitRef="usd">-28000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNi01LTEtMS0xMDIz_eaf3a4fb-8f2f-4cff-8376-0ae8ba9a2c47"
      unitRef="usd">-12000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i079d0741b4814caf97785cd103555063_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfNi03LTEtMS0xMDIz_9b1b5ae7-e520-46e9-8fb7-bfca702c7eeb"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfOC0xLTEtMS0xMDIz_f8a3510f-86bb-425e-a833-be17be3bc6a7"
      unitRef="usd">101000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i48966b2b67e54988b474069368fd3c54_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfOC0zLTEtMS0xMDIz_691d77a6-efff-4f61-a653-332fe76e5674"
      unitRef="usd">32000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i16cd5c34318c477c88f2cfd0a71087aa_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfOC01LTEtMS0xMDIz_b23cc8e3-b55f-4f3f-86eb-d3404d86e189"
      unitRef="usd">31000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i079d0741b4814caf97785cd103555063_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RhYmxlOjljMGMxYThjMjk0YjQ3YTA5YTczYjMxZmQ4ZDE5MzVkL3RhYmxlcmFuZ2U6OWMwYzFhOGMyOTRiNDdhMDlhNzNiMzFmZDhkMTkzNWRfOC03LTEtMS0xMDIz_a59ac930-5a37-49c2-a29e-f1e3e646bba6"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfODU4_d2c69314-2e53-4798-9bb9-f8accb07fec9"
      unitRef="usd">97000000</mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits>
    <mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfODU4_ea16b3a3-2a19-4d31-8099-ffa1e885b7c9"
      unitRef="usd">97000000</mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod
      contextRef="idaeb19b601df4dc9b8505dbff45b9841_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM1Mw_28cc3d2a-5e20-4698-a194-a4383f3a0621"
      unitRef="usd">80000000</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod
      contextRef="i0579786642984f61b518ad7ce2988383_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM1Mw_4dc72bab-94bf-4be4-93c5-30e6db15fa41"
      unitRef="usd">80000000</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <mdt:DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM2Ng_398c1bf8-3836-4d42-b786-15355de1c689"
      unitRef="usd">11000000</mdt:DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits>
    <mdt:DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM2Ng_e595ff82-81a2-4ae4-8d98-07266a515c18"
      unitRef="usd">11000000</mdt:DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod
      contextRef="if525bf943aab4cbb91e9eb6d27a46bf6_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM3OQ_e0a74775-a244-4a21-a027-1d38ed9dfbc2"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod
      contextRef="i1d0206d6a5fc41a49d8a7cc2ef0f0f5a_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM3OQ_ec42e193-9e8b-454e-b8e0-609c0cf0f247"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <mdt:DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM5MQ_0487bb12-430a-4aca-bdbf-7a6a7d2b1bf0"
      unitRef="usd">2000000</mdt:DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits>
    <mdt:DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV84NS9mcmFnOjk2ZTQ2ZTBjZTVmMjQ4MzJhY2MyYjdiZGY4MWQ4ZTRmL3RleHRyZWdpb246OTZlNDZlMGNlNWYyNDgzMmFjYzJiN2JkZjgxZDhlNGZfNDM5ODA0NjUxODM5MQ_74dc4003-8cc0-49e8-9ee7-afcdc63e081f"
      unitRef="usd">2000000</mdt:DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjY1Nw_033a20c5-7ab0-4766-9653-c7ccbc019fb4">Accumulated Other Comprehensive Loss &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides changes in AOCI, net of tax, and by component:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Investment Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Change in Retirement Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(955)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,832)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized (Loss) Gain on Investment Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Change in Retirement Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;April 26, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:9pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax on gains and losses on investment securities in other comprehensive income before reclassifications during the six months ended October&#160;30, 2020 and October&#160;25, 2019 was an expense of $31 million and $1&#160;million, respectively. There was no income tax on gains and losses on investment securities reclassified from AOCI for the six months ended October&#160;30, 2020. During the six months ended October&#160;25, 2019, realized gains and losses on investment securities reclassified from AOCI were reduced by income taxes of $2&#160;million. When realized, gains and losses on investment securities reclassified from AOCI are recognized within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other non-operating income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Refer to Note&#160;6&#160;to the consolidated financial statements for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax on cumulative translation adjustment for the six months ended October&#160;30, 2020, was an expense of $4 million. For the six months ended October&#160;25, 2019, there was no income tax on cumulative translation adjustment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended October&#160;30, 2020 and October&#160;25, 2019, there were no tax impacts on net investment hedges. Refer to Note 8 to the consolidated financial statements for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net change in retirement obligations in other comprehensive income includes amortization of net actuarial losses included in net periodic benefit cost. During the six months ended October&#160;30, 2020, the net change in retirement obligations in other comprehensive income before reclassifications resulted in an income tax benefit of $5 million. During the six months ended October&#160;25, 2019, there was no income tax impact on the net change in retirement obligations in other comprehensive income before reclassifications. During the six months ended October&#160;30, 2020 and October&#160;25, 2019, the gains and losses on defined benefit and pension items reclassified from AOCI were reduced by income taxes of&#160;$8 million and $6&#160;million, respectively. When realized, net gains and losses on defined benefit and pension items reclassified from AOCI are recognized within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other non-operating income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Refer to Note&#160;14 to the consolidated financial statements&#160;for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax on unrealized gains and losses on cash flow hedges in other comprehensive income before reclassifications during the six months ended October&#160;30, 2020 and October&#160;25, 2019&#160;was&#160;a benefit of&#160;$93 million and an expense of $21&#160;million, respectively. During the six months ended October&#160;30, 2020 and October&#160;25, 2019, gains and losses on cash flow hedges reclassified from AOCI were reduced by income taxes of&#160;$10 million and $26&#160;million, respectively. When realized, gains and losses on currency exchange rate contracts reclassified from AOCI are recognized within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other operating expense, net,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;and gains and losses on forward starting interest rate derivatives reclassified from AOCI are recognized within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;interest expense.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Refer to Note&#160;8&#160;to the consolidated financial statements for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjY2Mg_cc1ec859-619b-45e0-bb24-59431288d3a7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides changes in AOCI, net of tax, and by component:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Investment Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Change in Retirement Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;April 24, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(955)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,832)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized (Loss) Gain on Investment Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Change in Retirement Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;April 26, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida6a709f1f574db2a0ee55985446dde8_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMS0xLTEtMS0w_b3e99425-1bd5-44f8-923e-0c77a64eee05"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ffaa96aa77b425a843a25fa1ef58542_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMS0zLTEtMS0w_62e7916f-d84d-44a1-87ed-55e61b9612f3"
      unitRef="usd">-2210000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i05e20d1638064e7e909e1fc85204b962_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMS01LTEtMS0w_14b9163a-1218-48a0-81be-a0396c46f788"
      unitRef="usd">236000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib42695173b6e44668e0e633108f36472_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMS03LTEtMS0w_8b704bff-56c6-4e79-a51a-c1d1601be278"
      unitRef="usd">-1852000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6a3f0bf4841e4466b909762f6987805d_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMS05LTEtMS0w_61c3a20d-cfc5-4a24-ac00-0c9d48e25121"
      unitRef="usd">266000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5c85755ec4074136b1ee5356437a2b17_I20200424"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMS0xMS0xLTEtMA_58988cf7-9f0b-4a3c-bff5-714b1ac35890"
      unitRef="usd">-3560000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia259e32147694c1a90acdfc351d3be37_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMi0xLTEtMS0w_eafc94cd-1f59-49f1-ba13-6877017e09e7"
      unitRef="usd">114000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9ea3630e377a437682567a4587f0b46a_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMi0zLTEtMS0w_53800563-8952-474c-aa59-da8d6ef15d28"
      unitRef="usd">1255000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if0d4590a839f4f359683bd936959376a_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMi01LTEtMS0w_1ad11276-4e08-420d-b218-1d1954d2aa05"
      unitRef="usd">-1276000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if8db26e60a874f328bde32ae1fffb625_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMi03LTEtMS0w_cf74a54c-1475-47bd-a427-32daa32ccf12"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id5b5d4d785ba4390854bcea8e68a032f_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMi05LTEtMS0w_4b3d7835-32e0-4c24-aed8-280b9bfd7d5f"
      unitRef="usd">-359000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iefd7e349f18840e98869efd76dfa5aee_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMi0xMS0xLTEtMA_80887c35-ea50-4902-9b43-d7ed0241fd90"
      unitRef="usd">-280000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia259e32147694c1a90acdfc351d3be37_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMy0xLTEtMS0w_3b6427f2-d646-463b-bdca-b51173198b5a"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9ea3630e377a437682567a4587f0b46a_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMy0zLTEtMS0w_b1b78d4b-4452-45f6-b3dc-de2fc09864c2"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if0d4590a839f4f359683bd936959376a_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMy01LTEtMS0w_c90c2128-dd08-4f01-a003-d0a0e8a06387"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if8db26e60a874f328bde32ae1fffb625_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMy03LTEtMS0w_b8c29865-7ad9-4386-a639-bdefbb5a51bf"
      unitRef="usd">-34000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id5b5d4d785ba4390854bcea8e68a032f_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMy05LTEtMS0w_e7702a7f-da39-4eec-b9eb-4492cb113265"
      unitRef="usd">36000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iefd7e349f18840e98869efd76dfa5aee_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMy0xMS0xLTEtMA_e0de67f7-118b-46db-93ae-ae760f02a593"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia259e32147694c1a90acdfc351d3be37_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNC0xLTEtMS0w_80c874f2-5ba2-4e26-a6a5-c5452992b0e3"
      unitRef="usd">113000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9ea3630e377a437682567a4587f0b46a_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNC0zLTEtMS0w_7ff765de-ecdc-47fc-ac7e-90de62e1dc2b"
      unitRef="usd">1255000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if0d4590a839f4f359683bd936959376a_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNC01LTEtMS0w_244cc634-f5de-416b-a834-616e04df3d2e"
      unitRef="usd">-1276000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if8db26e60a874f328bde32ae1fffb625_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNC03LTEtMS0w_6f82f9c4-21d3-41e7-8a1e-7a84080e8919"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id5b5d4d785ba4390854bcea8e68a032f_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNC05LTEtMS0w_3ad66252-ebe7-477a-9429-71b4d9d9ff27"
      unitRef="usd">-395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iefd7e349f18840e98869efd76dfa5aee_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNC0xMS0xLTEtMA_12ad672d-dad2-4e26-a3b6-0ee9d542edea"
      unitRef="usd">-283000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i25a603a65af64e6889139205388d2a5e_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNS0xLTEtMS0w_45865f2b-973c-474d-9324-dd29f2485655"
      unitRef="usd">113000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie00c23bcd7924f48a43b264894ae1590_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNS0zLTEtMS0w_dded9396-e23d-40de-bef9-092d06f29ef5"
      unitRef="usd">-955000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5386101e521b4ca1b362aaa02cd87dcb_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNS01LTEtMS0w_e507c7b1-b2c8-4f49-b599-e7698e598610"
      unitRef="usd">-1040000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i449e4d657bf0449ba7b52e557589bbf1_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNS03LTEtMS0w_22746b0b-7bf8-4e63-8911-276fed2f9974"
      unitRef="usd">-1832000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99b3bd351a494528906e3d120cfc830f_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNS05LTEtMS0w_cfa118a7-a8c4-42ad-b666-52d3e42cd447"
      unitRef="usd">-129000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1fb60693b842404b9c6c710c434a9f46_I20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfNS0xMS0xLTEtMA_04fad310-b5ea-4522-9938-075c72b937ec"
      unitRef="usd">-3843000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ea2e72c446043e2a75ada4300c76bf2_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfOS0xLTEtMS0w_83354cf1-25c3-4fa2-b792-8390f39164ea"
      unitRef="usd">-45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c2ce4c6cbd84b4fb1294afa3a54a8a7_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfOS0zLTEtMS0w_b0d6f943-7e03-48b2-bd2f-96c03aef64f0"
      unitRef="usd">-1383000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice02b0738fd5434fb3f67530d843a491_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfOS01LTEtMS0w_39e1062c-a77f-4ce4-a398-0e270e05f573"
      unitRef="usd">-169000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i707bc78abce44fed88d7746e65fcc6c1_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfOS03LTEtMS0w_4ce98125-5bd8-40e7-a663-0fa52ea5eb73"
      unitRef="usd">-1308000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie9eea4603bf34820985c1564d60a7ae8_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfOS05LTEtMS0w_d477995e-5227-49d4-a5ef-066bffdd518e"
      unitRef="usd">194000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idce4f3b26c5a4fefb9a2268a16c018e1_I20190426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfOS0xMS0xLTEtMA_0d341a3a-e2a4-45f7-b80e-b6c35a89f9b8"
      unitRef="usd">-2711000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie397d3f57a424feab9c1039773fe2c37_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTAtMS0xLTEtMA_bf206a4b-6046-4646-93be-a8616816c19b"
      unitRef="usd">68000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i594c98fce3834e6c911b55d203d09432_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTAtMy0xLTEtMA_677085a7-bcfe-4098-90fc-29e414a8b3b0"
      unitRef="usd">-148000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0fc63908080e457f944dc31cb02f1ece_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTAtNS0xLTEtMA_46d4e697-ea12-40b5-9881-46aa4fa5ea22"
      unitRef="usd">152000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia6233127143d474ca30c57ef1e30c869_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTAtNy0xLTEtMA_4b29d02e-53c2-4d8f-8808-e7a0de211984"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i853467b20db64187814759647e0063ff_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTAtOS0xLTEtMA_ed4c5389-c029-431a-bb53-f6f8b3f8ac18"
      unitRef="usd">82000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3c01efddfd944a258a76ab642888a572_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTAtMTEtMS0xLTA_afbac7f5-3cc3-4a20-85f4-5de905103faf"
      unitRef="usd">153000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie397d3f57a424feab9c1039773fe2c37_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTEtMS0xLTEtMA_d2339a22-9616-4e29-8c58-1d58864804c8"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i594c98fce3834e6c911b55d203d09432_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTEtMy0xLTEtMA_8724e9f4-994b-4178-881c-7e20adaa0bc6"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0fc63908080e457f944dc31cb02f1ece_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTEtNS0xLTEtMA_26422f6b-d1f6-44ba-a7d6-182a8bd32eda"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia6233127143d474ca30c57ef1e30c869_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTEtNy0xLTEtMA_d13cc358-f676-4cef-875e-cb88e32e0cc1"
      unitRef="usd">-26000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i853467b20db64187814759647e0063ff_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTEtOS0xLTEtMA_813767d9-1453-4921-b92f-a13ddff341c6"
      unitRef="usd">84000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3c01efddfd944a258a76ab642888a572_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTEtMTEtMS0xLTA_6e6b739c-2f34-4410-9a4e-c8ba5b9d1e3b"
      unitRef="usd">53000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie397d3f57a424feab9c1039773fe2c37_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTItMS0xLTEtMA_8fc6b6b0-3518-4723-8e07-0b3cd93e54bc"
      unitRef="usd">73000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i594c98fce3834e6c911b55d203d09432_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTItMy0xLTEtMA_7c81bd4f-b936-49ca-a48c-a7ad72b27f96"
      unitRef="usd">-148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0fc63908080e457f944dc31cb02f1ece_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTItNS0xLTEtMA_7bd5e090-d2f1-44ad-92e2-1fd534ba3449"
      unitRef="usd">152000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia6233127143d474ca30c57ef1e30c869_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTItNy0xLTEtMA_94475d4a-75d9-4da5-bcbb-18cb6fc9b84c"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i853467b20db64187814759647e0063ff_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTItOS0xLTEtMA_36600e10-dac4-4c53-b1b7-04e420d517d1"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3c01efddfd944a258a76ab642888a572_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTItMTEtMS0xLTA_b5cfca9b-7a8c-4e61-9e4d-bf788ca6d576"
      unitRef="usd">100000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8fcd13d6b3740c6a5a4e7d8f673420a_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTQtMS0xLTEtMA_ea05e19a-33bb-44dd-abe0-40f878e0e7bb"
      unitRef="usd">28000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6555488fb0954ade9760238ea2f0aee2_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTQtMy0xLTEtMA_33e2b3e3-1959-4772-8bce-609cfc8ca3bf"
      unitRef="usd">-1531000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if2dc5e7853c24bc8a015eae803815058_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTQtNS0xLTEtMA_670a8eda-1504-486a-adb5-887b03d1876b"
      unitRef="usd">-17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i54f47cb7887f45f1b52b527c507264dc_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTQtNy0xLTEtMA_11d808ab-75fd-421f-8c37-29dc3b9da156"
      unitRef="usd">-1283000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8a7dc5cbd8f473f99e012510c678690_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTQtOS0xLTEtMA_2a58a828-a6f6-4cec-8300-9606022e0922"
      unitRef="usd">192000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36754839d63e4461b94b37c7bae9a3fb_I20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RhYmxlOjA1ZThiZjE2NDcxMjQxN2E4M2RkNDY0MGY2OTVjZmYwL3RhYmxlcmFuZ2U6MDVlOGJmMTY0NzEyNDE3YTgzZGQ0NjQwZjY5NWNmZjBfMTQtMTEtMS0xLTA_da0e16a5-cd87-48d6-9d49-f8733c80d852"
      unitRef="usd">-2611000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ia259e32147694c1a90acdfc351d3be37_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjQ5_2b647f98-26e6-4dcd-b72c-430dca4bfe96"
      unitRef="usd">31000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ie397d3f57a424feab9c1039773fe2c37_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjY5_d569163c-f0e7-4596-8e26-cad37a757231"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ia259e32147694c1a90acdfc351d3be37_D20200425-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjk3_f643fc55-89cc-4281-acf7-054bb906df03"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ie397d3f57a424feab9c1039773fe2c37_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfNTM1_f5b1a1aa-ada4-494d-b9f3-c2e9d3064213"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i9ea3630e377a437682567a4587f0b46a_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfODQ1_5728635f-b244-44d4-ba3f-89eb3e539731"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i594c98fce3834e6c911b55d203d09432_D20190427-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfODkw_5261c13c-ce6f-4e3d-81cf-3710932287d4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="if0d4590a839f4f359683bd936959376a_D20200425-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfOTc5_1de2c0a6-5bb1-46c4-a718-9aa210b30db6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i0fc63908080e457f944dc31cb02f1ece_D20190427-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfOTc5_2fc191b3-ab27-4623-a27b-2a1da4fd72f4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="if8db26e60a874f328bde32ae1fffb625_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMTQxNA_69b25115-c45e-4570-8c58-77aa00d90a6a"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ia6233127143d474ca30c57ef1e30c869_D20190427-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMTQ0Ng_675a6458-b295-4c39-9aa0-f0bc4cc6f69c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="if8db26e60a874f328bde32ae1fffb625_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMTcwNQ_ba26bbf8-40be-4e53-a122-356203d02a1f"
      unitRef="usd">-8000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ia6233127143d474ca30c57ef1e30c869_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMTcxMg_5e5a4b18-000b-4b0c-be42-44c6d95952b2"
      unitRef="usd">-6000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="id5b5d4d785ba4390854bcea8e68a032f_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjEyOQ_202b3746-cb95-4c48-b113-3bb93d7874b8"
      unitRef="usd">-93000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i853467b20db64187814759647e0063ff_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjE1MA_4a7b6e82-b365-4a8d-b2a3-846e7933cd13"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="id5b5d4d785ba4390854bcea8e68a032f_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfMjI4NQ_358b4298-75d5-4b4e-a079-ada450c92e0c"
      unitRef="usd">-10000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i853467b20db64187814759647e0063ff_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85MS9mcmFnOjNkOGUzOGQzMWNmYzRlMmNhNGU0ZGE4MDI0ODMzYmY3L3RleHRyZWdpb246M2Q4ZTM4ZDMxY2ZjNGUyY2E0ZTRkYTgwMjQ4MzNiZjdfNzE0NjgyNTU4Mzk2NQ_2e22fe92-ee1d-456e-873b-9b32d05a8735"
      unitRef="usd">-26000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:LossContingencyDisclosures
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMTg5MjA_e73bc3e2-976c-484d-b492-266e78bee7f7">Commitments and Contingencies &lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company and its affiliates are involved in a number of legal actions involving product liability, intellectual property and commercial disputes, shareholder related matters, environmental proceedings, tax disputes, and governmental proceedings and investigations, including those described below. With respect to governmental proceedings and investigations, like other companies in our industry, the Company is subject to extensive regulation by national, state and local governmental agencies in the United States and in other jurisdictions in which the Company and its affiliates operate. As a result, interaction with governmental agencies is ongoing. The Company&#x2019;s standard practice is to cooperate with regulators and investigators in responding to inquiries. The outcomes of legal actions are not within the Company&#x2019;s complete control and may not be known for prolonged periods of time. In some actions, the enforcement agencies or private claimants seek damages, as well as other civil or criminal remedies (including injunctions barring the sale of products that are the subject of the proceeding), that could require significant expenditures, result in lost revenues, or limit the Company's ability to conduct business in the applicable jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company records a liability in the consolidated financial statements on an undiscounted basis for loss contingencies related to legal actions when a loss is known or considered probable and the amount may be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is reasonably possible but not known or probable, and may be reasonably estimated, the estimated loss or range of loss is disclosed. When determining the estimated loss or range of loss, significant judgment is required. Estimates of probable losses resulting from litigation and governmental proceedings involving the Company are inherently difficult to predict, particularly when the matters are in early procedural stages with incomplete scientific facts or legal discovery, involve unsubstantiated or indeterminate claims for damages, potentially involve penalties, fines or punitive damages, or could result in a change in business practice. The Company classifies litigation charges and gains related to significant legal matters as certain litigation charges. During the three and six months ended October&#160;30, 2020, the Company recognized charges of $84 million and a net benefit of $4 million, respectively, primarily due to favorable settlements in the first quarter of fiscal year 2021, partially offset by charges recognized in the second quarter of fiscal year 2021. During the three and six months ended October&#160;25, 2019, the Company recognized $121 million and $168 million, respectively, of certain litigation charges. At October&#160;30, 2020 and April&#160;24, 2020, accrued litigation was approximately $0.4&#160;billion and $0.5 billion, respectively. The ultimate cost to the Company with respect to accrued litigation could be materially different than the amount of the current estimates and accruals and could have a material adverse impact on the Company&#x2019;s consolidated earnings, financial position, and/or cash flows. The Company includes accrued litigation in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;other accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;other liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; on the consolidated balance sheets. While it is not possible to predict the outcome for most of the legal matters discussed below, the Company believes it is possible that the costs associated with these matters could have a material adverse impact on the Company&#x2019;s consolidated earnings, financial position, and/or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Liability Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Pelvic Mesh Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company is currently involved in litigation in various state and federal courts against manufacturers of pelvic mesh products alleging personal injuries resulting from the implantation of those products. Two subsidiaries of Covidien supplied pelvic mesh products to one of the manufacturers, C.R. Bard (Bard), named in the litigation. The litigation includes a federal multi-district litigation in the U.S. District Court for the Northern District of West Virginia and cases in various state courts and jurisdictions outside the U.S. Generally, complaints allege design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. In fiscal year 2016, Bard paid the Company $121 million towards the settlement of 11,000 of these claims. In May 2017, the agreement with Bard was amended to extend the terms to apply to up to an additional 5,000 claims. That agreement does not resolve the dispute between the Company and Bard with respect to claims that do not settle, if any. As part of the agreement, the Company and Bard agreed to dismiss without prejudice their pending litigation with respect to Bard&#x2019;s obligation to defend and indemnify the Company. The Company estimates law firms representing approximately 16,200 claimants have asserted or may assert claims involving products manufactured by Covidien&#x2019;s subsidiaries. As of November 4, 2020, the Company had reached agreements to settle approximately 15,900 of these claims. The Company's accrued expenses for this matter are included within accrued litigation as discussed above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Hernia Mesh Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal year 2020, plaintiffs filed lawsuits against certain subsidiaries of the Company in U.S. state and federal courts alleging personal injury from hernia mesh products sold by those subsidiaries. The majority of the pending cases are in Massachusetts state court, where they have been consolidated before a single judge. Certain plaintiffs' law firms have advised the Company that they may file additional cases in the future. The pending lawsuits relate to hernia mesh products that have not been subject to recalls, withdrawals or other adverse regulatory action. The Company has not recorded an expense related to damages in connection with these matters because any potential loss is not currently probable or reasonably estimable under U.S. GAAP. Additionally, the Company is unable to reasonably estimate the range of loss, if any, that may result from these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patent Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Ethicon&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 14, 2011, Ethicon filed an action against Covidien in the U.S. District Court for the Southern District of Ohio, alleging patent infringement and seeking monetary damages and injunctive relief. On January 22, 2014, the district court entered summary judgment in Covidien's favor, and the majority of this ruling was affirmed by the Federal Circuit on August 7, 2015.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Following appeal, the case was remanded back to the District Court with respect to one patent. On January 21, 2016, Covidien filed a second action in the U.S. District Court for the Southern District of Ohio, seeking a declaration of non-infringement with respect to a second set of patents held by Ethicon. The court consolidated this second action with the remaining patent issues from the first action. Following consolidation of the cases, Ethicon dismissed six of the asserted patents, leaving a single asserted patent. The court has scheduled this matter for a bench trial in the first half of calendar year 2021. The Company has not recognized an expense related to damages in connection with this matter because any potential loss is not currently probable or reasonably estimable under U.S. GAAP. Additionally, the Company is unable to reasonably estimate the range of loss, if any, that may result from this matter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Sasso&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company is involved in litigation in Indiana relating to certain patent and royalty disputes with Dr. Sasso under agreements originally entered into in 1999 and 2001. On November 28, 2018, a jury in Indiana state court returned a verdict against the Company for approximately $112&#160;million. The Company has strong arguments to appeal the verdict and has filed post-trial motions and appeals with the appropriate appellate courts. The Company's accrued expenses for this matter are included within accrued litigation as discussed above.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shareholder Related Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Covidien Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 2, 2014, Lewis Merenstein filed a putative shareholder class action in Hennepin County, Minnesota, District Court seeking to enjoin the then-potential acquisition of Covidien. The lawsuit named Medtronic, Inc., Covidien, and each member of the Medtronic, Inc. Board of Directors at the time as defendants, and alleged that the directors breached their fiduciary duties to shareholders with regard to the then-potential acquisition. On August 21, 2014, Kenneth Steiner filed a putative shareholder class action in Hennepin County, Minnesota, District Court, also seeking an injunction to prevent the potential Covidien acquisition. In September 2014, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Merenstein&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Steiner&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; matters were consolidated and in December 2014, the plaintiffs filed a preliminary injunction motion seeking to enjoin the Covidien transaction. On March 20, 2015, the District Court issued an order and opinion granting Medtronic&#x2019;s motion to dismiss the case. In May 2015, the plaintiffs filed an appeal, and, in January 2016, the Minnesota State Court of Appeals affirmed in part, and reversed in part. On April 19, 2016 the Minnesota Supreme Court granted the Company&#x2019;s petition to review the issue of whether most of the original claims are properly characterized as direct or derivative under Minnesota law. In August 2017, the Minnesota Supreme Court affirmed the decision of the Minnesota State Court of Appeals, sending the matter back to the trial court for further proceedings, which are ongoing. In April 2020, the District Court issued an order and opinion denying the plaintiffs' motion for class certification. In June 2020, the Minnesota State Court of Appeals denied the plaintiffs' request to review the District Court's denial of class certification, and in September 2020, the Minnesota Supreme Court denied the plaintiffs' request to review the Court of Appeals decision. The Company has not recognized an expense related to damages in connection with this matter because any potential loss is not currently probable or reasonably estimable under U.S. GAAP. Additionally, the Company is unable to reasonably estimate the range of loss, if any, that may result from these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Environmental Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company is involved in various stages of investigation and cleanup related to environmental remediation matters at a number of sites. These projects relate to a variety of activities, including removal of solvents, metals and other hazardous substances from soil and groundwater. The ultimate cost of site cleanup and timing of future cash flows is difficult to predict given uncertainties regarding the extent of the required cleanup, the interpretation of applicable laws and regulations, and alternative cleanup methods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company is a successor to a company that owned and operated a chemical manufacturing facility in Orrington, Maine from 1967 until 1982, and is responsible for the costs of completing an environmental site investigation as required by the Maine Department of Environmental Protection (MDEP). MDEP served a compliance order on Mallinckrodt LLC and U.S. Surgical Corporation, subsidiaries of Covidien, in December 2008, which included a directive to remove a significant volume of soils at the site. After a hearing on the compliance order before the Maine Board of Environmental Protection (Maine Board) to challenge the terms of the compliance order, the Maine Board modified the MDEP order and issued a final order requiring removal of two landfills, capping of the remaining three landfills, installation of a groundwater extraction system and long-term monitoring of the site and the three remaining landfills.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company has proceeded with implementation of the investigation and remediation at the site in accordance with the MDEP order as modified by the Maine Board order. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Since the early 2000s, the Company or its predecessors have also been involved in a lawsuit filed in the U.S. District Court for the District of Maine by the Natural Resources Defense Council and the Maine People&#x2019;s Alliance. Plaintiffs sought an injunction requiring the Company's predecessor to conduct extensive studies of mercury contamination of the Penobscot River and Bay and options for remediating such contamination, and to perform appropriate remedial activities, if necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Following a trial in March 2002, the Court held that conditions in the Penobscot River and Bay may pose an imminent and substantial endangerment and that the Company&#x2019;s predecessor was liable for the cost of performing a study of the River and Bay. Following a second trial in June 2014, the Court ordered that further engineering study and engineering design work was needed to determine the nature and extent of remediation in the Penobscot River and Bay. The Court also appointed an engineering firm to conduct such studies and issue a report on potential remediation alternatives. In connection with these proceedings, reports have been produced including a variety of cost estimates for a variety of potential remedial options. A third trial to determine the course of remediation to be pursued is scheduled to occur in fiscal year 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's accrued expenses for environmental proceedings are included within accrued litigation as discussed above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2009, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2005 and 2006. Medtronic, Inc. reached agreement with the IRS on some, but not all matters related to these fiscal years. The remaining unresolved issue for fiscal years 2005 and 2006 relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico, which is one of the Company's key manufacturing sites. The U.S. Tax Court reviewed this dispute, and on June 9, 2016, issued its opinion with respect to the allocation of income between the parties for fiscal years 2005 and 2006. The U.S. Tax Court generally rejected the IRS&#x2019;s position, but also made certain modifications to the Medtronic, Inc. tax returns as filed. On April 21, 2017, the IRS filed their Notice of Appeal to the U.S. Court of Appeals for the 8th Circuit regarding the Tax Court Opinion.&#160;Oral argument for the Appeal occurred on March 14, 2018. The 8th Circuit Court of Appeals issued their opinion on August 16, 2018 and remanded the case back to the U.S. Tax Court for additional factual findings. The U.S. Tax Court trial is scheduled to occur in June of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2011, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2007 and 2008. Medtronic, Inc. reached agreement with the IRS on some, but not all matters related to these fiscal years. The remaining unresolved issue for fiscal years 2007 and 2008 relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for the businesses that are the subject of the U.S. Tax Court Case for fiscal years 2005 and 2006. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2014, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2009, 2010, and 2011. Medtronic, Inc. reached agreement with the IRS on some but not all matters related to these fiscal years. The remaining unresolved issue for fiscal years 2009, 2010, and 2011 relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for the businesses that are the subject of the U.S. Tax Court Case for fiscal years 2005 and 2006. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2012, 2013, and 2014. Medtronic, Inc. reached agreement with the IRS on some but not all matters related to these fiscal years. The significant issues that remain unresolved relate to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico, and proposed adjustments associated with the utilization of certain net operating losses. The Company disagrees with the IRS and will attempt to resolve these matters at the IRS Appellate level.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to quarter-end, in November 2020, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2015 and 2016. Medtronic, Inc. reached agreement with the IRS on some but not all matters related to these fiscal years. The significant issue that remains unresolved relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for the businesses that are the subject of the U.S. Tax Court Case for fiscal years 2005 and 2006.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medtronic, Inc.&#x2019;s fiscal years 2017, 2018, and 2019 U.S. federal income tax returns are currently being audited by the IRS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Covidien and the IRS have concluded and reached agreement on its audit of Covidien&#x2019;s U.S. federal income tax returns for all tax years through 2012. The statute of limitations for Covidien&#x2019;s 2013 and 2014 U.S. federal income tax returns lapsed during the first quarter of fiscal years 2018 and 2019, respectively. Covidien's fiscal year 2015 U.S. federal income tax returns are currently being audited by the IRS. The statute of limitations for Covidien's 2016 U.S. federal income tax return lapsed during the third quarter of fiscal year 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While it is not possible to predict the outcome for most of the income tax matters discussed above, the Company believes it is possible that charges associated with these matters could have a material adverse impact on the Company&#x2019;s consolidated earnings, financial position, and/or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 11 for additional discussion of income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the Company&#x2019;s sale of the Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses to Cardinal on July 29, 2017, the Company has indemnified Cardinal for certain contingent tax liabilities related to the divested businesses that existed prior to the date of divestiture. The actual amounts that the Company may be required to ultimately accrue or pay could vary depending upon the outcome of the unresolved tax matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company and/or its affiliates periodically enter into agreements that require one or more of the Company and/or its affiliates to indemnify customers or suppliers for specific risks, such as claims for injury or property damage arising as a result of the Company or its affiliates&#x2019; products, the negligence of the Company's personnel, or claims alleging that the Company's products infringe on third-party patents or other intellectual property. The Company also offers warranties on various products. The Company&#x2019;s maximum exposure under these guarantees is unable to be estimated. Historically, the Company has not experienced significant losses on these types of guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes the ultimate resolution of the above guarantees is not expected to have a material effect on the Company&#x2019;s consolidated earnings, financial position, and/or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:LossContingencyDisclosures>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMjU0MA_7bb32e8d-fb76-43c3-a483-df5319aa3b5d"
      unitRef="usd">84000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMzI5ODUzNDkwMjMxMQ_2e2f1fa1-0cd7-46e7-b580-52fbfef6d6d6"
      unitRef="usd">-4000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMjY1OA_6811a97a-5b79-466d-905d-75351685b787"
      unitRef="usd">121000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMzI5ODUzNDkwMjU5OA_485769a7-2dd6-412f-a9dd-74aa56f755ee"
      unitRef="usd">168000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i56cbe72d4f164d52b063093c431c9843_I20201030"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMjc0Mw_a521f46a-ac0c-4a2b-85b8-5bdaaf8421ce"
      unitRef="usd">400000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ib91d3cafbd584b8ca35b1b380bde9703_I20200424"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMjc1MA_757bb423-396b-4827-ac82-b59335074ede"
      unitRef="usd">500000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <mdt:LossContingencyNumberofSubsidiaries
      contextRef="i9f541ce4dcef4da4a428c97cc7a8f5c3_D20200425-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMzcxMw_38ec7a10-b730-4cc9-9688-ec1c7f05624a"
      unitRef="subsidiary">2</mdt:LossContingencyNumberofSubsidiaries>
    <mdt:LossContingencyNumberofManufacturers
      contextRef="i9f541ce4dcef4da4a428c97cc7a8f5c3_D20200425-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMzc3NA_2523d9bd-e30b-4fe8-8d9a-be3326d80ab4"
      unitRef="manufacturer">1</mdt:LossContingencyNumberofManufacturers>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i9229de7c6045441d80355b6acb70f350_D20150425-20160429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNDI2Ng_7b500a11-57b1-4ff9-bab1-ca618cafcc90"
      unitRef="usd">121000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <us-gaap:LossContingencyClaimsSettledNumber
      contextRef="i9229de7c6045441d80355b6acb70f350_D20150425-20160429"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNDI5NQ_f2b99c59-b443-45e4-948c-a9742df838ec"
      unitRef="claim">11000</us-gaap:LossContingencyClaimsSettledNumber>
    <us-gaap:LossContingencyClaimsSettledNumber
      contextRef="i60457532fbeb40878969effee2b3390c_D20170501-20170531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNDQxNg_fb72af05-6531-4087-a673-2d46b25fe0e8"
      unitRef="claim">5000</us-gaap:LossContingencyClaimsSettledNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i7ef87e2613a04c5888f894f05867fc25_I20201030"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNDc4OQ_d3836901-60c3-4012-9bc8-82029ceac9dc"
      unitRef="claim">16200</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyClaimsSettledNumber
      contextRef="ic14d3bd294c046c9afca0a4d2276f819_D20201104-20201104"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNDk3OA_46ea9c05-a43e-488c-9704-5df4ffe5e29a"
      unitRef="claim">15900</us-gaap:LossContingencyClaimsSettledNumber>
    <us-gaap:LossContingencyPatentsAllegedlyInfringedNumber
      contextRef="i77dc59d697684886bbf5fe519c310541_D20111214-20111214"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNjUwMA_f89f8d20-a345-4da3-8db7-ad9437c7dde7"
      unitRef="patent">1</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
    <us-gaap:LossContingencyPatentsFoundNotInfringedNumber
      contextRef="i77dc59d697684886bbf5fe519c310541_D20111214-20111214"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNjg3OA_bc5742a1-c806-4fbe-9bc0-1b8d86af62bf"
      unitRef="patent">6</us-gaap:LossContingencyPatentsFoundNotInfringedNumber>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i86701a14cb434b819fd00f6ad2cdbbaa_D20181128-20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfNzYzNQ_4b2762b1-00bc-4a55-a7f1-a4e00ad8efc4"
      unitRef="usd">112000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mdt:SiteContingencyNumberofLandfillsRequiringRemoval
      contextRef="ife64dfaf0edf41ea9552b05b5b7e1839_D20200425-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMTExNDg_81f3fac7-4a10-4d72-88a3-f18b2eb3bd7e"
      unitRef="landfill">2</mdt:SiteContingencyNumberofLandfillsRequiringRemoval>
    <mdt:SiteContingencyNumberOfLandfillsRequiringCapping
      contextRef="ife64dfaf0edf41ea9552b05b5b7e1839_D20200425-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMTExODc_b0b8a2af-7782-4ca4-851c-b2efb00e1176"
      unitRef="landfill">3</mdt:SiteContingencyNumberOfLandfillsRequiringCapping>
    <mdt:SiteContingencyNumberOfLandfillsRequiringCapping
      contextRef="ife64dfaf0edf41ea9552b05b5b7e1839_D20200425-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85NC9mcmFnOjQ1ZjExZGI1OTgxMTQ1YjE4OTA2MGY0MTgyZDNmZTI5L3RleHRyZWdpb246NDVmMTFkYjU5ODExNDViMTg5MDYwZjQxODJkM2ZlMjlfMTEyOTQ_b61602f0-e5ab-4257-8169-51ba9146fb09"
      unitRef="landfill">3</mdt:SiteContingencyNumberOfLandfillsRequiringCapping>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RleHRyZWdpb246NTVjYzgzNDNkNGVjNDFlNzlmZjdlMDA4YTU5ZTg2MWRfMTY3OA_0e047a82-12cd-41b7-9962-ed34c3c511a6">Segment and Geographic Information&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment disclosures are on a performance basis consistent with internal management reporting. Net sales of the Company's reportable segments include end-customer revenues from the sale of products the segment develops, manufactures, and distributes. There are certain corporate and centralized expenses that are not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s management evaluates performance of the segments and allocates resources based on net sales and segment operating profit. Segment operating profit represents income before income taxes, excluding interest expense, amortization of intangible assets, centralized distribution costs, non-operating income or expense items, certain corporate charges, and other items not allocated to the segments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note 1 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 24, 2020. Certain depreciable assets may be recorded by one segment, while the depreciation expense is allocated to another segment. The allocation of depreciation expense is based on the proportion of the assets used by each segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Operating Profit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:16pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac and Vascular Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Minimally Invasive Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restorative Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-operating income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(884)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(881)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centralized distribution costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and associated costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certain litigation charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit of businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt tender premium and other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical device regulations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution to Medtronic Foundation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Geographic Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales are attributed to the country based on the location of the customer taking possession of the products or in which the services are rendered. The following table presents net sales for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 for the Company's country of domicile, countries with significant concentrations, and all other countries:&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other countries, excluding Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RleHRyZWdpb246NTVjYzgzNDNkNGVjNDFlNzlmZjdlMDA4YTU5ZTg2MWRfMTY3OQ_aadc2fc0-e085-4c1e-8ad8-b55cbe12477b">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Operating Profit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:16pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac and Vascular Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Minimally Invasive Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restorative Therapies Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-operating income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(884)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(881)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centralized distribution costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and associated costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certain litigation charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit of businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt tender premium and other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical device regulations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution to Medtronic Foundation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="i63d7c5081980421eb104ef0db2d640cc_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMi0xLTEtMS0w_71534b01-cd53-4288-8fd5-7cf8ccb9f8c0"
      unitRef="usd">992000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9f4ddf14e8a5413696daf99ce008d00b_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMi0zLTEtMS0w_fcb92d0a-8dee-4fb0-8caf-7ca18959819a"
      unitRef="usd">1128000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i009f0737e76549b7bdd8727292bc324c_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMi01LTEtMS03OTA_3185dcde-5b2f-4eca-9b34-66549fcb042c"
      unitRef="usd">1751000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i34ef1f0d5805418690793935607c575e_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMi03LTEtMS03OTA_b8e7cc84-3cf4-419e-9ef7-f45464641eb6"
      unitRef="usd">2183000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i75f00ee586cf4b098983f7fd448c12ed_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMy0xLTEtMS0w_cdc5a3dc-2fe7-4a9b-8af7-c890796630ba"
      unitRef="usd">775000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6b7f6004ebaa4580aa2cd2c369060e7c_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMy0zLTEtMS0w_7fcfe9ff-b53f-4493-8b21-a4df063f8712"
      unitRef="usd">823000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icaf85161beb9449b9986565bb7507a94_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMy01LTEtMS03OTA_5bcd705d-30b3-470e-9fcb-9e454d43abc8"
      unitRef="usd">1230000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie5e5b0ae3f9b4c4a8f83073dab95f175_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMy03LTEtMS03OTA_37123f7c-ee5c-44e5-bed2-0790f639e880"
      unitRef="usd">1593000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8a9fdeedad9e48189c04e1acb1feea25_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNC0xLTEtMS0w_d9214f41-9a41-4373-af1b-20b6cc2b5048"
      unitRef="usd">805000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iae65e8a1899f46cf9f81db9fd9dc523e_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNC0zLTEtMS0w_da808b62-e2cb-40fe-b37c-711ab75e3d87"
      unitRef="usd">840000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i190a27e4543e49f095f067588a9750ad_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNC01LTEtMS03OTA_27e7342d-ab5d-40b6-a0af-48771e7a3757"
      unitRef="usd">1327000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib3bd9b003d9d458cbf0d73f754eece1c_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNC03LTEtMS03OTA_004b1688-741e-43c9-8851-b7a34198a974"
      unitRef="usd">1633000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9c39d3319d5441938058ead345505a10_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNS0xLTEtMS0w_dc7d65c4-ebb7-4205-ad8a-def2cc99b824"
      unitRef="usd">132000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i81bf88cc900e42b7baca3ed7b2f9944f_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNS0zLTEtMS0w_f9c9addb-4e21-468d-8069-bf7279414351"
      unitRef="usd">148000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i20c9d172c84641f8b5f43c19bf9b11e3_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNS01LTEtMS03OTA_d1d03bbf-6df7-4673-959d-dae27605a7d7"
      unitRef="usd">235000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i75e5044db63f4573911d00a91522924b_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNS03LTEtMS03OTA_a5bf3506-17f6-4071-8833-2cceb3e9c00b"
      unitRef="usd">297000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if8fbed3ebbc54e9e8e04c5281af315e7_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNi0xLTEtMS0w_5933e754-1c84-4e10-aee0-f8a4dc8ab8de"
      unitRef="usd">2704000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibd9ab457b664428faf530e0f31bec7ee_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNi0zLTEtMS0w_76d0a078-dd13-463e-bfb7-fa1d8e50b848"
      unitRef="usd">2939000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i50e105716e0b4d349b5afd9f55b817bb_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNi01LTEtMS03OTQ_d344b449-1e63-4691-904b-e30cd591e27a"
      unitRef="usd">4543000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i33de1043570543228ee3f7f6b21ee2b8_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNi03LTEtMS03OTQ_eda064fa-563d-4d4c-abd4-9a7ea53c366a"
      unitRef="usd">5706000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNy0xLTEtMS0w_8f46e858-84db-411f-b41d-7deef96a1284"
      unitRef="usd">470000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNy0zLTEtMS0w_1d4a1b71-9cb5-4f76-921a-56b21e6bf5b2"
      unitRef="usd">165000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNy01LTEtMS03OTQ_82d21105-378b-455a-beaa-51600bf17399"
      unitRef="usd">641000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfNy03LTEtMS03OTQ_bf750b52-811e-45fe-8b8d-558d45e6e328"
      unitRef="usd">774000000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeOperating
      contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOC0xLTEtMS0w_05f0fac2-c1e0-46fe-8fa4-53a182d55b4d"
      unitRef="usd">65000000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOC0zLTEtMS0w_99f406f6-8e52-42e3-8217-eb15ebed720f"
      unitRef="usd">108000000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOC01LTEtMS03OTQ_49881183-477b-482d-a8c2-9bf5b8243edf"
      unitRef="usd">147000000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOC03LTEtMS03OTQ_7e755b9a-ff86-4367-9e91-eaa59aba8aad"
      unitRef="usd">209000000</us-gaap:InterestIncomeOperating>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOS0xLTEtMS0w_6e5d8a07-d707-4260-86ed-6b19cdb3aede"
      unitRef="usd">443000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOS0zLTEtMS0w_d0adf668-9c88-4e48-945d-c7e1406ce398"
      unitRef="usd">441000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOS01LTEtMS03OTg_e157aec1-5d7e-423e-89bf-ac8ecca24e58"
      unitRef="usd">884000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfOS03LTEtMS03OTg_c6c16942-ab51-41b4-b1a8-6580e6ab4925"
      unitRef="usd">881000000</us-gaap:AmortizationOfIntangibleAssets>
    <mdt:CorporateOverhead
      contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTAtMS0xLTEtMA_79844eee-39ca-49cf-aaf7-8760619de918"
      unitRef="usd">460000000</mdt:CorporateOverhead>
    <mdt:CorporateOverhead
      contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTAtMy0xLTEtMA_7ace6d72-6ec0-4e4e-bca6-c26f9672d2c2"
      unitRef="usd">350000000</mdt:CorporateOverhead>
    <mdt:CorporateOverhead
      contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTAtNS0xLTEtNzk4_e2e4b990-4401-4a6e-bbf3-58a360ae3f8b"
      unitRef="usd">825000000</mdt:CorporateOverhead>
    <mdt:CorporateOverhead
      contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTAtNy0xLTEtNzk4_13867956-a6a1-4b93-a759-5aff96bcbec2"
      unitRef="usd">657000000</mdt:CorporateOverhead>
    <mdt:CentralizedDistributionCosts
      contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTEtMS0xLTEtMA_6e2f5b8f-6270-47c9-82ef-a2a4f6e1b017"
      unitRef="usd">542000000</mdt:CentralizedDistributionCosts>
    <mdt:CentralizedDistributionCosts
      contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTEtMy0xLTEtMA_1f29d435-77b5-4287-b6c9-fbb0c9aa79c6"
      unitRef="usd">424000000</mdt:CentralizedDistributionCosts>
    <mdt:CentralizedDistributionCosts
      contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTEtNS0xLTEtODAy_831e2465-6a45-4dc7-a35d-cf256496a358"
      unitRef="usd">940000000</mdt:CentralizedDistributionCosts>
    <mdt:CentralizedDistributionCosts
      contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTEtNy0xLTEtODAy_0b87432e-b659-457f-8946-9cd4c1258a1c"
      unitRef="usd">768000000</mdt:CentralizedDistributionCosts>
    <mdt:RestructuringChargesNetofRestructuringReversals
      contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTItMS0xLTEtMA_0a8c44fc-bbdc-40db-ab21-7203ed5c2ef5"
      unitRef="usd">179000000</mdt:RestructuringChargesNetofRestructuringReversals>
    <mdt:RestructuringChargesNetofRestructuringReversals
      contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTItMy0xLTEtMA_40c8482f-adeb-4331-aac9-3c7154557993"
      unitRef="usd">94000000</mdt:RestructuringChargesNetofRestructuringReversals>
    <mdt:RestructuringChargesNetofRestructuringReversals
      contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTItNS0xLTEtODAy_dfc0f2c2-015d-4c43-8cbf-8d386fc7778c"
      unitRef="usd">307000000</mdt:RestructuringChargesNetofRestructuringReversals>
    <mdt:RestructuringChargesNetofRestructuringReversals
      contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTItNy0xLTEtODAy_ceada1ad-7bec-4383-a3dc-10865878f474"
      unitRef="usd">218000000</mdt:RestructuringChargesNetofRestructuringReversals>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTMtMS0xLTEtMA_bb620258-e05d-4845-b411-17ec98d75284"
      unitRef="usd">37000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTMtMy0xLTEtMA_4d55492d-c173-4909-bbb5-2cd4fcf3d51f"
      unitRef="usd">27000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTMtNS0xLTEtODA2_9aef38c1-af3b-4a07-8239-bb3a605ae613"
      unitRef="usd">-68000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTMtNy0xLTEtODA2_0a3f161f-be17-438b-a5c5-f81bb0ec0131"
      unitRef="usd">46000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTQtMS0xLTEtMA_6b56ea2c-6129-46bd-a376-db80221d1f0c"
      unitRef="usd">84000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTQtMy0xLTEtMA_4b7b7e42-36f2-4ec4-9c22-fb93eaec5796"
      unitRef="usd">121000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTQtNS0xLTEtODA2_3a672c9e-ee41-4da5-925d-d45dbe23a653"
      unitRef="usd">-4000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTQtNy0xLTEtODA2_e41f9b9d-8f0d-4873-b03c-d1b4d2e94e40"
      unitRef="usd">168000000</us-gaap:LossContingencyAccrualProvision>
    <mdt:ImpairmentOfInProcessResearchAndDevelopment
      contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTUtMS0xLTEtMA_987a8513-9ee7-493b-b602-4b1e06fac7eb"
      unitRef="usd">10000000</mdt:ImpairmentOfInProcessResearchAndDevelopment>
    <mdt:ImpairmentOfInProcessResearchAndDevelopment
      contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTUtMy0xLTEtMA_3908ab15-073d-429e-91ac-ead1d224952b"
      unitRef="usd">0</mdt:ImpairmentOfInProcessResearchAndDevelopment>
    <mdt:ImpairmentOfInProcessResearchAndDevelopment
      contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTUtNS0xLTEtODEw_481d06fd-1a93-4ee6-8cf8-3dfd18800f44"
      unitRef="usd">19000000</mdt:ImpairmentOfInProcessResearchAndDevelopment>
    <mdt:ImpairmentOfInProcessResearchAndDevelopment
      contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTUtNy0xLTEtODEw_b594611a-1088-4de8-83ff-20e393a615a7"
      unitRef="usd">0</mdt:ImpairmentOfInProcessResearchAndDevelopment>
    <us-gaap:BusinessExitCosts1
      contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTYtMS0xLTEtMA_681c5c08-4a64-493c-ba46-6dc92a216515"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTYtMy0xLTEtMA_503ff309-91cd-444a-8005-def0527b8db6"
      unitRef="usd">41000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTYtNS0xLTEtNjA3Nw_c26a139b-c3ef-4a54-9087-6231f2b847ad"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTYtNy0xLTEtNjA3Nw_59ac87e5-decc-445b-aaed-9e502eddce63"
      unitRef="usd">41000000</us-gaap:BusinessExitCosts1>
    <mdt:DebtTenderPremiumandOtherCharges
      contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTctMS0xLTEtMA_a657e9c6-da3e-4b19-bf5a-52e9aad2a188"
      unitRef="usd">0</mdt:DebtTenderPremiumandOtherCharges>
    <mdt:DebtTenderPremiumandOtherCharges
      contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTctMy0xLTEtMA_7dbdfcc8-9d56-4590-b0f9-69d9fe7aaf4e"
      unitRef="usd">0</mdt:DebtTenderPremiumandOtherCharges>
    <mdt:DebtTenderPremiumandOtherCharges
      contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTctNS0xLTEtODE0_06de42e1-b747-440d-b1d1-c48f887731b8"
      unitRef="usd">0</mdt:DebtTenderPremiumandOtherCharges>
    <mdt:DebtTenderPremiumandOtherCharges
      contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTctNy0xLTEtODE0_179866e6-f1c4-4501-92e5-b971bce595cd"
      unitRef="usd">7000000</mdt:DebtTenderPremiumandOtherCharges>
    <mdt:MedicalDeviceRegulations
      contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTgtMS0xLTEtMA_9a91fa9c-f8e1-47ef-b323-d74e127ddf7c"
      unitRef="usd">19000000</mdt:MedicalDeviceRegulations>
    <mdt:MedicalDeviceRegulations
      contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTgtMy0xLTEtMA_9e18ea51-6dfa-4f8e-9749-34bb68e08e96"
      unitRef="usd">10000000</mdt:MedicalDeviceRegulations>
    <mdt:MedicalDeviceRegulations
      contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTgtNS0xLTEtODE0_4459f442-bdb6-46f6-838f-e617ad9e21d7"
      unitRef="usd">37000000</mdt:MedicalDeviceRegulations>
    <mdt:MedicalDeviceRegulations
      contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTgtNy0xLTEtODE0_f1f89d2d-d586-4c50-bc46-fb0fdab3000c"
      unitRef="usd">18000000</mdt:MedicalDeviceRegulations>
    <mdt:SpecialChargesGains
      contextRef="i0c6a359a01da4befbe3a00c569226a59_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTktMS0xLTEtMA_7a120fda-a5d1-49a1-9a6c-2cfcc5bebde4"
      unitRef="usd">0</mdt:SpecialChargesGains>
    <mdt:SpecialChargesGains
      contextRef="i43fb2e4a64534ae8a1c8cf73bcc34d10_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTktMy0xLTEtMA_0bcf3d66-83d2-433a-aa80-4957cbf6a726"
      unitRef="usd">80000000</mdt:SpecialChargesGains>
    <mdt:SpecialChargesGains
      contextRef="i088828113b7e4efdae6630f46542249d_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTktNS0xLTEtNjA4MQ_2f2da480-d18c-4d82-a82d-53b86f60f044"
      unitRef="usd">0</mdt:SpecialChargesGains>
    <mdt:SpecialChargesGains
      contextRef="i43c088d078494fffa71401dbcabc89b0_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMTktNy0xLTEtNjA4MQ_64c3846e-6043-46d6-8c6b-84bee6a2dd94"
      unitRef="usd">80000000</mdt:SpecialChargesGains>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMjEtMS0xLTEtMA_372d3254-e703-4dc0-bdb2-4f7cb2e6af6d"
      unitRef="usd">525000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMjEtMy0xLTEtMA_e28e0ee5-ec8d-4d64-a5a3-e7007ecbfa97"
      unitRef="usd">1294000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMjEtNS0xLTEtODE4_0322dd4a-2e7f-4399-96c1-53af66b526bd"
      unitRef="usd">1109000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmEzZmEwZmUyNjY4NDQ0NTk5Y2JjMzllOWQwYjkwZDkyL3RhYmxlcmFuZ2U6YTNmYTBmZTI2Njg0NDQ1OTljYmMzOWU5ZDBiOTBkOTJfMjEtNy0xLTEtODE4_39d17ab3-f98e-4054-ab06-226223f03ada"
      unitRef="usd">2271000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RleHRyZWdpb246NTVjYzgzNDNkNGVjNDFlNzlmZjdlMDA4YTU5ZTg2MWRfMTY5MA_22031924-963a-4e31-997e-d8164b0b34d2">The following table presents net sales for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 for the Company's country of domicile, countries with significant concentrations, and all other countries:&#160;&#160;&#160;&#160;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 25, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other countries, excluding Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd378229d53d485bb7a50d60b19bcbf3_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfMi0xLTEtMS0w_b550daf3-6a4f-403e-b84f-ad4f9a9af6fe"
      unitRef="usd">24000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64a435269abb416984f5c417e8039a20_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfMi0zLTEtMS0w_596bab94-15ee-45ff-96c8-f83830a90414"
      unitRef="usd">23000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac6ac704ee814208a2a8abf74b89f68b_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfMi01LTEtMS04MzU_09e99a8b-6c0a-45e4-a469-977028606c1c"
      unitRef="usd">49000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea846304c7ad47a28600ef1e4d71c7b2_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfMi03LTEtMS04MzU_4d83dfd2-3fe3-489f-a794-c93ca8e35dc9"
      unitRef="usd">43000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e59a2f196984183a973f8905eda8c10_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNC0xLTEtMS0w_b698f740-17c2-4cea-83c4-252fc1bb5d44"
      unitRef="usd">4054000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc31344ce037435086c6584f0cbc5603_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNC0zLTEtMS0w_13e5ab0d-821e-4b1e-ac61-80f496951e6f"
      unitRef="usd">4129000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i650829f108154ef79219df52ed0dd76e_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNC01LTEtMS04MzU_5da0bba1-dc58-4074-87a7-8a148852ce41"
      unitRef="usd">7405000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e309488f2d44b4f90cf8c46966b9320_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNC03LTEtMS04MzU_6e5644ca-be18-44bd-a0d8-bfe505d7374f"
      unitRef="usd">8046000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1638723f8ae47fba660e3d982eb8ed6_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNS0xLTEtMS0w_7f596402-1fab-40e9-bdec-926704c7c712"
      unitRef="usd">3569000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3def68be9d64a24ac8a6ae505945a1d_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNS0zLTEtMS0w_9c99ab3c-3f29-4b07-96ea-108233afadd7"
      unitRef="usd">3554000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i785ae642d0794ba291eac2202104f152_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNS01LTEtMS04MzU_630661ea-9de5-40cc-a5f8-1468848b2846"
      unitRef="usd">6700000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa7a5c2518f94595a35212683b056ac2_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNS03LTEtMS04MzU_61c7af1d-ec5a-409b-8e2f-e51912c90623"
      unitRef="usd">7110000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf457dbfafc248478ffb42c3a45acab8_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNi0xLTEtMS0w_d7f020a6-381d-46fd-95cd-e70d149f26bf"
      unitRef="usd">7623000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i969f5c5c54b6415c806918f433b06994_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNi0zLTEtMS0w_61b4c896-a620-4f54-beab-8497d78356c5"
      unitRef="usd">7683000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69d3fa2bd18b4dc98db60dce376f37f2_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNi01LTEtMS04Mzk_0dc272b8-4a46-4b07-a0f1-164952f3f152"
      unitRef="usd">14105000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i457910bb69fc4038abf6fe2156ebc07f_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNi03LTEtMS04Mzk_4e859d93-a636-4e51-882e-b8e9d0e51519"
      unitRef="usd">15156000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNy0xLTEtMS0w_f2e59475-104f-4ace-879f-577328afa477"
      unitRef="usd">7647000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id878a47f7fe0468895f6089921c8baca_D20190727-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNy0zLTEtMS0w_5b23aa44-f157-495a-9628-d70a97baf3bc"
      unitRef="usd">7706000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNy01LTEtMS04Mzk_7d29f753-9ffe-49d9-988f-e25ec4832841"
      unitRef="usd">14154000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide057d3c9b83469f91a93dbdb3136e6d_D20190427-20191025"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV85Ny9mcmFnOjU1Y2M4MzQzZDRlYzQxZTc5ZmY3ZTAwOGE1OWU4NjFkL3RhYmxlOmY3NmEyOWIyNGJmMjRhYmNhZDY5MTBjYmE1MzA2ZGIyL3RhYmxlcmFuZ2U6Zjc2YTI5YjI0YmYyNGFiY2FkNjkxMGNiYTUzMDZkYjJfNy03LTEtMS04Mzk_da8061cf-52c5-4f28-a101-8e1065888ce6"
      unitRef="usd">15199000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMTYtMS0xLTA_970ca307-0bd1-473b-bf1f-c3bdbea9361e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMTYtMS0xLTA_970ca307-0bd1-473b-bf1f-c3bdbea9361e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtOC0xLTEtMA_64fed4ed-ae93-4548-bd94-6c4d709d1c30"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtOC0xLTEtMA_64fed4ed-ae93-4548-bd94-6c4d709d1c30"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMTItMS0xLTA_59c874bf-43c5-442b-8592-f58c242b75de"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMTItMS0xLTA_59c874bf-43c5-442b-8592-f58c242b75de"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNTgz_64fed4ed-ae93-4548-bd94-6c4d709d1c30"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNTgz_64fed4ed-ae93-4548-bd94-6c4d709d1c30"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczOA_d51809bd-4de2-47ba-92ac-2e5076ce670d" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczOA_d51809bd-4de2-47ba-92ac-2e5076ce670d" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The cumulative effect of change in accounting principle during the first quarter of fiscal year 2020 resulted from the adoption of accounting guidance that requires lessees to recognize right-of-use assets and lease liabilities on the balance sheet. As a result of the adoption, the Company adjusted the opening balance of retained earnings for $33 million as of April 27, 2019.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMTYtMS0xLTA_970ca307-0bd1-473b-bf1f-c3bdbea9361e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczOA_d51809bd-4de2-47ba-92ac-2e5076ce670d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtOC0xLTEtMA_64fed4ed-ae93-4548-bd94-6c4d709d1c30"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczOA_d51809bd-4de2-47ba-92ac-2e5076ce670d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOmE2MTQ5OThhYzJkMDRmZTdhYWJkMjFmNjk2ODNhZjY1L3RhYmxlcmFuZ2U6YTYxNDk5OGFjMmQwNGZlN2FhYmQyMWY2OTY4M2FmNjVfMTAtMTItMS0xLTA_59c874bf-43c5-442b-8592-f58c242b75de"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczOA_d51809bd-4de2-47ba-92ac-2e5076ce670d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNTgz_64fed4ed-ae93-4548-bd94-6c4d709d1c30"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczOA_d51809bd-4de2-47ba-92ac-2e5076ce670d"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtOC0xLTEtMA_e9f5a671-e985-4efa-a7de-32b8d8ba52dc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtOC0xLTEtMA_e9f5a671-e985-4efa-a7de-32b8d8ba52dc"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtMTItMS0xLTA_ddd13094-0923-471e-945c-abade1a03459"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtMTItMS0xLTA_ddd13094-0923-471e-945c-abade1a03459"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtMTYtMS0xLTA_9f0883c5-6692-4daf-b6ef-72a9af546716"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtMTYtMS0xLTA_9f0883c5-6692-4daf-b6ef-72a9af546716"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczNw_fa25eaf7-b332-49ab-a18e-8831f6fd4c6f" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczNw_fa25eaf7-b332-49ab-a18e-8831f6fd4c6f" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See Note 2 to the consolidated financial statements for discussion regarding the adoption of accounting standards during the first quarter of fiscal year 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtOC0xLTEtMA_e9f5a671-e985-4efa-a7de-32b8d8ba52dc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczNw_fa25eaf7-b332-49ab-a18e-8831f6fd4c6f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtMTItMS0xLTA_ddd13094-0923-471e-945c-abade1a03459"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczNw_fa25eaf7-b332-49ab-a18e-8831f6fd4c6f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RhYmxlOjY4YjYxZjBjNTljOTQyZjQ5NGI2MmQxYjU3N2FmMzlmL3RhYmxlcmFuZ2U6NjhiNjFmMGM1OWM5NDJmNDk0YjYyZDFiNTc3YWYzOWZfMTAtMTYtMS0xLTA_9f0883c5-6692-4daf-b6ef-72a9af546716"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV8yOC9mcmFnOjg1ZTUzYzc5ZmM4ZjQ2NzI5NDJhMWJiNWIxMThiMDQzL3RleHRyZWdpb246ODVlNTNjNzlmYzhmNDY3Mjk0MmExYmI1YjExOGIwNDNfNDM5ODA0NjUxMzczNw_fa25eaf7-b332-49ab-a18e-8831f6fd4c6f"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460330519912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Dec. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Medtronic plc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1183488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">20 On Hatch, Lower Hatch Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">438-1700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Ordinary Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,346,019,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001613103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--04-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D02 XH02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary shares, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2021FloatingMember', window );">Floating Rate Notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Floating Rate Notes due 2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2022Member', window );">0.00% Senior Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.00% Senior Notes due 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/22B<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20230.375PercentMember', window );">0.375% Senior Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.375% Senior Notes due 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/23B<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2023Member', window );">0.000% Senior Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.000% Senior Notes due 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/23C<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2025Member', window );">0.25% Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.25% Senior Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2025Member', window );">0.000% Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.000% Senior Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/25A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2027Member', window );">1.125% Senior Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.125% Senior Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2028Member', window );">0.375% Senior Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.375% Senior Notes due 2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.625PercentMember', window );">1.625% Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Senior Notes due 2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.00PercentMember', window );">1.00% Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.00% Senior Notes due 2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/31A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2032Member', window );">0.750% Senior Notes due 2032</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.750% Senior Notes due 2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20392.250PercentMember', window );">2.250% Senior Notes due 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.250% Senior Notes due 2039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/39A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20391.50PercentMember', window );">1.50% Senior Notes due 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.50% Senior Notes due 2039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/39B<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2040Member', window );">1.375% Senior Notes due 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.375% Senior Notes due 2040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/40A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2049Member', window );">1.75% Senior Notes due 2049</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.75% Senior Notes due 2049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2050Member', window );">1.625% Senior Notes due 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Senior Notes due 2050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2021FloatingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2021FloatingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20230.375PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20230.375PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.625PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.625PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.00PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.00PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20392.250PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20392.250PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20391.50PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20391.50PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2049Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2049Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460327602552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 7,647<span></span>
</td>
<td class="nump">$ 7,706<span></span>
</td>
<td class="nump">$ 14,154<span></span>
</td>
<td class="nump">$ 15,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">2,705<span></span>
</td>
<td class="nump">2,394<span></span>
</td>
<td class="nump">5,209<span></span>
</td>
<td class="nump">4,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expense</a></td>
<td class="nump">639<span></span>
</td>
<td class="nump">603<span></span>
</td>
<td class="nump">1,260<span></span>
</td>
<td class="nump">1,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative expense</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">2,620<span></span>
</td>
<td class="nump">5,017<span></span>
</td>
<td class="nump">5,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">443<span></span>
</td>
<td class="nump">441<span></span>
</td>
<td class="nump">884<span></span>
</td>
<td class="nump">881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_RestructuringChargesNetofRestructuringReversals', window );">Restructuring charges, net</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Certain litigation charges, net</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating expense, net</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="nump">930<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
<td class="nump">1,603<span></span>
</td>
<td class="nump">2,836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other non-operating income, net</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="num">(209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="nump">641<span></span>
</td>
<td class="nump">774<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">1,294<span></span>
</td>
<td class="nump">1,109<span></span>
</td>
<td class="nump">2,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (benefit)</a></td>
<td class="nump">31<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">494<span></span>
</td>
<td class="nump">1,371<span></span>
</td>
<td class="nump">985<span></span>
</td>
<td class="nump">2,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Medtronic</a></td>
<td class="nump">$ 489<span></span>
</td>
<td class="nump">$ 1,364<span></span>
</td>
<td class="nump">$ 976<span></span>
</td>
<td class="nump">$ 2,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (usd per share)</a></td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="nump">$ 0.73<span></span>
</td>
<td class="nump">$ 1.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (usd per share)</a></td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 1.01<span></span>
</td>
<td class="nump">$ 0.72<span></span>
</td>
<td class="nump">$ 1.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (shares)</a></td>
<td class="nump">1,344.4<span></span>
</td>
<td class="nump">1,340.8<span></span>
</td>
<td class="nump">1,343.1<span></span>
</td>
<td class="nump">1,340.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding (shares)</a></td>
<td class="nump">1,352.1<span></span>
</td>
<td class="nump">1,351.4<span></span>
</td>
<td class="nump">1,351.1<span></span>
</td>
<td class="nump">1,351.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_RestructuringChargesNetofRestructuringReversals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses, net of reversals, associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_RestructuringChargesNetofRestructuringReversals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460331414984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 494<span></span>
</td>
<td class="nump">$ 1,371<span></span>
</td>
<td class="nump">$ 985<span></span>
</td>
<td class="nump">$ 2,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized (loss) gain on investment securities</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Translation adjustment</a></td>
<td class="nump">144<span></span>
</td>
<td class="num">(214)<span></span>
</td>
<td class="nump">1,261<span></span>
</td>
<td class="num">(148)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax', window );">Net investment hedge</a></td>
<td class="num">(164)<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="num">(1,276)<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net change in retirement obligations</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized loss on cash flow hedges</a></td>
<td class="num">(45)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(395)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="num">(277)<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income including noncontrolling interests</a></td>
<td class="nump">434<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
<td class="nump">708<span></span>
</td>
<td class="nump">2,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Medtronic</a></td>
<td class="nump">$ 428<span></span>
</td>
<td class="nump">$ 1,237<span></span>
</td>
<td class="nump">$ 693<span></span>
</td>
<td class="nump">$ 2,328<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460333759288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 6,420<span></span>
</td>
<td class="nump">$ 4,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">7,857<span></span>
</td>
<td class="nump">6,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less allowances and credit losses of $312 and $208, respectively</a></td>
<td class="nump">5,348<span></span>
</td>
<td class="nump">4,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">4,484<span></span>
</td>
<td class="nump">4,229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">1,927<span></span>
</td>
<td class="nump">2,209<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">26,036<span></span>
</td>
<td class="nump">22,031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment</a></td>
<td class="nump">12,198<span></span>
</td>
<td class="nump">11,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(7,260)<span></span>
</td>
<td class="num">(6,816)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">4,938<span></span>
</td>
<td class="nump">4,828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">41,212<span></span>
</td>
<td class="nump">39,841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">18,412<span></span>
</td>
<td class="nump">19,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Tax assets</a></td>
<td class="nump">3,176<span></span>
</td>
<td class="nump">2,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">2,112<span></span>
</td>
<td class="nump">2,094<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">95,886<span></span>
</td>
<td class="nump">90,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current debt obligations</a></td>
<td class="nump">4,041<span></span>
</td>
<td class="nump">2,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,902<span></span>
</td>
<td class="nump">1,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Accrued compensation</a></td>
<td class="nump">2,133<span></span>
</td>
<td class="nump">2,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued income taxes</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">3,589<span></span>
</td>
<td class="nump">2,993<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">12,071<span></span>
</td>
<td class="nump">10,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">25,967<span></span>
</td>
<td class="nump">22,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Accrued compensation and retirement benefits</a></td>
<td class="nump">2,024<span></span>
</td>
<td class="nump">1,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued income taxes</a></td>
<td class="nump">2,569<span></span>
</td>
<td class="nump">2,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">1,251<span></span>
</td>
<td class="nump">1,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">1,688<span></span>
</td>
<td class="nump">1,664<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">45,570<span></span>
</td>
<td class="nump">39,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares&#8212; par value $0.0001, 2.6 billion shares authorized, 1,345,547,814 and 1,341,074,724 shares issued and outstanding, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">26,481<span></span>
</td>
<td class="nump">26,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">27,526<span></span>
</td>
<td class="nump">28,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(3,843)<span></span>
</td>
<td class="num">(3,560)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">50,164<span></span>
</td>
<td class="nump">50,737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">50,316<span></span>
</td>
<td class="nump">50,872<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 95,886<span></span>
</td>
<td class="nump">$ 90,689<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19512-108361<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20028-108363<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460322931624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowances for accounts receivable</a></td>
<td class="nump">$ 312<span></span>
</td>
<td class="nump">$ 208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares authorized (shares)</a></td>
<td class="nump">2,600,000,000<span></span>
</td>
<td class="nump">2,600,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares issued (shares)</a></td>
<td class="nump">1,345,547,814<span></span>
</td>
<td class="nump">1,341,074,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares outstanding (shares)</a></td>
<td class="nump">1,345,547,814<span></span>
</td>
<td class="nump">1,341,074,724<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460327324024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Equity (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th" colspan="2"><div>Cumulative effect of change in accounting principle</div></th>
<th class="th"><div>Total Shareholders&#8217; Equity</div></th>
<th class="th" colspan="2">
<div>Total Shareholders&#8217; Equity </div>
<div>Cumulative effect of change in accounting principle</div>
</th>
<th class="th"><div>Ordinary Shares</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th" colspan="2">
<div>Retained Earnings </div>
<div>Cumulative effect of change in accounting principle</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Apr. 26, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,341,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Apr. 26, 2019</a></td>
<td class="nump">$ 50,212<span></span>
</td>
<td class="num">$ (33)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 50,091<span></span>
</td>
<td class="num">$ (33)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 26,532<span></span>
</td>
<td class="nump">$ 26,270<span></span>
</td>
<td class="num">$ (33)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (2,711)<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="nump">227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to shareholders</a></td>
<td class="num">(724)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(724)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(724)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans</a></td>
<td class="nump">205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of ordinary shares (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="num">(328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Jul. 26, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,341,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jul. 26, 2019</a></td>
<td class="nump">50,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">50,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,470<span></span>
</td>
<td class="nump">26,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,484)<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Apr. 26, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,341,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Apr. 26, 2019</a></td>
<td class="nump">50,212<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">50,091<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,532<span></span>
</td>
<td class="nump">26,270<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(2,711)<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Oct. 25, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,340,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 25, 2019</a></td>
<td class="nump">50,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">50,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,171<span></span>
</td>
<td class="nump">27,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,611)<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Jul. 26, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,341,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jul. 26, 2019</a></td>
<td class="nump">50,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">50,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,470<span></span>
</td>
<td class="nump">26,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,484)<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(127)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(127)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(127)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to shareholders</a></td>
<td class="num">(723)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(723)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(723)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans</a></td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of ordinary shares (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="num">(552)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(552)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(552)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Oct. 25, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,340,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 25, 2019</a></td>
<td class="nump">$ 50,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">50,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,171<span></span>
</td>
<td class="nump">27,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,611)<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Apr. 24, 2020</a></td>
<td class="nump">1,341,074,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,341,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Apr. 24, 2020</a></td>
<td class="nump">$ 50,872<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">50,737<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,165<span></span>
</td>
<td class="nump">28,132<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(3,560)<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(217)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(222)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(222)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to shareholders</a></td>
<td class="num">(778)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(778)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(778)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Changes to noncontrolling ownership interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Jul. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,343,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jul. 31, 2020</a></td>
<td class="nump">$ 50,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">50,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,261<span></span>
</td>
<td class="nump">27,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,782)<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Apr. 24, 2020</a></td>
<td class="nump">1,341,074,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,341,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Apr. 24, 2020</a></td>
<td class="nump">$ 50,872<span></span>
</td>
<td class="num">$ (24)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">50,737<span></span>
</td>
<td class="num">$ (24)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,165<span></span>
</td>
<td class="nump">28,132<span></span>
</td>
<td class="num">$ (24)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(3,560)<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">$ (277)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(283)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Oct. 30, 2020</a></td>
<td class="nump">1,345,547,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 30, 2020</a></td>
<td class="nump">$ 50,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">50,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,481<span></span>
</td>
<td class="nump">27,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,843)<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Jul. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,343,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jul. 31, 2020</a></td>
<td class="nump">50,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">50,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,261<span></span>
</td>
<td class="nump">27,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,782)<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(61)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to shareholders</a></td>
<td class="num">(780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans</a></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Changes to noncontrolling ownership interests</a></td>
<td class="num">$ (14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Oct. 30, 2020</a></td>
<td class="nump">1,345,547,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 30, 2020</a></td>
<td class="nump">$ 50,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 50,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 26,481<span></span>
</td>
<td class="nump">$ 27,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (3,843)<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
</tr>
<tr><td colspan="14"></td></tr>
<tr><td colspan="14"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The cumulative effect of change in accounting principle during the first quarter of fiscal year 2020 resulted from the adoption of accounting guidance that requires lessees to recognize right-of-use assets and lease liabilities on the balance sheet. As a result of the adoption, the Company adjusted the opening balance of retained earnings for $33 million as of April 27, 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">See Note 2 to the consolidated financial statements for discussion regarding the adoption of accounting standards during the first quarter of fiscal year 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325786424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Equity (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Jul. 26, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends to shareholders (usd per share)</a></td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460333785320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 985<span></span>
</td>
<td class="nump">$ 2,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,340<span></span>
</td>
<td class="nump">1,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(245)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities, net of acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(669)<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories, net</a></td>
<td class="num">(145)<span></span>
</td>
<td class="num">(267)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">108<span></span>
</td>
<td class="num">(294)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other operating assets and liabilities</a></td>
<td class="num">(127)<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">2,139<span></span>
</td>
<td class="nump">3,377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="num">(370)<span></span>
</td>
<td class="num">(201)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property, plant, and equipment</a></td>
<td class="num">(615)<span></span>
</td>
<td class="num">(584)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(5,360)<span></span>
</td>
<td class="num">(4,226)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Sales and maturities of investments</a></td>
<td class="nump">4,337<span></span>
</td>
<td class="nump">3,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(2,012)<span></span>
</td>
<td class="num">(1,767)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess', window );">Change in current debt obligations, net</a></td>
<td class="num">(57)<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings (maturities greater than 90 days)</a></td>
<td class="nump">2,789<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Issuance of long-term debt</a></td>
<td class="nump">7,172<span></span>
</td>
<td class="nump">5,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on long-term debt</a></td>
<td class="num">(6,336)<span></span>
</td>
<td class="num">(5,594)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends to shareholders</a></td>
<td class="num">(1,558)<span></span>
</td>
<td class="num">(1,447)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Issuance of ordinary shares</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of ordinary shares</a></td>
<td class="num">(68)<span></span>
</td>
<td class="num">(962)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">1,991<span></span>
</td>
<td class="num">(2,015)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">162<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="nump">2,280<span></span>
</td>
<td class="num">(431)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">4,140<span></span>
</td>
<td class="nump">4,393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">6,420<span></span>
</td>
<td class="nump">3,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_IncomeTaxesandInterestPaidAbstract', window );"><strong>Cash paid for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">384<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">$ 321<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_IncomeTaxesandInterestPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Taxes and Interest Paid [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_IncomeTaxesandInterestPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460324424040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements of Medtronic plc and its subsidiaries (Medtronic plc, Medtronic, or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S.) (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the consolidated financial statements include all of the adjustments necessary for a fair statement in conformity with U.S. GAAP. Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Covid-19 pandemic ("COVID-19" or the "pandemic") has had, and may continue to have, an adverse effect on our business, results of operations, financial condition, and cash flows, and its future impacts remain highly uncertain and unpredictable. The Company has considered the disruptions caused by COVID-19, including lower sales and customer demand than the prior year in many businesses and macroeconomic factors, and has assessed the potential impact on certain accounting estimates including, but not limited to, the allowance for doubtful accounts, inventory reserves, return reserves, the valuation of goodwill, intangible assets, other long-lived assets, investments and contingent consideration, as of October 30, 2020 and through the date of this report. While there was not a material impact to the Company&#8217;s consolidated financial statements as of and for the three and six months ended October 30, 2020, changes in the Company&#8217;s assessment about the length and severity of the pandemic, as well as other factors, could result in actual results differing from estimates. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements include the accounts of Medtronic plc, its wholly-owned subsidiaries, entities for which the Company has a controlling financial interest, and variable interest entities for which the Company is the primary beneficiary. Intercompany transactions and balances have been eliminated in consolidation. </span></div>The accompanying unaudited consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements of the Company and related notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended April&#160;24, 2020. The Company&#8217;s fiscal years 2021, 2020, and 2019 will end or ended on April&#160;30, 2021, April&#160;24, 2020, and April&#160;26, 2019, respectively. Fiscal year 2021 is a 53-week year, with the extra week having occurred in the first fiscal month of the first quarter.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325899192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text">New Accounting Pronouncements<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Current Expected Credit Losses</span></div>In June 2016, the Financial Accounting Standards Board (FASB) issued guidance which changes the methodology to be used to measure credit losses for certain financial instruments and financial assets, including trade receivables. The new methodology requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset. The Company adopted this guidance using the modified retrospective method in the first quarter of fiscal year 2021. The adoption of this guidance did not have a material impact to the Company&#8217;s consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=SL108384541-122693<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=d3e31137-122693<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460324382152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue The Company's revenues are principally derived from device-based medical therapies and services related to cardiac rhythm disorders, cardiovascular disease, renal disease, neurological disorders and diseases, spinal conditions and musculoskeletal trauma, chronic pain, urological and digestive disorders, ear, nose, and throat conditions, and diabetes conditions as well as advanced and general surgical care products, respiratory and monitoring solutions, and neurological surgery technologies. The Company's primary customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations.  <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by segment and division for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.636%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm &amp; Heart Failure</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coronary &amp; Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aortic, Peripheral, &amp; Venous </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac &amp; Vascular Group</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,855&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,158&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,645&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Innovations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Respiratory, Gastrointestinal, &amp; Renal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cranial &amp; Spinal Technologies</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,706&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,154&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,199&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)   Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal year 2021, the Company realigned the divisions within the Restorative Therapies Group to the following: Cranial &amp; Spinal Technologies (includes Core Spine and Biologics, Enabling Technologies, and China Orthopedics), Specialty Therapies (includes ENT, Pelvic Health, and Neurovascular), and Neuromodulation (includes Pain Therapies, Brain Modulation, and Interventional). As a result, net sales for fiscal year 2020 have been recast to adjust for this realignment.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by market geography for each segment for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)(4)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac &amp; Vascular Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)(4)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac &amp; Vascular Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,621&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,460&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">U.S. includes the United States and U.S. territories.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of revenue recognized is reduced by sales rebates and returns. Adjustments to rebates and returns reserves are recorded as increases or decreases to revenue. At October&#160;30, 2020, $955 million of rebates were classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$464 million of rebates were classified as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheet. At April&#160;24, 2020, $706 million of rebates were classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $321 million of rebates were classified as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheet. For the three and six months ended October&#160;30, 2020 and October&#160;25, 2019, adjustments to rebate and return reserves recognized in revenue that were included in the rebate and return reserves at the beginning of the period were not material. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Revenue and Remaining Performance Obligations</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a deferred revenue liability if a customer pays consideration, or the Company has the right to invoice, before the Company transfers a good or service to the customer. Deferred revenue at October&#160;30, 2020 and April&#160;24, 2020 was $317 million and $303 million, respectively. At October&#160;30, 2020 and April&#160;24, 2020, $225 million and $213 million, respectively, was included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $92 million and $90&#160;million, respectively, was included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the six months ended October&#160;30, 2020, the Company recognized $162&#160;million of revenue that was included in deferred revenue as of April&#160;24, 2020. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations include deferred revenue and amounts the Company expects to receive for goods and services that have not yet been delivered or provided under existing, noncancellable contracts with minimum purchase commitments. At October&#160;30, 2020, the estimated revenue expected to be recognized in future periods related to unsatisfied performance obligations for executed contracts with an original duration of one year or more was approximately $1.1 billion. The Company expects to recognize revenue on the majority of these remaining performance obligations over the next four years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460324123256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">AcquisitionsThe Company had acquisitions during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 that were accounted for as business combinations. The assets and liabilities of the businesses acquired were recorded and consolidated on the acquisition date at their respective fair values. Goodwill resulting from business combinations is largely attributable to future yet to be defined technologies, new customer relationships, existing workforce of the acquired businesses, and synergies expected to arise after the Company's acquisition of these businesses. The pro forma impact of these acquisitions was not significant, either individually or in the aggregate, to the consolidated results of the Company for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019. The results of operations of acquired businesses have been included in the Company's consolidated statements of income since the date each business was acquired.<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year 2021</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair value of net assets acquired during the six months ended October&#160;30, 2020 was $539&#160;million, consisting of $577&#160;million of assets acquired and $38&#160;million of liabilities assumed. Based upon preliminary valuations, assets acquired were primarily comprised of $156 million of technology-based intangible assets and $13 million of customer-related intangible assets with estimated useful lives ranging from 8 to 15 years and $381&#160;million of goodwill. The goodwill is not deductible for tax purposes. The Company recognized $158&#160;million of contingent consideration liabilities in connection with business combinations during the six months ended October&#160;30, 2020, which are comprised of revenue and product development milestone-based payments. Additionally, during the six months ended October&#160;30, 2020, the Company recognized a gain of $132 million related to a change in amounts accrued for certain contingent liabilities from a recent acquisition. The benefit was recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income as the purchase accounting was finalized in fiscal year 2020. For the three and six months ended October&#160;30, 2020, purchase price allocation adjustments were not significant.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year 2020</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair value of net assets acquired during the six months ended October&#160;25, 2019 was $272 million, consisting of $324 million of assets acquired and $52 million of liabilities assumed. Assets acquired were primarily comprised of $139 million of technology-based intangible assets and $26 million of customer-related intangible assets with estimated useful lives ranging from 8 to 16 years, $40 million of inventory, and $92 million of goodwill. The goodwill is not deductible for tax purposes. The Company recognized $65&#160;million of contingent consideration liabilities in connection with business combinations during the six months ended October&#160;25, 2019, which are comprised of revenue milestone-based payments. For the three and six months ended October&#160;25, 2019, purchase price allocation adjustments were not significant.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s business combinations involve potential payment of future consideration that is contingent upon the achievement of certain product development milestones and/or contingent on the acquired business reaching certain performance milestones. A liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is remeasured at each reporting period, and the change in fair value is recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. Contingent consideration payments made soon after the acquisition date are classified as investing activities in the consolidated statements of cash flows. Contingent consideration payments not made soon after the acquisition date that are related to the acquisition date fair value are reported as financing activities in the consolidated statements of cash flows, and amounts paid in excess of the original acquisition date fair value are reported as operating activities in the consolidated statements of cash flows. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of contingent consideration at October&#160;30, 2020 and April&#160;24, 2020 was $461 million and $280 million,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively. At October&#160;30, 2020, $342 million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and $119 million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated balance sheets. At April&#160;24, 2020, $112 million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and $168 million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated balance sheets. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of contingent consideration:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of contingent consideration is measured using projected payment dates, discount rates, probabilities of payment, and projected revenues (for revenue-based consideration). Projected revenues are based on the Company's most recent internal operational budgets and long-range strategic plans. Changes in projected payment dates, discount rates, probabilities of payment, and projected revenues may result in adjustments to the fair value measurement. The recurring Level 3 fair value measurements of contingent consideration for which a liability is recorded include the following significant unobservable inputs:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:22.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.770%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">14.0% - 32.4%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">20.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Revenue and other performance-based payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">$203</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">40% - 100%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">99.4%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">2021 - 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">5.5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">5.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Product development and other milestone-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">$258</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">50% - 100%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">93.2%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">2021 - 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)   Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected fiscal year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460422014456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring</a></td>
<td class="text">Restructuring<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Enterprise Excellence</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of fiscal year 2018, the Company announced its Enterprise Excellence restructuring program, which is expected to leverage the Company's global size and scale, as well as enhance the customer and employee experience, with a focus on three objectives: global operations, functional optimization, and commercial optimization. Primary activities of the restructuring program include integrating and enhancing global manufacturing and supply processes, systems and site presence, enhancing and leveraging global operating models across several enabling functions, and optimizing certain commercial processes, systems, and models.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates that, in connection with its Enterprise Excellence restructuring program, it will recognize pre-tax exit and disposal costs and other costs across all segments of approximately&#160;$1.6 billion&#160;to&#160;$1.8 billion, the majority of which are expected to be incurred by the end of fiscal year 2022. Approximately half of the estimated charges are related to employee termination benefits. The remaining charges are costs associated with the restructuring program, such as salaries for employees supporting the program and consulting expenses. These charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">restructuring charges, net, cost of products sold, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;30, 2020, the Company recognized charges of $90 million and $169 million, respectively. Additionally, the Company incurred accrual adjustments of $3 million and $5 million for the three and six months ended October&#160;30, 2020, respectively, related to certain employees identified for termination finding other positions within Medtronic and contract terminations being settled for less than originally estimated. For the three and six months ended October&#160;30, 2020, charges included $32 million and $59 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $48 million and $95 million, respectively, recognized within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;25, 2019, the Company recognized charges of $95 million and $231 million, respectively. Additionally, the Company incurred accrual adjustments of $1 million and $13 million for the three and six months ended October&#160;25, 2019, respectively, related to certain employees identified for termination finding other positions within Medtronic. For the three and six months ended October&#160;25, 2019, charges included $32&#160;million and $67&#160;million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $35 </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million and $77 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Enterprise Excellence restructuring program for the six months ended October&#160;30, 2020:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Termination Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Associated Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 24, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplification</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2021, the Company initiated the Simplification restructuring program, designed to make the Company a more nimble and competitive organization focused on accelerating innovation, enhancing the customer experience, driving revenue growth, and winning market share, while also more efficiently and effectively leveraging the Enterprise scale. Under the oversight of the portfolio leaders, this new operating model, which will be fully operational the beginning of the fourth quarter of fiscal year 2021, will simplify the Company's organizational structure and accelerate decision-making and execution. Primary activities of the restructuring program will include reorganizing the Company into a portfolio-level structure, including the creation of highly focused, accountable, and empowered Operating Units (OUs), consolidating Operations at the Enterprise level, establishing Technology Development Centers in areas where the Company has deep core technology competencies to be leveraged by multiple OUs, and forming dedicated sales organizations that leverage the Company's scale but move with the same agility as smaller, local competitors.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company estimates that, in connection with its Simplification restructuring program, it will recognize pre-tax exit and disposal costs and other costs across all segments of approximately $400&#160;million to $450&#160;million, the majority of which are expected to be incurred by the end of fiscal year 2022. Approximately three quarters of the estimated charges are related to employee termination benefits. The remaining charges are costs associated with the restructuring program, such as salaries for employees supporting the program and consulting expenses. These charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">restructuring charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the three and six months ended October&#160;30, 2020, the Company recognized charges of $102 million and $153 million, respectively, which included $97 million of incremental defined benefit pension and post-retirement related expenses for employees that accepted voluntary early retirement packages. These costs are not included in the table summarizing restructuring charges below, because they are associated with costs that are accounted for under the pension and post-retirement rules. See Note 14 for further discussion on the incremental defined benefit pension and post-retirement expenses. The charges recognized for the three and six months ended October&#160;30, 2020 were partially offset by accrual adjustments of $8 million for both periods related to certain employees identified for termination finding other positions within the Company. The charges recognized for the three and six months ended October&#160;30, 2020 also included $2 million and $3 million, respectively, recognized within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the activity related to the Simplification restructuring program for the six months ended October&#160;30, 2020:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Termination Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Associated Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 24, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1)  Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460322565368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text">Financial Instruments<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Securities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company holds investments in marketable debt securities that are classified and accounted for as available-for-sale and held-to-maturity. Investments classified as available-for-sale are remeasured on a recurring basis. Investments classified as held-to-maturity are measured at amortized cost. The following tables summarize the Company's investments in available-for-sale and held-to-maturity debt securities by significant investment category and the related consolidated balance sheet classification at October&#160;30, 2020 and April&#160;24, 2020:&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Available-for-sale securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,435&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,435&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Held-to-maturity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,893&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,857&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,847&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,841&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,808&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost of debt securities excludes accrued interest, which is reported in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the gross unrealized losses and fair values of the Company&#8217;s available-for-sale debt securities that have been in a continuous unrealized loss position deemed to be temporary, aggregated by investment category at October&#160;30, 2020 and April&#160;24, 2020:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than 12 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,520&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than 12 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy. There were no transfers into or out of Level 3 during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019. When a determination is made to classify an asset or liability within Level 3, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no purchases, sales, settlements, or significant gains or losses recognized in earnings or other comprehensive income for debt securities classified as Level 3 during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity related to the Company&#8217;s available-for-sale debt securities portfolio is as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit losses represent the difference between the present value of cash flows expected to be collected on certain mortgage-backed securities and auction rate securities and the amortized cost of these securities. Based on the Company&#8217;s assessment of the credit quality of the underlying collateral and credit support available to each of the remaining securities in which the Company is invested, the Company believes it has recognized all necessary impairments, as the Company does not have the intent to sell, nor is it more likely than not that the Company will be required to sell, before recovery of the amortized cost. At October&#160;30, 2020 and April&#160;24, 2020, there were no debt securities in a credit loss position. No available-for-sale or held-to-maturity securities were sold for significantly less than carrying value during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The October&#160;30, 2020 balance of available-for-sale and held-to-maturity debt securities by contractual maturity is shown in the following table. Within the table, maturities of mortgage-backed securities have been allocated based upon timing of estimated cash flows assuming no change in the current interest rate environment. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.168%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-For-Sale</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-To-Maturity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,007&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Securities, Equity Method Investments, and Other Investments </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities with readily determinable fair values, equity investments without readily determinable fair values, investments accounted for under the equity method, and other investments. Equity securities with readily determinable fair values are included in Level 1 of the fair value hierarchy, as they are measured using quoted market prices. Equity method investments and investments without readily determinable fair values are included within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs to determine fair value. To determine the fair value of these investments, the Company uses all pertinent financial information available related to the investees, including financial statements, market participant valuations from recent and proposed equity offerings, and other third-party data. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's equity and other investments at October&#160;30, 2020 and April&#160;24, 2020, which are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheets:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.366%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments with readily determinable fair value (marketable equity securities)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method and other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity and other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes activity related to the Company&#8217;s portfolio of equity and other investments. Gains and losses on equity and other investments are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.100%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment losses recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The net gains recognized for the three months ended October&#160;30, 2020 were not significant, and the net gains recognized for the six months ended October&#160;30, 2020 were $12&#160;million, comprised of unrealized gains on equity securities and other investments still held at October&#160;30, 2020. The net gains recognized for the three and six months ended October&#160;25, 2019 were $14&#160;million comprised of unrealized gains on equity securities and other investments still held at October&#160;25, 2019. There were no impairment charges incurred on the Company's equity securities, equity method investments, and other investments during the three months ended October&#160;30, 2020. Impairment charges incurred on the Company's equity securities, equity method investments, and other investments during the six months ended October&#160;30, 2020 and the three and six months ended October&#160;25, 2019 were not significant.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460324371256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Financing Arrangements</a></td>
<td class="text">Financing Arrangements <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains commercial paper programs that allow the Company to issue U.S. dollar or Euro-denominated unsecured commercial paper notes. The aggregate amount outstanding at any time under the commercial paper programs may not exceed the equivalent of $3.5 billion. No commercial paper was outstanding at both October&#160;30, 2020 and April&#160;24, 2020. The issuance of commercial paper reduces the amount of credit available under the Company&#8217;s existing Credit Facility, as defined below.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Line of Credit</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a $3.5 billion five-year unsecured revolving credit facility (Credit Facility), which provides back-up funding for the commercial paper programs described above. The Credit Facility includes a multi-currency borrowing feature for certain specified foreign currencies. At October&#160;30, 2020 and April&#160;24, 2020, no amounts were outstanding under the Credit Facility. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rates on advances on the Credit Facility are determined by a pricing matrix, based on the Company&#8217;s long-term debt ratings, assigned by Standard &amp; Poor&#8217;s Ratings Services and Moody&#8217;s Investors Service. Facility fees are payable on the Credit Facility and are determined in the same manner as the interest rates. The agreement also contains customary covenants, all of which the Company was in compliance with at October&#160;30, 2020. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Obligations</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's debt obligations consisted of the following:</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.236%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity by <br/>Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current debt obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,041&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.150 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS04NDc2L3RleHRyZWdpb246MzI5ZGJlZDllYWVkNDA2YWI5MDdiMTQ4NzNkNWQxZDZfNzY5NjU4MTM5NDQ3OA_1fc66852-89e8-4b7b-81e1-6369f8dd3419">seven</span>-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.200 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS03MDUxL3RleHRyZWdpb246Zjg2ZWM0YTg4NDI3NGFhOWI0ZGJmYWViM2QzZThlZjBfNzY5NjU4MTM5NDQ3OA_0f544188-5492-43f0-8466-e9aa66f80bd2">ten</span>-year 2012 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS03MDU5L3RleHRyZWdpb246M2VjNzUyNTAyZmE1NDIzNWE0OWI2YzNhZTZlZGEyM2JfMTU_434d6196-cd71-423f-b1c6-94ab8fd6f545">four</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.375 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS0wL3RleHRyZWdpb246NjI0ZTZhYTM4MjA3NGI3ZDhkOTYyYWNiZjQ4NDUyNjVfMTU_4e71358d-8a7e-40b6-8487-19339f167751">four</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS02NTEyL3RleHRyZWdpb246ZWM4Njk1YWJlNjBlNGViOTg3ZWU3MjczM2E3NGIzODJfNzY5NjU4MTM5NDQ5NA_f18bfa88-ad2a-419f-b369-44b60f7697ef">two</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.750 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS0wL3RleHRyZWdpb246ZTc2YTM4MTBiNTI1NDMyYzkwY2FhNTg2ZWNhYmU0ZjJfMTU_7216313b-f8c0-40e6-99ac-4a1d7fa40514">ten</span>-year 2013 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.950 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfOS0wLTEtMS0wL3RleHRyZWdpb246NDM3NzdkMzViODVmNDM1NTlmNjI1MGRlNTNjYjIyNTZfMTU_73fcdfe3-1699-4e4e-a1b3-6abc413aba37">ten</span>-year 2013 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.625 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjBkZGE4M2Y1MTQ5YTQ2NWNiYTYyNGI3YzQ2Y2FmOTc2XzE1_3cf05ffe-b2a6-4335-96b8-f9d8eb8335a3">ten</span>-year 2014 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.500 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjMwZDAzODE1ZTQ2YjQ0MGI5YWRkOGIyNjE4NjI1MTY4XzE1_5a8917d8-b557-4f27-97d0-e5d0ca330706">ten</span>-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.250 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjY4MTNkM2VlNGE3MjQ2MzQ5ZGY4NjgzMGRjNjA5ZmI2XzE1_dd01a2f7-a10b-4245-962c-1c722b265da7">seven</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtNjUzMS90ZXh0cmVnaW9uOjY5NDIwNWJkNjIxNDQzYTE5ZmI3NGVmZDI1MzkyOTgzXzc2OTY1ODEzOTQ0OTU_7e8547d7-3068-4d97-88c7-8a5e777cd5be">five</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.125 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjVlMTZkMTQyM2ZlNjQ1ZTRiMzQzYjA0ZWU5YzMwZThhXzE1_aeaca299-dcdb-4b89-b32d-ea5647d9bdae">eight</span>-year 2019 senior notes </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.350 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjUwOWNjZGNhZTZjYzQ4NTBiNjg1YmNjMDYwZTVkYWYwXzE1_6c38aec9-7242-49e4-a3a0-97185e834427">ten</span>-year 2017 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.375 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtNjU1MS90ZXh0cmVnaW9uOjZiZjEyYmVlZGI5NTQwYzQ5N2ZiNTc3OGJmMjk5MmM1Xzc2OTY1ODEzOTQ0ODk_3f1d490f-a710-44cb-aa4c-f5db8f0fa208">eight</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.625 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOmQ1YTI2NTk1ZGQ3OTRmYjU4YmUzYjRhZDFmMjE1ZDk1XzE1_5b30e37a-feeb-41bf-b826-7121e730e737">twelve</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.000 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjZmZDA0ZmIzNjYyNDQ3ZDY5ZjAwN2FlYTRlZjRhZGU4XzE1_932ae6cf-26e5-4bad-b22d-29b416b48b23">thirteen</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtNjU2NC90ZXh0cmVnaW9uOjVjZTJlM2ZhNTQ5ZTQ4NjBhZmQyOGQxMDdmNDVkMTJmXzc2OTY1ODEzOTQ0OTk_c2fcbcbb-9062-4210-8500-cae9fda3b843">twelve</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDA2NzRiOTUwOTQzMjViMjhlYTFkZGQ2YWFjNzY3XzE1_d33f3c62-a9b3-4939-acb6-efa5d1c533e4">twenty</span>-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.550 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTI3ZmUyY2I4NjRiODBiYjg3ZDEzZjgzNjI2NDEwXzE1_3ef70171-17bb-4da9-8dc5-bfdf0b5cd24e">thirty</span>-year 2007 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2038</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjg1NzhjYzgwNmZjMzQ0NzNhNjczOTJiNGVlYjg5N2YwXzE1_3df5c742-c214-41f0-b3d0-5224780e9379">twenty</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.500 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOmY0MDRlOGZmYTIyMTQzOWM4YmRlNWYyNWIwNjE1YjQ5XzE1_c2981a7f-89c2-4f44-9205-b4e86754b2c1">thirty</span>-year 2009 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.500 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtNzA2Ny90ZXh0cmVnaW9uOjEwMDFhY2UzNjJkYjRkNDNiZjc4NWIwMmU2MzVlY2U5XzE1_057deae6-4bb1-452e-b86a-80173d533019">twenty</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.550 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjQ1ODFmMjY1ZmNmMjRjYzZiMmNlN2Q2MjViM2Q2NjA1XzE1_db79b77e-7b88-4758-a617-823b3f2a7b0c">thirty</span>-year 2010 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.375 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtNjU3NC90ZXh0cmVnaW9uOjhlYTQ1NjhhOTU4YzQwNDU5M2NkMGY1YzdkMjQxYjZmXzc2OTY1ODEzOTQ0OTU_ef0d6972-d506-46e3-9082-3bddd7a7d890">twenty</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2041</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.500 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlYTljZmNjYzNiOTQzODM5MzBkNWFhMDBkNmNhNWM4XzE1_df7243fa-33e3-441e-9e5c-0d5e8f72b28c">thirty</span>-year 2012 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2042</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjQtMC0xLTEtMC90ZXh0cmVnaW9uOjNhMmQ4M2U3MzY4YzQxYzBiYjk4NTU2YjA1ODJhYjA2XzE1_8015ac63-f366-4764-bf6a-46db806b09cf">thirty</span>-year 2013 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2043</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjg1ZmFkZGU0NTAyOTQ4OWFiZGI0NDVmMmNkN2Q2OTA5XzE1_194c751d-bc01-4752-9b92-6d1dd7b2c6bd">thirty</span>-year 2014 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2044</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOmY2MmI2NWE5YjUyMzRiN2NhYzMwNmRhNTRkZjFjNmE2XzE1_816125dd-3eea-4f07-9610-e050c2e8a8b8">thirty</span>-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.750 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmRjYTc3ZGQ5MTBlMTQzMWZiY2FmMGExNjI2ZjA1YzUyXzE1_affa4ede-4085-4b4a-8013-9f2c5a3af318">thirty</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.625 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzMtMC0xLTEtNjU4Ni90ZXh0cmVnaW9uOjEzNTMyNGVhY2U0MTQ2NmJiN2EyYTcxMmI4MzcyMDI3Xzc2OTY1ODEzOTQ0OTU_ecf3e18f-537f-414b-994f-f458754db39a">thirty</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 - 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 - 2051</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 - 2051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,967&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has outstanding unsecured senior obligations, described as senior notes in the tables above (collectively, the Senior Notes). The Senior Notes rank equally with all other unsecured and unsubordinated indebtedness of the Company. The indentures under which the Senior Notes were issued contain customary covenants, all of which the Company remained in compliance with at October&#160;30, 2020.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, Medtronic Luxco issued six tranches of Euro-denominated Senior Notes with an aggregate principal of &#8364;5.0 billion, with maturities ranging from fiscal year 2021 to fiscal year 2050, resulting in cash proceeds of approximately $5.6 billion, net of discounts and issuance costs. The Company used the net proceeds of the offering to fund the cash tender offer and early redemption of $5.2 billion of Medtronic Inc., CIFSA, and Medtronic Luxco Senior Notes for $5.6 billion of total consideration. The Company recognized a loss on debt extinguishment of $413 million during the first quarter of fiscal year 2020, which primarily included cash premiums and accelerated amortization of deferred financing costs and debt discounts and premiums. The loss was recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statement of income for the six months ended October&#160;25, 2019. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, Medtronic Luxco issued an additional six tranches of Euro-denominated Senior Notes with an aggregate principal of &#8364;6.3&#160;billion, with maturities ranging from fiscal year 2023 to fiscal year 2051, resulting in cash proceeds of approximately $7.2&#160;billion, net of discounts and issuance costs. The Company used the net proceeds of the offering to fund the early redemption of $4.3&#160;billion of Medtronic Inc. and CIFSA Senior Notes and &#8364;1.5&#160;billion of Medtronic Luxco Senior Notes for $6.3&#160;billion of total consideration in October 2020. Additionally, the Company intends to use the proceeds to repay its &#8364;750&#160;million floating rate senior notes at maturity in March 2021. The Company recognized a loss on debt extinguishment of $308&#160;million during the current quarter, which primarily included cash premiums and accelerated amortization of deferred financing costs and debt discounts and premiums. The loss was recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income for the three and six months ended October&#160;30, 2020. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Euro-denominated debt issued in June 2019 and September 2020 is designated as a net investment hedge of certain of the Company's European operations. Refer to Note 8 for additional information regarding the net investment hedge.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Agreements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2020, Medtronic Luxco entered into a term loan agreement (Loan Agreement) by and among Medtronic Luxco, Medtronic plc, Medtronic, Inc., and Mizuho Bank, Ltd. as administrative agent and as lender. The Loan Agreement provides an unsecured term loan in an aggregate principal amount of up to &#165;300&#160;billion, or approximately $2.8&#160;billion, with a term of six months, which may be extended for an additional six months at Medtronic Luxco&#8217;s option. On May 13, 2020, Medtronic Luxco borrowed the entire amount of the term loan under the Loan Agreement. Borrowings under the Loan Agreement will bear interest at the TIBOR Rate (as defined in the Loan Agreement) plus a margin of 0.50% per annum. Medtronic plc and Medtronic, Inc. have guaranteed the obligations of Medtronic Luxco under the Loan Agreement. On November 12, 2020, the Company exercised its option to extend the term loan for an additional six months. The Japanese Yen-denominated debt is designated as a net investment hedge of certain of our Japanese operations. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments Not Measured at Fair Value</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At October&#160;30, 2020, the estimated fair value of the Company&#8217;s Senior Notes was $29.9 billion compared to a principal value of $27.0 billion. At April&#160;24, 2020, the estimated fair value was $27.1 billion compared to a principal value of $24.5 billion. The fair value was estimated using quoted market prices for the publicly registered Senior Notes, which are classified as Level 2 within the fair value hierarchy. The fair values and principal values consider the terms of the related debt and exclude the impacts of debt discounts and hedging activity.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325865208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivatives and Currency Exchange Risk Management</a></td>
<td class="text">Derivatives and Currency Exchange Risk Management <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses operational and economic hedges, including currency exchange rate derivative contracts and interest rate derivative instruments, to manage the impact of currency exchange and interest rate changes on earnings and cash flows. In addition, the Company uses cross currency interest rate swaps to manage currency risk related to certain debt. In order to minimize earnings and cash flow volatility resulting from currency exchange rate changes, the Company enters into derivative instruments, principally forward currency exchange rate contracts. These contracts are designed to hedge anticipated foreign currency transactions and changes in the value of specific assets and liabilities. At inception of the contract, the derivative is designated as either a freestanding derivative or a cash flow hedge. Currencies of our derivative instruments include the Euro, Japanese Yen, Chinese Yuan, and others. The Company does not enter into currency exchange rate derivative contracts for speculative purposes. The gross notional amount of all currency exchange rate derivative instruments outstanding was $18.5 billion and $11.9 billion at October&#160;30, 2020 and April&#160;24, 2020, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also uses derivative and non-derivative instruments to manage the impact of currency exchange rate changes on net investments in foreign currency-denominated operations. The information that follows explains the various types of derivatives and financial instruments used by the Company, reasons the Company uses such instruments, and the impact such instruments have on the Company&#8217;s consolidated balance sheets and statements of income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Freestanding Derivative Contracts</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Freestanding derivative contracts are primarily used to offset the Company&#8217;s exposure to the change in value of specific foreign-currency-denominated assets and liabilities, and to offset variability of cash flows associated with forecasted transactions denominated in foreign currencies. The gross notional amount of the Company's freestanding currency exchange rate contracts outstanding at October&#160;30, 2020 and April&#160;24, 2020 was $10.7 billion and $4.9 billion, respectively. The Company's freestanding currency exchange rate contracts are not designated as hedges, and therefore, changes in the value of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related change in value of foreign-currency-denominated assets, liabilities, and cash flows. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also uses total return swaps to hedge the liability of a non-qualified, deferred compensation plan. The gross notional amount of the Company's total return swaps outstanding at October&#160;30, 2020 and April&#160;24, 2020 was $197 million and $181 million, respectively. The Company's total return swaps are not designated as hedges, and therefore, changes in the value of these instruments are recognized in earnings. The cash flows related to the Company's freestanding derivative contracts are reported as operating activities in the consolidated statements of cash flows. </span></div><div style="margin-bottom:9pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts and classification of the (gains) losses in the consolidated statements of income related to derivative instruments not designated as hedging instruments for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.866%"><tr><td style="width:1.0%"/><td style="width:26.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. The gross notional amount of these contracts, designated as cash flow hedges, outstanding at October&#160;30, 2020 and April&#160;24, 2020 was $7.8 billion and $7.0 billion, respectively, and will mature within the subsequent three-year period. For derivative instruments that are designated and qualify as a cash flow hedge, the gain or loss on the derivative instrument is reported as a component of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The gain or loss on the derivative instrument is reclassified into earnings and is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income in the same period or periods during which the hedged transaction affects earnings. Amounts excluded from the measurement of hedge effectiveness are recognized in earnings in the current period. The cash flows related to all of the Company's derivative instruments designated as cash flow hedges are reported as operating activities in the consolidated statements of cash flows. No components of the hedge contracts were excluded in the measurement of hedge effectiveness, and no forward contracts designated as cash flow hedges were derecognized or discontinued during the three and six months ended October&#160;30, 2020 and October&#160;25, 2019.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the (gains) losses recognized in accumulated other comprehensive loss (AOCI) related to the currency exchange rate contract derivative instruments designated as cash flow hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.100%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the (gains) losses recognized in the consolidated statements of income related to derivative instruments designated as cash flow hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other operating expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated statements of income in which the effects of cash flow hedges are recorded</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency exchange rate contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain reclassified from AOCI into income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forecasted Debt Issuance Interest Rate Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward starting interest rate derivative instruments designated as cash flow hedges are designed to manage the exposure to interest rate volatility with regard to future issuances of fixed-rate debt. The gains or losses on forward starting interest rate derivative instruments that are designated and qualify as cash flow hedges are reported as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Beginning in the period in which the planned debt issuance occurs and the related derivative instruments are terminated, the gains or losses are then reclassified into </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">over the term of the related debt. For the three and six months ended October&#160;30, 2020 and October&#160;25, 2019, the reclassifications of net (gains) losses on forward starting interest rate derivative instruments from accumulated other comprehensive loss to interest expense were not significant. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At October&#160;30, 2020 and April&#160;24, 2020, the Company had $129 million in after-tax net unrealized losses and $266 million in after-tax net unrealized gains, respectively, associated with cash flow hedging instruments recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company expects that $34 million of after-tax net unrealized losses at October&#160;30, 2020 will be recognized in the consolidated statements of income over the next 12 months.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated Euro-denominated and Japanese Yen-denominated debt as net investment hedges of certain of its European and Japanese operations to manage the exposure to currency and exchange rate movements for foreign currency-denominated net investments in foreign operations. At October&#160;30, 2020, the Company had &#8364;16.0 billion, or $18.9 billion, of outstanding Euro-denominated debt designated as a hedge of its net investment in certain of its European operations, and &#165;300 billion, or $2.9 billion, of outstanding Yen-denominated debt designated as a hedge of its net investment in certain of its Japanese operations. The Euro-denominated debt will mature in fiscal years 2023 through 2051 and the Yen-denominated debt will mature in fiscal year 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, during the first quarter of fiscal year 2020, the Company entered into and settled forward currency exchange rate contracts to manage the exposure to exchange rate movements in anticipation of the issuance of Euro-denominated senior notes. Certain of these forward currency exchange rate contracts were designated as a net investment hedge of certain of the Company's European operations. These contracts matured in conjunction with the issuance of Euro-denominated debt in the first quarter of fiscal year 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instruments that are designated and qualify as net investment hedges, the gains or losses are reported as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The gains or losses are reclassified into earnings upon a liquidation event or deconsolidation of the foreign subsidiary. Amounts excluded from the assessment of effectiveness are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The cash flows related to the Company's derivative instruments designated as net investment hedges are reported as investing activities in the consolidated statements of cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At October&#160;30, 2020 and April&#160;24, 2020, the Company had $1.0 billion in after-tax unrealized losses and $236 million in after-tax unrealized gains, respectively, associated with net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company does not expect any of the after-tax unrealized gains at October&#160;30, 2020 to be recognized in the consolidated statements of income over the next 12 months. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not recognize any gains or losses during the three and six months ended October&#160;30, 2020 or October&#160;25, 2019 on instruments that no longer qualify as net investment hedges. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount and classifications of the (gains) losses recognized in the consolidated statements of income for the portion of the net investment hedges excluded from the measurement of hedge effectiveness were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the (gains) losses recognized in AOCI related to instruments designated as net investment hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows: </span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.100%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance Sheet Presentation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the balance sheet classification and fair value of derivative instruments included in the consolidated balance sheets at October&#160;30, 2020 and April&#160;24, 2020. The fair value amounts are presented on a gross basis and are segregated between derivatives that are designated and qualify as hedging instruments and those that are not designated and do not qualify as hedging instruments and are further segregated by type of contract within those two categories.</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.770%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.770%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information by level for the derivative assets and liabilities that are measured at fair value on a recurring basis.</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to present the fair value of derivative assets and liabilities within the consolidated balance sheets on a gross basis, even when derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation. The cash flows related to collateral posted and received are reported gross as investing and financing activities, respectively, in the consolidated statements of cash flows. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recorded Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral Posted (Received)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recorded Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral Posted (Received)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325846104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory balances, net of reserves, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,484&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,229&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460326002600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">Goodwill and Other Intangible Assets <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of goodwill by segment: </span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cardiac and Vascular Group</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restorative Therapies Group</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diabetes Group</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 24, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,841&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as a result of acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,926&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,077&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill for impairment annually as of the first day of the third quarter of the fiscal year and whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Impairment testing for goodwill is performed at the reporting unit level. The test for impairment of goodwill requires the Company to make several estimates about fair value, most of which are based on projected future cash flows. The Company calculates the excess of each reporting unit's fair value over its carrying amount, including goodwill, utilizing a discounted cash flow analysis. The Company did not recognize any goodwill impairment during the three and six months ended October&#160;30, 2020 or October&#160;25, 2019. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the gross carrying amount and accumulated amortization of intangible assets: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,065)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology and patents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,354)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,605&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,633)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,244&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,704)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company assesses definite-lived intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of an intangible asset (asset group) may not be recoverable. When events or changes in circumstances indicate that the carrying value of an intangible asset may not be recoverable, the Company calculates the excess of an intangible asset's carrying value over its undiscounted future cash flows. If the carrying value is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value. The inputs used in the fair value analysis fall within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs to determine fair value. The Company did not recognize any definite-lived intangible asset charges during the three and six months ended October&#160;30, 2020. The Company recognized $33&#160;million of definite-lived intangible asset charges during the three and six months ended October 25, 2019 in connection with exit of businesses within the Restorative Therapies Group segment. Intangible asset impairment charges are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company assesses indefinite-lived intangibles for impairment annually in the third quarter of the fiscal year and whenever an event occurs or circumstances change that would indicate that the carrying value may be impaired. The Company did not recognize any indefinite-lived intangible asset impairments during the three and six months ended October&#160;30, 2020 or October&#160;25, 2019. Due to the nature of IPR&amp;D projects, the Company may experience future delays or failures to obtain regulatory approvals to conduct clinical trials, failures of clinical trials, delays or failures to obtain required market clearances, other failures to achieve a commercially viable product, or the discontinuation of certain projects, and as a result, may recognize impairment losses in the future.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortization Expense</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense for the three months ended October&#160;30, 2020 and October&#160;25, 2019 was $443&#160;million and $441&#160;million, respectively. For the six months ended October&#160;30, 2020 and October&#160;25, 2019, intangible asset amortization expense was $884&#160;million and $881&#160;million, respectively. Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at October&#160;30, 2020, excluding any possible future amortization associated with acquired IPR&amp;D which has not yet met technological feasibility, is as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.300%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460324452856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective tax rate for the three and six months ended October&#160;30, 2020 was 5.9 percent and 11.2 percent, respectively, as compared to (6.0) percent and 1.0 percent for the three and six months ended October&#160;25, 2019, respectively. The increase in the effective tax rate for the three and six months ended October&#160;30, 2020, as compared to the corresponding periods in the prior fiscal year, was primarily due to the impact of certain tax adjustments and year-over-year changes in operational results by jurisdiction. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Tax Adjustments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended October&#160;30, 2020, the cost from certain tax adjustments of $16&#160;million, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">income tax provision (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income, included a cost of $16&#160;million associated with the amortization of the previously established deferred tax assets from intercompany intellectual property transactions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the six months ended October&#160;30, 2020, the net cost from certain tax adjustments of $20&#160;million, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">income tax provision (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income, included the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">A benefit of $3&#160;million associated with the finalization of an intercompany sale of intellectual property and the establishment of a deferred tax asset. The cumulative amount of deferred tax benefit previously recognized from intercompany intellectual property transactions and recorded as Certain Tax Adjustments is $1.5&#160;billion. The corresponding deferred tax assets will be amortized over a period of approximately 20 years. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">A cost of $23&#160;million associated with the amortization of the previously established deferred tax assets from intercompany intellectual property transactions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended October&#160;25, 2019, the benefit from certain tax adjustments of $251&#160;million, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">income tax provision (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income, included a benefit of $251&#160;million related to tax legislative changes in Switzerland which abolished certain preferential tax regimes the Company benefited from and replaced them with a new set of internationally accepted measures. The legislation provided for higher effective tax rates but allowed for a transitional period whereby an amortizable asset was created for Swiss federal income tax purposes which will be amortized and deducted over a 10-year period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended October&#160;25, 2019, the net benefit from certain tax adjustments of $281&#160;million, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">income tax provision (benefit) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income, included the following: </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A net benefit of $30&#160;million related to U.S. Treasury&#8217;s issuance of certain Final Regulations associated with U.S. Tax Reform. The primary impact of these regulations resulted in the re-establishment of our permanently reinvested assertion on certain foreign earnings and reversing the previously accrued tax liability. This benefit was partially offset by additional tax associated with a previously executed internal reorganization of certain foreign subsidiaries. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A benefit of $251&#160;million related to tax legislative changes in Switzerland which abolished certain preferential tax regimes the Company benefited from and replaced them with a new set of internationally accepted measures. The legislation provided for higher effective tax rates but allowed for a transitional period whereby an amortizable asset was created for Swiss federal income tax purposes which will be amortized and deducted over a 10-year period.   </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At both October&#160;30, 2020 and April&#160;24, 2020, the Company's gross unrecognized tax benefits were $1.9&#160;billion. In addition, the Company had accrued gross interest and penalties of $251&#160;million at October&#160;30, 2020. If all the Company&#8217;s unrecognized tax benefits were recognized, approximately $1.8&#160;billion would impact the Company&#8217;s effective tax rate. At October&#160;30, 2020 and April&#160;24, 2020, the amount of the Company's gross unrecognized tax benefits recorded as a noncurrent liability within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">accrued income taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">on the consolidated balance sheets was $940&#160;million and $911&#160;million, respectively.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company recognizes interest and penalties related to income tax matters within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">income tax provision (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the consolidated statements of income and records the liability within either current or noncurrent </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">accrued income taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">on the consolidated balance sheets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 16 to the consolidated financial statements for additional information regarding the status of current tax audits and proceedings.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325999528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share Earnings per share is calculated using the two-class method, as the Company's A Preferred Shares are considered participating securities. Accordingly, earnings are allocated to both ordinary shares and participating securities in determining earnings per ordinary share. Due to the limited number of A Preferred Shares outstanding, this allocation had no effect on ordinary earnings per share; therefore, it is not presented below. Basic earnings per share is computed based on the weighted average number of ordinary shares outstanding. Diluted earnings per share is computed based on the weighted average number of ordinary shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive ordinary shares been issued, and reduced by the number of shares the Company could have repurchased with the proceeds from issuance of the potentially dilutive shares. Potentially dilutive ordinary shares include stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan.<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth the computation of basic and diluted earnings per share:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to ordinary shareholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic &#8211; weighted average shares outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,352.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The calculation of weighted average diluted shares outstanding excludes options to purchase approximately 8 million ordinary shares for both the three and six months ended October&#160;30, 2020, and 4 million ordinary shares for both the three and six months ended October&#160;25, 2019, because their effect would have been anti-dilutive on the Company&#8217;s earnings per share.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325931064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components and classification of stock-based compensation expense for stock options, restricted stock, and employee stock purchase plan shares recognized for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefits</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325999528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Retirement Benefit Plans</a></td>
<td class="text">Retirement Benefit Plans <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various retirement benefit plans, including defined benefit pension plans, post-retirement medical plans, defined contribution savings plans, and termination indemnity plans, covering substantially all U.S. employees and many employees outside the U.S. The net periodic benefit cost of the defined benefit pension plans included the following components for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost other than the service component are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2021, as part of the Simplification restructuring program, the Company offered certain eligible U.S. employees voluntary early retirement packages, resulting in incremental expense of $97&#160;million recognized during the three and six months ended October&#160;30, 2020. Of this amount, $80&#160;million related to U.S. pension benefits, $11&#160;million related to defined contribution plans, $4&#160;million related to U.S. post-retirement benefits, and $2&#160;million related to cash payments and administrative fees. See Note 5 for additional information on the Simplification restructuring program.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325809672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in AOCI, net of tax, and by component:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investment Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Change in Retirement Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 24, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,852)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,560)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,276)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(955)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,040)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,832)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,843)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Investment Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Change in Retirement Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 26, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,383)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,308)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,711)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 25, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,531)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,283)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,611)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:9pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax on gains and losses on investment securities in other comprehensive income before reclassifications during the six months ended October&#160;30, 2020 and October&#160;25, 2019 was an expense of $31 million and $1&#160;million, respectively. There was no income tax on gains and losses on investment securities reclassified from AOCI for the six months ended October&#160;30, 2020. During the six months ended October&#160;25, 2019, realized gains and losses on investment securities reclassified from AOCI were reduced by income taxes of $2&#160;million. When realized, gains and losses on investment securities reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to Note&#160;6&#160;to the consolidated financial statements for additional information.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax on cumulative translation adjustment for the six months ended October&#160;30, 2020, was an expense of $4 million. For the six months ended October&#160;25, 2019, there was no income tax on cumulative translation adjustment. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended October&#160;30, 2020 and October&#160;25, 2019, there were no tax impacts on net investment hedges. Refer to Note 8 to the consolidated financial statements for additional information. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in retirement obligations in other comprehensive income includes amortization of net actuarial losses included in net periodic benefit cost. During the six months ended October&#160;30, 2020, the net change in retirement obligations in other comprehensive income before reclassifications resulted in an income tax benefit of $5 million. During the six months ended October&#160;25, 2019, there was no income tax impact on the net change in retirement obligations in other comprehensive income before reclassifications. During the six months ended October&#160;30, 2020 and October&#160;25, 2019, the gains and losses on defined benefit and pension items reclassified from AOCI were reduced by income taxes of&#160;$8 million and $6&#160;million, respectively. When realized, net gains and losses on defined benefit and pension items reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to Note&#160;14 to the consolidated financial statements&#160;for additional information.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax on unrealized gains and losses on cash flow hedges in other comprehensive income before reclassifications during the six months ended October&#160;30, 2020 and October&#160;25, 2019&#160;was&#160;a benefit of&#160;$93 million and an expense of $21&#160;million, respectively. During the six months ended October&#160;30, 2020 and October&#160;25, 2019, gains and losses on cash flow hedges reclassified from AOCI were reduced by income taxes of&#160;$10 million and $26&#160;million, respectively. When realized, gains and losses on currency exchange rate contracts reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating expense, net,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and gains and losses on forward starting interest rate derivatives reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Refer to Note&#160;8&#160;to the consolidated financial statements for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460418787928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company and its affiliates are involved in a number of legal actions involving product liability, intellectual property and commercial disputes, shareholder related matters, environmental proceedings, tax disputes, and governmental proceedings and investigations, including those described below. With respect to governmental proceedings and investigations, like other companies in our industry, the Company is subject to extensive regulation by national, state and local governmental agencies in the United States and in other jurisdictions in which the Company and its affiliates operate. As a result, interaction with governmental agencies is ongoing. The Company&#8217;s standard practice is to cooperate with regulators and investigators in responding to inquiries. The outcomes of legal actions are not within the Company&#8217;s complete control and may not be known for prolonged periods of time. In some actions, the enforcement agencies or private claimants seek damages, as well as other civil or criminal remedies (including injunctions barring the sale of products that are the subject of the proceeding), that could require significant expenditures, result in lost revenues, or limit the Company's ability to conduct business in the applicable jurisdictions.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company records a liability in the consolidated financial statements on an undiscounted basis for loss contingencies related to legal actions when a loss is known or considered probable and the amount may be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is reasonably possible but not known or probable, and may be reasonably estimated, the estimated loss or range of loss is disclosed. When determining the estimated loss or range of loss, significant judgment is required. Estimates of probable losses resulting from litigation and governmental proceedings involving the Company are inherently difficult to predict, particularly when the matters are in early procedural stages with incomplete scientific facts or legal discovery, involve unsubstantiated or indeterminate claims for damages, potentially involve penalties, fines or punitive damages, or could result in a change in business practice. The Company classifies litigation charges and gains related to significant legal matters as certain litigation charges. During the three and six months ended October&#160;30, 2020, the Company recognized charges of $84 million and a net benefit of $4 million, respectively, primarily due to favorable settlements in the first quarter of fiscal year 2021, partially offset by charges recognized in the second quarter of fiscal year 2021. During the three and six months ended October&#160;25, 2019, the Company recognized $121 million and $168 million, respectively, of certain litigation charges. At October&#160;30, 2020 and April&#160;24, 2020, accrued litigation was approximately $0.4&#160;billion and $0.5 billion, respectively. The ultimate cost to the Company with respect to accrued litigation could be materially different than the amount of the current estimates and accruals and could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position, and/or cash flows. The Company includes accrued litigation in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> on the consolidated balance sheets. While it is not possible to predict the outcome for most of the legal matters discussed below, the Company believes it is possible that the costs associated with these matters could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position, and/or cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Liability Matters</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pelvic Mesh Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is currently involved in litigation in various state and federal courts against manufacturers of pelvic mesh products alleging personal injuries resulting from the implantation of those products. Two subsidiaries of Covidien supplied pelvic mesh products to one of the manufacturers, C.R. Bard (Bard), named in the litigation. The litigation includes a federal multi-district litigation in the U.S. District Court for the Northern District of West Virginia and cases in various state courts and jurisdictions outside the U.S. Generally, complaints allege design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. In fiscal year 2016, Bard paid the Company $121 million towards the settlement of 11,000 of these claims. In May 2017, the agreement with Bard was amended to extend the terms to apply to up to an additional 5,000 claims. That agreement does not resolve the dispute between the Company and Bard with respect to claims that do not settle, if any. As part of the agreement, the Company and Bard agreed to dismiss without prejudice their pending litigation with respect to Bard&#8217;s obligation to defend and indemnify the Company. The Company estimates law firms representing approximately 16,200 claimants have asserted or may assert claims involving products manufactured by Covidien&#8217;s subsidiaries. As of November 4, 2020, the Company had reached agreements to settle approximately 15,900 of these claims. The Company's accrued expenses for this matter are included within accrued litigation as discussed above. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hernia Mesh Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2020, plaintiffs filed lawsuits against certain subsidiaries of the Company in U.S. state and federal courts alleging personal injury from hernia mesh products sold by those subsidiaries. The majority of the pending cases are in Massachusetts state court, where they have been consolidated before a single judge. Certain plaintiffs' law firms have advised the Company that they may file additional cases in the future. The pending lawsuits relate to hernia mesh products that have not been subject to recalls, withdrawals or other adverse regulatory action. The Company has not recorded an expense related to damages in connection with these matters because any potential loss is not currently probable or reasonably estimable under U.S. GAAP. Additionally, the Company is unable to reasonably estimate the range of loss, if any, that may result from these matters.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patent Litigation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ethicon</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 14, 2011, Ethicon filed an action against Covidien in the U.S. District Court for the Southern District of Ohio, alleging patent infringement and seeking monetary damages and injunctive relief. On January 22, 2014, the district court entered summary judgment in Covidien's favor, and the majority of this ruling was affirmed by the Federal Circuit on August 7, 2015.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following appeal, the case was remanded back to the District Court with respect to one patent. On January 21, 2016, Covidien filed a second action in the U.S. District Court for the Southern District of Ohio, seeking a declaration of non-infringement with respect to a second set of patents held by Ethicon. The court consolidated this second action with the remaining patent issues from the first action. Following consolidation of the cases, Ethicon dismissed six of the asserted patents, leaving a single asserted patent. The court has scheduled this matter for a bench trial in the first half of calendar year 2021. The Company has not recognized an expense related to damages in connection with this matter because any potential loss is not currently probable or reasonably estimable under U.S. GAAP. Additionally, the Company is unable to reasonably estimate the range of loss, if any, that may result from this matter. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sasso</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is involved in litigation in Indiana relating to certain patent and royalty disputes with Dr. Sasso under agreements originally entered into in 1999 and 2001. On November 28, 2018, a jury in Indiana state court returned a verdict against the Company for approximately $112&#160;million. The Company has strong arguments to appeal the verdict and has filed post-trial motions and appeals with the appropriate appellate courts. The Company's accrued expenses for this matter are included within accrued litigation as discussed above.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholder Related Matters</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Covidien Acquisition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 2, 2014, Lewis Merenstein filed a putative shareholder class action in Hennepin County, Minnesota, District Court seeking to enjoin the then-potential acquisition of Covidien. The lawsuit named Medtronic, Inc., Covidien, and each member of the Medtronic, Inc. Board of Directors at the time as defendants, and alleged that the directors breached their fiduciary duties to shareholders with regard to the then-potential acquisition. On August 21, 2014, Kenneth Steiner filed a putative shareholder class action in Hennepin County, Minnesota, District Court, also seeking an injunction to prevent the potential Covidien acquisition. In September 2014, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Merenstein</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Steiner</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> matters were consolidated and in December 2014, the plaintiffs filed a preliminary injunction motion seeking to enjoin the Covidien transaction. On March 20, 2015, the District Court issued an order and opinion granting Medtronic&#8217;s motion to dismiss the case. In May 2015, the plaintiffs filed an appeal, and, in January 2016, the Minnesota State Court of Appeals affirmed in part, and reversed in part. On April 19, 2016 the Minnesota Supreme Court granted the Company&#8217;s petition to review the issue of whether most of the original claims are properly characterized as direct or derivative under Minnesota law. In August 2017, the Minnesota Supreme Court affirmed the decision of the Minnesota State Court of Appeals, sending the matter back to the trial court for further proceedings, which are ongoing. In April 2020, the District Court issued an order and opinion denying the plaintiffs' motion for class certification. In June 2020, the Minnesota State Court of Appeals denied the plaintiffs' request to review the District Court's denial of class certification, and in September 2020, the Minnesota Supreme Court denied the plaintiffs' request to review the Court of Appeals decision. The Company has not recognized an expense related to damages in connection with this matter because any potential loss is not currently probable or reasonably estimable under U.S. GAAP. Additionally, the Company is unable to reasonably estimate the range of loss, if any, that may result from these matters.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental Proceedings</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is involved in various stages of investigation and cleanup related to environmental remediation matters at a number of sites. These projects relate to a variety of activities, including removal of solvents, metals and other hazardous substances from soil and groundwater. The ultimate cost of site cleanup and timing of future cash flows is difficult to predict given uncertainties regarding the extent of the required cleanup, the interpretation of applicable laws and regulations, and alternative cleanup methods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is a successor to a company that owned and operated a chemical manufacturing facility in Orrington, Maine from 1967 until 1982, and is responsible for the costs of completing an environmental site investigation as required by the Maine Department of Environmental Protection (MDEP). MDEP served a compliance order on Mallinckrodt LLC and U.S. Surgical Corporation, subsidiaries of Covidien, in December 2008, which included a directive to remove a significant volume of soils at the site. After a hearing on the compliance order before the Maine Board of Environmental Protection (Maine Board) to challenge the terms of the compliance order, the Maine Board modified the MDEP order and issued a final order requiring removal of two landfills, capping of the remaining three landfills, installation of a groundwater extraction system and long-term monitoring of the site and the three remaining landfills.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has proceeded with implementation of the investigation and remediation at the site in accordance with the MDEP order as modified by the Maine Board order. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Since the early 2000s, the Company or its predecessors have also been involved in a lawsuit filed in the U.S. District Court for the District of Maine by the Natural Resources Defense Council and the Maine People&#8217;s Alliance. Plaintiffs sought an injunction requiring the Company's predecessor to conduct extensive studies of mercury contamination of the Penobscot River and Bay and options for remediating such contamination, and to perform appropriate remedial activities, if necessary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following a trial in March 2002, the Court held that conditions in the Penobscot River and Bay may pose an imminent and substantial endangerment and that the Company&#8217;s predecessor was liable for the cost of performing a study of the River and Bay. Following a second trial in June 2014, the Court ordered that further engineering study and engineering design work was needed to determine the nature and extent of remediation in the Penobscot River and Bay. The Court also appointed an engineering firm to conduct such studies and issue a report on potential remediation alternatives. In connection with these proceedings, reports have been produced including a variety of cost estimates for a variety of potential remedial options. A third trial to determine the course of remediation to be pursued is scheduled to occur in fiscal year 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's accrued expenses for environmental proceedings are included within accrued litigation as discussed above. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2009, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2005 and 2006. Medtronic, Inc. reached agreement with the IRS on some, but not all matters related to these fiscal years. The remaining unresolved issue for fiscal years 2005 and 2006 relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico, which is one of the Company's key manufacturing sites. The U.S. Tax Court reviewed this dispute, and on June 9, 2016, issued its opinion with respect to the allocation of income between the parties for fiscal years 2005 and 2006. The U.S. Tax Court generally rejected the IRS&#8217;s position, but also made certain modifications to the Medtronic, Inc. tax returns as filed. On April 21, 2017, the IRS filed their Notice of Appeal to the U.S. Court of Appeals for the 8th Circuit regarding the Tax Court Opinion.&#160;Oral argument for the Appeal occurred on March 14, 2018. The 8th Circuit Court of Appeals issued their opinion on August 16, 2018 and remanded the case back to the U.S. Tax Court for additional factual findings. The U.S. Tax Court trial is scheduled to occur in June of 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2011, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2007 and 2008. Medtronic, Inc. reached agreement with the IRS on some, but not all matters related to these fiscal years. The remaining unresolved issue for fiscal years 2007 and 2008 relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for the businesses that are the subject of the U.S. Tax Court Case for fiscal years 2005 and 2006. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2014, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2009, 2010, and 2011. Medtronic, Inc. reached agreement with the IRS on some but not all matters related to these fiscal years. The remaining unresolved issue for fiscal years 2009, 2010, and 2011 relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for the businesses that are the subject of the U.S. Tax Court Case for fiscal years 2005 and 2006. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2012, 2013, and 2014. Medtronic, Inc. reached agreement with the IRS on some but not all matters related to these fiscal years. The significant issues that remain unresolved relate to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico, and proposed adjustments associated with the utilization of certain net operating losses. The Company disagrees with the IRS and will attempt to resolve these matters at the IRS Appellate level.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to quarter-end, in November 2020, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2015 and 2016. Medtronic, Inc. reached agreement with the IRS on some but not all matters related to these fiscal years. The significant issue that remains unresolved relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for the businesses that are the subject of the U.S. Tax Court Case for fiscal years 2005 and 2006.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic, Inc.&#8217;s fiscal years 2017, 2018, and 2019 U.S. federal income tax returns are currently being audited by the IRS.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covidien and the IRS have concluded and reached agreement on its audit of Covidien&#8217;s U.S. federal income tax returns for all tax years through 2012. The statute of limitations for Covidien&#8217;s 2013 and 2014 U.S. federal income tax returns lapsed during the first quarter of fiscal years 2018 and 2019, respectively. Covidien's fiscal year 2015 U.S. federal income tax returns are currently being audited by the IRS. The statute of limitations for Covidien's 2016 U.S. federal income tax return lapsed during the third quarter of fiscal year 2020. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is not possible to predict the outcome for most of the income tax matters discussed above, the Company believes it is possible that charges associated with these matters could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position, and/or cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 11 for additional discussion of income taxes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Company&#8217;s sale of the Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses to Cardinal on July 29, 2017, the Company has indemnified Cardinal for certain contingent tax liabilities related to the divested businesses that existed prior to the date of divestiture. The actual amounts that the Company may be required to ultimately accrue or pay could vary depending upon the outcome of the unresolved tax matters.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company and/or its affiliates periodically enter into agreements that require one or more of the Company and/or its affiliates to indemnify customers or suppliers for specific risks, such as claims for injury or property damage arising as a result of the Company or its affiliates&#8217; products, the negligence of the Company's personnel, or claims alleging that the Company's products infringe on third-party patents or other intellectual property. The Company also offers warranties on various products. The Company&#8217;s maximum exposure under these guarantees is unable to be estimated. Historically, the Company has not experienced significant losses on these types of guarantees.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the ultimate resolution of the above guarantees is not expected to have a material effect on the Company&#8217;s consolidated earnings, financial position, and/or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127197<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127163<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325931064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Geographic Information</a></td>
<td class="text">Segment and Geographic Information<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment disclosures are on a performance basis consistent with internal management reporting. Net sales of the Company's reportable segments include end-customer revenues from the sale of products the segment develops, manufactures, and distributes. There are certain corporate and centralized expenses that are not allocated to the segments.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management evaluates performance of the segments and allocates resources based on net sales and segment operating profit. Segment operating profit represents income before income taxes, excluding interest expense, amortization of intangible assets, centralized distribution costs, non-operating income or expense items, certain corporate charges, and other items not allocated to the segments. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note 1 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 24, 2020. Certain depreciable assets may be recorded by one segment, while the depreciation expense is allocated to another segment. The allocation of depreciation expense is based on the proportion of the assets used by each segment. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Operating Profit</span></div><div style="margin-bottom:6pt;margin-top:16pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac and Vascular Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,704&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(641)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(774)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(441)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(884)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(881)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized distribution costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(542)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(424)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(940)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit of businesses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt tender premium and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution to Medtronic Foundation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,271&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Geographic Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales are attributed to the country based on the location of the customer taking possession of the products or in which the services are rendered. The following table presents net sales for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 for the Company's country of domicile, countries with significant concentrations, and all other countries:&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other countries, excluding Ireland</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,647&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,154&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325962216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The accompanying unaudited consolidated financial statements of Medtronic plc and its subsidiaries (Medtronic plc, Medtronic, or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S.) (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the consolidated financial statements include all of the adjustments necessary for a fair statement in conformity with U.S. GAAP. Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">The accompanying unaudited consolidated financial statements include the accounts of Medtronic plc, its wholly-owned subsidiaries, entities for which the Company has a controlling financial interest, and variable interest entities for which the Company is the primary beneficiary. Intercompany transactions and balances have been eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Period</a></td>
<td class="text">The Company&#8217;s fiscal years 2021, 2020, and 2019 will end or ended on April&#160;30, 2021, April&#160;24, 2020, and April&#160;26, 2019, respectively. Fiscal year 2021 is a 53-week year, with the extra week having occurred in the first fiscal month of the first quarter.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Current Expected Credit Losses</span></div>In June 2016, the Financial Accounting Standards Board (FASB) issued guidance which changes the methodology to be used to measure credit losses for certain financial instruments and financial assets, including trade receivables. The new methodology requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset. The Company adopted this guidance using the modified retrospective method in the first quarter of fiscal year 2021. The adoption of this guidance did not have a material impact to the Company&#8217;s consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325954152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by segment and division for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.636%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm &amp; Heart Failure</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coronary &amp; Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aortic, Peripheral, &amp; Venous </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac &amp; Vascular Group</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,855&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,158&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,645&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Innovations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Respiratory, Gastrointestinal, &amp; Renal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cranial &amp; Spinal Technologies</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,706&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,154&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,199&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)   Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal year 2021, the Company realigned the divisions within the Restorative Therapies Group to the following: Cranial &amp; Spinal Technologies (includes Core Spine and Biologics, Enabling Technologies, and China Orthopedics), Specialty Therapies (includes ENT, Pelvic Health, and Neurovascular), and Neuromodulation (includes Pain Therapies, Brain Modulation, and Interventional). As a result, net sales for fiscal year 2020 have been recast to adjust for this realignment.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by market geography for each segment for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)(4)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac &amp; Vascular Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)(4)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac &amp; Vascular Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,621&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,460&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">U.S. includes the United States and U.S. territories.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.</span></div>(4)Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325675512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Reconciliation of Beginning and Ending Balances of Contingent Consideration</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of contingent consideration:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurements, Contingent Consideration, Significant Unobservable Inputs</a></td>
<td class="text">The recurring Level 3 fair value measurements of contingent consideration for which a liability is recorded include the following significant unobservable inputs:<div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:22.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.770%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">14.0% - 32.4%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">20.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Revenue and other performance-based payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">$203</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">40% - 100%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">99.4%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">2021 - 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">5.5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">5.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Product development and other milestone-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">$258</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">50% - 100%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">93.2%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">2021 - 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)   Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected fiscal year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460331376504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Enterprise Excellence restructuring program for the six months ended October&#160;30, 2020:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Termination Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Associated Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 24, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the activity related to the Simplification restructuring program for the six months ended October&#160;30, 2020:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Termination Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Associated Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 24, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1)  Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460330152248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Investments by Category and Related Balance Sheet Classification, Debt Securities</a></td>
<td class="text">The following tables summarize the Company's investments in available-for-sale and held-to-maturity debt securities by significant investment category and the related consolidated balance sheet classification at October&#160;30, 2020 and April&#160;24, 2020:&#160;&#160;&#160;&#160;<div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Available-for-sale securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,435&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,435&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Held-to-maturity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,893&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,857&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,847&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,841&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,808&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Available-For-Sale Debt Securities in Continuous Unrealized Loss Position</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the gross unrealized losses and fair values of the Company&#8217;s available-for-sale debt securities that have been in a continuous unrealized loss position deemed to be temporary, aggregated by investment category at October&#160;30, 2020 and April&#160;24, 2020:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than 12 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,520&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than 12 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Activity Related to the Company's Available-for-Sale Debt Securities Portfolio</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity related to the Company&#8217;s available-for-sale debt securities portfolio is as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Debt Securities Contractual Maturities</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The October&#160;30, 2020 balance of available-for-sale and held-to-maturity debt securities by contractual maturity is shown in the following table. Within the table, maturities of mortgage-backed securities have been allocated based upon timing of estimated cash flows assuming no change in the current interest rate environment. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.168%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-For-Sale</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-To-Maturity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,007&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock', window );">Summary of Equity and Other Investments</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's equity and other investments at October&#160;30, 2020 and April&#160;24, 2020, which are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheets:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.366%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments with readily determinable fair value (marketable equity securities)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method and other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity and other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_ScheduleofInvestmentsTableTextBlock', window );">Activity Related to the Company's Equity and Other Investments Portfolio</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes activity related to the Company&#8217;s portfolio of equity and other investments. Gains and losses on equity and other investments are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.100%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment losses recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_ScheduleofInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Investments [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_ScheduleofInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325664696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Long-term Debt</a></td>
<td class="text"><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's debt obligations consisted of the following:</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.236%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity by <br/>Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current debt obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,041&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.150 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS04NDc2L3RleHRyZWdpb246MzI5ZGJlZDllYWVkNDA2YWI5MDdiMTQ4NzNkNWQxZDZfNzY5NjU4MTM5NDQ3OA_1fc66852-89e8-4b7b-81e1-6369f8dd3419">seven</span>-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.200 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNC0wLTEtMS03MDUxL3RleHRyZWdpb246Zjg2ZWM0YTg4NDI3NGFhOWI0ZGJmYWViM2QzZThlZjBfNzY5NjU4MTM5NDQ3OA_0f544188-5492-43f0-8466-e9aa66f80bd2">ten</span>-year 2012 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS03MDU5L3RleHRyZWdpb246M2VjNzUyNTAyZmE1NDIzNWE0OWI2YzNhZTZlZGEyM2JfMTU_434d6196-cd71-423f-b1c6-94ab8fd6f545">four</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.375 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNi0wLTEtMS0wL3RleHRyZWdpb246NjI0ZTZhYTM4MjA3NGI3ZDhkOTYyYWNiZjQ4NDUyNjVfMTU_4e71358d-8a7e-40b6-8487-19339f167751">four</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS02NTEyL3RleHRyZWdpb246ZWM4Njk1YWJlNjBlNGViOTg3ZWU3MjczM2E3NGIzODJfNzY5NjU4MTM5NDQ5NA_f18bfa88-ad2a-419f-b369-44b60f7697ef">two</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.750 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfNy0wLTEtMS0wL3RleHRyZWdpb246ZTc2YTM4MTBiNTI1NDMyYzkwY2FhNTg2ZWNhYmU0ZjJfMTU_7216313b-f8c0-40e6-99ac-4a1d7fa40514">ten</span>-year 2013 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.950 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfOS0wLTEtMS0wL3RleHRyZWdpb246NDM3NzdkMzViODVmNDM1NTlmNjI1MGRlNTNjYjIyNTZfMTU_73fcdfe3-1699-4e4e-a1b3-6abc413aba37">ten</span>-year 2013 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.625 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjBkZGE4M2Y1MTQ5YTQ2NWNiYTYyNGI3YzQ2Y2FmOTc2XzE1_3cf05ffe-b2a6-4335-96b8-f9d8eb8335a3">ten</span>-year 2014 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.500 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjMwZDAzODE1ZTQ2YjQ0MGI5YWRkOGIyNjE4NjI1MTY4XzE1_5a8917d8-b557-4f27-97d0-e5d0ca330706">ten</span>-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.250 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjY4MTNkM2VlNGE3MjQ2MzQ5ZGY4NjgzMGRjNjA5ZmI2XzE1_dd01a2f7-a10b-4245-962c-1c722b265da7">seven</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtNjUzMS90ZXh0cmVnaW9uOjY5NDIwNWJkNjIxNDQzYTE5ZmI3NGVmZDI1MzkyOTgzXzc2OTY1ODEzOTQ0OTU_7e8547d7-3068-4d97-88c7-8a5e777cd5be">five</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.125 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjVlMTZkMTQyM2ZlNjQ1ZTRiMzQzYjA0ZWU5YzMwZThhXzE1_aeaca299-dcdb-4b89-b32d-ea5647d9bdae">eight</span>-year 2019 senior notes </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.350 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjUwOWNjZGNhZTZjYzQ4NTBiNjg1YmNjMDYwZTVkYWYwXzE1_6c38aec9-7242-49e4-a3a0-97185e834427">ten</span>-year 2017 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.375 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtNjU1MS90ZXh0cmVnaW9uOjZiZjEyYmVlZGI5NTQwYzQ5N2ZiNTc3OGJmMjk5MmM1Xzc2OTY1ODEzOTQ0ODk_3f1d490f-a710-44cb-aa4c-f5db8f0fa208">eight</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.625 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOmQ1YTI2NTk1ZGQ3OTRmYjU4YmUzYjRhZDFmMjE1ZDk1XzE1_5b30e37a-feeb-41bf-b826-7121e730e737">twelve</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.000 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjZmZDA0ZmIzNjYyNDQ3ZDY5ZjAwN2FlYTRlZjRhZGU4XzE1_932ae6cf-26e5-4bad-b22d-29b416b48b23">thirteen</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtNjU2NC90ZXh0cmVnaW9uOjVjZTJlM2ZhNTQ5ZTQ4NjBhZmQyOGQxMDdmNDVkMTJmXzc2OTY1ODEzOTQ0OTk_c2fcbcbb-9062-4210-8500-cae9fda3b843">twelve</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDA2NzRiOTUwOTQzMjViMjhlYTFkZGQ2YWFjNzY3XzE1_d33f3c62-a9b3-4939-acb6-efa5d1c533e4">twenty</span>-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.550 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTI3ZmUyY2I4NjRiODBiYjg3ZDEzZjgzNjI2NDEwXzE1_3ef70171-17bb-4da9-8dc5-bfdf0b5cd24e">thirty</span>-year 2007 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2038</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjg1NzhjYzgwNmZjMzQ0NzNhNjczOTJiNGVlYjg5N2YwXzE1_3df5c742-c214-41f0-b3d0-5224780e9379">twenty</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.500 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOmY0MDRlOGZmYTIyMTQzOWM4YmRlNWYyNWIwNjE1YjQ5XzE1_c2981a7f-89c2-4f44-9205-b4e86754b2c1">thirty</span>-year 2009 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.500 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtNzA2Ny90ZXh0cmVnaW9uOjEwMDFhY2UzNjJkYjRkNDNiZjc4NWIwMmU2MzVlY2U5XzE1_057deae6-4bb1-452e-b86a-80173d533019">twenty</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.550 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjQ1ODFmMjY1ZmNmMjRjYzZiMmNlN2Q2MjViM2Q2NjA1XzE1_db79b77e-7b88-4758-a617-823b3f2a7b0c">thirty</span>-year 2010 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.375 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtNjU3NC90ZXh0cmVnaW9uOjhlYTQ1NjhhOTU4YzQwNDU5M2NkMGY1YzdkMjQxYjZmXzc2OTY1ODEzOTQ0OTU_ef0d6972-d506-46e3-9082-3bddd7a7d890">twenty</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2041</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.500 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlYTljZmNjYzNiOTQzODM5MzBkNWFhMDBkNmNhNWM4XzE1_df7243fa-33e3-441e-9e5c-0d5e8f72b28c">thirty</span>-year 2012 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2042</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjQtMC0xLTEtMC90ZXh0cmVnaW9uOjNhMmQ4M2U3MzY4YzQxYzBiYjk4NTU2YjA1ODJhYjA2XzE1_8015ac63-f366-4764-bf6a-46db806b09cf">thirty</span>-year 2013 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2043</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjg1ZmFkZGU0NTAyOTQ4OWFiZGI0NDVmMmNkN2Q2OTA5XzE1_194c751d-bc01-4752-9b92-6d1dd7b2c6bd">thirty</span>-year 2014 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2044</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOmY2MmI2NWE5YjUyMzRiN2NhYzMwNmRhNTRkZjFjNmE2XzE1_816125dd-3eea-4f07-9610-e050c2e8a8b8">thirty</span>-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.750 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmRjYTc3ZGQ5MTBlMTQzMWZiY2FmMGExNjI2ZjA1YzUyXzE1_affa4ede-4085-4b4a-8013-9f2c5a3af318">thirty</span>-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.625 percent <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMjg1OTNlMjBlNDRiYmM4YjA2NzFjNDgyZWM5Yjc5L3NlYzo2MTI4NTkzZTIwZTQ0YmJjOGIwNjcxYzQ4MmVjOWI3OV82MS9mcmFnOmM4YzVkN2YxYjYwMjQ3ODE4NjBkYzQxZTk2Y2IzY2I3L3RhYmxlOjU5ZTFiMjFmN2M0YTQ1MTY5Yzk1NWMzMGE4N2I2NDcyL3RhYmxlcmFuZ2U6NTllMWIyMWY3YzRhNDUxNjljOTU1YzMwYTg3YjY0NzJfMzMtMC0xLTEtNjU4Ni90ZXh0cmVnaW9uOjEzNTMyNGVhY2U0MTQ2NmJiN2EyYTcxMmI4MzcyMDI3Xzc2OTY1ODEzOTQ0OTU_ecf3e18f-537f-414b-994f-f458754db39a">thirty</span>-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 - 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 - 2051</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 - 2051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,967&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460324092504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock', window );">Amount and Location of (Gains) Losses in Statements of Income, Derivative Instruments Not Designated as Hedging Instruments</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts and classification of the (gains) losses in the consolidated statements of income related to derivative instruments not designated as hedging instruments for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.866%"><tr><td style="width:1.0%"/><td style="width:26.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Amounts of (Gains) Losses Recognized in AOCI</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the (gains) losses recognized in accumulated other comprehensive loss (AOCI) related to the currency exchange rate contract derivative instruments designated as cash flow hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.100%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Amount and Location of (Gains) Losses in Statements of Income</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the (gains) losses recognized in the consolidated statements of income related to derivative instruments designated as cash flow hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other operating expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated statements of income in which the effects of cash flow hedges are recorded</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency exchange rate contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain reclassified from AOCI into income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Amount and Location of (Gains) Losses in Statements of Income, Derivative Instruments Designated as Net Investment Hedges</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount and classifications of the (gains) losses recognized in the consolidated statements of income for the portion of the net investment hedges excluded from the measurement of hedge effectiveness were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Amounts of (Gains) Losses Recognized in AOCI for Net Investment Hedges</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the (gains) losses recognized in AOCI related to instruments designated as net investment hedges for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 were as follows: </span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.100%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the balance sheet classification and fair value of derivative instruments included in the consolidated balance sheets at October&#160;30, 2020 and April&#160;24, 2020. The fair value amounts are presented on a gross basis and are segregated between derivatives that are designated and qualify as hedging instruments and those that are not designated and do not qualify as hedging instruments and are further segregated by type of contract within those two categories.</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.770%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.770%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information by level for the derivative assets and liabilities that are measured at fair value on a recurring basis.</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsTableTextBlock', window );">Offsetting Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recorded Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral Posted (Received)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recorded Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral Posted (Received)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesTableTextBlock', window );">Offsetting Liabilities</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recorded Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral Posted (Received)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recorded Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral Posted (Received)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of gains and losses recognized in the statement of financial performance on foreign currency derivative instruments not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225877-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225877-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for net investment hedges of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460330868616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory Balances</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory balances, net of reserves, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,484&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,229&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325799672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in the Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of goodwill by segment: </span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cardiac and Vascular Group</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restorative Therapies Group</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diabetes Group</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 24, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,841&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as a result of acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,926&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,077&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Gross Carrying Amount and Accumulated Amortization of Definite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the gross carrying amount and accumulated amortization of intangible assets: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,065)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology and patents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,354)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,605&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,633)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,244&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,704)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Gross Carrying Amount of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the gross carrying amount and accumulated amortization of intangible assets: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 24, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,065)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology and patents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,354)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,605&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,633)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,244&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,704)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated Future Aggregate Amortization Expense, Definite-Lived Intangible Assets</a></td>
<td class="text">Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at October&#160;30, 2020, excluding any possible future amortization associated with acquired IPR&amp;D which has not yet met technological feasibility, is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.300%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325706600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth the computation of basic and diluted earnings per share:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to ordinary shareholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic &#8211; weighted average shares outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,352.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460330989592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Components and Classification of Stock-based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components and classification of stock-based compensation expense for stock options, restricted stock, and employee stock purchase plan shares recognized for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefits</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325724472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Components of Net Periodic Benefit Cost</a></td>
<td class="text">The net periodic benefit cost of the defined benefit pension plans included the following components for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460419552152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in AOCI by Component</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in AOCI, net of tax, and by component:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investment Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Change in Retirement Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 24, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,852)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,560)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,276)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(955)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,040)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,832)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,843)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Investment Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Change in Retirement Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 26, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,383)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,308)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,711)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 25, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,531)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,283)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,611)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460326000360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Operating Profit</span></div><div style="margin-bottom:6pt;margin-top:16pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac and Vascular Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimally Invasive Therapies Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restorative Therapies Group</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,704&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(641)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(774)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(441)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(884)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(881)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized distribution costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(542)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(424)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(940)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit of businesses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt tender premium and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution to Medtronic Foundation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,271&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Net Sales to External Customers by Geography</a></td>
<td class="text">The following table presents net sales for the three and six months ended October&#160;30, 2020 and October&#160;25, 2019 for the Company's country of domicile, countries with significant concentrations, and all other countries:&#160;&#160;&#160;&#160;<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 25, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other countries, excluding Ireland</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,647&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,154&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460331924504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Disaggregation of Net Sales by Segment and Division (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 7,647<span></span>
</td>
<td class="nump">$ 7,706<span></span>
</td>
<td class="nump">$ 14,154<span></span>
</td>
<td class="nump">$ 15,199<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember', window );">Cardiac &amp; Vascular Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,725<span></span>
</td>
<td class="nump">2,855<span></span>
</td>
<td class="nump">5,158<span></span>
</td>
<td class="nump">5,645<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember', window );">Cardiac &amp; Vascular Group | Cardiac Rhythm &amp; Heart Failure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,426<span></span>
</td>
<td class="nump">1,426<span></span>
</td>
<td class="nump">2,673<span></span>
</td>
<td class="nump">2,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember', window );">Cardiac &amp; Vascular Group | Coronary &amp; Structural Heart</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">831<span></span>
</td>
<td class="nump">955<span></span>
</td>
<td class="nump">1,611<span></span>
</td>
<td class="nump">1,896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember', window );">Cardiac &amp; Vascular Group | Aortic, Peripheral, &amp; Venous</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">468<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="nump">873<span></span>
</td>
<td class="nump">942<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember', window );">Minimally Invasive Therapies Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,285<span></span>
</td>
<td class="nump">2,142<span></span>
</td>
<td class="nump">4,086<span></span>
</td>
<td class="nump">4,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember', window );">Minimally Invasive Therapies Group | Surgical Innovations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,393<span></span>
</td>
<td class="nump">1,454<span></span>
</td>
<td class="nump">2,473<span></span>
</td>
<td class="nump">2,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember', window );">Minimally Invasive Therapies Group | Respiratory, Gastrointestinal, &amp; Renal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">893<span></span>
</td>
<td class="nump">688<span></span>
</td>
<td class="nump">1,613<span></span>
</td>
<td class="nump">1,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember', window );">Restorative Therapies Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,063<span></span>
</td>
<td class="nump">2,112<span></span>
</td>
<td class="nump">3,774<span></span>
</td>
<td class="nump">4,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember', window );">Restorative Therapies Group | Cranial &amp; Spinal Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
<td class="nump">2,015<span></span>
</td>
<td class="nump">2,167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember', window );">Restorative Therapies Group | Specialty Therapies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">581<span></span>
</td>
<td class="nump">575<span></span>
</td>
<td class="nump">1,035<span></span>
</td>
<td class="nump">1,138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember', window );">Restorative Therapies Group | Neuromodulation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">411<span></span>
</td>
<td class="nump">420<span></span>
</td>
<td class="nump">725<span></span>
</td>
<td class="nump">818<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 574<span></span>
</td>
<td class="nump">$ 596<span></span>
</td>
<td class="nump">$ 1,136<span></span>
</td>
<td class="nump">$ 1,188<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_CardiacRhythmandHeartFailureDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_CardiacRhythmandHeartFailureDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_CoronaryandStructuralHeartDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_CoronaryandStructuralHeartDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_AorticPeripheralandVenousDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_AorticPeripheralandVenousDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_SurgicalInnovationsDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_SurgicalInnovationsDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_RespiratoryGastrointestinalandRenalDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_RespiratoryGastrointestinalandRenalDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_CranialAndSpinalTechnologiesDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_CranialAndSpinalTechnologiesDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_SpecialtyTherapiesDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_SpecialtyTherapiesDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_NeuromodulationDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_NeuromodulationDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460332518072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 7,647<span></span>
</td>
<td class="nump">$ 7,706<span></span>
</td>
<td class="nump">$ 14,154<span></span>
</td>
<td class="nump">$ 15,199<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4,054<span></span>
</td>
<td class="nump">4,129<span></span>
</td>
<td class="nump">7,405<span></span>
</td>
<td class="nump">8,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember', window );">Non-U.S. Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,446<span></span>
</td>
<td class="nump">2,315<span></span>
</td>
<td class="nump">4,621<span></span>
</td>
<td class="nump">4,692<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember', window );">Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,147<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
<td class="nump">2,128<span></span>
</td>
<td class="nump">2,460<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember', window );">Cardiac &amp; Vascular Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,725<span></span>
</td>
<td class="nump">2,855<span></span>
</td>
<td class="nump">5,158<span></span>
</td>
<td class="nump">5,645<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember', window );">Cardiac &amp; Vascular Group | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,377<span></span>
</td>
<td class="nump">1,455<span></span>
</td>
<td class="nump">2,582<span></span>
</td>
<td class="nump">2,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember', window );">Cardiac &amp; Vascular Group | Non-U.S. Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">945<span></span>
</td>
<td class="nump">890<span></span>
</td>
<td class="nump">1,798<span></span>
</td>
<td class="nump">1,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember', window );">Cardiac &amp; Vascular Group | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">510<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember', window );">Minimally Invasive Therapies Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,285<span></span>
</td>
<td class="nump">2,142<span></span>
</td>
<td class="nump">4,086<span></span>
</td>
<td class="nump">4,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember', window );">Minimally Invasive Therapies Group | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">996<span></span>
</td>
<td class="nump">922<span></span>
</td>
<td class="nump">1,718<span></span>
</td>
<td class="nump">1,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember', window );">Minimally Invasive Therapies Group | Non-U.S. Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">837<span></span>
</td>
<td class="nump">782<span></span>
</td>
<td class="nump">1,556<span></span>
</td>
<td class="nump">1,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember', window );">Minimally Invasive Therapies Group | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="nump">811<span></span>
</td>
<td class="nump">834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember', window );">Restorative Therapies Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,063<span></span>
</td>
<td class="nump">2,112<span></span>
</td>
<td class="nump">3,774<span></span>
</td>
<td class="nump">4,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember', window );">Restorative Therapies Group | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,397<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
<td class="nump">2,533<span></span>
</td>
<td class="nump">2,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember', window );">Restorative Therapies Group | Non-U.S. Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">426<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">802<span></span>
</td>
<td class="nump">842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember', window );">Restorative Therapies Group | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="nump">439<span></span>
</td>
<td class="nump">504<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="nump">1,136<span></span>
</td>
<td class="nump">1,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes Group | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="nump">618<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes Group | Non-U.S. Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">465<span></span>
</td>
<td class="nump">457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes Group | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460416363704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 317<span></span>
</td>
<td class="nump">$ 303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was previously included in deferred revenue</a></td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Estimated revenue expected to be recognized in future periods related to unsatisfied performance obligations</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming', window );">Period over which remaining performance obligations are expected to be recognized as revenue</a></td>
<td class="text">four years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember', window );">Other accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent', window );">Rebate obligations</a></td>
<td class="nump">$ 955<span></span>
</td>
<td class="nump">706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember', window );">Reduction of accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent', window );">Rebate obligations</a></td>
<td class="nump">464<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 92<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121551570&amp;loc=SL49130611-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePerformanceObligationDescriptionOfTiming</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460331757960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
<th class="th"><div>Jul. 26, 2019</div></th>
<th class="th"><div>Apr. 26, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 41,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_BusinessAcquisitionPurchasePriceContingentConsideration', window );">Purchase price contingent consideration</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod', window );">Gain related to change in amounts accrued for certain contingent liabilities for recent acquisition</a></td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">461<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="nump">461<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember', window );">Other accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_AllBusinessAcquisitionsMember', window );">All Business Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="nump">539<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="nump">539<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill', window );">Total assets acquired</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">324<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="nump">324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">381<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_BusinessAcquisitionPurchasePriceContingentConsideration', window );">Purchase price contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_AllBusinessAcquisitionsMember', window );">All Business Acquisitions | Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
<td class="nump">$ 139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_AllBusinessAcquisitionsMember', window );">All Business Acquisitions | Technology-Based Intangible Assets | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_AllBusinessAcquisitionsMember', window );">All Business Acquisitions | Technology-Based Intangible Assets | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_AllBusinessAcquisitionsMember', window );">All Business Acquisitions | Customer-Related Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_AllBusinessAcquisitionsMember', window );">All Business Acquisitions | Customer-Related Intangible Assets | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_AllBusinessAcquisitionsMember', window );">All Business Acquisitions | Customer-Related Intangible Assets | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_BusinessAcquisitionPurchasePriceContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contingent consideration arrangement resulting from business combinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_BusinessAcquisitionPurchasePriceContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Including Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mdt_AllBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mdt_AllBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460331323480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Reconciliation of Beginning and Ending Balances of Contingent Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward', window );"><strong>Reconciliation of Beginning and Ending Balances of Contingent Milestone Payments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance</a></td>
<td class="nump">$ 297<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_BusinessAcquisitionPurchasePriceContingentConsideration', window );">Purchase price contingent consideration</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment', window );">Payments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value</a></td>
<td class="nump">7<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="nump">$ 461<span></span>
</td>
<td class="nump">$ 260<span></span>
</td>
<td class="nump">$ 461<span></span>
</td>
<td class="nump">$ 260<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent milestone payments in business acquisition transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_BusinessAcquisitionContingentConsiderationMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_BusinessAcquisitionPurchasePriceContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contingent consideration arrangement resulting from business combinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_BusinessAcquisitionPurchasePriceContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460447285224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Fair Value Measurement, Contingent Consideration, Significant Unobservable Inputs (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 24, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 25, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 26, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 26, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Inputs, Liabilities, Quantitative Information [Line Items] (Deprecated 2018-01-31)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, fair value</a></td>
<td class="nump">$ 461<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
<td class="nump">$ 260<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember', window );">Revenue and other performance-based payments | Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Inputs, Liabilities, Quantitative Information [Line Items] (Deprecated 2018-01-31)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, fair value</a></td>
<td class="nump">$ 203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember', window );">Revenue and other performance-based payments | Minimum | Recurring | Level 3 | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember', window );">Revenue and other performance-based payments | Minimum | Recurring | Level 3 | Probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember', window );">Revenue and other performance-based payments | Maximum | Recurring | Level 3 | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember', window );">Revenue and other performance-based payments | Maximum | Recurring | Level 3 | Probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember', window );">Revenue and other performance-based payments | Weighted Average | Recurring | Level 3 | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember', window );">Revenue and other performance-based payments | Weighted Average | Recurring | Level 3 | Probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember', window );">Product development and other milestone-based payments | Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Inputs, Liabilities, Quantitative Information [Line Items] (Deprecated 2018-01-31)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, fair value</a></td>
<td class="nump">$ 258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember', window );">Product development and other milestone-based payments | Recurring | Level 3 | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember', window );">Product development and other milestone-based payments | Minimum | Recurring | Level 3 | Probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember', window );">Product development and other milestone-based payments | Maximum | Recurring | Level 3 | Probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember', window );">Product development and other milestone-based payments | Weighted Average | Recurring | Level 3 | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember', window );">Product development and other milestone-based payments | Weighted Average | Recurring | Level 3 | Probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsQuantitativeInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsQuantitativeInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=mdt_MeasurementInputProbabilityofPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=mdt_MeasurementInputProbabilityofPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460330735864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits', window );">Incremental expense related to acceptance of voluntary early retirement packages</a></td>
<td class="nump">$ 97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember', window );">Enterprise Excellence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="nump">$ 231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Accrual adjustments</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember', window );">Enterprise Excellence | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember', window );">Enterprise Excellence | Selling, general, and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember', window );">Enterprise Excellence | Minimum | Pre-tax exit and disposal costs and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected cost</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember', window );">Enterprise Excellence | Maximum | Pre-tax exit and disposal costs and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected cost</a></td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember', window );">Simplification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Accrual adjustments</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment', window );">Charges, including incremental defined benefit pension and post-retirement expenses for employees that accepted voluntary early retirement packages</a></td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits', window );">Incremental expense related to acceptance of voluntary early retirement packages</a></td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember', window );">Simplification | Selling, general, and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember', window );">Simplification | Minimum | Pre-tax exit and disposal costs and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected cost</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember', window );">Simplification | Maximum | Pre-tax exit and disposal costs and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected cost</a></td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit And Contribution Plan, Cost of Providing Special and Contractual Termination Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges, Including Net Periodic Benefit Credit, Loss Due to Curtailment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mdt_PreTaxExitandDisposalCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mdt_PreTaxExitandDisposalCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460328568872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring - Activity Related to Restructuring Programs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember', window );">Enterprise Excellence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="nump">$ 231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Accrual adjustments</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember', window );">Enterprise Excellence | Employee Termination Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Accrual adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember', window );">Enterprise Excellence | Associated Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Accrual adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember', window );">Enterprise Excellence | Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Accrual adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember', window );">Simplification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Accrual adjustments</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember', window );">Simplification | Employee Termination Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Accrual adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember', window );">Simplification | Associated Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Accrual adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mdt_AssociatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mdt_AssociatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460332597160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Investments by Category and Related Balance Sheet Classification (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">$ 6,870<span></span>
</td>
<td class="nump">$ 6,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(141)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">7,007<span></span>
</td>
<td class="nump">6,841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Held-to-maturity securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Fair Value</a></td>
<td class="nump">886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Total debt securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost', window );">Cost</a></td>
<td class="nump">7,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue', window );">Fair Value</a></td>
<td class="nump">7,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_InvestmentsMember', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">6,971<span></span>
</td>
<td class="nump">6,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Total debt securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue', window );">Fair Value</a></td>
<td class="nump">7,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Total debt securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue', window );">Fair Value</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">6,337<span></span>
</td>
<td class="nump">6,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">6,435<span></span>
</td>
<td class="nump">6,219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">6,435<span></span>
</td>
<td class="nump">6,219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">4,234<span></span>
</td>
<td class="nump">4,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">4,326<span></span>
</td>
<td class="nump">4,261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">4,326<span></span>
</td>
<td class="nump">4,261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">497<span></span>
</td>
<td class="nump">542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">536<span></span>
</td>
<td class="nump">589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities | Level 1 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">536<span></span>
</td>
<td class="nump">589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities | Level 1 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities | Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember', window );">Mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">661<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">669<span></span>
</td>
<td class="nump">697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember', window );">Mortgage-backed securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">669<span></span>
</td>
<td class="nump">697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember', window );">Mortgage-backed securities | Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember', window );">Non-U.S. government and agency securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember', window );">Non-U.S. government and agency securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember', window );">Non-U.S. government and agency securities | Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Other asset-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">518<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">515<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Other asset-backed securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">515<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Other asset-backed securities | Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember', window );">Auction rate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember', window );">Auction rate securities | Level 3 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember', window );">Auction rate securities | Level 3 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember', window );">Time deposit | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Held-to-maturity securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Cost</a></td>
<td class="nump">886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Fair Value</a></td>
<td class="nump">886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember', window );">Time deposit | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Held-to-maturity securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Fair Value</a></td>
<td class="nump">886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember', window );">Time deposit | Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Held-to-maturity securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Held-To-Maturity, Accumulated Unrealized Gain, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Held-To-Maturity, Accumulated Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Held To Maturity, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Held-To-Maturity, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesClassifiedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_InvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_InvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460331636104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Available-For-Sale Securities in Continuous Unrealized Loss Position (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair Value</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 1,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">More than 12 months, Fair Value</a></td>
<td class="nump">1,520<span></span>
</td>
<td class="nump">4,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">More than 12 months, Unrealized Losses</a></td>
<td class="num">(56)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">More than 12 months, Fair Value</a></td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">More than 12 months, Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair Value</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">More than 12 months, Fair Value</a></td>
<td class="nump">858<span></span>
</td>
<td class="nump">2,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">More than 12 months, Unrealized Losses</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(88)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember', window );">Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair Value</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">More than 12 months, Fair Value</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">More than 12 months, Unrealized Losses</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair Value</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">More than 12 months, Fair Value</a></td>
<td class="nump">347<span></span>
</td>
<td class="nump">463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">More than 12 months, Unrealized Losses</a></td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember', window );">Auction rate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">More than 12 months, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">More than 12 months, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460332642792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Activity Related to the Company's Investment Portfolio and Debt Securities Contractual Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract', window );"><strong>Activities Related to Debt Securities Portfolio</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales</a></td>
<td class="nump">$ 1,932<span></span>
</td>
<td class="nump">$ 1,691<span></span>
</td>
<td class="nump">$ 4,335<span></span>
</td>
<td class="nump">$ 3,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Gross realized gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Gross realized losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Available-For-Sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less</a></td>
<td class="nump">1,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">3,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Due after five years through ten years</a></td>
<td class="nump">1,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Due after ten years</a></td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">7,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract', window );"><strong>Held-To-Maturity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less</a></td>
<td class="nump">886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Due after five years through ten years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Due after ten years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Total</a></td>
<td class="nump">$ 886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=SL120269825-111563<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=SL120269825-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62586-112803<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=SL120269825-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=SL120269825-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460419487528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld', window );">Debt securities in credit loss position</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold', window );">Reductions for available-for-sale or held-to-maturity securities sold</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems', window );"><strong>Gain (Loss) on Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment charges incurred</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mdt_EquityInvestmentsMember', window );">Equity Securities and Other Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems', window );"><strong>Gain (Loss) on Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net gains (losses) recognized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Net unrealized gains (losses) on equity and other investments still held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment charges incurred</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of credit losses recognized in earnings related to debt securities held for which a portion of an other than temporary impairment (OTTI) was recognized in other comprehensive income (a component of shareholders' equity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=SL6284393-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=SL6284393-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents reductions in the cumulative amount of credit losses recognized in earnings for an other than temporary impairment (OTTI) of a debt security because of the sale of impaired securities during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=SL6284393-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=mdt_EquityInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=mdt_EquityInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460324243672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Summary of Equity and Other Investments (Details) - Other Assets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments with readily determinable fair value (marketable equity securities)</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Investments without readily determinable fair values</a></td>
<td class="nump">478<span></span>
</td>
<td class="nump">391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method and other investments</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments', window );">Total equity and other investments</a></td>
<td class="nump">$ 577<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460331367480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Activity Related to the Company's Investment Portfolio, Equity and Other Investments (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Proceeds from sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,337,000,000<span></span>
</td>
<td class="nump">$ 3,260,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment losses recognized</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mdt_EquityInvestmentsMember', window );">Equity and Other Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Proceeds from sales</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_GainonInvestments', window );">Gross gains</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_LossonInvestments', window );">Gross losses</a></td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment losses recognized</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (2,000,000)<span></span>
</td>
<td class="num">$ (2,000,000)<span></span>
</td>
<td class="num">$ (3,000,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_GainonInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_GainonInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_LossonInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss on Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_LossonInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=mdt_EquityInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=mdt_EquityInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460327343784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 12, 2020</div></th>
<th class="th">
<div>May 12, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 26, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 25, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>EUR (&#8364;) </div>
<div>tranche</div>
</th>
<th class="th">
<div>May 12, 2020 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Apr. 24, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>EUR (&#8364;) </div>
<div>tranche</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Cash proceeds, net of discounts and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,172,000,000<span></span>
</td>
<td class="nump">$ 5,568,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308,000,000<span></span>
</td>
<td class="nump">$ 406,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Financial Instruments Not Measured at Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Term Loan Agreements | Medtronic Luxco</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAbstract', window );"><strong>Line of Credit Facility</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 300,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MediumtermNotesAbstract', window );"><strong>Term Loan Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DebtInstrumentExtensionOptionTermOfExtension', window );">Additional extension option, term of extension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Term Loan Agreements | Medtronic Luxco | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MediumtermNotesAbstract', window );"><strong>Term Loan Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DebtInstrumentExtensionOptionTermOfExtension', window );">Additional extension option, term of extension</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Term Loan Agreements | Medtronic Luxco | TIBOR Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MediumtermNotesAbstract', window );"><strong>Term Loan Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin added to variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_A2015CommercialPaperProgramMember', window );">Commercial Paper Program | Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowingsAbstract', window );"><strong>Commercial Paper</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_CommercialPaperMaximumBorrowingCapacity', window );">Commercial paper, maximum borrowing amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper, amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_AmendedandRestatedRevolvingCreditAgreementMember', window );">Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAbstract', window );"><strong>Line of Credit Facility</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit, maximum capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit, amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Member', window );">Senior Notes 2019 | Senior notes | Medtronic Luxco</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DebtInstrumentNumberofTranches', window );">Number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,000,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Cash proceeds, net of discounts and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember', window );">Medtronic Inc, CIFSA, and Medtronic Luxco Senior Notes | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 308,000,000<span></span>
</td>
<td class="nump">$ 413,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_MedtronicIncAndCIFSASeniorNotesMember', window );">Medtronic Inc and CIFSA Senior Notes | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_MedtronicLuxcoSeniorNotesMember', window );">Medtronic Luxco Senior Notes | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_MedtronicLuxcoSeniorNotesMember', window );">Medtronic Luxco Senior Notes | Senior notes | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Total consideration | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Member', window );">Senior Notes 2020 | Senior notes | Medtronic Luxco</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DebtInstrumentNumberofTranches', window );">Number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Cash proceeds, net of discounts and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_CommercialPaperMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial Paper, Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_CommercialPaperMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DebtInstrumentExtensionOptionTermOfExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Option, Term Of Extension</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DebtInstrumentExtensionOptionTermOfExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DebtInstrumentNumberofTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number of Tranches</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DebtInstrumentNumberofTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MediumtermNotesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MediumtermNotesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mdt_MedtronicLuxcoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mdt_MedtronicLuxcoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=mdt_TokyoInterBankOfferedRateTIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=mdt_TokyoInterBankOfferedRateTIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_A2015CommercialPaperProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_A2015CommercialPaperProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_AmendedandRestatedRevolvingCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_AmendedandRestatedRevolvingCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_MedtronicIncAndCIFSASeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_MedtronicIncAndCIFSASeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_MedtronicLuxcoSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_MedtronicLuxcoSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460327015608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements - Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current debt obligations</a></td>
<td class="nump">$ 4,041<span></span>
</td>
<td class="nump">$ 2,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligations</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="num">(133)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Debt discount, net</a></td>
<td class="num">(72)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">$ 25,967<span></span>
</td>
<td class="nump">22,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 3.150 percent seven-year 2015 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,534<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 3.200 percent ten-year 2012 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 0.000 percent four-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 886<span></span>
</td>
<td class="nump">815<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 0.375 percent four-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,772<span></span>
</td>
<td class="nump">1,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 0.000 percent two-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,477<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 2.750 percent ten-year 2013 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">530<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 2.950 percent ten-year 2013 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 3.625 percent ten-year 2014 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 3.500 percent ten-year 2015 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,890<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 0.250 percent seven-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 0.000 percent five-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.125 percent eight-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,772<span></span>
</td>
<td class="nump">1,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 3.350 percent ten-year 2017 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 368<span></span>
</td>
<td class="nump">368<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 0.375 percent eight-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.625 percent twelve-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.000 percent thirteen-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 0.750 percent twelve-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 4.375 percent twenty-year 2015 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,932<span></span>
</td>
<td class="nump">1,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 6.550 percent thirty-year 2007 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">6.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 253<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 2.250 percent twenty-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 6.500 percent thirty-year 2009 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 158<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.500 percent twenty-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 5.550 percent thirty-year 2010 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">5.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 224<span></span>
</td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.375 percent twenty-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 4.500 percent thirty-year 2012 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 4.000 percent thirty-year 2013 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 305<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 4.625 percent thirty-year 2014 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 127<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 4.625 percent thirty-year 2015 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,813<span></span>
</td>
<td class="nump">1,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.750 percent thirty-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.625 percent thirty-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Bank borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2012Due2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2012Due2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20230.000PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20230.000PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20230.375PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20230.375PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2013Due2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2013Due2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2013Due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2013Due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2014Due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2014Due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2017Due2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2017Due2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20311.625PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20311.625PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2007Due2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2007Due2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20392.250PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20392.250PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2009Due2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2009Due2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2010Due2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2010Due2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2012Due2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2012Due2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2013Due2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2013Due2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2014Due2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2014Due2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due2051Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due2051Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460330119160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 25, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 25, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 24, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>JPY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">After-tax net unrealized gains (losses) associated with cash flow hedging instruments recorded in AOCI</a></td>
<td class="num">$ (129,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (129,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 266,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Cash flow hedge unrealized losses to be reclassified over the next 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax', window );">After-tax net unrealized gains (losses) associated with net investment hedging instruments recorded in AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths', window );">Net investment hedge unrealized gains or losses to be reclassified over the next twelve months, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet', window );">Gains (losses) on firm commitments that no longer qualify as net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">18,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">10,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Derivatives designated as hedging instruments | Cash flow hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">7,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1', window );">Maximum remaining maturity of foreign currency derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Derivatives designated as hedging instruments | Net investment hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 16,000,000,000.0<span></span>
</td>
<td class="nump">&#165; 300,000,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Derivatives designated as hedging instruments | Net investment hedging | Euro-denominated Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">18,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Derivatives designated as hedging instruments | Net investment hedging | Japanese Yen-denominated Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">2,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember', window );">Total return swaps | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">$ 197,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) from Hedged Firm Commitment Not Qualifying as Net Investment Hedge, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Investment Hedge Gain (Loss) to be Reclassified Within Twelve Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss), net of tax as of the balance sheet date, related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrealized Gain (Loss) on Net Investment Hedges, Accumulated Other Comprehensive Income (Loss), Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460337734840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - Derivative (Gains) Losses Not Designated as Hedging Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Total</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other operating expense, net | Currency exchange rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Total</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other operating expense, net | Total return swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Total</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325876616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in AOCI, Cash Flow Hedges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Cash flow hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in AOCI, Cash flow hedges</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="num">$ (76)<span></span>
</td>
<td class="nump">$ 451<span></span>
</td>
<td class="num">$ (103)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460326218760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - Amount of (Gains) Losses Recognized in Consolidated Statements of Income, Cash Flow Hedges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating expense, net</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging | Currency exchange rate contracts | Other operating expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Amount of gain reclassified from AOCI into income</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (68)<span></span>
</td>
<td class="num">$ (55)<span></span>
</td>
<td class="num">$ (125)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460329848936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in Income, Net Investment Hedges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Other operating expense, net | Net investment hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">Recognized in Income, Net investment hedges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325622072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in AOCI, Net Investment Hedges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax', window );">Recognized in AOCI, Net investment hedges</a></td>
<td class="nump">$ 164<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
<td class="nump">$ 1,276<span></span>
</td>
<td class="num">$ (152)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Net investment hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax', window );">Recognized in AOCI, Net investment hedges</a></td>
<td class="nump">$ 164<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
<td class="nump">$ 1,276<span></span>
</td>
<td class="num">$ (152)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460333737416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets, Fair Value</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities, Fair Value</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets, Fair Value</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities, Fair Value</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember', window );">Total return swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets, Fair Value</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets, Fair Value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets, Fair Value</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities, Fair Value</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Currency exchange rate contracts | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets, Fair Value</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Currency exchange rate contracts | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets, Fair Value</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Currency exchange rate contracts | Other accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities, Fair Value</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Currency exchange rate contracts | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities, Fair Value</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets, Fair Value</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities, Fair Value</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Currency exchange rate contracts | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets, Fair Value</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Currency exchange rate contracts | Other accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities, Fair Value</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Total return swaps | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets, Fair Value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Total return swaps | Other accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Cross-currency interest rate contracts | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets, Fair Value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Cross-currency interest rate contracts | Other accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities, Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460330529400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460331955288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Derivative assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Gross Amount of Recorded Assets (Liabilities)</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction', window );">Gross Amount Not Offset on the Balance Sheet, Financial Instruments</a></td>
<td class="num">(80)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCollateralObligationToReturnCash', window );">Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Derivative liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Gross Amount of Recorded Assets (Liabilities)</a></td>
<td class="num">(201)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction', window );">Gross Amount Not Offset on the Balance Sheet, Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCollateralRightToReclaimCash', window );">Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DerivativeAssetLiabilityAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability', window );">Gross Amount of Recorded Assets (Liabilities)</a></td>
<td class="num">(114)<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction', window );">Gross Amount Not Offset on the Balance Sheet, Financial Instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash', window );">Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)</a></td>
<td class="nump">17<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet', window );">Net Amount</a></td>
<td class="num">(97)<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Derivative assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Gross Amount of Recorded Assets (Liabilities)</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction', window );">Gross Amount Not Offset on the Balance Sheet, Financial Instruments</a></td>
<td class="num">(80)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCollateralObligationToReturnCash', window );">Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Derivative liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Gross Amount of Recorded Assets (Liabilities)</a></td>
<td class="num">(201)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction', window );">Gross Amount Not Offset on the Balance Sheet, Financial Instruments</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCollateralRightToReclaimCash', window );">Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="num">(104)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Derivative assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Gross Amount of Recorded Assets (Liabilities)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction', window );">Gross Amount Not Offset on the Balance Sheet, Financial Instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCollateralObligationToReturnCash', window );">Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember', window );">Total return swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Derivative assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Gross Amount of Recorded Assets (Liabilities)</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction', window );">Gross Amount Not Offset on the Balance Sheet, Financial Instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCollateralObligationToReturnCash', window );">Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Derivative liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Gross Amount of Recorded Assets (Liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction', window );">Gross Amount Not Offset on the Balance Sheet, Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCollateralRightToReclaimCash', window );">Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DerivativeAssetLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Asset (Liability) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DerivativeAssetLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Asset (Liability), Fair Value, Gross Asset (Liability)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Assets and Liabilities, Net, Not Offset, Policy Election Deduction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCollateralObligationToReturnCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41678-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCollateralObligationToReturnCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCollateralRightToReclaimCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41678-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCollateralRightToReclaimCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount as of the balance sheet date of the fair value of derivative assets and derivative liabilities that in accordance with the entity's accounting policy were offset against collateral under a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41678-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effects of master netting arrangements, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset offset against an obligation to return collateral. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41678-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effects of master netting arrangements, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset offset against the right to receive collateral. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41678-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325918664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 2,944<span></span>
</td>
<td class="nump">$ 2,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in-process</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">893<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 4,484<span></span>
</td>
<td class="nump">$ 4,229<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460435650104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 39,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill as a result of acquisitions</a></td>
<td class="nump">381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation and other</a></td>
<td class="nump">987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">41,212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember', window );">Cardiac &amp; Vascular Group</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">6,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill as a result of acquisitions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation and other</a></td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">6,926<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember', window );">Minimally Invasive Therapies Group</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">20,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill as a result of acquisitions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation and other</a></td>
<td class="nump">772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">20,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember', window );">Restorative Therapies Group</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">10,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill as a result of acquisitions</a></td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation and other</a></td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">11,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes Group</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">1,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill as a result of acquisitions</a></td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation and other</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 2,261<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460525347896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 26, 2018</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Definite-lived intangible asset charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of indefinite-lived intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 443,000,000<span></span>
</td>
<td class="nump">$ 441,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 884,000,000<span></span>
</td>
<td class="nump">$ 881,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460435647496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Carrying Amount and Accumulated Amortization of Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 28,605<span></span>
</td>
<td class="nump">$ 28,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(10,633)<span></span>
</td>
<td class="num">(9,704)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">IPR&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross Carrying Amount, Indefinite-lived</a></td>
<td class="nump">440<span></span>
</td>
<td class="nump">523<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">17,017<span></span>
</td>
<td class="nump">16,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(5,567)<span></span>
</td>
<td class="num">(5,065)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdt_PurchasedTechnologyAndPatentsMember', window );">Purchased technology and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">11,041<span></span>
</td>
<td class="nump">10,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(4,767)<span></span>
</td>
<td class="num">(4,354)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(241)<span></span>
</td>
<td class="num">(232)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">$ (58)<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdt_PurchasedTechnologyAndPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdt_PurchasedTechnologyAndPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460331513816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Estimated Future Aggregate Amortization Expense of Amortizable Intangible Assets (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remaining 2021</a></td>
<td class="nump">$ 888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">1,738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">1,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">1,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">1,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">$ 1,604<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460327181880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Apr. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">5.90%<span></span>
</td>
<td class="num">(6.00%)<span></span>
</td>
<td class="nump">11.20%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions', window );">Certain tax adjustments, provision (benefit)</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">$ (251)<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="num">$ (281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty', window );">Benefit associated with finalization of intercompany sale of intellectual property and establishment of deferred tax asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Recognition of previously deferred tax benefit from intercompany intellectual property transactions</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DeferredTaxAssetsAmortizationPeriod', window );">Deferred tax asset amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization', window );">Cost associated with amortization of previously established deferred tax assets from intercompany intellectual property transactions</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign', window );">Benefit related to tax legislative changes in Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit', window );">Net benefit related to measurement period adjustment related to U.S. Tax Reform</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued gross interest and penalties</a></td>
<td class="nump">251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Gross unrecognized tax benefits recorded as noncurrent liability</a></td>
<td class="nump">$ 940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember', window );">Amortizable Asset Created for Swiss Federal Income Tax Purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Period over which amortization asset will be amortized and deducted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DeferredTaxAssetsAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Amortization Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DeferredTaxAssetsAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Expense (Benefit) Associated With Sale of Intellectual Property</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible amortization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in foreign income tax contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingenciesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121573983&amp;loc=d3e28511-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121573983&amp;loc=d3e28446-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2A<br> -Subparagraph (SAB Topic 5.EE.Q2(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=SL116722634-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460421235848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Schedule of Basic and Diluted Earnings (Loss) Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_EarningsPerShareReconciliationNumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to ordinary shareholders</a></td>
<td class="nump">$ 489<span></span>
</td>
<td class="nump">$ 1,364<span></span>
</td>
<td class="nump">$ 976<span></span>
</td>
<td class="nump">$ 2,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_EarningsPerShareReconciliationDenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic - weighted average shares outstanding (shares)</a></td>
<td class="nump">1,344.4<span></span>
</td>
<td class="nump">1,340.8<span></span>
</td>
<td class="nump">1,343.1<span></span>
</td>
<td class="nump">1,340.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Employee stock options (shares)</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends', window );">Employee restricted stock units (shares)</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares', window );">Other (shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted - weighted average shares outstanding (shares)</a></td>
<td class="nump">1,352.1<span></span>
</td>
<td class="nump">1,351.4<span></span>
</td>
<td class="nump">1,351.1<span></span>
</td>
<td class="nump">1,351.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (usd per share)</a></td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="nump">$ 0.73<span></span>
</td>
<td class="nump">$ 1.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (usd per share)</a></td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 1.01<span></span>
</td>
<td class="nump">$ 0.72<span></span>
</td>
<td class="nump">$ 1.65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_EarningsPerShareReconciliationDenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_EarningsPerShareReconciliationDenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_EarningsPerShareReconciliationNumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_EarningsPerShareReconciliationNumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental Common Shares Attributable to Dilutive Effect of Other Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares included in diluted EPS for potentially dilutive effect of nonvested equity-based payment award containing forfeitable rights to dividends or dividend equivalents, whether paid or unpaid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 68B<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5498026-109256<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460329856456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Narrative (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (shares)</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460331614344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 140<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
<td class="nump">$ 169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefits</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Total stock-based compensation expense, net of tax</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general, and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mdt_EmployeesStockPurchasePlanMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mdt_EmployeesStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mdt_EmployeesStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460338731016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefit Plans (Details) - Pension plans - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod', window );">Special termination benefits</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net actuarial loss</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod', window );">Special termination benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net actuarial loss</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost of providing special or contractual termination benefits payable from defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460337642728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefit Plans - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits', window );">Incremental expense related to acceptance of voluntary early retirement packages</a></td>
<td class="nump">$ 97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits', window );">Incremental expense related to acceptance of voluntary early retirement packages, amount related to defined contribution plans</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits', window );">Incremental expense related to acceptance of voluntary early retirement packages, amount related to cash payments and administrative fees</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States | Pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod', window );">Incremental expense related to acceptance of voluntary early retirement packages, amount related to defined benefit plans</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States | Post-retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod', window );">Incremental expense related to acceptance of voluntary early retirement packages, amount related to defined benefit plans</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit And Contribution Plan, Cash Payments And Administrative Expense Related To Providing Special And Contractual Termination Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit And Contribution Plan, Cost of Providing Special and Contractual Termination Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan, Cost of Providing Special and Contractual Termination Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost of providing special or contractual termination benefits payable from defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460332772392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss - Changes in AOCI (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Jul. 26, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 50,443,000,000<span></span>
</td>
<td class="nump">$ 50,872,000,000<span></span>
</td>
<td class="nump">$ 50,497,000,000<span></span>
</td>
<td class="nump">$ 50,212,000,000<span></span>
</td>
<td class="nump">$ 50,872,000,000<span></span>
</td>
<td class="nump">$ 50,212,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(60,000,000)<span></span>
</td>
<td class="num">(217,000,000)<span></span>
</td>
<td class="num">(127,000,000)<span></span>
</td>
<td class="nump">227,000,000<span></span>
</td>
<td class="num">(277,000,000)<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">50,316,000,000<span></span>
</td>
<td class="nump">50,443,000,000<span></span>
</td>
<td class="nump">50,719,000,000<span></span>
</td>
<td class="nump">50,497,000,000<span></span>
</td>
<td class="nump">50,316,000,000<span></span>
</td>
<td class="nump">50,719,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total Accumulated Other Comprehensive (Loss) Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(3,782,000,000)<span></span>
</td>
<td class="num">(3,560,000,000)<span></span>
</td>
<td class="num">(2,484,000,000)<span></span>
</td>
<td class="num">(2,711,000,000)<span></span>
</td>
<td class="num">(3,560,000,000)<span></span>
</td>
<td class="num">(2,711,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(280,000,000)<span></span>
</td>
<td class="nump">153,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(53,000,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(61,000,000)<span></span>
</td>
<td class="num">(222,000,000)<span></span>
</td>
<td class="num">(127,000,000)<span></span>
</td>
<td class="nump">227,000,000<span></span>
</td>
<td class="num">(283,000,000)<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(3,843,000,000)<span></span>
</td>
<td class="num">(3,782,000,000)<span></span>
</td>
<td class="num">(2,611,000,000)<span></span>
</td>
<td class="num">(2,484,000,000)<span></span>
</td>
<td class="num">(3,843,000,000)<span></span>
</td>
<td class="num">(2,611,000,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized Gain (Loss) on Investment Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(45,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,000,000<span></span>
</td>
<td class="nump">68,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,000,000<span></span>
</td>
<td class="nump">73,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">113,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,000,000<span></span>
</td>
<td class="nump">28,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other Comprehensive Income (Loss), Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Cumulative Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,210,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,383,000,000)<span></span>
</td>
<td class="num">(2,210,000,000)<span></span>
</td>
<td class="num">(1,383,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,255,000,000<span></span>
</td>
<td class="num">(148,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,255,000,000<span></span>
</td>
<td class="num">(148,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(955,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,531,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(955,000,000)<span></span>
</td>
<td class="num">(1,531,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other Comprehensive Income (Loss), Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember', window );">Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(169,000,000)<span></span>
</td>
<td class="nump">236,000,000<span></span>
</td>
<td class="num">(169,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,276,000,000)<span></span>
</td>
<td class="nump">152,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,276,000,000)<span></span>
</td>
<td class="nump">152,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,040,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,040,000,000)<span></span>
</td>
<td class="num">(17,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other Comprehensive Income (Loss), Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Net Change in Retirement Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,852,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,308,000,000)<span></span>
</td>
<td class="num">(1,852,000,000)<span></span>
</td>
<td class="num">(1,308,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,000,000)<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="nump">26,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,832,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,283,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,832,000,000)<span></span>
</td>
<td class="num">(1,283,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other Comprehensive Income (Loss), Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Unrealized Gain (Loss) on Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 266,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 194,000,000<span></span>
</td>
<td class="nump">266,000,000<span></span>
</td>
<td class="nump">194,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(359,000,000)<span></span>
</td>
<td class="nump">82,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,000,000)<span></span>
</td>
<td class="num">(84,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(395,000,000)<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (129,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 192,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(129,000,000)<span></span>
</td>
<td class="nump">192,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other Comprehensive Income (Loss), Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93,000,000)<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,000,000)<span></span>
</td>
<td class="num">$ (26,000,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460326610520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 04, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Nov. 28, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 14, 2011 </div>
<div>patent</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 25, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($) </div>
<div>landfill </div>
<div>manufacturer </div>
<div>subsidiary </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 25, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 29, 2016 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Apr. 24, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Certain litigation charges, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued litigation charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EnvironmentalRemediationSiteAxis=mdt_OrringtonMaineChemicalManufacturingFacilityMember', window );">Orrington, Maine chemical manufacturing facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_SiteContingencyNumberofLandfillsRequiringRemoval', window );">Number of landfills requiring removal | landfill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_SiteContingencyNumberOfLandfillsRequiringCapping', window );">Number of landfills requiring capping | landfill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mdt_PelvicMeshLitigationMember', window );">Pelvic mesh | Product liability litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_LossContingencyNumberofSubsidiaries', window );">Number of subsidiaries | subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_LossContingencyNumberofManufacturers', window );">Number of manufacturers | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Amount of settlement received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsSettledNumber', window );">Number of claims settled | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of claimants | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mdt_PelvicMeshLitigationMember', window );">Pelvic mesh | Product liability litigation | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsSettledNumber', window );">Number of claims settled | claim</a></td>
<td class="nump">15,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mdt_EthiconPatentInfringementLitigationMember', window );">Ethicon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber', window );">Number of patents allegedly infringed upon | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsFoundNotInfringedNumber', window );">Number of claims dismissed | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mdt_SassoLitigationMember', window );">Sasso</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Approximate amount of verdict returned against the Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_LossContingencyNumberofManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_LossContingencyNumberofManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_LossContingencyNumberofSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Subsidiaries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_LossContingencyNumberofSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_SiteContingencyNumberOfLandfillsRequiringCapping">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Site Contingency, Number of Landfills Requiring Capping</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_SiteContingencyNumberOfLandfillsRequiringCapping</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_SiteContingencyNumberofLandfillsRequiringRemoval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Site Contingency, Number of Landfills Requiring Removal</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_SiteContingencyNumberofLandfillsRequiringRemoval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsSettledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of claims settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsSettledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of another entity's patents that the entity has allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPatentsAllegedlyInfringedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPatentsFoundNotInfringedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of another entity's patents that the entity was found not to have infringed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPatentsFoundNotInfringedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalRemediationSiteAxis=mdt_OrringtonMaineChemicalManufacturingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalRemediationSiteAxis=mdt_OrringtonMaineChemicalManufacturingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mdt_PelvicMeshLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mdt_PelvicMeshLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DamagesFromProductDefectsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DamagesFromProductDefectsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mdt_EthiconPatentInfringementLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mdt_EthiconPatentInfringementLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mdt_SassoLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mdt_SassoLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460335178440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract', window );"><strong>Segment Operating Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating profit</a></td>
<td class="nump">$ 930<span></span>
</td>
<td class="nump">$ 1,351<span></span>
</td>
<td class="nump">$ 1,603<span></span>
</td>
<td class="nump">$ 2,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(470)<span></span>
</td>
<td class="num">(165)<span></span>
</td>
<td class="num">(641)<span></span>
</td>
<td class="num">(774)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="num">(443)<span></span>
</td>
<td class="num">(441)<span></span>
</td>
<td class="num">(884)<span></span>
</td>
<td class="num">(881)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_RestructuringChargesNetofRestructuringReversals', window );">Restructuring and associated costs</a></td>
<td class="num">(97)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Certain litigation charges, net</a></td>
<td class="num">(84)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">1,294<span></span>
</td>
<td class="nump">1,109<span></span>
</td>
<td class="nump">2,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">7,647<span></span>
</td>
<td class="nump">7,706<span></span>
</td>
<td class="nump">14,154<span></span>
</td>
<td class="nump">15,199<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4,054<span></span>
</td>
<td class="nump">4,129<span></span>
</td>
<td class="nump">7,405<span></span>
</td>
<td class="nump">8,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,569<span></span>
</td>
<td class="nump">3,554<span></span>
</td>
<td class="nump">6,700<span></span>
</td>
<td class="nump">7,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mdt_TotalOtherCountriesExcludingIrelandMember', window );">Total other countries, excluding Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">7,623<span></span>
</td>
<td class="nump">7,683<span></span>
</td>
<td class="nump">14,105<span></span>
</td>
<td class="nump">15,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract', window );"><strong>Segment Operating Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating profit</a></td>
<td class="nump">2,704<span></span>
</td>
<td class="nump">2,939<span></span>
</td>
<td class="nump">4,543<span></span>
</td>
<td class="nump">5,706<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract', window );"><strong>Segment Operating Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(470)<span></span>
</td>
<td class="num">(165)<span></span>
</td>
<td class="num">(641)<span></span>
</td>
<td class="num">(774)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Other non-operating income, net</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="num">(443)<span></span>
</td>
<td class="num">(441)<span></span>
</td>
<td class="num">(884)<span></span>
</td>
<td class="num">(881)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_CorporateOverhead', window );">Corporate</a></td>
<td class="num">(460)<span></span>
</td>
<td class="num">(350)<span></span>
</td>
<td class="num">(825)<span></span>
</td>
<td class="num">(657)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_CentralizedDistributionCosts', window );">Centralized distribution costs</a></td>
<td class="num">(542)<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="num">(940)<span></span>
</td>
<td class="num">(768)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_RestructuringChargesNetofRestructuringReversals', window );">Restructuring and associated costs</a></td>
<td class="num">(179)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="num">(307)<span></span>
</td>
<td class="num">(218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related items</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Certain litigation charges, net</a></td>
<td class="num">(84)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_ImpairmentOfInProcessResearchAndDevelopment', window );">IPR&amp;D charges</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit of businesses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_DebtTenderPremiumandOtherCharges', window );">Debt tender premium and other charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_MedicalDeviceRegulations', window );">Medical device regulations</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdt_SpecialChargesGains', window );">Special Charges (Gains)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember', window );">Cardiac &amp; Vascular Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,725<span></span>
</td>
<td class="nump">2,855<span></span>
</td>
<td class="nump">5,158<span></span>
</td>
<td class="nump">5,645<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember', window );">Cardiac &amp; Vascular Group | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,377<span></span>
</td>
<td class="nump">1,455<span></span>
</td>
<td class="nump">2,582<span></span>
</td>
<td class="nump">2,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember', window );">Cardiac &amp; Vascular Group | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract', window );"><strong>Segment Operating Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating profit</a></td>
<td class="nump">992<span></span>
</td>
<td class="nump">1,128<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">2,183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember', window );">Minimally Invasive Therapies Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,285<span></span>
</td>
<td class="nump">2,142<span></span>
</td>
<td class="nump">4,086<span></span>
</td>
<td class="nump">4,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember', window );">Minimally Invasive Therapies Group | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">996<span></span>
</td>
<td class="nump">922<span></span>
</td>
<td class="nump">1,718<span></span>
</td>
<td class="nump">1,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember', window );">Minimally Invasive Therapies Group | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract', window );"><strong>Segment Operating Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating profit</a></td>
<td class="nump">775<span></span>
</td>
<td class="nump">823<span></span>
</td>
<td class="nump">1,230<span></span>
</td>
<td class="nump">1,593<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember', window );">Restorative Therapies Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,063<span></span>
</td>
<td class="nump">2,112<span></span>
</td>
<td class="nump">3,774<span></span>
</td>
<td class="nump">4,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember', window );">Restorative Therapies Group | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,397<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
<td class="nump">2,533<span></span>
</td>
<td class="nump">2,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember', window );">Restorative Therapies Group | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract', window );"><strong>Segment Operating Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating profit</a></td>
<td class="nump">805<span></span>
</td>
<td class="nump">840<span></span>
</td>
<td class="nump">1,327<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="nump">1,136<span></span>
</td>
<td class="nump">1,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes Group | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="nump">618<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes Group | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract', window );"><strong>Segment Operating Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating profit</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 235<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_CentralizedDistributionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Centralized Distribution Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_CentralizedDistributionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_CorporateOverhead">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate overhead expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_CorporateOverhead</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DebtTenderPremiumandOtherCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Tender Premium and Other Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DebtTenderPremiumandOtherCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_ImpairmentOfInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impairment of In Process Research and Development</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_ImpairmentOfInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_MedicalDeviceRegulations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Device Regulations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_MedicalDeviceRegulations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_RestructuringChargesNetofRestructuringReversals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses, net of reversals, associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_RestructuringChargesNetofRestructuringReversals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_SpecialChargesGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Special Charges (Gains)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_SpecialChargesGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mdt_TotalOtherCountriesExcludingIrelandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mdt_TotalOtherCountriesExcludingIrelandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_CardiacAndVascularGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_MinimallyInvasiveTherapiesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_RestorativeTherapiesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140460325766648">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
<td class="text">us-gaap:AccountingStandardsUpdate201602Member<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>104
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MX2I5M\7S)[%^HMI@5*1E_9<]-]?:SHQ%JU(5V;JP=I E>?,_?%E'8D@!<UW
M_*F 8?<4L-8%K/I!&V?U8UV$*CPYEL4SD]756JWZ4,>F+JV?)LFK>KQ34G^;
MZ'+JY**(5KI:% OSF'W,5:)>V57>Y$<5YD-6+D(IRN.YTG>KRLRCM?)9HVSV
M*+OL<Y&K1:E58Q&_+3_7+K=6S8W5,Q,5_!JI(V;Q V9RDW?X.<>+7XCHB'&C
MJ_@;.]8V<E:M9_7H=03KW]?Z&G:E1%;^![F#O;V#7=_!INKF_G4INBH +V[P
MPV^("V?KPAGFXMLJE$K(])7=BF4A59<C7$K)E4 <N5M'[C!'-T(F196V,=/)
MWQDB7&F34G_XY1<B*[RM-V]@G<E0PZY.B_YPX5J/85IB\?*WGGQ49YVIETDJ
MV)=5]B!DEQ=<@W/CT')]-$;!UD\PQ,^M>$I*I<.DV)<PZZP]7.>SB)4L\B1B
MRS1"?!D<8,B'.+O*HT+J.JM;]0&[4SJY6"'9>;'*E7S5_^-.NX3ZM8F9;!';
M&&+R/GQA5[%.M>0QB1K^]%<N(1GXAX;A6[;O8PY-<&@.<7@:Q[KG* \V'UB-
MQZ]Y=^QP29/K@NQ3J*+% ;LNGH5L#G3E2-WW8;8!Z(;U+MOGU9&N]OOB.>^T
MC,M=K![T*896.G0%!@[S__/6I&*G+5SIZB-F"'H% V?YIBU4K;CH#@\N8#D6
M9@0Z P-G>%U+IWH,V]\L<0$#LP'<-W!87Q=1F+*;19%CD"5$;$LW1(]CD#6
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M2%)2HV/26CK/=^4DI5#EILTQ4!J\M7*>3X5*2HG,S=8J>D[1LJ\:,#X8O+5
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MM__5@Q+'\GI[(Y02A_+CGM&4%0:@O]\*H=X>S #-;S"+_P%02P,$%     @
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M?7_S_HLEK\FLL"0+7GRCF<IG@_$ 9&2-=X7ZP@^_DIK0T/A+>2'M+SC4V'
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M!X62Q*7>1L$P[.".CMQ1+_>%;ZO0CT(?P]@&,*Y'F!)<'[[T)V6*"%W__DQ
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M8)_?22N7^POW.>GP^?#Z'U!+ P04    " #A@8-1T+>R8[\"  ""!P  &
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M9YV@V;HHLV7=F'FPC-/-O\%?=4?L-?!U#4C=@$@-*-$TL.L&MM0 VYH&3MW
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MF9@(L$1<1\:=&U!FRYOP!)#UB./+>RP@8[VNZ6Z!$-C,$(^D>0SM_"U302
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MXABSJ2 4\M/*.@1 $D>NZW01C5M$S2,- 3?V<U5V;*"R0XWG+ )L[">N[-@
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MR^9%F:VJAV%\S<HR6U9_+J* <0P7L,_G&1NY^@6_P.ZA.^?_!U!+ P04
M" #A@8-1W[;0>GT"  !J!@  &    'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;(U5;6_;(!#^*\B:M%;:@N,X;5<YEIJ7:9U4+6K4[<.T#\2^Q*@87#@G[;\?
M8,=+JZ3+%P-W]SP/=\ YV2K]: H ),^ED&84%(C5-:4F*Z!DIJ<JD-:S4KID
M:)=Z34VE@>4>5 H:A>$%+1F709IXVURGB:I1< ES34Q=EDR_C$&H[2CH!SO#
M/5\7Z PT32JVA@7@0S77=D4[EIR7( U7DFA8C8*;_O4L=O$^X">'K=F;$Y?)
M4JE'M[C-1T'H-@0",G0,S X;F( 0CLANXZGE##I)!]R?[]B_^MQM+DMF8*+$
M+YYC,0JN I+#BM4"[]7V&[3Y#!U?IH3Q7[)M8B^' <EJ@ZILP78')9?-R)[;
M.NP!^L< 40N(W@+B(X!!"QB<"HA;0'PJ8-@"?.JTR=T7;LJ0I8E66Z)=M&5S
M$U]]C[;UXM+=DP5JZ^46A^E$2:,$SQE"3A9H!WL)T!"U(K.GFN,+.7N0K,ZY
M]9^3LSG3UET \HR)<_*9?""4F,):34+1[L>QTJS5'C?:T1'M ;E3ELR0F<PA
M?XVG-H\NF6B7S#AZE_!'ACTR"#^1*(S" _N9O __7@L+[Q^%3T]0CX8.WO]R
M #X[03VZ. 1_58Q!=[(#SS<XPM<=ICO+!:KLL5 B!VT^[D[V]\W2H+9/]<\[
M<G$G%WNY^(C<E&]X#C(W!%5S(UHY<E:;G%2@&^OYH7O24%]Z:M?9-FG8&UXE
M=+-_>*<$30\&Q:^#9O\):O*G>X^J!+WVW<R03-42FRO96;N&>>/[Q!O[V#;2
MIN_]HVFZ\!W3:RX-$;"RE&'/]2W==+9F@:KR3W>IT#8"/RWLSP"T"[#^E5*X
M6SB![O>2_@502P,$%     @ X8&#4?7\X;C]!@  -!T  !@   !X;"]W;W)K
M<VAE971S+W-H965T."YX;6R5F5UOV[@2AO\*8>Q%"]2U1$JR720!4G>+4V#;
M#1KTG&M:HFV>RJ*7I/.QOWZ'E".ZXD>\-XDD#ZF70\X\0_'J4<B?:L>81D_[
MME/7DYW6AP^SF:IW;$_5>W%@'?RR$7)/-=S*[4P=)*.-;;1O9SC+JMF>\FYR
M<V6?W<F;*W'4+>_8G43JN-]3^?R1M>+Q>I)/7AY\Y]N=-@]F-U<'NF7W3/\X
MW$FXFPV]-'S/.L5%AR3;7$]N\P^KPC:P%O_E[%&=72,SE+40/\W-E^9ZDAE%
MK&6U-EU0^/? 5JQM34^@XZ]3IY/AG:;A^?5+[Y_MX&$P:ZK82K3_XXW>74\6
M$]2P#3VV^KMX_ \[#:@T_=6B5?8O>CS99A-4'Y46^U-C4+#G7?^?/IT<<=8
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M^\&WP;A8#$:_J"H'565RM+?-_V&U]HM'"XCP6G0U;QGJ!KGFN;FKS<(Z2/'
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M>9J \=)!F/H7VF"\W)[_ U!+ P04    " #A@8-1<,YA?!D"  #1!   &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6RM5$UOVS ,_2N$ST/L.ND'"B=
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M(5Z!<*WXFX/6!_#[SA@Z&C[!\!6;_0%02P,$%     @ X8&#4:./2)MH"@
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MNBCQ5L;3^ =EP5>+A6\/_!_&/PY2!(N7%9%?;LSF&?]G,>7 ;.:?PG#^F"P
M>40].N,VF*;4E5*T^PRARR;)-YI>.J&F1R*S$)E$+7LR%VEX1^.+Q12"DFF*
M1$,*A:&(L"RX;7Y)R'D<A)P'23"-(_\_]]9&<>;S9!IR*^0<& "5T.8S%N\4
MQ(8AB_"$YP!#':_J:9&.%+G-H&+(H*K+E'Z-_HM$0PO$&0-@J;&=>:NNQ3\!
ME]PZ_XY>@[$+:60A^]V*PHX$39GD]!WO-S@/BW!QB3ZP4<>4B+?9N2]SEP.:
M+0V\T44!1+X$@$.=I<-"+1#_0#B,. ,C?J27MU+N4@?,SFHM,8H-%>T!J-EW
M<@O1M69SKUL"VE@5:JFIM<L%-A8P)?ES5B/4E3Q_LJ+;15-+LRML4TA[:F/8
MS^&6MB'<I)Q:##G@%);9M)4YX^9'_:DF3>Z80ZV5&J[?I),,1VI+CI'C73#V
M1_!$_\!L6".P;[ZJ[4 <TI*^MY/U]T*O82QV?[*N]5)[$7XW)_/<M1A0-QME
M2(0/YV$R31[)1WIW--U,,/3!@3E*7W%_[P*.#31VN;K@4X0%I7:N!)\]L35G
MV,*60/?!%EJ6_B^V=*9,4-A_IBFO?M!B).B63WL9-$J@V_P9YZ<9LI;+C^W<
MK[T'6(&$9BP40,/P#MTCPP;5;PO/CJJE @.'=2LUQB4@#\R'^C1T3V>Z1(_=
M))_^DHO>86&\ZK9\GW96\I3[%(&B9]8; 31<Z%)C>:P1DN%\0VSDEL]D:CJO
MZ!:QG>=[KFOI@=K1V2IY4)LKJW.4_()+?V<R@-?42SZ%$BL+2\&L._OJ@:27
M/3*YUU)^78WLAMVD%M?0Z'""_>((BS 03OH!?T:D^+"YW-Y9Y7?P1;'$<;K+
M-([N81JP%N.,N <*F VZX0Y;K/N^BVL?/FH+.WN];Q;%_EYOR/##:!KO5O0X
MW?>T^"J?I&]/._X['J7K9I2N=I2N?=O\FB'<TG>DL<;DQ[RO7 (0Q?L4RJV]
MDU56G)L9%=86>QUN8X4J042B0-:=S!6"6ANV/S>:SD!6=(!I<E*V+!F@\NZH
MVJ\)Z,Q?5VW5G[C1^ZK2'E/NZ2%D QVP5 QNO97>&M]4%VH/<)9M0V=2'B)V
M3HI;4\-_-2/L?9[E[=R-RENBV=-?(L(H7]Z(%ZVO<XJ?Q;:;]YZ@K:B4*>YR
M R_=L.)8"AQ&QY%8^#39.2W=BXRW8S#4>H2LY.\0#-3Q\%?3A&^E")V =BN.
M&]J4MHYUK(_O^CQP,OKJ0DLT_K94^T64_P SC Z?K\[\5YO;Z?[;%_8=\% M
M2K4$:7@\2P\\YO4/C=WP-YR%;0!@?+M6$GE$$_!^:6W3/Y" X:/>Z7\!4$L#
M!!0    ( .&!@U'Y'V[+[P@  "T=   9    >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;,59:V_CN!7]*X2;:7< QP_9SF.:!$BRG7:!+AK,='91%/U 2[3-
M75G4DE0<]]?WW$L]8SL9S\Z@'Z)8$N_[W >IJXVQO[J54EX\K=/,7?=6WN?O
MAD,7K]1:NH')588W"V/7TN/6+H<NMTHF3+1.A]%H=#9<2YWU;J[XV8.]N3*%
M3W6F'JQPQ7HM[?9.I69SW1OWJ@<?]'+EZ<'PYBJ72_51^4_Y@\7=L.:2Z+7*
MG#:9L&IQW;L=O[N;TGI>\)-6&]?Z+<B2N3&_TLT/R75O1 JI5,6>.$C\>U3W
M*DV)$=3XK>39JT428?MWQ?T]VPY;YM*I>Y/^K!._NNY=]$2B%K)(_0>S^9LJ
M[9D1O]BDCJ]B$]9.)CT1%\Z;=4D,#=8Z"__E4^F'%L'%Z !!5!)$K'<0Q%I^
M+[V\N;)F(RRM!C?ZP:8R-933&07EH[=XJT'G;V[CWPKM-'G(70T].-+S85Q2
MWP7JZ #UF?C19'[EQ%^R1"5=^B$TJ=6)*G7NHA<9_B/V S$9]44TBD8O\)O4
MYDV8W^0 O[O"X8ESXMZLYSJ3;*?X]^W<>0M _.<%$=-:Q)1%3+_0@Y]/_<^5
M(CUSF6W%2B9 ;/-.)(75V5)XK/$KJY2062*<?A+K$ %%$1#PGYDK6[N05U4/
MHQD]'%^"@?1BHRR8Q+$I,@]*Y+>03LPKA\4MAPT$J2:=4]XQQU3+N4ZAF7+"
M+%BIBA!/6&\+GBS"JMA8THT(8W SJ4XDB412$F7+3$$O!)3#<VU!ZG+%:2L6
M$O>/,BT4M/FK,<E&IRDM0/:17Q;6K/<K+[03J;1+E6[!V5L]+[R<IW"C$8O"
M%U!QB^*'N[FB? :'1'@5KS*3FB4L[(L,Q27DHB*ETL!XI7.\4T_:L094?>#$
M6%4>J=W0N*8?HK;-E"7.(";[2)X1TFH'HH6'#-\@X4^NXZ# V[7]':*36R.X
M1@L-NM@W*SLPVB#&F?% SC+3"QW+S,,&C956Z"S1CSHI9 I7&;H/=BR75BT1
MF#ZI24\Z40PQJ'%0 9CP]#7 &JQK"4$_LF5D<;?'R<@= &:N5 8+XK0@4:4I
MC4\[)CB/?^@T00"($&BHF\6*J1B42L:K!F#DQDKT0+S7+I:I^)>2E@P9AW1Y
M#NL&PB0E ^:JC*IL:.7XZ\XB%4YFDTMTA32%D#[;5((1 DYFY^?5._;4,V'D
M[)/)17M).ZVQO%B3<7?H>8DH<BQ!VT\UFA"Z-QL2PM#?8<UYGUN--J\!);@S
M)W GK-9X=M:666?:]G3.DG3F9;;4E*&MBG,RGK2IJFP\Y6S<2[4!J(6".]:\
MH'!J4:0P\1'&65I;58T+@O5XABH@K:O<,FY+6Y;U)F"QNJ/"0JF$Z!0H4B2:
M02^?1%[8W-2I6:4$54)DW7\5F3/K>!ZAH[@!@B&*28GQ3D@ 8KS,RGF&[=M?
M\8[!45]L5AK0EE9U V75H\J*D+HH+F0C3'W$&)=3JI#V\*[)5!FW7&XYA0;B
M-DD8]E1'^D<JX_?[2XHE!LR GTE4>ZZ*/I5/$:\0545>DFMJ:@3(V!9E;XN5
M]3)XL/)TV[>,!$DBZ4TK=T,(YRI#9_"<="VU2"4NG651@IU4TC.G^IS@9=EY
MO=B +2T$;F"%J_LR]Q6\0U.2:25Q$:K-MJPV(]2?XVMMOY&%D*/0(5@F#IB3
MR2](KZ BI_*SAK%3\$;?LN#54PL7O.@\.ECP)M'TU8(WBUXM>+='5;.F !]3
MS:*S;UO-SD(UZXN3Z:@M26=(:F_L-DPB)Y?1-ZYS9[/_;YFKT/-JF3M<SH[(
MKD;:[\FN^\9+]QTOW9<UK#MJ_?$/%]'X_,\'9G<*N4DQ$.7&@Z-&VI:F$9MR
M .X&@[<'VK6CQ>T_#+4K#8]5]%55?;%!,.:'5(,;ANW9OSV^(1XD F&M62O+
M<RU-8PU+I&D-FBTI6V\SJL&S299N'2H+\GX<'MB2!'P?P8<56BOI"JX\/HR/
M5N7&<KF"4=HD(0F94=V[6D)TI]=0(GRM?M/!6%?S"O=B+1/DE2'$UGN2W:T:
M@2=%C0)XR5"&FPHEF0]<ZI1^1:]8NI58I&;C/D<W2IG/TH^A+'D76D\*>Q>V
MW!Z64Z2"1=1\L_AW6!3"7 TEN=3<QM533'@OD62L7E*3/TJS!@5?[.M=7!_$
M-#RY=\=VBQ*7BFC:WI=,SYH!.C2\BU'3MYM]?;I%(N_R1=^:3)O65$U=-FG/
M7-5T5V: $V5/&X\O7Z%\UFUVW#67*9<;/E9SK&'7R#Y)^6+]SBZ^LGX<1(,6
ML^%^R*<;J,C8RU/M90$ ,+BVCA PT@)P&8,'6J&/T<^2LWL)".\@CSIAIP-^
M?-X2OX/BI97N[2YP=J:[UU?<U0I7]I^(Z/*<KF>7= 7$<(TB\=!MO@<139NP
M<[YB3'FHBLMWX[?XF^$2T=_E6W&_KSJ?\\)H)B(Z_>RJ1? GM4:=WT?D&DI_
MW3VH,RXIGK^$LZ*J?1,64%L2S.)463 &\CT6SCNG<^7Z?K63*]F4@P_LI8Y9
MWI7#3T>9MP/QL$M%M2@L-L_/5M;&^6HGA4E66:IK];$-?L^+9%D?)9IL>6K9
MOW0FZQ'D6.1P)#4"]COGP+<S?RVWY?$2;QU;TUG9*UHA*V-"KZMSJ;BP/(7^
MG28?,3FP^L6$XI&E'$\/##7E05;0I\[TUM0HBLS,G;*/G/PZRPOOWHGWI,Q/
MH7?XUU+R4YO##\1!?."X_,R?-J#%[2,TQ@,"_O=MOXOQ=#!Z(T[%)!I,WX#=
MX/R-^- Z0 AUK37*/9NRT2!&$X+9O+*^B9R8,NOQ"/\N+XE_ \?V7KA%P8=P
MI_3OG"[39]K.!K,WX?*P9VYM]#VT)X"VJ!D'M)VUM)T,HB_1EOS[:3>>8;NP
MJ:(QWS(<PGGTXU'C:0VRL+O)7]$P',N$ 88&$*1+2) 5@3S1LFXJI:+DPG+7
M*!N%98#/8-]'EV'K$Q9VPDO^4$=;$(@,7[/JI_6WP-OP":Q9'CXD_B@M&H43
MJ5J %%"<]80-'^?"C3<Y?Q";&X]M-_]<*4R3EA;@_<)@JU3>D(#Z"^G-_P!0
M2P,$%     @ X8&#4:Q(0'T0"0  _AX  !D   !X;"]W;W)K<VAE971S+W-H
M965T,3,N>&UL[5E=<]NX%?TK&-73)C.*)5&28[NV9QQO.MV'-)E\M ^=/D#D
MI8B$)+@ &%O[ZWLN %*4UO(FGB2=G>F#+9( [N>Y%SCDQ:TVGVQ!Y,1=5=;V
M<E0XUYQ/)C8MJ)+V6#=48R37II(.MV8]L8TAF?E%53E)IM.32255/;JZ\,_>
MF*L+W;I2U?3&"-M6E32;%U3JV\O1;-0]>*O6A>,'DZN+1J[I';D/S1N#NTDO
M)5,5U5;I6AC*+T?7L_,7"Y[O)_Q3T:T=7 OV9*7U)[[Y.;L<3=D@*BEU+$'B
MYS/=4%FR()CQ2Y0YZE7RPN%U)_UOWG?XLI*6;G3Y+Y6YXG)T.A(9Y;(MW5M]
M^W>*_BQ97JI+Z_^+VS!W@<EI:YVNXF)84*DZ_,J[&(?!@M/I@05)7)!XNX,B
M;^5/TLFK"Z-OA>'9D,87WE6_&L:IFI/RSAF,*JQS5V_).M.FKC6J7E],'$3R
MP"2-RU^$Y<F!Y2?BE:Y=8<7+.J-L=_T$IO3V))T]+Y('!;Y.W;&83\<BF2;3
M!^3->__F7M[\2_P3LL[$6RJEHTQ<,QZ44V3%OZ]7F 6 _.<!C8M>X\)K7#PV
MH@\NYR(\MXU,Z7*$*K-D/M-HSXN7M2/3&&5)O+Q+ 6BJ4Q(_U\(5A#]E,O%+
M*PTF"9V+7-E4EF)#TB"HL].QGW:CJT;6&T2DUBV69T(Y>T"RV='>&+TVLAJ+
MVT*EA5!6T%V#&H,(IT5)G\F@FH=*_F+%NM0K&&'5K^23P";16$@K;J&%?ZDN
M)"OC=0'W,)^G4M64>D/DU1C%%D&W<H60(M>8*C1[;C!#KSZ2KW)[WFE$]S*2
MZ]^.10Y'^=(_=JI2O_J1L5>3Z@H:4[4W>"S>&,7M*O2/@!=$E<V\-RY"U6G9
M9H1?1VO6'7$7'.2[:%HEZS:70VC:MFG*#4M*R5J"R79C'54VC"I'PF/"AV K
MCP=CW ?BH^=X4.F,2LA(C;966#^SQ'JY*GFX"XL-@8C>\TA*QJ&O#V/S6]O"
MJJ#C6+P?8 OA0>@< N8*Z<;"2ZKKV(]]"K\:=,IA(1!C*-7KFN&$B#QS\@[P
MP!B;DBG;: M;4VU=")U&NDQW'\(@(<32&ON+\PF5#73<>7N1@J/9\8E801%;
M"ECC_K2[#P54R8_:*+?AM:$2I*&=4E@Q!M+6&-RN-GX1L2W[)9DDQ^)Z1WLA
MR[P#61=$(+209HU@LAX3FQC4]/6!*&*#\*B%[IIR!#<DQ!!OSSZC QDQ'-9J
M9):%^8P<!#82WK*70) LI>$ZP)F@5V\]>K7QB&,A73V$XJHMMDD>X@C5P(^W
M#"G?]2HF-=BBZCU+XMRQJ EP8OLY2E"480H,T&46T(A=GZ$]%FO$ 6 /3V6&
M^"CN]-PC.DL8EK[IP$9=JLR'PCK\]-A &M&.C@7. ;''<K<)-7D'Z/L=D'@'
M%-B_] I8Z[:PW6X[<+#S&^*/SJ;8V@/66.C1[.2L>S#F$#2AJY4; "7+5.AA
MY697=H\UF::F!;QD]A%]M'?B:+ZK9-G?YH]Q:VC6>(C'KFEL@:$RV*!RA7&O
M:H#37-499S84*,K6.V>[]+^BS!E=J[1#D=^EAQ(LH,X"+#E71@4E&A2WG%J@
M0M$2.5;;.GID&KM\Q?:. ,Z3O8 >2-KX'ES?B]T@9G&Z*_9L^>5B__>X3Y8<
ML-G9E^%^N>MJ,I]]!]S/]HIK_AC@;_WZL<!_9/!_'ZTGS[\)6N=[*7S^%6*_
M$UIYQ\MU";KIMR*<<BAR3BBW7DH\RVV&Z>/G7W$4Z<'SN[WC7#R!\3$J]JEX
MV6W8[P=X>!$W;'&]W8]O_ ;]9/94O/8H"??OM0/(KV%E*9)%4"&.Q.D9_LWX
MWX(O9HFXB1B8/1>SY50D@K>5&VD+T<A-B-J31?(4"A8G^#_GJS,HN[ZGCGCT
MSW\Z36;)7\437K-\^AL_H?9DAG_)G U@DY;>^(%'X<C1G9#[NUB_. 3@\ :<
M. XYS@L/'K2_^7GDG<)25&L:,A+Y5*X,P'^03R6S_6Z$0@Z0PM,]D0?\R,BJ
M=1U06,E/.]P)(:DTCD:UJAC'D:DTY)2O#FW6LHY4); AB/$O.X#>[OROP/$^
M1ZJS90T[1&O(K3*#VL $ Z)0MR36(,"N",6)DO+G2!33)W+" F+DF2#;5EH=
MC*4<+D.:*S>!^N1YUP>&1&6OXCPG/!8?4$2ALC1F6GZKTN& TXG*5DPS)699
MCCT(:$VW^W2GHZ>>+. DGK=\".C9(!+( E>TC@Y%#;EN#0[!#Z;;B[0ALYL]
MGCO,!_/=F.Z0N#XIA)2GBM]K/4.^>X)X1VG[.,[I3>K*RE"THHOQ%IL F-Q&
M\1GG8F#D.(KHT6$H  NZ"^0! 8P0&[,ONJU]<QUW-%W?$M?QZSX3'VKN:$]>
M?[!/QX/.S4.O>UXNI-M'@K=KS$<VIJBVX 7O*2UJ7>KU1OS$P[KASB1NB)=Q
M%V$&P>\3T"EW*ZC TXRH@04\LI43"@F@Y_@&PM:]OO",K>(6T0#9<" XR2]!
MV1BT>:YIWH* V=VT![9[Z$6(![E8M0XP1?WVE,O*"B!9JY)W)>YI%4XZ9,:B
MU*FGLJ'FM7D<Q_ZR1O2CR/5BNB4\3*X7R^GVU/"]R74X1\4*M_^GV0_3;'&
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M??%_5>K%>QN",1^AA@MU72RB4?4+S75%%[<;3=WKMTT]<*30[P[@(SD[]GG
M9>=;BXVR*_ZB!(4^!;+PV473VGRT<AV^U6B[AR]>WDF[(C%RM<30X<5T?!(2
MI_K&FRU_N;$PWIL-7Z[A&<I2!SQ?&D2>ZH8F:#[E>?DG4$L#!!0    ( .&!
M@U&SE#,Z-@L  "X@   9    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;-U:
M6V_;1A;^*P,WVXT!F99(49*;"V G#=9%;HC;+A:+?1B1(VD0DL/,D++=7[_?
M.4-2I"[9IL7NPSY(%LDSYWZGG]\;^]EME*K$0YX5[L79IJK*'RXO7;)1N72!
M*56!)RMC<UGATJXO76F53/E0GEV&X_'L,I>Z.'OYG.]]M"^?F[K*=*$^6N'J
M/)?V\49EYO[%V>2LO?%)KS<5W;A\^;R4:W6GJE_*CQ97EQV65.>J<-H4PJK5
MB[/KR0\W4X)G@%^UNG>]WX(D61KSF2YNTQ=G8V)(92JI"(/$GZUZI;*,$(&-
M+PW.LXXD'>S_;K&_8=DARU(Z]<ID?]=IM7EQMC@3J5K).JL^F?N_J4:>F/ E
M)G/\+>X];#@_$TGM*I,WA\%!K@O_5SXT>N@=6(Q/' B; R'S[0DQEZ]E)5\^
MM^9>6((&-OK!HO)I,*<+,LI=9?%4XUSU\HTN9)'H8BVNK97%6D'AE7M^60$W
M05PF#9X;CR<\@6<FWIFBVCCQ8Y&J='C^$CQUC(4M8S?A5Q%^2*I 1..1",?A
M^"OXHD[0B/%%)_"]5LM*O-8NR8RKK1+_O%ZZRL(I_O45Y-,.^9213_^T%O\(
M'O'*Y+FRB9:9^"A+9<7/&T4W2UD\"HJ\"A\GDAU8R6"E-6LK<R>JC:R$S!"!
M^+D[6AFAG:N5^"6X"T1JLDQ:8:SXL;;F(E6%@</)2J6B+IQ*H+7TD$9A*N4"
MYDBNUU:M<4#(W-1%)9 $7"6+E 0B!H@D(AKH4IPD3DZSG,M'PBW40Z) EX#5
MEUIO9:8(\TH\B8)8+'66(;@#\=X<XKJ7;I^%I:DV JYEEGC>>A<82\5U:74F
MPJF_Y04BY< >BL@=8(<VZD0YYJR5%V"XK2'J5NI,+K.^K(W6O_]N$4[FSQPD
MTZXBOE[Y,V]DHC-=/8X$^$9B@6^D8DEI,Q!O<4'H&]"^_3> E@-MB!42W<6C
M@C%WAK-J:[(MD6M87#7DQ-,]^N<C<;_1R89LL=4I1%S*Y/-%78I5[16)6O ?
MK(=3B=5+T)5+LU5>G7MTA"Z2K";\4N1(HOH"G%I5)(\PDT4$,BDE*PI7(IDH
M2XXN7*D2O=) CKM(NX5H#FKRQ.OJ]QAX!.=JS.;$O0*%OJ?TC#;D.1"W105H
M5PD+1X=_H;"D6W(2_GWDB)! GBJ<RKU%<0>*TASF*"M6/XRXL*0=@CU'R4RQ
MOJ#S0+-DPCCJR$T<A/<H[XAU:5/QO<S+9^*C,;8[_\D?$'?*;C4Q2NIX9TRZ
M(W%;;"&3L1U0L.-_I>@(A"CE([OT*3F!=4]6[2&=1-#GLBB@5.DC1@_4V.8/
MJSCC(54YBN<VKW$91,N 6UN%#%F1\%E& >$]M9_4*.I!%[Y99IJC]UXCZ.6A
M6P2"B\*'9::1M1 XKA]8?W5>W:;W&"PY!"V9:L5$5X:2*K3[@W@*HKD/0'<N
MWI';DE9@FP-W'+JB>,7>6QV2P].)>"*FH_&4_H:C^7PFW@Z](0HF\5@@^!)"
MX1041.="P;8-GXG)*(ZF $.;UH%5'BCJ@&; ,0[&/9"5J:V'62QF8C&)\3R:
MQT>>3\!6B.]9--G#4=V;%F0ZGW?$PF >?X67.!H#Y.H09-J!1),Q))J%\6F0
M:10")#X4.@8WBZLQ:7-,0H?'U#<#T&0QP?=X,=_7#+)K'Z93=##I,<3M(('-
M!PJ*@NA0L+F(9@O^#'7<X;@Z(#60_5YES%(T&; ]&1ICHVVEF& 4[HDWL$>'
M+=JC.ATP![@"_@TXTN@5XZ3O61#'>U09:B'"./*?@<YW>*X&7,V&QNOP "I>
M^,\0HL4S'0_PQ,?Y 50(=Z'/Y+A<T\F!_$<YFD+R<<R?Z:'&&2)"[,?\F0XM
MUT& "_(4?$Y!L-].HO9[:+,6*A[O><!17/&^9#>R^+PKNLXG$' =Q\*WI$ID
M"B5J/SN%XL([0#P38/"U6BE+S<:JZV,3XZHFD5UXRD\G472.[_'TW.??%$TY
MU6&49%4-0><A0<;G^TD/N3 >7<WF]",<T8D[56BT".^I&SUHCX:EO>V(G#_2
M$VG4[UM<"\ =;EO**JJ SG<UXBFF+QXOMRI#VT;/^WR<^[(V8,V2IM'(HGP]
M-H6)"AF.]ILU*J6XJF&2M&G!=4&2J[10SK75IY&Q:58!4%"OY)KV95<:!QQP
ML\-M?]J6V&^LL%;1S.'+^^\JL[>%^*DN**=,KD;BG4HK:PJ=B+?U0V):7IQ^
M$!C(BF2C6,"#(60H!1,K>C,':BI<KI3,-!P[FDV?Q<&X;8I'_DCNZ[+VIEAS
MBVE-#H]U"8YRT\PNB-EH>"^&.% N-:HX1*)+QSTRS2?,L2QQ]:!! NX@GL3!
M;$><7!L@K:_['JR;+SA*@H'?UJZ9>NADGPK=,RL$&K%!7,+:OALG?E!1R/8,
MP#3 ?$8F2U5>\AZ$1J<X"+MA =<[B]P623 2KV[?W%V/?)NX9ZR!$:@I[XO)
M[)D*.N-&"8QP7 T%LRHQZT+_1FZ.UM9QW\Q1K1Y(M;5VF[R=\:9(=4U3)=+:
MBTQME[9H'1%%J&@D[+[YQKL1!N9 L]4-&VEK-I7K.O=FD$FB,N*56,J-K?1O
MLE55>BJET<&TG[[\K1:QEYG%HX:T)S0\IVM^U4.I$/1M<B&MF4RGS DR5J5:
M18![DZMN\*)8R?V^A>R==C&'M,A1QC%WITI@X-NLDA.!1U&4HI.'Q%#A?R,,
M9T'TQ\(P.A*&DV\,P_G.U_\G87@TX*8[#1P&'#/!,3=4+MUN-#CI3?>#\Z>B
M<C8D>"0J27>=VW":ONZ\H*UFK1;(80O(#3FA$'[4Z0+WK,)H*#34V;!+O4D;
MMJO,\/S)D]ZPIJ)8Y.V<!&[>28N0I>S[)S)&-%X<RQA),V,U.>/_*3^X(PFB
MVF"49H(G4\6N/!,G!V'.O#<90O?J-R,=9A: 4>.DU_XD[Z,H7#0O%=@R&Y6N
M_1JMV>$,.QC,VL1 J9!*\.T=%#KZ1-HE#R//%@L6KY>K=.'?2O@7!&MIT];<
MQ\A#4&H@WQH0N6Y7#4Y\(,=[1.L].I$F%5N#M !&I. N-#.<]-I]Q=,ATG->
M\A3L+6!H#V&?0IDEO<M14W^Y\.K?ZHWASGPDWE9IP'I-81Y->VOJ.<$ +TL*
MUGG&E=];<\C.;I&'N[LF<R<(['$BA^\6FW5)=OC^N\DL?A:->VT5F628<<-@
ML9?N&ZT!S<X=VQ"D1>]242A[_V0;'Y2DQH61,?:TV:VP3.E[C=:>T2E[^CFG
MW2D7E;;]!2Y'3Z>9W2)PJ-) W.RFI5- D!TM])+J5A?1LF+ GV]O/GRBQ1R&
MB-ZVMXGS?6\JLYJ7I-*N?>B,,8G^A>8Z:*JH\V#H4</&S3L5YB XS!K9#\U]
MNU#O3W-'JLIIX:'C]Q@4. /L J=?,=0#+8:I>%)9\+8A!_)FWM/RUTSN'?HG
M":P*F? ?JCB6IOY(_J$%5H>WGW6:MS!@X[9 K-4^3R %04/2^0&-]I[:BE]E
M5JMC*V>O#9#GJ(!7$_26H8>IK_/?85\%(9Z$5\%55\1IT)(<ML;OCYL([7 ^
M">>[:8?7X/L;[Y,<>6KS8/(MU*;]UR]DHSV$.TJUH[3\I39T 2?^S*T4;Z+;
M>E76<,6$^Z8U+5CM7J/9)@O:+R<9+;YY_P\R;Q6&;Q%RGFG"I\?(1L.LZ"H>
M]UELJ_% ,-=U2)V#=KV>5=G.X7BP>N"&P6^SH:W$%^(C-9^<C]\_T:: 7B(<
M>^-XV7N'FRN[YC?5Q!#0^->YW=WN9?BU?P>\ _=OTM]QGJ"*L,)1VNZ=">O?
M3ON+RI3\1GAI*HS]_'.C),0F #Q?&>B\N2 "W;\(O/PW4$L#!!0    ( .&!
M@U&0VSKW_ X  *E    9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;.5<
M;6_;.!+^*T2VV$L -['DU[X":;JY[6%W6[2]/1P.]X&6:9M7671%*8[OU]_,
MD))(6;+E-+M8['V);8D:SNLSPR&5EUN5?M$K(3)VOXX3_>ILE66;YU=7.EJ)
M-=>7:B,2N+-0Z9IG\#-=7NE-*OB<'EK'5V&_/[Y:<YF<O7Y)USZDKU^J/(ME
M(CZD3.?K-4]W;T2LMJ_.@K/BPD>Y7&5XX>KURPU?BD\B^_OF0PJ_KDHJ<[D6
MB98J8:E8O#J[#IZ_&>)X&O"K%%OM?&<HR4RI+_CCW?S561\9$K&(,J3 X>-.
MW(@X1D+ QE=+\ZR<$A]TOQ?4;TEVD&7&M;A1\3_D/%N].IN>L;E8\#S./JKM
MC\+*,T)ZD8HU_65;,W8,@Z-<9VIM'P8.UC(QG_S>ZL%Y8-IO>2"T#X3$MYF(
MN'S+,_[Z9:JV+,710 V_D*CT-# G$S3*IRR%NQ*>RUZ_%:F\XZ@9S7@R9S=Y
MFHHDVK$?[J,53Y:"?93Z"_N9)V B,$;V\BJ#:?'AJ\A.\<9,$;9,,68_JR1;
M:?9#,A=S__DK8+?D.2QX?A,>)/@^RB[9H-]C83_L'Z W*'4P('J#HSI@[Q*=
MI3G*:=3QHY@O9;)DU^@\,I.@I;=21['2>2K8OZYG,!P<Z]\'N!B67 R)B^%O
M:8F#4V" /]<;'HE79Q#!6J1WXNST>=GGE6 W:KWAR8[E&AX#B$@Y!AF/B82(
M5*+6,F(K4)_0/2:3*,[GJ,BHH"X*ZO"D@#@J30#/DDX--S+)!+":[0V3E:5Z
M+%,0$\@?RX W":Q%&5.+AMGV:9H;($3"!$\38-+,''&]8@L +7T);L'X?"Y1
MQ!Y-X8D?I4KK:BZ?O-[RC788+(>EJ-54Q#!HCO<CD68 HB#C+*,950KBTI,R
MD6OY7]'"'[M30$3&,@.B0@,<H:(7J5JW:=N*[(LBD&V-W*M6/6]2L*3<\#C>
M,4@(6Y[.6^<HS'B)_J(]NZ9H22V7B9&<O 1DRB321G4 ;8#3I*(-3R::$Y!;
MZ:W50&$HQ!V/<X$6UQL1R06X'M=:6!^*)9^A>B!Z+]EUAMXH-I03X %\NF#-
M*,057EM&B2NNF9 P(F4<U"O Q$ ==>T\H?!F91H2[;*(*80/F%+E:8N&;: 8
M-_XA3U6/_8V#=5!__Q3@>S<K:7[D''ZA< H9,DHN33E7,%&B,F-38])3 @_4
M3XK,8W-GDZ<;I86=94GN#N1MP*]5GE"T@5MTF,85%ZJ$4HE;4.^38'HY8F"L
MF#(VB/<D""Z?55<R!N"O9B!4@?\TZAH<,V;AT%SJ81AL!.7[>.>KAL=:F:AU
M6$(2B4J>MG#9'5WJ@)((]#9 UJPP[YYKPZ2(E<;#2B"UJI:)*;M0]FP%TB]4
MC(@$,VYB  MMG3^5*H?ONXUQL'D-TA= 'KP/C.6*!5J8L]G.!0'4'-?*TO5
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M)YB02B(MU6L1MD1"J=8%26]]X!QL:5 3:QE="%!5%?L'U2#T!W51;;>O)'1
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MBUOQ D<'O<FHPTSY^EE.G%[[%\>Y=KA9^.%*H+\WM '?%UJ[>D(,FB?HF_\
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MG8 FVIU+E[?["LA4T=4&;9P-5:[J,P#$+2/B];Y_TX'3H'-\5Y";QT-*/KE
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M1F#[9Z6?>-.%JWQE/#T,P6SH)4;+ -I?&^,/$W9P?-OGWP%02P,$%     @
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M7115!E/OC]!7G,R9/!P1J8-'- =#X 2 [2W+8 J9(E(^:W7K'5P'TL(H-*H
M+X.?C887' YMO/1KRQQA.7E'99/O'/*=D*UFR;9/V$C5'::S<)@<GS28KXU^
MW8(/\KZ1\\C1*ZE1^DH!L=O_7M%#)2^@6%2<P>O?Q&G9U<0>'8VQ_/C#49JD
M/SVZ6[#=R(P;'Z>'E,XI.:1D1N\U1++S_<TDI4/\O;V#1@];D%NUU=3ZGH1S
M#)6OYLD^O9K-L233L,SVZ:(TULNO#3C$,009A5HCV8%<&>>BSBG-:4K73V;
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M4< +[0NA9(B<4NUR'ZI!8^M>JPB'5*<BW>NB+I=99LAO:5%@:Z>+RNLXC%N
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MS'"^'196K]V9<J$M#E#NL9*BE(8)\'ZIM=TN6,'N3X;3_P%02P,$%     @
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M$^#Y2BE;W""#\D/+R_\"4$L#!!0    ( .&!@U$E^%X?;0(  "(%   9
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;(54W4_;,!#_5T[1'D#J2$A#6ZJV
M4@M#XP$- 1L/TQ[<Y-I:.+[,=@G\]YR=-.LD*"^Q[^/WNX_<>5*3>;(;1 <O
MI=)V&FV<J\9Q;/,-EL*>4(6:+2LRI7 LFG5L*X.B"*!2Q6F2#.)22!W-)D%W
M:V83VCHE-=X:L-NR%.9U@8KJ:70:[11W<KUQ7A'/)I58XSVZG]6M82GN6 I9
MHK:2-!A<3:/YZ7B1>?_@\$MB;??NX"M9$CUYX;J81HE/"!7FSC,(/I[Q I7R
M1)S&WY8SZD)ZX/Y]QWX5:N=:EL+B!:E'6;C--!I%4.!*;)6[H_H[MO6<>;Z<
ME U?J!O??AI!OK6.RA;,&912-Z=X:?NP!Q@E'P#2%I"&O)M (<M+X<1L8J@&
MX[V9S5]"J0'-R4GM?\J],VR5C'.S:_V,VI&1:.'H02P5VN-)[)C9V^.\95DT
M+.D'+ .X(>TV%K[I HO_\3%GU*65[M):I <)?^3N!/I)#](D30[P];LR^X&O
M_TF9KW I;:[(;@W"[_G2.L-S\>= A*R+D(4(V:<1%D()G:-]KXT'.?P"CFTE
M<IQ&O&$6S3-&>\3+EK@'FK>55M#ZL*)&KD=86)'B-;-C.)*:QT4IGGQ[#-Q.
M6J+I.@KSRD@%:=:*5U)+GJ$"UD2%A2^0]LZS+)RC80:/O%@@]=?*$(>W,,B&
M,$A&<"=JGD6'1@IE873>AR%;'L@)Q=BLEXVR<*;I.;S7XGAO;DLTZ["=%G+:
M:M>,<*?M'H!Y,_?_W)O7XT:8M=06%*X8FIP,SR(PS48V@J,J;,&2'.]4N&[X
M$4/C'=B^(G([P0?HGL79&U!+ P04    " #A@8-1Z//H#Q0%  #T#@  &0
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M"Q.J0!QX& Z.4'7<4W5\E*I8<&.>,)3PSK.LK?"(+<]I6EOQ;Y<,%O**+_'
M+7_Q.Y[F 64=HO51'#])Z\*A?\QF0L]VT+-'Z,4#7.;@GCX]A4?DVQ?"X:)]
MLV _N+POKJ3BGB*CZ'>"ZQ>:=ZN1$*GG!T2(D[$W3M(A32%KDJB;\I/QL"=Q
M#I9G9:VD*M:N- TZH0(2JU L)[&7D@L44QJ'-(S&\1#N-,NQ0\#NP6VR-*Q9
MA1J-DRF<A'$P1"M&*PJ'F]^6=(+1)T-(Q_B,AAL=(VTG7N*/"1L&2:)HV,V%
M,6GV9.JE/@:\QM^0_<2O;VZ?LZIY=46,CTD96YD]@W$8[8R/""'IA9#\A!"0
M+3NX?H#M1X/]8OLOMO\_;$][MJ='V?[:6/R]IO*^:2WU/_.BT+S F?W3>?T5
M[P>&>S_UQ3\*X; &'G"Q'M >H7D'B+J4)79O6/ U9UWKCC^QC[J;>R9;3AK8
MK_5320"S3T3A8:Q,MKF36KV&!FGMMBR[BNW!0C<J$P[X2MBRZS0T%:H_U54I
MLA*0HU KBZ@M5/C7LU50+DN.O=-"2&'7'@A#_4OW13"/>[%#IX0M%EW4"# F
M0'W"9#(A$_L-+XV<&:&9I#&9,9EQ1.:83)08F@F9?GR09*.=FPA*M'#W+?PB
MD<*[2TD_VU_IYMU-YF%Y=Q]\SW0AL N3?(E;_9<IM@>ZNV-U ZL:=Z]9*(O?
M V>6>"WEFA;@^Z52=CN@ /U%=_8?4$L#!!0    ( .&!@U&7;<ZE4@,  &T'
M   9    >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;)5576_;.@S]*X1W,6Q
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MN1Z_([0T%UVG5152(SA,>=DXN(:79Z;I1/OPNV/53F([6SB/A1#O8*C,IIP
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M7<@:3:YQ*=ZJ2D(VEFB'7C("J "S+P&5"3+V>!80"KA[:UK</N_,NJW[8@P
M9[LITF0CG_->3'MN0;E(3/=8QK/0<KQ,^Q8$QZCU>!&S9X0]&X0]>U;8_\3)
M7 O22.!^>X^>:)'W6;BNI0UJOKU,'WZDT,]&_V6%W@JT"TQQ 0^*$435!SFD
MTW/?JN!WJD96WRG;-M"N.J]Q8 ]$I]HT"A<">KE?)!&Z4WZ%S9:M6H %$!6Z
M-$+K!0I,^A;2>DNGK>/!_R3=Y]2:@ 1:$$<@M'LL)99 [#ZVBIKVFBX>!P&,
MLA1CS$M63%*2V4F4YD$AJ!KX[M0U2R997M((VQQB&<$VCB-V8[SX+ND)!+32
MZYK.<@NDF.0 @1'70XS=L$^<3>(LWX38HW?02WJ2%N\%JRP0''9E^4-F3W>^
M#<'-9?@"WAQF_YDXK X?V2?]M^6C>?^%?@$!4&AF+1=PC5X5H+'MOWK[B3==
M^-*<&X]&"#]7^*,@+1G@_<(8OYW0!L-?C^-_ 5!+ P04    " #A@8-1N;),
M<J@%  #H&P  &0   'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6RUF5MOVS84
MQ[\*811#"V2Q2.KFS#&0V&X;8.F"N.T>ACTP,F,3E42/HIP&V(<?)<NB+=),
M%L,OB27]#R_G1Y[#R_")BQ_%DE()?F9I7ESVEE*N+OK](EG2C!3G?$5S]>61
MBXQ(]2@6_6(E*)G71EG:1YX7]C/"\MYH6+^[$Z,A+V7*<GHG0%%F&1'/US3E
M3Y<]V-N^N&>+I:Q>]$?#%5G0&97?5G="/?7;4N8LHWG!> X$?;SL7<&+J>]5
M!K7B.Z-/Q<YO4'7E@?,?U</-_++G52VB*4UD5011_]9T3-.T*DFUXY^FT%Y;
M9V6X^WM;^L>Z\ZHS#Z2@8Y[^R>9R>=F+>V!.'TF9RGO^])DV'0JJ\A*>%O5?
M\-1HO1Y(RD+RK#%6+<A8OOE/?C:.V#%0Y=@-4&. N@;^ 0/<&.#7UN W!OYK
M:P@:@[KK_4W?:\=-B"2CH>!/0%1J55KUH_9^;:W\Q?)JH,RD4%^9LI.C>[JF
M>4G!KV#""K)8"+H@-4'^"+ZH<3HC*2W PS.8T84:'Q*0?*ZD:U:/E/<3*@E+
MBP_*_MML MZ_^P#> 9:#6Y:F2E ,^U(ULJJJGS0-NMXT"!UH$ :W/)?+ DSS
M.9U;["=N^]!AWU?.:3V$MAZZ1LX"_TCD.<#>&4 >\BSM&;_"' 65.1S8NG-<
M[=,WU[[G#-P.%UR7AP^49PZ2[0#ZZW<E!3>29L7?CHK\MB*_KL@_4%$U]HIJ
M[-E&T,8TK$VK2+@>1:$?#?OK72P64>2%^Z*)*8(^#/Q]U=2B"N!@T*KV>ABT
M/0R</1P3,6<D ;^0;/4;^$Z*I$R) )\$+U<.!X9M\>%I245M1=';26U,@QW/
MH0@%'5(641QT1!-3%, @[H"RB$(_L'.*V_[%;^8$_@7;S_?+9[G,&M5G2H0$
M'U5H+ 5U^'C0MF%P6IC0T_G >SO.QC;8FR^H,ZG&KU)-+"H41KA#U*:*O<B.
M%.YD/7@45"YXKM9-S7=E62:R%"3=D'4Y&NDFH!,SU4$;XB.88L/#,89=I*9H
M8$Q1BPB&$':)6E3Q(#Q 5.<+Z$X8+Q"]XD*RY S<4<%62ZI0GFVE-.=EX?*S
MCN@P.#%2'=UA> 32T'"Q'\9=I!91Y'>1FJ+8G*.F:."C T!U6H'NO'++<I:1
M-'T&-_F:%&H[ ;Y6X%9,+4A?RI)01W<8GYB9#N)P< 2S@1GH5!KL0K.HX(ZO
M&VJFRO?BL(O-HD*'N"&=0) [@;S,34W'62D6+%'Q]";/^;IVO6L*(AW8$3PM
M3J0#.$)OQ]G8[D4Y/.C,G+%-Y7>7GQ.+"OG&++2IX@@>P*ES!W+GCE?AO*?%
MB@DBN7@^ Y]((05GN:2%9+D.M/=4/;@\KV,]\D\,68=TY%ZENR$'9G0T&9NB
M,(Z[B$V12IT&8HL*'T2L<PERYQ)%3Y$C\O^%6*0C.8I.C$M'<^1>K+MQQ>8,
M\4*#ET4%83?$6E0XZJ;/J47E0^0? *83"7(G$@>P:O$J2,Y4:&W6KJMJ#H*O
M-%GF/.4+UO7-_CF #O/8.RU4K&,Z=B_6G5 ;V[TYX47=]:M-!6'GR&!B42$/
M=G+PU*:"X8$M"=;I!+O3B1OJ;$43!54^ZV\NW^Z<YYSX0 ?KJ(V/.-)I;/>V
M[K%!T2**NKL0BPAZV(!H44$<'X"HTP5VIPLWQ"^T%#SC<[4SJ;SM\JH.WOC$
MYSQ8QW%\Q$D/-L]>_.[>;VP35<>:^P!-D7%F-+6(8G@(GTX?V)T^)HP\4/F*
MY(=UK,8G/KKQ=4CVCSBZ:6S#O;G3R5=CFVA@G)F:(C5UNKL+JRKN$NKOW%QD
M5"SJ*Z,")+S,Y>94NGW;7DM=U9<QG??7\&(,+>\G\&*ZN732Q6_NP&Z)VH+D
M!4CIHZK*.X_46!*;:Z7-@^2K^M[D@4O)L_KGDI(Y%95 ?7_D7&X?J@K:R[W1
M?U!+ P04    " #A@8-1A5!F&)@&  !6)P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970T,2YX;6RU6FMOVS84_2N$,0PML,;B2X\L"=!:7E=@V8ID[3X,^\#8
MC"U4#T^2DP;8CQ\E*Z9-7M&)#7U)+/E<4N0AS[FZYL5C47ZKEE+6Z'N6YM7E
M:%G7J_/QN)HM92:JLV(E<_7-?5%FHE:7Y6)<K4HIYFU0EHZ)Y_GC3"3YZ.JB
MO?>YO+HHUG6:Y/)SB:IUEHGRZ8-,B\?+$1X]W[A)%LNZN3&^NEB)A;R5]9?5
MYU)=C;>MS)-,YE52Y*B4]Y>C]_A\ZK<!+>)K(A^KG<^H&<I=47QK+C[-+T=>
M\T0RE;.Z:4*H?P]R(M.T:4D]Q[]=HZ-MGTW@[N?GUG]I!Z\&<R<J.2G2OY)Y
MO;P<A2,TE_=BG=8WQ>.OLAL0;]J;%6G5_D6/'=8;H=FZJHNL"U9/D"7YYK_X
MWDW$3H!J!PX@70 Q UA/ .T"Z$M[8%T >VD/O MHAS[>C+V=N%C4XNJB+!Y1
MV:!5:\V'=O;;:#5?2=XLE-NZ5-\F*JZ^NI$/,E]+] [%2246BU(N1,M@<8]^
M5^OT5J2R0G=/Z%J4W]3U1UDL2K%:/B&U2-%4S);H5B[4RJG1FUC6(DFKMZJQ
M+[<Q>O/#6_0#2G)TG:2I:K*Z&-?JB9M^Q[/NZ3YLGH[T/!U%UT5>+RLTS>=R
M#L3'[GC?$3]6,[6=+O(\71^(L\$_9O49HMY/B'C$ YYG\H)PPIMP'$'#.:WW
MZ=&][TT&W:X=VK9'>]JS5\SS:OK[-P5%GVJ95?\X.F+;CEC;$>OIJ%F(5;,0
MH16T"?7;T$86'ZX"GP47XX==6@!0X/G[H-@&888YVT=- 13'4;1%[8V0;T?(
MG2/\<G9[YI@H?]N,/RPCP;:CX'A&-J%\9X:89T[C! !A$AF,V*! -6408H-"
MC_DP'^%V?*%[?$7^KN$$Q6K^4F7+\TX *\?D1=O&HV%9PIY6=^]XGKK8W9DC
MC!F[8@*A*#9(B $4\PDVJ )1$8&YPCL>AIVCG&:R7"3YX@4<8:(;)0.SI'44
MTQ-8HM:<86P)'(0B/C%9LE$$D]!D"4 QW^MA28LX=JOX1)3S1,S0CR);_8R^
MBFJV3D6)/I;%>N6:1JVAF _,F-99[)_ F&_/7T"XR1B "KFUKVP4Q]QB#$#Y
MC/<PID4>NU7>Q1CZ#QTP+:S%%H<#$Z>E%T<G$!?9FX@&UE8#4,PFSD81'A*3
M.  5XA[S(EKVB5OV#Q!WE+L1+<<$#TLGT2)-R/%T=K&[DQLQ<QL"H##R##(!
M$ XB<Q="J)#TZ";1[D#<[G" S%>8']%:3=C %&K5)N[4UTTA!W)),Y4$0!Q;
M%-J@(+ 8M$'8\WIR>Z+=@KC=XCK)DTRDZ1/ZE#^(*GF0Z,^E5*_1B7JW/N1_
M1,LU"08F32LV.9 ?.TD+;5%3UF:R!J P,S,6 ,6\T#=Y U"$]>251)L%<9O%
M8=X.NR#5HDV]8>FC6J&I.V%VTM?%[LEF9+X50"!BD@> <(#-30>A0MJ3O%!M
M#=1M#2\B[R@GI#L%DH$K)%0K-CVA1M+%[ID<-?,: !28"4L,@##GYGX$40'M
MH51;!75;Q8LH?84?4JW@=.#""M4J3D\HK5"@;,*)220 HJ%))% VP>;[.@2B
MK(=&;1[4;1XWLJJ+4M2O\T&J99L.7%]A6K/9"?45!E1./)\:;$$HC,U]!Z#4
MFXE5FP3J*YCT$,:T73"W73@(.VR 3"LV&[CBPK0PLQ,J+@RHI=#(*BD#*,;,
MM!- $4ZIR1N VLU.]T>Y4S9W>X*;MZ.\CVFQ9@-78YA69W9"-8;9M1%&S'0&
M F'K]P$;%'KF&ST$ZLM$F38%YC8%-Y.OL#RF59H-7)1A6K#9"449!I1(S&TV
M@4!F5A(#($8CDS\;Q+T>!>7:)[C;)^)$W,GZ!2['M2CS@:LL7 LS/Z'*PNVJ
M!S>-:0*!S'>*& !A3,W<$D2%/5K)M2-PMR/L,W38UKA683YP+87O_(IX0BV%
MV\4-$EI$V2!JIH4Q .*!*80 R,=]-&FIYVZIMV@ZRL6X%EX^<$V%:\'E)]14
M.% M,7/Z"00RK2X&0,PW?U.%0#SH(4_K/'?KO$7>*XS+UUKK#UQ'\;4&^R?4
M4;K8W9,"W-A)$PAC_@@.8+!G&. 4 F'SA7N\<TZHF?GV@%:%9L4ZKS?'/K9W
MMX? WK='GXS['_#Y! /W8WP^W1SQTLUO3IPI@A71%4KEO>K*.PO4TBHWA[@V
M%W6Q:D\IW15U763MQZ44<UDV /7]?5'4SQ=-!]NC=%?_ U!+ P04    " #A
M@8-12('Y_IP#   =#   &0   'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6RU
M5VUOVS@,_BN"L0\;L*LM)W':(0G0EQUNP/56M-C=AV$?%)NVA<E63I*3]G[]
M4;)CNXGC%ACZ)=$+^? A13+,8B?53YT#&/)8B%(OO=R8S2??UW$.!=-G<@,E
MWJ12%<S@5F6^WBA@B5,JA!\&0>07C)?>:N'.[M1J(2LC> EWBNBJ*)AZN@(A
M=TN/>ON#>Y[EQA[XJ\6&9?  YMOF3N'.;U$27D"IN2R)@G3I7=)/UW1N%9S$
MWQQVNK<FUI6UE#_MYDNR] ++" 3$QD(P_-K"-0AAD9#'OPVHU]JTBOWU'OUW
MYSPZLV8:KJ7XAR<F7WKG'DD@994P]W+W!S0.S2Q>+(5VGV37R 8>B2MM9-$H
M(X."E_4W>VP"T5- G&&%L%$(#Q6F)Q0FC<+$.5HS<V[=,,-6"R5W1%EI1+,+
M%QNGC=[PTC[C@U%XRU'/K.YA"V4%Y#?R%U.*V9B2]S=@&!?Z YY^>[@A[]]]
M(.\(+\DM%P)CKQ>^0=,6P(\;,U>UF?"$F8C<RM+DFGPN$TB>Z_M(N>4=[GE?
MA:. 7V-S1B;!1Q(&83# YWI<_7*CSD@X'5)_1F?2AG'B\"8G\&ZX9EFF(&,N
M.65*]H']_B>*DB\&"OUCQ-"T-31UAJ:G#$$*2D&")>3PAYZB1H@<@BWC[6I"
MYPM_VP_/@$PP:66>49NUU&:CU/8>*XAE5O+_D*3)F2$[I@FVF"V7E19/F$>Q
MJ# );$(EK_"F-CKK,:51.,PT:IE&HTP_:\.Q W1V"3QNL*]8QI*LG[F +-/*
M5 K(!A27B<9+P1K1JM3XX#KEN,5KUU7+&(A<"UZGPF"M1$?!IS0(AGV:MS[-
M1WVZ<^R(W((BNYS'.?*T;9R7V2EJA*DQSYD>>Y9Q-JFL%'D"IO1(SI^WKIV/
M@GTU.3K%XEA52,L2+C6, 5^TP!=O6[4TZ-IL\$)QK#%I7DJ,!J2?&1>SV4'I
M-D+]BI@'T7#VT-[O /WEQM) ]"V'X1&] 2%ZHK70L*,7OA"_I(KWKX2I(*O2
MV/R,@6_96L#8(W5-G+YQ%Z==&Z?C??R5^3 ]BN4TFAX&_%AH$M(3 >^:.1WO
MYG71"<[67'##1^N-=HV71F\<X:X?TO$6]*J$GA_76W@8W@&9PU[M]P:P E3F
MYE)-7);6LUA[VLZ^EV[B\SOQ>G"^92KCV)L%I*@:G,WQF50]B]8;(S=NG%M+
M@\.A6^8XOX.R GB?2FGV&VN@_4>P^A]02P,$%     @ X8&#4:V4'9K*!0
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M4A*\ *.U=F,>03^+0#/FZV0T&#NOVPA912J)]<K$>M;$YHFB(A4,\IEO F!
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MZR  )WQ0"-$3S+D%?&YI<2.A$8)O3IUO;?R+>2?1@@M$H4_X&X4WM22J.#V
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MCC?_(R!@Q*991I%VP(5O[09L;AY<V6QND7+;' @:X03UL[FG;XB D9&8R.B
MQPC?"PX8W=S@]7T#*G*L%  U&M@"GEV?!7?%DRHW[0SN#K[3.[59OMA,3S!#
M "\C_ #K9%MS@!X_[22+FPB+DOY>VR+$(VJW- ?.\?&G7=P2E!HGMQ;6.<X
M.)".O\&!&#=W?/TIBHH<ZP8\Y&-"7VZ&OMP(]FU"TK%5Y4!1/I G>-W:\785
M7,L&3!16<P C'W,.Q\VPV6)]BY#3^H!3/A!:O]KZGDZ# SRYG,C\P$H^)@+F
MYH;16)&8R'&:!^@J!K:4KS(]%EP(P*>8*"H6 $$QM-VS.PUA0DUJAR^[S)4I
M%$>.S;L ]@F<?3Y.0YAPZQ^$HR+'J@']A'>6U.TRA+E)G!O*F3*N&0I@%&/B
M<&$&V987:@K%+D<KM!0ICM-7+AUOGR& FV*B*%T %\68-(:PY40-ZUMR'4[K
M TW%0*3^:NM[^HP8V!E/E!R) 97QF(@Z-O>/?9^!BAPK!7"-<;A^+LKZKK'U
M_"9=?F^8\4I'$0,RXXG"YQC0%^/H<SF*V"29$'W<683BT'$&%0/P8N^+(4Y'
M$9M$H_W8QR;C>O< O7@ >CZN(C9WB7/2#WYL0M219HBU"R)C(O/8#+N%,!2S
M""4.7L4 TA@'J<^B\781,6 RGBA EX!!B6\A!V[-F!&X:7*;D,OD$N I<7AZ
MFMS3+TC@HYSHFIT$,LHQ@;0T]XA]OX"*'"L%+)4X2_];;.9O%T]( *:<*'26
M@#UY6D9:FA S8F:;3.2P-7!.CL]&2TLVNJ^;]SFDU"[1O4$J6IJ;0F.*8B+'
MN@$.Y9@87)H!MG&[P";C>)L)(#3!$7K"RO'V%0GP,IDH+D\ C<F8;'5B!MZ&
M_6TR+OL#3A,<IZ?9W]-Q) #09**L=@*L3,9$T\EP5AL5.58*Z)K@=-T:,FT-
M>6),D0 XDXEBY@0 F)R6V4Y,H''2CY8M0E'B.&%-M'O&X_/:B4FV?E;;(N(X
M?"*A?E7Y#=+:^TZ.XH4^'*Q"KJ"'A-KUYG!,'+YO??QF^[=L;%*1="JGW8 .
M<:AZ+A]OCT%"[0IT.%&(3D+MRG,X)L>];SUD?4N2VVU][?YTB!/5W_J>_H*$
MVLWJ<*)<-PFU.]+AF)AZWQIS&KA,3S'MBG6(@_;]X[:RKKMC8#$Z0PV@W:H.
M)PJBB5ZP<6K%AJ5DPX@Q!H1Z2NEE'6]1US%\#(G+]-33R/<FQ1^6Z@]3/TN%
MB*M60Z\0&5<B8JD1L;Q:BY!3-0VJ X4D@XO'WU_HU2:3E9OH]2;C"DXLM23F
M?,!D>HII)"4X27UL[NLE]%(4,E%RF^BE)P.U)T-&M\3-YE3?"@F?J:X5L1"*
MH_6/;-W>07LHJJSV"B>(5KY"*!XUGUB32+12%$)/RV;OVWG5)!*M0H4,E*AX
M8=]2J>):(EJE"ADH5?&LY_-.-!.MLH70,<'QOK6GM35<#92[V*>G/WZU&A9"
M)RF@)5HA"AFH1!DRXBO*:(E67D(&ZDN<1O3EJ58O0AB>^#W5BEKA"&&C LY=
M:X',_X7V%0OM%UQ\3LN[9BD'N;IMVH1G;7JPW'YEQ/9#73QTW[IP4]1UL>Y^
MO%?I2I6M0//WVZ*H]Q_:+W(X?'/'Y?\!4$L#!!0    ( .&!@U&ZGUBJD00
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MZ-4S9 9559;3!YO'SW_N8-P<%?4=QPBIZBW'"3;/DW=T;W,V- 2;(%7!Y6C
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M\2<%2!. WV^$T$\#DZ#^D3+Y!5!+ P04    " #A@8-1;]IXC*X"   "!P
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MU$$[+FAT(&C3]49@RFS#"OE"#Q9!T[/@<V*TX$*S-9<%L%,JWB-5QAY#R=)
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MD&MW?.C5+7TNYM<O!3-8M"Y9%(_7X<=D]7?K*%O$158S7<05+R)T8F(]'LR
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M5"] FI%XQDS\R[EJ9)6 *ZP$MK12J*9.M:25S%*3>AI<79=8BN8K4]_79T/
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M\]NJ(\33B_X$Y^<&7_T?4$L#!!0    ( .&!@U$-P=RWDP4  !\;   9
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M\)X:AL9]$-12_CY<7EQ?7K)#B*FT%7V1]8ZX=JL3=-\JE;W*9>]EJ2Q@G<T
M1[54-IB$-9O)8YLPZM1RV<#3;4YEOU+5?TTJG6CJQ&:I!.@56^Q*WE'E\^BM
MDA<&#PTF>%GZ2MSV!:GEK\&F?A.;:*)^+7]-1NU: OV-+IJCFKOQ1=/M60I3
M?.NJW6I$^N &@]K^27@\#AOV)W:D<EW[@;Z8Q\Z9HBZI(<,9N0H.>U1IJAAQ
MBH61"]?#;Z2AB< ]IC06HK(&]'XFI5DOK(-JT!S] U!+ P04    " #A@8-1
M2_@42<H"  !S!P  &0   'AL+W=O<FMS:&5E=',O<VAE970U."YX;6RE5>]/
MVS 0_5=.$1]  I(F;=E06XG^8%2B A6Q?9CVP237Q"*Q.]MM8=H?O[.3A@)M
MA[8OK>W<>^_N_'3NK*1ZU!FB@:<B%[KK9<;,SWU?QQD63)_*.0KZ,I.J8(:V
M*O7U7"%+'*C(_3 (VG[!N/!Z'7=VJWH=N3 Y%WBK0"^*@JGG/N9RU?4:WOI@
MRM/,V ._UYFS%._0W,]O%>W\FB7A!0K-I0"%LZYWT3@?M6R\"_C*<:4WUF K
M>9#RT6[&2=<+;$*88VPL Z._)0XPSRT1I?&SXO1J20O<7*_9+UWM5,L#TSB0
M^3>>F*SK??(@P1E;Y&8J5U=8U>,2C&6NW2^LJMC @WBAC2PJ,&50<%'^LZ>J
M#QL XMD.""M ^!;0W &(*D#T485F!6A^5*%5 5SI?EF[:]R0&=;K*+D"9:.)
MS2Y<]QV:^L6%]<F=4?25$\[TAJCXDMG+TL!$ H.%4BCB9Q@]Q1D3*<*4ZT>8
M,$&N(7\8.('#+^0_?0374FN"33&6J>"_, $NX.)F,#Z& =,97)()X0J3E((.
MAV@8SPEU O=W0S@\.((#&S_A>4Z.T1W?4#DV*3^N4N^7J8<[4H]@(H7)-(Q$
M@LD6_' _OKT'[U,;ZUZ&ZU[VP[V$-[$YA2@XAC (@RWY##X #UL6WOB\K9S_
M4Q_]L_JK9D2UL2+'U]S!5QL)UT92S"#$U')%TT'#[](D,VN2C$S"1;I'MEG+
M-IUL]%<_PUAHHQ;6L_JX]&QI6?A^32 8&RSTCSV2K5JRM;?2G?ZO2\.M[BY9
MVX[5CO-EKQUU_.6F8=Z'G)RU7\<,W\<T6XW7,:,M/(W@1:PLV]^8(@6JU(UO
M33>V$*:\]_JT?B$NW&!\<]YOG \:6\Z']**4#\ +??D<39BB^]>0XXRD@M,S
M2EB5([[<&#EW,^Q!&IJ(;IG1JXC*!M#WF91FO;$"]3O;^P-02P,$%     @
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M U*G+OMW.;%JX1O4G;+4[OPPIU\>U,Z OJ=*V?7$;5#_1(U_ 5!+ P04
M" #A@8-175ZOR-$"  "<!P  &0   'AL+W=O<FMS:&5E=',O<VAE970V,"YX
M;6RE5=M.VT 0_961Q0-(@!TG@18ED<BE)1(I*(CVH>K#8D_L%?9NNKM.H.+C
M.[MV3$IS0>U+O)<Y9RY[,M-92O6H4T0#3WDF=-=+C9E?^+Z.4LR9/I5S%'0S
MDRIGAK8J\?5<(8L=*,_\, C._)QQX?4Z[NQ6]3JR,!D7>*M %WG.U',?,[GL
M>@UO=3#E26KL@=_KS%F"=VCNY[>*=G[-$O,<A>92@,)9U[ML7(S:UMX9?.6X
MU&MKL)D\2/EH-^.XZP4V(,PP,I:!T6>! \PR2T1A_*PXO=JE!:ZO5^R?7.Z4
MRP/3.)#9-QZ;M.M]\"#&&2LR,Y7+*ZSR<0%&,M/N%Y:5;>!!5&@C\PI,$>1<
ME%_V5-5A#4 \FP%A!0C? EI; ,T*T'ROAU8%:+W70[L"N-3],G=7N"$SK-=1
M<@G*6A.;7;CJ.S35BPNKDSNCZ)83SO2&J/B"V<?2P$0,@T(I%-$SC)ZBE(D$
M8<KU(TR8(-60/@R<P.%GTI\^@FNI-<&F&,E$\%\8 Q<P%I',\1B^D,;'@FB-
M0UUAG)#MX1 -XQF!3^#^;@B'!T=P8&$3GF4D'-WQ#65E8_.C*H-^F4&X)8,F
M3*0PJ8:1B#'>@!_NQI_MP/M4S;JDX:JD_7 GX4UD3J$9'$,8A,&&> ;O@(=M
M"V]\W)3._WD?_;/W/XK1K/75='RM+7RUGG"E)\4,0D0E5]0D-+S C4E1 74^
MNN$B(4MJ@IHD)$A"+TY(_%5(J1/2CLA:=60M%UESK_))I]JHPM+KXU+=I;CA
M^S6!8&PPUS]VN&S7+ML[B[']G[(GP5)V)?F9([?]?]&C!UZL*VNOQ7"OQ>AO
MB_/:HLS:7VLW.:K$]7E-;UH(4RJC/JU'R:7KH&_.^XV+06/#^9!&3SDI7NG+
MN35A*J'> QG.R%5P>D[1JG(6E!LCYZ[9/4A#K=,M4QJ?J*P!W<^D-*N-=5 /
MY-YO4$L#!!0    ( .&!@U%:N W?[0(  /0(   9    >&PO=V]R:W-H965T
M<R]S:&5E=#8Q+GAM;+U66V_:,!3^*U;4AU9JFY!PV2I *I>M2&6MJ+H]3'MP
MDT-B-;&9;2Z=]N-W[(042F!HT_8"MG.^[]R^^*2]%/)9)0":K+*4JXZ3:#V[
M<ET5)I!1=2EFP/')5,B,:MS*V%4S"32RH"QU?<]KNAEEW.FV[=F][+;%7*>,
MP[TD:IYE5+[T(!7+CE-SU@<3%B?:'+C=]HS&\ #Z<78O<>>6+!'+@"LF.)$P
M[3C7M:MAR]A;@\\,EFIC34PF3T(\F\THZCB>"0A2"+5AH/BW@#ZDJ2'",+X7
MG$[IT@ WUVOV#S9WS.6)*NB+] N+=-)QWCDD@BF=IWHBEC=0Y-,P?*%(E?TE
MR\+6<T@X5UID!1@CR!C/_^FJJ,,& 'FJ 7X!\-\"ZGL 00$(CO50+P#U8STT
M"H!-W<USMX4;4$V[;2F61!IK9#,+6WV+QGHQ;G3RH"4^98C3W0%(MJ"F68I0
M'I'^7$K@X0L9KL*$\AC(A*EG,J8<58/ZT.2"G'Y$_:DS<BN40M@$0A%S]@,B
MPCBYONN/SLDG5/B((ZFVF!N(8K0\'8"F+$7H!7E\&)#3DS-R8D!CEJ8H&]5V
M->9D(G/#(OY>'K^_)_Z C 77B2)#'D%4@1\<QC</X%VL95E0?UW0GG^0\"[4
MER3PSHGO^5Y%//TCX'[#P&OOJ]+Y.^_#/_:^58R@5%=@^8+?J@O5H+2<&S6H
M\UQ!N8#(UUL$D9&&3'T[X+)>NJQ;E_4]+O>ID;VJ,;%JK-):3MVTU.:&771K
MS7K;76SV;]?FHA%LVPPJ>/Q6<]MH6$%4:_BET5;VC3+[QL'LR]<7UJ^OI!I(
MB!J7>"<K\O.88FRY;I:NF_^KUZW29>O?];IU1*]W;79[7<&SV^L*HMU>NQO7
M> 8RMO-38?/F7.?O7'E:CNAK.YG>G/=J5_U:Q?D 1WH^@5_I\^^!,94QWNDD
MA2FZ\BY;*#.9S]A\H\7,#I$GH7$DV66"GR4@C0$^GPJAUQOCH/S0Z?X"4$L#
M!!0    ( .&!@U$-HO1S.P4  .\@   9    >&PO=V]R:W-H965T<R]S:&5E
M=#8R+GAM;+6:46_;-A#'OPIA]*$%VD@B*=LI' .)LV(!&C1(UNYAV ,CTS81
M2?1(.DZ!??A1LBPJHJ30G?226/;=\7A_\J<SY=F>BR>YH52!ER1.Y<5HH]3V
ML^?):$,3(L_XEJ;ZDQ47"5'Z4JP]N164+'.G)/:@[X^]A+!T-)_E[]V)^8SO
M5,Q2>B> W"4)$3^O:,SW%Z-@='SCGJTW*GO#F\^V9$T?J/J^O1/ZRBNC+%E"
M4\EX"@1=78PN@\^+$&4.N<4/1O>R\AID4WGD_"F[N%E>C/PL(QK32&4AB/[W
M3!<TCK-(.H]_BJ"C<LS,L?KZ&/U+/GD]F4<BZ8+'?[*EVER,IB.PI"NRB]4]
MW_].BPF%6;R(QS+_"_:%K3\"T4XJGA3..H.$I8?_Y*4H1,4AP"T.L'" K@ZH
M<,@KYQTRRZ=U3129SP3? Y%9ZVC9B[PVN;>>#4LS&1^4T)\R[:?FUU2P9Y*5
M4@*2+L%B)P1-HY_@MY=H0](U!?=,/H%;DFI1M7P*? *+F$C)5BPB!R6TVQ?"
M!/A!XAT%EPG?I4H"O@(F.+A)I1*[+( $+ 57)"9I1,%#EK@$[Z^I(BR6'W3T
M[P_7X/V[#^!=9G?+XEB/(6>>TI/-4O:B8F)7AXG!EHE]B]090/Y' 'WH-[@O
MNMTOM^(,0-SD[ND2EW6&99UA'@^]7>>/U6K]]54;@AM%$_EWQS"H' ;EP^ W
MAP&74NK25@=K*N(AW#@/EVWYY_ET,O.>JX6R3; /2YM7:>(R3>R:YE=&'EG,
M%*-OYGJ(&582@7Y02]:VP2VYAF6N86>NY8Z@QQTAB*(@XJD2&D*R0[5Q.<1X
MR,4Q*8>9]+LX)E8QIZA6;]L$G9\W%WQ:ICD=8'%,'1:';1-,FG,]+W,][\SU
M#ZY(K&]G:B=2(/=DV[4< M] V1]R0005^@?]+HDBWJLZ-Y<P,&@,8/^"+XJ@
MKS()6U(Q^ RZ^;D07,I/T7'+LU110:5RW_*!06" !]78\"OH!MCI&H<=&A?%
MMTU02^T-!(.Q8YY2-V*2K5-=]"4@$FSH<LW2M9:C;"*Z*F-X&$P&E< 0+7!&
MFJ,$-JI"OZZ!;8,FN$4% [2@FVB_1M\BZ"NTAM-ZPK912[K0D!+Z_2T:\"]X
MZVZN3;ZI#17@P "E(V5Z=76 !K8P&'*YP4JOZ0Q4M^4&;99B7%.OP09.@A;]
M#'"A:\/:LWYOZV9(#0<E-32DACV3&MH8'M=ELTT"OX75T+ :]LCJDV2+(K'3
MD>C+EJ:2=@IH. \'Y3PTG(=#M*[0!OFTSLX&FY:^"QK40U?4]RQB;.;>]9W6
M0!X-V@XC0VCDW Z?H!^R>^))_6;=8-.B'S*81ZZ8ER#EZG\U3:ARPH &%<-@
M%SD?$CB>9=A?_I%UF-%PB#!M$<)P&SES^Y1E8Y,9U[]>-]B@MG0-O)$[O)W6
MS2!]$S+X1H/B&QE\HY[;=-30@EL2-I"[Y7LJ,NA&[NCN7<(3[L'8,!P/RG!L
M&(Z'8#BV^6QMQ@:;H*63P@;BN&>(:YGL4Z?3MQ\VP,># A]7#H5[!CYN@'E=
M,]O$;Y',X!Z[XKX7R4[9;H;Q>- C96S@C)T/E4_9;O:Y<;UC:C!IXR8VA,>N
MA#^!FTYG@K^P PWM\?F08H8&TJ'K:8KC#BSB=>W !I,6:(:&\:$KXP>3\81=
M&1K8AX,^!0P-LT/GYX G[,K0?M17WY6=)H=DO<K3Z.RG +=$:#DDB.E*^_AG
M$[T4Q.'I^N%"\6W^@/J1*\63_.6&DB45F8'^?,6Y.EYDS[S+WSC,_P-02P,$
M%     @ X8&#49EN"=FS @  'P@  !D   !X;"]W;W)K<VAE971S+W-H965T
M-C,N>&ULS59=;]HP%/TK5U$?6JDE(>&S@D@MK%HEV"JJ=@_3'DRX$*N.S6P#
M[;^?[:0AXVN5MH>]$'_<<WS.O5<VO8V0+RI%U/":,:[Z7JKU\MKW59)B1E1-
M+)&;G;F0&=%F*A>^6DHD,P?*F!\&0<O/".5>W'-K#S+NB95FE..#!+7*,B+?
M;I&)3=^K>^\+$[I(M5WPX]Z2+/ 1]=/R09J97[+,:(9<4<%!XKSOW=2O!UT;
M[P*>*6Y490S6R52(%SNYG_6]P I"AHFV#,1\UCA QBR1D?&SX/3*(RVP.GYG
MOW/>C9<I43@0[!N=Z;3O=3R8X9RLF)Z(S6<L_#0M7R*8<K^P*6(##Y*5TB(K
MP$9!1GG^):]%'BJ >N,(("P X4<!40&(G-%<F;,U))K$/2DV(&VT8;,#EQN'
M-FXHMU5\U-+L4H/3\1 E71.;2@6$SV"PDA)Y\@:?7I.4\ 7"A*H7&!-N:FJJ
MI^$*MABX40IUCAQ1,J6,:FJ8QDC42N(,B(8[0B4\$[9"L&6#"2;F#,H7<$L4
M57 ^1$TH4Q>&>;MW!4^/0S@_NX SH!S&E#%3==7SM3%MI?M)8? V-Q@>,?@U
MT36(@DL(@S X !^<AM\L90W"QB&X;U)=YCLL\QTZOL81OA&ND4']!%-4,D6.
M*3K"M,WKY1_+8!*_3:V-^B*XW*G#]Y$Y .XU9NK'"7F-4E[CI-%*DQ"G[E#I
M<HJ6H[#WS3KN1#U_72W/?DC4[98QOTEKEM*:'Y7&MMDZI"_G:58.#X/ZCL#]
MF'K[L+Y6J:_U@1X)3Q2A73*U_\<>Z93R.G_?(YV]_#9V*K ?$1TN0+?4U?U'
M#=+=Z\Y@1]Q^1-C<4>=7KF_[=(Z)7%"N@.'<@():VUB3^7.43[18NAM]*K1Y
M']PP-2\X2AM@]N="Z/>)?23*_P3Q+U!+ P04    " #A@8-1,L=KDAT%  #+
M'0  &0   'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6S%65UOXC@4_2L6FH=6
MFC:Q';XJBM32G=V1IC-5N[/[[ 8#5I.8M4WI_/MU0H@A=EQ@:/L""=Q[<^ZU
MSSVV,UAR\21GE"KPDB:9O&S-E)I?!(&,9S0E\IS/::;_F7"1$J5OQ320<T')
MN'!*DP"%82=("<M:PT'QVYT8#OA")2RC=P+(19H2\>N:)GQYV8*M]0_W;#I3
M^0_!<# G4_I U<_YG=!W015ES%*:2<8S(.CDLG4%+T91E#L4%O\PNI0;UR!/
MY9'SI_SFZ_BR%>:(:$)CE8<@^NN9CFB2Y)$TCO_*H*WJF;GCYO4Z^I<B>9W,
M(Y%TQ)-_V5C-+EN]%AC3"5DDZIXO_Z)E0NT\7LP367R"96D;MD"\D(JGI;-&
MD+)L]4U>RD)L.,"HP0&5#FA7!UPZX"+1%;(BK1NBR' @^!*(W%I'RR^*VA3>
M.AN6Y</XH(3^EVD_-;RA@CV3O)02D&P,1@LA:!;_ G^\Q#.232FX9_()W)),
M#ZH>/@7.P(_)1%*E6#8%5U)?K3R_,?+($J:8CG1R0Q5AB3S5UC\?;L#)IU/P
M"; ,W+(DT:,G!X'2X',(05P"O5X!10U ?\3J'.#P,T A"AWN([_[U5R< Q2Y
MW -=LJINJ*H;*N+A5^L&2%&#"T]07 7%1="H(>B?@DL)KE*^T'7F$W!/8R[&
M=+PN\\E&C4]=)5R%[Q3A<P(_#WO=0?"\62;;) I19;,%.ZI@1[O#_LY5.4&
M9JF:47!-$I+%%#SDD_0S^,(R?<M( KYF4HE%/JF<\V'UT/8&TK->6,O&80.[
M[FS:53;M(V8S(G(&= ])B*)"YW3'I=(#=J*'CNK),78.4]M"7<_+MCB+>NZ\
M.E5>'6]>WW4.JZQ<D#K6 ^L3Q[; N*'4W0I2=U<2)69F^YC4JR+WWI9)/7L
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M;:6D02EW6YFMC>],[<PN-CL=)/_'6,/ 01]4D795'-8P:#4,@AKF6RDISYZ
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MK4597:XIR:FT'<SSI1#Z^<86:(_NIO\"4$L#!!0    ( .&!@U%[C]_G 0,
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M7;9UF431>Q03Q9?VKIQQI6]>.\QTNP;" /3[.>=J,S$.J@:P_Q=02P,$%
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M'C#[:RGQ;6([TO ]R?\ 4$L#!!0    ( .&!@U$#YL)P-@4  .L2   9
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M'F.X31*N /!^SY@\-]0 ]?UT^3]02P,$%     @ X8&#47;KJ6N= @  3P<
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MQQ?W?+'CBP[P70ED.>.-.U$KR!K%D)DCM'C,>&/VCQ1*5F0FJ[I!ZMJ'+,C
MP?SQR1"3:X1*_SPB:]S+&A]-<T^6?I(%>[*R?5FPE54;6>XJD)/V1IP.78-6
MP=@IL"W[(;U(_(?=@_72(][WF/^58W&,HRV-O],A*E!KUYJU2:X1V!Z,WMIW
M_RO7])[9IZ/+V6C /C>O1=O<G^C;I^:&JC43FG H3*C@[)W1J=KVW4Y0UJX_
MW4DTW<X-2_/B@;(.9KV0$K<3&Z!_0],_4$L#!!0    ( .&!@U&1IRFD6 0
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MZJ#/JD\!U8V@Q_*L^TR%/#F7EP>,4LP40#[?42HN-RI!\T%F_C]02P,$%
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MCL&^*_.P3@9Y3L8%,3J\]L5G1*U#1"QB ?$,S>:_K4)ICFO-1PWV3EAFC@>
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MH'C"D>I*<_)5JX3-O=)K8#+&>H.!<4WYT*4](P>):D2(N1'97IP)T## <8X
M*7DY%\H+&HV=NDV<5@>O^A6"C44,ZO&ORI,FKZ&'18$ZGZ0B\7QA*DY$M1ZD
M?>O1[%0]1$*&PY_NI9443WC$9X& +M^-B0YT"I\6@-+():+ 3\S@U\[?-O'K
MQ-0"AZ!JC%P1E9B).BR6@=F1^9YX41IZ!=VF?Z\*G)H@2A1$R?Y!E"B(DAU
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MHURR\!1AQP3CE!K(O ;DJAWDGCZC/G88HZ9LKMLA/H?F%/7]747R;)J@_NP
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M3T< HG;?D78#(U/W^K^0QLC87:X9C9BR!O!\*:5Y&=@O"L77O-E/4$L#!!0
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M)8/=%%LW1=#-+\NJUOG?/5M4]X8:=%HN\KM"H;1IE 8)0@!^,R<H$Q#DAA<
MQ3%S_ 9!&/9;;OV60;]O3&CK=:;7=;N06P8U[E99GFHU1UG5P(Y+_TX2Z?@-
M8(B#F0(8S)V%,P- 0]&.MU['0:\GJC9R4*(BU_FBCWGVD-8+U?R*2@7NY!B8
M?"= $P"#B1MJ'^3&&3(C8MCC9.MQ<F ;9]52H3ME-%&9U=U]TNFS N.;>'?
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( .&!@U$PK3/[V@4  "<T   /
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MWV("  "T+@  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=I+;J-
M%(7AK5@L(+CNJYQ6G%%/,FUE \@I/Q3;(*#5R>[;<@;V03WH2<09H0)Q^4>?
M4,'3KW)LQD-['O:';EA\G([G85WMQ['[4=?#9E].S?#0=N5\N;)M^U,S7I;]
MKNZ:S7NS*[4LEU'W]S.JYZ?[F8O7SZ[\S\1VNSULRL]V\_M4SN,_!M=_VOY]
MV)<R5HO7IM^5<5W5'\?;Z:&^'M+#97*U>'E;5_W+6ZKJN8,$@F3^((4@G3_(
M(,CF#W((\OF# H)B_J ,07G^H!4$K>8/>H2@Q_F#TA)E7!(D3; FT#HAUXG
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M<F^Y/?ZZ_#J).*^N.-?W%</S7U!+ P04    " #A@8-1W2=K"Q@"  "%+0
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MT_O])\?/SWIPW?B2S^9_7U__!E!+ 0(4 Q0    ( .&!@U$'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ X8&#4=QM6M#N    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ X8&#49E<G",0!@  G"<  !,
M     ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #A@8-1
M,]VV^LL(  #B/P  &               @($-"   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ X8&#40:8OY,3!@  CQD  !@
M     ("!#A$  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    (
M .&!@U%8\YD.2P0   D0   8              " @5<7  !X;"]W;W)K<VAE
M971S+W-H965T,RYX;6Q02P$"% ,4    " #A@8-17_(9M] &  !*'   &
M            @('8&P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#
M%     @ X8&#4="WLF._ @  @@<  !@              ("!WB(  'AL+W=O
M<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( .&!@U$3O0C]K@L  (!'
M   8              " @=,E  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q0
M2P$"% ,4    " #A@8-1W[;0>GT"  !J!@  &               @(&W,0
M>&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ X8&#4?7\X;C]
M!@  -!T  !@              ("!:C0  'AL+W=O<FMS:&5E=',O<VAE970X
M+GAM;%!+ 0(4 Q0    ( .&!@U$8#]2D508  .@.   8              "
M@9T[  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #A@8-1
M<,YA?!D"  #1!   &0              @($H0@  >&PO=V]R:W-H965T<R]S
M:&5E=#$P+GAM;%!+ 0(4 Q0    ( .&!@U&CCTB;: H  . ;   9
M      " @7A$  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%
M  @ X8&#4?D?;LOO"   +1T  !D              ("!%T\  'AL+W=O<FMS
M:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " #A@8-1K$A ?1 )  #^'@
M&0              @($]6   >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+
M 0(4 Q0    ( .&!@U%&^G,98@L  -8C   9              " @81A  !X
M;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ X8&#4;.4,SHV
M"P  +B   !D              ("!'6T  'AL+W=O<FMS:&5E=',O<VAE970Q
M-2YX;6Q02P$"% ,4    " #A@8-1D-LZ]_P.  "I0   &0
M@(&*>   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( .&!
M@U'_07R/90(  !X%   9              " @;V'  !X;"]W;W)K<VAE971S
M+W-H965T,3<N>&UL4$L! A0#%     @ X8&#46.3%STW"   CA8  !D
M         ("!68H  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
M    " #A@8-1\I8SV[D&   I%@  &0              @(''D@  >&PO=V]R
M:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( .&!@U&=\[T@K00  *D+
M   9              " @;>9  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL
M4$L! A0#%     @ X8&#4?SWE,MC P  YP<  !D              ("!FYX
M 'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #A@8-1?,.@
MPK,$   M#   &0              @($UH@  >&PO=V]R:W-H965T<R]S:&5E
M=#(R+GAM;%!+ 0(4 Q0    ( .&!@U%=Z%?CRP4   L5   9
M  " @1^G  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @
MX8&#404R*=&"&   QD\  !D              ("!(:T  'AL+W=O<FMS:&5E
M=',O<VAE970R-"YX;6Q02P$"% ,4    " #A@8-1VVLXU!8'  !$$0  &0
M            @(':Q0  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4
M Q0    ( .&!@U&'?]2N6 4  %0-   9              " @2?-  !X;"]W
M;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ X8&#45*SX6&G!@
M<!   !D              ("!MM(  'AL+W=O<FMS:&5E=',O<VAE970R-RYX
M;6Q02P$"% ,4    " #A@8-1:(OIXR@$   ]"@  &0              @(&4
MV0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( .&!@U&X
M$W%<8@,  "4(   9              " @?/=  !X;"]W;W)K<VAE971S+W-H
M965T,CDN>&UL4$L! A0#%     @ X8&#45YFB@J""   EAL  !D
M     ("!C.$  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .&!@U&7;<ZE4@,  &T'   9              "
M@23_  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ X8&#
M42?KPMQV P    @  !D              ("!K0(! 'AL+W=O<FMS:&5E=',O
M<VAE970S-BYX;6Q02P$"% ,4    " #A@8-1;=S?744#   W"   &0
M        @(%:!@$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0
M   ( .&!@U%2.SR*LP,  # )   9              " @=8) 0!X;"]W;W)K
M<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ X8&#4=G06WJ8!0  A@P
M !D              ("!P T! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q0
M2P$"% ,4    " #A@8-1N;),<J@%  #H&P  &0              @(&/$P$
M>&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( .&!@U&%4&88
MF 8  %8G   9              " @6X9 0!X;"]W;W)K<VAE971S+W-H965T
M-#$N>&UL4$L! A0#%     @ X8&#44B!^?Z< P  '0P  !D
M ("!/2 ! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " #A
M@8-1K90=FLH%   L'P  &0              @($0) $ >&PO=V]R:W-H965T
M<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( .&!@U&6)9K/,P,  )T*   9
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M970T."YX;6Q02P$"% ,4    " #A@8-1NI]8JI$$  "9%P  &0
M    @($Y1P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    (
M .&!@U%&$E8C+00  ($0   9              " @0%, 0!X;"]W;W)K<VAE
M971S+W-H965T-3 N>&UL4$L! A0#%     @ X8&#46CJDFJ: P  L P  !D
M             ("!95 ! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"
M% ,4    " #A@8-1;]IXC*X"   "!P  &0              @($V5 $ >&PO
M=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( .&!@U$E7^-[10,
M *X+   9              " @1M7 0!X;"]W;W)K<VAE971S+W-H965T-3,N
M>&UL4$L! A0#%     @ X8&#45C3@T4A!P  X24  !D              ("!
MEUH! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " #A@8-1
M;D9AA*@*  !#6   &0              @('O80$ >&PO=V]R:W-H965T<R]S
M:&5E=#4U+GAM;%!+ 0(4 Q0    ( .&!@U$-P=RWDP4  !\;   9
M      " @<YL 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%
M  @ X8&#469 H8(S P  = H  !D              ("!F'(! 'AL+W=O<FMS
M:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " #A@8-12_@42<H"  !S!P
M&0              @($"=@$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+
M 0(4 Q0    ( .&!@U%[1H/O3P,  % )   9              " @0-Y 0!X
M;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ X8&#45U>K\C1
M @  G <  !D              ("!B7P! 'AL+W=O<FMS:&5E=',O<VAE970V
M,"YX;6Q02P$"% ,4    " #A@8-16K@-W^T"  #T"   &0
M@(&1?P$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( .&!
M@U$-HO1S.P4  .\@   9              " @;6" 0!X;"]W;W)K<VAE971S
M+W-H965T-C(N>&UL4$L! A0#%     @ X8&#49EN"=FS @  'P@  !D
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M=#8W+GAM;%!+ 0(4 Q0    ( .&!@U%C\,[;MP,  #P/   9
M  " @<:: 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @
MX8&#4=6A!Z=R @  6P8  !D              ("!M)X! 'AL+W=O<FMS:&5E
M=',O<VAE970V.2YX;6Q02P$"% ,4    " #A@8-1 ^;"<#8%  #K$@  &0
M            @(%=H0$ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4
M Q0    ( .&!@U%"*QE># 0  *L.   9              " @<JF 0!X;"]W
M;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ X8&#47;KJ6N= @
M3P<  !D              ("!#:L! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX
M;6Q02P$"% ,4    " #A@8-1D:<II%@$   ]%   &0              @('A
MK0$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( .&!@U%#
M-@72$@0  )P1   9              " @7"R 0!X;"]W;W)K<VAE971S+W-H
M965T-S0N>&UL4$L! A0#%     @ X8&#4=$U@X5A P  I@P  !D
M     ("!N;8! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .&!@U&#GG:Y@@(  #P.   -              "
M 633 0!X;"]S='EL97,N>&UL4$L! A0#%     @ X8&#49>*NQS     $P(
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9>&UL4$L%!@    !7 %< V!<  .3A 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>662</ContextCount>
  <ElementCount>431</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>160</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Statements of Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited</Role>
      <ShortName>Consolidated Statements of Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Statements of Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited</Role>
      <ShortName>Consolidated Statements of Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Equity (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical</Role>
      <ShortName>Consolidated Statements of Equity (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2104103 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2109104 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2114105 - Disclosure - Restructuring</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/Restructuring</Role>
      <ShortName>Restructuring</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2118106 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2126107 - Disclosure - Financing Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancingArrangements</Role>
      <ShortName>Financing Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2130108 - Disclosure - Derivatives and Currency Exchange Risk Management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2141109 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2144110 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2150111 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2152112 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2156113 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2159114 - Disclosure - Retirement Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RetirementBenefitPlans</Role>
      <ShortName>Retirement Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2163115 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2166116 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2168117 - Disclosure - Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/SegmentandGeographicInformation</Role>
      <ShortName>Segment and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/BasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/NewAccountingPronouncements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/Revenue</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/Acquisitions</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2315303 - Disclosure - Restructuring (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RestructuringTables</Role>
      <ShortName>Restructuring (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/Restructuring</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2319304 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/FinancialInstruments</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2327305 - Disclosure - Financing Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancingArrangementsTables</Role>
      <ShortName>Financing Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/FinancingArrangements</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2331306 - Disclosure - Derivatives and Currency Exchange Risk Management (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2342307 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/Inventories</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2345308 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2353309 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/EarningsPerShare</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2357310 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/StockBasedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2360311 - Disclosure - Retirement Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RetirementBenefitPlansTables</Role>
      <ShortName>Retirement Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/RetirementBenefitPlans</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2364312 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2369313 - Disclosure - Segment and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/SegmentandGeographicInformationTables</Role>
      <ShortName>Segment and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/SegmentandGeographicInformation</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - Revenue - Disaggregation of Net Sales by Segment and Division (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails</Role>
      <ShortName>Revenue - Disaggregation of Net Sales by Segment and Division (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails</Role>
      <ShortName>Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - Acquisitions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Acquisitions - Reconciliation of Beginning and Ending Balances of Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails</Role>
      <ShortName>Acquisitions - Reconciliation of Beginning and Ending Balances of Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Acquisitions - Fair Value Measurement, Contingent Consideration, Significant Unobservable Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails</Role>
      <ShortName>Acquisitions - Fair Value Measurement, Contingent Consideration, Significant Unobservable Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - Restructuring - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RestructuringNarrativeDetails</Role>
      <ShortName>Restructuring - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Restructuring - Activity Related to Restructuring Programs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails</Role>
      <ShortName>Restructuring - Activity Related to Restructuring Programs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2420409 - Disclosure - Financial Instruments - Investments by Category and Related Balance Sheet Classification (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails</Role>
      <ShortName>Financial Instruments - Investments by Category and Related Balance Sheet Classification (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2421410 - Disclosure - Financial Instruments - Available-For-Sale Securities in Continuous Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails</Role>
      <ShortName>Financial Instruments - Available-For-Sale Securities in Continuous Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - Financial Instruments - Activity Related to the Company's Investment Portfolio and Debt Securities Contractual Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails</Role>
      <ShortName>Financial Instruments - Activity Related to the Company's Investment Portfolio and Debt Securities Contractual Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Financial Instruments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Financial Instruments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - Financial Instruments - Summary of Equity and Other Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails</Role>
      <ShortName>Financial Instruments - Summary of Equity and Other Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2425414 - Disclosure - Financial Instruments - Activity Related to the Company's Investment Portfolio, Equity and Other Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails</Role>
      <ShortName>Financial Instruments - Activity Related to the Company's Investment Portfolio, Equity and Other Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - Financing Arrangements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails</Role>
      <ShortName>Financing Arrangements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - Financing Arrangements - Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails</Role>
      <ShortName>Financing Arrangements - Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2432417 - Disclosure - Derivatives and Currency Exchange Risk Management - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - Derivatives and Currency Exchange Risk Management - Derivative (Gains) Losses Not Designated as Hedging Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - Derivative (Gains) Losses Not Designated as Hedging Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in AOCI, Cash Flow Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in AOCI, Cash Flow Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - Derivatives and Currency Exchange Risk Management - Amount of (Gains) Losses Recognized in Consolidated Statements of Income, Cash Flow Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - Amount of (Gains) Losses Recognized in Consolidated Statements of Income, Cash Flow Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in Income, Net Investment Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in Income, Net Investment Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in AOCI, Net Investment Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in AOCI, Net Investment Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2438423 - Disclosure - Derivatives and Currency Exchange Risk Management - Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2439424 - Disclosure - Derivatives and Currency Exchange Risk Management - Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2440425 - Disclosure - Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2443426 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/InventoriesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2446427 - Disclosure - Goodwill and Other Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2447428 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2448429 - Disclosure - Goodwill and Other Intangible Assets - Carrying Amount and Accumulated Amortization of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Carrying Amount and Accumulated Amortization of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2449430 - Disclosure - Goodwill and Other Intangible Assets - Estimated Future Aggregate Amortization Expense of Amortizable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Estimated Future Aggregate Amortization Expense of Amortizable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2451431 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/IncomeTaxes</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2454432 - Disclosure - Earnings Per Share - Schedule of Basic and Diluted Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails</Role>
      <ShortName>Earnings Per Share - Schedule of Basic and Diluted Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2455433 - Disclosure - Earnings Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/EarningsPerShareNarrativeDetails</Role>
      <ShortName>Earnings Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2458434 - Disclosure - Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/StockBasedCompensationDetails</Role>
      <ShortName>Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/StockBasedCompensationTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2461435 - Disclosure - Retirement Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RetirementBenefitPlansDetails</Role>
      <ShortName>Retirement Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/RetirementBenefitPlansTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2462436 - Disclosure - Retirement Benefit Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails</Role>
      <ShortName>Retirement Benefit Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2465437 - Disclosure - Accumulated Other Comprehensive Loss - Changes in AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss - Changes in AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2467438 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/CommitmentsandContingencies</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2470439 - Disclosure - Segment and Geographic Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/SegmentandGeographicInformationDetails</Role>
      <ShortName>Segment and Geographic Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/SegmentandGeographicInformationTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="mdt-20201030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - mdt-20201030.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - mdt-20201030.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="mdt-20201030.htm">mdt-20201030.htm</File>
    <File>ex101-formofperformanc.htm</File>
    <File>ex102-amendedandrestat.htm</File>
    <File>ex103-medtronicnonxqua.htm</File>
    <File>ex104-medtroniccapital.htm</File>
    <File>mdt-20201030.xsd</File>
    <File>mdt-20201030_cal.xml</File>
    <File>mdt-20201030_def.xml</File>
    <File>mdt-20201030_lab.xml</File>
    <File>mdt-20201030_pre.xml</File>
    <File>mdt-2021q210qxex311.htm</File>
    <File>mdt-2021q210qxex312.htm</File>
    <File>mdt-2021q210qxex321.htm</File>
    <File>mdt-2021q210qxex322.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mdt-20201030_g1.jpg</File>
    <File>mdt-20201030_g2.jpg</File>
    <File>mdt-20201030_g3.jpg</File>
    <File>mdt-20201030_g4.jpg</File>
    <File>mdt-20201030_g5.jpg</File>
    <File>mdt-20201030_g6.jpg</File>
    <File>mdt-20201030_g7.jpg</File>
    <File>mdt-20201030_g8.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/currency/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>110
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mdt-20201030.htm": {
   "axisCustom": 0,
   "axisStandard": 39,
   "contextCount": 662,
   "dts": {
    "calculationLink": {
     "local": [
      "mdt-20201030_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mdt-20201030_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "mdt-20201030.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mdt-20201030_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mdt-20201030_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mdt-20201030.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 716,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 31,
    "http://xbrl.sec.gov/dei/2020-01-31": 7,
    "total": 38
   },
   "keyCustom": 41,
   "keyStandard": 390,
   "memberCustom": 83,
   "memberStandard": 69,
   "nsprefix": "mdt",
   "nsuri": "http://www.medtronic.com/20201030",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://www.medtronic.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - New Accounting Pronouncements",
     "role": "http://www.medtronic.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104103 - Disclosure - Revenue",
     "role": "http://www.medtronic.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109104 - Disclosure - Acquisitions",
     "role": "http://www.medtronic.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114105 - Disclosure - Restructuring",
     "role": "http://www.medtronic.com/role/Restructuring",
     "shortName": "Restructuring",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118106 - Disclosure - Financial Instruments",
     "role": "http://www.medtronic.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126107 - Disclosure - Financing Arrangements",
     "role": "http://www.medtronic.com/role/FinancingArrangements",
     "shortName": "Financing Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130108 - Disclosure - Derivatives and Currency Exchange Risk Management",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement",
     "shortName": "Derivatives and Currency Exchange Risk Management",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141109 - Disclosure - Inventories",
     "role": "http://www.medtronic.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144110 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150111 - Disclosure - Income Taxes",
     "role": "http://www.medtronic.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Statements of Income (Unaudited)",
     "role": "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
     "shortName": "Consolidated Statements of Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152112 - Disclosure - Earnings Per Share",
     "role": "http://www.medtronic.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156113 - Disclosure - Stock-Based Compensation",
     "role": "http://www.medtronic.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2159114 - Disclosure - Retirement Benefit Plans",
     "role": "http://www.medtronic.com/role/RetirementBenefitPlans",
     "shortName": "Retirement Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2163115 - Disclosure - Accumulated Other Comprehensive Loss",
     "role": "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2166116 - Disclosure - Commitments and Contingencies",
     "role": "http://www.medtronic.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2168117 - Disclosure - Segment and Geographic Information",
     "role": "http://www.medtronic.com/role/SegmentandGeographicInformation",
     "shortName": "Segment and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation (Policies)",
     "role": "http://www.medtronic.com/role/BasisofPresentationPolicies",
     "shortName": "Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Revenue (Tables)",
     "role": "http://www.medtronic.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - Acquisitions (Tables)",
     "role": "http://www.medtronic.com/role/AcquisitionsTables",
     "shortName": "Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315303 - Disclosure - Restructuring (Tables)",
     "role": "http://www.medtronic.com/role/RestructuringTables",
     "shortName": "Restructuring (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Statements of Comprehensive Income (Unaudited)",
     "role": "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited",
     "shortName": "Consolidated Statements of Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319304 - Disclosure - Financial Instruments (Tables)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327305 - Disclosure - Financing Arrangements (Tables)",
     "role": "http://www.medtronic.com/role/FinancingArrangementsTables",
     "shortName": "Financing Arrangements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mdt:ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331306 - Disclosure - Derivatives and Currency Exchange Risk Management (Tables)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables",
     "shortName": "Derivatives and Currency Exchange Risk Management (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mdt:ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342307 - Disclosure - Inventories (Tables)",
     "role": "http://www.medtronic.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345308 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353309 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.medtronic.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2357310 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.medtronic.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2360311 - Disclosure - Retirement Benefit Plans (Tables)",
     "role": "http://www.medtronic.com/role/RetirementBenefitPlansTables",
     "shortName": "Retirement Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2364312 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "role": "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2369313 - Disclosure - Segment and Geographic Information (Tables)",
     "role": "http://www.medtronic.com/role/SegmentandGeographicInformationTables",
     "shortName": "Segment and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited",
     "shortName": "Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406401 - Disclosure - Revenue - Disaggregation of Net Sales by Segment and Division (Details)",
     "role": "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
     "shortName": "Revenue - Disaggregation of Net Sales by Segment and Division (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i06dc9f6bc4aa419bbfe27b17af09fe0a_D20200801-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details)",
     "role": "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
     "shortName": "Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i8c0b9d71f9af4be0bdef0b12e789d63a_D20200801-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Revenue - Narrative (Details)",
     "role": "http://www.medtronic.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411404 - Disclosure - Acquisitions - Narrative (Details)",
     "role": "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
     "shortName": "Acquisitions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i08ae410a74984dc0a1a2e5d64185b3a1_I20200731",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Acquisitions - Reconciliation of Beginning and Ending Balances of Contingent Consideration (Details)",
     "role": "http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails",
     "shortName": "Acquisitions - Reconciliation of Beginning and Ending Balances of Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mdt:BusinessAcquisitionContingentConsiderationMilestonePayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Acquisitions - Fair Value Measurement, Contingent Consideration, Significant Unobservable Inputs (Details)",
     "role": "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
     "shortName": "Acquisitions - Fair Value Measurement, Contingent Consideration, Significant Unobservable Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i0e362e921abc4ec38c51136161f1dd32_I20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - Restructuring - Narrative (Details)",
     "role": "http://www.medtronic.com/role/RestructuringNarrativeDetails",
     "shortName": "Restructuring - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "ifc70a688a0d74e63819c4ade21969f2d_D20200801-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i1da6f2608bec495282ec262dc76cf183_I20200424",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Restructuring - Activity Related to Restructuring Programs (Details)",
     "role": "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails",
     "shortName": "Restructuring - Activity Related to Restructuring Programs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i1da6f2608bec495282ec262dc76cf183_I20200424",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420409 - Disclosure - Financial Instruments - Investments by Category and Related Balance Sheet Classification (Details)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails",
     "shortName": "Financial Instruments - Investments by Category and Related Balance Sheet Classification (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421410 - Disclosure - Financial Instruments - Available-For-Sale Securities in Continuous Unrealized Loss Position (Details)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
     "shortName": "Financial Instruments - Available-For-Sale Securities in Continuous Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical",
     "shortName": "Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - Financial Instruments - Activity Related to the Company's Investment Portfolio and Debt Securities Contractual Maturities (Details)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails",
     "shortName": "Financial Instruments - Activity Related to the Company's Investment Portfolio and Debt Securities Contractual Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Financial Instruments - Narrative (Details)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails",
     "shortName": "Financial Instruments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "ib91d3cafbd584b8ca35b1b380bde9703_I20200424",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - Financial Instruments - Summary of Equity and Other Investments (Details)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails",
     "shortName": "Financial Instruments - Summary of Equity and Other Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i8b4432b5c6914f0b8d0bb13ac46f806a_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425414 - Disclosure - Financial Instruments - Activity Related to the Company's Investment Portfolio, Equity and Other Investments (Details)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails",
     "shortName": "Financial Instruments - Activity Related to the Company's Investment Portfolio, Equity and Other Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mdt:ScheduleofInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i92bacf56288041769a792da708300ace_D20200801-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - Financing Arrangements - Narrative (Details)",
     "role": "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails",
     "shortName": "Financing Arrangements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "ib91d3cafbd584b8ca35b1b380bde9703_I20200424",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - Financing Arrangements - Long-Term Debt (Details)",
     "role": "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
     "shortName": "Financing Arrangements - Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432417 - Disclosure - Derivatives and Currency Exchange Risk Management - Narrative (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "ib91d3cafbd584b8ca35b1b380bde9703_I20200424",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mdt:ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - Derivatives and Currency Exchange Risk Management - Derivative (Gains) Losses Not Designated as Hedging Instruments (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - Derivative (Gains) Losses Not Designated as Hedging Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mdt:ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i16ecf308db934c58b716f575ffc1e8e2_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in AOCI, Cash Flow Hedges (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in AOCI, Cash Flow Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i16ecf308db934c58b716f575ffc1e8e2_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherOperatingIncomeExpenseNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - Derivatives and Currency Exchange Risk Management - Amount of (Gains) Losses Recognized in Consolidated Statements of Income, Cash Flow Hedges (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - Amount of (Gains) Losses Recognized in Consolidated Statements of Income, Cash Flow Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id17a89cb1d9e431db69c4426862755a5_D20200801-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i52de462b431c4555b295ebb144b8351f_I20190426",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Equity (Unaudited)",
     "role": "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited",
     "shortName": "Consolidated Statements of Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i044332ce225b4db4897be21e46da5d03_D20190427-20190726",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i0e2b35bd149d4cbfb0cca99cf6451e78_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in Income, Net Investment Hedges (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in Income, Net Investment Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i0e2b35bd149d4cbfb0cca99cf6451e78_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in AOCI, Net Investment Hedges (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - (Gains) Losses Recognized in AOCI, Net Investment Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i9dd052a01e6746ebaefd3cc094cc9a4e_D20200801-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OffsettingLiabilitiesTableTextBlock",
       "us-gaap:OffsettingAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438423 - Disclosure - Derivatives and Currency Exchange Risk Management - Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i2971cc416b8c4c3baf1b346e6ac07274_I20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i75a0c623324e4c58a147690be5ec9a8c_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439424 - Disclosure - Derivatives and Currency Exchange Risk Management - Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i75a0c623324e4c58a147690be5ec9a8c_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OffsettingLiabilitiesTableTextBlock",
       "us-gaap:OffsettingAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440425 - Disclosure - Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OffsettingLiabilitiesTableTextBlock",
       "us-gaap:OffsettingAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443426 - Disclosure - Inventories (Details)",
     "role": "http://www.medtronic.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "ib91d3cafbd584b8ca35b1b380bde9703_I20200424",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446427 - Disclosure - Goodwill and Other Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)",
     "role": "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Other Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillImpairmentLoss",
       "us-gaap:GoodwillImpairmentLoss",
       "us-gaap:GoodwillImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id878a47f7fe0468895f6089921c8baca_D20190727-20191025",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447428 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details)",
     "role": "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Other Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillImpairmentLoss",
       "us-gaap:GoodwillImpairmentLoss",
       "us-gaap:GoodwillImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id878a47f7fe0468895f6089921c8baca_D20190727-20191025",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448429 - Disclosure - Goodwill and Other Intangible Assets - Carrying Amount and Accumulated Amortization of Intangible Assets (Details)",
     "role": "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets - Carrying Amount and Accumulated Amortization of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449430 - Disclosure - Goodwill and Other Intangible Assets - Estimated Future Aggregate Amortization Expense of Amortizable Intangible Assets (Details)",
     "role": "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets - Estimated Future Aggregate Amortization Expense of Amortizable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i56cbe72d4f164d52b063093c431c9843_I20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Equity (Unaudited) (Parenthetical)",
     "role": "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical",
     "shortName": "Consolidated Statements of Equity (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451431 - Disclosure - Income Taxes (Details)",
     "role": "http://www.medtronic.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454432 - Disclosure - Earnings Per Share - Schedule of Basic and Diluted Earnings (Loss) Per Share (Details)",
     "role": "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails",
     "shortName": "Earnings Per Share - Schedule of Basic and Diluted Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i038d289ad6de4b8f85679e45d0448c91_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455433 - Disclosure - Earnings Per Share - Narrative (Details)",
     "role": "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails",
     "shortName": "Earnings Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i038d289ad6de4b8f85679e45d0448c91_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458434 - Disclosure - Stock-Based Compensation (Details)",
     "role": "http://www.medtronic.com/role/StockBasedCompensationDetails",
     "shortName": "Stock-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i0579786642984f61b518ad7ce2988383_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461435 - Disclosure - Retirement Benefit Plans (Details)",
     "role": "http://www.medtronic.com/role/RetirementBenefitPlansDetails",
     "shortName": "Retirement Benefit Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i0579786642984f61b518ad7ce2988383_D20200801-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mdt:DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462436 - Disclosure - Retirement Benefit Plans - Narrative (Details)",
     "role": "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails",
     "shortName": "Retirement Benefit Plans - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mdt:DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i08ae410a74984dc0a1a2e5d64185b3a1_I20200731",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465437 - Disclosure - Accumulated Other Comprehensive Loss - Changes in AOCI (Details)",
     "role": "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails",
     "shortName": "Accumulated Other Comprehensive Loss - Changes in AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "iefd7e349f18840e98869efd76dfa5aee_D20200425-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467438 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.medtronic.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "ib91d3cafbd584b8ca35b1b380bde9703_I20200424",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "i29a7dfb811884a6fbcdbb5cd1ad61e60_D20200801-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470439 - Disclosure - Segment and Geographic Information (Details)",
     "role": "http://www.medtronic.com/role/SegmentandGeographicInformationDetails",
     "shortName": "Segment and Geographic Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "ifd378229d53d485bb7a50d60b19bcbf3_D20200801-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation",
     "role": "http://www.medtronic.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20201030.htm",
      "contextRef": "id6bcdb57106f45f085d0f4bcf70b8931_D20200425-20201030",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": null,
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - mdt-20201030.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - mdt-20201030.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 160,
   "tag": {
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States",
        "verboseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails",
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro-denominated Debt"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Japanese Yen-denominated Debt"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r753"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r755"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Ordinary Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r755"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r755"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r756"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r755"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r755"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r755"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r755"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mdt_A2015CommercialPaperProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2015 Commercial Paper Program [Member]",
        "label": "2015 Commercial Paper Program [Member]",
        "terseLabel": "Commercial Paper Program"
       }
      }
     },
     "localname": "A2015CommercialPaperProgramMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_AllBusinessAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All Business Acquisitions [Member]",
        "label": "All Business Acquisitions [Member]",
        "terseLabel": "All Business Acquisitions"
       }
      }
     },
     "localname": "AllBusinessAcquisitionsMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_AmendedandRestatedRevolvingCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amended and Restated Revolving Credit Agreement [Member]",
        "label": "Amended and Restated Revolving Credit Agreement [Member]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "AmendedandRestatedRevolvingCreditAgreementMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortizable Asset Created for Swiss Federal Income Tax Purposes",
        "label": "Amortizable Asset Created for Swiss Federal Income Tax Purposes [Member]",
        "terseLabel": "Amortizable Asset Created for Swiss Federal Income Tax Purposes"
       }
      }
     },
     "localname": "AmortizableAssetCreatedForSwissFederalIncomeTaxPurposesMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_AorticPeripheralandVenousDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aortic, Peripheral and Venous Division [Member]",
        "label": "Aortic, Peripheral and Venous Division [Member]",
        "terseLabel": "Aortic, Peripheral, &amp; Venous"
       }
      }
     },
     "localname": "AorticPeripheralandVenousDivisionMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_AssociatedCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Associated Costs [Member]",
        "label": "Associated Costs [Member]",
        "terseLabel": "Associated Costs"
       }
      }
     },
     "localname": "AssociatedCostsMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Business Acquisition, Contingent Consideration, at Fair Value [Roll Forward]",
        "terseLabel": "Reconciliation of Beginning and Ending Balances of Contingent Milestone Payments [Roll Forward]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationAtFairValueRollForward",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_BusinessAcquisitionContingentConsiderationMilestonePayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent milestone payments in business acquisition transactions.",
        "label": "Business Acquisition, Contingent Consideration, Milestone Payment",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationMilestonePayment",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_BusinessAcquisitionPurchasePriceContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contingent consideration arrangement resulting from business combinations.",
        "label": "Business Acquisition, Purchase Price Contingent Consideration",
        "terseLabel": "Purchase price contingent consideration"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceContingentConsideration",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Including Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Including Goodwill",
        "terseLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_CardiacAndVascularGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cardiac and Vascular Group",
        "label": "Cardiac and Vascular Group [Member]",
        "terseLabel": "Cardiac &amp; Vascular Group"
       }
      }
     },
     "localname": "CardiacAndVascularGroupMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_CardiacRhythmandHeartFailureDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cardiac Rhythm and Heart Failure Division [Member]",
        "label": "Cardiac Rhythm and Heart Failure Division [Member]",
        "terseLabel": "Cardiac Rhythm &amp; Heart Failure"
       }
      }
     },
     "localname": "CardiacRhythmandHeartFailureDivisionMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_CentralizedDistributionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Centralized Distribution Costs",
        "label": "Centralized Distribution Costs",
        "negatedTerseLabel": "Centralized distribution costs"
       }
      }
     },
     "localname": "CentralizedDistributionCosts",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_CommercialPaperMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commercial Paper, Maximum Borrowing Capacity",
        "label": "Commercial Paper, Maximum Borrowing Capacity",
        "terseLabel": "Commercial paper, maximum borrowing amount"
       }
      }
     },
     "localname": "CommercialPaperMaximumBorrowingCapacity",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_CoronaryandStructuralHeartDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Coronary and Structural Heart Division [Member]",
        "label": "Coronary and Structural Heart Division [Member]",
        "terseLabel": "Coronary &amp; Structural Heart"
       }
      }
     },
     "localname": "CoronaryandStructuralHeartDivisionMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_CorporateOverhead": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate overhead expenses",
        "label": "Corporate Overhead",
        "negatedLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateOverhead",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_CranialAndSpinalTechnologiesDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cranial And Spinal Technologies Division",
        "label": "Cranial And Spinal Technologies Division [Member]",
        "terseLabel": "Cranial &amp; Spinal Technologies"
       }
      }
     },
     "localname": "CranialAndSpinalTechnologiesDivisionMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_DebtInstrumentExtensionOptionTermOfExtension": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Extension Option, Term Of Extension",
        "label": "Debt Instrument, Extension Option, Term Of Extension",
        "terseLabel": "Additional extension option, term of extension"
       }
      }
     },
     "localname": "DebtInstrumentExtensionOptionTermOfExtension",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mdt_DebtInstrumentNumberofTranches": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Number of Tranches",
        "label": "Debt Instrument, Number of Tranches",
        "terseLabel": "Number of tranches"
       }
      }
     },
     "localname": "DebtInstrumentNumberofTranches",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdt_DebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Debt [Line Items]",
        "terseLabel": "Debt [Line Items]"
       }
      }
     },
     "localname": "DebtLineItems",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Held-To-Maturity, Accumulated Unrealized Gain, Before Tax",
        "label": "Debt Securities, Available-For-Sale And Held-To-Maturity, Accumulated Unrealized Gain, Before Tax",
        "totalLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Held-To-Maturity, Accumulated Unrealized Loss, Before Tax",
        "label": "Debt Securities, Available-For-Sale And Held-To-Maturity, Accumulated Unrealized Loss, Before Tax",
        "negatedTotalLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Held To Maturity, Amortized Cost",
        "label": "Debt Securities, Available-For-Sale And Held To Maturity, Amortized Cost",
        "totalLabel": "Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Held-To-Maturity, Fair Value",
        "label": "Debt Securities, Available-For-Sale And Held-To-Maturity, Fair Value",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DebtTenderPremiumandOtherCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Tender Premium and Other Charges",
        "label": "Debt Tender Premium and Other Charges",
        "terseLabel": "Debt tender premium and other charges"
       }
      }
     },
     "localname": "DebtTenderPremiumandOtherCharges",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DeferredTaxAssetsAmortizationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Tax Assets, Amortization Period",
        "label": "Deferred Tax Assets, Amortization Period",
        "terseLabel": "Deferred tax asset amortization period"
       }
      }
     },
     "localname": "DeferredTaxAssetsAmortizationPeriod",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mdt_DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined Benefit And Contribution Plan, Cash Payments And Administrative Expense Related To Providing Special And Contractual Termination Benefits",
        "label": "Defined Benefit And Contribution Plan, Cash Payments And Administrative Expense Related To Providing Special And Contractual Termination Benefits",
        "terseLabel": "Incremental expense related to acceptance of voluntary early retirement packages, amount related to cash payments and administrative fees"
       }
      }
     },
     "localname": "DefinedBenefitAndContributionPlanCashPaymentsAndAdministrativeExpenseRelatedToProvidingSpecialAndContractualTerminationBenefits",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined Benefit And Contribution Plan, Cost of Providing Special and Contractual Termination Benefits",
        "label": "Defined Benefit And Contribution Plan, Cost of Providing Special and Contractual Termination Benefits",
        "verboseLabel": "Incremental expense related to acceptance of voluntary early retirement packages"
       }
      }
     },
     "localname": "DefinedBenefitAndContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringNarrativeDetails",
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined Contribution Plan, Cost of Providing Special and Contractual Termination Benefits",
        "label": "Defined Contribution Plan, Cost of Providing Special and Contractual Termination Benefits",
        "verboseLabel": "Incremental expense related to acceptance of voluntary early retirement packages, amount related to defined contribution plans"
       }
      }
     },
     "localname": "DefinedContributionPlanCostOfProvidingSpecialAndContractualTerminationBenefits",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DerivativeAssetLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative Asset (Liability) [Abstract]",
        "label": "Derivative Asset (Liability) [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "DerivativeAssetLiabilityAbstract",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative Asset (Liability), Fair Value, Gross Asset (Liability)",
        "label": "Derivative Asset (Liability), Fair Value, Gross Asset (Liability)",
        "totalLabel": "Gross Amount of Recorded Assets (Liabilities)"
       }
      }
     },
     "localname": "DerivativeAssetLiabilityFairValueGrossAssetLiability",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash",
        "label": "Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash",
        "negatedTotalLabel": "Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)"
       }
      }
     },
     "localname": "DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative Assets and Liabilities, Net, Not Offset, Policy Election Deduction",
        "label": "Derivative Assets and Liabilities, Net, Not Offset, Policy Election Deduction",
        "negatedTotalLabel": "Gross Amount Not Offset on the Balance Sheet, Financial Instruments"
       }
      }
     },
     "localname": "DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DiabetesGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Diabetes Group [Member]",
        "label": "Diabetes Group [Member]",
        "terseLabel": "Diabetes Group"
       }
      }
     },
     "localname": "DiabetesGroupMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_EarningsPerShareReconciliationDenominatorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Earnings Per Share Reconciliation, Denominator [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationDenominatorAbstract",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_EarningsPerShareReconciliationNumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Earnings Per Share Reconciliation, Numerator [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationNumeratorAbstract",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_EmployeesStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Employees Stock Purchase Plan [Member]",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeesStockPurchasePlanMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_EnterpriseExcellenceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Enterprise Excellence [Member]",
        "label": "Enterprise Excellence [Member]",
        "terseLabel": "Enterprise Excellence"
       }
      }
     },
     "localname": "EnterpriseExcellenceMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_EquityInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Investments [Member]",
        "label": "Equity Investments [Member]",
        "terseLabel": "Equity and Other Investments",
        "verboseLabel": "Equity Securities and Other Investments"
       }
      }
     },
     "localname": "EquityInvestmentsMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments",
        "label": "Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments",
        "totalLabel": "Total equity and other investments"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments [Table Text Block]",
        "label": "Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments [Table Text Block]",
        "terseLabel": "Summary of Equity and Other Investments"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mdt_EthiconPatentInfringementLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ethicon Patent Infringement Litigation [Member]",
        "label": "Ethicon Patent Infringement Litigation [Member]",
        "terseLabel": "Ethicon"
       }
      }
     },
     "localname": "EthiconPatentInfringementLitigationMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gain (Loss) from Hedged Firm Commitment Not Qualifying as Net Investment Hedge, Net",
        "label": "Gain (Loss) from Hedged Firm Commitment Not Qualifying as Net Investment Hedge, Net",
        "terseLabel": "Gains (losses) on firm commitments that no longer qualify as net investment hedges"
       }
      }
     },
     "localname": "GainLossfromHedgedFirmCommitmentNotQualifyingasNetInvestmentHedgeNet",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_GainonInvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gain on Investments",
        "label": "Gain on Investments",
        "terseLabel": "Gross gains"
       }
      }
     },
     "localname": "GainonInvestments",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_ImpairmentOfInProcessResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Impairment of In Process Research and Development",
        "label": "Impairment of In Process Research and Development",
        "negatedLabel": "IPR&amp;D charges"
       }
      }
     },
     "localname": "ImpairmentOfInProcessResearchAndDevelopment",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_IncomeTaxesandInterestPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Taxes and Interest Paid [Abstract]",
        "label": "Income Taxes and Interest Paid [Abstract]",
        "terseLabel": "Cash paid for:"
       }
      }
     },
     "localname": "IncomeTaxesandInterestPaidAbstract",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental Common Shares Attributable to Dilutive Effect of Other Shares",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Other Shares",
        "terseLabel": "Other (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributabletoDilutiveEffectofOtherShares",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Japan, Australia, New Zealand, Korea, Canada, and Western Europe [Member]",
        "label": "Japan, Australia, New Zealand, Korea, Canada, and Western Europe [Member]",
        "terseLabel": "Non-U.S. Developed Markets"
       }
      }
     },
     "localname": "JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_LossContingencyNumberofManufacturers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Manufacturers",
        "label": "Loss Contingency, Number of Manufacturers",
        "terseLabel": "Number of manufacturers"
       }
      }
     },
     "localname": "LossContingencyNumberofManufacturers",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdt_LossContingencyNumberofSubsidiaries": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Subsidiaries",
        "label": "Loss Contingency, Number of Subsidiaries",
        "terseLabel": "Number of subsidiaries"
       }
      }
     },
     "localname": "LossContingencyNumberofSubsidiaries",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdt_LossonInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss on Investments",
        "label": "Loss on Investments",
        "negatedTerseLabel": "Gross losses"
       }
      }
     },
     "localname": "LossonInvestments",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_MeasurementInputProbabilityofPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement Input, Probability of Payment [Member]",
        "label": "Measurement Input, Probability of Payment [Member]",
        "terseLabel": "Probability of payment"
       }
      }
     },
     "localname": "MeasurementInputProbabilityofPaymentMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_MedicalDeviceRegulations": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical Device Regulations",
        "label": "Medical Device Regulations",
        "negatedTerseLabel": "Medical device regulations"
       }
      }
     },
     "localname": "MedicalDeviceRegulations",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_MedtronicIncAndCIFSASeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medtronic Inc And CIFSA Senior Notes",
        "label": "Medtronic Inc And CIFSA Senior Notes [Member]",
        "terseLabel": "Medtronic Inc and CIFSA Senior Notes"
       }
      }
     },
     "localname": "MedtronicIncAndCIFSASeniorNotesMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medtronic Inc, CIFSA, and Medtronic Luxco Senior Notes [Member]",
        "label": "Medtronic Inc, CIFSA, and Medtronic Luxco Senior Notes [Member]",
        "terseLabel": "Medtronic Inc, CIFSA, and Medtronic Luxco Senior Notes"
       }
      }
     },
     "localname": "MedtronicIncCIFSAandMedtronicLuxcoSeniorNotesMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_MedtronicLuxcoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medtronic Luxco [Member]",
        "label": "Medtronic Luxco [Member]",
        "terseLabel": "Medtronic Luxco"
       }
      }
     },
     "localname": "MedtronicLuxcoMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_MedtronicLuxcoSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medtronic Luxco Senior Notes",
        "label": "Medtronic Luxco Senior Notes [Member]",
        "terseLabel": "Medtronic Luxco Senior Notes"
       }
      }
     },
     "localname": "MedtronicLuxcoSeniorNotesMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Middle East, Africa, Latin America, Eastern Europe, and Asia, Excluding Japan and Korea [Member]",
        "label": "Middle East, Africa, Latin America, Eastern Europe, and Asia, Excluding Japan and Korea [Member]",
        "terseLabel": "Emerging Markets"
       }
      }
     },
     "localname": "MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_MinimallyInvasiveTherapiesGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimally Invasive Therapies Group [Member]",
        "label": "Minimally Invasive Therapies Group [Member]",
        "terseLabel": "Minimally Invasive Therapies Group"
       }
      }
     },
     "localname": "MinimallyInvasiveTherapiesGroupMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Investment Hedge Gain (Loss) to be Reclassified Within Twelve Months",
        "label": "Net Investment Hedge Gain (Loss) to be Reclassified Within Twelve Months",
        "terseLabel": "Net investment hedge unrealized gains or losses to be reclassified over the next twelve months, net of tax"
       }
      }
     },
     "localname": "NetInvestmentHedgeGainLosstobeReclassifiedWithinTwelveMonths",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_NeuromodulationDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Neuromodulation Division",
        "label": "Neuromodulation Division [Member]",
        "terseLabel": "Neuromodulation"
       }
      }
     },
     "localname": "NeuromodulationDivisionMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_OffsettingAssetsandLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Line Items] for Offsetting Assets and Liabilities [Table]",
        "label": "Offsetting Assets and Liabilities [Line Items]",
        "terseLabel": "Offsetting Assets and Liabilities [Line Items]"
       }
      }
     },
     "localname": "OffsettingAssetsandLiabilitiesLineItems",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_OffsettingAssetsandLiabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Offsetting Assets and Liabilities [Table]",
        "label": "Offsetting Assets and Liabilities [Table]",
        "terseLabel": "Offsetting Assets and Liabilities [Table]"
       }
      }
     },
     "localname": "OffsettingAssetsandLiabilitiesTable",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_OrringtonMaineChemicalManufacturingFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Orrington, Maine Chemical Manufacturing Facility [Member]",
        "label": "Orrington, Maine Chemical Manufacturing Facility [Member]",
        "terseLabel": "Orrington, Maine chemical manufacturing facility"
       }
      }
     },
     "localname": "OrringtonMaineChemicalManufacturingFacilityMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_OtherAccruedExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Accrued Expenses",
        "label": "Other Accrued Expenses [Member]",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedExpensesMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_PelvicMeshLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pelvic Mesh Litigation [Member]",
        "label": "Pelvic Mesh Litigation [Member]",
        "terseLabel": "Pelvic mesh"
       }
      }
     },
     "localname": "PelvicMeshLitigationMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_PreTaxExitandDisposalCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pre Tax Exit and Disposal Costs [Member]",
        "label": "Pre Tax Exit and Disposal Costs [Member]",
        "terseLabel": "Pre-tax exit and disposal costs and other"
       }
      }
     },
     "localname": "PreTaxExitandDisposalCostsMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_ProductDevelopmentMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A milestone in achieving certain product development target.",
        "label": "Product Development Milestone [Member]",
        "terseLabel": "Product development and other milestone-based payments"
       }
      }
     },
     "localname": "ProductDevelopmentMilestoneMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_PurchasedTechnologyAndPatentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchased technology and patents.",
        "label": "Purchased Technology and Patents [Member]",
        "terseLabel": "Purchased technology and patents"
       }
      }
     },
     "localname": "PurchasedTechnologyAndPatentsMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_RespiratoryGastrointestinalandRenalDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Respiratory, Gastrointestinal, and Renal Division [Member]",
        "label": "Respiratory, Gastrointestinal, and Renal Division [Member]",
        "terseLabel": "Respiratory, Gastrointestinal, &amp; Renal"
       }
      }
     },
     "localname": "RespiratoryGastrointestinalandRenalDivisionMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_RestorativeTherapiesGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restorative Therapies Group",
        "label": "Restorative Therapies Group [Member]",
        "terseLabel": "Restorative Therapies Group"
       }
      }
     },
     "localname": "RestorativeTherapiesGroupMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring Charges, Including Net Periodic Benefit Credit, Loss Due to Curtailment",
        "label": "Restructuring Charges, Including Net Periodic Benefit Credit, Loss Due to Curtailment",
        "terseLabel": "Charges, including incremental defined benefit pension and post-retirement expenses for employees that accepted voluntary early retirement packages"
       }
      }
     },
     "localname": "RestructuringChargesIncludingNetPeriodicBenefitCreditLossDueToCurtailment",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_RestructuringChargesNetofRestructuringReversals": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses, net of reversals, associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges, Net of Restructuring Reversals",
        "negatedLabel": "Restructuring and associated costs",
        "terseLabel": "Restructuring charges, net"
       }
      }
     },
     "localname": "RestructuringChargesNetofRestructuringReversals",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_RevenueMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A milestone in achieving certain revenue target.",
        "label": "Revenue Milestone [Member]",
        "terseLabel": "Revenue and other performance-based payments"
       }
      }
     },
     "localname": "RevenueMilestoneMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SassoLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sasso Litigation [Member]",
        "label": "Sasso Litigation [Member]",
        "terseLabel": "Sasso"
       }
      }
     },
     "localname": "SassoLitigationMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_ScheduleOfDebtTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table]",
        "terseLabel": "Schedule of Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfDebtTable",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of gains and losses recognized in the statement of financial performance on foreign currency derivative instruments not designated as hedging instruments.",
        "label": "Schedule of Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]",
        "terseLabel": "Amount and Location of (Gains) Losses in Statements of Income, Derivative Instruments Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossInStatementOfFinancialPerformanceTableTextBlock",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mdt_ScheduleofInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Investments [Table Text Block]",
        "label": "Schedule of Investments [Table Text Block]",
        "terseLabel": "Activity Related to the Company's Equity and Other Investments Portfolio"
       }
      }
     },
     "localname": "ScheduleofInvestmentsTableTextBlock",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mdt_SeniorNotes2007Due2038Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2007 Due 2038 [Member]",
        "label": "Senior Notes 2007 Due 2038 [Member]",
        "terseLabel": "6.550 percent thirty-year 2007 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2007Due2038Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2009Due2039Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2039 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.",
        "label": "Senior Notes 2009 Due 2039 [Member]",
        "terseLabel": "6.500 percent thirty-year 2009 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2009Due2039Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2010Due2040Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2040 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.",
        "label": "Senior Notes 2010 Due 2040 [Member]",
        "terseLabel": "5.550 percent thirty-year 2010 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2010Due2040Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2012Due2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2012 Due 2023 [Member]",
        "label": "Senior Notes 2012 Due 2023 [Member]",
        "terseLabel": "3.200 percent ten-year 2012 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2012Due2023Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2012Due2042Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2042 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.",
        "label": "Senior Notes 2012 Due 2042 [Member]",
        "terseLabel": "4.500 percent thirty-year 2012 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2012Due2042Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2013Due2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2023 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.",
        "label": "Senior Notes 2013 Due 2023 [Member]",
        "terseLabel": "2.750 percent ten-year 2013 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2013Due2023Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2013Due2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2013 Due 2024 [Member]",
        "label": "Senior Notes 2013 Due 2024 [Member]",
        "terseLabel": "2.950 percent ten-year 2013 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2013Due2024Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2013Due2043Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2043 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.",
        "label": "Senior Notes 2013 Due 2043 [Member]",
        "terseLabel": "4.000 percent thirty-year 2013 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2013Due2043Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2014Due2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2024 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.",
        "label": "Senior Notes 2014 Due 2024 [Member]",
        "terseLabel": "3.625 percent ten-year 2014 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2014Due2024Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2014Due2044Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2044 Senior Notes - unsecured debt not collateralized by pledge, mortgage or other lien in the entity's assets.",
        "label": "Senior Notes 2014 Due 2044 [Member]",
        "terseLabel": "4.625 percent thirty-year 2014 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2014Due2044Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2015Due2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2015 Due 2022 [Member]",
        "label": "Senior Notes 2015 Due 2022 [Member]",
        "terseLabel": "3.150 percent seven-year 2015 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2015Due2022Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2015Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2015 Due 2025 [Member]",
        "label": "Senior Notes 2015 Due 2025 [Member]",
        "terseLabel": "3.500 percent ten-year 2015 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2015Due2025Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2015Due2035Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2015 Due 2035 [Member]",
        "label": "Senior Notes 2015 Due 2035 [Member]",
        "terseLabel": "4.375 percent twenty-year 2015 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2015Due2035Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2015Due2045Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2015 Due 2045 [Member]",
        "label": "Senior Notes 2015 Due 2045 [Member]",
        "terseLabel": "4.625 percent thirty-year 2015 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2015Due2045Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2017Due2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2017 Due 2027 [Member]",
        "label": "Senior Notes 2017 Due 2027 [Member]",
        "terseLabel": "3.350 percent ten-year 2017 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2017Due2027Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2021FloatingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2021, Floating [Member]",
        "label": "Senior Notes 2019 Due 2021, Floating [Member]",
        "terseLabel": "Floating Rate Notes due 2021"
       }
      }
     },
     "localname": "SeniorNotes2019Due2021FloatingMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2022 [Member]",
        "label": "Senior Notes 2019 Due 2022 [Member]",
        "terseLabel": "0.00% Senior Notes due 2022"
       }
      }
     },
     "localname": "SeniorNotes2019Due2022Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20230.000PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2023, 0.000 Percent [Member]",
        "label": "Senior Notes 2019 Due 2023, 0.000 Percent [Member]",
        "terseLabel": "0.000 percent four-year 2019 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2019Due20230.000PercentMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20230.375PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2023, 0.375 Percent [Member]",
        "label": "Senior Notes 2019 Due 2023, 0.375 Percent [Member]",
        "terseLabel": "0.375% Senior Notes due 2023",
        "verboseLabel": "0.375 percent four-year 2019 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2019Due20230.375PercentMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation",
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2025 [Member]",
        "label": "Senior Notes 2019 Due 2025 [Member]",
        "terseLabel": "0.25% Senior Notes due 2025"
       }
      }
     },
     "localname": "SeniorNotes2019Due2025Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2026Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2026 [Member]",
        "label": "Senior Notes 2019 Due 2026 [Member]",
        "terseLabel": "0.250 percent seven-year 2019 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2019Due2026Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2027 [Member]",
        "label": "Senior Notes 2019 Due 2027 [Member]",
        "terseLabel": "1.125% Senior Notes due 2027",
        "verboseLabel": "1.125 percent eight-year 2019 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2019Due2027Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation",
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20311.00PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2031, 1.00 Percent [Member]",
        "label": "Senior Notes 2019 Due 2031, 1.00 Percent [Member]",
        "terseLabel": "1.00% Senior Notes due 2031"
       }
      }
     },
     "localname": "SeniorNotes2019Due20311.00PercentMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20311.625PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2031, 1.625 Percent [Member]",
        "label": "Senior Notes 2019 Due 2031, 1.625 Percent [Member]",
        "terseLabel": "1.625% Senior Notes due 2031",
        "verboseLabel": "1.625 percent twelve-year 2019 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2019Due20311.625PercentMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation",
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2032Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2032 [Member]",
        "label": "Senior Notes 2019 Due 2032 [Member]",
        "terseLabel": "1.000 percent thirteen-year 2019 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2019Due2032Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20391.50PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2039, 1.50 Percent [Member]",
        "label": "Senior Notes 2019 Due 2039, 1.50 Percent [Member]",
        "verboseLabel": "1.50% Senior Notes due 2039"
       }
      }
     },
     "localname": "SeniorNotes2019Due20391.50PercentMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20392.250PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2039, 2.250 Percent [Member]",
        "label": "Senior Notes 2019 Due 2039, 2.250 Percent [Member]",
        "terseLabel": "2.250 percent twenty-year 2019 senior notes",
        "verboseLabel": "2.250% Senior Notes due 2039"
       }
      }
     },
     "localname": "SeniorNotes2019Due20392.250PercentMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation",
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2040Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2040 [Member]",
        "label": "Senior Notes 2019 Due 2040 [Member]",
        "terseLabel": "1.500 percent twenty-year 2019 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2019Due2040Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2049Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2049 [Member]",
        "label": "Senior Notes 2019 Due 2049 [Member]",
        "verboseLabel": "1.75% Senior Notes due 2049"
       }
      }
     },
     "localname": "SeniorNotes2019Due2049Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2050Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2050 [Member]",
        "label": "Senior Notes 2019 Due 2050 [Member]",
        "terseLabel": "1.750 percent thirty-year 2019 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2019Due2050Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2019 [Member]",
        "label": "Senior Notes 2019 [Member]",
        "terseLabel": "Senior Notes 2019"
       }
      }
     },
     "localname": "SeniorNotes2019Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2023",
        "label": "Senior Notes 2020 Due 2023 [Member]",
        "terseLabel": "0.000% Senior Notes due 2023",
        "verboseLabel": "0.000 percent two-year 2020 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2020Due2023Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation",
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2025",
        "label": "Senior Notes 2020 Due 2025 [Member]",
        "terseLabel": "0.000% Senior Notes due 2025"
       }
      }
     },
     "localname": "SeniorNotes2020Due2025Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2026Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2026",
        "label": "Senior Notes 2020 Due 2026 [Member]",
        "terseLabel": "0.000 percent five-year 2020 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2020Due2026Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2028Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2028",
        "label": "Senior Notes 2020 Due 2028 [Member]",
        "terseLabel": "0.375% Senior Notes due 2028"
       }
      }
     },
     "localname": "SeniorNotes2020Due2028Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2029Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2029",
        "label": "Senior Notes 2020 Due 2029 [Member]",
        "terseLabel": "0.375 percent eight-year 2020 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2020Due2029Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2032Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2032",
        "label": "Senior Notes 2020 Due 2032 [Member]",
        "terseLabel": "0.750% Senior Notes due 2032"
       }
      }
     },
     "localname": "SeniorNotes2020Due2032Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2033Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2033",
        "label": "Senior Notes 2020 Due 2033 [Member]",
        "terseLabel": "0.750 percent twelve-year 2020 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2020Due2033Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2040Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2040",
        "label": "Senior Notes 2020 Due 2040 [Member]",
        "terseLabel": "1.375% Senior Notes due 2040"
       }
      }
     },
     "localname": "SeniorNotes2020Due2040Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2041Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2041",
        "label": "Senior Notes 2020 Due 2041 [Member]",
        "terseLabel": "1.375 percent twenty-year 2020 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2020Due2041Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2050Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2050",
        "label": "Senior Notes 2020 Due 2050 [Member]",
        "terseLabel": "1.625% Senior Notes due 2050"
       }
      }
     },
     "localname": "SeniorNotes2020Due2050Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2051Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2051",
        "label": "Senior Notes 2020 Due 2051 [Member]",
        "terseLabel": "1.625 percent thirty-year 2020 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2020Due2051Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes 2020",
        "label": "Senior Notes 2020 [Member]",
        "terseLabel": "Senior Notes 2020"
       }
      }
     },
     "localname": "SeniorNotes2020Member",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SimplificationRestructuringProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Simplification Restructuring Program",
        "label": "Simplification Restructuring Program [Member]",
        "terseLabel": "Simplification"
       }
      }
     },
     "localname": "SimplificationRestructuringProgramMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SiteContingencyNumberOfLandfillsRequiringCapping": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Site Contingency, Number of Landfills Requiring Capping",
        "label": "Site Contingency, Number of Landfills Requiring Capping",
        "terseLabel": "Number of landfills requiring capping"
       }
      }
     },
     "localname": "SiteContingencyNumberOfLandfillsRequiringCapping",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdt_SiteContingencyNumberofLandfillsRequiringRemoval": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Site Contingency, Number of Landfills Requiring Removal",
        "label": "Site Contingency, Number of Landfills Requiring Removal",
        "terseLabel": "Number of landfills requiring removal"
       }
      }
     },
     "localname": "SiteContingencyNumberofLandfillsRequiringRemoval",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdt_SpecialChargesGains": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Special Charges (Gains)",
        "label": "Special Charges (Gains)",
        "negatedTerseLabel": "Special Charges (Gains)"
       }
      }
     },
     "localname": "SpecialChargesGains",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_SpecialtyTherapiesDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Specialty Therapies Division [Member]",
        "label": "Specialty Therapies Division [Member]",
        "terseLabel": "Specialty Therapies"
       }
      }
     },
     "localname": "SpecialtyTherapiesDivisionMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SurgicalInnovationsDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Surgical Innovations Division [Member]",
        "label": "Surgical Innovations Division [Member]",
        "terseLabel": "Surgical Innovations"
       }
      }
     },
     "localname": "SurgicalInnovationsDivisionMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/IncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax Expense (Benefit) Associated With Sale of Intellectual Property",
        "label": "Tax Expense (Benefit) Associated With Sale of Intellectual Property",
        "negatedLabel": "Benefit associated with finalization of intercompany sale of intellectual property and establishment of deferred tax asset"
       }
      }
     },
     "localname": "TaxExpenseBenefitAssociatedWithSaleOfIntellectualProperty",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_TokyoInterBankOfferedRateTIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tokyo Inter-bank Offered Rate (TIBOR)",
        "label": "Tokyo Inter-bank Offered Rate (TIBOR) [Member]",
        "terseLabel": "TIBOR Rate"
       }
      }
     },
     "localname": "TokyoInterBankOfferedRateTIBORMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_TotalOtherCountriesExcludingIrelandMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Other Countries, Excluding Ireland [Member]",
        "label": "Total Other Countries, Excluding Ireland [Member]",
        "terseLabel": "Total other countries, excluding Ireland"
       }
      }
     },
     "localname": "TotalOtherCountriesExcludingIrelandMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Other Countries, Excluding United States and Ireland [Member]",
        "label": "Total Other Countries, Excluding United States and Ireland [Member]",
        "terseLabel": "Rest of world"
       }
      }
     },
     "localname": "TotalOtherCountriesExcludingUnitedStatesandIrelandMember",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain (loss), net of tax as of the balance sheet date, related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.",
        "label": "Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "After-tax net unrealized gains (losses) associated with cash flow hedging instruments recorded in AOCI"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unrealized Gain (Loss) on Net Investment Hedges, Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "label": "Unrealized Gain (Loss) on Net Investment Hedges, Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "After-tax net unrealized gains (losses) associated with net investment hedging instruments recorded in AOCI"
       }
      }
     },
     "localname": "UnrealizedGainLossonNetInvestmentHedgesAccumulatedOtherComprehensiveIncomeLossNetofTax",
     "nsuri": "http://www.medtronic.com/20201030",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r188",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r208",
      "r212"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r188",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r208",
      "r212"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r140",
      "r150",
      "r269",
      "r502",
      "r503",
      "r504",
      "r525",
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative effect of change in accounting principle"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r140",
      "r150",
      "r269",
      "r502",
      "r503",
      "r504",
      "r525",
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r140",
      "r150",
      "r269",
      "r502",
      "r503",
      "r504",
      "r525",
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r479",
      "r485",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r667",
      "r724",
      "r726"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r479",
      "r485",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r667",
      "r724",
      "r726"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r420",
      "r479",
      "r485",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r667",
      "r724",
      "r726"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r420",
      "r479",
      "r485",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r667",
      "r724",
      "r726"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r215",
      "r216",
      "r375",
      "r381",
      "r725",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r215",
      "r216",
      "r375",
      "r381",
      "r725",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r338",
      "r480",
      "r635"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r642",
      "r644",
      "r647"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r147",
      "r266",
      "r267",
      "r268",
      "r269",
      "r272",
      "r273",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r506",
      "r525",
      "r526",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Reduction of accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r21",
      "r220",
      "r221"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less allowances and credit losses of $312 and $208, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r15",
      "r678",
      "r708"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r17",
      "r678",
      "r708"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r72",
      "r78",
      "r81",
      "r565"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Net Change in Retirement Obligations"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r38",
      "r315"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r78",
      "r88",
      "r564"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Unrealized Gain (Loss) on Cash Flow Hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r69",
      "r70",
      "r71",
      "r78",
      "r81"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Unrealized Gain (Loss) on Investment Securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r24",
      "r75",
      "r77",
      "r78",
      "r710",
      "r734",
      "r738"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r625"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r74",
      "r78",
      "r81",
      "r137",
      "r138",
      "r139",
      "r565",
      "r729",
      "r730"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Total Accumulated Other Comprehensive (Loss) Income",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r65",
      "r78",
      "r81",
      "r565",
      "r620",
      "r621",
      "r622",
      "r623",
      "r625"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Cumulative Translation Adjustments"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r22",
      "r506"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r502",
      "r503",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r487",
      "r489",
      "r508",
      "r509"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r489",
      "r496",
      "r507"
     ],
     "calculation": {
      "http://www.medtronic.com/role/StockBasedCompensationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/StockBasedCompensationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "totalLabel": "Total stock-based compensation expense, net of tax"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r28",
      "r222",
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowances for accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r122",
      "r300",
      "r307"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedTerseLabel": "Amortization of intangible assets",
        "terseLabel": "Amortization of intangible assets",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember": {
     "auth_ref": [
      "r78",
      "r601"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from increase (decrease) in value of excluded component of derivative hedge, attributable to parent.",
        "label": "AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]",
        "terseLabel": "Net Investment Hedges"
       }
      }
     },
     "localname": "AociDerivativeQualifyingAsHedgeExcludedComponentParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r246",
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r131",
      "r196",
      "r203",
      "r210",
      "r265",
      "r558",
      "r566",
      "r614",
      "r675",
      "r707"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r54",
      "r131",
      "r265",
      "r558",
      "r566",
      "r614"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AuctionRateSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt instrument securities (for example, but not limited to, corporate or municipal bonds) that typically have long-term nominal maturities for which the interest rate is reset through an auction process.",
        "label": "Auction Rate Securities [Member]",
        "terseLabel": "Auction rate securities"
       }
      }
     },
     "localname": "AuctionRateSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": 1.0,
       "parentTag": "mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r232"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": 2.0,
       "parentTag": "mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r229",
      "r281"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": 2.0,
       "parentTag": "mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale [Abstract]",
        "terseLabel": "Available-for-sale securities:"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r233",
      "r236",
      "r702"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r233",
      "r235",
      "r701"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r233",
      "r237",
      "r703"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Due after ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Available-For-Sale"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r233",
      "r234",
      "r700"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r224",
      "r230",
      "r281",
      "r684"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Realized Gain (Loss) [Abstract]",
        "terseLabel": "Activities Related to Debt Securities Portfolio"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossRealizedGainLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r491",
      "r497"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails",
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r577",
      "r582"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails",
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BankTimeDepositsMember": {
     "auth_ref": [
      "r693"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.",
        "label": "Bank Time Deposits [Member]",
        "terseLabel": "Time deposit"
       }
      }
     },
     "localname": "BankTimeDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccounting": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccounting",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r475",
      "r481"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r475",
      "r481",
      "r540",
      "r541"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "verboseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r539"
     ],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "negatedLabel": "Acquisition-related items"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r121",
      "r550"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedTerseLabel": "Change in fair value"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r547",
      "r548",
      "r549"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "netLabel": "Contingent consideration liabilities",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Contingent consideration, fair value"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Contingent consideration, significant unobservable inputs"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod": {
     "auth_ref": [
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period",
        "terseLabel": "Gain related to change in amounts accrued for certain contingent liabilities for recent acquisition"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r542",
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "verboseLabel": "Intangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r542",
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r543"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r543"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r122",
      "r323",
      "r329",
      "r334"
     ],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "negatedTerseLabel": "Exit of businesses"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r35",
      "r124"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r118",
      "r124",
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r118",
      "r617"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r600"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "negatedTerseLabel": "Cash flow hedge unrealized losses to be reclassified over the next 12 months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash flow hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r129",
      "r131",
      "r162",
      "r166",
      "r167",
      "r170",
      "r173",
      "r181",
      "r182",
      "r183",
      "r265",
      "r614"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaper": {
     "auth_ref": [
      "r12",
      "r676",
      "r709"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.",
        "label": "Commercial Paper",
        "terseLabel": "Commercial paper, amount outstanding"
       }
      }
     },
     "localname": "CommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r49",
      "r337",
      "r685",
      "r715"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Dividends to shareholders (usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r137",
      "r138"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary Shares",
        "verboseLabel": "Ordinary shares, par value $0.0001 per share"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited",
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Ordinary shares authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Ordinary shares issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r20",
      "r356"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (shares)",
        "periodStartLabel": "Beginning balance (shares)",
        "terseLabel": "Ordinary shares outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Ordinary shares\u2014 par value $0.0001, 2.6 billion shares authorized, 1,345,547,814 and 1,341,074,724 shares issued and outstanding, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r84",
      "r86",
      "r87",
      "r94",
      "r690",
      "r720"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Medtronic"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r84",
      "r86",
      "r93",
      "r556",
      "r557",
      "r570",
      "r689",
      "r719"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r84",
      "r86",
      "r92",
      "r555",
      "r570",
      "r688",
      "r718"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income including noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r128",
      "r560"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r363",
      "r364",
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized that was previously included in deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerRefundLiabilityCurrent": {
     "auth_ref": [
      "r379"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.",
        "label": "Contract with Customer, Refund Liability, Current",
        "terseLabel": "Rebate obligations"
       }
      }
     },
     "localname": "ContractWithCustomerRefundLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r421",
      "r469",
      "r739"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r99",
      "r668"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringNarrativeDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r421",
      "r592"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross-currency interest rate contracts"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer-related",
        "verboseLabel": "Customer-Related Intangible Assets"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DamagesFromProductDefectsMember": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The risk of loss arises with respect to product defects and recalls, or improperly performed services which actually or allegedly resulted in damages suffered by the injured party, excluding major product liability matters.",
        "label": "Damages from Product Defects [Member]",
        "terseLabel": "Product liability litigation"
       }
      }
     },
     "localname": "DamagesFromProductDefectsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Financing Arrangements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r13",
      "r15",
      "r16",
      "r677",
      "r679",
      "r705"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Margin added to variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r629",
      "r632"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Instrument, Fair Value Disclosure [Abstract]",
        "terseLabel": "Financial Instruments Not Measured at Fair Value"
       }
      }
     },
     "localname": "DebtInstrumentFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r47",
      "r133",
      "r357",
      "r358",
      "r359",
      "r360",
      "r628",
      "r629",
      "r632",
      "r704"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r628",
      "r629",
      "r630",
      "r631",
      "r632"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedLabel": "Debt discount, net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale and Held-to-maturity [Abstract]",
        "terseLabel": "Total debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r256",
      "r283",
      "r286"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "More than 12 months, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r256",
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedLabel": "More than 12 months, Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r256",
      "r283",
      "r286"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Less than 12 months, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r256",
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedLabel": "Less than 12 months, Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Gain",
        "terseLabel": "Gross realized gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Loss",
        "negatedLabel": "Gross realized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Investments by Category and Related Balance Sheet Classification, Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r255",
      "r282",
      "r286"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Available-For-Sale Debt Securities in Continuous Unrealized Loss Position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCompensationLiabilityCurrent": {
     "auth_ref": [
      "r392",
      "r393"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.",
        "label": "Deferred Compensation Liability, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r39",
      "r630"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedTerseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r515",
      "r516"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r515",
      "r516"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Recognition of previously deferred tax benefit from intercompany intellectual property transactions"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r398",
      "r436",
      "r463",
      "r469",
      "r470"
     ],
     "calculation": {
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Amortization of net actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost of providing special or contractual termination benefits payable from defined benefit plan.",
        "label": "Defined Benefit Plan, Cost of Providing Special and Contractual Termination Benefits",
        "terseLabel": "Incremental expense related to acceptance of voluntary early retirement packages, amount related to defined benefit plans",
        "verboseLabel": "Special termination benefits"
       }
      }
     },
     "localname": "DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails",
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails",
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r398",
      "r435",
      "r462",
      "r469",
      "r470"
     ],
     "calculation": {
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r398",
      "r402",
      "r434",
      "r461",
      "r469",
      "r470"
     ],
     "calculation": {
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r432",
      "r459",
      "r469",
      "r470"
     ],
     "calculation": {
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r400",
      "r433",
      "r460",
      "r469",
      "r470"
     ],
     "calculation": {
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r122",
      "r191"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction": {
     "auth_ref": [
      "r57",
      "r63"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative assets.",
        "label": "Derivative Asset, Not Offset, Policy Election Deduction",
        "negatedTerseLabel": "Gross Amount Not Offset on the Balance Sheet, Financial Instruments"
       }
      }
     },
     "localname": "DerivativeAssetNotOffsetPolicyElectionDeduction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r56",
      "r62",
      "r613"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Asset [Abstract]",
        "terseLabel": "Derivative assets:"
       }
      }
     },
     "localname": "DerivativeAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeCollateralObligationToReturnCash": {
     "auth_ref": [
      "r58",
      "r63",
      "r596"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets.",
        "label": "Derivative, Collateral, Obligation to Return Cash",
        "negatedTerseLabel": "Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)"
       }
      }
     },
     "localname": "DerivativeCollateralObligationToReturnCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeCollateralRightToReclaimCash": {
     "auth_ref": [
      "r58",
      "r63",
      "r596"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities.",
        "label": "Derivative, Collateral, Right to Reclaim Cash",
        "terseLabel": "Gross Amount Not Offset on the Balance Sheet, Cash Collateral Posted (Received)"
       }
      }
     },
     "localname": "DerivativeCollateralRightToReclaimCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet": {
     "auth_ref": [
      "r595"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net amount as of the balance sheet date of the fair value of derivative assets and derivative liabilities that in accordance with the entity's accounting policy were offset against collateral under a master netting arrangement.",
        "label": "Derivative, Fair Value, Amount Offset Against Collateral, Net",
        "totalLabel": "Net Amount"
       }
      }
     },
     "localname": "DerivativeFairValueAmountOffsetAgainstCollateralNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r55",
      "r64",
      "r580",
      "r649"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative Assets, Fair Value",
        "verboseLabel": "Gross Amount of Recorded Assets (Liabilities)"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral": {
     "auth_ref": [
      "r59",
      "r63",
      "r595"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after effects of master netting arrangements, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset offset against an obligation to return collateral. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Fair Value, Amount Offset Against Collateral",
        "totalLabel": "Net Amount"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r55",
      "r64",
      "r580",
      "r649"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "negatedTerseLabel": "Gross Amount of Recorded Assets (Liabilities)",
        "terseLabel": "Derivative Liabilities, Fair Value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral": {
     "auth_ref": [
      "r59",
      "r63",
      "r595"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after effects of master netting arrangements, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset offset against the right to receive collateral. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Fair Value, Amount Offset Against Collateral",
        "negatedTotalLabel": "Net Amount"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r578",
      "r581",
      "r588",
      "r593"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivatives and Currency Exchange Risk Management"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r576",
      "r578",
      "r588"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r576",
      "r578",
      "r588",
      "r593",
      "r594",
      "r597",
      "r599"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "verboseLabel": "Derivative Instruments, (Gain) Loss [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r56",
      "r62",
      "r613"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Liability [Abstract]",
        "terseLabel": "Derivative liabilities:"
       }
      }
     },
     "localname": "DerivativeLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction": {
     "auth_ref": [
      "r57",
      "r63"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative liabilities.",
        "label": "Derivative Liability, Not Offset, Policy Election Deduction",
        "terseLabel": "Gross Amount Not Offset on the Balance Sheet, Financial Instruments"
       }
      }
     },
     "localname": "DerivativeLiabilityNotOffsetPolicyElectionDeduction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r572",
      "r573"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Gross notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated as hedging instruments"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r375",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r361"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Dividends to shareholders"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r474",
      "r478",
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails",
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r95",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r159",
      "r162",
      "r170",
      "r172",
      "r173",
      "r177",
      "r178",
      "r691",
      "r721"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings per share (usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r95",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r162",
      "r170",
      "r172",
      "r173",
      "r177",
      "r178",
      "r691",
      "r721"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted earnings per share (usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r179"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r617"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r496"
     ],
     "calculation": {
      "http://www.medtronic.com/role/StockBasedCompensationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "negatedLabel": "Income tax benefits"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Termination Benefits"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EnvironmentalRemediationSiteAxis": {
     "auth_ref": [
      "r319",
      "r320",
      "r321",
      "r322",
      "r346"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location or named area designated for environmental remediation.",
        "label": "Environmental Remediation Site [Axis]",
        "terseLabel": "Environmental Remediation Site [Axis]"
       }
      }
     },
     "localname": "EnvironmentalRemediationSiteAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EnvironmentalRemediationSiteDomain": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location or named area designated for environmental remediation.",
        "label": "Environmental Remediation Site [Domain]",
        "terseLabel": "Environmental Remediation Site [Domain]"
       }
      }
     },
     "localname": "EnvironmentalRemediationSiteDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r144",
      "r153",
      "r155",
      "r180",
      "r269",
      "r356",
      "r361",
      "r502",
      "r503",
      "r504",
      "r525",
      "r526",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r625",
      "r729",
      "r730",
      "r731"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r36",
      "r197",
      "r263"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method and other investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r612"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Investments with readily determinable fair value (marketable equity securities)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r262"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Investments without readily determinable fair values"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of debt"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r603",
      "r604",
      "r605",
      "r610"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Inputs, Liabilities, Quantitative Information [Line Items] (Deprecated 2018-01-31)"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurements, Contingent Consideration, Significant Unobservable Inputs"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r421",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r469",
      "r604",
      "r639",
      "r640",
      "r641"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r603",
      "r604",
      "r607",
      "r608",
      "r611"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r421",
      "r423",
      "r428",
      "r469",
      "r604",
      "r639"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r421",
      "r423",
      "r428",
      "r469",
      "r604",
      "r640"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r421",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r469",
      "r604",
      "r641"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsQuantitativeInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Abstract]",
        "terseLabel": "Fair Value Inputs"
       }
      }
     },
     "localname": "FairValueInputsQuantitativeInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r421",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r469",
      "r639",
      "r640",
      "r641"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r609",
      "r611"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r577",
      "r583",
      "r597"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r633"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r246",
      "r250",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r284",
      "r285",
      "r286",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful life",
        "verboseLabel": "Period over which amortization asset will be amortized and deducted"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r306"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remaining 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r301",
      "r303",
      "r306",
      "r310",
      "r669",
      "r673"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails",
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r306",
      "r673"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails",
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r301",
      "r305"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails",
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Period"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r421",
      "r591"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Currency exchange rate contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r421",
      "r739"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt security issued by government not domiciled in United States of America (US).",
        "label": "Debt Security, Government, Non-US [Member]",
        "terseLabel": "Non-U.S. government and agency securities"
       }
      }
     },
     "localname": "ForeignGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r474",
      "r478",
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Non-U.S."
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": {
     "auth_ref": [
      "r578",
      "r587"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.",
        "label": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments",
        "negatedLabel": "Total"
       }
      }
     },
     "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r101",
      "r122",
      "r227"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "totalLabel": "Net gains (losses) recognized"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security.",
        "label": "Gain (Loss) on Securities [Table Text Block]",
        "terseLabel": "Activity Related to the Company's Available-for-Sale Debt Securities Portfolio"
       }
      }
     },
     "localname": "GainLossOnInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r122",
      "r353",
      "r354"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss on extinguishment of debt",
        "negatedTerseLabel": "Loss on debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographic Areas, Revenues from External Customers [Abstract]",
        "terseLabel": "Geographic Information"
       }
      }
     },
     "localname": "GeographicAreasRevenuesFromExternalCustomersAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r289",
      "r291",
      "r674"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r292"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill as a result of acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r294"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation and other"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r122",
      "r290",
      "r293",
      "r297"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r295",
      "r538"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Purchase accounting adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r576",
      "r594"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecurities": {
     "auth_ref": [
      "r224",
      "r238",
      "r684"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": 1.0,
       "parentTag": "mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity",
        "totalLabel": "Cost"
       }
      }
     },
     "localname": "HeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": {
     "auth_ref": [
      "r240",
      "r248"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": 2.0,
       "parentTag": "mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedGainBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": {
     "auth_ref": [
      "r241",
      "r249"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": 1.0,
       "parentTag": "mdt_DebtSecuritiesAvailableForSaleAndHeldToMaturityAccumulatedUnrealizedLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesClassifiedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Held-to-maturity [Abstract]",
        "terseLabel": "Held-to-maturity securities:"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesClassifiedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r244",
      "r253",
      "r698",
      "r702"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r243",
      "r252",
      "r697",
      "r701"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r245",
      "r254",
      "r699",
      "r703"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Due after ten years"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Held-To-Maturity"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r242",
      "r251",
      "r696",
      "r700"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in one year or less"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesFairValue": {
     "auth_ref": [
      "r239",
      "r247",
      "r684"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Fair Value",
        "terseLabel": "Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r122",
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "Definite-lived intangible asset charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r122",
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment of indefinite-lived intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfInvestments": {
     "auth_ref": [
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.",
        "label": "Other than Temporary Impairment Losses, Investments",
        "negatedTerseLabel": "Impairment losses recognized",
        "terseLabel": "Impairment charges incurred"
       }
      }
     },
     "localname": "ImpairmentOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "IPR&amp;D"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r134",
      "r196",
      "r202",
      "r206",
      "r209",
      "r212"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r519",
      "r523",
      "r524",
      "r530",
      "r532",
      "r535",
      "r536",
      "r537"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r132",
      "r154",
      "r155",
      "r194",
      "r517",
      "r531",
      "r534",
      "r722"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax provision (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization": {
     "auth_ref": [
      "r518"
     ],
     "calculation": {
      "http://www.medtronic.com/role/IncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible amortization.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount",
        "terseLabel": "Cost associated with amortization of previously established deferred tax assets from intercompany intellectual property transactions"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxContingenciesForeign": {
     "auth_ref": [
      "r518"
     ],
     "calculation": {
      "http://www.medtronic.com/role/IncomeTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in foreign income tax contingency.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Amount",
        "negatedTerseLabel": "Benefit related to tax legislative changes in Switzerland"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxContingenciesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.",
        "label": "Increase (Decrease) in Accounts and Notes Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsAndNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other operating assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r171",
      "r173"
     ],
     "calculation": {
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of additional shares included in diluted EPS for potentially dilutive effect of nonvested equity-based payment award containing forfeitable rights to dividends or dividend equivalents, whether paid or unpaid.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends",
        "terseLabel": "Employee restricted stock units (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r173"
     ],
     "calculation": {
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Employee stock options (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r302",
      "r309"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Gross Carrying Amount, Indefinite-lived"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r302",
      "r309"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r299",
      "r304"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r89",
      "r190",
      "r627",
      "r630",
      "r692"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      },
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeOperating": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.",
        "label": "Interest Income, Operating",
        "terseLabel": "Other non-operating income, net"
       }
      }
     },
     "localname": "InterestIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r115",
      "r119",
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r29",
      "r287"
     ],
     "calculation": {
      "http://www.medtronic.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r52"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.medtronic.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r31",
      "r287"
     ],
     "calculation": {
      "http://www.medtronic.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r30",
      "r287"
     ],
     "calculation": {
      "http://www.medtronic.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Debt Securities Contractual Maturities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Assets held for their financial return, rather than for the entity's operations.",
        "label": "Investments [Member]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r43",
      "r131",
      "r204",
      "r265",
      "r559",
      "r566",
      "r567",
      "r614"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r27",
      "r131",
      "r265",
      "r614",
      "r681",
      "r713"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r45",
      "r131",
      "r265",
      "r559",
      "r566",
      "r567",
      "r614"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "terseLabel": "Gross unrecognized tax benefits recorded as noncurrent liability"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r16",
      "r679",
      "r705"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Line of credit, amount outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Line of Credit Facility [Abstract]",
        "terseLabel": "Line of Credit Facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit, maximum capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Amount of settlement received"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Approximate amount of verdict returned against the Company"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "totalLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Current debt obligations",
        "verboseLabel": "Current debt obligations"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Long-term debt, fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, gross"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Long-term Debt, Excluding Current Maturities [Abstract]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r47",
      "r352"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r341",
      "r342",
      "r343",
      "r344",
      "r349",
      "r350"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r341",
      "r342",
      "r343",
      "r344",
      "r349",
      "r350"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Accrued litigation charges"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r337"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "negatedTerseLabel": "Certain litigation charges, net",
        "terseLabel": "Certain litigation charges, net"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails",
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyClaimsSettledNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of claims settled.",
        "label": "Loss Contingency, Claims Settled, Number",
        "terseLabel": "Number of claims settled"
       }
      }
     },
     "localname": "LossContingencyClaimsSettledNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r347",
      "r348"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r341",
      "r342",
      "r343",
      "r344",
      "r349",
      "r350"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyPatentsAllegedlyInfringedNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of another entity's patents that the entity has allegedly infringed.",
        "label": "Loss Contingency, Patents Allegedly Infringed, Number",
        "terseLabel": "Number of patents allegedly infringed upon"
       }
      }
     },
     "localname": "LossContingencyPatentsAllegedlyInfringedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPatentsFoundNotInfringedNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of another entity's patents that the entity was found not to have infringed.",
        "label": "Loss Contingency, Patents Found Not Infringed, Number",
        "terseLabel": "Number of claims dismissed"
       }
      }
     },
     "localname": "LossContingencyPatentsFoundNotInfringedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of claimants"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Marketable Securities [Line Items]",
        "terseLabel": "Marketable Securities [Line Items]"
       }
      }
     },
     "localname": "MarketableSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about investment in marketable security.",
        "label": "Marketable Securities [Table]",
        "terseLabel": "Marketable Securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Segment Reconciling Items"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Remaining Maturity of Foreign Currency Derivatives",
        "terseLabel": "Maximum remaining maturity of foreign currency derivatives"
       }
      }
     },
     "localname": "MaximumRemainingMaturityOfForeignCurrencyDerivatives1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt instruments with maturities ranging from five to ten years.",
        "label": "Medium-term Notes [Member]",
        "terseLabel": "Term Loan Agreements"
       }
      }
     },
     "localname": "MediumTermNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MediumtermNotesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Medium-term Notes [Abstract]",
        "terseLabel": "Term Loan Agreements"
       }
      }
     },
     "localname": "MediumtermNotesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r51",
      "r131",
      "r265",
      "r614",
      "r680",
      "r712"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Changes to noncontrolling ownership interests"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r228",
      "r421",
      "r423",
      "r469",
      "r739"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities collateralized by mortgage loans.",
        "label": "Collateralized Mortgage Backed Securities [Member]",
        "terseLabel": "Mortgage-backed securities"
       }
      }
     },
     "localname": "MortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r118",
      "r120",
      "r123"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r82",
      "r85",
      "r90",
      "r123",
      "r131",
      "r143",
      "r148",
      "r149",
      "r150",
      "r151",
      "r154",
      "r155",
      "r168",
      "r196",
      "r202",
      "r206",
      "r209",
      "r212",
      "r265",
      "r614",
      "r686",
      "r716"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to Medtronic"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r82",
      "r85",
      "r154",
      "r155",
      "r562",
      "r569"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r151",
      "r159",
      "r160",
      "r169",
      "r173",
      "r196",
      "r202",
      "r206",
      "r209",
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income attributable to ordinary shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net investment hedging",
        "verboseLabel": "Net investment hedges"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r141",
      "r142",
      "r145",
      "r146",
      "r156",
      "r157",
      "r158",
      "r270",
      "r271",
      "r387",
      "r388",
      "r389",
      "r390",
      "r505",
      "r527",
      "r528",
      "r529",
      "r670",
      "r671",
      "r672",
      "r733",
      "r734",
      "r735",
      "r736",
      "r738"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r361",
      "r553"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "verboseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated as hedging instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableToBanksMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A written promise to pay a note to a bank.",
        "label": "Notes Payable to Banks [Member]",
        "terseLabel": "Bank borrowings"
       }
      }
     },
     "localname": "NotesPayableToBanksMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OffsettingAssetsTableTextBlock": {
     "auth_ref": [
      "r60",
      "r61"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements.",
        "label": "Offsetting Assets [Table Text Block]",
        "terseLabel": "Offsetting Assets"
       }
      }
     },
     "localname": "OffsettingAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OffsettingLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r60",
      "r61"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements.",
        "label": "Offsetting Liabilities [Table Text Block]",
        "terseLabel": "Offsetting Liabilities"
       }
      }
     },
     "localname": "OffsettingLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r196",
      "r202",
      "r206",
      "r209",
      "r212"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Segment operating profit",
        "totalLabel": "Operating profit"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r212"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r577",
      "r597"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other assets",
        "verboseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r66",
      "r75",
      "r615",
      "r616",
      "r618"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r78",
      "r88",
      "r619",
      "r621",
      "r625"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications, tax expense (benefit)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r67",
      "r75"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Unrealized loss on cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r67",
      "r75",
      "r579",
      "r584",
      "r598"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "negatedLabel": "Recognized in AOCI, Cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCICashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r75",
      "r79",
      "r586"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedLabel": "Amount of gain reclassified from AOCI into income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax": {
     "auth_ref": [
      "r68",
      "r585"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax",
        "negatedLabel": "Recognized in AOCI, Net investment hedges",
        "terseLabel": "Net investment hedge"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinAOCINetInvestmentHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": {
     "auth_ref": [
      "r68",
      "r75",
      "r585",
      "r589",
      "r598"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax",
        "negatedLabel": "Recognized in Income, Net investment hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r83",
      "r86",
      "r88",
      "r91",
      "r356",
      "r619",
      "r624",
      "r625",
      "r687",
      "r717"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive (loss) income",
        "verboseLabel": "Other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails",
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r73",
      "r75"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Net change in retirement obligations"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Tax [Abstract]",
        "terseLabel": "Other Comprehensive Income (Loss), Tax [Abstract]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r69",
      "r75"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized (loss) gain on investment securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r44"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r577",
      "r597"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other non-operating income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Other operating expense, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsLossesRecognizedinIncomeNetInvestmentHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedLabel": "Other operating expense, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementAmountofGainsLossesRecognizedinConsolidatedStatementsofIncomeCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r395",
      "r396",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r445",
      "r447",
      "r450",
      "r454",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Post-retirement benefits"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "verboseLabel": "Other Costs"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld": {
     "auth_ref": [
      "r257",
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of credit losses recognized in earnings related to debt securities held for which a portion of an other than temporary impairment (OTTI) was recognized in other comprehensive income (a component of shareholders' equity).",
        "label": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held",
        "terseLabel": "Debt securities in credit loss position"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents reductions in the cumulative amount of credit losses recognized in earnings for an other than temporary impairment (OTTI) of a debt security because of the sale of impaired securities during the period.",
        "label": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Securities Sold",
        "terseLabel": "Reductions for available-for-sale or held-to-maturity securities sold"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r105",
      "r108",
      "r135"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other investing activities"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of ordinary shares"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r116",
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends to shareholders"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property, plant, and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r420",
      "r422",
      "r428",
      "r446",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r469",
      "r471",
      "r472",
      "r473",
      "r486"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Retirement Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r17",
      "r396",
      "r397",
      "r419",
      "r469"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Accrued compensation and retirement benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r394",
      "r396",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r445",
      "r447",
      "r450",
      "r454",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r473",
      "r474",
      "r481",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension plans"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails",
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Issuance of long-term debt",
        "verboseLabel": "Cash proceeds, net of discounts and issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Issuance of ordinary shares"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r111",
      "r114",
      "r135"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": {
     "auth_ref": [
      "r110",
      "r113",
      "r125"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.",
        "label": "Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less",
        "terseLabel": "Change in current debt obligations, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.",
        "label": "Proceeds from Sale, Maturity and Collection of Investments",
        "terseLabel": "Proceeds from sales",
        "verboseLabel": "Sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r103",
      "r104",
      "r225"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from sales"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "terseLabel": "Proceeds from short-term borrowings (maturities greater than 90 days)"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r82",
      "r85",
      "r117",
      "r131",
      "r143",
      "r154",
      "r155",
      "r196",
      "r202",
      "r206",
      "r209",
      "r212",
      "r265",
      "r555",
      "r561",
      "r563",
      "r569",
      "r570",
      "r614",
      "r694"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited",
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r37",
      "r314"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant, and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r10",
      "r11",
      "r316",
      "r714"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r96",
      "r276"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r78",
      "r81",
      "r88",
      "r619",
      "r623",
      "r625"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Reclassifications"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r76",
      "r80"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Reclassifications, tax expense (benefit)"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r202",
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "terseLabel": "Total consideration"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r511"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "verboseLabel": "Restricted stock"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/Restructuring"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r324",
      "r326",
      "r333",
      "r335"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r122",
      "r323",
      "r329",
      "r334"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r325",
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r323",
      "r330"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "negatedLabel": "Accrual adjustments",
        "terseLabel": "Accrual adjustments"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r23",
      "r361",
      "r506",
      "r711",
      "r733",
      "r738"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r144",
      "r153",
      "r155",
      "r269",
      "r502",
      "r503",
      "r504",
      "r525",
      "r526",
      "r729",
      "r731"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r447",
      "r450",
      "r455",
      "r456",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r474",
      "r478",
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails",
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r447",
      "r450",
      "r455",
      "r456",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r474",
      "r478",
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails",
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r394",
      "r395",
      "r396",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r445",
      "r447",
      "r450",
      "r454",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r481",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails",
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r394",
      "r395",
      "r396",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r445",
      "r447",
      "r450",
      "r454",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r481",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails",
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r187",
      "r188",
      "r201",
      "r207",
      "r208",
      "r214",
      "r215",
      "r218",
      "r374",
      "r375",
      "r668"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r373",
      "r378",
      "r391"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuePerformanceObligationDescriptionOfTiming": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.",
        "label": "Revenue, Performance Obligation, Description of Timing",
        "terseLabel": "Period over which remaining performance obligations are expected to be recognized as revenue"
       }
      }
     },
     "localname": "RevenuePerformanceObligationDescriptionOfTiming",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Estimated revenue expected to be recognized in future periods related to unsatisfied performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r78",
      "r624",
      "r625"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Changes in AOCI by Component"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Reconciliation of Beginning and Ending Balances of Contingent Consideration"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r540",
      "r541"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Amounts of (Gains) Losses Recognized in AOCI"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Amount and Location of (Gains) Losses in Statements of Income"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Components and Classification of Stock-based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r453",
      "r454",
      "r457",
      "r458",
      "r469"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansDetails",
      "http://www.medtronic.com/role/RetirementBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computation of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r1",
      "r131",
      "r264",
      "r265",
      "r614"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r603",
      "r604"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r301",
      "r305",
      "r669"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails",
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r301",
      "r305"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Gross Carrying Amount and Accumulated Amortization of Definite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Gain (Loss) on Securities [Line Items]",
        "terseLabel": "Gain (Loss) on Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGainLossOnInvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about realized and unrealized gain (loss) on investment in security.",
        "label": "Schedule of Gain (Loss) on Securities [Table]",
        "terseLabel": "Schedule of Gain (Loss) on Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfGainLossOnInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r296",
      "r298"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r296",
      "r298"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in the Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r309",
      "r312"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r309",
      "r312"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Gross Carrying Amount of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r32",
      "r33",
      "r34"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventory Balances"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r740"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Components of Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.",
        "label": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Amounts of (Gains) Losses Recognized in AOCI for Net Investment Hedges"
       }
      }
     },
     "localname": "ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for net investment hedges of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Amount and Location of (Gains) Losses in Statements of Income, Derivative Instruments Designated as Net Investment Hedges"
       }
      }
     },
     "localname": "ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r327",
      "r328",
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r327",
      "r328",
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r98",
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Net Sales to External Customers by Geography"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r196",
      "r199",
      "r205",
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r491",
      "r497"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Estimated Future Aggregate Amortization Expense, Definite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r184",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r218",
      "r723"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r196",
      "r200",
      "r206",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r217",
      "r218",
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting Information, Income (Loss) before Income Taxes [Abstract]",
        "terseLabel": "Segment Operating Profit"
       }
      }
     },
     "localname": "SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general, and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general, and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringNarrativeDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Senior Notes [Abstract]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorLongtermNotesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r488",
      "r492"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Short-term Debt [Abstract]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "ShortTermBorrowingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r14",
      "r682",
      "r683",
      "r706"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r184",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r218",
      "r296",
      "r318",
      "r326",
      "r335",
      "r723"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r129",
      "r131",
      "r162",
      "r166",
      "r167",
      "r170",
      "r173",
      "r181",
      "r182",
      "r183",
      "r265",
      "r356",
      "r614"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r50",
      "r137",
      "r138",
      "r139",
      "r144",
      "r153",
      "r155",
      "r180",
      "r269",
      "r356",
      "r361",
      "r502",
      "r503",
      "r504",
      "r525",
      "r526",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r625",
      "r729",
      "r730",
      "r731"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r180",
      "r668"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r19",
      "r20",
      "r356",
      "r361"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of shares under stock purchase and award plans (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r19",
      "r20",
      "r361",
      "r490",
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of shares under stock purchase and award plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r19",
      "r20",
      "r356",
      "r361"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Repurchase of ordinary shares (shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r19",
      "r20",
      "r356",
      "r361"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedLabel": "Repurchase of ordinary shares"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r25",
      "r26",
      "r131",
      "r223",
      "r265",
      "r614"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r131",
      "r137",
      "r138",
      "r139",
      "r144",
      "r153",
      "r265",
      "r269",
      "r361",
      "r502",
      "r503",
      "r504",
      "r525",
      "r526",
      "r553",
      "r554",
      "r568",
      "r614",
      "r619",
      "r620",
      "r625",
      "r730",
      "r731"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails",
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r130",
      "r361",
      "r362"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r626",
      "r634"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r626",
      "r634"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r626",
      "r634"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": {
     "auth_ref": [
      "r512",
      "r513"
     ],
     "calculation": {
      "http://www.medtronic.com/role/IncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.",
        "label": "Tax Adjustments, Settlements, and Unusual Provisions",
        "totalLabel": "Certain tax adjustments, provision (benefit)"
       }
      }
     },
     "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r533"
     ],
     "calculation": {
      "http://www.medtronic.com/role/IncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Measurement Period Adjustment, Income Tax Expense (Benefit)",
        "negatedLabel": "Net benefit related to measurement period adjustment related to U.S. Tax Reform"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TotalReturnSwapMember": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts in which one party makes payments at a fixed or variable rate while the counterparty makes payments based on an asset, including the income and capital gains derived therefrom.",
        "label": "Total Return Swap [Member]",
        "verboseLabel": "Total return swaps"
       }
      }
     },
     "localname": "TotalReturnSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and tradenames"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r246",
      "r250",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r421",
      "r695"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government and agency securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_GainLossOnInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Net unrealized gains (losses) on equity and other investments still held"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r514",
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Gross unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r520"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued gross interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r161",
      "r173"
     ],
     "calculation": {
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted weighted average shares outstanding (shares)",
        "totalLabel": "Diluted - weighted average shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r159",
      "r173"
     ],
     "calculation": {
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic weighted average shares outstanding (shares)",
        "verboseLabel": "Basic - weighted average shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3098-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "68B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5498026-109256"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=SL6284422-111562"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27405-111563"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL6283291-111563"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(4)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269825-111563"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269825-111563"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269825-111563"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269825-111563"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL6284393-111563"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL6284393-111563"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL6284393-111563"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922890-210455"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13283-110859"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13296-110859"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e14981-108350"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB TOPIC 5.Y.Q2)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127163"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127197"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130611-203046-203046"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28511-109314"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28446-109314"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.EE.Q2(f))",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=SL116722634-122817"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=SL65897772-128472"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=d3e5291-111683"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)(i)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "83",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121636179&loc=d3e34841-113949"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80784-113994"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226016-175313"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28567-108399"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Subparagraph": "b.",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=121551529&loc=d3e60009-112784"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611133-123010"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r751": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r752": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r753": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r754": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r755": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r756": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>111
<FILENAME>0001613103-20-000051-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001613103-20-000051-xbrl.zip
M4$L#!!0    ( .&!@U$@"6N\+[@  & 1!0 :    97@Q,#$M9F]R;6]F<&5R
M9F]R;6%N8RYH=&WLO>E6(U>V+OK_/D4<>U<5C"%D1),)SMHU!@;2YFPGF1>P
M??UKCY!B"<(9BE!% ZEZ^CN[U44C";)!@/89QY5(H16KG6LVW_SF/__/R?OC
MJS\_G 8WY20)/OSVTZ]GQ\%W6S_\\,?N\0\_G%R=!+]<O?LUV.MO#X*K/$R+
MN(RS-$Q^^.'T_+O@NYNRG/[XPP]W=W?]N]U^EE__<'7Q S:U]T.2987J1V7T
MW;_^B9_ ?U48_>O_^>?_V=H*3K)1-5%I&8QR%98J"JHB3J^#/R)5? RVMN2I
MXVPZR^/KFS+8V=[9#O[(\H_Q;<C?EW&9J'_I=O[Y __]SQ_H)?\<9M'L7_^,
MXML@CO[[NS@\>+T7[JG!Z[UHO'=P,#K<WMG=WC\(1]'^:_@\_-_=U]#+'^!Y
M_E%1SA+UW]]-XG3K1F$'?GRU.RW?W,51>?/C8'O[;]_1<__ZYSA+2WA;#C_F
M?W(;C99*]:G<"I/X.OUQ!-U5^1OZ)$XC^.O'P=ZT_*ZSL7G-K'^U_M7*_VKI
M%N4X[+XRQT%_/<J2+/_Q^VWZOS?XS=8XG,3)[,=_7,43503GZBZXR"9A^H]>
M 5)JJU!Y/.8'B_@_BHX8_WG'!WH/VDGB5.D#/MC!4WUUHPH53$ DY7&8%+W@
M[B8>W< 'LR!.1TD5J0!$U"B/IR@&BR ;!Z-L,@W3&?0T&WT,I@F\O1=,\ZR8
MJE%9%="W,(V"K+Q1.;0QSG)H'7Y+GT8BON 7^"<\XST"?\^@_;0,XQ2>R!6V
M>QM'("^'LV"65;E^>R](LQ(_? O?)G$YXP;Q)_A%F$)/Q]"!+ ^*+(E'<<EO
M<'X1P'NI!],J']V$, TP.!J8&E4YB'T8"3PQCM,P'<'D0$^+,N?N]X.@-G/!
MG:+NJBGTH:6[/*]Q@=U1R2S(53&%"8V'B=(=B7,:.[9/@\&/\?=)#!U0P5U<
MW@2)NH:>X+>YNJZ2L,QR;.O?59PKW3,S0'@;3@8TFL+20*^H"1PB30Y>0/"*
M<%3BOT)\:5#!CLSO8/2T>/JG.',MOQU[8_Q'L>3,F?Y%F>(>YNHV5G>PA%-<
M;X4_5FF4Y3#!N$!F5N"-96W:<2IBW<J<*>U_P[/M7J'3C#6('W,%JQ7?JL:E
MJG\US,HRF_RX;7\2#F&S5&7W3[Y0U^MW^'(JQ-ZV42%N<MVC:7BMMH:@XWS<
M"L?0H1_#Y"Z<%=]])35C$N;7T%B934&>04M=$_+EQ.JKFEA]W2I6WYV>7%V\
M/P?5<IJ,.O>)]%X6G@;P[0>TL]2 /IQ>O'U_\>[H_/@TN/SEZ.(T^.W\["HX
M^N/HXB0X^OGB]/3=Z?E5T+'GOG5OCZ S)Z?0L?.3X.+T\NKH"O[8V1[L!I=7
M[X__1W<;OCV# 9U?G?U^&GSX]>A\0?>'X>CC=9Z!C-R2D8SA_Z '7WY<[;?U
M>3A1?_]^_^#-O<32B@WB%&ZT;*94<';2/I86Z49&T1+";64&>9S$:.W]#!9D
MV3G0)S0>'L@)7+O/9"@?\GCT7,9R-9L^_:%<P<VG8%T:%PW=-)>?.[YO-8P/
M*B=[!C5V^'><1=1ST'K_W-G>&01EQO_:#3;^_OW!SL[VF[9?P!>#-YM+*@ZH
MDDS#* *=?"M18^C)@?,)B<X?MW;Z@_TEG2X/;MWS\6SA<U]=6VE?A('1]K^]
M]N%/UB'.@;O"ES=HH_Z6QF5P=!?FT3?J:?L\!4'P3D5EGJ7Q"#55-**#LSPN
M;L H'H+9'"3Q)$;+41O]>M.:G\E>#<26EJ^/^7&]D7O!#5C'8!-?H[PJ\!"P
MZ0^[+HXJL!!3T&S ?!^B]:?? <:E;@#[1=,5;#AOH4_,(R.T_8I2+-/V.2]:
M3YWSO6DM)F]$4+)42JO)$"QB_6,MJQ:T07X0;L?>GVAHJU!\ = (M("&-8Z<
MO0IHD-.4\#OGC*6\"4NPRY,D&"IH,T]A"F,RD0,PL>))-0FFSD_+&["0;[*$
M#&;H0:QN%?T;6JC 0">_-(S[4BS^'6@VR>[ZP2EVMV,3YVH*K9)UCN]E[S6L
M;ZY&*D93/D5S'@Y$F,^"@G['5GQPK%TCTS /;L.D4L%_;?=APP^PU_*LGG%Z
MH]U.137\"WJI-Q+TH(3[G%Q4/=ZSH?R!:P [(XK9?R7.)1YH>0.#GW<X@Z/K
M7)%?Q=]W^E-OI67'> <J.(+'T'V%#UQ +VF.V1(A]QF_!K\]2]' PRG[D,!N
M=]^''^A7]>%!>@\L'G1+7%9Q*KM?I:,9+%MYIY1L8)5/M./$&8[VOF'3O>:#
MU 58 =A:U[ Q\Q2VYG$XA6E-0+Q$\G!5H*>K*LG[$JDQS2O_ZB:\9=_-1(4I
MNY=&>3Q4]-9<P;K)=.&;NGTS+1:R8Q7\!;LV'L]>R*6VL[J7&LO#XI'O,I2=
MTQ!NC;*'8I!D"_DS^:#S4=/B<ACBYA7I/,X2$'2X34&8;>$QA<NON($'//G)
MHPSP0-#/=K=F('6##I7O/IO:F][=5RN_%\/-QUMJ?[(.^J]H.\IMXBV87FN0
M0465FZ KWH,J&)&3.PY%/;] >5KA19W=P7UL+A[_<WL#78@[-[C*0"CRS8%W
M*VR-"U56>>JTH)^\O+"_IVB%WD'R"]B-9^DM;#_HJDC;8))%\3AV=(^+]V?'
MP3OYU%Y H$S<9'>IOK+Y,#AS(7-0F$GA&<:KJ9#]7[1/A7EP'V_GO[E#O[RH
M?]NG%WM]I& 2O#"<3I,8+P!4#J(*^K2A[PZXOG+HG]JD8[6DXD/AH3"&0UR5
M-& XXWC;%$LVHG^K^W=-D7D\V7@EJG^C#E9F/=1L$U702]MTPMH;5C<H\,V-
ML*]MD1\LUXW=#[^__6/0'?%X[.#% ^Z!1UI1]_2$>)NB]"C9J LBD!APM,5X
M<46/WN2BK1?M@FE9)9!CY7A#*WM(H"LY^JV2<%JH'_4_WD1Q,4W"V8]Q2H.A
M'[V!V[N,1V$B9Z3,IK*&AWO]G4-:QA+6KHQT\[+"??KJAS)J?K>SW]\^>-7Y
M]79_T/G=O&;W^Z\&W=^N6UVWNF[U<UK=6ZK5'T@:L$0 R5* FOG?W^U^U^TX
M/]C&__=&I!*;E].2<"A1H*6T?$N!WL:7(O1_W)E^"@:^S8O-U478)(ZB1'W7
M?<>.Z?^^8L"UIC(N=_-_]5ZY>ME%F%ZKVH4L*__XBRH0R:YE_;)S-U@T=Z3*
M[/S-3-9ZFKJG:7<]3<M,T]YZFI:9IOWU-"TS3:_6T[3,-+U>3],RTW2PGJ9E
MINEP/4W+3!.8*NMY6F:>!E]_GMAG]JRG\>_?'QQL[[\9U-3U138K3X#V/'9-
MT+<T7;^L/W.YR?M P<*::3AG,S[*K-U_TWWU>=M?3L:MITO4U?5TW4MM74_7
MO=37]73=2XU=3]?]U-GU?-UKOG;6\W6O^=I;S]>]YFNM3-QOOK[A]?CXYN97
MG\Z=^G5 AN8/!*QH06[, 3%^ 03O&@:R;G7=ZKK5-0RD"0.I2V!Z_5Y_KQ,\
M^#4]E0(1L:CA3AF_.MU=8T<^0TM8Q[&7 X^L8T7+S=-Z/RV'LEGOI^7F:;V?
MOF2<9SU/Z_WT)0-AZWE:[Z<O&2E<*0S)LH;;DEE\7]T.$H#):V=+6@-H#3-9
MPTP>7?U83]<:9K*&F7SMZ5K#3-8PDS7,9&7F:PTS6<-,UC"3U9FO-<SDJ<-,
M'H56C?H8J5&6$U_ACT17AD]]]R_ABT6&I\'@C2:-G<,4Y1)$&5ZH%6'%;9)"
M$0V5\$ 1#^#E;X$8RF_#49GE6$)C=_MOFM!R=^MM7,#V#/XDPBQLRY2/F"A5
M!J'AO,S&P0!^J,M[\$1NR00VR=KZ79-T7T+!.G?_:I/Y7!&3%1RH0FA7D3^,
MZZ&H'&5">&VH.N?SG2*OCR4@]8CUA VHC9PMO ZQ+(@P OF<;)9BK_T4M"UB
M-_/60WB6#E>(;&^X0F1[VP.<AJLLB!1R@,+3AG*QMG7"49X5S,4&)T+OI.L\
M)LK9^F81.MJ)<)JVT2YB 1HA#:56\'P3D:XTW48JU0LF55+&3#P' @6?X]'"
MACF']>5N^Z()V7$M5YT=*#%%QJE'S2OCZ#@9_0!FRK+K?AXMY-YA?W^)C7KX
M:/LTWD1AW7;6825@&0KD?'T\#M,&2PTLGTV1?XP)ZSWR;#@TCC 73A3S,2:#
M&#$?=3Y0")#NT-]^Y&V!DN9O(EBQ2PONW[NL2B*\@D$_&F%1L":KY^.CJ@?]
MW?V#AZ"J]_;[!_N'7QSY.7C=WQWL?/EF7_5?[3X, S[_E;L[7Q[].MCK[[S>
M_1+PUWO&XV!??/%+:GO1X=J>;W"YI^L=ZP]+F/3W-JQ7<>A_$W+L4])F7LJH
M_Z#'[C':[8"TWWL_^CS.3EU_>D[;A",00?#I>0V*.;F?UYC^_OVKP9O/&])J
MG:J617H^ J,EY^-9[$+4U-?BX@F,Z=F)BU?/5US\34< %IN\&S\I^+SFN=O\
M!KK<W,!>,_9V_\#;ZA^5!PUVM7;:8/!\3Y%W)#J7\]7G#:S3@[3K!\)VFQ[K
MKQ))63@U F8>O-I^\SG_Q8CD!48MJ4)>/"8!M*1S;?'4'+8)B$>:*UWE)BM-
MK<#E4V 72HBO)5-7ZRB>9W:S/$M9<Y\;^PA+ZJS8A=V*Q.E&TCSCV_P+SL1J
M;='.J[X!)[H_ZN,I!FG74=IUE/891&D/7E*0]L75#MQ9UPZ\3^W KQBVW^GO
M'^X\*&R_UW^]NUQL^9YA^Q5K=MYW._W=[:\0MM_I'VXOUZ'G86BLP_;KL/TZ
M;+\.VZ_#]DN/B2S/U1G2LPO#K:/V3_!@K:/V:VFQ#MJO@_:?$6!ZHB?E.3OR
MG\$A6O68_2H%IK]N"'Z;2*=79K!?-PJ_EF\K--2-791OF\]3P*V! L_DA#U;
MG,#!LC"!SA",>[.XE ),YW+0O&L\_H?/8)NXQ\M6AM1@M_]X461_L@B+<2Q!
M650I0$3Y+M->X$7A,03>8 U8KJ3%-YGPI6 5KO1E@;Q"(^A";S*_C3<08;I!
MTH9(C>.4H^KO5%3F61J/B#CD]9LBV-V:(7%,$4^FB0I"$#M$4I&FR$^2Y=<A
M/!SDTO0USY&P2$"+)4C$M"A#&/2HRG.5CF;](#A%]HDQT])@Z^9E\GOHDVD"
MC]Q4T;E+9GH+I;HCR%_R7CIQK-]T+&_2S:E/HZ2*%'-J#+[*\7G=7R8PWH)!
M0#&TM=?'A:Q)=*3XX,!-47Z;(]^!7*'UA[,]"8EC)@&%^M]5S ,I'D@"M#J'
MVY%/3_EHVV&T'^P-.$+F]!:D-4[S& ;Z"0XOW&O(B44D,F,BD=H,M@;P%=SP
M 8PZCBP+#!RQO&QK"4XB4B.UM1:H?X.TX/,WJB:5=-:RP? [H(?47N&^,TOE
M+?U[+\93V8*=S&1>B%ZS[*S0@!;LR?LQKOG[]3Q+MWX^.OI ,7H858$?YFJ:
MY273"W&C65X$TZ0JX$\03O!!</H);HL"-I<2F^E3S]U.C;X8-B04<SUSKU@F
M+;D IYHN2_I>;ZC]V%UE^(Y3D)?EC#MZ#OTZ4<,RV+B\R? DP:[_-8-ENU+Y
MA+[9#!)5%-!N<4/?GIGC5,@9(P5J\F!&N( 9X;8^EQ$.W]-&*&;[6'_$]'D$
M"@2\+DY'.5STMM^""F2Q@4W=!U#\1>IC4DMS&>G(2%@5<V!OM<R!WV&GPB=P
M2'8/W@0G<5'F\;!RTS@>8Y+ZM",[_"8]E":X_V!%\<IJ,*R591BGFF"MBS -
M#[MA/#.7):+%01JQ>01_3.*R5 J!XN%H!*8_-8'\;,&E8K?L#I,*]OA4CZL$
ME%X\_MB3H^H:MG6P^_0TV#QZS.7O!2BO>J"F9'P/E#=@F("@"6Y"5$-8$*'1
M #([N*(U-!;M*=@]V8R6/ZIRW-NR!4#6!4,%8@*O)\W;^'..!L@):,HDND&E
MD2_7B_=9B[>!DRLWKY8Q?-]H_4&N1IV?0<<G+HH*611IK4-'W[QD-9/44GW\
M[;>==)VX;?!/$1$;L&O L,2^X"N-$@O-QK=A@A<VR(1B!"*0#%ESR%_W8.<D
MV=TF2HTB0R$#:DP.EQXL &*1&=RN-QNV*:+''SMR,68ER@\T?".S.7,U4O17
M@2$8&$8/[WZ<!-KGRVYR_V78QU!R7? WT%P.PPO1S0."/AS&"2HYH"J YA?G
M1$G9HY>*@C(!,0IC*>,R814.NXEVP$JNC,.P252LKM"WNB$[,5A#;.I"O<]?
MW]^F\&N:ZH<L&2IN. &H9.'/X!'L>)@N7KBR^\;D!5TG71B7[#KIXCY)%\MI
MV(^TEF$%70SI(@3-:XA'-1^KN&0Q@?H87>PC/!.)K^CA08-SCC;3@-*2MK>#
M:7_2#XZO@HU)'*7XFN#T:E,K"Q&J"?!X48'YV7F\00B\A;,YK7(X&:I@20%6
MYM%UKIRSBJIGH:](>ZRU68J=MH:YG'+]97$#HV5E")L"G5:;W"(A21!GA;RE
M)\-TQU#O$N'.1?;HUX$!'*;ZA^:BOHE'Y/%%B8_&822_U2)Y;WM@?Q.I8(-_
MP>YD] F+6E>0M'/>AA,)7:"@*/JJ]O<=%=!H?T.EX%:BV6Y9SA3TB[W7;Z =
M]$/!_TP0AW4T'L/DPLCYG7#W)"!@2YB=E-P(,$/SN_)J9Y,>L;,4>8)XP9R)
M5#?=8-IEOEI$VXE8\5'VEH"AP46;I5N_]2_[SF_1_V&?0M/$/I5D(]J1]V0)
M?SKF\_YJF<]O6=@XJ3B/8RZ?C>T!$2TMHEV'*E:+!A>!J0 ZT<S1X&K:HB\?
M7$[RABE5Q)_@F*6@U*)C&5U/F2=J%FA#CMU5WJGD5NG&?*5KN=9Z[KGKX>E
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MWCVO_59^GLPU=DC/L<')GE_XT[1ABK,U8\S& V0L+WM<]0X+T2..*<FEHN.
MES^>6AJZIDEQA<.X G.O1=9B2^J3RD=43SQU>>#X7?!;6H]"&#;\][CD.66C
MBZAHFFY*X]A;:9"8'_WV=-%E-;?#V&ZSTP@IF=>RJ)<"K! Z'_Q1*+02=Q3B
M&H45M2KZ,CT7-SQ7\/K)M.10)[::& ^&AG3P)NR4^=A.0A24^ )N3IQ,[?U
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MI;(6>W"C&7=9_A'_E\T93<2<^7A/6*G#]4I]U972Z%X/Q J" XZ<*E&Q<='
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ML_ S_\ 8V%U)N12ZAK;_30_,+E+B05!KY5#\ 8C/9;0@5@O;[)'YC?YQ[3!
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M:?]S_WW1R!==-J_.NZ .7MY<APL9#&H>8D^D=3@2"*5I)%Y,_N.;L. R!2(
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M(Y&D?XXQ%K!+1[0]06IF4]Y(LN:%K#_^7-=W'^65J<)%(V,>7=S"!5X:B2:
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M\QMAP3O  ?0[!WV/Z_N]P!2Y[OA/FX.416+JAEVU@]JRRKFW!.9C#)6YN4W
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M'S&SC"$C%+AN&870!STR?2DQ&6.@\#3:X\ND!JB%DN;A92;&$.M1TU4'B0R
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MG[7/ULOHZCPF+W[QIS!'_TYS].%]L>WPNMJ(BL'OBX'9.G,-.E&(YZWS'(V
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MG>D1>?]W4U%%89]K)91&@WK?H=3GXS('L SJ&S2!GR;MJ@UPVTBH)M,&)V@
MK,$C?P[1L.[-4*Z?32G6@;YK!<TFA%RBFI\VM?3!Q=*ZM+](!KT#/W&]!SY&
M8P*UN5]!U[^=)4@0ZC170>YO"(O8(0'TE73[ZLY7[^#]2%E";#*B6B\2T%ZZ
MC/*."CDL;7>457T"40\,TG5,RZ9^5VEJLDC^=/QH2CJ9#'1K>FI1VCF40)R
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MNWT!6@_ DKL; _=X>EC<?#6^O[E_QW9MK,(,C&HPK6VBVTM=46^;$:PFZ%^
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MW'7HQ4%%K';SR;2/S!B^-/BGM"6@M-U!SK;6.5#!* Q?1&XT(,)K@27#Q.+
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M4UX>C376REP8!G"6Z/NM+^IU([07/O8(8#FRHY+6?^LK#40*).O+)O2"NHJ
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M1 O@5$69DX\[>)WG60[:#B@](;*OG1SJ_02[R*V7EMS%;!8G,659H$HMTM5
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M.A (!ZOZOQ@^G?420O6?<3F?9PDN9/!!?!HLGLMS(+!>0JF^GLW I'1$Y8[
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M5OO9/1*%8>FKYCM@?VZ :[)6>G2&NS0Y&C,M_L.2SL\D>MY>>V< /MK77Q_
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MPEH6/,ZUF,5*MBI)P>U_**#>[C<D=".$:8#K24HV'&M4JMPMKXK@]("QD%_
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M8($Q?!NBLF'R?XB'%&66M59(9IX)KO/B2=.B-^XI?8JXCI+BH$6-_,:6D4R
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MBV5]46SNMP:'EW<S%,+?-H 0ZP/HC.4_\8$@71,TG26,D].MQD$M_0I)T3A
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M$6.ZS(6"F,V#7Q=Q43QY I"KR;H'J#W_GW7&""SZD$)L<*A %2235.MW=;#
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M5&ZRXTW.BCL!7(,_R-DV:G/Q')6&HVZEX?MI%JW@GWFY2/[^_P%02P,$%
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MUCD34NVO<SJR<M!+G6O+//C/C7#@*<W$+'1 =X!Q/P6D;6:Z>?D5L$'HZUB
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M8JIN$G$.?+[T9<<-UF<&6T;B /<OY-.4$]4,^&5)\TF)(FOU<I(K/@4<2YJ
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MSZ=U*-E6=3_V$_4_7Z<\]=6+F%9FL=R8C4T=(J,XO%%4I#*<\E%!ED$B?&I
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M9!&^P6$2H$'6?C;(J^P3R)7_ZO,9_.L-EB;?4W(>+1AE@Q8)G+SN*)&_\,.
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M$KGL?*N^EDO&4R%K4"E81>0)9*K\Q2)!P_1,.KMN;,>. :G.(QA[FL3AQ/N
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MQ9'<\RX,1CNFORW3G,I,?1<$,38(/5\>>@FIYTX>?1XG)KN)>GY_%U\YL[N
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MV-,P9@HRA.G*]MX8?D*"2+R*XWV3$,S(]M,$WQ*##!* USHCL0,,=@R@,=@
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MT([P]+R<"R]?I$F>9M080)Y!?KD44?H'?V,B6E;S$2LY0.5Z/8NT=6$*!PQ
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MQQP.=>2;#X@ELATGI"K-#STNW=YB]:D_>#[T61^B+: LQS"KW6SGH ^I#8[
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MG+FJ3I7(ND)0)AVZ6V:OVEP&1$D(!IO*V#K7R+0T7NI@4G$7_A'Y"=;P#^\
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MKJFA^;=^%--D.UZK@HX1K,X-:9:ZN41UV+Q*%ANP)UYS>K,0L5C,L.Y,\N[
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MT<O\XL)B?]+K']5[^KOC-;I_A*[[-;I!15)J)8V:-5XMML01M<8C1O7*ON2
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M7!F8;GKP\(KP$;2IK[;7)$=4PX1$AC)3L9Q3M#6M##Y+,'AX99#E5HTU-M:
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M4")0HE")L<64R!G0/-*4%K/)84@:;$VT)=9DP-4$"!$T4F*S?<O&JCHM570
MY :ER=9$6V*-YME%GWIY2>?10TX)JN3JG"HUQ&+6&FW@VBB:&GK!C%8#8U(]
MU#2 !7$JRG,,J:RUT< UR;P,&;!!R@%+*>R\*S[XY#1<F.C6FF3@6B!:C?I5
MQ68U%EN-9)D25R$,V48[J%DF2P[P@OI)!&/AQI$-HT/@AD(NN@9%-*L8_IKP
M&1U.:?_.87WRJNNJ+2F[AT?[1R\4U 7TQ*GB4[4WWP]A]<._:'8:G$UD-$(
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M!U61YVKA7,ZD8I!N":G:/D<6:J]QB(42&W'B@'PJ[\J5+[E;6I-LV3T9)BO
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M'?12Z!B]226))\>:]HF(6XE.B8%F>LM"$2HIAAQL4D&"9(&"!5-:5I(DBF4
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M$*4QE7.H9YEV ^AVLF&L+V3V#J!DX'^#=TXMIMV#]5G*GG&NC0GM3+<8)T<
MY;5!+P!";=;H+86H';FL"IJ><;H!CN4S3E'6V5JHTV(!$HP=!"E],:ZRC^E
MI>P[#:#;J7U4-PU "N!* **ZP9"!X5$D1H20'=@@U4Y,*-&MC%F4(5NK(9&3
MX)7SK#>$@AQRRB[8TK-,>P&Q?&:)T64?DE6""88(T(H$(6B)V:$L'2CQ=^=
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M&D"HW'Z@KAPTEA>MM :4I:XF*C92"A!D1FFM*04,)60D=J#[3>\]6]EXY<8
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M*<VC0$IK@IU*XV0R"V*-))&07V!$>&'!^K+@SRL6]()9K9$ &9$%9HT&C5@
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MI !WIL"]3 ]\>/3BDR2:.D$,$!(8,&<(&!8H)+L*1214DD\LLV#59X'R'L?
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M4A]U;H;I4M:<'*8]\UK(H3;D,')B.10B<L@!]U(!4UQ 8OP(*')*&'>)_=F
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M]*L0Z*0$.A[&9;GFR,:TD+FD:3*I."AC&5"D"#=<"$-0%<:U$K9[Y;K]5^7
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M.->;N^Z>KC/U(*S]@/X&?LN#LHWM82JM1JMI;+/5[#=#[]D#)L^R2_#7O7K
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M/#B&9-(2A<4A<,H%H](0^ROU</)$L848%T&,/ZYJU^Y\(I$[Z@4!%ZD IKD
MQ8D')(E0PDL;+)L^?VPAQ4**M2/%"3A16FZEQQ(E>XJA(+3P 3O,)/)!.^^+
MCKBT5-@<)7 ACFNM"1!O["!#;7:(@*,L>",HM=8L6[K*0HB%$)^"$+%-ZH'3
MB >!F?-(4>6LL59019V7Z*')] KK+83U#L840,0M(SXI@)8'8%RSQ'K*@ L.
M(\-%/D$[DQ1\A?(*Y2TSY97L7"O+ALVQ^K$8::<%Q*AS$K\0P 8E06@=6%K:
M(I=\3;-SU9F^#D*_T:SJ"CTJD'!%<R@_;.R&41$ETW614I%2D=(:2&F2S6&-
MN;!)J-$I%EDPT3@GD=?*:^>)_;0[5/HX5"\DQ;\V>%]W.['9SR?UBIHVB9IV
M,;:=RR,7U H!" L'C%('FDH'V'@BN$78Z&2R,C6UEZX L]!GD=(4]"FHQ(((
MPF2D#.D$3&J)=P1Q39"QJM#GW.AS?*>#,(=D2+8M=UP"\PZ#MMX"EAX'C8FT
MK!#HBD-3<2<ELE%SQ9CW6E/L0F32XBAM8+1 <W[0''/'(ZJ-2AHGF)#S628H
M@D&"@J>).JGQV >6H%F N;+ #$@A97F0+.J$/F*B5HA%03V1W%)<@#E'8([6
M3*:CHU@F)+HH@"EATII)?'IE$--<:RQ4 J:>^J3E#*&Y4L?([P96E0^GX<9S
MX33^:*6Y_L]I',(S/%F^?%SU."OL%U7.EJ#J4)%2D5*14I%2D5)]I33)(08A
MJ0V4^BBC3WJTM3YX3##BG CID7^ $GUUFN&Z-ETI'-=R[^U5>D;6KP]"_S >
MF1]%SYY S\[&[]B!A%S9"&.&DUPB H:)!&LT 6:=Q<3:J!C?V";D=OC%Q,<1
M"G+KB-SI7<8%N7-$[LA"SL>(-*$1A* :6. *E+8."*&"2T8)4;$@=[F0NTB'
M<L'K$^!US-6LK60$.P_!6PN,<P[*6PR6.N-4HELI<JSCC,(<"V1KN-C.P-=<
M%MLY@G>TV":"E982 P*QI"93[D %@2$JE P<2HEU*"VV^/86[D(6VWG'(,^^
M6-'#P+?;_-;TH>U[C7ZGT1O+/-[XXQ^_PN7KT*WR8LX6GWL'+W^1B/.JK9<_
MOAM<*_WQ5[A$!9>_Q^4[]/TR,BT]IQ7^]VWJLS^SA(F/'_926W?HP<_C]/>O
M9AJ?KZFMJ1_I^>1M+FF(]X_V\?&'@[C_<^^38%0++!U('T.R?34%FU9H,)%1
MA(B1W-F-;;3%U2U4-\Y"M]&YK+]1S;P;U;+*9FT)0RM2*E(J4BI2FL9FF'E(
M_)4>,J:;/*^2[!;S8!(U9"Q 7A(5'380B4K&@2,45"0!-.,:14XB9F9C6\K;
M:L3#C8,"T4*D14H+WNDH1/H41#J^J<$L9902#=XQ#,PF4M7.15 A..$<8332
M0J7+!=)"I<L@I3G[L0N5/@F5CKFL,47.B$HA90R8M@RLP ZPB-(+%[40I$94
MN@;!TWN]WKEIN]#HQ('+L)= YD.N9ICF>^/LO.M.3"\T3-LWS'?3]8VS5OJU
M$E(]LVWT.^MQ>8D#I0AACPF+4FK&.''>.8NT$V3RG?2*OK*P@]\][^9L0JD7
M'3^HQ%7]^U<2L\_;=:'=,[F)A>@F(;KQHEPJ:H.29@A*Z B,1 .&B@!*"DJH
MMR[)<&-[5MF#RK9ZK97&(J6:$.T=%<$$U9&I1*N!IX>QG,XR"FPLC59:)V?%
MLE5]TT*RLR#948$;85B,+CH(D@9@01(PCGJ@!BO)&5&19)(5A667"[^%98N4
MBI26/T]+60N?>BV\EL\%2\*(-R!57@UM1#F25X!."D[@T4;%95D-EP_!A6>7
M04J+]%,7GGURGAT/NJ8Z(.,<Y.!.8)ZQG!V: <TELUA4BE%6,Y[]C1?;-WMG
M+7.1&QM^#?IR9[FS'G>N03[SBM;!9NZN<MM<DG?);E[V^HN4BI1JK^C.W+F^
MX[^<]_JGH=WO'75VTLCE%IC6:]/T>^WGYJS9-ZU*X;4W%=ZWX;_GS5ZS']Z%
M[K>F"P,-^6UPG<_MZBF5LES4X@G4XL/GX[7FM30$:P[>\AS;(2QH&@E(;1%'
ME 0MTM(M;Y</+6BO-=H+)Q<I%2DMORN^K)SU6CG''?<*R>A81"!RM5D6& 9#
MO 1&$0W:11G+VKF,>"^LO Q26J3COK!RS5AYS,U/A.&.2 T,!09,( $Z<@6.
M>R-DT-8%73-67H-@]><GIOTY5(E5VM?JGC8ZW]NAVSMIGC6:PQ*H)42][#47
M*14I%2D5*14I%2D5*14I%2DM-)OO?K/=Z3;[%WM#%7U@MNZU73<D"W<W#/X6
MLW42L_7=]=)Q5@DMN 0DG,D5JA1802UPBHU @7.+S<8VK5%P6@%MS;U4!;1/
M ]J1KXD[9[QC.:248V#8*%!(.O"1(.>]PM2%>H%V75+Y/C\_/6^9?BXHEX8N
MN'[.DN J)U2CV6X8YU(G^]G_=-9MMEWSK'55:VZFK>5;BC^@P7^>=7J5^_=9
M-PR:_6>_<_8,Z!;.7[\YN@FV^0D;VW_@DB>V[/(4*14I%2D5*<TP)Y=-*J@6
M1EK& PO4VT"\D!HAP;AGE'_:&RJC[($E):J@^&$Z_1?_/:_44M<ZST/XNM/-
MS=GI][M->]XWMA6..@?7=HDN5=BBK$Y2 _EHIW\XLC"#CMP(B2%HQ8&%G-I&
M^@"46.65-9QXM[%-;E<G+[D0ZXKHPKO+(*6)>!=CI!7V5D7,G':6.6L%54HK
M);V7A7>7@W=3GW* ?>+>7.W'8XHT Z0)!29QE<O;@;'&!VP095P7XETJ2!?B
M708I34*\CB$=L.,<><M4X-9YYH*0 @M-N5.%>)>%>(^OB%='I!1U'(3(-8B]
MB6!%B"")T29REI1A41_B7:DH0'DG(/]]WKIH4+S9R%A:=)2?[703-B'[6;/(
M>IU6TS?R$"PATTV6HE82@;C.&6JC3"3'M;2(*(>T9]Y3<ZEDWK'!%#O=4]-/
MC_C1?]8^/_6=_O#Z+RK5#1+5'I[W>WW3SN-:.&TB3DO&^VC'R9F E<")TKQ*
ME!:#!6.(!.J$]8G2=%5D#F]2-JM=IX?!9,&;R$^(];I%4O_C:00X@>#JQ&^W
M%;G9D-O/T.WXJF1 T>IJP(!C@3*&!"^QU!!93N/$# 5#C0-/G8J)')DU\<I
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M<M5/*:2./(A$)9#&J_6.2W1]J96XY JO@I3FH8TZ>"J#5M9$GBUPT$TL2$K
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M0%58>,ND7$2_0.EJ*6F!TE60TCQ0NG ?=H'2!4'IC-\ZT* 2)A0E3P% -0[
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MFN/%=J.^JQX]<L[.8Z+%LJ4:_..1EL <HE\F"+W&6[L0_+RIH5D#FN,^,*_
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M%-@J-GCD!"8(<R& .5A"E%O;9'B9XL[%R[!\O*'H[D/I[I1+Z"A"C#ZAR%)
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MDD]!JUK+<V:68A)69BF+A4H.<G4LAZ>0:O';$/M=[,U:>AS6#(O.;H[[?1K
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M4#!(1[VFQF=;G>+*K0Z?=)*FZ(06. KOT+D07+'>J@@WJ>+9DM##DM"+^6@
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MJ%RP@'#1V5H'"+Q&QT.(-^F/W;+@\K#@UQ,6+%8&48\NR(B"@="1>8F*::5
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MOCL88Z_M6M*6^_K6OF;6'F41WG@'PBGT5A7GN<X)712\3?!?(9*>[UH28CV
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M@D<F)/E<ROKJ?!.2U3+UCG\*Q]U>9Q+Z85.<8R$A_TNFX/$Q$D^Y*# EU\!
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MH;\2MW-43KNDF#)U?UA7;O<Y,FX)Q;02D$7\1D*6*I'K$'@E6:X\YJ1<]%D
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M@>SDUG.U]TYON=%Y-M]U9G1:MVA6R>8T-G1V+WF:W7 Y*UQ1XVBB?VYQGV9
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M\%IC-<*G0OOB"AO\36VM<Y'E86VM-S>0SGMZ)P.I"2*+(GU*Z"&Y%#A/493
M=:7"9)LL=6_;_57=XJH *?I$?:3UV^D6CU*Q8#)*HXW*V5]H()WL@ML2H.3
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MK3)!_5-_7&9I^GL<](?TOXKQO'=2Z!8_TSO^'G>48'"34M.V<%^TMIPK!ZY
ML"9HY8)QW(;,Q>6*Q^TJ3)\N:/OCW[4P\N3G)Q^KLJ2JT]M_OWGUP8"1D+-@
M0EFLB1T-<]9JY@47*J,5(/7&%FW?2Q2/6>5QXHV;[(:BE2HAR&P=!P0?DE4*
M0.3H#&T0U7;#@^\&OO/KAV"L\]$IV@C2,A!2,N= USSIW@80*?BZ&R[-S7=2
MB;QR^0%^[ \JCQ-O3*00'$P*>L=IV6 Z:4YTD3"1(7+EH7/BAMSLO#K%/*/]
M0<XS^>1$*IAQ* F'DTQ0XS<NU"F>J2IT_,WK1X9I_<C-SNY8LCC [E@66FQC
M2HISO>KDQ'H838EZ1@+!Z5&M;'7W\=EV>EZF/7]!,NKHD6JYCWOU8L5FJ>ZK
MNGMI R2:K&$UM*3'G:"Z!U=KDH:96.5P[T5GCY ZP-ZDCY@(P5W:9./ZG#.L
M/.;<59EMK#"<B/A5,A[1_T[D)Z([4C3707;]:5K"?<+$=4&N5\S]M)U@@<5F
MY$:S=!-)0OA@(T\:@C-@N0\.11(0HT6=M$S3P&?'Q;4N-ETH4ARDT86)!G^9
MZ8D[>?0?FL8^J4/3:L0_T)G6'?TOR="OC_)N_P?2I[';J_N@R1M5WOCXR_'V
MW@>?N/2V%$::0*W+$A)S6@)3!HUS*F"JJ3L$/W]M85;C>KSS;K)? KK$74 .
M)@.H'!PI([X4ZHAV+J8;7H1K^^6!]LN/QSM?/DAAO# Z,<R:]HL3R&CU$C,J
M*).LMUYCS1U]/H:G<R*:DF#R>6:&FYG'IC:CF^VDAV*>U[0_#G.:;A329'Z@
M7@RZ86PD^T\/#ZL:\Z;\9]#_JULWU^\TO"[V9A^D@1QA;Z%@^JQ>>MM8DXWU
M=?M+)2((1$8,E9$,B@-2@X&S>HM&9X[HN;M9". #T4S;'/>_.7)0.DH?F%)"
M,$"K&&G#A<XKH[/F%DH-'/3GBU]<?FI-1,'!6# D/3=-5G&FBG:J*#L[W#[3
M K)!'G4GGSY19V?*X1G-<FQUK2;VS_5#?_5[U3P]..Z0)MVK\M9).Y\Q?L*]
M!>5RHN)6)TM_-&?$J4P[-G&3VGI \NC$I'ZA@D<CZ/6_O*#_13P:CJV^Q^,V
MSZK.D[=-.EL?3^SH>6Q;)ES-?!]73L11K_;^=Q(_=_JCW!$P_G*IK@OZ>NH.
MX]%P_.W^9 RWG?%3:OC)2!=$UW)+6;A3/06T$(,10;+Z94H9YE$UA>#YY"DW
M%8R7P$ G-P)O9W1;V\N"2R*7;;[]ZP=!4"'113+E(V< ,C.4X)DPA7NO2A3!
MWJR$V]W%DK;N][_NFHL,67EF,Y+$$5-@06O!:J5Z%*!!:[ZQY6YPIE06"GWB
MUL]CU6*X:/B,N>H3APOG1+>&S71+=T9?"P918L:Q\W/B#R(V[$X<>E,[XX+^
MOGQ&''O/;R6.FZ 0A# 8% >(&HVGGT.,R>:LDUF&.+[.50>6LKFWO^[)>J,Y
M9 -0.).I)N.U23'4/C,GLS%$= ZCNB@9P:VU^AQR<D6)+$.$&+SSSJ1D1(K1
M@7;7N?[>%O_.S+;[26[O?= B%B^280Z48E#M.8Y[Q8SA"64F(5KIBQ)B7::B
MG_-TK)9UNK-^YNDS@7FT3A5LW<.CR?DPWN!.*G19*Z5=!@/2DXZDN4S<Q(S1
M3P%*W\GI5445%Y P(GCT&43B/@J5 (&4Z^P<AXTG:@??'8=+]4CK&3OS3JE)
M8W4LS\*7CA</Y.N&Q9V<I-<[/U]>T[-@+IO"Z0"FX<.3(&":RAY^'N:7LQ^^
MF]WJZAZ.)V3\I;/AOK12WWWIIM%^#5+?Y)- ]6GBB&G[T\>;XT=G0I<GSXS:
MY$I=^IAOBDN?7=6LX)N:7_[XJF:O?J;6M+-/[#KW-2?U>A/WC8PG*Y'8Q)WA
M*GMQ0B$Z ::'[/!<\IB;#2V. PY7:7 _SF([%JR9G9DY\P:#O<;UU]LN^0(=
MGYO*QYFTA9L"U5 \O!?Y1&_*:W3FNYFB^7)\3)+0]%T][)G<K$,Y.Z5(4E>W
M0G_A]L7T&L%2EG@EV>VI0W2W3T+U*2@^AVQ2KSX/NKV.A#OEDCI_$>L9W>#\
MUN#7YG8F"@%1AZ(*CY"""ED(C]DGQ574$"=AL1PD+"LY[U,W7$SO;/XJWG^,
M\LWNNZ_O/KX5U/;Q^]T?8?OGW[IO7O_R=4?2YU__N[OS]9TX>V=SY_4?!_1W
MO?-QI[Z'QO'OWO;NWI?W/_\"] [U;O?ME^V#7]3.QS_*]CSO]]]O7D?Y@4M,
M)0G-C-? ("3-4%5C5RV7*4$5*^+2TO'>"!-/X^YZ8[7GP&J\".!H0:NBP2N+
MUA;A0:-Q*FLC&ZL]-JM]/<5J/A4;'5JF2C8,0$GF@P=6M$VU2'>0.C]+5ELY
MZ?]NV94:^SX']E5&^*RSC2)9(%Q[*ZU1QE8K/?C89,I'9U]]BGV%2]+;Y%A6
MA61*EX$YE8B'M9,NJ2RT5T^+?9]9X:NI2_B9%;NZB;,^>00-P@>N(*#T*H$F
M=E+><47;^\85&]?1(_^P)-0]H]BBX."QU%*-4M9JRI9A%IE%6HQ20H!@2;&]
M(,Y^?4K,/'N8"B4M^E*$<QZRAY ,6.L(O1) :-%@^@@P/:VI.5H@F91AI*X)
M!D(YYKCCI+BIY+B,EF.Y*-1F?5"ZXII88Y,EAJ,W-EDVFYS6/&S218$)S'*)
MC(YXQ[P4D4F/1D&)T@72/+19(3I9DO_PR:@6I(%W/D_KD]]*P7@>->&7KF&L
M>4WX!R*<XS-:1N Z.YM2+5^I&5@5&0I!_*/ \B*#Y 8WMOQJU(1?M@VYH73I
M"D9#Z7)0>EK),#%I5<O-.ILY@U*3-'A$9K./@MN8C8IW*W"]PBA=!_WB>;#)
MTA6,QB;+89/32@97LEH6*X< G?D>Z?27VC!I06NKM2M!;VR)NQ2J72*=+-5U
ML>+*Q:OS=\Z?F0_C@56,5G#WH5AHYX<3S>-XY^.O^@.HHJ07B@D4P" I9-Y;
MR8I*6<A:;4%<>/NZ5<M>6? ^K.)QV]B(!N2[ OGK',AOOWX0VA2-1C".PC"(
MVC+B8LF@+G&Q**6R2XN66&%,KX.>\G2YYX'UE"8X/"#?Z 6^41]BED)%!ZR0
MEL' .&1!R,P4J@#2Z9B-6!G!X3G<KII>@^_,;L OM1)6BY2]\]2L-G'?I')>
MSB+'X$7Q"H3%$)*3O 01O#0JI58Y[^&5N:G?.FNKL*8-+C5YITZ>82Z*@>-2
M16)EC&YC2]W9;[U$6#R-ZUF-%!LI7DV*VB=2GX';'!24$H,.Z"4/N03)@<OK
MU7%IEPON7UV>72[(J0C2CU6QG@%7)+[J8EE&:0($H["$>[I<\)3Y<D64YV5=
M_&J\WGC]&]Z-8K70-+1H$22$(&R,(>A<D@@Q\B;L/KP!8LK@7DH##A@O"1F
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M%:RF@\R<1<&R4TI[,%J+6CI5-QYX/CQP$VO_8Q-!L_;?A0@6K/V\1*>\0^9
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MF5DH-C(P@7Y*3C*.K@B@S>ZY6/YM_L<BSW'<PK]&=5O1_U/WKZW_IG]FO3[
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MJ\_XBQG=HXG)61>8%@(98*@IKY)D&J+GRCH?;"0E[<[Y7UN=GG7$=$OI_L2
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M)E&D _4(*YZD"A0'[%;1IKZ%>/AV[]AVAGF/7]!.7%)*E #YB@?([Y/8?;G
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M1]<M IC:]AT(?/-XV.E. 3:?#<5EJP4N4<QVX,;W@)DZ\1FEM"\-$7P,7NZ
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M9S]]]#.N=TV'6IB-$.&JWL2IAE= "W>JPT[8KL/.CW>@OD<W H,_??7NH'^
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M1XUO\ Q;>ZEQWA*-PR^\WJR+QM8NJY_N:Y[#HH8BX:G+GD=NYBLLBL0X[*B
MGZOZ B+PS03.X\F:UJ[L\YQ)BSH_4+L30NS_5A9W28N[L[E/DI=2"XJTB1IQ
MIW)3U$B09-(D'0+C!!9W%+_'_M2&524'F;5%U$:QWQE,:YFO92DLV=UX,>>?
MM'1W6B3^?9SMNF]3IUGHVQA,N)@*QGVH>L.SZFU?1\H$PQAI+Q+B+$KDN+7(
M<,>-D-$&CDM?IS<@NB):J8R5L/J*1Q>=EC3IZ,';8)0G/^>CJR*_CY5?>D5^
MK6"16)!?C"7-U:@)P4L@R=B(( 4#YX*L;9!W@MWDC5R>]#[WB<0+@7Z"8,^9
MQ(K@R+/!)#Q(E@BWWB6/4X%^RQ>_"W3 ZO"YZ^A@[_" PAS ]Q^ >&ZSQL</
M;7@^#(BA!VBA4Z>[,!?M[M[A[[=!/R_ Z"8I4 RYM-PDCBPE!CELJ(@D8&=(
MAGZ@APOT>U&+"] /)\$YT1H)#N">LP0^%Y<216.ME"G'B.C:QO@F\*/S GX+
M.-![,<"/+?1(^,UW)W^<Y2K ;QG KU)N^PK6QS,5 ?A1<!>M=L@%01"8( PK
MQ")5<17;DQ?1G;/H)@K_\62C9ABL$G-21VJ4)C89@^D=P*\(Z>+0W41(P4G
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M1XC4OM!=+EOP=OZ\(U5OJ\X:Y^&H?OZUL[/UM0>_$[AWKW&X3>H?/W<;S=S
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MY4J(;N>*Z H 9$):\"B,R&0*'B/C,$:Y%:UE1'DF^2K6O9:@WNW="@0/G-
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M.D[S-:^C.EPH,N> ZG0)V"TT8/<HNU0X^!:DMV:@&W,6H+422#.=P/VC$EF
M<RB*&"SVU -\ PD1;(6.](MXSANXY1Y)(F+%;>242N<!P GL3$P>6\\+1>;S
MBN=,UJ6P/,-GI!+)%)G1(8N#0$0J;(-7PDBR:N)9(FZW8C/K$E5*&<4%")=G
MAEJI#36<8!\I+3F7RQ>]HSL\^@/2.&\?MLX/3AN]O</Z^2Y<TVC#LY[O-#]U
M&A^_=L&[%_!<%39C1AICP(V/RO"<+0T./686!6X$<12L:R6WZ[1@LY5>R8S-
M<I:9XA1Y2F I26XISP)&@E*N-(Z&91+QVR-NI9)N#MBLD%\NU/E[G%TJI_;/
MK])F.])I;<#$4)0TSXW&C4961X&"#HP8%\'8S(LAI43<5E=VI4GP'V5$6LM=
M,%8Z$;P56$9MA=$EXK8RLGN)Z7"0243M$571(.ZR[-I<G,\BPX(1G5PHE70O
M!-7)I+"G#+2NQ;"4UN+$E234V6"YU 75+5WX9FJM;F;?M7!]ZW-WY^->K]6$
M^S5WSW>^P;/T/G<;WUIGC6_YN=^3UN&NR*@N)*Q!I"RB$N25!Z^058 '@DM2
M2!45((0JXE884E9Z)0'5>9JYY51"VGB*>.(<&8H%<CQJJ43N6D%^%7$KO)=+
M0W7E2/_>O8H?8Y?*D?Z"Z^ R01[.56Z4(F6]0%Q[AIP"<Z)9,J!\G)(J)TN*
M5>IZ5<1SWN(I-<-:1QFQX)A**ZURP9DHF2'6V!)Q6TJM6^X9Z:0CB1ED>'8,
M)*/@&"B/#/8.&YHCY&35Q+-$W&[%9M$SRZV5AF#"I>=6Z)"\4402G"PA!9LM
M7?0NF>P;Y_#<9]=C->]/ZUL?VBWZY;QQ^.FH=?CYJ+'5Z.P=>IX]^GKO"ZV?
M?^W"^Q4^LQ$VM! ,^20XXCXX9$E,*(9H DM.ITIV"SY[ :L)& T+%:+-1 '.
MD<P6$)'3TB*-B6)!,(9)B;PM$*-Q7")OBW0"'V>?RNG]\ZNUQJQ:.]TG042E
M24*:8X,XQPG!&CJDG1?@/888<M.4$GU[Y?(;* Y::28XD5P9;17\5S4M@#\I
MAA)]6QGY[5R1W]P,/FGC4*)"@)^8)+))<^0U#L&Z('%*)0+W0E >4^"HQ&@L
ME89+I:RTPC!'(PU,>JT+RENZ +Z_(QMOE^Q4/<E:9*_7@'\_'[;.]SKU7J/;
MH+NTXL* ?QN'FU7G.9:,#8)3%+GQB$MKD$DR("R%,D$X3PQ?VQ"EYFW%5S(S
MF3AEG%(1*:<UXDIH9"512%/F6*)6.>Q_$8$CA:1R:>BN'/'?TSM\G%TJ1_P+
MTELS$3@5')&..22)48@3\/P<!_@6"4DDZ)0P82 AE*_0$7\1SSF+9THDMYDV
MEHG &?R;5.Y&$$GDE@292@3N><5S)C\2&P7HV2*E?4#<"(PT5AZ1S$KN<?#&
MDE43SQ*!NQ6;4>QE9AZTUBI.+#&).TD8$<%*:20OV&SIHN=GF>C932;ZS$.X
M2QJ'[39<#\^Q>PKW$W7:.*I_;,']PA$\#SS7WBU]!G;WN5/1" =B;+'.T?2(
MG+(88:<Y4=2#<,L<D2O,DR]N=9M?]F/"01I%48!EA-6-#.74)L1<"$%9%;3!
MOPC0S:_/P%L.T#VN>7@YX+^GC_@X\U4.^)]?R\WT&6#UW?V@G#&6)R0H \6$
M%4'@-$8$*LE;YU7D290 W:N77QL%P29J##(,& ];89E6T84HO5;JGH24I<_
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M*VS&2MCMZ=CL<>V]R[']?>MJ'F67BO.W(+TU@\V<,%+':!&).($1<1A9ZBP
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M971):Z2T)X@#)B(GK44I,DNU(#'AM'? Q;T[K14X+'"X@7"X5,LJ'JWGTK%
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M7EIXF^L/3"UX>J&]3.6CZ\>KV*_=IN'?U.3_Z_]H)OD_;D7E>-&=067-O05
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M+Y$AGB*"E:*62)[$_$FP.U%ZLYN\NE96?6K3UA^/:R?F7T@C(E8\(F&D!LN
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MYTFB,B9O?\520T!J)(W!!(Z1M5+!IH\]<MAH%*QQ$0B:QE:_C%B,_>,X#K$
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M^L^B8\^+;F]8N%CTH^_!NS-F;A5?H"6/V8KKW[M9/F$RC+!K^O+\K*HQ'W_
M"P<W//#_#>9>G,>Q!<V'K;LU\+E.*4Q!&@U'_=S(P7&1VKVSP5;Q/EW7[M:@
M;-^EQN7W3B>KG2NAPFWYEJ]=6"JA<&4^<5C)^8&VK(U:N'.8UI8_ONXEN4LQ
M5-U+\-SJXZTB+Z96]W246S\H%\Z56Z IMGT^@+<GVVX79ZWA,=SS'YBP=L'R
M$%VY_;@%?>C[X_,BP&\ +_DZ/#K?.@#A:26816CLJ-MS( #?<W\G+8"[0P1P
M!QB?;^5DKD(K% LH==18%9+3A&C-K4S.!^>$#\0&2:+$1[NE4J<Q0==9-M\W
MWUXZHP6A]?F<]JS7#X/8G5/]+B9M+UW5^ZH#W%(^+S0^O)X:7SO^ST=X;SAU
ME,N#SL=OC?V_.OFYS9/WY\UW!^2P\X;O[<*[?AZPPY,&:>Z^(<TO_TV-?7_>
M_'H4*5:>8B"Z 6O0VU)$AA"&F,"6R9!B3&RQC+0RSZM0!,O$!4"Z"#AQYY/"
M3AM&QK/,J:AG^<EF.1G!@PX.1:X$X@D&/T<O(QL$QYX$&AEHY]W>G'(^]\%P
M"GU%B0&_WNWR)M+/FT@8]3,$9@@:'O=C+),P#EH_B@XLGN-!$;L!OK[GAST7
M^Y5RQG!5R?XRZ,P@[_]99%EJI2U7226@$YE?B"2Q-H82KW.6U;PLB<&**I1_
M()B*7RW+7SN(++HJU]3:=.]5V=QMB+W='=P\^?RCN>O/8(5B2HD4B2)"L$+<
M)H>,T1892CE/2FD5W6(X%+%0@7GC-./2)$.L8<$%QPB348;QA/,;)GPAAZ!Z
MOA>>[Z2(P,QA)+V6B,,6A*Q1'FE@_XEAGET;-[:O\=N^P7X([+Z=5P1PFT>!
MI(**C$;$E'2XU^W&:@5F%@:4KC7,;W:C ?"E4@L8L[/\\(]Q,.SU2ZM!1K*^
M/6W!#>\R%R\&\6M>-D!(K[9RAG1.&FS[<1;^X/$3!>N1E)_RB;^UAJ!K^3NH
M0[V<Y*?HG<;<61C9^.,T=@? H;MQ^,@M_66[)E3:SZK7@PNE.L]<J^M[G;BU
M@#:[-OIHJWNC0,SIHK8+:GF[?3X9,5C#_5#\[\CVAWEFQRI&*\-8<1YMOQ29
M"P76CK7'HN?]J%_ID)<4QTJCK-3&L]ZH'6Y7);/."/IBU<88'J2 +)D#/(":
M3L^ERBFY^1SJU?'5DQW6V#G"#@<LM4(LY:0MAA/D NP3.-I('5P ;65-M9)Z
MZG\]]80SDQSF*$B.02$-!&D7#/*2.I-D\E0N1@17Q^Q03_VOIUYIR9GS$5G%
M*'!"+Y#E"2.&&8O,T6#E@K:(A^D ]=0_V=1KAP&(F4%),)!ZZ@TRDG%$<!39
MX5' 5GTW \7B)HQ?$*0Y+OX@0T8F1)<N3'2*K6)W:J'MVM):#63KPN>W..WW
M3D#A&%RVE6=NE#EVOQ6!7DW,W"&V[7E)OI)MM>&3TIK;<T,+I*X?OV;K>J\/
M!/$4G@HDJ[P,8A-&'E0-()7YY+H8]EMP:7/Z#&C/W,5;7O6_HTS9BEQT(ZM=
M;2",)0_<+"I-8?9+UA^W@#P6%IK2Z<1^/O@"'OJ]55JEH:6Y>9OY57D$2N/^
MS"%2;ESLEZ^=#E6>& M:$[1D,&K#E_-X3:?^BE6_.N@H^6TYCO.ZP,71)FAC
MK2X:'_1J8.;C3[+/NK[LVO%4^L#UYW2S(4C%FTH;6ZMN77]./:<KV]E^CK7.
M4K692ND=I#.OEVO%LSB#9;2(L?&!E&,AV]/L',_O.Z_7Y/3S0#1//O/&?D,T
M?WXXS_2"Z+PP.<J%XA&W7B$KJ$',:]A>8%Z(\MD]^R87M8F)*:^3)S0]UZMA
MZ:OA9_/K$8F$)<\C,C:'52NFD#9!(@\,U(?$L[#FU7!30=SQ:MC,N\MI-@9^
MC^WSK>+M&'7NR ANQ)S->19R+<HM"DT/5(3KQ;B,,[D=L;?_^4=C_^!\;_?-
MS\;^YR-LHB, !D!]<\DX1@+2P1*$07NA46,6K-C8AMUDV=CTA*<D]7*XVW(X
M:1Q)@3'E(6]5%-:$"@HY!C\9@8GCSBE+0UX."X+3OR^Y/RX!&"Y/\"=_',.H
M'7OI%Q'R;TMV/;L6QL1T/S/]?6C/'^V>__;:%L')-YQ/0952F8@@'_.F%&U"
M+@J%HL) %ZC@3O%*@D'UB6$GBQU6@4B@%D)*S3W3QDJN"8BTEM[BI#>*"))U
MFL\I^J.XL?T&J'NG/ *Q7[^"/IBM[]=N+>[\DJG_DI_3O,/7K6YO=GC]'KB9
M/:(J:TBICI^",E9^;ZS/7FH;/*L'JF%N?7GR9OU8R9SJRI7CU;&M?+G.L]\9
M_!E&?]P%_>1KJ<"F:.$=K79K>+Z9W;EL/@EI9]>PW^9]A.^D+\D[ZDO7NC_>
M.H7;_R[=FJ<^QF6,-.A;;7LZB+]-?OA]XA;=ZI9:4_FEJ][HT+RI+^X6KOQQ
MQ_[HX^>/+V^5EZ[XQE?7M-IB^.;+>(O<>.U7CR5X2]SQL;>XT:]$;+>^4\*$
M?[2ZQ1BP!W,I*Q;K6N4^ODJ=^Z4)XN6EQ+@^YN1C[%@ 1P X #RR:/;C5YO%
M:.'^KW;DT9,DJKQ[IJ)Y!E8M4QCK/2!P>>,_@'U_W7GY."3R #?V_V@=[K_A
M!U_^>WRP_P'H5_.X>?*VU3SYRIN=S]#.0[CW_5Q(Y.')AQ^-=W^U&_O'QX=?
MWAXW=T.G0=_0QI?W%-Y)#_>/6\W.V];!R=O4F$T'8+ "C2H01'.2=*ZQ1$8)
MCYPR@5#B(Q#Y3.*753-H];(7K6&>%9 K6E<$7]$$NO.0U82F[9_%]O?8*(UM
M-5HM@E:S!<X8-9XZG[W# ;( L3 R)BKDJ$N12*%L K0BFXH]&*^>+ICV1;!'
M$"EV+TA:W](QZPQ)F33MG_5J)%H$B6:+&C#I$N72(QP% ]YD!+*:"D2"UH1I
M9X0JD4BJ!^>[7;WZ,JN.1+PF1^N%1-G[H<:B!;"H^><,%@GL@[+!HFBCK1R1
MM9,,X4"QY!'@B+$2BV[T&JA9T:-AD:A9T5IAT=O>J#8G+01%E[)+<DE3Z;2$
MB40\2($,C0XY'TQDU&N58R( BHBJ:=%30Y&L:=%Z01'<6T/1(E T:RMR(A&2
MD_);G ,U+%;(69L3W9I(I#="<%%"T35)^5>6%2TS^=A<6K%I.K(;TXW=W__Z
MIO#4<E%+0K4P+%(<.7?.:Y _13S7-'KCE#E2<F--O,&O=W(GY)EBB\NW;SUV
M#/8O^_[(#EWORZCH??MCMS7P[=Y@U%\9!ZUF:XR9)\<GC4X#[MFAC9^?"6#F
M\>'N9]'XN7-VL/^5-=]]9HUWAQD?Z54'K;V<W/0G?&\WX^KG\^:[M]_R^QN[
M?P#F>GRX[\\..QD?#Q/TY4?SPQ'34=L4%&(RY8*;-B%+02E4L)-):BA)QEUU
MT)+2&"UMC%1RCIFRE%BJ-+%*.B8-N>J@58UZ <,."^77[DC7>A/=_K[+[8.+
MRBH>(F>8"VD-=I%%Z(LAFCEG-E8>&*X7S9E(\?\W*(#05HZ0Q=#^*/K9Z^UR
MA,@"<5S9Z?I&!@1,!;ZQW(@0M@ 9>C/IZ(7T?H3._EE-.>RA>U5^AEYW>EB&
MZ"N3YKW=G2,;,0]*.62(LHA3BY'U@B,5K ["<.VQVM@66V:.PA0P@KY*E_"+
M_ /7KH,'NM_7ZV#)J+Y_@/?VWT/;/^#F[@>1$Z+EF:>P#B0(+.+&<628U(AP
M$14F40NA,NG8HC>NB\MNUYO9N]1G',I^JL-><7,UL^N7S,/"AS)M!2R&R:T7
MR#V 8O_;48I6<@42&3@&H "Y18;'A(Q0T7HE,?:P(N36?%F/?SX$*1X6F5$C
MQ6,BQ6?<^'KDB!"6Z(0B-AJ!<A5R/*%"5FJGJ'?845"MR#7KXF)9+,I IM%A
MEP,[JMRAOA_M($["F)=(>.8@K,JFU,^-Z'5+S_T<A=X+%S'4I_!;?S9\8+,D
M3? QL$6@>K,I27,@MA_.QG#G!MN0V6,5<Y];FA^"<EI65$8CS"2G[4V6)[RJ
M"O4>Y-B%DU&_-0BM<L2G6MH:*[I_CD<'Y+/8F8[.6O7L^KQ5NU=S*MQE259K
M< !"U.]U;EPZL*I6-7(;YG%F&C_%X;!=)23;Z8;/W=%@9-M_]WO?6X-+R/O<
MQLIG!%X"]XK&V5$.V-9*4&1\+O[NHT8V8 \SHDFB6OJ(08TF\O;@N-7-I5<E
MI"N7\^ED$13_<+$;4VOXS[7(II=#F'-@5XXTJR1UA85Q2GU@471]J]TJMY1F
M+T/0")KJVG%\?K"2A7V?5RP/<DI/)XS0@GB4J(S AXQ!-B6.L,R1;91[8^7M
M8CD7XC=.JSZ-(AJG(3SMQ^^MWF@ 9"(.LN&]-3B&[X288K^D*7DG&&?<SSM$
M*X=&^7'JG/Q+NPW\"$ V"QA0B.%Y,>R#7%2-&JQ7_I=;]]6[$KTR U'.UK/L
MG?4I$P_4.^M=1'@F*^]Y>:RX<Z03$3IA!U-@,.(L!60(B##W)+L98,9RW#F]
MJ8!EO;,^^<Y:)JPJ0Y?S\>C],6M\P(JR<\5O3%Z+8M5'.4*L._P-$5U607N.
M@<HUO*C\_?GFZO)P$9X+'&UL[Q3C5?0,V'AAX[L5)#MAF %R3&;^J%J\<['I
M?H$]]Q/@89FAXV*/_'N\1;Y:L+S"=W[L?3@B7C++,$6@BY ,EAIIYPRBFM$<
M1,.=!K"\-9O4-70GM;H@>%.Z4]6^F;*7 4Q!A0;7L9AL+2D-0!-65.:XRX^Y
MAAQ5MB,_ZHRJNF:3"C951H?IS9.5/<.Z9D#^/@2K;&=^1K_4$ ;%#?:-G)]A
M$6&ZI[^17H!?[(Y')O.,DF%.TG@"O[@QKXUYW1+SL_'A2%GL+,^9MC!FH"&D
MG-%&*^0M#I2FB),GV6(J;I 95\G,>,U>LC]>1_OSC.3DX6/M(6<O*=.4CXV5
MI4CD))@_RGPHL**7[DYQ-7EL&/7/RYCJ*13/K:59]?+OLJ&O;.%<X:6Y?DVN
M2^28RZIE<"@G"0:HM0D);;@5 6!7IUE>.O&6**W&@X=8?VM>M Q>=!_KSU,J
MC+7UYT'8CIL?CJQ(B6-.D(#)0!PS@DP(^:>4+!/)ZF"J$J-K:/VIZ\1>JA/+
MKXQ.72>VKA/[)'5B7Z"KXJ('H%,7@'SW1"U;JJ7VX?F*[VZ-J$VV#]AWR=[.
MD:<16ZL<TDF#3L6819ISB333BBFMK; >(%O<(55H;;-]JM/0^]H)GT,R;^#&
M\$'E(?8UPH=Q\+;7AW&I*?%8-%GCZQ$CR05N%%).)<23,\AX0A"A HBR3;F,
MU1U$LRBYY-CQ"B2@';^V!F-KW8P;U"?@RS]COUV59,LY4*WKC6GQM#A&YL>P
M,#-=*-W"X%F=<:WM25F1\>*<F/4J,]UIV_KJN*$SSKQ:=$&"<E[RL2&RWQT[
M80$EM]['T_R$3K0Y:F10F6PN6M[K5G*<I2$[I1V#1.4*Z',N:X/"C8:%S><;
MXUMMQ=-;8X>OL2GG#+X>7;9]7F@+T\3IV?,L^\8-QX^ D1J 6A!#[,,39K%E
MU <VGJLWEN,W;S_*8U%IA%-CTJ^,1HJ&E)@7U )?R<8O9V0R0C+ ;%@:\EJ!
MO<5H='O0X^=!3*/V?UHIOC(9O&(YPKFP$,"T%S8[^%/8'BWLD<Z#EAJ%-YY3
MS82G&]MDSG)4>1E6JVO-O >O5]KN[ MPF6!F7X!'(9D/3SQ?D\RGV,D\V_MP
M!&)"L%<&86-!BISVR G/D<-,<N*EUUS"3G:7?/0K23)+"?DUR7RB.,^;FO9
MQX!78 $O!^IY+>#0A)LLX+,XNB90^>>H!,:_>FZPXX=["1ZN&A6?R\NN.IN:
MXNF%GG#9LZ"&T4HAX,VO1R8J%CEH ((G#3#*$W(V&J2Q$$IH8KEG&]OL%O>J
M67W@\]8GH-;]<E;.\^(GZO=\8@Y;62X).!-3D<V$[>)C5?^O.G^_8FJOG@7H
M!\L.EDE%V:N(C?.9( T ED&<%!(L'U0%7520GF&G']&<[T%O5+(ID"[XH'0>
M:'6_PUWET?\@IVW(MOWN17-3I4X6P,)RXO2)MP!0[L&$QLP< 8"^T1^-K?Z@
MGU:5'7('6H,+J2OC3VQ_6!46[*6458.L,H"\CI6)\:'!Y0H3EXX:?D0_JGI:
M*CPYX*37_VJ[,Z<35WLP&+E!*[1LOQ5?Q4GD:N/P.F%P;7FY#U_-$2+<*6.U
M50@FS"-N@D&@=8,2R)6*.!"</*\M+R_9\A(EB]1*!]NMY0KF/D5#+:PLGI0)
M05XKL+7E95F6E^;9$15!,AX\H+N0B"=&D.5$(Q>#SBYY3 M]N^6E6'/;2WE(
ML -$HP>2>W,-R!W@6>VQ_87/QF),$YA\[?= =D;=&15ZQC$3) ?D<-4<)3_/
MM!:VK;%*4/M$5EO5US,0D^2L(Q%[I&G>H$S*5A7,D$J95PAI&$L+Y=MSA@!1
ML<D%H;.EQC+AB&,:NQ"-PN-I!>3C];0^XK3ZR((D!DG'$N(@9<A$#G,;@4$2
M(T";SC&JUV27N<WW]7WW0F6Y7 [^V(8+1:@"BY(<@))50@PHY;8];,6%3;5/
MD,#QA@5U08#_GK2]<K N.[53=;6FO=6B.V]\.&(F"<D%1UY%A[B@' &X!$1@
MM6GCJ,3A3K3WIE*-L/A2IH2SR^["Z'#+SC2]N'G%ZWH]]JS]8SO\TANUP_O2
M$G*1,V6<+:7&OFH9_FQ^.-+!)46H0"HH#%L:%DA+[A"VPB3,73329.R[J9#,
M&.J*LSS<$\O3=4MN7FO9*G9N6+N_IEG3J)?%2-=L_ KH9:"EC_I9RYM:H4J=
M;97..DI&.MDGIBI8F6OP^?QH>M><<#C;+JV8H$B7X1P+ECI_@GWK/Y-9?MOK
M?^Z.=?V\7XU]>@?-BQ51[U,50."]#T<BQFB#8(CX7.&%8(*<#ACP(GCJF91,
MDXUMPV\SA"]:[?R>U+A>$8^Z(FCC["@JJRT5"K%$%.(V!_APK) T2CD5?(R:
MPHH@BQ4\7RW,?59\G4F&.J5B-VH(,W;/&2,=2 #</5C-'>T%N(C.1,16=N$Y
M$A'AG]@O)B2CUY^E'*LU'VO(,-8\Y0NM2DTG6" @MSE8I"!RFJUOIMOI(F1D
M9AF6)O[I66BK6^UYU3'(5]L/%^YC\)U1N6PG*Z\\-\V!'M4Q+<@? ':^_VYQ
M5'?,4V_NDZ?^N9+2T^=T%WK12>G?C#T"_H[]3\=V=3+2[WV:L*C0:7YYPQLG
M'W[N[;>/#T\^X"8]$,!XV-[^&]SLO"%-VH!G?3Z_RJ+@/@),Z[P\3OGRMM/<
MS=4\OHD&M*FQ_X$>[']F!S\_ @/["U@4O/_LR"JOJ308Q<1]9DX:&2DDHBPP
M^#@P9O%<QG?F01'W.GC&N;;2F:!%E#1*KV,R^FI&^LF0%S#F13GHM^2E7TOH
MO"'D[-:QNCRV"N=\=120U&J>%'&>".*DM*!_6D;LS&B>PF@.RM%L#0I0!?RH
M8EVC"Q>7X5D/^;8=#(I.'![W0IF(];*%8J?XNS\)>BVG!C"X7^%]*\3\:>GT
MXENG-KL,%(,(J-T:ELXH.SYS#?@T9ZF>>MK U_.YKY]0P/+LJKPQ>P(-QB_I
MWOSDS'A"!*[8:>5'3A^=>WSY05O%[C03;+O5*4^_JX3(>8>YIG>]T1!VH#+K
M0[;=P-"-&YNG+-O N[VQ82C[$UV\+<Z-^N_YG?WLZY3])H=Y$KJ],L/)($?7
M CN([=[95O&''0",S7^_G#68AU'%) ;Y8+KB&-4RRU:A[[%OO\:9#ET=QIG>
MP%"TVN7#'O]=FQ?I@D/V@2H]O2^^-\,"QM\<'MOAV!QW#.^!D8G=V<>5XU[Z
M9 'KZ(Y=K$+N33;.76U'^>WLHU;:@DO.&T;^NI9<O'ZJO/AI*_KQ=-3WQV4G
M+H+%Q^1C$O8]XPEW8_NJMVP5?]^E\6,'6P GV')0-17VS&;*_K5ORW4SZH8\
M;S,WY*F+W<'8_P(X9R4_XT?"55CW$V&+Q;17U9/*9#Z=TW;O/([?>W%+^;"M
MZPH.W0#'KR]87=3!ZG6P^G,$J]_*!*XPA^BL(M:17&"6<QZLIT8P; 4+R7-F
M'IU9?_+' ,0Y]=M5CEUN@3O=,-Z@]K.+UROFW6QOY\B1',(I">+YE)]SX7.^
M$X.4B-X&#QS<JZL\>CUY<38=EH7M*D)45$E5>OWQAEO1D@OW9U>RI=)=[T8V
M<]<\E?*.HU*U[F*OZL.FF>L'MNWI(/XV^>'W2=F^5K?L8_FEJQ4#X3533-_"
M%:Z/:P:.GS^^O%5>NE*_L+HF\):2\L;+>(O<>.U7CR5X2^";+__JL;^^QM>I
ML8RQNK&8WNFQMU2\7(D:N_I.]6:OKQIZT2=SESY5-/1Y>C5'.7"%K%=SO=S8
MP_E9P[E_UQ4J7=/!^'0E*OG24*SC2KZ^F_]H=8OQ:>5@LX@_LKO^C)X/--G^
M\PZK8+S+Y6TQU\,M&78Q:?Q:S?O86Z>8..HLJ_,WRL=+'L1)\/XR<.0.X[2>
M@[2,E;:49;:>PW?M&KL%H.<+>WL?XWQA[^=![MLM!.4 E'JW'<*[[K)R;NKQ
M?4'GUQ7.5X^3+3#Y=Y&A>CB?=SB7\O1G:.$Z,,?;#3$5_L3AA:?0<-AON5%E
M^!CVKIQ2'/?:,$2#JVOIFB[C8ATZ_G_NTI-G$NX[=N%IRYY=MNO"NJDB:?[3
M&PQVOMM6N[3?]O[L=4#A^I0/E,8KIK3SKHQ?ZCTMN\<'G1_MO9,/HG'RGA_L
M-[\=_/PLX-GG#0IMVW_;.MQO'A_N'IP=_/SOR>')86OR'7C7Z)!^ELW=;^>-
MD^/C!OUXTMQO0S_>_SSX";]_^:O=H&^_-4_^.&E^:7::G;]2XQS_^,_^FV'C
M$SX[HC%Z(AA#D0J/.)4).1<42LFZ8+&1/#LQ<3T?]'4]^%^/4<6"R_T>.D"-
M%&N!%$O(!WIGQ_8:1!X51'Y>@(BQ@8J4BPD!X4&P1A*RD27$9(PAGQLZ83>V
MR2:3O(:1&D:6 2,/K[118\438@498P7=V_]Z%"+5@ \,A1 YXCPJ9!(U2!"N
MM30T"*<WMHVZJ>QJ#18U6"P$%@_/A%5SCM7 $3:+(T:4F9(2PHI(Q#6U2!OG
M4 R:P#X0L:1T8YMN4GI3V/8C(LEKL"[OQFZOT^H^V+Y<VSSK$7NJ$5O)9[P@
MBV\5>E#FNR"_S[OZS_OUW[@PZ+7]OY9@K1$]J09@R?93L0!#^3*>DIUJ1IIE
MY,)>JD)5]J;S4O.31?E)\].,895[)WE*'BGM#.+!8V1, IU')!D#L\%+7=I$
M.-]:>:O(:Y3)AUHJ:YE<$9F<VBFEHYIZ&9#@E"!.?$)&THBB$5)3IK%RHI))
M?&.FIUHFGU,F'VCVJV5R161R8@]DC=TW1S"326G8&[WA#G%L4LXY21%+RK/
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M6FZPU=A%+JT7D;BD0KB#4T -;8\/;=.B4I1QH0E@F? D(JZ=1)I[@4*TPMH
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M>('YTVN9O; E$6\EDX3&D+C5U A"I4V@J>(H;>2U+6DE9/:2+0EF@WFC" (
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MS*FX=[BX'<>Y%#$Y[AWO_K[[[>/!T?'N\1?\\?@M^WBP(SX>^(N/Q[O?/IW
MYU__*G8O_O-E.6*R_]_=LX\7OQWM_[Y[OG_PKKOW.ASMONX=[5WL=4OTY?71
MEUUXA[W_OIN?&,?WCC_0SX98'[FRB)M $;=6(F-Q1,P('$)DE$>[L:U_.(^Q
M'5W<HN+31D6NC92..JFBX$9KQQ7'TC"I4V!>\#HDS-O1Q<\'*R\6L)+G64(\
M,>2P"XAK;Y QR2!'),<L]]MG_IF,+FX!LP7,'P5,(GT0GG%&M.=*>:T3]2E@
MJPC6RMI;J)$M8#XQP"0+@.F%<-80B:S+372LC,CII! !N6F$E$G(YS+KO07,
M%C!_N!10F8 5)XYKPKU-1BDM? !@%$)@R5H-\_D!)EL 3"D4L49)A%/N5*2Q
M1X;Z@+#2,3%%(TC09P*8Z^<9?O"B^+4&['H&[?T'6C[=!KKKY2I]=L. '][5
M^6WW]9N+S]H8K3*D4IDPXC)QE+V?*()1KT2@(7"WL2U^N/5,V_!Z??EU!4Z\
MEE]_NKNMXM<@G>!2$@0 2Q&G4B.3!$&,<4DT8=Y*"?SZP^,L6WY=7WY=@0^I
MY=>?[NVI^340'K'ER)O($><*(VU20L%Y::.P@>4Q,*R5K\^87U?@PFCY]:<[
M&]C>P<YGP8RAJO1@E"!>/;4@7@WP; K.T-P368$ZS%;5P:CU)+S4;+1F_NS]
M70DOH[?MSW<E/+])P ^$G7NOEGP)H-<DED1 @1F7V[_E0O/H$3-8)Z$B4Y*O
MPI?0-J->7X9] %]"R[#W9]A%9P)1@FDM"7*41L2#MLB*I,%6,8%Z(H3B()1E
MR[#/F&$?P)G0,NS]&7;1FT 2E902@118D8@3+)$Q3B#0A)2WRG*F_,8V82W#
M/E^&?0!O0LNP]V=8ML"P3 9#P'9!.D6-N. >F>0-$A34HN ,2X5AUU_"KI^7
MH,U,F >09J!L9U@FRG8 0V ?^AU;ALJ^L%R%.PW[_?D>AN<^[/>AP/7]LK\A
M8!FBU8CX$!!742$;I4 2=-@H& [!YF&_]'(P=(VF_;9QE?OS[@,X&UK>717O
M7BSE'0'@ZI20DAHCL%L2,MA8Y(A7B@9%;&GC2UK>?::\^P!^AY9W5\6[BUX(
M03CF 42N(BSE"A:-#',:81>3H]9Q(L+&-M4MZSY/UGT #T3+NJMBW45_1,"8
MI* ]DLHK4)DI1<[GNEU%>4B4 /7&*_,;UHAUU\_!T*8VS$/)_(S8SB!U^G'<
M*?52P]Q^IS<8W<\=\2*<NROP1K2S?!\68KO+7@D!9DT0#IF8O1(1<Z0)%O"'
M%#P:.%<B &+%VKM\VQC-8V9!M&S\T&R\Z*!@P,)>*H6(3!KQD,OT)<=(88^5
M<(33(*\T<EHV?C9LO (?1<O&#\W&B[Z*:!.S/#D$1Y<0]RDAS7(MN8W:66,I
M'&R.$;1L_'S9> 7^BI:-'YJ-%_T6QA$G;%0H"IK+E*,!AG8*N>2MPM2K&-W&
MMEI[+EX_C\3*?!?KM^#VDVM**G=R&JHM)=;<X[47QYW3>FQATU/ZRL*>[[U_
M.XJS'<6Y+EE+SWD4YP.I,?O+%5))6R8(!AM$.H?@="*RFC'D(E$NLEP3GJT1
M_'QG<;;3BUO(?+(^V18R'P(R%_VPTI"@E)4(#+.$>)($62D88HRFJ&044O&-
M;;:JAC<M8K:(V2+F@Z7HM8BY"L1<='D[RKS7$;1*(3)BLJQN1H<"RVE[\"/1
M!A"SU3%;Q&P1<^TB#2UB/@1B+D87K##6&X:1L$PA;CQ%EIJ($HDL2@ZVNLVQ
M_N>+F.OG0;ZCK_FO8PL;"'^'[M?M<DR9+[O]20G$;?\=?MW<X\0.#[O]9O?S
M.,CZ-WG']2(^'T]&XVXZ?WC@H1EX7@U.3N%%^^-1DT9YI9.Y,Q@?Q6%G? 0K
MA)\ZHVF3ZOKK'3N,G>&T,WVGV^\T)/N37JO<\9?N&';1W^)%JQ> 0T4#>$,X
MLOXA+!+6'S?S:__DQ=ZXM+Q9>5.!G HGVEQC.QK#7R?-P50KW9KN:46#3Y+B
MJJ$%G=3-TJ1S'NTPCY EFQT[ZIS:X3B_;MZ-]]V3TUXW <H4B9A[!0PG?EQ]
M^W0X.!S:D\WRR4S#MG\.7TQQ"%OG 9PL[&F$M^UFS/NP]7ZK$^%V@_,(+_)U
MT)OTQW9XWH&']\YS.7-W6/8:%N"_V,,XVLS/F_1J*LG;7WT 5AR_G<;^*.9E
M_L\=Q#8U5H7D-"%:<RN3\\&Y++=MD"1*7!LZ&I-;#>7I3T["8%Q?;R3Z21@O
M2?.=?BBS)+INDA=X_<R)YH/7#9UX\KD%O?C/=_#<<.HHE_L'GV!=GWJ[O^_U
M]O[[\1S6=+%[\MOQQXM_=??HO[Y\.C[\!M*\M_?[I[3_^@/_'*B7AA&.:!0,
M<64T,LX9E+3UWF&5HC=W"Z[(3  "K%R9N$A8BX 3=SXI[#0\Z8XSFEIR>%!R
MB)9(QRQ#U!*#>& $:6R ')(E46OA5"8'<SE7Y!KMKAY9/R] 0P5T&=_&1\,8
M.[8/0J'[K7,"YW(TZL1^@$_5,Z2KNS33N+<Z^QE"NZ../0'5<+QY)Z!:0=CO
MNY393L3YF22Z]WI7[+_>P7O''[[MO]XENV>?J?:>!6J1B"6W"? +*)<CRYEF
MB5DL*;F;%2J445I*3H$FDB1.$&V#\A'^K>&>JQ!G+94\,)4 NROJK$.&NX2X
MBQP9Y@5B.,K@B$B6DRMG$G\7UGI%IQT/*E4L*U#SH]'O!E /K$FU G.E=$;W
M#C\SHSUQ22, "@GBDU/D $P0$4R($(F7>JVUJ98D5DX241B1DJ9($YO'H0/T
MZ !2"BLJI15$>*)SKXX?@)Y0'5ZAG.;T2@.K.^)/$E2X9#BSUG$/5@"))CH9
MJ+)<NB1;T??$Z(_MO_T<L55<*8$LY1SHCQ)D,56(!*9C,"!O/+U;8#/ V<L
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MV8UA/!STNQ[L!7\I!O<X:\IL,<JL]&H^;/@;H%H_XUWG_32 N"8+_O.'OIT
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M5@ZV?@BVKG4!+3#= YCV7LU%!33VV4BD"-1("OH&S;:$%<@++J@QU.'(<@'
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MSU()*SF0CZ-&(.Z9R?H.1@D[S[V721K_73NBDGM9[/UDX+L'&']'D[_2]Q@
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M[H/4Z947KTR%4?VIK$R>#@=AXL<=N(6#^XS/-XM^V>O%G,G3R]=!81Y7S_-
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M/P/OUZ'4.F8UK5TZKZLK%M6F(]OHF;GN(RYTIIK+VJ[SQ?-+P;;VXUSEU6(
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MAY-IX+(R,0I934FM'\K'*TWP=# :HTJHG SJ+EA9F2K?&\VTJ4*(I\-N"4'
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M$R)>>M[FI2>=#$(U8*U<R&<P4]@:):ZTI^G5%ZK#7L*^:X, /;@/6 Z]I4A
MBI*'9!..(7$2K1&Y[9YPPJE(-#.K:X?P'H[CBG8(_Z[7-7K7O,Z[ZFU>;,AY
M]R!?/_RL26* + KQW%>#!T61UI:A1+2CT3$75-S8'E_54J,Y;(![#P*A%DZ+
MB0]/C%+VKZ"45]6[O6A*V7_M/SOLM*4V(:4T1=Q;CK0@'@&9)(=Q)$1)H)3<
M6_A&6LE11MOKS72)>64HZR,-K8S.1V!IU3T>^H<H0UU.1.R.!\,Y8BM"JLD0
M;.GM.=#;^?[!V\].$HEIPB@*ZQ"<@$*:2(,$<=80+H'HS+7T-D.@*>6]$)TS
M^P=JAT[3SRYWQ2H1\85\LLM&UKP--:?>=*K8*)!TT2RF =EY]6$TTRP6M,):
MO\D?6DYLN;%BYKY'\N(J;1AN*VW:2IO'J+3Y;N7,4J6-B R$*N4Q.,6]4<Y;
M%A-\U"OE9337\M?C8NO[;K]J7E'/]@%M (\679EY'L]X5)PNL3+UFSK1'/8L
M-9J+DPV;.'059+E%ZO-\QG,%K#7*[MEQ&3/T+H[@"]G/]#I'G$?%G0R4V)MJ
M1M77_H@#D 73.,E.KS(7MSI_S$(_<"=X_:4P[<P.G'OS/RV\]/QDM-D(P=%X
M$FJ+/(]?S$EIF2YL&5TT)X[^B/V!&_G!N/,.OC:L>XN<U\Z1*B\H%;]S+:1@
M*:,)6/$+=ZMK10:Y$#GK90M90_57>XO.O=3IEQ>PP_-GK"+,U7S,,GB;L".F
M#4&7-."<^EZ/TNM7[OMIZ?)UIY2=\:>#$D8 =0-.8UI -)U<U>N43(A#T.*;
MB],LB$OQNSFJRB4IN;_QDO.JZAA:#KG.;P9"FU:++ZQN/K5^FN\_W80ZR-2$
M>NLPS+ :*5=6V,3)8O\07BP6+JB>5O)$YGY;=\(#]?]+67>_TL)*YYIJ7%<%
M)7U;/+CEZU,'[+SZ=?-V-Q&A$C+,& -4/NCVQW4L:&Y!.9PXSY>%8QJ6G#I]
MRA3-T\&P5$G-@D +^N#,F5OUO[JZYGLAE%C=<S17?U^5L1?,:USJ"U[W<K"S
MMCU5VOG<]4MKZS78L-79R6&M87.PE[8\ASU'<7F?QQF?.Z=P*;N^N@OY[X/.
MP/LR,O7R.)V5 <6C&PS794M>._SVQ30/N5J/>M,O7<D/[+?X]-,3\^O,I$ ]
MZ.G-N_>-+[@T"LE:XQP^+"?!E4R"&7^,\IU$DY\NMRY]_E)_HYE%F9\\J";3
M;DZ'6-K>K-O[7/BOPIOY!U>H.+/\)_VZ4UJ#<C>OM+[YJ,F6@.<._%1%Z5;'
MWO196WZI9DKQV1%(FG-4Q75F3:7K\$XU];;SQR0.X2'ONGXP#47D2:EQJ>\*
ML.:7TD]D/@PTBV)6&B,08BT)JER"IG*GKC2H%*)!+>9,4XTW=[Y-GL9R9=QW
M]Z"D->0Y935BW$0$5RSWL&DI"P_-H=@Z* $T,%,#IMWQ,S$427=B0YP66%0^
M!U^WBZW7O'PT>51W5>]0YDD6G7LNUZC.AE0SVJ^T\BH+$\R\W+MNFI71/*2\
MRZ6,C48_T;"33=WQ8KAU]OK[U;9O52GU^UF);_+FI_>IGUG$4-9&!@VSUH7B
MNMK8^<==6E-]TM7K-&<]*X;.Q)#OU#B JLK?:3WP?/K0TOD5X3SK<%,H-/_=
M+3E(5Y-HK71=)V8+C<+:;Q:Q3PI<ZVE7=5G_BN!5-9REUQU>9RM]%'B=<E(S
MM#;>/$U\B5Q?91;X'K0]#SIM$OP:,V@%5%H)&[Q9[Q4A]R76!Z+52^MM27:M
M27:Q _./$RRI2EK8E #X0Q/L?+Y)W2N@''U%R/-4/,M:>T!5-7\S>],&Q:(+
MF0"J,K\K!BAU)N-NKWLQ752CLN6ARK,G5,/<%Q-<07$MNSM:W-K\\+,N[&?>
MSI/3.GMVV@EYKM]<[5/*7]J9U@GVXM?8>PXZ19X'D_.'^V4'ZI&_*-;9^;-*
MX&ER\@H8H\$.<F]S;F4<,<\0H\L<\>RP^AE0[-)N3ZV[92I3T]KUBMA,M5]-
MJ]'Z#!?,N6&<RTYWL?@3JR!7$R !&GP.>S@KANM/S>3*K^H'TRS&_A7-HS,#
MSMA^+BUR>@S?V^1BYP'7YM]59S4^&N8041&9-9N.[3BWH<^9^MV3[MC.XC67
MGI=%[%3"?O?I/7N:I4V832^_:7KZ:&;+5H/+%P>$SG<66YP+(U9%:[?=CC^-
MJ@JGFQ][Q>M73N[K1[WC9Z'>_>B0R+F=O#PILCBC[S ILIY>W<Z)_&G'_2ZF
M6.+'.:VB Y;7DG.I/KM%:3[.+OBV#>]-R4&D30YJDX,>(SGH;LD^ZPA45V_4
M[R!W<]GQLXC]+0WY619*(]N;1J3^@+/-VN0K4(,V.Z]C/.W\)_?Z. !5\,0!
M,-8U7WN3\; ![3?]T237I'5SOO."B33(]PE5E4G33L3,AV'FDUF;03\YMW3Z
MM5(U7+L4?)-5/2[R?FX6]I*%"6(DI[QFA6W)7HO?NN7WI\-NE<=4/FTK%:[Z
M5G?6L[^.=%0SX$>7LEA*,HR;*Z;+\[WJ\K[>>1TJSTECI_:\UAJ^ECX?L1D&
M,#FM]81&O:E/8<[<G=-LGH,"\*9ZWWY.I>_-Y6HT!W5I[M1?ZZ2[7#'?ZQ;+
M'XST[B#DPK"F:5K5,FU^D$[E/"CG4@5<L]HX7 Z\7O. TGZMF3H%^@AL:AE=
M/&R&R XK'3^;'-EIT1EV1U]R67Y.N@%*KAL+Y(_4XS$&P[K%P+CIK QV1G=4
M;(M1R<HI]<U+J[NTLIIEIU,BJMWJQT,XV=CW5\25JSD=_=C;[%3U]Z7C0=,-
M>IFB2YY?/8"BZ:9:J;)@BZ",(>?3QJG3:1,Y'PEN6/%*\Y:+KKX2T1VD5-IQ
M5(- 2ZK@K"9X-KKYX J$.K'?NB>3DYRX,ACEA*JJ_KS2RP^G4+U8:PZ<V608
MA:W./X'Q!\.*:"YC3S8]<E;,,&-8]@G-N:,JWV6MT</SQN>G59KC[,'/@3,/
MKK*2QO,5RP63)O.YG,7 6CJ 9BM]C<?+AE(>5O@@!M+5)D+16B2A6A@6*8Z<
M.^>UPU(1SS6-WCAE/ANU<8_#?"1=A:A'ZK-3GK[U0"W.KW[WN@YL+T\-!B!>
MJ/D*TOG@A")8)BX2UB+@Q)U/"CMM&+FRYFNQW>3[6+K5ORM>="#%UV"?]@H$
M'<!C_M$;^"^/7;5UWE1M?2 ?Z2[?O7A[\>GU.[C/VV^?#KSX=/*1?3K8.=O_
M_5>R_]\/?._XMR^7JK8._G/\\>+P8N_UWI>]W_\#:_JMMW?1._ET''J[KW?X
MQX,/XM/!(=W][[NT>_ QMS#&$7-E-46$^H X<0H9(RF*@7'/O"#$RN7" .9Q
M8-I+1;7FQ@;C6=0\ZI1+4[F%S8\C;T^S70V*T\9VO?E%W_P]#@Z']O0(SOA-
MORK$*UWT%HY_R6RY>F[(=Q>QN&CB,-4X18&#Y%1;PU)22@D6-/<RX/4W<*X)
M+]6;&Z84/:J; >6>5U6^=2D#<Q:4_H++675NPCZE542_ZEU@ZY;KPX9+MF"1
MXV)6+$\8^].H_E01TJ-J#:,FRS0GCJ-&WRI]H_H+;=0;0V5N2-;T)J!5?XV]
MP6GNTS&;UUA;*]50"C=I,NIR2O8PSAD657N!*E$[>W*&<$07\YFRTVA/'=O*
M,:>9O=&\R#/3 ^;TK^DAQZ^V-VG4\"F1-"6ZS8'6+1#++I6^%'71"A!3E=[6
MGQ)(-7VD.L-9_ V..'7'6YWWUUR9S7<=S8)^I>?"O--P$PZPR3\O%)N[,=5G
MNIGM.B#7B[G@X=CV#XL[.#=/S^KU/"U,B2A_O+35V"QC!^:#AI41-YRV:>J.
MXTFYS3*AU:[FS;EN,N6SWZ&OY^#RKRQKGVWJ<IZ@[OFY6817X<,TS&JK;IO5
M+,$ X@(.9%99U0R9*5UU9@K\50\K(?3L@FZV>$'QG*F;HZD';Y8*W^TO0=I.
MOS\IM5E-K/VW7)%$,/I_T\#Q?/"FFA1>)V+5XV%GXPA#)FQ?U<%49#CS,]1S
M^MQYL6GK[2FIQ;UZ3'3]Y4*C4R(<+5*4[5<$5W^_]G4LQ-&ON\^4?TM.<$X1
M&2[8 ]5Z)Z-JD:6SZO0IK0/_!@<^;1WXK0/_,1SXM]!O?ZZ)]2Z7Z?GBX()%
M[:?]1IS^401]'BSS&RB M2(P.AC,']6+ML+>?K8V>)H\1A%V'G%/(M(V:.2$
M\"X2RI5RRU;5TU4:TK2XLZ@'I7IT5!D>\R0TJI(E&A;NSLS%.4NBT2R:++*Y
M/G>YD+#2Q2X)^N\J";_<6S][)-]1HU]/N:Y3L=TMWT,NO@>1Y45J[:V1RKG$
M%L$+E1R77YH?_I8+EWKV_)=NORRK?.EO7W,O5M"4:J*#F\ZDUQ:N)-AX"/\+
MS?WKRUOETE_'X?(U@;>4E-=>QEODVFLWW9;@+8&OOWS3;6^^QI_28AEC[6(Q
MO=5M_UHHMZ)>8(/,8?_?!MN8J7<A6ZJ_T--O';((OKV8QLN\4;'@JG%#?P^.
MR\%4Q6Q3D*A??/I.YC;O5"G<C_-6E\ 05T)F&&/N/#8^&E56VK5O>/G4<'Z_
MC>>S&>^[WZ[?BJ=(R5>_YI]S>6DUYVCTEUL<=RW.BK0['7>*.M!I5OFD#KBI
M6&2X<D&LZN6O983GO(E4E+06LPK >,[[U!+;SR*V[T!R+O"N^F^B>K7>QYC2
M33OP<%C]?2NP;$!)"[.^.,W_8T=^TK/#SN_P5J?+]/2]M[XU4>#.4]B8__EY
M[S__WL/\R+5Z\3N,J90L*"^P)D9C3DET!/.8<' T2(Z]KWU5&I,K6\#F,96+
MGJNIS5RUBLF>JO69.'D_A]31QY-OO?V37R\^G?QZ]NGDP_G>\4>^]_HMAN>*
MC_1?Q[L7O=[^?]^>?3S^<O;I]9?SYCOPK,DG^D%^/-@[^7CPC]P<ENX='V+X
M+KQC[QC>[0*>(SZ]_D=W_^ ?7_8/_I5VN_C;OP]^'>^^QV>?%1&,.]A['P1#
MG&J-= H"*9^T]\[ GWACVYCK9E7^- ;(5^_("#<)H^_!\+) :X&L!;(E(#.)
MAY (C]H*3I@T,MADC(\ 7@%C5^;M&JRHRO-V#<%4W'O>;HMQ/XQQ%U.,2X!C
M-&"+=(@QSWW'2/O<:-U;HHTP()KLQC;9)%2W*->BW,M&.8Q-PHJIJ*3@QBD7
M@@9(HX8ZSRCWW^G8WZ+<PZ(<J5&.[1_L?&9$B^!#1,+1A'CT%AG'.)+Y* $%
MX=1\!CHE2 MT+="];*!C8(42L$.%QJ#.:0F:FV&&"8G!7%4BUNH<;]6YM0 Z
M-@]T3D?EO>:(^<01)R8B$Y-"B0LNX3\2G=S8IIM$LZ<"='?V(Z;R?T_*C[C;
M[6?NZ)UWWO2_VM*^/F>%V].<&GJE/W&Z$_1N.W$E3#]IN%(B81RCT!)(WF&C
MC69)I<"Y]H3&T+K1'AJ3SN?<:#YX85GPB*:89[T9A[0%0/(ZBQ4I&79@8BHE
M?A2.KN;ZGZI:+3WRVM#/BV=1Z5228!I%9RT'M<):Z@/U#%0+B4%@W<)!U++H
MBEETY@52R:=H4D).,#".N&%(.TJ0Y2%AR9)6A&YL:_K#&D/+HNO+HMXF+8@D
M+CH#).",T5)(X9P2.$]6:KT;:\6]"]X-X7Q06 0$PI0AKC H_<D[T/Q!ZP^<
M6>=U]F[0/+.M9>'GRL)11.&PC2P9QSVW.FF&%0O6&9&($JW=OE8LO&"W,Y"Q
M8+5X!(:,!QD<!7(Q4 0Z,DZ2F:@USBPLS#I)X9>0XO,NYCXMI=!O)3;Y%5OP
M_*!(6Y-"C,$&D$&::.-!^2?6.Y)BM%2T-OD#X\W>JSF;/!A*>.($&0M_<*88
MLHDX. HGO:=.8 [Z@L8_;)-?S>Z/&>YH6;1A41NEB#K'^4WBTB>3- D.V-8$
M+RB+K4W^\"PZL\F#U5B[W+^&@B+/<8KH_V?OVYO<-G9\OPIK-GO6J1(5/IHO
M^ZRK)K:3];FQG;6=9'/^<36;38DQ12HD-3/RI[] DY2HUXRHT4B4U'7WYGC$
M5S=^ !I HP'?!// T74*+ADW ]<!$26/-NBEB'971$'\J.&@$V=RXH4:F/&:
M[5@NK*[@E=- ^N2=DMX%GQQP<TQB!"KUP3$GL+*J5*.A2ES'T;E#3<=RT* W
M#4>*\/F*L&_Z@>=KF@G+*K%<YH=:X("C9Q'.&=>9],D[)<(+/CEH5E^W75=U
MB,[!3&:>ZKJ6KOH@O43W4 L3%&';W-=>NMPNWTX 7T?4YX7<&G\P,9N97F":
MNA=8!#C6!)?.Y30PB65I%M4UZ88?6L5\:KKAS ELBQ&5^[ZC$D.S5!JX5 UX
M:##F>;YKH'XQ'WW"1 ;MNRNBKNZ'K@MP:QHGAN\ &:C) \<W0L\C))1N^.%%
MM'% PF,>L!]XX-S056*[@>IJMJ?Z(0#B$9V8E@XB2AY]/$**:'=%U-"8%^B.
MP5Q,H Q=WPK!&-0]/_1\7>?F%FZX%-$]B^B"KQWH@6;Z?JC:00@+J>V8JF=Y
M@1I0;C@V6#I. +ZV8<H<LS.64L?BED9(X-MF2"S']'3@"HUZNF48GD'\+3QM
M*:5[EM(%=YI:?FA:FJWJ3FBK1'-T<*=-4P5;E_LF]YBF^2"EWJ/C8=W;X!;?
M=OJ.U7&_>E-QZ\=L=#_N -%)JZ30#7T>F.#>,8MPC[M<(\PR7)V&IFYQ9POW
M6P;_#J6MFK4?+,\TN6,15<>C-(3KFDHYU]30I21@+O7=@.,I&D<CIW**Y@B1
M_0N6?#_PJ ]6B&_;A!AN2$/+U+@&8N]SYO!M-M>EY!].\ANY\':@4<UQU2#0
M37 E3 Z^ON\ 0^F!"P:F[V)JC-'S3$]*OI3\5<FW-%@M+$>WN>:3P"2>;]$P
M\$++\EW=\7VY9]\IR6_$$?[W"\!%?$(\5><V"K^GJ^ P^BHW-198GLX-AUZ]
M)#V+G,SA62G\!STY;P8@_<2T' UXQ#!<SO$HJNT;.N>&[\K=_DX)O]D4?AY0
MS28A52W;#%02$*92/R"J1QU.+9.9M@W";X'-;Y^*\%]"*L#;I2Y:%Y8,\*Q-
M 2-F4]/RJ*8'E/@\]+E)-8U9MF<8-K6\UMD ->W?E*27ZJ>-^FD>DG=#8G/7
M<E67X%ZCKH>J3_1 =0)0%)Y-=<,E8'@XJ]F^*Q7"Y=[%*8HF,4/?X(3:Q#()
MQ;1\YK+0,7W&3!*4B3JML@"D:#Y*-.<! 3T@5/<=\ 28;ZDD=&S5,W2T$M"H
ML_W0\HVKE[J]NK<H1?,L1%-S7==P==WT'4YX&%".14M 85O$,(BW31*^%,T]
MBN:"Q^X:@:'KFJ6:C@L+IV51U><4I!/L<<T/=<?TO*N7-EFMZB>E\RRDDY@,
M!#30')=X!.9+'9V ?>LSK'G@^5KK77\IG8^2S@67V@\=2_,M0P7UR4$Z0ZZZ
MOANHEN4&Q.(V-PT7:S^M;J(=13HOX33[!]%H=UV7Z!ZVP)8GV@_N/)?ANUDT
M3RJ<%@KG0_-4NV:%6DB9H3*=:RJQ4=N$E*B6276P$RS+)P'8 O)0^QE+Z9/Y
MT5)*'R6E<W\:JPUH=FBK+@?#@!C<5%U#=U3NZQ;W>> 86@C^M+:OA@-23#LH
MID_F4TLQ?928+OC6Q',!(A<+RCG@6[MXEMV%Y=7#F)=K$),'**E$GE\_8TE]
M,O]:2NJC)'7!SW:X ]:M1]4P=&V5F+:C>MS354[!,:$^=2D%R]?0]I6R)O>F
MMY.SZU$*@_E&A9"E(3C:!4T&$?:BIWG.BUQN5A_.WVZ"\2%\.X/B6B A]4\;
M_=,\Q6YS*W"IYJB!H^$I=EM379L'JNWK'@M\DW+,E2=K4N9D"/XL)'7O/K>4
MU'U*:J.FG$:#T+9=U6.NJQ).X%_$ FYU.!AU-N.FYZ*DRLVR,Y74O;O=4E+W
M*:D-[WOPA>N60SG352MP."RK)E?!WPI5RES.&#4(M[!&J]N1O3,IK)W?V9;"
MND]A-9O"RFRFVQXQL-BCKA+=)ZJO4U>U+5?C-O6)!^" L'9D9;V$C>Y7:3;&
MLNV[)82?;FSO*#[V*"B>SPC^ <@QY#20&J5-/XC/UZA-2K?Z^HOCN81PSE73
M8U0E'H.%'[NFN8ZMV;H7<$]'4]U^3$*X#+MW6#3WYE1+T=R+:$[GHDD9MP/'
M4&W.-/2BN0HVF:TRPPX]VS$"@QE7+TU+BN:9BN;>O&@IFOL0S;JDZOMO7\D7
M#CK3]SR02_"55%"?()Q^:*J62TU;M,9R?6QE^)C3&E(X.RR<>_.:I7#N13BG
M#>'43==V/,M6J4U!.'W/5*EC>:I%0U@Y?>9S7#EM:S6AY"C">0D[U*]X4F0P
MCF\\4((H+[+(GP@18VDNMZ</YCK/47C= .$58B!53BN5\Z;I1=O<P%2U4+4-
M!TP"!QLX&!Q<:8.2T.:ZK^G.U4LPV[H1EI,Q]&Y[T5)*]RBE<X=:#PTO(*:E
M.@Z>L#9<1_5M$-70]S7F4>IXS+YZ20RYTW6F4KI?AUI*Z?ZDM/:M/[R^GGYQ
M39T; (IJ4P)R&C!'!1,(>#4T+)MX: ^Y5R^]-2T)I9R>A9SNU[>6<KI'.9TV
MY%3S78>8!H=5%)QK8CFAZGK$5CT6$*8;%EI!5R\=>_6$E=R,?L(>XMF$%9,,
MSUO3),#\[Y1%M.#!(USMRPCI[=757D#BU9!F YZ_YT4:+ESXR(%8.3PN-5$K
M3?2VZ7UKU&6$A$SU_8"I1 M\E?J&KCJ&9O+ 8N")6U<O=6?U5(J,Q9^%X.[5
M^Y:"^\2".W?(B<9<XAJA2@/NJ\0T=952<,A-YN@6L2S'\TPT]*7<GJ?<[M4?
MEW+[M'*[X*('(=-"@QFJIF/3<49,%5M.JVY@NG;(',=QP?0WM8[LL$G1[;2+
M+D7WB46WZ;4S3@.JTT!U? [6LNF:*C7!;M8UU[9<QPT)-ALW],=X[7)SO-WQ
M;?;W),HC)+*:\5@XZU'!1W)?_(#'MG^<Y#"@/'^5COPH$8=7&KA\+&&14</V
M^N==TU?W?1O@L%R5:V@XN,3" N2ZJCN<>6[@6*( N?D8NT&&]CLLMGL_PRW%
M]NG$MN&I!Y9%/ .857=,E7B:I_J^#VX9"TC(0C.P]!",!BFV)R2VAW74<Y@O
M_$N*[\'$M^&P&U\\RD/39;I*0]-7"991<0T3I=BDV+B<V[IY]7+-5IUL7-YM
M*3[J26\IO4\GO=.&]&K4#'4;F_5PW4&?W5>IQ2PU='7?USC3=%/'4YK=6'XO
M8:/]%8R%1HD2 Z</RKIKK Q<76)Y\Z,Z[MB0\!5\ 6C&$S:]9BR;T/C7++T!
M/90F4O.TTCS_NY#7[ELVIP93;=WP5&+[@4I-QU8#W]4,0P_T4&-7+Q]5&D9&
M^3LLJWOWUJ6L[EE6&RZZ[Z!W9JBF'1HJX8RH'C,,-?0]DU/.+,>SKU[JQF-*
MPTAAO40?70KM?H5VP3$']]LQF,=5SHFNDH!:JF=8@1H0*_"Y 9<M<,Q75UA9
M^KS;DGM4OUQ*[)XEMNF,@YR&GN\%JAMJN(7EF*JOF4P-=)\$!O<()QHVZI0;
MZ(?KS?WKQW_0T?C%Z]H)EQOGA\ER?SL:TR@;\:3 0H^@8!C/\X\\YS1CP^LD
M>,UO>)R.\0:I=%HIG=^:?KCG.M2U=%/U.'=4XIF^ZML:6/F^SC4[I,SA/O8R
MZD;\3P;NN]=L+$RS$2W@77?%\V\\2P.:#Z4@'TB0YTZZZ6DN]75+U1P3; <#
M['Y/ITSE-- #=-,L P3Y'__A&KKQ0N[%G9A('RWW74KOTTGOW%M_<_N%N'H
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MMFFE;08+"?+4TT/J,35TP4@@#@]5WS1,-7 (UPTG"$*'/3(O3P;Y.RR@>ZT
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MV%@-Y)6Z&LBKY3 _M*EC@+?MRGH1)R2;W=KNE@+[>(%MI*R3=__[Q0@-L()
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M$;/]9$@.,7BWN:;ZZ9ETS3V22XK$F3LV$)3^ZJ$0:ILQ*P$ZM CMV)]6(G1
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MQ9#/RT K/^%,151NIW,%I^M/N/)06,<1DJ''KB-DR]ACQQ$"<ZBMR2HQ.G0
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MO"J;E.9L$M-,^1GF.'Y,T/01)<&[QXM&SS%VC-;MN\3UT?W;,P/6W34,>W;
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MTU6I1]IWNX0X\:N,)A&-ZRH18PP/*Y_K)M%@=<N<YYFOKNWJJW=#A\@DO4W
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M2*J9CC. 6#J0!:Z_8=#E_SZ79V_0MN&?&,QA8>7#+'EQWSS-6 DY+?"G=SS
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M-+"/</92&925?L=_4X<OBV#@Z3F8<I;E* ?P."19;\CR!F/L^6/,-UBV3)Y
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M?NQ0DO("#YC]6Y2*$I;!9CXJEF,\(3ZVSV2\]EJ4-DJ4,%62JD(O4TI[%).
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MOH;(!GG24MR>:OJHWI#(IB'F]L,&1-P"!??\A.["L-1V# $L6(H&95I=OHL
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M9S>)U'6T<H+G%]+FJL;EZ%;3,&H8)]YRC9EX+(M[0]1E#;E&SOML5J-,"]5
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MV;--:[$PNSV'A>PT_]O+3>OGI75%97&V30PAI8OPSD+ZH)#,IE9?=B:AFF?
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M_G^CIEYM=+_"K*7ZCIURO*\"05A?Q/#+?SB.[E'OAP3F)ZOB.F%&MX#49FY
M.\6'B[\E_3.E+Z[$UPVYA@/5D3'/&)Q622/G83-%$=R@*QG">X=1@&>1W%PB
M>4%H)-63&4)W35I&'>CPD+J/UE,HE,',8L5WY5;ZGLK?76D/B78"#BL,R51-
M4B1@3U.?2FY61Y@"JVP5K\'C*!!].J%O@H+Y$48/3(4)0\ \*%[I"*8-WP/[
M1A>(2807<_PF5CD*=6*/$ZNN2(5#S_'O\0ZR%[AP.%#/)$K]<#P7NV05F9%8
M4_3\>[#J$1VQ$=5[(&#5LUHG<4C^9Q;*3+N@K@QZP0U(F^=-Q+2&HK]FW3]5
M+R=V-\O\H:'O;Q'%(^:RX :1[0)[0Y M[G4OC&/@!*7&T.&?Z J \R-YV@:M
M%<J:0:=)ZE#N=%&E_PE19H*@#][D"U8G(JA=^@J\BSC,2+%F^*K49IV:*40^
MOF](Y3'(P:;[:Y;;&R!_/@Y*1%@.E9"0VGP/*6\>^1E8W\LBYB0]#%AQR9P^
M([%BD4KT%@E-\E&?4K!@U.O.18--E\N(Q_&P+@^W78L,&RL1EX^YA><NHO0@
MV!@W8'^CCVO;(+E# B:\.S<_I?0];Z_>.A<;,(1T)Y1OS)C*FWMJVA7FJ10.
MISC"65)PA(^,)TQHSU3.T-^2IUVY+;.0U6;B$D5".7>@Y6Y ,\7WFV A0(,B
MX4V"5YD\)A+X!N82J2$'.Y_@</59&>!_HZ*.%9SZT&!1>-?[64#$O&/TA/%L
M4MY'_#51)L(R6/QAX/]0G&/JYOT_E"<^+"8_%6ED<M%8,2.5-GB93>=W<OHL
MQ][OX]?UH9'WNC3J'#J3,(Y*OQ@DGIZ*1!>$^DI 5F"<VLUU0<."9F#'%X05
M?R1N-*54R>T!4RA7K^QW)X(G>5"$&X,S\V]6N7)+2][Q"-S7+"Y\SAS>/'RM
MPSFHX+D0 [AR&=4" S]L&3"VS,=,@UH&_EO/ MS5E'NTTJL1;IN-] (%06&)
MD- !/NHBOM,=T4H0<S-\AW!\63K$!+'$5;CS9"@#Y0TX= B"RN" #34L5T]7
M;4BA$+[<=J-%DR$VU25*)GI1%HH$R7=L>Z&?QJKW4>1T(._A&)_+'U."RO6+
MUD6S8UOM:X4]@4S/'TH>AGI?$/YFX)8XH\@6IR*_%?9--5-JJA^6BP[!UO4!
MPB^*O)!N1TBA^:)--(\?QY@:*/Q"F[68X-GO_0^H]]EDR2KRB1'!?^_#-SA^
M1/N1"Y*&96&_;/H:/\E8$,N4TZJX#X[=V X_ZU%\2$;13S@K:L@=:6KO_?L/
M[$\]FG)T.636X]%<T!U0GYT-O6^WEK'* _Q$.S2>3OU(P$*I%1(<UH=-YRP
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MDW/QW]\OKFYW D]Y9V-Q"/-,;35=)E/H22[ X 9 $+S&S%29<!AAQ3:ZQT)
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M2GTE#^#+14N7B6K6AL<&2C$R$WM^:F?<%/+5]R'V?<C)UO:WV1B/:ZF#\M*
M_Z@<\+<6#?B74BD+Y0%6'/T_$?Q;$7P,0S4<*IX2K:E/.=>J>C9 *:<0MTF6
MS8S*A-A++A;J'CGP&KM9&C"/)''OJ0+'*-P+//GPM01-4P^+^! 5);1>A;B?
M,EBX?+'+V"5#EX%*$KR6A$J]D%DVGS41R$&D5O8\%MFSU4D++D4?-.A*Y$"*
MMR3MP^@ _$!)]-#KQ?!)8M&,5Z^Q;,4++D=.-_)RY#GW"%+#2'D"N^1]T9S[
M4=4T4P']BX'$IC![/<SOCQ/UJ_['1^&V^=4/:=#THZGT>33.[4BSQ;8DC>'_
M//U\^7.3_O3WU)O^VV&K>7QT-///K69[YM_F/;;=:AZV9O]YWF/G_^U@FP:[
MO[]?#[;56>BQ?R?)9>F%8X '[/_\LO]+[FD1E]2O+:=-QT@_SWSUU'RUZ_9^
M#*AAVY[HD3[]/\U']6MG_(A/F;X *Y\P/L>KUDTG3\5M+59-98MDM$YYZON+
M3_W-+-]MR04K+-Z"LE8Q4:0RVZ1IOK?O@A<1$#8X:(Y@9@YE/!P]RJW:8$V9
MJ3VS54U^Y@G9Y4744(,%%O%-KU,M;*\E;$^HY&FCU.LI-=\H_3Q=_72T00MP
M-L)BFW^;HK I)'19K)Z:_,*RT7*V87W>O=[\[7G'^,J-FOC!P3ZG&5YM ?"O
M2R[$4FYFZ326]5HMR&]%D-NU(->"O/V"?')R4 MR+<B[(,B;JI&7]OB?3D-M
MG-C=%&[:>T.$Z2:$-)H907:66X'*X[=Y8GAZO*045F_VJVK,15.EN[E#G7J'
M-GR'VH>M>HLV>XN.E_4:5[A#;R&#=BZ(-HLJ]\5&M6(9MD3:GANC;% 8LN,[
MU.X\T_NNM^AG;='[@ZE[TWIS-F5SVD<GZSL_;R% O9Y3#//&0M3VP6GM7M=;
M5&_1B[9H_[#>H<W>H?8Z,SUO(4AEFQI&X5YN5[ER\RT&J>^/#FL'>W-WI]TZ
MJ;=G@[?GX+C>GLW=GD[K="W;\Q9"TTNBWT@,:\$;"T</CNO;G@W?HO91'>QL
M^!8=+0U(K+?H9]^9KOW2].]47KLE5 LSV(!+I0733:/62^WR9.F#IO9-=-^4
M_.NZF%[X!Y^BDV]HIA7A+LS;*+U")Z9("(9*8V@Z9U4S(*J*@X/](NO:R<F!
M^>#Y3)(VQ\44HP"\M%U^:?O9+]4%/&5BC6=S!AQTGL,9L#FGKPCS.]>(A"N+
M4&RS9T=/7)Q"K9(Z8CMF^@0)>44OC2EZP/8)L9NY(9/8>[HYYQ[]73IP5K-K
M?&<&$^Q2"[.5?F1(VN)@?^X];&^1=UF3?C=T'KFK*U%'*.SWC$PN0F4S_TV^
MQ6=%'(4Q:2S#IV4U#4VX5R>\K>>2)C,D*\*+*43KHB.)$6,T#J*)4A:]S'9Q
MILVF!7ER62T^3U:<$?4C1[*QV00AXK/L8;3]Z_Y1Y:3Y(^R;$J:_[K77QXZ"
M+>XZ1Q_7YS=\+"Q7^Z!YB&OQA<7UVO2X=:@77QN[D:=J(!EW$D^26_PO$?$B
M#3&?K/%8]T-/B#DMF22I&B5B!U,E/0%[3'#,)->:K;6A26<G3")'K&NZZ4PM
M!*\H!)]!]:;,@W?--./L:FE1R+>>6H[F1%C%#LGPP2B"/93MUEO/#95-$R)4
MO,1;+2]-;%'0;.GW1'E=K11K47A%43@WS*/5HF#1T)LN[M7'741AWN863. "
M&SS3IE5Q_:VW%_$+;.&T/V.=+S+R=GL V[4@TF2D=$]2;G"-$\3^7 ._IST@
MB\93F,Z,2R-$9TS>KFGDD"4\HM;TL%SO]G,F0":8(TU-O'%Y&\#<'[))[OVP
M'[O:M5>:5T]AW#?%&=V!F \)<A^I7QF8E'>'K98)L3 &.[;^&WMQTIAE GKH
M2*MK^VM=I&X;8NMNS_1BF#>&-RZ']M))LP,Z[<B@]ECB/17@.+4VMC>.8]QW
M[9Q1DC])(_.7DYQ:$C?C'F0$Q/Q/;&H^*3:A+>VEYEQ^0I0T2ZN,GSR**$L#
M=Y+(@PPSN"O<RV/JC3#WL?ME"1VZ05_WG\R;8.MUX9;<@2NC-U:->_"QBNVJ
M4/7]5'@BF<[?7EMNGDG\>16==8O[8=@=-=FM(<FE3A#R^H0\-FE:RV2(O/O<
M.3G4W>H-JRUR\/,N2 MZX?VG9;38SW%4&\=57BFQA")I5/<I66>.CS-BF[6
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M=:MQ-X% \(OH&<)RWINDU*Q!-)TOU.D;%V>FF)%XD%S"P_PP(X\P@L7L@0S
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M!UIB#QDY:0F0Y0HFL9?'>QA14$9)^EOG5]!$!,$D%N$>_<< =B8.*9U$#O2
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M:=6L27,KMWYF8F\QLI@S=B<Y:?TJU]:'S<X"(ZG(HJ(^W>LT<1[E]02G"Q^
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MWD#Q>&%)11^98V^Y> ,8 OZJZ2R?Q7@"9K QV8\_E#-TP79W2=NF%+S.B<S
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MJ*EN!60MA,DYIZSA:2M&9!7TG$(-6\G0.>96BXE2-L_E5YVU*9-<:L"@+KR
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M10,'+8F",EO8')!C\[C50YI=';7CNSK*]MQ9\X.[_/1??@!02P,$%     @
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M6/@\</R PYC5\&B34%I?RK3-K*U(P>_K:->.\V1A]>[4B96W@TA@V4=_*C4
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M1DBIL20UK9$1L5(S$^0>M#3:),JD]3-ZJ[4W7\%HMQXG73-[)#EZM$R![^=
MU]^-9T"UD^K$M"WML.^EIE\B+J^-% ^8/TT1K_[X0 90K_,],WOH.D9A  Y#
M(=GC@:^YF2X UVZ>3RPK&X+-"F$?M\KKP_GD3+$;>+"6RQ2EHUX0\ )85>.&
MZE:4J'%=R[65SO2VSK:M"M--'GJ/^E:7R,K>HW<+5/\KD!\E"3\E=>1@*YM?
M6E^*2"_<$]O*5*'D"G>_=[E//G.^@4YC5YZU!V=7T5-92 7@^F7NU,S>-Z$0
M=10F(XEJ[T51<\G3(M$O?&=6-MA?))9]7/[RA[:N6=-CT=NT<]O*5"852V@/
MK=DC]DEX#?<73 &Q_^"A&@]T%(#KK5G?S-YSLD)D1)@,A6KO15'[RFD-$JTU
M.^U:V?A!D5CVT9KE#VW]6XQU6+36[-2TK9Q[V8LD=+!FT>!N<&5X)71ZH<D3
M,96%MN_.=2+3H6+1<GWF> I+-(R(W"S6> BC#)-VD3H%8YCS7LHJ#Q.&RE-8
MU4&1@[!60US[\:EJ^/3+F&UE0X)5!+>/2UKIB"_K*N1QI_IOT33!KK>F)[:5
M*<^H)-U4>8;L;R_M*PS,C(2W_<G:ZOC=G5I/:.MPZ&WJJ9F]\RF!+:RS3N([
M2,9I4%!: 95^DIW95J8"1BNGO9Q+JV> X\=7B7--QXS/:D8$2_#HY]2YF;VB
M)_E6\ JGD4!Z$%,\$G6CA96PZ3V4OI43S2T5V3[Z)R6C73N26 V=UCB>=6TK
MD^VL(KW_; OYR_&;^(CF<P(LRV_"SY2RD';U%7R#O7#7*X4[<_T_GY 0[ ;Z
M"U^WOL6S$>9'!AH)=<W]IR.?!_C(H&B&01OR&U-97P4S(V[\-N(>^3C'G#!7
M$OCIR UX9))% )B)'\A/OW(6S#\=A<V)CV='AJ^:4T9I,/OHLADB]!I^D%B.
MC@MY"/B$./+>:,I>5#\B?J"]A)]RP-9YPY0P?L=\+'I=LW\1X%ZW=U;"EA:F
M;8[T9Z+OL#]DGMQ*<.3=C[Q(U>3S8G[ J;SM)LGV&'EBR?<6,)</#J$"[)<?
M_S0*C^M_.G(X=HE?<<C";V:,@DGBBRIC!D8!*T^2DY'"+<-50R;\^_$#9R]$
M/@S[-,?RHO)!Z')&KU3(2UL)5:Q&D2ZA&<#M=E-'U=:&T\6C]Q[-B,Z8CR3#
MH L/:!'>0$_=@0NL$3EB4K>B LOHVO=GMO7A;X^N'977+<PLL-(7^(4XP-\D
M6E:+![(88$<YO  SA<%<*X1ZXY[;M&V;'CYJL'HFY^KWN^OU[_X@_I0%_B-&
M+O$6X(R%&B@?K(IOOY!/;BNH6PQMW<3+"(6B_@X]-U\3WM>()1]26G_\"R;[
M;]@#*Q"]4;18<JJQ/DT1[NX /6/J8O[ \8P$L_@(P'"*^ 3KS' 9X 96Y%W=
MA+3C=Z(</_NDCK.X#M.V81DR/F?0 ;Y_P7P*$[A0:CDM=]38K[GGM7SY79%+
MBJQ>-]QBU-&T#$S;'*UM'N*-P\K.04="I'^KNA.IB&PW[>@S\V&_%*:/ NF/
M8G'YYGB!="V_4A)?K2IW6]<<RX-6>C5HCJ]M%5%$#QP'.G<C;UOH>=5!M,W-
M]6P.VAC>X7--8;?@8"$>L<"(.].!?*GQ!7ML'CYG4:#GM7#\'<QQ;)9.&YBR
MTUV1+,C!#1P_,?BWQ -_%H9$SU8%P+9YRW-7K 8NCK4S"\^70,"N'U8#!S8@
MX<.W#P%,'R3P X?]ZS+/Y\O;H FXI1$Q!7.R,;Z=]6JCHRSW8]B+8#*A\4U@
MN?=_IAY&&.0\C"#OE)4%"==T>:$V8(Y?^7O 7*4,@"V5[7G&;_X7CSG?"L=[
M5\A[+SWVXRZ:^U"#:.0*8QJE<%MG+OP&T,O1;V1U>KWZ5F<%T[;5B8*"_N(9
M/!0TEY4)U5(FI7"M<Y:3_;"[]3,F*YBV.9(!B96%N LD56S\S,$*3$OB&#JP
M&MN-&E.*4!]/,&^8V:KC=V5@=DM.EV^^+']C]'ZN"A,PG]V/EU]6E%H9DG>R
MBS%0A=@\H62&/&]Q35^0+/9;VH4*L>R*P&W+]2OE&'GRWOEX<68TYVY\;;5E
M>"&!A 5(F(7HK5 #WJN[7?7O8H<5&!A%*:G53?_7+C0E8X*6-ZTHOQ;H&:2R
MN_ ;3!@W; +<A_&$^&Z54F?Y7?O>S;A.S7A_=)F,S Z+XH# 9DAW<Z#2B\Y9
M@Q*,=9BV#5J*NFY(G75>@Z,,3-L<7> QAEV7"X8NFJF).Y$>%!FZM'LY;.L+
M;5JCN@W<VG68MF66%T0[J<-1!J9MCF[CBL>;X,UA);Y/;MNV.<ASL*U^[T/O
MI LSP9$1P=H.>CY\VYS*<GJ@2,94$/1ZB][(+)A]89RS5UB]AVB.'%V*IS+\
MCI:4)2Z'4U9O"$ZGO 8/5NI7(L05EH%!;WD9UT/ YZPTW[$ATK9UX@X'G,V8
M&]4+58N(E "US9/^@0851"S,7E4!W0)_KO]Q"BVY$XSP=>,8W>5L[K$%QD)=
M+[$,><-<TLNO'*YM$48QMZC\1+V)5AR-SFN[HYFW>'L[AOFC]K3N%>&SU3DG
M6$;^-X"=\%A>QXI$=@\,WQ0.Q':0[^J>>8AE):<*$ES("M"H2%1NHXIU0P^T
MHTJ2]BBL<"=EU?%"UF':GLXY";J"G-Q@]3#8(_,\6$9?$7>+N-X<;\M9EEOB
MNAZ^1,(?C#EQT UT10?@9<'?\EO,Z26LM7-9K3D0!"W+1OX)SI9\(O!_&/@;
M92'';?;1MBH]XA=, UPQO5_4NFTNG@!V=9IU$68J[L<W,-IC($T\8AEU"YWJ
M.?Q7O/C51O1.&E\Y"1(6'2?*C4M\E:+F;8LP&[.^I]<P"!P(?80M0/JM[>JA
MZ_N:D?*M]KJC.[=5P8&J5-9Y\+E-=\9CSP\6F!\VBC7D@+<].8:PN!+D#*C[
M.Q+R4"BOD!LK 6J;IX'<Z#LR.CJ7.3M9IOD[IBRH6$90&;QM/O,"CE:=RH\,
MS$YQ%->E-*B@VZ72[;)S<^]S3O(=.OQ;;,+Z]4/U&9BV=69U-W?"FZI9\:>%
MW8%RO+0$[##]8]>1VCI,ZU++V=C;#8(!]LX$ X:,,PIS$!; )Z  + .LAK]A
MQ/UJ"VEU^+8Y3<NA%\JA5@WE.LQ.<12? JBCC1F8MCF";4]T3"5>VX1@L'3!
MEDD>HI4U'/*@AX\]#ZM%[$&&2K@F3;8!QK_16FC7.\6W!M.VU'/]U09Z;.V,
M'I?>! *$A]FM!^819W$IE4\F[[ \_Z(OS]P8\XZ&%=[])'U%[^J[T[%SGEJ_
M_BXS ]/V#-3GCF]@^R1QB&:IYP1XVP=#R&SND3%QHM)1$?E@  P+V82C68D0
M*\.W+= \@U^K_BP#TS9',B1:JHAKC5I6-W5G[WJ"@XV?H"?B$L2)YCA()=BV
M\R&W&,D;_>1WUW0>^# )1M%A,#:.KCXJJZNKCJ%M#4S-]ZAD0]7KIWZ0:3LN
MD%<LVMIX=M2U'G)$PSC9TQR6<^\9.U/*/#:I?#RM#H:VI9^[@)OFA^X&Z8\\
M\+;YO*9..!^1)\MO&%7/F(F!'X9,)6D^4R_3R5O,QF-PF-E89>C"AL6W#VR,
M^+W,N4+?,/'-<O+5CWC&7E#Q,9;ZB-HV]-(RL?#BNCHGQDK!VE;V@>?EU.&4
ME<WJ@=KFJ<!SN$4T&,M<!H=EI:[;L0;<MCKF'BQML ';G0/>E[(.8LZ)P)=O
MCHRNP>I=4ERB@6B;FP?LO1#G%HMIU;N*=1!M<Y.[+S(;[*7,G>0HX8R<]DXV
M<F:R\&US6O>$XZKH:%6M)&WB%SQF\GGGXNJF=^AI1T./N4F1.N<1,S!M:\DS
M^[9@JA3M"Z+?[L'WA/&3)6G/UU_N'\LN2*L"VS:'Z?-K"6G4.?:6 ]8V7^MO
M.,OCX-0A'E%]@OLB:Z@9+[O2IC::EB-+E_Z4 (4/H&8R<#*64*I%U?6V!H*V
M1;QF.FK9F9WD(:K3Z#6H[>CM:&U'Y$Z;5QZ3%?J3!JYX!K9M#O/"=,OK(NZP
M'YXU)TZ4*1^J)5>NX,#/,QL&7+Y?HKV/<8L][&B(4&]7+S!EJJAN4P.=BZCM
M7%/>J:9:4WX=INT)$=YM4^6:]YR6.ZJ@2P<'YITL^+R^>AK4]X[TP&W++=?W
MKE,"DX%IFZ/L\<_X1(G/1M(V>$@(,B9AU1*ASZ_8>\&WC/K38J7=#.G.'CT-
M#R8\3A?^5%Z-KXH-KV#="#BNF*2I@:%MQ<BK0*QW_'0=9K<XBGPEJ_O!.FL>
MJLF';YO3^"R_N\P"+L"HACN4$D-<";1M_G(E4>LDQSI,VQP]J#C5Y1N13P1>
M$#%G0N;V1*FX2N':YDQ:_FJN3D[+75T*8+LQ)RJ.L?@5 3-,YEN@&ZH.=#UB
M^+_:BM  4=L"S;V)JD$,_V1G8O@#>;1K[5JC2D5L%0#;YNV>RSV6#^H#S?%P
MBF?R@;!5$A)^O$*.JA+2\]H 4=N\IV_NB\_)UKGM;QVF;8Y69P@JK T%C=OF
M0=TG,0B$NI$%W>'7_\/*V*G[)8:((A?!IS]PXDH*/9\;(&Q[+(I<RNX&I5#Y
M\&USJGO\9N/7<W;LN9QMY"^E,_1],J5K/>WF5;35K_A97O(2E;S6>2ZD,LH=
M#<$-9O+U/E=YCD(^H@'_OS#O1<;$E3L\F'",RTN)Z^-I>\HEXX<J>*C,P6:)
MVCJHVN9_>;-D^'Q8=!7, R)N63J@"N1WB_^KM]N% \XE^OS#_P-02P,$%
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M4Y]Q-[>.4"ZYIM($ZYH$91Z@:4R7@)JBHY9<6NR;DZ!2P'W?$Z&+-VO1S N
MO\5D:.0R^$B;I")NT#"FV%I3(.S+]WJU+&[/)RCM?"HI!,)$(KUDQ.7,B=*!
MJY"RCK9)F;?Z1E%99O/9ZKG_Y:?G,$F49BK1$HU"22(56J<6?")42;#)&6=U
MDSO;-PD9DT%T( +N4FU[\[QBI;FE[V:07OM^AJIU<<T'SETL5V>,H89)2\!F
M='U8R,1%CC]"E!!RLD(TJF;X&&EC,I(JHZ.R7*KA98..K4+/(&@(%LTW%H-
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M9@K)._AX<5IWG*\*WA7O:IV%4.YW?L!9PD_SV?)T<=S_" M4$C9&'J0D7$1
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M$LE")EYK36C2,K"HO!5-NB</9E6TT>M/C\^*ML@N&!A9)"3IJ+FWNBBE4HN
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MB&]S[P[G_EG.4YS-+O^ITQ4#FI(D<T(Q5ZQF6GNR(+,1#,'&8D$XARV,\HT
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MKC8L-M%D+G(2?1)O;^(X/?_I #EW"*V_!N=2I[<!U-5K6D7T0)[3(3QMYOP
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MH;0WOMK]2O[4=*!Q(L@+,4S*<_PP'-<RS##./XUK[OFEN&:3LB%RM4U)EX9
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M(KE $!X+XQI-73XR"TB;B/!2Z&*M3:9+?/,6V/ZPGC?=/33BLT?WA3714E<
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M$LZ6I$Q.3"K'Z]N%S'NK6/#<B5Q\T*ME01]6,6^@_T,Q#^:T0_3M9AG=G,[
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M2?I^_.JZ9ZV!1Z.MNS#;04NW3BZV%1K68!Y1FU)8Z9BW13*1!8DP6<XU]-#
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MJ&+IH%.:@#&)G@='?]?$(=V)Z"(48!AY-[_=6&QO2F.*1A7@)>?:>@,AY&1
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MZU>?:K//*Y]\UHY[L*56>(EZ;2>] *.Y=,HD[E2C3N[; 9W"'!E+FQXW0!B
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M3)_Y_6%I9<RJ@$F)D#K.20#T'^O)S"8#C/AMDMG0'>+X%LQ0Q$Y'8:6!^[/
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M1T:?SUD2N";YQT]@>FE:<@@5._>2T^4#O"F%#,XZ.'?;U>\X=_W=,(Q]CW^
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MI'?%HL2QS.9]6"] S<9B:F"+^&G;<)D4;Z7-,NC*=;WY0P+J37# ;0T^2/H
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MZ^LT8J[)/U#%0Y$E>W(#R478,BUOOA;W'-/?/DR__*_5$Y>$KWZSR?6WMY[
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M4M0>='&U/A,%Q,05F,(,VJ!98$U\AR[@?NCC\!PVZ'0ZD.DBR'*1)EC2%*U
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M(Q T0Y]4TL()H\\I8'AM^[^9^=EPKSP9?\KFKT9:C3(%:UEL4RHK!@VS+7W
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M/[65#P"I=*O^GP/K(4:K_B^2 K:DL &KT"@]2I+2HTT#](V:!"@;#A<!^D;
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M\6: *V!-3R?]+5R[W/!$@$E %FHZD6]G 6M$ #L)K^<3@3E $  6&QO0#EL
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M,"7.;8=*;7A3P.*!4<5F+%T*MT&X;*Y/B ;DQG#9I"PM D:QH(@ALD@H,)C
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M5(J"$OAXD8C.MOV_\^OQ_]B/VX O_ _^[/[?_0T? H'SIT[]X[G>K\_O?G\
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M;3TBW?I90R_[]XSHD8(5]LS8@EM\<C!Y7S\^&?1O#V%RYV\[C,S.G2T'E.@
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M/4DZG1)<;IZ4T[\Y1Q^1M>XX<R7CT.6GY!^5D**7A4.SOKW\\QSCK8NQJH+
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M;I^47'?!T_>O:]74R0<O4D+[7Q);&"NB-&;-H2(6'P9\#\9N$[DI?=(*#=V
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M^R.A/>\_0W4DL:.TL5<KF81Q^TBW./UK8F(1L_&GA=TG9EYPLQU0?D)I)LJ
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M\"!A&C?5Z7_#0R*V96XT4U^)_AS7NHE)(3.TS:%K\1/NV[1N#F(]9 \CN68
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M4 Z*1^8QT0J,\7^$U;V<T\DIJWKE-7>YYEBM8/B1K[7:RK5;Q-_N#,V 6ZN
M$R;\]&'>;>R+ Y33RT9)?@<H2//1#:)(U$?R&RL;8W;WY4U?W<!WU;S3_6.'
M\,-6'3TQ0=7.] 5(,(Z=/1.,1H&2A15*0JVC\GW[[[#M^.L<LB6+5&[E+$OK
MO\#]^-9,G(Z'I2;=M48-J#-#'Q_^0I;]%.IW*-@EJVUW8Z:"4,3)3K\?U_&6
MML/]TQ(\P;>BNF[$=2>[SZ1CWVW;2]FF[BWLB>QS54U<646;+ZVG1R G&(()
MK J&XP+FZ\QB3BXT2"@5>0Y)SKG+?NM;#L7:'%N&R,51[FG Y2].0^<H%1:C
MI,_FL*CF ;5HW.,QD10.8H]CXK95V#K_S=*BLBAD[(W[A=K,U)C;;R>+U8^3
MY#&47E)PY[ 3((R6&;ES-&UG&6WD>=:YH6_O([-XRT=*YX:$6>)".RXA#F)?
M>4"NNHR57 /6FZ7L]U:DD8\L>ZY'5S\&;P_9;%RI,1X<\_^VD[^3:RB+Z^PL
M(BN]9C>K]E-K<!)OEFX(U_S)"]Q_Q_$..]0E?[WZY,18F,O$RTGRH5AJY@OU
MF;Q'K@5#W)^E6^WT4NDQO0QZ2=[^E"5M]#0IUYTA[U/W&8W&U9.$0-D3_"?G
M:R0KG1\.(K<O7[)[AO<XY4'X04J(FTHMCKGBNTU8('23W&#*KY$HC:!M2(YH
M/9KM[:?B9)L&GJHQ-JSWM*97;EBK\0IOJ(+[(S?#"9MN, !$!NK]UIN)O$Q7
MIM$Z/GT8?_AR(U'F1(#BL-^!@QS$Y86IW,(L)RUQ=+:[CZ/T!2]'1;.#><+R
M\W7!.Y\>B9H9K"%+OHB10^KI;<8YKZ#/\(0GHO;OH8TJ8[Y!I F[?T9>>A#,
MU]H#_ZZ+%K S[VS:_\UO9*Q9E%8<&BP/_X 5<,R/._RK\M<3C=CF1^5KP_L[
M/Q#3:_8SIC$1J#UZFM1+ZI.,,)/2WZ]S)EPZ,T-16[TX2Z"N%R7TJ82&_X'9
MV7A$;6P4N^!CG!:]QV"O',HT$M]'(FB[<VU$]25*!6UP$.5>;.38-SQJ(S"W
MX)BD)6%SDY##Z*^JN>+9@4EB=,%101P_\UCB*VI4FSBPPCC-@OAZ'#-]=6HP
MOGGF,:[7;SJ> *6%?P!-6=_C)?J?[:]OKNM"7HWX0[V Q6,$0>$ NA)U5]AX
MNZ;>B%&#^'-QUURNN-7V8S]#Z2=X@-L$GAI11\+.FH,,^[I!#9?N*M6L.W/>
M*8C+CW\6OM2&C@D="(@SPP50#[GJH0]IF[AU9*W,YC/+<,'CT,V]AHJW<B/F
M4_/G.8@6Z<R7FG<?&%WFCJG9.(XX92MD1>W#..PY_V'C7\5JUUD.N.918789
MQG[$N1:M6&I4^CL^*'7P\UI)Y8?=,=/2OS4>TE^+F1YEW@H%*T%_AFP!K@,C
M5F5.<3]P)]+5^4?Y2O9P;FC1>9+W1;FXJ,I[YH^II/S*X#?<:=5Y-!C;0]AI
M#VCN2_P4(/S051GCB7L:9J?!=-K6Z4?>9R2"IE\Z]*=U<H''2!=I6UJI)VQK
MS5CQE3;73#B("#"6.?9*[*+B TM=_M&7^';,*O >H_(Y/8+] 739PC-D*610
MR(I"9,>(^T!X$RCSF,4WFA+3_2\AYR!:#7![.(@_X]G [#IQWA!3Y4PG'N @
MQAQ@J<A!N&'NT\;8W40&!['9Q9 *>7\L2I#7VDMZ'67QMV+])!V ! M%&<'_
M*EDD_JMDT83M\K>.D33Y(5"$@_B*R^<@,I2=5Z^0/C!4H8N_]5'0&_+,*"S8
M8AO=DZ"XD)HXN".8. SE$["K&CQ+V%9>^/?%BG_:.8C_6JUX\S">&TSVYOV0
M^:^Z165 G="S^_R'3:%OC4+7N:?,&<IC8#J9.L/VM0;F@DJ!DZ353@XB;8.M
M#OSOE_4&];3@_@69_ZW1+\2(T5%LB,# 6"KO/) M>;8Y/>0QYKE]?Q8N3!E/
M3ISI)M%,\0RYF+\^*,1.GZ M^IR<PQWL^D<\[)77Q7,U@V,R)RSL0T]%J56P
M,CSO+]9!> X"]M-@J7WL]VBQN1I!FF'HH_$5I&,L];"#",]0=+<.J_M24Z*W
M;/B\N7LL0!D9&_A)IHR!!_LOT94&TQ>P!U0^];E-/63/O([IO&.45KGCZ&-=
M[I.Q6S$X^LW=:@CN0=+.";WE BU)73YH^;VCRI+;&/QHW%MN>UL4[M,L"OI7
M%&6&5@-4SWE<NJ%6A\";6"M-D L+8R?((HYC2#V1/.?M+RW.GQS*/+$VEX=W
M?PSGKT2EYV!> /)CI;Q-U>:;Z>R/@;9T;BL5U<#;N::X?[Q57#/D7*Y.;NS_
MF2.Z:= D2IS5@OB;Z!'FH6.TR^ZO=@VZ'V<U[ABK[PP<,LUOR)7#_ARQG_C6
M#IRN?6!HK@U+1."(T@99@+;GE-.$;&5@7M>=#?M)G/1$2M[UNJ:'%01X<)\]
M2TFV>.8W%PO.R7><>2B5\=N'V#/ ?+?)"^XOA_A^8"@?4"474/N:3F&1>E*Q
M8\[=(5WLBK?Q LEJK"R::>S6-:UE \ ()T9;"GOQU/G>R<M%Q3TE"[L3^9WO
M.%C*YV=8E%H(^]Y$(!"BHL1X#.4%J?@4IA@ #[;5=9NY3CFGZ;YB9%Q+J/!#
M]X2Z94<]*_LAB*FZNZ6Y*7I5\*P8<694M<,>W]2J "T+?"::C>79KPQ+QU_@
M#HY*WIHFRC%5O]V]BN#]D![!M)U__J=B%J/XD)Z#=[QZCA+UT%8"2I#=R?V;
M.V)G+[ENA:$M#?$EV+.T L^7,\HI09HGJD0F^,>*G3;5CEQZFFI<K_;T)O?#
MD\\:N'XTYP]T(MO/JT>YU>_%7PDAY2&'B)N/2]AYI(<8E.\.9]^I]]CNXS%-
MVE(W!Y$: VM#+BUBZ-H(Z$;!L0#'405IA\SHB**O]0KKTH42R,^:+,(.^Y,_
M*??$.]:R'^'R]8D,8BP#D'A(J[.]::W8F>/C%KY1/K,F:NC?%_8<O Y0L,)S
MWZ?C/643\S+O&038>QP6]K4+#_U)B3FW-_><Y&YA@J$Y+46=@KJ ]9!)=B0<
MR.SYCOF"_+.P&5+(SN4@[-QY B]\O7D)O)YEX'/*Z8GR\JYKOB3*P1/A' 07
M\;*^TIH])!#!:(!.L2/T#,:5PB/;*(3])F5=27*M)=^C[<[R/ICAC^&MQL5+
M)8#D%$HB$F6UMRPJM5H7Q[N>9A;M6\5SXL*HA=7& H/080]*R,&08DPO9_LZ
M MOG> +-L#!6U?T 5M\0#@/]+Y,XB,Q]5@V]+ Y"$&C.0T*[(2/*W7,<A+2>
M$6.*^>(IA@\M.C\F7B//\/D!4Y>9V_336>Z?;AL.#-HE&UP\873TW'WC1:X"
M_QHJ#(&^N$/U=!2TY]'XPM"KOEM51S/'%E[<>N2SN['HM/[-Y9MA'Q$;POW)
M$^B\T+QPZ%;YFJEYPW2;&L&ZL:>>@S@5Q]0B4G KN.:Q8JTP#N*AZC,;<4;0
M^+?]IS@(Y, 7\]/MQ"#,KCOP5VY&;2BS.J,]//YVO!\^4Z]F<W_-46(F9MW^
MG9)[P\=UI&8EAZUL^$:A[GI(D4F+]WG7G:'!L>?.>M;.$"4='3Z?TEO9+&"G
MK*,&29O^=&S]RGZ#PXXU<H5QOUMM!?OB8EDYG:B)Z!_?MBRPK4D-!*YY@!]W
MU+E&K,]VU0L0G-<2?[1X+R--3%S+)DCLTE;=NC#;IY7+QH\XG0?QOZ,<!L((
MM!OFX9N;CYL$/F5Y..=^P%(#(K5E$_!]=F]8*5O$'KW33<;_*%*&N@H>S2>;
MT^RG<=*4#[/=C5FY@<2N/&(S4S&ZLAF[LD\^ZWK).IEBAJO%&>)^_]T- W5H
MJA>W/_ &[53'#WWDS9*^)8OOL5X'+QSA[CQ\$<2.DF[ET;(A 0>Z1"*A+ F_
M'DQ0W*HS]QVFOW7_T@D+5=>A-70I*Q]+!MW#;A3[E[$L@1!XMK<Z^!IT*PS.
ML-\3&_YO%YS^V@YF\C9F&PZ9ZV]1O%15,.HC!V'3#R6H9>H;]26^WD!9LWD(
MA(QM&--"?(!6#+0+&$!W8M:'W&T:;<[ \GF9@W@#@'LYB**@#\!<V6AU!"G)
M8VQ%$]/ 09S<]N&"ELQ!I=6357>H9U1Y?6VO]FXH=/=?Z5[*K/K^KN.0:,;Y
MY:8_BO$,J]4DE@W4I1NV9,LR99"IAW*F,R&%WU.5+_EX3Y=1F(\O$+;M=UPD
MT+BQG=G@(0YB0H+$PT%0WF$/+.<_4A]SWOS*P US1U-7'[Z$13I.W)9AM68R
M%A!R.N8L61LSLT'\'7BZ5M:D0,/4DFF57@R\8X:]8C!U2[[&#JC8KW7ASDM=
M">C6^1&'/&O>'V%]GGM?9G!E,--JGG?:J =%,UEAR-7 0HX'R?YTGS94W4>@
ML,5V?:3J&TKPAOP^O=,B;O=:EOL;X.FA0,FWF&[[.O+S&DF&&&W+A$9XONZL
MS%O_7?+[T.W;=XX?$);TTRN42[1K4Y<IE$EF\D,"+':B*PD.LG\.&O2[N1[
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M30:>BO@16P@GNOJC@N-V72+[RW=P$8?TS1O)?1B&IJGQ6HU:X(.:L9(A1_'
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M!H9MPE8<$@2J]?=YZ"\51!Z*_BS)>K_D;;M8E+C,+QJZ]ON20) 8]OD8S8T
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M3-A$><\%"G$0SRLW+]+<H\?#@LBA>A<V;Q]&S>>[_Z,X^=_*>\^@)L.@;32
M"HB 2)$>%) FO=> 2%>0&BD2%0%I M);0A&0&A4$I86.@A"D(R4@7930J[30
MI"<T RE\\?V^]SMGSON>F7-^G%_G1V8RD\SS[+WW[E[7[NR]=]YB>]PT5/'L
MI;9@GL?&/EX<T0G'0R@1!YCDR&]X[R]LFM4]T+=\K;BIMN>WL>;,DO69;)5&
MS/5CA]Z4P",+\%$HJ&,;C478#E:8FX"O>UN7@S+O\>:<:,;SG@..#PU@)0)
M60&G[2F*@:9(PHPEX1NTJX"GB:*E K2TFY 1 R)/'_9QN"A%\^[!0>89K(S[
MJ0$2\U"?P9CZ8H(&)"IQ00FX#SYL*]D\W#K+K2_Y(NT;$'"SZXJQW&@+7WG1
M[[1$<AW,%13+0<FDM*CQTITV33)X,]V:4?;(OH^KVF\SS[Y:&.T9*9XV)J@,
MW9/4D"-8M!S!B=?QP*)@OU<;/>/=H%J>\+5S !5?B9+.&ZVZK6<=;V2W(:G
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M>BQKJEEB&WN5[TLVIB-$XJNF,\)494?E7C[55%H+_>R"UV LX],9&* %+??
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ME>B3E:=5)@=QEI#.#B4-\#NZ882-W_AT=&60')&K&8B(H;(5<"^$%3J,8 N
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MX /0NUSG@+MF&!"9;@^$S_K' !RA([Z?);%@C!H<LJ-Z#BB?@IWDL9*A7><
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M*BV/7+-.SH:9 'V<F-B+\50&*U,:N&W=2^8#CL&[OT*W3/SZ:Z>U3N2'U,+
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M:5,+)<T-&;VNB<]D38!,-6),Q?POZ59*9!B[ #%]T#(4)_*E7'*#!I@CKQ!
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M*;8Z*ZN<TGUEF,6RZ56;Z,;\[$MJS#\B\Z_ZR*F4%.:W_&>(^?_C!W@^\S\
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M_TM)TM'2U,31TMCB$:V<J;FA+>H5QB?T7S$%$0H[Y'RZ^8]T?63$KVET+EX
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MUK0-QK.LX@)62%*D;ZD];9->>TH5XI))<;KL53!X=+PC9%CE,<9=ZZ9]6IY
M%4.\68^VUQ[@I;6PSE'H3):6P!KP_H.M^>2XFO5\%=VN,6Q=2XQJZ(HM_RSG
M\$G] .&D6J1:1<KLBD&BH<C=;H_OO=[5ZB!]_Y4J@YKZN15G)& V7 H2/CV9
MNPH7A-: ";Q$JP:O#$W3QV7, A7!:P>=(5\1;',[8>X;S%XJYM S674]&E$B
M VEL.CD7-]X<TVENUYNF@%/(88=83*F#ZFI76OX(PH#G]JN-YOCA 8DI?23
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M75Z74#>EL1UEN'JR>2SOP<C[%Y\-%*)QA_)%)& 3EBA0$6:Q7(I?]ZK*3VB
M,D7-1)GHP-,XWTQ)8:(Y+K:KZ:1,*.D\>4XG$;078\4&<7K#-MCGX)BB6RA"
M\",:L8:;P7+8_TI9ZRQ;_=O G$QY IHQG:V[_B CGE-2^3)]"J;^9YJ8" D.
M4_G190/[ZSK5W6X$XO)ZI<F]4"-<AZ+6J:EB(_'F#\N[W]>';'G">$+@(8M9
M-+RC33-?$X9QX-5K.%A@+V^=I5486%G!LQ$:E2Z]2WQZQXB5+0MQ0CSN+M54
MGM 6[O9U^IF3E\V2Q>Q@KYH6G0';9VF_V];E1&AA3QEI"72]G6?Q1YUG2+9M
M"\SKBFL^=*A;F1 ^^MKY-B3C+=8K+!$_!=I7%"%2X!*OQ 1#T=1R_2&[S>73
MR+7)6Z$YA1](A J6$;VE"1N3"WI*)FH@)A,6A;&(HUW=F6A%A3=$;D[7*3<@
M'NPSK:J.]H]3GVZ&Q8R-NY=((X;VJ8^/W-2W\YIY<8A+L3;O0N#TU4NK0F2K
MHT5LX 62NU/!\-S:%*N/DP2$[VCP!K^LKO1.^SF,)?02)CBN*&0OP_)?J+P6
MR7<YV,Q.:<L.]A+(='?T?N@>I6QE-:XMS<8>;Y0BXOP#@]9E_5T(2)_GRBI-
MQ]VI58#")O@'/1?+W:&[.C$WCP"W(]BQJ ]JG9(:+.5Q<#_A?[0UYO@]2]^3
MI;T![0E\%Z'9RM-.,9NZ""80@V5=9S[O2H-7?M0P&P%>!0CUBA;MJDA-PB3D
M+\%]"DU( *9V_>[]]*.RT/K5GK.I(Z$N)FA-N."__.[^[QE-:5) XUF RB?O
M._)CUGF()]C%2=7%K$[K'>MJ:YDF;8G/=[U%@A8F%.)/&UQK$='C!:;^KFWC
MY--HBO;>DIX@!R4EB4]Z49E'^SD8IN=X&DP9[S:3E(,O_:?*/MDPQ!$4WD00
MZP<)*3J)+2T>V%?B 9UTRR!V3W@8&%O)6["=^:"@\;+LLCZ9I8Y("Y-G1^$D
M*]K7WNVAH_A7C**AA^D)ZBEF$8A#JB05)F@'^Y^.0?Z*_QT;$J[UMT?OE^S-
M?7#ND1E2I+#-I)(62S<D62EC:2G8>0OK[.CHN(E7UJK>'BBBDNNNHQQT*%T=
M<4/0]6W'(K/#Q,B+:5;AHI70B$PAQZZM8SV.9J<S[KY6C83Z$I[T]9,>O-S7
M(78/U.F9L*8+7.>OF@$\*:6>*ZV!0H[Z^^@9ZX.ZB:'"K%_8#,TCHF*X7WRQ
MGZ"Z-*K\4"N1W_A5VANO"$*]E$ZHRS#TD<J3I%>.BV]&__&Y7?J(G?*."3-#
MT[1@Q#"<MMQ1"CW\]:K_[3:O[4TD< <A>9A_^UD$:NX@@>Y3/1;!L58*DL ;
M.WL9"(K#S.!7!Z:,#$NV4R45C%_[&L"B(VO'/=IL7*7C9;(M1=8!93J!!%0'
M/B_A1SE\F13LB6XFZCDY#":H/G:F6OC'5?T(\WFV^V(T6IO5OO7)')2G<://
MA5%.\E&J#VU&<8#JM*/8'CK9>>UL'67CK." %V,6[TD @C7[N4Z^H&3AG2D6
M&0$/_WH)AG1Z&WJ;[QV,5,?GY][-T$!&@7K5 =YPM T*5:A'[=.':5;993,_
MF@QE[;N^;%/ZVM6*.R]=.FG2$.ZU(!Z-B37CKMO@.O">"G ;6Q-PJ--&I'PQ
MIHOD?M)Y=W+CT\29@6+1!^F3FG4H(=?34O%XFR^K0AS?X&3G&,X^U/O@@%HP
M[LFGYAQINUQ+.7-8S8<?S5P&#5@W;757 VB/A. 8LBDLNA5V7^"=C#16#,.M
M^V$?08''<$-B_^-/FLWXY7U4^=PIS]Z13:)1^UK?E73/PU[W<EC4@=Q[7:Y@
M3%0T.:[YS)C@,W# 8K[RZC80V?Y68;0J9S15X,'*=%<VQ^/E7^!)?_>?#H8F
MG=>1P,+],^T3X9OM"G5%0RT"GG(;/BO;7EEV_%QMU.\\TJIWU+8/020%[Q#W
MO-T0!"<#B&&_&:@F+I3HGL>3NP\.@9D23+(^A;@L"4/MQ*\QU90#7[_,7"2+
M-H1?28";KPUM=^G"Y0[H!K>VX!6*7[ZMW@D=UXP(I#]8K.J[=19GT'^,7W2F
M[;Y=<"P$#>RVB.E<>MO 27M#\UZ;.\UY\YO-C[QK>=H*1Q8F'LJ<7PS'F8P4
M5)HX]#\OENY<&1886+E.UHVL12)&[^/R>'"%!J$!K]BY!6@<4CN43Z0?1JI#
M!D%E-EE30Q>FX2"KOD4.BKE9RO#2MA#: 'W.M7<6AF&<XVSMI[E)T*!)+J6@
MH#5C9B'ISF/LOX"D__, ^[]F8J/>ME7%SZWFH,\+;@25>&!0OL:O(2=Y'*(2
M='W[-8MT&]Z+:@?EA& 6)-#$DXL$^K(1$@K[Z0B"9 .$-_B !1+JB4'<> P[
MD4H[EO&>6$4">R$;2. 0]7DC5*XLD,![<PTDD*IP%90*U_>5 &FGFH!4LV=2
M($@ J[<0"8BEGA.#V\+/)%T@YT<HH A#\*T1*:'J>_H7U5F);8Q:/0[P6^:7
MJ9RNPB0GW]9/TX<L0L[)"B#SH NL_+71&&FMSQII% [5W!;0H$W!IG_E+<K_
M-F.QO'CUE/HI;"M#TS96FLY<[69R>L3NF=KFB=6;SUF')&H,Y4*ZQ8Y@$=>+
MX2JM\4S*W'A5]8"BP 3R_@ M.C+!1L&=U\,D^"1QX)V# TF\K; W\][,3KD/
M-4IL2D.TF:!Y?YI0_[[3UH+=A;8(4V_S_+D[8M3&6M^"A'BOV>>OHDR_;:G0
M=I8:+^\FN9$%12F&\[ G42UWA1$&;5J77H,U]K\,FNWU'$>/*;?BJJN?9M&A
M&Z^:'QI'?$"PCZ,W:*?#;7A>#'CIO<ER]['ZN&U#V65I2ZV5\/1T'X7K19RW
MI57E=<L/*;.&/>HE,8C7[LQ["WE1FL,TI_2M!&Q,; O]4[)OX(A$57!9F]-1
M^P1&3/6M-T&3MYB'[,M08R"7-I*,H=+QV_.#;^3WB:+"F[(0/?6H8<D:?GDT
MMZ"M?P\)?"IM./Z."M)D]?QML%_+K,8$M<OXRS\O\-@]L3F].M>%S&4A 6QP
MB5W#:A<<<2UPII&FI+&EX91XJ0SI"A?];7U2OY4X8F$Z8:V$O%8X5UIMF*B8
M.UQV0 (^B5=,OY70]Y>@:77#WY9& BPBIY?\EPBO O#N$,0?]!L)UOZOZ>,%
M"]<P\+)4"A(PFX/TQ;1?7]CMI?]&P).8Z WQ-+B,\>KKX=S6U.[Y0242:)!#
M$*O7<=?V%B<)R5_1L&B&6>5J-TH0J9M[.#8U;\^:[_);M^^M"O6=J?7],V#C
M!9V[(X&W2$![O."S.+N >;Q^W0M5A^#^=@1JE&6G7@4B@;'T2TQ$"N0 A 3T
MRYER3^RW#(]S9E 1#NB?[\-_&P.&F^,U_CM+$-K<Z_)?NI1T9;:VWO0]SLO9
M*$ "\"[(Q<I<5Y5V4X:J?J /24:.1!4J?F6ER_L?WT'[7V)G&I0_^M3]MP&'
M0GR_>]921U#RI5T]=QU6DO# +/V'LUY%,**\8- J @T)? DZPCY$ JAQV]'J
MA 0 )- OX6+H([#FL(@$ NI>)C!!Z^BZ_^Z0!*X(4%T1$WY=B@0&;/1K]"7F
MP\^I\B#;V8C@U\>3>SP<< Z%D52%: C:!>*76QR'"G]Y,_8_Y4+>$1\.U+"T
M(BT'C?O83=C24",!J[;M/$F'DI#%'$C3-BI@0+E]1LBEGO,C/O5"8_P\%3T%
M=6AM-N+_8>^]PYILMK7Q*"@JS4*5IH*B%!&D"T1$NH!TZ4H5D [2C8* ]"8@
M2)$N+9'>B=*+]!)Z[SW4 "F_AW<?&^][SM[?;Y]OG^\ZVS]R77E@9IXU:V:M
M==]K2BBM,+(XT-X='&CP\-*B(1Q("0?"RN- .V4B.>K%TQS92JLNM4H5'%6W
M/;O3[)3C[HTW:M^B5BJ_%U@B+,':")YXC@/UP'&@<#@&&HS2@6\#DDRO >]/
MW=:$+6/%W8UC!O6BE_R=!1MU](C434:H".<)1!\$.5\)DNK\E >B,LAQYD/?
M'-N/PH$V''&@PDX<B+ 8FXH#H>-PH!5[=S78!O;>?BMX%MW^]R2&J&4-;5#V
MW7 4UO3;2/A9F.1?JNT7ZHZ%N.M'V?5^A#)_@9\#3[#W7?V$;3E@CK(T'ML)
MOLUO1%7?B5GK*C=KMGY+EV).?2.K%E"U1_6_<MT ZE/M*$(G^\5BTMS<*\B4
M\F)@90OCP*M>CQ,6#>E6J78]*LU"S742VM"Y1%*_URBDF^PUOS!IJR<[=Z1B
MQB/?;)V_';$W=,)'- 0B(BG98W]@(>$:")&U,+H:^%*BS$DJ).2^5Q335#RI
M=I\.^;G44UE,VIEM\LM+6PG4IE7T^>46A/<BB256:P>$OR)&S:Y;54P*>\[R
M$X3=;9"9OIX$O:5H 4UIMI1F/CPVGD3<?AHP"$V]_7'(UE5H->#Y?GDNRW!C
M;C4&-^P=$DWEMC^%[4W!K>9-P>IBL:'FJK&60S16VOZLOP,R,X7%PYCKYV[]
MY!";(<>%M-61"=M_G%>?.]K6Y7)@,&X L?@]A&7&//.7IYBB^:UU/4*@V*<[
MWX:2)/S'-1X9"WH;1/Y(K#%4W5Z$S(D'XLNA!C@ Q7=_?1<0V3'7^]W=J@BV
MY6LE6H8E$09<Q>*M]O1L'?8PTC')"YIF9P4%6;\P??!_@_XDVW#SZW&:2P'T
M"E3S CF"LE*%I_247LT5$A_T3[EGJ_?O!\&]' 1Q(-]E'G9"A<X3(S-UE16A
MI65A V*U6:?D_,JQEHX7(FG7N02@,E7=0Q*(8KVE_8T['P\XGMPTM]-36-H^
MV+KN-%:S$T^#2,[O'C7Q7>G2;OORCJ*=&N3BH@8-'-<R/Z!CN1-M>?[@D?>D
MUG,U1=HKMWB]M<\/E4V?"Q+LH;^*J!">!)-IC&E#3'/"ODP/7Q&_V,CK69#!
M)MHD-$>%5^64FX*:;5<H[&:*O!-5WCE5XM?S3"F<+<&^M)&U. WT#-GZA/F-
MO7[R"TNX7?&4%<H@C;,Z^_YP3HN[\$T82G=L5J4+?>>#63QEC['/PXJ+.8'I
M@PG7\0FJOH26)$RT23(S7E)GU-&)3)XPMR+D>3LVQ.',O&;RJ-:4J(V@,<!6
MZ['(.V:F_6/-ZJKTEJ:Z.U51_+FTL9]F"E=R/ !\Y?GVT!7>4-489KEA;/ 2
MU'0M+(&$"+D64EONK4VT0KV$>DAH!U%?M^@+-IC3UADL0+(4]N;ECH'8BX4"
M;N&_E GW (BS*D*(SR91LU^[Q<'"CB21.HR@F*,YP($H4U)SN4+9\<2:Q[VE
M*%Z^_21R+>)[U ^;!/>R2>YM/?1$Y3;-S6:*L'FSCA!41UHO"MJ$C9ZSL!9?
M?G#9F(5KZ%%<,@$;UTG6UM0W'X>=#PJPJPG@#6&S?DUIV5![.<?>(;VHO1P2
M1XGURME"LYM7X@<'F4NUI&(FWCGGWVH4'R3E7[466)+/74]=V8[/8FFW(BJ3
M*=<>DM&6.KY=3Y8Q?0Y1Z*#)U!<Y*!<4>C,U_;1]G MKDQ$E"V/D60%[@T#L
M.]JMR;CD18JH353?NL[@W9A8VP:S8DK%VB[.)MK;Q_D9PQO@)WWU64;E+-+G
M]G,DB=@IDN)7=P\2IK>$1LM(3P*6;/PW2\X^J12D,L5B;2W*\&Y)"_MS[-0I
MA'NW"P8CSPTIBI-/TS=^,Q/U!%0"5H(U 46 ]6#M8&U'*P !D;P=C8<#B9+W
M>J'&$AO\L1>W#TG#5O"M_XO9JS^MG\XFD$,:I[(!*(7&@?8YLZX55J@"L@7E
MXT!Z0(2?K\^.V9U83ZZ-JJW^JV.V6Z2>D W^$0@"<._SC4M#K+6'^FB<<@ @
M$2D.E,P(>P9CI$0K]]1 B(#R,X+W_I7!(R>8!*6GB.3YFO'XLA^A ZF=H]VE
M(!H'[&;I/+](NF<#>; .XJ6>BCNI]B?_FLVE&)YQ7RO]HO!GG7E%BLGUTHS0
M6RY$4U4.AE.$R3**2G'1[7!/]%V>T\L?NBPMYXI/&6LQ'4@%\#?/) ^?E&2,
M:8=W6Q5D)>0O1JI3**\0SVC?[RPB%?,&359RR*,<TC70CPNZSZ] [9=DC7J@
M7>[E$ZISS>&T%^)*%VK4F5_P)/CJ\O9RV+<\+XV1VSW.&WJVX7@(:.\-+7&R
M7S-Y:?R^)B;01#+"(F=EN"Y8K#>U:TC)7[;2]03^^]1BN[-?ONPA@_L^JG?$
MJ.06^W&SVY[$JPYQ,F^*U)EJ\O46JQ\IGK.45 ZV%'%-E\C_.-*1I:32E0^$
M@#(2.[MJR ;%WPBW^2<H^)>G3+W3FQK!2*P4,!H]FQY'-PY4M!VB^D\Y'3L;
ML.(-##!:4+LAWI^ >[8[P=]V>Q2QYB5\#J8D1YM@[('7%@@<W81PRO(G7/P+
M2)[-*1,6HJP&*F23K/^360ER(^ZAA7,Z;%#J1X:W?-\P(E+58+) 4\1&.)#V
MA4-C]#*#QLC1=*1D%D4#['] TP>-TL:!QB(/R5=>(>G>>BG 9]BQY OVZGQ]
M,_V+^[&N\::8B(^0=J]VS-XA&6)]"/ JPH2##8!718DS:$4]_D?+/.&)Z,TC
M*"F*N<I\+)XK622VAWS(J05[%PE! !3L0Z$-#T(F.8/>V*8O+:,E H#RFM$G
MR%L7QS8N1*UC[V7TD13&93O6$+22W[1 !U7[3<VGKE3X[0?OPO$^)97L7]\9
M%=UF6'M!\$2'P!,R?9L#8PW>/X^(0ABM-V ES(/W-ZTPQ*R"$58GLU5NQ88I
MS0H#E!TFM/P#GQP!_"XG ,+C"V!+?4 G+R'S5\H^P6FV^)&0&MTT.3)%W=#9
M_ZO+QD<^;MV3L#U:AX1]0+,XD 2/85^Q'WS:I@^RA(5@J'K#==$ F E#O?NK
MFUCH7ZU;825I8/OK$ PUG:N14\(7^!ZM)7P)()I;A@XK$=/Z.)"?RSNK":"F
M=KK4=[<N^@'2 /@FA#+:RV[[YS2ZABI*[B/:.!4H[O/TCZ(1V [(AL(R9/D&
M ]8OLE+ISUZMVPLKY"[_3'V=R6U.G$R]A^'6'U/6_$$/=,M=GEA,/JJIK-@:
M*5W V[?]!9^A/K-33#J+,ZV[#!B=5]]5'?]K,L$&^^NS@Q)*(>8K)'A#%.#?
MZ;%_,I!9AX6(60<O2Y_B"'=XU"+P-[OX@=P/.%!+ YI@OZ_.8![\'WM-<W7>
M8O&=2F!3X*4/@%(3VXZV)080&7IE0#N\6-5FA.HO3SP6G0OC511 L<>.7O_T
M.N\1&YZ-6 "<PJML^)(',"M+D) S=ZPA%]@[Q<GGXD.^H=9VU"^6=<30%B;@
MWL[\L$E +AUFSA\VUMNJA;UGBV5H5!6<B*IM=XE:GSK<:IC!_8>%+%=1 0;2
M"K2A:X$#):;:% ZX<0(S/V8*6P%0-#&9:#2;@D'O82#\'DF/@('Y(SQ[L1IM
MU3%5AP,1NT1S*XJ[2+[[[SS1\G<^QS85?K$AS5$60+0&#1P(M@=,60,U.==U
ME.*D[.23O[HIT(7@B!5-0@ 4-6U3!E0'8GUG**)(/=0?>V/Q"=P;*&\;=_G;
MRL<OER&U(WZR,B/U"=YD9,Q;H#A=XC]UJZFZX_J45%Y5?M^:=P));G:_.&W,
MBRCK%])Y_<]OA!@.<F[LMMT)L([H0,G/U60XL5?(65CGMEZ94BPN-72])?CI
M;D[)ULI6=M:U\65S\50>.XC8ND.ZKP/[\YU-A?![>9WC@:G=?>YAU%2TI%QV
MK_$SF(I%@W/L1%@Z$T01%YNV#G+ NT\G63.ZC 7HQ)*\C-JL[Z[HB.- =0HK
M6I5R/'3D1MT.-%3/1D<L;5CV[N=)ST8(/-8(DMEWL7N?@4+((X3N%P^V^RC-
M-A.>R"O(TVH(;B+<?51"K<\U_!@OP:R>?D!F0]-EWQEPAM$%&/_ I&UL!1Q:
M[^G$(*]W<F!1C1<1TSJD09,U89+QV:.=:>6K%G5C@U[B]//-_7^(^K)JRIA6
M&; $$=]\",!.@PO_5ACB9^=2T57)<4B=>:(PU@H8?'5ZC@E)2]))H[+K216;
M7=]"IP .1 UII.?87P5O44"OE5O]_%0IQ+?>SDR.O@MH,F56H/*[@RG-@C3*
MZ]7LG4G7YD)%KREA:=T/S?C:'[?YZD35,.Q10\%+K? M;BAO.8<W>..V-@3Q
M'C)OJ@SV\EUV.8P]*=\CW9%077F\ @>JQ8$V. %T\QF\=4[GD5[@/JT3? *F
M? T(^U*;Q_^[ER[8;R8PWJ,M8^7R5F$.$T#?>6B_4-7</7-*,?+N&%>PC3K[
MM$3W5T<KVD\G3L@O<]'2<R(^HBLSR7V:NA,L>HZE4#N</]Y/1W:F)3IF(RFU
ML+3LW?V@S(:TY<V],X9O#$)#RS(N34('[K-O7Y=M/?V0C^(\$:FE:Z]6KG^I
MM8K'M$?VJ4L)9N6+8FJ!C1^3_)+N'9DZI#%N1VE/'U(='238CH&T SSF8I[Y
MF$]U\'F]"W^Y2-8A\B?6<P'%!S08B, X@;$!095Y%0%Z2 5E8O1AHO?MPG?%
M_%@G@;[XB1*QP$\7,@3T &5#5OXH=]2I91X!%&5_W-C6ZH?%#XZ=3_+;]YS]
M6]=8#6JJ*'O<Y.Q8'IW2]Q@1&QX9;F3T'H%4K+J0D&:,(^MN2(OK!'':/I<0
M)D^WF6C5'-,45.B/=T6?W&"7BGO#R$BO\=A)8#)SS'2WS*BSJ">'.3\6]$#]
M'/>S8_/6$D^5%(Q)V"W]>E116\*:.NR%UPO*$9\>2I=I.7(2T3(D4&',O$ZG
M?^+NFQ G4SY7.@'>(Y0%HC0I]G5AOSK#KX^J'*_WLAM0.! 38&5FSE_^='.=
MB6ZTKLDCM7E79_6AO1> ]U<76'E_D11= ?D,R7FF=G@7$0?#.L.2%OF PKBD
MOQ_V-K;L$"3_6%'_CP\^'P0Y \;86<UHYSBH__ANIS9"'T\X 00S-0*G;R&P
MR_1;.DQ5F!4K&OH"_+6W>168"R=AR*N+AZ3X]E\NPFU5LF+O]NEM?P&,2]=4
M-RH5TGBQ!5O"C/5@#:9<3RXF0'*- "#9>>$;<J/%@0+@TZ24&$>&?4+U"SK%
M/S_IQM.@3,+]L)< !]!E1SN: V!, 0CI-$N<=B]\FIEC NVE#*5V>["; 2$1
M.4RAA]_](WO:,A&,#D P;,^.[5]4I_G%:60D5-?N'&)\J-)W:SCB%'1?_;R\
M"<WFJ,>0".FM(S+" >6G.+_Z#WT"4?W7S$1CQ9&$_TDCM-'"?O["1O X6*\3
MZ*VNZ?(/ *[^%@W I7?,F K(BF#76^&4G@>+"F$W);,4]6YTZL"5L+OCMNY6
M!^F];]6;[16W.=9>'-N&KR:H'?Y;L@=>B2+HPX'*W#7$W=+%&0Y+,VAA%[:-
MR#?BR-QE#\9>_F5=  S2?9L8!*TB1X&-N5,65I+.Y#\N_]+@6:N9D/3E\#V,
M"E)'4=(\PY]PC2^:!FBP?@E;P0"0$4G= 5T)#E1ZAC>6"GAQL_UWM_RON +R
M'\AQP G5"EIEUB1[QGNX%]S>9SF2DKT7L[#2/BN*-A<,G?N/C3<[.JPU??'G
MK"@77"AX="0LN$;-705BLR=DP>]/<YZM>SDHI7TA@M8!*EF'/<4GPGW1Y/6S
MW:\QAH[JSR'FI#L2>$3O1_*L>=>EA?;5$Q0U) *2;UI:0"8J6HTTN8(Y;B8@
M0K>N1;!93 82:K]ZN9Y"?W'#*,II0_])"++88F\HM&=J*#A^/BDS@L%X%-X'
MGY73'.UD!^> #R]K'?X\O)Z ]DK%@:" DNYI+K,&'WG.C*IVZS- 0\( XRP4
M&O\3@[@->P"[G<UJ+UR1M8*&'Z*:V)W6P._(@P$ F5'!*-+M'+_E]'7&NCH(
M-3!.@,WDD%@?:>LX#1RUD8 M+=Z JI5E_?A>FF49K'!B_1/0-%[%/[_0YZ)[
M6-R<8W\\8?\4C/L(!6KP1RD.>:*B+0\I_-8WT$4"J=?;(/#'E@=C3F3Y0H=^
M?H(I$*-O-]5!S@)B+0@$6:D!J"86[K-!+@\U^\9^$$15UUQ[X#X,AQQ=^L,?
M,/J7[$'@+PY'I7U"WY7^</O8C>_0_F>' KL+ R/!Z !U\#HI@)W4**=>^-!S
MH,Q[F@ ==0E]_A9=_YF#7Q7I4U;H+^"5*1S(%)'UBZ>9KX&00W1(W"37HV<
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M:!@HB^)*PZ=*)*CM'2+P 4##VK-R@=_\ !@?,9*1/\'L:,J,P)\K<^"ZB:!
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MI%)W)M_P6D.SCP,9.5A. S?G>YU$---B4Q8.8GV=L3+<D+*A+L$\U%YU$Y:
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M(/4VQ7H(N6=J&$^=\)/(CMK$RZY[]-_N^S7%RSKO#IF&.QM!B0#2*#. X*M
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M&DJ=9EXS@I(RP26G2^AQ% T[RLB+COLHJ5.F^'_=Y\66ZNX[_>L"'VLHY$Z
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M@_='RE# 9!3*'EU#KC$YM;/"-K?=YZO)M(,,^T*=QB6;!7#3+$=%+^KU>__
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M9 NW0B*_5B%[4B$?4A?8Y*#DMGTQ#QO@?W3:54V?5DX>,V:&KN>>KY7KRC>
ME\/YWHS]N0 <Y"M(%PN/_WV#D,[?.76MQ,IA '/L<(_BE#LW&7U2_ZB=,U'E
MA:?RA"'3)S=IY\,["'^(OO./GEXV&A,+R,J1_#@[70H[5J0>IY["=GA[;G(Y
MTD,K_+N_0^*/2(^X7E;E\8V!Z?)J<2=DG,FYM2(Q\[-C/_"A=[?8W<7^^;X0
MP3&ME_$QD.%B0;'E.<Z]%N*-IT*\(TO6%)(U;MDE)YNYM47YX,S@V2"N1CE
M47R9V'Q.J EKBH3W8;# [*ESUJWYL=OH $%RUR'#E7H)73SE.'F9Q:; )78"
MR<9U!_PFR%"%0'S%<<A".O=UQ)'[$ T$6#&(T#%9X!'T+_-X&3?VH>\ 6G(,
M,;*HS]*[X"(2,WZ+5L+7-N%^\O 3,ZSN1? %%B:8:@4V6;K/W6TA=O(V62F
M(CU#.$R_/K[\,6N0;^7QD_+7NGG6W\RJ_EF@<3$6D"^V!CTC0>D#7U/<S>@N
M<>GV+[P3?6F.I0"):BR)V!PA^A]F!H5*E$P_MZG)?Q3&%^VZCM A3$HJM\[E
M?_=OO)M9[9\#P:!JFW">716+9'J:%<!WWXN(^TM-_I]X;5L(8S.\F68L6O(3
MD?MVB4=GV>1%AD058"&#:ERH'?[ )-4W-KB+V_(H,5@IX_GBTT';KYUI_ _;
MD[B^@Y/AWI.$6:*\3A_EMQ?L["^&2P'65Z)3#MW1N]P\#_VP#&AN9<FJZ3^
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M\:2]'L)AD[#3_JIBNDCU35?:+#K?N%M9G\+(R5C$ERY1=(B6#\LS4#(/S5Q
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M$:H*0N6*0K454U3J4N)8J#QS FYPSWJ:?C0TV"#-#/L1*\? M(U+-7"6;P.
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M4-)T.X/=>%6)MAY-,:;<OAP3WL%X@G\ O:M:.)=52T>B!L&T5,0X/O78D[I
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M=KN8V$D(=)!=QG28B968^X2I-H)FH#2%KKRQ=@T)_K$J^.>Y*G 6#XGEK03
M"$<GP=VBJ4_L0&2@PZIZGG+R;O^5XD,0N"J&9R5IM!F0^L1H"V"=&&4-1A<\
MOB?(7)LULW1'8 UD:#D\M*OEICE;6>;W5BO=UPJK6"O%KPW)<A#EA-NQ.HD+
M7V84S$@J5)D^5AU#.[T8..-YI!3Q'6HHJ*=TAR:&'[*M#M[F_#7*4"L28IJ"
MQ>Q[4MN9=B.8_T*VW4OZ>3+!1//"A50)K$!51X7E?@MD@8Q^MZ!+JEW0!C\"
M-\5NE_7[<:0:&AL/=[^Q\I?9Q1^%05?6<4BM5G\V%MB$<55HHA1<C:)B/24T
MJ.-)])KFSR^8#1SWNAJSP*-\SFLI[-<K8?N2A4W9UGPCQ(G;WPA]$DS?*3:V
M+C@Z"4DY7-]^<'=U>+%4MD[JUE1]Z7-!+F,C#O2Z_I/5/#A1:S5O7ROB3/V8
M67/6-,+55 O[!P"K%IFN27QBY**[T5.>L=XJ1PU=007_Y=Y>,A-$\($,G7?G
M/F/5PF)=Z&-DYVGY,B:US?%WL:ZIGPX/J)'.]JB.;AW*RXZ-@NJ!]Z9F??"_
MFR[.+"?$:?SB5.\9A8:6'UL&VV'-!\?2M"JWSK!)!S.]&*E*2DG;#ZS9QI>U
M['O6R+ZBY&'J"+M89\EW:+^X2+A^ZWS_*"SN\:#F4* =S\DQ0J$5\5)!%'>8
M;9$=C\YO]]-XM1\()FZNXNM%96-,8%O@* @)_HD+0(G338O:_@? &ZYZ%.=V
M,3V^46+2X,U!K:H#8 X9]MCT /@X,.@0\%;R3L^=K"ZL ?PG6)(*:536E\;N
M1/5T@ N9J&ZRVIYKA)?NGM/RF*)VF*.3"N-2!67EN#'9G.KJ#_#LGL%B<1*=
MG56$IH:V!L"[5@RVT&F)'GW. -;7Z#3HE/R=9P<RI%<Q]DO,[/Q-WTHKAC-T
MQK:FIN:\RTO$&_XJ4&-: N$ 9:2_[]12X*#TR QV)#CTI]H+G/EU/G_O:')T
MB\%S7@.U!+D2#6%B:W]?$TG_3WKJ9[82WDG&0#OSU!<\-3![=[H^*,/F?S6
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M,KY_IG7-(\R1*Y"=K*;X"+1BC3H7E(BW^](ZS[V=@-;\HV>4R[6>[=U%M[9
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M[J^ <4]1<E9BVM@ -?3P3@GA2D]G5[?ZAH)AU,][C538:>CV#S+J*H!!_]U
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MX&N%+EO!HY!&Z8_RH4O=6D,P[I3&UHOU+WX9GLS"U^\;E;9]5"F(8V9WX 6
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M/BG+CD<7?$L@XN5?12N5BD0@C*&/(?!-N58%?Y OVWTS2M /F C2IQ%9V30
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MGA7!1,VCBS3[A_A7FQ?Z#L5^8,4-8K0ME M1 +4=<KPJ*X(L_ICC$7M@GA,
MVT!Q10$6ESZ?#I$C&+Y)?SS<)V4.1R*GUQG;D<&?*#0ZOD!;;5S8-P99FRG!
MW[\O9U? $@GZ,9!V?3_DI:=WH]YA6MT8MT4PNVXL7M@D8^^0 ?^J11]YH!V9
M7KAYD$E.[M$5!CBBUS=3@#]$>0.[8N]PA<J?],X\!7$]>5*9JX@Q>!'7#Y8
M-A>543'4HY*B) =?;*:\CDNZ:)>RC@P@!6JF"+;'%,W&W-=T]^ADIV2N'OTQ
MC8[>:7=5NM @"9*$Y5@']X,I#XAMXNVA8F[(A)['4^JTIK$*5QK8PZGXO\OA
MZ:\>(8+POYN=W+?IP*896O^M(9_-SJ\Z<L1NC)<&)([R)E5GQ"K3^DTD_]F[
MKQ\TJ.=G[F.9DA"VX:IN&-]FHZXG@K[OUWD@G0H ];0GGR)3M!5)F/[/?VS^
M:?]N&\/\XQEEY'UR#6O!GVH+3M>]C(49O.HNY]B;NA%D96J$;NKUU8RQHB!L
M58/5/?MCN/='?)8<>W.&Y.EDK;CA\^U5_S'1>&E@54GJ5W:*S,K1]=S4]C'?
MG:Y-A<',3,AOZ.M5\Y."-<]U*D86O\]66MG,,.KFM)1O(P"\UI5%X2F/";9U
MACA&9DOR.%W6_9GQ$?9V9F]SV7_XZ3AH[] ><Z0EN"*MAG-T(_\%#"Z#%:4*
M6UZ'V!(<:"+Y_KFGN!3E:+$!R^U@)\/S#%Q?'YM 8:U9E/HU*9)O+?:F^9VW
M^J![D#\F.Y:-TZJC(UKZWE+RN&RJ78NN6*3W;I+7Z10,A.K4GY&3')RI*P86
MGODJ'=(V3&!.!'\!5EK>+'TMX,F6N5BJP.%F_U!4;J/K+Z&#*+,)>3+PK6);
M?_CL%LNF)7RL1%B;):YFYC43?9(J-G\;<>1&14G"+3,_XCB@YT?E!DJ%O?"R
ML ;E>"9VQ:_2 9P*K(.(U+DF66H0S[3(28<J=KI U-7(^OY5P9<?39&#'@/N
M D*S"Y\ZPPFN^'FRF@'(FM+7>V+,2-G!D-#Z6J%@M@_QQF&E+=WYO\_'K%0[
M,RP,--J_8JY8]B<(\V)Q30<Z]B\'J?U6CO7BXGB25DTSS%;I63JLJF&QMAL6
MX]3<EI5Z^E!R88/'X6-C]HCL%%;M<%)==2P^--?9U01>"2K,BE!ARO1[5:-,
M7TR8%L[/%Z)UN5Q:X@C1*#WC4R[=,F\];VM:<TTW6_>* _\$< AKO1FTV4GB
MFY_3G6&X+DY?@+)4&!F/%>=]$O,BO='GTLCG)A6903Q?/+*+4 >%[B#EWREK
M7I)6.E7[!1S>#/8$_XC>!6/;%S48;1FMZ<N/'GQ['0E(UY]I/.R*>WLS*J9]
M]-MU(._C>W'RB,$KU%G&# X62OM?2RLH4ZP*7=^G-[-H>/VK,VA1H0O/3(4G
M;F?:B0KR7U5M@]IL&)#4B,%,#!L4%&$#/!^4^,Q*B<7!EN-)$H.?7_VXTDS(
M")@N+-GLN$$-WU/A(D*\0GF'VJ^R)BLC\LVS^\<:=FGMH^5=" HD.JJ4OS'J
M3>+&WK2#, G;) 75P,4 3D*4J\EV4:8 GI[_Y%\ KG>6QG;F+JXP26=W2[>-
M!D7X\#(<F1')C?=;HI*8Z(R0RQ[\OM2W\M3D2^==I^F&(X&C<"U>?B]P@MB*
M!0>G/.#;,.8O357Z) #BN.H>C/?.TYS\LO4PNL9)/+^P)K@39**7K5+42C!$
MQ8[Z2\FXD\?GY-1?R.I2\K\ZF-JDU57*4C]BZ"8988L#+,VH>CKDH[TIA%IR
M-\@!U(8?%;4$-L2TQSX^Z@*7;X6;EI\5L#?Z+Z?LO.W*?TGK78EZIR^5!#]7
M[)"0<VVC>2(^TSA2QOM%!6L-JCU0;@@?&VSU*N/P8-O2.4F('8MNB4.J+G[:
MEY6S-'@4?RF ;_[Y\U)9<6K.Q/IR<][4"W(V$ 650ZSF5 BSUJ*M2B\59*K.
M%[LOMYHKY9S<?>N ==767A!2S_55XC#T^81$PM2L"(YV&=$7(EYE*2EBSW_Q
M'M_R QIU_ECP#JL#LC9;?=(2>)+,L8M2!(P<^'=%OTGLFF2COV=0+,!X-'[F
M@O_RFLA3TU"?;,_V^$DT2#;I,21K[@X.2!L3[>VEP27NR#&@8^^>1E^ =_]I
MR4;%&/1?@,JX71L/MK&SVJ\9O_-0F=1OJ"%C($MX8(B*3(X4FA*1?QELN<)M
M7+ ,N[@@!8E"*RG0M&W<W^"1J*"\^G)AFM]Q5E%VQ,JMET2F><D-*=NP%U"L
M/T' 6#-^>S&TE ^&1B*M/_Q1SJ1#J9]:8 *12Y.>$IQT>E>NG!\("PNL,DV4
M9F*"\VT2*'[X<HMP(^10<:&>)\2Z]V R9DUD_.C?^]*?@A3+VRY(!&V'P7N$
M=6Y_ 5=7$T$CZ^6[/ .U.MA8WYNNB E:$>FT69]'-#F;2AS'J%,C>! ;3"D>
M1K3M)-MSZC"5H)@C8'^3S$ QW+K:U/4)8W7H4=&0CGMVW1 %I4Q\+]QSR@H8
M)+EHD:;-ICLW*7*_?/_37I#AWIM @ 19@(\*TP>GVW/4=LBWY4,Y,W5%WV5Y
MY-[E3#0>^)/QG@.S1TQ"JA+UD8W]Y-"' !?)M+.P@K)'[NN%@9_PZBE+;JC,
MO0.(*=3$N?W:V%B?%G2@HN]LJZT**_EOY$HG1\:3W@;A5ZFC%9V*WW5O=()J
MVGX'E6NQZTYJ1!X@?]SBE0N#6.R#\<GC_Q\,KZNWHK0_=CJM-FU8S:/OH#G>
MW+FKB;_@NOKHCQ:9AJ- 6Z)O;9PY'RDDZ%(9]U#H42(:10;8]!J%35K,G84?
MM*<?VLS]_%VH)=,&4>K367U#/UNV-D8D!?Y^^Z2*G4IM%Q7TNLH^8*AV$]%L
M&XC;DT[ZE2%9TSY>D8+%J#$KZCS?K^^6A"LY@J?V%N-R\[ E4YKNB;/-O9=+
MV/079TU<HO!U"7L;$F;)_YPTI3.LTGKN 1_#A9Q<"8]_UY7O*G:^C#4'BNZ%
M]UD*,($.E;B?GXLEY(\2K'./SZ2)@X&#R[^+MC$M204<'@P.:8;M;;RL2!YP
MH_>'W39>)U 3SLVIYVW!Q]O$<)GZ1'P\CJ].8?VG!MEX/\_W2?/UBO?Y*M,?
M4AGTF-TJT\:FO&^U5<>ZA\% --VEO?9,A9ZDX3>?.@/]2<D1Z-:^[#[1-(NY
M=K Z;16[))XO4'5/UYKJX^QP]0H_FY-^]:YJ4ZP5_U=$(FO4(;SZF-_=U &J
MUI *!Y/-Z>+[#B@/UP:9.9UX4-N4NTL0A$@  "]P&.W;8Y)\O=7-&+<"DQ[T
M8)K8OT14];RZ)&GY3)95?ZN>8]>A&&@Q6Z,>BVG-BG=S@T/K?F-QI:,.Q]7T
MK+:_**ZQ^@OX:*;MG0[F2AUF5D5'#YH11+-!<1%[6JU_7P&J*^XRQE%GC]FW
MSYF*W!O3#5?:X9<BMZ']GBU5C/?./P\1N>L%#J2B09WY"R!1.SWQ9=G7[KW\
M%;>ZDX6"MV<GJ\*\0^$BZ/IZ?: ""#MND@3MLOUX>J<#%)Q"V4>$JJG5A.X0
M/:F@7HSM!X#L-LY@MOD=ML4;6TK9B8\^D+;]YDBT;U>S%K2: @EX]O?)#1V&
MGE->,Z^<?'S$G<&/'KN*\U!%SXIX,1=XAK%5YN2J/DR>8K83;/;UP -+R#$$
MY\QGSF%AW3Y-9>&Q^,DET(CM2W 25XX/T?3WCNG=UVYCG[50?T?:G9K<9Q5O
MKIJ<&J;VN5=,[9N\\S QO 7XT,S(I::-%L-4NR-2F=W%,;Z4-"[#-0SE%NOJ
MN(0H$* [A>K&EL&DGX>_6)VK4P[48BZ!DCN'$*BR9:5,@J1(Y<DRKC])CJFR
M])JVY \^$OVD7?YB# DYZ= 5;47U')<#CY(:__PT>*+OD\Q -M=+AD6!W&+D
MQ!FC48(O8?A!'&#+PE\$T/<5SRA#$F7V<49ND4>(YO6@.+7VQJD)\?P830G8
MW^I0C.DM([HDAS4Y6T*2>^[R5G*]0_:S(?_Q2NJ6LI/;\CS4'\;\ 0MP*^/G
MP2]U)I^3T[WZ53_)\51*8:C3["4]I$2K>-7,9,)5P%Q22R!3I]@B3OD#NF>&
MV"@ SX./*7JH<D?_LN">UM5@YDG2<=L^_CQ'V/FF#7'C"<G+_[BU)WK8C1RG
M9G LK9NT J5B>^8 FI').9]2"KJIEZDS 'Y=6A2R?=\,+V\C7QII700]H_@D
M6[(L5_OC) O50E/WU?F8*WQM=2J[*-@0Y=0[ANIZ0C2>&O.NG%S>V.WP]L5/
MUUQ68EP<>VS_*QI9W<ACM"&X!3&U?P%P9&NXANI?0 .]+52_O66,=:VP_]"]
M( =W_4"Z@Z0>+[[V,7.$X#'"L"U-OG6!B[5MX?M-<<;^V!ND(U#7W@=B0'7&
MOLW5D"^QKF=PY'@2\.-\JPH4H]9(SK/B,>KZ?MF(P;AGBJK2ZXV8?JQ/N(=G
MV@K%B5Z=X%B])'81;/O1Y/KT98G)" X\OMB:US,K4A#T.-#;J['-P4#<D:QK
MJV<57N>Z1#K@#US0CH_?E7;W+ M1S[QI-V#UYYO^Y(:H*E2F*G#<3VI=^S<=
M?!<=C/[; 98<W^XW21_.W)O ]%(H#7$VHZBEV8_5\5X-+>03L]T8_S5*K9I?
M$I?V0A@A7>#KZ0H/(3#Z. [*5BU9(7(JFI.^N\Y6M9$G*^@QE&A,(%(NF3,)
M5%)FE%P>4;X2+J"+XD&T1 3\!BV=9&_-@6H/KP\,8.?A<GC7(URM/^(E<Y>X
M! 9>WK:T7N8:]M"!8#X07W\Q"#1RT&UT_H+-DT<L4]1LF_TH2@*C>I'Q5"!H
M.<?VAI3OK2O+,Y1(263/03)X8Q^'VB+N\]S]RX\RZICKRF>A^I'"56-(Y$%G
M^T*0IC?Y85*@<XN,D[]QFE<$A?QWE'!-.0#.M^W^WU!2\4XC/VX_VXXKKIYB
MBMCSA6"H2V)";&=B<FC@&&+U[O?,BM"%P$  \%3\8-_')T8^BXZ-^1:  PX.
M+:M2+R)CE!P%;JI6;9QB:$+3!AK.9JI^I7!50_+H$*N_RO9Y/QQ[]&B[5)&'
M<[0\QMO]RZ2PVQOF;M=:L7-B&9$8P<RKI(H>JJF+UMA)_![*Y&.4B?"/^,*U
M?RI@I-^\\7G5[YOMZ'*@(:3/=M*_JDW^95=%#H:4&;6>-+5Y3:X9#OBO9"K9
M0C&84S $<Q$+"MI-OJ*;;"J++(\1]:<%JV3B@@%E.3A\6QUMG."Z/T-?/)KM
M#C4#S\]ZIT&947?QB3(#!B;E4<\9EQL>I8.-$ZBIIWR_N CCZ$VIU:\;B;Y0
M>YJG.WF27.2*&,ST4.P9,SD3=JB,BDK>"G'QV ^DTRK^WY8>JYN 'Q:$E#^*
M/,D8+[ N'*I7EUT?@%DWP)K7;]%%+.=ZQ?I&I1HT84XPFWS&X%<2H]NZ2=L7
M/,X=G*G[.&FS'LJH1[E[)(7ORF!+J%89(UAPH%E@'R7OY;S]Z].V-I?=X1?8
M(;%R8MXW+(7.IO1I+'WG)"4M$J'AQ%H':>'H(8/E^"JAY7S.5@X)9:--8Z"'
M*MFW/B.;=(8LOSZ*$[-:XHY-A+09IT< ;7+%EA_L9JASJ')A2YUEX8+31-&?
M*4;%+%_^2]VA,P')-Z1MYC"@^N5T>?FS[.*K&NN!YID_U:3D-F9-Y/L:W6XA
MRW9ENQ*'72:55:=MXJSI[O_MN,#6UEE_?4JY+/X-]@-XJ (\E07^^1/S<\?+
M("V0 1W>]J;12*G0]VR*VNAO3X.YZ.F:HNNCU$^>1MG$YKP+TE0#\"X>;"WT
M,AVCGA5_7Q>NPBV$;P&WLF?H0&AN]FVU_UYG:]PN^C;Q* T5JJW*J.23WM=?
MMZV1$\M' D6/TF;8*O."9_@$CKQ A[:K_MDAFIZ)\'+.J1YA]R[1_H;>85[_
MJ@:3TX)+",);9*XN32--+6G(%:?AG!NLR@ JTGA2<<.8R+T#>)I%DDC.:%\7
MS]0&$4%>."$]E!K+L65&6T+PUK0/=F2^=/V[J*E%B4@LS0_QWJ\$NNIG[]J%
MSL1<0%9^\V^W4#I5-OC,2P2=QY5=.E )9.GCYHNB61_0J)R)M155E>@2;H$%
M!(]*#^\;_,"[KES% GQZXZ/UX;+,=BX"$49DTA17HM 5VK662JLKDDXNV)1@
M_/W;=_*,UOUT0CZA;D%-*I)U?O]<E8Z#42;QM)WY94GF-HY+$%>Y9I%".;8H
M2SL;:A4:6@SJ_1%@F;44ODUZ*M[3''3?R9ZG_([2ZLTBRR\JK\3VE[T4R7FI
M>SL4'[)9^[*R6=$R_Z9'Y%\NH+J?7O@X9SK">6@EEZ?<1L Q4CU)'7+R=%LF
M=GTW9=WLXV>[0D>3D7"@\MS\R$Q*?\D4DQP1.W\CC,3T+P 3*1!E)2G \<V1
M[WLQ_1IWRK^ B/+%9W52"'?D=R<NKG"3&;NJ1@Z4XF;T. 7L7#J^/BHR4=UA
M/F/83!A4@24ZQNL/U1/=>>?=5S[1U/U0X]&4F)A$$G+R4<7>48X9\_1_OD*?
M\I]#[:G?*7B] 3QS,YXJF?D#*9:SE)R'-OSB5VJJTT?N.9"V\T$-H+8X=0C
MB+W%U;QW(IMW7= UHH4?@HUPH6-$@Y,Q) ^%F"5O;<5&9\1H2O\]%374%3=Y
M(7W2C#T+0;;E#D?OG4((WK-$J2*8E>6M8_%VF.BM)T3[)"#X74D@<[^/@XG2
M/6T%:XFNNT8$9K$(9B[KMU_D#R65GPY@2(!?-GMM?C_?E%^0=V@?&KZ@7KTV
M]LO1:DA6%^ZLRW(M7U>7N@U_1U IBT!EMHEF ^0K2>Q[2[/,>YNYPI?NDU$-
MW$]%,I36TA%T8PE-%VQ^R>XHS,E?[=9KO;[J>#H'5=PX)6/YU?DL \]A_'G*
M<O&J<G^*>4;'J<EDVD^>EO?^I)Z-*%0>PX9^]I\EOA*M,=1I7S 9C.H(8?%E
MRP"&9+;O4._9C^TEM2YJ*^18CB>+_+A4CA&JKC1XD>*&P4"X@O-7FZI\QB30
MWB$<-0I? .;HZ,Q\:?NET,5,I.MYK:0,/!'OVMU%[Z0T?'INO(D&P:!3?;V#
M(V-ZE!2,]V]%BD\EST9D>M<^*@&QNX!4.5GI. VJG+'8!*=#[^)OZA5:>T=%
MG7WJM(-H=G^</U$%3HP*J1LA7&P*-'XL'GK9;[MF),ND=WK+4U^DNBE$BL%P
M X2(O\*HXNRR'*11KTAJ/K]NZ='@A1VW&9+Z$BD$L_XBU<?J0(H&A'[?R2^G
MV&,=3M[!CL>E-!-WQ7U4M06^Y0II88C]DAE:-W?(.%PF-9 QF#@M>Y9ZW/*?
M1644*T [#JB+=@VDK?08QOJ$Z_3)M:2;M((8N<B!T#0\X"V&BWCNBDBE']40
MD;%6R0F$4KM9_'AI!]H!5F"/X,TJM@^'QUBM6NS1(T5.*Y=JJ^>5NU]7&]T$
M&_9)LQ4\J<UHYJ@"G;H]:,RXC\ Z9RV#[S\1M.\,:P9-*_U#37SVQS";!4D%
MP9^%?AZ_F!?S[Z5,_*[\"7QO7EU<3Q_B&''\BD!QI>/&]U>4L;^P]&#*O1*.
MKW2D' ZK.$&?'2O=5&4J76@*;Y*_L@'I@D4B( E[%#1.K];[*&<70% )?Z&O
MV4+Y93R%/<:F9OR<6Q[#<^?K>2,NEW\!OGD=];)%X!RU@8/W1Y(?X95WJ\ZN
M@M4QM=Z)K'L7!OS3D;M<+1'4H00^O*+,'J),93B-L+. _@G777).SAI:MB3U
M0([,=J?$4[THGT3A-ZB72,Q[AP""]46=0Y^&B\K^=3_/H<Z0+S-?SNN\EIM4
MI,=<JR<X"^SC<-L/ 3G&2Q[??X52HS-5+;>5[DQ(%$3S^VD.96,2S5FTI>2V
MN'SCZV!JMS68J:@#QP6=FU;T+7A= #4O8Z-TG0)KW]=R#0@F$O,(Y+:1<Q 4
MB])QNQ7'[7,%,>P^:=#UW<<[%*F\4+F=C^A\P[IZK<3WDN3SY_SA)#G@%O9&
MUYY:5_0I!/L4-A(/O\*(VV^-/B=4Q\NS+!]',-P0<();AK3C"[X!2.03/#0U
M[#?]@FN@8I7&QTI.\?'M"8Y"4CJ[^JB)'5N'\NVHN4AC**<BQ__#_DLOR"WM
M/#J4^P7<J,W>8<<[V8-8XA"^X+4,020;^J$,B72@)<J?%P%#21&X^\X%D007
M*6S:P:Y+8&LLN:F0^[//.T4+X00T370 6C,X0.W-82!V.AJQMLX';45BP/^5
M##/]ZB;>N<8M%! X^,):6V"8K%ODK%UHS\LHA*P^EWA4 /0CAABV12=./T\-
M6E;Q1_7DB]=D8)LGTR[A$-^)S6::EY_F 3>&6!Y--G7^D"A)_HD]+FY\LA,(
MY$$8ALJG+K0$72&]VJAV^7</(]VZ*!X%W;DT@X=E\;:2)D)?39(BJ[;L><\R
MYS\:;ZQJ,8.5F?@@Z47>V_SA<I)\&#A*ALGV1=6P)G]\LDS9J<-HW*VT*HVB
M9 (-H=+4Y@Z_G4;[5[LJ_2EQMFR8.P0U2L@9*-#'B+(U2/\?H$:\VI-:/!9#
M4TM;DX!SV@0'Z:"BA)O/3BCRW>B0]U<=;RJ'>\K$-$DP-H>Z%HF?2S";TC+G
MA>Z[KBAWIS)3^8;1=??(-R3,GXSQW+!^J3*35/E0FM<[?7<DY;6O=R]78$F!
M@A<T\X>!3UYL,_'GTV[ GP+^RLYAH_N-).>WNO?A^Y)=P(5;ZZ(UV/%GLJYX
MY0(]?M-?G8J3J>L0\+;X&@$6!< CW\BZRXG0V)PF"3&_TIOAZ9 ]"^(Q['Z=
MY=4QDD;E/T'(K-S"S9R<>AUV3+RW5E$,<[#87SZBN\)X%Q4LO3[H9M3G7OGX
M6;_G"]311&4ABVGLSC3UN$_+\>A9$0YJ"]#=6-U4L [VE-IJILTI'_+Z"[#_
MBJX$9DV28ZS<Z%A5D0 FM1Z;1"7:56FY<AWGO4Q[--9.QE)YX,]0-AB+XY%3
M=JMJE$3M^?B5QTI*$7?B9B2C9]:8KRF4;+(D'MQG/!C26H9L]L<V3[0=M_LF
M$'S[8+V>6@W'%5[1?0SG:36CT\E:46ZZ/EH2?$I)W7P']-?EOS"@>XMJ#1[T
M,.DV^0=Y6/^^80=:^K[OO8,G\F1JCQM;&-P](DF[UW*A_:'RN*A)\'_;E/E_
MH\JJ[LD J?75"6H1#NP6'57:.P.4<$,FF?=Q$/U6*G]$RT1\H&IQN(.UC2I+
MPFB5RK!:E,[G+.+E'?^,Y-TIGP6-R[;ZJL<P5XMEP:[X^-7L::F,'CU:N]PB
M7NJ=T#IL N-'K/XXMJ%\GN9YJ-Q?P&L[N^B!QM,V\':?RPW#!CS'AD%;!&U4
M9W[O@#DWO>XOH._E5>-E701NFESYAEEMY[I6(%I<[\.;8NQ#CZ$DP+0F_O<3
MW9!^##AR&'ZDET:QZ,?S8S>9JVU+H&?_$X7'^'INWD5=.5GB,P/+0]P=!AGI
M@R$11M(:HP$VV3@@)JC<G8Z/$T,)%6PU!]6M/U4M.PF(:N(J[UZZPS86(N?:
MDT?%\5&D;+=%^P'#<ROQ^&QYC"$[!Z,2S5%MY%NEAC&TO0<6& U+?QP@,9-D
M@K>WK'D]/LN4LGR=9@:O.1<3=N$E&+I@T;9*7K55!-4<F=\8-EY]BBPU?2Q$
M%$$;>M0KBR'AO"Q?1MIDA?/J4*/=F.L,$4F*GC">&*!9^Z-WU;8CX=8T\Z+B
MY$ES5>\?>0#2>A* Y.3UHYU<1V-;<\><X$DM" ^T YX75M%Z>J5$=EDB33[[
M?CF-YK4F_UK(2/4?L-1LT'J/0G)FOM^(Y&PY58BYY?B,\#S4>#?V9W)FC>#]
MRF_<Z6('KH,6)IR$'!NCHKYW#$DD^SXO]YCTL"[QQ)6H()0*1UC+PX-X5+VE
MV]!NG%!,"Q$1 6.2V OC=NANUZ=+GB_?+*%<107?(.)!9EJZ#P&YK_*>V>!K
M7%P@FUG!-D@SY_)L:ZXM/:?'$#IOAV2NM^"OO3D,#C$@]J:7T\IGDNZ5GU0Z
MZHN=4<=]+A2WUR5'R/3EA[I4U#9\NBEX'*Y#L.ZEQ.7H,M@FC:3CP[9MX&7<
M,+42@D0AO&OCNW8[;7F$">6G+'_<YY7?W9O=F^O?HX0A;;S,[LB:O-/[C6QI
M71C8O7VL!R]YME5KW?F5=JZ!SOMDX8<LJ5083.R]$>$".OMU$A*TZO _)C_?
M+W+OM*Q UW[ A9W4%_6_9.V!A0#M,+7<825#^VF$:&^GI'7M! LBMOSL@^E6
M >%8.=?2X&S_Y3N&K=CTR$4!<?'PN3:WB174 +IG)G'\>^!)P6JV[RJSQ4^'
M>Y7G,@L :AFORBOH7L-M*2WU''HZZS=!D*3#=3J_27"Z9#D'Y-]I]U;WD<MD
M.?T9LEG3)H3>)<PI\?N$TZ[$F=UB<>J>""DW3:K*..FD8X^% >ISF!:&"QY'
MZ&5^;0AZ/+R6X5G1ESA[<VIOPI^Q=W[00)D]QD2J(Q5"W6[ETTZ^YUIEY' ?
M8/;5)\"VA-2G\<B&] ISCE]5] . @KF@LBH1GH=V^ZOFX[N%[/E=:\GEPWD!
M:K#[3=,>6CMUOE^ECDGB4%8^[F(KC9;&$E>K>K)TL,2'["$>L)""6P4Z,PQ]
MMK=1-RRA<,>K7KPQ[O='O&-'H;4C:-K0=61@29("'G.GV9/>6Y:VM!LB?E$
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MZ^'#ON(;RRY%'/T5#U[8)*^2GR@3=9BAMYGR$X^64WI35X_%>+RK'>DOZF8
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MMI6(@Z<D6*/N[.P[Y%,L"9G1:86/7R\/K[Q?C+S5T2K:&'S@YM?<SPX1^"E
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MR7&.;XA@MT2SCM;V&$6FJKKHIY0H?\_*\_;2<?VE/P0E]M+&YF&VRDJ&]=\
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M45W0Q$==F:SJ(L:QANU80]O+YZ$7\E/P4GPYR-4CB7B+@:'I6^*UJRG\TU(
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M!8:@HHXA7/R*Q@^FY_10T?U)V9D-U;:OIW!OI3M%2GMFVR1)("7_T$-D@/
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M<;<LQXIR+J3#\^%AV4H2X]T2X&O8"[;R?>J. <]/0EE5WQLO2.P&+-@HH_?
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M8,!SR/@LP0BZT>U!&;INKVQ"OU S$SY6IWR\90J? 9TH _&DRAMGEP X/(9
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M/TY5(?C&8L EP$^GJC0JIQKK<>L2$$$1&,US5I-WRE^T7S@!3"(0B0!#7<.
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M-W_AGF!UHF/M9>#75^9*;).B=96<[!*0FF9PO"2M$$YMHE\<1A^9]WNIIA?
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M8LYK ;!*4[(9*R.E8;X\Q[HYTK2T_J4%*)1=+>7@>[ \Z,*._8/J%?2:R5L
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M91G?RI\;"PX5<>_]O6:9 SG!K_[/:_"\K&>VMA8M39#I<<84CS0&AZQ^<V$
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M79$\X\>%"%U)_[O/[C+EJ)^G!47/!D0?.)J9NCFYKQ5N]\:WK4'9M:#<./H
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M(_:6*;>E:AKT>?F&6C=A2WC\G9A7VL9%%EX+F!#T<D;.3N3<\I#I^S.,KX^
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M1V>]6^/N4H&>6]129DK:-B$/T>B^U^<,:8R:CIZ[BG,2V+X8+3 !JV>^%C<
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M]WIXI$I!_J[G]G>:A&?C+^;[LIX15E.43\&2FA D1Y$O&VA'J!J/?<=+U[1
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M\])":.,<FDR&/*'&(.Y3<.[P\;0C4%/M^WRZM<6UK%)"3UKW)^_AM(I W.0
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M7_96=H'GIQXCL3OGI" CTC.?+8[%G=AU:&S=!7=6RE#RK]X/)9&!ODS@'S$
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MPK:5VB$!]"X/4.Y#K5C2O#)CW$J;TC0/I'5ILRV(]P.>\;,O9OF8-E1;37,
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MR=]"-2<%+E0&JS "76_.DU=*3<[^1E"CUT,VM<2<1O%]O9B/)P+@$:ZB4;?
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MUI^-%7TGT[^ ?A?RNY#?A?PNY'<AOPOY7<C_+2%_ ;P6CFB4ZXF&LZAIX"&
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MO^*S"#W;IS!U&22@9!5>N /_J=HOFOW7% OZ'VGV9\7^HM<4< ,3 [UXF*0
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M+37;5+6IT/8SH>:2TSED>^9.OSI]C+;+O"!%T-(BZ+3S$'8'IA=\)8.NDOW
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MJ91>.5,?2V<C7_HNCT>HJ]^3MQV2ZU#E>[@GC=GFHQ8NG#WB1K<.XX$@WAU
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M&0II";(KP1K7AW'<"-T:$&WTK*9"G#+>X"N2/BW8()\K=G(_CP597+^MJXM
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M-Q!-Q*G!FD3**':O^[NVF3GT'U!+ P04    " #A@8-1FXMS\\9F  #,G0
M$P   &UD="TR,#(P,3 S,%]G-RYJ<&?L>@547$NV:!,@! O!@DN00'#7A@Y)
M\.#NP8*[-6XA. 0($ CN! NN08([P=T:]T8;:W[GSMRQ/_/^O#?WS?MKO;M[
M[=5U3E?7KJKMN^IN^FX9\$A&0EH"@(2$!'B#^ #N5A[!Q<$6;P$ .3D $P
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M1\1$:* >7=X8K [CWKPXFD@,Y[4RJ363%4XJ,TTJZ>O;"2'I)\2^>?UPCYT
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M%V\>1'DCFUG<G.SK'5'[B?6(/"@;3MYKHH6J=*9AF8_)C:=Y\D#V-$QZ'XH
M&)CO $@T]69!< D[<LD3*DN$%UDNBUXDA3Z+FM*Y X127+\Q<AMXZ)T#H9)
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MB-<K4W:S-[#HG-C BV_!M=^LY%.^R/1T59N/1O.$5B_A6R]8Y37K9 \(>^)
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MK:W3=Y"EB)2@3A?4"G)&CM/D)\);>#TZ+^AFFW,'2&-,6-7*CJ2SSI&M)@
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M6%M_JU/<M(T(2&BI<I+G^OCQY Z_H_VCU&)Y[E:!ITW?P];3\/#F7E80[\3
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MXS#XLIZ?Q!G@]D@+W2$B<(\"0<5QT^& V$+,E8@IW6\B3PPL;T6]WCSTVAQ
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M7+F)O5&ZO?O">Z..#^ M8?";YP(LS^]@"DMLN^#W[&ZP%R)-J=69-&L;T\X
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MD'K55ND+WPOW[D5WB1&'+:?+21];CMAOHQ4F_"BGOX<?2O.?HA4'X5:TF*#
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M6K56K5U[K>[>=_-WJ\#C%_)*\@ *"@I@=O\![F"/;^5\[6T 0$4%8 ,  !-
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MD4O& @;UXTMBO;XU+^/H_>(.41W-1R<ATU0>*&=>Q-O!#^"-'; \\GT/XSO
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M&0(5+HZLE>A^3& 5P^'PM:N*.@R5?'#4L0$!*]X]#?1%!#^K:7QC:OP]T[Q
M\^+UM0P7;?([YW4,D+L4=5YR.Z-O?)<D<1LG;%_Q;/!LQ'N+[-VP*W,.IKV.
M</<CH;13*^HV?XIS@]\+ZR8?7$G[N*.RG.-NPN>-9'%D?F"VW0^'4H>*G31/
MI9T7Z>!)"Q7N6Z:8LGHO4!RN-/OHF1_//J.4D%ZJ*J-Y6MJ1%*W4*U,A7^^3
M]<Y@4!-\K.>&7KNM?49C;:RG,3+JVYL7Y"0VVS^2O<&:EWPB9#C@^(YF1Q6A
MK2V!4QHR$SEIY/,'[E(D+-69('3SM9#8=IR9AAS1^F;DRZSF#]?!)[>*A\XR
MGWD2"<R=Y,*[*;_OIWROI(UKT=(-J:<-D[)J_#K]L5'8QQO#4G'9W'AO/?L
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M')XL^;DIL4&C1#39/Z8G2S2E&.-^ZQ'V/EXT&*8:'RI83Q7"J2JR>JR 1FL
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M]:F^C=2;$V3Z#/$0^_6)!P<YAF7"YN+Z#X# (,R)K&Z[4$.)C8^:M)F;F7>
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M7] =YLTU.X#P*!KK@EI !(7K,E*3ZAIV[P-6WFRH.6/S&T;VP/9E:V4*^+9
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MA0S:5H$T7DE0<O]ZH5>Y-DPN&_+LMM5DB>4SZ?K94ED<D1JW<9Y,E=Q/]&E
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M639.4C;:% V,CFR]S62<EWA1_+*Z#F]C8Z;#E@+Z6LWWEP YS<<41>I"][:
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M?1O?)<$!,1Y\4_YJC5'/ZJOJJN:([SWGRKWJS%FPQWWY87386(QG-/(LOGH
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MIU=(DX4:YYJ0N/_82/]_7Q#_Z/SOBD(-.G]3F\#DAPJSI_\AYGZ3.?Z^=OB
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M1QTDCYD?:88U)91]O(\"W18?+1O$=U2Q!V'@J+,3$WL7/2RGO)?:U(M+?\_
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M2X(DB>Q!P U* )O\4[H.J]B6MB7PHIAM$N,!=?%"K1FSEJ4H\9;EIW1?@M@
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M;ZT<+X 5,]:1^RX:DV*8^L6E.YTR-\%@[4=C=5I9:DPKL7$)!U"@O.K1::!
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M^BZN^T>H01?#(,,"TTLS=&[;11U^.=OCW*WCP&7 ,>RAG3,Z*F"M!<^LL]<
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MU^M/O[6BGXI@[]P!R.$:Q2LP>Z6:22Z-!.KZ6"4U$1 I_L,*,;30?"OI@V@
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MZG8]-1YZ8ZRFA1HV4%R'N(CH'77D;< !<].!N11T@]$4\&"W#'6"PHA:FG<
M8SDK_%<^^.;A:AU 1$I*WFV^4L-F6)BM(51XM&-6F+A%3_C:0L?RW1;*![8$
M[GQ$)$-I>B=)?J-$P ^XRIHLUF.0_K7^=$B([/.+NE#CK]%XJFYQE%C%+L47
M/4OZ':.=/+7D.%7^HUW''ROB] R]0W$SWGXK(ZM'QQIL#-YO>5D2O8)Z=@>
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M3A#V!$P7WX562(:IPU+C0J"N),$NW;_U=#G\ Y6\#:M:L_V<.?PMK+4()F^
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M!-9B19.\TNN8JUE8<=EJ3 >_U0(K#V'Y9--%IMI5&I7:+O56:C11 MFIN^7
MG'Q,T1Z<2+.7#V"T.M6"98CS*>RN@GXUU2D9R3E/0?"HMF[M]JV*GY8W(B"Z
M2RY#&TDAT! 7+7RH6;HAT'>]*!;0\K\P=/E?3T?52.IF< JA<?MMO]1D88P0
MEK .GT0:FO ]FMI?B9$CJ ;KC[PZ^_."T#BYJRO[Q:2WR'I*F7&N=<&.\L9#
M>A.^[WAH@__0E?_?@_Z$>)#)%8CI2:JF?<G!M_#5AX3/PK2?^J=BJ1$#=@)N
MBDHHCV3BBPBSTEO^I':EC)-A57)> )?-0"G:32?W)NY3M#WG9QI5(B/B>J!
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MU!K$Y\VGVJJ)Y]O1(V+4.&6M&/CR$'7,VR]UA]1MP$J;J[H?+X*23>J<>BA
M(D6P"JL'/\]D:9Q/&"00[*K;\1WM410/C=DH27C"]H7L44_F13N?.%2MF_,<
M&.MK473U\8D7HCR&/;P348F>"S/$T8&!OIB.:^4Y84+?8([F#B+-G?A.PL%9
MUQ,ZFM9[PIXIV2WR.^\X(P*%P*E8 LAR*5:ZI)"WPY5N;L743.JQZ R]'>$$
MWPNJEU.FB=D^ECR8[C@D@O]G-\]\04^C2"LP\QZD9/=U>&GJ*->)/LRFGX4J
M0FJI%C/UF3ZR0^:<Q"QS;3$SQOY:!^#Z?[KD_G_^KP?O;N5? %!+ P04
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M%?^^J=;NO9VG6&H[RW]F"SCR![5IRO9"W9<ER\[M)1K5MP6$3^TM0(L :"
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M7</U+V-LQP6>D1N9'';2WH 6/]!*O#.-ME+[#*ZWALAO(/WE:2<.FK?&X3A
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M6\8*[APNH52F3!$8I9FV/"-M=#*2!E"D+*4\933+G%JA'D\Q-_;927@%SYP
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ML=XO) )FDLLDU39(RIW*UQ]/,3>Z,3*9SZDPIQ?Y3E17Q^,1DK9>QFOPF>)
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M7+]#YOD MQ_?O#?&;=$&GK@Y$3RNJYU?8>*UFH;5:J7 "ZVV$2V-2^$&&-V
M4:ZN'R)ON@X'XX9XJ>0-8+6:)@S&GP_"/_8^W1(>I9O44^$?U4/GQ0@S#/L*
MO C;OUV)UJFY=W/NG(P)YXHS4WXR"21$H5YNPC(& TX0"DA*L%LS(NN9YV8"
MODPZ,>Z&K2>XXQRV<#A>N1YVY#P*RB-SKR^ G=G4&2R?9&D_^:1<Z(S)(=6Y
M#^"MA-+^96&""ZQY"LJ :0O5E-(E66KRE'E,4) JG.$A#:Q/338WOCI5U6<X
M0?7";,=)OL ;F88&X^:C_-&H5-,[WVN7.+I(*%;WN)_NO,WUC];UZ='FJ?7.
MA'%&DS BD(HXAHC''+(H2B%F3. P44F861V"GQE_;DRQ%1'4,MH[Y4]!=_GL
MXTI QCYK?H'%9:>6%2CV9Q!7@C/1Z8(K2$XG!CT0])P%G+IK,B]_C\A=_WW?
M96[$)62^>+=:FW;6CW2YW%+C(E.,282TJ9-@!1%2FL)0@F 6!(ED&9(IL[)W
MSHP_-^)J1 2UC& KI-VK>@[!?O[R@,O(_.4&B?6+>4'QGE0.?6=CH>B_'!HF
MYT:=Y,6]H-+VQ;UTV< D:VV\%,M<U$3]2?^-/]_);^N?M&!_++*$\U@D,<PP
MT^9'F@00)RF'),F$PF&84N14.K%OLKF]TB]D=<RW[L/4;HOB"ZF17_(78MZ
M1E#P>_M?(S&H1?:9EFV!C-<$[;[YIDW5MM#\*&G;YIXKSN\^/LE2C[VZ;]S'
M;53 ;W*]D(S$D0@#&%&4:3,@)I#%.()I1),H8$FJHGC F=S9">=WSM8<X11;
M@8%L9+T!*]OH+TNH'8[)KH-ORJ.OG:2[8Z]6V.]OP&\]  X[PKJ(B_=CJ?,S
M3G_4=%'[D\='E^^:KD=(4X@TX"%!&$LH)<<0<1Q#FC$%21@3E=$ X\"Q8,1
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M(\V+UQ5BO/=O*RLH:V&-:^])7]#$!#IZ]9P6PG97[!G<R4(#C=B@E1L8(6_
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MQF<K]0VX;^1NWC7Z0O1MNR/7*LY6RV!YQ.0=W+$/C;:XMB+7L+X4&KR[ .N
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M,M/)7.@]NHJTP1OPD&,69DEHU='STD1S(]*F,.FJE1'06LBA+<P/,+7;9OM
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M !Q+T+FQTDX?\,M2J?$K>- !D?E*&3!MI=O!0?&CS;89T\UA#D>FRJ]WGVY
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M4]@+*:8^138?_MF1YO;Q:]$ S8LB_TL9$):)D.?Q-/O^G: T,@?4$42-D-K
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M!*J1[ZI: I]6=9#\5WGFEJUSTE_$^M B_/^X>],FMW$L7?BO(&*VJ@BA+A>
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MN\]S]?UAN=C</UBZL;2S>L^*Y5_9;*.FN9*QT!F#),FL\T@32#46D. LBHA
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MWP@W4IUN/X=>W1M79G7%J8Y',[!SMOZE[??]?WMVP^FJ>C:OH W$:;&H,@Q
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M'4?(9@=[32U\#9@:>1S==)^!?5600;56#GO%;5X2$NO0&TP755; ;UO[0>O
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M%+U":;155"EM+D$0094MT.>9:4CX0I_>GI#S0-E 2BE;R*Y31^D#W0LKHKA
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M2/P"<]*^2D+2!,/@J^.)#E[.GJ(3_:$;*9ZH NL9CA!L%M5AI"'ZZF32O'I
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MT*_Z6#OC?MIG/#WXOL]=>^HC[W;*!_/3O_]#^R_F#\Y*]>__\/\ 4$L#!!0
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M9^V$#=$Y-IH(=D2;\B _8LM'M-;P$#F(8!(H)0QXSQB@98%9SGTHX5" B#V
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MC44A$=M Y5YJ1A[VW0(RQTN] U_H-A,OIK-S,E\3IID3M<BH2"0V>%80N&)
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M'B^=+YXW]86- =F\J_:H6>)ZNMSXT=M"E3<S,BW?I'!M2S;:<6)>.U%3[EC
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MED_;()GC6;(F<V2^1]BXX5*S5.^@^N@ 7]^I"7OY9=L?^=EJA?1??A^^3'3
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MRQ U)'MHKO<:DM_"\B*3=G15R)U/&K3.XW$Z3URYD;@G9\PZ8"E%4+0=U\#
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MVH>@DVA2/O0\61-W!?:"R1%UUP$2?UU<X.S3_/Z8;3Q>3OD452UVS<6#8DF
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M*4X %TH'R;1FIDDN9W<2.RQ1&B=N:J2ECO%W%J/A/E0A15-7^/H,SNH(1<3
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M6!T3;B.K:6_@?<.+N!@)>K_\>4FQZ=5L^?EZ8UCEXN80">\]1@R09.W!"L5
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M=BDW&/*=$R]8'T/!6[,-(TJ[@_ON,6^OPW*V_$"TA/QN_K!GBI]9= FCQOI
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M;]'1M-0=_E:;GJ7WG >+D#"1=?;601"900@YH4XB>W<$?ZR#[=K'PM-@J7>
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MJ]1JKT$)0G#NM6+8 NB;R9D6I+V 97..Y1#-=8F_FZ1!0%Z\"77C&/E\2I@
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M>[NLL>N:(A8B'%]^PL_3%&9_A/EEJ=WTZP]_"VDZFZZ_746T.3GI4P',NHX
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MPI.[X$ANUK&839-CA2%F+C7K*CLB%H?45Q_[\^^?OX3ILLJS!C3$2:*E1AL
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M^W:VNQ_4CQA6^#__QW\#4$L#!!0    ( .&!@U'G#L@PZ <  (@G   7
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M9F]R;6%N8RYH=&U02P$"% ,4    " #A@8-1AW)O.C)?  !,: , &@
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M 0 0              "  3&A!0!M9'0M,C R,#$P,S N>'-D4$L! A0#%
M  @ X8&#49G_'F],-   EC," !0              ( !WKH% &UD="TR,#(P
M,3 S,%]C86PN>&UL4$L! A0#%     @ X8&#42&0!):QG0  <-P& !0
M         ( !7.\% &UD="TR,#(P,3 S,%]D968N>&UL4$L! A0#%     @
MX8&#4051/X;OL0  M-P  !,              ( !/XT& &UD="TR,#(P,3 S
M,%]G,2YJ<&=02P$"% ,4    " #A@8-1LE9]@JU[ 0!U @( $P
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M9'0M,C R,#$P,S!?9S8N:G!G4$L! A0#%     @ X8&#49N+<_/&9@  S)T
M !,              ( !<4P* &UD="TR,#(P,3 S,%]G-RYJ<&=02P$"% ,4
M    " #A@8-1Q*Y7C7[E  #E: $ $P              @ %HLPH ;61T+3(P
M,C Q,#,P7V<X+FIP9U!+ 0(4 Q0    ( .&!@U%$GS1F&EH! &P%#@ 4
M          "  1>9"P!M9'0M,C R,#$P,S!?;&%B+GAM;%!+ 0(4 Q0    (
M .&!@U&AH/0" ]   *^("0 4              "  6/S# !M9'0M,C R,#$P
M,S!?<')E+GAM;%!+ 0(4 Q0    ( .&!@U'G#L@PZ <  (@G   7
M      "  9C##0!M9'0M,C R,7$R,3!Q>&5X,S$Q+FAT;5!+ 0(4 Q0    (
M .&!@U'P3P:-^P<  *0H   7              "  ;7+#0!M9'0M,C R,7$R
M,3!Q>&5X,S$R+FAT;5!+ 0(4 Q0    ( .&!@U&JUBPF700  #P2   7
M          "  >73#0!M9'0M,C R,7$R,3!Q>&5X,S(Q+FAT;5!+ 0(4 Q0
M   ( .&!@U&U8?] =P0  -\2   7              "  7?8#0!M9'0M,C R
F,7$R,3!Q>&5X,S(R+FAT;5!+!08     %@ 6 , %   CW0T    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
